LGND-USA,PGNX-USA,ILMN-USA,SPPI-USA,ENDP-USA,ARWR-USA,BDSI-USA,TECH-USA,REGN-USA,SIGA-USA,OPK-USA,IONS-USA,BMRN-USA,ALXN-USA,NBIX-USA,SGEN-USA,IMMU-USA,BIIB-USA,IMGN-USA,BCRX-USA,GILD-USA,ARNA-USA,MYL-USA,CGEN-USA,AKRX-USA,AMGN-USA,MYGN-USA,LXRX-USA,MGTX-USA,INSM-USA,AUPH-USA,INO-USA,NKTR-USA,RIGL-USA,GERN-USA,AERI-USA,AMRN-USA,INCY-USA,UTHR-USA,SRPT-USA,ALKS-USA,CERS-USA,AMAG-USA,ARQL-USA,LMNX-USA,SGMO-USA,EXEL-USA,SNY-USA,VRTX-USA,ALLO-USA,ASND-USA,BLUE-USA,ACAD-USA,AFMD-USA,PTGX-USA,PRQR-USA,TXMD-USA,ZGNX-USA,ALLK-USA,OMER-USA,RVNC-USA,XON-USA,IRWD-USA,ADVM-USA,RARE-USA,AGLE-USA,NSTG-USA,PDLI-USA,SYRS-USA,RDUS-USA,ASMB-USA,ANIP-USA,ENTA-USA,ALNY-USA,WVE-USA,AKCA-USA,MRTX-USA,PCRX-USA,RTRX-USA,PACB-USA,EDIT-USA,CHMA-USA,MGNX-USA,BPMC-USA,AKBA-USA,EIGR-USA,MNTA-USA,PRTA-USA,ZLAB-USA,SAGE-USA,CTMX-USA,GMAB-USA,VNDA-USA,MEDP-USA,CBAY-USA,INVA-USA,CCXI-USA,HALO-USA,CBPO-USA,MNKD-USA,URGN-USA,CYTK-USA,ESPR-USA,AMRS-USA,PTCT-USA,ACHN-USA,SYNH-USA,FOLD-USA,EGRX-USA,DCPH-USA,ADMA-USA,GWPH-USA,EPZM-USA,JAZZ-USA,MYOK-USA,GRFS-USA,GLPG-USA,PTLA-USA,VCYT-USA,DRNA-USA,CLLS-USA,CARA-USA,FLXN-USA,QURE-USA,AGIO-USA,IOVA-USA,ANAB-USA,XLRN-USA,FATE-USA,HZNP-USA,CSTL-USA,ICPT-USA,KPTI-USA,GLYC-USA,XNCR-USA,ITCI-USA,TBPH-USA,NVCR-USA,ARDX-USA,AMPH-USA,ATRA-USA,RCKT-USA,DERM-USA,FOMX-USA,PRAH-USA,SUPN-USA,FGEN-USA,PBYI-USA,CHRS-USA,CRBP-USA,BOLD-USA,COLL-USA,XBIT-USA,MCRB-USA,AIMT-USA,GBT-USA,RGNX-USA,KURA-USA,APLS-USA,AXSM-USA,VYGR-USA,BGNE-USA,RARX-USA,RETA-USA,HCM-USA,NTLA-USA,ACIU-USA,CRSP-USA,GTHX-USA,ARGX-USA,RUBY-USA,ATNX-USA,PETQ-USA,RYTM-USA,OPTN-USA,TORC-USA,DNLI-USA,QTRX-USA,SLDB-USA,EOLS-USA,FIXX-USA,EYPT-USA,SRRK-USA,UBX-USA,AXNX-USA,TCDA-USA,EIDX-USA,AVRO-USA,MGTA-USA,XERS-USA,AUTL-USA,FTSV-USA,TBIO-USA,MRNA-USA,PRNB-USA,ARVN-USA,YMAB-USA,KOD-USA,GRTS-USA,GH-USA,OSMT-USA,NGM-USA,TWST-USA,ORTX-USA,GOSS-USA,ALEC-USA,DTIL-USA,TPTX-USA,PRVL-USA,AKRO-USA,BCEL-USA,PSNL-USA,STOK-USA,BBIO-USA,ADPT-USA,KRTX-USA
 9/23/2019 53220K50 GNW  Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medicine Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer, 3/13/2020 PGNX-US  GNW  PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS, 9/24/2019 45232710    GNW  Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx," 3/02/2020 SPPI-US  GNW  The Rosen Law Firm P.A. and Bronstein Gewirtz & Grossman, LLC Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Spectrum Pharmaceuticals, Inc. -- SPPI", 6/18/2019 G3040110 GNW  Nevakar Enters $50 Million Product Financing Agreement with NovaQuest Capital for Continued Development of Injectable Products," 3/18/2020 AMC-US   GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Mammoth Energy, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm", 3/12/2020 BDSI-US  GNW  BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 Results, 3/28/2019 09073M10 GNW  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling, 4/14/2020 09X7JK-E GNW  Kymab announces that the US Patent Trial and Appeal Board rejects  requests for invalidation filed by Regeneron, 4/03/2020 MTEC.XX10-US GNW  SIGA Announces Award of First International Contract for Oral TPOXXÂ® with Purchase by the Canadian Department of National Defence, 8:00a     OPK-US   GNW  Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020, 4/21/2020 AKCA-US  GNW  Akcea Therapeutics to Hold First Quarter 2020 Financial Results Webcast,"12/07/2018 09061G10    GNW  Analysis: Positioning to Benefit within BioMarin Pharmaceutical, Ritchie Bros. Auctioneers, ADTRAN, Aspen Technology, AMC Entertainment, and Halliburton â€” Research Highlights Growth, Revenue, and Consolidated Results",12/19/2019 01535110 GNW  Achillion Shareholders Approve Agreement to be Acquired by Alexion, 1/13/2020 64125C10 GNW  Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update,"10/31/2018 81257810 GNW  New Research: Key Drivers of Growth for Covanta Holding, Seattle Genetics, DSW, Canada Goose, Oaktree Capital Group, and Arthur J. Gallagher â€” Factors of Influence, Major Initiatives and Sustained Production", 4/07/2020 IMMU-US  GNW  CORRECTION - FDA GRANTS FAST TRACK DESIGNATION TO SACITUZUMAB GOVITECAN FOR LOCALLY-ADVANCED OR METASTATIC UROTHELIAL CANCER," 4/20/2020 BIIB-US   GNW  Biogen Releases 2019 Corporate Responsibility Report Demonstrating Continuous Progress Across Environmental, Social and Governance Metrics"," 5/29/2019 45253H10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN", 7:00a     BCRX-US  GNW  BioCryst to Report First Quarter 2020 Financial Results on May 6,12/11/2019 GILD-US  GNW  Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of YescartaÂ® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma,11/14/2019 0JF15C-E GNW  Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative Colitis Patients in Asia," 2/03/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL, OPRA, WBK INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",#N/A, 2/26/2020 AKRX-US  GNW  Akorn Provides Fourth Quarter and Full Year 2019 Results," 2/26/2020 AMGN-US  GNW  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis", 4/20/2020 MYGN-US  GNW  Myriad Genetics Announces Publication of a Meta-Analysis Demonstrating the Clinical Utility of the GeneSightÂ® Psychotropic Test in People with Major Depressive Disorder," 4/07/2020 LXRX-US  GNW  LEXICON PHARMACEUTICALS TO HOST VIRTUAL ANNUAL MEETING OF STOCKHOLDERS ON APRIL 23, 2020", 3/11/2020 MGTX-US  GNW  MeiraGTx Reports Full Year 2019 Financial Results,12/04/2018 INSM-US  GNW  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),"11/27/2018 05156V10 GNW  Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results"," 4/21/2020 AAN-US    GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AAN, BDX, FLR and INO", 1/29/2020 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Nektar TherapeuticsÂ  - NKTR," 8/31/2018 76655960 GNW  New Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, Hertz Global, and ACADIA Pharmaceuticals â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 4/08/2020 GERN-US  GNW  Geron to Present at Needham Virtual Healthcare Conference," 3/01/2019 00771V10 GNW  New Research Coverage Highlights Micron Technology, Varian Medical, St. Joe, Himax Technologies, Aerie Pharmaceuticals, and Hexcel â€” Consolidated Revenues, Company Growth, and Expectations for 2019"," 4/08/2020 AMRN-US  GNW  Amarin to Host Conference Call on April 13, 2020 to Provide Preliminary First Quarter 2020 Results and Operational Update", 1/13/2020 BCT-CA   GNW  BriaCell Provides Update on Remarkable Responder,11/04/2019 UTHR-US  GNW  MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics, 3/31/2020 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/30/2019 BIIB-US  GNW  Biogen and Alkermes Announce FDA Approval of VUMERITYâ„¢ (diroximel fumarate) for Multiple Sclerosis,"11/12/2018 15708510 GNW  Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus â€” Future Expectations, Projections Moving into 2018", 4/16/2020 AMAG-US  GNW  AMAG Pharmaceuticals Provides COVID-19 Company Update,"12/28/2019 04269E10 GNW  THOR, ARQL, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts","10/18/2018 55027E10 GNW  Market Trends Toward New Normal in LSC Communications, Corindus Vascular Robotics, Sprouts Farmers Market, Luminex, ChromaDex, and CareDx â€” Emerging Consolidated Expectations, Analyst Ratings"," 8/23/2018 80067710 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Aurora Cannabis, Canopy Growth, MobileIron, Sangamo Therapeutics, BioDelivery Sciences International, and First Solar â€” New Research Emphasizes Economic Growth"," 8/23/2018 30161Q10 GNW  Recent Analysis Shows KB Home, Sleep Number, Exelixis, Sprint, PayPal, and Halozyme Therapeutics Market Influences â€” Renewed Outlook, Key Drivers of Growth", 4/17/2020 SAN-FR   GNW  Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis, 1/07/2020 VRTX-US  GNW  Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc., 4/01/2020 ALLO-US  GNW  Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences, 4/19/2020 ASND-US  GNW  Ascendis Pharma A/S Announces Top-line Data from Fixed Dose Portion of Phase 2 Trial Demonstrating Potential of TransConâ„¢ PTH as a Replacement Therapy for Hypoparathyroidism," 4/16/2019 09609G10 GNW  Consolidated Research: 2019 Summary Expectations for Nokia, bluebird bio, Verastem, Twilio, Logitech International S.A, and Rapid7 â€” Fundamental Analysis, Key Performance Indications", 1/11/2019 00422510 GNW  Glancy Prongay & Murray LLP Announces Investigation On Behalf Of ACADIA Pharmaceuticals Inc. Investors (ACAD)," 4/16/2020 AFMD-US  GNW  Affimed Announces First Patient Successfully Dosed in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung and Other Cancers","11/09/2018 74366E10 GNW  New Research Coverage Highlights American Public Education, Protagonist Therapeutics, TravelCenters of America, Five Prime Therapeutics, Red Robin Gourmet Burgers, and Hemisphere Media Group â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 3/31/2020 PRQR-US  GNW  ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update," 3/05/2019 88338N10 GNW  Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson â€” Fundamental Analysis, Key Performance Indications"," 4/20/2020 ZGNX-US  GNW  Zogenix Appoints Shawnte Mitchell as Executive Vice President, General Counsel & Secretary", 4/21/2020 ALLK-US  GNW  Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 DDW Annual Meeting, 2/03/2020 68214310 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER, 2/11/2019 76133010 GNW  CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors,#N/A,"11/12/2018 46333X10 GNW  Research Report Identifies Ironwood Pharmaceuticals, The AES, Accuray, Ball, Park Hotels & Resorts, and NeoGenomics with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement"," 4/20/2020 ADVM-US  GNW  Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Scott Whitcup, M.D. to Board of Directors", 3/31/2020 RARE-US   GNW  Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology, 4/08/2020 AGLE-US  GNW  Aeglea BioTherapeutics Announces Approval of Clinical Trial Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177), 2/06/2020 JNCE-US  GNW  Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies," 4/09/2019 69329Y10 GNW  New Research: Key Drivers of Growth for PDL BioPharma, Teekay LNG Partners, Atlantic Power, Chaparral Energy, Encore Capital Group, and Universal Electronics â€” Factors of Influence, Major Initiatives and Sustained Production",12/18/2019 87184Q10 GNW  GBT Secures $150 Million Non-Dilutive Term Loan Financing," 4/20/2020 RDUS-US  GNW  Radius Health to Announce First Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday May 7, 2020", 4/06/2020 ASMB-US  GNW  Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy,"11/12/2018 00182C10 GNW  Research Report Identifies Canopy Growth, MSG Networks, ANI Pharmaceuticals, Mistras Group, Rowan Companies, and Chemours with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement","10/26/2018 29251M10 GNW  Report: Developing Opportunities within Assured Guaranty, Potbelly, Enanta Pharmaceuticals, Seagate Technology, Ctrip.com International, and CyberArk Software â€” Future Expectations, Projections Moving into 2018", 7/02/2019 02043Q10 GNW  Arbutus Sells Part of its ONPATTROâ„¢ (patisiran) Royalty Interest to OMERS, 3/02/2020 WVE-US   GNW  Wave Life Sciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update, 4/21/2020 AKCA-US  GNW  Akcea Therapeutics to Hold First Quarter 2020 Financial Results Webcast,12/13/2019 6160-HK  GNW  BeiGene Announces Clinical Data on Investigational Anti-PD-1 Antibody Tislelizumab in Combination with Sitravatinib at European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress 2019, 3/09/2020 PCRX-US  GNW  Pacira BioSciences to Present at the 2020 Barclays Global Healthcare Conference," 4/09/2020 RTRX-US  GNW  Retrophin Appoints Suzanne L. Bruhn, Ph.D. to Board of Directors", 4/20/2020 PACB-US  GNW  inqaba biotec acquires the first PacBio Sequel II System in Africa, 3/04/2020 AGN-US   GNW  Allergan and Editas Medicine Announce Dosing of First Patient in Landmark Phase 1/2 Clinical Trial of CRISPR Medicine AGN-151587 (EDIT-101) for the Treatment of LCA10, 4/08/2020 CHMA-US  GNW  Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners, 3/04/2020 MGNX-US  GNW  MacroGenics Announces Departure of Chief Medical Officer," 3/01/2019 09627Y10 GNW  Market Trends Toward New Normal in ITT, Palo Alto Networks, Enterprise Products Partners, Blueprint Medicines, Lincoln Electric, and NewMarket â€” Emerging Consolidated Expectations, Analyst Ratings",12/11/2018 AKBA-US  GNW  Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia Therapeutics," 9/01/2016 EIGR-US  GNW  Eiger BioPharmaceuticals to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016", 4/02/2020 MNTA-US  GNW  Momenta Provides Corporate Update Amid COVID-19 Pandemic, 9:15a     PRTA-US  GNW  Update on Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinsonâ€™s Disease, 4/16/2020 ZLAB-US  GNW  Zai Lab Announces Chinaâ€™s NMPA Grants Priority Review to the sNDA for ZEJULA (Niraparib) for First-Line Ovarian Cancer Maintenance Treatment,"12/11/2019 78667J10 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics, Inc. (SAGE) Investors With 100K+ Losses to Contact Its Attorneys, Securities Fraud Investigation Opened", 3/30/2020 CTMX-US  GNW  CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 PartnershipÂ and Provides Update on Impact of COVID-19 on Clinical Stage Pipeline, 4/14/2020 0CPNB1-E GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for First Quarter of 2020," 7/16/2019 92165910 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Vanda Pharmaceuticals Inc. â€“ VNDA","11/01/2018 58506Q10 GNW  Detailed Research: Economic Perspectives on Watsco, T-Mobile US, Medpace, eHealth, AllianceBernstein Holding, and Limelight Networks â€” What Drives Growth in Today's Competitive Landscape", 3/12/2020 CBAY-US  GNW  CymaBay Reports Fourth Quarter and Fiscal Year End 2019 Financial Results and Provides Corporate Update,"11/06/2018 45781M10 GNW  Research Report Identifies Oil States International, Brightcove, Electronics for Imaging, Cirrus Logic, Innoviva, and Marinus Pharmaceuticals with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 3/10/2020 CCXI-US  GNW  ChemoCentryx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights,11/12/2019 40637H10 GNW  Bernadette Connaughton Appointed to Syneos Health Board of Directors," 9/26/2018 G2151510 GNW  Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and Spectra Energy Partners, LP with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 4/15/2020 MNKD-US   GNW  MannKind Receives Forgivable Loan under the Paycheck Protection Program, 8/14/2018 URGN-US  GNW  UroGen Pharma Reports Second Quarter 2018 Financial Results and Recent Corporate Developments Â , 4/14/2020 CYTK-US  GNW  Cytokinetics Provides Clinical Trials and Business Update in Response to COVID-19 Pandemic," 4/20/2020 001LBG-E    GNW  Esperion Announces Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of NEXLETOLâ„¢ (bempedoic acid) and NEXLIZETâ„¢ (bempedoic acid and ezetimibe) Tablets in Japan"," 9/05/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Amyris, Inc. - AMRS", 4/17/2020 CLPT-US  GNW  Biotechnology Leader and Surgeon Dr. Matthew Klein Joins ClearPoint Neuro Board of Directors,12/19/2019 00448Q20 GNW  Achillion Shareholders Approve Agreement to be Acquired by Alexion, 4/07/2020 SYNH-US  GNW  Syneos Health Provides COVID-19 Business Update," 3/23/2020 FOLD-US  GNW  Amicus Therapeutics Confirms Business Continuity, 2020 Strategic Priorities and Announces Proactive Efforts to Support Public Health Initiatives, Patients & Employees","10/23/2018 26979610 GNW  Market Trends Toward New Normal in IAC/InterActiveCorp, Eagle Pharmaceuticals, Arrowhead Pharmaceuticals, The Manitowoc, Brookdale Senior Living, and LATAM Airlines Group S.A â€” Emerging Consolidated Expectations, Analyst Ratings"," 6/11/2019 ZLAB-US  GNW  Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China", 3/12/2020 ADMA-US  GNW  ADMA Biologics Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress," 4/21/2020 GWPH-US  GNW  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the First Quarter Ending March 31st, 2020 and Host Conference Call on May 11th, 2020","11/09/2018 29428V10 GNW  Market Trends Toward New Normal in Paramount Group, Envestnet, Assurant, HubSpot, Epizyme, and Cytosorbents â€” Emerging Consolidated Expectations, Analyst Ratings",12/18/2019 JAZZ-US  GNW  Pfenex Earns $15 Million Development Milestone Under its Development and License Agreement With Jazz Pharmaceuticals, 3/30/2020 MYOK-US  GNW  MyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive Hypertrophic Cardiomyopathy Patients," 4/11/2019 39843840 GNW  New Research: Key Drivers of Growth for Grifols, S.A, LG Display Co., Summit Midstream Partners, LP, Mammoth Energy Services, Reading International, and Great Ajax â€” Factors of Influence, Major Initiatives and Sustained Production", 4/17/2020 GLPG-NL  GNW  Galapagos creates new subscription right plans," 3/11/2020 ALGN-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ALGN, OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 6/21/2018 92337F10 GNW  New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending â€” Factors of Influence, Major Initiatives and Sustained Production"," 8/29/2018 25303110 GNW  Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott â€” Fundamental Analysis, Key Performance Indications"," 4/13/2020 ALCLS-FR GNW  Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer", 4/21/2020 CARA-US  GNW  Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Positive Results From Global KALM-2 Pivotal Phase 3 Trial of KORSUVATM Injection in Hemodialysis Patients with Pruritus, 4/07/2020 FLXN-US  GNW  Flexion Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference," 4/17/2020 QURE-US  GNW  uniQure Announces the Nomination of Leonard E. Post, Ph.D. to its Board of Directors"," 4/16/2020 AGIO-US   GNW  Agios to Webcast Conference Call of First Quarter 2020 Financial Results  on April 30, 2020", 4/13/2020 IOVA-US  GNW  Iovance Biotherapeutics Announces H. Lee Moffitt Cancer Center to Present Lung Cancer Clinical Data at American Association for Cancer Research (AACR) Virtual Annual Meeting 2020," 4/21/2020 ALGN-US  GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ALGN, ANAB, TLRY and WWE","10/24/2018 00434H10 GNW  Research Report Identifies Cato, Roadrunner Transportation, Talend S.A, Vi, MannKind, and Acceleron Pharma with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 4/02/2020 0CPNB1-E GNW  Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies,10/24/2019 XGN-US   GNW  AVISEÂ® MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout,#N/A, 3/26/2020 ICPT-US  GNW  Intercept Pharmaceuticals Provides Regulatory and Business Update, 4/21/2020 KPTI-US    GNW  Norton Healthcare enrolls first patient in world for COVID-19 drug trial," 4/11/2019 38000Q10 GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Monster Beverage, Kennametal, Waddell & Reed Financial, GlycoMimetics, W.W. Grainger, and Immersion â€” New Research Emphasizes Economic Growth"," 3/06/2019 98401F10 GNW  New Research Coverage Highlights Clovis Oncology, Welltower, The Ultimate Software Group, Nielsen Holdings Plc, Xencor, and 21Vianet Group â€” Consolidated Revenues, Company Growth, and Expectations for 2019", 4/16/2020 ITCI-US  GNW  Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"11/14/2018 G8807B10 GNW  New Research Coverage Highlights Nexa Resources S.A, Qumu, Clearway Energy, Vermillion, Cantel Medical, and Theravance Biopharma â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 1/09/2020 G6674U10 GNW  Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer, 4/17/2020 ARDX-US  GNW  Knight Therapeutics Announces Approval of IBSRELAâ„¢ in Canada," 4/13/2020 AMPH-US  GNW  Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure"," 2/27/2020 ATRA-US    GNW  Atara Biotherapeutics Announces Fourth Quarter and Full Year 2019 Financial ResultsÂ and Recent Clinical, Operational and Strategic Progress", 3/11/2020 FTSV-US  GNW  Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia," 2/04/2020 24983L10 GNW  CSFL, DLPH, DERM, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers"," 4/02/2020 FOMX-US  GNW  Menlo Announces Settlement to Conclude Finacea Foam Litigation and Announces that Partner, LEO Pharma A/S, Remedies Finacea Foam Supply Issues", 4/13/2020 PRAH-US  GNW  PRA Health Sciences to Report First Quarter 2020 Earnings, 4/21/2020 SUPN-US  GNW  Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138, 4/20/2020 FGEN-US  GNW  FibroGen Reports UK Court Ruling, 7/16/2019 74587V10 GNW  Knight Therapeutics Announces Health Canada Has ApprovedÂ NERLYNX Â® for Early-Stage Breast Cancer, 9:30a     CHRS-US  GNW  Coherus BioSciences to Report First Quarter Financial Results on May 7th, 3/12/2020 CRBP-US  GNW  Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results,"12/21/2019 05070R10 GNW  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders â€“ BOLD, INST, THOR", 4/07/2020 COLL-US  GNW  Collegium to Participate in Upcoming Investor Conference, 4/14/2020 XBIT-US  GNW  XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1âº),"10/18/2018 81750R10 GNW  New Research Coverage Highlights Altair Engineering, Genomic Health, Seres Therapeutics, REV Group, MACOM Technology Solutions, and New Mountain Finance â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 8/23/2018 00900T10 GNW  Report: Developing Opportunities within Aimmune Therapeutics, Everbridge, Roku, Bristow Group, Atlas Air Worldwide, and Edgewell Personal Care â€” Future Expectations, Projections Moving into 2018", 4/03/2020 GBT-US   GNW  GBT Announces New Employment Inducement Grants,10/30/2019 75901B10 GNW  Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjectorâ„¢ in AAV Gene Therapy Delivery, 3/03/2020 KURA-US  GNW  Kura Oncology Receives Fast Track Designation for Tipifarnib in T-Cell Lymphomas, 4/06/2020 APLS-US  GNW  Paul Fonteyne Joins Apellis Board of Directors, 4/06/2020 AXSM-US  GNW  Axsome Therapeutics Announces AXS-07 Achieves Both Co-Primary Endpoints and Prevents Migraine Pain Progression in the INTERCEPT Phase 3 Trial in the Early Treatment of Migraine, 4/03/2020 VYGR-US  GNW  Voyager Therapeutics Provides Update on the RESTORE-1 Parkinsonâ€™s Disease Trial, 4/20/2020 BGNE-US  GNW  BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination with Chemotherapy in First-Line Advanced Squamous Non-Small Cell Lung Cancer in China,"11/25/2019 74933V10 GNW  Rigrodsky & Long, P.A. Files Class Action Suit Against Ra Pharmaceuticals, Inc.", 3/30/2020 RETA-US  GNW  Reata Pharmaceuticals Provides Update on the Impact of the COVID-19 Pandemic on Its Clinical Studies and Business Operations, 4:00a     HCM-GB   GNW  Chi-Med Highlights Presentations of Surufatinib at the UpcomingÂ AACR VirtualÂ AnnualÂ Meetings, 3/31/2020 NTLA-US  GNW  FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia Therapeutics, 4/02/2020 ACIU-US  GNW  AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases, 2/26/2020 CRSP-US  GNW  CRISPR Therapeutics Proposes Changes to the Board of Directors," 4/07/2020 GTHX-US  GNW  G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020", 2/27/2020 ARGX-BE  GNW  argenx reports full year 2019 financial results and provides fourth quarter business update, 3/12/2020 RUBY-US GNW  Rubius Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Announces Strategic Focus on Oncology and Autoimmunity, 4/09/2020 ATNX-US  GNW  Athenex Provides an Update on Oral PaclitaxelÂ FDA Meeting," 3/20/2020 PETQ-US  GNW  PetIQ, Inc. Announces Business Update Related to COVID-19", 4/07/2020 RYTM-US  GNW  Rhythm Pharmaceuticals to Present Virtually at Needham & Co. 19th Annual Healthcare Conference, 3/05/2020 OPTN-US  GNW  Optinose Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Operational Highlights, 4/03/2020 TORC-US  GNW  resTORbio Announces Delay of its Ongoing Phase 1b/2a trial of RTB101 in Patients with Parkinsonâ€™s Disease Due to COVID-19 Level 4 Alert in New Zealand, 4/02/2020 DNLI-US  GNW  Denali Therapeutics Provides Pipeline and Business Update in Response to the COVID-19 Pandemic,12/07/2017 74766Q10 GNW  Quanterix Corporation (Nasdaq: QTRX) to Ring The Nasdaq Stock Market Closing Bell, 4/16/2020 SLDB-US  GNW  Solid Biosciences Announces Appointment of Ian F. Smith to its Board of Directors, 4/16/2020 EOLS-US  GNW  Evolus Provides Strategic Business Update, 3/16/2020 FIXX-US GNW  Homology Medicines Announces Peer-Reviewed Publication of HMI-102 Investigational Gene Therapy Demonstrating Restoration of Normal Metabolic Pathway in PKU Disease Model, 4/01/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Provides COVID-19 Pandemic Business Operations Update, 2/06/2020 SRRK-US  GNW  Scholar Rock Presents Data for SRK-015 at the SMA Europe 2nd International Scientific Congress, 3/31/2020 UBX-US   GNW  UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101,#N/A,#N/A, 2/26/2020 EIDX-US  GNW  Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update," 4/09/2019 05455M10 GNW  Detailed Research: Economic Perspectives on AVROBIO, TheStreet, Youngevity International, Universal Logistics, The Madison Square Garden, and Ooma â€” What Drives Growth in Today's Competitive Landscape",#N/A," 2/27/2020 XERS-US  GNW  Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 11, 2020", 4/16/2020 AUTL-US  GNW  Autolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic Leukemia," 3/26/2020 CBB-US  GNW  SHAREHOLDER ALERT: WeissLaw LLP Reminds MEET, CBB, DLPH, and FTSV Shareholders About Its Ongoing Investigations", 2/26/2020 TBIO-US  GNW  Translate Bio Receives FDA Fast Track Designation for MRT5005 for the Treatment of  Cystic Fibrosis,"12/07/2018 60770K10 GNW  Nasdaq Welcomes Moderna, Inc. (Nasdaq: MRNA) to The Nasdaq Stock Market", 3/10/2020 PRNB-US GNW  Principia Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results, 4/13/2020 ARVN-US GNW  Arvinas Provides Update on Business Continuity Related to the Impact of the COVID-19 Pandemic, 4/15/2020 YMAB-US  GNW  Y-mAbs enters into Worldwide Exclusive License Agreement for SADA Technology â€“ a Novel Radioimmunotherapy Platform,#N/A, 4/06/2020 GRTS-US  GNW  Gritstone Oncology Announces the Appointment of Veteran Legal Executive  Rahsaan Thompson as General Counsel, 2/24/2020 GH-US    GNW  Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook, 3/18/2020 OSMT-US  GNW  Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2019 Results and Provides Business Updates, 3/17/2020 NGM-US   GNW  NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights,#N/A, 3/31/2020 ORTX-US  GNW  Orchard Therapeutics Outlines Business Impact of COVID-19," 4/17/2020 GOSS-US GNW  Zhang Investor Law Announces Securities Class Action Lawsuit Against Gossamer Bio, Inc. â€“ GOSS", 3/25/2020 ALEC-US  GNW  Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China, 4/15/2020 DTIL-US GNW  Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources, 4/16/2020 TPTX-US GNW  Clinical Cancer Research Highlights Potent Antitumor Activity of Repotrectinib in Treatment-NaÃ¯ve and Solvent-Front Mutation Ros1-Positive Non-Small Cell Lung Cancer, 3/31/2020 PRVL-US GNW  Prevail Therapeutics to Present at AAT-AD/PDÂ Focus Meeting 2020: Advances in Alzheimerâ€™s and Parkinsonâ€™s Therapies," 8/20/2019 00973Y10 GNW  Arbutus Biopharma Appoints Andrew Cheng, M.D., Ph.D., to its Board of Directors", 4/06/2020 BCEL-US GNW  Atreca Announces Participation in Two Upcoming Virtual Investor Conferences, 2/11/2020 ADXS-US  GNW  Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503 Clinical Program,#N/A, 4/03/2020 BBIO-US  GNW  BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)," 4/09/2020 ADPT-US  GNW  Adaptive Biotechnologies Expands Executive Leadership Team to Support Development and Commercialization of Clinical Products, including immunoSEQ Dx",#N/A
 5/06/2019 NOVN-US  GNW  Novan Completes Funding Transaction with Ligand Pharmaceuticals, 2/06/2020 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the 2020 American Society of Clinical Oncology Genitourinary Cancers Symposium Annual Meeting (ASCO GU)," 4/30/2019 ILMN-US     GNW  HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases"," 8/31/2018 84763A10 GNW  Report: Exploring Fundamental Drivers Behind International Bancshares, Morgan Stanley, Equity Residential, Hormel Foods, Spectrum Pharmaceuticals, and Cousins Properties â€” New Horizons, Emerging Trends, and Upcoming Developments",12/18/2018 ENDP-US  GNW  Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets," 2/13/2020 ARWR-US  GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zuora, Arrowhead Pharmaceuticals, ResMed, and Covetrus and Encourages Investors to Contact the Firm", 3/09/2020 BDSI-US  GNW  BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors,"11/02/2018 09073M10 GNW  Report: Exploring Fundamental Drivers Behind Equity Lifestyle Properties, AvalonBay Communities, Kadant, Mastercard, Bio-Techne, and Erie Indemnity â€” New Horizons, Emerging Trends, and Upcoming Developments", 4/08/2020 REGN-US  GNW  Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)," 3/05/2020 SIGA-US      GNW  SIGA Technologies, Inc. Reports Financial Results for Â Fiscal Year 2019", 3/25/2020 OPK-US   GNW  OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies," 3/11/2020 AKCA-US  GNW  Dr. Lisa Johnson-Pratt Joins Akcea Therapeutics as Senior Vice President, New Product Strategy; Joshua Patterson promoted to General Counsel, adding to the companyâ€™s leadership team"," 6/27/2018 09061G10    GNW  Report: Developing Opportunities within American Homes 4 Rent, Invitation Home, Graphic Packaging Holding, Flotek Industries, Sunstone Hotel Investors, and BioMarin Pharmaceutical â€” Future Expectations, Projections Moving into 2018"," 3/06/2019 01535110 GNW  Analysis: Positioning to Benefit within Bristol-Myers Squibb, AAR, Central Garden & Pet, Alexion Pharmaceuticals, Tribune Media, and Civitas Solutions â€” Research Highlights Growth, Revenue, and Consolidated Results",12/07/2019 64125C10 GNW  Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting,"10/03/2018 81257810 GNW  Research Report Identifies Ultragenyx Pharmaceutical, Helmerich & Payne, Buckeye Partners, Covanta Holding, Summit Midstream Partners, LP, and Seattle Genetics with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 4/07/2020 IMMU-US  GNW  FDA GRANTS FAST TRACK DESIGNATION TO SACITUZUMAB GOVITECAN FOR NEOADJUVANT/ADJUVANT METASTATIC UROTHELIAL CANCER," 4/16/2020 BIIB-US   GNW  Biogen, Broad Institute of MIT and Harvard, Partners HealthCare Launch Consortium  to Build and Share a COVID-19 Biobank"," 5/15/2019 45253H10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN", 4/09/2020 BCRX-US  GNW  BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19, 7/25/2019 GLPG-NL  GNW  Strong clinical progress in H1 and transformative collaboration with Gilead announced," 8/14/2018 04004760 GNW  New Research Coverage Highlights Arena Pharmaceuticals, Varian Medical, SS&C Technologies, Globus Medical, Zynga, and Diamondrock Hospitality â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 1/31/2020 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,12/16/2019 AKRX-US  GNW  Akorn Announces Extension of Standstill Agreement, 1/02/2020 6160-HK  GNW  BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment, 4/08/2020 MYGN-US  GNW  Myriad Withdrawing Financial Guidance for FY2020 Due to Business Impact from Coronavirus Pandemic, 3/19/2020 LXRX-US  GNW  LEXICON PHARMACEUTICALS PROVIDES AN UPDATE ON THE SOTAGLIFLOZIN TYPE 2 DIABETES PROGRAM, 3/02/2020 MGTX-US  GNW  MeiraGTx Announces Priority Medicines (PRIME) and Advanced Therapy Medicinal Product (ATMP) Designations Granted by the European Medicines Agency to AAV-RPGR Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa,"11/08/2018 45766930 GNW  Consolidated Research: 2018 Summary Expectations for Insmed, Service Corporation International, EPR Properties, Nielsen Holdings Plc, NiSource, and Criteo S.A â€” Fundamental Analysis, Key Performance Indications","10/16/2018 05156V10 GNW  New Research: Key Drivers of Growth for Haverty Furniture Companies, BLACKLINE INC, MagnaChip Semiconductor, Kinross Gold, Aurinia Pharmaceuticals, and NEXEO SOLUTIONS â€” Factors of Influence, Major Initiatives and Sustained Production"," 4/17/2020 INO-US    GNW  Zhang Investor Law Announces Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. â€“ INO", 1/21/2020 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Nektar Therapeutics - NKTR," 7/27/2018 76655960 GNW  Recent Analysis Shows Synopsys, Rigel Pharmaceuticals, Fate Therapeutics, Philip Morris International, Sally Beauty, and Kimberly-Clark Market Influences â€” Renewed Outlook, Key Drivers of Growth", 4/02/2020 GERN-US  GNW  Geron Provides COVID-19 Related Business Update,"10/25/2018 00771V10 GNW  Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers â€” New Horizons, Emerging Trends, and Upcoming Developments", 3/31/2020 AMRN-US  GNW  Amarin Investors Who Lost Money Should Contact Block & Leviton: The Firm Is Investigating Securities Fraud at the Company,10/07/2019 INCY-US  GNW  BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMTâ„¢ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer, 8/19/2019 91307C10 GNW  iBio Inks 3D Bioprinting Agreement, 2/28/2020 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 7/30/2019 G0176710 GNW  Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis,"10/18/2018 15708510 GNW  Detailed Research: Economic Perspectives on Cerus, AdvanSix, Spark Therapeutics, Imperva, Central Garden & Pet, and Francesca's â€” What Drives Growth in Today's Competitive Landscape", 3/04/2020 AMAG-US  GNW  AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update," 4/10/2019 04269E10 GNW  Analysis: Positioning to Benefit within Autodesk, Pebblebrook Hotel Trust, Boston Properties, FORTERRA INC, ArQule, and MongoDB â€” Research Highlights Growth, Revenue, and Consolidated Results", 8/31/2018 LMNX-US  GNW  Press Release for Early Warning Report Regarding Luminex Resources Corp.," 6/13/2018 80067710 GNW  New Research Coverage Highlights Accenture, Chico's FAS, The Allstate, Sangamo Therapeutics, ABB, and First Internet â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 6/14/2018 30161Q10 GNW  Consolidated Research: 2018 Summary Expectations for Rayonier Advanced Materials, CYS Investments, Avid Bioservices, American Airlines Group, Exelixis, and International Business Machines â€” Fundamental Analysis, Key Performance Indications", 4/16/2020 0L9D06-E GNW  Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution,11/19/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001Â® for Severe Hemoglobinopathies, 2/27/2020 ALLO-US  GNW  Allogene Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, 4/15/2020 ASND-US  GNW  Ascendis Pharma A/S Receives Orphan Drug Designation for TransConâ„¢ hGH as Treatment for Growth Hormone Deficiency in the United States,"12/07/2018 09609G10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of bluebird bio, Inc. â€“ BLUE"," 9/16/2018 00422510 GNW  CLASS ACTION UPDATE -- DEADLINE MONDAY for ACAD and FIZZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 4/02/2020 AFMD-US  GNW  Affimed Provides COVID-19-Related Business Update and Announces Full Year 2019 Financial Results Conference Call on April 28, 2020","10/10/2018 74366E10 GNW  Report: Developing Opportunities Within Apollo Investment, Ladder Capital, Medpace, MPLX LP, Silicon Laboratories, and Protagonist Therapeutics â€” Future Expectations, Projections Moving into 2018", 3/25/2020 PRQR-US  GNW  ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome, 7/31/2018 88338N10 GNW  Knight Therapeutics and TherapeuticsMD Announce Strategic Partnership, 4/15/2020 ZGNX-US  GNW  Zogenix to Host Investor Conference Call and Webcast on Two Studies Evaluating FINTEPLAÂ® in Dravet Syndrome and Sunflower Syndrome," 4/01/2020 AAN-US   GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates AAN, ALGN, ALLK, CCI Investors, Encourages Investors with Losses to Contact Firm",11/11/2019 68214310 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER,"10/11/2018 76133010 GNW  Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals â€” Discovering Underlying Factors of Influence",,"10/11/2018 46333X10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Ironwood Pharmaceuticals, Erie Indemnity, ONEOK, Sterling Construction, Colgate-Palmolive, and ON Semiconductor â€” New Research Emphasizes Economic Growth", 3/12/2020 ADVM-US  GNW  Adverum Biotechnologies Reports Recent Business Progress and Fourth Quarter 2019 Financial Results, 3/31/2020 RARE-US   GNW  REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAVÂ® Technology Platform for the Treatment of Rare Metabolic Disorder," 2/24/2020 AGLE-US  GNW  Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones", 9/24/2019 63009R10 GNW  CareDx Adds HistoMap To Testing Portfolio,"10/23/2018 69329Y10 GNW  Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma â€” New Horizons, Emerging Trends, and Upcoming Developments","12/18/2019 GBT-US   GNW  GBT and Syros Partner to Discover, Develop and CommercializeÂ Novel Therapies for Sickle Cell Disease and Beta Thalassemia", 3/03/2020 RDUS-US  GNW  Radius Health to Present at Cowen 40th Annual Healthcare Conference, 3/31/2020 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4),"10/18/2018 00182C10 GNW  Analysis: Positioning to Benefit within Clovis Oncology, Destination Maternity, MSG Networks, Lindblad Expeditions, NetScout, and ANI Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results"," 9/25/2018 29251M10 GNW  Recent Analysis Shows Enanta Pharmaceuticals, Multi-Color, Otter Tail, Franklin Resources, CubeSmart, and EnPro Industries Market Influences â€” Renewed Outlook, Key Drivers of Growth","11/25/2018 02043Q10 GNW  DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 2/19/2020 WVE-US   GNW  Wave Life Sciences to Present at the Cowen and Company 40th Annual Healthcare Conference, 3/24/2020 AKCA-US  GNW  Akcea Therapeutics Announces Appointment of Dr. Damien McDevitt as CEO,"10/25/2018 60468T10 GNW  Research Report Identifies CSG Systems International, Zumiez, Urban Outfitters, Mirati Therapeutics, Applied Materials, and Xencor with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 2/20/2020 PCRX-US  GNW  Pacira Reports Record Fourth Quarter and Full-Year Revenues, 3/09/2020 RTRX-US  GNW  Retrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis," 4/08/2020 PACB-US  GNW  Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs", 2/26/2020 EDIT-US  GNW  Editas Medicine Announces Fourth Quarter and Full Year 2019 Results and Update, 3/16/2020 CHMA-US  GNW  Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results, 2/27/2020 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences,"11/05/2018 09627Y10 GNW  Report: Exploring Fundamental Drivers Behind SkyWest, Blueprint Medicines, HP, Hewlett Packard Enterprise, Cardinal Health, and The Medicines â€” New Horizons, Emerging Trends, and Upcoming Developments",11/30/2018 AKBA-US  GNW  Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote â€œFORâ€ the Proposed Merger with Akebia Therapeutics," 8/26/2015 28249U10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Celladon Corporation of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2015 -- CLDN", 2/26/2020 MNTA-US  GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results, 4/03/2020 PRTA-US  GNW  Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), 4/08/2020 REGN-US  GNW  Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody),"10/19/2018 78667J10 GNW  Detailed Research: Economic Perspectives on W.W. Grainger, Jabil, Grand Canyon Education, Sage Therapeutics, H. B. Fuller, and Jazz Pharmaceuticals â€” What Drives Growth in Today's Competitive Landscape", 3/25/2020 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grant, 3/10/2020 GMAB-DK  GNW  Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer, 4/24/2019 92165910 GNW  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors (VNDA),"10/10/2018 58506Q10 GNW  Report: Developing Opportunities Within Apollo Investment, Ladder Capital, Medpace, MPLX LP, Silicon Laboratories, and Protagonist Therapeutics â€” Future Expectations, Projections Moving into 2018"," 3/09/2020 CBAY-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Fraud Ongoing"," 8/28/2018 45781M10 GNW  Report: Exploring Fundamental Drivers Behind Allscripts Healthcare Solutions, Dean Foods, Alder BioPharmaceuticals, Innoviva, Chegg, and TEGNA â€” New Horizons, Emerging Trends, and Upcoming Developments"," 3/03/2020 CCXI-US  GNW  ChemoCentryx to Hold Fourth Quarter and Full Year 2019 Financial Results Conference CallÂ on Tuesday, March 10, 2020","12/03/2018 40637H10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. â€“ HALO",12/20/2011 G2151510 GNW  China Nuokang Bio-Pharmaceutical Inc. Appoints David Gao to Board of Directors, 3/24/2020 MNKD-US   GNW  Jennifer Grancio Appointed to MannKind Board of Directors, 8/08/2018 URGN-US  GNW  UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer, 4/08/2020 CYTK-US  GNW  Cytokinetics to Participate in the 19th Annual Needham Virtual Healthcare Conference, 4/09/2020 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the 19th Annual Needham Virtual Healthcare Conference," 8/26/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Amyris, Inc. - AMRS"," 2/14/2020 CLPT-US  GNW  ClearPoint Neuro, Inc. Announces 2020 Revenue Outlook Ahead of Nasdaq Investor Presentation Today",12/09/2019 ACHN-US  GNW  Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting, 4/03/2020 SYNH-US  GNW  Syneos Health Responds to COVID-19 Public Health Challenge by Joining Call to Action to Activate Clinically-Qualified Healthcare Professionals, 3/05/2020 FOLD-US  GNW  AmicusÂ Opens New Global Research and Gene Therapy Center of Excellence in Philadelphia," 8/28/2018 26979610 GNW  Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results", 9/18/2018 DCPH-US  GNW  Deciphera Pharmaceuticals Appoints Daniel C. Martin as Chief Commercial Officer," 3/05/2020 ADMA-US  GNW  ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020"," 4/06/2020 0JBRH7-E GNW  GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEXÂ® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance","10/17/2018 29428V10 GNW  Research Report Identifies Oxford Immunotec Global, Ascena Retail Group, Groupon, Epizyme, Regulus Therapeutics, and B Communications with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement","10/19/2018 G5087110 GNW  Detailed Research: Economic Perspectives on W.W. Grainger, Jabil, Grand Canyon Education, Sage Therapeutics, H. B. Fuller, and Jazz Pharmaceuticals â€” What Drives Growth in Today's Competitive Landscape", 3/26/2020 MYOK-US  GNW  MyoKardia Provides Clinical Trial Update in the Context of the COVID-19 Pandemic," 9/26/2018 39843840 GNW  Recent Analysis Shows Green Plains Partners LP, Companhia Paranaense de Energia (COPEL), China Yuchai International, AerCap Holdings N.V., Northwest Natural Gas, and Grifols, S.A Market Influences â€” Renewed Outlook, Key Drivers of Growth", 4/16/2020 GLPG-NL  GNW  Important update to Galapagosâ€™ invitation to its ordinary and extraordinary shareholdersâ€™ meetings," 3/10/2020 ALGN-US  GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ALGN, PTLA, QD and WWE"," 1/08/2018 92337F10 GNW  Report: Exploring Fundamental Drivers Behind United Fire Group, Almost Family, Spark Therapeutics, Veracyte, Ruth's Hospitality Group, and IDT â€” New Horizons, Emerging Trends, and Upcoming Developments"," 7/25/2018 25303110 GNW  Report: Developing Opportunities within Clearwater Paper, Intercept Pharmaceuticals, Community Trust, Community Bank System, Laboratory Corporation of America, and Dicerna Pharmaceuticals â€” Future Expectations, Projections Moving into 2018", 1/12/2020 15117K10 GNW  Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement, 4/08/2020 CARA-US  GNW  Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Conference, 4/03/2020 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/30/2020 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Investor Conferences in April, 3/30/2020 AGIO-US   GNW  Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiency, 3/02/2020 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Conferences," 4/03/2020 ANAB-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ANAB, SIX INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 6/22/2018 00434H10 GNW  Market Trends Toward New Normal in RCI Hospitality, Phillips 66 Partners LP, Acceleron Pharma, Destination Maternity, The RMR Group, and Cohen & Steers â€” Emerging Consolidated Expectations, Analyst Ratings", 4/02/2020 FATE-US  GNW  Fate Therapeutics Announces First Patient Treated in First-in-human Clinical Trial of FT596 and Provides Corporate Update," 8/21/2018 G4618810 GNW  Investor Expectations to Drive Momentum within Materialise NV, Southern First Bancshares, Ensco plc, Corbus Pharmaceuticals, TCP Capital, and Horizon Pharma Public â€” Discovering Underlying Factors of Influence",, 2/28/2020 ICPT-US  GNW  Intercept to Present at the Cowen 40th Annual Health Care Conference, 4/20/2020 KPTI-US    GNW  Karyopharm Announces Dosing of First Patient in Randomized Study Evaluating Low Dose Selinexor in Patients with Severe COVID-19,"11/06/2018 38000Q10 GNW  Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP â€” Future Expectations, Projections Moving into 2018","10/25/2018 98401F10 GNW  Research Report Identifies CSG Systems International, Zumiez, Urban Outfitters, Mirati Therapeutics, Applied Materials, and Xencor with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 4/02/2020 ITCI-US  GNW  Intra-Cellular Therapies Initiates Promotional Activities for CAPLYTAâ„¢ (lumateperone) for the Treatment of Schizophrenia in Adults,,12/04/2019 G6674U10 GNW  SI-BONE Names Jeryl (â€œJeriâ€) Hilleman to Board of Directors," 4/10/2019 03969710 GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Cousins Properties, Versum Materials, Meritor, Ardelyx, Molecular Templates, and Talend S.A â€” New Research Emphasizes Economic Growth", 4/09/2020 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference, 2/21/2020 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)," 2/27/2017 77313F10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed a Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 â€“ ITEK"," 1/28/2020 24983L10 GNW  PRMW, DERM, HABT, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers"," 3/09/2020 FOMX-US  GNW  Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications", 4/08/2020 0CKCV6-E GNW  Symphony Health to provide free access to new MetysTM COVID-19 Module for U.S. based life sciences industry during pandemic, 3/30/2020 SUPN-US  GNW  Supernus Provides Business Update, 3/02/2020 FGEN-US  GNW  FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results, 2/28/2019 74587V10 GNW  Predictive Technology Group Names Jay M. Moyes to Its Board of Directors, 4/15/2020 CHRS-US  GNW  Coherus BioSciences Prices $200.0 Million Convertible Senior Subordinated Notes Offering," 3/10/2020 CRBP-US  GNW  Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director","12/16/2019 05070R10 GNW  TECD, TIF, BOLD, and WLH SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts", 2/27/2020 COLL-US  GNW  Collegium Reports Full-Year 2019 Revenue of $296.7 Million, 4/03/2020 XBIT-US  GNW  XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients," 8/24/2018 81750R10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel â€” New Research Emphasizes Economic Growth"," 6/15/2018 00900T10 GNW  New Research Coverage Highlights Avery Dennison, Raymond James Financial, Genuine Parts, Kimco Realty, Bristow Group, and Aimmune Therapeutics â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 4/02/2020 GBT-US   GNW  GBT Commits $250,000 to Support the Sickle Cell Disease Community During COVID-19 Pandemic"," 8/27/2018 75901B10 GNW  New Research: Key Drivers of Growth for REGENXBIO, Syndax Pharmaceuticals, Rowan Companies, CTS, Basic Energy Services, and Impinj â€” Factors of Influence, Major Initiatives and Sustained Production", 2/25/2020 KURA-US  GNW  Kura Oncology Reports Fourth Quarter and Full Year 2019 Financial Results, 2/27/2020 APLS-US  GNW  Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results, 3/30/2020 AXSM-US  GNW  Axsome Therapeutics Announces Topline Results of the STRIDE-1 Phase 3 Trial in Treatment Resistant Depression and Expert Call to Discuss Clinical Implications, 3/09/2020 VYGR-US  GNW  Voyager Therapeutics Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference, 4/13/2020 BGNE-US  GNW  BeiGene Announces that the Phase 3 Trial of Tislelizumab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis,"11/23/2019 74933V10 GNW  Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders â€“ RARX, IPHS, CISN, LPT", 3/16/2020 RETA-US  GNW  WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE, 4/17/2020 HCM-GB   GNW  Chi-Med Announces Surufatinib Granted U.S. FDA Fast Track Designations for the Treatment of Both Pancreatic and Non-Pancreatic NeuroendocrineÂ Tumors, 2/27/2020 NTLA-US  GNW  Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results, 3/30/2020 ACIU-US  GNW  AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook, 2/12/2020 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results, 3/12/2020 GTHX-US  GNW  G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer,11/12/2019 ARGX-BE  GNW  argenx announces closing of global offering, 3/03/2020 RUBY-US GNW  Rubius Therapeutics to Report Fourth Quarter and Full-Year 2019 Financial Results  and Host Webcast, 3/13/2020 ATNX-US  GNW  Athenex Provides a Corporate Update," 3/10/2020 PETQ-US  GNW  PetIQ, Inc. Reports Record Full Year 2019 and Fourth Quarter Financial Results", 3/30/2020 RYTM-US  GNW  Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations," 2/27/2020 OPTN-US  GNW  Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020", 3/12/2020 TORC-US  GNW  resTORbio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update, 2/27/2020 DNLI-US  GNW  Denali Therapeutics Reports Full Year 2019 Financial Results and Business Highlights,, 3/12/2020 SLDB-US  GNW  Solid Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update, 3/04/2020 EOLS-US  GNW  Evolus Provides Update on International Trade Commission (ITC) Case, 3/12/2020 FIXX-US GNW  Homology Medicines Reports Fourth Quarter and Full Year 2019 Financial Results and  Recent Accomplishments, 3/05/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Corporate Progress, 1/10/2020 SRRK-US  GNW  Scholar Rock Provides Corporate Update and Outlines Key R&D Priorities for 2020, 3/30/2020 UBX-US   GNW  UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants,,,11/16/2019 28249H10 GNW  CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures," 2/01/2019 AVRO-US  GNW  AVROBIO, Inc. Announces Time Change for Analyst and Investor Presentation and Webcast, now 5:30 p.m. ET on Wednesday, February 6, 2019",, 2/11/2020 XERS-US  GNW  Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock, 3/03/2020 AUTL-US  GNW  Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results  and Operational Progress," 3/23/2020 FTSV-US GNW  Lifshitz Law Firm, P.C. Announces Investigation of Forty Seven, Inc., Hexcel Corporation, Legg Mason, Inc., and Mobile Mini, Inc.", 2/19/2020 TBIO-US  GNW  Translate Bio to Present at Upcoming Investor Conferences,, 2/19/2020 PRNB-US GNW  Principia to Present at 9th Annual SVB Leerink Global Healthcare Conference, 3/31/2020 ARVN-US GNW  Arvinas to Present at the American Society of Clinical Oncology Annual Meeting, 4/01/2020 YMAB-US  GNW  Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA,, 3/11/2020 GRTS-US  GNW  Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights, 2/12/2020 GH-US    GNW  Guardant Health to Participate in Upcoming Investor Conferences," 3/12/2020 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2019 Business and Financial Update on March 18, 2020"," 3/09/2020 NGM-US   GNW  Aetna Wun Trombley, Ph.D. to Step Down as President and Chief Operating Officer of NGM BioÂ to Assume Chief Executive Officer Role at Undisclosed Privately Held Company",," 3/18/2020 ORTX-US  GNW  Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer"," 4/06/2020 GOSS-US GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (GOSS)", 3/24/2020 ALEC-US  GNW  Alector Reports 2019 Fourth Quarter and Full Year Financial Results and Business Highlights," 4/07/2020 DTIL-US GNW  Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A for Relapsed/Refractory NHL, CLL, and SLL"," 3/16/2020 TPTX-US GNW  TURNING POINT THERAPEUTICS REPORTS FOURTH-QUARTER, FULL- YEAR 2019 FINANCIAL AND OPERATIONAL RESULTS", 3/26/2020 PRVL-US GNW  Prevail Therapeutics Reports Full Year 2019 Financial Results and Business Highlights,," 3/12/2020 BCEL-US GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atreca, Inc. - BCEL"," 6/24/2019 71535D10 GNW  Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman",, 3/12/2020 0JVC6M-E GNW  BridgeBio Pharmaâ€™s QED Therapeutics Announces Dosing of First Patients in Phase 3 and Phase 2 Clinical Trials of Infigratinib in Tumors with FGFR Genetic Alterations, 2/26/2020 ADPT-US  GNW  Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial Results,
" 4/11/2019 GLYC-US  GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Monster Beverage, Kennametal, Waddell & Reed Financial, GlycoMimetics, W.W. Grainger, and Immersion â€” New Research Emphasizes Economic Growth", 1/21/2020 PGNX-US  GNW  Progenics Pharmaceuticals Provides Update on Reconstituted Boardâ€™s Ongoing Strategic Review," 4/11/2019 45232710    GNW  Recent Analysis Shows Healthcare Trust of America, Illumina, Tucows, Asure Software, Saga Communications, and Miller Industries Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 8/28/2018 84763A10 GNW  AVANT DIAGNOSTICS ADDS TWO ESTEEMED, INTERNATIONALLY RECOGNIZED BOARD MEMBERS AND FILES ITS 2016 10-K IN PREPARATION OF GETTING CURRENT WITH THE SEC","10/26/2018 G3040110 GNW  Recent Analysis Shows Supernus Pharmaceuticals, GDS HOLDINGS, Golden Ocean Group, Golar LNG, Endo International plc, and 51job Market Influences â€” Renewed Outlook, Key Drivers of Growth","10/23/2018 04280A10 GNW  Market Trends Toward New Normal in IAC/InterActiveCorp, Eagle Pharmaceuticals, Arrowhead Pharmaceuticals, The Manitowoc, Brookdale Senior Living, and LATAM Airlines Group S.A â€” Emerging Consolidated Expectations, Analyst Ratings", 2/27/2020 BDSI-US  GNW  BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicineâ€™s 36th Annual Meeting," 8/01/2018 09073M10 GNW  Market Trends Toward New Normal in Horizon Global, Bio-Techne, Adamis Pharmaceuticals, Kadant, Semgroup, and Provident Financial Services â€” Emerging Consolidated Expectations, Analyst Ratings", 4/06/2020 REGN-US  GNW  Sanofi finalizes PraluentÂ® (alirocumab) restructuring with Regeneron, 3/02/2020 SIGA-US      GNW  SIGA Announces Collaboration with Turnstone Biologics, 2/26/2020 OPK-US   GNW  OPKO Health Reports 2019 Fourth Quarter Business Highlights and Financial Results, 2/28/2020 AKCA-US  GNW  Akcea Supports Rare Disease Day 2020 and Global Efforts to â€œReframe Rareâ€,"10/16/2017 BMRN-US     GNW  BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN) to Ring The Nasdaq Stock Market Closing Bell", 1/31/2019 0H9PHY-E GNW  Fortress Biotech Announces CAEL-101 Strategic Partnership with Alexion Pharmaceuticals,12/02/2019 NBIX-US  GNW  Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on License and Collaboration Agreement with Neurocrine Biosciences, 6/29/2018 GMAB-DK  GNW  HuMaxÂ®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics, 4/06/2020 IMMU-US  GNW  IMMUNOMEDICS ANNOUNCES ASCENT STUDY TO BE STOPPED FOR COMPELLING EFFICACY, 4/02/2020 BIIB-US   GNW  Biogen Announces First Patient Treated With Higher Dose of SPINRAZAÂ® (nusinersen)Â in Phase 2/3 DEVOTE Study,"11/07/2018 45253H10 GNW  Report: Developing Opportunities within TE Connectivity, EnPro Industries, Innophos, Ameren, ImmunoGen, and ICF International â€” Future Expectations, Projections Moving into 2018", 4/08/2020 BCRX-US  GNW  BioCryst to Present at 19th Annual Needham Healthcare Conference, 6/19/2019 37555810 GNW   Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases,"11/27/2017 04004760 GNW  Market Trends Toward New Normal in Arena Pharmaceuticals, National Fuel Gas, Capitol Federal Financial, Comfort Systems, National Instruments, and Navistar International â€” Emerging Consolidated Expectations, Analyst Ratings"," 1/29/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL, OPRA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,11/05/2019 AKRX-US  GNW  Akorn to Present at the Credit Suisse Healthcare Conference,11/18/2019 03116210 GNW  New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function, 4/06/2020 MYGN-US  GNW  Myriad Receives Reimbursement for the BRACAnalysisÂ® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC, 3/13/2020 LXRX-US  GNW  LEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYLâ€™S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROME, 2/24/2020 MGTX-US  GNW  MeiraGTx to Present at Upcoming Investor Conferences,11/08/2018 INSM-US  GNW  Insmed Announces Changes to its Board of Directors," 8/17/2018 05156V10 GNW  Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals â€” Discovering Underlying Factors of Influence"," 4/06/2020 INO-US    GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Important Application Deadline Approaching",10/15/2019 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Nektar Therapeutics - NKTR,"12/04/2017 76655960 GNW  Detailed Research: Economic Perspectives on TiVo, Eli Lilly, Rigel Pharmaceuticals, SpartanNash, Nustar GP, and Hornbeck Offshore Services â€” What Drives Growth in Today's Competitive Landscape"," 3/20/2020 GERN-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline 3 Days Away, Investors with Losses Encouraged to Contact Firm"," 9/05/2018 00771V10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group â€” New Research Emphasizes Economic Growth", 3/31/2020 AMRN-US  GNW  Amarin Highlights VASCEPAÂ® (Icosapent Ethyl)-Related Data Presented at American College of Cardiologyâ€™s Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC)," 9/25/2019 45337C10 GNW  BriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker, to Scientific Advisory Board; BriaCell CEO to Lead Special â€˜Targeted Immunotherapyâ€™ Issue in Prestigious Journals"," 4/01/2019 91307C10 GNW  Report: Exploring Fundamental Drivers Behind Coeur Mining, Owens & Minor, Telenav, Cedar Realty Trust, j2 Global, and United Therapeutics â€” New Horizons, Emerging Trends, and Upcoming Developments"," 2/27/2020 SRPT-US  GNW  Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program", 5/30/2019 BIIB-US  GNW  New Phase 3 Interim Results Support Safety and Efficacy of Diroximel Fumarate in Multiple Sclerosis," 8/28/2018 15708510 GNW  New Research Coverage Highlights Evertec, Cerus, REV Group, U.S. Silica, The Manitowoc, and World Fuel Services â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 3/04/2020 AMAG-US  GNW  AMAG Pharmaceuticals Announces Changes to Medical Development Organization," 8/21/2018 04269E10 GNW  Analysis: Positioning to Benefit within PagSeguro Digital, ChannelAdvisor, Transocean, Arcos Dorados, Precision Drilling, and ArQule â€” Research Highlights Growth, Revenue, and Consolidated Results"," 8/24/2018 55027E10 GNW  Market Trends Toward New Normal in Hornbeck Offshore Services, The Chefs' Warehouse, Installed Building Products, Corindus Vascular Robotics, Capstone Turbine, and Luminex â€” Emerging Consolidated Expectations, Analyst Ratings",11/18/2014 80067710 GNW  Sangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference,"11/27/2017 30161Q10 GNW  Report: Developing Opportunities within PayPal, Exelixis, International Business Machines, Opko Health, Envision Healthcare, and Zynga â€” Future Expectations, Projections Moving into 2018", 4/14/2020 GSK-GB   GNW  Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19,11/18/2019 MTEM-US  GNW  Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants," 2/19/2020 ALLO-US  GNW  Allogene Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020", 4/01/2020 ASND-US  GNW  Ascendis Pharma A/S Reports Full-Year 2019 Financial Results," 6/28/2018 09609G10 GNW  Analysis: Positioning to Benefit within EMCOR Group, Ring Energy, A. O. Smith, bluebird bio, Ligand Pharmaceuticals, and Synovus Financial â€” Research Highlights Growth, Revenue, and Consolidated Results", 9/14/2018 00422510 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ACAD, 4/01/2020 AFMD-US  GNW  Affimed Announces FDA Granted Orphan Drug Designation for Lead Innate Cell Engager AFM13 for the Treatment of T-cell Lymphoma," 8/01/2018 74366E10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Protagonist Therapeutics, HD Supply, BIOHAVEN PHARM, Big Lots, Clean Energy Fuels, and H&E Equipment Services â€” New Research Emphasizes Economic Growth", 2/26/2020 PRQR-US  GNW  ProQR Announces Fourth Quarter and Full Year 2019 Results and Provides Business Update, 5/16/2018 TXMD-US  GNW  TikaMobile Selected by TherapeuticsMD as Business Intelligence Platform Provider," 3/06/2020 ZGNX-US  GNW  Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares", 4/01/2020 ALLK-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Allakos Inc. - ALLK,11/04/2019 68214310 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of Omeros Corporation - OMER," 8/07/2018 76133010 GNW  New Research Coverage Highlights Titan International, Revance Therapeutics, Ryerson Holding, Iridium Communications, Chase, and Peoples â€” Consolidated Revenues, Company Growth, and Expectations for 2018",," 8/09/2018 46333X10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Omnicom Group, Ironwood Pharmaceuticals, CorEnergy Infrastructure Trust, Cypress Semiconductor, Yum! Brands, and Zendesk â€” New Research Emphasizes Economic Growth", 3/11/2020 ADVM-US  GNW  Adverum Biotechnologies Announces Data Presentations at ARVO 2020, 3/16/2020 0K8KRW-E  GNW  GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome, 1/13/2020 AGLE-US  GNW  Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177), 8/28/2019 NSTG-US  GNW  NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference," 8/28/2018 69329Y10 GNW  Report: Developing Opportunities within Parker Drilling, CoreLogic, Steven Madden, Diebold Nixdorf, Nevro, and PDL BioPharma â€” Future Expectations, Projections Moving into 2018", 9/12/2019 SYRS-US  GNW  UPDATE - Igneous Selected by Syros Pharmaceuticals to Modernize HPC Backup Environment, 2/27/2020 RDUS-US  GNW  Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results, 3/30/2020 ASMB-US  GNW  Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer," 8/27/2018 00182C10 GNW  Recent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences â€” Renewed Outlook, Key Drivers of Growth",,"11/25/2018 02043Q10 GNW  ALNY NOV 26 DEADLINE: Rosen Law Firm Reminds Alnylam Pharmaceuticals, Inc. Investors of Important Deadline in Class Action", 2/18/2020 WVE-US   GNW  Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntingtonâ€™s Disease Program at CHDI Foundationâ€™s 15th Annual HD Therapeutics Conference," 3/11/2020 AKCA-US  GNW  Dr. Lisa Johnson-Pratt Joins Akcea Therapeutics as Senior Vice President, New Product Strategy; Joshua Patterson promoted to General Counsel, adding to the companyâ€™s leadership team", 1/08/2018 60468T10 GNW  BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region," 2/13/2020 PCRX-US  GNW  Pacira to Report 2019 Financial Results on Thursday February 20, 2020", 2/28/2020 RTRX-US  GNW  Retrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care, 3/18/2020 00BDDM-E GNW  Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies, 2/19/2020 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2019 Results and Corporate Update," 3/09/2020 CHMA-US  GNW  Chiasma To Report Fourth Quarter and Full Year 2019 Financial Results On March 16, 2020", 2/25/2020 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 2019 Financial Results," 6/21/2018 09627Y10 GNW  New Research: Key Drivers of Growth for Illinois Tool Works, Aircastle, TriState Capital, Blueprint Medicines, MGE Energy, and Cubic â€” Factors of Influence, Major Initiatives and Sustained Production",11/29/2018 AKBA-US  GNW  ISS Recommends that Keryx Biopharmaceuticals Stockholders  Vote â€œFORâ€ the Proposed Merger with Akebia Therapeutics, 8/11/2015 28249U10 GNW  Celladon Reports Second Quarter 2015 Financial Results, 2/19/2020 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Cowen 40th Annual Health Care Conference, 3/31/2020 PRTA-US  GNW  Baseline Data from Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinsonâ€™s Disease to be Presented at AAT-AD/PD," 3/19/2020 ZLAB-US  GNW  Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates"," 6/12/2018 78667J10 GNW  Market Trends Toward New Normal in Cheniere Energy Partners, LP, UnitedHealth Group, Anthem, Sage Therapeutics, Harris, and A-Mark Precious Metals â€” Emerging Consolidated Expectations, Analyst Ratings", 3/23/2020 CTMX-US  GNW  CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ProbodyÂ®  T-Cell Engaging Bispecific Therapies for Treatment of Cancer, 2/21/2020 GMAB-DK  GNW  Genmab Board of Directors Chairman to Step Down, 4/23/2019 92165910 GNW  VANDA FRIDAY DEADLINE: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important April 26th Deadline in First-Filed Case â€“ VNDA," 8/01/2018 58506Q10 GNW  New Research Coverage Highlights Brunswick, Liberty Global, LaSalle Hotel Properties, Denny's, Medpace, and eHealth â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 3/05/2020 CBAY-US  GNW  CymaBay Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 12"," 6/26/2018 45781M10 GNW  Recent Analysis Shows Church & Dwight Co., Innoviva, PTC Therapeutics, KBR, Murphy Oil, and F.N.B. Market Influences â€” Renewed Outlook, Key Drivers of Growth", 2/19/2020 CCXI-US  GNW  ChemoCentryx to Present at the 9th Annual SVB Leerink Global Healthcare Conference,"12/03/2018 40637H10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Halozyme Therapeutics, Inc. â€“ HALO", 5/14/2010 G2151510 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index, 3/17/2020 MNKD-US   GNW  MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic," 8/07/2018 URGN-US  GNW  UroGen Pharma to Report Second Quarter 2018 Financial Results on Tuesday, August 14, 2018", 3/30/2020 CYTK-US  GNW  Correction: Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual, 4/06/2020 ESPR-US     GNW  Esperion Announces European Commission Approval of the NUSTENDIâ„¢ (bempedoic acid and ezetimibe) Tablet for the Treatment of Hypercholesterolemia and Mixed Dyslipidemia," 6/27/2019 03236M20  GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance Innovations, Amyris and Nutanix and Encourages Investors to Contact the Firm",11/18/2019 0DLJDW-E GNW  CENTOGENE Signs New Collaboration with PTC Therapeutics for Global Diagnostic Testing Program,"11/29/2019 00448Q20 GNW  Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc.", 3/27/2020 SYNH-US  GNW  Syneos Health Launches Ventilator Initiative to Raise Awareness of Bridging Option to Address Ventilator Shortage for COVID-19 Patients, 3/02/2020 FOLD-US  GNW  Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates," 6/29/2018 26979610 GNW  Investor Expectations to Drive Momentum within Education Realty Trust, Eagle Pharmaceuticals, Boingo Wireless, United Parcel Service, Marathon Petroleum, and Coherent â€” Discovering Underlying Factors of Influence"," 8/29/2018 24344T10 GNW  Report: Exploring Fundamental Drivers Behind CIRCOR International, Duluth, Griffon, Despegar, SEACOR, and Deciphera Pharmaceuticals â€” New Horizons, Emerging Trends, and Upcoming Developments", 3/03/2020 ADMA-US  GNW  ADMA Biologics Highlights Expanded Intellectual Property Portfolio for Specialty Plasma Derived Immune Globulins Targeted Against Respiratory Infections, 3/31/2020 GWPH-US  GNW  GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEXÂ® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis Complex," 8/20/2018 29428V10 GNW  Research Report Identifies Blucora, Sapiens International Corporation N.V, AxoGen, Epizyme, Nova Measuring Instruments, and Silver Standard Resources with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement","12/04/2017 G5087110 GNW  Vital Therapies Appoints Russell J. Cox as Chief Executive Officer and Board Member Effective January 3, 2018", 3/19/2020 MYOK-US  GNW  Data from MAVERICK-HCM Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy Selected for Virtual Late-Breaker Presentation at theÂ American College of Cardiologyâ€™s 69th Annual Scientific Session Together with World Congress of Cardiology," 3/13/2018 39843840 GNW  Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V.Â â€” Fundamental Analysis, Key Performance Indications", 4/16/2020 GLPG-NL  GNW  Galapagos and Ryvu announce research collaboration," 3/09/2020 PTLA-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,11/17/2014 DRNA-US  GNW  Tekmira Announces Licensing and Collaboration Agreement With Dicerna,"10/17/2018 15117K10 GNW  New Research Coverage Highlights Esperion Therapeutics, Summit Therapeutics, Ocwen Financial, Keane Group, Cellectis S.A, and Rapid7 â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 3/25/2020 CARA-US  GNW  Cara Therapeutics Reports Clinical Updates, 4/01/2020 FLXN-US  GNW  Flexion Therapeutics Announces ZILRETTAÂ® License Agreement and Provides Business Update Amid Coronavirus Pandemic, 3/26/2020 QURE-US  GNW  uniQure Announces Achievement of Target Patient Dosing in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Hemophilia B," 3/25/2020 AGIO-US   GNW  Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb", 2/25/2020 IOVA-US  GNW  Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update," 4/02/2020 ANAB-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed, Important Deadlines Established"," 5/03/2018 00434H10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Sonic Automotive, STERIS plc, AquaVenture, Senseonics, Acceleron Pharma, and Steelcase â€” New Research Emphasizes Economic Growth", 3/02/2020 FATE-US  GNW  Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook, 6/15/2018 HZNP-US  GNW  Horizon Pharma plc Presents Data at EULAR 2018 Advancing the Understanding and Management of Uncontrolled Gout,," 2/25/2020 ICPT-US  GNW  Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results, Issues 2020 Operating Expense Guidance and Provides Business Update", 4/07/2020 KPTI-US    GNW  Karyopharm to Evaluate Low Dose Selinexor as a Potential Treatment for Hospitalized Patients with COVID-19," 8/31/2018 38000Q10 GNW  Research Report Identifies FS Investment, Rush Enterprises, GlycoMimetics, Federal Signal, ATN International, and Novavax with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement"," 8/08/2018 98401F10 GNW  New Research Coverage Highlights Goldman Sachs BDC, PTC, Weingarten Realty Investors, Astronics, Xencor, and Chemours â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 3/23/2020 ITCI-US  GNW  Intra-Cellular Therapies Announces Availability of CAPLYTAâ„¢ (lumateperone) for Adult Patients with Schizophrenia,, 8/12/2019 ZLAB-US  GNW  China National Medical Products Administration Grants Innovative Medical Device Designation for OptuneÂ® in China,"10/16/2018 03969710 GNW  Analysis: Positioning to Benefit within Ardelyx, AXT, TG Therapeutics, MarineMax, Oclaro, and BioCryst Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results"," 3/12/2020 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019", 2/20/2020 ATRA-US    GNW  Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences, 2/23/2017 77313F10 GNW  IMPORTANT INOTEK INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP  announces that a securities class action lawsuit has been filed in the District of Massachusetts against Inotek Pharmaceuticals Corporation," 1/24/2020 24983L10 GNW  SHAREHOLDER ALERT: WeissLaw LLP Reminds HABT, DERM, and MFSF Shareholders About Its Ongoing Investigations", 2/25/2020 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Cowen and Companyâ€™s 40th Annual Health Care Conference, 3/24/2020 PRAH-US  GNW  PRA Health Sciences expands remote clinical study support with its Mobile Health Platform during COVID-19 pandemic, 2/26/2020 SUPN-US  GNW  Supernus to Present at the 2020 Cowen Health Care Conference, 2/18/2020 FGEN-US  GNW  FibroGen to Report Fourth Quarter and Full Year 2019 Financial Results, 1/11/2019 GUD-CA   GNW  Knight Therapeutics Runs with Exclusive Canadian License to Pumaâ€™s NERLYNXÂ®, 4/14/2020 CHRS-US  GNW  Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering," 3/05/2020 CRBP-US  GNW  Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020","12/10/2019 05070R10 GNW  BOLD, MDCO, AYR, and PEGI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts", 2/26/2020 COLL-US  GNW  Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update, 2/19/2020 001LHB-E GNW  XBiotech Announces Final Results of Tender Offer," 6/19/2018 81750R10 GNW  Report: Exploring Fundamental Drivers Behind Diamondback Energy, Global Net Lease, Ambac Financial Group, IDACORP, Francesca's, and Seres Therapeutics â€” New Horizons, Emerging Trends, and Upcoming Developments"," 8/06/2015 NDAQ-US  GNW  Photo Release -- Nasdaq Welcomes Aimmune Therapeutics, Inc. (Nasdaq: AIMT) to The Nasdaq Stock Market", 3/17/2020 GBT-US   GNW  GBT Takes Steps to Support Public Health Efforts to Address COVID-19 Pandemic," 6/25/2018 75901B10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Immune Pharmaceuticals, Wells Fargo, Anadarko Petroleum, CTS, REGENXBIO, and TripAdvisor â€” New Research Emphasizes Economic Growth", 2/19/2020 KURA-US  GNW  Kura Oncology to Participate in Three Upcoming Investor Conferences, 2/26/2020 APLS-US  GNW  Apellis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference, 3/20/2020 AXSM-US  GNW  Axsome Therapeutics Accelerates Completion of the ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimerâ€™s Disease Agitation, 3/03/2020 VYGR-US  GNW  Voyager Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates, 4/10/2020 BGNE-US  GNW  China National Medical Products Administration Approves BeiGeneâ€™s Tislelizumab for Patients with Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma,"11/20/2019 74933V10 GNW  Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of United Community, Highlands, MB Bancorp, and Ra Pharmaceuticals on behalf of Stockholders and Encourages Investors to Contact the Firm"," 2/19/2020 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2019 Financials and Provides an Update on Development Programs", 3/31/2020 HCM-GB   GNW  Chi-Med Initiates a Phase II Trial of HMPL-453 in Patients with Advanced Malignant Mesothelioma in China, 2/20/2020 NTLA-US  GNW  Intellia Therapeutics to Hold Conference CallÂ to Discuss Fourth Quarter and Full-Year 2019 EarningsÂ and Company Update, 3/23/2020 ACIU-US  GNW  AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomerâ„¢ Tau Partnership, 1/06/2020 CRSP-US  GNW  CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference, 2/26/2020 GTHX-US  GNW  G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update,11/08/2019 ARGX-BE  GNW  argenx announces full exercise of underwritersâ€™ option to purchase additional ADSs, 1/30/2020 RUBY-US GNW  Rubius Therapeutics Announces First Patient Dosed in Phase 1b Trial of RTX-134 for the Treatment of Patients with Phenylketonuria, 3/09/2020 ATNX-US  GNW  Athenex Announces FDA Acceptance for Filing of U.S. NDA for Tirbanibulin Ointment in Actinic Keratosis," 2/25/2020 PETQ-US  GNW  PetIQ, Inc. to Report Fourth Quarter and Full Year 2019 Results on Tuesday, March 10th, 2020", 3/30/2020 RYTM-US  GNW  Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities, 2/19/2020 OPTN-US  GNW  Optinose Appoints Victor Clavelli as Chief Commercial Officer, 2/20/2020 TORC-US  GNW  resTORbio to Present at the 9th Annual Leerink Partners Global Healthcare Conference," 1/31/2020 DNLI-US  GNW  Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",, 1/09/2020 SLDB-US  GNW  Solid Biosciences Announces Organizational Changes to Prioritize Development of SGT-001, 3/03/2020 EOLS-US  GNW  Evolus to Participate in Barclays 2020 Global Healthcare Conference, 2/20/2020 FIXX-US GNW  Homology Medicines to Participate in Upcoming Investor and Scientific Conferences, 3/02/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Positive Topline 36-month Follow-up Data for Second Phase 3 Study of YUTIQÂ®, 1/09/2020 SRRK-US  GNW  Scholar Rock Achieves First Milestone in Strategic Fibrosis Collaboration with Gilead Sciences," 3/11/2020 UBX-US   GNW  UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results",,,10/31/2019 28249H10 GNW  Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update," 1/18/2019 AVRO-US  GNW  AVROBIO, Inc. Announces Acceptance of Investigational New Drug (IND) Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis",," 2/10/2020 XERS-US  GNW  Xeris Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of Common Stock", 2/25/2020 AUTL-US  GNW  Autolus Therapeutics to Present at the Cowen 40th Annual Health Care Conference," 3/20/2020 FTSV-US GNW  Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights",11/13/2019 TBIO-US  GNW  Translate Bio to Present at Upcoming Investor Conferences,, 1/09/2020 PRNB-US GNW  Principia Announces Expansion of its BTK Franchise with PRN473 Topical, 3/16/2020 ARVN-US GNW  Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update, 3/12/2020 YMAB-US  GNW  Y-mAbs Announces 2019 Financial Results and Recent Corporate Developments,, 2/25/2020 GRTS-US  GNW  Gritstone Oncology to Present at Two Investor Conferences in March," 2/10/2020 GH-US    GNW  Guardant Health to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020", 3/03/2020 OSMT-US  GNW  Osmotica to Present at Barclays Global Healthcare Conference 2020, 2/25/2020 NGM-US   GNW  NGM Bio to Present at Cowen and Company 40th Annual Health Care Conference,, 2/27/2020 ORTX-US  GNW  Orchard Therapeutics Reports 2019 Financial Results and Reviews Key Strategic Priorities for 2020," 3/27/2020 GOSS-US GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Gossamer Bio, Inc. â€“ GOSS"," 3/23/2020 ALEC-US  GNW  Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors", 3/11/2020 DTIL-US GNW  Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano," 3/02/2020 TPTX-US GNW  Turning Point Therapeutics to Host Fourth-Quarter, Full-Year 2019 Conference Call", 3/24/2020 PRVL-US GNW  Prevail Therapeutics Receives U.S. FDA Fast Track Designation for PR006 to Slow the Progression of Frontotemporal Dementia with a GRN Mutation,, 3/11/2020 BCEL-US GNW  Atreca Reports Fourth Quarter and Full Year 2019 Financial Results,"12/14/2016 ARGSQ-US GNW  Argos Therapeutics Enters into Strategic Research Agreement with Personalis, Inc.",," 3/04/2020 BBIO-US  GNW  BridgeBio Pharma, Inc. Prices Upsized Offering of $475 Million Convertible Senior Notes", 2/19/2020 ADPT-US  GNW  Adaptive Biotechnologies to Present at the 40th Annual Cowen Health Care Conference,
 3/11/2019 53220K50 GNW  Sermonix to Present at Boston Oncology Investor Conference on Potential for Lasofoxifene in Metastatic Breast Cancer Treatment, 1/16/2020 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter Meeting,"12/10/2018 45232710    GNW  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm"," 7/27/2018 84763A10 GNW  New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit â€” Factors of Influence, Major Initiatives and Sustained Production"," 9/27/2018 G3040110 GNW  Recent Analysis Shows Golar LNG, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, Oracle, Ross Stores, Mellanox Technologies, and Endo International plc Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 8/28/2018 04280A10 GNW  New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 2/20/2020 BDSI-US  GNW  BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020"," 4/18/2018 09073M10 GNW  New Research: Key Drivers of Growth for Bonanza Creek Energy, MarketAxess, LivaNova, Cintas, Bio-Techne, and Provident Financial Services â€” Factors of Influence, Major Initiatives and Sustained Production", 3/30/2020 REGN-US  GNW  Sanofi: First patient outside U.S. treated in global KevzaraÂ® (sarilumab) clinical trial program for patients with severe COVID-19," 2/20/2020 SIGA-US      GNW  SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results"," 2/20/2020 OPK-US   GNW  OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020", 2/18/2020 AKCA-US  GNW  Akcea Therapeutics to Hold Fourth Quarter and Full Year 2019 Financial Results Webcast, 7/18/2017 09061G10    GNW  Sarepta Therapeutics and BioMarin Pharmaceutical Inc. Announce Execution of a Global Settlement and a License Agreement Resolving Exon Skipping Patent Litigation,"10/11/2018 01535110 GNW  Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals â€” Discovering Underlying Factors of Influence",12/02/2019 64125C10 GNW  Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy," 6/26/2018 81257810 GNW  Analysis: Positioning to Benefit within The Manitowoc, Omeros, Catabasis Pharmaceuticals, Zayo Group, Covanta Holding, and Seattle Genetics â€” Research Highlights Growth, Revenue, and Consolidated Results", 4/06/2020 IMMU-US  GNW  IMMUNOMEDICS ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AND THE APPOINTMENT OF HAROUT SEMERJIAN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER, 3/16/2020 BIIB-US   GNW  Biogen Foundation Commits $10 Million to Support COVID-19 Relief Efforts in the U.S. and Around the World," 8/06/2018 45253H10 GNW  Investor Expectations to Drive Momentum within Ingevity, First Industrial Realty Trust, ImmunoGen, PriceSmart, Pacific Gas & Electric, and Procter & Gamble â€” Discovering Underlying Factors of Influence", 4/03/2020 BCRX-US  GNW  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/31/2019 37555810 GNW  Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of YescartaÂ® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma," 3/06/2017 ARNA-US  GNW  Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter and Full-Year 2016 Financial Results on Tuesday, March 14, 2017"," 1/28/2020 N5946510 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MAT, MYL and TCNNF",,10/31/2019 AKRX-US  GNW  Akorn Provides Preliminary Third Quarter 2019 Results,10/31/2019 03116210 GNW  BeiGene Announces Global Strategic Oncology Collaboration with Amgen, 3/30/2020 MYGN-US  GNW  Myriad Seeks Japanese Regulatory Approval for its BRACAnalysisÂ® Diagnostic System in People with Advanced Pancreatic and Prostate Cancer, 3/12/2020 LXRX-US  GNW  LEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE,12/05/2019 MGTX-US  GNW  MeiraGTx to Host Parkinsonâ€™s Disease R&D Day in New York,11/06/2018 INSM-US  GNW  Insmed to Present at Three November Conferences," 3/13/2018 05156V10 GNW  Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V.Â â€” Fundamental Analysis, Key Performance Indications"," 4/04/2020 INO-US    GNW  Kessler Topaz Meltzer & Check, LLP Reminds Inovio Pharmaceuticals, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit","10/10/2019 64026810 GNW  SHAREHOLDER ALERT:  Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against Nektar Therapeutics", 2/17/2015 76655960 GNW  Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee," 3/17/2020 GERN-US  GNW  GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm"," 8/16/2018 00771V10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within inTest, Hooker Furniture, American Public Education, Gevo, Envestnet, and Aerie Pharmaceuticals â€” New Research Emphasizes Economic Growth", 3/30/2020 AMRN-US  GNW  Amarin Comments on Ruling in VASCEPAÂ® ANDA Litigation, 9/16/2019 45337C10 GNW  BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia,10/16/2018 91307C10 GNW  United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement, 2/26/2020 SRPT-US  GNW  Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments," 2/28/2019 G0176710 GNW  Research Report Identifies Sunoco LP, Citrix, Alkermes plc, CubeSmart, Morningstar, and Synopsys with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement"," 6/28/2018 15708510 GNW  Report: Developing Opportunities within Torchmark, Cerus, American Equity Investment Life Holding, Southern Copper, F5 Networks, and Diebold Nixdorf â€” Future Expectations, Projections Moving into 2018"," 2/28/2020 AMAG-US  GNW  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call  and Webcast on Wednesday, March 4, 2020 at 8:00 a.m. ET"," 6/11/2018 04269E10 GNW  The Race to Treat Cancer, ArQule Inc. Continues Progress Across All Pipeline Assets"," 6/20/2018 55027E10 GNW  Detailed Research: Economic Perspectives on MGM Growth Properties, Acacia Research, Luminex, Eastman Chemical, Mobile Mini, and Kilroy Realty â€” What Drives Growth in Today's Competitive Landscape", 2/12/2013 SAVA-US  GNW  Pain Therapeutics Announces New Board Member,"10/06/2017 30161Q10 GNW  New Research: Key Drivers of Growth for Bed Bath and Beyond, The Finish Line, Exelixis, Garmin, Juno Therapeutics, and Mattel - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production", 4/10/2020 SAN-FR   GNW  COVID-19:Â  Sanofi to donate 100 million doses of hydroxychloroquine across 50 countriesÂ , 4/16/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia, 2/06/2020 ALLO-US  GNW  Allogene Therapeutics Announces February and March 2020 Investor Conference Schedule, 3/25/2020 ASND-US  GNW  Ascendis Pharma A/S Announces Full Year 2019 Financial Results and Business Update Conference Call on April 1, 6/22/2015 09609G10 GNW  Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers, 9/13/2018 00422510 GNW  Investors: The Law Offices of Howard G. Smith Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. (ACAD), 3/26/2020 AFMD-US  GNW  Affimed Announces Participation at Upcoming Virtual Investor Conferences,, 2/24/2020 PRQR-US  GNW  ProQR to Present at Cowen and Company 40th Annual Health Care Conference,"10/06/2017 TXMD-US  GNW  TherapeuticsMD, Inc. (Nasdaq: TXMD) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its Listing On Nasdaq", 3/03/2020 ZGNX-US  GNW  Zogenix Prices Public Offering of Common Stock," 4/01/2020 ALLK-US  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Funko, Allakos, Cronos Group, and Gulfport Energy and Encourages Investors to Contact the Firm","10/23/2018 68214310 GNW  New Research: Key Drivers of Growth for Hecla Mining, Atlas Air Worldwide, Encana, Omeros, Lowe's Companies, and Oaktree Specialty Lending â€” Factors of Influence, Major Initiatives and Sustained Production", 6/13/2016 RVNC-US  GNW  Revance Reports Results for RT001 Topical Phase 3 Trial for Lateral Canthal Lines,,12/21/2012 46333X10 GNW  Ironwood Begins Phase I Trial of Investigational IW-2143 Anxiety Drug in US, 3/05/2020 ADVM-US  GNW  Adverum Biotechnologies to Host a Conference Call and Webcast to Report Fourth Quarter 2019 Financial Results and Provide Corporate Update, 3/09/2020 RARE-US   GNW  Ultragenyx to Present at Barclays Global Healthcare Conference, 1/06/2020 AGLE-US  GNW  Aeglea BioTherapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference, 8/19/2019 NSTG-US  GNW  NanoString to Present at the Baird 2019 Global Healthcare Conference," 6/26/2018 69329Y10 GNW  Research Report Identifies PDL BioPharma, TEGNA, Patterson Companies, Boardwalk Pipeline Partners, Exact Sciences, and Berkshire Hathaway with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement"," 8/29/2018 87184Q10 GNW  Report: Developing Opportunities within Cree, ArcBest, Syros Pharmaceuticals, Aegion, Adecoagro S.A, and Nevsun Resources â€” Future Expectations, Projections Moving into 2018"," 2/13/2020 RDUS-US  GNW  Radius Health to Announce Fourth Quarter and Full Year 2019 Financial Results, Host Conference Call and Live Webcast on Thursday, February 27, 2020", 3/04/2020 ASMB-US  GNW  Assembly Biosciences Reports Fourth Quarter and Year End 2019 Financial Results," 6/25/2018 00182C10 GNW  Market Trends Toward New Normal in EnviroStar, Rowan Companies, Del Taco Restaurants, ANI Pharmaceuticals, Infinity Property and Casualty, and Viacom â€” Emerging Consolidated Expectations, Analyst Ratings",,"11/25/2018 02043Q10 GNW  MONDAY DEADLINE: Kaskela Law LLC Announces Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm â€“ ALNY"," 2/13/2020 WVE-US   GNW  Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020", 2/28/2020 AKCA-US  GNW  Akcea Supports Rare Disease Day 2020 and Global Efforts to â€œReframe Rareâ€,"11/08/2017 60468T10 GNW  Market Trends Toward New Normal in ONEOK, ServiceNow, Mirati, ImmunoCellular, United Technologies, and USG â€“ Emerging Consolidated Expectations, Analyst Ratings", 1/21/2020 0H5BMT-E GNW  Pacira BioSciences Launches National Regional Anesthesia Training Initiative with Envision Physician Services, 2/24/2020 RTRX-US  GNW  Retrophin Reports Fourth Quarter and Full Year 2019 Financial Results, 3/05/2020 PACB-US  GNW  Christian Henry Appointed Chairman of Pacific Biosciencesâ€™ Board of Directors, 1/13/2020 EDIT-US  GNW  Editas Medicine Reports on Recent Progress at J.P. Morgan Healthcare Conference, 1/13/2020 CHMA-US  GNW  Chiasma Announces FDA Acceptance of MYCAPSSAÂ® New Drug Application Resubmission, 2/13/2020 MGNX-US  GNW  MacroGenics Announces Date of Fourth Quarter and Full Year 2019 Financial Results Conference Call," 5/01/2018 09627Y10 GNW  Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical â€” Future Expectations, Projections Moving into 2018",10/30/2018 00972D10 GNW  Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia Therapeutics, 7/27/2015 28249U10 GNW  LAWSUIT ALERT REMINDER: The Law Firm of Andrews & Springer LLC Announces That a Securities Fraud Class Action Has Been Filed Against Celladon Corporation - CLDN, 2/12/2020 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2019 Financial Results Conference Call and Webcast, 3/03/2020 PRTA-US  GNW  Prothena Announces Appointment of Brandon Smith as Chief Business Officer, 3/16/2020 ZLAB-US  GNW  Zai Lab Announces Acceptance of sNDA Submission of ZEJULAÂ® (Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China by the NMPA,"12/04/2017 78667J10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Exelon, Newell Brands, Sage Therapeutics, Advanced Disposal Services, Opus Bank, and Anworth Mortgage Asset â€” New Research Emphasizes Economic Growth", 3/23/2020 CTMX-US  GNW  CYTOMX THERAPEUTICS ANNOUNCES APPOINTMENT OF CARLOS CAMPOY AS CHIEF FINANCIAL OFFICER, 2/19/2020 GMAB-DK  GNW  Genmab Publishes 2019 Annual Report, 4/17/2019 92165910 GNW  A Securities Class Action Has Been Filed Against Vanda; Block & Leviton LLP Encourages Shareholders to Contact the Firm,," 3/03/2020 CBAY-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud",10/01/2013 45781M10 GNW  Xumanii Buys Trakkers, 1/09/2020 16383L10 GNW  ChemoCentryx Announces Credit Facility of Up to $100 Million with Hercules Capital,"11/29/2018 40637H10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Halozyme Therapeutics, Inc. (HALO)",, 2/25/2020 MNKD-US   GNW  MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results, 7/11/2018 URGN-US  GNW  UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGelâ„¢) for the Treatment of Low-Grade Non-Muscle Invasive Bladder Cancer (LG NMIBC), 3/30/2020 CYTK-US  GNW  Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual, 4/06/2020 ESPR-US     GNW  Esperion Announces European Commission Approval of the NILEMDOâ„¢ (bempedoic acid) Tablet for the Treatment of Hypercholesterolemia and Mixed Dyslipidemia," 6/03/2019 03236M20  GNW  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm","10/23/2018 69366J20 GNW  Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA â€” Emerging Consolidated Expectations, Analyst Ratings",11/19/2019 ACHN-US  GNW  European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Not Adequately Responding to a C5 Inhibitor, 2/20/2020 SYNH-US  GNW  Syneos Health Reports Fourth Quarter and Full Year 2019 Results, 2/26/2020 FOLD-US  GNW  Amicus Therapeutics to Present at the Cowen & Company 40th Annual Health Care Conference,"12/19/2017 26979610 GNW  Research Report Identifies 2U, AK Steel Holding, American Water Works, Urban Edge Properties, Guidewire Software, and Eagle Pharmaceuticals with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement"," 7/25/2018 24344T10 GNW  Analysis: Positioning to Benefit within Xylem, Duluth, Deciphera Pharmaceuticals, Mesabi Trust, Associated Banc-Corp, and AG Mortgage Investment Trust â€” Research Highlights Growth, Revenue, and Consolidated Results", 2/24/2020 ADMA-US  GNW  ADMA Biologics Announces Closing of Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares in Connection with Its Public Offering of Common Stock," 3/13/2020 GWPH-US  GNW  GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEXÂ®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)", 7/23/2018 EPZM-US  GNW  Epizyme Appoints Dr. Shefali Agarwal as Chief Medical Officer, 3/05/2014 GENTY-US GNW  Gentium S.p.A. Announces Decision to Voluntarily Delist American Depositary Shares from The NASDAQ Global Market, 2/27/2020 MYOK-US  GNW  MyoKardia Reports Fourth Quarter and Full Year 2019 Financial Results,11/22/2013 0CG9F4-E GNW  TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols, 3/27/2020 GLPG-NL  GNW  Publication of the annual report and invitation to the ordinary and extraordinary shareholdersâ€™ meetings, 3/09/2020 PTLA-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,,," 8/20/2018 15117K10 GNW  Report: Exploring Fundamental Drivers Behind Ballard Power, Reading International, Odonate Therapeutics, Stitch Fix, Summit Therapeutics, and Cellectis S.A â€” New Horizons, Emerging Trends, and Upcoming Developments", 2/27/2020 CARA-US  GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, 3/12/2020 FLXN-US  GNW  Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, 3/03/2020 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences in March," 3/23/2020 AGIO-US   GNW  Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator"," 2/19/2020 IOVA-US  GNW  Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Tuesday, February 25, 2020"," 4/01/2020 ANAB-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS ANAB, SSL, XP INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 2/28/2018 ELOX-US  GNW  Eloxx Pharmaceuticals Appoints Biotech Leader, Dr. Jasbir Seehra, Co-founder of Acceleron Pharma, to Board of Directors", 2/26/2020 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2019 Financial Results, 6/14/2018 HZNP-US  GNW  Epidemiologic Study Findings Show 27 Percent Increase in Emergency Department VisitsÂ for Gout in the United States Over the Past Decade,," 2/18/2020 ICPT-US  GNW  Intercept to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020", 4/01/2020 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 7/27/2018 38000Q10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Minerals Technologies, USG, Continental Resources, Take-Two Interactive Software, Trimble, and GlycoMimetics â€” New Research Emphasizes Economic Growth"," 5/04/2018 98401F10 GNW  Market Trends Toward New Normal in LRAD, Xencor, QuinStreet, Old Second, WesBanco, and Invitae â€” Emerging Consolidated Expectations, Analyst Ratings", 3/02/2020 ITCI-US  GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update,,"12/07/2018 G6674U10 GNW  Recent Analysis Shows Moody's, Hershey, NovoCure, Mohawk Industries, La-Z-Boy, and Lockheed Martin Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 8/17/2018 03969710 GNW  Consolidated Research: 2018 Summary Expectations for PDF Solutions, MYOS RENS Technology, Aldeyra Therapeutics, The Ensign Group, Everi, and Ardelyx â€” Fundamental Analysis, Key Performance Indications"," 3/05/2020 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020"," 2/19/2020 ATRA-US    GNW  Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020", 2/02/2017 77313F10 GNW  IMPORTANT INOTEK INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the District of Massachusetts against Inotek Pharmaceuticals Corporation, 1/17/2020 DERM-US  GNW  Emerging Markets Report:Â  A Very Big Deal, 2/18/2020 FOMX-US  GNW  Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea, 3/20/2020 PRAH-US  GNW  PRA Health Sciences Launches COVID-19 Monitoring Program, 2/25/2020 SUPN-US  GNW  Supernus Announces Fourth Quarter and Full Year 2019 Financial Results, 2/11/2020 31572Q80 GNW  FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease,"10/17/2018 74587V10 GNW  Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis â€” Discovering Underlying Factors of Influence", 4/13/2020 CHRS-US  GNW  Coherus BioSciences Provides First Quarter 2020 Financial Update  and Fiscal Year 2020 COVID-19 Impact Insights, 2/11/2020 21833P10 GNW  Corbus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares,"10/16/2018 05070R10 GNW  Report: Developing Opportunities within The Ensign Group, Forterra, Inc., Audentes Therapeutics, Assembly Biosciences, Capital Senior Living, and Myomo â€” Future Expectations, Projections Moving into 2018", 2/13/2020 COLL-US  GNW  Collegium Announces Closing of the Nucynta Franchise Acquisition, 2/13/2020 XBIT-US  GNW  Corrected Press Release: XBiotech Announces Preliminary Results of Tender Offer,"11/28/2016 81750R10 GNW  DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Seres Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2016 â€“ MCRB"," 8/06/2015 00900T10 GNW  Aimmune Therapeutics, Inc. (Nasdaq:AIMT) to Ring The Nasdaq Stock Market Opening Bell", 3/04/2020 GBT-US   GNW  GBT Announces New Employment Inducement Grants," 3/22/2018 75901B10 GNW  Consolidated Research: 2018 Summary Expectations for REGENXBIO, WD-40, Chesapeake Utilities, Astronics, Park-Ohio, and Cass Information â€” Fundamental Analysis, Key Performance Indications", 2/18/2020 KURA-US  GNW  Kura Oncology to Report Fourth Quarter and Full Year 2019 Financial Results, 1/16/2020 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/12/2020 AXSM-US  GNW  Axsome Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update, 2/26/2020 VYGR-US  GNW  Voyager Therapeutics to Participate in Upcoming Investor Conferences, 3/25/2020 BGNE-US  GNW  BeiGene Announces Supply Update for ABRAXANEÂ® in China,"11/16/2019 74933V10 GNW  Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to ShareholdersÂ â€“ WLH, CISN, RARX, TECD"," 2/12/2020 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2019 Financials and to Provide an Update on Development Programs on February 19, 2020", 3/03/2020 HCM-GB   GNW  Chi-Med Reports 2019 Full Year Results and Provides Updates on KeyÂ ClinicalÂ Programs, 2/10/2020 NTLA-US  GNW  Intellia Therapeutics Presents New Data From Its Engineered Cell Therapy and In Vivo Programs at Keystone Symposiaâ€™s Engineering the Genome Conference, 3/20/2020 ACIU-US  GNW  Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immuneâ€™s Clinical Advisory Board,11/27/2019 CRSP-US  GNW  CRISPR Therapeutics to Present at Upcoming Investor Conferences, 2/24/2020 GTHX-US  GNW  G1 Therapeutics to Present at Investor Conferences in March 2020,11/06/2019 ARGX-BE  GNW  argenx raises $484 million in gross proceeds in a global offering, 1/13/2020 RUBY-US GNW  Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference, 3/02/2020 ATNX-US  GNW  Athenexâ€™s Partner Almirall Announces EMA Acceptance for Filing of Marketing Authorization Application (MAA) for Tirbanibulin Ointment in Actinic Keratosis," 2/18/2020 PETQ-US  GNW  PetIQ, Inc. to Participate in the Bank of America Merrill Lynch Animal Health Summit", 3/18/2020 RYTM-US  GNW  Rhythm Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for Setmelanotide for the Treatment of AlstrÃ¶m Syndrome,12/17/2019 OPTN-US  GNW  Optinose Announces Peer-Reviewed Publication of the Fourth Major XHANCE Registration Trial, 2/19/2020 TORC-US  GNW  resTORbio Announces Interim Results for Phase 1b/2a Trial of RTB101 in Patients with Parkinsonâ€™s Disease and Provides Corporate Update, 1/28/2020 DNLI-US  GNW  Denali Therapeutics Announces Pricing of Public Offering of Common Stock,,12/18/2019 SLDB-US  GNW  Solid Biosciences Provides Data Update from SGT-001 Development Program, 2/25/2020 EOLS-US  GNW  Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update, 2/13/2020 FIXX-US GNW  Homology Medicines Presents New Data Characterizing AAVHSCs as Potential Gene Therapies for Nervous System Disorders, 2/27/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Fourth Quarter and Full-Year 2019 Financial Results Release Date and Conference Call Information,12/19/2019 80706P10 GNW  Scholar Rock Added to NASDAQ Biotechnology Index," 3/03/2020 UBX-US   GNW  UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results",,, 9/30/2019 EIDX-US  GNW  Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy at the AHA 2019 Scientific Sessions in a Late-Breaking Featured Science Oral Presentation," 1/17/2019 AVRO-US  GNW  AVROBIO, Inc. Announces Analyst and Investor Event and Upcoming Clinical Data Presentations at WORLDSymposium 2019",,12/27/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/24/2020 AUTL-US  GNW  Autolus Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 3," 3/11/2020 FTSV-US GNW  Lifshitz & Miller LLP Announces Investigation of Forty Seven, Inc., Mobile Mini, Inc., Qiagen N.V. and The Meet Group, Inc.",10/31/2019 TBIO-US  GNW  Translate Bio Presents MRT5005 Data at the 33rd Annual North AmericanÂ Cystic Fibrosis Conference,, 1/07/2020 PRNB-US GNW  Principia Announces Expanded Development Program to Broaden BTK Footprint in Immune-Mediated Diseases,11/27/2019 ARVN-US GNW  Arvinas to Present at the 31st Annual Piper Jaffray Healthcare Conference," 3/05/2020 YMAB-US  GNW  Y-mAbs to Announce 2019 Financial and Operating Results on March 12, 2020",, 1/08/2020 GRTS-US  GNW  Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/21/2020 GH-US    GNW  Guardant Health Appoints High-Tech-Veteran Kumud Kalia Chief Information Officer, 2/18/2020 OSMT-US  GNW  Osmotica to Present at 9th Annual SVB Leerink Global Healthcare Conference," 2/24/2020 NGM-US   GNW  NGM Bio Announces Positive Preliminary Topline Liver Histology and Biomarker Data from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in NASH Patients, Including Statistically Significant Achievement of Composite Endpoint of Both Fibrosis Improvement and Resolution of NASH versus Placebo",, 2/26/2020 ORTX-US  GNW  Orchard Therapeutics to Present at Investor Conferences in March,, 2/24/2020 ALEC-US  GNW  Alector to Present at the Cowen 40th Annual Health Care Conference, 3/10/2020 DTIL-US GNW  Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update, 2/20/2020 TPTX-US GNW  Turning Point Therapeutics Names Siegfried Reich as Executive Vice President and Chief Scientific Officer, 3/03/2020 PRVL-US GNW  Prevail Therapeutics Provides Clinical Advancement Update on PR001 for the Treatment of Parkinsonâ€™s Disease with GBA1 mutations,, 2/24/2020 BCEL-US GNW  Atreca to Present at the Cowen and Company 40th Annual Health Care Conference,,," 3/04/2020 BBIO-US  GNW  BridgeBio Pharma, Inc. Announces Proposed Offering of $350 Million Convertible Senior Notes"," 2/12/2020 ADPT-US  GNW  Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020",
" 3/05/2019 53220K50 GNW  Detailed Research: Economic Perspectives on Twenty-First Century Fox, Acadia Healthcare, Targa Resources, WellCare Health Plans, Ligand Pharmaceuticals, and Duke Energy â€” What Drives Growth in Today's Competitive Landscape",12/23/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyLâ„¢ in Prostate Cancer Achieved Primary Endpoint,"10/11/2018 45232710    GNW  Analysis: Positioning to Benefit within Tenet Healthcare, GAIN Capital, Illumina, First Cash, Regis, and Cornerstone OnDemand â€” Research Highlights Growth, Revenue, and Consolidated Results","11/04/2016 84763A10 GNW  SPPI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016", 8/08/2018 G3040110 GNW  Nevakar and Endo Enter into Exclusive Licensing Agreement for Multiple 505(b)(2) Injectable Products," 6/26/2018 04280A10 GNW  Investor Expectations to Drive Momentum within AMC Entertainment, Arrowhead Pharmaceuticals, U.S. Silica, Catalent, RSP Permian, and KapStone Paper and Packaging â€” Discovering Underlying Factors of Influence", 1/13/2020 BDSI-US  GNW  BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic," 1/26/2018 09073M10 GNW  Research Report Identifies Methode Electronics, Bio-Techne, VOXX International, American Tower Corporation (REIT), Medical Properties Trust, and HRG Group with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",12/10/2019 REGN-US  GNW  Sanofi and Regeneron announce intent to restructure Antibody collaboration for KevzaraÂ® (sarilumab) and PraluentÂ® (alirocumab),"12/05/2019 SIGA-US      GNW  SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXXÂ®","12/19/2019 06JJ0P-E GNW  BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience", 1/28/2020 46222210 GNW  Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx,12/12/2016 BMRN-US     GNW  BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia," 9/04/2018 ABEO-US  GNW  Karyopharm Appoints Carsten Thiel, Ph.D., to its Board of Directors", 3/28/2019 64125C10 GNW  Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinsonâ€™s Disease in the Annals of Neurology," 5/09/2018 81257810 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Patterson Companies, Zayo Group, Six Flags Entertainment Corporation New, Leucadia National, Seattle Genetics, and RPC â€” New Research Emphasizes Economic Growth"," 4/03/2020 IMMU-US  GNW  IMMUNOMEDICS TO HOST CONFERENCE CALL AND WEBCAST ON APRIL 6, 2020 TO PROVIDE CLINICAL AND CORPORATE UPDATE", 3/12/2020 BIIB-US   GNW  Vir Biotechnology Announces Intent to Collaborate with Biogen on Manufacturing of Antibodies to Potentially Treat COVID-19, 3/31/2017 MGNX-US  GNW  Eight Posters Based on MacroGenics-developed Molecules Featured at AACR Annual Meeting 2017, 4/02/2020 BCRX-US  GNW  BioCryst Appoints Anthony Doyle Chief Financial Officer,"10/31/2018 37555810 GNW  Investor Expectations to Drive Momentum within Gilead Sciences, SCANA, Brink's, Fortive, Asbury Automotive Group, and Helmerich & Payne â€” Discovering Underlying Factors of Influence", 8/19/2013 04004760 GNW  Innovus Pharma Provides Corporate Update," 1/27/2020 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,"10/14/2019 AKRX-US  GNW  Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%", 9/13/2019 AMGN-US  GNW  Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma, 3/23/2020 MYGN-US  GNW  Myriad Announces Board of Directors Leadership Transition," 3/05/2020 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call and Webcast on March 12, 2020",11/26/2019 MGTX-US  GNW  MeiraGTx to Present at Upcoming Healthcare Conferences,10/30/2018 INSM-US  GNW  Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update,11/12/2014 05156V10 GNW  Aurinia Reports Third Quarter 2014 Financial Results," 4/03/2020 AAN-US    GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AAN, FLR, INO, MGPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits","10/09/2019 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NetApp, SAExploration, Nektar Therapeutics, and Valaris and Encourages Investors to Contact the Firm",," 3/15/2020 GERN-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 8 Days Remain Until Application Deadline, Investors with Losses Encouraged to Contact Firm", 7/09/2018 EYEN-US  GNW  Eyenovia Appoints Michael Rowe as Vice President of Marketing Ahead of Initiation of Multiple Phase III Programs, 3/30/2020 AMRN-US  GNW  Eicosapentaenoic Acid (EPA) Levels From VASCEPAÂ® (Icosapent Ethyl) in REDUCE-ITÂ® Strongly Correlated with Cardiovascular Outcomes," 9/09/2019 45337C10 GNW  BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49", 9/04/2018 91307C10 GNW  United Therapeutics and MannKind Announce Collaboration for Pulmonary Hypertension Products," 2/19/2020 SRPT-US  GNW  Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments on February 26, 2020"," 2/25/2019 G0176710 GNW  CLASS ACTION UPDATE for YRIV, ALKS, MKL and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/07/2017 CERS-US  GNW  Cerus Corporation (Nasdaq: CERS) to Ring the Nasdaq Stock Market Closing Bell Remotely from the Nasdaq Entrepreneurial Center in San Francisco," 2/14/2020 AMAG-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG"," 6/08/2018 04269E10 GNW  Research Report Identifies Qudian Inc., ICICI Bank, Mobile TeleSystems OJSC, ArQule, Alibaba Group Holding, and Arcos Dorados with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 6/20/2016 LMNX-US  GNW  Nanosphere Announces Intent to Voluntarily Delist From NASDAQ Capital Market," 7/07/2010 80067710 GNW  Liberty Analytics Co. Initiates Independent Research Coverage on Sangamo BioSciences, Inc.", 8/26/2010 XOMA-US  GNW  XOMA Appoints Jack L. Wyszomierski to Its Board of Directors, 4/06/2020 REGN-US  GNW  Sanofi finalizes PraluentÂ® (alirocumab) restructuring with Regeneron," 3/06/2019 92532F10 GNW  Detailed Research: Economic Perspectives on KAR Auction Services, Spectrum Brands, Vertex Pharmaceuticals, The Kraft Heinz, comScore, and Retrophin â€” What Drives Growth in Today's Competitive Landscape", 1/13/2020 ALLO-US  GNW  Allogene Therapeutics and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate ALLO-715 in Combination with Nirogacestat in Multiple Myeloma, 2/12/2020 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentation in February, 5/26/2015 09609G10 GNW  bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy," 9/13/2018 00422510 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Beverage, ACADIA, and Vuzix and Encourages Investors to Contact the Firm"," 3/17/2020 AFMD-US  GNW  Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer",, 2/06/2020 0FWYJ1-E GNW  ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina TrackerÂ® Program for People Living with Inherited Retinal Diseases," 6/19/2017 88338N10 GNW  DEADLINE TODAY: TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017", 3/03/2020 ZGNX-US  GNW  Zogenix Announces Proposed Public Offering of Common Stock," 3/25/2020 ALLK-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Losses to Contact Its Attorneys: Application Deadline Approaching"," 8/28/2018 68214310 GNW  Detailed Research: Economic Perspectives on Allegheny Technologies, Ring Energy, Aerohive Networks, Omeros, Adtalem Global Education, and BioPharmX â€” What Drives Growth in Today's Competitive Landscape", 6/02/2016 RVNC-US  GNW  Revance Expands Botulinum Toxin Assets by Acquiring Intellectual Property (IP) Portfolio,,11/08/2012 IRWD-US  GNW  IND Submission to FDA for IW-2143 (BNC210) Anti-Anxiety Drug Candidate," 3/04/2020 ADVM-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc.Â â€“ ADVM", 3/03/2020 RARE-US   GNW  Ultragenyx Announces Planned Transition of Chief Financial Officer,11/26/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences, 8/06/2019 NSTG-US  GNW  New Publication Demonstrates First Use of NanoStringâ€™s GeoMx Digital Spatial Profiler in Neuroscience,"11/14/2014 69329Y10 GNW  PDL BIOPHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against PDL BioPharma, Inc. -- PDLI"," 7/26/2018 87184Q10 GNW  Investor Expectations to Drive Momentum within ShotSpotter, Kohl's, Cheniere Energy Partners LP, Palo Alto Networks, Syros Pharmaceuticals, and Ryman Hospitality Properties â€” Discovering Underlying Factors of Influence", 2/13/2020 RDUS-US  GNW  Radius Health to Present at 9th Annual SVB Leerink Partners Global Healthcare Conference, 2/19/2020 ASMB-US  GNW  Assembly Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference, 5/14/2012 TSRX-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,"11/20/2018 02043Q10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Alnylam, MGT Capital, and Applied Optoelectronics and Encourages Investors to Contact the Firm",12/30/2019 WVE-US   GNW  Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2aÂ PRECISION-HD2 Trial in Huntingtonâ€™s Disease, 2/26/2020 AKCA-US  GNW  Akcea Therapeutics to Present at the Cowen 40th Annual Health Care Conference,, 1/09/2020 PCRX-US  GNW  Pacira BioSciences Reports Full-Year 2019 Preliminary Revenue of $421.0 Million, 2/19/2020 RTRX-US  GNW  Retrophin to Present at Upcoming Investor Conferences, 2/25/2020 PACB-US  GNW  Pacific Biosciences to Support Sequencing of California Species for the Earth BioGenome Project," 1/13/2020 EDIT-US  GNW  Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer", 1/10/2020 CHMA-US  GNW  Chiasma Provides Corporate Update and Previews 2020 Milestones, 2/10/2020 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences, 9/26/2017 BPMC-US  GNW  AUTOLUS LIMITED: Autolus Secures US$80 million Series C Funding," 8/21/2018 00972D10 GNW  Report: Exploring Fundamental Drivers Behind Oaktree Specialty Lending, uniQure N.V, Mercury, Akebia Therapeutics, Mitel Networks, and Greenlight Capital Re â€” New Horizons, Emerging Trends, and Upcoming Developments", 7/24/2015 28249U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Celladon Corporation of Class Action Lawsuit and Upcoming Deadline â€“ CLDN, 1/13/2020 MNTA-US  GNW  Momenta Provides Year-End 2019 Update and 2020 Outlook," 2/12/2020 PRTA-US  GNW  Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update"," 3/05/2020 ZLAB-US  GNW  Zai Lab to Announce Financial Results for the Full Year Ended December 31, 2019 and Corporate Updates on March 19, 2020"," 7/18/2017 CRM-US   GNW  dinCloudâ€™s New Virtual Robot Improves Quality Assurance and Customer Experience in SAP, Salesforce, Sage, and Microsoft Dynamics", 3/16/2020 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grant, 1/22/2020 GMAB-DK  GNW  Genmab Announces 2019 Net Sales Figures for DARZALEXÂ® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen, 4/16/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,, 1/29/2020 CBAY-US  GNW  CymaBay Publishes Shareholder Letter, 9/19/2013 45781M10 GNW  Inova Revenue Increased 90% to $7.6 Million for Quarter, 1/08/2020 CCXI-US  GNW  ChemoCentryx to Present at the 38th Annual JP Morgan Healthcare Conference,"11/08/2018 40637H10 GNW  Report: Exploring Fundamental Drivers Behind Entergy, BLACKLINE INC, HollyFrontier, Hill-Rom, Apache, and Halozyme Therapeutics â€” New Horizons, Emerging Trends, and Upcoming Developments",, 2/24/2020 MNKD-US   GNW  MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference, 7/10/2018 URGN-US  GNW  UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors Â , 3/20/2020 CYTK-US  GNW  CYTOKINETICS TO ANNOUNCE BASELINE CHARACTERISTICS FROM GALACTIC-HF DURING ACC.20/WCC, 3/30/2020 ESPR-US     GNW  Esperion Announces Commercial Availability of the NEXLETOLâ„¢ (bempedoic acid) Tablet and Pledges a Conscientious Launch During Unprecedented Moment in Healthcare," 6/02/2019 03236M20  GNW  AMYRIS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Amyris, Inc. - AMRS"," 8/28/2018 69366J20 GNW  New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix â€” Consolidated Revenues, Company Growth, and Expectations for 2018",11/11/2019 ACHN-US  GNW  Achillion Announces Clearance of Investigational New Drug Application for ACH-5228," 1/22/2020 SYNH-US  GNW  Syneos Health Schedules Fourth Quarter and Year End 2019 Earnings Call for Thursday, February 20, 2020"," 2/19/2020 FOLD-US  GNW  Amicus Therapeutics to Announce Full-Year 2019 Financial Results on March 2, 2020"," 8/01/2016 26979610 GNW  SHAREHOLDER ALERT: Rosen Law Firm Reminds Eagle Pharmaceuticals, Inc. Investors of Important August 1 Deadline in Class Action - EGRX","12/18/2017 DCPH-US  GNW  Deciphera Pharmaceuticals, Inc. Added to Russell 2000Â® Index", 2/11/2020 ADMA-US  GNW  ADMA Biologics Receives BioNJ 2020 Innovator Award for ASCENIVâ„¢, 3/02/2020 0JBRH7-E GNW  JAMA Neurology Publishes Results from Positive Phase 3 Trial of EPIDIOLEXÂ® (cannabidiol) oral solution in Children with Seizures Associated with Dravet Syndrome, 7/19/2018 EPZM-US  GNW  Epizyme Announces Date of Second Quarter 2018 Financial Results  and Business Update Conference Call,12/19/2013 G5087110 GNW  Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share, 2/24/2020 MYOK-US  GNW  MyoKardia to Present at 40th Annual Cowen Health Care Conference,11/20/2013 39843840 GNW  TiGenix Raises EUR 12 million via a Private Placement of New Ordinary Shares, 3/17/2020 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises," 3/09/2020 PTLA-US  GNW  PTLA ALERT: Pawar Law Group Reminds Investors of March 16 Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc.â€“ PTLA",,, 4/01/2015 15117K10 GNW  Nasdaq Leads U.S. Exchanges for IPOs in 2015," 2/20/2020 CARA-US  GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020", 3/11/2020 FLXN-US  GNW  Flexion Therapeutics Names Melissa Layman Chief Commercial Officer, 3/02/2020 QURE-US  GNW  uniQure Announces 2019 Financial Results and Highlights Recent Company Progress," 2/18/2020 AGIO-US   GNW  Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020", 2/12/2020 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences," 4/01/2020 ANAB-US  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exela Technologies, RTI Surgical, DouYu, and AnaptysBio and Encourages Investors to Contact the Firm",, 2/07/2020 FATE-US  GNW  Fate Therapeutics to Present at Upcoming Investor Conferences, 6/04/2018 HZNP-US  GNW  Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention,, 1/29/2020 ICPT-US  GNW  Intercept Completes Enrollment of Phase 3 REVERSE Study Evaluating Obeticholic Acid for the Treatment of Compensated Cirrhosis due to NASH, 3/17/2020 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)," 1/26/2018 38000Q10 GNW  New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America â€” Factors of Influence, Major Initiatives and Sustained Production"," 3/01/2018 98401F10 GNW  Consolidated Research: 2018 Summary Expectations for Sonic Automotive, Xencor, Gevo, OSI, Buckeye Partners, and Glatfelter â€” Fundamental Analysis, Key Performance Indications", 2/24/2020 ITCI-US  GNW  Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast,,11/14/2018 ZLAB-US  GNW  Zai Lab and Novocure Awarded Deal of the Year," 4/05/2018 03969710 GNW  Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics â€” Research Highlights Growth, Revenue, and Consolidated Results"," 2/27/2020 AMPH-US  GNW  Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL", 2/05/2020 ATRA-US    GNW  Atara Biotherapeutics Names Kristin Yarema as Chief Commercial Officer," 1/27/2017 77313F10 GNW  ITEK INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017"," 1/15/2020 24983L10 GNW  DERM, CRCM, LOGM, and WAAS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts", 2/06/2020 FOMX-US  GNW  Foamix and Menlo Announce Shareholder Approval of Proposed Merger, 3/11/2020 PRAH-US  GNW  Symphony Health Partners with Datavant for the Industryâ€™s Deepest View of the Patient Journey, 2/11/2020 SUPN-US  GNW  Supernus to Host Fourth Quarter and Full Year 2019 Results Earnings Conference Call, 2/11/2020 FGEN-US  GNW  FibroGen to Present at 9th Annual SVB Leerink Global Healthcare Conference," 8/23/2018 74587V10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Patterson-UTI Energy, Puma Biotechnology, Echelon, McEwen Mining, New Gold, and Qudian Inc. Sponsored ADR â€” New Research Emphasizes Economic Growth", 3/20/2020 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 2/07/2020 CRBP-US  GNW  Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock," 8/17/2018 05070R10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within AgroFresh Solutions, SMART SAND INC, Advantage Oil & Gas, Abeona Therapeutics, B. Riley Financial, and Audentes Therapeutics â€” New Research Emphasizes Economic Growth"," 2/10/2020 COLL-US  GNW  Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering", 2/13/2020 001LHB-E GNW  XBiotech Announces Preliminary Results of Tender Offer,"10/26/2016 81750R10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Seres Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2016 â€“ MCRB",, 2/26/2020 GBT-US   GNW  GBT Reports Recent Business Progress and Fourth Quarter and Full YearÂ 2019 Financial Results, 3/07/2018 RGNX-US  GNW  REGENXBIO to Participate in Upcoming Investor Conferences, 1/23/2020 KURA-US  GNW  Kura Oncology Announces Transition ofÂ Chief Medical Officer, 1/13/2020 APLS-US  GNW  Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares, 3/05/2020 AXSM-US  GNW  Axsome Therapeutics Announces the Promotion of Mark Jacobson to Chief Operating Officer," 2/25/2020 VYGR-US  GNW  Voyager Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 3, 2020", 3/02/2020 BGNE-US  GNW  BeiGene Reports Fourth Quarter and Full Year 2019 Financial Results,"11/15/2019 74933V10 GNW  SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, RARX, and IPHS Shareholders About Its Ongoing Investigations","11/18/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares"," 2/25/2020 HCM-GB   GNW  Chi-Med to announce 2019 Final Results on Tuesday, March 3, 2020 â€“ adjustment to announcement and presentation logistics due to travel restrictions", 1/09/2020 NTLA-US  GNW  Intellia Therapeutics Highlights Recent Progress and Anticipated 2020 Milestones, 3/05/2020 ACIU-US  GNW  AC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimerâ€™s and Parkinsonâ€™s Therapies Focus Meeting,11/20/2019 CRSP-US  GNW  CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares," 2/19/2020 GTHX-US  GNW  G1 Therapeutics to Provide Fourth Quarter and Full Year 2019 Corporate and Financial Update on February 26, 2020",10/24/2019 ARGX-BE  GNW  argenx reports third quarter 2019 financial results and provides business update," 1/08/2020 RUBY-US GNW  Rubius Therapeutics Appoints Internationally Recognized Autoimmunity and Translational Immunology Leader Laurence Turka, M.D., as Chief Scientific Officer"," 2/27/2020 ATNX-US  GNW  Athenex, Inc. Reports Fourth Quarter and Year Ended December 31, 2019 Financial Results and Provides Corporate Update"," 2/03/2020 PETQ-US  GNW  PetIQ, Inc. Announces Appointment of Lauren Olavessen, DVM as Chief Medical Officer", 3/02/2020 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results,11/26/2019 OPTN-US  GNW  Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference,11/26/2019 TORC-US  GNW  resTORbio to Present at Upcoming Investor Conferences, 1/27/2020 DNLI-US  GNW  Denali Therapeutics Announces Proposed Offering of Common Stock,,11/12/2019 83422E10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Solid Biosciences Inc. - SLDB, 2/13/2020 EOLS-US  GNW  Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference,12/17/2019 FIXX-US GNW  Homology Medicines Announces Encouraging Initial Clinical Data from its pheNIX Gene Therapy Trial for PKU, 2/21/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock,11/19/2019 SRRK-US  GNW  Scholar Rock Reports Preliminary Pharmacokinetic and Pharmacodynamic Data from TOPAZ Phase 2 Trial of SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy," 3/02/2020 UBX-US   GNW  UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer",,, 9/19/2019 EIDX-US  GNW  Eidos Therapeutics to Present at the 2019 Cantor Global Healthcare Conference," 1/07/2019 AVRO-US  GNW  AVROBIO, Inc. Appoints Philip J. Vickers to its Board of Directors",,11/29/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/30/2020 AUTL-US  GNW  Autolus Therapeutics Presents Encouraging Additional Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers, 3/11/2020 FTSV-US GNW  Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia,10/01/2019 TBIO-US  GNW  Translate Bio Announces Upcoming MRT5005 Presentations at the 33rd Annual North American Cystic Fibrosis Conference,,12/30/2019 PRNB-US GNW  Principia Updates PRN1008 Pemphigus Clinical Program,"11/21/2019 ARVN-US GNW  Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors", 2/26/2020 YMAB-US  GNW  Y-mAbs Announces Positive Pre-BLA Meeting with FDA for Omburtamab,,"12/12/2019 GRTS-US  GNW  Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE", 1/13/2020 GH-US    GNW  Guardant Health Announces Collaboration With Amgen to Develop a Global Liquid Biopsy Companion Diagnostic for AMG 510 KRAS G12C Inhibitor, 1/08/2020 OSMT-US  GNW  Osmotica Announces Pricing of Public Offering of Ordinary Shares," 2/23/2020 NGM-US   GNW  NGM Bio to Host Conference Call to Discuss Preliminary Topline Results, Including Histology Data,Â from 24-Week Phase 2 Study of Aldafermin in Patients with NASH",, 2/20/2020 ORTX-US  GNW  Orchard Therapeutics to Webcast Conference Call of 2019 Financial Results,, 2/05/2020 ALEC-US  GNW  Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia, 2/21/2020 DTIL-US GNW  Precision BioSciences to Report Fiscal Year and Fourth Quarter 2019 Financial Results and Present at Upcoming Investor Conferences, 2/18/2020 TPTX-US GNW  Turning Point Therapeutics to Participate in Upcoming Investor Conferences, 3/02/2020 PRVL-US GNW  Prevail Therapeutics Announces Investigational New Drug Application Active for PR006 for the Treatment of Frontotemporal Dementia with GRN Mutation,, 2/13/2020 BCEL-US GNW  Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors,,, 3/03/2020 BBIO-US  GNW  BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), 1/23/2020 ADPT-US  GNW  Adaptive Announces Pricing of Public Offering of Common Stock,
" 1/24/2019 53220K50 GNW  Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders","12/22/2019 PGNX-US  GNW  Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyLâ„¢ in Prostate Cancer on Monday, December 23rd"," 8/06/2018 45232710    GNW  Detailed Research: Economic Perspectives on Allete, Sterling Construction, Illumina, PROS, Altra Industrial Motion, and Pacific Biosciences of California â€” What Drives Growth in Today's Competitive Landscape","10/31/2016 84763A10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 â€“ SPPI"," 4/09/2018 G3040110 GNW  New Research: Key Drivers of Growth for Seagate Technology, AveXis, Banco Latinoamericano de Comercio Exterior, S.A, SunOpta, Orix Corp Ads, and Endo International plc â€” Factors of Influence, Major Initiatives and Sustained Production"," 5/09/2018 04280A10 GNW  Recent Analysis Shows Extreme Networks, Lumber Liquidators, Owens-Illinois, Arrowhead Pharmaceuticals, Intrepid Potash, and General Cable Market Influences â€” Renewed Outlook, Key Drivers of Growth", 1/06/2020 BDSI-US  GNW  BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development,11/07/2017 09073M10 GNW  Women In Bio Announces that Alpna Seth Joins Bio-Techneâ€™s Board of Directors, 6/26/2019 SAN-FR   GNW  Sanofi : FDA approves DupixentÂ® (dupilumab) for chronic rhinosinusitis with nasal polyposis,11/18/2019 SIGA-US      GNW  SIGA Announces Canadian Release of the Advanced Contract Award Notice to Support Regulatory Filing for Oral TPOXXÂ®,12/19/2019 OPK-US   GNW  OPKO Health to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/10/2020 AKCA-US  GNW  Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy,11/03/2016 BMRN-US     GNW  BioMarin to Attend Three Upcoming Investor Conferences," 8/08/2018 01535110 GNW  Recent Analysis Shows Washington Real Estate Investment Trust, FirstEnergy, Alexion Pharmaceuticals, Alaska Air Group, Fortune Brands Home & Security, and Baxter International Market Influences â€” Renewed Outlook, Key Drivers of Growth", 1/29/2019 64125C10 GNW  Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinsonâ€™s Disease and Friedreichâ€™s Ataxia, 4/16/2018 0882RC-E GNW  Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline," 3/25/2020 IMMU-US  GNW  IMMUNOMEDICS PROVIDES COVID-19 BUSINESS CONTINUITY UPDATE, AFFIRMS 2020 STRATEGIC PRIORITIES, AND SHARES R&D AND REGULATORY UPDATE"," 2/27/2020 BIIB-US   GNW  Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimerâ€™s, Parkinsonâ€™s, Neuromuscular, and Other Neurological Diseases", 2/08/2013 LLY-US   GNW  Bavarian Nordic Appoints James B. Breitmeyer as Executive Vice President and Divison President of Its Cancer Vaccine Division," 3/30/2020 BCRX-US  GNW  European Medicines Agency Validates Marketing Authorization Application for Oral, Once-Daily Berotralstat (BCX7353) to Prevent HAE Attacks",10/22/2018 GLPG-NL  GNW  POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET, 7/17/2013 04004760 GNW  CombiMatrix Appoints Robert E. Hoffman to Board of Directors," 1/24/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,10/14/2019 AKRX-US  GNW  Akorn to Report Third Quarter 2019 Financial Results and Host Conference Call, 9/09/2019 081N5P-E GNW  Toronto Innovation Acceleration Partners Announces Strategic Partnership with Amgen, 3/18/2020 MYGN-US  GNW  NCCN Updates Professional Guidelines Recommending Biomarker Testing for Unfavorable Intermediate and High-Risk Patients with Prostate Cancer, 1/24/2020 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethylâ€™s Antiproliferative Effects in Patients With Carcinoid Syndrome,11/07/2019 MGTX-US  GNW  MeiraGTx Reports Third Quarter 2019 Financial Results,"10/23/2018 INSM-US  GNW  Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018",10/21/2014 05156V10 GNW  Aurinia Pharmaceuticals to Host Lupus Opinion Leader Meeting and Webcast on October 23 in New York City," 4/01/2020 ALGN-US   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS ALGN, INO, TLRY, WWE INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",10/03/2019 64026810 GNW  Zhang Investor Law Reminds Investors of October 18 Deadline in Securities Class Action Lawsuit Against Nektar Therapeutics - NKTR,, 3/12/2020 GERN-US  GNW  Geron Corporation Reports Fourth Quarter and Full Year 2019 Financial Results and 2020 Milestones," 5/03/2018 00771V10 GNW  Investor Expectations to Drive Momentum within Roper Technologies, Inter Parfums, SunCoke Energy Partners, Aerie Pharmaceuticals, Forrester Research, and Diamond Hill Investment Group â€” Discovering Underlying Factors of Influence"," 3/16/2020 AMRN-US  GNW  Eight Data Presentations Relevant to VASCEPAÂ® (Icosapent Ethyl) Capsules and Persistent Cardiovascular Risk to be Presented at the American College of Cardiologyâ€™sÂ 69th Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC), March 28 â€“ 30"," 8/27/2019 45337C10 GNW  BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019", 7/31/2018 91307C10 GNW  SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics, 1/31/2020 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/25/2019 G0176710 GNW  Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis," 2/25/2015 CERS-US  GNW  Mid Atlantic Bio Angels Close New Funding Round for UK-Based Cerus Endovascular, Ltd.", 2/14/2020 AMAG-US  GNW  AMAG Pharmaceuticals to Participate in Upcoming Investor Conferences, 1/03/2018 ARQL-US  GNW  VBL Therapeutics Announces the Appointments of Susan Kelley and David Hastings to Its Board of Directors,,, 6/21/2010 SGP-US   GNW  Athersys Elects Jack Wyszomierski to Board of Directors, 4/06/2020 SAN-FR   GNW  Sanofi successfully prices taps on outstanding bond issues for EUR 500 million, 2/25/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001, 1/02/2020 ALLO-US  GNW  Allogene Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/12/2020 ASND-US  GNW  Ascendis Pharma A/S Provides Pipeline Update and Reviews Progress Towards Vision 3x3 at 38th Annual J.P. Morgan Healthcare Conference,," 9/13/2018 00422510 GNW  KESSLER TOPAZ MELTZER & CHECK, LLP:Â  Final Deadline Reminder for ACADIA PHARMACEUTICALS INC. Investors â€“ ACAD", 2/19/2020 AFMD-US  GNW  Affimed to Present at the SVB Leerink 9th Annual Global Healthcare Conference,, 1/30/2020 PRQR-US  GNW  ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a," 6/15/2017 TXMD-US  GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc.", 3/02/2020 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results," 3/25/2020 ALLK-US  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against World Wrestling Entertainment, NMC Health, Funko, and Allakos and Encourages Investors to Contact the Firm"," 6/26/2018 68214310 GNW  Analysis: Positioning to Benefit within The Manitowoc, Omeros, Catabasis Pharmaceuticals, Zayo Group, Covanta Holding, and Seattle Genetics â€” Research Highlights Growth, Revenue, and Consolidated Results", 5/31/2016 008ZWN-E GNW  Revance to Participate in Upcoming Investor Conferences,,11/12/2010 46333X10 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index, 2/25/2020 ADVM-US  GNW  Adverum Biotechnologies Appoints Angela Thedinga as Chief Technology Officer, 2/27/2020 4151-JP   GNW  Ultragenyx and Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for CrysvitaÂ® (burosumab) for Tumor-Induced Osteomalacia (TIO),11/06/2019 AGLE-US  GNW  Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights, 7/31/2019 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Second Quarter of 2019,"11/14/2014 PDLI-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in PDL BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadline -- PDLI",, 1/13/2020 RDUS-US  GNW  Radius Exceeds 2019 Financial Guidance and Provides Business Update at the 38th Annual J.P. Morgan Healthcare Conference,12/16/2019 ASMB-US  GNW  Assembly Biosciences Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares," 4/02/2012 00182C10 GNW  Deadline on April 6 in Lawsuit for Investors in BioSante Pharmaceuticals, Inc. announced by Shareholders Foundation",,11/19/2018 02043Q10 GNW  SHAREHOLDER ALERT: APOG ALNY ACHC COST TRVN SFIX ALGN AQUA TSRO MGI MDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,12/16/2019 WVE-US   GNW  Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy, 2/25/2020 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2019,, 1/08/2020 PCRX-US  GNW  Pacira BioSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference," 2/13/2020 RTRX-US  GNW  Retrophin, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"," 2/07/2020 PACB-US  GNW  Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development", 1/10/2020 EDIT-US  GNW  Editas Medicine Reports Inducement Grants to New Chief Financial Officer,12/19/2019 CHMA-US  GNW  Chiasma Added to NASDAQ Biotechnology Index, 1/13/2020 MGNX-US  GNW  MacroGenics to Present at the J.P. Morgan Healthcare Conference,10/14/2014 0BP4MZ-E GNW  Blueprint Medicines to Present at JMP Securities Life Sciences Private Company Conference," 7/06/2018 00972D10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Keryx Biopharmaceuticals, Inc. to Akebia Therapeutics, Inc. is Fair to Shareholders"," 7/20/2015 28249U10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Celladon Corporation of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2015 -- CLDN", 1/03/2020 MNTA-US  GNW  Momenta Pharmaceuticals Announces CFO Transition, 2/05/2020 PRTA-US  GNW  Prothena to Report Fourth Quarter and Full Year 2019 Financial Results and Host Webcast Conference Call on February 12, 2/11/2020 ZLAB-US  GNW  Zai Lab Announces Upcoming Participation at February Conferences, 3/28/2016 SAGE-US  GNW  Sage Therapeutics to Present Data at the Society of Biological Psychiatry  71st Annual Scientific Meeting, 2/27/2020 CTMX-US  GNW  CytomX Therapeutics Announces Full-Year 2019 Financial ResultsÂ and Provides Business Update," 1/20/2020 0CPNB1-E GNW  Genmab Announces European Marketing Authorization for DARZALEXÂ® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma", 4/15/2019 92165910 GNW  VNDA APRIL 26th DEADLINE: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc.; Encourages Investors With Losses In Excess of $100K to Contact the Firm â€“ VNDA,,11/25/2019 CBAY-US  GNW  CymaBay Therapeutics Halts Clinical Development of Seladelpar," 9/09/2013 45781M10 GNW  Inova Completes $3.5 Million of Projects for Dallas, Fort Worth and Socorro School Districts",11/26/2019 CCXI-US  GNW  ChemoCentryx to Present at the 31st Annual Piper Jaffray Healthcare Conference,"10/17/2018 40637H10 GNW  Market Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Technologies, and Capricor Therapeutics â€” Emerging Consolidated Expectations, Analyst Ratings",, 2/20/2020 MNKD-US   GNW  MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)," 6/13/2018 URGN-US  GNW  UroGen Pharmaâ€™s Chairman, Arie Belldegrun, MD, FACS to Receive EY 2018 Master Entrepreneur Award", 3/04/2020 CYTK-US  GNW  Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis, 3/28/2020 ESPR-US     GNW  Esperion Announces Three Data Presentations of the NEXLETOLâ„¢ (bempedoic acid) Tablet and the NEXLIZETâ„¢ (bempedoic acid and ezetimibe) Tablet at the American College of Cardiologyâ€™s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC)," 5/31/2019 03236M20  GNW  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc."," 6/26/2018 69366J20 GNW  Recent Analysis Shows Church & Dwight Co., Innoviva, PTC Therapeutics, KBR, Murphy Oil, and F.N.B. Market Influences â€” Renewed Outlook, Key Drivers of Growth",11/07/2019 ACHN-US  GNW  Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update, 1/09/2020 SYNH-US  GNW  Syneos Health Announces Strategic Collaboration and Investment in Indegene Omnipresence and the Companyâ€™s Next-Generation CRM and Omnichannel Engagement SaaS Platform, 2/07/2020 FOLD-US  GNW  Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposiumâ„¢ 2020," 7/22/2016 26979610 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 â€“ EGRX","11/28/2017 DCPH-US  GNW  Deciphera Pharmaceuticals, Inc. Announces Orphan Drug Designation from the EMA for DCC-2618 for the Treatment of Gastrointestinal Stromal Tumors", 2/06/2020 ADMA-US  GNW  ADMA Biologics Announces Pricing of Upsized $82.3 Million Public Offering of Common Stock, 2/25/2020 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2019 Financial Results and Operational Progress, 6/15/2018 EPZM-US  GNW  Epizyme Reports Positive Updated Interim Data from Phase 2 Study of Tazemetostat in Patients With Relapsed or Refractory Follicular Lymphoma at the Congress of the European Hematology Association (EHA), 5/14/2012 TSRX-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index," 2/20/2020 MYOK-US  GNW  MyoKardia to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020",11/14/2011 39843840 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index, 2/20/2020 GLPG-NL  GNW  Transformational year for Galapagos," 3/08/2020 PTLA-US  GNW  ROSEN, NATIONAL TRIAL COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action â€“ PTLA",,, 3/25/2015 ALCLS-FR GNW  Photo Release -- Nasdaq Welcomes Cellectis SA (Nasdaq: CLLS) to The Nasdaq Stock Market, 1/08/2020 CARA-US  GNW  Cara Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference, 3/06/2020 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/02/2020 QURE-US  GNW  uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters, 2/13/2020 AGIO-US   GNW  Agios Reports Fourth Quarter and Full Year 2019 Financial Results, 1/15/2020 IOVA-US  GNW  Iovance Biotherapeutics Completes Patient Dosing in Registration-Enabling Cohort 4 of the C-144-01 Melanoma Study with Lifileucel," 4/01/2020 ANAB-US  GNW  ANAPTYSBIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for Southern District of California against AnaptysBio, Inc.",, 1/13/2020 FATE-US  GNW  Fate Therapeutics Announces Expansion of FT516 Clinical Investigation and Publication of Preclinical Data in the Journal Blood, 5/30/2018 HZNP-US  GNW  Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference,, 1/08/2020 ICPT-US  GNW  Intercept to Present at the 38th Annual J.P. Morgan Healthcare Conference, 3/12/2020 KPTI-US    GNW  Karyopharm Expands Executive Leadership Team with the Appointment of John Demaree as Chief Commercial Officer,10/03/2014 38000Q10 GNW  GlycoMimetics to Present at BIO Investor Forum,12/07/2014 MOR-DE   GNW  MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting, 2/21/2020 ITCI-US  GNW  Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,"10/30/2018 G6674U10 GNW  New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure â€” Consolidated Revenues, Company Growth, and Expectations for 2018",," 1/28/2020 AMPH-US  GNW  Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial"," 1/12/2020 ATRA-US    GNW  Atara Biotherapeutics to Present 2020 Key Milestones and Progress in Bringing Off-The-Shelf, Allogeneic T-Cell Immunotherapies to Patients in Need at the 38th Annual J.P. Morgan Healthcare Conference"," 1/26/2017 77313F10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek Pharmaceuticals Corporation (ITEK) & Lead Plaintiff Deadline: March 7, 2017", 3/25/2019 DERM-US  GNW  Dermira Announces â€œLife Unfoldsâ€ Direct-to-Consumer Campaign to Highlight QBREXZAâ„¢ (glycopyrronium) Cloth, 2/06/2020 FOMX-US  GNW  Foamix and Menlo Announce Shareholder Approval of Proposed Merger," 2/20/2020 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2019 Results and Provides First Quarter and Full Year 2020 Guidance", 1/21/2020 SUPN-US  GNW  Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD," 2/03/2020 31572Q80 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of FibroGen, Inc. - FGEN"," 6/12/2018 74587V10 GNW  Detailed Research: Economic Perspectives on Amphenol, Hologic, Newell Brands, Ciena, SAExploration, and Puma Biotechnology â€” What Drives Growth in Today's Competitive Landscape", 3/05/2020 CHRS-US  GNW  Coherus BioSciences Management to Present at Barclays Global Healthcare Conference 2020, 2/06/2020 CRBP-US  GNW  Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock, 6/24/2018 BOLD-US  GNW  NodThera secures Â£28 million ($40 million) Series A Financing," 2/10/2020 COLL-US  GNW  Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering"," 1/14/2020 XBIT-US  GNW  XBiotech Commences Tender Offer to Purchase up to $420,000,000 of its Shares"," 9/30/2016 81750R10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Seres Therapeutics, Inc. (MCRB)",, 2/25/2020 GBT-US   GNW  GBT Announces Participation at the Cowen and Company 40th Annual Healthcare Conference, 3/06/2018 RGNX-US  GNW  REGENXBIO Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights, 1/09/2020 KURA-US  GNW  Kura Oncology to Present at J.P. Morgan Healthcare Conference, 1/08/2020 APLS-US  GNW  Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock," 3/04/2020 AXSM-US  GNW  Axsome Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020",11/06/2019 VYGR-US  GNW  Voyager Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Highlights, 2/25/2020 BGNE-US  GNW  BeiGene to Present at the Cowen and Companyâ€™s 40th Annual Health Care Conference,"11/11/2019 74933V10 GNW  Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders â€“ IPHS, INXN, RARX, VSI","11/13/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Pricing of Upsized Class A Common Stock Public Offering", 2/10/2020 HCM-GB   GNW  Chi-Med Highlights Updated Phase II Savolitinib / ImfinziÂ® Combination Data in Advanced Papillary Renal Cell Carcinoma at 2020 ASCO Genitourinary Cancers Symposium,11/26/2019 NTLA-US  GNW  Intellia Therapeutics to Present at Evercore ISI 2nd Annual HealthCONx Conference,11/14/2019 ACIU-US  GNW  AC Immune to Present at Jefferies 2019 London Healthcare Conference,11/19/2019 CRSP-US  GNW  CRISPR Therapeutics Announces Proposed Public Offering of Common Shares," 2/18/2020 GTHX-US  GNW  G1 Therapeutics to Participate in BTIG Targeted Therapeutics Conference on February 24, 2020", 9/03/2019 ARGX-BE  GNW  argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference, 1/02/2020 RUBY-US GNW  Rubius Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference, 2/25/2020 ATNX-US  GNW  Athenex Announces Participation at the Cowen 40th Annual Health Care Conference," 1/13/2020 PETQ-US  GNW  PetIQ, Inc. Provides Update on Wellness Center Openings", 2/25/2020 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Cowen & Co. 40th Annual Health Care Conference,11/21/2019 OPTN-US  GNW  Optinose Announces Pricing of Public Offering of Common Stock,11/15/2019 TORC-US  GNW  resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of RTB101 in Clinically Symptomatic Respiratory Illness Did Not Meet the Primary Endpoint, 1/14/2020 DNLI-US  GNW  Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinsonâ€™s Disease,,11/12/2019 SLDB-US  GNW  Solid Biosciences Provides SGT-001 Program Update," 2/12/2020 EOLS-US  GNW  Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020",12/16/2019 FIXX-US GNW  Homology Medicines Announces Peer-Reviewed Publication of Five-Year Retrospective Study Conducted in Collaboration with Two PKU Key Opinion Leaders Demonstrating Substantially Elevated Phe Levels in Adults with Classical PKU on Standard of Care, 2/20/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock,11/12/2019 SRRK-US  GNW  Scholar Rock Reports Third Quarter 2019 Financial Results and Highlights Business Progress, 2/25/2020 UBX-US   GNW  UNITY Biotechnology Provides Pipeline and Business Updates,,, 8/01/2019 EIDX-US  GNW  Eidos Therapeutics Reports Second Quarter 2019 Financial Results,"12/21/2018 05455M10 GNW  AVROBIO, Inc. Added to NASDAQ Biotechnology Index",,11/21/2019 XERS-US  GNW  Xeris Pharmaceuticals Provides a Business Update During Recent Investor Conference, 1/27/2020 AUTL-US  GNW  Autolus Announces Closing of Public Offering," 3/04/2020 FSCT-US GNW  FTSV, GCAP, MINI, and FSCT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts", 9/30/2019 TBIO-US  GNW  Translate Bio to Present at the 3rd Annual Chardan Genetic Medicines Conference,,12/07/2019 PRNB-US GNW  Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial,"11/06/2019 ARVN-US GNW  Arvinas, Inc. Announces Pricing of Public Offering of Common Stock", 1/07/2020 YMAB-US  GNW  Y-mAbs Therapeutics To Present At 38th Annual J.P. Morgan Healthcare Conference,,12/09/2019 GRTS-US  GNW  Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress, 1/12/2020 GH-US    GNW  Guardant Health and NRG Oncology Initiate Randomized Trial to Investigate Circulating Tumor DNA Guided Adjuvant Therapy in Stage II Colon Cancer, 1/06/2020 OSMT-US  GNW  Osmotica Announces Proposed Public Offering of Ordinary Shares, 2/11/2020 NGM-US   GNW  NGM Bio Announces Initiation of Phase 1a/1b Clinical Study of NGM120 for the Potential Treatment of Cancer and Cancer Anorexia/Cachexia Syndrome (CACS),, 2/10/2020 ORTX-US  GNW  Orchard Therapeutics Announces Presentation of Clinical Data from Neurometabolic Franchise at 16th Annual WORLD Symposium,, 2/03/2020 ALEC-US  GNW  Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares," 1/13/2020 DTIL-US GNW  Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma", 2/03/2020 TPTX-US GNW  Turning Point Therapeutics to Participate in Guggenheim Oncology Day, 2/21/2020 PRVL-US GNW  Prevail Therapeutics to Present at Upcoming Conferences,, 2/05/2020 BCEL-US GNW  Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody Targets in Oncology,,, 3/02/2020 BBIO-US  GNW  BridgeBio Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Portfolio Progress, 1/21/2020 ADPT-US  GNW  Adaptive Announces Proposed Public Offering of Common Stock,
12/10/2018 53220K50 GNW  Sermonix Announces FDA Acceptance of IND Application; Will Begin Phase 2 Trial of Lasofoxifene for Targeted Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer,11/25/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the Radiological Society of North America (RSNA) Annual Meeting, 4/10/2018 ILMN-US     GNW  Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics,"10/11/2016 84763A10 GNW  SPPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016", 1/06/2018 G3040110 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline â€“ ENDP,"11/13/2017 04280A10 GNW  Analysis: Positioning to Benefit within Catabasis, Flowserve, MGIC Investment, Arrowhead, Silver Spring, and Live Nation â€“ Research Highlights Growth, Revenue, and Consolidated Results",12/19/2019 09060J10 GNW  BioDelivery Sciences Added to NASDAQ Biotechnology Index,, 4/26/2019 SAN-FR   GNW  CHMP issues positive opinion for LibtayoÂ® (cemiplimab) in advanced cutaneous squamous cell carcinoma,"10/21/2019 SIGA-US      GNW  SIGA Technologies CEO to Speak at NCT Asia Conference on October 23, 2019",11/26/2019 OPK-US   GNW  OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference, 1/02/2020 46222210 GNW  New England Journal of Medicine Publishes Results from Phase 2 Study of AKCEA-APO(a)-LRx in Patients with Lp(a)-driven Cardiovascular Disease,10/27/2016 BMRN-US     GNW  BioMarin Announces Third Quarter 2016 Financial Results, 6/27/2018 0CWPXK-E GNW  iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director," 8/13/2018 64125C10 GNW  Report: Developing Opportunities within Energy Recovery, Lamb Weston, Neurocrine Biosciences, Pioneer Natural Resources, Meritor, and Ophthotech â€” Future Expectations, Projections Moving into 2018", 4/02/2018 SGEN-US  GNW  Women In Bio Closes Boardroom Ready 2018 Applications and Celebrates Board Appointments of Program Alumni, 2/27/2020 IMMU-US  GNW  Immunomedics Appoints Robert W. Azelby to Board of Directors, 1/13/2020 09062X10  GNW  Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimerâ€™s Disease and Parkinsonâ€™s Disease from Pfizer Inc.,"12/04/2012 45253H10 GNW  Monro Muffler Brake, Inc. Announces Board of Directors Appointment and Acceleration of Fourth Quarter Fiscal 2013 Dividend Payment to Combine Payment With Third Quarter Fiscal 2013 Dividend Payment", 3/16/2020 BCRX-US  GNW  BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2," 9/27/2018 37555810 GNW  Analysis: Positioning to Benefit within Enerplus, ExlService, Gilead Sciences, 51job, QUALCOMM, and Perrigo Company plc â€” Research Highlights Growth, Revenue, and Consolidated Results", 6/27/2013 04004760 GNW  Innovus Appoints Robert E. Hoffman to Newly Formed Business and Finance Advisory Board," 1/22/2020 MAT-US   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 8/26/2019 AKRX-US  GNW  Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%"," 7/15/2019 CYTK-US  GNW  Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure", 2/14/2020 MYGN-US  GNW  New Study Demonstrates the Ability of ProlarisÂ® to Predict Which Men With Prostate Cancer Will Benefit from Multi-Modality Therapy, 1/20/2020 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium,10/03/2019 MGTX-US  GNW  MeiraGTx to Present at Upcoming Scientific and Investor Conferences,10/11/2018 INSM-US  GNW  Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatment with ARIKAYCEÂ® (amikacin liposome inhalation suspension), 9/02/2014 05156V10 GNW  Aurinia Pharmaceuticals to Begin Trading on the NASDAQ Global Market," 4/01/2020 INO-US    GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Inovio Pharmaceuticals, Inc.Â - INO","10/02/2019 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NetApp, SAExploration, Nektar Therapeutics, and Valaris and Encourages Investors to Contact the Firm",," 3/09/2020 GERN-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors to 2 Week Deadline: Investors Who Suffered Losses Encouraged to Contact Firm"," 9/11/2017 AERI-US  GNW  Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) to Ring The Nasdaq Stock Market Closing Bell", 3/15/2020 AMRN-US  GNW  Amarin Takes Proactive Steps to Support Public Health Priorities, 8/12/2019 45337C10 GNW  BriaCell Appoints Richard J. Berman to Board of Directors, 7/20/2018 91307C10 GNW  HSR Act Waiting Period Terminated for United Therapeuticsâ€™ Acquisition of SteadyMed Ltd., 1/13/2020 SRPT-US  GNW  Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors," 2/24/2019 G0176710 GNW  CLASS ACTION UPDATE for DNKEY, ALKS, ATVI and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 5/14/2012 TSRX-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index," 2/03/2020 00163U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AMAG Pharmaceuticals, Inc.Â â€“ AMAG"," 7/20/2016 ARQL-US  GNW  ArQule To Report Second Quarter 2016 Financial Results On August 3, 2016",,, 4/30/2010 VRTX-US  GNW  Vical CEO Selected as Panelist at BIO and PGH Conferences, 4/03/2020 SAN-FR   GNW  Sanofi: Availability of the Pre-quarterly Results Communication, 1/04/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease,11/11/2019 ALLO-US  GNW  Allogene Therapeutics Announces Year-End 2019 Media Event and Investor Conference Schedule, 1/09/2020 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in 38th Annual J.P. Morgan Healthcare Conference,," 9/12/2018 00422510 GNW  CLASS ACTION UPDATE for ACAD and FB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 2/03/2020 AFMD-US  GNW   Affimed Mourns Passing of Chief Financial Officer Dr. Florian Fischer,,12/11/2019 PRQR-US  GNW  ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa," 6/14/2017 88338N10 GNW  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline - June 19, 2017", 2/27/2020 ZGNX-US  GNW  Zogenix Announces FDA Extension of Review Period for FINTEPLAÂ® in Dravet Syndrome, 3/24/2020 ALLK-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc.Â â€“ ALLK," 6/21/2018 68214310 GNW  Report: Developing Opportunities within ABIOMED, Avid Technology, Unit, Omeros, Strayer Education, and NeoGenomics â€” Future Expectations, Projections Moving into 2018", 5/09/2016 RVNC-US  GNW  Revance Releases First Quarter 2016 Results,, 4/26/2010 46333X10 GNW  NASDAQ OMX Announces First Quarter 2010 New Listings Statistics," 2/24/2020 ADVM-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM", 2/21/2020 RARE-US   GNW  Ultragenyx to Present at SVB Leerink Global Healthcare Conference,11/04/2019 AGLE-US  GNW  Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C. Hanley as Chief Commercial Officer, 7/30/2019 NSTG-US  GNW  NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays,"11/11/2014 09SR4K-E GNW  EQUITY ALERT: Rosen Law Firm Reminds PDL BioPharma, Inc. Investors of Important November 17, 2014 Class Action Deadline -- PDLI",, 1/06/2020 RDUS-US  GNW  Radius Health to Present at the 38th Annual J.P. Morgan Healthcare Conference,12/12/2019 ASMB-US  GNW  Assembly Biosciences Announces Pricing of $125 Million Public Offering, 2/16/2012 00182C10 GNW  Small-Cap Stock Trade Review: BioSante Pharmaceuticals Report featured on MicroStockProfit.com,,"11/18/2018 02043Q10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ALNY, ACHC, TRVN, HTHT and SFIX",11/05/2019 WVE-US   GNW  Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update, 2/18/2020 AKCA-US  GNW  Akcea Therapeutics to Hold Fourth Quarter and Full Year 2019 Financial Results Webcast,, 1/07/2020 PCRX-US  GNW  EXPAREL Achieves Primary and Key Secondary Endpoints in Phase 4 CHOICE Study in Cesarean Section Patients, 2/10/2020 RTRX-US  GNW  Retrophin to Report Fourth Quarter and Full Year 2019 Financial Results, 2/06/2020 PACB-US  GNW  Pacific Biosciences Announces Fourth Quarter and Annual 2019 Financial Results, 1/09/2020 EDIT-US  GNW  Editas Medicine Strengthens Executive Leadership Team to Support Long-term Growth,11/26/2019 CHMA-US  GNW  Chiasma to Present at the Piper Jaffray 31st Annual Healthcare Conference, 1/09/2020 MGNX-US  GNW  MacroGenics Outlines Corporate Priorities for 2020, 9/30/2014 0BP4MZ-E GNW  Blueprint Medicines to Present at 13th Annual BIO Investor Forum,11/09/2015 00972D10 GNW  Akebia Announces Third Quarter 2015 Financial Results, 7/13/2015 28249U10 GNW  IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Lawsuit Has Been Filed Against Celladon Corporation in the United States District Court for the Southern District of California -- CLDN,12/24/2019 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the 38th Annual J.P. Morgan Healthcare Conference,12/05/2019 PRTA-US  GNW  Prothena Announces Appointment of Oleg Nodelman to its Board of Directors, 2/10/2020 ZLAB-US  GNW  Zai Lab Announces Acceptance of NDA Submission of Omadacycline in China by the NMPA, 3/03/2016 SAGE-US  GNW  Sage Therapeutics to Present SAGE-547 Clinical Data and SRSE Health Economic Data  in Five Abstracts at the American Academy of Neurology 2016 Annual Meeting, 2/25/2020 CTMX-US  GNW  CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference,12/19/2019 00BMFX-E GNW  Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics," 4/13/2019 92165910 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines â€“ VNDA, SYNH, BPI and USX",,11/14/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at Upcoming Investor Conferences," 8/22/2013 45781M10 GNW  Inova Completes $750,000 of Projects for Clint Independent School District",11/25/2019 CCXI-US  GNW  ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopanâ€™s Superiority Over Standard of Care in ANCA-Associated Vasculitis," 8/23/2018 40637H10 GNW  Recent Analysis Shows KB Home, Sleep Number, Exelixis, Sprint, PayPal, and Halozyme Therapeutics Market Influences â€” Renewed Outlook, Key Drivers of Growth",," 2/18/2020 MNKD-US   GNW  MannKind Corporation to Hold 2019 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2020", 6/05/2018 URGN-US  GNW  UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance, 3/03/2020 CYTK-US  GNW  Cytokinetics Reports Fourth Quarter 2019 Financial Results, 3/23/2020 ESPR-US     GNW  Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Development Program of the NEXLETOLâ„¢Â (bempedoic acid) Tablet and Phase 2 Study Results of the NEXLIZETâ„¢Â (bempedoic acid and ezetimibe) Tablet to be Presented at the American College of Cardiologyâ€™s 69th Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC)," 5/30/2019 03236M20  GNW  KESSLER TOPAZ MELTZER & CHECK, LLP:Â  Final Deadline Reminder for AMYRIS, INC. Investors â€“ AMRS","12/12/2017 69366J20 GNW  Update in Lawsuit for Investors in NASDAQ:PTCT shares against PTC Therapeutics, Inc. announced by Shareholders Foundation",11/06/2019 ACHN-US  GNW  Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting, 1/03/2020 SYNH-US  GNW  Syneos Health to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/13/2020 FOLD-US  GNW  Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance," 7/18/2016 26979610 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. - EGRX","11/21/2017 DCPH-US  GNW  Deciphera Pharmaceuticals, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference", 2/06/2020 ADMA-US  GNW  ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock, 2/24/2020 GWPH-US  GNW  GW Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference, 6/03/2018 EPZM-US  GNW  Epizyme Presents Encouraging Phase 2 Data of Tazemetostat for Malignant Mesothelioma at ASCO, 8/12/2010 G5087110 GNW  Stock Alert for Jazz Pharmaceuticals Inc. Issued by MicroStockProfit, 1/06/2020 MYOK-US  GNW  MyoKardia to Present at 38th Annual J.P. Morgan Healthcare Conference,, 1/29/2020 GLPG-NL  GNW  Orphan Drug Designation for GLPG1690 in systemic sclerosis," 3/06/2020 OPRA-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 3/25/2015 15117K10 GNW  Cellectis SA (Nasdaq: CLLS) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO,12/06/2019 CARA-US  GNW  Cara Therapeutics Announces Equity Grants to Employees Under Inducement Plan," 3/04/2020 FLXN-US  GNW  Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2019 Financial Results on March 12, 2020", 2/27/2020 QURE-US  GNW  uniQure Presents Multiple New Preclinical Data on AMT-130 at the CHDIâ€™s 15th Annual Huntingtonâ€™s Disease Therapeutics Conference," 2/11/2020 AGIO-US   GNW  Agios to Present at the Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020", 1/12/2020 IOVA-US  GNW  Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog," 3/30/2020 ANAB-US  GNW  ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",,"12/10/2019 FATE-US  GNW  Fate Therapeutics Presents its First Off-the-shelf, iPSC-derived CAR T-Cell Cancer Immunotherapy Program at ASH Annual Meeting", 5/22/2018 HZNP-US  GNW  Horizon Pharma plc Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE,,12/13/2019 ICPT-US  GNW  Intercept Provides Regulatory Update, 3/09/2020 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 9/26/2014 38000Q10 GNW  GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel,10/25/2013 REGN-US  GNW  Protein Engineering Market - Global Forecast to 2017, 2/20/2020 ITCI-US  GNW  Pivotal Study of CAPLYTAâ„¢ (lumateperone) for the Treatment of Schizophrenia in Adults Published in JAMA Psychiatry,," 8/23/2018 G6674U10 GNW  Research Report Identifies Genesis Healthcare, Maiden, Ichor, Armstrong World Industries, Rexnord, and NovoCure with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",,11/27/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference,12/09/2019 ATRA-US    GNW  Atara Biotherapeutics Reports Updated Long-Term Clinical Results from a Tab-celÂ® Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st American Society of Hematology (ASH) Annual Meeting," 1/23/2017 77313F10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 â€“ ITEK", 3/22/2019 DERM-US  GNW  Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 2/06/2020 FOMX-US  GNW  Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea inÂ Journal of the American Academy of Dermatology, 2/03/2020 PRAH-US  GNW  PRA Health Sciences to Report Fourth Quarter 2019 Earnings, 1/08/2020 SUPN-US  GNW  Supernus to Present at the 2020 J.P. Morgan Healthcare Conference, 1/06/2020 FGEN-US  GNW  FibroGen Names Enrique Conterno as Chief Executive Officer,12/12/2017 74587V10 GNW  Update in Lawsuit for Investors in Puma Biotechnology Inc (NYSE:PBYI) shares announced by Shareholders Foundation, 3/05/2020 CHRS-US  GNW  United States Manufactured UDENYCAÂ® (pegfilgrastim-cbqv) Well Positioned to Meet Market Demand,12/09/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System,, 2/06/2020 COLL-US  GNW  Collegium to Acquire U.S. Rights to Nucynta Franchise,12/30/2019 0CPNB1-E GNW  XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen," 9/29/2016 81750R10 GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Seres Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline",, 2/20/2020 GBT-US   GNW  GBT Accepting Proposals for 2020 ACCEL Grants to Support Novel Access-to-Care Programs for People Living with Sickle Cell Disease, 2/27/2018 RGNX-US  GNW  REGENXBIO to Host Conference Call on March 6 to Discuss Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights, 1/06/2020 KURA-US  GNW  Kura Oncology Appoints Kirsten Flowers as Chief Commercial Officer, 1/07/2020 APLS-US  GNW  Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock, 2/20/2020 AXSM-US  GNW  Axsome Therapeutics Completes Patient Enrollment in the INTERCEPT Phase 3 Trial of AXS-07 in the Early Treatment of Migraine,10/31/2019 VYGR-US  GNW  Voyager Therapeutics to Present at the Credit Suisse Healthcare Conference, 1/21/2020 BGNE-US  GNW  BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis,"11/04/2019 74933V10 GNW  Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders â€“ VSI, RARX, SRCI, UCFC","11/12/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock", 2/06/2020 HCM-GB   GNW  Chi-Med Announces the Exercise of Underwritersâ€™ Over-allotment Option for Public Offering of ADSs,10/31/2019 NTLA-US  GNW  Intellia Therapeutics Announces Third Quarter 2019 Financial Results,11/13/2019 ACIU-US  GNW  AC Immune Q3 2019 Financial Results and Business Update,11/19/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001Â® for Severe Hemoglobinopathies," 2/17/2020 GTHX-US  GNW  G1 Therapeutics to Participate in BTIG Targeted Therapeutics Conference on February 24, 2020", 8/06/2019 ARGX-BE  GNW  argenx to Present at 2019 Wedbush PacGrow Healthcare Conference,"12/23/2019 RUBY-US GNW  Rubius Therapeutics Appoints Christina Coughlin, M.D., Ph.D., as Chief Medical Officer"," 2/06/2020 ATNX-US  GNW  Athenex, Inc. to Report Fourth Quarter and Full Year 2019 Earnings Results on February 27, 2020"," 1/13/2020 71639T10 GNW  PetIQ, Inc. Enters Into Definitive Agreement to Acquire the CapstarÂ® portfolio of products from Elanco", 1/06/2020 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Leadership Transition,11/20/2019 OPTN-US  GNW  Optinose Announces Proposed Public Offering of Common Stock,11/05/2019 TORC-US  GNW  resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update,11/06/2019 DNLI-US  GNW  Denali Therapeutics Reports Third Quarter 2019 Financial Results and Business Highlights,,10/02/2019 SLDB-US  GNW  Solid Biosciences to Participate in the Chardan 3rd Annual Genetic Medicines Conference," 1/27/2020 EOLS-US  GNW  Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crowâ€™s Feet Lines Published in Dermatologic Surgery","12/03/2019 FIXX-US GNW  Homology Medicines Announces Appointment of Gabriel M. Cohn, M.D., as  Chief Medical Officer", 2/18/2020 EYPT-US    GNW  EyePoint Pharmaceuticals and Vision Center Network of America Sign Purchase Agreement for DEXYCUÂ®,11/08/2019 SRRK-US  GNW  Scholar Rock to Present at the 2019 Jefferies London Healthcare Conference," 2/24/2020 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference",,, 6/18/2019 EIDX-US  GNW  Eidos Therapeutics to Present at the 2019 BMO Prescriptions for Success Healthcare Conference,12/19/2018 AVRO-US  GNW  AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVR RD 01 for the Treatment of Fabry Disease,,11/07/2019 XERS-US  GNW  Xeris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights," 1/27/2020 AUTL-US  GNW  Autolusâ€™ Chief Scientific Officer, Dr Martin PulÃ©, to give Keynote Lecture at the EHA-EBMT 2nd European CAR T Cell Meeting"," 3/02/2020 CBB-US  GNW  Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Mobile Mini, Forty Seven, Cincinnati Bell, and Telaria on behalf of Stockholders and Encourages Investors to Contact the Firm", 6/26/2019 TBIO-US  GNW  Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency,,11/13/2019 PRNB-US GNW  Principia to Present at the Stifel Healthcare Conference 2019,"11/06/2019 ARVN-US GNW  Arvinas, Inc. Announces Proposed Offering of Common Stock",12/12/2019 YMAB-US  GNW  Y-mAbsâ€™ GD2-GD3 Vaccine Granted Rare Pediatric Disease Designation,,11/26/2019 GRTS-US  GNW  Gritstone Oncology to Present at the Piper Jaffray Annual Healthcare Conference,12/30/2019 GH-US    GNW  Guardant Health to Present at the 38th Annual J.P. Morgan Healthcare Conference,"11/20/2019 08405D-E GNW  Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)",12/05/2019 NGM-US   GNW  NGM Bio Announces Appointment of Shelly Guyer to Board of Directors,," 2/03/2020 ORTX-US  GNW  Orchard Therapeutics Appoints Industry Veteran Steven Altschuler, M.D. to its Board of Directors",, 1/31/2020 ALEC-US  GNW  Alector Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering, 1/06/2020 DTIL-US GNW  Precision BioSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/23/2020 TPTX-US GNW  Turning Point Therapeutics Names Garry Nicholson to Its Board of Directors, 2/12/2020 PRVL-US GNW  Prevail Therapeuticsâ€™ PR001 Receives Orphan Drug Designation and Rare Pediatric Disease Designation from FDA,,12/03/2019 BCEL-US GNW  Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101,,," 2/24/2020 BBIO-US  GNW  BridgeBio Pharma, Inc. Appoints Ronald J. Daniels To Its Board of Directors", 1/21/2020 ADPT-US  GNW  Adaptive Announces Preliminary Unaudited Revenue forÂ Full Year 2019,
" 6/28/2018 53220K50 GNW  Analysis: Positioning to Benefit within EMCOR Group, Ring Energy, A. O. Smith, bluebird bio, Ligand Pharmaceuticals, and Synovus Financial â€” Research Highlights Growth, Revenue, and Consolidated Results",11/21/2019 PGNX-US  GNW  Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer, 2/20/2018 0625VS-E    GNW  Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract,"10/07/2016 84763A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 â€“ SPPI"," 1/03/2018 G3040110 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International plc (ENDP)Â & Lead Plaintiff Deadline - January 16, 2018"," 1/13/2017 04280A10 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead Pharmaceuticals, Inc. and Certain Officers â€“ ARWR",11/27/2019 BDSI-US  GNW  BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference,, 1/07/2019 SAN-FR   GNW  Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs,"10/03/2019 SIGA-US      GNW  SIGA Completes Clinical Studies for IV Formulation of TPOXXÂ®, NDA to be Submitted in 2020 Â Â ",11/15/2019 OPK-US   GNW  Novitas Issues Final Local Coverage Determination for the 4KscoreÂ® Test,12/18/2019 46222210 GNW  Akcea Retains Rights to AKCEA-APOCIII-LRx,10/19/2016 BMRN-US     GNW  BioMarin Presents Vosoritide Data in Achondroplasia at American Society of Human Genetics (ASHG) 2016 Meeting, 5/31/2018 ALXN-US  GNW  Alexion SmartPanel Developed in Partnership With EPAM Wins Judgesâ€™ Prize in the 2018 Bio-IT World Best Practices Awards," 5/14/2018 64125C10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Fred's, Nexstar Broadcasting Group, CNO Financial Group, Neurocrine Biosciences, Kosmos Energy, and Loews â€” New Research Emphasizes Economic Growth",11/08/2017 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2017, 2/27/2020 IMMU-US  GNW  Immunomedics Reports Fourth Quarter and Full Year 2019 Results and Provides Corporate Update,12/19/2019 BIIB-US   GNW  Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration," 1/30/2012 45253H10 GNW  ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors", 3/05/2020 BCRX-US  GNW  BioCryst Reports Fourth Quarter and Full Year 2019 Financial Results and Upcoming Key Milestones," 6/14/2018 37555810 GNW  Consolidated Research: 2018 Summary Expectations for Encana, Netflix, Veon, The Walt Disney, Gilead Sciences, and Cloudera â€” Fundamental Analysis, Key Performance Indications"," 6/28/2012 04004760 GNW  UPDATED BELL RINGER: Arena Pharmaceuticals, Inc. [ARNA] Rings The NASDAQ Stock Market Closing Bell for BELVIQ"," 1/21/2020 N5946510 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MAT, MYL and TCNNF",, 8/01/2019 AKRX-US  GNW  Akorn Provides Preliminary Second Quarter 2019 Results, 3/28/2019 ENTX-US  GNW  Entera Bio Reports 2018 Annual Financial Results and Operating Update, 2/12/2020 MYGN-US  GNW  Myriad Genetics to Present at the SVB Leerink Global Healthcare Conference, 1/06/2020 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference, 9/10/2019 MGTX-US  GNW  MeiraGTx To Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferences,10/04/2018 INSM-US  GNW  Insmed Extends Patent Protection in Japan to 2033, 8/14/2014 AUP-CA   GNW  Aurinia Reports Second Quarter 2014 Financial Results," 3/31/2020 AAN-US    GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AAN, BDX, FLR and INO",10/02/2019 64026810 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nektar Therapeutics,, 3/09/2020 GERN-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline â€“ GERN," 6/26/2015 00771V10 GNW  AERIE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Aerie Pharmaceuticals, Inc. â€“ AERI", 2/25/2020 AMRN-US  GNW  Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations," 7/23/2019 45337C10 GNW  BriaCell Announces $350,000 Equity Investment by Board of Directors"," 6/25/2018 91307C10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics, Universal Health Realty Income Trust, Forestar Group, Schlumberger, and Thermo Fisher Scientific â€” New Research Emphasizes Economic Growth", 1/06/2020 SRPT-US  GNW  Sarepta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference," 2/24/2019 G0176710 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ALKS, GSM, UXIN and AVP",," 1/27/2020 00163U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG"," 7/18/2016 ARQL-US  GNW  ArQule Presents Preclinical Data for ARQ 531, a Proprietary Reversible Inhibitor of Wild Type and Mutant BTK, at the 2016 Pan Pacific Lymphoma Conference",,,, 4/03/2020 SAN-FR   GNW  Sanofi: DupixentÂ® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years,10/10/2018 92532F10 GNW  CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease,11/06/2019 ALLO-US  GNW  Allogene Therapeutics Announces Pre-Clinical Data Presentations Supporting AlloCAR Tâ„¢ Pipeline at 61st American Society of Hematology Annual Meeting,11/18/2019 ASND-US  GNW  Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results,," 9/08/2018 00422510 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"," 1/10/2020 AFMD-US  GNW  Affimed Announces Appointment of Andreas Harstrick, M.D., as Chief Medical Officer",,11/21/2019 PRQR-US  GNW  ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa," 6/08/2017 88338N10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against TherapeuticsMD, Inc. and Certain Officers â€“ TXMD", 2/24/2020 ZGNX-US  GNW  Zogenix to Release Fourth Quarter and Full-Year 2019 Financial Results and Host Conference Call and Webcast on March 2, 3/24/2020 ALLK-US  GNW  Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies, 5/14/2012 TSRX-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index," 4/25/2016 RVNC-US  GNW  Revance Therapeutics to Release First Quarter 2016 Financial Results Monday, May 9, 2016",,, 2/19/2020 ADVM-US  GNW  Adverum Biotechnologies to Present at Upcoming Investor Conferences, 2/13/2020 RARE-US   GNW  Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update, 9/05/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference, 7/22/2019 NSTG-US  GNW  CORRECTING and REPLACING - Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy,"10/27/2014 69329Y10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 17, 2014 -- PDLI",,12/06/2019 RDUS-US  GNW  Radius Health Announces Scientific Presentations at 2019 San Antonio Breast Cancer Symposium (SABCS),12/11/2019 ASMB-US  GNW  Assembly Biosciences Announces Proposed Public Offering of Common Stock,11/14/2011 00182C10 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,"11/13/2018 02043Q10 GNW  CLASS ACTION UPDATE for MCHP, COCP and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 9/16/2019 WVE-US   GNW  Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen, 2/13/2020 AKCA-US  GNW  Akcea Expands Board of Directors with Appointment of Dr. Amber Salzman,,12/17/2019 PCRX-US  GNW  Pacira BioSciences Announces Positive Results from Phase 3 PLAY Study of EXPARELÂ® in Pediatric Patients, 1/13/2020 RTRX-US  GNW  Retrophin Provides Corporate Update and 2020 Outlook," 1/21/2020 PACB-US  GNW  CORRECTION â€“ Pacific Biosciences of California, Inc. Fourth Quarter 2019 Financial Results Call", 1/02/2020 EDIT-US  GNW  Editas Medicine to Present at the 38th Annual J.P. Morgan Healthcare Conference,11/14/2019 CHMA-US  GNW  Chiasma to Present at the 13th Acromegaly Consensus Conference,12/19/2019 MGNX-US  GNW  MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA, 9/09/2014 0BP4MZ-E GNW  Blueprint Medicines to Participate in Morgan Stanley Global Healthcare Conference 2014,11/07/2015 00972D10 GNW  Akebia Announces Presentation of Vadadustat Phase 2 Dialysis Data at American Society of Nephrology Kidney Week 2015 Annual Meeting, 7/13/2015 28249U10 GNW  Deadline in Lawsuit for Investors in Celladon Corp (NASDAQ:CLDN) Shares Announced by Shareholders Foundation,12/13/2019 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Dr. Jane F. Barlow to Board of Directors,11/05/2019 PRTA-US  GNW  Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update, 2/04/2020 ZLAB-US  GNW  Zai Lab Announces First Patients Treated in Separate Phase 1b and Registrational Bridging Studies, 2/29/2016 SAGE-US  GNW  Sage Therapeutics to Present at the Cowen & Co. 36th Annual Health Care Conference, 2/24/2020 BMY-US   GNW  Bristol-Myers Squibb Advances CytomX Therapeuticsâ€™ Anti-CTLA-4 Probody Therapeutic BMS-986249 into Randomized Cohort Expansion (Part 2a) of Ongoing Clinical Trial,12/19/2019 GMAB-DK  GNW  Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics, 4/11/2019 92165910 GNW  VNDA APR 26 DEADLINE: Zhang Investor Law Reminds of Deadline in Class Action Against Vanda Pharmaceuticals Inc. â€“ VNDA,,11/05/2019 CBAY-US  GNW  CymaBay Reports Third Quarter 2019 Financial Results and Provides Corporate Update, 7/18/2013 45781M10 GNW  Inova Completes $3.1 Million of Projects for Lewisville Independent School District,11/05/2019 CCXI-US  GNW  Presentations at ASN Kidney Week 2019 Highlight Breadth of ChemoCentryx Platform in Treatment of Complement 3 Glomerulopathy (C3G) and Focal Segmental Glomerulosclerosis (FSGS)," 6/13/2018 40637H10 GNW  Report: Exploring Fundamental Drivers Behind Virtu Financial, Littelfuse, Gogo, Brookfield Asset Management, Protalix BioTherapeutics, and Halozyme Therapeutics â€” New Horizons, Emerging Trends, and Upcoming Developments",, 1/06/2020 MNKD-US   GNW  AfrezzaÂ® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month, 5/29/2018 URGN-US  GNW  UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference, 3/03/2020 CYTK-US  GNW  Cytokinetics Announces Preclinical Data for AMG 594 Presented at the Keystone Symposium on Heart Failure, 3/18/2020 ESPR-US     GNW  Esperion Announces the Appointment of Alan Fuhrman to its Board of Directors," 5/29/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm"," 4/29/2016 69366J20 GNW  PTC 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against PTC Therapeutics, Inc. - PTCT","11/04/2019 00448Q20 GNW  Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders â€“ LPT, CISN, IPHS, ACHN","12/09/2019 SYNH-US  GNW  Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization", 1/09/2020 FOLD-US  GNW  Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance," 6/21/2016 26979610 GNW  EAGLE PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Reminds Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Investors of August 1, 2016 Lead Plaintiff Deadline in Securities Class Action",11/20/2017 DCPH-US  GNW  Deciphera Pharmaceuticals Reports Data from Ongoing Phase 1 Clinical Study of DCC-2618Â at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, 1/09/2020 ADMA-US  GNW  ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook," 2/12/2020 GWPH-US  GNW  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Fourth Quarter and Year Ending December 31, 2019 and Host Conference Call on February 25th, 2020", 6/01/2018 EPZM-US  GNW  Epizyme to Host Investor Conference Call to Discuss Interim Follicular Lymphoma Clinical Data, 5/14/2010 G5087110 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,11/27/2019 MYOK-US  GNW  MyoKardia to Present at Evercore ISI 2nd Annual HealthCONx Conference,, 1/23/2020 GLPG-NL  GNW  Galapagos appoints Michele Manto as Chief Commercial Officer," 3/04/2020 PTLA-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 1/20/2011 ALCLS-FR GNW  Cellectis Acquires Exclusive License to Tal Effector Patents From University of Minnesota,12/03/2019 CARA-US  GNW  Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference, 2/24/2020 FLXN-US  GNW  Flexion Therapeutics to Present at the 41st Annual Raymond James Institutional Investors Conference, 2/04/2020 QURE-US  GNW  uniQure Announces Presentations at the Upcoming 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)," 1/30/2020 AGIO-US   GNW  Agios to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial ResultsÂ on February 13, 2020", 1/12/2020 46226010 GNW  Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement," 3/27/2020 ANAB-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed",,"12/08/2019 FATE-US  GNW  Fate Therapeutics Announces New Preclinical Data for FT596 Off-the-Shelf, iPSC-derived CAR NK Cell Cancer Immunotherapy", 5/22/2018 HZNP-US  GNW  Horizon Pharma plc Launches GoutRevealed.com to Spotlight the Journey and Stories of People Living with Uncontrolled Gout,,"12/10/2019 ICPT-US  GNW  Intercept to Host NASH Commercial Day for Investors on December 16, 2019 in New York", 3/06/2020 KPTI-US    GNW  Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwritersâ€™ Option to Purchase Additional Shares, 9/22/2014 38000Q10 GNW  GlycoMimetics to Present at BioCentury's 21st Annual Newsmakers in the Biotech Industry Conference,, 2/18/2020 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 9th Annual SVB Leerink Global Healthcare Conference,," 6/15/2018 G6674U10 GNW  Investor Expectations to Drive Momentum within NovoCure, Canada Goose, Telephone and Data, FMC, MobileIron, and Viking Therapeutics â€” Discovering Underlying Factors of Influence",,11/15/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference,11/26/2019 ATRA-US    GNW  Atara Biotherapeutics to Participate at Evercore ISI Second Annual HealthCONx Conference, 1/13/2017 77313F10 GNW  IMPORTANT INOTEK PHARMACEUTICALS CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the District of Massachusetts against Inotek Pharmaceuticals Corporation, 3/19/2019 DERM-US  GNW  Dermira Prices $130.0 Million Public Offering of Common Stock, 1/17/2020 002F9P-E GNW  Foamix Announces OrbiMedâ€™s Support of Merger with Menlo Therapeutics,"10/30/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Third Quarter 2019 ResultsÂ and Updates Full Year 2019 Guidance",12/09/2019 SUPN-US  GNW  Supernus Provides Update on Results from Phase III Study (P301) of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients,12/23/2019 FGEN-US  GNW  FibroGen Submits New Drug Application to the U.S. FDA for Roxadustat in Patients With Anemia of Chronic Kidney Disease,"12/04/2017 74587V10 GNW  Analysis: Positioning to Benefit within Emerson Electric, Puma Biotechnology, Amgen, SunCoke Energy Partners, Carrols Restaurant Group, and First Financial â€” Research Highlights Growth, Revenue, and Consolidated Results", 2/27/2020 CHRS-US  GNW  Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results,11/18/2019 CRBP-US  GNW  Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis,, 1/07/2020 COLL-US  GNW  Collegium Provides 2020 Financial Guidance,12/17/2019 98400H10 GNW  XBiotech Added to NASDAQ Biotechnology Index," 9/28/2016 81750R10 GNW  UPDATE â€“ SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Seres Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2016 â€“ MCRB",," 2/19/2020 GBT-US   GNW  GBT to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020", 2/08/2018 RGNX-US  GNW  REGENXBIO Announces Completion of Dosing of Third Cohort in Phase I Clinical Trial of RGX-314 Gene Therapy for Wet AMD,12/16/2019 KURA-US  GNW  Kura Oncology Receives Fast Track Designation for Tipifarnib in HRAS Mutant HNSCC and Provides Enrollment Guidance for AIM-HN Trial, 1/07/2020 APLS-US  GNW  Apellis Reports Positive Top-line Results from Phase 3 Head-to-Head Study of Pegcetacoplan (APL-2) Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH), 2/19/2020 AXSM-US  GNW  Axsome Therapeutics to Present at Upcoming Investor Conferences,10/30/2019 VYGR-US  GNW  Voyager Therapeutics to Host Third Quarter 2019 Financial Results and Corporate Highlights Conference Call, 1/13/2020 BGNE-US  GNW  EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANTÂ® and QARZIBAÂ®â–¼ in Greater China,"11/04/2019 74933V10 GNW  MERGER ALERT â€“ RARX, EMPK, and CETV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies","11/12/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results and an Update on Development Programs", 1/31/2020 HCM-GB   GNW  Chi-Med to Announce 2019 Final Results,10/24/2019 NTLA-US  GNW  Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2019 Earnings and Company Update,11/06/2019 ACIU-US  GNW  AC Immune Hosts Key Opinion Leader Event: â€˜Untanglingâ€™ Tau Pathology to Treat Alzheimerâ€™s and Neurodegenerative Diseases,10/28/2019 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results," 2/06/2020 GTHX-US  GNW  G1 Therapeutics to Participate in Guggenheim Health Talks: Oncology Day on February 13, 2020", 8/01/2019 ARGX-BE  GNW  argenx reports half year 2019 financial results and  second quarter business update,"12/18/2019 RUBY-US GNW  Rubius Therapeutics Appoints Anne Prener, M.D., Ph.D., to its Board of Directors", 2/03/2020 ATNX-US  GNW  Athenex CEO Informs Shareholders of Unrelated Matter Regarding Past Board Membership at Porton Pharma," 1/06/2020 PETQ-US  GNW  PetIQ, Inc. to Participate in the 2020 ICR Conference",12/05/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Completes Enrollment of Pivotal Cohort in Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and AlstrÃ¶m Syndromes,11/12/2019 OPTN-US  GNW  Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights,10/08/2019 76133L10 GNW  AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP, 9/04/2019 DNLI-US  GNW  Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinsonâ€™s Disease and Launch of Its Engage Parkinsonâ€™s Website,, 9/05/2019 SLDB-US  GNW  Solid Biosciences Announces Publication Highlighting the Important Role of the nNOS Domain in Microdystrophin Function and its Potential Utility in DMD Gene Therapy in the Journal Neuromuscular Disorders, 1/09/2020 EOLS-US  GNW  Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue,11/26/2019 FIXX-US GNW  Homology Medicines Announces Peer-Reviewed Publication Demonstrating its AAVHSC Vectors Crossed the Blood-Brain-Barrier and Blood-Nerve-Barrier in NHPs," 2/03/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion",10/02/2019 SRRK-US  GNW  Scholar Rock to Present Preclinical and Phase 1 Clinical Data on SRK-015 at the World Muscle Society Congress,"11/06/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates",,, 5/07/2019 EIDX-US  GNW  Eidos Therapeutics Reports First Quarter 2019 Financial Results,"12/18/2018 AVRO-US  GNW  AVROBIO, Inc. Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)",,11/01/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 1/22/2020 AUTL-US  GNW  Autolus Announces Pricing of Public Offering, 2/25/2020 FTSV-US GNW  Forty Seven to Present at Upcoming Investor Conferences in March, 5/28/2019 TBIO-US  GNW  Translate Bio to Present at the Jefferies 2019 Healthcare Conference,,11/05/2019 PRNB-US GNW  Principia Biopharma Reports Third Quarter Financial Results,11/04/2019 ARVN-US GNW  Arvinas Reports Third Quarter 2019 Financial Results and Provides Corporate Update,12/11/2019 YMAB-US  GNW  Y-mAbs Announces Positive Naxitamab Frontline DataÂ ,,11/12/2019 GRTS-US  GNW  Gritstone Oncology Reports Third Quarter 2019 Financial ResultsÂ and Recent Highlights,12/19/2019 GH-US    GNW  Guardant Health Receives Expanded Medicare Coverage for Guardant360 Across the Vast Majority of Solid Tumor Cancers,11/14/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc Reports Third Quarter 2019 Results,11/14/2019 NGM-US   GNW  NGM Bio to Present at the Stifel 2019 Healthcare Conference,, 1/29/2020 ORTX-US  GNW  Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD),, 1/29/2020 ALEC-US  GNW  Alector Announces Upsizing and Pricing of Public Offering,"12/09/2019 DTIL-US GNW  Precision BioSciences Presents Updated Interim Clinical Data at the ASH Annual Meeting from Relapsed / Refractory NHL and B-ALL Patients Treated at Dose Levels 1 & 2 in the Ongoing Phase 1/2a Clinical Trial of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate", 1/13/2020 TPTX-US GNW  Turning Point Therapeutics Announces Program Updates and Milestones for 2020, 2/06/2020 PRVL-US GNW  Prevail Announces Presentations at the 16th Annual WORLDSymposiumâ„¢ 2020,,11/14/2019 BCEL-US GNW  Atreca to Present at Two Upcoming Investor Conferences,,, 2/21/2020 BBIO-US  GNW  BridgeBio Pharma And Eidos Therapeutics To Present At Upcoming Investor Conferences, 1/13/2020 00650F10 GNW  Adaptive and Genentech Partner to Use clonoSEQÂ® Assay to Measure Minimal Residual Disease as a Primary Endpoint in Phase III Study of Chronic Lymphocytic Leukemia Patients,
"12/12/2016 53220K50 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ligand Pharmaceuticals Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ LGND",11/08/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Delivery of Consents and Revocations to Independent Inspector of Elections, 6/28/2017 45232710    GNW  Adamas Appoints New Chief Financial Officer," 9/23/2016 84763A10 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - SPPI","12/12/2017 G3040110 GNW  ENDO INTERNATIONAL LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Endo International, Plc. To Contact The Firm"," 1/13/2017 04280A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ ARWR","11/25/2019 BDSI-US  GNW  BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors",," 8/31/2018 75886F10 GNW  Market Trends Toward New Normal in Sykes Enterprises, Carnival, Covenant Transportation Group, Synergy Pharmaceuticals, Regeneron Pharmaceuticals, and Minerals Technologies â€” Emerging Consolidated Expectations, Analyst Ratings"," 9/26/2019 SIGA-US      GNW  SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019",11/05/2019 OPK-US   GNW  OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results,12/04/2019 46222210 GNW  Akcea Announces Appointment of New Chief Operating Officer,10/13/2016 BMRN-US     GNW  UK Regulatory Agency Approves Continued Enrollment in BioMarin Phase 1/2 Study  of BMN 270 in Hemophilia A," 4/02/2018 ABEO-US  GNW  Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer"," 1/05/2017 NAVB-US  GNW  BioXcel Appoints Eric K. Rowinsky, M.D. to its Board of Directors",10/10/2017 GMAB-DK  GNW  Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer, 2/25/2020 IMMU-US  GNW  Immunomedics to Participate in Upcoming Healthcare Conferences Â ,12/13/2019 BIIB-US   GNW  Biogen Reports Top-Line Results from Phase 2 Study in Progressive Supranuclear Palsy," 1/27/2012 45253H10 GNW  ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and Provides Quarterly Update"," 3/05/2020 BCRX-US  GNW  BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930",12/07/2017 37555810 GNW  Gilead Sciences to Acquire Cell Design Labs, 1/09/2012 04004760 GNW  Small-Cap Stock Trade Review: Arena Pharmaceuticals Report Featured on MicroStockProfit.com," 1/20/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL, PRU INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",, 7/11/2019 AKRX-US  GNW  Akorn to Report Second Quarter 2019 Financial Results and Host Conference Call," 3/20/2019 CYTK-US  GNW  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis", 2/11/2020 MYGN-US  GNW  Myriad Submits sPMA for myChoiceÂ® CDx with LynparzaÂ® in First-Line Maintenance Therapy in Advanced Ovarian Cancer,12/20/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Topline Phase 3 Data for Sotagliflozin in Type 2 Diabetes, 8/08/2019 MGTX-US  GNW  MeiraGTx Announces Pricing of Public Offering of Ordinary Shares,10/01/2018 INSM-US  GNW  Insmed to Present at Two October Conferences, 8/12/2014 AUP-CA   GNW  Aurinia Pharmaceuticals to Present at the Canaccord Genuity 34th Annual Growth Conference," 3/30/2020 AAN-US    GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AAN, FLR, INO, MGPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits","10/02/2019 64026810 GNW  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in ERI, NKTR, and GVA of Filing Deadlines",, 3/03/2020 GERN-US  GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline â€“ GERN," 6/22/2015 00771V10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aerie Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2015 -- AERI", 2/20/2020 AMRN-US  GNW  Amarin to Present at Two Upcoming Investor Conferences, 7/02/2019 ZLAB-US  GNW  Incyte and Zai Lab Announce Collaboration and License Agreement for INCMGA0012 in Greater China, 5/15/2018 91307C10 GNW  SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results,12/31/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 2/22/2019 G0176710 GNW  CLASS ACTION UPDATE for ALKS, MU, SVXY and UXIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",," 1/21/2020 00163U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG"," 7/05/2016 ARQL-US  GNW  ArQule to Present at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference on July 12, 2016",,,," 4/01/2020 SAN-FR   GNW  Sanofi: Information on Sanofiâ€™s Shareholder General Meeting of Tuesday, April 28, 2020"," 8/10/2018 92532F10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Immunomedics, Vertex Pharmaceuticals, Ralph Lauren, Alliant Energy, TreeHouse Foods, and Lincoln National â€” New Research Emphasizes Economic Growth",11/05/2019 ALLO-US  GNW  Allogene Therapeutics Reports Third Quarter 2019 Financial Results,11/14/2019 ASND-US  GNW  Ascendis Pharma Expands TransConâ„¢ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARAÂ® in the United States,, 9/07/2018 00422510 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ACAD,12/17/2019 AFMD-US  GNW  Affimed Announces Addition to NASDAQ Biotechnology Index,,11/18/2019 PRQR-US  GNW  ProQR to Present at Upcoming Scientific Conferences," 5/27/2017 88338N10 GNW  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm", 2/06/2020 ZGNX-US  GNW  Zogenix Announces Positive Top-line Results from Global Pivotal Phase 3 Trial  of FINTEPLAÂ® for the Treatment of Lennox-Gastaut Syndrome, 3/24/2020 ALLK-US  GNW  Allakos Announces Positive Phase 1 Results with Antolimab (AK002) in Mast Cell Gastrointestinal Disease,," 3/14/2016 RVNC-US  GNW  Revance Therapeutics Expands Leadership Team, Appoints Roman G. Rubio, MD, MBA, as Senior Vice President of Clinical Development",,, 2/14/2020 ADVM-US  GNW  Adverum Biotechnologies Announces Closing of $150 Million Public Offering of Common Stock, 2/06/2020 RARE-US   GNW  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2019  Financial Results and Corporate Update, 9/03/2019 AGLE-US  GNW  Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium, 7/15/2019 NSTG-US  GNW  NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimerâ€™s Disease Research,"10/15/2014 69329Y10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in PDL BioPharma, Inc. to Contact Brower Piven Before the November 17, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- PDLI",,12/02/2019 RDUS-US  GNW  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),12/06/2019 ASMB-US  GNW  Assembly Biosciences Announces Plenary Lecture at HEP DART 2019,10/06/2011 00182C10 GNW  Key Executive Video Interviews Now Available on Equities.com,,"11/12/2018 02043Q10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MCHP, ALNY, CHGG, FIT and SONS"," 9/06/2019 WVE-US   GNW  Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019", 1/28/2020 00972L10 GNW  Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx,,11/26/2019 PCRX-US  GNW  Pacira BioSciences to Present at the 31st Annual Piper Jaffray Healthcare Conference,11/14/2019 RTRX-US  GNW  Retrophin to Present at the Jefferies 2019 London Healthcare Conference,"11/07/2019 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2019 Financial Results","12/09/2019 EDIT-US  GNW  Editas Medicine Announces In Vivo Proof-of-Concept Data for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia",11/05/2019 CHMA-US  GNW  Chiasma Reports Third Quarter 2019 Results,12/11/2019 MGNX-US  GNW  MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium, 8/06/2014 0BP4MZ-E GNW  Blueprint Medicines to Present at Wedbush 2014 Life Sciences Management Access Conference,11/05/2015 AKBA-US  GNW  UPDATE: Akebia to Present at the Credit Suisse 24th Annual Healthcare Conference," 7/10/2015 28249U10 GNW  Stull, Stull & Brody Announces the Filing of a Class Action Suit on Behalf of Purchasers of Securities of Celladon Corporation (NASDAQ: CLDN) During the Period July 7, 2014 through June 25, 2015",12/12/2019 MNTA-US  GNW   Momenta Pharmaceuticals Announces  Pricing of Public Offering of Common Stock,10/29/2019 PRTA-US  GNW  Prothena to Report Third Quarter 2019 Financial Results on November 5, 1/27/2020 ZLAB-US  GNW  Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option, 2/24/2016 SAGE-US  GNW  Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results, 2/20/2020 CTMX-US  GNW  CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results,"12/13/2019 GMAB-DK  GNW  CHMP Issues Positive Opinion Recommending DARZALEXÂ® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma"," 4/11/2019 92165910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm",,11/04/2019 CBAY-US  GNW  CymaBay Therapeutics Reaches Target Enrollment in the ENHANCE Global Phase 3 Study Evaluating Seladelpar for Primary Biliary Cholangitis, 7/02/2013 45781M10 GNW  Inova Announces $42 Million of Awarded Contracts,11/04/2019 CCXI-US  GNW  ChemoCentryx Reports Third Quarter 2019 Financial Results and Recent Highlights,"11/13/2017 40637H10 GNW  Recent Analysis Shows Pure Storage, Catalent, Boyd Gaming, Halozyme Therapeutics, Clovis Oncology, and General Cable Market Influences â€“ Renewed Outlook, Key Drivers of Growth",,12/20/2019 MNKD-US   GNW  Study 171 Shows Hypoglycemia is Reduced with Use of AfrezzaÂ® Relative to Insulin Aspart in Type 1 Diabetes, 5/21/2018 URGN-US  GNW  UroGen Pharma Announces Positive Interim Results from Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGelâ„¢) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC), 2/28/2020 CYTK-US  GNW  Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day, 2/28/2020 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 5/29/2019 03236M20  GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc."," 4/27/2016 69366J20 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of PTC Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 2, 2016 â€“ PTCT","10/23/2019 00448Q20 GNW  MERGER ALERT â€“ ACHN, JAG, and ROAN: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies",11/21/2019 SYNH-US  GNW  Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement," 1/07/2020 FOLD-US  GNW  Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease"," 6/20/2016 26979610 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 â€“ EGRX","11/14/2017 24344T10 GNW  Deciphera Pharmaceuticals, Inc. (Nasdaq: DCPH) to Ring The Nasdaq Stock Market Opening Bell", 1/07/2020 ADMA-US  GNW  ADMA Biologics Enters Into a Manufacturing and Supply Agreement to Produce and Sell Plasma-Derived Intermediate Fractions, 2/03/2020 GWPH-US  GNW  GW Pharmaceuticals and Greenwich Biosciences Submit Supplemental New Drug Application to U.S. FDA for EpidiolexÂ® (cannabidiol) for the Treatment of Tuberous Sclerosis Complex, 5/17/2018 EPZM-US  GNW  Epizyme to Present New Tazemetostat Data at the American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Congress,,11/11/2019 MYOK-US  GNW  MyoKardia Announces 48-week Data from PIONEER-OLE Study of Mavacamten,, 1/15/2020 GLPG-NL  GNW  Fibrocor and Galapagos sign expanded collaboration in fibrosis, 3/03/2020 PTLA-US  GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PTLA and QD,,,12/02/2010 HBIO-US  GNW  Cellectis Grants Harvard Bioscience a License to CytoPulse Electroporation Instruments,12/03/2019 CARA-US  GNW  Cara Therapeutics Announces Positive Topline Data From Phase 2 Trial of Oral KORSUVAâ„¢ in Chronic Kidney Disease Patients with Moderate-to-Severe Pruritus, 2/07/2020 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/31/2020 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences in February, 1/12/2020 AGIO-US   GNW  Agios Announces â€œAgios 2025â€ Strategic Vision and Highlights 2020 Milestones,12/02/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Investor Conferences in December," 3/27/2020 ANAB-US  GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against AnaptysBio, Inc. (ANAB)",,"12/07/2019 FATE-US  GNW  Fate Therapeutics Announces Clinical Data from Landmark Phase 1 Studies of First-ever Universal, Off-the-shelf, iPSC-derived NK Cell Cancer Immunotherapy Programs", 5/09/2018 HZNP-US  GNW  Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidance and Announces New Company Operating Structure to Enhance Focus on Rare Diseases,,12/05/2019 ICPT-US  GNW  Intercept Announces Publication of Results from the Interim Analysis of the Phase 3 REGENERATE Study of OCA for the Treatment of Fibrosis Due to NASH in The Lancet, 3/03/2020 KPTI-US    GNW  Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock, 9/08/2014 38000Q10 GNW  Data on GlycoMimetics' Drug Candidate's Potential to Treat Lung Infections Caused by Pseudomonas Aeruginosa to Be Presented at North American Cystic Fibrosis Conference,, 1/07/2020 ITCI-US  GNW  Intra-Cellular Therapies Prices Public Offering of Common Stock,,10/12/2016 NVCR-US  GNW  Novocure Enrolls First Patient in Phase 3 Pivotal Brain Metastases Trial,,"11/07/2019 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019","11/07/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress"," 1/07/2017 77313F10 GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Inotek Pharmaceuticals Corporation To Contact The Firm Before Lead Plaintiff Deadline", 3/18/2019 DERM-US  GNW  Dermira Announces Proposed Public Offering of Common Stock," 1/14/2020 FOMX-US  GNW  Foamix Announces AMZEEQâ„¢ (minocycline)Â Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.",10/09/2019 PRAH-US  GNW  PRA Health Sciences to Report Third Quarter 2019 Earnings,11/12/2019 SUPN-US  GNW  Supernus to Present at Two November Healthcare Conferences,12/02/2019 FGEN-US  GNW  FibroGen Announces Roxadustat Inclusion in Chinaâ€™s National Reimbursement Drug List," 6/01/2017 74587V10 GNW  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm", 2/26/2020 CHRS-US  GNW  Coherus BioSciences Management to Present at the 40th Annual Cowen Healthcare Conference,11/12/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London,,11/26/2019 COLL-US  GNW  Collegium to Participate in Upcoming Investor Conferences,12/07/2019 XBIT-US  GNW  XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen," 9/28/2016 81750R10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Seres Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 29, 2016 â€“ MCRB",, 2/03/2020 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 2/07/2018 RGNX-US  GNW  REGENXBIO to Participate in Upcoming Investor Conferences,12/08/2019 KURA-US  GNW  Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma, 1/02/2020 APLS-US  GNW  Apellis Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/22/2020 AXSM-US  GNW  Axsome Therapeutics Completes Patient Randomization in the STRIDE-1 Phase 3 Trial of AXS-05 in Treatment Resistant Depression, 9/25/2019 VYGR-US  GNW  Voyager Therapeutics to Present at Upcoming Investor Conferences in October 2019, 1/08/2020 BGNE-US  GNW  BeiGene to Present at the 38th Annual J.P. Morgan Healthcare Conference,"11/01/2019 74933V10 GNW  SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, and RARX Shareholders About Its Ongoing Investigations",11/11/2019 RETA-US  GNW  Reata Announces Positive Topline Year One Results From Pivotal Phase 3 Cardinal Study of Bardoxolone Methyl in Patients With Alport Syndrome, 1/23/2020 HCM-GB   GNW  Chi-Med Announces Pricing of US$110 Million Public Offering of ADSs,10/24/2019 NTLA-US  GNW  Intellia Therapeutics Presents In Vivo and Ex Vivo Data at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT),10/24/2019 ACIU-US  GNW  AC Immune to Host Key Opinion Leader Event: â€˜Untanglingâ€™ Tau Pathology to Treat Alzheimerâ€™s and Neurodegenerative Diseases,10/15/2019 0GPQYV-E GNW  CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companiesâ€™ Respective Cell Therapy Programs in Oncology, 1/14/2020 GTHX-US  GNW  Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer," 7/25/2019 ARGX-BE  GNW  argenx to report half year 2019 financial results and second quarter business update on August 1, 2019",11/14/2019 RUBY-US GNW  Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress,"12/16/2019 04685N10 GNW  Athenex Expands its Strategic Partnership with Guangzhou Xiangxue Pharmaceutical Through a Licensing Agreement for its Product Candidates Oral Paclitaxel and Oral Irinotecan, as well as Tirbanibulin Ointment, in China, Hong Kong and Macao","12/05/2019 PETQ-US  GNW  PetIQ, Inc. Provides Update on Wellness Center Openings",11/13/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Stifel 2019 Healthcare Conference,"11/01/2019 OPTN-US  GNW  Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019",10/02/2019 TORC-US  GNW  resTORbio Presents New Findings on RTB101 During Late-Breaking Session at IDWeek 2019, 8/06/2019 DNLI-US  GNW  Denali Therapeutics Reports Second Quarter 2019 Financial Results and Business Highlights,, 8/14/2019 SLDB-US  GNW  Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update,11/07/2019 EOLS-US  GNW  Evolus to Participate in Stifel Healthcare Conference,11/12/2019 FIXX-US GNW  Homology Medicines Reports Third Quarter 2019 Financial Results and Recent Highlights," 1/27/2020 EYPT-US    GNW  EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize DEXYCUÂ® for Post-operative Inflammation in Mainland China, Hong Kong, Macau and Taiwan"," 9/05/2019 SRRK-US  GNW  Scholar Rock Announces Appointment of George Nomikos, M.D., Ph.D., as Vice President, Head of Medical Research, Muscle Franchise","10/31/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee",,, 4/19/2019 EIDX-US  GNW  Eidos Therapeutics to Present at Two Upcoming Investor Conferences,"12/18/2018 AVRO-US  GNW  AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires",,10/01/2019 XERS-US  GNW  Xeris Pharmaceuticals Appoints Mark Thierer to Board of Directors, 1/22/2020 AUTL-US  GNW  Autolus Announces Proposed Public Offering in the United States, 2/06/2020 FTSV-US GNW  Forty Seven to Present at Upcoming Investor Conferences in February, 5/01/2019 TBIO-US  GNW  Translate Bio Announces $47.5 Million Private Placement,,10/15/2019 PRNB-US GNW  Principia Announces Pricing of Public Offering of Common Stock,"10/23/2019 ARVN-US GNW  Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTACÂ® Targeted Protein Degraders",12/05/2019 YMAB-US  GNW  Y-mAbs and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for Omburtamab,,11/05/2019 GRTS-US  GNW  Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy,12/13/2019 GH-US    GNW  Large-Scale Study Shows Guardant360 Effectively Guides Precision Oncology Treatment in Metastatic Breast Cancer Patients,"11/08/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Provide Third Quarter 2019 Business and Financial Update on November 15, 2019",11/12/2019 NGM-US   GNW  NGM Reports Business Highlights and Third Quarter 2019 Financial Results,, 1/13/2020 ORTX-US  GNW  Orchard Therapeutics Highlights 2020 Strategic Priorities,, 1/28/2020 01444210 GNW  Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimerâ€™s Disease Patients,"11/13/2019 DTIL-US GNW  Precision BioSciences Welcomes Healthcare Industry Expert, Kevin J. Buehler, to its Board of Directors", 1/09/2020 TPTX-US GNW  Turning Point Therapeutics Announces Management Transition, 1/09/2020 PRVL-US GNW  Prevail Therapeutics Provides PR001 Program Update,,11/12/2019 BCEL-US GNW  Atreca Reports Third Quarter 2019 Financial Results and Recent Corporate Developments,,, 2/05/2020 BBIO-US  GNW  BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), 1/08/2020 ADPT-US  GNW  Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQÂ® for Monitoring MRD in Patients With Chronic Lymphocytic Leukemia,
"11/27/2016 53220K50 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ligand Pharmaceuticals Incorporated To Contact Brower Piven Before The Lead Plaintiff Deadline â€“ LGND",11/07/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Business Update And Third Quarter 2019 Financial Results," 4/27/2017 NGEN-US     GNW  OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors", 9/23/2016 84763A10 GNW  SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Class Action and Lead Plaintiff Deadline,12/02/2017 G3040110 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline â€“ ENDP," 1/06/2017 04280A10 GNW  ARWR LOSS NOTICE: Rosen Law Firm Reminds Arrowhead Pharmaceuticals, Inc. Investors of Important Deadline in Class Action - ARWR","11/12/2019 BDSI-US  GNW  BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations",," 7/27/2018 75886F10 GNW  Recent Analysis Shows Ameriprise Financial, Covenant Transportation Group, Popular, Suburban Propane Partners, AAC, and Regeneron Pharmaceuticals Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 9/25/2019 SIGA-US      GNW  SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019","11/04/2019 OPK-US   GNW  BioReference Laboratories and GeneDx to Present at NSGC 2019,  Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders",11/25/2019 46222210 GNW  Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis,"10/11/2016 BMRN-US     GNW  BioMarin to Host Third Quarter 2016 Financial Results Conference Call and Webcast on Thursday, October 27 at 4:30pm ET", 3/16/2017 01535110 GNW  Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidate,12/01/2016 NBIX-US  GNW  Neurocrine Biosciences (Nasdaq: NBIX) to Ring The Nasdaq Stock Market Opening Bell, 8/29/2017 GMAB-DK  GNW  Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors," 2/20/2020 IMMU-US  GNW  Immunomedics to Report Results for the Fourth Quarter and Full Year 2019 and Host Conference Call and Webcast on February 27, 2020",12/03/2019 BIIB-US   GNW  Biogen Announces Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)," 1/03/2012 45253H10 GNW  ImmunoGen, Inc. Announces Webcast of Presentation at the J.P. Morgan 30th Annual Healthcare Conference", 3/03/2020 BCRX-US  GNW  BioCryst to Present at Barclays Global Healthcare Conference,"11/28/2017 37555810 GNW  Analysis: Positioning to Benefit within Garmin, J P Morgan Chase, Gilead Sciences, Windstream, Cardinal Health, and QEP Resources â€” Research Highlights Growth, Revenue, and Consolidated Results", 2/01/2011 VVUS-US  GNW  Orexigen Therapeutics Inc. is Today's Focus Stock on MicroStockProfit.com," 1/17/2020 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 6/28/2019 AKRX-US  GNW  Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%"," 2/25/2019 03116210 GNW  Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer", 2/06/2020 MYGN-US  GNW  Myriad Announces Leadership Transition,12/05/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211, 8/07/2019 MGTX-US  GNW  MeiraGTx Announces Proposed Public Offering of Ordinary Shares," 9/28/2018 INSM-US  GNW  Insmed Announces FDA Approval of ARIKAYCEÂ® (amikacin liposome inhalation suspension), the First and Only Therapy Specifically Indicated for the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease in Adult Patients with Limited or No Alternative Treatment Options", 7/29/2014 AUP-CA   GNW  Aurinia Adds Financial Expertise to Its Board of Directors," 3/27/2020 ALGN-US   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS ALGN, INO, TLRY, WWE INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",10/01/2019 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Nektar Therapeutics - NKTR,," 3/02/2020 GERN-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Geron Corporation (GERN) Investors Who Suffered Losses to Contact its Attorneys: Application Deadline in Three Weeks"," 6/09/2015 00771V10 GNW  Hagens Berman Reminds Investors With Losses Over $100,000 in Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) of the June 29th Lead Plaintiff Deadline"," 2/19/2020 AMRN-US  GNW  Amarin To Report Fourth Quarter and Full Year 2019 ResultsÂ and Host Conference Call on February 25, 2020", 5/28/2019 45337C10 GNW  BriaCellâ€™s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 4/30/2018 91307C10 GNW  United Therapeutics to Acquire SteadyMed Ltd.,"12/23/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001"," 2/22/2019 G0176710 GNW  Alkermes Public Limited Company Reminder: Pawar Law Reminds of Important February 25, 2019 Lead Plaintiff Deadline in Class Action â€“ ALKS",," 1/09/2020 00163U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG", 6/30/2016 ARQL-US  GNW  ArQule Presents Preliminary Clinical Data for ARQ 087 Demonstrating Evidence of Anticancer Activity in Intrahepatic Cholangiocarcinoma at the ESMO 18th World Congress on Gastrointestinal Cancer,,,, 3/30/2020 REGN-US  GNW  Sanofi: First patient outside U.S. treated in global KevzaraÂ® (sarilumab) clinical trial program for patients with severe COVID-19, 5/30/2018 92532F10 GNW  CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease,11/05/2019 ALLO-US  GNW  Allogene Therapeutics and Notch Therapeutics Announce Collaboration to Research and Develop Induced Pluripotent Stem Cell (iPSC)-Derived Allogeneic Therapies for Hematologic Cancer Indications,11/08/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentation in November,," 9/06/2018 00422510 GNW  CLASS ACTION UPDATE for GLCNF GLNCY, ACAD and FPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",11/19/2019 AFMD-US  GNW  Affimed Reports Third Quarter 2019 Financial Results and Recent Operational Progress,,11/13/2019 PRQR-US  GNW  ProQR to Present at Upcoming Investor Conferences," 5/25/2017 88338N10 GNW  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm",12/17/2019 ZGNX-US  GNW  The Lancet Publishes Phase 3 Trial Results for Zogenix  Investigational Drug FINTEPLAÂ® in Dravet Syndrome," 3/18/2020 ALLK-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Losses to Contact Its Attorneys: Application Deadline Approaching",, 3/05/2016 06PNP8-E GNW  Revance Announces Late-Breaking Podium Presentation of Positive 6-Month Duration Results for BELMONT Phase 2 Active Comparator Study of Injectable RT002 at the 74th Annual Meeting of the American Academy of Dermatology,,, 2/11/2020 ADVM-US  GNW  Adverum Biotechnologies Announces Pricing of Public Offering of Common Stock, 1/15/2020 RARE-US   GNW  GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome, 8/29/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium," 7/10/2019 NSTG-US  GNW  NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019",10/14/2014 69329Y10 GNW  Deadline in Lawsuit for Investors in PDL BioPharma Inc (PDLI) Shares Announced by Shareholders Foundation,,11/15/2019 RDUS-US  GNW  Radius Health to Present at Jefferies 2019 Global Healthcare Conference in London,11/18/2019 ASMB-US  GNW  Assembly Biosciences Announces Presentation at Jefferies London Healthcare Conference," 3/31/2011 00182C10 GNW  IDEAS Investor Conferences to be held in Boston, Chicago and Dallas",,11/11/2018 02043Q10 GNW  SHAREHOLDER ALERT: ALNY ACHC JT TRVN HON DY AQUA SONS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 9/05/2019 WVE-US   GNW  Wave Life Sciences Expands Board of Directors with Three New Appointments, 1/10/2020 AKCA-US  GNW  Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy,,11/13/2019 PCRX-US  GNW  Pacira BioSciences to Present at the Jefferies 2019 London Healthcare Conference,10/30/2019 RTRX-US  GNW  Retrophin Reports Third Quarter 2019 Financial Results,10/10/2019 PACB-US  GNW  Highly Accurate SMRT Sequencing for Human Genetics to Be Showcased at ASHG 2019 Annual Meeting,11/12/2019 EDIT-US  GNW  Editas Medicine Announces Third Quarter 2019 Results and Update,11/01/2019 CHMA-US  GNW  Chiasma Supports Acromegaly Awareness Day,12/09/2019 MGNX-US  GNW  MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting, 6/20/2014 0BP4MZ-E GNW  Blueprint Medicines to Present at JMP Securities Healthcare Conference,11/03/2015 AKBA-US  GNW  Akebia to Present at the Credit Suisse 24th Annual Healthcare Conference, 7/08/2015 28249U10 GNW  LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That a Securities Fraud Class Action Has Been Filed Against Celladon Corporation - CLDN,12/10/2019 MNTA-US  GNW  Momenta Pharmaceuticals AnnouncesÂ Proposed Public Offering of Common Stock, 8/06/2019 PRTA-US  GNW  Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update, 1/22/2020 ZLAB-US  GNW  Zai Lab Announces Pricing of Public Offering of American Depositary Shares," 2/17/2016 SAGE-US  GNW  Sage Therapeutics to Report Fourth Quarter and Full Year 2015 Financial Results  on Wednesday, February 24, 2016", 2/07/2020 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grant,12/05/2019 GMAB-DK  GNW  Genmab Achieves USD 100 Million Sales Milestone in DARZALEXÂ® (daratumumab) Collaboration with Janssen," 4/08/2019 92165910 GNW  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In AMRN, KHC, DPLO or VNDAÂ To Contact The Firm",,"10/28/2019 CBAY-US  GNW  CymaBay Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 5", 6/17/2013 45781M10 GNW  Inova Stock Split Effective and Inova Receives $1.4 Million PO From Clint & Socorro Independent School Districts,"10/28/2019 CCXI-US  GNW  ChemoCentryx to Hold Third Quarter 2019 Financial Results Conference Call on Monday, November 4, 2019",,,11/29/2019 MNKD-US   GNW  MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference, 5/15/2018 URGN-US  GNW  UroGen Pharma Reports First Quarter 2018 Financial Results and Recent Corporate Developments," 2/26/2020 AMGN-US  GNW  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis", 2/28/2020 ESPR-US     GNW  Esperion to Participate in Upcoming Investor Conferences," 5/24/2019 03236M20  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AMRS, BV, FLEX, REV of Lead Plaintiff Deadline in Class Action Lawsuits"," 3/28/2016 69366J20 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of PTC Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 2, 2016 â€“ PTCT", 9/26/2019 ACHN-US  GNW   Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference,11/13/2019 SYNH-US  GNW  Syneos Health to Present at the Jefferies 2019 London Healthcare Conference,11/11/2019 FOLD-US  GNW  Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates," 6/03/2016 26979610 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of aÂ Class Action against Eagle Pharmaceuticals, Inc. and Certain Officers â€“ EGRX","11/14/2017 DCPH-US  GNW  Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial ResultsÂ and Corporate Highlights",12/17/2019 ADMA-US  GNW  ADMA Biologics Added to NASDAQ Biotechnology Index, 1/12/2020 GWPH-US  GNW  GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales, 5/08/2018 EPZM-US  GNW  Epizyme Reports First Quarter 2018 Financial Results and Provides Business Updates,,11/11/2019 MYOK-US  GNW  MyoKardia Announces Positive Topline Data from its Phase 2 MAVERICK-HCM  Clinical Trial of Mavacamten,, 1/13/2020 GLPG-NL  GNW  Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis, 3/03/2020 PTLA-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,,,,11/12/2019 CARA-US  GNW  Cara Therapeutics to Present at November Investor Conferences, 1/13/2020 33938J10 GNW  Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update,12/19/2019 QURE-US  GNW  uniQure Announces Publication of Preclinical Data for AMT-130 in Huntingtonâ€™s Disease Supporting Non-Selective HTT-Lowering Approach,"12/23/2019 AGIO-US   GNW  Agios to Present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020",11/21/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy, 3/27/2020 ANAB-US  GNW  AnaptysBio (ANAB) Class Action Alert: Johnson Fistel Encourages Investors to Contact Firm,,11/27/2019 FATE-US  GNW  Fate Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference, 5/08/2018 HZNP-US  GNW  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTIÂ® (glycerol phenylbutyrate) Oral Liquid,,12/02/2019 ICPT-US  GNW  Intercept Pharmaceuticals Appoints Jason Campagna as Chief Medical Officer, 3/02/2020 KPTI-US    GNW  Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock, 3/27/2014 38000Q10 GNW  The NASDAQ Stock Market Leads U.S. Exchanges for IPOs in Q1 2014,, 1/06/2020 ITCI-US  GNW  Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock,, 9/30/2016 NVCR-US  GNW  CORRECTING and REPLACING â€“ Novocure to Report Third Quarter 2016 Financial Results,,"11/01/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019",11/06/2019 ATRA-US    GNW  Atara Biotherapeutics to Present Tab-celÂ® Long-Term Clinical Outcomes from a Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st American Society of Hematology (ASH) Annual Meeting," 1/06/2017 77313F10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces It Has Filed a Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 â€“ ITEK", 3/18/2019 DERM-US  GNW   Dermira Announces Positive Topline Results from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis, 1/09/2020 FOMX-US  GNW  Foamix Announces AMZEEQâ„¢ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne," 9/18/2019 PRAH-US  GNW  PRA Health Sciences, Symphony Health Launch Metys(TM) National Market Measurement Tool",11/11/2019 SUPN-US  GNW  Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD,"11/13/2019 31572Q80 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys, Firm Investigating Possible Securities Fraud"," 5/22/2017 74587V10 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with  Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ PBYI", 2/20/2020 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,11/11/2019 CRBP-US  GNW  Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting,,11/08/2019 COLL-US  GNW  Collegium to Participate in Upcoming Investor Conference,12/07/2019 XBIT-US  GNW  XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen," 8/19/2015 MCRB-US  GNW  Seres Therapeutics, Inc. (Nasdaq: MCRB) to Ring The Nasdaq Stock Market Closing Bell",, 1/08/2020 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 1/23/2018 RGNX-US  GNW  REGENXBIO Enhances Gene Therapy Manufacturing Capabilities by Entering into Strategic Partnership with FUJIFILM Diosynth Biotechnologies,11/26/2019 KURA-US  GNW  Kura Oncology to Participate in Piper Jaffray Healthcare Conference,11/26/2019 APLS-US  GNW  Apellis Pharmaceuticals to Present at Upcoming Investor Conferences, 1/13/2020 AXSM-US  GNW  Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizerâ€™s Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate, 8/28/2019 VYGR-US  GNW  Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019, 1/02/2020 6160-HK  GNW  BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment,"10/23/2019 74933V10 GNW  MERGER ALERT â€“ RARX, DOVA, and SEMG: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies","11/05/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report Third Quarter 2019 Financial Results and to Provide an Update on Development Programs on November 12, 2019", 1/21/2020 HCM-GB   GNW  Chi-Med Announces Proposed Public Offering of ADSs,10/16/2019 NTLA-US  GNW  Intellia Therapeutics Announces Presentations at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), 9/20/2019 ACIU-US  GNW  AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomerâ„¢ Program,10/01/2019 CRSP-US  GNW  CRISPR Therapeutics to Present at Upcoming Investor Conferences, 1/07/2020 GTHX-US  GNW  G1 Therapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference, 5/22/2019 ARGX-BE  GNW  argenx announces pipeline expansion and â€œargenx 2021â€ vision  to build integrated immunology company at 2019 R&D Day,11/12/2019 RUBY-US GNW  Rubius Therapeutics to Participate in Jefferies London Healthcare Conference,12/13/2019 ATNX-US  GNW  Athenex Announces Superior Response and Survival with Lower Neuropathy of a Novel Oral Paclitaxel versus IV Paclitaxel in Treatment of Metastatic Breast Cancer,"11/07/2019 PETQ-US  GNW  PetIQ, Inc. Reports Record Third Quarter 2019 Financial Results",11/04/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019,"10/04/2019 OPTN-US  GNW   Optinose Appoints Michael Richardson to New Position of Vice President, Business Development", 9/25/2019 TORC-US  GNW  resTORbio to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference, 8/05/2019 DNLI-US  GNW  Denali Therapeutics Announces That Its Partner Sanofi has Commenced Dosing of DNL758 in a Phase 1 Study,, 7/26/2019 SLDB-US  GNW  Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors,11/07/2019 EOLS-US  GNW  Evolus Announces Pricing of Public Offering of Common Stock,"10/25/2019 FIXX-US GNW  Homology Medicines Presents Preclinical Data From Its Investigational PKU Gene Editing Program, Demonstrating Phenotypic Correction and Molecular Confirmation of Editing Precision", 1/23/2020 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Preliminary Fourth Quarter and Full-Year 2019 Revenues, 9/04/2019 SRRK-US  GNW  Scholar Rock to Present at Upcoming Healthcare Conferences,"10/24/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting",,, 4/15/2019 EIDX-US  GNW  Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results,"11/13/2018 AVRO-US  GNW  AVROBIO, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update",, 9/27/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 1/13/2020 AUTL-US  GNW  Autolus Therapeutics to provide outlook for 2020 at the 38th Annual J.P. Morgan Conference, 1/10/2020 FTSV-US GNW  Forty Seven Announces 2020 Strategic Priorities and Expected Milestones, 4/08/2019 TBIO-US  GNW  Translate Bio Appoints Richard Wooster as Chief Scientific Officer,,10/15/2019 PRNB-US GNW  Principia Announces Proposed Public Offering of Common Stock,10/17/2019 ARVN-US GNW  Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit,"12/05/2019 YMAB-US  GNW  Y-mAbs to Host R&D Event and Live Webcast on Wednesday, December 11",,10/31/2019 GRTS-US  GNW  Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference,11/07/2019 GH-US    GNW  Guardant Health Reports Third Quarter 2019 Financial Results and Raises 2019 Revenue Guidance, 9/27/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc Appoints Industry Executive Michael J. DeBiasi to Board of Directors,10/29/2019 NGM-US   GNW  NGM Bio Announces Appointment of Valerie Pierce as General Counsel,, 1/06/2020 ORTX-US  GNW  Orchard Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference,, 1/27/2020 ALEC-US  GNW  Alector Announces Proposed Public Offering of Common Stock,11/12/2019 DTIL-US GNW  Precision BioSciences Reports Third Quarter 2019 Financial Results and Highlights Ongoing Operational Progress Including Initial Data from PBCAR0191 Phase 1/2a Clinical Trial," 1/06/2020 TPTX-US GNW  Turning Point Therapeutics Names Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs",12/26/2019 PRVL-US GNW  Prevail Therapeutics Announces IND Active for PR001 for Treatment of Neuronopathic Gaucher Disease,,11/05/2019 BCEL-US GNW  Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting,,, 1/13/2020 BBIO-US  GNW  BridgeBio Pharma Grows Pipeline to 20+ Genetic Medicines with Four Assets Focused on Treating Genetically Driven Diseases at Their Source,12/30/2019 ADPT-US  GNW  Adaptive Biotechnologies to Present at the 38th Annual J.P. Morgan Healthcare Conference,
"11/21/2016 53220K50 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ligand Pharmaceuticals Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ LGND",11/06/2019 0LDDK2-E GNW  Progenics Reminds Shareholders that November 17 is the True Deadline for Velanâ€™s Consent Solicitation, 3/07/2017 45232710    GNW  OPKO Subsidiary GenPath Womenâ€™s Health Announces the Availability of ClariTestâ„¢,"11/19/2015 84763A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 â€“ SPPI",11/15/2017 G3040110 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Endo International plc and Certain Officers â€“ ENDP,"12/23/2016 04280A10 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Arrowhead Pharmaceuticals, Inc. - ARWR",11/07/2019 BDSI-US  GNW  BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London,, 6/21/2018 INO-US   GNW  Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneronâ€™s PD-1 Inhibitor," 8/28/2019 SIGA-US      GNW  SIGA to Present at the 14th Annual Wells Fargo Securities Healthcare Conference on September 5, 2019","11/01/2019 OPK-US   GNW  OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019",11/19/2019 46222210 GNW  Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx), 9/21/2016 BMRN-US     GNW  BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases against Sarepta Therapeutics," 1/06/2017 01535110 GNW  ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. â€“ (ALXN)"," 9/03/2013 SERO-CH  GNW  BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs"," 3/08/2017 81257810 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Seattle Genetics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 â€“ SGEN", 2/14/2020 IMMU-US  GNW  Immunomedics Appoints Dr. Loretta Itri Chief Medical Officer,11/22/2019 BIIB-US   GNW  Biogen Presents Data Demonstrating Improved Gastrointestinal Tolerability With VUMERITYâ„¢ (diroximel fumarate) Compared to TECFIDERAÂ® (dimethyl fumarate),"12/20/2011 45253H10 GNW  ImmunoGen, Inc. Announces Antibody-Drug Conjugate Collaboration With Lilly", 3/02/2020 BCRX-US  GNW  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4), 7/31/2017 STDY-US  GNW  SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs, 1/31/2011 04004760 GNW  Arena Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com," 1/15/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FSCT, MAT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",, 6/25/2019 AKRX-US  GNW  Akorn Receives FDA Warning Letter," 2/21/2019 CYTK-US  GNW  Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure", 2/06/2020 MYGN-US  GNW  Myriad Genetics Reports Fiscal Second-Quarter 2020 Financial Results,"12/03/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer", 8/07/2019 MGTX-US  GNW  MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update, 9/17/2018 INSM-US  GNW  Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Published in American Journal of Respiratory and Critical Care Medicine, 6/26/2014 AUP-CA   GNW  Aurinia Pharmaceuticals Initiates Phase 2b Clinical Trial of Voclosporin to Treat Lupus Nephritis," 3/27/2020 INO-US    GNW  INO SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts Inovio Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm","10/01/2019 64026810 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Nektar Therapeutics Investors",," 2/24/2020 GERN-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Geron Corporation (GERN) Investors With Losses to Contact its Attorneys: Application Deadline Approaching"," 5/14/2015 00771V10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aerie Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2015 -- AERI", 2/06/2020 AMRN-US  GNW  Amarin Honored by BioNJ with Innovator Award for VASCEPAÂ® Development and Regulatory Approval, 5/13/2019 45337C10 GNW  BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders," 3/26/2018 PSTI-US  GNW  Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem's Strategic Advisory Board",12/13/2019 SRPT-US  GNW  Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing," 2/22/2019 G0176710 GNW  CLASS ACTION UPDATE for DBVT, AXGN, ALKS and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",," 1/09/2020 AMAG-US  GNW  AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review  to Unlock Shareholder Value and Financial Update"," 6/23/2016 06CR5C-E GNW  ArQule to Present Preliminary Phase 1/2 Data for FGFR Inhibitor, ARQ 087, in Intrahepatic Cholangiocarcinoma at the ESMO 18th World Congress on Gastrointestinal Cancer",,,, 3/27/2020 SAN-FR   GNW  Sanofi receives positive CHMP opinion for SarclisaÂ® (isatuximab) for the treatment of relapsed and refractory multiple myeloma," 3/27/2017 PRQR-US  GNW  ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer","10/29/2019 ALLO-US  GNW  Allogene Therapeutics to Report Third Quarter 2019 Financial Results on November 5, 2019",11/06/2019 ASND-US  GNW  Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransConâ„¢ Technology in Oncology at SITC 2019,," 9/04/2018 00422510 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, RMTI, ORCL, AMPE and CBS",11/14/2019 AFMD-US  GNW  Affimed to Present at the Jefferies 2019 London Healthcare Conference,,11/06/2019 PRQR-US  GNW  ProQR Announces Recent Progress and Financial Results for the Third Quarter of 2019," 5/24/2017 88338N10 GNW  IMPORTANT THERAPEUTICSMD, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Florida against TherapeuticsMD, Inc.",12/05/2019 ZGNX-US  GNW  Zogenix to Host Investor Update Lunch on FINTEPLAÂ® at the American Epilepsy Society 2019 Annual Meeting," 3/18/2020 ALLK-US  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Funko, Allakos, and Cronos Group and Encourages Investors to Contact the Firm",, 3/02/2016 RVNC-US  GNW  Revance Releases Fourth Quarter and Full Year 2015 Results,,, 2/10/2020 ADVM-US  GNW  Adverum Biotechnologies Announces $100 Million Public Offering of Common Stock, 1/13/2020 RARE-US   GNW  Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance, 8/06/2019 AGLE-US  GNW  Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights, 6/18/2019 NSTG-US  GNW  Publication in the Journal Clinical Cancer Research Uses NanoStringâ€™s GeoMx Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy,"10/10/2014 69329Y10 GNW  EQUITY ALERT: Rosen Law Firm Reminds PDL BioPharma, Inc. Investors of Important Class Action Deadline -- PDLI",,11/05/2019 RDUS-US  GNW  Radius Health Announces Third Quarter 2019 Results and Corporate Update,11/11/2019 ASMB-US  GNW  Data for Assembly Biosciencesâ€™ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019,,,"11/09/2018 02043Q10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alnylam Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â ALNY", 8/26/2019 WVE-US   GNW  Wave Life Sciences to Present at the Morgan Stanley Global Healthcare Conference, 1/02/2020 00972L10 GNW  New England Journal of Medicine Publishes Results from Phase 2 Study of AKCEA-APO(a)-LRx in Patients with Lp(a)-driven Cardiovascular Disease,,11/07/2019 PCRX-US  GNW  Pacira BioSciences Reports Third Quarter 2019 Financial Results and Business Update,10/16/2019 RTRX-US  GNW  Retrophin to Report Third Quarter 2019 Financial Results, 9/05/2019 PACB-US  GNW  European Research Initiative Adopts PacBio Sequel II System to Solve Rare Diseases,11/12/2019 CELG-US  GNW  Editas Medicine and Celgene Corporation Amend Existing Collaboration to Develop and Commercialize Autologous and Allogeneic T Cell Medicines for the Treatment of Cancer and Autoimmune Diseases,"10/29/2019 CHMA-US  GNW  Chiasma to Report Third Quarter Financial Results on November 5, 2019",12/02/2019 MGNX-US  GNW  MacroGenics to Participate in the Evercore ISI HealthCONx Conference, 4/07/2014 0BP4MZ-E GNW  Blueprint Medicines Presents Positive Data on First Selective FGFR4 Inhibitor,10/28/2015 00972D10 GNW  Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2015 Annual Meeting, 7/07/2015 28249U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Celladon Corporation and Certain Officers â€“ CLDN,11/07/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Poster Presentation at the 61st American Society of Hematology Annual Meeting and Exposition, 7/30/2019 PRTA-US  GNW  Prothena to Report Second Quarter 2019 Financial Results on August 6, 1/21/2020 ZLAB-US  GNW  Zai Lab Announces Proposed Public Offering of American Depositary Shares, 2/03/2016 SAGE-US  GNW  Sage Therapeutics to Present at the 2016 Leerink Global Healthcare Conference," 2/03/2020 CTMX-US  GNW  CytomX Therapeutics Appoints Alison L. Hannah, M.D. as Chief Medical Officer",11/19/2019 0CPNB1-E GNW  Genmab Announces European Marketing Authorization for DARZALEXÂ® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma, 4/07/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,,10/14/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at the H.C. Wainwright 3rd Annual NASH Investor Conference, 6/12/2013 45781M10 GNW  Inova Announces Stock Split," 9/24/2019 CCXI-US  GNW  ChemoCentryx to Host R&D Day on October 1, 2019",,,11/21/2019 MNKD-US   GNW   MannKind Appoints Tony Hooper to Its Board of Directors," 5/08/2018 URGN-US  GNW  UroGen Pharma to Report First Quarter 2018 Financial Results on Tuesday, May 15, 2018", 2/20/2020 CYTK-US  GNW  Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the Biophysical Society 64th Annual Meeting, 2/27/2020 ESPR-US     GNW  Esperion Provides Lipid Management Franchise Updates;Â Reports Fourth Quarter and Full Year 2019 Financial Results, 5/24/2019 AMRS-US   GNW  Amyris Appoints Two New Board Members with Significant Experience in Building High Growth Product and Consumer Companies," 3/07/2016 69366J20 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of PTC Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 2, 2016 â€“ PTCT", 9/25/2019 ACHN-US  GNW  Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria,11/12/2019 87166B10 GNW  Bernadette Connaughton Appointed to Syneos Health Board of Directors,"10/30/2019 FOLD-US  GNW  Amicus Therapeutics to Announce Third Quarter 2019 Financial Results on November 11, 2019"," 6/02/2016 26979610 GNW  IMPORTANT SHAREHOLDER NOTICE:Â  Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Eagle Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline â€“ EGRX","11/10/2017 DCPH-US  GNW  Deciphera Pharmaceuticals, Inc. Reports Data Analysis from the Ongoing Phase 1 Clinical Trial of DCC-2618 at the Annual Meeting of The Connective Tissue Oncology Society",11/13/2019 ADMA-US  GNW  ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference, 1/07/2020 GWPH-US  GNW  GW Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference, 5/01/2018 EPZM-US  GNW  Epizyme Announces First Quarter 2018 Financial Reporting Date and Upcoming Conference Call,,11/06/2019 MYOK-US  GNW  MyoKardia to Present at Credit Suisse 28th Annual Healthcare Conference,, 1/09/2020 GLPG-NL  GNW  Galapagos to present at 38th Annual J.P. Morgan Healthcare Conference," 3/02/2020 OPRA-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,,11/11/2019 CARA-US  GNW  Cara Therapeutics Announces Publication of Difelikefalin (KORSUVAâ„¢ Injection) KALMâ„¢-1 Phase 3 Trial Results in the New England Journal of Medicine," 1/09/2020 FLXN-US  GNW  Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 RevenueÂ and Initial Revenue Guidance for 2020",12/08/2019 QURE-US  GNW  uniQure Announces One-Year Follow-Up Data from the Phase IIb Study of Etranacogene Dezaparvovec and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B,12/16/2019 AGIO-US   GNW  Agios Receives FDA Breakthrough Therapy Designation for TIBSOVOÂ® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation,11/08/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer 34th Annual Meeting, 3/02/2020 ANAB-US  GNW  AnaptysBio Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Pipeline Updates,,11/14/2019 FATE-US  GNW  Fate Therapeutics to Present at the Jefferies 2019 London Healthcare Conference, 5/04/2018 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,11/25/2019 ICPT-US  GNW  FDA Accepts Interceptâ€™s NDA for OCA for the Treatment of Liver Fibrosis Due to NASH and Grants Priority Review, 3/02/2020 KPTI-US    GNW  Karyopharm Announces Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Multiple Myeloma Following One to Three Prior Lines of Therapy,,, 1/02/2020 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 38th Annual J.P. Morgan Healthcare Conference,, 9/30/2016 NVCR-US  GNW  Novocure to Report Third Quarter 2016 Financial Results,, 8/29/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference,"10/30/2019 ATRA-US    GNW  Atara Biotherapeutics to Announce Third Quarter 2019 Operational Progress and Financial Results on Thursday, November 7, 2019", 5/05/2015 77313F10 GNW  Horizon Technology Finance Announces First Quarter 2015 Financial Results, 3/05/2019 DERM-US  GNW  Dermira to Present at the Cowen and Company 39th Annual Health Care Conference,11/25/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference," 9/04/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Pricing of Secondary Offering and Concurrent Share Repurchase",11/05/2019 SUPN-US  GNW  Supernus Announces Third Quarter 2019 Financial Results and Topline Data fromÂ Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients,11/11/2019 FGEN-US  GNW  FibroGen Reports Third Quarter 2019 Financial Results," 5/17/2017 74587V10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017", 2/06/2020 CHRS-US  GNW  Coherus BioSciences to Report Fourth Quarter and Full Year Financial Results on February 27th,11/07/2019 CRBP-US  GNW  Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates,,11/06/2019 COLL-US  GNW  Collegium Reports Third Quarter 2019 Financial Results,11/19/2019 XBIT-US  GNW  XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa,,, 1/07/2020 GBT-US   GNW  GBT to Present at the 38th Annual J.P. Morgan Healthcare Conference, 1/08/2018 RGNX-US  GNW  REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy,11/12/2019 KURA-US  GNW  Kura Oncology to Present at StifelÂ Healthcare Conference,11/15/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/30/2019 AXSM-US  GNW  Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with History of Inadequate Response, 8/09/2019 VYGR-US  GNW  Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights,"12/28/2019 07725L10 GNW  ROSEN, NATIONAL TRIAL LAWYERS, Continues to Investigate Securities Claims Against BeiGene, Ltd. â€“ BGNE"," 8/15/2018 74933V10 GNW  Report: Developing Opportunities within RA PHARMCTL INC, Oclaro, Emergent Biosolutions, Kennametal, Instructure, and Donegal Group â€” Future Expectations, Projections Moving into 2018",10/14/2019 RETA-US  GNW  Reata Announces Positive Topline Results from the MOXIe Registrational Trial of Omaveloxolone in Patients with Friedreichâ€™s Ataxia, 1/20/2020 HCM-GB   GNW  Chi-Med Announces that Surufatinib Phase III SANET-p Study Has Already Achieved its Primary Endpoint in Advanced Pancreatic Neuroendocrine Tumors in China and Will Stop Early, 9/30/2019 NTLA-US  GNW  Intellia Therapeutics to Present at October Healthcare Investor Conferences, 9/17/2019 ACIU-US  GNW  AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620, 9/17/2019 CRSP-US  GNW  CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019,12/11/2019 GTHX-US  GNW  G1 Therapeutics Presents Updated Data from Phase 1b/2a Trial of Oral CDK4/6 Inhibitor Lerociclib at 2019 San Antonio Breast Cancer Symposium (SABCS), 2/04/2019 ARGX-BE  GNW  argenx and Halozyme enter global collaboration and license agreement for ENHANZEÂ® technology,11/12/2019 RUBY-US GNW  Rubius Therapeutics Appoints Maiken Keson-Brookes as Chief Legal Officer and Corporate Secretary,"12/11/2019 ATNX-US  GNW  Athenex Announces Details of Investor Event and Webcast at SABCS on December 13, 2019","10/30/2019 PETQ-US  GNW  PetIQ, Inc. to Participate in the Credit Suisse Healthcare Conference",11/01/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results, 9/27/2019 OPTN-US  GNW  Optinose to Present at the 2019 Cantor Global Healthcare Conference, 9/23/2019 TORC-US  GNW  resTORbio to Present Findings on Investigational TORC1 Inhibitor RTB101 in Late-Breaking Session at IDWeekâ„¢ 2019," 6/11/2019 DNLI-US  GNW  Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs",, 5/13/2019 SLDB-US  GNW  Solid Biosciences Reports First Quarter 2019 Financial Results and Provides Business Update,11/06/2019 EOLS-US  GNW  Evolus Announces Proposed Public Offering of Common Stock,10/21/2019 FIXX-US GNW  Homology Medicines Presents Data from Investigational PKU and MLD Gene Therapy Programs that Demonstrate Preclinical Proof-of-Concept for Potential One-Time Therapies,12/04/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces New Agreement for Expanded Access of DEXYCUÂ® Within One of the Largest Integrated Delivery Systems in the U.S., 8/27/2019 SRRK-US  GNW  Scholar Rock Announces Upcoming Departure of Chief Financial Officer,"10/23/2019 UBX-US   GNW  Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results",,," 4/01/2019 28249H10 GNW  Bragar Eagel & Squire, P.C. is Investigating Eidos Therapeutics, Inc. (EIDX) on Behalf of Stockholders and Encourages EIDX Investors to Contact the Firm","10/04/2018 AVRO-US  GNW  AVROBIO, Inc. to Present at Chardan's 2nd Annual Genetic Medicines Conference",, 8/30/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4),12/20/2019 AUTL-US  GNW  Autolus Therapeutics to Present at the 38th Annual J.P. MorganÂ Healthcare Conference,"12/16/2019 FTSV-US GNW  Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares", 4/01/2019 PRPO-US  GNW  Translate Bio Appoints Pasquale (Pat) Sacco as Senior Vice President of Technical Operations,,10/15/2019 PRNB-US GNW  Principia Announces Positive Preliminary Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial,10/02/2019 ARVN-US GNW  Arvinas Strengthens Scientific Advisory Board with Leaders in Oncology and Neurological Disorders,11/29/2019 YMAB-US  GNW  Y-mAbs Initiates Rolling Submission of Biologics License Application to U.S. FDA for Naxitamab for Treatment of Neuroblastoma,,10/07/2019 GRTS-US  GNW  Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within â€œOff-The-Shelfâ€ SLATE Immunotherapy at SITC 2019 Annual Meeting,"11/04/2019 GH-US    GNW  Guardant Health to Report Third Quarter 2019 Financial Results on November 7, 2019"," 9/18/2019 08405D-E GNW  Vertical Pharmaceuticals LLC, an Osmotica company, Announces Presentation of Phase III RVL-1201 Clinical Trial Data in Patients with Acquired Blepharoptosis (droopy eyelid)",10/18/2019 NGM-US   GNW  NGM Bio to Present at Upcoming Investor Conferences,,12/08/2019 ORTX-US  GNW  Orchard Therapeutics Showcases Clinical Data at the 61st American Society of Hematology Annual Meeting,, 1/08/2020 ALEC-US  GNW  Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference,"11/06/2019 DTIL-US GNW  Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting",12/17/2019 TPTX-US GNW  Turning Point Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference,12/16/2019 PRVL-US GNW  Prevail Therapeutics Announces FDA Orphan Drug Designation Granted to PR006 for the Treatment of Patients with Frontotemporal Dementia with a GRN Mutation,, 8/26/2019 BCEL-US GNW  Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors,,, 1/10/2020 BBIO-US  GNW  BridgeBio Pharmaâ€™s Gene Therapy Subsidiaries Enter Strategic Partnership with Catalent for Dedicated Gene Therapy Development and Manufacturing Capacity,12/09/2019 ABBV-US  GNW  Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQÂ® Assay,
" 8/05/2015 LGNZZ-US GNW  Poseida Therapeutics, Inc., Expands Board of Directors",11/04/2019 PGNX-US  GNW  Progenics Urges Shareholders to Reject the Risk and Uncertainty That Would be Caused by Giving Velanâ€™s Nominees Control of the Board," 2/13/2017 45232710    GNW  DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 â€“ ILMN","11/04/2015 84763A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 â€“ SPPI",10/17/2017 G3040110 GNW  DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Endo International plc and Reminds Investors with Losses to Contact the Firm,"12/07/2016 04280A10 GNW  EXPANDED CLASS PERIOD: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ ARWR","10/30/2019 BDSI-US  GNW  BioDelivery Sciences to Report Third Quarter 2019 Financial Results and Host Conference Call on November 12, 2019",,12/27/2017 MRUS-US  GNW  Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron, 7/08/2019 SIGA-US      GNW  SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXXÂ® as Post-Exposure Prophylactic for Smallpox,"10/24/2019 OPK-US   GNW  OPKO Health, Inc. Announces Pricing of its Offering of Common Stock",10/22/2019 46222210 GNW  Akcea Therapeutics to Hold Third Quarter 2019 Financial Results Webcast," 9/15/2016 BMRN-US     GNW  BioMarin Announces EMA Validation of Brineuraâ„¢ (Cerliponase Alfa) Marketing Authorization Application for Treatment of CLN2 Disease, a Form of Batten Disease","12/22/2016 01535110 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. â€“ ALXN", 6/07/2011 64125C10 GNW  Neurocrine Biosciences (NBIX) to Ring The NASDAQ Stock Market Opening Bell," 3/05/2017 81257810 GNW  DEADLINE ALERT: Brower Piven Reminds Investors Of The March 13, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Seattle Genetics Inc. (SGEN) To Contact The Firm", 2/06/2020 IMMU-US  GNW  Immunomedics to Participate in Guggenheim Healthcare Talks | Oncology Day,11/21/2019 BIIB-US   GNW  Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study for an Inherited Retinal Disorder,"12/06/2011 45253H10 GNW  ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 22nd Annual Healthcare Conference"," 2/27/2020 BCRX-US  GNW  BioCryst to Present New Data at American Academy of Allergy, Asthma & Immunology Annual Meeting", 7/10/2017 SBPH-US  GNW  Spring Bank Announces Collaboration with Gilead for Hepatitis B (HBV) Phase 2 Study Exploring Combination Treatment of SB 9200 and VemlidyÂ®,"10/29/2010 04004760 GNW  Important November 19, 2010 Securities Class Action Deadline Approaching for Arena Pharmaceuticals, Inc. Investors, Says the Rosen Law Firm -- ARNA"," 1/14/2020 N5946510 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MAT, MYL and TCNNF",, 5/30/2019 AKRX-US  GNW  Akorn to Present at the Jefferies 2019 Global Healthcare Conference, 1/25/2019 CHRS-US  GNW  Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgenâ€™s Humira Biosimilar Formulation," 1/30/2020 MYGN-US  GNW  Myriad to Announce Fiscal Second-Quarter 2020 Financial Results on February 6, 2020",12/02/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision From FDAâ€™s Office of New Drugs for Sotagliflozin in Type 1 Diabetes, 5/14/2019 MGTX-US  GNW  MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update," 8/17/2018 45766930 GNW  Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals â€” Discovering Underlying Factors of Influence", 6/23/2014 AUP-CA   GNW  Aurinia to Present at the BIO International Convention," 3/25/2020 AAN-US    GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AAN, FLR, INO, MGPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 9/27/2019 64026810 GNW  ROSEN, A TOP RANKED LAW FIRM, Reminds Nektar Therapeutics Investors of Important October 18th Deadline in Securities Class Action - NKTR",, 2/24/2020 GERN-US  GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline â€“ GERN," 5/01/2015 00771V10 GNW  AERIE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Aerie Pharmaceuticals, Inc. â€“ AERI"," 1/13/2020 AMRN-US  GNW  Amarin Launches True To Your Heart, a Campaign to Educate People on Persistent Cardiovascular Risk", 5/09/2019 45337C10 GNW  Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors," 1/23/2018 CELG-US  GNW  Cynata Executes MoU for Commercial Evaluation with Celularity, Inc.",12/12/2019 SRPT-US  GNW  Sarepta Therapeutics Announces FDA Approval of VYONDYS 53â„¢ (golodirsen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 53," 2/21/2019 G0176710 GNW  CLASS ACTION UPDATE for AXGN, ALKS, GE and BRS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 1/03/2020 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference," 6/16/2016 DARE-US  GNW  Immune Design Appoints Susan L. Kelley, M.D. to Board of Directors",,,, 3/27/2020 SAN-FR   GNW  Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19, 6/04/2015 VRTX-US  GNW  Vertex and Parion Sciences Establish Collaboration to Develop Epithelial Sodium Channel (ENaC) Inhibitors in Cystic Fibrosis and Other Pulmonary Diseases, 9/19/2019 ALLO-US  GNW  Allogene Therapeutics Enters Research Collaboration Directed at Enhancing Future Cancer Immunotherapies,11/04/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Third Quarter 2019 Financial Results and Business UpdateÂ Conference Call on November 18,," 9/04/2018 00422510 GNW  Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline","11/14/2019 AFMD-US  GNW  Affimed Announces Third Quarter 2019 Financial Results and Corporate Update Conference Call on November 19, 2019",,10/18/2019 PRQR-US  GNW  ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares," 5/15/2017 88338N10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017",12/02/2019 ZGNX-US  GNW  JAMA Neurology Publishes Phase 3 Study of Zogenix Investigational Drug FINTEPLAÂ® in Dravet Syndrome Patients Taking Stiripentol-Containing Antiepileptic Drug Regimens, 3/17/2020 ALLK-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc.Â â€“ ALLK,, 2/23/2016 RVNC-US  GNW  Revance to Participate in Upcoming Investor Conferences,,," 2/08/2020 ADVM-US  GNW  Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020", 1/13/2020 90400D10  GNW  Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for CrysvitaÂ® (burosumab) for Tumor-Induced Osteomalacia (TIO), 7/24/2019 AGLE-US  GNW  Aeglea BioTherapeutics Receives FDA Breakthrough Therapy Designation for Pegzilarginase for Treatment of Arginase 1 Deficiency, 5/30/2019 NSTG-US  GNW  NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports,"10/03/2014 69329Y10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in PDL BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadline -- PDLI",,"10/23/2019 RDUS-US  GNW  Radius Health to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 5, 2019",11/07/2019 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4),,,"11/08/2018 02043Q10 GNW  CLASS ACTION UPDATE for OPK, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 8/06/2019 WVE-US   GNW  Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer,12/18/2019 00972L10 GNW  Akcea Retains Rights to AKCEA-APOCIII-LRx,,"10/25/2019 PCRX-US  GNW  Pacira to Report Third Quarter 2019 Financial Results on Thursday November 7, 2019",10/11/2019 RTRX-US  GNW  Retrophin Announces Presentation of Abstracts at ASN Kidney Week 2019," 8/06/2019 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2019 Financial Results",11/05/2019 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Third Quarter 2019 Results and Corporate Update, 9/25/2019 CHMA-US  GNW  Chiasma to Present at the Cantor 2019 Global Healthcare Conference,"11/12/2019 55609910 GNW  CLASS ACTION UPDATE for SNDL, DBX, MGNX and WTRH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/24/2014 0BP4MZ-E GNW  Blueprint Medicines to Present on the First Isoform Selective FGFR4 Inhibitor at the AACR Annual Meeting 2014,12/15/2014 00972D10 GNW  Annual Changes to the NASDAQ Biotechnology Index, 6/26/2015 28249U10 GNW  Celladon Corporation Provides Business Update,11/06/2019 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 7/01/2019 PRTA-US  GNW  Prothena Announces Appointment of Paula K. Cobb to its Board of Directors, 1/14/2020 ZLAB-US  GNW  Zai Lab Appoints Lonnie Moulder to Board of Directors, 1/06/2016 SAGE-US  GNW  Sage Therapeutics Announces Pricing of Public Offering of Common Stock, 1/17/2020 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grants,11/06/2019 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2019, 4/04/2019 92165910 GNW  Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Vanda Pharmaceuticals Inc. - VNDA,,10/01/2019 CBAY-US  GNW  CymaBay Therapeutics Announces Presentations at The Liver MeetingÂ® 2019, 6/11/2013 45781M10 GNW  Inova Receives $1.05 Million PO From Dallas & Fort Worth Independent School Districts, 8/29/2019 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,,11/06/2019 MNKD-US   GNW  MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results, 4/24/2018 URGN-US  GNW  UroGen Pharma to Ring the Nasdaq Stock Market Opening Bell," 2/18/2020 CYTK-US  GNW  Cytokinetics to Announce Fourth Quarter ResultsÂ on March 3, 2020"," 2/26/2020 ESPR-US     GNW  Esperion Announces FDA Approval of the NEXLIZETâ„¢ (bempedoic acid and ezetimibe) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine", 5/23/2019 AMRS-US   GNW  Amyris Teams Up with Model and Businesswoman Rosie Huntington-Whiteley as Brand Partner for its Pipette Baby Brand, 2/09/2016 FOLD-US  GNW  Amicus Therapeutics Strengthens Executive Leadership Team, 8/29/2019 ACHN-US  GNW  Achillion to Present at the Baird 2019 Global Healthcare Conference,11/12/2019 SYNH-US  GNW  Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success,10/24/2019 FOLD-US  GNW  Amicus Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 48th Annual Meeting of the Child Neurology Society," 6/02/2016 26979610 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 â€“ EGRX","11/06/2017 0HCJCC-E GNW  Deciphera Pharmaceuticals, Inc. to Report Clinical Data with DCC-2618 at the Upcoming 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology",11/06/2019 ADMA-US  GNW  ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress,"12/07/2019 GWPH-US  GNW  Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEXÂ® (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting", 4/23/2018 EPZM-US  GNW  Epizyme Provides Update Regarding Tazemetostat Clinical Program,,11/04/2019 MYOK-US  GNW  MyoKardia Reports Third Quarter 2019 Financial Results,, 1/09/2020 GLPG-NL  GNW  Gilead holds 25.84% of Galapagos shares," 2/28/2020 PTLA-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,,11/05/2019 CARA-US  GNW  Cara Therapeutics Reports Third Quarter 2019 Financial Results, 1/03/2020 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/02/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences in December,12/09/2019 AGIO-US   GNW  Agios Presents Updated Data for Mitapivat from Extension Phase of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency,11/07/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Investor Conferences in November, 2/25/2020 ANAB-US  GNW  AnaptysBio to Present at The Cowen and Company 40th Annual Health Care Conference,,11/06/2019 FATE-US  GNW  Fate Therapeutics Announces Six Presentations at the 2019 ASH Annual Meeting, 5/03/2018 HZNP-US  GNW  Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomenâ€™s Association Rising Star,,11/08/2019 ICPT-US  GNW  New REGENERATE Interim Analysis Data Presented at The Liver MeetingÂ® Report OCA Improved Multiple Noninvasive Markers of Liver Fibrosis in Patients with NASH, 2/28/2020 KPTI-US    GNW  Karyopharm Appoints Richard Paulson to its Board of Directors,,,"12/23/2019 ITCI-US  GNW  FDA Approves Intra-Cellular Therapiesâ€™ Novel Antipsychotic, CAPLYTAÂ® (lumateperone) for the Treatment of Schizophrenia in Adults",,10/02/2015 NVCR-GB  GNW  Nasdaq Welcomes NovoCure Limited to The Nasdaq Stock Market,," 8/07/2019 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019",10/25/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Executive Departures, 4/08/2015 77313F10 GNW  Horizon Technology Finance Provides Investment Portfolio Update for First Quarter 2015, 3/01/2019 DERM-US  GNW  Dermira Presents New Data from its Phase 3 Clinical Program Evaluating Glycopyrronium Tosylate (QBREXZAâ„¢ (glycopyrronium) cloth) in Patients with Primary Axillary Hyperhidrosis,11/18/2019 FOMX-US  GNW  Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam," 9/03/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Announces $500 Million Share Repurchase Program",10/24/2019 SUPN-US  GNW  Supernus to Host Third Quarter 2019 Earnings Conference Call,11/08/2019 AZN-GB   GNW  FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease," 5/15/2017 74587V10 GNW  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Puma Biotechnology, Inc.", 1/13/2020 CHRS-US  GNW  Coherus Acquires Commercial Rights for AvastinÂ® Biosimilar in the United States,"11/04/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss  Third Quarter 2019 Operational and Financial Results on November 7, 2019",,10/23/2019 COLL-US  GNW  Collegium to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update,11/12/2019 XBIT-US  GNW  XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1âº Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema),,,12/18/2019 37890U10 GNW  GBT Secures $150 Million Non-Dilutive Term Loan Financing, 1/08/2018 75901B10 GNW  REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy,11/06/2019 KURA-US  GNW  Kura Oncology Announces Upcoming Presentation at ASH Annual Meeting,11/08/2019 APLS-US  GNW  Apellis Presents First Data on APL-2 in C3 Glomerulopathy at ASN Kidney Week,"12/23/2019 AXSM-US  GNW  Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares", 8/05/2019 VYGR-US  GNW  Voyager Therapeutics to Host Second Quarter 2019 Financial Results and Corporate Highlights Conference Call,12/27/2019 BGNE-US  GNW  China National Medical Products Administration Approves BeiGeneâ€™s Tislelizumab for Patients with Classical Hodgkinâ€™s Lymphoma Who Have Received at Least Two Prior Therapies,10/27/2016 RARX-US  GNW  Nasdaq Welcomes Ra Pharmaceuticals Inc. (Nasdaq: RARX) to The Nasdaq Stock Market,"10/11/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Presentations at the American Society for Nephrology Kidney Week 2019", 1/13/2020 HCM-GB   GNW  Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors, 9/26/2019 NTLA-US  GNW  Arbitration Decision Affirms Intellia Therapeuticsâ€™ Interpretation of Licensing Agreement with Caribou Biosciences on the CRISPR/Cas9 Technology, 9/04/2019 ACIU-US  GNW  AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinsonâ€™s Disease Diagnostic Imaging Agent, 7/31/2019 CRSP-US  GNW  CRISPR Therapeutics to Present at Upcoming Investor Conferences,"11/26/2019 GTHX-US  GNW  G1 Therapeutics to Participate in Evercore ISI 2nd Annual HealthCONx Conference on December 4, 2019","12/02/2018 ARGX-BE  GNW  argenx enters exclusive global collaboration and license agreement with  Cilag GmbH International, an affiliate of Janssen, for cusatuzumab (ARGX-110)",11/08/2019 RUBY-US GNW  Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,12/05/2019 ATNX-US  GNW  Athenex Announces $60 Million Private Placement,"10/24/2019 PETQ-US  GNW  PetIQ, Inc. to Report Third Quarter 2019 Results on Thursday, November 7th",10/30/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ObesityWeekÂ® 2019, 9/26/2019 OPTN-US  GNW  OptiNose Announces License Agreement Related to ONZETRA XSAIL, 8/14/2019 TORC-US  GNW  resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update, 5/08/2019 DNLI-US  GNW  Denali Therapeutics Reports First Quarter 2019 Financial Results,, 4/15/2019 SLDB-US  GNW  Solid Biosciences Announces Upcoming Preclinical Data Presentations at The American Society of Gene and Cell Therapy Annual Meeting,11/04/2019 EOLS-US  GNW  Evolus Reports Third Quarter 2019 Financial Results and  Provides Business Update, 9/30/2019 FIXX-US GNW  Homology Medicines to Participate in Conferences in October,11/19/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility, 8/14/2019 SRRK-US  GNW  Scholar Rock Reports Second Quarter 2019 Financial Results and Highlights Business Progress," 9/20/2019 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference",,, 4/01/2019 28249H10 GNW  Eidos Therapeutics Investigated by Block & Leviton LLP For Violations of Federal Securities Laws,10/01/2018 AVRO-US  GNW  AVROBIO Receives No Objection to Clinical Trial Application from Health Canada for AVR-RD-02 Gene Therapy for Gaucher Disease,, 8/29/2019 XERS-US  GNW  Xeris Pharmaceuticals to Present at Two September Healthcare Conferences,12/08/2019 AUTL-US  GNW  Autolus Therapeutics Announces New Data ShowcasingÂ Clinical Progress of AUTO3 in B Cell Malignancies,"12/11/2019 FTSV-US GNW  Forty Seven, Inc. Prices Underwritten Public Offering of 4,860,000 Shares of Common Stock", 3/26/2019 TBIO-US  GNW  Translate Bio Granted U.S. Patent Relating to Messenger RNA (mRNA) Delivery,,10/10/2019 PRNB-US GNW  Principia Announces Positive Preliminary Data of PRN1008 from its Ongoing Phase 2 Part B Trial in Pemphigus,"10/01/2019 ARVN-US GNW  Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio",11/15/2019 YMAB-US  GNW  Y-mAbs Announces Update on Omburtamab in DSRCT,, 9/26/2019 GRTS-US  GNW  Gritstone Oncology to Present at Cantor Global Healthcare Conference,10/23/2019 GH-US    GNW  Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 Blood Test for Colorectal Cancer Screening," 9/17/2019 08405D-E GNW  Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Submission of New Drug Application for RVL-1201",10/07/2019 NGM-US   GNW  NGM Bio Announces Positive Interim Results from Ongoing 24-Week Phase 2 Study Evaluating Aldafermin (NGM282) in Patients with NASH,,12/02/2019 ORTX-US  GNW  Orchard Therapeutics Announces the Filing and Validation of Marketing Authorization Application by European Medicines Agency for OTL-200 for the Treatment of Metachromatic Leukodystrophy,, 1/06/2020 ALEC-US  GNW  Alector Initiates First-in-Human Dosing in Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases,10/30/2019 DTIL-US GNW  Precision BioSciences to Report Third Quarter 2019 Financial Results and Present at Upcoming Investor Conferences in November,11/13/2019 TPTX-US GNW  Turning Point Therapeutics to Participate in Upcoming Investor Conferences,"11/18/2019 PRVL-US GNW  Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors",, 8/13/2019 BCEL-US GNW  Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments,,, 1/06/2020 0JVC6M-E GNW  BridgeBio Pharmaâ€™s QED Therapeutics Receives Fast Track Designation for Infigratinib in Adults with First-Line Advanced or Metastatic Cholangiocarcinoma and Orphan Drug Designation for Infigratinib for Treatment of Cholangiocarcinoma,"12/04/2019 ADPT-US  GNW  Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQÂ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients",
 6/24/2014 53220K50 GNW  TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4,11/01/2019 PGNX-US  GNW  Progenics Reminds Shareholders that November 17 is the Only Deadline for Velanâ€™s Consent Solicitation," 1/24/2017 45232710    GNW  ILMN LOSS ALERT: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action â€“ ILMN"," 9/03/2013 84763A10 GNW  Tekmira Provides Update on Licensed Product Candidate, Marqibo(R)","10/11/2017 ENDP-US  GNW  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Endo International plc Shareholders and a Lead Plaintiff Deadline of October 17, 2017 (ENDP)","12/02/2016 04280A10 GNW  INVESTOR ALERT: Stull, Stull & Brody Filed a Securities Class Action Lawsuit on Behalf of Purchasers of Arrowhead Pharmaceuticals, Inc. Common Stock and Encourages Shareholders with Losses to Contact the Firm",10/01/2019 BDSI-US  GNW  BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCAÂ® and SymproicÂ®,,11/01/2017 75886F10 GNW  Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical StudyÂ for Glioblastoma in Combination with Regeneronâ€™s PD-1 Inhibitor," 6/18/2019 SIGA-US      GNW  SIGA Technologies CEO to Speak at NCT Europe  on June 27, 2019","10/22/2019 OPK-US   GNW  OPKO Health, Inc. Announces Proposed Offering of Common Stock",10/07/2019 IONS-US  GNW  Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx), 9/08/2016 BMRN-US     GNW  BioMarin Announces Two Oral and 16 Poster Presentations at Society for the Study of Inborn Errors of Metabolism 2016 Annual Meeting,"12/16/2016 01535110 GNW  ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. â€“ (ALXN)"," 6/17/2010 64125C10 GNW  Skymark Research Initiates Independent Research Coverage on Neurocrine Biosciences, Inc.", 2/28/2017 81257810 GNW  IMPORTANT SEATTLE GENETICS INC.Â INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the Western District of Washington against Seattle Genetics Inc.,12/26/2019 IMMU-US  GNW  Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer,11/06/2019 BIIB-US   GNW  Biogen to Expand Biosimilars Portfolio and Gain Access to Additional Markets Through New Transaction with Samsung Bioepis,"11/14/2011 45253H10 GNW  ImmunoGen, Inc. Earns Milestone Payment From Amgen With IND Achievement for Second TAP Compound", 2/25/2020 BCRX-US  GNW  BioCryst Appoints Alan G. Levin to Board of Directors, 8/10/2016 GMAB-DK  GNW  Genmab Enters Commercial License Agreement with Gilead for DuoBody(R) Technology,"10/05/2010 04004760 GNW  Spector Roseman Kodroff & Willis, P.C. Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. -- ARNA"," 1/13/2020 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MATT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 5/20/2019 AKRX-US  GNW  Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.1%","10/19/2018 03116210 GNW  Investor Expectations to Drive Momentum within Amgen, Crown Castle International, Constellation Brands, Nice, NetEase, and The Hanover Insurance Group â€” Discovering Underlying Factors of Influence", 1/22/2020 MYGN-US  GNW  Myriad Submits sPMA for myChoiceÂ® CDx with ZejulaÂ® in First-Line Platinum Responsive Advanced Ovarian Cancer,11/26/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference, 5/14/2019 MGTX-US  GNW  MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency, 8/07/2018 INSM-US  GNW  FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmedâ€™s ALIS for the Treatment of NTM Lung Disease Caused by MAC for Adult Patients with Limited or No Treatment Options, 6/18/2014 0DDLD3-E GNW  Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference," 3/24/2020 AAN-US    GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AAN, BDX, FLR and INO", 9/26/2019 64026810 GNW  Zhang Investor Law Reminds Investors of October 18 Deadline in Securities Class Action Lawsuit AgainstÂ Nektar Therapeutics- NKTR,," 2/19/2020 GERN-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS GERN, OPRA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 4/30/2015 00771V10 GNW  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. (AERI)", 1/07/2020 AMRN-US  GNW  Amarin Provides Update to Preliminary 2019 Results and Further Details on 2020 Outlook, 4/02/2019 INCY-US  GNW  BriaCell Announces Clinical Trial Collaboration Agreement with Incyte," 1/18/2018 91307C10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within United Therapeutics, LTC Properties, WageWorks, Clearwater Paper, United Insurance, and CONMED â€” New Research Emphasizes Economic Growth",11/29/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/21/2019 G0176710 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc. of Class Action Lawsuit and Upcoming Deadline Â â€“Â ALKS,,12/18/2019 AMAG-US  GNW  AMAG Pharmaceuticals Awards Four Grants to Support Preterm Birth and Preeclampsia Research, 5/04/2016 ARQL-US  GNW  ArQule Reports First Quarter 2016 Financial Results,,,, 3/24/2020 SAN-FR   GNW  Sanofi successfully prices EUR 1.5 billion of bond issue,"12/07/2012 VRTX-US  GNW  Video Interview: Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer, Regulus Therapeutics Inc. [RGLS]", 9/03/2019 ALLO-US  GNW  Allogene Therapeutics Announces September 2019 Investor Conference Schedule,10/21/2019 ASND-US  GNW  Ascendis Pharma A/S Receives Orphan Designation for TransConâ„¢ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe,," 9/04/2018 00422510 GNW  CLASS ACTION UPDATE for FPI and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",11/13/2019 AFMD-US  GNW  Affimed Announces Closing of Public Offering of Common Shares and Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,10/15/2019 PRQR-US  GNW  ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares," 5/11/2017 88338N10 GNW  TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017",12/02/2019 ZGNX-US  GNW  Zogenix to Present New Data for Its Investigational Drug FINTEPLAÂ® at the American Epilepsy Society Annual Meeting," 3/16/2020 ALLK-US  GNW  ALLK LOSS NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Reminds Allakos Inc. Investors of Important Deadline in Securities Class Action First Filed by the Firm â€“ ALLK",," 2/17/2016 RVNC-US  GNW  Revance Therapeutics to Release Fourth Quarter and Full Year 2015 Financial Results Wednesday, March 2, 2016",,," 1/28/2020 ADVM-US  GNW  Adverum Biotechnologies to Present Additional Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD at the  Angiogenesis, Exudation, and Degeneration 2020 Meeting", 1/09/2020 RARE-US   GNW  Ultragenyx Announces Positive Topline Cohort 3 Results and Improved Longer-Term Cohort 2 Results from Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency, 6/03/2019 AGLE-US  GNW  Aeglea BioTherapeutics Doses First Patient in Pivotal Phase 3 PEACE Trial of Pegzilarginase in Arginase 1 Deficiency, 5/15/2019 NSTG-US  GNW  NanoString to Present at the UBS Global Healthcare Conference," 9/23/2014 69329Y10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 17, 2014 -- PDLI",, 9/13/2019 RDUS-US  GNW  Radius Health to Present Data on Abaloparatide at ASBMR 2019 Annual Meeting,11/07/2019 ASMB-US  GNW  Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights,,,"11/06/2018 02043Q10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alnylam Pharmaceuticals, Inc. To Contact The Firm", 7/29/2019 WVE-US   GNW  Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update,12/16/2019 AKCA-US  GNW  Akcea Therapeutics Announces New Appointments to its Board of Directors,, 9/19/2019 PCRX-US  GNW  Pacira BioSciences Appoints Chris Christie to Board of Directors,10/01/2019 RTRX-US  GNW  Retrophin Announces Appointment of Peter Heerma as Chief Commercial Officer, 6/13/2019 PACB-US  GNW  Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants,"10/28/2019 EDIT-US  GNW  Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer", 9/05/2019 CHMA-US  GNW  Chiasma Hosting Key Opinion Leader Meeting on Maintenance Therapy of Adult Patients with Acromegaly,"11/10/2019 55609910 GNW  2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of November 12th Lead Plaintiff Deadline, Encourages Investors with Significant Losses to Contact the Firm", 3/20/2014 0BP4MZ-E GNW  Blueprint Medicines to Present at Upcoming Investor Conferences,, 6/01/2015 28249U10 GNW  Celladon Corporation Announces Strategic Direction Following Review of CUPID2 Data,10/31/2019 MNTA-US  GNW  Momenta Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results, 5/30/2019 PRTA-US  GNW  Prothena to Participate in the Jefferies Healthcare Conference, 1/09/2020 98887Q10 GNW  Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer, 1/05/2016 SAGE-US  GNW  Sage Therapeutics Announces Proposed Public Offering of Common Stock,12/19/2019 CTMX-US  GNW  CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook,10/30/2019 GMAB-DK  GNW  David Eatwell to Retire as Chief Financial Officer of Genmab," 4/04/2019 92165910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm",, 9/30/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at the 2019 Cantor Global Healthcare Conference, 5/28/2013 45781M10 GNW  Inova Receives $4 Million PO From Lewisville Independent School District for Network Solutions Project, 8/05/2019 CCXI-US  GNW  ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights,,,11/04/2019 UTHR-US   GNW  MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics, 4/03/2018 URGN-US  GNW  UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGelâ„¢) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)," 2/06/2020 CYTK-US  GNW  Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure"," 2/21/2020 ESPR-US     GNW  Esperion Announces FDA Approval of NEXLETOLâ„¢ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine"," 5/22/2019 03236M20  GNW  AMRS DEADLINE:  Pawar Law Group Reminds Investors of June 3 Deadline In Securities Class Action Lawsuit Against Amyris, Inc. â€“ AMRS", 6/20/2013 69366J20 GNW  NASDAQ Welcomes PTC Therapeutics to The NASDAQ Stock Market, 8/08/2019 ACHN-US  GNW  Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate Update,10/31/2019 SYNH-US  GNW  Syneos Health Reports Third Quarter 2019 Results,10/10/2019 FOLD-US  GNW  Amicus Therapeutics Announces Preliminary Third Quarter 2019 Revenue and Financial Outlook at 2019 Analyst Day, 9/28/2015 ZIOP-US  GNW  ZIOPHARM Appoints Scott Tarriff to Its Board of Directors,10/03/2017 DCPH-US  GNW  Deciphera Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of Option to Purchase Additional Shares,11/04/2019 ADMA-US  GNW  ADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association,12/05/2019 0JBRH7-E GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEXÂ® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting, 4/09/2018 EPZM-US  GNW  Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology,,11/04/2019 MYOK-US  GNW  MyoKardia Announces Abstracts Selected for Presentation at the American Heart Association Scientific Sessions 2019,,12/19/2019 GLPG-NL  GNW  Gilead submits new drug application to U.S. Food and Drug Administration under priority review for filgotinib for rheumatoid arthritis treatment," 2/27/2020 PTLA-US  GNW  PTLA LOSS ALERT: ROSEN, A GLOBAL LAW FIRM, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action â€“ PTLA",,,,11/01/2019 CARA-US  GNW  Cara Therapeutics Announces Presentations at Kidney Week 2019,12/26/2019 FLXN-US  GNW  Flexion Therapeutics Announces FDA Approval of sNDA to Revise ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) Product Label,11/06/2019 QURE-US  GNW  uniQure Announces Clinical Data Presentations at the 61st American Society of Hematology (ASH) Annual Meeting,12/09/2019 AGIO-US   GNW  Agios Presents Translational Data to Further Characterize the Role of TIBSOVOÂ® (ivosidenib) Treatment in IDH1 Mutant Acute Myeloid Leukemia (AML),11/04/2019 IOVA-US  GNW  Iovance Biotherapeutics Reports Third Quarter and September Year-to-Date 2019 Financial Results, 1/08/2020 ANAB-US  GNW  AnaptysBio to Present at J.P. Morgan Annual Healthcare Conference,,11/05/2019 FATE-US  GNW  Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress, 5/01/2018 HZNP-US  GNW  Horizon Pharma plc to Participate in the UBS Global Healthcare Conference,,11/05/2019 ICPT-US  GNW  Intercept Pharmaceuticals Reports Third Quarter 2019 Financial Results  and Provides Business Update, 2/19/2020 KPTI-US    GNW  U.S. Food and Drug Administration Accepts Karyopharmâ€™s Supplemental New Drug Application for XPOVIOÂ® (Selinexor) as a Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,,,12/12/2019 ITCI-US  GNW  Intra-Cellular Therapies Highlights Lumateperone Presentations at the 58th Annual Meeting of the American College of Neuropsychopharmacology,,10/02/2015 NVCR-GB  GNW  NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO,," 8/05/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019", 9/13/2019 ATRA-US    GNW  Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019,, 2/26/2019 DERM-US  GNW  Dermira Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,"11/13/2019 M4613510 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Menlo Therapeutics Inc. with Foamix Pharmaceuticals Ltd. is Fair to MNLO Shareholders"," 9/03/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Secondary Offering and Concurrent Share Repurchase", 9/25/2019 SUPN-US  GNW  Supernus to Present at the 2019 Cantor GlobalÂ Healthcare Conference,11/07/2019 FGEN-US  GNW  FibroGen Presents Phase 3 Efficacy and Safety Results for Roxadustat Versus Epoetin Alfa as Treatment of Anemia in Incident Dialysis Patients with Chronic Kidney Disease," 5/15/2017 74587V10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Puma Biotechnology, Inc. Shareholders and a Lead Plaintiff Deadline of July 7, 2017 (PBYI)", 1/03/2020 CHRS-US  GNW  Coherus BioSciences Management to Present at the 38th Annual J.P. Morgan Healthcare Conference,10/03/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting,, 9/25/2019 COLL-US  GNW  Collegium to Participate in Upcoming Investor Conference,10/23/2019 XBIT-US  GNW  XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa,,,"12/18/2019 GBT-US   GNW  GBT and Syros Partner to Discover, Develop and CommercializeÂ Novel Therapies for Sickle Cell Disease and Beta Thalassemia", 1/04/2018 RGNX-US  GNW  REGENXBIO Provides Year-End 2017 Corporate Update,11/05/2019 KURA-US  GNW  Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update,11/07/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/19/2019 AXSM-US  GNW  Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock, 7/30/2019 VYGR-US  GNW  Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019,12/22/2019 BGNE-US  GNW  BeiGene Announces Acceptance of a Supplemental New Drug Application in China for REVLIMIDÂ® in Relapsed or Refractory Indolent Lymphoma,10/27/2016 74933V10 GNW  Ra Pharmaceuticals Inc. (Nasdaq: RARX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO,"10/10/2019 ABBV-US  GNW  Reata Pharmaceuticals Reacquires Rights From AbbVie to Develop and Commercialize Bardoxolone Methyl, Omaveloxolone, and All Next-Generation Nrf2 Activators", 1/06/2020 HCM-GB   GNW  Chi-Med to Present at the 38th Annual JP Morgan Healthcare Conference, 8/01/2019 NTLA-US  GNW  Â Intellia Therapeutics AnnouncesÂ Second Quarter 2019 Financial Results and Company Update," 8/14/2019 ACIU-US  GNW  AC Immune Reports Q2 2019 Financial Results, Business and  Clinical Update", 7/29/2019 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results,"11/12/2019 GTHX-US  GNW  G1 Therapeutics to Present at Stifel Healthcare Conference on November 19, 2019",12/02/2018 ARGX-BE  GNW  argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia,11/05/2019 RUBY-US GNW  Rubius Therapeutics to Announce Third Quarter 2019 Financial Results,11/19/2019 ATNX-US  GNW  Athenex Announces Key Company Activities at San Antonio Breast Cancer Symposium," 8/07/2019 PETQ-US  GNW  PetIQ, Inc. Reports Record Second Quarter 2019 Financial Results","10/18/2019 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares", 9/17/2019 OPTN-US  GNW  Optinose Announces Departure of Chief Commercial Officer," 8/07/2019 TORC-US  GNW  resTORbio to Present at the 2019 Wedbush PacGrow Healthcare Conference on Wednesday, August 14, 2019", 3/12/2019 DNLI-US  GNW  Denali Therapeutics Reports Full Year 2018 Financial Results and Business Highlights,, 3/13/2019 SLDB-US  GNW  Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update,"10/28/2019 EOLS-US  GNW  Evolus to Report Third Quarter 2019 Financial Results and ProvideÂ a Business Update on Monday, November 4, 2019", 9/03/2019 FIXX-US GNW  Homology Medicines to Participate at Upcoming Investor Conferences,11/14/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development, 8/07/2019 SRRK-US  GNW  Scholar Rock to Present at the 2019 Wedbush PacGrow Healthcare Conference," 8/27/2019 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences",,, 3/18/2019 EIDX-US  GNW  Eidos Therapeutics Announces Publication in the Journal of the American College of Cardiology (JACC) and Presentation at American College of Cardiology (ACC) Scientific Sessions,10/01/2018 AVRO-US  GNW  AVROBIO Announces Updated Clinical Data for AVR-RD-01 Gene Therapy in Fabry Disease,, 8/06/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Second Quarter 2019 Financial Results and Highlights,12/07/2019 AUTL-US  GNW  Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers,"12/11/2019 FTSV-US GNW  Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock", 3/18/2019 TBIO-US  GNW  Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model in the Journal Molecular Therapy,, 8/30/2019 PRNB-US GNW  Principia Biopharma Appoints Shawn Tomasello to Its Board of Directors," 8/27/2019 ARVN-US GNW  Arvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTACÂ® Protein Degrader",11/13/2019 YMAB-US  GNW  Y-mAbs Announces Third Quarter 2019 Financial Results and Recent Corporate Developments,," 9/12/2019 GRTS-US  GNW  Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones", 9/28/2019 GH-US    GNW  Data Presented at ESMO Show Metastatic CRC Patients with HER2 Amplification Detected by Guardant360 Experience Clinical Benefit After Targeted Therapy, 8/28/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Present at 2019 Wells Fargo Healthcare Conference,10/06/2019 NGM-US   GNW  NGM Bio to Host Conference Call to Discuss Interim Results from OngoingÂ 24-Week Phase 2 Study of Aldafermin (NGM282) in Patients with NASH,,11/18/2019 ORTX-US  GNW  European Medicines Agency Grants Orchard Therapeutics Accelerated Assessment of OTL-200 for Patients with Metachromatic Leukodystrophy,,12/20/2019 01444210 GNW  Alector Added to the NASDAQ Biotechnology Index," 9/30/2019 DTIL-US GNW  Precision BioSciences Appoints Nicholas Riddle, MB, BChir, PhD, as Vice President, Financial Strategy and Investor Relations",11/12/2019 TPTX-US GNW  Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of Repotrectinib in Pediatric Patients,11/12/2019 PRVL-US GNW  Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights,, 7/11/2019 BCEL-US GNW  Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel,,,"12/19/2019 BBIO-US  GNW  BridgeBio Pharma, Inc. to Present at Upcoming Investor Conference",11/12/2019 ADPT-US  GNW  Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results,
,10/28/2019 0LDDK2-E GNW  Progenics Strongly Agrees With ISS Recommendation that Velan GroupÂ SHOULD NOT Get Majority Control of the Board of Directors, 1/24/2017 45232710    GNW  CareDx to acquire SBT Resolverâ„¢ HLA Typing Products from Illumina," 7/18/2013 84763A10 GNW  Tekmira Provides Update on Licensed Product Candidate, Marqibo(R)",10/10/2017 G3040110 GNW  ONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Endo International plc and Reminds Investors with Losses to Contact the Firm,"11/18/2016 04280A10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Arrowhead Pharmaceuticals, Inc. (ARWR)", 9/17/2019 BDSI-US  GNW  BioDelivery Sciences Announces Participation in Upcoming Investor Conferences,,10/05/2017 SAN-FR   GNW  Sanofi  : Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding PraluentÂ® (alirocumab)," 6/11/2019 SIGA-US      GNW  SIGA Technologies to Host Business Update Webcast on June 18, 2019","10/21/2019 68375N10 GNW  OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency", 9/23/2019 IONS-US  GNW  Akcea Announces CEO Transition and Elects Two New Board Members," 9/06/2016 BMRN-US     GNW  BioMarin Announces Update to Brineuraâ„¢ (Cerliponase Alfa) Program  for Treatment of CLN2 Disease, a Form of Batten Disease","12/12/2016 01535110 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ ALXN",, 2/27/2017 81257810 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Seattle Genetics Inc. ofÂ Class Action Lawsuit and Upcoming Deadline â€“ SGEN,12/09/2019 IMMU-US  GNW  Immunomedics Announces Closing of Public Offering of Common Stock,"11/04/2019 BIIB-US   GNW  Biogen to Host Investor Webcasts from Clinical Trials on Alzheimerâ€™s Disease (CTAD) Congress on December 5, 2019","11/07/2011 45253H10 GNW  ImmunoGen, Inc. Named One of The Boston Globe's 2011 Top Places to Work", 2/20/2020 BCRX-US  GNW  BioCryst to Report Fourth Quarter and Full Year 2019 Financial Results on March 5," 1/25/2016 GLPG-BE  GNW  Transparency notification - Gilead Sciences, Inc. holds 14.75% of Galapagos shares","10/01/2010 ARNA-US  GNW  Pomerantz Law Firm Investigates Claims on Behalf of Investors of Arena Pharmaceuticals, Inc."," 1/10/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FSCT, MAT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",, 5/20/2019 AKRX-US  GNW  Akorn to Present at the RBC Capital Markets Healthcare Conference," 6/12/2018 03116210 GNW  Research Report Identifies Avangrid, Entercom Communications, Kennedy-Wilson, Emerson Electric, Amgen, and vTv Therapeutics with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 1/21/2020 62855J10 GNW  Myriad Submits sPMA for BRACAnalysisÂ® CDx as a Companion Diagnostic  for LynparzaÂ® in Metastatic Castration-resistant Prostate Cancer,11/14/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference, 5/10/2019 MGTX-US  GNW  MeiraGTx Appoints Nicole Seligman to Board of Directors, 8/02/2018 INSM-US  GNW  Insmed Reports Second Quarter 2018 Financial Results and Provides Business Update, 6/11/2014 AUP-CA   GNW  Aurinia to Commence Trading on Toronto Stock Exchange," 3/24/2020 INO-US    GNW  Kaskela Law LLC Announces Deadline in Shareholder Class Action Lawsuit Filed Against Inovio Pharmaceuticals, Inc. (INO) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"," 9/25/2019 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nektar Therapeutics, Valaris, Sarepta Therapeutics, and Canada Goose and Encourages Investors to Contact the Firm",," 2/18/2020 GERN-US  GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GERN, OPRA and QD"," 4/30/2015 00771V10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Aerie Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2015 -- AERI", 1/06/2020 AMRN-US  GNW  Amarin to Present at 38th Annual J.P. Morgan Healthcare Conference, 4/01/2019 MRUS-US  GNW  Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019,11/14/2017 91307C10 GNW  SteadyMed Receives Favorable Ruling from U.S. Court of Appeals for the Federal Circuit,11/14/2019 SRPT-US  GNW  Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies, 2/21/2019 G0176710 GNW  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Alkermes plc (ALKS),,11/13/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences," 4/20/2016 ARQL-US  GNW  ArQule To Report First Quarter 2016 Financial Results On May 4, 2016",,,, 3/05/2020 SAN-FR   GNW  Sanofi : Filing of the 2019 U.S. Form 20-F and French â€œDocument dâ€™Enregistrement Universelâ€ containing the Annual Financial Report," 9/12/2012 92532F10 GNW  Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in Vertex Pharmaceuticals Incorporated to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the November 5, 2012 Lead Plaintiff Deadline -- VRTX", 8/07/2019 ALLO-US  GNW  Allogene Therapeutics Reports Second Quarter 2019 Financial Results, 9/26/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentation in October,," 9/02/2018 00422510 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, ACAD, RMTI and ABBV",11/08/2019 AFMD-US  GNW  Affimed Announces Pricing of Public Offering of Common Shares,,10/15/2019 PRQR-US  GNW  ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares," 5/10/2017 88338N10 GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Complaint to Recover Losses Suffered by Investors in TherapeuticsMD, Inc.",11/27/2019 ZGNX-US  GNW  Zogenix to Participate in the 31st Annual Piper Jaffray Healthcare Conference," 3/12/2020 ALLK-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Who Have Suffered Losses to Contact Its Attorneys: Securities Fraud Class Action Filed",, 1/07/2016 RVNC-US  GNW  Revance Specifies 2016 Clinical Program Milestones,,," 1/27/2020 ADVM-US  GNW  Adverum Biotechnologies Moves to New Headquarters andÂ Expands Laboratory Space in Redwood City, CA",12/19/2019 RARE-US   GNW  Ultragenyx to Present at 38áµ—Ê° Annual J.P. Morgan Healthcare Conference, 5/30/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Participate in Upcoming Investor and Industry Conferences, 5/09/2019 NSTG-US  GNW  NanoString Technologies Releases Operating Results for First Quarter of 2019," 9/23/2014 69329Y10 GNW  Robbins Arroyo LLP: PDL BioPharma, Inc. (PDLI) Accused of Violating Federal Law and Causing Investor Losses",, 9/03/2019 RDUS-US  GNW  Radius Health to Participate in the Citi 14th Annual Biotech Conference and Morgan Stanley 17th Annual Global Healthcare Conference in September,"11/07/2019 ASMB-US  GNW  Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer",,,11/06/2018 02043Q10 GNW  SHAREHOLDER ALERT: OPK APOG ALNY MGTI CPB CHGG DY IGC FIT SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 6/27/2019 Y9530810 GNW  Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer,12/04/2019 00972L10 GNW  Akcea Announces Appointment of New Chief Operating Officer,, 9/17/2019 PCRX-US  GNW  Pacira BioSciences Completes Enrollment in Multicenter Registration Study of EXPARELÂ® in Pediatric Patients, 9/26/2019 RTRX-US  GNW  Retrophin to Present at the 2019 Cantor Global Healthcare Conference," 5/03/2019 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results",10/15/2019 EDIT-US  GNW  Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases, 9/05/2019 CHMA-US  GNW  Chiasma to Present at the H.C. Wainwright 21st Annual Global Investment Conference,"11/09/2019 55609910 GNW  ROSEN, A LEADING GLOBAL LAW FIRM, Reminds MacroGenics, Inc. Investors of Important November 12th Deadline in Securities Class Action â€“ MGNX",,, 5/14/2015 28249U10 GNW  Celladon Reports First Quarter 2015 Financial Results,10/17/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2019 Financial Results Conference Call and Webcast, 5/07/2019 PRTA-US  GNW  Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update,12/27/2019 ZLAB-US  GNW  Zai Lab Announces NMPA Approval of ZEJULAÂ® (Niraparib) in China as Maintenance Therapy for Patients with Recurrent Ovarian Cancer, 1/04/2016 SAGE-US  GNW  Sage Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference,12/17/2019 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grants,10/18/2019 GMAB-DK  GNW  CHMP Issues Positive Opinion Recommending DARZALEXÂ® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma, 4/03/2019 92165910 GNW  SHAREHOLDER ALERT: STMP VNDA SYNH UMC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 9/17/2019 CBAY-US  GNW  CymaBay Therapeutics Announces Departure of Chief Medical Officer, 5/08/2013 45781M10 GNW  Inova Provides Lead Tracking Solution for Lenovo Event, 8/01/2019 CCXI-US  GNW  ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference,,,"10/30/2019 MNKD-US   GNW  MannKind Corporation to Hold 2019 Third Quarter Financial Results Conference Call on November 6, 2019", 3/15/2018 URGN-US  GNW  UroGen Reports Fourth Quarter and Full Year 2017 Financial Results, 1/22/2020 CYTK-US  GNW  Cytokinetics Announces Recipients of Second Annual Communications Fellowship Grants, 1/31/2020 ESPR-US     GNW  Esperion Announces Positive CHMP Opinion for the Marketing Authorisation Application for the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet for the Treatment of Hypercholesterolemia and Mixed Dyslipidemia," 5/21/2019 03236M20  GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Amyris, Inc. Investors"," 4/16/2012 FOLD-US  GNW  Amicus Therapeutics Names William D. Baird, III Chief Financial Officer", 7/22/2019 ACHN-US  GNW  Achillionâ€™s ACH-5228 Achieves Positive Results in Phase 1 Multiple Ascending Dose Study in Healthy Volunteers,"10/14/2019 SYNH-US  GNW  Syneos Health Schedules Third Quarter 2019 Earnings Call for Thursday, October 31, 2019",10/02/2019 FOLD-US  GNW  Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study of AT-GAA at the 24th International Annual Congress of the World Muscle Society,, 9/27/2017 0HCJCC-E GNW  Deciphera Pharmaceuticals Announces Pricing of Initial Public Offering,10/22/2019 ADMA-US  GNW  ADMA Biologics Named Company of the Year by BioFlorida,11/22/2019 GWPH-US  GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences, 3/13/2018 EPZM-US  GNW  Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones,,10/28/2019 MYOK-US  GNW  MyoKardia Announces Positive MYK-491 Data; Advancing Program into Targeted Genetic Dilated Cardiomyopathy Population,,12/05/2019 GLPG-NL  GNW  Galapagos completes recruitment of NOVESA trial in systemic sclerosis," 2/25/2020 FSCT-US  GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of FSCT, PTLA and QD",,,,"10/29/2019 CARA-US  GNW  Cara Therapeutics to Announce Third Quarter 2019 Financial Results on November 5, 2019",12/17/2019 FLXN-US  GNW  Flexion Therapeutics Enrolls First Patients in Phase 2 Trial of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in OA of the Shoulder and Adhesive Capsulitis,11/05/2019 QURE-US  GNW  uniQure Announces the Allowance of New Patent Providing Further Protection of the Padua and Padua-Related Variants of Factor IX in Gene Therapy,12/08/2019 AGIO-US   GNW  Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results,"10/31/2019 IOVA-US  GNW  Iovance Biotherapeutics to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Monday, November 4, 2019",11/08/2019 ANAB-US  GNW  AnaptysBio Announces Third Quarter 2019 Financial Results and Provides Pipeline Updates,,10/29/2019 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2019 Financial Results, 4/12/2018 HZNP-US  GNW  Horizon Pharma plc Named No. 1 Biopharma Company to Work for by Great Place to WorkÂ® and FORTUNE,,"10/29/2019 ICPT-US  GNW  Intercept to Announce Third Quarter 2019 Financial Results on November 5, 2019", 2/18/2020 KPTI-US    GNW  Karyopharm to Participate at 9th Annual SVB Leerink Global Healthcare Conference,,,12/04/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology,,,, 6/24/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference, 9/09/2019 ATRA-US    GNW  Atara Biotherapeutics to Present Initial Efficacy and Additional Safety Results from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019,, 2/26/2019 DERM-US  GNW  Dermira to Present New Analyses of the Glycopyrronium Tosylate Clinical Program at the 77th American Academy of Dermatology Annual Meeting,11/11/2019 FOMX-US  GNW  Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update, 8/19/2019 PRAH-US  GNW  PRA Health Sciences Announces Strategic Alliance between Symphony Health and Close-Up International, 8/26/2019 SUPN-US  GNW  Supernus to Present at Two SeptemberÂ Healthcare Conferences,"11/05/2019 31572Q80 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEN"," 5/12/2017 74587V10 GNW  PBYI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Puma Biotechnology, Inc. and a Lead Plaintiff Deadline of July 7, 2017",11/12/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences, 8/08/2019 CRBP-US  GNW  Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate UpdatesÂ ,, 9/03/2019 COLL-US  GNW  Collegium to Participate in Upcoming Investor Conferences,10/02/2019 XBIT-US  GNW  XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis,,,12/04/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants,12/19/2017 RGNX-US  GNW  REGENXBIO Announces IND Active for Phase I/II Trial of RGX-121 to Treat Mucopolysaccharidosis Type II,11/04/2019 KURA-US  GNW  Kura Oncology Appoints James Basta as Chief Legal Officer,11/05/2019 APLS-US  GNW  Apellis Pharmaceuticals Reports Third Quarter 2019 Business Update and Financial Results,12/18/2019 AXSM-US  GNW  Axsome Therapeutics Announces Proposed Public Offering of Common Stock, 6/17/2019 0GBP93-E GNW  Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update,12/16/2019 BGNE-US  GNW  BeiGene Announces Results of Phase 3 ASPEN Trial of Zanubrutinib Compared to Ibrutinib for the Treatment of Patients with WaldenstrÃ¶mâ€™s Macroglobulinemia,," 8/28/2019 RETA-US  GNW  Reata Appoints Manmeet S. Soni as Chief Financial Officer; Jason D. Wilson to Assume New Role as EVP, Operations",12/20/2019 HCM-GB   GNW  Chi-Medâ€™s New Drug Application for Surufatinib in Non-Pancreatic Neuroendocrine Tumors Granted Priority Review in China, 7/30/2019 NTLA-US  GNW  Intellia Therapeutics to Present at August Healthcare Investor Conference, 8/12/2019 ACIU-US  GNW  AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases, 7/01/2019 CRSP-US  GNW  CRISPR Therapeutics Announces Oral Presentation at the 55th Annual Meeting of the European Association for the Study of Diabetes,11/05/2019 GTHX-US  GNW  G1 Therapeutics Provides Third Quarter 2019 Corporate and Financial Update,11/01/2018 ARGX-BE  GNW  argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition,10/17/2019 RUBY-US GNW  Rubius Therapeutics Announces Oncology Poster Presentations  at Upcoming Medical Conferences,"11/07/2019 ATNX-US  GNW  Athenex, Inc. Announces Third Quarter 2019 Financial Results"," 7/17/2019 PETQ-US  GNW  PetIQ, Inc. to Report Second Quarter 2019 Results on Wednesday, August 7th","10/15/2019 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering", 9/12/2019 OPTN-US  GNW  Optinose Announces $150 Million Debt Financing from Pharmakon, 7/23/2019 TORC-US  GNW  resTORbio Announces Early Completion of Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101 in Clinically Symptomatic Respiratory Illness, 2/15/2019 DNLI-US  GNW  Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimerâ€™s Disease,, 2/07/2019 SLDB-US  GNW  Solid Biosciences Announces Preliminary SGT-001 Data and Intention to Dose Escalate in IGNITE DMD Clinical Trial for Duchenne Muscular Dystrophy,10/16/2019 EOLS-US  GNW  Evolus and Clarion Medical Technologies Announce First Shipment of Nuceivaâ„¢ (prabotulinumtoxinA) to Customers in Canada, 8/08/2019 FIXX-US GNW  Homology Medicines Reports Second Quarter 2019 Financial Results and Recent Highlights,11/07/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress, 7/02/2019 SRRK-US  GNW  Scholar Rock Announces Exercise in Full of Underwritersâ€™ Option to Purchase Additional Shares of Common Stock in Public Offering," 8/07/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates",,, 3/11/2019 EIDX-US  GNW  Eidos Therapeutics to Present at 31st Annual ROTH Conference," 8/28/2018 AVRO-US  GNW  AVROBIO, Inc. to Present at Upcoming Investor Conferences",, 8/02/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),12/05/2019 AUTL-US  GNW  Autolus Therapeutics Announces Conference Call to Review Clinical Data for Programmed T Cell Therapy Pipeline Presented at the 2019 ASH Annual Meeting,"12/09/2019 FTSV-US GNW  Forty Seven, Inc. Announces Foundational Preclinical Data Supporting the Development of FSI-174 in Combination with Magrolimab as a Novel All Antibody Conditioning Regimen for Hematopoietic Stem Cell Transplantation", 3/04/2019 TBIO-US  GNW  Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference,, 8/27/2019 PRNB-US GNW  Principia to Present at the 2019 Baird Global Healthcare Conference and the Wells Fargo Healthcare Conference, 8/07/2019 ARVN-US GNW  Arvinas To Present at the Wedbush PacGrow Healthcare Conference,11/06/2019 YMAB-US  GNW  Y-mAbs to Announce Third Quarter 2019 Financial and Operating Results on November 13,," 8/14/2019 GRTS-US  GNW  Gritstone Oncology Announces First Patient Dosed with SLATE, its â€œOff-The-Shelfâ€ Neoantigen Immunotherapy", 8/06/2019 GH-US    GNW  Guardant Health Reports Second Quarter 2019 Financial Results and Raises 2019 Revenue Guidance, 8/08/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc Reports Second Quarter 2019 Results,10/03/2019 NGM-US   GNW  NGM Bio Announces Multiple Aldafermin (NGM282) Poster Presentations at Upcoming AASLDâ€™s The Liver MeetingÂ®,,11/06/2019 ORTX-US  GNW  Orchard Therapeutics Reports Third Quarter 2019 Financial Results and Achievement of Key 2019 Milestones for Neurometabolic and Primary Immune Deficiencies Franchises,,"12/13/2019 ALEC-US  GNW  Alector Appoints Dr. Richard Scheller, Lasker Prize Awarded Scientist, and Dr. Thomas SÃ¼dhof, Nobel Laureate as Co-Chairs of its Strategic Portfolio Advice and Review Committee", 9/26/2019 DTIL-US GNW  Precision BioSciences to Present at Upcoming Industry and Investor Conferences,"11/11/2019 TPTX-US GNW  Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of TPX-0046, a Novel RET/SRC Inhibitor",11/06/2019 PRVL-US GNW  Prevail Therapeutics to Participate in Upcoming November Conferences,, 6/19/2019 BCEL-US GNW  Atreca Announces Pricing of Initial Public Offering,,,12/18/2019 06V2PS-E GNW  BridgeBio Pharmaâ€™s Origin Biosciences Enters Partnership With Medison to Commercialize BBP-870 in Israel for MoCD Type A,"10/29/2019 ADPT-US  GNW  Adaptive Biotechnologies to Report Third Quarter Financial Results on November 12, 2019",
,"10/23/2019 0LDDK2-E GNW  Progenics Highlights Additional Serious Concerns About Velan Capital, L.P."," 1/11/2017 45232710    GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Illumina, Inc. and Certain Officers â€“ ILMN", 7/17/2013 84763A10 GNW  Spectrum Pharmaceuticals Acquires Talon Therapeutics,"10/09/2017 ENDP-US  GNW  ENDP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of October 17, 2017","11/16/2016 04280A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Arrowhead Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ ARWR", 8/29/2019 BDSI-US  GNW  BioDelivery Sciences Announces Upcoming Investor Conference Presentations,, 7/21/2017 SAN-FR   GNW  Sanofi and Regeneron Receive Positive CHMP Opinion for DupixentÂ® (dupilumab) to Treat Adult Patients with  Moderate-to-Severe Atopic Dermatitis," 6/03/2019 PFE-US       GNW  SIGA Announces TPOXXÂ® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets"," 8/29/2019 OPK-US   GNW  OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency", 9/18/2019 46222210 GNW  Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study Evaluating a Higher Dose of SPINRAZAÂ® (nusinersen) and Additional Data in a Broad Range of Patients, 8/31/2016 BMRN-US     GNW  BioMarin to Attend Upcoming Investor Conferences,"12/02/2016 01535110 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ALXN",, 2/27/2017 81257810 GNW  Immunomedics Issues Open Letter Highlighting the Clear Decision to Vote for Immunomedics to Ensure Continued Value Creation,12/04/2019 IMMU-US  GNW  Immunomedics Announces Pricing of Public Offering of Common Stock,10/30/2019 BIIB-US   GNW  Biogen and Alkermes Announce FDA Approval of VUMERITYâ„¢ (diroximel fumarate) for Multiple Sclerosis,"11/03/2011 45253H10 GNW  ImmunoGen, Inc. Earns Milestone From Amgen With IND Achievement"," 2/18/2020 BCRX-US  GNW  FDA Accepts BioCrystâ€™s NDA for Oral, Once Daily Berotralstat (BCX7353) to Prevent HAE Attacks", 1/19/2016 GLPG-BE  GNW  Galapagos and Gilead complete closing of their global collaboration for filgotinib, 9/30/2010 04004760 GNW  Private Investor Files Lawsuit Against Arena Pharmaceuticals," 1/08/2020 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, MAT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",, 5/07/2019 AKRX-US  GNW  Akorn Provides Preliminary First Quarter 2019 Results and Full Year Guidance," 6/08/2018 05MKJ0-E GNW  Innovest Global, Inc. New Record $350K Sales in May, Premier Clients, New Institutional Investor Highlight our June Shareholder Update", 1/14/2020 MYGN-US  GNW  Dr. Thomas P. Slavin Named Senior Vice President of Medical Affairs for Myriad Oncology,11/07/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update, 5/06/2019 MGTX-US  GNW  MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference," 7/26/2018 INSM-US  GNW  Insmed to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 2, 2018", 6/02/2014 AUP-CA   GNW  Aurinia to Present at the Jefferies 2014 Global Healthcare Conference," 3/23/2020 ALGN-US   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS ALGN, INO, TLRY, WWE INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 9/24/2019 64026810 GNW  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in CARB, NKTR, and GVA of Filing Deadlines",," 2/18/2020 GERN-US  GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Geron Corporation (GERN) Investors With Losses to Contact its Attorneys: Application Deadline Approaching",12/15/2014 00771V10 GNW  Annual Changes to the NASDAQ Biotechnology Index, 1/02/2020 AMRN-US  GNW  VASCEPAÂ® Approved in Canada to Reduce the Risk of Cardiovascular Events, 1/07/2019 45337C10 GNW  Merus Announces IND Clearance for MCLA-145, 5/12/2017 91307C10 GNW  SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update,11/07/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments," 2/20/2019 G0176710 GNW  CLASS ACTION UPDATE for ALKS, GSM, ASTE and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,"11/07/2019 00163U10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG"," 4/05/2016 05KDBG-E GNW  ArQule to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016",,,, 3/04/2020 SAN-FR   GNW  Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors, 9/07/2012 92532F10 GNW  CORRECTING AND REPLACING/Vertex Pharmaceuticals Incorporated: Scott+Scott LLP Files Shareholder Class Action Against Vertex Pharmaceuticals Incorporated -- VRTX," 8/05/2019 ALLO-US  GNW  Allogene Therapeutics Appoints Rafael G. Amado, M.D. as  Executive Vice President of Research and Development and Chief Medical Officer", 9/12/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransConâ„¢ CNP at International Skeletal Dysplasia Society Meeting,," 8/31/2018 00422510 GNW  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD",11/07/2019 AFMD-US  GNW  Affimed Announces Proposed Public Offering of Common Shares,,10/15/2019 PRQR-US  GNW  ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10," 5/10/2017 88338N10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline: June 19, 2017",11/25/2019 ZGNX-US  GNW  Zogenix Announces FDA Acceptance for Filing of New Drug Application and Priority Review for FINTEPLAÂ® for the Treatment of Dravet Syndrome, 3/12/2020 ALLK-US  GNW  ALLK LOSSES ALERT: Bernstein Liebhard Reminds Investors of its Investigation of the Allakos Inc.,,12/23/2015 RVNC-US  GNW  Revance Announces Positive Phase 2 Results for RT001 Botulinum Toxin Type A Topical Gel to Treat Axillary Hyperhidrosis,,, 1/12/2020 ADVM-US  GNW  Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial forÂ ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook,12/18/2019 RARE-US   GNW  Ultragenyx Announces Sale of Future European Royalties on CrysvitaÂ® (burosumab) for $320 Million to Royalty Pharma, 5/07/2019 AGLE-US  GNW  Aeglea BioTherapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights," 4/08/2019 NSTG-US  GNW  NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019"," 9/22/2014 69329Y10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in PDL BioPharma, Inc. to Contact Brower Piven Before the November 17, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- PDLI",, 8/07/2019 RDUS-US  GNW  Radius Health Announces Second Quarter 2019 Operating Results,10/28/2019 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4),,,"11/05/2018 02043Q10 GNW  CLASS ACTION UPDATE for OPK, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 6/27/2019 WVE-US   GNW  Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of Suvodirsen",11/25/2019 00972L10 GNW  Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis,, 8/08/2019 PCRX-US  GNW  Pacira BioSciences Reports Second Quarter 2019 Financial Results and Business Update, 8/22/2019 RTRX-US  GNW  Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN," 4/24/2019 PACB-US  GNW  Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output",10/07/2019 MXCT-GB  GNW  Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell Medicines, 8/08/2019 CHMA-US  GNW  Chiasma Reports Second Quarter 2019 Results,"11/08/2019 55609910 GNW  MGNX NOTICE: Zhang Investor Law Reminds Investors of November 12 Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNXÂ ",,, 4/26/2015 28249U10 GNW  Celladon Reports Negative Results for CUPID2 Trial of MYDICAR(R) in Advanced Heart Failure, 9/19/2019 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Dr. Donna Grogan to Board of Directors, 4/30/2019 PRTA-US  GNW  Prothena to Report First Quarter 2019 Financial Results on May 7,12/23/2019 ZLAB-US  GNW  Zai Lab Announces Upcoming Presentation at 38th Annual J.P. Morgan Healthcare Conference,12/15/2015 SAGE-US  GNW  SAGE Updates Guidance for Top-Line Results of Phase 3 STATUS Trial of SAGE-547,12/06/2019 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grants,10/15/2019 JNJ-US   GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for Third Quarter of 2019, 4/02/2019 92165910 GNW  VNDA APRIL 26th DEADLINE: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case â€“ VNDA,, 9/03/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at Upcoming Investor Conferences in September," 4/09/2013 45781M10 GNW  Inova Subsidiary Completes Mineral Wells School District Project Worth $367,000 and Commences Debt Reduction Plan"," 7/31/2019 CCXI-US  GNW  ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019",,, 9/26/2019 MNKD-US   GNW  MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference," 3/08/2018 URGN-US  GNW  UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018", 1/13/2020 CYTK-US  GNW  Cytokinetics Announces Vision 2025 and Outlines 2020 Corporate Milestones, 1/31/2020 ESPR-US     GNW  Esperion Announces Positive CHMP Opinion for the Marketing Authorisation Application for Bempedoic Acid for the Treatment of Hypercholesterolemia and Mixed Dyslipidemia," 5/21/2019 AMRS-US   GNW  Amyris to Present at B. Riley FBR 20th Annual Institutional Investor Conference on Thursday, May 23, 2019",, 6/13/2019 ACHN-US  GNW  Achillion to Present at the JMP Securities Life Sciences Conference,10/14/2019 SYNH-US  GNW  Syneos Health Wins Society for Clinical Research Sites Eagle Award for Third Consecutive Year,10/01/2019 FOLD-US  GNW  Amicus Therapeutics to Present at Upcoming Medical and Investor Conferences in October 2019,,,10/21/2019 ADMA-US  GNW  ADMA Biologics Announces First Commercial Sales of ASCENIVâ„¢,"11/10/2019 GWPH-US  GNW  GW Pharmaceuticals receives positive NICE recommendation for EPIDYOLEXÂ® (cannabidiol) oral solution for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy"," 3/12/2018 EPZM-US  GNW  Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors",, 9/26/2019 MYOK-US  GNW  MyoKardia to Present at 2019 Cantor Global Healthcare Conference,,11/25/2019 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises," 2/24/2020 FSCT-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, PTLA, QD, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,,10/14/2019 CARA-US  GNW  Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Phase 3 Global Trial of KORSUVAâ„¢ Injection in Hemodialysis Patients with Pruritus,"12/10/2019 FLXN-US  GNW  Flexion Therapeutics Announces the Retirement of Neil Bodick, M.D., Ph.D., Chief Scientific Officer and Company Co-Founder",11/01/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences in November,"12/02/2019 AGIO-US   GNW  Agios Appoints Bruce Car, Ph.D., as Chief Scientific Officer",10/02/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces Four Abstracts to be Presented at the Upcoming 2019 SITC Annual Meeting,11/08/2019 ANAB-US  GNW  AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Fails to Meet Primary Endpoint,, 9/30/2019 FATE-US  GNW  Fate TherapeuticsÂ Announces the Opening of its cGMP Manufacturing Facility Dedicated to iPSC-derived Cell Therapies," 4/09/2018 HZNP-US  GNW  Horizon Pharma plc to Release First-Quarter 2018 Financial ResultsÂ and Host Webcast on May 9, 2018",,10/28/2019 ICPT-US  GNW  Intercept Announces New NASH and PBC Data to be Presented at The Liver MeetingÂ® 2019, 2/13/2020 KPTI-US    GNW  Karyopharm Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress,,,11/05/2019 ITCI-US  GNW  Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results,,,," 6/19/2019 AMPH-US  GNW  Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz", 8/28/2019 ATRA-US    GNW  Atara Biotherapeutics to Participate in Citi 14th Annual Biotech Conference,, 2/22/2019 DERM-US  GNW  Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZAâ„¢ (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis,"11/11/2019 MNLO-US  GNW  Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications"," 7/31/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Second Quarter 2019 Results and Updates Full Year 2019 Guidance", 8/06/2019 SUPN-US  GNW  Supernus Announces Second Quarter 2019 Financial Results,"11/04/2019 31572Q80 GNW  FibroGen, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities LawsÂ "," 5/11/2017 74587V10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 â€“ PBYI",11/08/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 8/01/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Operational and Financial Results on August 8, 2019",, 8/29/2019 COLL-US  GNW  Collegium Announces Scientific Presentations at PAINWeek 2019 National Conference," 9/27/2019 XBIT-US  GNW  XBiotech Announces Oral Presentation of Atopic Dermatitis Results for Bermekimab at 2019 EADV Congress in Madrid, Spain",,,11/26/2019 GBT-US   GNW  GBT Announces Participation at Upcoming Investor Conferences in December,11/22/2017 RGNX-US  GNW  REGENXBIO to Present at Upcoming Investor Conferences,10/30/2019 KURA-US  GNW  Kura Oncology to Report Third Quarter 2019 Financial Results,10/11/2019 APLS-US  GNW  Apellis to Present Data on APL-2 in Complement 3 Glomerulopathy at  ASN Kidney Week 2019,12/17/2019 05464T10 GNW  Axsome Therapeutics Added to NASDAQ Biotechnology Index, 6/11/2019 VYGR-US  GNW  Voyager Therapeutics to Present at the Raymond James Life Sciences & MedTech Conference,12/13/2019 6160-HK  GNW  BeiGene Announces Clinical Data on Investigational Anti-PD-1 Antibody Tislelizumab in Combination with Sitravatinib at European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress 2019,," 8/08/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Second Quarter 2019 Financial Results and an Update on Development Programs",11/28/2019 HCM-GB   GNW  Chi-Medâ€™s ElunateÂ® (Fruquintinib Capsules) Included in the NationalÂ Reimbursement Drug List inÂ China, 7/25/2019 NTLA-US  GNW  Intellia Therapeutics to Hold Conference CallÂ to Discuss Second Quarter 2019 EarningsÂ and Company Update, 8/01/2019 ACIU-US  GNW  AC Immune Initiates Ph1b/2a Study of Anti-Phospho-Tau Vaccine in Alzheimerâ€™s Disease, 5/29/2019 CRSP-US  GNW  CRISPR Therapeutics to Present at Upcoming Investor Conferences,"10/29/2019 GTHX-US  GNW  G1 Therapeutics to Provide Third Quarter Corporate and Financial Update on November 5, 2019",10/24/2018 ARGX-BE  GNW  argenx reports third quarter 2018 financial results and provides business update, 9/03/2019 RUBY-US GNW  Rubius Therapeutics to Participate in 17th Annual Morgan Stanley Global Healthcare Conference,10/30/2019 ATNX-US  GNW  Athenex Announces European Commission Grants Orphan Designations for Paclitaxel and Encequidar for the Treatment of Soft Tissue Sarcoma," 7/08/2019 71639T10 GNW  INVESTIGATION REMINDER for VRNT, PETQ, CTSH and PT: Hagens Berman Reminds Investors of Ongoing Investigations","10/15/2019 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering", 8/12/2019 OPTN-US  GNW  Optinose Reports Second Quarter 2019 Financial ResultsÂ and Recent Operational Highlights, 5/20/2019 TORC-US  GNW  resTORbio Presents Additional Phase 2b Data at the American Thoracic Society International Conference for RTB101 as a Potential Immunotherapy to Reduce the Incidence of Respiratory Tract Infections in Patients 65 Years of Age and Older with Asthma, 1/08/2019 DNLI-US  GNW  Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for ALS,, 1/02/2019 SLDB-US  GNW  Solid Biosciences to Present at the J.P. Morgan Healthcare Conference,10/01/2019 EOLS-US  GNW  Evolus Receives Approval for Nuceivaâ„¢ in the European Union, 8/01/2019 FIXX-US GNW  Homology Medicines to Participate at Upcoming Conferences,11/04/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Addition of DEXYCUÂ® and YUTIQÂ® to Department of Veteran Affairs Federal Supply Schedule, 6/19/2019 SRRK-US  GNW  Scholar Rock Announces Pricing of Public Offering of Common Stock," 7/30/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee",,," 2/27/2019 EIDX-US  GNW  Eidos Therapeutics Initiates ATTRibute-CM, a Phase 3 Study of AG10 in ATTR-CM with Registrational 12-month Endpoint"," 8/09/2018 AVRO-US  GNW  AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update",, 6/28/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/13/2019 AUTL-US  GNW  Autolus Therapeutics to Present at the Jefferies 2019 London Healthcare Conference,"12/09/2019 FTSV-US GNW  Forty Seven, Inc. Announces Updated Data from Ongoing Clinical Trial of Magrolimab Showing Robust, Durable Activity in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia", 2/14/2019 TBIO-US  GNW  Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference,, 8/08/2019 PRNB-US GNW  Principia Biopharma Reports Second Quarter Financial Results, 8/05/2019 ARVN-US GNW  Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update,11/01/2019 YMAB-US  GNW  Y-mAbs Announces Closing of Public Offering and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares,, 8/12/2019 GRTS-US  GNW  Gritstone Oncology Reports Second Quarter 2019 Financial ResultsÂ and Recent Highlights, 8/05/2019 GH-US    GNW  Largest Study of its Kind Finds Guardant360 MSI Highly Concordant to Tissue," 8/01/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Provide Second Quarter 2019 Business and Financial Update on August 8, 2019", 8/12/2019 NGM-US   GNW  NGM Bio Provides Pipeline Update and Reports Second Quarter 2019 Financial Results,,11/06/2019 ORTX-US  GNW  Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting,,12/13/2019 ALEC-US  GNW  Alector Showcases Progress in Immuno-Neurology Clinical Programs and Research Portfolio at R&D Day," 9/23/2019 DTIL-US GNW  Precision BioSciences Appoints David Thomson, PhD, as Chief Operating Officer",11/04/2019 TPTX-US GNW  Turning Point Therapeutics Reports Third Quarter 2019 Financial and Operational Results,10/08/2019 PRVL-US GNW  Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases,,,,,"12/16/2019 BBIO-US  GNW  BridgeBio Pharma, Inc. Appoints Industry Leader Jennifer Cook as New Board Member", 9/24/2019 00650F10 GNW  Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx,
,10/21/2019 0LDDK2-E GNW  Progenics Sends Letter to Shareholders," 1/03/2017 45232710    GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 â€“ ILMN"," 5/03/2013 84763A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of the Class Action Lawsuit and Upcoming Deadline -- SPPI",10/05/2017 G3040110 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endo International plc â€“ ENDP,"12/05/2014 04280A10 GNW  ARROWHEAD 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Arrowhead Research Corp. -- ARWR", 8/28/2019 BDSI-US  GNW  BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeekÂ® 2019 National Conference on Pain Management,, 5/08/2017 75886F10 GNW  Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy, 5/20/2019 SIGA-US      GNW  SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXXÂ® Manufacturing Totaling $11 Million, 8/07/2019 OPK-US   GNW  OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results, 9/16/2019 IONS-US  GNW  Positive Phase 1 Results of AKCEA-TTR-LRx Presented at the Heart Failure Society of America Annual Meeting, 8/24/2016 BMRN-US     GNW  Forbes Ranks BioMarin 10th Most Innovative Company in the World,"11/27/2016 01535110 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alexion Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline â€“ ALXN",, 2/15/2017 81257810 GNW  SGEN NOTICE: Rosen Law Firm Reminds Seattle Genetics Inc. Investors of Important Deadline in Class Action â€“ SGEN,12/03/2019 IMMU-US  GNW  Immunomedics Announces Proposed Public Offering of Common Stock,10/22/2019 4523-JP   GNW  Biogen Plans Regulatory Filing for Aducanumab in Alzheimerâ€™s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies,"11/02/2011 45253H10 GNW  ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences", 2/06/2020 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),12/17/2015 GLPG-BE  GNW  GALAPAGOS AND GILEAD ANNOUNCE GLOBAL PARTNERSHIP TO DEVELOP FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY DISEASES," 9/17/2010 ARNA-US  GNW  Sarraf Gentile LLP Investigates Arena Pharmaceuticals, Inc."," 1/07/2020 N5946510 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MATT and MYL",," 4/19/2019 00972810 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: AKRX, SYNH, INGN, BPI"," 3/26/2018 PSTI-US  GNW  Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem's Strategic Advisory Board", 1/06/2020 MYGN-US  GNW  Myriad Genetics to Present at the J.P. Morgan 2020 Healthcare Conference,"10/31/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on November 7, 2019", 4/25/2019 MGTX-US  GNW  MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019, 6/15/2018 INSM-US  GNW  Insmed Announces FDA Advisory Committee Meeting to Review ALIS as a treatment for NTM Lung Disease Caused by MAC, 5/15/2014 AUP-CA   GNW  Aurinia Reports First Quarter 2014 Financial Results," 3/23/2020 INO-US    GNW  KESSLER TOPAZ MELTZER & CHECK, LLP - IMPORTANT DEADLINE REMINDER FOR INOVIO PHARMACEUTICALS, INC. INVESTORS"," 9/24/2019 64026810 GNW  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",," 2/17/2020 GERN-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS GERN, OPRA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits","10/25/2013 007KSQ-E GNW  NASDAQ Welcomes Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) to The NASDAQ Stock Market",12/13/2019 AMRN-US  GNW  Amarin Receives FDA Approval of VASCEPAÂ® (icosapent ethyl) to Reduce Cardiovascular Risk,"11/05/2018 45337C10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Molson Coors Brewing, Coca-Cola European Partners, Brinker International, Incyte, RPC, and Group 1 Automotive â€” New Research Emphasizes Economic Growth", 1/09/2017 06CR5C-E GNW  SteadyMed Outlines Strategic Goals and Priorities for 2017 and Provides Update on Trevyent Launch Plans,11/05/2019 SRPT-US  GNW  Sarepta Therapeutics to Present at the Credit Suisse 28th Annual Healthcare Conference, 2/20/2019 G0176710 GNW  ALKS UPCOMING FEBRUARY 25th DEADLINE: Rosen Law Firm Reminds Alkermes Public Limited Company Investors of Important Deadline in Securities Class Action â€“ ALKS,,11/01/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces Third Quarter 2019 Financial ResultsÂ and Provides Corporate Update, 3/22/2016 ARQL-US  GNW  Daiichi Sankyo and ArQule Announce Continuation of METIV-HCC Phase 3  Study of Tivantinib in Second-Line Hepatocellular Carcinoma,,,, 3/02/2020 SAN-FR   GNW  Sanofi : FDA approves SarclisaÂ® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma, 9/07/2012 VRTX-US  GNW  Morgan & Morgan Announces That it is Conducting an Investigation on Behalf of Investors in Vertex Pharmaceuticals Incorporated," 7/29/2019 ALLO-US  GNW  Allogene Therapeutics to Report Second Quarter 2019 Financial Results on August 7, 2019", 8/29/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Three Investor Presentations in September,, 8/31/2018 00422510 GNW  Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of ACADIA Pharmaceuticals Inc. Investors,11/07/2019 AFMD-US  GNW  Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Expressing Cancers,,10/10/2019 PRQR-US  GNW  ProQR Announces Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients," 4/29/2017 88338N10 GNW  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm",11/12/2019 ZGNX-US  GNW  Zogenix to Present at Two Investor Conferences in November, 3/11/2020 ALLK-US  GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Allakos Inc. (ALLK),,"12/14/2015 RVNC-US  GNW  Revance Appoints Abhay Joshi, PhD, as Chief Operating Officer",,, 1/11/2020 ADVM-US  GNW  Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at theÂ Atlantic Coast Retina Club Macula 20/20 Annual Meeting,11/26/2019 RARE-US   GNW  Ultragenyx to Present at Piper Jaffray 31st Annual Healthcare Conference, 4/07/2019 AGLE-US  GNW  Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders, 4/02/2019 NSTG-US  GNW  NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leicaâ€™s BOND RX Platforms for High Throughput Spatial Analysis," 9/21/2014 69329Y10 GNW  EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Against PDL BioPharma, Inc. - PDLI",, 8/05/2019 RDUS-US  GNW  Radius Health Initiates Phase 3 wearABLe Study of Abaloparatide-Patch in Postmenopausal Osteoporosis Patients at High Risk for Fracture,10/28/2019 ASMB-US  GNW  Assembly Biosciences Appoints Thomas J. Russo as Chief Financial Officer,,,"11/05/2018 02043Q10 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Alnylam Pharmaceuticals, Inc. Investors", 6/12/2019 WVE-US   GNW  Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference,11/19/2019 00972L10 GNW  Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx),, 8/07/2019 PCRX-US  GNW  Pacira BioSciences to Present at the 2019 Wedbush Pacgrow Healthcare Conference, 8/06/2019 RTRX-US  GNW  Retrophin Reports Second Quarter 2019 Financial Results, 4/02/2019 PACB-US  GNW  Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates,10/01/2019 EDIT-US  GNW  Editas Medicine to Participate in Upcoming Investor Conferences," 8/01/2019 CHMA-US  GNW  Chiasma to Report Second Quarter Financial Results on August 8, 2019","11/08/2019 55609910 GNW  DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019",,, 3/30/2015 28249U10 GNW  Celladon Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights, 8/02/2019 MNTA-US  GNW  Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results, 4/18/2019 PRTA-US  GNW  Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis,"12/16/2019 ZLAB-US  GNW  Zai Lab Announces the Appointment of Timothy Yap, M.D., Ph.D., to its Scientific Advisory Board",11/24/2015 SAGE-US  GNW  SAGE to Present at the Piper Jaffray 27th Annual Healthcare Conference,11/11/2019 CTMX-US  GNW  CytomX Therapeutics to Present at Upcoming Healthcare Conferences," 9/26/2019 GMAB-DK  GNW  Genmab Announces U.S. FDA Approval of DARZALEXÂ® (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone for Frontline Multiple Myeloma"," 4/02/2019 92165910 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm",, 8/07/2019 CBAY-US  GNW  CymaBay Reports Second Quarter 2019 Financial Results and Provides Corporate Update, 1/31/2013 45781M10 GNW  Inova Subsidiary Has Completed Projects Worth $18 Million Out of a Total of $30 Million, 6/11/2019 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 9/19/2019 MNKD-US   GNW  MannKind Presents Positive AfrezzaÂ® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD, 3/07/2018 URGN-US  GNW  UroGen to Present at March 2018 Investor Conferences," 1/06/2020 CYTK-US  GNW  Cytokinetics Announces Start of Redwood-HCM, a Phase 2 Clinical Trial of CK-3773274", 1/07/2020 ESPR-US     GNW  Esperion to Present at the 38th Annual J.P. Morgan Healthcare Conference," 5/21/2019 AMRS-US   GNW  Amyris Announces the Execution of Strategic Supply Agreements with RaÃ­zen, the Largest Sugar Producer in the World",, 6/10/2019 ACHN-US  GNW  Achillion Announces Upcoming Scientific Presentation at the 24th Congress of the European Hematology Association," 9/30/2019 SYNH-US  GNW  Syneos Health Introduces New Book, Why We Resist: The Surprising Truths About Motivating Behavior Change", 9/04/2019 FOLD-US  GNW  Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2019,,,10/17/2019 ADMA-US  GNW  ADMA Biologics Announces Publication of an Article Describing the Manufacturing Process Optimization for its Commercial Products BIVIGAMÂ® and ASCENIVâ„¢ in the Peer Reviewed Journal Immunotherapy,"11/05/2019 GWPH-US  GNW  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019", 3/12/2018 EPZM-US  GNW  Epizyme to Participate in Oppenheimer & Co. 28th Annual Healthcare Conference,, 9/10/2019 MYOK-US  GNW  MyoKardia to Evaluate Mavacamten as an Alternative to Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Patients,,11/18/2019 GLPG-NL  GNW  Galapagos receives transparency notification from Wellington Management Group LLP, 2/24/2020 PTLA-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,,,, 9/26/2019 CARA-US  GNW  Cara Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference,12/09/2019 FLXN-US  GNW  Flexion Therapeutics to Host Physician Event at Orthopaedic Summit 2019 Featuring Panel of Former Professional Athletes Treated With ZILRETTAÂ® for Osteoarthritis Knee Pain,10/31/2019 QURE-US  GNW  uniQure Announces Publication of Positive Interim Data from Phase IIb Clinical Trial of Etranacogene Dezaparvovec,11/25/2019 AGIO-US   GNW  Agios Appoints Jonathan Biller as Chief Legal Officer, 9/27/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Conferences, 9/30/2019 ANAB-US  GNW  AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis,, 9/18/2019 FATE-US  GNW  Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares, 4/04/2018 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 9/27/2019 ICPT-US  GNW  Intercept Submits New Drug Application to the U.S. FDA for Obeticholic Acid in Patients with Fibrosis Due to NASH," 2/11/2020 09Q93P-E   GNW  Karyopharm and Promedico, a Member of the Neopharm Group, Enter into an Exclusive Distribution Agreement to Commercialize XPOVIOÂ® (Selinexor) in Israel",,,10/29/2019 ITCI-US  GNW  Intra-Cellular Therapies to Host Third Quarter 2019 Financial Results Conference Call and Webcast,,,, 6/14/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference, 8/08/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Second Quarter 2019 Financial Results and Recent Operational Progress,, 2/21/2019 DERM-US  GNW  Dermira to Present at the 8th Annual SVB Leerink Global Healthcare Conference,"11/11/2019 MNLO-US  GNW  Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications", 7/09/2019 PRAH-US  GNW  CORRECTING and REPLACING -- PRA Health Sciences to Report Second Quarter 2019 Earnings, 7/23/2019 SUPN-US  GNW  Supernus to Host Second Quarter 2019 Earnings Conference Call,"11/04/2019 FGEN-US  GNW  FibroGen To Report Third Quarter 2019 Financial Results on Monday, November 11, 2019"," 5/10/2017 74587V10 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Puma Biotechnology, Inc. (Nasdaq: PBYI) To Contact Brower Piven Before The Lead Plaintiff Deadline",11/06/2019 CHRS-US  GNW  Coherus Acquires Commercial Rights for Leading Lucentis Biosimilar in the United States, 6/17/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Host 2019 R&D Day in New York City,, 8/07/2019 COLL-US  GNW  Collegium Reports Second Quarter 2019 Financial Results, 9/20/2019 XBIT-US  GNW  XBiotech Announces Granting of Canadian Patent for Treatment of Dermatological Pathologies,,,"11/25/2019 GBT-US   GNW  FDA Approves Oxbrytaâ„¢ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease",11/08/2017 RGNX-US  GNW  REGENXBIO Reports Third Quarter 2017 Financial Results and Recent Operational Highlights,10/29/2019 KURA-US  GNW  Kura Oncology Reports Durable Anti-Tumor Activity in Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer,10/04/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/16/2019 AXSM-US  GNW  Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder, 5/20/2019 VYGR-US  GNW  Voyager Therapeutics Announces Management Updates,12/08/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on BRUKINSAâ„¢ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting,," 8/01/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report Second Quarter 2019 Financials and to Provide an Update on Development Programs on August 8, 2019",11/25/2019 HCM-GB   GNW  Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors, 5/30/2019 NTLA-US  GNW  Intellia Therapeutics to Participate at June Healthcare Investor Conferences," 7/17/2019 LLY-US   GNW  AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomerâ„¢, an Investigational Treatment for Alzheimerâ€™s Disease", 5/01/2019 CRSP-US  GNW  CRISPR Therapeutics to Participate in Upcoming Investor Conferences, 9/29/2019 GTHX-US  GNW  G1 Therapeutics Presents First Clinical Data on Oral SERD G1T48 Demonstrating Safety and Tolerability in Patients with Advanced Breast Cancer at ESMO 2019,10/08/2018 ARGX-BE  GNW  argenx awarded â‚¬2.6 million VLAIO grant to explore new applications of ABDEG technology, 8/13/2019 RUBY-US GNW  Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress,10/28/2019 ATNX-US  GNW  Athenex Announces Progress Update from Partner Almirall on Tirbanibulin Ointment," 7/08/2019 71639T10 GNW  PetIQ, Inc. Completes Acquisition of Perrigo Animal Health", 9/25/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Provides Update on Research and Development Programs," 8/01/2019 OPTN-US  GNW  Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019", 5/15/2019 TORC-US  GNW  resTORbio Reports First Quarter 2019 Financial Results and Corporate Update,12/10/2018 DNLI-US  GNW  Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinsonâ€™s Disease,,11/13/2018 SLDB-US  GNW  Solid Biosciences Reports Third Quarter 2018 Financial Results And Provides Business Update, 9/18/2019 EOLS-US  GNW  Evolus will Participate in Cantor Global Healthcare Conference," 7/15/2019 FIXX-US GNW  Homology Medicines Appoints Alise Reicin, M.D., to the Board of Directors",11/01/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCUÂ®, 6/19/2019 SRRK-US  GNW  Scholar Rock to Present at the 2019 BMO Prescriptions for Success Healthcare Conference," 7/30/2019 UBX-US   GNW  UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results",,, 2/25/2019 EIDX-US  GNW  Eidos Therapeutics to Host Conference Call and Webcast to Discuss ATTR-CM Phase 3 Trial (ATTRibute-CM) Design," 8/08/2018 AVRO-US  GNW  AVROBIO, Inc. to Present at the 2018 Wedbush PacGrow Healthcare Conference",, 6/06/2019 XERS-US  GNW  Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvokeâ„¢,11/13/2019 0HPZPJ-E GNW  Autolus Therapeutics and Noile-Immune Announce Licensing Agreement,"11/12/2019 FTSV-US GNW  Forty Seven, Inc. Reports Third Quarter 2019 Financial Results and Recent Business Highlights", 1/03/2019 TBIO-US  GNW  Translate Bio Advances Programs in Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency,, 7/30/2019 PRNB-US GNW  Principia Announces Update to Ongoing Phase 2 Clinical Trial in Patients with ITP," 7/29/2019 ARVN-US GNW  Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer",10/29/2019 YMAB-US  GNW  Y-mAbs Announces Pricing of Public Offering of Common Stock,," 7/08/2019 GRTS-US  GNW  Gritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical Operations", 8/01/2019 GH-US    GNW  Guardant Health to Participate in Upcoming Investor Conferences, 5/30/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Present at Jefferies 2019 Global Healthcare Conference, 6/10/2019 NGM-US   GNW  NGM Bio to Present at Goldman Sachs 40th Annual Global Healthcare Conference,,10/30/2019 ORTX-US  GNW  Orchard Therapeutics to Webcast Conference Call of Third Quarter 2019 Financial Results,,"12/11/2019 ALEC-US  GNW  Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer"," 9/16/2019 DTIL-US GNW  Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy",10/21/2019 TPTX-US GNW  Turning Point Therapeutics to Host Third Quarter 2019 Conference Call,10/01/2019 PRVL-US GNW  Prevail Therapeutics to Present at Upcoming October Conferences,,,,,"12/09/2019 BBIO-US  GNW  BridgeBio Pharma, Inc. Appoints Eli Wallace as Chief Scientific Officer in Residence for Oncology Programs", 9/17/2019 ADPT-US  GNW  Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQÂ® as Preferred MRD Test for Drug Development Across Amgenâ€™s Hematology Franchise,
,10/09/2019 PGNX-US  GNW  Progenics Sends Letter to Shareholders,"12/19/2016 45232710    GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 â€“ ILMN"," 4/30/2013 84763A10 GNW  Deadline on May 13, 2013 in Lawsuit for Investors in Spectrum Pharmaceuticals, Inc. (SPPI) Announced by Shareholders Foundation","10/04/2017 ENDP-US  GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Endo International plc and Set a Lead Plaintiff Deadline of October 17, 2017 -- ENDP",12/05/2014 04280A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Arrowhead Research Corporation of Class Action Lawsuit and Upcoming Deadline -- ARWR, 8/08/2019 BDSI-US  GNW  BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations,, 4/28/2017 SAN-FR   GNW  Sanofi and Regeneron Announce KevzaraÂ® (sarilumab) Biologics License Application Resubmission  Accepted for Review by US FDA," 2/21/2019 SIGA-US      GNW  SIGA to Present at the 8th Annual SVB Leerink Global Healthcare Conference on March 1, 2019"," 8/01/2019 OPK-US   GNW  OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019", 8/29/2019 46222210 GNW  Akcea and Ionis to Present New Data for TEGSEDI and AKCEA-TTR-LRx at Two Upcoming Medical Meetings, 8/09/2016 BMRN-US     GNW  BioMarin Announces Pricing of Public Offering of Common Stock,"11/21/2016 01535110 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 â€“ ALXN",," 2/03/2017 81257810 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Seattle Genetics Inc. (SGEN) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",12/03/2019 IMMU-US  GNW  Immunomedics Resubmits Biologics License Application to the FDA for Sacituzumab Govitecan,10/21/2019 BIIB-US   GNW  Biogen and Samsung Bioepis to Present Data for Infliximab and Adalimumab Biosimilars at United European Gastroenterology Week,"10/27/2011 45253H10 GNW  ImmunoGen, Inc. Reports First Quarter Fiscal Year 2012 Financial Results and Provides Quarterly Update"," 2/03/2020 BCRX-US  GNW  BioCryst Submits Japanese New Drug Application for Oral, Once Daily Berotralstat", 9/30/2015 ALDR-US  GNW  Alder BioPharmaceuticals Appoints Paul R. Carter to Board of Directors," 8/03/2010 04004760 GNW  Skymark Research Initiates Independent Research Coverage on Arena Pharmaceuticals, Inc."," 1/06/2020 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MATT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 4/18/2019 AKRX-US  GNW  Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5%","12/04/2017 03116210 GNW  Analysis: Positioning to Benefit within Emerson Electric, Puma Biotechnology, Amgen, SunCoke Energy Partners, Carrols Restaurant Group, and First Financial â€” Research Highlights Growth, Revenue, and Consolidated Results", 1/06/2020 MYGN-US  GNW  New Publication Demonstrates GeneSightÂ® Improved All Clinical Outcomes Using HAM-D6 Analysis in Large Prospective GUIDED Study,10/02/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium, 3/26/2019 MGTX-US  GNW  MeiraGTx Reports Full Year 2018 Financial Results, 6/07/2018 INSM-US  GNW  Insmed to Present at Three June Conferences, 3/31/2014 AUP-CA   GNW  Aurinia Reports Fourth Quarter and Full Year 2013 Financial Results," 3/20/2020 AAN-US    GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AAN, FLR, INO, MGPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 9/23/2019 64026810 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Nektar Therapeutics Investors",," 2/14/2020 GERN-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS GERN, OPRA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,"12/02/2019 AMRN-US  GNW  European Medicines Agency Accepts for Review Marketing Authorization Application for Amarinâ€™s Icosapent Ethyl (VascepaÂ®) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in REDUCE-ITÂ® Study","10/12/2018 45337C10 GNW  Report: Developing Opportunities within Packaging Corporation of America, Jones Energy, Pitney Bowes, Mercury General, Invacare, and Incyte â€” Future Expectations, Projections Moving into 2018", 4/25/2016 91307C10 GNW  SteadyMed Announces Public Availability of PTAB Decision to InstituteÂ Inter Partes Review Proceedings,10/31/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 2/19/2019 G0176710 GNW  CLASS ACTION UPDATE for ARLO, PRGO, ALKS and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,10/29/2019 AMAG-US  GNW  AMAG Reports on FDA Advisory Committee Meeting for MakenaÂ® (Hydroxyprogesterone Caproate Injection), 2/29/2016 ARQL-US  GNW  ArQule Reports Fourth Quarter and Full Year 2015 Financial Results,,,, 2/24/2020 SAN-FR   GNW  Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*), 9/06/2012 92532F10 GNW  Vertex Pharmaceuticals Incorporated: Scott+Scott LLP Files Shareholder Class Action Against Vertex Pharmaceuticals Incorporated -- VRTX," 6/04/2019 ALLO-US  GNW  Allogene Therapeutics Announces FDA Clearance of the IND for ALLO-715, a BCMA Allogeneic CAR T (AlloCAR Tâ„¢) Therapy", 8/28/2019 ASND-US  GNW  Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results,, 8/31/2018 00422510 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ACAD,11/07/2019 AFMD-US  GNW  Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech,,10/07/2019 PRQR-US  GNW  ProQR to Present Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients ahead of AAO," 4/27/2017 88338N10 GNW  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm",11/07/2019 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Third Quarter 2019 Financial Results, 2/25/2020 ALLK-US  GNW  Allakos Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update,,11/19/2015 76133010 GNW  Revance Therapeutics to Present in the 27th Annual Piper Jaffray Healthcare Conference,,,12/18/2019 ADVM-US  GNW  Adverum Biotechnologies to Present at Upcoming Conferences,11/08/2019 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences, 4/01/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Present Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders, 4/01/2019 NSTG-US  GNW  NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler," 9/19/2014 69329Y10 GNW  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against PDL BioPharma, Inc. -- PDLI",," 7/23/2019 RDUS-US  GNW  Radius Health to Announce Second Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, August 7, 2019",10/16/2019 ASMB-US  GNW  Safety and Antiviral Activity of Assembly Biosciencesâ€™ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD,,,"11/05/2018 02043Q10 GNW  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 5/22/2019 WVE-US   GNW  Wave Life Sciences to Present at the Jefferies 2019 Healthcare Conference,11/13/2019 AKCA-US  GNW  Akcea Therapeutics to Present at Upcoming Investor Conferences,," 7/30/2019 PCRX-US  GNW  Pacira to Report Second Quarter 2019 Financial Results on Thursday August 8, 2019", 7/31/2019 RTRX-US  GNW  Retrophin to Present at Canaccord Genuityâ€™s 39th Annual Growth Conference, 2/26/2019 PACB-US  GNW  Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference, 8/29/2019 EDIT-US  GNW  Editas Medicine to Participate in Upcoming Investor Conferences, 7/26/2019 CHMA-US  GNW  Chiasma Announces Pricing of Underwritten Public Offering of $55.0 Million of Common Stock,11/07/2019 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences,,, 3/25/2015 28249U10 GNW  Celladon to Report Fourth Quarter and Fiscal 2014 Results on March 31, 8/01/2019 MNTA-US  GNW  Momenta Pharmaceuticals Launches Phase 2/3 Trial of M281 for the Treatment of Warm Autoimmune Hemolytic Anemia and is Granted FDA Fast Track Designation, 3/14/2019 G7280010 GNW  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Prothena Corporation plc and Encourages Investors who Purchased Shares in the March 2017 Secondary Offering to Contact the Firm,10/30/2019 ZLAB-US  GNW  Zai Lab Announces Upcoming Presentations at November Conferences,11/05/2015 SAGE-US  GNW  SAGE Announces Third Quarter 2015 Financial Results and Recent Pipeline Progress,11/07/2019 CTMX-US  GNW  CytomX Therapeutics Announces Third Quarter 2019 Financial ResultsÂ and Provides Business Update, 9/13/2019 AMGN-US  GNW  Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma, 3/28/2019 92165910 GNW  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors,, 8/05/2019 CBAY-US  GNW  CymaBay Therapeutics Strengthens Management Team with Appointment of Janet Dorling as Chief Commercial Officer,10/16/2012 INVA-US  GNW  Theravance and Merck Sign Cardiovascular Disease Collaboration, 5/06/2019 CCXI-US  GNW  ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights,,, 8/30/2019 MNKD-US   GNW  MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference, 2/14/2018 URGN-US  GNW  UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as Chief Operating Officer,12/18/2019 4503-JP  GNW  Cytokinetics Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis, 1/03/2020 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 5/20/2019 AMRS-US   GNW  Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q,, 5/17/2019 ACHN-US  GNW  Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting, 9/09/2019 SYNH-US  GNW  Syneos Health Showcases Evolved Deployment Solutions at Future Pharma in Boston, 8/08/2019 FOLD-US  GNW  Amicus Therapeutics Announces Second Quarter 2019 Financial Results and Corporate Updates,,,10/07/2019 ADMA-US  GNW  ADMA Biologics Announces Data Presented at IDWeek 2019,10/31/2019 GWPH-US  GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences, 2/27/2018 EPZM-US  GNW  Epizyme Announces Date of Fourth Quarter and Full Year 2017 Results Conference Call and Upcoming Presentation at the Cowen 38th Annual Health Care Conference,, 8/31/2019 MYOK-US  GNW  MyoKardia Presents 36-week Data from PIONEER-OLE Study of Mavacamten at the European Society of Cardiology Congress 2019,,11/13/2019 GLPG-NL  GNW  Transparency notification â€“ Gilead holds 25.10% of Galapagos shares," 2/21/2020 FSCT-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS FSCT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,," 8/21/2019 CARA-US  GNW  Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for PeptelligenceÂ® Oral Formulation Technology",12/06/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/28/2019 QURE-US  GNW  uniQure Announces Third Quarter 2019 Results and Highlights Recent Company Progress,11/22/2019 AGIO-US   GNW  Agios Presents New Pharmacodynamic and Response Data from Both Cohorts of the Perioperative Study of Vorasidenib and TIBSOVOÂ® (ivosidenib) in Patients with IDH1 Mutant Positive Low-Grade Glioma, 8/26/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Investor Conferences in September, 9/27/2019 ANAB-US  GNW  AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference,, 9/12/2019 FATE-US  GNW  Fate Therapeutics Announces Pricing of Public Offering of Common Stock, 3/06/2018 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 9/25/2019 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conference in October," 2/06/2020 KPTI-US    GNW  Karyopharm to Report Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020",,, 9/30/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare Conference,,,, 5/31/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference," 8/01/2019 ATRA-US    GNW  Atara Biotherapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 8, 2019",," 2/19/2019 DERM-US  GNW  Dermira to Report Fourth Quarter 2018 Results and Host Conference Call on Tuesday, February 26, 2019",11/07/2019 FOMX-US  GNW  Foamix Announces Issuance of New U.S. Patent for Compositions Combining a Retinoid and a Tetracycline Antibiotic," 5/14/2019 PRAH-US  GNW  PRA Health Sciences Earns Recognition, Industry Awards", 5/29/2019 SUPN-US  GNW  Supernus to Present at the Jefferies 2019 Global Healthcare Conference,"10/23/2019 FGEN-US  GNW  FibroGen Announces First Patient Dosed in LAPIS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients With Locally Advanced Pancreatic Cancer Â "," 5/08/2017 74587V10 GNW  Pomerantz Law Firm Announces the Filing of a  Class Action against Puma Biotechnology, Inc. and Certain Officers â€“ PBYI",11/06/2019 CHRS-US  GNW  Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results, 6/12/2019 CRBP-US  GNW  Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies,, 7/24/2019 COLL-US  GNW  Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update, 7/11/2019 XBIT-US  GNW  Dr. Seth Forman to Chair XBiotechâ€™s Second Phase 2 Study of Bermekimab in Atopic Dermatitis,,,11/07/2019 GBT-US   GNW  GBT Reports Recent Business Progress and Third Quarter 2019 Financial Results,11/01/2017 RGNX-US  GNW  REGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2017 Financial Results and Recent Operational Highlights,10/23/2019 KURA-US  GNW  Kura Oncology Data Selected for Oral Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 9/27/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/03/2019 AXSM-US  GNW  Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in CONCERT Phase 2 Trial in Narcolepsy, 5/07/2019 VYGR-US  GNW  Voyager Therapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights,"11/29/2019 07725L10 GNW  BGNE LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd. â€“ BGNE",," 6/05/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease",11/22/2019 HCM-GB   GNW  Chi-Med Highlights Oral Presentations at 2019 ESMO Asia Annual Meeting," 5/28/2019 NTLA-US  GNW  Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D.,  Chief Scientific Officer", 7/11/2019 ACIU-US  GNW  AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimerâ€™s Disease-like Symptoms in Subjects with Down Syndrome, 4/29/2019 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results, 9/28/2019 GTHX-US  GNW  G1 Therapeutics Presents Updated Data at ESMO 2019 from Randomized Phase 2 Trial of Trilaciclib in Combination with Chemotherapy in Metastatic Triple-Negative Breast Cancer Demonstrating Significant Improvement in Overall Survival," 8/22/2018 ARGX-BE  GNW  argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody", 8/07/2019 RUBY-US GNW  Rubius Therapeutics to Announce Second Quarter 2019 Financial Results,10/24/2019 ATNX-US  GNW  Athenex Provides An Update to Shareholders," 6/19/2019 71639T10 GNW  INVESTIGATION ALERT FOR CTSH, PETQ, AND EROS: Hagens Berman Alerts Investors in CTSH, PETQ, and EROS to the Firmâ€™s Investigation of Potential Disclosure Violations, Encourages Investors to Contact the Firm", 9/09/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Provide an Update on Genetic Sequencing Efforts and Expansion of Phase 2 Basket Study with Four Additional Rare MC4R Pathway-driven DisordersÂ , 6/20/2019 OPTN-US  GNW  Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference," 5/14/2019 TORC-US  GNW  resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer",11/19/2018 DNLI-US  GNW  Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule and Intention to Initiate Patient Studies in Multiple Indications in Collaboration With Sanofi,,11/09/2018 SLDB-US  GNW  Solid Biosciences to Present at the Credit Suisse Healthcare Conference, 9/04/2019 EOLS-US  GNW  Evolus Announces Successful Completion of theÂ JeuveauÂ® Experience Treatment (J.E.T) Program, 6/27/2019 FIXX-US GNW  Homology Medicines Announces Leadership Updates,10/24/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Third Quarter 2019 Financial Results Release Date and Conference Call Information, 6/18/2019 SRRK-US  GNW  Scholar Rock Announces Proposed Public Offering of Common Stock, 6/18/2019 UBX-US   GNW  UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee,,, 2/21/2019 EIDX-US  GNW  Eidos Therapeutics to Present at Two Upcoming Investor Conferences," 6/27/2018 NOVN-CH  GNW  AVROBIO, Inc. Appoints Phillip B. Donenberg to its Board of Directors",, 5/09/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline,11/09/2019 AUTL-US  GNW  Autolus Therapeutics Presents Preclinical Data on AUT06NG at the SITC Annual Meeting,"11/06/2019 FTSV-US GNW  Forty Seven, Inc. to Present New Clinical and Preclinical Data on Magrolimab and FSI-174 at 61st ASH Annual Meeting"," 1/03/2019 TBIO-US  GNW  Translate Bio Appoints Robert Meyer, MD, to its Board of Directors",, 6/11/2019 PRNB-US GNW  Principia Biopharma Appoints Patrick Machado to Board of Directors, 7/25/2019 ARVN-US GNW  Arvinas Strengthens Board of Directors with Addition of Leslie Norwalk,10/29/2019 YMAB-US  GNW  Y-mAbs Announces Proposed Public Offering of Common Stock,, 6/05/2019 GRTS-US  GNW  Gritstone Oncology to Present at Two Upcoming Investor Conferences in June," 8/01/2019 GH-US    GNW  Guardant Health to Report Second Quarter 2019 Financial Results on August 6, 2019", 5/14/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Present at 2019 RBC Capital Markets Global Healthcare Conference, 6/05/2019 NGM-US   GNW  NGM Bio to Present New Data from Phase 1b Study of NGM313 at  79th Scientific Sessions of the American Diabetes Association,,10/22/2019 ORTX-US  GNW  Orchard Therapeutics Presents Data from OTL-200 in Patients with Metachromatic Leukodystrophy Using Cryopreservation,,12/06/2019 01444210 GNW  Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimerâ€™s Disease (CTAD) Meeting, 9/04/2019 DTIL-US GNW  Precision BioSciences to Present at Upcoming Scientific Conferences," 9/30/2019 TPTX-US GNW  Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0046, a Novel RET/SRC Inhibitor"," 9/19/2019 PRVL-US GNW  Prevail Therapeutics Announces Addition to Russell 2000Â®, 3000Â® and MicrocapÂ® Indexes",,,,,12/05/2019 BBIO-US  GNW  BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), 8/13/2019 ADPT-US  GNW  Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results,
,"10/08/2019 74318710 GNW  SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, PGNX, DOVA Shareholders About Its Ongoing Investigations", 6/16/2014 ILMN-US     GNW  CareDx and Illumina Enter Into Supply Agreement for Next Generation Sequencing Technologies," 4/19/2013 84763A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- SPPI", 9/28/2017 G3040110 GNW  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm,"11/24/2014 04280A10 GNW  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important December 9, 2014 Deadline in Class Action Filed by Firm - ARWR"," 7/30/2019 BDSI-US  GNW  BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019",, 4/06/2017 REGN-US  GNW  Regeneron Science Talent Search to Ring The Nasdaq Stock Market Closing Bell,11/01/2018 SIGA-US      GNW  SIGA Announces Priority Review Voucher Transaction Totaling $80 Million, 8/01/2019 OPK-US   GNW  BIOREFERENCE LABORATORIES SELECTED AS PREFERRED LABORATORY PROVIDER  BY THE IPA ASSOCIATION OF AMERICA, 8/07/2019 46222210 GNW  New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRAÂ® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome, 8/08/2016 BMRN-US     GNW  BioMarin Announces Public Offering of Common Stock," 2/29/2016 ALXN-US  GNW  Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) to Ring The Nasdaq Stock Market Opening Bell",," 2/03/2017 81257810 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Seattle Genetics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 â€“ SGEN",11/13/2019 IMMU-US  GNW  Immunomedics to Present at Upcoming Healthcare Conferences,10/02/2019 BIIB-US   GNW  Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZAÂ® (nusinersen) Published in Neuromuscular Disorders,"10/20/2011 IMGN-US  GNW  ImmunoGen, Inc. Earns Milestone With Start of SAR3419 Phase II Testing", 1/15/2020 BCRX-US  GNW  BioCryst Strengthens Commercial Rare Disease Leadership, 7/08/2015 07FYYR-E GNW  Nora Therapeutics Appoints Joseph L. Turner to Board of Directors," 7/21/2010 04004760 GNW  Liberty Analytics Co. Initiates Independent Research Coverage on Arena Pharmaceuticals, Inc."," 1/03/2020 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, FCAU, MYL, REAL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 4/18/2019 00972810 GNW  Akorn Receives FDA Approval for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)",10/05/2017 SAN-FR   GNW  Sanofi  : Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding PraluentÂ® (alirocumab),12/30/2019 AZN-GB   GNW  Myriad Receives FDA Approval of BRACAnalysis CDxÂ® as Companion Diagnostic for LynparzaÂ® (olaparib) In Patients with Germline BRCA-mutated Metastatic Pancreatic Cancer, 9/10/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi, 3/06/2019 MGTX-US  GNW  MeiraGTx to Present at the Barclays Global Healthcare Conference," 5/30/2018 45766930 GNW  Recent Analysis Shows Northwest Natural Gas, Brooks Automation, Insmed, Host Hotels & Resorts, Prospect Capital, and Inphi Market Influences â€” Renewed Outlook, Key Drivers of Growth", 3/04/2014 AUP-CA   GNW  Aurinia to Present at the 26th Annual ROTH Conference," 3/18/2020 ALGN-US   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS ALGN, INO, TLRY, WWE INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits", 9/23/2019 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR,, 2/14/2020 GERN-US  GNW  Pomerantz Law Firm Announces the Filing of a Class Action againstÂ Geron Corporation and Certain Officers â€“ GERN,,11/18/2019 AMRN-US  GNW  Amarin Highlights Key REDUCE-ITÂ®-Related Data Presented at American Heart Association 2019 Scientific Sessions, 9/21/2018 AGEN-US  GNW  XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte, 4/11/2016 UTHR-US  GNW  SteadyMed Announces Initiation of Inter Partes Review Proceedings by U.S. Patent and Trademark Office Against a United Therapeutics Patent,"10/24/2019 SRPT-US  GNW  Sarepta Therapeutics to Announce Third Quarter 2019 Financial Results and Recent Corporate Developments on November 7, 2019"," 2/19/2019 G0176710 GNW  CLASS ACTION UPDATE for GS, ALKS, MU and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,10/29/2019 AMAG-US  GNW  AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial, 2/29/2016 ARQL-US  GNW  ArQule Announces $15.3 Million Registered Direct Offering of Common Stock,,,, 2/18/2020 SAN-FR   GNW  Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine,11/21/2011 SEEL-US  GNW  Apricus Biosciences Announces Appointment of Dr. Kleanthis G. Xanthopoulos to Its Board of Directors, 5/29/2019 ALLO-US  GNW  Allogene Therapeutics Announces June 2019 Investor Conference Schedule, 8/14/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Second Quarter 2019 Financial Results and Business UpdateÂ Conference Call on August 28,," 8/31/2018 00422510 GNW  New Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, Hertz Global, and ACADIA Pharmaceuticals â€” Consolidated Revenues, Company Growth, and Expectations for 2018",10/15/2019 AFMD-US  GNW  Affimed Reports Progress on Key Clinical Development Programs,, 9/30/2019 PRQR-US  GNW  ProQR to Present at Two Investor Conferences in October," 4/24/2017 88338N10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017",10/31/2019 ZGNX-US  GNW  Zogenix to Release Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 7, 2/24/2020 ALLK-US  GNW  Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 AAAAI Annual Meeting,,11/09/2015 76133010 GNW  Revance Therapeutics Releases Third Quarter 2015 Results,,,11/20/2019 ADVM-US  GNW  Adverum Biotechnologies to Participate in Piper Jaffrayâ€™s 31st Annual Healthcare Conference,11/05/2019 RARE-US   GNW  Ultragenyx Reports Third Quarter 2019 Financial Results and Corporate Update, 3/28/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences, 3/28/2019 63009R10 GNW  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling, 9/19/2014 69329Y10 GNW  PDL BIOPHARMA -- Law Firm Announces Class Action Lawsuit Brought on Behalf of Shareholders to Recover Losses - PDLI,, 7/17/2019 RDUS-US  GNW  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), 8/09/2019 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),,,"11/02/2018 02043Q10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alnylam Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â ALNY", 5/10/2019 WVE-US   GNW  Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update,11/05/2019 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for Third Quarter 2019,, 6/26/2019 PCRX-US  GNW  New Retrospective Analysis Shows EXPAREL Associated with Significantly Less Opioid Use Following Third Molar Extraction, 7/23/2019 RTRX-US  GNW  Retrophin to Report Second Quarter 2019 Financial Results, 2/11/2019 PACB-US  GNW  Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results," 8/12/2019 28106W10 GNW  Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors", 7/25/2019 CHMA-US  GNW  Chiasma Announces Proposed Offering of Common Stock,"11/07/2019 55609910 GNW  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MGNX, ERI, and SNDL of Filing Deadlines",,, 3/24/2015 28249U10 GNW  Novasep and Celladon Execute MYDICAR API Supply Agreement, 7/30/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Fast Track Designation for M281 (nipocalimab) in Hemolytic Disease of the Fetus and Newborn (HDFN), 3/05/2019 PRTA-US  GNW  Prothena to Participate in Upcoming March Healthcare Conferences,"10/25/2019 ZLAB-US  GNW  Zai Lab Partner, MacroGenics, Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer",11/03/2015 SAGE-US  GNW  SAGE Announces Presentations at Upcoming November Investor Conferences,10/29/2019 CTMX-US  GNW  CytomX Therapeutics Announces Initiation of Phase 2 Clinical Trial Evaluating the Anti-PD-L1 Probody CX-072 in Combination with YERVOYÂ® in Patients with Relapsed or Refractory Melanoma, 9/13/2019 GMAB-DK  GNW  Detailed Results from the Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsing Multiple Sclerosis Presented at ECTRIMS, 3/28/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,," 7/31/2019 CBAY-US  GNW  CymaBay Therapeutics to Report Second Quarter 2019 Financial Results on Wednesday, August 7",10/02/2012 45781M10 GNW  Theravance and Alfa Wassermann Enter Into Agreement to Develop and Commercialize Velusetrag for Gastroparesis," 4/29/2019 CCXI-US  GNW  ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019",,, 8/07/2019 MNKD-US   GNW  MannKind Corporation Reports 2019 Second Quarter Financial Results and Recent Business Highlights, 1/23/2018 URGN-US  GNW  UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option,12/05/2019 CYTK-US  GNW  Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND,11/22/2019 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 5/20/2019 03236M20  GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm",, 5/14/2019 ACHN-US  GNW  Achillion Granted Twentieth Patent for Factor D Portfolio, 8/13/2019 SYNH-US  GNW  Syneos Health to Present at the 2019 Baird Global Healthcare Conference, 8/02/2019 FOLD-US  GNW  Amicus Therapeutics Receives Marketing Authorization for GalafoldÂ® (migalastat) for Fabry Disease in Argentina,,,10/03/2019 ADMA-US  GNW  ADMA Biologics Announces Poster Presentation at IDWeek 2019,"10/09/2019 GWPH-US  GNW  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Third Quarter Ending September 30, 2019 and Host Conference Call on November 5, 2019", 2/07/2018 EPZM-US  GNW  Epizyme to Participate in Leerink Partners 7th Annual Global Healthcare Conference,, 8/28/2019 MYOK-US  GNW  MyoKardia to Participate in September Investor Conferences,,11/09/2019 GLPG-NL  GNW  NEW  DATA  ON  FILGOTINIB IN  RHEUMATOID  ARTHRITIS  (RA)  DEMONSTRATE  DURABLE  EFFICACY  AND  SAFETY  PROFILE," 2/19/2020 FSCT-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,, 8/07/2019 CARA-US  GNW  Cara Therapeutics Reports Second Quarter 2019 Financial Results,11/11/2019 FLXN-US  GNW  Flexion Therapeutics Presents ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) Efficacy Data at the AAHKS and ACR Annual Meetings, 9/27/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences in October,11/13/2019 AGIO-US   GNW  Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares, 8/01/2019 IOVA-US  GNW  Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update, 8/08/2019 ANAB-US  GNW  AnaptysBio Announces Second Quarter 2019 Financial Results andÂ Provides Pipeline Updates,, 9/11/2019 FATE-US  GNW  Fate Therapeutics Announces Proposed Public Offering of Common Stock, 2/28/2018 HZNP-US  GNW  Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2017 Results,," 9/11/2019 ICPT-US  GNW   Intercept Launches NASHTRUTH.com, an Online Educational Resource for People with Advanced Fibrosis Due to NASH", 2/03/2020 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 9/25/2019 ITCI-US  GNW  Intra-Cellular Therapies Announces Progression to Higher Dose Cohort in ITI-214 Translational Medicine Study in Patients with Heart Failure,,,, 5/10/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019, 7/18/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering,, 2/12/2019 24983L10 GNW  Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab,11/04/2019 FOMX-US  GNW  Foamix Announces Publication of AMZEEQâ„¢ (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology," 5/01/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Reports First Quarter 2019 Results", 5/07/2019 SUPN-US  GNW  Supernus Announces First Quarter 2019 Financial Results,10/11/2019 FGEN-US  GNW  Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019," 7/24/2015 74587V10 GNW  SECURITIES ALERT: The Rosen Law Firm Reminds Puma Biotechnology Inc. Investors of the Important August 3, 2015 Deadline in the Class Action to Recover Investor Losses -- PBYI",10/18/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 5/29/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June,, 5/29/2019 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences," 7/10/2019 XBIT-US  GNW  XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board",,,11/06/2019 GBT-US   GNW  GBT Announces Upcoming Data Presentations at 61st American Society of Hematology Annual Meeting & Exposition,10/03/2017 RGNX-US  GNW  REGENXBIO to Present at Upcoming Investor Conferences,10/16/2019 KURA-US  GNW  Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 9/26/2019 APLS-US  GNW  Apellis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference,11/21/2019 AXSM-US  GNW  Axsome Therapeutics to Host Investor R&D Call with Key Opinion Leaders Focusing on AXS-07 and the Unmet Needs in the Acute Treatment of Migraine, 5/05/2019 VYGR-US  GNW  Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinsonâ€™s Disease at the American Academy of Neurology Annual Meeting,11/26/2019 BGNE-US  GNW  BeiGene to Present at the 31st Annual Piper Jaffray Healthcare Conference,, 6/04/2019 RETA-US  GNW  Reata Announces Presentations at the 56thÂ Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA),11/11/2019 HCM-GB   GNW  Chi-Med Announces NDA Acceptance in China for Surufatinib in Non-Pancreatic Neuroendocrine Tumors, 5/02/2019 NTLA-US  GNW  Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company Update, 6/28/2019 ACIU-US  GNW  AC Immune Announces Election of New Chairman of the Board at Annual General Meeting, 4/16/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia, 9/10/2019 GTHX-US  GNW  G1 Therapeutics to Present New Clinical Data Across Pipeline at European Society for Medical Oncology (ESMO) 2019 Congress, 8/09/2018 ARGX-BE  GNW  argenx to Present at 2018 Wedbush PacGrow Healthcare Conference, 7/25/2019 RUBY-US GNW  Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy,"10/24/2019 ATNX-US  GNW  Athenex, Inc. to Report Third Quarter 2019 Earnings Results on November 7, 2019"," 6/13/2019 71639T10 GNW  INVESTIGATION REMINDER for SWDBF/SWDBY, PETQ, VRNT and ZUO: Hagens Berman Reminds Investors of Ongoing Investigations", 9/03/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September, 6/19/2019 OPTN-US  GNW  Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal, 5/13/2019 TORC-US  GNW  resTORbio to Present RTB101 Phase 2b Clinical Trial Data at American Thoracic Society 2019 International Conference,11/08/2018 DNLI-US  GNW  Denali Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights and Announces the Appointment of Jennifer Cook to Board of Directors,,10/05/2018 SLDB-US  GNW  Solid Biosciences to Present at the Chardan Genetic Medicines Conference, 8/22/2019 EOLS-US  GNW  Evolus to Participate in Two Upcoming Investor Conferences," 6/17/2019 FIXX-US GNW  Homology Medicines Presents Data Showing Single Dose HMI-102 Resulted in Long-Term Correction of PKU, Including Reduction of Phe and Increased Brain Neurotransmitters in Murine Model",10/02/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQÂ® Now in Effect, 6/03/2019 SRRK-US  GNW  Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers," 5/29/2019 UBX-US   GNW  UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline",,, 1/02/2019 EIDX-US  GNW  Eidos Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference," 6/25/2018 AVRO-US  GNW  AVROBIO, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option",, 5/01/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Results From a Phase 1 Study of Its Novel Formulation of Diazepam,11/07/2019 AUTL-US  GNW  Autolus Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress,"11/05/2019 FTSV-US GNW  Forty Seven Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019",12/04/2018 TBIO-US  GNW  Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRTâ„¢),, 5/20/2019 PRNB-US GNW  Principia Presents Phase 1 Data of PRN1371 in Patients with Metastatic Bladder Cancer, 7/18/2019 ARVN-US GNW  Arvinas to Present Preclinical Tau-Directed PROTACÂ® Protein Degrader Data at Alzheimer's Association International Conference,10/28/2019 YMAB-US  GNW  Y-mAbs Announces Positive Omburtamab Clinical Data,, 5/30/2019 GRTS-US  GNW  Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting, 5/29/2019 GH-US    GNW  Guardant Health to Present at the William Blair 2019 Growth Stock Conference, 5/09/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc Reports First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress, 5/16/2019 NGM-US   GNW  NGM Bio Reports Recent Highlights and First Quarter 2019 Financial Results,,10/02/2019 ORTX-US  GNW  Orchard Therapeutics Announces Appointment of CEO Mark Rothera to The Alliance for Regenerative Medicineâ€™s 2020 Board of Directors,,12/05/2019 ALEC-US  GNW  Alector Announces FDA Fast Track Designation Granted to AL001 for the Treatment of Patients with Frontotemporal Dementia, 8/28/2019 DTIL-US GNW  Precision BioSciences to Present at Upcoming Investor Conferences, 9/05/2019 TPTX-US GNW  Turning Point Therapeutics Announces Pricing of Public Offering of Common Stock, 9/10/2019 PRVL-US GNW  Prevail Therapeutics Provides Program Update on PR001 in Parkinsonâ€™s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease,,,,,12/03/2019 0JVC6P-E GNW  BridgeBio Pharmaâ€™s Origin Biosciences Initiates Rolling Submission of New Drug Application with the U.S. FDA for BBP-870 for the Treatment of MoCD Type A," 8/07/2019 ADPT-US  GNW  Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattleâ€™s Growing Biotech Hub",
,"10/03/2019 74318710 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigations of Mergers",10/14/2013 PKI-US      GNW  Global Bioinformatics Market Report 2013-2017," 4/18/2013 84763A10 GNW  The O'Mara Law Firm Files Class Action Suit Against Spectrum Pharmaceuticals, Inc. and Reminds Investors of Lead Plaintiff Deadline", 9/25/2017 G3040110 GNW  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm,"11/14/2014 04280A10 GNW  Important Reminder to Shareholders of Arrowhead Research Corporation of Upcoming Lead Plaintiff Deadline on December 9, 2014", 7/09/2019 BDSI-US  GNW  BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCAÂ®,," 4/03/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Appointment of Catherine Stehman-Breen, M.D., M.S. as Chief Medical Officer",10/04/2018 SIGA-US      GNW  SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXXÂ® as a Post-Exposure Prophylactic for Smallpox, 7/01/2019 OPK-US   GNW  OPKO Healthâ€™s BioReference Laboratories Forms a Strategic Collaboration With SOMOS to Improve Health Outcomes of Underserved New Yorkers, 8/06/2019 46222210 GNW  Akcea Reports Financial Results and Highlights for Second Quarter 2019, 8/04/2016 BMRN-US     GNW  BioMarin Announces Second Quarter 2016 Financial Results," 9/09/2015 ALXN-US  GNW  Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) to Ring The Nasdaq Stock Market Closing Bell",, 1/27/2017 81257810 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Seattle Genetics Inc. ofÂ Class Action Lawsuit and Upcoming Deadline â€“ SGEN,10/30/2019 IMMU-US  GNW  Immunomedics Reports Third Quarter 2019 Results and Provides Corporate Update,10/01/2019 BIIB-US   GNW  Biogen Announces Leadership Update,"10/13/2011 45253H10 GNW  ImmunoGen, Inc. Announces Webcast of Presentation at the 18th Annual NewsMakers in the Biotech Industry Conference", 1/12/2020 BCRX-US  GNW  BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference, 3/14/2014 37555810 GNW  Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe, 7/02/2010 04004760 GNW  Arena Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com,"12/30/2019 N5946510 GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, FCAU, MYL, REAL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 4/17/2019 00972810 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akorn, Inc.", 8/23/2017 ONVO-US  GNW  Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease,"12/19/2019 MYGN-US  GNW  Myriad Geneticsâ€™ Board Member, S. Louise Phanstiel, Recognized by WomenInc. Magazine in 2019 List of Most Influential Corporate Directors", 9/10/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting, 2/27/2019 MGTX-US  GNW  MeiraGTx Announces $80 Million Private Placement of Ordinary Shares, 5/22/2018 INSM-US  GNW  Insmed Announces Presentations at the American Thoracic Society 2018 International Conference, 2/25/2014 AUP-CA   GNW  Aurinia to Present at the 34th Annual Cowen Health Care Conference," 3/18/2020 INO-US    GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO"," 9/20/2019 64026810 GNW  Nektar Therapeutics (NKTR), Pluralsight, Inc. (PS)Â & Burford Capital Limited (BRFRF, BRFRY) Class Action Reminder - Bronstein, Gewirtz & Grossman, LLC",," 2/12/2020 BYND-US  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qudian, Geron Corporation, Opera Limited, and Beyond Meat and Encourages Investors to Contact the Firm",,11/18/2019 09ZV3Y-E GNW  Amarinâ€™s John Thero Awarded EY Entrepreneur of The YearÂ® 2019 Life Sciences National Award, 9/11/2018 INCY-US  GNW  Idera Pharmaceuticals Announces Corporate Organizational Changes,12/08/2015 PSTI-IL  GNW  Pluristem and United Therapeutics End Licensing Agreement;Â Report Positive Data in Pulmonary Arterial Hypertension,"10/15/2019 80360710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Valaris, Sarepta Therapeutics, Canada Goose, and Meredith Corporation and Encourages Investors to Contact the Firm"," 2/18/2019 G0176710 GNW  CLASS ACTION UPDATE for YRIV, ALKS, ASTE and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,10/25/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology," 2/15/2016 ARQL-US  GNW  ArQule to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016",,,, 2/06/2020 SAN-FR   GNW  Sanofi delivers strong 2019 business EPS growth of 6.8% at CER,11/09/2011 0BGXN5-E GNW  LaVoie Group Named One of Fastest Growing Private Companies in the US by Inc. Magazine, 5/07/2019 ALLO-US  GNW  Allogene Therapeutics Reports First Quarter 2019 Financial Results, 7/29/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in August Investor Conferences,," 8/29/2018 00422510 GNW  CLASS ACTION UPDATE for ACAD and TTPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 8/28/2019 AFMD-US  GNW  Affimed to Participate in Investor Conferences in September,, 9/09/2019 PRQR-US  GNW  ProQR Receives Fast Track Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa," 4/20/2017 88338N10 GNW  IMPORTANT THERAPEUTICSMD, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Florida against TherapeuticsMD, Inc.",10/25/2019 ZGNX-US  GNW  Zogenix Announces New Positive Data for Its Investigational Drug FINTEPLAÂ®  in Dravet Syndrome," 2/19/2020 ALLK-US  GNW  ROSEN, NATIONAL TRIAL LAWYERS, Continues to Investigate Securities Claims Against Allakos Inc. â€“ ALLK",,11/09/2015 76133010 GNW  Revance Therapeutics Announces Closing of Public Offering of Common Stock,,,"11/11/2019 00773U10 GNW  Adverum Biotechnologies Shareholder Alert â€“ Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM",10/30/2019 RARE-US   GNW  Ultragenyx to Host Conference Call for Third Quarter 2019 Financial Results and Corporate Update, 3/07/2019 AGLE-US  GNW  Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights, 3/27/2019 NSTG-US  GNW  NanoString Announces Commercial Launch of GeoMx Digital Spatial Profiler at the 2019 American Association of Cancer Research Conference," 9/18/2014 69329Y10 GNW  Pomerantz Law Firm Announces the Filing of a Class Action Against PDL BioPharma, Inc. and Certain Officers -- PDLI",, 6/04/2019 RDUS-US  GNW  Radius Health to Present at Goldman Sachs 40th Annual Global Healthcare Conference," 8/07/2019 ASMB-US  GNW  Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer",,,"11/02/2018 02043Q10 GNW  CLASS ACTION UPDATE for ABBV, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/16/2019 WVE-US   GNW  Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design,11/01/2019 AKCA-US  GNW  Akcea Recognizes Landmark Year for Familial Chylomicronemia Syndrome (FCS) Community with Commemoration of 2nd Annual FCS Awareness Day,, 6/25/2019 PCRX-US  GNW  Pacira BioSciences Announces Validation of EXPAREL Marketing Authorization Application from European Medicines Agency, 6/28/2019 RTRX-US  GNW  Retrophin Announces FDA Approval of THIOLAÂ® EC (tiopronin) 100mg and 300mg Tablets for the Treatment of Cystinuria,"12/12/2018 69404D10 GNW  Wolf Haldenstein Adler Freeman & Herz  LLP announces that it has filed a class action complaint in the United States District Court for the Northern District of California on behalf of holders of  Pacific Biosciences of California, Inc.", 8/06/2019 EDIT-US  GNW  Editas Medicine Announces Second Quarter 2019 Results and Update, 7/23/2019 CHMA-US  GNW  Chiasma Announces Positive Phase 3 Top-Line Results from CHIASMA OPTIMAL Clinical Trial of MycapssaÂ® for the Maintenance Treatment of Adults with Acromegaly,11/06/2019 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results,,, 3/16/2015 28249U10 GNW  Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 7/19/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast," 2/14/2019 PRTA-US  GNW  Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update","10/24/2019 ZLAB-US  GNW  Zai Lab Partner, GSK, Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer","10/29/2015 SAGE-US  GNW  SAGE to Report Third Quarter 2015 Financial Results on Thursday, November 5, 2015",10/24/2019 CTMX-US  GNW  CytomX Therapeutics to Announce Third Quarter 2019 Financial Results, 9/09/2019 0GNC1Z-E GNW  Genmab and Tempus Enter into Strategic Collaboration Agreement," 3/27/2019 92165910 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm",, 6/18/2019 CBAY-US  GNW  CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar to Treat Primary Sclerosing Cholangitis, 9/26/2012 INVA-US  GNW  GSK and Theravance Announce FDA Acceptance of FF/VI New Drug Application (NDA) Submission in the US for COPD, 4/02/2019 CCXI-US  GNW  ChemoCentryx to Present at the H.C. Wainwright Global Life Sciences Conference,,, 8/05/2019 MNKD-US   GNW  MannKind and One Drop Sign Collaboration Agreement to Integrate Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform, 1/18/2018 URGN-US  GNW  UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares,11/27/2019 CYTK-US  GNW  Cytokinetics to Participate in the Piper Jaffray Healthcare Conference,11/17/2019 ESPR-US     GNW  Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Clinical Development Program of Bempedoic Acid Presented at the American Heart Association 2019 Scientific Sessions," 5/20/2019 03236M20  GNW  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 5/09/2019 ACHN-US  GNW  Achillion Reports First Quarter 2019 Financial Results, 8/06/2019 SYNH-US  GNW  Syneos Health Reports Second Quarter 2019 Results, 8/01/2019 FOLD-US  GNW  Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease,,, 9/23/2019 ADMA-US  GNW  ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference," 9/24/2019 0JBRH7-E GNW  GW Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2nd, 2019",12/11/2017 EPZM-US  GNW  Epizyme Presents Preclinical Data on Novel G9a Program and Introduces Next Drug Development Candidate at the American Society of Hematology Annual Meeting,, 8/26/2019 MYOK-US  GNW  MyoKardia Announces Abstracts Selected for Presentation at the European Society of Cardiology Congress 2019,,11/06/2019 GLPG-NL  GNW  Galapagos increases share capital through warrant exercise by Gilead," 2/19/2020 PTLA-US  GNW  PTLA DEADLINE: Pawar Law Group Reminds Investors of March 16 Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc.â€“ PTLA",,,," 7/31/2019 CARA-US  GNW  Cara Therapeutics to Announce Second Quarter 2019 Financial Results on August 7, 2019",11/07/2019 FLXN-US  GNW  Flexion Therapeutics Reports Third-Quarter 2019 Financial Results and Recent Business Highlights, 9/05/2019 QURE-US  GNW  uniQure Announces Pricing of its Public Offering,11/07/2019 AGIO-US   GNW  Agios Announces Pricing of $256 Million Public Offering of Common Stock," 7/26/2019 IOVA-US  GNW  Iovance Biotherapeutics to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1, 2019", 8/06/2019 ANAB-US  GNW  AnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference,," 9/03/2019 FATE-US  GNW  Fate Therapeutics Announces FDA Clearance of IND Application for FT596 Off-the-Shelf, iPSC-derived CAR NK Cell Cancer Immunotherapy", 2/27/2018 HZNP-US  GNW  Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTIÂ® (glycerol phenylbutyrate) Oral Liquid to Expand Age Range to Include Newborns,," 9/09/2019 ICPT-US  GNW  Intercept Appoints Lisa DeFrancesco as Vice President, Investor Relations", 1/13/2020 KPTI-US    GNW  Karyopharm Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Product Sales for XPOVIOÂ® (selinexor) and Provides Commercial Update,,, 9/10/2019 ITCI-US  GNW  Intra-Cellular Therapies Provides Lumateperone Regulatory Update,,,," 5/09/2019 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019", 7/18/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Proposed Offering of Common Stock,,12/11/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/01/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 11," 4/11/2019 69354M10 GNW  Research Report Identifies Spirit Aerosystems, The Descartes Systems Group, Lantheus, Quanex Building Products, News Corporation, and PRA Health Sciences with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 4/24/2019 SUPN-US  GNW  Supernus to Host First Quarter 2019 Earnings Conference Call,"10/07/2019 FGEN-US  GNW  FibroGen Congratulates Dr. William G. Kaelin, Jr., Scientific Advisory Board Member, on Receipt of the 2019 Nobel Prize in Physiology or Medicine", 7/10/2015 74587V10 GNW  EQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Against Puma Biotechnology Inc. to Recover Investor Losses - PBYI,10/15/2019 CHRS-US  GNW  Coherus BioSciences to Report Third Quarter Financial Results on November 6th, 5/28/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting,, 5/08/2019 COLL-US  GNW  Collegium Reports First Quarter 2019 Financial Results, 7/09/2019 XBIT-US  GNW  Medical Research Council Funds Phase 2 Multi-Center Study of XBiotechâ€™s Bermekimab in Advanced Cancer Patients,,,11/04/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants,10/02/2017 75901B10 GNW  REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension Therapeutics,10/15/2019 KURA-US  GNW  Kura Oncology Expands Board of Directors with Appointment of Diane Parks, 9/18/2019 APLS-US  GNW  Phase 2 Study Published in Ophthalmology Highlights Efficacy and Safety Data of Intravitreal APL-2 for Geographic Atrophy Secondary to Age-Related Macular Degeneration,11/07/2019 AXSM-US  GNW  Axsome Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update, 4/29/2019 VYGR-US  GNW  Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting,11/23/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on Tislelizumab Presented at European Society for Medical Oncology (ESMO) Asia 2019 Congress,, 5/30/2019 RETA-US  GNW  Reata Announces First Patient Enrolled in Phase 3 FALCON Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease,10/17/2019 HCM-GB   GNW  Chi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancers, 4/29/2019 NTLA-US  GNW  Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy, 6/27/2019 ACIU-US  GNW  AC Immune to Host Key Opinion Leader Meeting on Treating Alzheimerâ€™s in Down Syndrome, 4/01/2019 CRSP-US  GNW  CRISPR Therapeutics to Participate in Upcoming Investor Conferences," 9/03/2019 GTHX-US  GNW  G1 Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference on September 9, 2019", 6/28/2018 ARGX-BE  GNW  argenx receives second preclinical milestone payment under its development agreement with AbbVie, 6/05/2019 RUBY-US GNW  Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs, 9/23/2019 ATNX-US  GNW  Athenex Completes Construction of New API Facility in Chongqing," 5/22/2019 PETQ-US  GNW  PetIQ, Inc. to Participate in Upcoming Investor Conferences", 8/07/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities, 5/09/2019 OPTN-US  GNW  Optinose Reports First Quarter 2019 Financial ResultsÂ and Recent Operational Highlights, 5/09/2019 TORC-US  GNW  resTORbio Announces Initiation of Phase 3 Clinical Program of RTB101 in Clinically Symptomatic Respiratory Illness,11/01/2018 DNLI-US  GNW  Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases,,10/01/2018 SLDB-US  GNW  Solid Biosciences to Present at the Cell & Gene Meeting on the Mesa, 8/12/2019 EOLS-US  GNW  Evolus Reports Second Quarter 2019 Financial Results, 6/13/2019 FIXX-US GNW  Homology Medicines to Present at JMP Securities Life Sciences Conference, 9/27/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces YUTIQÂ® Presentations at the American Academy of Ophthalmology 2019 Annual Meeting, 5/28/2019 SRRK-US  GNW  Scholar Rock to Present at the Jefferies 2019 Global Healthcare Conference," 5/23/2019 UBX-US   GNW  UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences",,,12/06/2018 EIDX-US  GNW  Eidos Therapeutics Appoints William Lis to Board of Directors," 6/20/2018 AVRO-US  GNW  AVROBIO, Inc. Announces Pricing of Initial Public Offering",, 4/26/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/06/2019 AUTL-US  GNW  Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 61st ASH Annual Meeting, 9/27/2019 FTSV-US GNW  Forty Seven Inc. to Present at 2019 Cantor Global Healthcare Conference,11/08/2018 TBIO-US  GNW  Translate Bio Announces Third Quarter 2018 Financial Results and Reviews Recent Highlights,," 5/14/2019 PRNB-US GNW  Principia Biopharma Announces First Patient Dosed in Sanofiâ€™s Phase 2b Trial of SAR442168 in Multiple Sclerosis, Triggering $30 Million Milestone"," 6/25/2019 ARVN-US GNW  Arvinas Receives Authorization to Proceed for ARV-471, a PROTACÂ® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+ / HER2- Breast Cancer",10/25/2019 YMAB-US  GNW  Y-mAbs Announces Naxitamab Update,, 5/13/2019 GRTS-US  GNW  Gritstone Oncology Reports First Quarter 2019 Financial Results and Recent Highlights, 5/23/2019 GH-US    GNW  Guardant Health Announces Pricing of Public Offering of Common Stock, 5/06/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc Announces Positive Topline Results of Phase III Clinical Trials of RVL-1201 (â€œRVLâ€) for Acquired Blepharoptosis (ptosis or droopy eyelid), 4/08/2019 NGM-US   GNW  NGM Bio Announces Multiple Presentations at The International Liver Congressâ„¢ 2019,, 9/30/2019 ORTX-US  GNW  Orchard Therapeutics Announces Presentation of New Clinical Data for OTL-200 for Metachromatic Leukodystrophy at Upcoming European Society of Gene & Cell Therapy Annual Congress,,"12/04/2019 ALEC-US  GNW  Alector to Host R&D Day on December 13, 2019", 8/14/2019 DTIL-US GNW  Precision BioSciences Reports Second Quarter 2019 Financial Results and Highlights Ongoing Operational Progress, 9/03/2019 TPTX-US GNW  Turning Point Therapeutics Announces Proposed Public Offering of Common Stock, 9/04/2019 PRVL-US GNW  Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare Conference,,,,,11/27/2019 BBIO-US  GNW  BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)," 8/01/2019 ADPT-US  GNW  Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019",
,"10/02/2019 74318710 GNW  Progenics Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Progenics Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm â€“ PGNX","10/18/2012 ILMN-US     GNW  Complete Genomics Announces Court's Favorable Ruling in Patent Litigation Against Illumina, Inc."," 4/05/2013 84763A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- SPPI"," 9/14/2017 G3040110 GNW  The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Endo International plc Shareholders and a Lead Plaintiff Deadline of October 17, 2017 (ENDP)","11/12/2014 04280A10 GNW  ARWR INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR", 6/24/2019 BDSI-US  GNW  BioDelivery Sciences Expands Upon Report from Pain Management Task Force,,11/15/2016 75886F10 GNW  Merus Announces Favorable Decisions in Europe and Japan for Patents Covering Genetically-Modified Mice for Common Light Chain Human Monoclonal Antibodies," 9/27/2018 SIGA-US      GNW  SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018", 7/01/2019 OPK-US   GNW  BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers, 8/06/2019 46222210 GNW  Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRAÂ® (volanesorsen) in Patients with Familial Partial Lipodystrophy," 7/27/2016 BMRN-US     GNW  FDA Accepts BLA for BioMarinâ€™s Cerliponase Alfa for CLN2 Disease, Form of Batten Disease"," 9/26/2013 ALXN-US  GNW  Datto, Inc. LLC Named Connecticut's Fastest Growing Technology Company as Marcum LLP and The Connecticut Technology Council Name Tech Top 40 Winners",," 1/27/2017 81257810 GNW  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Seattle Genetics, Inc. (SGEN) and Lead Plaintiff Deadline: March 13, 2017","10/23/2019 IMMU-US  GNW  Immunomedics to Report Third Quarter 2019 Results and Host Conference Call and Webcast on October 30, 2019"," 9/23/2019 BIIB-US   GNW  Interferon Beta Treatments, Including PLEGRIDYÂ® (peginterferon beta-1a) and AVONEXÂ® (interferon beta-1a), Receive Positive CHMP Opinion for Use During Pregnancy and Breastfeeding", 9/24/2011 45253H10 GNW  T-DM1 Significantly Improved Progression-Free Survival Compared to Standard of Care for Previously Untreated HER2-Positive Metastatic Breast Cancer, 1/06/2020 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4),12/09/2013 GILD-US  GNW  Idenix Pharmaceuticals Announces Declaration of Senior Party in a Second Patent Interference by the USPTO," 6/24/2010 04004760 GNW  Emerging Stock Report Initiates Independent Research Coverage on Arena Pharmaceuticals, Inc.","12/27/2019 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",," 4/15/2019 00972810 GNW  AKORN APRIL 22nd DEADLINE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important Deadline in Securities Class Action Lawsuit Filed by the Firm â€“ AKRX", 4/25/2017 CHRS-US  GNW  Coherus BioSciences Completes Patent Dance Exchange with Amgen for Neulasta Biosimilar,12/14/2019 MYGN-US  GNW  Myriadâ€™s Polygenic Risk Score Personalizes Risk of Breast CancerÂ for Woman with a Genetic Mutation in Important Breast Cancer Genes, 8/30/2019 LXRX-US  GNW  Lexicon Pharmaceuticals To Present At Upcoming Investor Conference," 2/21/2019 MGTX-US  GNW  MeiraGTx Appoints Martin Indyk, Ph.D. to Board of Directors", 5/17/2018 MRK-DE   GNW  Insmed Appoints Leo Lee to its Board of Directors, 2/19/2014 AUP-CA   GNW  Aurinia Announces Management Change and Grant of Stock Options," 3/17/2020 AAN-US    GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AAN, BDX, FLR and INO", 9/20/2019 64026810 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nektar Therapeutics,," 2/11/2020 37416310 GNW  DEADLINE ALERT for GDOT,Â  MHK, Â GERN and OPRA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders",,11/14/2019 AMRN-US  GNW  Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of VascepaÂ® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-ITÂ® Outcomes Trial," 8/10/2018 45337C10 GNW  New Research: Key Drivers of Growth for United Rentals, DISH Network, Terex, Plains Group Holdings, The Hain Celestial Group, and Incyte â€” Factors of Influence, Major Initiatives and Sustained Production",12/07/2015 91307C10 GNW  SteadyMed Demonstrates Potential for Reduced Infusion Site Sensitivity Associated With Trevyent Compared to Remodulin,"10/15/2019 80360710 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT", 2/15/2019 G0176710 GNW  ALKS FEBRUARY 25th DEADLINE: Rosen Law Firm Reminds Alkermes Public Limited Company Investors of Important Deadline in Securities Class Action â€“ ALKS,,"10/24/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Friday, November 1, 2019 at 8:00 a.m. ET", 2/04/2016 ARQL-US  GNW  ArQule to Present at Upcoming Investor Conferences,,,, 2/06/2020 SAN-FR   GNW  Sanofi : Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis,11/16/2010 VRTX-US  GNW  OCZ Technology to Deliver Optimized Vertex Plus and Colossus Plus Solid-State Drive Solutions, 5/01/2019 ALLO-US  GNW  Allogene Therapeutics Announces Expansion of Scientific Advisory Board, 7/18/2019 ASND-US  GNW  Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransConâ„¢ CNP in Children with Achondroplasia,, 8/24/2018 00422510 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â ACAD, 8/07/2019 AFMD-US  GNW  Affimed Reports Second Quarter 2019 Financial and Operational Results,, 8/12/2019 PRQR-US  GNW  ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)," 4/20/2017 88338N10 GNW  TXMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017",10/21/2019 ZGNX-US  GNW  Zogenix Announces Presentation of New Data for FINTEPLAÂ® for the Treatment of Dravet Syndrome at the Child Neurology Society Annual Meeting," 2/05/2020 01671P10 GNW  ALLK ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Allakos Inc. â€“ ALLK",,11/04/2015 76133010 GNW  Revance Therapeutics to Present at Credit Suisse 24th Annual Healthcare Conference,,,11/07/2019 ADVM-US  GNW  Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2019 Financial Results,10/14/2019 RARE-US   GNW  Ultragenyx Announces FDA Accepts New Drug Application for UX007 (triheptanoin) for Treatment of Long-chain Fatty Acid Oxidation Disorders, 2/28/2019 AGLE-US  GNW  Aeglea BioTherapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights Conference Call, 3/26/2019 NSTG-US  GNW  NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference,,, 5/10/2019 RDUS-US  GNW  Radius Health to Present at Bank of America Merrill Lynch Health Care Conference 2019, 8/05/2019 ASMB-US  GNW  Assembly Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights,,,"10/31/2018 02043Q10 GNW  CLASS ACTION UPDATE for ALNY and CPB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/12/2019 WVE-US   GNW  Wave Life Sciences to Host Investor Conference Call to Discuss Suvodirsen DMD Clinical Data Being Presented at MDA Clinical and Scientific Conference,10/23/2019 AKCA-US  GNW  Akcea Announces Appointment of New Chief Commercial Officer,," 6/19/2019 PCRX-US  GNW  Pacira BioSciences Appoints Former Johnson & Johnson Executive, Max Reinhardt, as President", 6/18/2019 RTRX-US  GNW  Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome,"12/10/2018 69404D10 GNW  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm", 8/06/2019 EDIT-US  GNW  Editas Medicine Appoints Cynthia Collins as President and Chief Executive Officer, 6/27/2019 CHMA-US  GNW  Chiasma Set to Join Russell 3000Â® Index,11/06/2019 MGNX-US  GNW  MacroGenics Announces Flotetuzumab Presentations at the ASH Annual Meeting 2019,,, 2/03/2015 28249U10 GNW  Celladon Corporation to Present at the BIO CEO & Investor Conference, 6/19/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation, 2/04/2019 PRTA-US  GNW  Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14,"10/04/2019 ZLAB-US  GNW  Dr. Samantha Du, Zai Lab Founder and CEO, to Participate in Forbes Global CEO Conference",10/08/2015 SAGE-US  GNW  SAGE to Present Data at Upcoming Scientific Conferences,10/18/2019 CTMX-US  GNW  CytomX Therapeutics Announces New Employment Inducement Grants, 8/30/2019 GMAB-DK  GNW  Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Sclerosis Studies, 3/26/2019 92165910 GNW  SHAREHOLDER ALERT: STMP VNDA USX CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 6/17/2019 CBAY-US  GNW  CymaBay Therapeutics to Participate in the Raymond James Life Sciences and MedTech Conference, 8/29/2012 45781M10 GNW  Theravance to Present at the Morgan Stanley Global Healthcare Conference," 3/28/2019 CCXI-US  GNW  ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors",,," 8/01/2019 MNKD-US   GNW  MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019", 1/16/2018 URGN-US  GNW  UroGen Pharma Announces Proposed Public Offering of Ordinary Shares,11/26/2019 CYTK-US  GNW  Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND,11/12/2019 ESPR-US     GNW  Esperion Announces Publication in the Journal of the American Medical Association of Bempedoic Acid Phase 3 Study 2 Results, 5/20/2019 AMRS-US   GNW  Amyris Announces Receipt of $10 Million Payment from LAVVAN for Delivering on First Major CBD Milestone,," 4/04/2019 00448Q20 GNW  Report: Developing Opportunities within Mattel, Achillion Pharmaceuticals, Celgene, Adesto Technologies, New Residential Investment, and Entegris â€” Future Expectations, Projections Moving into 2019", 8/01/2019 SYNH-US  GNW  Syneos Health CEO Alistair Macdonald Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine," 7/29/2019 FOLD-US  GNW  Amicus Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019",,, 8/22/2019 ADMA-US  GNW  ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAMÂ®," 9/23/2019 GWPH-US  GNW  GW Pharmaceuticals receives European Commission approval for EPIDYOLEXÂ® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy",12/10/2017 EPZM-US  GNW  Epizyme Presents New Biomarker Data on Tazemetostat at the American Society of Hematology Annual Meeting,, 8/21/2019 MYOK-US  GNW  MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy,,11/01/2019 GLPG-NL  GNW  Gilead delivers exercise notice to Galapagos for Initial Warrant A to increase ownership to 25.1%," 2/18/2020 FSCT-US  GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of FSCT, MAT, PTLA and TCNNF",,,, 7/29/2019 CARA-US  GNW  Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,11/01/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4), 9/04/2019 QURE-US  GNW  uniQure Announces Proposed Public Offering,11/06/2019 AGIO-US   GNW  Agios Announces Proposed Offering of Common Stock," 7/18/2019 IOVA-US  GNW  Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein, M.D., as Chief Medical Officer", 6/05/2019 ANAB-US  GNW  AnaptysBio Presents Updated Data from Etokimab Phase 2a Proof-of-Concept Clinical Trial in Severe Eosinophilic Asthma,, 8/29/2019 FATE-US  GNW  Fate Therapeutics to Present at 2019 Wells Fargo Healthcare Conference, 2/26/2018 HZNP-US  GNW  Horizon Pharma Gift Establishes First Clinical Team Endowment at Childrenâ€™s National Rare Disease Institute,, 8/23/2019 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences in September, 1/07/2020 KPTI-US    GNW  Karyopharm to Present at the 38th Annual J.P. Morgan Healthcare Conference,,, 8/07/2019 ITCI-US  GNW  Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results,,,," 5/06/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019", 7/16/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Plan to Initiate Tab-celÂ® FDA Biologics License Application Submission Next Year,,12/04/2018 DERM-US  GNW  Dermira Enters into Credit Facility with Athyrium Capital Management,10/23/2019 FOMX-US  GNW  Foamix Enters Into Manufacturing and Supply Agreement For AMZEEQâ„¢ and FMX103, 4/09/2019 PRAH-US  GNW  PRA Health Sciences to Report First Quarter 2019 Earnings," 4/01/2019 SUPN-US  GNW  Supernus Announces Webcast of Investor Day on April 16, 2019", 9/30/2019 FGEN-US  GNW  FibroGen Receives One of China Pharmaceutical Industryâ€™s Highest Awards for Clinical Innovation for Roxadustat," 6/22/2015 74587V10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Puma Biotechnology, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 3, 2015 -- PBYI", 9/20/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 5/15/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May,, 4/30/2019 COLL-US  GNW  Collegium to Participate in Upcoming Investor Conferences," 6/26/2019 XBIT-US  GNW  XBiotech Wins â€œCommercial Real Estate Award for Industrial Developmentâ€ for its Headquarters in Austin, Texas",,,10/21/2019 GBT-US   GNW  GBT Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with Sickle Cell Disease Treated with Voxelotor,10/02/2017 75901B10 GNW  Dimension Board Determines that Ultragenyxâ€™s Unsolicited ProposalÂ to Acquire Dimension for $6.00 Per Share Constitutes a â€œSuperior Proposalâ€, 9/16/2019 KURA-US  GNW  Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia, 9/16/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes,"10/29/2019 AXSM-US  GNW  Axsome Therapeutics to Report Third Quarter 2019 Financial Results on November 7, 2019", 4/15/2019 VYGR-US  GNW  Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting,11/14/2019 BGNE-US  GNW  U.S. FDA Grants BeiGeneâ€™s BRUKINSAâ„¢ (zanubrutinib) Accelerated Approval to Treat Adult Patients with Mantle Cell Lymphoma Who Received at Least One Prior Therapy,," 5/09/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results and an Update on Development Programs",10/10/2019 HCM-GB   GNW  Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors, 4/25/2019 NTLA-US  GNW  Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company Update, 6/20/2019 ROG-CH   GNW  AC Immune Reports Initiation of a Phase 2 Substudy to Increase Understanding of Disease Progression in Familial Alzheimerâ€™s Disease, 3/06/2019 CRSP-US  GNW  CRISPR Therapeutics to Participate in Upcoming Investor Conferences, 8/07/2019 GTHX-US  GNW  G1 Therapeutics Provides Second Quarter 2019 Corporate and Financial Update, 6/20/2018 ARGX-BE  GNW  argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris, 5/28/2019 RUBY-US GNW  Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference, 9/23/2019 ATNX-US  GNW  Athenex to Present at the 2019 San Antonio Breast Cancer Symposium," 5/21/2019 PETQ-US  GNW  PetIQ, Inc. Announces Grand Opening of VetIQ Location with Meijer", 7/29/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results," 4/25/2019 OPTN-US  GNW  Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019", 5/01/2019 TORC-US  GNW  resTORbio to Participate at Upcoming Investor Conferences in May,10/03/2018 DNLI-US  GNW  CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials,," 9/13/2018 SLDB-US  GNW  Solid Biosciences Welcomes Sukumar Nagendran, M.D., To Its Board Of Directors"," 8/01/2019 EOLS-US  GNW  Evolus to Report Second Quarter 2019 Financial Results and Provide a Business UpdateÂ on Monday, August 12, 2019", 6/10/2019 FIXX-US GNW  Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU and Expects Initial Clinical Results by Year End 2019, 9/26/2019 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference, 5/14/2019 SRRK-US  GNW  Scholar Rock Reports First Quarter 2019 Financial Results and Highlights Business Progress," 5/08/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Reports First Quarter 2019 Financial Results",,,11/14/2018 EIDX-US  GNW  Eidos Therapeutics to Present at Two Upcoming Investor Conferences,,, 3/29/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),11/05/2019 AUTL-US  GNW  Autolus Therapeutics to Present Preclinical Data on AUT06NG at theÂ SITC Annual Meeting, 9/03/2019 FTSV-US GNW  Forty Seven Inc. to Present at Morgan Stanley 17th Annual Global Healthcare Conference,11/01/2018 TBIO-US  GNW  Translate Bio to Participate in Upcoming Investor Conferences,, 5/09/2019 PRNB-US GNW  Principia Biopharma to Present at the 2019 Bank of America Merrill Lynch Health Care Conference, 6/20/2019 ARVN-US GNW  Arvinas to Present at the BMO Prescriptions for Success Healthcare Conference, 8/30/2019 YMAB-US  GNW  Y-mAbs Announces Data to be Presented at 2019 CTOS,, 4/24/2019 GRTS-US  GNW  Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock," 5/20/2019 GH-US    GNW  Guardant Health, Inc. Announces Proposed Public Offering of Common Stock"," 5/02/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Provide First Quarter 2019 Business and Financial Update on May 9, 2019", 4/03/2019 NGM-US   GNW  NGM Bio Announces Pricing of Initial Public Offering,, 9/25/2019 ORTX-US  GNW  Orchard Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa,,11/14/2019 ALEC-US  GNW  Alector to Present at the Jefferies 2019 London Healthcare Conference, 7/18/2019 DTIL-US GNW  Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States," 9/03/2019 TPTX-US GNW  Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib and Preclinical Data for TPX-0046, a Novel RET/SRC Inhibitor", 8/14/2019 PRVL-US GNW  Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights,,,,,11/16/2019 10806X10 GNW  CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures, 7/31/2019 ADPT-US  GNW  Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers,
," 9/18/2019 PGNX-US  GNW  Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution", 9/17/2012 09X295-E    GNW  Station X Closes Second Round of Equity Financing to Accelerate Commercial Launch," 3/29/2013 84763A10 GNW  Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Spectrum Pharmaceuticals, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 13, 2013 Lead Plaintiff Deadline -- SPPI"," 9/12/2017 G3040110 GNW  ENDP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of October 17, 2017","11/06/2014 04280A10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit --- ARWR", 6/20/2019 BDSI-US  GNW  BioDelivery Sciences Named to the Russell 3000Â® Index,," 7/26/2016 CLSD-US  GNW  Clearside Biomedical, Inc. Announces Patient Treatment Comparison from the Phase 2 Trial (TANZANITE) in Patients with Macular Edema Associated with Retinal Vein Occlusion"," 9/17/2018 SIGA-US      GNW  SIGA Technologies to Host Business Update Webcast on September 27, 2018", 6/28/2019 OPK-US   GNW  Novitas Issues Proposed Local Coverage Determination for the 4KscoreÂ® Test, 7/16/2019 IONS-US  GNW  hATTR Compassâ„¢ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch, 7/27/2016 BMRN-US     GNW  BioMarin Provides Positive Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A in Late Breaking Oral Presentation at the World Federation of Hemophilia (WFH) 2016 World Congress," 8/13/2013 ROG-US   GNW  Connecticut Technology Council and Marcum LLP Announce Marcum 2013 Tech Top 40 Winners, Focusing on Innovation and Economic Growth",, 1/19/2017 81257810 GNW  SEATTLE GENETICS INC.  INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Western District of Washington against Seattle Genetics Inc.,"10/04/2019 45290710 GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm", 9/18/2019 09062X10  GNW  Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study Evaluating a Higher Dose of SPINRAZAÂ® (nusinersen) and Additional Data in a Broad Range of Patients," 9/22/2011 45253H10 GNW  ImmunoGen, Inc. Announces Submission of IND for Wholly Owned Product Candidate for Non-Hodgkin's Lymphoma", 1/03/2020 BCRX-US  GNW  BioCryst to Present at 38th Annual J.P. Morgan Healthcare Conference,12/02/2013 37555810 GNW  Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences,,"12/23/2019 N5946510 GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL, UNIT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",, 4/15/2019 AKRX-US  GNW  Akorn to Report First Quarter 2019 Financial Results and Host Conference Call, 3/29/2017 INOV-US  GNW  Amgen Enters Into Agreement With Inovalon and Avalere to Engage Value-Based Contracting Opportunities,12/04/2019 MYGN-US  GNW  Myriadâ€™s Prequelâ„¢ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Prenatal Screening, 8/09/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference, 2/05/2019 MGTX-US  GNW  MeiraGTx to Present at the BIO CEO & Investor Conference, 5/16/2018 INSM-US  GNW  Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC, 2/14/2014 AUP-CA   GNW  Aurinia Announces US$52 Million Private Placement," 3/17/2020 INO-US    GNW  KESSLER TOPAZ MELTZER & CHECK, LLP ANNOUNCES A SECURITIES FRAUD CLASS ACTION FILED AGAINST INOVIO PHARMACEUTICALS, INC."," 9/18/2019 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NetApp, SAExploration, Nektar Therapeutics, and Valaris and Encourages Investors to Contact the Firm",," 2/10/2020 37416310 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Geron Corporation (GERN) Investors With Losses to Contact its Attorneys; Application Deadline Pending",,11/14/2019 AMRN-US  GNW  Amarin Corporation plc (NASDAQ:AMRN) Stock Trading Halted Today for Scheduled FDA Advisory Committee Review of sNDA Seeking New Indication for VascepaÂ® (Icosapent Ethyl) toÂ Reduce the Risk of Major Adverse Cardiovascular Events Based on  Landmark REDUCE-ITÂ® Cardiovascular Outcomes Study," 5/10/2018 45337C10 GNW  Detailed Research: Economic Perspectives on Voya Financial, Dominion Energy, Incyte, MeetMe, Ventas, and Select Medical â€” What Drives Growth in Today's Competitive Landscape",10/21/2015 STDY-IL  GNW  SteadyMed Files Inter Partes Review to Invalidate United Therapeutics Patent,"10/09/2019 80360710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, Meredith Corporation, and MacroGenics and Encourages Investors to Contact the Firm"," 2/14/2019 G0176710 GNW  CLASS ACTION UPDATE for SOGO, ALKS, W and MKL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,10/11/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesiâ„¢ (Bremelanotide Injection) Data in Obstetrics & Gynecology, 1/28/2016 ARQL-US  GNW  ArQule Provides Proprietary Pipeline Update for AKT Inhibitors,,,," 1/30/2020 SAN-FR   GNW  Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency", 6/18/2010 VRTX-US  GNW  NASDAQ OMX Hosts 24th Investor Program in London in Association With Piper Jaffray," 4/30/2019 ALLO-US  GNW  Allogene Therapeutics to Report First Quarter 2019 Financial Results on May 7, 2019", 6/19/2019 ASND-US  GNW  Ascendis Pharma A/S Announces R&D Day on June 26 to Review Endocrinology Rare Disease Pipeline and Introduce Oncology Programs,," 8/24/2018 00422510 GNW  CLASS ACTION UPDATE for FPI, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 7/31/2019 AFMD-US  GNW   Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019",, 8/07/2019 PRQR-US  GNW  ProQR Announces Financial Results for the Second Quarter of 2019," 4/19/2017 88338N10 GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In TherapeuticsMD, Inc. To Contact The Firm","10/08/2019 98978L20 GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of CBL & Associates Properties, EQT Corporation, and Zogenix and Encourages Investors to Contact the Firm", 2/03/2020 01671P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Allakos Inc.Â â€“ ALLK,,"11/04/2015 76133010 GNW  Revance Therapeutics to Release Third Quarter 2015 Financial Results Monday, November 9, 2015",,,10/31/2019 ADVM-US  GNW  Adverum Biotechnologies to Host a Conference Call and Webcast to Report Third Quarter 2019 Financial Results and Provide Corporate Updates,10/02/2019 RARE-US   GNW  Ultragenyx to Present at Jefferies Gene Therapy/Editing Summit, 2/06/2019 AGLE-US  GNW  Aeglea BioTherapeutics Announces Pricing of $60.0 Million Public Offering," 3/25/2019 NSTG-US  GNW  NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares",,, 5/08/2019 RDUS-US  GNW  Radius Health Announces First Quarter 2019 Operating Results, 6/27/2019 ASMB-US  GNW  Assembly Biosciences Announces First Patient Dosed with ABI-M201 in Phase 1b Clinical Trial for Mildly to Moderately Active Ulcerative Colitis,,,10/30/2018 02043Q10 GNW  SHAREHOLDER ALERT: COCP TGTX ABBV ALNY MGTI HAS CPB HTHT SFIX GOOG OZK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 4/10/2019 WVE-US   GNW  Wave Life Sciences Provides Timing Update on PRECISION-HD Clinical Programs,10/22/2019 00972L10 GNW  Akcea Therapeutics to Hold Third Quarter 2019 Financial Results Webcast,, 6/12/2019 PCRX-US  GNW  New Analysis Shows Use of EXPAREL Associated with Improved Clinical and Economic Outcomes Following Hip Replacement Surgery, 5/30/2019 RTRX-US  GNW  Retrophin to Present at Upcoming Investor Conferences,11/14/2018 PACB-US  GNW  PacBioâ€™s SMRT Sequencing Provides Unprecedented Insight into Genome of Disease-causing Mosquito, 7/30/2019 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Second Quarter 2019 Results and Corporate Update, 6/27/2019 CHMA-US  GNW  Chiasma Provides Update on Ongoing MycapssaÂ® Phase 3 Clinical Trials,"11/05/2019 55609910 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys Now, 7-Day Application Deadline is Approaching",,, 1/09/2015 28249U10 GNW  Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 6/04/2019 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the  Goldman Sachs 40th Annual Global Healthcare Conference,11/06/2018 PRTA-US  GNW  Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update," 9/29/2019 ZLAB-US  GNW  Phase 3 PRIMA trial of ZejulaÂ® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer",10/06/2015 SAGE-US  GNW  SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217,"10/14/2019 CTMX-US  GNW  CytomX Therapeutics Announces Appointment of Amy C. Peterson, M.D. as Chief Development Officer", 8/22/2019 GMAB-DK  GNW  Genmab Announces Approval of DARZALEXÂ® (daratumumab) in Frontline Multiple Myeloma in Japan," 3/26/2019 92165910 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: AMRN, ASTE, INGN, VNDA",, 6/11/2019 CBAY-US  GNW  CymaBay Therapeutics Reports Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis, 8/24/2012 45781M10 GNW  GSK and Theravance Announce Completion of the Phase III Programme for Once-Daily LAMA/LABA (UMEC/VI) in COPD, 3/11/2019 CCXI-US  GNW  ChemoCentryx Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights,,, 7/31/2019 MNKD-US   GNW  AfrezzaÂ® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3, 1/08/2018 URGN-US  GNW  UroGen Pharma Appoints Former Kite Pharma Executive Christine Cassiano as Corporate Affairs Officer,11/18/2019 23282W60 GNW  New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function,11/07/2019 ESPR-US     GNW  Esperion to Participate in Upcoming Investor Conferences," 5/17/2019 03236M20  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AMRS, BV, FLEX, REV of Lead Plaintiff Deadline in Class Action Lawsuits",, 4/03/2019 ACHN-US  GNW  Achillion Announces Enrollment Milestone in Phase 2 Trials for C3 Glomerulopathy," 7/08/2019 87166B10 GNW  Syneos Health Schedules Second Quarter 2019 Earnings Call for Tuesday, August 6, 2019", 7/02/2019 FOLD-US  GNW  Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing,,, 8/08/2019 ADMA-US  GNW  ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results," 9/04/2019 0JBRH7-E GNW  GW Pharmaceuticals to Present at the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, September 11th, 2019",11/09/2017 EPZM-US  GNW  Epizyme to Present at the Jefferies 2017 London Healthcare Conference,, 8/15/2019 MYOK-US  GNW  MyoKardia Launches 2nd Annual MyoSeedsâ„¢ Research Grants Program to Advance Independent Research in Heart Disease,,10/31/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  TO  PRESENT  NEW  DATA  ON  FILGOTINIB   AT  2019  ACR/ARP  ANNUAL  MEETING, 2/18/2020 PTLA-US  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,,,, 7/24/2019 CARA-US  GNW  Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock,"10/31/2019 FLXN-US  GNW  Flexion Therapeutics to Report Third-Quarter 2019 Financial Results on November 7, 2019", 9/03/2019 QURE-US  GNW  uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B,11/06/2019 AGIO-US   GNW  Agios to Present Broad Set of Clinical and Translational Data for Oncology and Rare Genetic Disease Programs at the 2019 ASH Annual Meeting, 7/02/2019 IOVA-US  GNW  Iovance Biotherapeutics Provides Cervical Cancer Program Updates Following End of Phase 2 Meeting with U.S. Food and Drug Administration (FDA), 5/28/2019 ANAB-US  GNW  AnaptysBio to Present at the Jefferies 2019 Healthcare Conference,, 8/14/2019 FATE-US  GNW  Fate Therapeutics Announces Issuance of Foundational U.S. Patent Covering iPSC-derived CAR T Cells, 2/26/2018 HZNP-US  GNW  Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference,, 8/07/2019 ICPT-US  GNW  Intercept Pharmaceuticals Reports Second Quarter 2019 Financial Results  and Provides Business Update, 1/02/2020 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 8/06/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference,,,, 3/19/2019 AMPH-US  GNW  Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial, 6/29/2019 ATRA-US    GNW  Atara Biotherapeutics Presents Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN),,11/19/2018 DERM-US  GNW  Dermira to Present at Evercore ISI HealthCONx Conference,10/21/2019 FOMX-US  GNW  Foamix Announces Settlement of Litigation with Teva Relating to Finacea Foam, 4/08/2019 PRAH-US  GNW  PRA Health Sciences Receives CRO Leadership Awards, 3/28/2019 SUPN-US  GNW  Supernus Announces P304 Phase III Data Confirming Positive Results from Previous Three Phase III Studies on SPN-812 in ADHD, 9/30/2019 FGEN-US  GNW  FibroGen Announces Publication in the Lancet Respiratory Medicine of Positive Pamrevlumab Efficacy and Safety Data for the Praise Phase 2 Study in Idiopathic Pulmonary Fibrosis," 6/19/2015 74587V10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ PBYI", 8/22/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 5/10/2019 21833P10 GNW  Bronstein, Gewirtz & Grossman, LLC Class Action Update: BPI, CRBP & NIO",, 4/24/2019 COLL-US  GNW  Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update, 6/25/2019 XBIT-US  GNW  XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa,,,10/07/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 9/20/2017 RGNX-US  GNW  REGENXBIO Announces Completion of Dosing of First Cohort in Phase I Clinical Trial of RGX-314 Gene Therapy for Wet AMD, 9/03/2019 KURA-US  GNW  Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in HRAS Mutant Urothelial Carcinoma, 9/12/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes,10/28/2019 AXSM-US  GNW  Axsome Therapeutics Announces Results of MINDSET Physician Survey Affirming Unmet Need and Favorable Profile of AXS-07 in the Acute Treatment of Migraine, 4/03/2019 VYGR-US  GNW  Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c)(4),"11/13/2019 07725L10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of BeiGene, Ltd. - BGNE",, 5/02/2019 RETA-US  GNW  Reata Announces Presentation at the Annual CKD3 Chronic Kidney Disease Drug Development Summit,10/04/2019 HCM-GB   GNW  Chi-Med Initiates an International Phase I/Ib Trial of HMPL-523 in Patients with Advanced Relapsed or Refractory Lymphoma, 4/15/2019 NTLA-US  GNW  Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy, 5/15/2019 ACIU-US  GNW  AC Immune Reports Q1 2019 Financial Results and Business Update, 2/27/2019 CRSP-US  GNW  CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2019 Annual Meeting, 8/06/2019 GTHX-US  GNW  G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August, 6/14/2018 ARGX-BE  GNW  argenx announces data from Phase 1 study of efgartigimod (ARGX-113) subcutaneous formulation demonstrating comparable characteristics to intravenous formulation, 5/15/2019 RUBY-US GNW  Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress, 9/23/2019 ATNX-US  GNW  Athenex to Highlight Oral Paclitaxel Clinical Programs Targeting Various Solid Tumors at the ESMO Congress 2019," 5/13/2019 71639T10 GNW  PETIQ INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In PetIQ Inc. To Contact The Firm", 7/29/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for Setmelanotide for the Treatment of Bardet-Biedl Syndrome, 3/06/2019 OPTN-US  GNW  Â Optinose Reports Fourth Quarter and Full Year 2018 Financial ResultsÂ and Recent Operational Highlights, 4/02/2019 TORC-US  GNW  resTORbio Announces Initiation of Phase 1b/2a Trial of RTB101 in Parkinsonâ€™s Disease, 8/09/2018 DNLI-US  GNW  Denali Therapeutics Reports Second Quarter 2018 Financial Results,, 8/10/2018 SLDB-US  GNW  Solid Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update," 7/15/2019 30052C10 GNW   Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.", 5/14/2019 FIXX-US GNW  Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU, 9/09/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Data Highlighting YUTIQÂ® to be Presented at the 52nd Annual Retina Society Scientific Meeting, 5/08/2019 SRRK-US  GNW  Scholar Rock Announces Initiation of Patient Dosing in Phase 2 Trial of SRK-015 in Spinal Muscular Atrophy," 4/29/2019 UBX-US   GNW  UNITY Biotechnology, Inc. to Announce First Quarter 2019 Financial Results",,,11/10/2018 EIDX-US  GNW  Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in Symptomatic Patients with Mutant or Wild-Type TTR Amyloid Cardiomyopathy,,, 3/06/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline Progress,11/05/2019 AUTL-US  GNW  Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia," 9/03/2019 FTSV-US GNW  Forty Seven, Inc. Granted Fast Track Designation for Magrolimab (5F9) for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia",10/18/2018 TBIO-US  GNW  Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference,, 5/07/2019 PRNB-US GNW  Principia Biopharma Reports First Quarter Financial Results, 6/06/2019 ARVN-US GNW  Arvinas to Present at the Goldman Sachs 40th Annual Global Healthcare Conference, 8/14/2019 YMAB-US  GNW  Y-mAbs Announces Second Quarter 2019 Financial Results and Recent Corporate Developments,, 4/22/2019 GRTS-US  GNW  Gritstone Oncology Announces Proposed Public Offering of Common Stock, 5/15/2019 GH-US    GNW  Guardant Health to Present Precision Oncology Data Across the Continuum of Care at the ASCO Annual Meeting, 3/27/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress, 1/04/2018 009Z8P-E GNW  Ablexis Announces Licensing of the AlivaMab Mouse to NGM Biopharmaceuticals,, 9/13/2019 ORTX-US  GNW  Orchard Therapeutics Announces Departure of Chief Commercial Officer,,11/12/2019 ALEC-US  GNW  Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results, 7/10/2019 DTIL-US GNW  Elo Life Systemsâ€™ Mario G. Pennisi Awarded BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture at BIO World Congress, 8/28/2019 TPTX-US GNW  Turning Point Therapeutics Participate in Upcoming Investor Conferences, 8/07/2019 PRVL-US GNW  Prevail Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference,,,,,11/07/2019 BBIO-US  GNW  BridgeBio Pharma Reports Third Quarter 2019 Financial Results and Highlights Portfolio Progress, 7/01/2019 ADPT-US  GNW  Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares,
, 9/03/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations," 6/19/2012 ILMN-US     GNW  Complete Genomics, Inc. to Vigorously Defend Against Patent Infringement Suit"," 3/25/2013 84763A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Spectrum Pharmaceuticals, Inc. and Certain Officers -- SPPI"," 9/11/2017 ENDP-US  GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Endo International plc and Set a Lead Plaintiff Deadline of October 17, 2017 -- ENDP","11/04/2014 07YM31-E GNW  Hagens Berman Announces the Filing of a Class Action Lawsuit Against Arrowhead Research Corporation, Inc. (NASDAQ: ARWR)", 5/29/2019 BDSI-US  GNW  BioDelivery Sciences Announces Upcoming Investor Conference Presentations,," 4/01/2016 REGN-US  GNW  Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to Ring The Nasdaq Stock Market Opening Bell"," 9/13/2018 SIGA-US      GNW  SIGA Technologies to Ring the Nasdaq Opening Bell on Friday, September 14, 2018", 6/20/2019 OPK-US   GNW  OPKO Health Submits De Novo Request to the U.S. FDA for the 4KscoreÂ® Test, 7/01/2019 46222210 GNW  Biogen Announces New Data Further Establishing SPINRAZAÂ® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients, 7/21/2016 BMRN-US     GNW  BioMarin to Provide Updated Data for BMN 270 in Hemophilia A in Late Breaking Oral Presentation at the World Federation of Hemophilia (WFH) 2016 World Congress July 27th, 9/10/2012 01535110 GNW  Raptor Pharmaceutical Corp. Expands Senior Management,," 1/12/2017 81257810 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Seattle Genetics Inc. (SGEN) To Contact Brower Piven Before The Lead Plaintiff Deadline",10/01/2019 IMMU-US  GNW  Immunomedics to Present at the 2019 Cantor Global Healthcare Conference Â , 9/17/2019 BIIB-US   GNW  Biogen Ranked #1 Biotechnology Company on Dow Jones Sustainability World Index," 8/31/2011 45253H10 GNW  ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences","12/11/2019 BCRX-US  GNW  BioCryst Submits New Drug Application for Oral, Once Daily Berotralstat (BCX7353) to Prevent HAE Attacks", 8/12/2013 YM-CA    GNW  Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer,,"12/20/2019 N5946510 GNW  INVESTOR ALERT - Mylan N.V. (MYL) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: February 14, 2020",," 4/12/2019 00972810 GNW  AKRX, HIIQ & AMRN - Class Action Reminder Bronstein, Gewirtz & Grossman, LLC"," 3/06/2017 AMGN-US  GNW  Advaxis Announces FDA Acceptance of IND for Groundbreaking Personalized Neoepitope Immunotherapy, ADXS-NEO",12/03/2019 MYGN-US  GNW  Myriad Genetics to Present Multiple Studies on Breast Cancer at the  2019 San Antonio Breast Cancer Symposium, 8/08/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Publication of Positive Data for Zynquistaâ„¢ (Sotagliflozin) on Cardiorenal Clinical Biomarkers in Adults With Type 1 Diabetes, 1/31/2019 005Y9C-E GNW  MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases, 5/02/2018 INSM-US  GNW  Insmed Reports First Quarter 2018 Financial Results and Provides Business Update,12/09/2013 AUP-CA   GNW  Aurinia Announces Change to Board of Directors," 3/17/2020 INO-US    GNW  INOVIO PHARMACEUTICALS, INC.  CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for the Eastern District of New York against Inovio Pharmaceuticals, Inc.", 9/17/2019 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Nektar Therapeutics - NKTR,, 2/10/2020 37416310 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Geron Corporation - GERN,,11/11/2019 AMRN-US  GNW  New Analysis Shows Icosapent Ethyl (VascepaÂ®) Is Cost Effective and Offers Rare Finding of Better Outcomes at Lower Healthcare Costs When Used to Treat High-Risk Patients with Cardiovascular Disease or Diabetes and Other Risk Factors, 4/16/2018 IMV-CA   GNW  New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccineâ€™s Proprietary Delivery Platform, 9/17/2014 91307C10 GNW  Axsome Therapeutics Announces Appointments to Its Board of Directors,"10/08/2019 80360710 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT"," 2/13/2019 G0176710 GNW  CLASS ACTION UPDATE for SOGO, PRGO, AGN and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,10/08/2019 00163U10 GNW  AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP, 1/25/2016 ARQL-US  GNW  ArQule Presents Clinical Biomarker Data From Phase 2 Study and Ongoing Phase 3 METIV-HCC Study of Tivantinib in Second-Line Hepatocellular Carcinoma at the 2016 Gastrointestinal Cancers Symposium,,,, 1/28/2020 SAN-FR   GNW  Sanofi : FDA accepts for priority review DupixentÂ® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis, 4/30/2010 VRTX-US  GNW  Vical CEO Selected as Panelist at BIO and PGH Conferences, 4/15/2019 ALLO-US  GNW  Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715 (an Anti-BCMA AlloCAR Tâ„¢ Therapy) in Multiple Myeloma, 5/30/2019 ASND-US  GNW  Ascendis Pharma A/S Reports First Quarter 2019 Financial Results,," 8/20/2018 00422510 GNW  CLASS ACTION UPDATE for ACAD and FB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 7/01/2019 AFMD-US  GNW  Affimed Added to the Russell 2000Â®, 3000Â® and Microcap Indexes",, 7/29/2019 PRQR-US  GNW  European Medicines Agency Grants PRIME Access to ProQRâ€™s Sepofarsen for Leberâ€™s Congenital Amaurosis 10," 4/19/2017 TXMD-US  GNW  SHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed to Recover Losses Suffered by Investors in TherapeuticsMD, Inc.",10/07/2019 ZGNX-US  GNW  Zogenix Presents Positive Clinical Study Results for Investigational Treatment for TK2 Deficiency," 1/23/2020 01671P10 GNW  ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc. â€“ ALLK",,11/04/2015 76133010 GNW  Revance Therapeutics Announces Pricing of Public Offering of Common Stock,,,10/30/2019 ADVM-US  GNW  Adverum Biotechnologies Expands Leadership Team with the Appointment of Peter Soparkar as Chief Legal Officer, 9/30/2019 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for CrysvitaÂ® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH), 2/05/2019 AGLE-US  GNW  Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock," 3/19/2019 NSTG-US  GNW  NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock",,," 4/23/2019 RDUS-US  GNW  Radius Health to Announce First Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, May 8, 2019", 6/25/2019 ASMB-US  GNW  Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit,,,"10/30/2018 02043Q10 GNW  CLASS ACTION UPDATE for TGTX, ALNY and SFIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/25/2019 WVE-US   GNW  Wave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific Conference,10/07/2019 IONS-US  GNW  Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx),, 6/04/2019 PCRX-US  GNW  Pacira Announces Publication of Pivotal Study of EXPAREL as a Single-Dose Interscalene Brachial Plexus Nerve Block in Patients Undergoing Shoulder Surgery, 5/13/2019 RTRX-US  GNW  Retrophin Appoints Sandra E. Poole to Board of Directors,"11/07/2018 69404D10 GNW  Consolidated Research: 2018 Summary Expectations for Pacific Biosciences of California, NXP Semiconductors N.V., Consolidated Communications, Alexander & Baldwin, Willdan Group, and OneMain â€” Fundamental Analysis, Key Performance Indications", 7/25/2019 AGN-US   GNW  Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10, 6/05/2019 CHMA-US  GNW  Chiasma Strengthens Leadership Team Ahead of Anticipated Commercial Availability of MycapssaÂ®,"11/04/2019 55609910 GNW  IMPORTANT  REMINDER FOR MACROGENICS, INC.  INVESTORS: Wolf Haldenstein Adler Freeman & Herz LLP announces that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District for the District of Maryland against MacroGenics, Inc.",,, 1/05/2015 28249U10 GNW  Celladon Corporation Conducts Initial Scale Up of Manufacturing Process for MYDICAR to Commercial Scale, 5/09/2019 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the  2019 Bank of America Merrill Lynch Healthcare Conference,10/30/2018 PRTA-US  GNW  Prothena to Report Third Quarter 2018 Financial Results on November 6," 9/03/2019 ZLAB-US  GNW  Zai Lab Announces Financial Results and Corporate Update for the Six Months Ended June 30, 2019", 9/23/2015 78667J10 GNW  SAGE Therapeutics to Participate in the 4th Annual Leerink Partners Rare Disease Roundtable, 8/28/2019 CTMX-US  GNW  CytomX Therapeutics to Present at Upcoming Healthcare Conferences, 8/14/2019 GMAB-DK  GNW  Genmab Announces Financial Results for the First Half of 2019 and Updates 2019 Financial Guidance," 3/26/2019 92165910 GNW  CLASS ACTION UPDATE for SPB, STMP, VNDA and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 5/20/2019 CBAY-US  GNW  CymaBay Therapeutics Presents Data in Patients with Primary Biliary Cholangitis at DDW 2019, 7/31/2012 45781M10 GNW  Theravance Reports Second Quarter 2012 Financial Results," 3/04/2019 CCXI-US  GNW  ChemoCentryx to Hold Fourth Quarter 2018 Financial Results Conference CallÂ on Monday, March 11, 2019",,, 7/18/2019 MNKD-US   GNW  MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants, 1/02/2018 URGN-US  GNW  UroGen Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference,11/11/2019 CYTK-US  GNW  Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2019,11/06/2019 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates;Â Reports Third Quarter Financial Results," 5/16/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm",, 3/27/2019 ACHN-US  GNW  Achillion Announces Completion of Enrollment in Phase 2 PNH Combination Trial, 6/24/2019 SYNH-US  GNW  Syneos Health Introduces FSP 360 â€“ Next Evolution Model Provides Customers Broadest Range of Functional Service Provider Solutions," 7/01/2019 TMO-US   GNW  Amicus Therapeutics and Brammer Bio, a part of Thermo Fisher Scientific, Enter Strategic Gene Therapy Development and Manufacturing Collaboration",,, 7/08/2019 ADMA-US  GNW  ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAMÂ® and Nabi-HBÂ®," 8/06/2019 GWPH-US  GNW  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019",11/01/2017 EPZM-US  GNW  Epizyme Reports Third Quarter 2017 Operating Results and Company Updates,, 8/07/2019 MYOK-US  GNW  MyoKardia Reports Second Quarter 2019 Financial Results,,10/28/2019 GLPG-NL  GNW  MOR106 clinical development in atopic dermatitis stopped for futility," 2/17/2020 FSCT-US  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS FSCT, MAT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,, 7/24/2019 CARA-US  GNW  Cara Therapeutics Announces Proposed Offering of Common Stock,"10/31/2019 FLXN-US  GNW  Flexion Therapeutics Announces FDA Clearance of the Investigational New Drug Application for FX201, a Gene Therapy Candidate for the Treatment of Osteoarthritis", 8/30/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences in September,10/31/2019 AGIO-US   GNW  Agios Reports Business Highlights and Third Quarter 2019 Financial Results," 6/11/2019 IOVA-US  GNW  Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors", 5/07/2019 ANAB-US  GNW  AnaptysBio Announces First Quarter 2019 Financial Results andÂ Provides Pipeline Updates,, 8/06/2019 FATE-US  GNW  Fate Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Operational Progress, 2/22/2018 HZNP-US  GNW  Horizon Pharma plc Announces Release of the First RAREisâ„¢ Song in Partnership with Sing Me a Story Foundation and Global Genes,," 7/31/2019 ICPT-US  GNW  Intercept to Announce Second Quarter 2019 Financial Results on August 7, 2019",12/23/2019 KPTI-US    GNW  Karyopharm Submits New Drug Application to U.S. FDA for XPOVIOÂ® (selinexor) as a Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,,, 8/05/2019 ITCI-US  GNW  Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA,,,," 3/12/2019 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018", 6/25/2019 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,11/08/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/18/2019 FOMX-US  GNW  UPDATE -- Foamix Receives FDA Approval of AMZEEQâ„¢ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers, 3/07/2019 PRAH-US  GNW  PRA Blue Bell Named 2019 Top Workplace by Philadelphia Inquirer, 3/27/2019 SUPN-US  GNW  Supernus Hosts Conference Call to Present Topline Results of Final Phase III Study for SPN-812 in Adolescents with ADHD, 9/26/2019 FGEN-US  GNW  FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment of Anemia in Cancer Patients Receiving Chemotherapy," 6/12/2015 74587V10 GNW  IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against Puma Biotechnology, Inc. -- PBYI", 8/21/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in September," 5/10/2019 21833P10 GNW  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",," 4/02/2019 COLL-US  GNW  Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer", 6/11/2019 XBIT-US  GNW  XBiotech Added to Russell 3000Â® Index,,,10/02/2019 GBT-US   GNW  GBT Announces Upcoming Presentations at the 47th Annual National Sickle Cell Disease Association of America (SCDAA) Convention, 9/19/2017 75901B10 GNW  Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to a â€œSuperior Proposalâ€, 8/29/2019 KURA-US  GNW  Kura Oncology to Participate in Two Upcoming Investor Conferences, 9/11/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Proposed Private Offering of $200 Million of Convertible Senior Notes,10/28/2019 AXSM-US  GNW  Axsome Therapeutics Announces Continued Progress in Clinical Development of AXS-07 for the Acute Treatment of Migraine, 4/02/2019 VYGR-US  GNW  Voyager Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference,11/12/2019 BGNE-US  GNW  BeiGene Reports Third Quarter 2019 Financial Results,," 5/02/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report First Quarter 2019 Financials and to Provide an Update on Development Programs on May 9, 2019", 9/30/2019 44842L10 GNW  CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its intention to hold Chi-Med as a strategic investment for the long term, 2/27/2019 NTLA-US  GNW  Intellia Therapeutics AnnouncesÂ Fourth Quarter and Full-Year 2018 Financial Results, 4/01/2019 ACIU-US  GNW  AC Immune to Present at the H.C. Wainwright Global Life Sciences Conference, 2/25/2019 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results," 7/31/2019 GTHX-US  GNW  G1 Therapeutics to Provide Second Quarter Corporate and Financial Update on August 7, 2019", 6/05/2018 ARGX-BE  GNW  argenx selected for BEL 20 Index, 5/06/2019 RUBY-US GNW  Rubius Therapeutics to Announce First Quarter 2019 Financial Results, 9/11/2019 04685N10 GNW  Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical," 5/09/2019 71639T10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of PetIQ, Inc. - PETQ", 7/24/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors," 2/27/2019 OPTN-US  GNW  Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019"," 3/22/2019 TORC-US  GNW  resTORbio, Inc. Announces Closing Public Offering of Common Stock"," 8/07/2018 DNLI-US  GNW  Denali Therapeutics Appoints Dana Andersen, Ph.D., as Chief Technical and Manufacturing Officer",, 6/26/2018 SLDB-US  GNW  Solid Biosciences Welcomes Industry Expert Dr. Martin Freed To ItsÂ Board Of Directors, 6/10/2019 EOLS-US  GNW  Evolus Provides Update on Nuceivaâ„¢ Marketing Authorization Application in Europe, 5/13/2019 FIXX-US GNW  Homology Medicines Reports First Quarter 2019 Financial Results and Recent Highlights, 8/07/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress," 4/30/2019 SRRK-US  GNW  Scholar Rock Appoints Akshay Vaishnaw, M.D., Ph.D. to Its Board of Directors"," 3/06/2019 UBX-US   GNW  UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates",,,11/06/2018 EIDX-US  GNW  Eidos Therapeutics Reports Third Quarter 2018 Financial Results andÂ Provides Corporate Update,,, 3/01/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),10/31/2019 AUTL-US  GNW  Autolus Therapeutics to Report Third Quarter 2019 Financial Results and Host Conference Call on November 7, 8/13/2019 FTSV-US GNW  Forty Seven Inc. Reports Second Quarter 2019 Financial Results and Recent Business Highlights, 9/25/2018 TBIO-US  GNW  Translate Bio to Participate in the Leerink Partners Roundtable Series: Rare Disease & Oncology,," 4/18/2019 PRNB-US GNW  Principia Biopharma Appoints Shao-Lee Lin, M.D., Ph.D. to Board of Directors", 6/04/2019 BAYN-DE GNW  Bayer and Arvinas to Collaborate on Human PROTACÂ® Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTACÂ® Applications, 8/07/2019 YMAB-US  GNW  Y-mAbs to Announce Second Quarter 2019 Financial and Operating Results on August 14,, 4/22/2019 GRTS-US  GNW  Gritstone Oncology Announces Clinical Acceleration of â€œOff-The-Shelfâ€ Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback, 5/09/2019 GH-US    GNW  Guardant Health Reports First Quarter 2019 Financial Results and Raises 2019 Revenue Guidance," 3/21/2019 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2018 Business and Financial Update on March 27, 2019", 4/20/2015 009Z8P-E GNW  NGM Biopharmaceuticals to Present New Data on NGM282 at the European Association for the Study of the Liver International Liver Congress(TM) 2015,, 9/04/2019 ORTX-US  GNW  Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I),, 9/09/2019 ALEC-US  GNW  Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia, 6/12/2019 DTIL-US GNW  Precision BioSciences Appoints Dario Scimeca as General Counsel, 8/06/2019 TPTX-US GNW  Turning Point Therapeutics Reports Second Quarter 2019 Financial and Operational Results, 7/08/2019 PRVL-US GNW  Prevail Therapeutics Receives U.S. FDA Fast Track Designation for PR001 for the Treatment of Parkinsonâ€™s Disease Patients with aÂ GBA1Â Mutation,,,,,10/31/2019 10806X10 GNW  Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update, 6/27/2019 00650F10 GNW  Adaptive Biotechnologies Corporation (Nasdaq: ADPT) to Ring The Nasdaq Stock Market Opening Bell,
, 8/09/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update, 2/21/2012 45232710    GNW  Illumina Class Action Lawsuit Announced by Gilman Law LLP on Behalf of Shareholders Alleging Conflict of Interest in Recent Proposed Acquisition by Roche -- ILMN," 3/22/2013 84763A10 GNW  Gainey McKenna & Egleston Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. -- SPPI", 8/30/2017 G3040110 GNW  IMPORTANT ENDO INTERNATIONAL PLC INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Endo International plc,11/03/2014 ARWR-US  GNW  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Arrowhead Research Corp., 5/28/2019 BDSI-US  GNW  BioDelivery Sciences Strengthens Financial Position with Debt Refinancing,,11/03/2015 073CH8-E GNW  Merus Announces Final Ruling in Inequitable Conduct Case Against Regeneron, 9/10/2018 SIGA-US      GNW  SIGA Technologies Awarded BARDA Contract for TPOXXÂ®, 6/07/2019 OPK-US   GNW  BioReference Laboratories Supports Man Cave Health During National Menâ€™s Health Month, 6/26/2019 IONS-US  GNW  Akcea and Ionis Announce Upcoming Data Presentations at the 5th European Academy of Neurology Annual Congress," 7/18/2016 BMRN-US     GNW  BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg", 1/06/2012 INSM-US  GNW  Amarantus Biosciences Releases New Video Interview With President and CEO Gerald Commissiong,," 1/11/2017 81257810 GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Seattle Genetics, Inc. To Contact The Firm Before Lead Plaintiff Deadline", 9/28/2019 IMMU-US  GNW  Immunomedics Provides Corporate Update, 9/12/2019 BIIB-US   GNW  New Research Demonstrate Biogenâ€™s Continued Commitment to Improve Care of Patients with Multiple Sclerosis Across Treatment Spectrum, 2/23/2011 NVLN-CA  GNW  QLT Chief Medical Officer Steps Down,12/04/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 8/06/2013 HPTX-US  GNW  Hyperion Therapeutics Announces Larry J. Singer as Vice President, Manufacturing",,10/28/2019 N5946510 GNW  Mapi Announces First Patient Enrolled in the Phase III Clinical Trial of GA Depot for Relapsing Multiple Sclerosis (RMS),," 4/10/2019 00972810 GNW  AKRX ALERT: Zhang Investor Law Reminds Investors of April 22 Deadline in Securities Class Action Lawsuit Against Akorn, Inc. â€“ AKRX", 1/26/2017 03116210 GNW  SCYNEXIS Announces Appointment of Industry Veteran Marion McCourt to its Board of Directors,"11/26/2019 62855J10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SEE, MYGN, ZEN and YJ", 7/31/2019 LXRX-US  GNW   Lexicon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides a Business Update, 1/02/2019 MGTX-US  GNW  MeiraGTx to Present at the 37th Annual J.P. Morgan Healthcare Conference, 5/01/2018 INSM-US  GNW  Insmed to Present at the Deutsche Bank 43rd Annual Health Care Conference,11/21/2013 AUP-CA   GNW  Aurinia Reports Third Quarter 2013 Financial Results," 3/16/2020 AAN-US    GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AAN, FLR, INO, MGPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits"," 9/17/2019 64026810 GNW  Kessler Topaz Meltzer & Check, LLP Reminds Nektar Therapeutics Investors of Important Deadline in Securities Fraud Class Action Lawsuit",, 2/05/2020 37416310 GNW  The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation (GERN),,"11/11/2019 AMRN-US  GNW  REDUCE-ITÂ® USA Results, in Prespecified Subgroup Analyses of Landmark REDUCE-IT Global Study, Showed Robust Cardiovascular Risk Reductions Across a Variety of Study Endpoints, Including Cardiovascular Death and All-Cause Mortality", 9/19/2017 45337C10 GNW  Merus Announces Second Quarter 2017 Financial Results and Highlights Recent Progress, 9/16/2014 91307C10 GNW  Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market,"10/08/2019 80360710 GNW  CLASS ACTION UPDATE for PS, IFF, SRPT and SNDL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 2/13/2019 G0176710 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SOGO, PRGO, AGN and ALKS",, 9/25/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference,12/15/2015 ARQL-US  GNW  ArQule Announces Orphan Drug Designation in Cholangiocarcinoma and Clinical Update for ARQ 087,,,," 1/23/2020 SAN-FR   GNW  Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.",, 4/03/2019 ALLO-US  GNW  Allogene Therapeutics Announces April 2019 Investor Conference ScheduleÂ , 5/20/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Preliminary Data from Single Arm Phase 3 fliGHt Trial Demonstrated TransConâ„¢ hGH was Safe and Well-Tolerated in Pediatric Subjects Previously Treated with Daily Growth Hormone,," 8/20/2018 00422510 GNW  CLASS ACTION UPDATE for HAIR and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 6/24/2019 AFMD-US  GNW  Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019,, 7/02/2019 PRQR-US  GNW  ProQR Announces Presentation on QR-421a Program in Ophthalmology at Usher Syndrome Coalition Conference in July, 1/03/2013 TXMD-US  GNW  BUYINS.NET Updates TherapeuticsMD SqueezeTrigger Report, 9/26/2019 ZGNX-US  GNW  Zogenix Resubmits New Drug Application for FINTEPLAÂ® for the Treatment of Dravet Syndrome to U.S. Food and Drug Administration," 1/16/2020 01671P10 GNW  ALLK Investor Alert: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm â€“ ALLK",,11/02/2015 76133010 GNW  Revance Therapeutics Announces Proposed Public Offering of Common Stock,,,10/24/2019 ADVM-US  GNW  Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD, 9/10/2019 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for CrysvitaÂ® (burosumab) in Tumor-Induced Osteomalacia (TIO),12/11/2018 AGLE-US  GNW  Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency, 3/18/2019 NSTG-US  GNW  NanoString Technologies Announces Commencement of Public Offering of Common Stock,,, 4/17/2019 RDUS-US  GNW  Radius Health to Present Two Posters at AACE 2019 Annual Meeting, 6/21/2019 ASMB-US  GNW  Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China,,,"10/29/2018 02043Q10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SKX, OPK, PVG, ALNY and CPB", 3/06/2019 WVE-US   GNW  Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference, 9/23/2019 IONS-US  GNW  Akcea Announces CEO Transition and Elects Two New Board Members,, 5/28/2019 PCRX-US  GNW  Pacira BioSciences to Present at the Jefferies 2019 Healthcare Conference, 5/07/2019 RTRX-US  GNW  Retrophin Reports First Quarter 2019 Financial Results,"11/01/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2018 Financial Results", 6/15/2019 EDIT-US  GNW  Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association, 5/14/2019 16706W10 GNW  Chiasma and Lonza Announce Progression of Oral Octreotide Capsules Development and Definitive Commercial Supply Agreement,"10/31/2019 55609910 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds MacroGenics (MGNX) Investors of Securities Class Action: Encourages Investors Who Have Suffered Losses to Contact Firm",,,12/16/2014 28249U10 GNW  Celladon Corporation Added to NASDAQ Biotechnology Index, 5/02/2019 MNTA-US  GNW  Momenta Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results,"10/16/2018 G7280010 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within 1-800 FLOWERS.COM, Bojangles', Prothena Corporation plc, Lydall, Daktronics, and ServiceSource International â€” New Research Emphasizes Economic Growth", 8/27/2019 ZLAB-US  GNW  Zai Lab Announces Publication of Pharmacokinetic Study of Niraparib in Chinese Ovarian Cancer Patients, 9/21/2015 78667J10 GNW  SAGE Therapeutics Expands Leadership Team With Key Appointments, 8/07/2019 CTMX-US  GNW  CytomX Therapeutics Announces Second Quarter 2019 Financial ResultsÂ and Provides Business Update, 7/23/2019 GMAB-DK  GNW  Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase, 3/21/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,, 5/08/2019 CBAY-US  GNW  CymaBay Reports First Quarter 2019 Financial Results and Provides Corporate Update," 7/17/2012 45781M10 GNW  Theravance to Report Second Quarter 2012 Financial Results on July 31, 2012", 2/20/2019 CCXI-US  GNW  ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference,,, 7/15/2019 MNKD-US   GNW  MannKind Partners with GoodRx to Help Raise Awareness on Reducing Out of Pocket Insulin Cost for Patients,12/12/2017 URGN-US  GNW  UroGen Pharma Expands Clinical Development Leadership Team,11/08/2019 CYTK-US  GNW  Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes,11/04/2019 ESPR-US     GNW  Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Development Program of Bempedoic Acid to be Presented at the American Heart Association 2019 Scientific Sessions," 5/16/2019 03236M20  GNW  AMRS NOTICE:Â  Zhang Investor Law Reminds Investors of June 3 Deadline in Securities Class Action Lawsuit Against Amyris, Inc. â€“ AMRS",, 3/08/2019 ACHN-US  GNW  Achillion to Present at the Barclays Global Healthcare Conference," 5/31/2019 SYNH-US  GNW  Syneos Health Appoints Patrick Nealon,Â Head of Oncology", 6/13/2019 FOLD-US  GNW  Amicus Therapeutics Adds Key Executives in Gene Therapy Science and Global Commercial Leadership,,, 5/29/2019 ADMA-US  GNW  ADMA Biologics to Present at Upcoming Investor Conferences," 7/26/2019 GWPH-US  GNW  GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEXâ„¢ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy",10/27/2017 EPZM-US  GNW  Epizyme Presents Data from a Phase 1 Trial of Tazemetostat in Children with Relapsed or Refractory INI1-Negative Solid Tumors at the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,, 8/07/2019 MYOK-US  GNW  MyoKardia to Present at 2019 Wedbush PacGrow Healthcare Conference,,10/25/2019 GLPG-NL  GNW  Galapagos receives transparency notification from Wellington Management Group LLP," 2/14/2020 FSCT-US  GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, PTLA, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,, 7/22/2019 CARA-US  GNW  Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVAâ„¢ in Chronic Kidney Disease Patients with Pruritus after Completion of Interim Statistical Assessment,10/14/2019 FLXN-US  GNW  Flexion Therapeutics Announces Extended FDA Review of Supplemental New Drug Application for ZILRETTAÂ®, 8/20/2019 QURE-US  GNW  uniQure Announces Leadership Promotions and Executive Transition,"10/27/2019 AGIO-US   GNW  Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study of AG-270, a MAT2A Inhibitor, in Patients with MTAP-Deleted Tumors", 5/31/2019 IOVA-US  GNW  Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating Lymphocyte (TIL) Therapy, 5/01/2019 ANAB-US  GNW  AnaptysBio to Present at the Bank of America Merrill Lynch Healthcare Conference,, 7/30/2019 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2019 Financial Results, 2/06/2018 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 5/30/2019 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences in June,12/08/2019 KPTI-US    GNW  Karyopharm Presents XPOVIOÂ® (Selinexor) and Eltanexor Data at the American Society of Hematology 2019 Annual Meeting,,, 7/23/2019 ITCI-US  GNW  Intra-Cellular Therapies Provides Update on FDA Advisory Committee Meeting for Lumateperone for the Treatment of Schizophrenia,,,," 3/07/2019 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019", 6/05/2019 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),,11/07/2018 DERM-US  GNW  Dermira Reports Third Quarter 2018 Financial Results,10/17/2019 FOMX-US  GNW  Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea," 2/27/2019 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2018 Results and Provides First Quarter and Full Year 2019 Guidance"," 3/07/2019 86845910 GNW  Recent Analysis Shows Golar LNG, AG Mortgage Investment Trust, AmerisourceBergen, Caesarstone, Dycom Industries, and Supernus Pharmaceuticals Market Influences â€” Renewed Outlook, Key Drivers of Growth", 9/20/2019 31572Q80 GNW  Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients," 6/05/2015 74587V10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 3, 2015 -- PBYI", 8/01/2019 CHRS-US  GNW  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2019 Financial Results, 5/09/2019 CRBP-US  GNW  Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates,, 4/01/2019 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences, 6/04/2019 XBIT-US  GNW  XBiotech Announces Closing of Public Offering of Common Shares,,,10/01/2019 GBT-US   GNW  GBT to Host Analyst & Investor Day on October 8 in New York, 8/31/2017 RGNX-US  GNW  REGENXBIO to Present at Upcoming Investor Conferences, 8/12/2019 KURA-US  GNW  Kura Oncology Announces Appointment ofÂ Kathleen Ford as Chief Operating Officer, 9/09/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/21/2019 AXSM-US  GNW  Axsome Therapeutics Completes Patient Enrollment in the CONCERT Phase 2 Trial of AXS-12 in Narcolepsy, 3/28/2019 92915B10 GNW  Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinsonâ€™s Disease in the Annals of Neurology,"11/10/2019 07725L10 GNW  ROSEN, A LEADING GLOBAL LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd. â€“ BGNE",," 2/28/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2018 Financials and Operating Results", 9/30/2019 HCM-GB   GNW  CK Hutchison offers 1.3% of Chi-Medâ€™s share capital aiming to deconsolidate and hold Chi-Med as a strategic investment for the long term," 1/24/2019 NTLA-US  GNW  Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors", 3/29/2019 ACIU-US  GNW  AC Immune Presents New Data on Alpha-Synuclein PET Tracer at AD/PDâ„¢ Conference, 2/25/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001, 7/30/2019 GTHX-US  GNW  G1 Therapeutics Appoints Mark Avagliano as Chief Business Officer, 5/09/2018 ARGX-BE  GNW  argenx reports first quarter 2018 financial results and provides business update, 4/03/2019 RUBY-US GNW  Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit, 9/04/2019 ATNX-US  GNW  Athenex Announces Appointment of Daniel Lang MD to Lead TCR-T Immunotherapy Operations and Support Corporate Development Strategy," 5/08/2019 71639T10 GNW  PetIQ, Inc. Reports Record First Quarter 2019 Financial Results", 7/17/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity, 2/19/2019 OPTN-US  GNW  Optinose Announces Issuance of Four Additional U.S. Patents Covering XHANCE," 3/19/2019 TORC-US  GNW  resTORbio, Inc. Announces Pricing of Public Offering of Common Stock", 8/01/2018 DNLI-US  GNW  Denali Therapeutics Announces Positive Clinical Results From LRRK2 Inhibitor Program for Parkinsonâ€™s Disease,, 6/18/2018 SLDB-US  GNW  Solid Biosciences Announces FDA Removes Clinical Hold on SGT-001, 6/05/2019 EOLS-US  GNW  Evolus Accelerates Next Phase of U.S. Launch of Jeuveauâ„¢ with â€˜#NEWTOX NOWâ€™ Consumer Conversion Program, 5/09/2019 FIXX-US GNW  Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference, 7/30/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Presents Positive Data Showcasing YUTIQÂ® at the 37th Annual Scientific Meeting of the American Society of Retina Specialists," 4/11/2019 SRRK-US  GNW  Scholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human Resources"," 3/04/2019 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference",,,10/29/2018 EIDX-US  GNW  Eidos Therapeutics to Host Conference Call and Webcast to Discuss Phase 2 Clinical Trial Results,,, 2/20/2019 XERS-US  GNW  Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference,10/08/2019 AUTL-US  GNW  Autolus Announces Changes to Executive Leadership Team," 8/06/2019 FTSV-US GNW  Forty Seven Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019", 8/30/2018 TBIO-US  GNW  Translate Bio to Participate in Citiâ€™s 13th Annual Biotech Conference,, 3/19/2019 PRNB-US GNW  Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results, 5/29/2019 ARVN-US GNW  Arvinas Receives Fast Track Designation for its Targeted Protein Degrader ARV-110 as a Treatment for Men with Metastatic Castration-Resistant Prostate Cancer, 7/08/2019 YMAB-US  GNW  Y-mAbs Announces Successful Pre-BLA Meeting with FDA for Naxitamab,," 4/04/2019 GRTS-US  GNW  Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board", 5/03/2019 GH-US    GNW  Guardant Health to Present at the Bank of America Merrill Lynch 2019 Health Care Conference,12/27/2018 OSMT-US  GNW  Osmotica Pharmaceuticals Appoints Seasoned Financial Executive Gregory Cowan to Board of Directors and Audit Committee," 3/24/2015 009Z8P-E GNW  NGM Biopharmaceuticals Announces Positive Phase 2 Clinical Data in Primary Biliary Cirrhosis Patients for NGM282, a First-in-Class Investigational Medicine",, 9/04/2019 ORTX-US  GNW  Orchard Therapeutics Presents an Integrated Data Analysis Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of Metachromatic Leukodystrophy,, 9/03/2019 ALEC-US  GNW  Alector to Present at 17th Annual Morgan Stanley Global Healthcare Conference, 5/29/2019 DTIL-US GNW  Precision BioSciences to Present at Upcoming Investor Conferences, 7/31/2019 TPTX-US GNW  Turning Point Therapeuticsâ€™ CEO to Present at Canaccord Genuity 39th Annual Growth Conference,,,,,, 9/24/2019 0JVC6M-E GNW  Ivy Brain Tumor Center and BridgeBio Subsidiary QED Therapeutics Announce Collaboration to Advance Cancer Research and Treatment Options, 6/26/2019 ADPT-US  GNW  Adaptive Biotechnologies Announces Pricing of Initial Public Offering,
, 8/08/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Additional Governance Enhancements,12/09/2011 VRUS.XX1-US GNW  Quarterly Changes to the NASDAQ Q-50 Index," 3/20/2013 84763A10 GNW  Lawsuit on Behalf of Spectrum Pharmaceuticals, Inc. (SPPI) Investors Announced by Shareholders Foundation","12/23/2016 G3040110 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Endo International plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 6, 2017 â€“ ENDP","10/31/2014 04280A10 GNW  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Arrowhead Research Corp. (ARWR) to Contact the Firm", 5/06/2019 BDSI-US  GNW  BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCAÂ® Full-Year Expectations,," 3/15/2015 REGN-US  GNW  Sanofi, Regeneron: 18-Month Results of ODYSSEY LONG TERM Trial with Praluent(TM) (alirocumab) Published in The New England Journal of Medicine", 7/13/2018 SIGA-US      GNW  U.S. Food and Drug Administration Approves SIGA Technologiesâ€™ TPOXXÂ® (tecovirimat) for the Treatment of Smallpox, 5/17/2019 OPK-US   GNW  Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories, 6/20/2019 46222210 GNW  Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting," 7/14/2016 BMRN-US     GNW  BioMarin to Host Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4 at 4:30pm ET", 4/05/2011 ALXN-US  GNW  Diagnosis and Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) to be Presented Live Online Via Video at Oncology Care Live April 27th,," 1/11/2017 81257810 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Seattle Genetics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 â€“ SGEN"," 9/12/2019 IMMU-US  GNW  Immunomedics to Host Investor Event and Webcast on September 28, 2019 During ESMO Congress", 9/11/2019 BIIB-US   GNW  New Data Presented at ECTRIMS Reinforce Long-term Benefits of TECFIDERAÂ® (dimethyl fumarate) Over 10 Years,,11/18/2019 BCRX-US  GNW  BioCryst Announces Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock, 7/18/2013 PACB-US  GNW  Pacific Biosciences Appoints John F. Milligan to Board of Directors,, 6/25/2019 N5946510 GNW  Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors,," 4/08/2019 00972810 GNW  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In AKRX, UMC, CAG or CNDT To Contact The Firm","12/01/2016 CYTK-US  GNW  Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil","11/22/2019 62855J10 GNW  4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching"," 7/30/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Date Change for Second Quarter 2019 Financial Results Conference Call and Webcast to July 31, 2019",12/12/2018 MGTX-US  GNW  MeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinsonâ€™s Disease," 4/25/2018 INSM-US  GNW  Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018","11/06/2013 AUP-CA   GNW  Aurinia Appoints Accomplished Biotech and Pharma Industry Veteran, Stephen W. Zaruby, as President & CEO"," 3/16/2020 INO-US    GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed"," 9/12/2019 64026810 GNW  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Nektar Therapeutics Investors of Important October 18th Deadline in Securities Class Action - NKTR",," 2/05/2020 37416310 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm",,11/11/2019 AMRN-US  GNW  Amarin to Present at the Jefferies 2019 London Healthcare Conference, 9/18/2017 45337C10 GNW  Incyte Corporation (Nasdaq: INCY) to Ring The Nasdaq Stock Market Closing Bell, 7/08/2014 91307C10 GNW  Supernus to Receive $30 Million in Non-Dilutive Royalty Deal,"10/04/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Positive Functional Results from the SRP-9003 (MYO-101) Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy"," 2/12/2019 G0176710 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ALKS, ASTE and WRCDF/WCAGY",, 9/23/2019 AMAG-US  GNW  AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders,12/10/2015 ARQL-US  GNW  ArQule and Daiichi Sankyo Announce Completion of Accrual in METIV-HCC Phase 3 Trial of Tivantinib for Second-Line Hepatocellular Carcinoma,,,, 1/20/2020 SAN-FR   GNW  Sanofi : Hart-Scott-Rodino waiting period expires for Sanofiâ€™s acquisition of Synthorx,, 4/01/2019 ALLO-US  GNW  Allogene Therapeutics Presents Preclinical Data Demonstrating the Potential of AlloCAR Tâ„¢ Therapy in Renal Cell Carcinoma (RCC) at the 2019 AACR Annual Meeting, 5/16/2019 ASND-US  GNW  Ascendis Pharma A/S Announces First Quarter 2019 Financial Results and Business Update Conference Call on May 30,," 8/18/2018 00422510 GNW  Kaskela Law LLC Announces Shareholder Class Action Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm â€“ ACAD"," 6/12/2019 AFMD-US  GNW  Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland",, 6/03/2019 PRQR-US  GNW  ProQR to Present at the JMP Securities Life Sciences Conference,," 9/23/2019 98978L20 GNW  ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zogenix, Inc. and Encourages Investors with Losses to Contact the Firm", 1/16/2020 01671P10 GNW  Block & Leviton LLP Alerts Investors of Investigations into Allakos and Sterling Bancorp for Violations of Federal Securities Laws,,10/29/2015 76133010 GNW  Revance Reports Positive 6-Month Duration in BELMONT Study,,,10/23/2019 ADVM-US  GNW  Adverum Biotechnologies Announces Data Presentations at the European Society of Gene and Cell Therapy (ESGCT) 2019 Congress, 9/04/2019 RARE-US   GNW  Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia,12/06/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present at BMO Capital Markets 2018 Prescription for Success Healthcare Conference, 3/07/2019 NSTG-US  GNW  NanoString Technologies Releases Fourth Quarter andÂ Full Year 2018 Operating Results and Provides 2019 Outlook,,, 3/23/2019 RDUS-US  GNW  Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOSÂ® (abaloparatide) Injection at ENDO 2019 Annual Meeting, 5/09/2019 ASMB-US  GNW  Assembly Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights,,,"10/29/2018 02043Q10 GNW  Recent Analysis Shows Harley-Davidson, Broadcom Inc., MedEquities Realty Trust, Alnylam Pharmaceuticals, Stein Mart, and Patterson Companies Market Influences â€” Renewed Outlook, Key Drivers of Growth", 3/01/2019 WVE-US   GNW  Wave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business Update, 9/16/2019 IONS-US  GNW  Positive Phase 1 Results of AKCEA-TTR-LRx Presented at the Heart Failure Society of America Annual Meeting,, 5/07/2019 PCRX-US  GNW  Pacira BioSciences to Present at Two Healthcare Conferences in May, 4/23/2019 RTRX-US  GNW  Retrophin to Report First Quarter 2019 Financial Results,"10/16/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call", 5/07/2019 0GQ0VB-E GNW  Editas Medicine Announces First Quarter 2019 Results and Update, 5/09/2019 CHMA-US  GNW  Chiasma Reports First Quarter 2019 Results,10/30/2019 MGNX-US  GNW  MacroGenics Announces Date of Third Quarter 2019 Financial Results Conference Call,,,12/01/2014 28249U10 GNW  Celladon Corporation to Present at 11th Global Cardio Vascular Clinical Trial Forum, 4/18/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2019 Financial Results Conference Call and Webcast, 9/13/2018 G7280010 GNW  The Law Offices of Howard G. Smith Reminds Investors of Extended Lead Plaintiff Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA), 8/26/2019 ZLAB-US  GNW  Zai Lab Announces Upcoming Presentations at September Conferences, 9/03/2015 78667J10 GNW  SAGE Therapeutics Announces Results From Successful Exploratory Trial in Essential Tremor, 8/06/2019 CTMX-US  GNW  CytomX Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference, 7/22/2019 GMAB-DK  GNW  Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) in the United States and Registration of Capital Increase, 3/20/2019 92165910 GNW  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. â€“ VNDA,, 5/08/2019 CBAY-US  GNW  CymaBay Therapeutics Announces Multiple Presentations at DDW 2019, 7/13/2012 45781M10 GNW  GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe, 1/24/2019 CCXI-US  GNW  ChemoCentryx Announces Withdrawal of Phase II-Based Conditional Marketing Authorization (CMA) Application forÂ ANCA-Associated Vasculitis in Europe; Phase III ADVOCATE Trial Data Release Planned for Q4 2019,,, 7/11/2019 MNKD-US   GNW  MannKind Expands Commercial Scale Manufacturing Capabilities for High-Potency Molecules,11/27/2017 URGN-US  GNW  UroGen Pharma Announces Oral Presentation at Society of Urologic Oncology (SUO) Annual Meeting,11/06/2019 CYTK-US  GNW  Cytokinetics Announces Proposed Public Offering of  Convertible Senior Notes,"10/29/2019 ESPR-US     GNW  Esperion to Report Third Quarter 2019 Financial Results November 6, 2019"," 5/16/2019 03236M20  GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.",, 3/07/2019 ACHN-US  GNW  Achillion Reports Fourth Quarter and Full Year 2018 Financial Results, 5/21/2019 SYNH-US  GNW  Syneos Health to Present at Upcoming Investor Conferences, 6/04/2019 FOLD-US  GNW  Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock,,, 5/21/2019 ADMA-US  GNW  ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares," 7/23/2019 GWPH-US  GNW  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending June 30, 2019 and Host Conference Call on August 6, 2019",10/25/2017 EPZM-US  GNW  Epizyme Announces Date of Third Quarter 2017 Financial Results,," 7/31/2019 MYOK-US  GNW  MyoKardia to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019",,10/24/2019 GLPG-NL  GNW  Solid third quarter 2019 performance with strong balance sheet for continued R&D growth, 2/10/2020 73701010 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,,,, 7/09/2019 CARA-US  GNW  Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVAâ„¢ (CR845/difelikefalin) for Pruritus in Patients with Atopic Dermatitis,10/04/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 7/29/2019 QURE-US  GNW  uniQure Announces Second Quarter 2019 Results and Highlights Recent Company Progress,"10/17/2019 AGIO-US   GNW  Agios to Webcast Conference Call of Third Quarter 2019 Financial Results  on October 31, 2019", 5/31/2019 IOVA-US  GNW  Iovance Biotherapeutics to Participate in Upcoming Conferences in June, 3/04/2019 ANAB-US  GNW  AnaptysBio to Present at the Cowen and Company 39th Annual Health Care Conference,, 7/17/2019 FATE-US  GNW  Fate Therapeutics Announces the Appointment of Dr. Shefali Agarwal to its Board of Directors," 1/30/2018 HZNP-US  GNW  Horizon Pharma plc Announces the Launch of â€œCystinosis Unitedâ€ to  Educate, Inspire and Connect the Cystinosis Community",, 5/10/2019 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences in May,12/07/2019 KPTI-US    GNW  Karyopharm Reports New and Updated XPOVIOÂ® (Selinexor) Data in Relapsed or Refractory Multiple Myeloma at the American Society of Hematology 2019 Annual Meeting,,, 7/08/2019 ITCI-US  GNW  Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression,,,," 1/03/2019 AMPH-US  GNW  Amphastar Pharmaceuticals, Inc. Announces Launch of PrimateneÂ® MIST to Nationwide Retail Pharmacies", 6/04/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Collaborator Presentation Updating Positive Phase 1 Clinical Results for a Mesothelin-Targeted CAR T Immunotherapy in Patients with Advanced Mesothelioma,,"10/31/2018 DERM-US  GNW  Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018","10/10/2019 FOMX-US  GNW  Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference", 2/25/2019 PRAH-US  GNW  PRA Health Sciences and CISCRP Collaborate to Provide Clinical Trial Results Summaries to Patients and the Public, 3/06/2019 SUPN-US  GNW  Supernus to Present at the 2019 Cowen Health Care Conference," 8/26/2019 FGEN-US  GNW  Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive"," 6/03/2015 74587V10 GNW  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Puma Biotechnology, Inc. (PBYI)", 7/29/2019 CHRS-US  GNW  Coherus BioSciences Reports Victory in Pegfilgrastim Patent Dispute," 5/08/2019 21833P10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bridgepoint, Corbus, and NIO and Encourages Investors to Contact the Firm",, 3/28/2019 ASRT-US  GNW  Assertio Therapeutics Announces Favorable NUCYNTAÂ® Patent Ruling, 5/31/2019 XBIT-US  GNW  XBiotech Announces Pricing of Public Offering of Common Shares,,, 9/25/2019 GBT-US   GNW  GBT Announces Participation at the 2019 Cantor Global Healthcare Conference, 8/25/2017 75901B10 GNW  REGENXBIO to Acquire Dimension Therapeutics, 8/07/2019 KURA-US  GNW  Kura Oncology to Present at Wedbush PacGrow Healthcare Conference, 9/03/2019 APLS-US  GNW  Apellis Dosed First Patient in Phase 3 Study of APL-2 for Treatment-NaÃ¯ve Patients with Paroxysmal Nocturnal Hemoglobinuria,10/16/2019 AXSM-US  GNW  Axsome Therapeutics Announces Completion of Patient Enrollment in the GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder," 3/11/2019 92915B10 GNW  MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAGâ„¢ Device","11/07/2019 07725L10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of BeiGene, Ltd. - BGNE",," 2/21/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2018 Financials and to Provide an Update on Development Programs", 9/29/2019 HCM-GB   GNW  Chi-Med to Discuss Surufatinib Phase III and U.S. Phase I/Ib Efficacy and Safety Data Presented at the 2019 ESMO Annual Meeting,12/06/2018 NOVN-CH  GNW  Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population," 3/27/2019 ACIU-US  GNW  New Clinical Data on AC Immuneâ€™s Novel Next Generation Tau PET-Tracer Presented by Licensing Partner, Life Molecular Imaging, at AD/PDâ„¢ Conference", 2/21/2019 CRSP-US  GNW  CRISPR Therapeutics Proposes New Members to the Board of Directors, 6/18/2019 GTHX-US  GNW  G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistically Significant Improvement in Overall Survival in Women with Metastatic Triple-Negative Breast Cancer, 3/26/2018 ARGX-BE  GNW  argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis in Europe, 4/02/2019 RUBY-US GNW  Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting," 8/07/2019 ATNX-US  GNW  Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance"," 5/08/2019 PETQ-US  GNW  PetIQ, Inc. Enters Into Definitive Agreement to Acquire Perrigo Animal Health", 6/19/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors, 2/15/2019 OPTN-US  GNW  Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco," 3/18/2019 TORC-US  GNW  resTORbio, Inc. Announces Proposed Public Offering of Common Stock", 5/30/2018 DNLI-US  GNW  Denali Therapeutics Announces Early Exercise of Its Option to Acquire F-star Gamma,, 5/29/2018 83422E10 GNW  Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the May 29th Deadline in the Class Action Lawsuit Against Solid Biosciences Inc. (SLDB), 5/28/2019 EOLS-US  GNW  Evolus to Participate in Three Upcoming Investor Conferences, 5/02/2019 FIXX-US GNW  Homology Medicines Presents Data from Gene Therapy and Gene Editing Programs and Manufacturing Capabilities at ASGCT Meeting, 7/25/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Early Assignment of Permanent and Specific J-Code J7314 for YUTIQÂ® by the Center for Medicare and Medicaid Services (CMS), 4/02/2019 SRRK-US  GNW  Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFÎ²1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy," 2/25/2019 UBX-US   GNW  CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results",,,"10/26/2018 EIDX-US  GNW  Eidos Therapeutics Receives Positive Opinion for Orphan Designation from the European Medicines Agency for AG10, a Potent Oral Stabilizer for the Treatment of Transthyretin Amyloidosis",,, 2/13/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock,10/03/2019 AUTL-US  GNW  Autolus Announces Data Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting," 8/06/2019 FTSV-US GNW  Forty Seven, Inc. Announces $6 Million in Funding from the Leukemia & Lymphoma Society TAP to Accelerate the Development of 5F9 in Myelodysplastic Syndrome", 8/09/2018 TBIO-US  GNW  Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate AchievementsÂ ,, 3/11/2019 PRNB-US GNW  Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program, 5/08/2019 ARVN-US GNW  Arvinas Reports First Quarter Financial Results and Provides Corporate Update, 7/01/2019 YMAB-US  GNW  Y-mAbs Announces Recruitment Status for Pivotal Trials,, 4/03/2019 GRTS-US  GNW  Gritstone Oncology to Present at Needham Healthcare Conference," 5/02/2019 GH-US    GNW  Guardant Health to Report First Quarter 2019 Financial Results on May 9, 2019",12/03/2018 OSMT-US  GNW  Osmotica Pharmaceuticals to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference, 3/02/2015 009Z8P-E GNW  NGM Biopharmaceuticals Announces Expansion of Management Team,, 9/03/2019 ORTX-US  GNW  Orchard Therapeutics to Webcast Presentation at the Morgan Stanley 17th Annual Global Healthcare Conference,, 8/12/2019 ALEC-US  GNW  Alector Reports Recent Business Highlights and Second Quarter 2019 Financial Results," 5/14/2019 DTIL-US GNW  Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer"," 7/31/2019 TPTX-US GNW  Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors",,,,,, 9/05/2019 BBIO-US  GNW  BridgeBio Pharmaâ€™s Origin Biosciences Presents New Data on the Natural History of Molybdenum Cofactor Deficiency (MoCD) Type A at the Society of the Study of Inborn Errors of Metabolism (SSIEM) Conference," 4/03/2017 ADPTQ-US GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Adeptus Health Inc.Â (ADPT) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",
, 8/06/2019 PGNX-US  GNW  CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRAÂ® (iobenguane I 131), 8/30/2011 UNH-US      GNW  Product Development and Management Association Announces 2011 Outstanding Corporate Innovator Award Winners," 3/18/2013 84763A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of May 13, 2013 to Seek a Lead Plaintiff Position -- SPPI","12/06/2016 G3040110 GNW  UPCOMING DEADLINE: Levi & Korsinsky, LLP NotifiesÂ Shareholders of Endo International plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 6, 2017 â€“ ENDP",10/27/2014 04280A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Arrowhead Research Corporation of Class Action Lawsuit and Upcoming Deadline -- ARWR, 4/25/2019 BDSI-US  GNW  BioDelivery Sciences to Report First Quarter 2019 Financial Results,," 9/11/2014 ADVM-US  GNW  Avalanche Biotechnologies, Inc. Reports Second Quarter 2014 Financial Results", 7/05/2018 SIGA-US      GNW  Pivotal Trial Data for SIGA Technologiesâ€™ Oral TPOXXÂ® Published in the New England Journal of Medicine, 5/07/2019 OPK-US   GNW  OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results, 5/28/2019 IONS-US  GNW  Akcea Therapeutics to Present at Upcoming Investor Conferences," 6/20/2016 BMRN-US     GNW  BioMarin Announces Acceptance of Late Breaking Abstract for BMN 270 at the World Federation of Hemophilia (WFH) 2016 World Congress July 27 in Orlando, FL"," 3/29/2011 003ZHQ-E GNW  Alexion Pharmaceuticals, Inc. to Join the NASDAQ-100 Index Beginning April 4, 2011",, 9/10/2014 GMAB-DK  GNW  Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration," 9/05/2019 45290710 GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of MGT Capital Investments, First American Financial, Immunomedics, and AAC Holdings and Encourages Investors to Contact the Firm", 8/20/2019 BIIB-US   GNW  Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients,,11/14/2019 BCRX-US  GNW  BioCryst to Present at Upcoming Investor Conferences, 5/01/2013 GWP-GB   GNW  NASDAQ Welcomes GW Pharmaceuticals to The NASDAQ Stock Market,, 4/30/2019 MYL-US   GNW  Mapi Pharma to Present Phase II Extension Results of Glatiramer Acetate Depot (GA Depot) at the 2019 AAN Annual Meeting in Philadelphia on May 7 2019,," 4/07/2019 00972810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â AKRX",11/30/2016 03116210 GNW  The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patients With Chronic Heart Failure,"11/22/2019 62855J10 GNW  DEADLINE ALERT - Myriad Genetics, Inc. (MYGN)Â - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 26, 2019", 7/26/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Provides Preliminary Update for Zynquistaâ„¢ (Sotagliflozin) Type 2 Diabetes Phase 3 Program,11/08/2018 MGTX-US  GNW  MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update, 3/29/2018 INSM-US  GNW  Insmed Submits New Drug Application to FDA for ALIS in  NTM Lung Disease Caused by MAC,," 3/16/2020 INO-US    GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. (INO)"," 9/11/2019 64026810 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Nektar Therapeutics Investors",," 2/05/2020 37416310 GNW  GERN ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Geron Corporation Investors of Important Deadline in Securities Class Action â€“ GERN",,11/05/2019 AMRN-US  GNW  Amarin Reports Third Quarter 2019 Financial Results and Provides Update on Operations, 7/11/2017 45337C10 GNW  Merus Announces First Quarter 2017 Financial Results and Mid-Year Operating Results, 5/20/2014 91307C10 GNW  Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM),"10/02/2019 80360710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, Meredith Corporation, and MacroGenics and Encourages Investors to Contact the Firm"," 2/11/2019 G0176710 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GS, AXGN, ALKS and SVXY",, 9/12/2019 AMAG-US  GNW  AMAG Sends Letter to Shareholders,11/17/2015 ARQL-US  GNW  ArQule and the National Human Genome Research Institute of the National Institutes of Health Announce Enrollment of First Patient in the Phase 1 Proteus Syndrome Trial With ARQ 092,,,, 1/09/2020 SAN-FR   GNW  Sanofi : Availability of the Pre-quarterly Results Communication,, 3/08/2019 ALLO-US  GNW  Allogene Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results, 5/07/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in the Bank of America Merrill Lynch 2019 Healthcare Conference,, 8/18/2018 00422510 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ACAD, 6/04/2019 AFMD-US  GNW   Affimed Announces Annual General Meeting of Shareholders,, 5/15/2019 PRQR-US  GNW  ProQR to Present at the RBC Capital Markets Healthcare Conference,," 9/18/2019 98978L20 GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Orion Group Holdings, Zogenix, and Apyx and Encourages Investors to Contact the Firm", 1/03/2020 01671P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK,, 9/29/2015 76133010 GNW  Revance Therapeutics Initiates Phase 2 Clinical Study of Its Unique Botulinum Toxin Type A for Injection to Treat Cervical Dystonia,,,10/11/2019 ADVM-US  GNW  Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at theÂ American Academy of Ophthalmology 2019 Annual Meeting, 9/03/2019 0K8KRW-E  GNW  GeneTx and Ultragenyx Announce Orphan Drug Designation and  Rare Pediatric Disease Designation for GTX-102,11/20/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present at Evercore ISI HealthconX Conference, 3/04/2019 NSTG-US  GNW  NanoString to Present at the 39th Annual Cowen Healthcare Conference,,, 3/18/2019 RDUS-US  GNW  Radius Health to Present Data on TYMLOSÂ® (abaloparatide) Injection at ENDO 2019 Annual Meeting, 5/02/2019 ASMB-US  GNW  Assembly Biosciences Announces Changes to Senior Leadership Team,,,"10/28/2018 02043Q10 GNW  CLASS ACTION UPDATE for ALNY, CHGG and ACHC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 1/24/2019 WVE-US   GNW  Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares, 8/29/2019 00972L10 GNW  Akcea and Ionis to Present New Data for TEGSEDI and AKCEA-TTR-LRx at Two Upcoming Medical Meetings,, 5/07/2019 PCRX-US  GNW  Phase 4 Study Demonstrates Superiority of EXPAREL plus Bupivacaine versus Bupivacaine Alone in Cesarean Section Procedures," 3/06/2019 76129910 GNW  Detailed Research: Economic Perspectives on KAR Auction Services, Spectrum Brands, Vertex Pharmaceuticals, The Kraft Heinz, comScore, and Retrophin â€” What Drives Growth in Today's Competitive Landscape",10/15/2018 PACB-US  GNW  PacBio Long-Read Sequencing Featured at ASHG Annual Meeting, 4/30/2019 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing First Quarter 2019 Results and Corporate Update," 4/30/2019 CHMA-US  GNW  Chiasma to Report First Quarter Financial Results on May 9, 2019","10/30/2019 55609910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, ViewRay, Cadence Bancorp, and ProPetro and Encourages Investors to Contact the Firm",,,"11/14/2014 28249U10 GNW  Celladon Selected to Present During the ""Best of Circulation Research"" Symposium at the American Heart Association Scientific Sessions 2014", 3/28/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019, 9/06/2018 G7280010 GNW  September 17th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA)," 8/20/2019 ZLAB-US  GNW  Zai Lab to Report Financial Results for the Six Months Ended June 30, 2019 and Provide Corporate Update on September 3, 2019", 8/17/2015 78667J10 GNW  SAGE Announces First Patient Treated in Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus, 7/30/2019 CTMX-US  GNW  CytomX Therapeutics to Announce Second Quarter 2019 Financial Results, 7/19/2019 GMAB-DK  GNW  Major Shareholder Announcement, 3/20/2019 92165910 GNW  CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) To Contact Brower Piven Before The Lead Plaintiff Deadline,," 4/30/2019 CBAY-US  GNW  CymaBay Therapeutics to Report First Quarter 2019 Financial Results on Wednesday, May 8", 7/10/2012 45781M10 GNW  Theravance Announces Positive Topline Results From TD-1211 Phase 2b Study 0084 for the Treatment of Opioid-Induced Constipation, 1/02/2019 CCXI-US  GNW  ChemoCentryx to Present at the 37th Annual J.P. Morgan Healthcare Conference,,, 6/12/2019 MNKD-US   GNW  MannKind to Present at the JMP Securities Life Sciences Conference,11/14/2017 URGN-US  GNW  UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments,11/05/2019 CYTK-US  GNW  Cytokinetics to Participate in the Credit Suisse 28th Annual Healthcare Conference,10/25/2019 ESPR-US     GNW  Bempedoic Acid Included in Top 10 Medical Innovations for 2020 List, 5/15/2019 AMRS-US   GNW  Amyris Retires May 2019 Convertible Note Debt,, 2/21/2019 ACHN-US  GNW  Achillion Pharmaceuticals Expands Operations and Clinical Development into Philadelphia Area Office Market, 5/09/2019 SYNH-US  GNW  Syneos Health Leaders Honored by the Healthcare Businesswomenâ€™s Association for Visionary Healthcare Expertise, 6/03/2019 FOLD-US  GNW  Amicus Therapeutics to Present at Upcoming Scientific and Investor Conferences,,, 5/17/2019 ADMA-US  GNW  ADMA Biologics Announces Pricing of Public Offering of Common Stock, 6/27/2019 36197T10 GNW  Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer, 9/19/2017 EPZM-US  GNW  Epizyme Announces Closing of Public Offering of Common Stock,, 7/18/2019 MYOK-US  GNW  MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi,,10/10/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  ANNOUNCE  EFFICACY  AND  SAFETY  RESULTS  OF  FILGOTINIB  THROUGH  52  WEEKS  IN  FINCH  1  AND  FINCH  3  STUDIES  IN  RHEUMATOID  ARTHRITIS," 2/07/2020 73701010 GNW  Saxena White P.A. Files New Securities Fraud Class Action Complaint Against Portola Pharmaceuticals, Inc. with Expanded Class Period",,,, 6/26/2019 CARA-US  GNW  Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVAáµ€á´¹ (CR845/difelikefalin) for Pruritus in Patients with Primary Biliary Cholangitis (PBC),10/02/2019 FLXN-US  GNW  Former NY Yankees Outfielder Chris Dickerson Teams Up With Flexion Therapeutics to Raise Awareness of Impact of Osteoarthritis (OA), 7/26/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences,10/09/2019 AGIO-US   GNW  Agios to Present Data from AG-270 Phase 1 Dose-Escalation Study in Patients with MTAP-Deleted Tumors in a Proffered Papers Oral Presentation and Poster Session at the AACR-NCI-EORTC International Conference, 5/29/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces New Facility to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products, 2/28/2019 ANAB-US  GNW  AnaptysBio Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Pipeline Updates,, 5/30/2019 FATE-US  GNW  Fate Therapeutics to Present at the Jefferies 2019 Healthcare Conference," 1/29/2018 HZNP-US  GNW  Horizon Pharma plc to Release Fourth-Quarter and Full-Year 2017 Financial ResultsÂ and Host Webcast on Feb. 28, 2018",, 5/10/2019 ICPT-US  GNW  Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026,12/02/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 7/02/2019 ITCI-US  GNW  Intra-Cellular Therapies Appoints Karen Patruno Sheehy, Esq. as Senior Vice President, Chief Compliance Officer",,,,11/20/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference 2018, 6/01/2019 ATRA-US    GNW  Atara Biotherapeutics Presents Tab-celÂ® Clinical Biomarker Results and Nasopharyngeal Carcinoma Study Design at American Society of Clinical Oncology (ASCO) Annual Meeting,,10/23/2018 DERM-US  GNW  Dermira Completes Patient Enrollment in Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis, 9/20/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Cantor Global Healthcare Conference, 2/04/2019 PRAH-US  GNW  PRA Health Sciences to Report Fourth Quarter 2018 Earnings, 2/26/2019 SUPN-US  GNW  Supernus Announces Record Full Year 2018 Financial Results, 8/21/2019 FGEN-US  GNW  Roxadustat Approved in China for Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis,, 7/19/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 5/08/2019 21833P10 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.",, 2/27/2019 COLL-US  GNW  Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results, 5/30/2019 XBIT-US  GNW  XBiotech Announces Public Offering of Common Shares,,, 9/05/2019 GBT-US   GNW  GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease, 8/11/2017 RGNX-US  GNW  REGENXBIO to Present on RGX-314 Gene Therapy Program for Wet AMD at 35th Annual Scientific Meeting of the American Society of Retina Specialists, 8/01/2019 KURA-US  GNW  Kura Oncology Reports Second Quarter 2019 Financial Results and Provides Corporate Update, 8/28/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/02/2019 AXSM-US  GNW  Axsome Therapeutics to Provide Update on Continued Progress at the 2019 Cantor Global Healthcare Conference, 2/26/2019 VYGR-US  GNW  Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights,11/06/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on Zanubrutinib to Be Presented at the 61st American Society of Hematology Annual Meeting,, 2/20/2019 RETA-US  GNW  Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in Patients with Focal Segmental Glomerulosclerosis and in Patients From All Four Cohorts of PHOENIX, 9/25/2019 HCM-GB   GNW  Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-ep Phase III Trial at ESMO Annual Meeting,11/08/2018 NTLA-US  GNW  Intellia Therapeutics to Present at November Healthcare Investor Conferences, 3/21/2019 LLY-US   GNW  AC Immune Reports Full-Year 2018 Financial Results andÂ Provides Business Update, 2/19/2019 0H304H-E GNW  CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement, 6/14/2019 GTHX-US  GNW  G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting, 3/01/2018 ARGX-BE  GNW  argenx reports fourth quarter business update  and full year 2017 financial results, 3/28/2019 RUBY-US GNW  Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates, 8/07/2019 ATNX-US  GNW  Athenex Announces Oral Paclitaxel and Encequidar had a Significantly Higher Response Rate Over IV Paclitaxel in a Phase III Pivotal Study in Metastatic Breast Cancer," 5/07/2019 71639T10 GNW  PETIQ INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In PetIQ Inc. To Contact The Firm", 5/30/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference, 2/04/2019 68404V10 GNW  Optinose Announces License Agreement, 3/18/2019 TORC-US  GNW  resTORbio Reports Fourth Quarter and Full Year 2018 Financial Results, 5/11/2018 DNLI-US  GNW  Denali Therapeutics Reports First Quarter 2018 Financial Results,," 5/26/2018 SLDB-US  GNW  FINAL DEADLINE ALERT: Shareholder Class Action Lawsuit Against Solid Biosciences, Inc.", 5/15/2019 EOLS-US  GNW  Evolus Announces First Shipment of Jeuveauâ„¢ (prabotulinumtoxinA-xvfs) to Customers in the United States, 4/30/2019 FIXX-US GNW  Homology Medicines Presents Data Demonstrating Suite of Novel AAV Vectors Targeted Key Cell Types for Inherited Retinal Diseases, 7/24/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Second Quarter 2019 Financial Results Release Date and Conference Call Information, 3/18/2019 SRRK-US  GNW  Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress, 1/22/2019 UBX-US   GNW  UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee,,,10/05/2018 EIDX-US  GNW  Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR Amyloidosis Cardiomyopathy at the AHA 2018 Scientific Sessions in a Late-Breaking Featured Science Oral Presentation,,, 2/11/2019 XERS-US  GNW  Xeris Pharmaceuticals Announces Proposed Public Offering of Shares of Common Stock, 9/03/2019 AUTL-US  GNW  Autolus Announces Publication in Nature Medicine of Data Supporting the Development of AUTO1 for Treatment of Patients with ALL, 7/31/2019 FTSV-US GNW  Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference, 7/09/2018 0072XH-E GNW  Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases,, 3/02/2019 PRNB-US GNW  Principia Biopharma Announces Positive Data from Phase 2 Pemphigus Vulgaris Trial at 2019 American Academy of Dermatology Annual Meeting in Late-Breaking Presentation," 4/02/2019 ARVN-US GNW  Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer and Ian Taylor, Ph.D. as Chief Scientific Officer", 7/01/2019 YMAB-US  GNW  Y-mAbs Secures Commercial Radiolabeling Capacity,, 4/02/2019 GRTS-US  GNW  Gritstone Oncology Presents Data at AACR Demonstrating MHC Class II Neoantigen Prediction with EDGEâ„¢ Significantly Outperforms Current Prediction Methods, 4/23/2019 GH-US    GNW  Guardant Health Appoints Dr. Bahija Jallal to its Board of Directors,11/08/2018 OSMT-US  GNW  Osmotica Pharmaceuticals plc Reports Third Quarter 2018 Results,,," 8/30/2019 ORTX-US  GNW  Orchard Therapeutics Further Strengthens Board of Directors with Appointment of John Curnutte, M.D., Ph.D.",," 8/12/2019 ALEC-US  GNW  Alector Announces the Addition of Kristine Yaffe, M.D., to the Board of Directors", 5/09/2019 DTIL-US GNW  Precision BioSciences Announces Presentations at the 14th Annual Terrapinn World Advanced Therapies & Regenerative Medicine Congress & Expo 2019, 7/29/2019 TPTX-US GNW  Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer,,,,,,, 6/15/2016 ARGSQ-US GNW  Argos Therapeutics Enters into Strategic Research Agreement with Adaptive Biotechnologies,
, 8/05/2019 PGNX-US  GNW  Progenics Pharmaceuticals Completes Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer,,12/16/2011 0BLM55-E GNW  Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA,"11/27/2016 G3040110 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Endo International plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit â€“ ENDP",10/24/2014 04280A10 GNW  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important Deadline in Class Action Filed by Firm - ARWR," 4/11/2019 BDSI-US  GNW  BioDelivery Sciences International, Inc. Announces Pricing of Public Offering of Common Stock",, 7/09/2014 REGN-US  GNW  Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis," 5/31/2018 SIGA-US      GNW  SIGA to Present at the Jefferies Global Healthcare Conference on June 8, 2018"," 5/02/2019 OPK-US   GNW  BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions"," 5/14/2019 46222210 GNW  Biogenâ€™s SPINRAZAÂ® (nusinersen) Receives Positive Recommendation from NICE for Funding in the United Kingdom for the Treatment of Infants, Children and Adults with Spinal Muscular Atrophy", 5/31/2016 BMRN-US     GNW  BioMarin Announces Withdrawal of Market Authorization Application for Kyndrisaâ„¢ (drisapersen) in Europe," 2/25/2011 01535110 GNW  Alexion Pharmaceuticals, Inc. (ALXN) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell",, 6/14/2013 TWTC-US  GNW  Quarterly Changes to the NASDAQ Q-50 Index, 9/04/2019 IMMU-US  GNW  Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Metastatic Urothelial Cancer at ESMO 2019 Annual Congress, 7/30/2019 09062X10  GNW  Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis,,11/13/2019 BCRX-US  GNW  BioCryst Prices Public Offering of Common Stock, 3/22/2013 IDIX-US  GNW  Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference,, 3/18/2019 N5946510 GNW  Mapi Pharma Receives Government of Israel Funding for the Establishment of a Finished Dosage Form Facility for the Manufacturing of GA Depot Pharmaceuticals,," 4/02/2019 00972810 GNW  AKORN CLASS ACTION NOTICE: Rosen Law Firm Reminds Akorn, Inc. Investors of Important April 22nd Deadline in Securities Class Action Lawsuit Filed by the Firm â€“ AKRX",11/10/2016 GMAB-DK  GNW  Genmab Announces Phase III Study of Daratumumab in Combination with Carfilzomib in Multiple Myeloma,"11/21/2019 62855J10 GNW  CLASS ACTION UPDATE for SNDL, MYGN, DOMO and ET: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 7/25/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on August 1, 2019",10/31/2018 MGTX-US  GNW  MeiraGTx Announces Exclusive Licensing Agreement with National Institutes of Health for Gene Therapy Treatment for SjÃ¶grenâ€™s Syndrome and Associated Xerostomia or Xerophthalmia, 3/07/2018 INSM-US  GNW  Insmed to Present at the Cowen and Company 38th Annual Health Care Conference,,12/04/2018 AZN-GB    GNW  Inovio Announces Initiation of â€œMD Andersonâ€™s HPV-Related Cancers Moon Shotâ€ Phase 2 Trial in New HPV Indications," 9/10/2019 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nektar Therapeutics, Valaris, Burford, and Canada Goose and Encourages Investors to Contact the Firm",," 2/03/2020 37416310 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Geron Corporation (GERN) Investors Who Have Suffered Significant Losses to Contact its Attorneys; Securities Class Action Filed",,"11/04/2019 AMRN-US  GNW  Seven Data Presentations Relevant to VascepaÂ® (Icosapent Ethyl) Capsules and Persistent Cardiovascular Risk to be Presented at American Heart Associationâ€™s  2019 Scientific Sessions, November 16 â€“ 18", 4/28/2017 MRUS-US  GNW  Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Developments,"12/23/2013 91307C10 GNW  Supernus Announces FDA Approval of Its Partner's Product, Orenitram(TM)","10/01/2019 80360710 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT", 2/08/2019 G0176710 GNW  ALKS REMINDER: Rosen Law Firm Reminds Alkermes Public Limited Company Investors of Important February 25th Deadline in Securities Class Action â€“ ALKS,, 9/05/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference,11/09/2015 ARQL-US  GNW  UPDATE -- ArQule Presents Data on Tivantinib and Proprietary Pipeline at AACR-NCI-EORTC Conference,,,,"12/23/2019 SAN-FR   GNW  Sanofi commences tender offer for acquisition of Synthorx, Inc.",," 2/27/2019 ALLO-US  GNW  Allogene Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results on March 8, 2019", 4/24/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Presentations Related to Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences,," 8/16/2018 00422510 GNW  CLASS ACTION UPDATE for MRCY and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 6/03/2019 AFMD-US  GNW  Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagenâ€™s Patented Mammalian Expression Technology,, 5/08/2019 PRQR-US  GNW  ProQR Announces Financial Results for the First Quarter of 2019,," 9/16/2019 98978L20 GNW  ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zogenix, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",12/18/2019 01671P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Allakos Inc. - ALLK,, 9/28/2015 76133010 GNW  Revance Therapeutics Initiates Phase 3 Clinical Trial of Botulinum Toxin Type A Topical Gel to Treat Lateral Canthal Lines,,, 9/26/2019 ADVM-US  GNW  Adverum Biotechnologies to Present Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting, 8/30/2019 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences,11/08/2018 AGLE-US  GNW  Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights," 2/27/2019 63009R10 GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Wayfair, Valero Energy, Barrick Gold, U.S. Silica, NanoString Technologies, and Pzena Investment Management â€” New Research Emphasizes Economic Growth",,, 3/11/2019 RDUS-US  GNW  Radius Health to Present at Cowen 39th Annual Healthcare Conference," 4/22/2019 ASMB-US  GNW  Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development",,,"10/25/2018 02043Q10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRCO, COCP, ALNY and CHGG", 1/23/2019 WVE-US   GNW  Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares, 8/07/2019 00972L10 GNW  New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRAÂ® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome,, 5/02/2019 PCRX-US  GNW  Pacira BioSciences Reports First Quarter 2019 Revenues of $91.3 Million, 3/05/2019 RTRX-US  GNW  Retrophin to Present at Upcoming Investor Conferences,10/10/2018 PACB-US  GNW  Pacific Biosciences Announces a New Paradigm in DNA Sequencing â€“ Highly Accurate Single-Molecule Long Reads, 4/29/2019 AGN-US   GNW  Allergan and Editas Medicine Announce Initial Data from Natural History Study to Evaluate Patients with Leber Congenital Amaurosis 10 (LCA10), 4/03/2019 CHMA-US  GNW  Chiasma Announces Closing of $34.5 Million Offering of Common Stock and Full Exercise of Underwritersâ€™ Option,"10/28/2019 55609910 GNW  ROSEN, A HIGHLY RANKED LAW FIRM, Reminds MacroGenics, Inc. Investors of Important Deadline in Securities Class Action â€“ MGNX",,,11/12/2014 28249U10 GNW  Celladon Reports Third Quarter 2014 Financial Results and Recent Highlights, 3/21/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Publication of New Data Supporting M281 as First Anti-FcRn Antibody to Inhibit Maternal-Fetal IgG Transfer in the Human Term Placenta Â , 8/31/2018 G7280010 GNW  Glancy Prongay & Murray LLP Announces Extended Lead Plaintiff Deadline in Securities Class Action on Behalf of  Prothena Corporation plc Investors (PRTA), 8/12/2019 ZLAB-US  GNW  China National Medical Products Administration Grants Innovative Medical Device Designation for OptuneÂ® in China, 8/12/2015 78667J10 GNW  SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress," 7/09/2019 CTMX-US  GNW  CytomX Therapeutics Announces Second Target Selection and Program Initiation  with AbbVie Under Ongoing, Multi-Program Strategic Oncology Collaboration", 7/19/2019 GMAB-DK  GNW  Genmab Announces Full Exercise of Underwritersâ€™ Over-Allotment Option in Initial Public Offering," 3/19/2019 92165910 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm",, 4/12/2019 CBAY-US  GNW  CymaBay Therapeutics Presents Positive Phase 2 Data for Seladelpar in Patients with Primary Biliary Cholangitis at the International Liver Congressâ„¢ 2019, 7/02/2012 45781M10 GNW  GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD,11/29/2018 CCXI-US  GNW  ChemoCentryxâ€™s Novel Small Molecule Antagonists of Checkpoint Inhibitors and Chemokine Receptors to be Presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Conference,,, 6/09/2019 MNKD-US   GNW  MannKind Presents Positive AfrezzaÂ® Clinical Data from Three Studies at ADA 79th Scientific Sessions,11/09/2017 URGN-US  GNW  UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference,10/31/2019 CYTK-US  GNW  Cytokinetics Reports Third Quarter 2019 Financial Results, 9/05/2019 ESPR-US     GNW  Esperion Completes Patient Enrollment in the Global CLEAR Cardiovascular Outcomes Trial for Bempedoic Acid," 5/14/2019 03236M20  GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Amyris, Inc. Investors",, 2/19/2019 ACHN-US  GNW  Achillion to Present at the SVB Leerink 8th Annual Global Healthcare Conference, 5/09/2019 SYNH-US  GNW  Syneos Health Reports First Quarter 2019 Results, 5/30/2019 FOLD-US  GNW  Amicus Therapeutics Prices Underwritten Offering of Common Stock,,, 5/16/2019 00089910 GNW  NeuBase Therapeutics Designates Industry Leaders to Board of DirectorsÂ ," 6/04/2019 0JBRH7-E GNW  GW Pharmaceuticals to Present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11th, 2019", 9/14/2017 EPZM-US  GNW  Epizyme Announces Pricing of Public Offering of Common Stock,, 6/24/2019 MYOK-US  GNW  MyoKardia Publishes Data in Nature Digital Medicine Showing Potential of Wrist-Worn Biosensor to Screen for Hypertrophic Cardiomyopathy,,10/07/2019 GLPG-NL  GNW  Galapagos receives transparency notification from Wellington Management Group LLP," 2/05/2020 73701010 GNW  The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PLT)",,,, 5/31/2019 CARA-US  GNW  Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference, 9/30/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa, 7/06/2019 QURE-US  GNW  uniQure Announces 36 Weeks of Follow-Up Data from Phase IIb Study of AMT-061 and Long-Term Follow-Up Data for AMT-060 in Patients with Hemophilia B, 9/30/2019 AGIO-US   GNW  Data from Agiosâ€™ Phase 3 ClarIDHy Trial of TIBSOVOÂ® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients, 5/22/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy, 1/02/2019 ANAB-US  GNW  AnaptysBio to Present at J.P. Morgan 37th Annual Healthcare Conference,, 5/07/2019 FATE-US  GNW  Fate Therapeutics Reports First Quarter 2019 Financial Results and Highlights Operational Progress, 1/08/2018 HZNP-US  GNW  Horizon Pharma plc Increases Peak Net Sales Guidance for Key Growth Drivers and  Announces Rheumatology and Orphan Pipeline Developments,, 5/08/2019 ICPT-US  GNW  Intercept Pharmaceuticals Announces Proposed Offerings of $200 Million of Common Stock and $200 Million of Convertible Senior Notes due 2026,11/06/2019 KPTI-US    GNW  Karyopharm Announces XPOVIOÂ® (Selinexor) Clinical Data to be Presented at the American Society of Hematology 2019 Annual Meeting,,, 6/19/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at JMP Securities Life Sciences Conference,,,,11/09/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018, 5/30/2019 ATRA-US    GNW  Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences,,"10/17/2018 24983L10 GNW  Report: Exploring Fundamental Drivers Behind Dermira, California Resources, OGE Energy, Oasis Petroleum, Harmonic, and CBIZ â€” New Horizons, Emerging Trends, and Upcoming Developments", 9/19/2019 FOMX-US  GNW  Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam," 1/16/2019 69354M10 GNW  Zosano Appoints Linda Grais M.D., J.D. to Board of Directors", 2/12/2019 SUPN-US  GNW  Supernus to Host Fourth Quarter and Full Year 2018 Earnings Conference Call, 8/08/2019 FGEN-US  GNW  FibroGen Reports Second Quarter 2019 Financial Results,, 7/08/2019 CHRS-US  GNW  Coherus BioSciences Announces UnauditedÂ SecondÂ Quarter 2019 UDENYCAÂ®Â Net Sales of $79 Million to $84 Million," 5/03/2019 21833P10 GNW  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 2/13/2019 COLL-US  GNW  Collegium to Host Conference Call to Discuss Fourth Quarter 2018 Financial Results and Provide Corporate Update, 5/23/2019 XBIT-US  GNW  XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa,,, 9/04/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 8/08/2017 RGNX-US  GNW  REGENXBIO Reports Second Quarter 2017 Financial Results and Recent Operational Highlights, 7/25/2019 KURA-US  GNW  Kura Oncology to Report Second Quarter 2019 Financial Results, 8/28/2019 APLS-US  GNW  Apellis Pharmaceuticals to Present at Upcoming Investor Conferences, 9/05/2019 AXSM-US  GNW  Axsome Therapeutics Presents Positive AXS-07 Phase 1 Trial Results at the 19th Congress of the International Headache Society, 2/22/2019 ABBV-US  GNW  Voyager Therapeutics and AbbVie Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinsonâ€™s Disease and Other Synucleinopathies,10/31/2019 07725L10 GNW  BeiGene Announces Global Strategic Oncology Collaboration with Amgen,," 1/07/2019 RETA-US  GNW  Reata Pharmaceuticals, Inc. Appoints Geoffrey A. Block, M.D. as Vice President, Nephrology", 9/18/2019 HCM-GB   GNW  Chi-Med Highlights Oral Presentations at 2019 CSCO Annual Meeting,"11/07/2018 45826J10 GNW  Consolidated Research: 2018 Summary Expectations for STORE Capital, Ares Commercial Real Estate, Intellia Therapeutics, City Office REIT, RealPage, and Data I/O â€” Fundamental Analysis, Key Performance Indications", 3/04/2019 ACIU-US  GNW  AC Immune to Report Progress of Early-Stage Pipeline at AD/PDâ„¢ Congress, 1/22/2019 CRSP-US  GNW  CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies, 6/13/2019 GTHX-US  GNW  G1 Therapeutics Announces Updates to Board of Directors,12/18/2017 ARGX-BE  GNW  argenx announces closing of U.S. public offering for gross proceeds of approximately $266 million, 3/25/2019 RUBY-US GNW  Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer, 8/02/2019 ATNX-US  GNW  Athenex Provides an Update Regarding the Vasopressin Case," 4/23/2019 PETQ-US  GNW  PetIQ, Inc. to Report First Quarter 2019 Results on Wednesday, May 8th", 5/07/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Bank of America Merrill Lynch 2019 Health Care Conference,12/11/2018 OPTN-US  GNW  Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAILÂ Â , 3/18/2019 TORC-US  GNW  resTORbio Announces Positive End-of-Phase 2 Meeting with FDA and Planned Initiation of Global Phase 3 Program for RTB101, 3/19/2018 DNLI-US  GNW  Denali Therapeutics Announces First-In-Human Dosing Of Its RIPK1 Inhibitor Clinical Program And The Appointment Of Peter Klein To Board Of Directors; Reports Fourth Quarter And Full Year 2017 Financial Results And Business Highlights,, 5/26/2018 83422E10 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline â€“ SLDB, 4/30/2019 EOLS-US  GNW  Evolus Reports First Quarter 2019 Financial Results, 4/15/2019 FIXX-US GNW  Homology Medicines Announces Upcoming Presentations on its Gene Therapy and Gene Editing Platform and Manufacturing Capabilities at the American Society of Gene & Cell Therapy Meeting, 7/23/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Data Highlighting YUTIQÂ® to be Presented at the 37th Annual Scientific Meeting of the American Society of Retina Specialists," 3/12/2019 SRRK-US  GNW  Scholar Rock to Develop Cancer Immunotherapy Product Candidate, SRK-181, a Selective Inhibitor of TGFÎ²1 Activation, to Overcome Checkpoint Inhibitor Resistance", 1/03/2019 UBX-US   GNW  UNITY Biotechnology Announces Completion of  UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye,,,"10/03/2018 EIDX-US  GNW  FDA Grants Orphan Drug Designation to Eidos Therapeuticsâ€™ Product Candidate, AG10, for Treatment of Transthyretin Amyloidosis",,,11/07/2018 XERS-US  GNW  Xeris Pharmaceuticals Announces Third Quarter 2018 Financial Results and Highlights Pipeline Progress, 8/28/2019 AUTL-US  GNW  Autolus Therapeutics to Participate in Upcoming Investor Conferences in September," 7/22/2019 FTSV-US GNW  Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares",,, 3/01/2019 PRNB-US GNW  Principia Biopharma Presents Phase 1 Clinical Data from CNS Penetrating BTK Inhibitor Candidate PRN2246/SAR442168 at ACTRIMS 2019, 3/26/2019 ARVN-US GNW  Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update, 6/26/2019 YMAB-US  GNW  Y-mAbs Announces Data to be Presented at 2019 SIOP,, 3/28/2019 GRTS-US  GNW  Gritstone Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights, 4/15/2019 GH-US    GNW  NILE Study Results Demonstrating Guardant360â€™s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research,"11/05/2018 OSMT-US  GNW  Osmotica Pharmaceuticals plc to Discuss Third Quarter 2018 Financial Results on November 8, 2018",,, 8/27/2019 ORTX-US  GNW  Orchard Therapeutics Announces Presentation of Data from Neurometabolic Portfolio at Upcoming Society for the Study of Inborn Errors of Metabolism (SSIEM) 2019 Annual Symposium,, 7/17/2019 ALEC-US  GNW  Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients, 4/29/2019 DTIL-US GNW  Precision BioSciences Reports First Quarter 2019 Financial Results," 7/25/2019 TPTX-US GNW  Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors",,,,,,,,
, 8/01/2019 PGNX-US  GNW  Progenics Pharmaceuticals Sets Second Quarter 2019 Financial Results and Business Update Call for August 9,,"12/01/2011 SPPI-US  GNW  Video Interview: Rajesh C. Shrotriya, MD, Chairman, CEO & President, Spectrum Pharmaceuticals Inc (SPPI)",11/25/2016 G3040110 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline â€“ ENDP,10/23/2014 04280A10 GNW  Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Arrowhead Research Corporation -- ARWR," 4/10/2019 BDSI-US  GNW  BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock",,"12/19/2013 SNY-FR   GNW  Sanofi, Regeneron To Collaborate with American College of Cardiology for PCSK9 Inhibitor Clinical Program", 5/01/2018 SIGA-US      GNW  SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXXÂ®," 4/30/2019 OPK-US   GNW  OPKO Health to Report First Quarter 2019 Financial Results on May 7, 2019", 5/08/2019 46222210 GNW  Akcea Reports Financial Results and Highlights for First Quarter 2019, 5/04/2016 BMRN-US     GNW  BioMarin to Attend Upcoming Investor Conferences,,, 8/03/2011 SGEN-US  GNW  Genmab Announces Financial Results for the First Half of 2011 and Improved Guidance, 8/28/2019 IMMU-US  GNW  Immunomedics to Participate in Upcoming Healthcare Conferences," 7/23/2019 0L50GC-E  GNW  REPEAT - Pfizer, Bristol-Myers Squibb, and Biogen Advisor, Dr. Alex Makriyannis, PhD, Joins ICC Funded Biosynthesis Cannabinoid Company; to Champion Cannabinoid Pharmaceutical Research and THC/CBD Edibles Application Mandates",,11/12/2019 BCRX-US  GNW  BioCryst Commences Public Offering of Common Stock, 9/04/2012 GILD-US  GNW  EFI Announces $100 Million Share Repurchase Program,," 3/07/2019 N5946510 GNW  New Research: Key Drivers of Growth for Toll Brothers, Mylan N.V, Eldorado Resorts, Sinclair Broadcast Group, Eldorado Gold, and Pegasystems â€” Factors of Influence, Major Initiatives and Sustained Production",," 4/02/2019 00972810 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL", 9/01/2016 CYTK-US  GNW  Cytokinetics and Amgen to Advance Omecamtiv Mecarbil to Phase 3 Clinical Development,"11/21/2019 62855J10 GNW  MYGN ALERT: Zhang Investor Law Reminds Investors of NOVEMBER 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. â€“ MYGN", 6/04/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present New Clinical Data at 79th American Diabetes Association Scientific Sessions,10/25/2018 MGTX-US  GNW  MeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial Officer, 2/23/2018 INSM-US  GNW  Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update,,11/26/2018 INO-US    GNW  Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Antibody (dMAbâ„¢) Platform in Three Preclinical Publications and Prepares for First Clinical Trial in Early 2019," 9/06/2019 64026810 GNW  KESSLER TOPAZ MELTZER & CHECK, LLP â€“ Reminds Investors of Securities Fraud Class Action Lawsuit Against NEKTAR THERAPEUTICS â€“ NKTR",," 2/03/2020 37416310 GNW  GERON DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm",,"10/24/2019 AMRN-US  GNW  Amarin to Report Third Quarter 2019 Results and Host Conference Call on November 5, 2019", 3/28/2017 CALA-US  GNW  Calithera to Receive $12 Million Milestone Payment From Incyte for Achievement of Pharmacokinetic and Pharmacodynamic Goals in Phase 1 Study, 4/11/2013 UTHR-US  GNW  United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension, 9/30/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/07/2019 G0176710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc. of Class Action Lawsuit and Upcoming Deadline â€“ ALKS,, 9/04/2019 AMAG-US  GNW  AMAG Urges Stockholders to Take No Action on Caligan Partnersâ€™ Consent Solicitation Materials,11/09/2015 ARQL-US  GNW  ArQule Presents Data on Tivantinib and Propietary Pipeline at AACR-NCI-EORTC Conference,,,,12/10/2019 REGN-US  GNW  Sanofi and Regeneron announce intent to restructure Antibody collaboration for KevzaraÂ® (sarilumab) and PraluentÂ® (alirocumab),, 2/20/2019 ALLO-US  GNW  Allogene Therapeutics Enters Lease to Build Manufacturing Facility to Develop and Commercialize Allogeneic CAR T (AlloCAR Tâ„¢) Therapies, 4/03/2019 ASND-US  GNW  Ascendis Pharma A/S Reports Full Year 2018 Financial Results,," 8/15/2018 00422510 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MD, HAIR and ACAD", 5/29/2019 AFMD-US  GNW  Affimed to Present at the Jefferies 2019 Healthcare Conference,, 4/22/2019 PRQR-US  GNW  ProQR to Present at Three Scientific Conferences in April,," 9/09/2019 ZGNX-US  GNW  Zogenix Completes Acquisition of Modis Therapeutics, Inc.",11/12/2019 ALLK-US  GNW  Allakos Reports Third Quarter 2019 Financial Results,, 9/09/2015 76133010 GNW  Revance Therapeutics Initiates Phase 2 Clinical Trial of Botulinum Toxin Type A Topical Gel to Treat Axillary Hyperhidrosis,,, 9/12/2019 ADVM-US  GNW  Adverum Biotechnologies Reports Positive 24-Week Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD, 8/14/2019 RARE-US   GNW  Ultragenyx Announces Partnership with GeneTx to Advance Treatment  for Angelman Syndrome,10/26/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present Preclinical Data on a New Pipeline Therapeutic for Cystinuria in an Oral Presentation at the 2018 American Society of Nephrology (ASN) Annual Meeting, 2/27/2019 NSTG-US  GNW  NanoString Showcases GeoMx and Hyb & Seq Platforms at 2019 Advances in Genome Biology and Technology (AGBT) Conference,,, 3/01/2019 RDUS-US  GNW  Radius Health to Participate in 2019 Credit Suisse Global Healthcare Conference, 4/13/2019 ASMB-US  GNW  Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019,,,"10/24/2018 02043Q10 GNW  CLASS ACTION UPDATE for AMPE, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 1/03/2019 WVE-US   GNW  Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected forÂ FDA Complex Innovative Trial Designs Pilot Program, 8/06/2019 00972L10 GNW  Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRAÂ® (volanesorsen) in Patients with Familial Partial Lipodystrophy,," 4/25/2019 PCRX-US  GNW  Pacira to Report First Quarter 2019 Financial Results on Thursday May 2, 2019", 2/28/2019 RTRX-US  GNW  Retrophin Recognizes Rare Disease DayÂ® 2019 and Honors People Living with Rare Disease and Their Caregivers,"10/08/2018 PACB-US  GNW  Pacific Biosciences Releases Highest-Quality, Most Contiguous Individual Human Genome Assembly to Date", 4/03/2019 0GQ0VB-E GNW  Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms, 3/29/2019 CHMA-US  GNW  Chiasma Announces Pricing of Underwritten Public Offering of $30.0 Million of Common Stock,"10/25/2019 55609910 GNW  Zhang Investor Law Reminds Investors of November 12 Deadline in Securities Class Action Lawsuit Against MacroGenics, Inc.- MGNX",,,11/07/2014 28249U10 GNW  Celladon Corporation to Present at Credit Suisse Healthcare Conference, 2/22/2019 MNTA-US  GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results," 8/20/2018 G7280010 GNW  Investor Expectations to Drive Momentum within Rapid7, 1-800 FLOWERS.COM, SMART Global, Prothena Corporation plc, Amphastar Pharmaceuticals, and Silvercorp Metals â€” Discovering Underlying Factors of Influence", 7/02/2019 ZLAB-US  GNW  Incyte and Zai Lab Announce Collaboration and License Agreement for INCMGA0012 in Greater China, 8/06/2015 78667J10 GNW  SAGE Receives Special Protocol Assessment for Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus, 6/01/2019 CTMX-US  GNW  CytomX Therapeutics Provides Update on Anti-PD-L1 Probody CX-072  at 2019 ASCO Annual Meeting, 7/17/2019 GMAB-DK  GNW  Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States," 3/17/2019 92165910 GNW  CLASS ACTION UPDATE for GSM, WRCDF, CAG and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 3/27/2019 CBAY-US  GNW  CymaBay Therapeutics Announces Multiple Presentations During The International Liver Conferenceâ„¢ 2019," 6/13/2012 INVA-US  GNW  Amicus Therapeutics Appoints Ted W. Love, M.D. to Board of Directors",11/20/2018 CCXI-US  GNW  ChemoCentryx to Present at the 30th Annual Piper Jaffray Healthcare Conference,,, 6/03/2019 56400P70  GNW  AfrezzaÂ® (insulin human) Inhalation Powder Approved in Brazil,"11/08/2017 URGN-US  GNW  UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017","10/24/2019 CYTK-US  GNW  Cytokinetics to Announce Third Quarter ResultsÂ on October 31, 2019", 8/30/2019 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 5/14/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. â€“ AMRS",, 2/11/2019 ACHN-US  GNW  Achillion Appoints Brian Di Donato as Chief Financial Officer," 4/28/2019 87166B10 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines â€“ SYNH, BPI and USX", 5/29/2019 FOLD-US  GNW  Amicus Therapeutics Announces Public Offering of Common Stock,,, 5/15/2019 ADMA-US  GNW  ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock," 5/09/2019 GWPH-US  GNW  GW Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019", 9/13/2017 EPZM-US  GNW  Epizyme Announces Proposed Public Offering of Common Stock,, 6/18/2019 MYOK-US  GNW  MyoKardia to Present at 2019 BMO Prescriptions for Success Healthcare Conference,, 9/24/2019 GLPG-NL  GNW  Galapagos initiates Phase 1 trial for second Toledo compound," 2/05/2020 73701010 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm",,,, 5/29/2019 CARA-US  GNW  Cara Therapeutics Announces Positive Results From KALM-1 Pivotal Phase 3 Trial of KORSUVAâ„¢ Injection in Hemodialysis Patients with Pruritus, 9/23/2019 FLXN-US  GNW  Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S., 6/21/2019 QURE-US  GNW  uniQure Announces Presentations at the Upcoming 27th Congress of the International Society on Thrombosis and Haemostasis (ISTH), 9/10/2019 AGIO-US   GNW  Agios to Present Data From the Phase 3 ClarIDHy Study of TIBSOVOÂ® in Previously Treated IDH1 Mutant Cholangiocarcinoma in Presidential Symposium at ESMO, 5/16/2019 GNCA-US  GNW  Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating Lymphocyte) Products,"11/26/2018 03272410 GNW  Research Report Identifies Ebix, Gold Resource, Mastech Digital, AmeriGas Partners, Tactile Systems Technology, and AnaptysBio with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 4/30/2019 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2019 Financial Results, 1/08/2018 HZNP-US  GNW  Horizon Pharma plc Announces Agreement to License Pre-Clinical Uricase Derivative (MEDI4945) from MedImmune,, 5/08/2019 ICPT-US  GNW  Intercept Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update,11/04/2019 KPTI-US    GNW  Karyopharm Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress,,, 6/13/2019 ITCI-US  GNW  Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults,,,,"11/08/2018 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018"," 5/28/2019 ATRA-US    GNW  Atara Biotherapeutics Appoints Pascal Touchon President, Chief Executive Officer and Member of the Board of Directors",,10/09/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 9/04/2019 FOMX-US  GNW  Foamix Announces Issuance of New U.S. Patent Covering A Method of Treating Acne that Expires in 2037,12/13/2018 PRAH-US  GNW  Symphony Health Announces Availability of 340B Drug Discount Program Data,12/21/2018 SUPN-US  GNW  Supernus to Present at the 2019 J.P. Morgan Healthcare Conference," 8/01/2019 FGEN-US  GNW  CORRECTION - FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019",, 7/08/2019 CHRS-US  GNW  Coherus BioSciences to Report Second Quarter Financial Results on August 1st," 5/02/2019 21833P10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inogen, Spectrum Brands, Bridgepoint, and Corbus and Encourages Investors to Contact the Firm",, 1/07/2019 COLL-US  GNW  Collegium Provides Full-Year 2019 Financial Guidance," 5/02/2019 XBIT-US  GNW  XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study",,, 9/03/2019 GBT-US   GNW  GBT Announces Participation at the 2019 Morgan Stanley Global Healthcare Conference, 8/01/2017 RGNX-US  GNW  REGENXBIO to Host Conference Call on August 8 to Discuss Second Quarter 2017 Financial Results and Recent Operational Highlights, 7/24/2019 KURA-US  GNW  Kura Oncologyâ€™s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia, 8/16/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 9/03/2019 AXSM-US  GNW  Axsome Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference, 2/19/2019 VYGR-US  GNW  Voyager Therapeutics to Present at Upcoming Investor Conferences,"10/29/2019 07725L10 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds BeiGene, Ltd. (BGNE) Investors of Ongoing Investigation of Possible Securities Fraud: Investors Who Suffered Losses Encouraged to Contact Firm",," 1/03/2019 RETA-US  GNW  Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease", 9/03/2019 HCM-GB   GNW  Chi-Med to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference,10/31/2018 NTLA-US  GNW  Intellia Therapeutics AnnouncesÂ Third Quarter 2018 Financial ResultsÂ and Corporate Developments, 2/20/2019 ACIU-US  GNW  AC Immune Announces Anti-Tau Monoclonal Antibody Entering Second Phase 2 Trial in Moderate Alzheimerâ€™s Disease, 1/04/2019 CRSP-US  GNW  CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease, 6/11/2019 GTHX-US  GNW  G1 Therapeutics to Present at Raymond James Life Sciences and MedTech Conference,12/13/2017 ARGX-BE  GNW  argenx raises approximately $231 million in gross proceeds in an upsized U.S. public offering, 3/19/2019 RUBY-US GNW  Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results," 7/29/2019 ATNX-US  GNW  Athenex, Inc. to Report Second Quarter 2019 Earnings Results on August 7, 2019"," 3/11/2019 PETQ-US  GNW  PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2018 Financial Results", 5/03/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results,12/10/2018 OPTN-US  GNW  Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis, 2/21/2019 TORC-US  GNW  resTORbio to Present at 8th Annual SVB Leerink Global Healthcare Conference, 2/08/2018 DNLI-US  GNW  Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines,, 5/25/2018 83422E10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline â€“ SLDB, 4/29/2019 EOLS-US  GNW  Evolus to Participate in Two Upcoming Investor Conferences, 4/09/2019 FIXX-US GNW  Homology Medicines Announces Pricing of Public Offering of Common Stock," 7/15/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints Wendy DiCicco, CPA, to Board of Directors", 3/06/2019 SRRK-US  GNW  Scholar Rock to Participate in Upcoming Investor Conferences,"12/04/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors",,, 9/25/2018 EIDX-US  GNW  Eidos Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology,,, 8/13/2018 XERS-US  GNW  Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights, 8/08/2019 AUTL-US  GNW  Autolus Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress," 7/17/2019 FTSV-US GNW  Forty Seven, Inc. Prices Underwritten Public Offering of 9,375,000 Shares of Common Stock",,, 2/22/2019 PRNB-US GNW  Principia Biopharma Announces the Acceptance of Data from Phase 2 Pemphigus Vulgaris Trial as a Late-Breaking Presentation at 2019 American Academy of Dermatology Meeting," 3/25/2019 ARVN-US GNW  Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTACâ„¢ Protein Degrader, ARV-110", 5/15/2019 YMAB-US  GNW  Y-mAbs Announces Data to be Presented at 2019 ASCO Annual Meeting,," 3/21/2019 GRTS-US  GNW  Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001", 4/09/2019 GH-US    GNW  Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360,,,, 8/08/2019 ORTX-US  GNW  Orchard Therapeutics Reports Second Quarter 2019 Financial Results and Builds Momentum Ahead of Regulatory Filings,, 7/11/2019 ALEC-US  GNW  Alector Announces Upcoming Presentations at 2019 Alzheimer's Association International Conference, 4/24/2019 DTIL-US GNW  Precision BioSciences Announces Presentations at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy, 7/22/2019 TPTX-US GNW  Turning Point Therapeutics to Host Second Quarter 2019 Conference Call,,,,,,,,
, 7/25/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Collaboration with Veterans Affairs on the AI Research Program for Medical Image Analysis,,"11/28/2011 84763A10 GNW  Spectrum Pharmaceuticals, Inc. (SPPI) President & CEO to Ring The NASDAQ Stock Market Opening Bell",11/07/2016 G3040110 GNW  Pomerantz Law Firm Announces the Filing of a  Class Action against Endo International plc and Certain Officers â€“ ENDP,"10/20/2014 04280A10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR", 4/10/2019 BDSI-US  GNW  BioDelivery Sciences Acquires U.S. Commercial Rights to SymproicÂ®,,10/25/2013 REGN-US  GNW  Protein Engineering Market - Global Forecast to 2017, 5/01/2018 SIGA-US      GNW  SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXXÂ®, 4/17/2019 OPK-US   GNW  BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019, 5/07/2019 46222210 GNW  New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)," 5/03/2016 BMRN-US     GNW  BioMarin Announces EMA Grants Accelerated Assessment for  Cerliponase Alfa, Experimental Treatment for a Form of Batten Disease",,, 5/11/2011 SGEN-US  GNW  Genmab Announces Financial Results for the First Quarter 2011, 8/07/2019 IMMU-US  GNW  Immunomedics Reports Second Quarter 2019 Results and Provides Corporate Update, 7/01/2019 09062X10  GNW  Biogen Announces New Data Further Establishing SPINRAZAÂ® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients,,"11/07/2019 BCRX-US  GNW  Biocryst to Present Abstracts at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology", 8/08/2012 GILD-US  GNW  Achillion Reports Second Quarter and Six Month 2012 Financial Results,, 2/21/2019 N5946510 GNW  Mapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer Acetate (GA Depot) for Primary Progressive Multiple Sclerosis and New Treatments for MS,," 3/28/2019 00972810 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm",12/28/2015 TURN-US  GNW  Harris & Harris Group Announces Receipt of Milestone PaymentÂ from Acquisition of BioVex Group by Amgen,11/21/2019 MYGN-US  GNW  Myriad Genetics Announces Regulatory Approval of the BRACAnalysisÂ® Diagnostic System in Japan for Breast Cancer Patients, 5/23/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,10/16/2018 MGTX-US  GNW  MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology, 2/21/2018 INSM-US  GNW  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,11/15/2018 INO-US    GNW  Inovio Prepares for Growth & CommercializationÂ With Leadership Appointments," 9/06/2019 64026810 GNW  Nektar Therapeutics (NKTR), Pluralsight, Inc. (PS)Â & Burford Capital Limited (BRFRF, BRFRY) Class Action Update - Bronstein, Gewirtz & Grossman, LLC",, 1/28/2020 37416310 GNW  GERON CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court for the Northern District of California on behalf of investors in Geron Corporation,,"10/17/2019 AMRN-US  GNW  Independent Drug-Pricing Assessment Finds VascepaÂ® (icosapent ethyl) Cost-Effective as an Adjunct to Statins in Treating Patients at High Risk of Cardiovascular Events, such as Heart Attack, Stroke and Cardiac Death"," 1/30/2017 45337C10 GNW  Incyte and Calithera Biosciences Announce Global Collaboration  to Develop and Commercialize CB-1158, a First-in-class, Small Molecule Arginase Inhibitor"," 3/27/2013 UTHR-US  GNW  Governor Tommy Thompson, Former Secretary of Health and Human Services, Appointed Chairman of the Board of Poliwogg Holdings, Inc."," 9/25/2019 80360710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nektar Therapeutics, Valaris, Sarepta Therapeutics, and Canada Goose and Encourages Investors to Contact the Firm"," 2/07/2019 G0176710 GNW  CLASS ACTION UPDATE for WBT, SOGO, IMMU and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 8/27/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces Commercial Availability of Vyleesiâ„¢ (Bremelanotide Injection),11/04/2015 ARQL-US  GNW  ArQule Reports Third Quarter 2015 Financial Results,,,,12/10/2019 SAN-FR   GNW  Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease,, 2/05/2019 ALLO-US  GNW  Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule, 3/27/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Year-End 2018 Financial Results and Business UpdateÂ Conference Call on April 3,, 8/14/2018 00422510 GNW  ACAD NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. â€“ ACAD, 5/22/2019 AFMD-US  GNW  Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress,, 4/18/2019 PRQR-US  GNW  ProQR Announces Annual Meeting of Shareholders,," 9/04/2019 98978L20 GNW  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zogenix, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",10/28/2019 ALLK-US  GNW  Allakos Announces Multiple Presentations from Its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting,, 8/06/2015 76133010 GNW  Revance Therapeutics Releases Second Quarter 2015 Results,,, 9/04/2019 ADVM-US  GNW  Adverum Biotechnologies to Host a Conference Call and Webcast to Present 24-week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at Retina Society 2019 Annual Meeting, 8/13/2019 RARE-US   GNW  Ultragenyx to Present at Wedbush PacGrow Healthcare Conference,10/22/2018 AGLE-US  GNW  Aeglea BioTherapeutics Announces Positive Interim Clinical Data for Pegzilarginase in Advanced Melanoma Patients at the European Society for Medical Oncology 2018 Congress," 2/25/2019 NSTG-US  GNW  NanoString to Host Inaugural Spatial Genomics Summit on Wednesday, February 27th at the 2019 Advances in Genome Biology and Technology (AGBT) Conference",,, 2/28/2019 RDUS-US  GNW  Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results, 4/11/2019 ASMB-US  GNW  Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019,,,"10/23/2018 02043Q10 GNW  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",12/06/2018 WVE-US   GNW  Wave Life Sciences Announces Positive Phase 1 Results for WVE-210201 in Duchenne Muscular Dystrophy (DMD), 8/06/2019 00972L10 GNW  Akcea Reports Financial Results and Highlights for Second Quarter 2019,," 4/09/2019 PCRX-US  GNW  Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraÂº System", 2/26/2019 RTRX-US  GNW  Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results, 9/13/2018 PACB-US  GNW  Large-Scale Global Genome Projects Choose PacBio Sequencing to Help Decode Life, 2/28/2019 EDIT-US  GNW  Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update, 3/28/2019 CHMA-US  GNW  Chiasma Announces Proposed Offering of Common Stock,"10/25/2019 ZLAB-US  GNW  Zai Lab Partner, MacroGenics, Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer",,,11/05/2014 28249U10 GNW  Celladon Corporation to Present at Credit Suisse Healthcare Investor Conference, 2/08/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2018 Financial Results Conference Call and Webcast, 8/09/2018 G7280010 GNW  Notice of Voluntary Dismissal of Class Action Concerning Prothena Corporation, 6/12/2019 ZLAB-US  GNW  Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer, 8/05/2015 78667J10 GNW  SAGE Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference, 5/28/2019 CTMX-US  GNW  CytomX Therapeutics to Present at Upcoming Healthcare Conferences, 7/16/2019 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for Second Quarter of 2019, 3/15/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,, 3/12/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at Upcoming Investor Conferences in March, 5/22/2012 INVA-US  GNW  Theravance to Present at Investor Conferences in June 2012,11/08/2018 CCXI-US  GNW  ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights,,, 5/16/2019 0HJ60Y-E  GNW  MannKind Announces AfrezzaÂ® Distribution Agreement in Australia,11/06/2017 0CV67B-E GNW  UroGen Pharma Announces First Patient Enrolled in Allergan Phase 2 Clinical Trial of RTGelâ„¢ in Combination with BOTOXÂ® for the Treatment of Overactive Bladder,10/04/2019 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting, 8/29/2019 ESPR-US     GNW  Esperion Announces Positive Top-Line Results from Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Tablet in Patients with Hypercholesterolemia and Type 2 Diabetes, 5/14/2019 AMRS-US   GNW  Amyris to Videocast its Exclusive Annual Industry Forum â€“  BioDisrupt 2019,, 1/31/2019 ACHN-US  GNW  Achillion Announces First Dosing in Phase 1 Multiple Ascending Dose Study of ACH-5228 Next-Generation Oral Factor D Inhibitor in Healthy Volunteers," 4/26/2019 87166B10 GNW  KESSLER TOPAZ MELTZER & CHECK, LLP:Â Final Deadline Reminder for SYNEOS HEALTH, INC. Investors â€“ SYNH", 5/29/2019 FOLD-US  GNW  Amicus Therapeutics and the University of Pennsylvania Announce Major Expansion of Gene Therapy Collaboration,,, 5/10/2019 ADMA-US  GNW  FDA Approves Prior Approval Supplement for BIVIGAMÂ®, 5/06/2019 GWPH-US  GNW  GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEXÂ® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex, 8/30/2017 EPZM-US  GNW  Epizyme to Participate in Upcoming Investor Conferences,," 5/28/2019 MYOK-US  GNW  MyoKardia Presents Results from Phase 1a Clinical Trial of MYK-491 at the European Society of Cardiology Heart Failure Congress in Athens, Greece",, 9/20/2019 GLPG-NL  GNW  Invitation to the special and extraordinary shareholders' meetings," 2/04/2020 73701010 GNW  PORTOLA DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm",,,, 5/08/2019 CARA-US  GNW  Cara Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference, 9/09/2019 33938J10 GNW  Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexionâ€™s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain, 5/31/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences, 9/04/2019 AGIO-US   GNW  Agios Announces Publication of Data for Mitapivat from Core and Extension Phases of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency in the New England Journal of Medicine, 5/15/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs,11/08/2018 ANAB-US  GNW  AnaptysBio Announces Third Quarter 2018 Financial Results and Provides Pipeline Updates,, 4/24/2019 FATE-US  GNW  Fate Therapeutics Announces Five Presentations at the American Society of Gene & Cell Therapy 22nd Annual Meeting, 1/05/2018 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 5/01/2019 ICPT-US  GNW  Intercept to Announce First Quarter 2019 Financial Results on May 8, 2019",11/01/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/30/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present atÂ Jefferies 2019 Global Healthcare Conference,,,,"11/07/2018 AMPH-US  GNW  Amphastar Pharmaceuticals, Inc. Announces Reintroduction of PrimateneÂ® MIST", 5/15/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Presentations Highlighting Tab-celÂ® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting,,10/02/2018 DERM-US  GNW  Dermira and Christian Siriano Collaborate to Inspire People Living with Excessive Underarm Sweating to Feel Confident in Their Own Skin, 8/07/2019 FOMX-US  GNW  Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update,11/27/2018 PRAH-US  GNW  PRA Health Sciences Launches Pediatric Site Network,12/20/2018 SUPN-US  GNW  Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD, 7/24/2019 FGEN-US  GNW  The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis,, 7/01/2019 CHRS-US  GNW  Coherus BioSciences Production Exceeds Four-Hundred Thousand UDENYCAÂ® (pegfilgrastim-cbqv) Pre-Filled Syringes," 5/02/2019 21833P10 GNW  CRBP CLASS ACTION REMINDER: Hagens Berman Reminds Corbus Pharmaceutical Holdings (CRBP) Investors of Securities Class Action, Encourages Investors with $50,000+ Losses to Contact the Firm",,11/12/2018 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences," 3/05/2019 XBIT-US  GNW  Phase 2 Clinical Trial of Bermekimab Shows Potential New Standard of Care for Treatment of Hidradenitis Suppurativa, Including Significant Pain Reduction without Antibiotics",,, 9/03/2019 GBT-US   GNW  GBT and Sickle Cell Disease Association of America to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference, 7/06/2017 RGNX-US  GNW  REGENXBIO to Participate in the Piper Jaffray GenomeRx Symposium, 7/11/2019 KURA-US  GNW  Kura Oncology Expands Protection for Tipifarnib with New U.S. and European Patents, 7/31/2019 APLS-US  GNW  Apellis Pharmaceuticals Reports Second Quarter 2019 Business Update and Financial Results, 8/20/2019 AXSM-US  GNW  Axsome Therapeutics Appoints David Marek as Chief Commercial Officer, 2/18/2019 VYGR-US  GNW  Voyager Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights Conference Call,"10/18/2019 07725L10 GNW  ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd. â€“ BGNE",,"11/07/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results and an Update on Development Programs", 9/03/2019 HCM-GB   GNW  Chi-Med Initiates an International Phase I/Ib Trial of HMPL-689 in Patients with Advanced Relapsed or Refractory Lymphoma,10/30/2018 NTLA-US  GNW  Intellia Therapeutics to Hold Conference CallÂ to Discuss Third Quarter 2018 EarningsÂ and Corporate Developments, 2/07/2019 ACIU-US  GNW  AC Immune Makes Two Appointments to Executive Committee to Accelerate Product Development,11/21/2018 CRSP-US  GNW  CRISPR Therapeutics to Participate in Upcoming Investor Conferences, 6/01/2019 GTHX-US  GNW  G1 Therapeutics Presents Additional Phase 2 Data on Trilaciclib in Small Cell Lung Cancer at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting,12/11/2017 ARGX-BE  GNW  argenx announces launch of proposed public offering in the United States," 3/11/2019 RUBY-US GNW  Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for  First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria", 6/28/2019 ATNX-US  GNW  Athenex Announces Strategic Global Initiatives to Expand Clinical Operations," 2/25/2019 PETQ-US  GNW  PetIQ, Inc. Announces Appointment of R. Michael Herrman as General Counsel", 4/02/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference,12/05/2018 OPTN-US  GNW  Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference," 2/06/2019 TORC-US  GNW  resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry",12/20/2017 DNLI-US  GNW  Denali Therapeutics Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinsonâ€™s Disease,," 5/24/2018 83422E10 GNW  SLDB $100,000 Threshold: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Solid Biosciences Inc. Investors", 4/26/2019 EOLS-US  GNW  Evolus Receives Positive CHMP Opinion for Nuceivaâ„¢ in the European Union, 4/08/2019 FIXX-US GNW  Homology Medicines Announces Proposed Public Offering of Common Stock, 7/01/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Added to Russell 3000Â® and 2000Â® Indexes, 2/26/2019 SRRK-US  GNW  Scholar Rock Announces Positive Interim Results from Phase 1 Trial of SRK-015 in Healthy Volunteers and Updates on Future Development Plans,12/03/2018 UBX-US   GNW  UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee,,, 9/17/2018 EIDX-US  GNW  Eidos Therapeutics Presents Data from its Phase 1 Clinical Trial of AG10 at the 22nd Annual Scientific Meeting of the Heart Failure Society of America,,, 7/31/2018 XERS-US  GNW  Xeris Pharmaceuticals to Present at Two Upcoming Investor Conferences, 8/02/2019 AUTL-US  GNW  Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8," 7/16/2019 FTSV-US GNW  Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock",,, 2/20/2019 PRNB-US GNW  Principia Biopharma to Present at 8th Annual SVB Leerink Global Healthcare Conference, 2/07/2019 ARVN-US GNW  Arvinas Announces Poster Presentation at ASCO 2019 Genitourinary Cancers Symposium, 5/14/2019 YMAB-US  GNW  Y-mAbs Announces Development Update on Cancer Vaccine Program,," 3/11/2019 GRTS-US  GNW  Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth", 3/28/2019 GH-US    GNW  Palmetto GBA issues Draft Local Coverage Determination Expanding Guardant360 Medicare Coverage to Most Solid Tumor Types,,,, 8/06/2019 ORTX-US  GNW  Orchard Therapeutics to Webcast Presentation at the 2019 Wedbush PacGrow Healthcare Conference,, 5/13/2019 ALEC-US  GNW  Alector Reports Recent Business Highlights and First Quarter 2019 Financial Results, 4/17/2019 DTIL-US GNW  Precision BioSciences Announces Dosing of First Patient in Off-The-Shelf CAR T Cell Therapy Phase 1/2a Clinical Trial, 6/20/2019 TPTX-US GNW  Turning Point Therapeutics Initiates Phase 2 Registrational Portion of TRIDENT-1 Clinical Study,,,,,,,,
, 7/12/2019 PGNX-US  GNW  Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders,,"10/08/2010 84763A10 GNW  Video Interview: Rajesh C. Shrotriya, MD, Chairman/CEO/President, Spectrum Pharmaceuticals, Inc."," 7/22/2016 G3040110 GNW  ENDO 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Endo International plc - ENDP","10/17/2014 04280A10 GNW  ARROWHEAD RESEARCH CORP. SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Arrowhead Research Corp. -- ARWR", 2/21/2019 BDSI-US  GNW  BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results,,12/17/2012 YNDX-US  GNW  Quarterly Changes to the NASDAQ Q-50 Index, 3/20/2018 82691710     GNW  SIGA Technologies Announces Relisting on Nasdaq," 4/12/2019 OPK-US   GNW  OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial", 5/07/2019 IONS-US  GNW  Akcea and Ionis Announce Approval of WAYLIVRAÂ® (volanesorsen) in the European Union, 4/28/2016 BMRN-US     GNW  BioMarin Announces First Quarter 2016 Financial Results,,, 9/14/2010 SGEN-US  GNW  Genmab Updates Corporate Strategy," 8/01/2019 IMMU-US  GNW  Immunomedics to Report Second Quarter 2019 Results and Host Conference Call and Webcast on August 7, 2019", 6/11/2019 BIIB-US   GNW  Biogen to Present New Safety and Efficacy Data on Biosimilars and Estimates 1.8 Billion Euros in Savings for the European Healthcare System in 2019,,11/06/2019 BCRX-US  GNW  BioCryst Reports Third Quarter 2019 Financial Results and Upcoming Key Milestones, 7/19/2012 GILD-US  GNW  EFI Reports Record Revenue for the Second Quarter of 2012,,"10/29/2018 N5946510 GNW  Consolidated Research: 2018 Summary Expectations for Green Brick Partners, Alliqua BioMedical, Buckle, DaVita, CDK Global, and Mylan N.V â€” Fundamental Analysis, Key Performance Indications",," 3/27/2019 00972810 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm",11/08/2015 AMGN-US  GNW  Amgen and Cytokinetics Announce Late-Breaking Presentation of COSMIC-HF Trial at AHA Scientific Sessions 2015,"11/20/2019 62855J10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ MYGN", 5/08/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,"10/09/2018 MGTX-US  GNW  MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinsonâ€™s Disease", 2/20/2018 INSM-US  GNW  Insmed Extends ALIS Intellectual Property Protection to 2035 with Issuance of Ninth U.S. Patent,,11/08/2018 INO-US    GNW  Inovio Pharmaceuticals ReportsÂ 2018 Third Quarter Financial Results, 9/04/2019 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR,, 1/27/2020 37416310 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN,, 9/23/2019 AMRN-US  GNW  Amarin to Participate in the Cantor Global Healthcare Conference, 1/23/2017 45337C10 GNW  Merus Announces Closing of Global Strategic Research Collaboration with Incyte to Discover and Develop Bispecific Antibodies, 2/26/2013 UTHR-US  GNW  United Therapeutics Moves Forward Towards a Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension," 9/25/2019 SRPT-US  GNW  Sarepta Therapeutics to Announce 9-Month Functional Results from the SRP-9003 Gene Therapy Trial to Treat Limb-girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy"," 2/07/2019 XRAY-US  GNW  CLASS ACTION UPDATE for XRAY, PRGO, ALKS and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 8/20/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4),"10/27/2015 ARQL-US  GNW  ArQule to Present Data on Tivantinib, ARQ 087, ARQ 092, and ARQ 751 at AACR-NCI-EORTC Conference",,,,12/09/2019 SAN-FR   GNW  Sanofi CEO unveils new strategy to drive innovation and growth,," 1/28/2019 05K0PC-E GNW  Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR Tâ„¢) Therapy", 3/25/2019 ASND-US  GNW  Ascendis Pharma Announces Results of Study at ENDO 2019 Evaluating Impact of Hypoparathyroidism on Patient Quality-of-Life,," 8/13/2018 00422510 GNW  CLASS ACTION UPDATE for FPI, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 5/16/2019 AFMD-US  GNW  Affimed Announces First Quarter 2019 Financial Results and Corporate Update Conference Call on May 22, 2019",," 4/18/2019 PRQR-US  GNW  ProQR nominates Bart Filius, COO and CFO at Galapagos and Theresa Heggie, Head of CEMEA at Alnylam for its Supervisory Board",," 8/26/2019 ZGNX-US  GNW  Zogenix Announces Acquisition of Modis Therapeutics, Inc.", 8/06/2019 ALLK-US  GNW  Allakos Announces Upsizing and Pricing of Public Offering of Common Stock,," 7/23/2015 76133010 GNW  Revance Therapeutics to Release Second Quarter 2015 Financial Results Thursday, August 6, 2015",,, 8/28/2019 ADVM-US  GNW  Adverum Biotechnologies to Present 24-Week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October, 8/01/2019 RARE-US   GNW  Ultragenyx Reports Second Quarter 2019 Financial Results and Corporate Update,10/19/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference," 2/21/2019 NSTG-US  GNW  NanoString to Release Fourth Quarter and Fiscal Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019",,, 2/19/2019 RDUS-US  GNW  Radius Health to Present at Leerink Partners 8th Annual Global Healthcare Conference, 3/27/2019 ASMB-US  GNW  Assembly Biosciences Announces Multiple Abstracts Highlighting HBV Core Inhibitor Portfolio Accepted for Oral and Poster Presentations at EASL 2019,,,"10/22/2018 02043Q10 GNW  CLASS ACTION UPDATE for AMPE, ALNY and HTHT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",11/09/2018 WVE-US   GNW  Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update, 7/29/2019 AKCA-US  GNW  Akcea Therapeutics to Hold Second Quarter 2019 Financial Results Webcast,, 4/02/2019 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference, 2/14/2019 RTRX-US  GNW  Retrophin to Present at the 8th Annual SVB Leerink Global Healthcare Conference," 9/12/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock", 2/28/2019 EDIT-US  GNW  Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease DayÂ®, 3/21/2019 CHMA-US  GNW  Chiasma Announces Three Poster Presentations at ENDO 2019,10/25/2019 MGNX-US  GNW  MacroGenics Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer,,,10/27/2014 28249U10 GNW  Celladon Corporation Announces Publication of Data From Its Stem Cell Factor Gene Therapy Program in Circulation Heart Failure, 2/07/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces Oral Presentation of New Data for M281 at the Society for Maternal-Fetal Medicine 2019 Annual Meeting, 8/07/2018 PRTA-US  GNW  Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update," 6/11/2019 ZLAB-US  GNW  Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China"," 7/08/2015 SAGE-US  GNW  SAGE Therapeutics, Inc. (Nasdaq: SAGE) to Ring The Nasdaq Stock Market Opening Bell", 5/15/2019 CTMX-US  GNW  CytomX Therapeutics Announces Presentations at 2019 ASCO Annual Meeting, 7/12/2019 GMAB-DK  GNW  Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulation of Daratumumab," 3/14/2019 92165910 GNW  Vanda Pharmaceuticals Inc. (VNDA)Â Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline: April 26, 2019",," 3/11/2019 CBAY-US  GNW  CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares", 5/16/2012 45781M10 GNW  GlaxoSmithKline Completes Transaction to Increase Its Ownership in Theravance,"11/01/2018 CCXI-US  GNW  ChemoCentryx to Hold Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018",,, 5/07/2019 MNKD-US   GNW  MannKind Corporation Reports 2019 First Quarter Financial Results,11/02/2017 URGN-US  GNW  UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors, 9/26/2019 CYTK-US  GNW  Cytokinetics Announces Additional Results From FORTITUDE-ALS to be Presented at the 18th Annual NEALS Meeting, 8/08/2019 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates;Â Reports Second Quarter Financial Results," 5/10/2019 03236M20  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AMRS, BV, FLEX, HCSG of Lead Plaintiff Deadline in Class Action Lawsuits",, 1/03/2019 ACHN-US  GNW  Achillion Announces Nicole Vitullo Elected to Chair the Board of Directors," 4/24/2019 87166B10 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc.", 5/13/2019 03152W10 GNW  Amicus Therapeutics Appoints Burke W. Whitman to its Board of Directors,,, 5/08/2019 ADMA-US  GNW  ADMA Biologics Reports First Quarter 2019 Financial Results," 5/06/2019 GWPH-US  GNW  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019", 8/15/2017 EPZM-US  GNW  Epizyme Announces Leadership Transition for Finance Organization,, 5/09/2019 MYOK-US  GNW  MyoKardia Reports First Quarter 2019 Financial Results,, 9/20/2019 GLPG-NL  GNW  Invitation to the special and extraordinary shareholders' meetings, 1/29/2020 73701010 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,,,, 5/07/2019 CARA-US  GNW  Cara Therapeutics Reports First Quarter 2019 Financial Results, 9/06/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/22/2019 QURE-US  GNW  uniQure Strengthens Intellectual Property Portfolio with Granted Patent Claims Covering AMT-130 for Huntingtonâ€™s Disease," 8/29/2019 AGIO-US   GNW  Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019", 5/07/2019 IOVA-US  GNW  Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update,11/05/2018 ANAB-US  GNW  AnaptysBio to Participate in Upcoming Investor Conferences,," 4/18/2019 FATE-US  GNW  Fate Therapeutics Appoints Wayne Chu, M.D. as Vice President, Clinical Development", 1/04/2018 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 4/11/2019 ICPT-US  GNW  Intercept Reports Additional Positive Data from REGENERATE, the First Successful Phase 3 Study in NASH","10/28/2019 KPTI-US    GNW  Karyopharm to Report Third Quarter 2019 Financial Results on November 4, 2019",,, 5/16/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at  2019 RBC Capital Markets Global Healthcare Conference,,,,"11/06/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018", 5/15/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Presentation of Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN),,10/01/2018 DERM-US  GNW  Dermiraâ€™s QBREXZAâ„¢ (glycopyrronium) Cloth Is Now Available in Pharmacies Nationwide for the Treatment of Primary Axillary Hyperhidrosis, 8/05/2019 FOMX-US  GNW  Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea,"11/06/2018 69354M10 GNW  New Research: Key Drivers of Growth for PRA Health Sciences, Newmont Mining, Hyster-Yale Materials Handling, MGP Ingredients, Noble Midstream Partners LP, and Principal Financial Group â€” Factors of Influence, Major Initiatives and Sustained Production",12/14/2018 SUPN-US  GNW  Supernus Announces FDA Approval of sNDA to Expand Oxtellar XRÂ® Label to Include Monotherapy, 7/24/2019 FGEN-US  GNW  Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM),, 6/21/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 5/02/2019 21833P10 GNW  CRBP MAY 13th DEADLINE: Rosen Law Firm Reminds Corbus Pharmaceuticals Holdings, Inc. Investors of Important Deadline in Securities Class Action; Investors with Losses in Excess of $100K are Encouraged to Contact the Firm â€“ CRBP",,11/08/2018 COLL-US  GNW  Collegium Reports Third Quarter Financial Results," 3/01/2019 XBIT-US  GNW  Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting",,, 8/07/2019 GBT-US   GNW  GBT Reports Recent Business Progress and Second Quarter 2019 Financial Results, 6/07/2017 75901B10 GNW  REGENXBIO and AveXis Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector, 6/21/2019 KURA-US  GNW  Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares, 7/26/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 8/08/2019 AXSM-US  GNW  Axsome Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update, 1/29/2019 92915B10 GNW  Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinsonâ€™s Disease and Friedreichâ€™s Ataxia,"10/07/2019 07725L10 GNW  BGNE INVESTOR REMINDER: Hagens Berman Reminds BeiGene, Ltd. (BGNE) Investors of Ongoing Investigation of Possible Securities Fraud",,"10/31/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report Third Quarter 2018 Financial Results and Provide an Update on Development Programs on Wednesday, November 7, 2018", 8/23/2019 HCM-GB   GNW  Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients withÂ Immune Thrombocytopenia (ITP) in China,10/29/2018 NTLA-US  GNW  Intellia Therapeutics Names Glenn Goddard as New Chief Financial Officer, 1/30/2019 ACIU-US  GNW  AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimerâ€™s Disease,"11/13/2018 H1718210 GNW  New Research Coverage Highlights CAS Medical, Saia, Core Laboratories N.V, Perceptron, CRISPR Therapeutics AG, and IEC Electronics â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 5/16/2019 GTHX-US  GNW  G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting,12/11/2017 ARGX-BE  GNW  argenx to provide updates on Phase 1/2 clinical trials of ARGX-110 in Acute Myeloid Leukemia and Cutaneous T-Cell Lymphoma during American Society of Hematology Annual Meeting, 2/27/2019 RUBY-US GNW  Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting, 6/27/2019 04685N10 GNW  SunGen Pharma Announces to Partner with Athenex Pharmaceutical toÂ Launch Bivalirudin through PIV Challenges in US," 2/20/2019 PETQ-US  GNW  PetIQ, Inc. to Report Fourth Quarter and Full Year 2018 Results on Monday, March 11th", 3/28/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development,11/13/2018 OPTN-US  GNW  Optinose Reports Third Quarter 2018 Financial Results and Recent Operational Highlights, 1/31/2019 TORC-US  GNW  resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition and Neurodegenerative Disease,"12/12/2017 DNLI-US  GNW  Denali Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",," 5/22/2018 0CJTL1-E GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Solid Biosciences Inc. To Contact The Firm"," 4/24/2019 EOLS-US  GNW  Evolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019", 4/04/2019 FIXX-US GNW  Homology Medicines Presents Preclinical Data from PKU Gene Therapy Program Demonstrating Restored Metabolic Pathway and Increased Neurotransmitter Production, 6/13/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/03/2019 SRRK-US  GNW  Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference,"11/13/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence",,, 8/23/2018 EIDX-US  GNW  Eidos Therapeutics Announces Publication of AG10 Molecular Design in Journal of Medicinal Chemistry,,, 7/30/2018 XERS-US  GNW  Xeris Pharmaceuticals Announces New Board Members and New Executive to Management Team, 5/28/2019 AUTL-US  GNW  Autolus Therapeutics to Participate in Upcoming Investor Conferences in June," 7/11/2019 FTSV-US GNW  Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9 in Japan, South Korea, Taiwan and Select Countries in Southeast Asia",,, 2/19/2019 PRNB-US GNW  Principia Biopharma Appoints John W. Smither to Board of Directors, 1/04/2019 ARVN-US GNW  Arvinas Receives Authorization to Proceed for its IND Application for PROTACâ„¢ Therapy to Treat Patients with Metastatic Castration-Resistant Prostate Cancer, 5/10/2019 YMAB-US  GNW  Y-mAbs Announces First Quarter 2019 Financial Results and Recent Corporate Developments,, 3/05/2019 GRTS-US  GNW  Gritstone Oncology to Present at Two Upcoming Investor Conferences in March, 3/27/2019 GH-US    GNW  Guardant Health Announces Definitive Agreement to Acquire Bellwether Bio,,,, 8/01/2019 ORTX-US  GNW  Orchard Therapeutics to Webcast Conference Call of Second Quarter 2019 Financial Results,," 5/08/2019 ALEC-US  GNW  Alector to Present at the Bank of America Merrill Lynch Healthcare Conference on May 15, 2019", 4/01/2019 DTIL-US GNW  Precision BioSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares, 6/04/2019 TPTX-US GNW  Turning Point Therapeuticsâ€™ CEO to Present at Goldman Sachs 40th Annual Global Healthcare Conference,,,,,,,,
, 7/08/2019 PGNX-US  GNW  Progenics Urges Shareholders to Vote Today â€œFORâ€ the Highly Qualified Director Candidates on the WHITE Proxy Card,," 9/27/2010 84763A10 GNW  Spectrum Pharmaceuticals, Inc. (SPPI) Chairman, CEO and President to Ring the NASDAQ Stock Market Opening Bell"," 7/18/2016 G3040110 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Endo International plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 25, 2016 â€“ ENDP",10/15/2014 04280A10 GNW  Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Has Been Filed in the Central District of California Against Arrowhead Research Corporation -- ARWR, 2/04/2019 BDSI-US  GNW  BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCAÂ®,,12/14/2012 NDAQ-US  GNW  Annual Changes to the NASDAQ-100 Index, 2/07/2018 SIGA-US      GNW  SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox, 3/21/2019 OPK-US   GNW  OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial, 5/02/2019 46222210 GNW  Akcea Announces Upcoming Data Presentations at the 2019 American Academy of Neurology Meeting (AAN.19), 4/21/2016 BMRN-US     GNW  BioMarin Enrolls First Patient in Phase 1/2 Trial of NAGLU Fusion Protein BMN 250 for Treatment of MPS IIIB (Sanfilippo B Syndrome),,, 9/14/2010 SGEN-US  GNW  Genmab and Seattle Genetics Enter Into Antibody-Drug Conjugate Research Collaboration, 5/29/2019 IMMU-US  GNW  Immunomedics to Participate in Upcoming Healthcare Conferences, 6/07/2019 09062X10  GNW  Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million,,"11/06/2019 BCRX-US  GNW  New Clinical Trial Results and Market Research Support Significant Commercial Opportunity for Oral, Once Daily BCX7353 in HAE", 7/19/2012 GILD-US  GNW  EFI Enters Into Real Estate Asset Sale Agreement With Gilead Sciences,,10/09/2018 N5946510 GNW  Mapi Pharma Presents Phase II Extension Results of Glatiramer Acetate Depot (GA Depot) at ECTRIMS 2018 in Berlin,," 3/26/2019 00972810 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm","10/27/2015 03116210 GNW  Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, aÂ Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure",11/20/2019 MYGN-US  GNW  The American College of Rheumatology Adds the VectraÂ® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis, 5/01/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides a Business Update,10/02/2018 MGTX-US  GNW  MeiraGTx to Present at Upcoming Conferences," 2/15/2018 INSM-US  GNW  Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018",,11/05/2018 INO-US    GNW  Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences," 8/30/2019 64026810 GNW  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Nektar Therapeutics",," 1/27/2020 37416310 GNW  SHAREHOLDER ALERT - Geron Corporation (GERN)Â - Bronstein, Gewirtz & Grossman, LLC Notifies Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: March 23, 2020",, 9/16/2019 AMRN-US  GNW  National Lipid Associationâ€™s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins, 3/24/2016 45337C10 GNW  Aduro Biotech Announces First Patient Dosed in Combination Clinical Trial of CRS-207 and Epacadostat to Treat Ovarian Cancer,11/22/2011 91307C10 GNW  Pluristem Therapeutics' CEO Letter to Shareholders," 9/24/2019 80360710 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT"," 2/05/2019 G0176710 GNW  CLASS ACTION UPDATE for ALKS, W, MAXR and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 8/13/2019 AMAG-US  GNW  AMAG PHARMACEUTICALSÂ ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4),"10/21/2015 ARQL-US  GNW  ArQule to Report Third Quarter 2015 Financial Results  on November 4, 2015",,,,12/09/2019 SAN-FR   GNW  Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion,,12/19/2018 ALLO-US  GNW  Allogene Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference, 3/24/2019 ASND-US  GNW  Ascendis Pharma Announces Phase 3 heiGHt Trial Demonstrated Superior Efficacy and Comparable Safety and Tolerability of TransConâ„¢ hGH to a Daily Growth Hormone,," 8/13/2018 00422510 GNW  CLASS ACTION UPDATE for FPI, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/17/2019 AFMD-US  GNW  Affimed Provides Regulatory Update on AFM11 Clinical Program,, 4/15/2019 PRQR-US  GNW  ProQR Doses First Patient in Phase 2/3 ILLUMINATE Trial of Sepofarsen for LCA10,, 8/06/2019 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Second Quarter 2019 Financial Results, 8/05/2019 ALLK-US  GNW  Allakos Announces Proposed Public Offering of Common Stock,," 7/02/2015 RVNC-US  GNW  Revance Therapeutics Announces Change in Role of Jacob Waugh, M.D.",,, 8/08/2019 ADVM-US  GNW  Adverum Biotechnologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update, 8/01/2019 RARE-US   GNW  Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation Disorders,10/17/2018 AGLE-US  GNW  Aeglea BioTherapeutics Announces New Positive Interim Clinical Data and Improvements in Disease Manifestations for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency, 1/06/2019 NSTG-US  GNW  NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018,,," 2/14/2019 RDUS-US  GNW  Radius Health to Announce Fourth Quarter and Full Year 2018 Financial Results, Host Conference Call and Live Webcast on Thursday, February 28, 2019", 3/13/2019 ASMB-US  GNW  Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit,,,"10/21/2018 02043Q10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LCI, PVG, ALNY, MGTI, HAS and CHGG",11/08/2018 WVE-US   GNW  Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference, 7/16/2019 IONS-US  GNW  hATTR Compassâ„¢ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch,," 3/13/2019 PCRX-US  GNW  New Analysis Shows Enhanced Recovery Pathway Including EXPAREL Infiltration Facilitates Rapid Discharge, High Satisfaction, and Limited Opioid Use in Medicare Patients Undergoing Total Joint Replacement", 2/12/2019 RTRX-US  GNW  Retrophin to Report Fourth Quarter and Full Year 2018 Financial Results," 9/10/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock", 2/21/2019 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2018 Corporate Update and Results, 3/08/2019 CHMA-US  GNW  Chiasma Reports Fourth Quarter and Year End 2018 Results,"10/23/2019 55609910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Canada Goose, Meredith Corporation, MacroGenics, and ViewRay and Encourages Investors to Contact the Firm",,,10/01/2014 28249U10 GNW  Celladon to Present at the 2014 Stem Cell Meeting on the Mesa," 1/29/2019 MNTA-US  GNW  Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G"," 8/06/2018 G7280010 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Prothena Corporation Investors and Set a Lead Plaintiff Deadline of October 5, 2018"," 6/03/2019 ZLAB-US  GNW  Zai Lab Appoints Valeria Fantin, Ph.D., as Chief Scientific Officer", 6/09/2015 78667J10 GNW  SAGE Therapeutics Announces Positive Top-Line Data in Exploratory Trial of SAGE-547 in Postpartum Depression, 5/09/2019 CTMX-US  GNW  CytomX Therapeutics Announces First Quarter 2019 Financial Results, 7/09/2019 GMAB-DK  GNW  Genmab Commences Public Offering of American Depositary Shares (ADSs) in the United States, 3/13/2019 92165910 GNW  VNDA APRIL 26th DEADLINE ALERT: Rosen Law Firm Reminds Vanda Pharmaceuticals Inc. Investors of Important Deadline in First-Filed Case; Encourages Investors With Losses in Excess of $100K to Contact the Firm â€“ VNDA,, 3/06/2019 CBAY-US  GNW  CymaBay Announces Pricing of Public Offering of Common Stock," 5/08/2012 45781M10 GNW  Theravance to Webcast 2012 Annual Meeting of Stockholders on May 15, 2012",10/25/2018 CCXI-US  GNW  Presentations at ASN Kidney Week 2018 Highlight ChemoCentryx Platform in Treatment of ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS),,," 4/30/2019 MNKD-US   GNW  MannKind Corporation to Hold 2019 First Quarter Financial Results Conference Call on May 7, 2019","10/26/2017 URGN-US  GNW  UroGen Pharma Expands Leadership Team, Appoints Industry Veterans Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs", 9/26/2019 CYTK-US  GNW  Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference, 8/06/2019 ESPR-US     GNW  Esperion to Present at the BTIG Biotechnology Conference," 5/09/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Amyris, Inc. Â â€“ AMRS",,12/17/2018 ACHN-US  GNW  Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Trials and Provides Clinical Development Strategy Update," 4/24/2019 87166B10 GNW  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Syneos Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 5/10/2019 FOLD-US  GNW  Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference,,, 5/03/2019 ADMA-US  GNW  ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing  Perceptive Advisors Credit Agreement," 5/02/2019 GWPH-US  GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EpidiolexÂ® (cannabidiol) oral solution, CV at the 2019 American Academy of Neurology Annual Meeting", 8/04/2017 EPZM-US  GNW  Epizyme Reports Second Quarter 2017 Financial Results and Clinical and Business Progress,, 5/08/2019 MYOK-US  GNW  MyoKardia to Present at Bank of America Merrill Lynch 2019 Health Care Conference,, 9/19/2019 GLPG-NL  GNW  Transparency notification," 1/27/2020 73701010 GNW  PORTOLA DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm",,,," 4/30/2019 CARA-US  GNW  Cara Therapeutics to Announce First Quarter 2019 Financial Results on May 7, 2019", 8/28/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the Wells Fargo Securities 2019 Healthcare Conference, 5/10/2019 QURE-US  GNW  uniQure Announces Updated Clinical Data from Phase IIb Study of  AMT-061 in Patients with Hemophilia B, 8/01/2019 AGIO-US   GNW  Agios Reports Business Highlights and Second Quarter 2019 Financial Results, 5/02/2019 IOVA-US  GNW  Iovance Biotherapeutics to Participate in Upcoming Conferences in May,"10/08/2018 03272410 GNW  Research Report Identifies AnaptysBio, Imperial Oil, Norbord, 3D, Apple Hospitality REIT, and Pinnacle Foods with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 4/02/2019 FATE-US  GNW  Fate Therapeutics Announces First Patient Treated with iPSC-derived NK Cell Cancer Immunotherapy FT500 Successfully Completes Initial Safety Assessment,12/27/2017 HZNP-US  GNW  Horizon Pharma plc Announces FDA Approval to Expand the Indication for PROCYSBIÂ® (cysteamine bitartrate) Delayed-Release Capsules to Include Children One Year of Age and Older Living with Nephropathic Cystinosis,, 4/04/2019 ICPT-US  GNW  Intercept to Present Results from the First Successful Phase 3 Trial in Patients with Liver Fibrosis Due to NASH at the International Liver Congressâ„¢ 2019,"10/04/2019 48576U10   GNW  Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm",,, 5/15/2019 ITCI-US  GNW  Intra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual Meeting,,,,"11/02/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018", 5/09/2019 ATRA-US    GNW  Atara Biotherapeutics Announces First Quarter 2019 Financial Results and Recent Operational Progress,, 9/25/2018 DERM-US  GNW  Dermira to Present at Cantor 2018 Global Healthcare Conference, 7/30/2019 FOMX-US  GNW  Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed,"10/31/2018 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Third Quarter 2018 Results and Updates 2018 Guidance",12/06/2018 SUPN-US  GNW  Supernus Announces Positive Results from Two Phase III Studies For SPN-812 in Children with ADHD," 7/22/2019 FGEN-US  GNW  FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis",, 5/23/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 5/02/2019 21833P10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ CRBP",,10/29/2018 COLL-US  GNW  Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER, 1/29/2019 XBIT-US  GNW  Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting,,, 8/06/2019 GBT-US   GNW  GBT Announces Participation at the 2019 Wedbush PacGrow Healthcare Conference, 6/07/2017 75901B10 GNW  AveXis and REGENXBIO Announce New Exclusive Worldwide Licenses for the Treatment of Two Rare Neurological Monogenic Disorders Using NAV AAV9 Vector, 6/18/2019 KURA-US  GNW  Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock," 7/22/2019 APLS-US  GNW  Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer"," 7/30/2019 AXSM-US  GNW  Axsome Therapeutics To Report Second Quarter 2019 Financial Results On August 8, 2019", 1/22/2019 VYGR-US  GNW  Voyager Therapeutics Appoints Robert Hesslein as General Counsel,"10/07/2019 07725L10 GNW  ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd. â€“ BGNE",,10/16/2018 RETA-US  GNW  Reata Announces Presentation of Four Clinical Abstracts at the American Society of Nephrology Kidney Week 2018, 7/30/2019 HCM-GB   GNW  Chi-Med Reports 2019 Interim Results and Provides Updates on  Key ClinicalÂ Programs,10/18/2018 NTLA-US  GNW  Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy, 1/03/2019 ACIU-US  GNW  AC Immune Announces Appointment of  Dr. Marie Kosco-Vilbois as Chief Scientific Officer,11/09/2018 MXCT-GB  GNW  CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology, 5/13/2019 GTHX-US  GNW  G1 Therapeutics to Present at UBS Global Healthcare Conference,12/11/2017 ARGX-BE  GNW  argenx reports positive topline results from Phase 2 proof-of-concept trial of ARGX-113 (efgartigimod) in generalized myasthenia gravis, 2/19/2019 RUBY-US GNW  Rubius Therapeutics to Participate at Upcoming Investor Conferences, 6/24/2019 ATNX-US  GNW  Athenex Announces U.S. FDA Allowance of Investigational New Drug Application for PT01 (Pegtomarginase)," 2/19/2019 PETQ-US  GNW  PetIQ, Inc. to Participate in the Bank of America Merrill Lynch Animal Health Summit", 3/08/2019 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results,"10/31/2018 OPTN-US  GNW  Optinose to Report Third Quarter 2018 Financial Results and Corporate Updates on November 13, 2018","12/19/2018 TORC-US  GNW  resTORbio Appoints William Marshall, M.D., as Vice President of Medical Sciences","12/08/2017 DNLI-US  GNW  Nasdaq Welcomes Denali Therapeutics, Inc. (NASDAQ: DNLI) to The Nasdaq Stock Market",," 5/18/2018 83422E10 GNW  SOLID BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB"," 4/08/2019 30052C10 GNW  Recent Analysis Shows Veritiv, Plains All American Pipeline, WESCO International, Evolus, Schnitzer Steel Industries, and Vornado Realty Trust Market Influences â€” Renewed Outlook, Key Drivers of Growth", 4/04/2019 FIXX-US GNW  Homology Medicines Announces FDA Clearance of Investigational New Drug Application for HMI-102 Gene Therapy Candidate for PKU, 6/10/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Strengthens Executive Leadership Team with Key Hires,12/03/2018 SRRK-US  GNW  Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy,"11/07/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results",,, 8/07/2018 EIDX-US  GNW  Eidos Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update,,, 7/18/2018 0C61PY-E GNW  Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus, 5/14/2019 AUTL-US  GNW  Autolus Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress," 6/15/2019 FTSV-US GNW  Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkinâ€™s Lymphoma",,,12/17/2018 PRNB-US GNW  Principia Biopharma Issues Statement About the Passing of Board Member Lewis J. Shuster,"12/07/2018 ARVN-US GNW  Arvinas Presents Preclinical Data on Protein Degrader, ARV-471, at the 2018 San Antonio Breast Cancer Symposium (SABCS)", 5/08/2019 YMAB-US  GNW  Y-mAbs Therapeutics To Present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas,, 2/27/2019 GRTS-US  GNW  Gritstone Oncology Announces Oral Presentation on MHC Class II Antigen Prediction at the AACR Annual Meeting in April 2019, 3/12/2019 GH-US    GNW  Guardant Health Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Outlook,,,, 7/29/2019 ORTX-US  GNW  Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich Syndrome,, 5/06/2019 01444210 GNW  Alector Announces First Alzheimerâ€™s Disease Patient Dosed in Phase 1b Study of AL002, 3/27/2019 DTIL-US GNW  Precision BioSciences Announces Pricing of Initial Public Offering, 5/31/2019 TPTX-US GNW  Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer,,,,,,,,
," 7/08/2019 PGNX-US  GNW  Progenics Pharmaceuticals Strengthens Management Team with Appointment of Huw Jones as Vice President, Commercial",," 5/12/2010 84763A10 GNW  Skymark Research Initiates Independent Research Coverage on Spectrum Pharmaceuticals, Inc.", 7/10/2016 G3040110 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline â€“ ENDP,"10/15/2014 04280A10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ARWR", 1/15/2019 BDSI-US  GNW  BioDelivery Sciences Appoints Terry Coelho as Chief Financial Officer,, 6/10/2011 75886F10 GNW  Quarterly Changes to the NASDAQ Q-50 Index,12/11/2017 SIGA-US      GNW  SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox, 2/28/2019 OPK-US   GNW  GeneDx Joins Rare Disease Organizations to Support Rare Disease Day 2019," 4/30/2019 AEP-US   GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Ionis Pharmaceuticals, American Electric Power, Hecla Mining, and Ulta Beauty â€” New Research Emphasizes Economic Growth", 4/20/2016 BMRN-US     GNW  BioMarin Provides Program Update on Vosoritide in Achondroplasia,,," 5/11/2010 81257810 GNW  Skymark Research Initiates Independent Research Coverage on Seattle Genetics, Inc.", 5/09/2019 IMMU-US  GNW  Immunomedics Reports First Quarter 2019 Results and Provides Corporate Update, 6/05/2019 NITE-US   GNW  Nightstar Therapeutics plcÂ Court Approval Received in Connection With Acquisition by Biogen,,11/05/2019 BCRX-US  GNW  BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks Â Â Â Â Â Â ," 4/03/2012 TST-US   GNW  TheStreet Exposes Unfair Selective Disclosure Policy of Prominent European Medical Association, Resulting in Change That Favors Investors",," 9/28/2018 N5946510 GNW  Report: Developing Opportunities within Sunoco LP, Mylan N.V., Ares Management, Las Vegas Sands, PPL, and Nokia â€” Future Expectations, Projections Moving into 2018",," 3/25/2019 00972810 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL", 4/30/2015 082NZ9-E GNW  Otonomy Appoints George Morrow to Board of Directors,"11/19/2019 62855J10 GNW  ROSEN, A GLOBALLY RANKED LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities Class Action â€“ MYGN", 4/26/2019 LXRX-US  GNW  Zynquistaâ„¢Â now Approved in the European Union for Treatment of Adults With Type 1 Diabetes, 8/27/2018 MGTX-US  GNW  MeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of Achromatopsia, 2/07/2018 INSM-US  GNW  Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference,,"10/25/2018 INO-US    GNW  Inovio HIV Vaccine PENNVAXÂ®-GP Delivered IntradermallyÂ Generated Robust, Long-Term Best-In-Class AntibodyÂ and T Cell Immune Responses"," 8/30/2019 64026810 GNW  ROSEN, A HIGHLY RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Nektar Therapeutics â€“ NKTR",, 1/24/2020 37416310 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN),, 9/03/2019 AMRN-US  GNW  New 2019 Updates to the European Society of Cardiologyâ€™s and European Atherosclerosis Societyâ€™s Guidelines for the Management of Dyslipidaemias Incorporate Findings from the REDUCE-ITâ„¢ Cardiovascular Outcomes Study," 9/30/2015 INCY-US  GNW  UPDATE -- Incyte Corporation to Join the NASDAQ-100 Index Beginning October 7, 2015", 8/03/2011 91307C10 GNW  Pluristem Announces Effectiveness of the Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension," 9/20/2019 80360710 GNW  GTT Communications, Inc. (GTT), Sarepta Therapeutics, Inc. (SRPT) & Aclaris Therapeutics, Inc. (ACRS) - Class Action Alert - Bronstein, Gewirtz & Grossman, LLC", 2/04/2019 G0176710 GNW  SHAREHOLDER ALERT: GS IMMU DXC ALKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 8/07/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update,10/15/2015 ARQL-US  GNW  ArQule Announces Publication of Manuscript Highlighting Activity of AKT Inhibitor ARQ 092 and Next Generation AKT Inhibitor ARQ 751 in Oncology,,,,11/04/2019 SAN-FR   GNW  Sanofi : FDA approves FluzoneÂ® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older,,12/03/2018 ALLO-US  GNW  Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia Â ," 3/07/2019 04351P10 GNW  Report: Exploring Fundamental Drivers Behind Manulife Financial, Fidelity National Financial, Heritage-Crystal Clean, Ericsson, Ascendis Pharma A/S, and Astec Industries â€” New Horizons, Emerging Trends, and Upcoming Developments",, 8/11/2018 00422510 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â ACAD, 4/01/2019 AFMD-US  GNW  Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting,, 4/01/2019 PRQR-US  GNW  ProQR to Present at the H.C. Wainwright Global Life Sciences Conference,, 7/30/2019 ZGNX-US  GNW  Zogenix to Release Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 6, 8/05/2019 ALLK-US  GNW  Allakos Reports Second Quarter 2019 Financial Results,," 6/03/2015 76133010 GNW  Revance Therapeutics to Initiate Two Key Trials for RT001, Its Topical Botulinum Toxin Type A Investigational Drug Product Candidate",,, 8/01/2019 ADVM-US  GNW  Adverum Biotechnologies Announces Board and Senior Management Changes, 7/23/2019 RARE-US   GNW  Ultragenyx to Host Conference Call for Second Quarter 2019 Financial Results and Corporate Update,10/10/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 ASHG Annual Meeting,12/21/2018 NSTG-US  GNW  NanoString to Present at the 37th Annual J.P. Morgan Healthcare Conference,,," 1/25/2019 RDUS-US  GNW  Radius Health Appoints Jessica Hopfield, Ph.D., to Board of Directors", 2/28/2019 ASMB-US  GNW  Assembly Biosciences Reports Fourth Quarter and Year End 2018 Financial Results,,,"10/19/2018 02043Q10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alnylam Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ALNY","10/24/2018 Y9530810 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Inter Parfums, United Continental, Turning Point Brands, TPI Composites, Nelnet, and WAVE Life Sciences â€” New Research Emphasizes Economic Growth", 6/26/2019 IONS-US  GNW  Akcea and Ionis Announce Upcoming Data Presentations at the 5th European Academy of Neurology Annual Congress,," 3/06/2019 69512710 GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Greif, GCP Applied Technologies, salesforce.com, inc, Chubb, Pacira Pharmaceuticals, and FARO Technologies â€” New Research Emphasizes Economic Growth", 1/07/2019 RTRX-US  GNW  Retrophin Provides Corporate Update and 2019 Outlook," 8/06/2018 69404D10 GNW  Detailed Research: Economic Perspectives on Allete, Sterling Construction, Illumina, PROS, Altra Industrial Motion, and Pacific Biosciences of California â€” What Drives Growth in Today's Competitive Landscape"," 2/19/2019 GMDA-US  GNW  ELBIT IMAGING ANNOUNCES THE SIGNING OF COLLABORATION AGREEMENT BETWEEN GAMIDA CELL AND EDITAS MEDICINE, INC.", 3/04/2019 CHMA-US  GNW  Chiasma to Participate in Three Investor Conferences in March,"10/23/2019 55609910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of MacroGenics, Inc. - MGNX",,," 9/22/2014 28249U10 GNW  Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning", 1/02/2019 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at theÂ 37th Annual J.P. Morgan Healthcare Conference, 7/31/2018 PRTA-US  GNW  Prothena to Report Second Quarter 2018 Financial Results on August 7, 5/29/2019 ZLAB-US  GNW  Zai Lab Announces Presentations at June Conferences, 6/03/2015 0C58C1-E GNW  SAGE Therapeutics to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference, 5/07/2019 CTMX-US  GNW   CytomX Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference," 7/08/2019 GMAB-DK  GNW  Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study of Transplant Eligible, Newly Diagnosed Patients with Multiple Myeloma Treated with Daratumumab in Combination with Lenalidomide, Bortezomib, and Dexamethasone"," 3/13/2019 92165910 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GSM, VALE, VNDA and NIO",, 3/05/2019 CBAY-US  GNW  CymaBay Announces Proposed Public Offering of Common Stock, 4/26/2012 45781M10 GNW  Theravance Reports First Quarter 2012 Financial Results,"10/16/2018 16383L10 GNW  Analysis: Positioning to Benefit within ChemoCentryx, Armstrong Flooring, Kornit Digital, NewLink Genetics, Silvercorp Metals, and Halcon Resources â€” Research Highlights Growth, Revenue, and Consolidated Results",,, 4/25/2019 06PCHP-E  GNW  MannKind Presents Scientific Data at 28th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (AACE 2019), 9/06/2017 URGN-US  GNW  UroGen Pharma Strengthens Management Team with the Appointment of Paul Chu as Vice President of Business Development, 9/25/2019 CYTK-US  GNW  Cytokinetics Announces Second Annual Communications Fellowship Program Call for Proposals," 7/30/2019 ESPR-US     GNW  Esperion to Report Second Quarter 2019 Financial Results August 8, 2019"," 5/09/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm",,"12/10/2018 ACHN-US  GNW  Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018"," 4/23/2019 87166B10 GNW  SYNEOS APRIL 30th DEADLINE ALERT: Rosen Law Firm Reminds Syneos Health, Inc. Investors of Important Deadline in the Securities Class Action Lawsuit â€“ SYNH", 5/08/2019 FOLD-US  GNW  Amicus Therapeutics Announces First Quarter 2019 Financial Results and Corporate Updates,,, 4/17/2019 ADMA-US  GNW  ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections," 4/23/2019 GWPH-US  GNW  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019", 8/01/2017 EPZM-US  GNW  US Oncology Research and Epizyme Establish Collaboration to Identify Non-Hodgkin Lymphoma Patients with EZH2 Mutations,, 5/07/2019 MYOK-US  GNW  MyoKardia Announces Inaugural MyoSeedsâ„¢ Research Grants Program Awardees,, 9/19/2019 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises," 1/27/2020 73701010 GNW  SHAREHOLDER ALERT - Portola Pharmaceuticals Inc. (PTLA) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: March 16, 2020",,,, 4/02/2019 CARA-US  GNW  Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference, 8/06/2019 FLXN-US  GNW  Flexion Therapeutics Reports Second-Quarter 2019 Financial Results and Recent Business Highlights, 5/07/2019 QURE-US  GNW  uniQure Announces Featured Presentations of New Data on Spinocerebellar Ataxia Type 3 at the 2019 American Academy of Neurology Annual Meeting," 7/18/2019 AGIO-US   GNW  Agios to Webcast Conference Call of Second Quarter 2019 Financial Results  on August 1, 2019"," 5/01/2019 IOVA-US  GNW  Iovance Biotherapeutics to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019", 9/28/2018 ANAB-US  GNW  AnaptysBio Announces Closing of Public Offering and Full Exercise of the Underwritersâ€™ Option,, 4/01/2019 FATE-US  GNW  Fate Therapeutics Presents Late-Breaking Preclinical Data Highlighting Unique Advantages of Clonal Master Engineered iPSC Lines for Off-the-Shelf CAR T-cell Therapy at 2019 AACR Annual Meeting,12/18/2017 HZNP-US  GNW  Horizon Pharma plc to Present at the 36th Annual J.P. Morgan Healthcare Conference,, 3/05/2019 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences,10/01/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/08/2019 ITCI-US  GNW  Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update,,,,"10/16/2018 03209R10 GNW  Consolidated Research: 2018 Summary Expectations for Freightcar America, Star Bulk Carriers, Avis Budget Group, Adamas Pharmaceuticals, Model N, and Amphastar Pharmaceuticals â€” Fundamental Analysis, Key Performance Indications"," 5/07/2019 ATRA-US    GNW  Atara Biotherapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019",, 9/13/2018 DERM-US  GNW  Dermira Presents New Pediatric Efficacy and Safety Data for Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis at the European Academy of Dermatology and Venereology Congress, 7/24/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8,"10/15/2018 69354M10 GNW  Consolidated Research: 2018 Summary Expectations for Lancaster Colony, Pioneer Natural Resources, Essex Property Trust, PRA Health Sciences, Pinnacle Entertainment, and Laredo Petroleum â€” Fundamental Analysis, Key Performance Indications",12/05/2018 SUPN-US  GNW  Supernus Schedules Conference Call to Present Topline Results of Two Phase III Studies for SPN-812 in Children with ADHD, 6/28/2019 FGEN-US  GNW  FibroGen to Present Interim Phase 2 Data on Pamrevlumab in Subjects with Duchenne Muscular Dystrophy at the Parent Project Muscular Dystrophy 2019 Annual Conference,, 5/22/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at Jefferies 2019 Global Healthcare Conference, 5/02/2019 CRBP-US  GNW  Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis,,"10/18/2018 19459J10 GNW  Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular â€” New Horizons, Emerging Trends, and Upcoming Developments", 1/28/2019 XBIT-US  GNW  Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual Meeting,,, 8/02/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 5/31/2017 RGNX-US  GNW  REGENXBIO Announces Initiation of Phase I Clinical Trial of RGX-314 Gene Therapy for Wet Age-Related Macular Degeneration, 6/18/2019 KURA-US  GNW  Kura Oncology Announces Commencement of Public Offering of Common Stock, 7/18/2019 APLS-US  GNW  Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies, 7/29/2019 AXSM-US  GNW  Axsome Therapeutics Amends Silicon Valley Bank Loan Agreement Increasing Financial Flexibility," 1/15/2019 VYGR-US  GNW  Voyager Therapeutics to Appoint Omar Khwaja, M.D., Ph.D., as Chief Medical Officer","10/01/2019 07725L10 GNW  Bragar Eagel & Squire, P.C. Is Investigating Tandy Leather Factory, ADTRAN, BeiGene, and Altria Group on Behalf of Stockholders and Encourages Investors to Contact the Firm",,"10/09/2018 75615P10 GNW  Research Report Identifies Cerner, Reata Pharmaceuticals, Lennar, Acacia Communications, GoPro, and ProAssurance with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 7/03/2019 HCM-GB   GNW  Chi-Med to Announce 2019 Half-Year Financial Results, 9/24/2018 NTLA-US  GNW  Intellia Therapeutics to Present  at October Healthcare Investor Conferences,12/19/2018 ACIU-US  GNW  AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership,11/07/2018 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results, 5/09/2019 GTHX-US  GNW  G1 Therapeutics Provides First Quarter 2019 Corporate and Financial Update,11/13/2017 ARGX-BE  GNW  argenx to Present at Upcoming Investor Conferences, 1/07/2019 RUBY-US GNW  Rubius Therapeutics Highlights Upcoming 2019 Milestones  at the 37th Annual J.P. Morgan Healthcare Conference, 6/06/2019 6446-TW  GNW  Athenex and PharmaEssentia Announce Positive Early Signals of Clinical Activity of KX2-391 (INN: tirbanibulin) in Patients with Psoriasis," 1/22/2019 00528Z-E GNW  PetIQ, Inc. Announces Amicable Legal Resolution", 3/04/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Cowen & Co. 39th Annual Health Care Conference,"10/22/2018 68404V10 GNW  Detailed Research: Economic Perspectives on Caseys General Stores, Evolus, OptiNose, Xunlei, Molina Healthcare, and Frontline â€” What Drives Growth in Today's Competitive Landscape",11/13/2018 TORC-US  GNW  resTORbio Reports Third Quarter 2018 Financial Results,12/08/2017 24823R10 GNW  Denali Therapeutics Inc. (Nasdaq: DNLI) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO,, 5/18/2018 SLDB-US  GNW  Solid Biosciences Announces New Preclinical Data at the  American Society of Gene and Cell Therapy Annual Meeting, 4/08/2019 EOLS-US  GNW  Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveauâ„¢ and BOTOXÂ® in Aesthetic Surgery Journal, 3/19/2019 FIXX-US GNW  Homology Medicines to Present at the Alliance for Regenerative Medicine Investor Day, 5/15/2019 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences,11/29/2018 SRRK-US  GNW  Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference,"10/31/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results",,,,,, 6/26/2018 XERS-US  GNW  Xeris Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 5/07/2019 AUTL-US  GNW  Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14," 6/03/2019 FTSV-US GNW  Forty Seven, Inc. Announces Updated Initial Data from Phase 1b Clinical Trial of 5F9 in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia",,,11/29/2018 PRNB-US GNW  Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program,11/20/2018 ARVN-US GNW  Arvinas To Present at the 30th Annual Piper Jaffray Healthcare Conference, 4/03/2019 YMAB-US  GNW  Y-mAbs Therapeutics To Present At The H.C. Wainwright Global Life Sciences Conference in London,, 2/20/2019 GRTS-US  GNW  Gritstone Oncology to Present at Leerink PartnersÂ Annual Global Healthcare Conference, 3/12/2019 GH-US    GNW  Guardant Health to Present at the 39th Annual Cowen Health Care Conference,,,," 6/10/2019 ORTX-US  GNW  Orchard Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference on June 12, 2019",, 4/17/2019 ALEC-US  GNW  Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001,," 5/15/2019 TPTX-US GNW  Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0022, a Novel MET/CSF1R/SRC Inhibitor",,,,,,,,
, 7/01/2019 PGNX-US  GNW  Leading Independent Proxy Advisory Firm Glass Lewis Recommends Progenics ShareholdersÂ Vote â€œFORâ€ ALL of Progenicsâ€™ Director Nominees,, 5/03/2010 84763A10 GNW  BioPharma Stock Alert for Spectrum Pharmaceuticals Inc. Issued by MicroStockProfit," 6/21/2016 G3040110 GNW  ENDO INTERNATIONAL INVESTOR ALERT: Hagens Berman Reminds Endo International plc (NASDAQ: ENDP) Investors of July 25, 2016 Lead Plaintiff Deadline in Securities Class Action",10/13/2014 04280A10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Arrowhead Research Corporation and Certain Officers -- ARWR,12/13/2018 09060J10 GNW  Antares Pharma Announces the Appointment of Peter S. Greenleaf to Companyâ€™s Board of Directors,,," 9/20/2017 SIGA-US      GNW  SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017", 2/27/2019 OPK-US   GNW  OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results, 4/24/2019 46222210 GNW  Akcea Therapeutics to Hold First Quarter 2019 Financial Results Webcast, 4/20/2016 BMRN-US     GNW  BioMarin Provides Encouraging Preliminary Data on First 8 Patients in Hemophilia A Gene Therapy Program,,,, 5/07/2019 IMMU-US  GNW  Immunomedics To Participate In Upcoming Healthcare Conferences, 5/30/2019 BIIB-US   GNW  New Phase 3 Interim Results Support Safety and Efficacy of Diroximel Fumarate in Multiple Sclerosis,,11/04/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"12/19/2011 NGSX-US  GNW  Oxygen Biotherapeutics Names Two New Board Members With Pharmaceutical Industry, Product and Business Development Emphasis",," 6/12/2018 N5946510 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Regency Centers, Motorola Solutions, California Resources, Echelon, Mylan N.V., and Nordstrom â€” New Research Emphasizes Economic Growth",," 3/21/2019 00972810 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ AKRX"," 3/24/2015 A-US     GNW  Dako, an Agilent Technologies Company, announces expanded collaboration with Amgen within companion diagnostics","11/15/2019 62855J10 GNW  Myriad Genetics, Inc. (MYGN), Overstock.com, Inc. (OSTK) & Waitr Holdings Inc. (WTRH) - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement"," 4/25/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on May 1, 2019", 8/20/2018 MGTX-US  GNW  MeiraGTx Announces AAV-CNGB3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia, 1/26/2018 INSM-US  GNW  Insmed Announces Closing of Public Offering,,"10/24/2018 INO-US    GNW  Inovio Pharmaceuticals to ReportÂ Third Quarter 2018 Financial Results on November 8, 2018"," 8/27/2019 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Granite Construction, Pluralsight, SAExploration, and Nektar and Encourages Investors to Contact the Firm",,11/21/2019 GERN-US  GNW  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),, 8/28/2019 AMRN-US  GNW  Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference," 9/29/2015 INCY-US  GNW  Incyte Corporation to Join the NASDAQ-100 Index Beginning October 7, 2015", 6/20/2011 05STML-E GNW  Pluristem and United Therapeutics Enter Into an Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension," 9/18/2019 80360710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, and Meredith Corporation and Encourages Investors to Contact the Firm"," 2/04/2019 G0176710 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm",," 7/29/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET", 9/28/2015 ARQL-US  GNW  ArQule Presents Results From Phase 1b Expansion Study of ARQ 092 at the 2015 European Cancer Conference,,,,11/04/2019 SAN-FR   GNW  Sanofi : Positive results in Phase 3 trial for ToujeoÂ® in children and adolescents with type 1 diabetes,,12/03/2018 ALLO-US  GNW  Allogene Therapeutics Presents Data from Preclinical Study of ALLO-715 (anti-BCMA) Demonstrating Allogeneic CAR T Potential in Multiple Myeloma at the 2018 ASH Annual Meeting, 3/05/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs,, 8/08/2018 00422510 GNW  SHAREHOLDER ALERT: HAIR TAL UNM ORA NWL PCG FLKS ACAD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 3/27/2019 AFMD-US  GNW  Affimed Reports 2018 Financial Results and Operational Progress,, 3/26/2019 PRQR-US  GNW  ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed Wings Therapeutics created by EB Research Partnership,, 7/08/2019 ZGNX-US  GNW  Zogenix Completes Enrollment in Phase 3 Trial of FINTEPLAÂ® in Lennox-Gastaut Syndrome," 8/05/2019 ALLK-US  GNW  Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)",, 5/21/2015 76133010 GNW  Revance to Participate in Upcoming Investor Conferences,,, 7/25/2019 ADVM-US  GNW  Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2019 Financial Results and Provide Corporate Updates," 7/15/2019 90400D10  GNW   Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.",10/01/2018 AGLE-US  GNW  FDA Grants Rare Pediatric Disease Designation to Pegzilarginase for Arginase 1 Deficiency,12/19/2018 NSTG-US  GNW  United Kingdomâ€™s National Institute for Health and Care Excellence (NICE) Recommends NanoStringâ€™s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualified Early-Stage Invasive Breast Cancer Patients,,, 1/07/2019 RDUS-US  GNW  Radius Exceeds 2018 Financial Guidance and Provides Business Update at the 37th Annual J.P. Morgan Healthcare Conference, 1/07/2019 ASMB-US  GNW  Assembly Biosciences Announces Completion of Enrollment in Two Phase 2a Studies with ABI-H0731 for Chronic Hepatitis B Virus,,,"10/19/2018 02043Q10 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alnylam Pharmaceuticals, Inc. (ALNY) and Lead Plaintiff Deadline â€“ November 26, 2018","10/09/2018 WVE-US   GNW  Wave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases", 6/20/2019 00972L10 GNW  Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting,," 3/05/2019 PCRX-US  GNW  Pacira to Acquire MyoScience, Adding FDA-approved ioveraÂº System for Non-opioid Pain Control"," 1/03/2019 RTRX-US  GNW  Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer"," 8/02/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2018 Financial Results"," 2/06/2019 EDIT-US  GNW  Editas Medicine Names David Scadden, M.D., to Board of Directors", 2/28/2019 CHMA-US  GNW  Chiasma Announces Support for Rare Disease Day 2019,"10/23/2019 55609910 GNW  IMPORTANT REMINDER FOR MACROGENICS, INC. INVESTORS: Wolf Haldenstein Adler Freeman & Herz LLP announces that aÂ securitiesÂ class action lawsuit has been filed in the United States District for the District of Maryland against MacroGenics, Inc.",,, 8/11/2014 28249U10 GNW  Celladon Announces Initiation of Clinical Trial to Investigate MYDICAR in Patients With Heart Failure and a Left Ventricular Assist Device (LVAD),12/11/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriterâ€™s Option to Purchase Additional Shares," 7/16/2018 G7280010 GNW  CLASS ACTION DEADLINE MONDAY for PRTA and FLR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 5/16/2019 ZLAB-US  GNW  Zai Lab Announces CTA Approval to Initiate a Phase 3 Clinical Trial of ETX2514SUL for the Treatment of Carbapenem-Resistant Acinetobacter Infections, 5/14/2015 78667J10 GNW  SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results, 5/02/2019 CTMX-US  GNW  CytomX Therapeutics to Announce First Quarter 2019 Financial Results, 6/27/2019 GMAB-DK  GNW  Genmab Announces U.S. FDA Approval of DARZALEXÂ® (daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma, 3/11/2019 92165910 GNW  Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. â€“ VNDA,, 2/28/2019 CBAY-US  GNW  CymaBay Reports Fourth Quarter and Fiscal Year End 2018 Financial Results and Provides Corporate Update, 4/24/2012 INVA-US  GNW  Theravance to Present at Investor Conferences in May 2012, 9/27/2018 CCXI-US  GNW  ChemoCentryx Determines Not to Proceed with Public Offering of Common Stock,,, 4/02/2019 MNKD-US   GNW  MannKind to Present at the H.C. Wainwright Global Life Sciences Conference, 9/05/2017 URGN-US  GNW  UroGen Pharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference, 9/16/2019 CYTK-US  GNW  Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23Ê³áµˆ Annual Scientific Meeting, 6/26/2019 ESPR-US     GNW  Esperion and Oberland Capital Announce $200 Million Funding Agreement," 5/07/2019 03236M20  GNW  Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Amyris, Inc. â€“ AMRS",,11/07/2018 ACHN-US  GNW  Achillion Reports Third Quarter 2018 Financial Results, 4/22/2019 SYNH-US  GNW  Syneos Health Wins Best CRO Award at the Vaccine Industry Excellence Awards, 4/30/2019 FOLD-US  GNW  Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting,,, 4/02/2019 ADMA-US  GNW  ADMA Receives Department of Health and Human Services U.S. License, 4/11/2019 GWPH-US  GNW  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Appointment of Darren Cline as U.S. Chief Commercial Officer, 7/31/2017 EPZM-US  GNW  Epizyme Announces Date of Second Quarter Financial Results and Presentation at Wedbush PacGrow Healthcare Conference,," 5/02/2019 MYOK-US  GNW  MyoKardia to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019",, 8/30/2019 GLPG-NL  GNW  Transparency notification," 1/23/2020 73701010 GNW  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. â€“ PTLA",,,, 3/12/2019 CARA-US  GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results, 8/02/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4), 5/02/2019 QURE-US  GNW  uniQure Announces New Preclinical Data in Hemophilia A and Fabry Disease in Oral Presentations at the 22nd ASGCT Annual Meeting," 7/01/2019 AGIO-US   GNW  Agios Announces Orlando Oliveira Appointed as Senior Vice President and General Manager, International", 4/03/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present New Data from Ongoing Studies of Tumor-Infiltrating Lymphocyte (TIL) Therapy at 2019 American Society of Clinical Oncology (ASCO) Meeting, 9/25/2018 ANAB-US  GNW  AnaptysBio Announces Pricing of Public Offering of Common Stock,," 3/18/2019 FATE-US  GNW  Fate Therapeutics Announces the Appointment of Karin Jooss, Ph.D. to its Board of Directors",12/05/2017 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 3/05/2019 45845P10 GNW  New Research: Key Drivers of Growth for American Tower Corporation (REIT), Lowe's Companies, Mimecast, Live Nation Entertainment, Intercept Pharmaceuticals, and Coherus BioSciences â€” Factors of Influence, Major Initiatives and Sustained Production"," 9/23/2019 48576U10   GNW  CLASS ACTION UPDATE for MMM, KPTI, GTT and VRAY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,, 5/02/2019 ITCI-US  GNW  Intra-Cellular Therapies to Host First Quarter 2019 Financial Results Conference Call and Webcast,,,, 8/29/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018," 4/01/2019 ATRA-US    GNW  Atara Biotherapeutics Presents Off-the-Shelf, Allogeneic CAR T Preclinical Results at the American Association of Cancer Research (AACR) Annual Meeting 2019",, 9/10/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 6/04/2019 FOMX-US  GNW  Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology, 9/25/2018 PRAH-US  GNW  PRA Health Sciences to Report Third Quarter 2018 Earnings,11/07/2018 SUPN-US  GNW  Supernus to Present at Three November Healthcare Conferences, 6/10/2019 FGEN-US  GNW  FibroGen to Present at the Goldman Sachs 40th Annual Global Healthcare Conference,, 5/09/2019 CHRS-US  GNW  Coherus BioSciences Reports Corporate Highlights and First Quarter 2019 Financial Results," 5/01/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Operational and Financial Results on May 9, 2019",,10/17/2018 COLL-US  GNW  Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update," 1/23/2019 XBIT-US  GNW  Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain",,, 7/10/2019 GBT-US   GNW  GBT and Advocates Launch Disease Awareness Campaign Focused onÂ Breaking Down Stigmas Associated with Sickle Cell Disease, 5/10/2017 RGNX-US  GNW  REGENXBIO to Present at the Bank of America Merrill Lynch 2017 Health Care Conference, 6/14/2019 KURA-US  GNW  Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma, 7/08/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 7/01/2019 AXSM-US  GNW  Axsome Therapeutics Added to Russell 3000Â® and Russell 2000Â® Indexes, 1/07/2019 VYGR-US  GNW  Voyager Therapeutics Provides Updates for VY-AADC Clinical Program for Parkinsonâ€™s Disease," 9/30/2019 07725L10 GNW  BGNE INVESTOR REMINDER: Hagens Berman Reminds BeiGene, Ltd. (BGNE) Investors of Ongoing Investigation of Possible Securities Fraud",, 9/25/2018 RETA-US  GNW  Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in IgA Nephropathy and Type 1 Diabetic Chronic Kidney Disease, 6/28/2019 HCM-GB   GNW  Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares," 9/10/2018 00GBNS-E GNW  CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding the Ruling by U.S. Patent and Trademark Office in Interference Proceeding Relating to CRISPR/Cas9 Genome Editing Technology",12/12/2018 LLY-US   GNW  AC Immune and Lilly Announce License and Collaboration Agreement,10/10/2018 H1718210 GNW  CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease," 5/02/2019 GTHX-US  GNW  G1 Therapeutics to Report First Quarter Financial Results on May 9, 2019",11/07/2017 ARGX-BE  GNW  argenx announces results of extraordinary shareholders' meeting 2017,12/27/2018 RUBY-US GNW  Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference, 6/06/2019 ATNX-US  GNW  Athenex Provides an Update on its Chongqing API Plant," 1/08/2019 PETQ-US  GNW  PetIQ, Inc. to Participate in the 2019 ICR Conference", 1/04/2019 RYTM-US  GNW  Rhythm Pharmaceuticals to Outline Expected 2019 Milestones and Review Updated Clinical Data in Bardet-Biedl Syndrome at 37th Annual J.P. Morgan Healthcare Conference,10/03/2018 OPTN-US  GNW  Optinose to Highlight Data at Two Upcoming Scientific Meetings,"11/08/2018 TORC-US  GNW  resTORbio Co-Founder and Chief Medical Officer Joan Mannick, M.D., to Present on TORC1 Inhibition at The Gerontological Society of America 2018 Annual Scientific Meeting",12/07/2017 DNLI-US  GNW  Denali Therapeutics Announces Pricing of Initial Public Offering,, 5/15/2018 SLDB-US  GNW  Solid Biosciences Announces Upcoming Preclinical Data Presentations, 4/01/2019 EOLS-US  GNW  Evolus Provides Regulatory Update on Nuceivaâ„¢ in the European Union, 3/12/2019 FIXX-US GNW  Homology Medicines Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Recent Accomplishments, 5/08/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress,11/27/2018 SRRK-US  GNW  Scholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular Atrophy," 9/24/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference",,,,,, 6/20/2018 XERS-US  GNW  Xeris Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock, 4/23/2019 AUTL-US  GNW  Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia," 5/16/2019 FTSV-US GNW  Forty Seven, Inc. to Present Updated Data from Ongoing Phase 1b/2 Clinical Trial of 5F9 in Patients with Relapsed/Refractory Non-Hodgkinâ€™s Lymphoma at 24th Congress of the European Hematology Association",,,11/08/2018 PRNB-US GNW  Principia Biopharma to Present atÂ 27th Annual Credit Suisse Healthcare Conference,10/23/2018 ARVN-US GNW  Arvinas to Present at Two Protein Degradation Conferences, 3/22/2019 YMAB-US  GNW  Y-mAbs Announces 2018 Financial Results and Corporate Development Highlights,, 1/06/2019 GRTS-US  GNW  Gritstone Oncology Announces Updated Presentation Time at theÂ 37th Annual J.P. Morgan Healthcare Conference," 3/12/2019 GH-US    GNW  Guardant Health to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019",,,, 6/05/2019 ORTX-US  GNW  Orchard Therapeutics Announced Pricing of Public Offering,, 4/01/2019 01444210 GNW  Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients  with Alzheimerâ€™s Disease,, 5/14/2019 TPTX-US GNW  Turning Point Therapeutics' CEO to Present at UBS Healthcare Conference,,,,,,,,
, 6/28/2019 05LY6L-E GNW  Progenics Reiterates Targeted Directorsâ€™ Indispensable Experience and Leadership Critical to the Companyâ€™s Long-Term Success,,," 6/14/2016 G3040110 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Endo International plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 25, 2016 â€“ ENDP",10/13/2014 04280A10 GNW  Robbins Arroyo LLP: Arrowhead Research Corporation (ARWR) Misled Shareholders According to a Recently Filed Class Action,12/11/2018 09060J10 GNW  Avadel Pharmaceuticals Appoints Kevin Kotler to the Companyâ€™s Board of Directors,,," 5/31/2017 SIGA-US      GNW  SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017"," 2/26/2019 OPK-US   GNW  OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019", 3/15/2019 46222210 GNW  Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19), 4/18/2016 BMRN-US     GNW  BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) to Ring The Nasdaq Stock Market Closing Bell,,,," 5/02/2019 IMMU-US  GNW  Immunomedics to Report First Quarter 2019 Results and Host Conference Call and Webcast on May 9, 2019", 5/20/2019 07KPGL-E  GNW  Biogen Recommends Stockholders Reject the Below-market Mini-tender Offer by TRC Capital Corporation,,"11/01/2019 BCRX-US  GNW  BioCryst Begins Phase 1 Trial With BCX9250, an Oral ALK-2 Inhibitor, for Treatment of Fibrodysplasia Ossificans Progressiva","10/18/2011 OCRX-US  GNW  Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer",," 1/03/2018 N5946510 GNW  Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEAÂ® (aflibercept)",," 3/21/2019 00972810 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL","11/10/2014 TURN-US  GNW  Harris & Harris Group Reports Financial Statements as of September 30, 2014","11/14/2019 62855J10 GNW  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MYGN, TME, and OSTK of Filing Deadlines", 4/02/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference, 8/13/2018 MGTX-US  GNW  MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia, 1/24/2018 INSM-US  GNW  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,10/22/2018 INO-US    GNW  Inovio Presents Progression Free Survival  & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150," 8/23/2019 64026810 GNW  INVESTOR ALERT - Nektar Therapeutics (NKTR) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Plaintiff Deadline: October 18, 2019",,11/06/2019 GERN-US  GNW  Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events,, 8/27/2019 AMRN-US  GNW  Amarin Provides Overview on Growing Global Attention on REDUCE-ITâ„¢ Results and Cardiovascular Risk Management Beyond Cholesterol Management, 9/09/2015 ADRO-US  GNW  Aduro Biotech Announces Clinical Trial Agreement to Evaluate Combination of Two Novel Cancer Immunotherapies for the Treatment of Ovarian Cancer, 6/10/2011 UTHR-US  GNW  Quarterly Changes to the NASDAQ Q-50 Index," 9/18/2019 80360710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NFLX, CARB, TWOU and SRPT"," 2/01/2019 G0176710 GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Alkermes plc (ALKS) and Encourages ALKS Investors to Contact the Firm",," 6/21/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces FDA Approval of Vyleesiâ„¢ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women"," 9/25/2015 ARQL-US  GNW  ArQule to Present at Leerink Partners 4th Annual Rare Disease Roundtable on September 30, 2015",,,,10/31/2019 SAN-FR   GNW  Sanofi Q3 well on track,,11/05/2018 ALLO-US  GNW  Allogene Therapeutics Announces November 2018 Investor Conference Schedule, 3/04/2019 ASND-US  GNW  Ascendis Pharma A/S Announces Proposed Public Offering of ADSs,," 8/08/2018 00422510 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Acadia Pharmaceuticals Inc. Investors"," 3/20/2019 AFMD-US  GNW  Affimed Announces Full Year 2018 Financial Results Conference Call on March 27, 2019",, 3/11/2019 PRQR-US  GNW  ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2,, 6/27/2019 ZGNX-US  GNW  Zogenix Announces FDA Agreement to Proceed with Resubmission of FINTEPLAÂ® NDA, 5/08/2019 ALLK-US  GNW  Allakos Reports First Quarter 2019 Financial Results,, 5/13/2015 76133010 GNW  Revance Therapeutics Releases First Quarter 2015 Financial Results,,, 7/15/2019 ADVM-US  GNW  Adverum Biotechnologies Appoints Senior Leaders, 6/19/2019 90400D10  GNW  Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases, 9/17/2018 AGLE-US  GNW  Aeglea BioTherapeutics Announces Oral Presentation of Preclinical Data on New Pipeline Therapeutic for Cystinuria at 2018 American Society of Nephrology,11/29/2018 NSTG-US  GNW  NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology,,, 1/02/2019 RDUS-US  GNW  Radius Health to Present at the 37th Annual J.P. Morgan Healthcare Conference,11/12/2018 ASMB-US  GNW  Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD,,,"10/18/2018 02043Q10 GNW  CLASS ACTION UPDATE for PZZA, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 9/20/2018 WVE-US   GNW  Wave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming Meetings, 5/28/2019 IONS-US  GNW  Akcea Therapeutics to Present at Upcoming Investor Conferences,, 2/28/2019 PCRX-US  GNW  Pacira Reports Record Fourth Quarter and Full Year Revenues, 1/02/2019 RTRX-US  GNW  Retrophin to Present at the 37th Annual J.P. Morgan Healthcare Conference, 7/31/2018 PACB-US  GNW  Pacific Biosciences Appoints Christian Henry to Board of Directors, 1/22/2019 EDIT-US  GNW  Editas Medicine Announces Chief Executive Officer Transition, 1/03/2019 CHMA-US  GNW  Chiasma Previews Important Upcoming Milestones,"10/22/2019 55609910 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMIND MACROGENICS (MGNX) INVESTORS OF SECURITIES CLASS ACTION: Firm Encourages Investors Who Have Suffered Losses to Contact the Firm Now",,, 8/07/2014 28249U10 GNW  Celladon Reports Second Quarter 2014 Financial Results and Recent Highlights,12/06/2018 MNTA-US  GNW  UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 7/15/2018 G7280010 GNW  SHAREHOLDER ALERT â€“ PRTA SYMC PPG MFGP FLR ATEN REPH DB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 5/09/2019 ZLAB-US  GNW  Zai Lab Announces Participation at Upcoming May Conferences, 5/14/2015 78667J10 GNW  SAGE Therapeutics Achieves 77 Percent Response Rate in Completed Phase 1/2 Clinical Trial of SAGE-547 in Super-Refractory Status Epilepticus," 4/22/2019 CTMX-US  GNW  CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors", 6/25/2019 GMAB-DK  GNW  Major Shareholder Announcement, 3/07/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,," 2/21/2019 CBAY-US  GNW  CymaBay Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results on Thursday, February 28"," 4/12/2012 45781M10 GNW  Theravance to Report First Quarter 2012 Financial Results on April 26, 2012", 9/26/2018 CCXI-US  GNW  ChemoCentryx Announces Proposed Public Offering of Common Stock,,, 4/01/2019 MNKD-US   GNW  MannKind Receives $12.5 Million Milestone Payment from United Therapeutics, 8/29/2017 URGN-US  GNW  UroGen Pharma Receives FDA Fast Track Designation for MitoGelâ„¢ for the Treatment of Upper Tract Urothelial Carcinoma (UTUC), 9/06/2019 CYTK-US  GNW  Cytokinetics Announces Presentations at  the 23rd Annual HFSA Scientific Meeting, 5/30/2019 ESPR-US     GNW  Esperion Announces the Appointment of Tracy M. Woody to Board of Directors," 5/07/2019 03236M20  GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm",,"10/17/2018 00448Q20 GNW  Investor Expectations to Drive Momentum within SunOpta, Acorda Therapeutics, Sapiens International Corporation N.V, The Descartes Systems Group, Achillion Pharmaceuticals, and CSS Industries â€” Discovering Underlying Factors of Influence"," 4/19/2019 87166B10 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: AKRX, SYNH, INGN, BPI"," 4/25/2019 FOLD-US  GNW  Amicus Therapeutics to Announce First Quarter 2019 Financial Results on May 8, 2019",,," 4/01/2019 ADMA-US  GNW  FDA Approves ASCENIVâ„¢, a Novel Intravenous Immune Globulin"," 4/03/2019 36197T10 GNW  Research Report Identifies Plug Power, Milacron, Genesis Healthcare, Jounce Therapeutics, GW Pharmaceuticals, and Earthstone Energy with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 7/24/2017 EPZM-US  GNW  Epizyme Announces Tazemetostat to be Evaluated in NCIâ€™s Recently Initiated NCI-COG Pediatric MATCH Trial,, 4/30/2019 MYOK-US  GNW  Clinical Trial Results from MyoKardiaâ€™s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine,, 8/28/2019 GLPG-NL  GNW  Transparency notification â€“ Gilead holds 22% of Galapagos shares," 1/23/2020 73701010 GNW  PORTOLA PHARMACEUTICALS, INC.Â CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that aÂ securitiesÂ classÂ actionÂ lawsuitÂ hasÂ beenÂ filedÂ inÂ theÂ United States District Court for the Northern District of California against Portola Pharmaceuticals, Inc.",,,," 3/05/2019 CARA-US  GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019"," 7/30/2019 FLXN-US  GNW  Flexion Therapeutics to Report Second-Quarter 2019 Financial Results on August 6, 2019", 5/01/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences," 6/10/2019 AGIO-US   GNW  Agios to Present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019", 4/03/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces Clinical Programs Update, 9/24/2018 ANAB-US  GNW  AnaptysBio Announces Proposed Public Offering of Common Stock,, 3/05/2019 FATE-US  GNW  Fate Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress,11/30/2017 HZNP-US  GNW  Horizon Pharma plc to Participate in BMO Prescriptions for Success Healthcare Conference,," 2/28/2019 ICPT-US  GNW  Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results, Issues 2019 Financial Guidance and Provides Business Update"," 9/22/2019 48576U10   GNW  KARYOPHARM 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI",,," 4/16/2019 ITCI-US  GNW  Intra-Cellular Therapies Mourns the Passing of Co-Founder and Nobel Laureate, Dr. Paul Greengard",,,," 8/20/2018 03209R10 GNW  Investor Expectations to Drive Momentum within Rapid7, 1-800 FLOWERS.COM, SMART Global, Prothena Corporation plc, Amphastar Pharmaceuticals, and Silvercorp Metals â€” Discovering Underlying Factors of Influence", 3/31/2019 04651310   GNW  Atara Biotherapeutics Announces Collaborator Presentation of Positive Phase 1 Clinical Results for a Mesothelin-Targeted CAR T Immunotherapy in Patients with Advanced Mesothelioma,, 9/05/2018 DERM-US  GNW  Dermira Provides Launch Readiness Update for QBREXZAâ„¢ (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis, 5/07/2019 FOMX-US  GNW  Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update," 8/09/2018 69354M10 GNW  New Research: Key Drivers of Growth for Tenet Healthcare, DDR, Newmont Mining, Tahoe Resources, PRA Health Sciences, and Arch Coal â€” Factors of Influence, Major Initiatives and Sustained Production",11/06/2018 SUPN-US  GNW  Supernus Announces Third Quarter 2018 Financial Results and Record Quarterly Revenue, 6/05/2019 FGEN-US  GNW  FibroGen Appoints Suzanne Blaug to Board of Directors,, 5/02/2019 CHRS-US  GNW  Coherus BioSciences and Amgen Settle Trade Secrets Action," 4/26/2019 21833P10 GNW  CRBP ALERT: Zhang Investor Law Reminds Investors of May 13  Deadline in Securities Class Action Lawsuit Corbus Pharmaceuticals Holdings, Inc. â€“ CRBP",, 9/28/2018 COLL-US  GNW  Collegium to Present at Upcoming Investor Conference,12/13/2018 XBIT-US  GNW  XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study,,, 7/09/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 5/09/2017 RGNX-US  GNW  REGENXBIO Reports First Quarter 2017 Financial Results and Recent Operational Highlights, 5/08/2019 KURA-US  GNW  Kura Oncology to Present at Bank of America Merrill Lynch Health Care Conference, 6/27/2019 APLS-US  GNW  Apellis Pharmaceuticals Completes Enrollment of Phase 3 APL-2 (pegcetacoplan) Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab, 6/24/2019 AXSM-US  GNW  Axsome Therapeutics Initiates GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder,12/17/2018 VYGR-US  GNW  Voyager Therapeutics Joins Michael J. Fox Foundation Initiatives and Education Campaigns to Accelerate the Development of New therapies and a Cure for Parkinsonâ€™s Disease, 9/30/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on Tislelizumab and Pamiparib Presented at the European Society for Medical Oncology (ESMO) Congress 2019,, 8/30/2018 RETA-US  GNW  Reata Announces Receipt of $30 Million Milestone Payment From Kyowa Hakko Kirin, 6/27/2019 44842L10 GNW  Chi-Med Announces Secondary Offering of American Depositary Shares, 8/27/2018 NTLA-US  GNW  Intellia Therapeutics to Present at September Healthcare Investor Conferences,"12/07/2018 ACIU-US  GNW  In Memoriam: Dr. Andreas Muhs CSO, Scientific Leader and Friend has Passed Away",10/02/2018 CRSP-US  GNW  CRISPR Therapeutics to Present at the Chardan Genetic Medicines Conference, 4/29/2019 GTHX-US  GNW  G1 Therapeutics AnnouncesÂ Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020,"11/02/2017 ARGX-BE  GNW  argenx to host KOL breakfast symposium on pemphigus vulgaris on November 10, 2017","12/21/2018 RUBY-US GNW  Rubius Therapeutics, Inc. Secures $75 Million Loan Facility", 5/30/2019 ATNX-US  GNW  Athenex to Present at the 2019 ASCO Annual Meeting,"11/13/2018 PETQ-US  GNW  PetIQ, Inc. Reports Third Quarter 2018 Financial Results",12/13/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and AlstrÃ¶m Syndromes, 9/24/2018 OPTN-US  GNW  Optinose to Present at the 2018 Cantor Global Healthcare Conference,11/07/2018 TORC-US  GNW  resTORbio to Present at Upcoming Investor Conferences in November,,," 5/11/2018 83422E10 GNW  SOLID BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB", 3/21/2019 EOLS-US  GNW  Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveauâ„¢ in Dermatologic Surgery, 3/06/2019 FIXX-US GNW  Homology Medicines to Present at Cowen Healthcare Conference, 5/01/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Presents Positive YUTIQâ„¢ 36-month Follow-up Phase 3 Data at the 2019 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting,11/19/2018 SRRK-US  GNW  Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors," 9/05/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference",,,,,, 1/07/2015 007TNF-E GNW  Xeris Pharmaceuticals Completes $17.9M Series B Round and Appoints Phillip Johnson as Chief Financial Officer, 4/15/2019 AUTL-US  GNW  Autolus Announces Closing of Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional American Depositary Shares," 5/15/2019 FTSV-US GNW  Forty Seven, Inc. to Present Initial Safety and Efficacy Data from Phase 1b Clinical Trial of 5F9 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome at 2019 ASCO Annual Meeting",,,11/06/2018 PRNB-US GNW  Principia Biopharma Reports Third Quarter Financial Results, 9/26/2018 ARVN-US GNW  Arvinas Announces Pricing of Initial Public Offering, 3/08/2019 YMAB-US  GNW  Y-mAbs Therapeutics To Present At Cowenâ€™s 39th Annual Health Care Conference,, 1/03/2019 GRTS-US  GNW  Gritstone Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference," 2/27/2019 GH-US    GNW  Guardant360 Performance Matches Standard-of-Care Tissue Testing in First-Line, Advanced Non-Small Cell Lung Cancer, NILE Study Shows, Meeting Primary Endpoint",,,, 6/03/2019 ORTX-US  GNW  Orchard Therapeutics Launches Proposed Public Offering,, 3/26/2019 ALEC-US  GNW  Alector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial Results,," 5/14/2019 TPTX-US GNW  Turning Point Therapeutics Names Biotech Veteran Patrick Machado, J.D. to Its Board of Directors",,,,,,,,
, 6/27/2019 PGNX-US  GNW  Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital,,," 6/03/2016 G3040110 GNW  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Endo International plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit â€“ ENDP",10/10/2014 04280A10 GNW  EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Arrowhead Research Corp. -- ARWR,11/08/2018 BDSI-US  GNW  BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results,,, 4/20/2017 SIGA-US      GNW  SIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXXÂ® (tecovirimat) to Treat Smallpox," 2/05/2019 OPK-US   GNW  OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes"," 3/04/2019 46222210 GNW  Detailed Research: Economic Perspectives on Huntsman, eHealth, Ionis Pharmaceuticals, Arch Capital Group, Copart, and Acorda Therapeutics â€” What Drives Growth in Today's Competitive Landscape", 4/18/2016 BMRN-US     GNW  BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on April 20th in New York,,,, 4/29/2019 IMMU-US  GNW  Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan," 5/14/2019 09062X10  GNW  Biogenâ€™s SPINRAZAÂ® (nusinersen) Receives Positive Recommendation from NICE for Funding in the United Kingdom for the Treatment of Infants, Children and Adults with Spinal Muscular Atrophy",,10/29/2019 BCRX-US  GNW  BioCryst to Provide Commercial Update and Report Third Quarter 2019 Financial Results on November 6,12/03/2010 NIHDQ-US GNW  NASDAQ OMX Hosts 25th Investor Program in London in Association With Morgan Stanley,,"11/01/2017 N5946510 GNW  Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIAÂ® (abatacept)",, 3/21/2019 AKRX-US  GNW  Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality," 9/24/2014 AMGN-US  GNW  Galectin Therapeutics Elects Gilbert S. Omenn, M.D., Ph.D., a Leading Cancer Researcher, to Its Board of Directors","11/13/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tencent, Myriad Genetics, Overstock.com, and Waitr Holdings and Encourages Investors to Contact the Firm"," 3/29/2019 52887230 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LXRX, UXIN, AVEO and AMRN", 8/08/2018 MGTX-US  GNW  MeiraGTx Reports Second Quarter 2018 Financial Results and Provides Corporate Update, 1/23/2018 INSM-US  GNW  Insmed Announces Pricing of Public Offering of Convertible Senior Notes,,"10/17/2018 INO-US    GNW  Inovioâ€™s DNA-Encoded Monoclonal Antibody (dMAbâ„¢) Platform Moves Ahead with Positive Data, Patents and Grants", 8/22/2019 64026810 GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR),,11/06/2019 GERN-US  GNW  Geron Announces Two Poster Presentations at Upcoming American Society of Hematology Annual Meeting,, 8/21/2019 AMRN-US  GNW  Amarin to Participate in a Fireside Chat at Citiâ€™s 14th Annual Biotech Conference, 2/11/2015 45337C10 GNW  Advaxis Forms Clinical Trial Collaboration With Incyte to Evaluate Investigational Combination of Two Novel Cancer Immunotherapies for Early Stage Cervical Cancer,," 9/18/2019 80360710 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Sarepta Therapeutics, Inc. to Contact the Firm", 2/01/2019 G0176710 GNW  SHAREHOLDER ALERT: YRCW PRGO YRIV ALKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 5/29/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference, 9/08/2015 ARQL-US  GNW  ArQule Presents Additional Clinical Biomarker Data From Phase 2 Study of Tivantinib in Hepatocellular Carcinoma at International Liver Cancer Association Conference,,,,10/29/2019 SAN-FR   GNW  Sanofi : DupixentÂ® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis,,"10/12/2018 ALLO-US  GNW  Nasdaq Welcomes Allogene Therapeutics, Inc. (Nasdaq: ALLO) To The Nasdaq Stock Market", 3/04/2019 ASND-US  GNW  Ascendis Pharma Announces Once-weekly TransConâ„¢ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency,," 8/06/2018 00422510 GNW  CLASS ACTION UPDATE for MRCY, GLNCY, GLCNF, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 3/19/2019 AFMD-US  GNW  Affimed Announces Milestone Payment from Genentech and ROCKÂ® Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity",, 3/05/2019 PRQR-US  GNW  ProQR to Present at Cowen Health Care Conference,," 6/07/2019 98978L20 GNW  Zogenix, Inc. (ZGNX), BrightView Holdings, Inc. (BV) & Taronis Technologies, Inc. f/k/a MagneGas Applied Technology (TRNX) - Bronstein, Gewirtz & Grossman, LLC Notifies of Class Actions", 5/07/2019 ALLK-US  GNW  Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis,," 4/29/2015 76133010 GNW  Revance Therapeutics to Release First Quarter 2015 Financial Results Wednesday, May 13, 2015",,, 7/08/2019 ADVM-US  GNW  Adverum Biotechnologies to Present Data at Upcoming Conferences, 6/17/2019 RARE-US   GNW  Ultragenyx Expands Leadership Team and Promotes Erik Harris to Chief Commercial Officer, 9/04/2018 AGLE-US  GNW  Aeglea BioTherapeutics Announces Positive Interim Clinical Data and Completion of Enrollment for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency,11/20/2018 NSTG-US  GNW  NanoString to Present at the Evercore ISI HEALTHCONx Conference,,,"12/06/2018 75046920 GNW  LogicBio Therapeutics Appoints Richard Moscicki, M.D., and Michael Wyzga to Board of Directors",11/08/2018 ASMB-US  GNW  Assembly Biosciences Announces Third Quarter 2018 Financial Results and Provides HBV Program Update,,,10/17/2018 02043Q10 GNW  SHAREHOLDER ALERT: TRCO MCHP ALNY MGTI CPB CHGG ADNT TRVN SFIX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 8/16/2018 WVE-US   GNW  Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201, 5/08/2019 00972L10 GNW  Akcea Reports Financial Results and Highlights for First Quarter 2019,," 2/21/2019 PCRX-US  GNW  Pacira to Report 2018 Financial Results on Thursday February 28, 2019",12/27/2018 RTRX-US  GNW  Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy," 7/23/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Second Quarter 2018 Financial Results Call", 1/21/2019 EDIT-US  GNW  Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101 to Treat Leber Congenital Amaurosis 10 (LCA10),11/08/2018 CHMA-US  GNW  Chiasma Reports Third Quarter 2018 Results,10/22/2019 MGNX-US  GNW  MacroGenics Announces Second Interim Overall Survival Data from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer,,," 7/30/2014 28249U10 GNW  Celladon to Report Second Quarter 2014 Results on August 7, 2014",12/06/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 7/13/2018 G7280010 GNW  The Law Offices of Howard G. Smith Reminds Investors of July 16th Deadline in the Class Action Lawsuit Against Prothena Corporation plc (PRTA), 5/02/2019 ZLAB-US  GNW  Zai Lab Announces Pricing of Public Offering of American Depositary Shares, 5/12/2015 0C58C1-E GNW  SAGE Therapeutics to Present at UBS Global Healthcare Conference," 4/02/2019 CTMX-US  GNW  AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166", 6/19/2019 GMAB-DK  GNW  Major Shareholder Announcement, 3/07/2019 92165910 GNW  Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. â€“ VNDA,, 2/20/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference, 4/02/2012 45781M10 GNW  GlaxoSmithKline to Increase Its Ownership in Theravance, 9/26/2018 CCXI-US  GNW  ChemoCentryx to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference,,," 3/14/2019 MNKD-US   GNW  MannKind to Sponsor Andretti Autosport Type 1 Diabetes Driver, Conor Daly", 8/14/2017 URGN-US  GNW  UroGen Pharma Reports Second Quarter 2017 Financial Results and Recent Corporate Developments, 9/03/2019 CYTK-US  GNW  Cytokinetics to Present at September Investor Conferences, 5/28/2019 ESPR-US     GNW   Esperion to Participate in Upcoming Investor Conferences," 5/03/2019 03236M20  GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of AMRS, CRCM, and FLEX of Upcoming Deadlines",, 9/25/2018 ACHN-US  GNW  Achillion to Present at the  Leerink Partners Roundtable Series, 4/18/2019 SYNH-US  GNW  Syneos Health Takes Top Honor at Inaugural ACRP All-Stars Challenge for Sponsors and CROs, 4/15/2019 FOLD-US  GNW  Amicus Therapeutics to Present Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting,,, 3/13/2019 ADMA-US  GNW  ADMA Biologics Reports Full Year 2018 Financial Results, 3/18/2019 GWPH-US  GNW  GW Pharmaceuticals plc Announces the Sale of Priority Review Voucher for $105M, 6/26/2017 EPZM-US  GNW  Epizyme Expands Clinical Collaboration to Study Tazemetostat and TECENTRIQÂ® Combination in NSCLC,, 3/26/2019 MYOK-US  GNW  MyoKardia Announces Pricing of Public Offering of Common Stock,, 8/23/2019 GLPG-NL  GNW  Gilead and Galapagos Complete Closing of Their Transformative Research and Development  Collaboration," 1/22/2020 73701010 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mohawk Industries, 500.com, and Portola Pharmaceuticals and Encourages Investors to Contact the Firm",,,, 1/07/2019 CARA-US  GNW  Cara Therapeutics Completes Enrollment of KALM-1 Pivotal Phase 3 Trial Of KORSUVAâ„¢ (CR845/ difelikefalin) Injection in Hemodialysis Patients with Pruritus, 7/15/2019 FLXN-US  GNW  Flexion Therapeutics Presents New Data Evaluating Repeat Administration of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in Patients with Advanced Knee OA, 4/29/2019 QURE-US  GNW  uniQure Announces First Quarter 2019 Results and Highlights Recent Company Progress," 6/05/2019 AGIO-US   GNW  Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019", 4/02/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces First Patient Dosed in Cohort 4 of Pivotal InnovaTIL-01 Study of Lifileucel in Metastatic Melanoma, 9/24/2018 ANAB-US  GNW  AnaptysBio Reports Positive Topline Data from Phase 2a Proof-of-Concept Clinical Trial of Etokimab in Severe Eosinophilic Asthma,, 2/28/2019 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2018 Financial Results,"11/30/2017 HZNP-US  GNW  Horizon Pharma plc Names Shao-Lee Lin, M.D., Ph.D. Executive Vice President, Research and Development and Chief Scientific Officer",," 2/20/2019 ICPT-US  GNW  Intercept to Announce Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019"," 9/20/2019 48576U10   GNW  INVESTOR ALERT - Karyopharm Therapeutics Inc. (KPTI)Â - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders With Losses Exceeding $100K of Class Action and Lead Deadline: September 23, 2019",,, 4/15/2019 ITCI-US  GNW  Intra-Cellular Therapies Presents Additional Results From Long-term Open Label Safety Study of Lumateperone at the 2019 Congress of the Schizophrenia International Research Society,,,," 8/08/2018 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2018", 3/07/2019 ATRA-US    GNW  Atara Biotherapeutics to Participate in Upcoming Conferences,," 8/20/2018 24983L10 GNW  Report: Exploring Fundamental Drivers Behind MediciNova, Dermira, FRP, BiondVax Pharmaceuticals, The Descartes Systems Group, and American Software â€” New Horizons, Emerging Trends, and Upcoming Developments", 5/06/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019," 8/07/2018 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Pricing of Secondary Offering of 6,500,000 Shares of Common Stock","10/26/2018 86845910 GNW  Recent Analysis Shows Supernus Pharmaceuticals, GDS HOLDINGS, Golden Ocean Group, Golar LNG, Endo International plc, and 51job Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 5/10/2019 31572Q80 GNW  FibroGen INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In FibroGen, Inc. To Contact The Firm",, 5/02/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at  Two Upcoming Investor Healthcare Conferences," 4/25/2019 21833P10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inogen, Spectrum Brands, Bridgepoint, and Corbus and Encourages Investors to Contact the Firm",, 9/04/2018 COLL-US  GNW  Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting,12/12/2018 XBIT-US  GNW  XBiotechâ€™s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease,,, 6/26/2019 GBT-US   GNW  Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering, 5/04/2017 RGNX-US  GNW  Preclinical Data from REGENXBIO RGX-314 Gene Therapy Program for Wet Age-Related Macular Degeneration to be Presented at Upcoming Conferences, 5/07/2019 KURA-US  GNW  Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones, 6/15/2019 APLS-US  GNW  Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress, 6/07/2019 AXSM-US  GNW  Axsome Therapeutics Provides Update on Continued Progress at Annual Stockholdersâ€™ Meeting,"12/10/2018 VYGR-US  GNW  Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinsonâ€™s Disease", 9/26/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on Tislelizumab and Pamiparib to Be Presented at the European Society for Medical Oncology (ESMO) Congress 2019,," 8/08/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Second Quarter 2018 Financial Results and an Update on Development Programs", 6/14/2019 HCM-GB   GNW  Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop Early, 8/23/2018 NTLA-US  GNW  Intellia Therapeutics Presents Progress in Lead In Vivo Program at Cold Spring Harbor Laboratoryâ€™s Fourth Meeting on Genome Engineering: The CRISPR-Cas Revolution,11/15/2018 ACIU-US  GNW  AC Immune Awarded Third Follow-up Grant from The Michael J. Fox Foundation for First-in-Human Study of a Positron Emission Tomography (PET) Tracer for Parkinson's Disease, 9/20/2018 CRSP-US  GNW  CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares, 4/02/2019 GTHX-US  GNW  G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference,10/30/2017 ARGX-BE  GNW  argenx launches Phase I trial with subcutaneous formulation of ARGX-113,12/17/2018 RUBY-US GNW  Rubius Therapeutics Added to Nasdaq Biotechnology Index," 5/09/2019 ATNX-US  GNW  Athenex, Inc. Announces First Quarter 2019 Financial Results and Provides Corporate Update","10/29/2018 PETQ-US  GNW  PetIQ, Inc. to Report Third Quarter 2018 Results on Tuesday, November 13th","12/06/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome", 8/14/2018 OPTN-US  GNW  Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights,11/06/2018 TORC-US  GNW  resTORbio Appoints Michael Grissinger to its Board of Directors,,, 5/10/2018 SLDB-US  GNW  Solid Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update, 3/18/2019 EOLS-US  GNW  Evolus Reports Fourth Quarter and Full Year 2018 Results, 1/07/2019 FIXX-US GNW  Homology Medicines Achieves 2018 Goals and Prepares PKU Gene Therapy Program for the Clinic with Initial Data Expected in 2019, 4/23/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces First Quarter 2019 Financial Results Release Date and Conference Call Information,11/09/2018 SRRK-US  GNW  Scholar Rock Demonstrates that Highly Specific TGFÎ²1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy," 8/09/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results",,,,,,11/12/2014 007TNF-E GNW  FDA and EMA Grant Orphan Designation to Xeris Pharmaceuticals' Soluble Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Patients, 4/10/2019 AUTL-US  GNW  Autolus Announces Pricing of Public Offering, 5/13/2019 FTSV-US GNW  Forty Seven Inc. Reports First Quarter 2019 Financial Results and Recent Business Highlights,,,"10/24/2018 PRNB-US GNW  Principia Biopharma Appoints Dolca Thomas, M.D. as Chief Medical Officer",, 2/13/2019 YMAB-US  GNW  Y-mAbs Therapeutics to Present at PEGS Boston,,12/20/2018 GRTS-US  GNW  Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer, 2/14/2019 GH-US    GNW  Guardant Health to Present at the 8th Annual Leerink Partners Global Healthcare Conference,,,, 5/28/2019 ORTX-US  GNW  Orchard Therapeutics Announces Expansion of Neurometabolic Disease Portfolio and Reports First Quarter 2019 Financial Results,, 3/06/2019 ALEC-US  GNW  Alector to Present at Investor Conferences in March,, 5/06/2019 TPTX-US GNW  Turning Point Therapeutics and Almac Diagnostic Services Announce Approval of an Investigational Device Exemption for the Companion Diagnostic Assay to the Registrational TRIDENT-1 Clinical Study,,,,,,,,
," 6/25/2019 PGNX-US  GNW  Data Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting Highlights Potential of Progenicsâ€™ PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer",,," 5/27/2016 G3040110 GNW  ENDO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Endo International plc - ENDP",,11/01/2018 BDSI-US  GNW  BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCAÂ®,,," 5/20/2015 SIGA-US      GNW  Delisting of Securities of Life Partners Holdings Inc., SIGA Technologies, Inc., Exceed Company Ltd., Video Display Corporation, and Home Loan Servicing Solutions, Ltd. From The NASDAQ Stock Market"," 2/04/2019 OPK-US   GNW  OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes", 3/01/2019 IONS-US  GNW  Akcea and Ionis Receive Positive EU CHMP Opinion for  WAYLIVRATM (volanesorsen)," 4/12/2016 BMRN-US     GNW  BioMarin to Host First Quarter 2016 Financial Results Conference Call and Webcast on Thursday, April 28 at 4:30pm ET",,,, 4/29/2019 IMMU-US  GNW  Immunomedics Announces Departure of Chief Medical Officer, 5/08/2019 NITE-US   GNW  Nightstar Therapeutics PLC Shareholders Approve Scheme of Arrangement for Acquisition By Biogen at General Meeting and Court Meeting Held on 8 May 2019,,10/28/2019 BCRX-US  GNW  BioCryst Reports Data From Phase 1 Trial of BCX9930 and Announces Plans to Advance Program Into Proof of Concept Study in PNH Patients,10/27/2010 GILD-US  GNW  Achillion Reports Third Quarter and Nine Month Financial Results,," 8/11/2017 PRPH-US  GNW  ProPhase Labs Reports Financial Results  for the Three Months and Six Months Ended June 30, 2017",," 3/20/2019 00972810 GNW  SHAREHOLDER ALERT: Pawar Law Group Announces aÂ Securities Class Action Lawsuit Against Akorn, Inc. â€“ AKRX",11/05/2013 AMGN-US  GNW  Sobi hosts Capital Market Day event - announces phase I Complement Inhibitor program,"11/13/2019 62855J10 GNW  Pawar Law Group Reminds Investors of NOV. 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. â€“ MYGN"," 3/22/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes", 6/26/2018 MGTX-US  GNW  MeiraGTx Receives Positive Opinion for Orphan Drug Designation in the European Union for AAV-CNGA3 for the Treatment of Achromatopsia, 1/22/2018 INSM-US  GNW  Insmed Announces Proposed Public Offering of Convertible Senior Notes,,10/15/2018 INO-US    GNW  Inovioâ€™s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies," 8/21/2019 64026810 GNW  NEKTAR THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that aÂ securitiesÂ classÂ actionÂ lawsuitÂ hasÂ beenÂ filedÂ inÂ theÂ United States District for the Northern District of California against Nektar Therapeutics, Inc.",,"10/31/2019 GERN-US  GNW  Geron to Announce Third Quarter Financial Results on November 6, 2019",, 8/08/2019 AMRN-US  GNW  Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With VascepaÂ® REDUCE-ITâ„¢ sNDA, 5/10/2013 45337C10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCY,," 9/17/2019 80360710 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT", 1/31/2019 G0176710 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Alkermes plc. and Certain Officers â€“Â ALKS,," 5/17/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York", 8/05/2015 ARQL-US  GNW  ArQule Reports Second Quarter 2015 Financial Results,,,,"10/15/2019 SAN-FR   GNW  Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing",,, 2/28/2019 ASND-US  GNW  Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia,," 8/03/2018 00422510 GNW  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD", 2/27/2019 AFMD-US  GNW  Affimed to Present Data on AFM13 and AFM24 at AACR Annual Meeting 2019,, 2/27/2019 PRQR-US  GNW  ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results,, 6/06/2019 98978L20 GNW  ZGNX and APYX DEADLINE ALERT: Hagens Berman Reminds APYX and ZGNX Investors of Lead Plaintiff Deadlines, 3/14/2019 ALLK-US  GNW  Allakos Reports Fourth Quarter and Full Year 2018 Financial Results and 2018 Corporate Highlights,, 3/02/2015 76133010 GNW  Revance Therapeutics Releases Fourth Quarter and Full Year 2014 Financial Results and Reiterates 2015 Outlook,,, 6/10/2019 ADVM-US  GNW  Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD, 5/31/2019 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences, 8/28/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present at 2018 Wells Fargo Healthcare Conference,11/08/2018 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Third Quarter of 2018,,,11/30/2018 RDUS-US  GNW  Radius Health Provides Updates on its Oncology Programs and Announces Scientific Presentations at 2018 San Antonio Breast Cancer Symposium (SABCS),10/31/2018 ASMB-US  GNW  Assembly Biosciences Announces November Conference Participation,,,"10/15/2018 02043Q10 GNW  CLASS ACTION UPDATE for COCP, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 8/09/2018 WVE-US   GNW  Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update, 5/07/2019 00972L10 GNW  New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN),, 2/12/2019 05LSMK-E GNW  Pacira Expands EXPAREL Manufacturing Capacity to Meet Growing Demand,12/20/2018 RTRX-US  GNW  Retrophin Completes Enrollment of Pivotal Phase 3 FORT Study of Fosmetpantotenate in PKAN, 7/10/2018 PACB-US  GNW  Pacific Biosciences Selected for NSF Project to Rapidly Sequence Maize Pangenome, 1/07/2019 EDIT-US  GNW  Editas Medicine Reports on Recent Progress at J.P. Morgan Healthcare Conference,11/01/2018 CHMA-US  GNW  Chiasma Supports Acromegaly Awareness Day,"10/19/2019 55609910 GNW  ROSEN, A LEADING LAW FIRM, Reminds MacroGenics, Inc. Investors of Important November 12th Deadline in Securities Class Action â€“ MGNX",,, 7/07/2014 28249U10 GNW  Celladon Corporation Announces New Clinical Development Initiatives for MYDICAR(R),12/05/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock," 7/13/2018 G7280010 GNW  CLASS ACTION DEADLINE MONDAY for PRTA and SYMC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 5/01/2019 ZLAB-US  GNW  Zai Lab Announces Proposed Public Offering of American Depositary Shares," 5/07/2015 78667J10 GNW  SAGE Therapeutics to Report First Quarter 2015 Financial Results on Thursday, May 14", 3/25/2019 CTMX-US  GNW  CytomX Therapeutics Announces Transition of Chief Financial Officer, 6/19/2019 GMAB-DK  GNW  Major Shareholder Announcement," 3/07/2019 92165910 GNW  VNDA CLASS ACTION ALERT: Hagens Berman Alerts Vanda Pharmaceuticals (VNDA) Investors to Securities Class Action and April 26, 2019 Lead Plaintiff Deadline",, 2/19/2019 CBAY-US  GNW  CymaBay Therapeutics Announces Early Enrollment of a Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis, 3/27/2012 45781M10 GNW  Theravance to Present at the 11th Annual Needham Healthcare Conference, 8/28/2018 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 2/26/2019 MNKD-US   GNW  MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call, 7/19/2017 URGN-US  GNW  Investigational New Drug Application for RTGelâ„¢Â in Combination with BOTOXÂ® for the Treatment of Overactive Bladder Submitted to FDA by Allergan, 8/27/2019 CYTK-US  GNW  Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA, 5/10/2019 ESPR-US     GNW  Esperion to Participate in Upcoming Investor Conferences," 5/02/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm",, 9/10/2018 ACHN-US  GNW  Achillion Appoints Paul Firuta Chief Operating Officer," 4/16/2019 87166B10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Syneos Health, Inc. - SYNH", 3/20/2019 FOLD-US  GNW  Amicus Therapeutics Issued Two U.S. Patents for Pompe Enzyme ATB200,,, 2/25/2019 ADMA-US  GNW  ADMA Biologics to Present at Upcoming Investor Conferences," 2/26/2019 GWPH-US  GNW  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018", 6/21/2017 EPZM-US  GNW  Epizyme Announces Tazemetostat Granted Orphan Drug Designation  for the Treatment of Soft Tissue Sarcoma,, 3/25/2019 MYOK-US  GNW  MyoKardia Announces Proposed Public Offering of Common Stock,, 8/15/2019 GLPG-NL  GNW  EUROPEAN  MEDICINES  AGENCY  VALIDATES MARKETING APPLICATION  FOR  FILGOTINIB  FOR  THE  TREATMENT  OF  RHEUMATOID  ARTHRITIS," 1/17/2020 73701010 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. (PTLA)",,,, 1/02/2019 CARA-US  GNW  Cara Therapeutics Announces No Modifications in Trial Size After Completion of Interim Statistical Assessment For KALM-1 Phase 3 Trial Of KORSUVAâ„¢ Injection in Hemodialysis Patients with Pruritus, 7/03/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 4/15/2019 QURE-US  GNW  uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT), 6/03/2019 AGIO-US   GNW  Agios Presents Updated Data from Phase 1 Studies of TIBSOVOÂ® (ivosidenib) in Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy, 4/01/2019 IOVA-US  GNW  Iovance Biotherapeutics Presents Data at AACR Annual Meeting on T-Cell Diversity and Persistence in Patients Receiving Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel, 8/07/2018 ANAB-US  GNW  AnaptysBio Announces Second Quarter 2018 Financial Results and Provides Pipeline Updates,, 2/22/2019 FATE-US  GNW  Fate Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference,11/10/2017 HZNP-US  GNW  Horizon Pharma plc Selected as One of Chicagoâ€™s Top Workplaces by the Chicago Tribune,, 2/19/2019 ICPT-US  GNW  Intercept Announces Positive Topline Results from Pivotal Phase 3 REGENERATE Study of Obeticholic Acid in Patients with Liver Fibrosis Due to NASH, 9/19/2019 48576U10   GNW  SHAREHOLDER ALERT: LB KPTI EGBN MDP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,, 4/09/2019 ITCI-US  GNW  Intra-Cellular Therapies Announces Presentation of Lumateperone Long-term Open Label Safety Study at the 2019 Congress of the Schizophrenia International Research Society,,,," 8/03/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2018", 2/27/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Presentations Highlighting Next-Generation CAR T Platform and Mesothelin-Targeted CAR T Clinical Results at American Association of Cancer Research (AACR) Annual Meeting 2019,, 8/08/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 4/29/2019 FOMX-US  GNW  Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology," 8/06/2018 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Secondary Offering of 6,500,000 Shares of Common Stock",10/24/2018 SUPN-US  GNW  Supernus to Host Third Quarter 2018 Earnings Conference Call, 5/09/2019 FGEN-US  GNW  FibroGen Reports First Quarter 2019 Financial Results,, 4/19/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 4/23/2019 21833P10 GNW  UPCOMING DEADLINE REMINDER: Rosen Law Firm Reminds Corbus Pharmaceuticals Holdings, Inc. Investors of Important May 13th Deadline in Securities Class Actionâ€“ CRBP",," 8/24/2018 19459J10 GNW  Report: Exploring Fundamental Drivers Behind Fiesta Restaurant Group, Emerge Energy Services LP, Collegium Pharmaceutical, Cutera, Resources Connection, and Spark Therapeutics â€” New Horizons, Emerging Trends, and Upcoming Developments",12/03/2018 XBIT-US  GNW  XBiotech Announces Successful Completion of GMP Audit,,, 6/25/2019 GBT-US   GNW  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock, 5/02/2017 RGNX-US  GNW  REGENXBIO to Host Conference Call on May 9 to Discuss First Quarter 2017 Financial Results and Recent Operational Highlights, 4/30/2019 KURA-US  GNW  Kura Oncology to Report First Quarter 2019 Financial Results, 6/06/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/21/2019 AXSM-US  GNW  Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting,11/29/2018 VYGR-US  GNW  Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies," 9/23/2019 07725L10 GNW  BGNE INVESTIGATION REMINDER: Hagens Berman Reminds BeiGene, Ltd. (BGNE) Investors of Ongoing Investigation of Possible Securities Fraud",," 8/06/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. to Report Second Quarter 2018 Financial Results and an Update on Development Programs on Wednesday, August 8, 2018", 4/15/2019 HCM-GB   GNW  Chi-Med Files Application to List in Hong Kong and Announces Proposed Global Offering, 8/23/2018 NTLA-US  GNW  Intellia Therapeutics to Host Educational Briefing Webinar on Interference Proceedings Relating to CRISPR/Cas9 Genome Editing Technology Patents,11/13/2018 ACIU-US  GNW  AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update, 9/19/2018 CRSP-US  GNW  CRISPR Therapeutics Announces Proposed Public Offering of Common Shares, 3/04/2019 GTHX-US  GNW  G1 Therapeutics to Present at Cowen and Company 39th Annual Healthcare Conference,10/26/2017 ABBV-US  GNW  argenx reports third quarter 2017 financial results and provides business update,11/19/2018 RUBY-US GNW  Rubius Therapeutics to Present at Evercore ISI HealthCONx Conference, 5/06/2019 ATNX-US  GNW  Athenex Announces $100 Million Private Placement,"10/17/2018 PETQ-US  GNW  PetIQ, Inc. Announces Strategic Acquisition of HBH Enterprises LLC",11/15/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in AlstrÃ¶m Syndrome at ObesityWeek 2018," 8/07/2018 OPTN-US  GNW  Optinose to Report Second Quarter 2018 Financial Results and Corporate Updates on August 14, 2018","10/16/2018 TORC-US  GNW  resTORbio Announces Additional RTB101 Phase 2b Data Demonstrating Decreased Incidence of Laboratory-Confirmed RTIs with Severe Symptoms, Total Infections and UTIs",,," 5/07/2018 07YM31-E GNW  Hagens Berman Reminds Solid Biosciences, Inc. Investors of the May 29, 2018 Securities Class Action Lead Plaintiff Deadline", 3/18/2019 EOLS-US  GNW  Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC, 1/07/2019 FIXX-US GNW  Homology Medicines Advances First Gene Editing Development Candidate into IND-Enabling Studies for Pediatric Patients with Phenylketonuria, 4/16/2019 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at Upcoming Medical Conferences,10/31/2018 SRRK-US  GNW  Scholar Rock to Present at the Jefferies 2018 London Healthcare Conference," 7/31/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results",,,,,," 4/16/2014 007TNF-E GNW  Xeris Pharmaceuticals Receives U.S. Patent for its Novel, Stable Non-Aqueous Glucagon Formulations", 4/08/2019 AUTL-US  GNW  Autolus Announces Proposed Public Offering in the United States, 5/10/2019 FTSV-US GNW  Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma,,,10/19/2018 PRNB-US GNW  Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura,,12/13/2018 YMAB-US  GNW  Y-mAbs Therapeutics To Present At 37th Annual J.P. Morgan Healthcare Conference,,"12/17/2018 GRTS-US  GNW  Gritstone Oncology Announces Publication in Nature Biotechnology of Neoantigen Identification Capabilities of its Artificial Intelligence Platform, EDGEâ„¢", 1/07/2019 GH-US    GNW  Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical Researchers,,,," 5/28/2019 ORTX-US  GNW  Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive Worldwide License Agreement for the Treatment of MPS-I",," 2/07/2019 01444210 GNW  Nasdaq Welcomes Alector, Inc. (Nasdaq: ALEC) to the Nasdaq Stock Market",, 4/22/2019 TPTX-US GNW  Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,,,,,,,
," 6/24/2019 PGNX-US  GNW  Independent Readers Using Progenicsâ€™ PSMA AI Demonstrated a Statistically Significant Improvement of Accuracy, Speed, and Reproducibility Over Readers Without PSMA AI",,," 5/27/2016 G3040110 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Endo International plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 25, 2016 â€“ ENDP",,10/29/2018 BDSI-US  GNW  BioDelivery Sciences Announces Changes to its Executive Leadership Team,,, 8/10/2014 82691710     GNW  Delaware Court of Chancery Issues Ruling on Remand in PharmAthene Litigation, 2/01/2019 OPK-US   GNW  OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the ClarosÂ® 1 Analyzer,12/06/2018 IONS-US  GNW  Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data," 3/24/2016 BMRN-US     GNW  BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia A",,,, 4/08/2019 IMMU-US  GNW  Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S., 5/07/2019 BIIB-US   GNW  Data at AAN Demonstrate Biogenâ€™s Leadership and Commitment to Innovation in MS,,10/03/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 8/13/2010 GILD-US  GNW  Achillion Reports Second Quarter and Six Month Financial Results,,"12/02/2016 N5946510 GNW  MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. â€“ MYL",," 3/20/2019 00972810 GNW  Class Action AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Update",10/25/2013 REGN-US  GNW  Protein Engineering Market - Global Forecast to 2017,"11/13/2019 62855J10 GNW  DEADLINE ALERT for TME, MYGN, CC, and RUHN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders"," 3/15/2019 52887230 GNW  (LXRX) Lexicon Pharmaceuticals, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds  Shareholders of Class Action & Deadline: April 1, 2019"," 6/21/2018 MGTX-US  GNW  MeiraGTx Announces MHRA Grants MIA (IMP) License for cGMP Manufacturing Facility in London, UK", 1/03/2018 INSM-US  GNW  Insmed Announces Additional Data from ALIS (Amikacin Liposome Inhalation Suspension) Phase 3 Clinical Program for Adult Patients with Treatment Refractory NTM Lung Disease Caused by MAC and Reports Progress with Commercial Preparations,,"10/09/2018 45773H20  GNW  Report: Developing Opportunities within Adamis Pharmaceuticals, Cass Information, Celldex Therapeutics, Par Pacific, Inovio Pharmaceuticals, and Liberty Global â€” Future Expectations, Projections Moving into 2018"," 3/04/2019 64026810 GNW  BioXcel Therapeutics Announces Addition of Merck KGaA, Darmstadt, Germany, and Pfizer to Clinical Collaboration with Nektar for Development of Triple-combination Therapy in Pancreatic Cancer",,10/17/2019 GERN-US  GNW  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),, 7/31/2019 AMRN-US  GNW  Amarin Reports Second Quarter 2019 Financial Results and Operational Update, 4/28/2013 45337C10 GNW  Law Offices of Howard G. Smith Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Incyte Corporation,," 9/17/2019 80360710 GNW  CLASS ACTION UPDATE for MNK, CAH, GVA and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 1/31/2019 G0176710 GNW  CLASS ACTION UPDATE for XRAY, DXC, YRIV and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 5/07/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update, 4/26/2012 06LJWP-E GNW  Valence Life Sciences Announces Promotion of Scott Morenstein and Hiring of Robert Ferraioli,,,,10/01/2019 SAN-FR   GNW  Sanofi : Availability of the Pre-quarterly Results Communication,,, 2/11/2019 ASND-US  GNW  Ascendis Pharma Initiates Global Phase 2 Trial for TransCon PTH in Adult Subjects with Hypoparathyroidism,, 8/03/2018 00422510 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against ACADIA Pharmaceuticals Inc. and Certain Officers â€“ ACAD, 2/21/2019 AFMD-US  GNW  Affimed to Present at Upcoming Investor Conferences,, 1/29/2019 PRQR-US  GNW  ProQR Announces â€œProQR Vision 2023â€ Strategy at its Annual R&D Day,," 6/06/2019 98978L20 GNW  CLASS ACTION UPDATE for ZGNX, MWA, KSHB and SCOR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 2/19/2019 ALLK-US  GNW  Allakos Announces Positive Phase 1 Results with AK002 in Indolent Systemic Mastocytosis,, 2/26/2015 76133010 GNW  Revance Appoints Dr. Philip Vickers to Its Board of Directors,,, 5/16/2019 ADVM-US  GNW  Adverum Biotechnologies Provides Update on OPTIC Phase 1 Trial for ADVM-022 in Wet AMD," 5/29/2019 RARE-US   GNW  Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIOâ€™s 2019 Henri A. Termeer Biotechnology Visionary Award", 8/27/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 SSIEM Annual Symposium,11/08/2018 NSTG-US  GNW  NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing,,,"11/07/2018 75046920 GNW  Recent Analysis Shows InterDigital, Alpha and Omega Semiconductor, Alliance Resource Partners, Aircastle, XPO Logistics, and Radius Health Market Influences â€” Renewed Outlook, Key Drivers of Growth","10/16/2018 04539610 GNW  Report: Developing Opportunities within The Ensign Group, Forterra, Inc., Audentes Therapeutics, Assembly Biosciences, Capital Senior Living, and Myomo â€” Future Expectations, Projections Moving into 2018",,,"10/12/2018 02043Q10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alnylam Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ALNY", 7/02/2018 WVE-US   GNW  Wave Life Sciences Receives Positive Opinion for Orphan Drug Designation in the European Union for WVE-210201, 5/07/2019 IONS-US  GNW  Akcea and Ionis Announce Approval of WAYLIVRAÂ® (volanesorsen) in the European Union,, 1/16/2019 PCRX-US  GNW  EXPAREL Achieves Statistically Significant Reductions in Opioid Consumption and Pain Scores in Cesarean Section Patients,11/28/2018 RTRX-US  GNW  Retrophin to Present at the BMO Prescriptions for Success Healthcare Conference," 6/07/2018 PACB-US  GNW  Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program", 1/02/2019 EDIT-US  GNW  Editas Medicine to Present at the 37th Annual J.P. Morgan Healthcare Conference,10/17/2018 CHMA-US  GNW  Chiasma Announces Oral Presentation at the 18th Congress of the European Neuroendocrine Association,"10/16/2019 55609910 GNW  IMPORTANTÂ REMINDER FOR MACROGENICS, INC.Â INVESTORS: Wolf Haldenstein Adler Freeman & Herz LLP announces that aÂ securitiesÂ classÂ actionÂ lawsuitÂ hasÂ beenÂ filedÂ inÂ theÂ United States District for the District of Maryland against MacroGenics, Inc.",,, 6/02/2014 28249U10 GNW  Celladon Corporation Appoints Industry Veteran Paul Cleveland as President and Chief Financial Officer,"12/03/2018 MNTA-US  GNW  Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRAÂ®"," 7/11/2018 G7280010 GNW  CLASS ACTION UPDATE for PRTA and ATEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 4/17/2019 ZLAB-US  GNW  Zai Lab to Host Analyst & Investor Day on April 30, 2019", 4/21/2015 78667J10 GNW  SAGE Therapeutics Announces Closing of $138 Million Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares, 3/05/2019 CTMX-US  GNW  CytomX to Present at Upcoming Healthcare Conferences," 6/11/2019 GMAB-DK  GNW  Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBodyÂ®-CD38", 3/06/2019 92165910 GNW  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Vanda Pharmaceuticals Inc. Investors,, 2/15/2019 CBAY-US  GNW  CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis, 3/23/2012 45781M10 GNW  GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD," 8/20/2018 16383L10 GNW  Recent Analysis Shows Ferroglobe, AXT, ChemoCentryx, RedHill Biopharma, GTx, and Achillion Pharmaceuticals Market Influences â€” Renewed Outlook, Key Drivers of Growth",,, 2/20/2019 MNKD-US   GNW  MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)," 6/07/2017 M9608810 GNW  UroGen Pharma Ltd. (Nasdaq: URGN), to Ring The Nasdaq Stock Market Opening Bell", 8/08/2019 CYTK-US  GNW  Cytokinetics Reports Second Quarter 2019 Financial Results, 5/08/2019 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates;Â Reports First Quarter Financial Results," 4/30/2019 03236M20  GNW  Kessler Topaz Meltzer & Check, LLP Reminds Amyris, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit",, 8/30/2018 ACHN-US  GNW  Achillion to Present at the Baird 2018 Global Healthcare Conference," 4/15/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder For Syneos Health, Inc. Investors", 2/28/2019 FOLD-US  GNW  Amicus Therapeutics Announces Full-Year 2018 Financial Results and 2019 Corporate Updates,,, 2/12/2019 ADMA-US  GNW  ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors, 2/26/2019 GWPH-US  GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences, 6/14/2017 EPZM-US  GNW  Epizyme Reports Positive Interim Data from Phase 2 Trial for Tazemetostat in Relapsed or Refractory Follicular Lymphoma and DLBCL Patients,, 3/06/2019 MYOK-US  GNW  MyoKardia to Present at Cowen & Co. 39th Annual Health Care Conference,, 7/25/2019 GLPG-NL  GNW  Strong clinical progress in H1 and transformative collaboration with Gilead announced, 5/28/2019 PTLA-US  GNW  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences,,,,11/08/2018 CARA-US  GNW  Cara Therapeutics to Present at November Investor Conferences, 6/20/2019 FLXN-US  GNW  Flexion Therapeutics Named one of Boston Business Journalâ€™s Best Places to Work for the Third Consecutive Year, 4/08/2019 QURE-US  GNW  uniQure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntingtonâ€™s Disease, 5/15/2019 AGIO-US   GNW  Agios to Present Clinical Data from its IDH Program at ASCO, 3/29/2019 IOVA-US  GNW  Iovance Biotherapeutics Announces April Scientific and Investor Presentations, 8/06/2018 ANAB-US  GNW  AnaptysBio to Present at the 2018 Wedbush PacGrow Healthcare Conference,," 2/20/2019 FATE-US  GNW  Fate Therapeutics Appoints Sarah Cooley, M.D., M.S. as Senior Vice President, Clinical Translation",11/07/2017 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 1/07/2019 ICPT-US  GNW  Intercept Announces NASH and PBC Program Updates," 9/18/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,," 3/26/2019 ITCI-US  GNW  Intra-Cellular Therapies Continues to Strengthen Its Commercial Leadership Team; John A. Bardi Appointed as Senior Vice President, Market Access, Policy and Government Affairs",,,, 7/09/2018 AMPH-US  GNW  Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc., 2/26/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress,, 8/06/2018 DERM-US  GNW  Dermira Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateÂ , 4/24/2019 FOMX-US  GNW  Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call &  Webcast Scheduled for May 8," 8/01/2018 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Second Quarter 2018 Results and Updates Full Year 2018 Guidance"," 9/27/2018 86845910 GNW  New Research Coverage Highlights Randgold Resources, California Water Service Group Holding, B&G Foods, Hawaiian, Bank of Nova Scotia, and Supernus Pharmaceuticals â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 5/09/2019 FGEN-US  GNW  FibroGen Announces Positive Topline Results from Pooled Safety Analyses of Roxadustat Global Phase 3 Program,, 4/05/2019 CHRS-US  GNW  Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCAâ„¢ Net Sales, 4/18/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study in Systemic Sclerosis in U.S. to ACR CRISS from mRSS Following Meeting with FDA,, 8/08/2018 COLL-US  GNW  Collegium Reports Second Quarter Financial Results and Provides Corporate Update,10/31/2018 XBIT-US  GNW  XBiotech Highlights Third Quarter Developments for 2018,,, 6/14/2019 GBT-US   GNW  GBT Announces Updated 24-Week Efficacy Data from All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor, 4/26/2017 RGNX-US  GNW  REGENXBIO Announces Full Exercise and Closing of Underwritersâ€™ Option to Purchase Additional Shares," 4/02/2019 KURA-US  GNW  Kura Oncology Identifies Farnesylated Proteins Associated with CXCL12 Expression,  Potential Biomarker of Clinical Benefit from Tipifarnib in Lymphoma Indications", 5/24/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/09/2019 AXSM-US  GNW  Axsome Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update,11/19/2018 VYGR-US  GNW  Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference, 9/22/2019 BGNE-US  GNW  BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO),," 7/27/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares", 3/29/2019 44842L10 GNW  Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in China," 8/06/2018 45826J10 GNW  Detailed Research: Economic Perspectives on IQVIA, Intellia Therapeutics, Deluxe, Superior Industries International, The Navigators Group, and CAI International â€” What Drives Growth in Today's Competitive Landscape",11/12/2018 ACIU-US  GNW  AC Immune to Present at the Jefferies 2018 London Healthcare Conference, 9/17/2018 CRSP-US  GNW  CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes, 2/28/2019 GTHX-US  GNW  G1 Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results,10/26/2017 ABBV-US  GNW  argenx reports third quarter 2017 financial results and provides business update,11/13/2018 RUBY-US GNW  Rubius Therapeutics Reports Third Quarter 2018 Financial Results and Operational Progress, 5/03/2019 ATNX-US  GNW  Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma," 9/26/2018 PETQ-US  GNW  PetIQ, Inc. Announces Pricing of Public Offering of Common Stock",11/09/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results, 7/02/2018 OPTN-US  GNW  Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal, 9/24/2018 TORC-US  GNW  resTORbio to Present at 2018 Cantor Fitzgerald Global Healthcare Conference,,," 5/07/2018 0DBJVZ-E GNW  Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Solid Biosciences, Inc. Investors â€“ SLDB"," 3/15/2019 EOLS-US  GNW  Evolus to Release Fourth Quarter and Full Year 2018 Financial Results and Provide a Business Update on Monday, March 18, 2019",11/13/2018 FIXX-US GNW  Homology Medicines Reports Third Quarter 2018 Financial Results, 4/02/2019 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences,10/01/2018 SRRK-US  GNW  Scholar Rock to Present Preclinical Data Highlighting the Role of TGFÎ²1 Inhibition in Overcoming Checkpoint Resistance at the SITC Annual Meeting," 6/25/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee",,,,,,"10/17/2013 007TNF-E GNW  Xeris Pharmaceuticals, Inc. Announces Dosing of First Patient in Phase 2 Clinical Trial of its Investigational Soluble Glucagon Formulation", 4/01/2019 AUTL-US  GNW  Initial Results from Autolus Therapeuticsâ€™ ALLCAR19 Phase 1/2 Trial in Adult Acute Lymphoblastic Leukemia Presented at the AACR Annual Meeting," 5/06/2019 FTSV-US GNW  Forty Seven Inc. to Report First Quarter 2019 Financial Results on Monday, May 13, 2019",,,10/16/2018 PRNB-US GNW  Principia Achieves $10 Million in Additional Milestones Related to Development of PRN2246/SAR442168,,12/11/2018 YMAB-US  GNW  Y-mAbs Announces Appointment of GÃ©rard Ber to its Board of Directors and Planned Departure of Michael Buschle,,12/10/2018 GRTS-US  GNW  Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead,12/20/2018 GH-US    GNW  Guardant Health to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,," 5/22/2019 ORTX-US  GNW  Orchard Therapeutics to Webcast Conference Call of First Quarter 2019 Financial Results on May 28, 2019",,,,,,,,,,,,
, 6/24/2019 PGNX-US  GNW  Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velanâ€™s Latest Inaccurate Claims,,," 9/17/2014 00FV7G-E GNW  QLT Provides Update on Merger With Auxilium Pharmaceuticals, Inc.",,"10/23/2018 BDSI-US  GNW  BioDelivery Sciences to Report Third Quarter 2018 Financial Results on November 8, 2018",,," 7/31/2014 82691710     GNW  SIGA to Host Quarterly Business Update Call on August 4, 2014"," 1/31/2019 OPK-US   GNW  OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator",11/29/2018 46222210 GNW  International Prix Galien Recognizes SPINRAZAÂ® as Best Biotechnology Product, 3/21/2016 BMRN-US     GNW  BioMarin Phase 3 Study of Pegvaliase for Phenylketonuria (PKU) Meets Primary Endpoint of Blood Phenylalanine (Phe) Reduction (p<0.0001),,,, 3/07/2019 IMMU-US  GNW  Immunomedics Appoints Barbara G. Duncan to Board of Directors, 5/06/2019 BIIB-US   GNW  Biogen Presents Data at 2019 AAN Annual Meeting Affirming Longer-Term Safety and Durability of Treatment with SPINRAZAÂ® (nusinersen),, 9/26/2019 BCRX-US  GNW  U.S. Government Exercises Option for Additonal RapivabÂ® for Strategic National Stockpile, 5/13/2010 GILD-US  GNW  Biopharma Stock Alert for Achillion Pharmaceuticals Inc. Issued by MicroStockProfit,,"11/08/2016 N5946510 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Mylan N.V. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit â€“ MYL",," 3/16/2019 AKRX-US  GNW  INVESTOR ALERT: Rosen Law Firm Reminds Akorn, Inc. Investors with over $100K in Losses of Important Deadline in Securities Class Action Lawsuit Filed by the Firm â€“ AKRX",10/23/2013 FPRX-US  GNW  Five Prime Therapeutics Appoints Aron Knickerbocker to Its Board of Directors and Marc Belsky to Chief Financial Officer,"11/12/2019 62855J10 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching"," 3/14/2019 52887230 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â LXRX", 6/12/2018 MGTX-US  GNW  MeiraGTx Announces Closing of Initial Public Offering,11/28/2017 INSM-US  GNW  Insmed to Present at the Nasdaq 37th Annual Investor Conference,,10/08/2018 INO-US    GNW  Inovio Successfully Develops First DNA-Encoded  Monoclonal Antibody (dMAbâ„¢) Checkpoint Inhibitor  and Demonstrates Tumor Shrinkage in Preclinical Studies,12/20/2018 64026810 GNW  NKTR DEADLINE ALERT: Rosen Law Firm Reminds Nektar Therapeutics Investors of Important Deadline in Class Action â€“ NKTR,,10/10/2019 GERN-US  GNW  Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes,, 7/29/2019 AMRN-US  GNW  Amarin Announces Underwritersâ€™ Full Exercise of Option to Purchase Additional American Depositary Shares, 4/26/2013 45337C10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCY,," 9/06/2019 80360710 GNW  SHAREHOLDER ALERT - Sarepta Therapeutics, Inc. (SRPT) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: October 29, 2019"," 1/30/2019 G0176710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNKEY, YRIV, ALKS and MKL",, 5/03/2019 AMAG-US  GNW  AMAGÂ Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual MeetingÂ , 2/02/2012 05JHV6-E GNW  Sunesis Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer,,,, 9/30/2019 SAN-FR   GNW  Sanofi : New England Journal of Medicine publishes data showing improved survival with JevtanaÂ® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer,,, 1/07/2019 ASND-US  GNW  Ascendis Pharma A/S Introduces Vision 3x3: A Strategic Roadmap Through 2025 to Achieve Sustainable Growth Using Multiple Approaches,," 8/03/2018 00422510 GNW  Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline", 1/04/2019 AFMD-US  GNW  Affimed to Present at the 37th Annual J.P. Morgan Healthcare Conference,, 1/07/2019 PRQR-US  GNW  ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Leberâ€™s Congenital Amaurosis 10,," 6/05/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orion, Zogenix, BrightView, and Eventbrite and Encourages Investors to Contact the Firm", 2/11/2019 ALLK-US  GNW  Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts,," 2/17/2015 76133010 GNW  Revance Therapeutics, Inc. Announces Participation in Cowen 35th Annual Health Care Conference",,, 5/08/2019 ADVM-US  GNW  Adverum Biotechnologies Reports First Quarter 2019 Financial Results and Provides Corporate Update, 5/10/2019 RARE-US   GNW  Ultragenyx to Present at Bank of America Merrill Lynch Healthcare Conference, 8/09/2018 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results,11/07/2018 NSTG-US  GNW  NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC),,,11/01/2018 RDUS-US  GNW  Radius Health Announces Third Quarter 2018 Operating Results and Financial Guidance for FY 2018 and FY 2019,10/02/2018 ASMB-US  GNW  Assembly Biosciences Announces Oral Presentation at 2018 AASLD,,,"10/10/2018 02043Q10 GNW  CLASS ACTION UPDATE for ABBV, ALNY and ADNT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 6/25/2018 WVE-US   GNW  Wave Life Sciences to Present at Parent Project Muscular Dystrophy Annual Conference, 5/02/2019 00972L10 GNW  Akcea Announces Upcoming Data Presentations at the 2019 American Academy of Neurology Meeting (AAN.19),," 1/04/2019 69512710 GNW  New Research Coverage Highlights LKQ, Pacira Pharmaceuticals, WellCare Health Plans, Masimo, Workday, and Potbelly â€” Consolidated Revenues, Company Growth, and Expectations for 2019",11/12/2018 RTRX-US  GNW  Retrophin Announces U.S. FDA Acceptance of NDA Filing for the New Formulation of ThiolaÂ® (tiopronin) in the Treatment of Cystinuria," 6/06/2018 PACB-US  GNW  Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria",12/21/2018 EDIT-US  GNW  Editas Medicine Announces Transition of Chief Financial Officer,10/01/2018 CHMA-US  GNW  Chiasma Completes Enrollment of CHIASMA OPTIMAL Phase 3 Clinical Trial of Octreotide Capsules in Patients with Acromegaly,"10/15/2019 55609910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Macrogenics, ViewRay, Cadence Bancorp, and ProPetro and Encourages Investors to Contact the Firm",,, 5/27/2014 28249U10 GNW  Celladon to Present at the Jefferies 2014 Global Healthcare Conference,"11/07/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281"," 7/09/2018 G7280010 GNW  CLASS ACTION UPDATE for KLIC, PRTA, and SYMC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/12/2019 ZLAB-US  GNW  Zai Lab Announces Presentations at March Conferences, 4/20/2015 78667J10 GNW  SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol to Evaluate SAGE-547 in Patients With Super-Refractory Status Epilepticus, 2/27/2019 CTMX-US  GNW  CytomX Therapeutics Announces Presentations at the  American Association for Cancer Research Annual Meeting 2019," 5/30/2019 GMAB-DK  GNW  U.S. FDA Grants Priority Review for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma"," 3/05/2019 92165910 GNW  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 1/02/2019 CBAY-US  GNW  CymaBay Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference, 2/22/2012 45781M10 GNW  Theravance to Present at the Cowen and Company 32nd Annual Health Care Conference, 8/09/2018 CCXI-US  GNW  ChemoCentryx Reports Second Quarter 2018 Financial Results and Recent Highlights,,, 2/20/2019 MNKD-US   GNW  MannKind Corporation Participating at Upcoming Conferences, 6/02/2017 URGN-US  GNW  UroGen Pharma to Ring the Nasdaq Stock Market Opening Bell, 7/31/2019 CYTK-US  GNW  Cytokinetics Announces Preclinical Data for CK-3773274Â Presented at the American Heart Associationâ€™sÂ Basic Cardiovascular Sciences Scientific Sessions, 5/07/2019 ESPR-US     GNW  Esperion to Host Analyst and Investor Day Event on May 30," 4/29/2019 AMRS-US   GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm",, 8/21/2018 ACHN-US  GNW  Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team," 4/13/2019 87166B10 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines â€“ VNDA, SYNH, BPI and USX", 2/26/2019 FOLD-US  GNW  Amicus Establishes Global Research and Gene Therapy Center of Excellence in Philadelphia,,, 1/07/2019 ADMA-US  GNW  ADMA Biologics Submits Response and Provides Supplemental Information to FDA for BIVIGAMÂ® Complete Response Letter, 2/07/2019 GWPH-US  GNW  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending 31 December 2018 and Host Conference Call on 26 February 2019, 5/18/2017 EPZM-US  GNW  Epizyme Announces Path Toward Tazemetostat Registration in Epithelioid Sarcoma and Reports New Clinical Data to be Presented at ASCO,," 3/04/2019 MYOK-US  GNW  MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM",, 7/18/2019 GLPG-NL  GNW  Transparency notification, 5/22/2019 PTLA-US  GNW  Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study  of its Factor Xa Inhibitor Reversal Agent AndexxaÂ® in Patients with  Spontaneous (Non-Traumatic) Intracranial Hemorrhage,,,,11/06/2018 CARA-US  GNW  Cara Therapeutics Reports Third Quarter 2018 Financial Results, 6/18/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference, 3/29/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences, 5/15/2019 AGIO-US   GNW  Agios Announces the Randomized Phase 3 ClarIDHy Trial of TIBSOVOÂ® (ivosidenib) Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients, 3/06/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Investor Conferences in March," 7/25/2018 03272410 GNW  Report: Exploring Fundamental Drivers Behind Martin Midstream Partners, AnaptysBio, Bright Horizons Family Solutions, Masonite International, Digimarc, and Cohu â€” New Horizons, Emerging Trends, and Upcoming Developments",, 2/07/2019 FATE-US  GNW  Fate Therapeutics to Present at Guggenheim Healthcare Talks Idea Forum Oncology Day,"11/06/2017 HZNP-US  GNW  Horizon Pharma plc Presents New Data at 2017 ACR/ARHP Annual Meeting, Advances Clinical Understanding of KRYSTEXXAÂ® (pegloticase injection) in Adults with Uncontrolled Gout",, 1/02/2019 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conference, 9/17/2019 48576U10   GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Karyopharm Therapeutics Inc. and Certain Officers â€“ KPTI,,, 3/05/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at The Cowen and Company 39th Annual Health Care Conference,,,," 6/19/2018 AMPH-US  GNW  Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP", 1/04/2019 ATRA-US    GNW  Atara Biotherapeutics to Participate in the 37th Annual J.P. Morgan Healthcare Conference,, 7/10/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 4/02/2019 FOMX-US  GNW  Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam, 7/12/2018 PRAH-US  GNW  PRA Health Sciences to Report Second Quarter 2018 Earnings, 9/20/2018 SUPN-US  GNW  Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference, 5/06/2019 FGEN-US  GNW  FibroGen to Report First Quarter 2019 Financial Results,, 4/05/2019 CHRS-US  GNW  Coherus BioSciences to Report First Quarter Financial Results on May 9th," 4/17/2019 21833P10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, INGN and CRBP",, 7/20/2018 COLL-US  GNW  Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update,10/26/2018 XBIT-US  GNW  XBiotech Announces New Patents for ThirdÂ Quarter 2018,,," 6/10/2019 GBT-US   GNW  GBT Awards More than $200,000 in Grants to Five Nonprofit Organizations through New ACCEL Program Aimed at Improving Access to Healthcare for People Living with Sickle Cell Disease", 3/28/2017 RGNX-US  GNW  REGENXBIO Enhances and Expands Scientific Leadership, 3/06/2019 KURA-US  GNW  Kura Oncology to Participate in Two Upcoming Investor Conferences, 5/17/2019 APLS-US  GNW  Apellis Pharmaceuticals to Present at Upcoming Investor Conferences, 5/06/2019 AXSM-US  GNW  Axsome Therapeutics Announces Acceleration of MOMENTUM Phase 3 Trial of AXS-07 in Migraine,11/07/2018 VYGR-US  GNW  Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinsonâ€™s Disease," 9/19/2019 07725L10 GNW  ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd. â€“ BGNE",," 7/25/2018 75615P10 GNW  Investor Expectations to Drive Momentum within Reata Pharmaceuticals, Shoe Carnival, United Fire Group, Approach Resources, Saul Centers, and Tennant â€” Discovering Underlying Factors of Influence", 3/28/2019 HCM-GB   GNW  Chi-Med Highlights Oral Presentations on Savolitinib Lung Cancer Programs at AACR Annual Meeting, 8/01/2018 NTLA-US  GNW  Intellia Therapeutics Announces Second Quarter 2018 Financial Results,11/09/2018 ACIU-US  GNW  AC Immune Shares Insights from Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases," 9/10/2018 00GBNS-E GNW  CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding the Ruling by U.S. Patent and Trademark Office in Interference Proceeding Relating to CRISPR/Cas9 Genome Editing Technology"," 2/27/2019 GTHX-US  GNW  G1 Therapeutics to Host Investor Day 2019 on March 6, 2019", 9/26/2017 ARGX-BE  GNW  argenx launches Phase II proof-of-concept clinical trial of ARGX-113 for the treatment of pemphigus vulgaris,11/06/2018 RUBY-US GNW  Rubius Therapeutics to Participate in Jefferies London Healthcare Conference," 4/25/2019 ATNX-US  GNW  Athenex, Inc. to Report First Quarter 2019 Earnings Results on May 9, 2019"," 9/24/2018 PETQ-US  GNW  PetIQ, Inc. Announces Public Offering of Common Stock",11/07/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference, 6/21/2018 OPTN-US  GNW  Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed Journals, 9/18/2018 TORC-US  GNW  resTORbio Appoints Meredith Manning as Chief Commercial Officer,,," 5/06/2018 83422E10 GNW  Kaskela Law LLC: Shareholder Class Action Filed Against Solid Biosciences, Inc. - SLDB", 2/27/2019 EOLS-US  GNW  Evolus Appoints Crystal Muilenburg as Vice President Corporate Communications & Public Relations,11/08/2018 FIXX-US GNW  Homology Medicines to Present at Stifel Healthcare Conference, 3/28/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 8/08/2018 SRRK-US  GNW  Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress," 6/13/2018 0BWGV3-E GNW  UNITY Biotechnology, Inc. Added to Russell 3000Â®, 2000Â® and MicroCapÂ® Indexes",,,,,, 9/23/2013 007TNF-E GNW  Xeris Pharmaceuticals Awarded a NIH/NIDDK SBIR Fast Track Grant to Advance its Glucagon Mini-Dose Pen for Treatment of Mild to Moderate Hypoglycemia, 3/29/2019 AUTL-US  GNW  Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019, 4/26/2019 FTSV-US GNW  Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkinâ€™s Lymphoma,,, 9/26/2018 PRNB-US GNW  Principia Biopharma to Present at 2018 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology,,12/10/2018 YMAB-US  GNW  Y-mAbs Therapeutics Announces FDA Clearance of IND for its Bispecific GD2 Antibody,,11/14/2018 GRTS-US  GNW  Gritstone Oncology Reports Third Quarter 2018 Financial Results and  Recent Business Highlights,12/13/2018 AZN-GB   GNW  Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi,,,, 4/29/2019 ORTX-US  GNW  Orchard Therapeutics Announces Clinical Proof-of-Concept Data for Gene Therapy OTL-300 Demonstrating Efficacy in Transfusion-Dependent Beta-Thalassemia,,,,,,,,,,,,
, 6/20/2019 PGNX-US  GNW  Progenics Pharmaceuticals to Initiate a Basket Trial by Year End to Support an Expanded Label for AZEDRAÂ® (iobenguane I 131) in Multiple MIBG Avid Neuroendocrine Tumors,,, 5/19/2014 00FV7G-E GNW  Zogenix Closes Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International,, 9/25/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference,,, 7/31/2014 82691710     GNW  SIGA Technologies Reports Financial Results for the Second Quarter 2014, 1/31/2019 OPK-US   GNW  Future Non-Coverage Determination for 4Kscore Test Posted by Novitas,11/29/2018 IONS-US  GNW  Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting, 3/03/2016 BMRN-US     GNW  BioMarin to Attend Three Upcoming Investor Conferences in March,,,, 3/04/2019 IMMU-US  GNW  Immunomedics to Participate in Cowen and Company 39th Annual Health Care Conference, 5/01/2019 BIIB-US   GNW  Biogen to Present New Interim Data from Its Phase 1/2 Clinical Study of Tofersen (BIIB067) for the Potential Treatment of a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS),, 9/24/2019 BCRX-US  GNW  BioCryst Pharmaceuticals to Present at Cantor Global Healthcare Conference, 5/10/2010 GILD-US  GNW  Achillion Reports First Quarter Financial Results,,"11/02/2016 N5946510 GNW  Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIAÂ® (abatacept)",," 3/14/2019 00972810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â AKRX","10/21/2013 AMGN-US  GNW  Global and Chinese Monoclonal Antibody Industry Report, 2013","11/11/2019 62855J10 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ MYGN", 3/13/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides a Business Update,,11/22/2017 INSM-US  GNW  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,10/02/2018 INO-US    GNW  Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial In Which A Patient Achieved Full Remission After Dosing With DNA Immunotherapy and Checkpoint Inhibitor,"12/20/2018 64026810 GNW  CLASS ACTION UPDATE for DY, NKTR and TX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 9/30/2019 GERN-US  GNW  Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis,," 7/24/2019 AMRN-US  GNW  Amarin to Report Second Quarter 2019 Results and Host Conference Call on July 31, 2019", 4/19/2013 45337C10 GNW  Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Incyte Corporation -- INCY,," 9/05/2019 80360710 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT"," 1/29/2019 G0176710 GNW  Hagens Berman Reminds Alkermes Public Limited Company (NASDAQ: ALKS) Investors of February 25, 2019 Lead Plaintiff Deadline",," 4/30/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019 at 8:00 a.m. ET",,,,, 9/20/2019 SAN-FR   GNW  Sanofi : CHMP recommends approval of DupixentÂ® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis Â ,,,12/21/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in 37th Annual J.P. Morgan Healthcare Conference,," 8/01/2018 00422510 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MabVax, Farmland, and ACADIA, and Encourages Investors to Contact the Firm",12/07/2018 AFMD-US  GNW  Affimed Announces U.S. Registrational Pathway and Updated Clinical Development Plan for AFM13 at R&D Day,, 1/03/2019 PRQR-US  GNW  ProQR to Host R&D Day in New York on January 29,," 6/05/2019 98978L20 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zogenix, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â ZGNX", 2/04/2019 ALLK-US  GNW  Allakos to Host Investor Day on February 19 in New York City,," 2/12/2015 76133010 GNW  Revance Therapeutics to Release Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Monday, March 2, 2015",,, 5/02/2019 ADVM-US  GNW  Adverum Biotechnologies Announces Board Changes, 5/06/2019 RARE-US   GNW  Ultragenyx Reports First Quarter 2019 Financial Results and Corporate Update, 7/30/2018 AGLE-US  GNW  Aeglea BioTherapeutics Announces Fall 2018 Medical Conference Schedule,11/05/2018 NSTG-US  GNW  NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum,,,"10/12/2018 RDUS-US  GNW  Radius Health to Announce Third Quarter 2018 Financial Results, Host Conference Call and Live Webcast on November 1, 2018", 8/28/2018 ASMB-US  GNW  Assembly Biosciences to Present at Upcoming Investor Conferences,,,"10/10/2018 02043Q10 GNW  CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) To Contact Brower Piven Before The Lead Plaintiff Deadline", 5/31/2018 WVE-US   GNW  Wave Life Sciences to Present at the Jefferies 2018 Healthcare Conference, 4/24/2019 00972L10 GNW  Akcea Therapeutics to Hold First Quarter 2019 Financial Results Webcast,, 1/03/2019 PCRX-US  GNW  Pacira Reports Preliminary 2018 Net EXPARELÂ® Sales of $331 Million,11/07/2018 RTRX-US  GNW  Retrophin to Present at the Jefferies 2018 London Healthcare Conference, 5/08/2018 PACB-US  GNW  Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore,12/10/2018 EDIT-US  GNW  Editas Medicine Names Cynthia Collins to Board of Directors, 9/13/2018 CHMA-US  GNW  Chiasma Announces Poster Presentation at the 9th International Congress of the Growth Hormone Research and IGF Societies,"10/15/2019 55609910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX",,, 5/13/2014 28249U10 GNW  Celladon Reports First Quarter 2014 Financial Results and Recent Highlights,11/07/2018 MNTA-US  GNW  Momenta Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update," 7/03/2018 G7280010 GNW  CLASS ACTION UPDATE for PRTA, MFGP, and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/07/2019 ZLAB-US  GNW  Zai Lab Announces Financial Results and Corporate Update for Full Year 2018, 4/14/2015 78667J10 GNW  SAGE Therapeutics Announces Pricing of Public Offering of Common Stock, 2/27/2019 CTMX-US  GNW  CytomX Therapeutics Announces Full-Year 2018 Financial Results, 5/28/2019 GMAB-DK  GNW  Genmab Files Registration Statement in the United States for a Proposed Public Offering of American Depositary Shares (ADSs) and Applies for Listing of the ADSs on Nasdaq," 3/05/2019 92165910 GNW  Analysis: Positioning to Benefit within IHS Markit, PRA Group, Acacia Communications, Vanda Pharmaceuticals, Gran Tierra Energy, and Kornit Digital â€” Research Highlights Growth, Revenue, and Consolidated Results",,11/20/2018 CBAY-US  GNW  CymaBay Therapeutics to Participate in Upcoming Investor Conferences, 9/26/2011 45781M10 GNW  Inova Releases Android & iPhone App for Lead Retrieval in Trade Shows," 8/02/2018 CCXI-US  GNW  ChemoCentryx to Hold Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018",,," 2/19/2019 MNKD-US   GNW  MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019", 5/30/2017 URGN-US  GNW  UroGen Pharma to Present at the Jefferies 2017 Global Healthcare Conference," 7/25/2019 CYTK-US  GNW  Cytokinetics to Announce Second Quarter Results on August 8, 2019", 5/05/2019 ESPR-US     GNW   Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review, 4/29/2019 AMRS-US   GNW  Amyris Announces Closing of $34 Million Private Placement,," 8/20/2018 00448Q20 GNW  Recent Analysis Shows Ferroglobe, AXT, ChemoCentryx, RedHill Biopharma, GTx, and Achillion Pharmaceuticals Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 4/11/2019 87166B10 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of AVEO, STMP, CAG and SYNH", 2/25/2019 FOLD-US  GNW  U.S. FDA Grants Breakthrough Therapy Designation (â€œBTDâ€) to Amicusâ€™ AT-GAA in Late Onset Pompe Disease,,,12/20/2018 ADMA-US  GNW  ADMA to Host Conference Call to Discuss Recent Regulatory Update on BIVIGAMÂ® PAS Submissions, 1/17/2019 36197T10 GNW  Mugglehead reveals a number of stocks set to take advantage of hemp, 5/08/2017 EPZM-US  GNW  Epizyme Reports First Quarter 2017 Results and Provides Corporate Update,, 2/28/2019 MYOK-US  GNW  MyoKardia Reports Fourth Quarter and Full Year 2018 Financial Results,, 7/14/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  ENTER  INTO  TRANSFORMATIVE RESEARCH  AND  DEVELOPMENT  COLLABORATION, 5/08/2019 PTLA-US  GNW  Portola Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update,,,,"10/30/2018 CARA-US  GNW  Cara Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018", 6/07/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4), 3/01/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences, 5/02/2019 AGIO-US   GNW  Agios Announces FDA Approval of Supplemental New Drug Application (sNDA) for TIBSOVOÂ® as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy, 2/27/2019 IOVA-US  GNW  Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update, 5/30/2018 ANAB-US  GNW  AnaptysBio to Present at the Jefferies 2018 Global Healthcare Conference,, 2/06/2019 FATE-US  GNW  Fate Therapeutics Announces FDA Clearance of IND Application for Worldâ€™s First Cell Therapy Derived from an Engineered Pluripotent Stem Cell,11/06/2017 HZNP-US  GNW  Horizon Pharma plc Announces Third-Quarter and Year-to-Date 2017 Results,,11/05/2018 ICPT-US  GNW  Intercept Announces New OCA Data to be Presented at The Liver MeetingÂ® 2018," 9/17/2019 48576U10   GNW  CLASS ACTION UPDATE for NFLX, KPTI, GTT and EVH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,, 2/27/2019 ITCI-US  GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update,,,, 6/04/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018, 1/03/2019 ATRA-US    GNW  Atara Biotherapeutics Announces Planned Chief Executive Officer Transition,, 6/29/2018 DERM-US  GNW  Dermira Receives FDA Approval for Qbrexzaâ„¢ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis, 3/08/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2019, 5/24/2018 PRAH-US  GNW  PRA Named International Clinical Research Company of the Year, 9/13/2018 SUPN-US  GNW  Supernus to Acquire Biscayne Neurotherapeutics, 4/15/2019 FGEN-US  GNW  FibroGen Receives Orphan Drug Designation from the U.S. FDA For Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy,, 3/28/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at H.C. Wainwright & Co. Global Life Sciences Conference," 4/16/2019 21833P10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ CRBP",, 7/10/2018 COLL-US  GNW  Collegium Announces Promotion of Scott Dreyer to CCO,10/24/2018 XBIT-US  GNW  XBiotech Announces Dismissal of Securities Class Action Suit,,, 6/07/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 3/21/2017 RGNX-US  GNW  REGENXBIO Announces Pricing of Public Offering of Common Stock, 3/05/2019 KURA-US  GNW  Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results, 5/13/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/06/2019 AXSM-US  GNW  Axsome Therapeutics Announces Expedited Development and Pivotal Status for AXS-05 in the Treatment of Major Depressive Disorder based on FDA Breakthrough Therapy Meeting,11/07/2018 VYGR-US  GNW  Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights," 9/17/2019 07725L10 GNW  BGNE SHAREHOLDER ALERT: Hagens Berman Reminds Investors in BeiGene, Ltd. (BGNE) of Ongoing Investigation of Possible Securities Fraud",," 7/24/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Public Offering", 3/11/2019 HCM-GB   GNW  Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs," 6/19/2018 00GBNS-E GNW  CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing",11/01/2018 ACIU-US  GNW  AC Immune to Present at 2018 Society for Neurosciences Meeting, 8/30/2018 CRSP-US  GNW  CRISPR Therapeutics to Present at Upcoming Investor Conferences," 2/21/2019 GTHX-US  GNW  G1 Therapeutics to Report Fourth Quarter and Full-Year 2018 Financial Results on February 28, 2019", 9/25/2017 ARGX-BE  GNW  argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis,11/05/2018 RUBY-US GNW  Rubius Therapeutics to Announce Third Quarter 2018 Financial Results, 4/23/2019 ATNX-US  GNW  Athenex Announces Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting," 9/19/2018 PETQ-US  GNW  PetIQ, Inc. Appoints Proven Multinational Animal Health Executive Susan Sholtis as President","10/17/2018 76243J10 GNW  Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals â€” New Horizons, Emerging Trends, and Upcoming Developments", 6/15/2018 OPTN-US  GNW  Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in Greater, 8/29/2018 TORC-US  GNW  resTORbio to Present at Wells Fargo 2018 Healthcare Conference,,," 5/02/2018 83422E10 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Solid Biosciences Inc. (SLDB)Â and Lead Plaintiff Deadline - May 28, 2018", 2/04/2019 EOLS-US  GNW  Evolus to Hold Conference Call Following Jeuveauâ„¢ FDA Approval,11/07/2018 FIXX-US GNW  Homology Medicines Presents Data on Platformâ€™s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy, 3/27/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock, 8/02/2018 SRRK-US  GNW  Scholar Rock to Participate in Upcoming Investor Conferences," 6/07/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results",,,,,, 4/17/2013 007TNF-E GNW  Xeris Pharmaceuticals Awarded Phase II Funding of NIH Fast -Track SBIR Grant to Advance Glucagon for the Artificial Pancreas, 3/26/2019 AUTL-US  GNW  Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day, 3/28/2019 FTSV-US GNW  Forty Seven Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights,,, 9/18/2018 PRNB-US GNW  Principia Biopharma Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,11/13/2018 YMAB-US  GNW  Y-mAbs Announces Third Quarter 2018 Financial Results and Recent Corporate Developments,, 9/27/2018 GRTS-US  GNW  Gritstone Oncology Announces Pricing of Initial Public Offering,11/19/2018 GH-US    GNW  Guardant Health Reports Third Quarter 2018 Financial Results,,,, 4/26/2019 ORTX-US  GNW  Orchard Therapeutics Strengthens Commercial Leadership Team with Appointment of Francis Pang as Vice President of Global Market Access,,,,,,,,,,,,
, 6/19/2019 PGNX-US  GNW  Progenics to Mail Letter to Shareholders,,, 4/24/2014 G3040110 GNW  Zogenix Announces Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International,," 9/13/2018 BDSI-US  GNW  BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday, October 5, 2018",,, 5/01/2014 82691710     GNW  SIGA Technologies Reports Financial Results for the First Quarter 2014, 1/28/2019 OPK-US   GNW  BioReference Laboratories Supports Federal Employees Amidst Government Shutdown,11/12/2018 46222210 GNW  Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions," 3/02/2016 BMRN-US     GNW  BioMarin Announces Positive Data From Cerliponase Alfa Program for Treatment of CLN2 Disease,  a Form of Batten Disease, at 12th Annual WORLDSymposium(TM) 2016",,,," 3/01/2019 45290710 GNW  Research Report Identifies Axalta Coating, The Home Depot, Immunomedics, Kosmos Energy, Casa, and Ormat Technologies with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 5/01/2019 BIIB-US   GNW  Biogen To Present Data At AAN Highlighting Its Innovative Marketed Treatments And Investigational Pipeline Programs For Complex Neurodegenerative Diseases,," 9/23/2019 BCRX-US  GNW  BioCryst Appoints Helen Thackray, M.D., to Board of Directors", 5/06/2010 MTEM-US  GNW  Threshold Announces New Vice President of Corporate Development,,10/28/2016 N5946510 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with  Losses on their Investment in Mylan N.V. of  Class Action Lawsuit and Upcoming Deadline â€“ MYL,," 3/12/2019 00972810 GNW  AKRX DEADLINE ALERT: Zhang Investor Law Reminds of April 22 Deadline in Securities Class Action Lawsuit Against Akorn, Inc. â€“ AKRX", 9/23/2013 AMGN-US  GNW  PCSK9 Inhibitors - The hot new approach to lower cholesterol,11/11/2019 MYGN-US  GNW  Myriadâ€™s Prequelâ„¢ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive Prenatal Screening," 3/11/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Financial Results Conference Call and Webcast on March 13, 2019",,11/08/2017 INSM-US  GNW  Insmed to Present at Two November Conferences,, 9/17/2018 INO-US    GNW  Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-Reactive Responses and Provides Complete Protection Against Lethal Preclinical Challenges,"12/14/2018 64026810 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ NKTR",, 9/26/2019 GERN-US  GNW  Geron to Present at 2019 Cantor Global Healthcare Conference,, 7/18/2019 AMRN-US  GNW  Amarin Prices Public Offering of American Depositary Shares, 4/15/2013 45337C10 GNW  Law Offices of Todd M. Garber Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Incyte Corporation -- INCY,," 9/05/2019 80360710 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT", 1/29/2019 G0176710 GNW  SHAREHOLDER ALERT: YOGA YRCW YRIV ALKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 4/30/2019 AMAG-US  GNW  AMAG PharmaceuticalsÂ Announces Grant of Inducement Awards Under NASDAQ Listing RuleÂ 5635(c)(4),,,,, 9/16/2019 SAN-FR   GNW  Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed,,,11/28/2018 ASND-US  GNW  Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results,," 7/31/2018 00422510 GNW  CLASS ACTION UPDATE for QCOM, ACAD and TTPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",12/03/2018 AFMD-US  GNW  Affimed Presents Data at ASH 2018 Substantiating Opportunity for AFM13 as Mono- and Combination Therapy in CD30-Positive Tumors,, 1/02/2019 PRQR-US  GNW  ProQR Receives Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2,," 6/04/2019 98978L20 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Zogenix, Inc.", 1/29/2019 ALLK-US  GNW  Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism,, 1/12/2015 76133010 GNW  Revance Therapeutics Defines Clinical Program Milestones and Provides Financial Guidance for 2015,,, 5/02/2019 ADVM-US  GNW  Adverum Biotechnologies to Present 30-month Preclinical Safety and Expression Data for ADVM-022 Gene Therapy in Wet AMD at theÂ ASGCT 22nd Annual Meeting, 4/30/2019 RARE-US   GNW  Ultragenyx to Host Conference Call for First Quarter 2019 Financial Results and Corporate Update, 7/19/2018 AGLE-US  GNW  Aeglea BioTherapeutics Appoints Dr. Anthony G. Quinn as President and Chief Executive Officer,10/30/2018 NSTG-US  GNW  NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference,,,10/03/2018 RDUS-US  GNW  Radius Health Announces Latest 2019 Medicare Part D Coverage for TYMLOSÂ® (abaloparatide) Injection," 8/16/2018 04539610 GNW  Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences â€” Research Highlights Growth, Revenue, and Consolidated Results",,,10/08/2018 02043Q10 GNW  SHAREHOLDER ALERT: SKX PM USAT MCHP ABBV ALNY MGTI CPB CHGG ADNT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 5/09/2018 WVE-US   GNW  Wave Life Sciences Reports First Quarter 2018 Financial Results and Provides Business Update, 3/15/2019 00972L10 GNW  Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19),, 1/02/2019 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference,11/01/2018 RTRX-US  GNW  Retrophin Reports Third Quarter 2018 Financial Results," 5/02/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2018 Financial Results",12/02/2018 EDIT-US  GNW  Editas Medicine Announces Pre-Clinical Data Supporting Novel Approach for Treatment of Sickle Cell Disease and Beta-Thalassemia, 8/29/2018 CHMA-US  GNW  Chiasma to Present at the H.C. Wainwright 20th Annual Global Investment Conference,"10/09/2019 55609910 GNW  ROSEN, A TOP RANKED FIRM, Reminds MacroGenics, Inc. Investors of Important Deadline in Securities Class Action â€“ MGNX",,," 5/06/2014 28249U10 GNW  Celladon to Report First Quarter 2014 Results on May 13, 2014","11/06/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Global Settlement with AbbVie to Enable Commercialization of M923, a Proposed Biosimilar to HUMIRAÂ® (adalimumab)"," 6/29/2018 G7280010 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Prothena Corporation plc To Contact The Firm", 2/21/2019 ZLAB-US  GNW  Zai Lab to Announce Full Year 2018 Financial Results, 4/13/2015 78667J10 GNW  SAGE Therapeutics Announces Proposed Public Offering of Common Stock, 2/26/2019 CTMX-US  GNW  CytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probodyâ„¢ Therapeutic Platform, 5/08/2019 GMAB-DK  GNW  Genmab Announces Financial Results for the First Quarter of 2019, 3/04/2019 92165910 GNW  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Vanda Pharmaceuticals Inc. Investors,,11/13/2018 CBAY-US  GNW  CymaBay Therapeutics Presents Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC at The Liver MeetingÂ® 2018, 8/29/2011 45781M10 GNW  Inova Releases iPhone App for Lead Retrieval in Trade Shows, 5/30/2018 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,," 2/05/2019 56400P70  GNW  Market Trends Toward New Normal in MannKind, IDEX, Belden, Bright Horizons Family Solutions, Masonite International, and Veritiv â€” Emerging Consolidated Expectations, Analyst Ratings"," 5/16/2017 URGN-US  GNW  UroGen Pharma Appoints Fred E. Cohen, MD, to its Board of Directors", 7/24/2019 CYTK-US  GNW  Cytokinetics Announces Publication of Preclinical Data DemonstratingÂ Fast Skeletal Muscle Troponin ActivatorÂ Improves Muscle Energetics, 4/02/2019 ESPR-US     GNW  Esperion to Present at the Needham & Company 18th Annual Healthcare Conference," 4/28/2019 03236M20  GNW  INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines â€“ CORT, HCSG, ARA and AMRS",, 8/15/2018 ACHN-US  GNW  Achillion Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer," 4/11/2019 87166B10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm"," 2/12/2019 FOLD-US  GNW  Amicus Therapeutics to Announce Full-Year 2018 Financial Results on February 28, 2019",,,12/19/2018 ADMA-US  GNW  ADMA Biologics Provides Regulatory Update on BIVIGAMÂ® PAS Submissions,12/31/2018 GWPH-US  GNW  GW Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference, 5/04/2017 EPZM-US  GNW  Epizyme Earns $10 Million Milestone Payment from GlaxoSmithKline for Initiation of GLP Toxicology Studies with Novel Methyltransferase Inhibitor,, 1/23/2019 MYOK-US  GNW  MyoKardia Appoints William Fairey as Chief Commercial Officer,, 7/02/2019 GLPG-NL  GNW  GILEAD  ANNOUNCES  INTENT  TO  SUBMIT  NEW  DRUG  APPLICATION  FOR FILGOTINIB  TO  U.S.  FOOD  AND  DRUG  ADMINISTRATION  THIS  YEAR," 4/26/2019 PTLA-US  GNW  European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticalsâ€™ Ondexxyaâ„¢ (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors",,,,"10/23/2018 CARA-US  GNW  Cara Therapeutics Appoints Joana Goncalves, M.D., as Chief Medical Officer", 6/05/2019 FLXN-US  GNW  Flexion Therapeutics Announces Issuance of New U.S. Patent Covering FX201 a Gene Therapy Product Candidate for the Treatment of Osteoarthritis, 2/28/2019 QURE-US  GNW  uniQure Announces 2018 Financial Results and Highlights Recent Company Progress, 5/02/2019 AGIO-US   GNW  Agios Reports Business Highlights and First Quarter 2019 Financial Results, 2/26/2019 46226010 GNW  Iovance Biotherapeutics was Granted Fast Track Designation for LN-145 for Cervical Cancer, 5/29/2018 ANAB-US  GNW  AnaptysBio Presents Updated ANB020 and ANB019 Clinical Data at the 2018 EAACI Congress,,12/04/2018 FATE-US  GNW  Fate Therapeutics Presents Off-the-ShelfÂ CAR T and NK Cell Cancer Immunotherapy Pipeline at ASH Annual Meeting,11/04/2017 HZNP-US  GNW  Horizon Pharma plc Presents Results from an Open-Label Study on the Use of PROCYSBIÂ® (cysteamine bitartrate) Delayed-Release Capsules in Treatment-NaÃ¯ve Children Younger than 6 Years of Age,,10/31/2018 ICPT-US  GNW  Intercept Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update," 9/16/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 2/21/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference,,,, 6/04/2018 AMPH-US  GNW  Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals, 1/03/2019 ATRA-US    GNW  Atara Biotherapeutics Exclusively Licenses Mesothelin-TargetedÂ CAR T Immunotherapy for Solid Tumors,, 6/08/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/07/2019 FOMX-US  GNW  Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne, 5/03/2018 PRAH-US  GNW  PRA Named Clinical Research Company of the Year and Makes the Forbes 2018 Americaâ€™s Best Large Employers List, 9/06/2018 SUPN-US  GNW  Supernus Wins Appeal on Oxtellar XRÂ® against TWi, 2/27/2019 FGEN-US  GNW  FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results,, 3/22/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 4/12/2019 21833P10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inogen, Spectrum Brands, Bridgepoint, and Corbus and Encourages Investors to Contact the Firm",," 6/18/2018 19459J10 GNW  New Research: Key Drivers of Growth for Outfront Media, Enel Chile, Banc of California, Northern Dynasty Minerals, Collegium Pharmaceutical, and Petroleo Brasileiro S.A. - Petrobras â€” Factors of Influence, Major Initiatives and Sustained Production",10/05/2018 XBIT-US  GNW  XBiotech Announces Enrollment Completion in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis,,, 5/16/2019 GBT-US   GNW  GBT Announces Upcoming Data Presentations at 24th European Hematology Association (EHA) Congress Supporting Voxelotor Sickle Cell Disease Program, 3/21/2017 RGNX-US  GNW  REGENXBIO Announces Proposed Public Offering of Common Stock, 3/05/2019 KURA-US  GNW  Kura Oncology Announces FDA Clearance of Investigational New Drug Application for Menin-MLL Inhibitor KO-539, 5/08/2019 APLS-US  GNW  Apellis Pharmaceuticals Reports First Quarter 2019 Business Update and Financial Results," 4/29/2019 AXSM-US  GNW  Axsome Therapeutics To Report First Quarter 2019 Financial Results On May 9, 2019",10/31/2018 VYGR-US  GNW  Voyager Therapeutics to Host Third Quarter 2018 Financial Results and Corporate Highlights Conference Call," 9/13/2019 07725L10 GNW  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BeiGene, Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",," 7/23/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock", 2/12/2019 HCM-GB   GNW  Chi-Med Highlights Preliminary Phase II Savolitinib / ImfinziÂ® Combination Data in Advanced Papillary Renal Cell Carcinoma at 2019 ASCO Genitourinary Cancers Symposium," 5/17/2018 NTLA-US  GNW  Intellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting",11/01/2018 ACIU-US  GNW  AC Immune to Host Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and the Involvement of Other Misfolded Proteins in AD and Neurodegenerative Diseases, 8/07/2018 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results," 2/20/2019 3621LQ10 GNW  Glancy Prongay & Murray LLP Continues Investigation on Behalf of G1 Therapeutics, Inc. Investors (GTHX)", 9/22/2017 ARGX-BE  GNW  Invitation to the extraordinary shareholders' meeting, 9/20/2018 RUBY-US GNW  Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology, 4/02/2019 ATNX-US  GNW  Athenex Announces Appointment of John Koh as a New Board Member," 8/14/2018 PETQ-US  GNW  PetIQ, Inc. Reports Second Quarter 2018 Financial Results","10/15/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer", 6/11/2018 OPTN-US  GNW  Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares," 8/15/2018 TORC-US  GNW  resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors",,," 5/01/2018 83422E10 GNW  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)", 2/01/2019 EOLS-US  GNW  Evolus Receives FDA Approval for Jeuveauâ„¢ prabotulinumtoxinA-xvfs for Injection,10/18/2018 FIXX-US GNW  Homology Medicines Presents Long-Term Efficacy Data of a Single Dose of Gene Therapy Development Candidate for Treatment of Phenylketonuria," 3/14/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Fiscal Period Ended December 31, 2018 Financial Results and Highlights Recent Clinical and Operational Developments", 6/04/2018 SRRK-US  GNW  Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering," 6/05/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference",,,,,, 2/11/2013 007TNF-E GNW  Xeris Pharmaceuticals Closed 2012 with $6M In Additional Funding," 3/07/2019 AUTL-US  GNW  Autolus Therapeutics to Host R&D Day on March 26, 2019"," 3/21/2019 FTSV-US GNW  Forty Seven Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 28, 2019",,, 9/13/2018 PRNB-US GNW  Principia Biopharma Announces Pricing of Initial Public Offering,,11/01/2018 YMAB-US  GNW  Bispecific GD2 Antibody In Vivo Data to be Presented at ASH,, 5/09/2016 0FTYWS-E GNW  Immune Design and Gritstone Oncology Announce Clinical Collaboration for Neoantigen Cancer Immunotherapy,"11/13/2018 GH-US    GNW  Guardant Health To Report Third Quarter Financial Results on November 19, 2018",,,, 4/25/2019 ORTX-US  GNW  Orchard Therapeutics Announces First Patient Dosed with Cryopreserved Formulation of OTL-103 Gene Therapy for the Treatment of Wiskott-Aldrich Syndrome,,,,,,,,,,,,
, 6/18/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Agreement with FUJIFILM Toyama Chemical Co. for Automated Bone Scan Index (aBSI) Product in Japan,,, 9/10/2010 G3040110 GNW  Quarterly Changes to the NASDAQ Q-50 Index,, 9/10/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference,,," 4/29/2014 82691710     GNW  SIGA to Host Quarterly Business Update Call on May 1, 2014"," 1/07/2019 OPK-US   GNW  OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories","11/08/2018 46222210 GNW  Recent Analysis Shows Automatic Data Processing, GTx, Ionis Pharmaceuticals, TriNet Group, Ternium S.A, and UNIVERSAL INSURANCE HOLDINGS INC Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 3/01/2016 BMRN-US     GNW  BioMarin Receives Orphan Drug Designation From FDA for First AAV-Factor VIII Gene Therapy, BMN 270, for Patients With Hemophilia A",,,," 2/25/2019 IMMU-US  GNW  Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership Changes", 4/30/2019 BIIB-US   GNW  Data Published in Neurology Show that Treatment with SPINRAZAÂ® (nusinersen) Improved Motor Function and Provided Long-Term Benefit for Individuals with Later-Onset Spinal Muscular Atrophy,, 9/04/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,"10/17/2016 N5946510 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Mylan N.V. To Contact Brower Piven Before The Lead Plaintiff Deadline â€“ MYL",," 3/11/2019 00972810 GNW  AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akorn, Inc. Investors", 9/09/2013 AMGN-US  GNW  Sobi acquires full rights for Kineret(R) and additional clinical data for Kepivance(R) from Amgen,11/09/2019 MYGN-US  GNW  New Studies Demonstrate the Predictive Value of the VectraÂ® Test in People Diagnosed with Rheumatoid Arthritis, 3/11/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceÂ ,,11/02/2017 INSM-US  GNW  Insmed Reports Third Quarter 2017 Financial Results and Provides Business Update,, 9/05/2018 45773H20  GNW  Inovio Doses 1st Subject in Phase 1/2 Clinical Trial  For Vaccine Against Deadly MERS Infection,"12/13/2018 64026810 GNW  CLASS ACTION UPDATE for IGCC, NKTR and SYF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 8/22/2019 GERN-US  GNW  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),," 7/17/2019 AMRN-US  GNW  Amarin Announces $400,000,000 Public Offering of American Depositary Shares", 4/12/2013 45337C10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of Incyte Corporation of Upcoming Deadline -- INCY,," 9/05/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program"," 1/28/2019 G0176710 GNW  Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of YOGA, MAR, ALKS and MAXR",," 4/16/2019 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations",,,,, 8/28/2019 SAN-FR   GNW  Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9,,,11/28/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Positive Preliminary Phase 1 Data for TransCon CNP,," 7/29/2018 00422510 GNW  CLASS ACTION UPDATE for MRCY, MD and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders","11/28/2018 AFMD-US  GNW  Affimed to Host Research & Development Day on Friday, December 7, 2018 in New York City",,12/24/2018 PRQR-US  GNW  ProQR Therapeutics Added to NASDAQ Biotechnology Index,," 5/31/2019 98978L20 GNW  CLASS ACTION UPDATES for BA, CRCM, ZGNX, INVVY: Hagens Berman Reminds Investors of Class Actions on Behalf of Shareholders", 1/07/2019 ALLK-US  GNW  Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-NaÃ¯ve Chronic Spontaneous Urticaria Patients,, 1/08/2015 76133010 GNW  Revance Therapeutics Announces Publication of Positive Results From RT002 Phase 1/2 Study,,, 4/30/2019 ADVM-US  GNW  Adverum Biotechnologies Presents First Preclinical Data on Dosing Contralateral Eye with ADVM-022 Gene Therapy for Wet AMD at the ARVO 2019 Annual Meeting, 4/16/2019 RARE-US   GNW  Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders, 7/16/2018 AGLE-US  GNW  Aeglea BioTherapeutics Appoints Dr. Bryan Lawlis to Board of Directors,10/29/2018 63009R10 GNW  MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology,,, 9/28/2018 RDUS-US  GNW  Radius Health to Present at the Leerink Partners Oncology Roundtable Series, 8/08/2018 ASMB-US  GNW  Assembly Biosciences Announces Second Quarter 2018 Financial Results,,,"10/07/2018 02043Q10 GNW  CLASS ACTION UPDATE for COCP, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 5/07/2018 Y9530810 GNW  Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer," 3/06/2019 00972L10 GNW  Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics â€” Future Expectations, Projections Moving into 2019",,12/12/2018 PCRX-US  GNW  New Retrospective Analysis Demonstrates Significant Reductions in Postsurgical Pain and Opioid Requirements with EXPAREL in Cesarean Section Patients,10/26/2018 RTRX-US  GNW  Retrophin Reports Positive Long-Term Data from Open-Label Extension of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis, 3/27/2018 PACB-US  GNW  Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad,11/30/2018 EDIT-US  GNW  Editas Medicine Announces FDA Acceptance of IND Application for EDIT-101, 8/09/2018 CHMA-US  GNW  Chiasma Reports Second Quarter 2018 Results,"10/09/2019 55609910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, Meredith Corporation, and MacroGenics and Encourages Investors to Contact the Firm",,, 4/29/2014 28249U10 GNW  Celladon to Host Investor and Analyst Day and Webcast on May 6th in New York City,11/06/2018 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Stifel 2018 Healthcare Conference, 6/29/2018 G7280010 GNW  SHAREHOLDER ALERT â€“ PRTA TAL NWL FLEX HAIR GOGO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 2/20/2019 ZLAB-US  GNW  Zai Lab to Present at the 8th Annual SVB Leerink Global Healthcare Conference, 4/09/2015 78667J10 GNW  SAGE Therapeutics Announces Presentations at Upcoming Scientific Conferences, 2/14/2019 CTMX-US  GNW  CytomX Therapeutics to Announce Full-Year 2018 Financial Results and Host Webcast Conference Call, 4/16/2019 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for First Quarter of 2019," 3/03/2019 92165910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Diplomat Pharmacy, Vanda Pharmaceuticals, and AVEO Pharmaceuticals and Encourages Investors to Contact the Firm",,11/06/2018 CBAY-US  GNW  CymaBay Reports Third Quarter 2018 Financial Results and Provides Corporate Update, 8/10/2011 45781M10 GNW  Inova Releases Its Form 10-K, 5/23/2018 CCXI-US  GNW  ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress,,, 1/16/2019 MNKD-US   GNW  MannKind Announces Direct Purchase Insulin Program Providing AfrezzaÂ® for as low as $4 a Day, 5/11/2017 URGN-US  GNW  UroGen Pharma Announces Two Data Presentations Related to its Clinical Stage Uro-Oncology Candidates at the American Urology Association 2017 Annual Meeting, 7/23/2019 CYTK-US  GNW  Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy, 4/01/2019 ESPR-US     GNW  Esperion Announces Publication in The Journal of the American Heart Association of Bempedoic Acid Study 3 Results," 4/25/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm",, 8/08/2018 ACHN-US  GNW  Achillion Reports Second Quarter 2018 Financial Results," 4/10/2019 SYNH-US  GNW  Syneos Health Schedules First Quarter 2019 Earnings Call for Thursday, May 9, 2019", 2/05/2019 FOLD-US  GNW  Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposiumâ„¢,,,12/19/2018 ADMA-US  GNW  ADMA Biologics Provides Regulatory Update for BIVIGAMÂ®,12/07/2018 36197T10 GNW  Breaking News: Expected Passage of 2018 Farm Bill on Monday Could Provide Opportunity to Gain Big in this Uncertain Market, 4/25/2017 EPZM-US  GNW  Epizyme Announces Tazemetostat Fast Track Designation for Follicular Lymphoma and Plenary Session on Phase 2 NHL Data at ICML,, 1/03/2019 MYOK-US  GNW  MyoKardia to Present at 37th Annual J.P. Morgan Healthcare Conference,, 6/20/2019 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises," 4/24/2019 PTLA-US  GNW  Portola Pharmaceuticals Announces Retirement of Dr. John Curnutte, Executive Vice President and Head of Research and Development",,,,"10/18/2018 14075510 GNW  Investor Expectations to Drive Momentum within Teradata, Liberty TripAdvisor, CPI Card Group, Cara Therapeutics, Ocular Therapeutix, and G-III Apparel Group, LTD â€” Discovering Underlying Factors of Influence", 5/14/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference, 2/27/2019 QURE-US  GNW  uniQure Presents New Preclinical Data on AMT-130 at the CHDIâ€™s 14th Annual Huntingtonâ€™s Disease Therapeutics Conference," 4/25/2019 AGIO-US   GNW  Agios to Webcast Conference Call of First Quarter 2019 Financial Results on May 2, 2019"," 2/22/2019 IOVA-US  GNW  Iovance Biotherapeutics to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call and Webcast on Wednesday, February 27, 2019", 5/08/2018 ANAB-US  GNW  AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates,,12/03/2018 FATE-US  GNW  Fate Therapeutics Secures Exclusive Option to Novel Humanized anti-BCMA CAR Constructs for Development of iPSC-derived Cell Products,11/03/2017 HZNP-US  GNW  Horizon Pharma plc Announces Poster Presentation on KRYSTEXXAÂ® (pegloticase injection) at the American Society of Nephrology Kidney Week 2017,,"10/24/2018 ICPT-US  GNW  Intercept to Announce Third Quarter 2018 Financial Results  on October 31, 2018"," 9/16/2019 48576U10   GNW  7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",,, 2/20/2019 ITCI-US  GNW  Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast,,,, 5/14/2018 AMPH-US  GNW  Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection,12/15/2018 ATRA-US    GNW  Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS),, 5/30/2018 DERM-US  GNW  Dermira to Present at Jefferies 2018 Global Healthcare Conference, 3/06/2019 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference, 4/25/2018 PRAH-US  GNW  PRA Health Sciences Announces Retirement of Chief Financial Officer and Promotion of Michael Bonello to CFO, 8/29/2018 SUPN-US  GNW  Supernus to Present at September 2018 Wells Fargo Healthcare Conference, 2/22/2019 FGEN-US  GNW  FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results,, 3/19/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 4/11/2019 21833P10 GNW  BPI, USX & CRBPÂ  Bronstein, Gewirtz & Grossman, LLC Reminder Shareholders of Class Action",, 6/04/2018 COLL-US  GNW  Collegium Announces CEO Succession, 9/26/2018 XBIT-US  GNW  XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases,,, 5/08/2019 GBT-US   GNW  GBT Reports Recent Business Progress and First Quarter 2019 Financial Results, 3/07/2017 RGNX-US  GNW  REGENXBIO Reports Fourth Quarter and Full-Year 2016 Financial Results and Recent Operational Highlights, 2/26/2019 KURA-US  GNW  Kura Oncology to Report Fourth Quarter and Full Year 2018 Financial Results, 4/05/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 4/15/2019 AXSM-US  GNW  Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Smoking Cessation,10/16/2018 VYGR-US  GNW  Voyager Therapeutics Announces Preclinical Data for Huntingtonâ€™s Disease and Amyotrophic Lateral Sclerosis Programs at the Congress of the European Society of Gene and Cell Therapy," 9/12/2019 07725L10 GNW  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Investigation of Securities Claims Against BeiGene, Ltd.; Encourages Investors with Losses over $100K to Contact the Firm â€“ BGNE",, 7/23/2018 RETA-US  GNW  Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in CKD Caused by Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease, 2/08/2019 44842L10 GNW  Chi-Med to Announce 2018 Final Results, 5/14/2018 NTLA-US  GNW  New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia Therapeutics,10/29/2018 ACIU-US  GNW  AC Immune Partner Life Molecular Imaging Presents New Clinical Study Results for Tau PET-Tracer 18F-PI-2620," 6/19/2018 00GBNS-E GNW  CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing",12/27/2018 GTHX-US  GNW  G1 Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference, 9/20/2017 ARGX-BE  GNW  argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia, 9/14/2018 RUBY-US GNW  Rubius Therapeutics Added to Russell 2000 and 3000 Indexes, 3/29/2019 ATNX-US  GNW  Athenex Announces Appointment of Jordan S. Kanfer to Board of Directors," 7/24/2018 PETQ-US  GNW  PetIQ, Inc. to Report Second Quarter 2018 Results on Tuesday, August 14th", 9/28/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Bardet-Biedl Syndrome and AlstrÃ¶m Syndrome at 57th Annual ESPE Meeting, 6/06/2018 OPTN-US  GNW  Optinose Announces Pricing of Public Offering of Common Stock, 8/09/2018 TORC-US  GNW  resTORbio Reports Second Quarter 2018 Financial Results,,," 4/29/2018 83422E10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Solid Biosciences Inc. (Nasdaq: SLDB) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",12/19/2018 30052C10 GNW  Evolus Added to NASDAQ Biotechnology Index,, 3/12/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces U.S. Commercial Launch of DEXYCUTM (dexamethasone intraocular suspension) 9%, 5/31/2018 SRRK-US  GNW  Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015," 5/29/2018 UBX-US   GNW  UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results",,,,,,, 3/04/2019 AUTL-US  GNW  Autolus Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference, 3/12/2019 FTSV-US GNW  Forty Seven Inc. to Present at Oppenheimer 29th Annual Healthcare Conference,,,,,10/23/2018 YMAB-US  GNW  Naxitamab Receives Positive Opinion for Orphan Medicinal Product Designation Approval in the EU,,,10/09/2018 GH-US    GNW  Guardant Health Announces Closing of Initial Public Offering and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares,,,, 4/15/2019 ORTX-US  GNW  Orchard Therapeutics Announces Presentation of Clinical Proof-of-Concept for OTL-300 for the Treatment of Transfusion-Dependent Beta-Thalassemia at the 22nd American Society of Gene & Cell Therapy Annual Meeting,,,,,,,,,,,,
, 6/13/2019 PGNX-US  GNW  Progenics to Mail Letter to Shareholders,,, 8/09/2010 G3040110 GNW  Penwest Pharmaceuticals Agrees to be Acquired by Endo Pharmaceuticals for $5.00 per Share in Cash,," 8/23/2018 09060J10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Aurora Cannabis, Canopy Growth, MobileIron, Sangamo Therapeutics, BioDelivery Sciences International, and First Solar â€” New Research Emphasizes Economic Growth",,, 3/10/2014 82691710     GNW  SIGA Technologies Reports Financial Results for the Fourth Quarter and Year Ended 2013,"11/12/2018 68375N10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, HON, DY and RYAAY",11/08/2018 46222210 GNW  Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions, 2/29/2016 BMRN-US     GNW  BioMarin Announces BioMarin RareConnections(TM) Rebranding and Consolidating BioMarinâ€™s Comprehensive Support and Services for Eligible Rare Disease Patients,,,," 2/24/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC Technology, Immunomedics, Natural Health, and Maiden Holdings and Encourages Investors to Contact the Firm", 4/29/2019 BIIB-US   GNW  Biogen Announces Three New Nominees for Election to Board of Directors,, 9/03/2019 BCRX-US  GNW  BioCryst to Present at H.C. Wainwright Global Investment Conference,,,"10/14/2016 N5946510 GNW  MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. â€“ MYL",," 3/08/2019 00972810 GNW  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akorn, Inc. Investors", 9/04/2013 AMGN-US  GNW  National Medal of Science Awardee Dr. Leroy Hood Joins Sera Prognostics as a Scientific Advisor,"11/08/2019 62855J10 GNW  MYGN NOTICE: Zhang Investor Law Reminds Investors of November 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. â€“ MYGN"," 3/07/2019 52887230 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â LXRX",,"10/25/2017 INSM-US  GNW  Insmed to Host Third Quarter 2017 Financial Results Conference Call on Thursday, November 2, 2017",, 9/04/2018 INO-US    GNW  Inovio and Korean Partner Dose 1st Subject In Trial to Develop Worldâ€™s First Vaccine to Prevent Hepatitis C Infection,"12/12/2018 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Jianpu, Nektar, Honeywell, and Fitbit and Encourages Investors to Contact the Firm",, 8/08/2019 GERN-US  GNW  Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes,," 7/02/2019 AMRN-US  GNW  Amarin Provides Mid-2019 Update, Including Commercialization Plans for VascepaÂ® and Updates Full Year 2019 Revenue Guidance", 4/03/2013 45337C10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Incyte Corporation and Certain Officers - INCY,, 9/03/2019 SRPT-US  GNW  Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference," 1/28/2019 G0176710 GNW  CLASS ACTION UPDATE for DNKEY, ALKS and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 4/12/2019 00163U10 GNW  AMAG Pharmaceuticals Appoints New Members to Board of Directors,,,,, 8/06/2019 SAN-FR   GNW  Sanofi : DupixentÂ® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis,,,11/14/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Third Quarter 2018 Financial Results and Business UpdateÂ Conference Call on November 28,," 7/27/2018 00422510 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Pharmaceuticals, Inc. To Contact The Firm",11/08/2018 AFMD-US  GNW  Affimed to Present at the Jefferies 2018 London Healthcare Conference,,12/17/2018 PRQR-US  GNW  ProQR Announces Publication in Nature Medicine of QR-110 Data for Leberâ€™s Congenital Amaurosis 10,," 5/29/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orion, Zogenix, BrightView, and Eventbrite and Encourages Investors to Contact the Firm",11/08/2018 ALLK-US  GNW  Allakos Announces Clinical Update and Third Quarter 2018 Financial Results,, 1/05/2015 76133010 GNW  Revance Therapeutics Announces Initiation of BELMONT Phase 2 Active Comparator Trial of Injectable RT002,,, 4/24/2019 ADVM-US  GNW  Adverum Biotechnologies Appoints Thomas Leung as  Chief Financial Officer, 4/11/2019 RARE-US   GNW  Ultragenyx to Present Corporate Update at Analyst and Investor Day on April 17 in New York, 6/29/2018 AGLE-US  GNW  Aeglea BioTherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"10/25/2018 63009R10 GNW  Recent Analysis Shows PennyMac Mortgage Investment Trust, Amicus Therapeutics, Children's Place, PLDT, NanoString Technologies, and Worthington Industries Market Influences â€” Renewed Outlook, Key Drivers of Growth",,, 9/24/2018 RDUS-US  GNW  Radius Health to Present Data on Abaloparatide at ASBMR 2018 Annual Meeting, 7/25/2018 ASMB-US  GNW  Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H0731 for the Treatment of Hepatitis B Virus Infection,,,"10/06/2018 02043Q10 GNW  Kessler Topaz Meltzer & Check, LLP â€“ Reminds Investors of Securities Fraud Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. â€“ ALNY", 4/17/2018 WVE-US   GNW  Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting, 3/01/2019 IONS-US  GNW  Akcea and Ionis Receive Positive EU CHMP Opinion for  WAYLIVRATM (volanesorsen),,12/07/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference,10/25/2018 RTRX-US  GNW  Retrophin Announces Publication of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis in the Journal of the American Society of Nephrology, 3/15/2018 PACB-US  GNW  Study Demonstrates Potential for SMRT Sequencing to Improve the Safety of Gene Therapy Protocols,11/07/2018 EDIT-US  GNW  Editas Medicine Announces Third Quarter 2018 Results and Update, 7/25/2018 CHMA-US  GNW  Chiasma Completes Enrollment of MPOWERED(TM) Phase 3 Clinical Trial of Octreotide Capsules in Patients with Acromegaly,"10/07/2019 55609910 GNW  MGNX INVESTOR REMINDER: Hagens Berman Reminds MacroGenics (MGNX) Investors of Securities Class Action, Encourages Investors Who Lost $50,000+ to Contact the Firm",,," 4/10/2014 28249U10 GNW  Celladon Receives Breakthrough Therapy Designation From FDA for MYDICAR(R), Novel, First-in-Class Therapy in Development to Treat Heart Failure",10/31/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2018 Financial Results Conference Call and Webcast," 6/28/2018 G7280010 GNW  CLASS ACTION UPDATE for DB, PRTA and ANW: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 2/01/2019 ZLAB-US  GNW  Zai Lab Announces the Appointment of Immuno-Oncology Pioneer, Lieping Chen, M.D., Ph.D., to its Scientific Advisory Board", 4/02/2015 78667J10 GNW  SAGE Therapeutics Announces Positive End-of-Phase 2 Meeting With FDA and Planned Initiation of SAGE-547 Global Phase 3 Trial in Mid-2015, 2/05/2019 CTMX-US  GNW  CytomX Therapeutics Announces Senior Management Appointments, 4/03/2019 GMAB-DK  GNW  Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma, 3/01/2019 92165910 GNW  VANDA PHARMACEUTICALS INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has beenÂ filedÂ inÂ theÂ United States District CourtÂ for the Eastern District of New York againstÂ Vanda Pharmaceuticals Inc.,,"10/30/2018 CBAY-US  GNW  CymaBay to Report Third Quarter 2018 Financial Results on Tuesday, November 6"," 7/11/2011 45781M10 GNW  Inova Completes Network Solutions Projects Worth $790,000", 5/09/2018 CCXI-US  GNW  ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights,,,12/27/2018 MNKD-US   GNW  MannKind Corporation to Hold Investor Conference Call, 5/10/2017 URGN-US  GNW  UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwritersâ€™ Option, 7/22/2019 CYTK-US  GNW  Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Associationâ€™s Basic Cardiovascular Sciences Scientific Sessions, 3/18/2019 ESPR-US     GNW  Esperion Announces Late-Breaking Presentation of Final Results of Bempedoic Acid Pivotal Phase 3 Study 2 at the American College of Cardiology 2019 Scientific Sessions," 4/25/2019 03236M20  GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Amyris, Inc. Investors",," 7/10/2018 ACHN-US  GNW  Achillion Initiates Phase I First-in-Human Study of ACH-5548, a Third Oral Small Molecule Inhibitor of Complement Factor D"," 4/08/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Syneos Health, Inc. â€“ SYNH", 1/18/2019 FOLD-US  GNW  Amicus Therapeutics Announces Presentations and Posters at 15th Annual WORLDSymposiumâ„¢ 2019,,,"11/13/2018 00089910 GNW  Report: Developing Opportunities within Evelo Biosciences, ADMA Biologics, Karyopharm Therapeutics, Pingtan Marine Enterprise, Rosetta Stone, and Williams Companies â€” Future Expectations, Projections Moving into 2018",11/27/2018 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress, 4/20/2017 EPZM-US  GNW  Epizyme Announces Date of First Quarter 2017 Financial Results and Tazemetostat Data Presentations at ASCO,, 1/02/2019 SAN-FR   GNW  MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi,, 6/17/2019 GLPG-NL  GNW  Transparency notification," 4/17/2019 PTLA-US  GNW  Portola Pharmaceuticals to Announce First Quarter 2019Â Financial Results on Wednesday, May 8, 2019",,,, 9/26/2018 CARA-US  GNW  Cara Therapeutics to Present at the 2018 Cantor Global Healthcare Conference, 5/10/2019 FLXN-US  GNW  Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension), 2/15/2019 QURE-US  GNW  uniQure Announces Publications on AAV Gene Therapy Approach to Treating Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) in the Journal Molecular Therapy Nucleic Acids, 4/02/2019 AGIO-US   GNW  Agios Announces New Commercial Leadership Structure, 2/01/2019 IOVA-US  GNW  Iovance Biotherapeutics to Present at Upcoming Investor and Medical Conferences, 5/01/2018 ANAB-US  GNW  AnaptysBio Announces ANB020 and ANB019 Clinical Data Presentations at the 2018 EAACI Congress,,"11/30/2018 FATE-US  GNW  Fate Therapeutics Announces FDA Clearance of Landmark IND for FT500 iPSC-derived, Off-the-Shelf NK Cell Cancer Immunotherapy",11/02/2017 HZNP-US  GNW  Horizon Pharma plc to Participate in Investor Conferences in November,,"10/24/2018 45845P10 GNW  Report: Developing Opportunities within Vitamin Shoppe, Intercept Pharmaceuticals, Viasat, Team, Valvoline, and ViewRay â€” Future Expectations, Projections Moving into 2018", 9/16/2019 06R6L0-E   GNW  Karyopharm Enters Into Royalty Agreement with Healthcare Royalty Partners for up to $150 Million,,, 1/03/2019 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,, 5/10/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018,12/03/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Next-Generation CAR T Discoveries and Positive T-Cell Immunotherapy Results in Patients with EBV+ PTLD Involving the CNS at 60th American Society of Hematology (ASH) Annual Meeting,," 5/14/2018 DERM-US  GNW  Dermira to Host Analyst & Investor Day on May 24, 2018", 2/28/2019 FOMX-US  GNW  Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update," 4/25/2018 PRAH-US  GNW  PRA Health Sciences, Inc. Reports First Quarter 2018 Results", 8/07/2018 SUPN-US  GNW  Supernus Announces Second Quarter 2018 Financial Results and  Record Quarterly Revenue,12/20/2018 FGEN-US  GNW  FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease,, 3/18/2019 CHRS-US  GNW  Coherus BioSciences Receives Transitional Pass-Through Status from CMS," 4/11/2019 21833P10 GNW  CRBP ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Corbus Pharmaceuticals Holdings, Inc. â€“ CRBP",, 5/30/2018 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences, 9/24/2018 XBIT-US  GNW  XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa,,, 5/06/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 3/07/2017 RGNX-US  GNW  REGENXBIO Announces Initiation of Phase I/II Clinical Trial of RGX-501 for the Treatment of Homozygous Familial Hypercholesterolemia, 2/20/2019 KURA-US  GNW  Kura Oncology to Present at SVB Leerink Global Healthcare Conference, 3/22/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 4/08/2019 05464T10 GNW  Market Trends Toward New Normal in BlackBerry, Axsome Therapeutics, Pulse Biosciences, Whitestone REIT, Anworth Mortgage Asset, and Synchronoss Technologies â€” Emerging Consolidated Expectations, Analyst Ratings", 8/28/2018 VYGR-US  GNW  Voyager Therapeutics to Present at Investor Conferences in September, 9/11/2019 BGNE-US  GNW  BeiGene Announces Clinical Data to Be Presented at the Annual Meeting of the Chinese Society of Clinical Oncology (CSCO),, 7/10/2018 RETA-US  GNW  Reata Receives Orphan Drug Designation from the European Commission for Omaveloxolone for the Treatment of Friedreichâ€™s Ataxia, 1/07/2019 HCM-GB   GNW  Chi-Med to Present at the 37th Annual JP Morgan HealthcareÂ Conference, 5/01/2018 NTLA-US  GNW  Intellia Therapeutics Announces First Quarter 2018 Financial Results,10/29/2018 ACIU-US  GNW  AC Immune SA: New Data Supporting Crenezumab as Potential Alzheimer's Therapy, 6/05/2018 CRSP-US  GNW  CRISPR Therapeutics to Participate in Three June Conferences,12/19/2018 GTHX-US  GNW  G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung Cancer, 8/24/2017 ARGX-BE  GNW  argenx reports second quarter business update and half-year 2017 financial results, 9/04/2018 RUBY-US GNW  Rubius Therapeutics to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference, 3/28/2019 ATNX-US  GNW  Athenex Announces Appointment of Dr. Daniel Von Hoff as Chairman of the Scientific Advisory Board of Axis Therapeutics Limited," 6/06/2018 PETQ-US  GNW  PetIQ, Inc. to Participate in the Jefferies 2018 Consumer Conference", 9/28/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity, 6/04/2018 OPTN-US  GNW  Optinose Announces Launch of Public Offering of Common Stock, 7/30/2018 TORC-US  GNW  resTORbio to Present at the Canaccord Genuity 38th Annual Growth Conference,,," 4/27/2018 83422E10 GNW  SLDB EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Solid Biosciences Inc. and a Lead Plaintiff Deadline of May 29, 2018",11/19/2018 EOLS-US  GNW  Evolus Receives Conditional FDA Acceptance of Jeuveauâ„¢ Brand Name,," 2/14/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Fiscal Period Ended December 31, 2018 Financial Results Release Date and Conference Call Information", 5/23/2018 SRRK-US  GNW  Scholar Rock Announces Pricing of Initial Public Offering," 5/14/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development",,,,,,, 3/04/2019 AUTL-US  GNW  Autolus Therapeutics to Present New Data on AUTO1 at the American Association of Cancer Research (AACR) Annual Meeting 2019, 2/07/2019 FTSV-US GNW  Forty Seven Inc. to Present at Guggenheim Healthcare Talks Idea Forum | Oncology Day,,,,, 9/25/2018 YMAB-US  GNW  Y-mAbs Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,,"10/04/2018 GH-US    GNW  Nasdaq Welcomes Guardant Health, Inc. (Nasdaq: GH) to The Nasdaq Stock Market",,,, 3/27/2019 ORTX-US  GNW  Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD,,,,,,,,,,,,
, 6/13/2019 PGNX-US  GNW  Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy for the Treatment of Metastatic Prostate Cancer,,, 7/16/2010 G3040110 GNW  Endo Pharmaceuticals Inc. (ENDP) Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell,, 8/21/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference,,," 3/03/2014 82691710     GNW  SIGA to Host Quarterly Business Update Call on March 10, 2014","11/12/2018 68375N10 GNW  DEADLINE TOMORROW for OPK, TRCO and USAT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",10/08/2018 46222210 GNW  Akcea Announces Changes to Board of Directors," 2/29/2016 BMRN-US     GNW  BioMarin Announces 21 Presentations at 12th Annual WORLDSymposiumâ„¢ 2016 February 29-March 4 in San Diego, California: 6 Oral and 15 Poster",,,," 2/24/2019 45290710 GNW  CLASS ACTION UPDATE for SOGO, IMMU, W and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/12/2019 BIIB-US   GNW  Biogen Continues to Advance Innovation in SMA with New Data in Adults and Infants to Be Presented at MDA Clinical and Scientific Conference,, 8/06/2019 BCRX-US  GNW  BioCryst Reports Second Quarter 2019 Financial Results,,,"10/11/2016 N5946510 GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Mylan N.V. To Contact The Firm Before Lead Plaintiff Deadline",," 3/08/2019 AKRX-US  GNW  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against and Lead Deadline: April 22, 2019"," 7/25/2013 07H55S-E GNW  NASDAQ Welcomes Cellular Dynamics International, Inc. to The NASDAQ Stock Market","11/08/2019 62855J10 GNW  Myriad Genetics, Inc. (MYGN), Overstock.com, Inc. (OSTK) & Waitr Holdings Inc. (WTRH) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action"," 3/07/2019 52887230 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",, 9/19/2017 INSM-US  GNW  Insmed to Present at Two September Investor Conferences,, 8/21/2018 INO-US    GNW  Inovio Pharmaceuticals to Participate inÂ Upcoming Investment Conferences,12/11/2018 64026810 GNW  SHAREHOLDER ALERT: COST NKTR FIT RBBN SONS MGI ATUS CMCM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 8/01/2019 GERN-US  GNW  Geron Corporation Reports Second Quarter 2019 Financial Results and Recent Events,, 6/21/2019 002PSJ-E GNW  Amarinâ€™s John Thero Awarded NJ EY Entrepreneur of The YearÂ®  2019 Award for Life Sciences," 3/18/2013 45337C10 GNW  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline -- INCY",, 8/30/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 1/25/2019 G0176710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DNKEY, DXC, ALKS and SNAP",, 4/02/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference,,,,, 8/06/2019 SAN-FR   GNW  Sanofi : DupixentÂ® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis,,,11/08/2018 ASND-US  GNW  Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransConâ„¢ Endocrinology Rare Disease Therapies in China,," 7/26/2018 00422510 GNW  CLASS ACTION UPDATE for FPI, FIZZ and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",11/07/2018 AFMD-US  GNW  Affimed Reports Financial Results for Third Quarter 2018 and Operational Progress,,12/13/2018 PRQR-US  GNW  ProQR Announces Strategic Changes to the Management Team and Key New Hires,, 5/23/2019 98978L20 GNW  ZGNX CLASS ACTION REMINDER: Hagens Berman Reminds Zogenix (ZGNX) Investors of Class Action of Upcoming Deadline,10/08/2018 ALLK-US  GNW  Allakos Presents Data from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting,,12/18/2014 76133010 GNW  Revance Therapeutics Added to NASDAQ Biotechnology Index,,, 4/16/2019 ADVM-US  GNW  Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO, 3/26/2019 RARE-US   GNW  Ultragenyx Announces Approval of CrysvitaÂ® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children, 5/15/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present at UBS Global Healthcare Conference,10/15/2018 NSTG-US  GNW  NanoString Announces $100 Million Term Loan Facility with CRG,,, 9/11/2018 RDUS-US  GNW  Radius Health to Present at the Morgan Stanley 16th Annual Global Health Care Conference, 7/16/2018 ASMB-US  GNW  Assembly Biosciences Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares,,,"10/05/2018 02043Q10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ampio, Microchip Technology, Chegg, and Alnylam and Encourages Investors to Contact the Firm", 4/10/2018 WVE-US   GNW  Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders, 2/28/2019 AKCA-US  GNW  AkceaÂ® Recognizes Rare Disease Day Through Efforts to Increase Awareness of Hereditary Transthyretin Amyloidosis and Familial Chylomicronemia Syndrome,,"11/27/2018 PCRX-US  GNW  New Data Show EXPAREL Plays a Key Role in Achieving Significant Reductions in Opioid Use, Hospital Stay and Total Hospitalization Costs Following Painful Knee Replacement Surgery",10/18/2018 RTRX-US  GNW  Retrophin to Report Third Quarter 2018 Financial Results, 3/13/2018 PACB-US  GNW  Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing,10/31/2018 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results, 6/18/2018 CHMA-US  GNW  Chiasma to Present on New Methodologies in Acromegaly Clinical Trial Design at 12th Acromegaly Consensus Conference,"10/02/2019 55609910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, Meredith Corporation, and MacroGenics and Encourages Investors to Contact the Firm",,, 4/01/2014 28249U10 GNW  Celladon Added to the Russell 2000(R) and Russell 3000(R) Indexes,"10/11/2018 60877T10 GNW  Recent Analysis Shows RadNet, Electro Scientific Industries, Koppers, Momenta Pharmaceuticals, IQVIA, and Columbia Property Trust Market Influences â€” Renewed Outlook, Key Drivers of Growth", 6/25/2018 PRTA-US  GNW  Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer, 1/28/2019 ZLAB-US  GNW  Priority Review Granted to Zai Labâ€™s NDA Application for ZEJULA (Niraparib) in China, 2/27/2015 78667J10 GNW  SAGE Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results," 1/30/2019 CTMX-US  GNW  CytomX Therapeutics to Host Research and Development Day on February 26, 2019"," 3/27/2019 GMAB-DK  GNW  Genmab Announces European Regulatory Submission for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma", 3/01/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,,10/30/2018 CBAY-US  GNW  CymaBay Announces the Initiation of the Seladelpar Global Phase 3 Registration Study (ENHANCE) for the Treatment of Primary Biliary Cholangitis and Additional Corporate Updates," 6/21/2011 45781M10 GNW  Inova Completes Network Solutions Projects Worth $950,000"," 5/02/2018 CCXI-US  GNW  ChemoCentryx to Hold First Quarter 2018 Financial Results Conference Call on Wednesday, May 9, 2018",,,12/19/2018 MNKD-US   GNW  MannKind Announces Pricing of $40 Million Public Offering, 5/03/2017 M9608810 GNW  UroGen Pharma Announces Pricing of Initial Public Offering," 7/15/2019 CYTK-US  GNW  Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure", 3/13/2019 ESPR-US     GNW  Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New England Journal of Medicine," 4/25/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc.  â€“ AMRS",, 6/14/2018 ACHN-US  GNW  Achillion to Present at the 2018 JMP Securities Life Sciences Conference," 4/08/2019 87166B10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SYNH, HCSG, USX and ARA", 1/07/2019 FOLD-US  GNW  Amicus Therapeutics Provides Full-Year 2019 Strategic Outlook and Financial Guidance,,,11/08/2018 ADMA-US  GNW  ADMA Biologics Reports Third Quarter 2018 Financial Results,11/26/2018 GWPH-US  GNW  GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEXÂ® (cannabidiol) oral solution CV in Patients with Dravet Syndrome, 3/29/2017 EPZM-US  GNW  Epizyme to Present New Preclinical Data on Tazemetostat and Epigenetic Target Identification Efforts at AACR Annual Meeting,,12/11/2018 MYOK-US  GNW  MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 in Dilated Cardiomyopathy and Systolic Heart Failure Patients,, 6/11/2019 GLPG-NL  GNW  Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients," 4/10/2019 73701010 GNW  New Research: Key Drivers of Growth for Newmont Mining, Johnson & Johnson, Portola Pharmaceuticals, MedEquities Realty Trust, Comtech Telecommunications, and Odonate Therapeutics â€” Factors of Influence, Major Initiatives and Sustained Production",,,, 9/05/2018 CARA-US  GNW  Cara Therapeutics to Present at the 27th European Academy of Dermatology & Venereology Congress, 5/08/2019 FLXN-US  GNW  Flexion Therapeutics Reports First-Quarter 2019 Financial Results and Recent Business Highlights, 2/08/2019 QURE-US  GNW  uniQure Announces Updated Clinical Data from Phase IIb Study of  AMT-061 in Patients with Hemophilia B, 3/26/2019 AGIO-US   GNW  Agios Receives FDA Breakthrough Therapy Designation for TIBSOVOÂ® (ivosidenib) in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) with an IDH1 Mutation in Adult Patients Ineligible for Intensive Chemotherapy,12/21/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference, 4/27/2018 ANAB-US  GNW  AnaptysBio To Participate in Upcoming Investor Conferences,,11/11/2018 FATE-US  GNW  Fate Therapeutics Announces Encouraging Dose-Escalation Clinical Data of FATE-NK100 and Provides Regulatory Update on Landmark IND Application for FT500,10/26/2017 HZNP-US  GNW  Horizon Pharma plc Announces Availability of PROCYSBIâ„¢Â (cysteamine bitartrate) in Canada,, 9/26/2018 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conference," 9/13/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,12/18/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Update on ITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer's Disease,,,," 5/09/2018 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018","11/29/2018 ATRA-US    GNW  Atara Biotherapeutics Highlights Next-Generation and Off-the-Shelf, Allogeneic CAR T Technologies and Pipeline",, 5/08/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/27/2019 FOMX-US  GNW  Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to 1 Year, 4/12/2018 PRAH-US  GNW  PRA Health Sciences to Report First Quarter 2018 Earnings, 7/25/2018 SUPN-US  GNW  Supernus to Host Second Quarter 2018 Earnings Conference Call,12/17/2018 FGEN-US  GNW  FibroGen Announces Approval of Roxadustat in China for the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis,, 3/18/2019 CHRS-US  GNW  Coherus BioSciences Appoints Thomas Fitzpatrick Chief Legal Officer, 4/11/2019 21833P10 GNW  SHAREHOLDER ALERT: MHLD BRS HCSG CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 5/09/2018 COLL-US  GNW  Collegium Reports First Quarter Financial Results and Provides Corporate Update, 9/20/2018 XBIT-US  GNW  XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team,,, 4/03/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 3/06/2017 RGNX-US  GNW  REGENXBIO to Present at the Cowen and Company 37th Annual Health Care Conference, 1/18/2019 KURA-US  GNW  Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression, 3/12/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/27/2019 AXSM-US  GNW  Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Major Depressive Disorder, 8/07/2018 VYGR-US  GNW  Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights," 9/08/2019 BGNE-US  GNW  BeiGene to Hold Conference Call and Webcast on September 8, 2019 at 7:00 p.m. ET to Provide Corporate Update",," 6/20/2018 RETA-US  GNW  Reata Announces Initiation of a Phase 1 Trial of RTA 1701, a Selective, Oral Allosteric Inhibitor of RORÎ³t",12/20/2018 HCM-GB   GNW  Chi-Med Announces Progress in Savolitinib Lung Cancer Program and Update on Kidney Cancer Strategy," 4/25/2018 45826J10 GNW  Consolidated Research: 2018 Summary Expectations for Caseys General Stores, EQT Midstream Partners, LP, Intellia Therapeutics, Blue Buffalo Pet Products, Life Storage, and Thor Industries â€” Fundamental Analysis, Key Performance Indications",10/25/2018 ACIU-US  GNW  AC Immune Selected to Present Progress on its  Tau Morphomer Program in the Late Breaking News Session at CTAD Conference in Barcelona, 5/30/2018 H1718210 GNW  CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease,12/04/2018 GTHX-US  GNW  Preliminary Results from Randomized Phase 2 Trial Demonstrate Trilaciclib Improved Progression-Free Survival in Combination with Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer, 8/23/2017 ARGX-BE  GNW  argenx announces publication in Nature Medicine of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM  ARGX-116 for the treatment of dyslipidemia, 8/31/2018 RUBY-US GNW  Rubius Therapeutics Reports Second Quarter 2018 Financial Results, 3/21/2019 ATNX-US  GNW  Athenex Announces Expansion of Board of Directors," 5/31/2018 PETQ-US  GNW  PetIQ, Inc. to Participate in the 38th Annual William Blair Growth Stock Conference", 9/25/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference, 5/14/2018 OPTN-US  GNW  Optinose Reports First Quarter 2018 Financial ResultsÂ and Recent Operational Highlights, 7/25/2018 TORC-US  GNW  resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101,,," 4/26/2018 83422E10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 â€“ SLDB",11/05/2018 EOLS-US  GNW  Evolus Reports Third Quarter 2018 Financial Results,, 2/13/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Secures Up to $60 Million Debt Facility,," 5/07/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Announces Closing of Initial Public Offering",,,,,,, 2/25/2019 0GBZHG-E GNW  Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies," 1/15/2019 FTSV-US GNW  Forty Seven Inc. to Host Key Opinion Leader Breakfast Symposium on FSI-174, anti-cKIT Antibody, on January 22, 2019",,,,, 9/20/2018 YMAB-US  GNW  Y-mAbs Therapeutics Announces Pricing of Initial Public Offering,,,10/03/2018 40131M10 GNW  Guardant Health Announces Pricing of Initial Public Offering,,,, 3/21/2019 ORTX-US  GNW  Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights,,,,,,,,,,,,
, 6/06/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting,,,,, 8/15/2018 BDSI-US  GNW  BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCAÂ®,,,11/06/2013 82691710     GNW  SIGA Technologies Reports Financial Results for the Third Quarter 2013,11/09/2018 OPK-US   GNW  OPKO Health Reports Third Quarter 2018 Financial Results,10/05/2018 46222210 GNW  Akcea Announces Its Access and Distribution Strategy for TEGSEDIâ„¢ (inotersen), 2/25/2016 BMRN-US     GNW  BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results,,,," 2/24/2019 45290710 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARLO, IMMU, MKL and SVXY"," 4/09/2019 NITE-US   GNW  Recommended Acquisition of Nightstar Therapeutics plc by Tungsten Bidco Limited, a Wholly-Owned Subsidiary of Biogen Switzerland Holdings GmbH; Posting of Scheme Document",, 8/05/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4),,, 1/08/2016 N5946510 GNW  Momenta Pharmaceuticals Announces Worldwide Collaboration With Mylan to Jointly Develop and Commercialize Six Biosimilar Products,," 3/07/2019 00972810 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against  Akorn, Inc. and Certain Officers â€“Â AKRX"," 6/24/2013 NVAX-US  GNW  Novavax Appoints Barclay ""Buck"" Phillips as Senior Vice President and Chief Financial Officer","11/07/2019 62855J10 GNW  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MYGN, TME, and OSTK of Filing Deadlines", 3/01/2019 LXRX-US  GNW  CHMP Recommends Zynquistaâ„¢ (Sotagliflozin) for the Treatment of Adults With Type 1 Diabetes,, 9/11/2017 INSM-US  GNW  Insmed Announces Closing of Public Offering,, 8/16/2018 INO-US    GNW  Inovio Treats First Patient in Immuno-Oncology Study  for Advanced or Metastatic Bladder Cancer in Combination  with Roche/Genentechâ€™s Atezolizumab,"12/10/2018 64026810 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NKTR, GSKY, RBBN (SONS), MDR and TX",," 7/25/2019 GERN-US  GNW  Geron to Announce Second Quarter Financial Results on August 1, 2019",, 6/18/2019 AMRN-US  GNW  Amarin to Present at the 2019 BMO Prescription For Success Healthcare Conference," 2/05/2013 SNOA-US  GNW  Ruthigen, Inc., Subsidiary of Oculus Innovative Sciences, Inc., Appoints Sameer Harish as Chief Financial Officer",, 8/19/2019 SRPT-US  GNW  Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application," 1/24/2019 G0176710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NVDA, YRIV, ALKS and W",," 3/20/2019 AMAG-US  GNW  March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program",,,,, 7/29/2019 SAN-FR   GNW  Sanofi delivered solid growth in Q2 2019,,,11/02/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentations,," 7/26/2018 00422510 GNW  Analysis: Positioning to Benefit within Citigroup, Cinedigm, FS Investment, ACADIA Pharmaceuticals, San Juan Basin Royalty Trust, and Fortress Transportation and Infrastructure Investors â€” Research Highlights Growth, Revenue, and Consolidated Results",11/01/2018 AFMD-US  GNW  Affimed Announces Oral Presentation and Five Poster Presentations at the 2018 American Society of Hematology Annual Meeting,,12/10/2018 PRQR-US  GNW  ProQR Receives â‚¬ 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10,," 5/22/2019 98978L20 GNW  CLASS ACTION UPDATE for CRCM, ZGNX, S and EQBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 8/29/2018 ALLK-US  GNW  Allakos Announces Second Quarter 2018 Financial Results,,"11/20/2014 76133010 GNW  Revance Therapeutics, Inc. Announces Participation in 26th Annual Piper Jaffray Healthcare Conference",,, 4/15/2019 ADVM-US  GNW  Adverum Biotechnologies Provides Clinical Program Update onÂ ADVM-022 Gene Therapy for Wet AMD, 3/11/2019 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences, 5/08/2018 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results,10/08/2018 NSTG-US  GNW  Landmark Publications in Nature Medicine use NanoStringâ€™s Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology,,, 9/06/2018 RDUS-US  GNW  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), 7/11/2018 ASMB-US  GNW  Assembly Biosciences Announces Pricing of $144 Million Offering of Common Stock,,,"10/05/2018 02043Q10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alnylam Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ALNY", 4/05/2018 WVE-US   GNW  Wave Life Sciences to Present at Upcoming Investor Conferences, 2/26/2019 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018,,11/16/2018 PCRX-US  GNW  Pacira Pharmaceuticals CMO Presents at FDA Advisory Committee Meeting Focused on Assessment of Opioid-Sparing Outcomes in Clinical Trials,10/05/2018 RTRX-US  GNW  Retrophin to Present Long-Term Data from Phase 2 DUET Study of Sparsentan in FSGS at ASN Kidney Week 2018, 3/07/2018 PACB-US  GNW  Pacific Biosciences Enhances Performance and Affordability of Key Applications on the Sequel System,10/01/2018 EDIT-US  GNW  Editas Medicine Grows Scientific Leadership with Two New Appointments, 6/14/2018 CHMA-US  GNW  Chiasma Achieves 50% of Target Patients Randomized in CHIASMA OPTIMAL Phase 3 Clinical Trial of Octreotide Capsules in Patients with Acromegaly,"10/02/2019 55609910 GNW  CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in VRAY, MDP, and MGNX of Filing Deadlines",,, 3/31/2014 28249U10 GNW  Celladon Reports Fourth Quarter and Year-End 2013 Financial Results and Recent Highlights,"10/04/2018 MNTA-US  GNW  Momenta Pharmaceuticals to Host R&D Day on October 11, 2018"," 6/25/2018 G7280010 GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Prothena Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 16, 2018 â€“ PRTA", 1/09/2019 ZLAB-US  GNW  Zai Lab Completes Enrollment of China Pivotal Trial of Niraparib as Second-Line Maintenance Therapy for Ovarian Cancer in China, 2/13/2015 78667J10 GNW  SAGE Therapeutics Appoints New Vice Presidents to Lead Key Organizational Functions," 1/07/2019 CTMX-US  GNW  CytomX Therapeutics Announces Technology Acquisition From Agensys, Inc., an Affiliate of Astellas Pharma Inc."," 3/26/2019 GMAB-DK  GNW  Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma", 3/01/2019 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. â€“ VNDA,,"10/10/2018 23257D10 GNW  Report: Developing Opportunities within Brunswick, Pebblebrook Hotel Trust, Avaya, Braskem S.A, CymaBay Therapeutics, and The Blackstone Group â€” Future Expectations, Projections Moving into 2018", 6/08/2011 45781M10 GNW  Inova Announces Total Project Contract Awards Have Grown to $47 million, 4/11/2018 CCXI-US  GNW  ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting,,,12/19/2018 MNKD-US   GNW  MannKind Announces Commencement of Public Offering, 4/24/2017 0CV67B-E GNW  UroGen Pharma Welcomes New Board Member Kate Falberg, 6/28/2019 CYTK-US  GNW  Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference," 3/05/2019 29664W10    GNW  New Research Coverage Highlights Advance Auto Parts, AxoGen, Encana, Federal Signal, Nelnet, and Esperion Therapeutics â€” Consolidated Revenues, Company Growth, and Expectations for 2019"," 4/24/2019 03236M20  GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CVS, WTW, ARA, AMRS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",, 5/11/2018 ACHN-US  GNW  Achillion Announces Upcoming Scientific Presentations at the 55th ERA-EDTA Congress," 4/07/2019 87166B10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Syneos Health, Inc. - SYNH", 1/03/2019 FOLD-US  GNW  Amicus Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,10/17/2018 ADMA-US  GNW  ADMA Biologics Receives PDUFA Date for RI-002,11/19/2018 GWPH-US  GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEXÂ® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting, 3/09/2017 EPZM-US  GNW  Epizyme Reports 2016 Financial Results and Provides 2017 Pipeline Goals,,12/05/2018 MYOK-US  GNW  MyoKardia to Present at the BMO 2018 Prescriptions for Success Healthcare Conference,, 5/29/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  TO  PRESENT  LATEST  DATA  ON  FILGOTINIB  AT  THE  ANNUAL  EUROPEAN  CONGRESS  OF  RHEUMATOLOGY  (EULAR 2019), 3/20/2019 PTLA-US  GNW  Portola Pharmaceuticalsâ€™ Co-Founder Dr. Charles Homcy Retires from the Companyâ€™s Board of Directors,,,," 8/27/2018 14075510 GNW  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products â€” Research Highlights Growth, Revenue, and Consolidated Results", 5/03/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4), 2/04/2019 QURE-US  GNW  uniQure Announces First Patient Treated in HOPE-B Pivotal Trial  of AMT-061 in Patients with Hemophilia B," 3/04/2019 AGIO-US   GNW  Agios to Present at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019",11/13/2018 IOVA-US  GNW  Iovance Biotherapeutics to Participate at November Investor Conferences, 3/26/2018 ANAB-US  GNW  AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline Adult Peanut Allergy Patients,,11/08/2018 FATE-US  GNW  Fate Therapeutics to Present at Upcoming Investor Conferences,10/25/2017 HZNP-US  GNW  Horizon Pharma plc Announces First Patient Enrolled in Confirmatory Phase 3 Clinical Trial Evaluating Teprotumumab for the Treatment of Moderate-to-Severe Active Thyroid Eye Disease,, 8/29/2018 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences, 9/13/2019 KPTI-US    GNW  Karyopharm Announces XPOVIOâ„¢ (Selinexor) Presentations at the 17th International Myeloma Workshop,,,12/11/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Favorable Results From Long-Term Open-Label Safety Switching Study With Lumateperone in Patients with Schizophrenia at the 57th Annual Meeting of the American College of Neuropsychopharmacology,,,," 5/03/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018","11/27/2018 ATRA-US    GNW  Atara Biotherapeutics to Host CAR T Breakfast Teach-In on November 29, 2018",, 5/03/2018 DERM-US  GNW  Dermira Reports First Quarter 2018 Financial Results and Provides Corporate UpdateÂ , 2/26/2019 FOMX-US  GNW  Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting, 4/03/2018 PRAH-US  GNW  Symphony Healthâ€™s New Enhanced Views Program Expands Evidence-Driven Insights," 6/27/2018 SUPN-US  GNW  Dr. Carrolee Barlow, M.D., Ph.D., Joins Supernusâ€™Â Board of Directors","12/06/2018 FGEN-US  GNW  FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors",," 3/05/2019 19249H10 GNW  New Research: Key Drivers of Growth for American Tower Corporation (REIT), Lowe's Companies, Mimecast, Live Nation Entertainment, Intercept Pharmaceuticals, and Coherus BioSciences â€” Factors of Influence, Major Initiatives and Sustained Production", 4/08/2019 CRBP-US  GNW  Corbus Pharmaceuticals Appoints Rachelle Jacques to Board of Directors,, 5/02/2018 COLL-US  GNW  Collegium to Present at the Deutsche Bank Health Care Conference, 9/13/2018 XBIT-US  GNW  XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic Dermatitis,,, 4/02/2019 GBT-US   GNW  GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference, 2/28/2017 RGNX-US  GNW  REGENXBIO to Host Conference Call on March 7 to Discuss Fourth Quarter and Full-Year 2016 Financial Results and Recent Operational Highlights, 1/03/2019 KURA-US  GNW  Kura Oncology to Present at J.P. MorganÂ Healthcare Conference, 3/11/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares, 3/14/2019 AXSM-US  GNW  Axsome Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update, 8/02/2018 VYGR-US  GNW  Voyager Therapeutics to Present at Investor Conferences in August, 9/03/2019 BGNE-US  GNW  BeiGene to Present at the Morgan Stanley 17th Annual Global Healthcare Conference,," 6/14/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Secures $125 Million Term Loan Facility",12/20/2018 HCM-GB   GNW  Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company, 4/23/2018 NTLA-US  GNW  UPDATE -- Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting,"10/22/2018 ACIU-US  GNW  AC Immune Announces Dr. Andreas Muhs, Chief Scientific Officer, to Take Medical Leave of Absence", 5/15/2018 CRSP-US  GNW  CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting,"11/26/2018 GTHX-US  GNW  G1 Therapeutics Announces Positive Myelopreservation Data from Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Trilaciclib in Combination with Chemotherapy/TecentriqÂ® in First-Line Small Cell Lung Cancer"," 8/17/2017 ARGX-BE  GNW  argenx to host conference call & webcast to report second quarter business update  and half year 2017 financial results on August 24, 2017", 8/21/2018 RUBY-US GNW  Rubius Therapeutics to Announce Second Quarter 2018 Financial Results, 3/21/2019 0KM71B-E GNW  Athenex Announces Xiangxue Life Sciences Receives IND Allowance from Chinaâ€™s National Medical Products Administration for Cancer Immunotherapy Drug Candidate," 5/15/2018 PETQ-US  GNW  PetIQ, Inc. Reports First Quarter 2018 Financial Results", 9/07/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference," 5/07/2018 OPTN-US  GNW  Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018", 7/11/2018 TORC-US  GNW  resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older,,, 4/25/2018 0F98BD-E GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline â€“ SLDB,11/01/2018 EOLS-US  GNW  Evolus to Participate in Two Upcoming Investor Conferences,, 2/04/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Announces U.S. Commercial Launch of YUTIQâ„¢ (fluocinolone acetonide intravitreal implant) 0.18 mg,," 5/02/2018 UBX-US   GNW  UNITY Biotechnology, Inc. Announces Pricing of Initial Public Offering of Common Stock",,,,,,, 6/26/2018 AUTL-US  GNW  Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional American Depositary Shares, 1/07/2019 FTSV-US GNW  Forty Seven Inc. Announces 2019 Strategic Priorities and Expected Milestones,,,,, 8/22/2018 0GJSDY-E GNW  Y-mAbs Receives Breakthrough Therapy Designation for Naxitamab for the Treatment of High Risk Neuroblastoma,,," 3/15/2016 00FYYJ-E GNW  Guardant HealthÂ® and COTA Partner to Explore the Costs, Benefits, and Barriers of Genotyping Patients with Advanced Lung Cancer with a Non-invasive Liquid Biopsy",,,, 3/18/2019 ORTX-US  GNW  Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer,,,,,,,,,,,,
, 6/03/2019 PGNX-US  GNW  Progenics Announces Updated Survival Data for  AZEDRAÂ® (iobenguane I 131) in Advanced Pheochromocytoma and Paraganglioma,,,,, 8/09/2018 BDSI-US  GNW  BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results,,,"11/04/2013 82691710     GNW  SIGA to Host Third Quarter Business Update Call on November 6, 2013",11/08/2018 68375N10 GNW  SHAREHOLDER ALERT: OPK TRCO USAT APOG MGTI HAS HTHT OZK DY FIT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,10/05/2018 46222210 GNW  Akcea and Ionis Receive FDA Approval of TEGSEDIâ„¢ (inotersen) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults," 1/28/2016 BMRN-US     GNW  BioMarin to Host Fourth Quarter and Full Year 2015 Financial Results Conference Call and Webcast on Thursday, February 25 at 4:30pm ET",,,," 2/22/2019 45290710 GNW  CLASS ACTION UPDATE for IMMU, GSM, TYME and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/21/2019 4523-JP   GNW  Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimerâ€™s Disease,, 7/23/2019 BCRX-US  GNW  BioCryst to Report Second Quarter 2019 Financial Results on August 6,,," 9/01/2015 N5946510 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mylan, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline -- MYL",," 3/07/2019 00972810 GNW  AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Akorn, Inc.", 5/01/2013 GWP-GB   GNW  NASDAQ Welcomes GW Pharmaceuticals to The NASDAQ Stock Market,11/07/2019 MYGN-US  GNW  Myriad Genetics to Present at the 2019 Stephens Nashville Investment Conference, 2/28/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Poster Presentations at the 16th Annual ENETS Conference,, 9/06/2017 INSM-US  GNW  Insmed Announces Pricing of Public Offering of Common Stock,, 8/14/2018 INO-US    GNW  Inovio Announces First Patient Dosed in Trial to Determine PENNVAXÂ®-GPâ€™s Ability to Induce Remission of HIV Infection,"12/10/2018 64026810 GNW  UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 7/18/2019 GERN-US  GNW  Geron Enhances Oncology Expertise to Advance Corporate Objectives,," 6/07/2019 AMRN-US  GNW  CORRECTING and REPLACING -- Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting", 9/17/2012 09X295-E GNW  Station X Closes Second Round of Equity Financing to Accelerate Commercial Launch,, 8/08/2019 SRPT-US  GNW  Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)," 1/22/2019 G0176710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NVDA, AGN, DXC and ALKS",, 3/08/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces Topline Results From the PROLONG TrialÂ Evaluating MakenaÂ® (hydroxyprogesterone caproate injection),,,,, 7/26/2019 SAN-FR   GNW  Sanofi : Â Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon,,,"10/26/2018 04351P10 GNW  Market Trends Toward New Normal in Ascendis Pharma A/S, Diodes, Laureate Education, Randgold Resources, Fastenal, and LTC Properties â€” Emerging Consolidated Expectations, Analyst Ratings",," 7/25/2018 00422510 GNW  CLASS ACTION UPDATE for FIZZ, ACAD and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders","10/31/2018 AFMD-US  GNW  Affimed Announces Third Quarter 2018 Financial Results and Corporate Update Conference Call on November 7, 2018",,12/04/2018 PRQR-US  GNW  ProQR Announces Clearance of IND to Start Clinical Trial of QR-421a in Usher Syndrome Type 2 Patients,," 5/22/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orion, Zogenix, BrightView, and Eventbrite and Encourages Investors to Contact the Firm", 7/24/2018 ALLK-US  GNW  Allakos Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,11/12/2014 76133010 GNW  Revance Therapeutics Releases Third Quarter 2014 Results,,," 4/01/2019 ADVM-US  GNW  Adverum Biotechnologies Appoints OphthalmologyÂ Industry Veteran Aaron Osborne, MBBS MRCOphth, as Chief Medical Officer", 2/26/2019 RARE-US   GNW  Ultragenyx Announces Pricing of Public Offering of Common Stock, 4/12/2018 AGLE-US  GNW  Aeglea BioTherapeutics Presents New Phase 1/2 Trial Data Demonstrating Clinically Relevant Treatment Effects in Arginase 1 Deficiency Patients at the 2018 ACMG Annual Clinical Genetics Meeting,"10/08/2018 NSTG-US  GNW  NanoString to Release Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 8, 2018",,, 9/04/2018 RDUS-US  GNW  Radius Health Appoints Dr. Charles Morris as Chief Medical Officer, 7/10/2018 ASMB-US  GNW  Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock,,,"10/01/2018 02043Q10 GNW  KESSLER TOPAZ MELTZER & CHECK, LLP â€“ Announces Investor Securities Fraud Class Action Lawsuit Against ALNYLAM PHARMACEUTICALS, INC. â€“ ALNY", 3/12/2018 WVE-US   GNW  Wave Life Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update, 2/25/2019 AKCA-US  GNW  AKCEA-APO(a)-LRx Advances as Leading Pharmaceutical CompanyÂ Exercises Option to License,,"11/08/2018 69512710 GNW  Report: Developing Opportunities within Rayonier Advanced Materials, Health Insurance Innovations, Columbus McKinnon, A. O. Smith, Pacira Pharmaceuticals, and Altice â€” Future Expectations, Projections Moving into 2018",10/03/2018 RTRX-US  GNW  Retrophin to Highlight Fosmetpantotenate Program for PKAN at Upcoming Medical Congresses," 2/26/2018 69404D10 GNW  Analysis: Positioning to Benefit within ADTRAN, NN, Sparton, Allete, The Ultimate Software Group, and Pacific Biosciences of California â€” Research Highlights Growth, Revenue, and Consolidated Results", 9/10/2018 07RL6W-E GNW  Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Affirms Favorable U.S. Patent and Trademark Office Decision in CRISPR Interference, 5/14/2018 CHMA-US  GNW  Chiasma Announces FDA Agreement to Redefine Certain Secondary Endpoints in CHIASMA OPTIMAL Phase 3 Clinical Trial,"10/02/2019 55609910 GNW  CLASS ACTION UPDATE for GNLN, PS, GVA and MGNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,," 3/21/2014 28249U10 GNW  Celladon to Report Fourth Quarter and Year-End 2013 Results on Monday, March 31, 2014",10/01/2018 MNTA-US  GNW  Momenta Pharmaceuticals Completes Strategic Review to Refocus its Operations and Drive Shareholder Value, 6/21/2018 G7280010 GNW  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PPG and PRTA,12/28/2018 ZLAB-US  GNW  Zai Lab Announces Launch of OptuneÂ® in Hong Kong for Patients with Glioblastoma Multiforme, 1/28/2015 78667J10 GNW  SAGE Therapeutics Announces Participation in February Conferences,12/20/2018 CTMX-US  GNW  CytomX Therapeutics Announces Changes to its Board of Directors, 3/22/2019 06Y1QQ-E GNW  Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma," 3/01/2019 92165910 GNW  Factors of Influence in 2019, Key Indicators and Opportunity within Vanda Pharmaceuticals, Range Resources, Fortune Brands Home & Security, Dr. Reddy's Laboratories, BWX Technologies, and K12 â€” New Research Emphasizes Economic Growth",,10/03/2018 CBAY-US  GNW  CymaBay Therapeutics Announces Additional Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC will be Presented During the Late-Breaking Session at The Liver MeetingÂ®," 5/26/2011 45781M10 GNW  Inova Completes Network Solutions Projects Worth $928,000 in April", 4/03/2018 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,,11/27/2018 MNKD-US   GNW  MannKind Appoints Christine Mundkur to its Board of Directors, 4/03/2017 0CV67B-E GNW  UroGen Pharma Announces Enrollment of First Patient in Phase 3 Clinical Trial of MitoGelâ„¢ for Treatment of Low-Grade Upper Tract Urothelial Carcinoma, 6/24/2019 CYTK-US  GNW  Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference, 3/04/2019 ESPR-US     GNW  Esperion to Participate in Upcoming Investor Conferences," 4/24/2019 03236M20  GNW  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 5/04/2018 ACHN-US  GNW  Achillion to Present at the Deutsche Bank 43rd Annual Health Care Conference," 4/04/2019 87166B10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, Syneos, Weight Watchers, and Mattel and Encourages Investors to Contact the Firm", 1/03/2019 FOLD-US  GNW  Amicus Therapeutics Announces Phase 1/2 Study of Gene Therapy for CLN3 Batten Disease,,,10/11/2018 ADMA-US  GNW  ADMA Biologics Provides Regulatory Update for BIVIGAMÂ®,"11/06/2018 GWPH-US  GNW  GW Pharmaceuticals to Report Fourth Quarter and Year-End Financial ResultsÂ and Host Conference Call on 27 November, 2018"," 3/09/2017 EPZM-US  GNW  Epizyme President of Research and Chief Scientific Officer, Robert Copeland, Announces Retirement from the Company",,11/12/2018 MYOK-US  GNW  MyoKardia Presents Preclinical Evidence of Mavacamtenâ€™s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions,, 4/25/2019 GLPG-NL  GNW  Galapagos reports on historic first quarter 2019, 3/06/2019 PTLA-US  GNW  Portola Pharmaceuticals to Webcast Presentation at Cowen and Companyâ€™sÂ 39th Annual Health Care Conference,,,, 8/07/2018 CARA-US  GNW  Cara Therapeutics Reports Second Quarter 2018 Financial Results, 5/02/2019 FLXN-US  GNW  Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI)  World Congress, 1/30/2019 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences, 2/25/2019 AGIO-US   GNW  Agios Reports Updated Data from Phase 1 Study of Ivosidenib in Combination with Azacitidine Demonstrating Deep and Durable Responses in Newly Diagnosed IDH1 Mutant Acute Myeloid Leukemia (AML) Patients,11/06/2018 IOVA-US  GNW  Iovance Biotherapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update, 3/05/2018 ANAB-US  GNW  AnaptysBio Announces Fourth Quarter and Full Year 2017 Financial Results and 2018 Pipeline Milestones,,11/01/2018 FATE-US  GNW  Fate Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Operational Progress,10/23/2017 HZNP-US  GNW  Horizon Pharma plc to Present KRYSTEXXAÂ® (pegloticase injection) Data for the Management of Uncontrolled Gout at the 2017 ACR/ARHP Annual Meeting,, 8/02/2018 ICPT-US  GNW  Intercept Pharmaceuticals Reports Second Quarter 2018 Financial Results  and Provides Business Update," 9/12/2019 48576U10   GNW  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Karyopharm Therapeutics Inc. Investors of Important September 23rd Deadline in Securities Class Action â€“ KPTI",,,12/11/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia,,,, 3/26/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Needhamâ€™s 17th Annual Healthcare Conference,"11/19/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement in Progressive Multiple Sclerosis Patients Treated with ATA190, an Autologous Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy",, 5/02/2018 DERM-US  GNW  Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S., 2/14/2019 FOMX-US  GNW  Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1, 3/14/2018 PRAH-US  GNW  PRA Health Sciences Receives CRO Leadership Award, 5/30/2018 SUPN-US  GNW  Supernus to Present at the 2018 Jefferies Healthcare Conference,11/08/2018 FGEN-US  GNW  FibroGen Reports Third Quarter 2018 Financial Results,, 2/28/2019 CHRS-US  GNW  Coherus BioSciences Reports Fourth Quarter and Full Year 2018 Financial Results," 4/07/2019 21833P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Corbus Pharmaceuticals Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ CRBP",," 4/23/2018 19459J10 GNW  Investor Expectations to Drive Momentum within WESCO International, Microchip Technology, Collegium Pharmaceutical, Actuant, Toro, and Expeditors International of Washington â€” Discovering Underlying Factors of Influence", 9/12/2018 XBIT-US  GNW  XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board,,, 3/06/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 2/28/2017 RGNX-US  GNW  REGENXBIO Honors Rare Disease DayÂ® 2017,"12/02/2018 KURA-US  GNW  Kura Oncology Announces Proof of Concept in Angioimmunoblastic T-Cell Lymphoma, Validation of CXCL12 as a Therapeutic Target of Tipifarnib in Peripheral T-Cell Lymphoma", 3/07/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 3/06/2019 AXSM-US  GNW  Axsome Therapeutics Secures $24 Million Growth Capital Loan Facility Led by Silicon Valley Bank, 7/31/2018 VYGR-US  GNW  Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights Conference Call, 8/21/2019 BGNE-US  GNW  BeiGene Announces U.S. FDA Acceptance and Grant of Priority Review for its New Drug Application of Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma,," 6/04/2018 RETA-US  GNW  Reata Announces That Kyowa Hakko Kirin Initiated Ayame, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Diabetic Kidney Disease",11/29/2018 HCM-GB   GNW  Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors, 4/23/2018 NTLA-US  GNW  Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting," 8/22/2018 H0026310 GNW  Recent Analysis Shows STMicroelectronics N.V, Jagged Peak Energy, Inovalon, AC Immune SA, Repligen, and RealNetworks Market Influences â€” Renewed Outlook, Key Drivers of Growth", 5/08/2018 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results,11/09/2018 GTHX-US  GNW  G1 Therapeutics to Present Preliminary Data from Randomized Phase 2 Trial of Trilaciclib in Metastatic Triple-Negative Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS), 8/08/2017 ARGX-BE  GNW  argenx to Present at Wedbush PacGrow Healthcare Conference," 7/25/2018 RUBY-US GNW  Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics", 3/13/2019 0H69ST-E GNW  SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch," 5/01/2018 PETQ-US  GNW  PetIQ, Inc. to Report First Quarter 2018 Results on Tuesday, May 15th"," 8/20/2018 76243J10 GNW  New Research: Key Drivers of Growth for Harmonic, Astec Industries, Marlin Business Services, Arsanis, SunOpta, and Rhythm Pharmaceuticals â€” Factors of Influence, Major Initiatives and Sustained Production", 4/23/2018 OPTN-US  GNW  Optinose CEO Peter Miller and President/COO Ramy Mahmoud NamedÂ EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia Area," 6/12/2018 TORC-US  GNW  resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development",,, 4/18/2018 SLDB-US  GNW  Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy,10/22/2018 EOLS-US  GNW  Evolus Expands Leadership Team with Appointments of Key Executives,," 1/28/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints David Guyer, M.D., to Board of Directors",, 3/23/2018 SNNA-US  GNW  eFFECTOR Announces Appointment of John W. Smither to its Board of Directors,,,,,,,,11/13/2018 FTSV-US GNW  Forty Seven Inc. Reports Third Quarter 2018 Financial Results and Recent Business Highlights,,,,,,,,,,,," 3/14/2019 ORTX-US  GNW  Orchard Therapeutics to Webcast Conference Call of 2018 Financial Results on March 21, 2019",,,,,,,,,,,,
, 6/03/2019 PGNX-US  GNW  Progenics Pharmaceuticals Mails Letter to Shareholders,,,,," 7/30/2018 BDSI-US  GNW  BioDelivery Sciences Appoints Thomas Smith, MD as Chief Medical OfficerÂ Further Expanding Companyâ€™s Expertise in Field of Pain Management",,, 8/05/2013 82691710     GNW  SIGA Technologies Reports Financial Results for the Second Quarter 2013,"11/08/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK, ALNY and CHGG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 9/24/2018 IONS-US  GNW  Akcea and Ionis Report Positive Data from  Phase 2 Study of AKCEA-APO(a)-LRx, 1/14/2016 BMRN-US     GNW  FDA Issues Complete Response Letter for KyndrisaTM for  Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,," 2/22/2019 45290710 GNW  CLASS ACTION UPDATE for YRCW, IMMU, MKL and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 3/12/2019 BIIB-US   GNW  Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in HillerÃ¸d, Denmark to Fujifilm",, 7/03/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,," 3/05/2019 00972810 GNW  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 5/01/2013 SLS-US   GNW  William L. Ashton Joins Galena Biopharma's Board of Directors,"11/06/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sundial, electroCore, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm"," 2/28/2019 52887230 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â LXRX",, 9/05/2017 INSM-US  GNW  Insmed Announces Proposed Public Offering of Common Stock,, 8/07/2018 INO-US    GNW  Inovio Pharmaceuticals Reports 2018 Second Quarter Financial Results,"12/10/2018 64026810 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Nektar Therapeutics To Contact The Firm",," 6/20/2019 GERN-US  GNW  Geron Appoints Vice President, Human Resources",, 6/04/2019 AMRN-US  GNW  Amarin to Present at the Goldman Sachs 40th Annual Global Healthcare Conference,,, 8/07/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Second Quarter 2019 Financial Results and Recent Corporate Developments, 1/18/2019 G0176710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc â€“ ALKS,, 3/07/2019 AMAG-US  GNW  AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting,,,,," 7/23/2019 80105N10 GNW  Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose",,," 9/27/2018 04351P10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Ascendis Pharma A/S, Fluor, InterDigital, Ruth's Hospitality Group, Aramark, and ManTech International â€” New Research Emphasizes Economic Growth",," 7/24/2018 00422510 GNW  CLASS ACTION UPDATE for ATEN, REVG and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",10/08/2018 AFMD-US  GNW  Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold,,11/20/2018 PRQR-US  GNW  ProQR to Present at the Evercore ISI HealthConX Conference,," 5/21/2019 98978L20 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm", 7/19/2018 ALLK-US  GNW  Allakos Announces Pricing of Initial Public Offering,,"11/04/2014 76133010 GNW  Revance Therapeutics, Inc. Announces Participation in Credit Suisse 2014 Healthcare Conference",,, 3/18/2019 ADVM-US  GNW  Adverum Biotechnologies to Participate in Upcoming Conferences, 2/25/2019 RARE-US   GNW  Ultragenyx Announces Proposed Public Offering of Common Stock, 4/05/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present Pegzilarginase Phase 1 Dose Escalation Data in Patients with Advanced Solid Tumors at 2018 AACR Annual Meeting,10/04/2018 NSTG-US  GNW  NanoString Announces the University of Oxford Selected as the Winning Recipient in GeoMx Digital Spatial Profiler Grant Program,,, 9/04/2018 75046920 GNW  BioXcel Therapeutics Appoints Dr. David C. Hanley as Vice President and Head of Global Pharmaceutical Development and Operations, 7/09/2018 ASMB-US  GNW  Assembly Biosciences Initiates Two Phase 2a Trials of ABI-H0731 for the Treatment of Hepatitis B Virus Infection,,, 9/30/2018 02043Q10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PVG USAT MCHP COCP ABBV and ALNY, 2/20/2018 WVE-US   GNW  Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders, 2/20/2019 AKCA-US  GNW  Akcea Therapeutics to Present at Upcoming Investor Conferences,,11/08/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at Healthcare Conferences in November, 9/27/2018 RTRX-US  GNW  Retrophin Announces Upcoming Presentations at the 15th International Symposium on IgA Nephropathy," 2/13/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock", 8/27/2018 EDIT-US  GNW  Editas Medicine Announces Transition of Chief Medical Officer, 5/10/2018 CHMA-US  GNW  Chiasma Reports First Quarter 2018 Results,"10/01/2019 55609910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX",,, 3/20/2014 28249U10 GNW  Celladon to Present at BioCentury's Future Leaders in the Biotech Industry Conference, 8/09/2018 MNTA-US  GNW  Momenta Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update, 6/19/2018 PRTA-US  GNW  Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology,12/19/2018 ZLAB-US  GNW  Zai Lab to Present at the 37th Annual J.P. Morgan Healthcare Conference, 1/12/2015 78667J10 GNW  SAGE Therapeutics Initiates Phase 2a Trial of SAGE-547 in Postpartum Depression,11/09/2018 CTMX-US  GNW  CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual Meeting, 2/25/2019 GMAB-DK  GNW  Genmab Announces Positive Topline Results in Phase III COLUMBA Study of Subcutaneous Daratumumab, 2/26/2019 92165910 GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA),, 9/24/2018 CBAY-US  GNW  CymaBay Therapeutics to Participate in Upcoming Investor Conferences in October," 4/19/2011 45781M10 GNW  Inova Technology Awarded $570,000 Project"," 3/22/2018 CCXI-US  GNW  ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)",,,11/01/2018 MNKD-US   GNW  MannKind Corporation Reports 2018 Third Quarter Financial Results,"12/12/2016 06CR5C-E GNW  UroGen Pharma Announces FDA Acceptance of Investigational New Drug Application for MitoGel, a Novel Sustained Release Formulation of Mitomycin C, for the Treatment of Low-Grade Upper Tract Urothelial Carcinoma", 6/12/2019 CYTK-US  GNW  Cytokinetics to Present at the JMP Securities Life Sciences Conference, 3/04/2019 ESPR-US     GNW  Esperion Announces Presentation of Bempedoic Acid Pivotal Phase 3 Study 2 Results in a Late-Breaking Clinical Trial Session at the American College of Cardiology 2019 Scientific Sessions," 4/19/2019 03236M20  GNW  AMRS CLASS ACTION NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. â€“ AMRS",, 5/02/2018 ACHN-US  GNW  Achillion Reports First Quarter 2018 Financial Results and Management Transition, 4/03/2019 87166B10 GNW  SHAREHOLDER ALERT: STMP VNDA SYNH UMC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,12/20/2018 FOLD-US  GNW  Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease,,,10/03/2018 ADMA-US  GNW  ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center,11/01/2018 GWPH-US  GNW  EPIDIOLEXÂ® (cannabidiol) Oral Solution â€“ the First FDA-approved Plant-derived Cannabinoid Medicine â€“ Now Available by Prescription in the U.S., 2/27/2017 EPZM-US  GNW  Epizyme Announces 2016 Fourth Quarter and Full-Year Results Conference Call Date and March Investor Conferences,,11/07/2018 MYOK-US  GNW  MyoKardia Reports Third Quarter 2018 Financial Results,, 4/23/2019 GLPG-NL  GNW  Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients, 3/01/2019 PTLA-US  GNW  Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,,,, 8/07/2018 CARA-US  GNW  Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of KORSUVAâ„¢ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus," 5/01/2019 FLXN-US  GNW  Flexion Therapeutics to Report First-Quarter 2019 Financial Results on May 8, 2019", 1/22/2019 QURE-US  GNW  uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntingtonâ€™s Disease," 2/21/2019 AGIO-US   GNW  Agios to Present at the Leerink Global Healthcare Conference on Thursday, February 28, 2019",11/06/2018 IOVA-US  GNW  Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancerâ€™s 33rd Annual Meeting, 2/17/2018 ANAB-US  GNW  AnaptysBio Presents Updated Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting,,11/01/2018 FATE-US  GNW  Fate Therapeutics Announces Seven Presentations at the 2018 ASH Annual Meeting,10/17/2017 HZNP-US  GNW  Horizon Pharma plc Named One of the Best Small & Medium Workplaces by FORTUNE and Great Place to WorkÂ® for the Second Year in a Row,," 7/26/2018 ICPT-US  GNW  Intercept to Announce Second Quarter 2018 Financial Results on August 2, 2018 and Present at Upcoming Investor Conference", 9/12/2019 48576U10   GNW  SHAREHOLDER ALERT: OMCL KPTI NTAP TXT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,,11/07/2018 ITCI-US  GNW  Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results,,,," 3/21/2018 00619R-E GNW  Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.",11/06/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Third Quarter 2018 Financial Results and Recent Operational Progress,, 5/01/2018 DERM-US  GNW  Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference, 1/23/2019 FOMX-US  GNW  Foamix Announces Appointment of Sharon Barbari to Board of Directors, 3/06/2018 PRAH-US  GNW  PRA Health Sciences Named Best CRO in Asia, 5/08/2018 SUPN-US  GNW  Supernus Announces First Quarter 2018 Financial Results and  Record Quarterly Revenue,"11/02/2018 FGEN-US  GNW  FibroGen to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018",, 2/26/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March," 4/04/2019 21833P10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inogen, Spectrum Brands, Bridgepoint, and Corbus and Encourages Investors to Contact the Firm",, 4/20/2018 COLL-US  GNW  Collegium to Host Conference Call to Discuss First Quarter 2018 Financial Results and Provide Corporate Update, 8/27/2018 XBIT-US  GNW  XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks,,," 3/04/2019 37890U10 GNW  Detailed Research: Economic Perspectives on Intelsat S.A, Sprint, Restaurant Brands International, Tower Semiconductor, TE Connectivity, and Global Blood Therapeutics â€” What Drives Growth in Today's Competitive Landscape", 2/14/2017 RGNX-US  GNW  REGENXBIO Announces IND Active for Phase I Trial of RGX-314 to Treat Wet Age-Related Macular Degeneration,11/28/2018 KURA-US  GNW  Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma, 3/06/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock," 3/05/2019 AXSM-US  GNW  Axsome Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019", 7/17/2018 VYGR-US  GNW  Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinsonâ€™s Disease and Provides Clinical Update, 8/08/2019 BGNE-US  GNW  BeiGene Reports Second Quarter 2019 Financial Results,, 6/01/2018 RETA-US  GNW  Reata Selected to Present Early-Stage Programs at the BIO International Convention,11/26/2018 HCM-GB   GNW  Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (ElunateÂ®), 3/14/2018 NTLA-US  GNW  Intellia Therapeutics Announces  Fourth Quarter and Full Year 2017 Financial Results, 8/20/2018 ACIU-US  GNW  AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and  Down Syndrome, 5/03/2018 CRSP-US  GNW  CRISPR Therapeutics to Participate in May Investor Conferences,11/07/2018 GTHX-US  GNW  G1 Therapeutics Reports Third Quarter 2018 Financial Results and Corporate Update, 7/07/2017 ARGX-BE  GNW  argenx presents full data from ARGX-111 Phase Ib study in patients with advanced cancers over-expressing the MET protein  at Best of ASCO Asia 2017 (Singapore), 7/23/2018 RUBY-US GNW  Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares," 3/11/2019 ATNX-US  GNW  Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update"," 4/02/2018 PETQ-US  GNW  PetIQ, Inc. Files Pro Forma Financial Results for the Acquisition of VIP Petcare", 8/08/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results, 3/15/2018 OPTN-US  GNW  Optinose Named Emerging Company of the Year by Life Sciences Pennsylvania, 6/01/2018 TORC-US  GNW  resTORbio to Present at the Jefferies 2018 Global Healthcare Conference,,, 4/16/2018 83422E10 GNW  Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Solid Biosciences Inc. â€“ Â SLDB,"10/22/2018 30052C10 GNW  Detailed Research: Economic Perspectives on Caseys General Stores, Evolus, OptiNose, Xunlei, Molina Healthcare, and Frontline â€” What Drives Growth in Today's Competitive Landscape",, 1/03/2019 EYPT-US    GNW  EyePoint Pharmaceuticals Provides 2019 Commercial Update,,,,,,,,,,11/07/2018 FTSV-US GNW  Forty Seven Inc. to Present at the Credit Suisse 27th Annual Healthcare Conference,,,,,,,,,,,, 3/11/2019 ORTX-US  GNW  Orchard Therapeutics Announces Acceptance of OTL-200 Abstract for MLD at the 45th Annual Meeting of the European Society for Blood and Bone Marrow Transplantation (EBMT),,,,,,,,,,,,
, 5/30/2019 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference,,,,," 7/24/2018 BDSI-US  GNW  BioDelivery Sciences to Report Second-Quarter 2018 Financial Results on August 9, 2018",,, 8/01/2013 82691710     GNW  SIGA Selects Lead Candidate for Dengue Antiviral Program,11/08/2018 OPK-US   GNW  BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services, 8/27/2018 46222210 GNW  Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA, 1/11/2016 BMRN-US     GNW  BioMarin Announces Interim Analysis of INSPIRE Clinical Trial in Pompe Disease at 34th Annual J.P. Morgan Annual Healthcare Conference,,,," 2/21/2019 45290710 GNW  CLASS ACTION UPDATE for YRCW, IMMU, W and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/04/2019 BIIB-US   GNW  Biogen Announces Agreement to Acquire Nightstar Therapeutics to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology,, 7/01/2019 BCRX-US  GNW  BioCryst Appoints Megan Sniecinski Chief Business Officer,,,,, 3/01/2019 AKRX-US  GNW  Akorn Comments on Favorable Court Order, 3/05/2013 CPRX-US  GNW  Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations,11/06/2019 MYGN-US  GNW  GeneSightÂ® Psychotropic Test Improved Clinical Outcomes for People with Depression Who Were Taking Medications with Gene-Drug Interactions," 2/21/2019 52887230 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â LXRX",, 9/05/2017 INSM-US  GNW  Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC),, 8/06/2018 INO-US    GNW  Inovio Partners with AIDS Malignancy Consortium to Advance Inovioâ€™s HPV Therapy for High-Grade Anal Dysplasia in HIV-positive Patients,12/09/2018 64026810 GNW  SHAREHOLDER ALERT: DY NKTR GSKY ATUS TX BA APHA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 6/17/2019 GERN-US  GNW  Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress,, 5/30/2019 AMRN-US  GNW  Pharmaceutical Industry Veteran Gwen Fisher Joins Amarin to Lead Corporate Communications,,, 7/31/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/15/2019 G0176710 GNW  ALKS ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Alkermes Public Limited Company; Reminds Investors with $100K in Losses of Important Deadline â€“ ALKS,, 3/05/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 7/23/2019 SAN-FR   GNW  Sanofi signs strategic deal for exclusive US over-the-counter rights to TamifluÂ® in Flu Care,,, 9/17/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Support for Childrenâ€™s Growth Awareness Week and Day 2018,," 7/23/2018 00422510 GNW  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD", 8/30/2018 AFMD-US  GNW  Affimed to Present at the 2018 Wells Fargo Securities Healthcare Conference,,11/07/2018 PRQR-US  GNW  ProQR Announces Financial Results for the Third Quarter of 2018,," 5/20/2019 98978L20 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zogenix, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â ZGNX", 3/05/2018 0CX82G-E GNW  Allakos Highlights Data Demonstrating Potential of AK002 to Rapidly Deplete Eosinophils at 2018 AAAAI/WAO Joint Congress,,"10/29/2014 76133010 GNW  Revance Therapeutics to Release Third Quarter 2014 Financial Results and Host Conference Call on Wednesday, November 12, 2014",,, 3/06/2019 ADVM-US  GNW  Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update, 2/21/2019 RARE-US   GNW  Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia, 4/03/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present New Phase 1/2 Trial Results in Arginase 1 Deficiency at the 2018 ACMG Annual Clinical Genetics Meeting," 9/25/2018 63009R10 GNW  Consolidated Research: 2018 Summary Expectations for PLDT, Fidus Investment, NanoString Technologies, Maximus, Prologis, and SailPoint Technologies â€” Fundamental Analysis, Key Performance Indications",,, 8/07/2018 RDUS-US  GNW  Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update," 6/13/2018 ASMB-US  GNW  Assembly Biosciences to Host Research and Development Day on Wednesday, June 20, 2018",,," 9/28/2018 02043Q10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Alnylam Pharmaceuticals, Inc. (ALNY)", 2/08/2018 WVE-US   GNW  Wave Life Sciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference, 2/13/2019 AKCA-US  GNW  Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast,,11/02/2018 PCRX-US  GNW  Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL, 9/17/2018 RTRX-US  GNW  Retrophin to Present at Upcoming Investor Conferences," 2/12/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock"," 8/27/2018 28106W10 GNW  Analysis: Positioning to Benefit within Editas Medicine, Alcoa, MaxLinear, Real Goods Solar, NII, and Preformed Line Products â€” Research Highlights Growth, Revenue, and Consolidated Results", 3/16/2018 CHMA-US  GNW  Chiasma Announces Poster Presentation at ENDO 2018 on Study Design of Phase 3 Double-Blind Trial Evaluating Oral Octreotide Capsules Versus Placebo in Patients with Acromegaly," 9/30/2019 55609910 GNW  MGNX CLASS ACTION REMINDER: Hagens Berman Reminds MacroGenics (MGNX) Investors of Securities Class Action, Encourages Investors Who Lost $50,000+ to Contact the Firm",,, 3/05/2014 28249U10 GNW  Celladon to Present at Barclays Global Healthcare Conference 2014," 8/06/2018 60877T10 GNW  Recent Analysis Shows Regis, Graco, Columbia Sportswear, Momenta Pharmaceuticals, Interface, and Bunge Market Influences â€” Renewed Outlook, Key Drivers of Growth"," 6/18/2018 G7280010 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Prothena Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 16, 2018 â€“ PRTA",12/12/2018 ZLAB-US  GNW  Zai Lab Announces Acceptance of NDA Submission of ZEJULA (Niraparib) in Mainland China by the NMPA, 1/09/2015 78667J10 GNW  SAGE Therapeutics Reports Updated Data From Ongoing Clinical Trial and Emergency Use Program of SAGE-547 in Patients With Super-Refractory Status Epilepticus,11/07/2018 CTMX-US  GNW  CytomX to Present at the Jefferies 2018 London Healthcare Conference, 2/20/2019 GMAB-DK  GNW  Genmab 2018 Annual Report," 2/26/2019 92165910 GNW  CLASS ACTION UPDATE for PRGO, W, AMRN and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 8/14/2018 CBAY-US  GNW  CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September, 4/14/2011 45781M10 GNW  Inova Completes $1.4 Million in Projects in Q1, 3/09/2018 CCXI-US  GNW  ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights,,,"10/25/2018 MNKD-US   GNW  MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018", 5/05/2016 0CV67B-E GNW  UroGen Pharma Announces Three Data Presentations Related to its Clinical Stage Uro-Oncology Candidates at the American Urology Associationâ€™s 2016 Annual Meeting, 5/30/2019 CYTK-US  GNW  Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS, 2/28/2019 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Fourth Quarter and Full Year 2018 Financial Results," 4/18/2019 03236M20  GNW  AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class actionÂ lawsuitÂ hasÂ beenÂ filedÂ inÂ theÂ United States District CourtÂ for Northern District of California against Amyris, Inc.",," 4/09/2018 00448Q20 GNW  Investor Expectations to Drive Momentum within Credicorp, Essent Group, Achillion Pharmaceuticals, Banco Santander, S.A, Check Point Software Technologies, and Fomento Economico Mexicano S.A.B. de C.V â€” Discovering Underlying Factors of Influence"," 4/02/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Syneos Health, Inc. â€“ SYNH",12/19/2018 FOLD-US  GNW  Amicus Therapeutics Announces Executive Team Updates,,,10/01/2018 ADMA-US  GNW  ADMA Biologics Resubmits Biologics License Application for RI-002,"10/19/2018 36197T10 GNW  Investor Expectations to Drive Momentum within Motorola Solutions, Shire plc, Bitauto, GRIDSUM HOLDING, GW Pharmaceuticals, and Actinium Pharmaceuticals â€” Discovering Underlying Factors of Influence", 2/07/2017 EXAS-US  GNW  Epizyme Elects Kevin Conroy to its Board of Directors,,11/07/2018 MYOK-US  GNW  MyoKardia to Present at the Credit Suisse 27th Annual Healthcare Conference,, 4/10/2019 GLPG-NL  GNW  Galapagos creates new warrant plans, 3/01/2019 07B431-E GNW  Portola Pharmaceuticals Enters into $125 Million Loan Agreement with  HealthCare Royalty Partners and Athyrium Capital Management,,,, 8/06/2018 CARA-US  GNW  Cara Therapeutics Appoints Christopher A. Posner to Board of Directors, 4/24/2019 FLXN-US  GNW  Flexion Therapeutics Announces Publication of Analysis of Patients with Unilateral Knee OA from Pivotal Trial of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension),12/03/2018 QURE-US  GNW  uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B, 2/20/2019 AGIO-US   GNW  Agios Announces FDA Acceptance of Supplemental New Drug Application for TIBSOVOÂ® (ivosidenib) for the Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation Not Eligible for Standard Therapy,"10/30/2018 IOVA-US  GNW  Iovance Biotherapeutics to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Tuesday, November 6, 2018", 2/07/2018 ANAB-US  GNW  AnaptysBio To Present Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting,,10/29/2018 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2018 Financial Results,"10/10/2017 HZNP-US  GNW  Horizon Pharma plc to Host Third-Quarter 2017 Conference Call andÂ Webcast on Nov. 6, 2017",," 7/25/2018 45845P10 GNW  Report: Developing Opportunities within Clearwater Paper, Intercept Pharmaceuticals, Community Trust, Community Bank System, Laboratory Corporation of America, and Dicerna Pharmaceuticals â€” Future Expectations, Projections Moving into 2018"," 9/11/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,11/01/2018 ITCI-US  GNW  Intra-Cellular Therapies to Host Third Quarter 2018 Financial Results Conference Call and Webcast,,,," 3/12/2018 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017","11/01/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Presentations Highlighting Robust Off-the-Shelf, Allogeneic T-Cell Immunotherapy Pipeline and  Next-Generation CAR T Technologies at the 60th American Society of Hematology (ASH) Annual Meeting and European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018",, 4/19/2018 DERM-US  GNW  Christopher Horan Joins Dermira as Chief Technical Operations Officer,12/21/2018 FOMX-US  GNW  Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne," 2/21/2018 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance", 4/24/2018 SUPN-US  GNW  Supernus to Host First Quarter 2018 Earnings Conference Call,10/30/2018 FGEN-US  GNW  ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis,, 2/22/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 4/02/2019 21833P10 GNW  CORBUS CLASS ACTION NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. â€“ CRBP",, 4/04/2018 COLL-US  GNW  Collegium to Present at the H.C. Wainwright Global Life Sciences Conference, 8/10/2018 XBIT-US  GNW  XBiotech Highlights Quarterly Developments,,, 3/04/2019 GBT-US   GNW  GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference, 2/09/2017 RGNX-US  GNW  REGENXBIO to Present at the 6th Annual LEERINK Partners Global Healthcare Conference,11/08/2018 KURA-US  GNW  Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors, 3/04/2019 APLS-US  GNW  Apellis Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference, 3/04/2019 AXSM-US  GNW  Axsome Therapeutics Initiates MOMENTUM Phase 3 Trial of AXS-07 in Migraine, 6/28/2018 VYGR-US  GNW  Voyager Therapeutics Appoints Andre Turenne as President and Chief Executive Officer, 7/07/2019 BGNE-US  GNW  Priority Review Granted to BeiGeneâ€™s Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma,, 5/31/2018 RETA-US  GNW  Reata Announces Orphan Drug Designation From the European Commission for Bardoxolone Methyl for the Treatment of Alport Syndrome,"11/16/2018 HCM-GB   GNW  Chi-Med Announces Phase III FALUCA Trial Results for Fruquintinib in Third-Line, Advanced Non-Small Cell Lung Cancer in China", 2/28/2018 NTLA-US  GNW  Intellia Therapeutics to Present  at March Healthcare Investor Conferences, 8/08/2018 ACIU-US  GNW  AC Immune Reports Second Quarter 2018 Financial Results and Corporate Update, 4/16/2018 CRSP-US  GNW  CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018,11/06/2018 GTHX-US  GNW  G1 Therapeutics to Present at Investor Conferences in November 2018, 6/20/2017 ARGX-BE  GNW  argenx receives second preclinical milestone payment in collaboration with LEO Pharma, 7/17/2018 RUBY-US GNW  Rubius Therapeutics Announces Pricing of Initial Public Offering, 3/08/2019 ATNX-US  GNW  Athenex to Present Preclinical Data of Oraxol in the Treatment of Angiosarcoma at the American Association for Cancer Research Annual Meeting 2019," 3/27/2018 PETQ-US  GNW  PetIQ, Inc. to Release Pro Forma Financial Results for the Acquisition of VIP Petcare on Monday, April 2nd", 7/23/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity, 3/13/2018 OPTN-US  GNW  Optinose Reports Fourth Quarter and Full Year 2017 Financial ResultsÂ and Recent Operational Highlights, 5/22/2018 TORC-US  GNW  resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition,,," 4/13/2018 83422E10 GNW  SOLID BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB","10/18/2018 EOLS-US  GNW  Evolus to Release Third Quarter 2018 Financial Results on  Monday, November 5, 2018",,12/17/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Added to NASDAQ Biotechnology Index,,,,,,,,,,11/01/2018 FTSV-US GNW  Forty Seven Inc. to Present New Preclinical Data on 5F9 at the 60th American Society of Hematology (ASH) Annual Meeting,,,,,,,,,,,," 3/04/2019 ORTX-US  GNW  Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019",,,,,,,,,,,,
, 5/23/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting,,,,," 6/15/2018 09060J10 GNW  Analysis: Positioning to Benefit within Uranium Energy, Bellicum Pharmaceuticals, Tutor Perini, Maiden, Hill-Rom, and BioDelivery Sciences International â€” Research Highlights Growth, Revenue, and Consolidated Results",,," 7/30/2013 82691710     GNW  SIGA to Host Second Quarter Business Update Call on August 5, 2013","11/08/2018 OPK-US   GNW  OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018"," 8/23/2018 46222210 GNW  Recent Analysis Shows Fitbit, Southwestern Energy, DAQO New Energy, ANGI Homeservices, Inc., Ionis Pharmaceuticals, and Cronos Group Market Influences â€” Renewed Outlook, Key Drivers of Growth", 1/05/2016 BMRN-US     GNW  BioMarin to Present at 34th Annual J.P. Morgan Healthcare Conference in San Francisco,,,," 2/21/2019 45290710 GNW  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Immunomedics, Inc.Â (IMMU)", 3/01/2019 BIIB-US   GNW  Biogen Responds to CADTHâ€™s updated recommendation regarding coverage for SPINRAZA,," 6/27/2019 BCRX-US  GNW  Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases",,,,," 3/01/2019 00972810 GNW  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. â€“ AKRX",11/07/2012 BBI-US   GNW  Vical Reports Third Quarter 2012 Financial Results and Progress in Key Development Programs,"11/04/2019 62855J10 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action, Encourages Investors Who Suffered Significant Losses to Contact the Firm"," 2/21/2019 52887230 GNW  Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 8/03/2017 INSM-US  GNW  Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update,," 8/01/2018 45773H20  GNW  Recent Analysis Shows Getty Realty, Keysight Technologies, Inovio Pharmaceuticals, Air Transport Services Group, Asure Software, and J.Jill Market Influences â€” Renewed Outlook, Key Drivers of Growth","12/07/2018 64026810 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ NKTR",," 6/10/2019 GERN-US  GNW  Geron to Webcast KOL Event on June 25, 2019",, 5/30/2019 AMRN-US  GNW  Amarin to Present at the Jefferies 2019 Healthcare Conference,,," 7/31/2019 SRPT-US  GNW  Sarepta Therapeutics to Announce Second Quarter 2019 Financial Results and RecentÂ Corporate Developments on August 7, 2019"," 1/15/2019 G0176710 GNW  CLASS ACTION UPDATE for DXC and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 2/19/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference,,,,, 7/10/2019 SAN-FR   GNW  Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma,,, 9/06/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Presentations on Technology and Rare Disease Endocrinology Pipeline at September Conferences,," 7/23/2018 00422510 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ACADIA Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 17, 2018 â€“ ACAD", 8/27/2018 AFMD-US  GNW  Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets,,10/31/2018 PRQR-US  GNW  ProQR Announces Presentations at the European Oligonucleotide and Peptide Therapeutics Conference,," 5/17/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orion, Zogenix, BrightView, and Eventbrite and Encourages Investors to Contact the Firm",12/13/2017 0CX82G-E GNW  Allakos Secures $100 Million In Series B Financing,,10/01/2014 76133010 GNW  Revance Therapeutics Provides Update on RT001 Clinical Program for the Lead Indication for Crow's Feet Lines,,, 2/28/2019 ADVM-US  GNW  Adverum to Present at the Cowen 39th Annual Health Care Conference," 2/21/2019 90400D10  GNW  Report: Exploring Fundamental Drivers Behind Canopy Growth, Adobe, Ultragenyx Pharmaceutical, Humana, Ship Finance International, and NexGen Energy â€” New Horizons, Emerging Trends, and Upcoming Developments", 4/02/2018 AGLE-US  GNW  Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDAÂ® (Pembrolizumab) Combination Trials, 9/10/2018 NSTG-US  GNW  NanoString to Present at the Morgan Stanley Global Healthcare Conference,,," 8/01/2018 75046920 GNW  New Research Coverage Highlights Ladder Capital, Gibraltar Industries, Norwegian Cruise Line, Wolverine World Wide, Catalyst Pharmaceuticals, and Radius Health â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 6/08/2018 ASMB-US  GNW  Assembly Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 9/28/2018 02043Q10 GNW  CLASS ACTION UPDATE for MCHP, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",12/11/2017 WVE-US   GNW  Preclinical Data Supporting Wave Life Sciences ALS and FTD Programs Presented at 28th International Symposium on ALS/MND,11/29/2018 IONS-US  GNW  Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting,,"11/01/2018 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results", 9/05/2018 RTRX-US  GNW  Retrophin Prices Upsized $240 Million Convertible Senior Notes Offering, 2/12/2018 PACB-US  GNW  SMRT Sequencing of Human Genomes to be Showcased at AGBT Conference, 8/16/2018 EDIT-US  GNW  Editas Medicine Announces the Completion of the Recombinant DNA Advisory Committee (RAC) Registration Process, 3/05/2018 CHMA-US  GNW  Chiasma to Present at the Cowen and Company 38th Annual  Health Care Conference, 9/30/2019 MGNX-US  GNW  MacroGenics Presents Margetuximab Data in Gastroesophageal Cancer at the ESMO 2019 Congress,,, 3/04/2014 28249U10 GNW  Celladon Completes Enrollment of CUPID 2 Trial for Advanced Heart Failure, 8/02/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2018 Financial Results Conference Call and Webcast," 6/15/2018 G7280010 GNW  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Prothena Corporation, Fluor Corporation, PG&E Corporation","11/29/2018 ZLAB-US  GNW  MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENTâ„¢ Molecule in Greater China", 1/05/2015 78667J10 GNW  SAGE Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference,11/06/2018 CTMX-US  GNW  CytomX Therapeutics Announces Third Quarter 2018 Financial Results, 1/31/2019 GMAB-DK  GNW  Genmab Announces that the Patent Infringement Lawsuit Relating to DARZALEXÂ® is Over," 2/25/2019 92165910 GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc. (VNDA) and Encourages VNDA Investors to Contact the Firm",, 8/09/2018 CBAY-US  GNW  CymaBay Reports Second Quarter 2018 Financial Results and Provides Corporate Update, 3/23/2011 45781M10 GNW  Inova Releases 10Q; Revenue Up by 32% for the 9 Months Ending January 2011 Compared to the Same Period Last Year, 3/06/2018 CCXI-US  GNW  ChemoCentryx to Present at the Cowen and Company 38th Annual Health Care Conference,,,"10/24/2018 56400P70  GNW  Research Report Identifies Cato, Roadrunner Transportation, Talend S.A, Vi, MannKind, and Acceleron Pharma with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 2/09/2016 0CV67B-E GNW  UroGen Pharma Strengthens Board of Directors and Senior Management Team, 5/09/2019 CYTK-US  GNW  Cytokinetics Reports First Quarter 2019 Financial Results, 2/28/2019 ESPR-US     GNW   Esperion Announces Submissions of Two NDAs and Official Completion of Two MAA Validations for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet, 4/18/2019 AMRS-US   GNW  Amyris Completes Sale of Vitamin E Royalty to DSM,, 3/08/2018 ACHN-US  GNW  Achillion to Present at the Barclays Global Healthcare Conference," 4/02/2019 87166B10 GNW  SYNEOS APRIL 30th DEADLINE: Rosen Law Firm Reminds Syneos Health, Inc. Investors of Important Deadline in the Securities Class Action Lawsuit â€“ SYNH",12/11/2018 FOLD-US  GNW  Amicus Therapeutics Awarded  United Kingdom Prix Galien Medal for GalafoldÂ® (Migalastat),,, 9/05/2018 ADMA-US  GNW  ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved,"10/05/2018 GWPH-US  GNW  GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs, Raising Gross Proceeds of $345 MillionÂ and Full Exercise of Underwriters' Option to Purchase Additional ADSs", 2/02/2017 EPZM-US  GNW  Epizyme to Present at Upcoming Investor Conferences,,11/05/2018 MYOK-US  GNW  MyoKardia to Present Clinical Evidence of Mavacamtenâ€™s Effect on Diastolic Function at 2018 American Heart Association Scientific Sessions,, 3/31/2019 GLPG-NL  GNW  Publication of the annual report and invitation to the annual shareholders' meeting, 3/01/2019 PTLA-US  GNW  European CHMP Adopts Positive Opinion on Ondexxyaâ„¢ (andexanet alfa) Portola Pharmaceuticalsâ€™ Factor Xa Inhibitor Reversal Agent,,,," 7/31/2018 CARA-US  GNW  Cara Therapeutics to Announce Second Quarter 2018 Financial Results on August 7, 2018", 4/05/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4),11/19/2018 QURE-US  GNW  uniQure Highlights Pipeline Expansion and Advancements in Technology at Research & Development Day, 2/14/2019 AGIO-US   GNW  Agios Reports Fourth Quarter and Full Year 2018 Financial Results,10/29/2018 IOVA-US  GNW  Iovance Biotherapeutics to Host Melanoma Program Update Event for Analysts and Investors During SITC 2018," 1/18/2018 03272410 GNW  Investor Expectations to Drive Momentum within Martin Marietta Materials, AnaptysBio, Hope, Agilysys, Albany International, and Goldman Sachs BDC â€” Discovering Underlying Factors of Influence",,"10/04/2018 FATE-US  GNW  Fate Therapeutics Appoints Wen Bo Wang, Ph.D. as Senior Vice President, Technical Operations",10/02/2017 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 6/07/2018 ICPT-US  GNW  Intercept to Present at Upcoming Conference," 9/10/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Omnicell, Ideanomics, Eagle Bancorp, and Karyopharm and Encourages Investors to Contact the Firm",,,"10/25/2018 46116X10 GNW  Investor Expectations to Drive Momentum within Tribune Media, Intra-Cellular Therapies, Icahn Enterprises, NVE, PetMed Express, and United Fire Group â€” Discovering Underlying Factors of Influence",,,," 3/05/2018 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018","10/16/2018 04651310   GNW  Report: Exploring Fundamental Drivers Behind Monroe Capital, Anavex Life Sciences, Haynes International, Atara Biotherapeutics, Lands' End, and Envestnet â€” New Horizons, Emerging Trends, and Upcoming Developments",, 4/11/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/27/2018 FOMX-US  GNW  Foamix Announces Appointment of Matt Wiley as Chief Commercial Officer, 2/12/2018 PRAH-US  GNW  PRA Health Sciences Partners with IMPACT2030, 3/06/2018 SUPN-US  GNW  Supernus to Present at the 2018 Cowen Health Care Conference,10/25/2018 FGEN-US  GNW  FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting,, 2/14/2019 CHRS-US  GNW  Coherus BioSciences to Report Fourth Quarter and Full Year 2018 Financial Results on February 28th," 4/02/2019 21833P10 GNW  Hagens Berman Reminds Corbus Pharmaceutical Holdings (CRBP) Investors of May 13, 2019 Lead Plaintiff Deadline",, 3/19/2018 COLL-US  GNW  Collegium Announces the Appointment of Shirley Kuhlmann as General Counsel, 7/10/2018 XBIT-US  GNW  XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa,,, 2/27/2019 GBT-US   GNW  GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results, 2/02/2017 RGNX-US  GNW  REGENXBIO to Participate in the SunTrust Robinson Humphrey 2017 Orphan Drug Day,11/06/2018 KURA-US  GNW  Kura Oncology to Participate in Two Upcoming Investor Conferences, 3/04/2019 APLS-US  GNW  Apellis Resumes Dosing in Its Phase 3 Program for Patients with Geographic Atrophy, 2/06/2019 AXSM-US  GNW  Axsome Therapeutics Receives FDA Agreement under Special Protocol Assessment (SPA) for the MOMENTUM Phase 3 Trial of AXS-07 in Migraine, 6/21/2018 VYGR-US  GNW  Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinsonâ€™s Disease, 6/28/2019 BGNE-US  GNW  BeiGene Granted Approval to Transition from the Biotech Chapter of the Hong Kong Stock Exchange to a General Listing,, 5/25/2018 RETA-US  GNW  Bardoxolone Methyl Improved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy in the Ongoing Phase 2 Phoenix Study,10/18/2018 HCM-GB   GNW  Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in  Elderly Patients with Acute Myeloid Leukemia in China, 2/27/2018 NTLA-US  GNW  Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Using Lipid Nanoparticle (LNP) Delivery Technology, 7/31/2018 ACIU-US  GNW  AC Immune Announces Successful Closing of Second Subscription Rights Offering, 4/13/2018 06P9WL-E GNW  CRISPR Therapeutics to Present Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018,"10/30/2018 GTHX-US  GNW  G1 Therapeutics to Provide Third Quarter 2018 Corporate and Financial Update on November 7, 2018", 6/14/2017 ARGX-BE  GNW  argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML),, 3/07/2019 ATNX-US  GNW  Athenex Regains Rights to KX2-391 in China," 3/19/2018 PETQ-US  GNW  PetIQ, Inc. Expands Its Board of Directors"," 6/25/2018 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwritersâ€™ Option to Purchase Additional Shares"," 3/06/2018 OPTN-US  GNW  Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018", 5/10/2018 TORC-US  GNW  resTORbio Reports First Quarter 2018 Financial Results,,," 4/13/2018 83422E10 GNW  The Klein Law Firm Announces a Class Action Commenced on Behalf of Solid Biosciences Inc. Shareholders and a Lead Plaintiff Deadline of May 29, 2018 (SLDB)", 9/20/2018 EOLS-US  GNW  Evolus to Present at the Cantor Global Healthcare Conference,,"11/27/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints Ron Honig, Esq., as SVP, General Counsel & Company Secretary",,,,,,,,,,10/31/2018 FTSV-US GNW  Forty Seven Inc. Announces Publication in The New England Journal of Medicine of 5F9 Phase 1b Clinical Data in Non-Hodgkinâ€™s Lymphoma (NHL),,,,,,,,,,,, 2/25/2019 ORTX-US  GNW  Orchard Therapeutics Presents Clinical Proof-of-Concept Data for OTL-102 for the Treatment of X-CGD,,,,,,,,,,,,
, 5/14/2019 PGNX-US  GNW  Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration for Prostate Cancer Imaging Agent 1404,,,,, 6/01/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the William Blair 2018 Growth Stock Conference,,, 7/16/2013 82691710     GNW  SIGA Meets Drug Delivery Condition Under BARDA Contract and Qualifies for First Payment for Delivering Arestvyr(TM),"11/08/2018 68375N10 GNW  Consolidated Research: 2018 Summary Expectations for AGCO, MDU Resources Group, Opko Health, Clean Harbors, LCI Industries, and Marathon Petroleum â€” Fundamental Analysis, Key Performance Indications", 8/06/2018 46222210 GNW  Akcea Reports Financial Results and Highlights for Second Quarter 2018," 1/04/2016 BMRN-US     GNW  BioMarin Announces Addition of David Pyott, Former Allergan Chairman and CEO, to Companyâ€™s Board of Directors",,,," 2/20/2019 45290710 GNW  CLASS ACTION UPDATE for ARLO, SOGO, IMMU and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 2/28/2019 BIIB-US   GNW  Biogen Further Expands Presence in China with Approval of SPINRAZAÂ® (nusinersen), the First and Only Treatment for Spinal Muscular Atrophy",, 6/04/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,, 2/28/2019 AKRX-US  GNW  Akorn Provides Fourth Quarter and Full Year 2018 Results,10/16/2012 001L8Q-E GNW  Vical Appoints George J. Morrow to Board of Directors,11/04/2019 MYGN-US  GNW  Myriad Genetics Reports Fiscal First-Quarter 2020 Financial Results," 2/14/2019 52887230 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ LXRX",," 7/27/2017 INSM-US  GNW  Insmed to Host Second Quarter 2017 Financial Results Conference Call on Thursday, August 3, 2017",," 7/24/2018 INO-US    GNW  Inovio Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 7, 2018","12/07/2018 64026810 GNW  CLASS ACTION UPDATE for IGCC, NKTR, FIT and SYF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 5/16/2019 GERN-US  GNW  Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress,, 5/29/2019 AMRN-US  GNW  U.S. FDA Grants Priority Review for VascepaÂ® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication,,, 6/28/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/14/2019 G0176710 GNW  SHAREHOLDER ALERT: DNKEY ATUS DXC ALKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 2/07/2019 AMAG-US  GNW  AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update,,,,, 7/02/2019 SAN-FR   GNW  Sanofi : Availability of the Pre-quarterly Results Communication,,, 8/31/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentations,," 7/20/2018 00422510 GNW  Hagens Berman Alerts Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) to the September 17, 2018 Securities Class Action Lead Plaintiff Deadline", 8/08/2018 AFMD-US  GNW  Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress,,10/29/2018 PRQR-US  GNW  ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals,," 5/13/2019 98978L20 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm", 8/15/2017 0CX82G-E GNW  Allakos Announces Additions to Senior Leadership Team,, 9/22/2014 76133010 GNW  Revance Therapeutics Announces the Appointment of Azita Nejad as Vice President of Quality,,, 2/13/2019 ADVM-US  GNW  Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference, 2/19/2019 RARE-US   GNW  Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update, 3/26/2018 AGLE-US  GNW  Aeglea BioTherapeutics Appoints Dr. Ivana MagovÄeviÄ‡-Liebisch to Board of Directors, 9/05/2018 NSTG-US  GNW  NanoString Launches Priority Site Program for New GeoMx Digital Spatial Profiler,,, 7/24/2018 RDUS-US  GNW  Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC, 6/04/2018 ASMB-US  GNW  Assembly Biosciences to Participate in Jefferies 2018 Global Healthcare Conference,,," 9/28/2018 02043Q10 GNW  Alnylam Class Action Lawsuit: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Alnylam Pharmaceuticals, Inc. â€“ ALNY", 3/03/2017 WVE-US   GNW  nLife Therapeutics Enters Research Collaboration with WAVE Life Sciences  to Explore Targeting of Nucleic Acids to Specific Cell-Types in the Central Nervous System,11/12/2018 00972L10 GNW  Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions,,"10/25/2018 PCRX-US  GNW  Pacira to Report Third Quarter 2018 Financial Results on Thursday November 1, 2018", 9/04/2018 RTRX-US  GNW  Retrophin Announces Proposed Convertible Senior Notes Offering, 2/08/2018 PACB-US  GNW  Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore, 8/06/2018 EDIT-US  GNW  Editas Medicine Announces Second Quarter 2018 Results and Update," 2/28/2018 CHMA-US  GNW  Chiasma Honors Patients, Researchers for Rare Disease Day 2018", 9/26/2019 MGNX-US  GNW  MacroGenics to Participate in Cantor Global Healthcare Conference,,, 3/03/2014 28249U10 GNW  Celladon Corporation Announces Appointments of Dr. Peter Honig and Dr. Patrick Yang to Its Board of Directors, 6/06/2018 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 39th Annual Global Healthcare Conference, 6/15/2018 G7280010 GNW  PRTA LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Prothena Corporation plc â€“ PRTA,11/14/2018 ZLAB-US  GNW  Zai Lab and Novocure Awarded Deal of the Year,12/17/2014 78667J10 GNW  SAGE Therapeutics Added to NASDAQ Biotechnology Index,11/06/2018 CTMX-US  GNW  CytomX Therapeutics Announces CX-072 Clinical Presentations at 2018 SITC Annual Meeting, 1/26/2019 GMAB-DK  GNW  Genmab Announces that the patents asserted against DARZALEXÂ® in the United States have been declared invalid by summary judgment.," 2/11/2019 92165910 GNW  Bragar Eagel & Squire, P.C. is Investigating Vanda Pharmaceuticals Inc. (VNDA) on Behalf of Stockholders and Encourages VNDA Investors to Contact the Firm",," 8/02/2018 CBAY-US  GNW  CymaBay to Report Second Quarter 2018 Financial Results on Thursday, August 9"," 2/28/2011 45781M10 GNW  Inova Files RFID Patents in Europe and Pays Down $600,000 of Debt"," 3/01/2018 CCXI-US  GNW  ChemoCentryx to Hold Fourth Quarter 2017 Financial Results Conference CallÂ on Friday, March 9, 2018",,,10/16/2018 56400P70  GNW  United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement,, 5/08/2019 CYTK-US  GNW  Cytokinetics to Hold Annual Meeting of Stockholders, 2/22/2019 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 4/17/2019 03236M20  GNW  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 2/28/2018 ACHN-US  GNW  Achillion Raises Awareness for C3 Glomerulopathy With Launch of WeC3Gâ„¢ Initiative as Part of Rare Disease Day 2018," 4/02/2019 87166B10 GNW  Hagens Berman Reminds Syneos Health (SYNH) Investors of April 30, 2019 Lead Plaintiff Deadline and Encourages Investors to Contact the Firm",11/12/2018 FOLD-US  GNW  Amicus Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference,,, 8/27/2018 ADMA-US  GNW  ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference,10/02/2018 GWPH-US  GNW  GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSsÂ Raising Gross Proceeds of $300 Million, 1/03/2017 EPZM-US  GNW  Epizyme Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference,,11/05/2018 MYOK-US  GNW  MyoKardia Announces Twelve Abstracts Accepted for Presentation During the 2018 American Heart Association Scientific Sessions,, 3/28/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  REPORT  UPDATED  SAFETY  INFORMATION  FOR  FILGOTINIB  IN  RHEUMATOID  ARTHRITIS  (RA), 2/07/2019 PTLA-US  GNW  Portola Pharmaceuticals Announces Full Results from the ANNEXA-4 Study of the Factor Xa Inhibitor Reversal Agent AndexxaÂ® in Patients with Life-Threatening Bleeding,,,, 7/23/2018 CARA-US  GNW  Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 4/03/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the 18th Annual Needham & Company Healthcare Conference,11/15/2018 QURE-US  GNW  uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B," 1/31/2019 AGIO-US   GNW  Agios to Webcast Conference Call of Fourth Quarter and Full Year 2018 Financial Results on February 14, 2019",10/18/2018 46226010 GNW  Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe, 1/02/2018 ANAB-US  GNW  AnaptysBio Announces Presentation at the J.P. Morgan 36th Annual Healthcare Conference,, 9/25/2018 FATE-US  GNW  Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 9/13/2017 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 5/08/2018 ICPT-US  GNW  Intercept Pharmaceuticals Announces First Quarter 2018 Financial Results, Issues 2018 Ocaliva Net Sales Guidance and Provides Business Update", 9/10/2019 48576U10   GNW  NATIONALLY RANKED ROSEN LAW FIRM Reminds Karyopharm Therapeutics Inc. Investors of Important September 23rd Deadline in Securities Class Action; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT THE FIRM â€“ KPTI,,,10/23/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Favorable Safety Profile for ITI-214 in a Phase 1/2 Clinical Trial in Patients with Parkinsonâ€™s Disease,,,,"12/19/2017 AMPH-US  GNW  Amphastar Announces Approval for Sodium Nitroprusside Injection, USP", 9/24/2018 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),, 3/20/2018 DERM-US  GNW  Dermira to Present at 17th Annual Needham Healthcare Conference,11/19/2018 FOMX-US  GNW  Foamix Announces Appointment of Anthony Bruno to Board of Directors, 1/24/2018 PRAH-US  GNW  PRA Health Sciences to Report Fourth Quarter 2017 Earnings," 2/27/2018 SUPN-US  GNW  Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance",10/16/2018 FGEN-US  GNW  FibroGen Announces Four Clinical Presentations on Roxadustat at Upcoming American Society of Nephrology Kidney Week 2018 Annual Meeting,, 2/07/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 4/01/2019 21833P10 GNW  SHAREHOLDER ALERT: CORT DPLO CRBP ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 3/16/2018 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences, 5/22/2018 XBIT-US  GNW  XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis,,, 2/21/2019 GBT-US   GNW  GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference, 1/06/2017 RGNX-US  GNW  REGENXBIO Provides Year-End 2016 Corporate Update,11/05/2018 KURA-US  GNW  Kura Oncology Reports Third Quarter 2018 Financial Results and Provides Corporate Update, 2/28/2019 00C8F3-E GNW  Apellis Pharmaceuticals Announces Collaboration with SFJ PharmaceuticalsÂ® for APL-2 in Hematologic Indications, 1/30/2019 AXSM-US  GNW  Axsome Therapeutics Initiates Phase 2 Trial of AXS-12 in Narcolepsy, 5/29/2018 VYGR-US  GNW  Voyager Therapeutics Announces Management Change, 6/20/2019 BGNE-US  GNW  BeiGene Announces Phase 1b Clinical Results of Zanubrutinib in Combination with GAZYVAÂ® (Obinutuzumab) in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Follicular Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML),," 5/08/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces First Quarter 2018 Financial Results and an Update on Development Programs", 9/05/2018 HCM-GB   GNW  Chi-Med Announces the Approval of Fruquintinib Capsules for Previously Treated Colorectal Cancer in China, 1/31/2018 NTLA-US  GNW  Intellia Therapeutics to PresentÂ at February Healthcare Investor Conferences, 7/25/2018 ROG-CH   GNW  New Phase 2 Data Analysis for Crenezumab Presented at Global Alzheimer's Conference Provides Strong Evidence for Engagement of the Principle Abeta Target, 4/04/2018 CRSP-US  GNW  CRISPR Therapeutics Announces the Appointment of Steve CaffÃ© as Head of Regulatory Affairs,"10/26/2018 3621LQ10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Delta Air Lines, Macy's, Sina, G1 THERAPEUTICS, Johnson Controls International plc, and Best Buy Co. â€” New Research Emphasizes Economic Growth", 6/13/2017 ARGX-BE  GNW  argenx to Present at JMP Securities Life Sciences Conference,, 3/04/2019 04685N10 GNW  Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting," 3/13/2018 PETQ-US  GNW  PetIQ, Inc. Announces the Expansion of its Veterinary Services Offering in the Mass Retail Channel"," 6/20/2018 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering", 2/27/2018 OPTN-US  GNW  Optinose to Highlight Data at the 2018 AAAAI/WAO Joint Congress, 5/09/2018 TORC-US  GNW  resTORbio to Present at the Bank of America Merrill Lynch 2018 Health Care Conference,,," 4/10/2018 83422E10 GNW  SLDB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Solid Biosciences Inc. and a Lead Plaintiff Deadline of May 29, 2018"," 9/05/2018 EOLS-US  GNW  Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury",,11/12/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Assignment of Permanent J-Code for DEXYCUâ„¢ by the Center for Medicare and Medicaid Services (CMS) Â ,,,,,,,,,,10/03/2018 FTSV-US GNW  Forty Seven Inc. Appoints Leading Experts in Immuno-Oncology to its Scientific Advisory Board (SAB),,,,,,,,,,,, 2/22/2019 ORTX-US  GNW  Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID,,,,,,,,,,,,
, 5/09/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update,,,,, 5/23/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference,,, 5/29/2013 82691710     GNW  SIGA Completes Second Delivery of Arestvyr(TM) Under BARDA Contract,"11/06/2018 68375N10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In OPKO Health, Inc. To Contact The Firm"," 8/01/2018 ONVO-US  GNW  Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer",12/18/2015 BMRN-US     GNW  BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisaâ„¢ (drisapersen) New Drug Application by the PDUFA Date,,,," 2/20/2019 45290710 GNW  KESSLER TOPAZ MELTZER & CHECK, LLP:  Final Deadline Reminder for IMMUNOMEDICS, INC. Investors â€“ IMMU", 2/25/2019 09062X10  GNW  Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis,, 5/31/2019 BCRX-US  GNW  BioCryst to Present at Upcoming Investor Conferences,,,,," 2/27/2019 00972810 GNW  AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Akorn, Inc."," 9/24/2012 ASMB-US  GNW  Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development",11/01/2019 MYGN-US  GNW  Myriad Genetics Announces Multiple Presentations at the 2019 American College of Rheumatology Annual Meeting," 2/07/2019 52887230 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â LXRX",," 7/12/2017 INSM-US  GNW  Insmed to Host Analyst and Investor Day on July 19, 2017",, 6/27/2018 011000-KR GNW  Inovioâ€™s MERS Vaccine Generates High Levels of Antibodies and Induces Broad-based T Cell Responses in Phase 1 Study,"12/07/2018 64026810 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, TRVN, GOOG, NKTR and RYAAY",, 5/16/2019 GERN-US  GNW  Geron Provides Imetelstat Program Update,, 5/16/2019 AMRN-US  GNW  VascepaÂ® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting,,, 6/04/2019 SRPT-US  GNW  Sarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference," 1/14/2019 G0176710 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm",," 1/30/2019 AMAG-US  GNW  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET",,,,, 7/01/2019 SAN-FR   GNW  Sanofi : LibtayoÂ® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union,,, 8/29/2018 ASND-US  GNW  Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results,," 7/09/2018 00422510 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of ACADIA Pharmaceuticals Inc.", 8/03/2018 AFMD-US  GNW  Affimed Announces Second Quarter 2018 Financial Results and Corporate Update Conference Call,,10/02/2018 PRQR-US  GNW  ProQR to Present at the Chardan Genetic Medicines Conference,, 5/13/2019 98978L20 GNW  SHAREHOLDER ALERT: MBT NTNX ZGNX INVVY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,, 9/02/2014 76133010 GNW  Revance Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 2/11/2019 ADVM-US  GNW  Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference", 2/14/2019 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for CrysvitaÂ® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH), 3/20/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present at 17th Annual Needham Healthcare Conference, 8/22/2018 NSTG-US  GNW  NanoString to Present at the Baird 2018 Global Healthcare Conference,,," 7/23/2018 RDUS-US  GNW  Radius Health to Announce Second Quarter 2018 Financial Results, Host Conference Call and Live Webcast on August 7, 2018", 5/07/2018 ASMB-US  GNW  Assembly Biosciences Announces First Quarter 2018 Financial Results,,," 9/27/2018 02043Q10 GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Alnylam Pharmaceuticals, Inc. (ALNY) and Encourages ALNY Investors to Contact the Firm", 2/16/2016 WVE-SG   GNW  WAVE Life Sciences (Nasdaq: WVE) to Ring The Nasdaq Stock Market Opening Bell,11/08/2018 00972L10 GNW  Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions,,"10/11/2018 PCRX-US  GNW  New Research Reveals Potency and Quantity of Opioids Prescribed for Postsurgical Pain Poses Danger to Patients, their Families and Friends"," 8/21/2018 76129910 GNW  New Research Coverage Highlights pdvWireless, Fortuna Silver Mines, Nordic American Tankers, Amarin, Himax Technologies, and Retrophin â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 2/01/2018 PACB-US  GNW  Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results, 8/06/2018 28106W10 GNW  Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101, 1/08/2018 CHMA-US  GNW  Chiasma Reports on Significant Progress Made During 2017," 9/25/2019 55609910 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meredith Corporation, Macrogenics, ViewRay, and Cadence Bancorp and Encourages Investors to Contact the Firm",,, 2/27/2014 28249U10 GNW  Celladon Announces Exercise in Full and Closing of Underwriters' Option to Purchase Additional Shares," 5/17/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Presentation on M281, an Anti-FcRn Monoclonal Antibody, at 11th International Congress on Autoimmunity"," 6/15/2018 G7280010 GNW  UPDATE -- The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Fluor Corporation, Aceto Corporation, Prothena Corporation, Allegiant Travel Company, and Myriad Genetics, Inc.",11/07/2018 ZLAB-US  GNW  Zai Lab Limited Announces Presentations at November Conferences,11/11/2014 78667J10 GNW  SAGE Therapeutics Reports Third Quarter 2014 Results,10/30/2018 CTMX-US  GNW  CytomX Therapeutics to Announce Third Quarter 2018 Financial Results, 1/22/2019 GMAB-DK  GNW  Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma,"10/24/2018 92165910 GNW  Consolidated Research: 2018 Summary Expectations for Airgain, Vanda Pharmaceuticals, Westlake Chemical, TransEnterix, Versum Materials, and Triumph Group â€” Fundamental Analysis, Key Performance Indications",," 8/01/2018 23257D10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Five Prime Therapeutics, Akorn, The Blackstone Group, Avaya, Tractor Supply, and CymaBay Therapeutics â€” New Research Emphasizes Economic Growth"," 2/15/2011 45781M10 GNW  Inova Completes More Than $700,000 of Projects", 1/22/2018 CCXI-US  GNW  ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer,,,10/15/2018 MNKD-US   GNW  AfrezzaÂ® Inhaled Insulin Television Advertising Campaign Wins Gold Award for Creativity,," 5/05/2019 CYTK-US  GNW  Cytokinetics Announces Results of FORTITUDE-ALS, a Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS, Presented at American Academy of Neurology Annual Meeting", 1/04/2019 ESPR-US     GNW  Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe," 4/16/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. â€“ AMRS",, 2/26/2018 ACHN-US  GNW  Achillion Announces ACH-4471 Receives Positive Opinion for Orphan Drug Designation in the European Union for the Treatment of C3 Glomerulopathy," 4/02/2019 87166B10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Syneos Health, Inc. To Contact The Firm",11/05/2018 FOLD-US  GNW  Amicus Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Updates,,, 8/10/2018 ADMA-US  GNW  ADMA Biologics Reports Second Quarter 2018 Financial Results,10/01/2018 GWPH-US  GNW  GW Pharmaceuticals Announces Proposed Public Offering of ADSs,11/28/2016 06CR5C-E GNW  Epizyme Announces Fast Track Designation for Tazemetostat in DLBCL and Provides Solid Tumor Program Update,,10/30/2018 MYOK-US  GNW  MyoKardia Shares Data from Ongoing Clinical Programs and Details Three New Research Programs at 2018 R&D Day,, 3/28/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  REPORT  UPDATED  SAFETY  INFORMATION  FOR  FILGOTINIB  IN  RHEUMATOID  ARTHRITIS  (RA)," 2/01/2019 PTLA-US  GNW  Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on Friday, March 1, 2019",,,, 7/18/2018 CARA-US  GNW  Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock, 4/02/2019 FLXN-US  GNW  Flexion Therapeutics Announces Publication of Independent Data Review of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in the Journal Drugs,11/06/2018 QURE-US  GNW  uniQure Announces Third Quarter 2018 Financial Results and Highlights Company Progress, 1/07/2019 AGIO-US   GNW  Agios Highlights Key 2019 Initiatives to Broaden Potential for Cancer and Rare Genetic Disease Programs to Build Long-Term Value,"10/17/2018 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering",11/07/2017 ANAB-US  GNW  AnaptysBio Announces Third Quarter 2017 Financial Results and Provides Pipeline Updates,, 9/25/2018 FATE-US  GNW  Fate Therapeutics to Present at Upcoming Investor Conferences," 9/11/2017 HZNP-US  GNW  Horizon Pharma plc Names Irina Konstantinovsky Executive Vice President, Chief Human Resources Officer",," 5/01/2018 ICPT-US  GNW  Intercept to Announce First Quarter 2018 Financial Results on May 8, 2018 and Present at Upcoming Investor Conferences"," 9/09/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,10/17/2018 ITCI-US  GNW  Intra-Cellular Therapies Presents Results from ITI-214 Phase 1/2 Clinical Trial in Patients with Parkinsonâ€™s Disease at 2018 American Neurological Association Annual Meeting,,,,"11/29/2017 AMPH-US  GNW  Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP"," 9/11/2018 ATRA-US    GNW  Atara Biotherapeutics Appoints Cancer Research and Clinical Development Veteran, Roy Baynes, to its Board of Directors",, 3/08/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/07/2018 FOMX-US  GNW  Foamix Reports Third Quarter 2018 Financial Results and Provides Corporate Update, 1/16/2018 PRAH-US  GNW  PRA Health Sciences Opens New Salt Lake City Clinic, 2/12/2018 SUPN-US  GNW  Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call,"10/16/2018 31572Q80 GNW  Research Report Identifies The Habit Restaurants, Datawatch, SMART SAND INC, Independence Contract Drilling, Pareteum, and FibroGen with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 1/25/2019 CHRS-US  GNW  Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgenâ€™s Humira Biosimilar Formulation," 3/28/2019 21833P10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Inogen, Spectrum Brands, Bridgepoint, and Corbus and Encourages Investors to Contact the Firm",, 3/07/2018 COLL-US  GNW  Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update, 4/16/2018 XBIT-US  GNW  XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology,,, 2/19/2019 GBT-US   GNW  GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease,11/29/2016 75901B10 GNW  Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors,11/05/2018 KURA-US  GNW  Kura Oncology Initiates Registration-Directed Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinomas, 2/26/2019 APLS-US  GNW  Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results, 1/07/2019 AXSM-US  GNW  Axsome Therapeutics Raises $23.3 Million Under Existing ATM Facility, 5/18/2018 VYGR-US  GNW  Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting, 6/20/2019 BGNE-US  GNW  BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML),, 4/24/2018 RETA-US  GNW  Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone in the Treatment of Friedreichâ€™s Ataxia and Other Severe Neurological Diseases, 8/20/2018 HCM-GB   GNW  Edison issues update on Hutchison China MediTech (HCM),"12/18/2017 NTLA-US  GNW  Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer", 7/23/2018 ACIU-US  GNW  AC Immune Announces Closing of First Subscription Rights Offering and Primary Offering as well as Full Exercise of Option to Purchase Additional Shares, 3/26/2018 CRSP-US  GNW  CRISPR Therapeutics Announces the Retirement of Tyler Dylan-Hyde and Appointment of Shelby Walker as Head of Intellectual Property,10/21/2018 GTHX-US  GNW  G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer, 5/23/2017 ARGX-BE  GNW  argenx announces closing of NASDAQ IPO,, 2/25/2019 ATNX-US  GNW  Athenex to Host Conference Call with Key Opinion Leader Following Oral Presentation of Phase III Results of KX2-391 Ointment in the Treatment of Actinic Keratosis at the American Academy of Dermatology Annual Meeting," 3/13/2018 PETQ-US  GNW  PetIQ, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results"," 6/18/2018 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering", 2/22/2018 OPTN-US  GNW  Optinose names Sandra L. Helton as Director and Chairperson of the Companyâ€™s Audit Committee, 5/09/2018 TORC-US  GNW  resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly,,," 4/09/2018 SLDB-US  GNW  SHAREHOLDER ALERT:Â  Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Solid Biosciences Inc. (Nasdaq: SLDB) To Contact Brower Piven Before The Lead Plaintiff Deadline", 8/29/2018 EOLS-US  GNW  Evolus Receives Acceptance of FDA BLA Resubmission for DWP-450,,11/06/2018 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference,,,,,,,,,, 9/06/2018 FTSV-US GNW  Forty Seven Inc. to Present at the Morgan Stanley 16th Annual Global Healthcare Conference,,,,,,,,,,,, 2/06/2019 ORTX-US  GNW  Orchard Therapeutics Announces Acceptance of Late-Breaking Abstracts of OTL-101 for ADA-SCID and OTL-102 for X-CGD at the 2019 Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR,,,,,,,,,,,,
, 5/07/2019 PGNX-US  GNW  Progenics Pharmaceuticals Comments on Velan Capitalâ€™s Preliminary Proxy Statement,,,,, 5/22/2018 06HPY0-E GNW  BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board,,, 5/26/2013 82691710     GNW  Delaware Supreme Court Reverses Equitable Payment Stream to PharmAthene and Remands Litigation to Trial Court for New Determination of Damages,11/06/2018 68375N10 GNW  SHAREHOLDER ALERT: OPK APOG ALNY MGTI CPB CHGG DY IGC FIT SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 7/23/2018 46222210 GNW  Akcea Therapeutics to Hold Second Quarter 2018 Financial Results Webcast,11/24/2015 BMRN-US     GNW  FDA Advisory Committee Discusses Clinical Data Package for BioMarinâ€™s  Kyndrisa(TM) (drisapersen) for the Treatment of Duchenne Muscular Dystrophy  Amenable to Exon 51 Skipping,,,, 2/20/2019 IMMU-US  GNW  Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine, 1/04/2019 BIIB-US   GNW  Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets,, 5/21/2019 BCRX-US  GNW  BioCrystâ€™s Oral BCX7353 Meets Primary Endpoint in Phase 3 APeX-2 Trial,,,,," 2/25/2019 00972810 GNW  INVESTOR ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. â€“ AKRX", 6/26/2012 0790QJ-E GNW  Immune Design Corp. Announces Appointment of Dr. Roger Perlmutter as a Member of Its Board of Directors,"10/30/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against electroCore, Tencent Music, Myriad Genetics, and Waitr Holdings and Encourages Investors to Contact the Firm"," 1/29/2019 52887230 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Lexicon Pharmaceuticals, Inc. (LXRX)Â & Lead Plaintiff Deadline: April 1, 2019",, 6/13/2017 INSM-US  GNW  Insmed to Present at the JMP Securities Life Sciences Conference,, 6/21/2018 INO-US    GNW  Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneronâ€™s PD-1 Inhibitor,12/06/2018 64026810 GNW  SHAREHOLDER ALERT: JT TRVN HTHT OZK NKTR FIT GSKY ATUS PPDF MAR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 5/16/2019 GERN-US  GNW  Geron Continues to Build Senior Leadership of Its Development Team,, 5/01/2019 AMRN-US  GNW  Amarin Reports First Quarter 2019 Financial Results and Provides Update on Operations,,, 5/31/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/14/2019 G0176710 GNW  February 25th Alkermes Shareholder Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Alkermes plc â€“ ALKS,, 1/17/2019 0KDYMJ-E GNW  AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals,,,,, 6/28/2019 SAN-FR   GNW  Sanofi : CHMP recommends approval of DupixentÂ® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents,,, 8/15/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Second Quarter 2018 Financial Results and Business Update Conference Call on August 29,,"10/31/2017 00422510 GNW  Consolidated Research: 2018 Summary Expectations for Columbia Property Trust, Dr Pepper Snapple, Immune Pharmaceuticals, Air Products and Chemicals, Box, and ACADIA Pharma â€“ Fundamental Analysis, Key Performance Indications", 6/28/2018 AFMD-US  GNW  MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens,, 9/24/2018 PRQR-US  GNW  ProQR Announces Presentations at the OTS Annual Meeting,," 5/10/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orion, Zogenix, BrightView, and Eventbrite and Encourages Investors to Contact the Firm",,, 8/12/2014 76133010 GNW  Revance Therapeutics Releases Second Quarter 2014 Financial Results,,, 1/06/2019 ADVM-US  GNW  Adverum Biotechnologies Provides 2019 Outlook, 2/12/2019 RARE-US   GNW  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018  Financial Results and Corporate Update, 3/13/2018 AGLE-US  GNW  Aeglea BioTherapeutics Provides Key Clinical Data Update from Phase 1/2 Trial in Arginase 1 Deficiency and Reports Q4 and Full Year 2017 Financial Results, 8/13/2018 NSTG-US  GNW  NanoString Technologies Announces Exercise of Underwritersâ€™ Option to Purchase Additional Shares of Common Stock,,, 7/16/2018 RDUS-US  GNW  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), 4/12/2018 ASMB-US  GNW  Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference,,," 9/26/2018 02043Q10 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Investor Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm â€“ ALNY",,11/06/2018 AKCA-US  GNW  Akcea Therapeutics to Present at Upcoming Investor Conferences,," 9/04/2018 ZIOP-US  GNW  Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors"," 7/30/2018 RTRX-US  GNW  Retrophin Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer", 1/25/2018 PACB-US  GNW  BGI Increases Long-Read Sequencing Capacity with Purchase of 10 PacBio Sequel Systems, 7/30/2018 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Second Quarter 2018 Corporate Update and Results,11/09/2017 CHMA-US  GNW  Chiasma Reports Third Quarter 2017 Results," 9/24/2019 55609910 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MDP, FTCH, MGNX and VRAY",,, 2/24/2014 28249U10 GNW  Celladon Announces Option Agreement With Servier, 5/10/2018 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch Health Care Conference 2018," 6/14/2018 G7280010 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Prothena Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 16, 2018 â€“ PRTA",10/22/2018 ZLAB-US  GNW  Zai Lab Announces Approval of ZEJULAÂ® (Niraparib) for Patients with Relapsed Ovarian Cancer in Hong Kong,11/10/2014 78667J10 GNW  SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus,10/22/2018 CTMX-US  GNW  CytomX Therapeutics Presents Clinical Data from Probodyâ„¢ Platform and CX-072 at 2018 ESMO Annual Meeting, 1/22/2019 GMAB-DK  GNW  Genmab Announces 2018 Net Sales Figures for DARZALEXÂ® (Daratumumab)," 6/27/2018 92165910 GNW  Detailed Research: Economic Perspectives on Comerica, Vanda Pharmaceuticals, Acadia Healthcare, The Charles Schwab, Ares Capital, and EQT â€” What Drives Growth in Today's Competitive Landscape",, 6/25/2018 CBAY-US  GNW  CymaBay Therapeutics Added to the Russell 3000Â® and Russell 2000Â® Indexes, 1/26/2011 45781M10 GNW  Inova Awarded a New $1.3 Million Contract; Total Backlog Over $20 Million, 1/08/2018 CCXI-US  GNW  ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer,,,10/04/2018 MNKD-US   GNW  MannKind Presents Positive AfrezzaÂ® STAT Study Clinical Data at 54th Annual Meeting of the European Association for the Study of Diabetes,," 4/25/2019 CYTK-US  GNW  Cytokinetics to Announce First Quarter ResultsÂ on May 9, 2019", 1/02/2019 ESPR-US     GNW  Esperion to Present at the 37th Annual J.P. Morgan Healthcare Conference, 4/16/2019 AMRS-US   GNW  Amyris Repays in Cash April 2019 Convertible Note Debt,, 2/22/2018 ACHN-US  GNW  Achillion Announces Restructuring to Advance Corporate Strategy; Announces 2017 Fourth Quarter and Full Year Financial Results," 4/02/2019 87166B10 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL","10/29/2018 FOLD-US  GNW  Amicus Therapeutics to Announce Third Quarter 2018 Financial Results on November 5, 2018",,, 7/26/2018 ADMA-US  GNW  ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection, 9/27/2018 0JBRH7-E GNW  GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEXÂ® (cannabidiol) Oral Solution to Schedule V,11/21/2016 06NC3H-E GNW  Epizyme President of Research and Chief Scientific Officer Named AAAS Fellow,,10/25/2018 MYOK-US  GNW  MyoKardia Announces Initiative to Create Hypertrophic Cardiomyopathy Patient Community in Collaboration with 23andMe,, 3/28/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  ANNOUNCE  FILGOTINIB  MEETS  PRIMARY  ENDPOINT  IN  THE  PHASE  3  FINCH 3  STUDY  IN  METHOTREXATE-NAÃVE  RHEUMATOID  ARTHRITIS  PATIENTS, 1/30/2019 PTLA-US  GNW  Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019,,,, 7/17/2018 CARA-US  GNW  Cara Therapeutics Announces Proposed Offering of Common Stock," 4/01/2019 FLXN-US  GNW  Flexion Therapeutics Announces Kerry Wentworth, Chief Regulatory Officer, Appointed to Massachusetts Biotechnology Council Board","11/05/2018 QURE-US  GNW  uniQure to Host Research & Development Day on Monday, November 19  in New York City","12/28/2018 AGIO-US   GNW  Agios to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019","10/12/2018 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock",11/06/2017 ANAB-US  GNW  AnaptysBio Reports Positive ANB019 Top-line Phase 1 Clinical Trial Results,, 9/20/2018 FATE-US  GNW  Fate Therapeutics Announces Pricing of Public Offering of Common Stock, 9/05/2017 HZNP-US  GNW  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 4/24/2018 ICPT-US  GNW  Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Board of Directors," 9/06/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,"10/16/2018 ITCI-US  GNW  Intra-Cellular Therapies Appoints Mark Neumann as Executive Vice President, Chief Commercial Officer",,,,11/20/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference, 9/06/2018 ATRA-US    GNW  Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to  Develop Next-Generation CAR T Immunotherapies,, 3/08/2018 DERM-US  GNW  Dermira to Present at Cowen & Company 38th Annual Healthcare Conference,11/07/2018 FOMX-US  GNW  Foamix Announces Positive Topline Results from Phase 3 Program Evaluating FMX103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea,11/30/2017 PRAH-US  GNW  Symphony Health Launches New Long Term Care Channel Offering, 1/12/2018 SUPN-US  GNW  Supernus Mourns the Loss of Board Member William Nuerge,10/01/2018 31572Q80 GNW  Astellas Submits New Drug Application in Japan of Roxadustat for The Treatment of Anemia  Associated with Chronic Kidney Disease in Patients on Dialysis,," 1/25/2019 ABBV-US  GNW  Coherus BioSciences Announces Global Settlement with AbbVie Securing Rights to Commercialize its Adalimumab Biosimilar Candidate, CHS-1420"," 3/28/2019 21833P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc. â€“ CRBP",, 2/26/2018 COLL-US  GNW  Collegium to Host Conference Call to Discuss Fourth Quarter 2017 Financial Results and Provide Corporate Update, 4/02/2018 0844NQ-E GNW  XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer,,, 2/05/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants,11/29/2016 75901B10 GNW  REGENXBIO and Voyager Therapeutics Announce Exercise of Options for Rights to NAV Vectors,11/01/2018 KURA-US  GNW  Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting, 2/12/2019 APLS-US  GNW  Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 1/07/2019 AXSM-US  GNW  Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder, 5/17/2018 VYGR-US  GNW  Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting, 6/19/2019 BGNE-US  GNW  BeiGene Announces Updated Results from Two Ongoing Clinical Trials of Zanubrutinib in Patients with Mantle Cell Lymphoma in Presentations at the 15th International Conference on Malignant Lymphoma (ICML),, 4/11/2018 RETA-US  GNW  Reata Provides Update on the Phase 2 Portion of the CARDINAL Study of Bardoxolone Methyl in Patients With Alport Syndrome, 7/27/2018 HCM-GB   GNW  Chi-Med Reports 2018 Interim Results and Updates Shareholders on Key ClinicalÂ Programs,"12/11/2017 NTLA-US  GNW  Intellia Therapeutics Announces New, Robust Genome Editing Data for Sickle Cell Disease at the American Society of Hematology Meeting", 7/18/2018 ACIU-US  GNW  AC Immune Announces Price of USD 11.75 for Offerings and Issuance of up to 10 Million Common Shares, 3/08/2018 CRSP-US  GNW  CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results,10/09/2018 GTHX-US  GNW  G1 Therapeutics to Present Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin at European Society for Medical Oncology (ESMO) 2018 Congress, 5/19/2017 ARGX-BE  GNW  argenx announces full exercise of underwriters' option to purchase additional ADSs,," 2/14/2019 ATNX-US  GNW  Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019"," 2/26/2018 PETQ-US  GNW  PetIQ, Inc. to Report Fourth Quarter and Fiscal 2017 Results on Tuesday, March 13th", 6/18/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity, 2/20/2018 OPTN-US  GNW  Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences Pennsylvania, 5/01/2018 TORC-US  GNW  resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference,,," 4/09/2018 0DBJVZ-E GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Solid Biosciences, Inc. Shareholders", 8/17/2018 EOLS-US  GNW  Evolus Granted Approval of DWP-450 by Health Canada,,11/06/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Fiscal First Quarter 2019 Financial Results and Highlights Recent Clinical and Operational Developments,,,,,,,,,, 8/13/2018 FTSV-US GNW  Forty Seven Inc. Reports Second Quarter 2018 Financial Results and Recent Business Highlights,,,,,,,,,,,, 1/22/2019 ORTX-US  GNW  Orchard Announces Publication by San Raffaele-Telethon Institute for Gene Therapy of OTL-300 Clinical Data for the Treatment of Transfusion-Dependent Beta-Thalassemia in Nature Medicine,,,,,,,,,,,,
, 5/06/2019 PGNX-US  GNW  Progenics Pharmaceuticals Issues Statement Regarding Velan Capital,,,,, 5/17/2018 BDSI-US  GNW  BioDelivery Sciences Announces Pricing of $50 Million Equity Financing,,, 5/15/2013 82691710     GNW  SIGA Technologies Reports Financial Results for the First Quarter 2013,"11/06/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, MGT Capital, and Applied Optoelectronics and Encourages Investors to Contact the Firm", 7/11/2018 46222210 GNW  Akcea and Ionis Announce Approval of TEGSEDIâ„¢ (inotersen) in the European Union,11/24/2015 BMRN-US     GNW  BioMarin Posts Presentation From FDA Advisory Committee Meeting for Kyndrisa(TM) (drisapersen) for the Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,," 2/20/2019 45290710 GNW  IMMU UPCOMING FEBRUARY 25th DEADLINE: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Securities Class Action Lawsuit; Expanded Class Period â€“ IMMU", 1/04/2019 BIIB-US   GNW  Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions,, 5/10/2019 BCRX-US  GNW  BioCryst to Present at Bank of America Merrill Lynch Health Care Conference,,,,, 2/20/2019 AKRX-US  GNW  Akorn Comments on Freseniusâ€™ Proposed Amended Claims, 5/03/2012 SLS-US   GNW  Galena Biopharma Strengthens Clinical Management Team,"10/30/2019 MYGN-US  GNW  Myriad to Announce Fiscal First-Quarter 2020 Financial Results on November 4, 2019"," 1/29/2019 52887230 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Lexicon Pharmaceuticals, Inc. and Certain Officers â€“Â LXRX",, 6/08/2017 INSM-US  GNW  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 5/31/2018 INO-US    GNW  Inovio CEO to Speak on Viral Epidemic Preparedness Panel at BIO International Convention,"12/05/2018 64026810 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HTHT, DY, ALGN, NKTR and SYF",, 5/02/2019 GERN-US  GNW  Geron Corporation Reports First Quarter 2019 Financial Results,, 4/29/2019 AMRN-US  GNW  New Drug Submission Filed for VascepaÂ® with Health Canada,,, 5/08/2019 SRPT-US  GNW  Sarepta Therapeutics Announces First Quarter 2019 Financial Results and Recent Corporate Developments," 1/13/2019 G0176710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YRCW, YRIV and ALKS",," 1/15/2019 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs",,,,," 6/27/2019 SAN-FR   GNW  Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate",,, 8/02/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in the 2018 Wedbush PacGrow Healthcare Conference,," 5/09/2015 00422510 GNW  ACADIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Before the Imminent Lead Plaintiff Deadline", 6/15/2018 AFMD-US  GNW  Affimed Announces Updated Data of AFM13 in Combination with KeytrudaÂ® (Pembrolizumab) in Patients with Relapsed/Refractory Hodgkin Lymphoma Presented at EHA,, 9/11/2018 PRQR-US  GNW  ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,," 5/09/2019 98978L20 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zogenix, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ZGNX",,," 8/12/2014 76133010 GNW  Revance Therapeutics Appoints Industry Veteran Arthur P. Bertolino, M.D., Ph.D., M.B.A. as Chief Medical Officer",,,12/20/2018 ADVM-US  GNW  Adverum to Present at the 37th Annual J.P. Morgan Healthcare Conference," 2/04/2019 RARE-US   GNW  Ultragenyx Appoints Shehnaaz Suliman, M.D., to Board of Directors", 3/08/2018 AGLE-US  GNW  Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase, 8/07/2018 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Second Quarter of 2018,,, 7/16/2018 RDUS-US  GNW  Radius Health Strengthens Senior Management Team with Appointment of Chhaya Shah as Senior Vice President of Technical Operations, 4/10/2018 ASMB-US  GNW  Assembly Biosciences to Host Conference Call on April 12 to Review ABI-H0731 Interim Phase 1b Data in HBV Patients Featured in Late-Breaker Poster at EASL,,," 9/26/2018 02043Q10 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Alnylam Pharmaceuticals, Inc. and Certain Officers â€“ ALNY",,11/05/2018 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for Third Quarter 2018,," 8/23/2018 69512710 GNW  Consolidated Research: 2018 Summary Expectations for SpartanNash, Encana, Hilltop, Pacira Pharmaceuticals, Menlo Therapeutics, and Rayonier Advanced Materials â€” Fundamental Analysis, Key Performance Indications", 7/26/2018 RTRX-US  GNW  Retrophin Reports Second Quarter 2018 Financial Results and Announces CEO Transition Plan," 1/22/2018 PACB-US  GNW  Pacific Biosciences of California, Inc. Fourth Quarter and Year-End 2017 Financial Results Call"," 6/21/2018 28106W10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within TrustCo Bank Corp NY, Highwoods Properties, Enova International, Editas Medicine, United Insurance, and Cutera â€” New Research Emphasizes Economic Growth",11/01/2017 CHMA-US  GNW  Chiasma Recognizes Acromegaly Awareness Day," 9/23/2019 MGNX-US  GNW  MGNX LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against MacroGenics, Inc. - MGNX",,, 1/29/2014 28249U10 GNW  Celladon Announces Pricing of Initial Public Offering, 5/08/2018 MNTA-US  GNW  Momenta Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update," 6/05/2018 G7280010 GNW  PRTA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Prothena Corporation and a Lead Plaintiff Deadline of July 16, 2018"," 9/27/2018 ZLAB-US  GNW  Zai Lab Appoints Industry Leader Tao Fu as President & Chief Operating Officer, Expands US Presence","11/07/2014 78667J10 GNW  SAGE Therapeutics Announces Six Scientific Presentations at Neuroscience 2014, the Society for Neuroscience's 44th Annual Meeting","10/12/2018 23284F10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Cloud Peak Energy, Ralph Lauren, CytomX Therapeutics, Extreme Networks, Heron Therapeutics, and Alteryx â€” New Research Emphasizes Economic Growth", 1/17/2019 GMAB-DK  GNW  Major Shareholder Announcement," 5/10/2018 92165910 GNW  Investor Expectations to Drive Momentum within Plains Group Holdings, EnteroMedics, Vanda Pharmaceuticals, Cinemark, EPR Properties, and The Estee Lauder Companies â€” Discovering Underlying Factors of Influence",," 6/19/2018 CBAY-US  GNW  CymaBay Therapeutics to Host Analyst and Investor Day on June 26, 2018"," 1/12/2011 45781M10 GNW  Inova Provides 1,450 Lead Retrieval Devices to Promotional Products Association International Expo", 1/04/2018 HTGC-US  GNW  ChemoCentryx Secures up to $100 Million in New Capital Commitments,,,10/03/2018 MNKD-US   GNW  MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes,, 4/01/2019 CYTK-US  GNW  Cytokinetics to Present at April Investor Conferences,11/10/2018 ESPR-US     GNW  Esperion Announces Late-Breaking Oral Presentation of Final Study 3 Results (1002-046) of Bempedoic Acid at the American Heart Association Scientific Sessions 2018, 4/15/2019 AMRS-US   GNW  Amyris Provides Update on Resolution of April 2019 Convertible Note Maturity,, 2/09/2018 ACHN-US  GNW  Achillion to Present at the Leerink Partners 7th Annual Global Healthcare Conference," 3/28/2019 87166B10 GNW  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc.","10/25/2018 03152W10 GNW  Recent Analysis Shows PennyMac Mortgage Investment Trust, Amicus Therapeutics, Children's Place, PLDT, NanoString Technologies, and Worthington Industries Market Influences â€” Renewed Outlook, Key Drivers of Growth",,, 7/26/2018 ADMA-US  GNW  ADMA Biologics Receives PDUFA Date for BIVIGAMÂ® Regulatory Submission, 8/07/2018 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal Third Quarter 2018 Financial Results and Operational Progress,11/03/2016 EPZM-US  GNW  Epizyme Provides Update on Execution of Clinical Program and Reports Third Quarter 2016 Financial Results,,10/24/2018 MYOK-US  GNW  MyoKardia Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy,, 3/28/2019 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  ANNOUNCE  FILGOTINIB  MEETS  PRIMARY  AND  KEY  SECONDARY  ENDPOINTS  IN  THE  PHASE  3  FINCH 1  RHEUMATOID  ARTHRITIS  STUDY, 1/28/2019 PTLA-US  GNW  Portola Pharmaceuticals Appoints Sheldon Koenig as Chief Commercial Officer,,,, 7/11/2018 CARA-US  GNW  Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVAâ„¢ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients, 3/04/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the Cowen 39th Annual Health Care Conference,10/31/2018 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences,12/03/2018 AGIO-US   GNW  Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS),"10/11/2018 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock",10/31/2017 ANAB-US  GNW  AnaptysBio to Participate in Upcoming Investor Conferences,, 9/20/2018 FATE-US  GNW  Fate Therapeutics Announces Proposed Public Offering of Common Stock, 8/24/2017 HZNP-US  GNW  Horizon Pharma plc to Participate in Morgan Stanley 15th Annual Global Healthcare Conference,, 4/13/2018 ICPT-US  GNW  Liver Biopsy Data from POISE Phase 3 Substudy Supports Obeticholic Acidâ€™s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients, 9/05/2019 48576U10   GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI,,, 9/28/2018 ITCI-US  GNW  Intra-Cellular Therapies Completes Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia,,,,"11/08/2017 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017", 8/31/2018 ATRA-US    GNW  Atara Biotherapeutics to Participate at Two Upcoming Conferences,, 3/05/2018 DERM-US  GNW  Dermiraâ€™s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints,10/29/2018 FOMX-US  GNW  Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 8,"10/25/2017 0CKCV6-E GNW  PRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance", 1/02/2018 SUPN-US  GNW  Supernus to Present at the 2018 J.P. Morgan Healthcare Conference, 9/12/2018 FGEN-US  GNW  FibroGen Receives Fast Track Designation From the U.S. FDA for Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis,, 1/18/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 3/28/2019 21833P10 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CAG, AMRN, SYNH and CRBP",, 1/10/2018 COLL-US  GNW  Collegium Announces Closing of Agreement to License Rights to Commercialize Nucynta Franchise, 1/26/2018 XBIT-US  GNW  XBiotech Announces Presentation of Data from Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa,,, 1/29/2019 GBT-US   GNW  GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease,11/17/2016 RGNX-US  GNW  REGENXBIO to Present at the 28th Annual Piper Jaffray Healthcare Conference,10/29/2018 KURA-US  GNW  Kura Oncology to Report Third Quarter 2018 Financial Results, 2/11/2019 APLS-US  GNW  Apellis Pharmaceuticalsâ€™ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria,12/27/2018 AXSM-US  GNW  Axsome Therapeutics Provides Year End 2018 Clinical Update," 5/15/2018 92915B10 GNW  MRI Interventions Announces Strategic Agreement with Voyager Therapeutics for Neurosurgical Device Service, Supply and Development"," 6/18/2019 0KT86V-E GNW  BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor",," 4/03/2018 RETA-US  GNW  Reata to Present Preclinical Data on RTA 1701, a Novel RORÎ³t Inverse Agonist, at Upcoming Immunology Conference", 7/23/2018 44842L10 GNW  Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Sulfatinib in Pancreatic Neuroendocrine Tumors and Biliary Tract Cancer in the UnitedÂ States,11/02/2017 NTLA-US  GNW  Intellia Therapeutics to Present at November Healthcare Investor Conferences, 7/17/2018 ACIU-US  GNW  AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares, 2/21/2018 CRSP-US  GNW  CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences," 9/26/2018 3621LQ10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Sina, Paratek Pharmaceuticals, Honda Motor Co., Prospect Capital, G1 THERAPEUTICS, and Gaming and Leisure Properties â€” New Research Emphasizes Economic Growth", 5/18/2017 04016X10 GNW  Nasdaq Welcomes argenx (Nasdaq: ARGX) to The Nasdaq Stock Market,, 2/04/2019 ATNX-US  GNW  Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting," 1/17/2018 PETQ-US  GNW  PetIQ, Inc. Completes Strategic Acquisition of VIP Petcare", 6/14/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity, 2/15/2018 OPTN-US  GNW  Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference, 3/29/2018 TORC-US  GNW  resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results,,, 4/06/2018 83422E10 GNW  WOLF HALDENSTEIN: Solid Biosciences Inc. Investor Alert," 8/15/2018 EOLS-US  GNW  Evolus Expands Role of Chief Medical Officer Rui Avelar, MD with Appointment as Head of R&D",,11/05/2018 EYPT-US    GNW  EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize Durasertâ„¢ Three-Year Treatment for Posterior Segment Uveitis in the Greater China Region,,,,,,,,,, 8/02/2018 FTSV-US GNW  Forty Seven Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference,,,,,,,,,,,, 1/07/2019 ORTX-US  GNW  Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy,,,,,,,,,,,,
, 5/06/2019 PGNX-US  GNW  Data Presented at the 2019 American Urological Association (AUA) Annual Meeting Showcases Potential for Progenicsâ€™ PyL Imaging Agent,,,,, 5/17/2018 06HPY0-E GNW  BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business,,, 5/10/2013 82691710     GNW  SIGA Announces Restatement of Certain Historical Financial Results to Reflect Reclassification of Warrants as a Liability,"11/05/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 6/13/2018 46222210 GNW  Detailed Research: Economic Perspectives on CarGurus, ArcelorMittal, Capricor Therapeutics, B&G Foods, Ionis Pharmaceuticals, and Photronics â€” What Drives Growth in Today's Competitive Landscape",11/24/2015 BMRN-US     GNW  BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Announced Today the Stock is Halted,,,," 2/20/2019 45290710 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, W",12/20/2018 07YYTN-E  GNW  Biogen Applauds Quebec Decision to Cover SPINRAZAâ„¢ (nusinersen) for a broad population of SMA Patients,, 5/09/2019 BCRX-US  GNW  BioCryst Completes Phase 1 Clinical Trial of Galidesivir,,,,, 2/11/2019 AKRX-US  GNW  Akorn to Report Fourth Quarter and Full Year 2018 Results, 3/27/2012 VVUS-US  GNW  VIVUS Announced Expansion of Management Team,"10/30/2019 62855J10 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Myriad Genetics, Inc."," 1/17/2019 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes",, 5/15/2017 INSM-US  GNW  Insmed Announces Key Additions to its Executive Management Team,, 5/24/2018 INO-US    GNW  Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D,12/03/2018 64026810 GNW  SHAREHOLDER ALERT: JT TRVN GOOG CWH OZK NKTR SYF AQUA GSKY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 4/18/2019 GERN-US  GNW  Geron Expands Senior Leadership of Its Development Team,," 4/24/2019 AMRN-US  GNW  Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019",,," 5/08/2019 SRPT-US  GNW  Sarepta Announces Agreement with Nationwide Childrenâ€™s Hospital for Rights to its Gene Therapy Program to Treat Limb-Girdle Muscular Dystrophy Type 2A, the Most Common Form of Limb-Girdle Muscular Dystrophy", 1/11/2019 G0176710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc â€“ ALKS,, 1/07/2019 AMAG-US  GNW  AMAG Pharmaceuticals Announces Preliminary 2018 Financial Results and Provides 2019 Financial Guidance,,,,, 6/26/2019 SAN-FR   GNW  Sanofi : FDA approves DupixentÂ® (dupilumab) for chronic rhinosinusitis with nasal polyposis,,, 7/23/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Poster Presentation on TransCon Technology at the Controlled Release Society Annual Meeting,," 5/08/2015 00422510 GNW  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD", 5/30/2018 AFMD-US  GNW  Affimed to Present at the Jefferies Global Healthcare Conference,, 9/07/2018 PRQR-US  GNW  ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares,, 5/08/2019 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports First Quarter 2019 Financial Results,,," 7/29/2014 76133010 GNW  Revance Therapeutics to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 12, 2014",,,"12/03/2018 ADVM-US  GNW  Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources", 1/22/2019 RARE-US   GNW  Ultragenyx Announces Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders, 3/06/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present Adult Repeat Dose Data at 2018 Annual Meeting of The Society for Inherited Metabolic Disorders, 8/07/2018 NSTG-US  GNW  NanoString Expands Centers of Excellence Program andÂ Initiates Early Access Launch for Digital Spatial Profiling,,, 6/07/2018 RDUS-US  GNW  Radius Health to Present at the Goldman Sachs 39th Annual Global Healthcare Conference," 4/02/2018 ASMB-US  GNW  Assembly Biosciences Appoints Jackie Papkoff, PhD, Senior Vice President, Chief Scientific Officer Microbiome",,," 9/24/2018 02043Q10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating Possible Securities Fraud Violations by Certain Officers and Directors of Alnylam, Global Blood, and NiSource on Behalf of Stockholders and Encourages Investors to Contact the Firm",,11/02/2018 AKCA-US  GNW  Akcea Recognizes First Global Familial Chylomicronemia Syndrome (FCS) Awareness Day,, 8/08/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2018 Wedbush Pacgrow Healthcare Conference, 7/12/2018 RTRX-US  GNW  Retrophin to Report Second Quarter 2018 Financial Results,"12/20/2017 69404D10 GNW  Report: Developing Opportunities within FLIR, Syntel, Pacific Biosciences of California, St. Joe, Blackbaud, and Webster Financial â€” Future Expectations, Projections Moving into 2018", 6/13/2018 EDIT-US  GNW  Editas Medicine to Participate in The JMP Securities Life Sciences Conference, 9/27/2017 CHMA-US  GNW  Chiasma Announces First Patient Is Randomized in Phase 3 CHIASMA OPTIMAL Clinical Trial of Octreotide Capsules in Patients with Acromegaly," 9/23/2019 55609910 GNW  IMPORTANT  MACROGENICS, INC.  INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the District of Maryland against MacroGenics, Inc.",,,, 5/01/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2018 Financial Results Conference Call and Webcast," 6/01/2018 PRTA-US  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Prothena Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 16, 2018 â€“ PRTA", 9/26/2018 ZLAB-US  GNW  Zai Lab Presents Interim Results of its ongoing Phase 2 study of ZL-2301 (brivanib) in Chinese Patients with Advanced Hepatocellular Carcinoma (HCC) at the 21st Annual Meeting of the Chinese Society of Clinical Oncology,11/05/2014 78667J10 GNW  SAGE to Present at Credit Suisse 23rd Annual Healthcare Conference,10/08/2018 CTMX-US  GNW  CytomX Therapeutics Announces Presentations at 2018 ESMO Annual Meeting, 1/08/2019 GMAB-DK  GNW  Genmab Achieves USD 75 Million Sales Milestone in DARZALEXÂ® (daratumumab) Collaboration with Janssen,"11/27/2017 92165910 GNW  Research Report Identifies Walker & Dunlop, Vanda Pharmaceuticals, Acushnet, SS&C Technologies, ManpowerGroup, and Glaukos with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 5/08/2018 CBAY-US  GNW  CymaBay Reports First Quarter 2018 Financial Results and Provides Corporate Update, 1/06/2011 45781M10 GNW  Inova Releases Subsidiary Desert Communication 12-Month Figures, 1/04/2018 CCXI-US  GNW  Avacopan Conditional Marketing Authorization Application Accepted for Regulatory Review by European Medicines Agency,,, 9/24/2018 MNKD-US   GNW  MannKind Announces Completion of Cohort 1 and Opens Enrollment for Cohort 2 of AfrezzaÂ® Safety and Pharmacokinetics Study in Pediatric Patients,," 3/20/2019 CYTK-US  GNW  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis","11/09/2018 29664W10    GNW  Report: Exploring Fundamental Drivers Behind American Vanguard, Pioneer Natural Resources, American States Water, Groupon, Esperion Therapeutics, and Paylocity Holding â€” New Horizons, Emerging Trends, and Upcoming Developments"," 4/13/2019 03236M20  GNW  INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines â€“ CORT, HCSG, ARA and AMRS",,"12/20/2017 ACHN-US  GNW  CORRECTION - Achillion Pharmaceuticals, Inc."," 3/28/2019 87166B10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH",10/11/2018 FOLD-US  GNW  Amicus Therapeutics to Host Analyst Day 2018 Today in New York City,,, 6/25/2018 ADMA-US  GNW  ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes, 7/24/2018 36197T10 GNW  Cannabinoids May Do More Than Manage Cancer Symptoms -- CFN Media,10/31/2016 EPZM-US  GNW  Epizyme Expands Clinical Programs through Cooperative Research and Development Agreements with the National Cancer Institute,,"10/22/2018 MYOK-US  GNW  MyoKardia to Host R&D Day on October 30, 2018",, 3/20/2019 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises,12/31/2018 PTLA-US  GNW  U.S. Food and Drug Administration Approves Portola Pharmaceuticalsâ€™  Prior Approval Supplement for AndexxaÂ® Generation 2 Manufacturing Process,,,, 6/27/2018 CARA-US  GNW  Cara Therapeutics Reports Positive Top-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery, 3/01/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4),"10/23/2018 N9006410 GNW  Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma â€” New Horizons, Emerging Trends, and Upcoming Developments",12/03/2018 AGIO-US   GNW  Agios Announces Updated Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Standard Induction and Consolidation Chemotherapy in Newly Diagnosed AML Patients With an IDH Mutation,10/11/2018 IOVA-US  GNW  Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Companyâ€™s Clinical Program,10/12/2017 ANAB-US  GNW  AnaptysBio Announces Pricing of Public Offering,," 9/17/2018 FATE-US  GNW  Fate Therapeutics Announces Strategic Collaboration with ONO Pharmaceutical to Develop Off-the-Shelf, iPSC-derived CAR-T Cell Cancer Immunotherapies", 8/07/2017 HZNP-US  GNW  Horizon Pharma plc Announces Second-Quarter and Year-to-Date 2017 Results and Increases Full-Year 2017 Net Sales and Adjusted EBITDA Guidance,, 4/05/2018 ICPT-US  GNW  Intercept Pharmaceuticals Announces Pricing of Upsized $250 Million Public Offering and Concurrent Private Placement of Common Stock, 9/05/2019 48576U10   GNW  SHAREHOLDER ALERT: INS KPTI EGBN VAL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,, 9/26/2018 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Cantor Fitzgerald Global Healthcare Conference,,,,"10/31/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2017"," 8/16/2018 04651310   GNW  Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biotherapeutics, Forward Industries, Apollo Endosurgery, and Myomo â€” Research Highlights Growth, Revenue, and Consolidated Results",, 2/22/2018 DERM-US  GNW  Dermira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update,10/12/2018 FOMX-US  GNW  Foamix to Present Clinical Data From Study FX2017-22 at the Fall Clinical Dermatology Conference,10/09/2017 PRAH-US  GNW  PRA Health Sciences to Report Third Quarter 2017 Earnings,11/08/2017 SUPN-US  GNW  Supernus to Present at Three November Healthcare Conferences," 8/15/2018 31572Q80 GNW  New Research: Key Drivers of Growth for comScore, Fonar, FibroGen, Resolute Energy, National Commerce, and THL Credit â€” Factors of Influence, Major Initiatives and Sustained Production",, 1/14/2019 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 3/28/2019 CRBP-US  GNW  Corbus Pharmaceuticals Provides Management Team Updates,,12/12/2017 COLL-US  GNW  Collegium to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference, 1/25/2018 XBIT-US  GNW  XBiotech Publishes Results in PLOS ONE for its True Human Antibody 514G3 Targeting S. aureus,,, 1/03/2019 GBT-US   GNW  GBT Announces New Employment Inducement Grants,11/09/2016 RGNX-US  GNW  REGENXBIO Reports Third Quarter 2016 Financial Results and Recent Operational Highlights,"10/23/2018 50127T10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Dropbox, Kura Oncology, DHT, Wayfair, US Foods Holding, and InflaRx N.V â€” New Research Emphasizes Economic Growth", 2/05/2019 APLS-US  GNW  Apellisâ€™ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia,12/18/2018 AXSM-US  GNW  Axsome Therapeutics to Present at Biotech Showcase 2019, 5/10/2018 VYGR-US  GNW  Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights, 6/17/2019 CELG-US  GNW  BeiGene Regains Full Global Rights to Its Investigational Anti-PD-1 Antibody Tislelizumab,, 3/29/2018 RETA-US  GNW  Reata Announces That Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan, 6/29/2018 HCM-GB   GNW  Chi-Med to Announce 2018 Half-Year Financial Results,11/01/2017 NTLA-US  GNW  Intellia Therapeutics Announces Pricing of  Public Offering of Common Stock, 7/17/2018 ACIU-US  GNW  Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at AAIC in Chicago," 2/08/2018 CRSP-US  GNW  CRISPR Therapeutics Announces Transition of Bill Lundberg, MD", 9/21/2018 GTHX-US  GNW  G1 Therapeutics Announces Closing of Offering of Common Stock, 5/18/2017 04016X10 GNW  argenx (Nasdaq: ARGX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO,, 1/09/2019 ATNX-US  GNW  Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study," 1/08/2018 PETQ-US  GNW  PetIQ, Inc. Enters Into Definitive Agreement to Acquire VIP Petcare", 6/01/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference, 2/09/2018 OPTN-US  GNW  Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference, 3/19/2018 TORC-US  GNW  resTORbio Announces Formation of Clinical Advisory Board,,," 4/05/2018 83422E10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Solid Biosciences Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018 â€“ SLDB"," 8/15/2018 EOLS-US  GNW  Evolus, Inc. Announces Full Exercise and Closing of Underwritersâ€™ Overallotment Option",,10/30/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces First Quarter Fiscal Year 2019 Financial Results Release Date and Conference Call Information,,,,,,,,,, 6/27/2018 FTSV-US GNW  Forty Seven Prices Initial Public Offering,,,,,,,,,,,," 1/02/2019 ORTX-US  GNW  Orchard Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019",,,,,,,,,,,,
, 5/02/2019 PGNX-US  GNW  Progenics Pharmaceuticals Sets First Quarter 2019 Financial Results and Business Update Call for May 9,,,,, 5/10/2018 BDSI-US  GNW  BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update,,," 4/30/2013 82691710     GNW  SIGA to Host First Quarter Business Update Call on May 6, 2013","11/02/2018 68375N10 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ OPK", 6/13/2018 46222210 GNW  Akcea Announces Completion of Landmark Study to Assess Disease Burden in People Living with FCS,11/23/2015 BMRN-US     GNW  NICE Recommends BioMarinâ€™s VimizimÂ® (elosulfase alfa) for the Treatment of Morquio A Syndrome in England,,,," 2/19/2019 IMMU-US  GNW  Immunomedics to Report Results for the Quarter and Six Months Ended December 31, 2018 and Host Conference Call and Webcast on February 25, 2019",12/17/2018 BIIB-US   GNW  Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis,, 5/08/2019 BCRX-US  GNW  BioCryst Reports First Quarter 2019 Financial Results,,,,, 1/28/2019 AKRX-US  GNW  Akorn Announces New Executive and Board Appointments, 3/19/2012 008D8Y-E GNW  Harris & Harris Group Notes Receipt of Funds Held in Escrow From Sale of BioVex,"10/29/2019 62855J10 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action: Investors Who Suffered Significant Losses are Encouraged to Contact the Firm", 1/17/2019 LXRX-US  GNW  FDA Advisory Committee Votes on Zynquistaâ„¢ (sotagliflozin) as Treatment for Adults With Type 1 Diabetes,, 5/03/2017 INSM-US  GNW  Insmed Reports First Quarter 2017 Financial Results and Provides Business Update,, 5/21/2018 INO-US    GNW  Inovio Opens Phase 2 Trial for VGX-3100 in Third Indication To Treat HPV â€“ The No. 1 Sexually Transmitted Disease,"12/03/2018 64026810 GNW  INVESTOR NOTICE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 4/02/2019 GERN-US  GNW  Geron to Present at Needham Healthcare Conference,," 4/23/2019 02311120 GNW  CLASS ACTION DEADLINE for CAG and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,," 5/01/2019 SRPT-US  GNW  Sarepta Therapeutics to Announce First Quarter 2019 Financial Results and Recent  Corporate Developments on May 8, 2019"," 1/09/2019 07YM31-E GNW  Hagens Berman Notifies Alkermes Public Limited Company (NASDAQ: ALKS) Investors of Securities Fraud Class Action and February 25, 2019 Lead Plaintiff Deadline",,12/19/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,,, 6/21/2019 SAN-FR   GNW  Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma,,, 6/06/2018 ASND-US  GNW  Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism,, 4/24/2015 00422510 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ACADIA Pharmaceuticals Inc. of  Class Action Lawsuit and Upcoming Deadline -- ACAD, 5/18/2018 AFMD-US  GNW  Affimed Announces Annual General Meeting of Shareholders,, 9/05/2018 PRQR-US  GNW  ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares,, 5/07/2019 ZGNX-US  GNW  Zogenix to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference,,, 6/24/2014 76133010 GNW  Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares,,,12/03/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy, 1/04/2019 RARE-US   GNW  Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia, 1/18/2018 AGLE-US  GNW  Aeglea BioTherapeutics to Present Preclinical Data at 2018 Keystone Symposia Tumor Metabolism Conference," 7/31/2018 63009R10 GNW  Investor Expectations to Drive Momentum within Builders FirstSource, NanoString Technologies, Polaris Industries, Navient, NIKE, and New Oriental Education & Technology Group â€” Discovering Underlying Factors of Influence",,," 6/05/2018 RDUS-US  GNW  Radius to Host Investor Day on June 8, 2018", 3/28/2018 ASMB-US  GNW  Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congressâ„¢ (EASL),,," 9/14/2018 02043Q10 GNW  ALNYLAM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alnylam Pharmaceuticals, Inc.Â To Contact The Firm",,"10/26/2018 00972L10 GNW  Investor Expectations to Drive Momentum within Adient, BT Group, The Kraft Heinz, Teladoc, Oracle, and Akcea Therapeutics â€” Discovering Underlying Factors of Influence",," 8/02/2018 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results", 6/14/2018 RTRX-US  GNW  Retrophin Announces Expansion of Intellectual Property Estate for Sparsentan with Newly Issued U.S. Patent,11/02/2017 PACB-US  GNW  Pacific Biosciences Appoints Kathy OrdoÃ±ez as Chief Commercial Officer, 5/18/2018 EDIT-US  GNW  Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human Primates, 8/10/2017 CHMA-US  GNW  Chiasma Reports Second Quarter 2017 Results," 9/17/2019 55609910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX",,,," 4/30/2018 60877T10 GNW  Report: Developing Opportunities within Interface, Oxford Industries, CVR Energy, Cubic, Momenta Pharmaceuticals, and RadiSys â€” Future Expectations, Projections Moving into 2018", 5/24/2018 PRTA-US  GNW  Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline, 9/26/2018 ZLAB-US  GNW  Zai Lab Presents Results of its Pharmacokinetics (PK) Study for ZL-2306 (niraparib) in Chinese Ovarian Cancer Patients Showing Comparable Profile to non-Chinese Patients at the 21st Annual Meeting of the Chinese Society of Clinical Oncology,11/03/2014 78667J10 GNW  First Evaluation of SAGE-547 to Treat Super-Refractory Status Epilepticus in Children Published in Annals of Neurology, 9/25/2018 CTMX-US  GNW  CytomX to Present at Upcoming Healthcare Conferences,12/13/2018 GMAB-DK  GNW  Genmab Announces Submission of Supplemental New Drug Application for Daratumumab in Front Line Multiple Myeloma in Japan,12/01/2014 92165910 GNW  Idera Pharmaceuticals Names Vincent J. Milano Chief Executive Officer,, 5/08/2018 CBAY-US  GNW  CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis,12/20/2010 45781M10 GNW  Inova Releases 10Q, 1/03/2018 CCXI-US  GNW  ChemoCentryx to Present at the 36th Annual J.P. Morgan Healthcare Conference,,, 9/13/2018 MNKD-US   GNW  Positive AfrezzaÂ® Clinical Data from STAT Study Published in Diabetes Technology & Therapeutics,, 3/18/2019 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at ACC.19,11/08/2018 ESPR-US     GNW  Esperion to Participate in Upcoming Investor Conferences," 4/12/2019 03236M20  GNW  AMYRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amyris, Inc. - AMRS",,"12/20/2017 ACHN-US  GNW  Achillion Initiates Phase I First-In Study of ACH-5228, a Next-Generation Oral Small Molecule Inhibitor of Complement Factor D"," 3/28/2019 87166B10 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CAG, AMRN, SYNH and CRBP",10/08/2018 FOLD-US  GNW  Amicus Therapeutics Enters Research and Development Collaboration with University of Pennsylvania to Develop AAV Gene Therapies,,, 6/12/2018 ADMA-US  GNW  ADMA Biologics Announces Closing of $40M Public Offering," 7/23/2018 GWPH-US  GNW  GW Pharmaceuticals to Report Third Quarter Financial Results and Host Conference Call on 7 August, 2018","10/27/2016 EPZM-US  GNW  Epizyme to Report Business Highlights and Third Quarter 2016 Financial Results on November 3, 2016",,"10/19/2018 62857M10 GNW  Recent Analysis Shows Vipshop, MyoKardia, HudBay Minerals, Nordic American Tankers, Yum China, and TIM Participacoes S.A. Market Influences â€” Renewed Outlook, Key Drivers of Growth",, 2/21/2019 GLPG-NL  GNW  Firmly on our way to becoming a fully integrated biopharma company,"12/18/2018 PTLA-US  GNW  Portola Pharmaceuticals to Webcast Corporate Update on January 8, 2019",,,," 6/21/2018 14075510 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Camden National, Cara Therapeutics, Albany International, Emerge Energy Services LP, Fiesta Restaurant Group, and Resources Connection â€” New Research Emphasizes Economic Growth", 2/28/2019 FLXN-US  GNW  Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2018 Financial Results,"10/18/2018 QURE-US  GNW  uniQure Announces Development of a  Highly Potent, Next-Generation Promoter for Liver-Directed Gene Therapies",11/16/2018 AGIO-US   GNW  Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma, 9/26/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at the 2018 Cantor Global Healthcare Conference,10/10/2017 ANAB-US  GNW  AnaptysBio Files Registration Statement for Proposed Public Offering,, 9/13/2018 FATE-US  GNW  Fate Therapeutics Enters into Exclusive License Agreement with Gladstone Institutes for CRISPR-based Cellular Reprogramming," 8/03/2017 HZNP-US  GNW  Horizon Pharma plc Appoints Pascale Witz and James Shannon, M.D. to Board of Directors",, 4/04/2018 ICPT-US  GNW  Intercept Pharmaceuticals Announces Proposed $120 Million Public Offering and Concurrent $92 Million Private Placement of Common Stock," 9/04/2019 48576U10   GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Karyopharm Therapeutics Inc. To Contact The Firm",,," 9/25/2018 ITCI-US  GNW  Intra-Cellular Therapies Appoints Michael Olchaskey as Senior Vice President, Head of Regulatory Affairs",,,," 9/25/2017 AMPH-US  GNW  Amphastar Announces Approval for Neostigmine Methylsulfate Injection, USP", 8/06/2018 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),, 2/17/2018 DERM-US  GNW  New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology,10/01/2018 FOMX-US  GNW  Foamix Announces Additional Positive Topline Results from Third Phase 3 Trial (Study FX2017-22) Evaluating FMX101 Topical Minocycline Foam for Moderate-to-Severe Acne, 8/14/2017 PRAH-US  GNW  PRA Health Sciences Announces Appointment of New Director,11/06/2017 SUPN-US  GNW  Supernus Announces Third Quarter 2017 Financial Results, 8/07/2018 FGEN-US  GNW  FibroGen Reports Second Quarter 2018 Financial Results,, 1/07/2019 06R6L0-E GNW  Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners, 3/26/2019 21833P10 GNW  SHAREHOLDER ALERT: STMP VNDA USX CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,12/04/2017 COLL-US  GNW  Collegium to License Rights to Commercialize Nucynta Franchise, 1/19/2018 XBIT-US  GNW  XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa,,, 1/02/2019 GBT-US   GNW  GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference,11/02/2016 RGNX-US  GNW  REGENXBIO to Host Conference Call on November 9 to Discuss Third Quarter 2016 Financial Results and Recent Operational Highlights,10/22/2018 KURA-US  GNW  Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC," 1/31/2019 APLS-US  GNW  Apellis Pharmaceuticals Appoints Thomas Lackner as Senior Vice President, Head of Europe",12/10/2018 AXSM-US  GNW  Axsome Therapeutics Announces Positive Outcome of Interim Analysis of ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimerâ€™s Disease Agitation, 4/30/2018 VYGR-US  GNW  Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2018 Annual Meeting, 6/14/2019 BGNE-US  GNW  BeiGene Announces Clinical Results from Three Posters on Zanubrutinib Presented at the 24th Congress of European Hematology Association (EHA),, 3/22/2018 RETA-US  GNW  Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial, 6/04/2018 44842L10 GNW  Chi-Med Presents Further Fruquintinib FRESCO Trial Data at ASCO 2018 Annual Meeting,11/01/2017 NTLA-US  GNW  Intellia Therapeutics Announces Proposed Public Offering of Common Stock, 7/06/2018 ACIU-US  GNW  AC Immune Announces Results of Annual General Meeting, 1/04/2018 CRSP-US  GNW  CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares, 9/18/2018 GTHX-US  GNW  G1 Therapeutics Announces Pricing of Offering of Common Stock,,, 1/03/2019 ATNX-US  GNW  Chongqing Jingdong Pharmaceutical and Athenex Announce a Strategic Partnership and Licensing Agreement to Develop and Commercialize KX2-391 in China," 1/02/2018 PETQ-US  GNW  PetIQ, Inc. to Participate in the 2018 ICR Conference", 5/14/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results, 1/02/2018 OPTN-US  GNW  Optinose Announces $100 Million Debt Financing from Athyrium Capital Management, 2/20/2018 TORC-US  GNW  resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference,,," 4/05/2018 07YM31-E GNW  Hagens Berman Alerts Solid Biosciences, Inc. Investors to the May 29, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action", 8/02/2018 EOLS-US  GNW  Evolus Reports Second Quarter 2018 Financial Results,,"10/30/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints John Landis, Ph.D., M.S., to Board of Directors",,,,,,,,,,,,,,,,,,,,,,12/14/2018 ORTX-US  GNW  Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency,,,,,,,,,,,,
, 4/24/2019 PGNX-US  GNW  Results from Clinical Trial Show Progenicsâ€™ PyL (18F-DCFPyL) PSMA PET/CT Imaging Agent Changes Management Plans for More Than 87% of Patients,,,,, 5/07/2018 BDSI-US  GNW  BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer,,, 3/12/2013 82691710     GNW  SIGA Delivers First Courses of Arestvyr(TM) Under BARDA Contract,"11/02/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK, QRTEA and PVG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 6/01/2018 46222210 GNW  Akcea and Ionis Receive Positive EU CHMP Opinion for TEGSEDI,11/20/2015 BMRN-US     GNW  BioMarin Announces Data Analysis Demonstrating Consistent Efficacy of Kyndrisaâ„¢ (drisapersen) in Comparable Patients Across Three Randomized Studies,,,," 2/15/2019 IMMU-US  GNW  IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU",12/06/2018 IONS-US   GNW  Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data,, 5/06/2019 BCRX-US  GNW  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,, 1/09/2019 AKRX-US  GNW  Akorn Receives FDA Warning Letter, 3/01/2012 AMGN-US  GNW  C3 Jian Appoints Vice President Product Development,"10/28/2019 62855J10 GNW  ROSEN, A HIGHLY RANKED LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities Class Action â€“ MYGN", 1/17/2019 LXRX-US  GNW  Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for the Treatment of Type 1 Diabetes,, 4/27/2017 INSM-US  GNW  Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference,, 5/17/2018 INO-US    GNW  Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for Prostate Cancer,"12/02/2018 64026810 GNW  CLASS ACTION UPDATE for GOOG, OZK, IGCC and NKTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 3/28/2019 GERN-US  GNW  Geron Appoints Two New Independent Board Members,," 4/12/2019 02311120 GNW  AKRX, HIIQ & AMRN - Class Action Reminder Bronstein, Gewirtz & Grossman, LLC",,, 4/30/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 1/07/2019 G0176710 GNW  CLASS ACTION UPDATE for PRGO and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,12/13/2018 AMAG-US  GNW  AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals,,,,, 6/18/2019 SAN-FR   GNW  Sanofi and Google to develop new healthcare Innovation LabÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ,,, 5/30/2018 ASND-US  GNW  Ascendis Pharma A/S Reports First Quarter 2018 Financial Results,," 3/23/2015 00422510 GNW  Hagens Berman Alerts ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Investors With Over $100,000 in Losses of May 12th Lead Plaintiff Deadline", 5/15/2018 AFMD-US  GNW  Affimed Reports Financial Results for First Quarter 2018,," 9/05/2018 PRQR-US  GNW  ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial",," 5/03/2019 98978L20 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of SCOR, MWA, and ZGNX of Upcoming Deadlines",,, 6/18/2014 76133010 GNW  Revance Therapeutics Announces Pricing of Its Public Offering of Common Stock,,,11/19/2018 ADVM-US  GNW  Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration, 1/03/2019 RARE-US   GNW  Ultragenyx to Present at J.P. Morgan Healthcare Conference,12/07/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference," 7/23/2018 NSTG-US  GNW  NanoString Technologies Announces Closing of Public Offering of 4,000,000 Shares of Common Stock",,, 5/11/2018 RDUS-US  GNW  Radius Health to Present at the Bank of America Merrill Lynch 2018 Annual Healthcare Conference, 3/12/2018 ASMB-US  GNW  Assembly Biosciences Announces Additions to Management Team and Board of Directors,,," 8/13/2018 02043Q10 GNW  Arbutusâ€™ LNP Licensee Alnylam Announces FDA Approval of ONPATTROâ„¢ (patisiran), for the Treatment of ATTR Amyloidosis",,10/22/2018 AKCA-US  GNW  Akcea Therapeutics to Hold Third Quarter 2018 Financial Results Webcast,," 7/25/2018 PCRX-US  GNW  Pacira to Report Second Quarter 2018 Financial Results on Thursday August 2, 2018"," 6/06/2018 76129910 GNW  Research Report Identifies Corbus Pharmaceuticals, Retrophin, Charter Financial, HighPoint Resources, Southern First Bancshares, and Oaktree Specialty Lending with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement","11/02/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2017 Financial Results", 5/08/2018 EDIT-US  GNW  Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference, 8/10/2017 CHMA-US  GNW  Chiasma Reaches Agreement with FDA Under Special Protocol Assessment for a New Phase 3 Clinical Trial of Octreotide Capsules in Acromegaly," 9/17/2019 55609910 GNW  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",,,," 3/21/2018 00619R-E GNW  Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc."," 5/22/2018 G7280010 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Prothena Corporation plc (Nasdaq: PRTA) To Contact Brower Piven Before The Lead Plaintiff Deadline", 9/25/2018 ZLAB-US  GNW  Zai Lab to Participate in the Leerink Rare Disease & Immuno-Oncology Roundtable,10/23/2014 78667J10 GNW  SAGE Therapeutics Initiates Exploratory Study of SAGE-547 in Essential Tremor, 8/08/2018 CTMX-US  GNW  CytomX Therapeutics Announces Second Quarter 2018 Financial Results,11/14/2018 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2018," 8/23/2013 92165910 GNW  Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA",," 5/01/2018 CBAY-US  GNW  CymaBay to Report First Quarter 2018 Financial Results on Tuesday, May 8",12/16/2010 45781M10 GNW  Inova Announces a $20.7 Million Backlog of Awarded and Funded Projects,11/17/2017 CCXI-US  GNW  ChemoCentryx to Participate at the Piper Jaffray 29th Annual Healthcare Conference,,, 9/04/2018 56400P70  GNW  United Therapeutics and MannKind Announce Collaboration for Pulmonary Hypertension Products,, 3/11/2019 CYTK-US  GNW  Cytokinetics Announces Additional Results From  COSMIC-HF to be Presented at ACC.19,11/01/2018 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2018 Financial Results, 4/11/2019 03236M20  GNW  A Securities Class Action Has Been Filed Against Amyris; Block & Leviton LLP Encourages Shareholders to Contact the Firm,,12/18/2017 ACHN-US  GNW  Achillion Announces ACH-4471 Granted Orphan Drug Designation for the Treatment of C3 Glomerulopathy (C3G) and the Initiation of a Phase 1 Extended-Release Bioavailability Study," 3/27/2019 87166B10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Syneos Health, Inc. To Contact The Firm",10/05/2018 FOLD-US  GNW  Amicus Therapeutics Announces Positive 18-Month Data in Pompe Disease Phase 1/2 Study at 23rd International Annual Congress of the World Muscle Society,,, 6/08/2018 ADMA-US  GNW  ADMA Biologics Announces Pricing of Public Offering of Common Stock, 6/27/2018 36197T10 GNW  Isodiol International Inc. Applauds the FDAâ€™s Decision to Recognize the Medical Benefits of CBD at Higher Concentrations and Announces Corporate Restructure," 9/29/2016 EPZM-US  GNW  Epizyme Appoints Pamela Strode as Vice President, Regulatory Affairs and Quality Assurance",, 9/24/2018 MYOK-US  GNW  MyoKardia to Present at the 2018 Cantor Global Healthcare Conference,, 2/07/2019 GLPG-NL  GNW  Evotec and Galapagos enter into collaboration in the field of fibrosis,12/11/2018 PTLA-US  GNW  CHMP Extends Review Period for Portola Pharmaceuticalsâ€™ Ondexxyaâ„¢ (andexanet alfa),,,, 5/29/2018 CARA-US  GNW  Cara Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference, 2/26/2019 FLXN-US  GNW  Flexion Therapeutics to Present at the 40th Annual Raymond James Institutional Investors Conference,10/17/2018 QURE-US  GNW  uniQure Presents New Data Demonstrating Its Large-Scale Manufacturing Capabilities at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting,"11/08/2018 00847X10  GNW  New Research Coverage Highlights John B. Sanfilippo & Son, Axcelis Technologies, Cogent Communications, Star Bulk Carriers, Agios Pharmaceuticals, and MDC Partners â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 8/29/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at Two Investor Conferences in September,10/10/2017 ANAB-US  GNW  AnaptysBio Reports Positive Topline Proof-of-Concept Data from Phase 2a Clinical Trial of ANB020 in Atopic Dermatitis,," 8/31/2018 31189P10 GNW  Research Report Identifies Kronos Worldwide, The Gap, Citigroup, Cadence Design, SPX FLOW, and Fate Therapeutics with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 7/25/2017 HZNP-US  GNW  Horizon Pharma plc Launches CGD Connectionsâ„¢ to Deliver Support and Resources Created by and for the Chronic Granulomatous Disease (CGD) Community,, 3/26/2018 ICPT-US  GNW  Intercept to Present at Upcoming Conference," 9/04/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,," 9/05/2018 46116X10 GNW  New Research: Key Drivers of Growth for Intra-Cellular Therapies, The, Bassett Furniture Industries, NVE, Equity Bancshares, and Cable One â€” Factors of Influence, Major Initiatives and Sustained Production",,,, 9/20/2017 AMPH-US  GNW  Amphastar Pharmaceuticals Receives FDA Approval for Sodium Bicarbonate Injection, 8/01/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Second Quarter 2018 Financial Results and Recent Operational Progress,, 2/12/2018 DERM-US  GNW  Dermira Showcases Commitment to Hyperhidrosis Education and Treatment at Leading Dermatology Conference, 9/26/2018 FOMX-US  GNW  Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference," 8/09/2017 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Pricing of Secondary Offering of 10,000,000 Shares of Common Stock",10/24/2017 SUPN-US  GNW  Supernus to Host Third Quarter 2017 Earnings Conference Call," 8/01/2018 FGEN-US  GNW  FibroGen to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018",, 1/02/2019 CHRS-US  GNW  Coherus BioSciences Management to Present at The 37th Annual J.P. Morgan Healthcare Conference Â Â ," 3/21/2019 21833P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc. â€“ CRBP",,11/22/2017 COLL-US  GNW  Collegium to Present at the 29th Annual Piper Jaffray Healthcare Conference,12/04/2017 XBIT-US  GNW  XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative Dermatology,,,12/21/2018 GBT-US   GNW  GBT Appoints Dawn Svoronos to Board of Directors,10/04/2016 RGNX-US  GNW  REGENXBIO to Present at the Jefferies Gene Editing and Gene Therapy Summit, 9/26/2018 KURA-US  GNW  Kura Oncology to Present at Leerink Partners Rare Disease & Oncology Roundtable, 1/02/2019 APLS-US  GNW  Apellis Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference,11/27/2018 AXSM-US  GNW  Axsome Therapeutics Expands Loan Agreement with Silicon Valley Bank Providing Additional Growth Capital Related to AXS-12 Product Candidate," 4/27/2018 92915B10 GNW  Report: Exploring Fundamental Drivers Behind W.R. Grace, NCI Building, Robert Half International, CACI International, PROS, and Voyager Therapeutics â€” New Horizons, Emerging Trends, and Upcoming Developments", 6/14/2019 BGNE-US  GNW  BeiGene Announces Updated Results from a Pivotal Phase 2 Study of Tislelizumab in Chinese Patients with Relapsed or Refractory Classical Hodgkin Lymphoma at the 24th Congress of the European Hematology Association (EHA),, 3/16/2018 RETA-US  GNW  Reata Selected to Present Early-Stage Programs at the BIO Asia International Conference, 5/11/2018 HCM-GB   GNW  Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference,10/31/2017 NTLA-US  GNW  Intellia Therapeutics Announces  Third Quarter 2017 Financial Results," 6/08/2018 H0026310 GNW  Research Report Identifies AC Immune SA, Vipshop, Infosys, STMicroelectronics N.V., BRF S.A., and National Steel with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 1/03/2018 CRSP-US  GNW  CRISPR Therapeutics Announces Proposed Public Offering of Common Shares, 9/17/2018 004GJQ-E GNW  G1 Therapeutics Announces Proposed Offering of Common Stock,,,"12/26/2018 0JS6YK-E GNW  Athenex Pharmaceutical Division, an Athenex, Inc. Company, Launches Levothyroxine Sodium for Injection","11/06/2017 PETQ-US  GNW  PetIQ, Inc. Reports Third Quarter Fiscal 2017 Financial Results", 5/09/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at the Bank of America Merrill Lynch 2018 Health Care Conference,12/07/2017 OPTN-US  GNW  Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference," 2/14/2018 TORC-US  GNW  resTORbio, Inc. (Nasdaq: TORC) to Ring The Nasdaq Stock Market Opening Bell",,, 4/03/2018 0F98BD-E GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Solid Biosciences Inc. and Certain Officers â€“ SLDB, 8/02/2018 EOLS-US  GNW  Evolus Announces Early Resubmission to the FDA of its Biologics License Application for DWP-450,,10/29/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Presents Positive YUTIQâ„¢ 24-month Follow-up Data at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,12/13/2018 ORTX-US  GNW  Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California,,,,,,,,,,,,
, 4/03/2019 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference,,,,, 5/03/2018 BDSI-US  GNW  BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital,,, 3/06/2013 82691710     GNW  SIGA Technologies Reports Financial Results for the Fourth Quarter and Year Ended 2012,"11/01/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qurate, OPKO Health and Cocrystal and Encourages Investors to Contact the Firm", 5/29/2018 IONS-US  GNW  Akcea Therapeutics to Present at the Jefferies Global Healthcare Conference,11/20/2015 BMRN-US     GNW  FDA Posts Briefing Documents for Advisory Committee Meeting to Review Kyndrisaâ„¢ (drisapersen) for the Potential Treatment of Duchenne Muscular Dystrophy Amendable to Exon 51 Skipping,,,," 2/14/2019 45290710 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Immunomedics, Inc. Investors",11/29/2018 09062X10  GNW  International Prix Galien Recognizes SPINRAZAÂ® as Best Biotechnology Product,, 4/24/2019 BCRX-US  GNW  BioCryst to Report First Quarter 2019 Financial Results on May 8,,,,, 1/08/2019 AKRX-US  GNW  Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"11/14/2011 IMGN-US  GNW  ImmunoGen, Inc. Earns Milestone Payment From Amgen With IND Achievement for Second TAP Compound","10/28/2019 62855J10 GNW  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Myriad Genetics, Inc.",12/21/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,," 4/26/2017 INSM-US  GNW  Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017",," 5/15/2018 INO-US    GNW  Inovio HIV Vaccine, Which Generated Near 100% Immune Responses, Sustained Durable Memory Responses Measured One Year After  The Start of Clinical Trial","11/30/2018 64026810 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â NKTR",, 3/21/2019 GERN-US  GNW  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),," 4/11/2019 02311120 GNW  CLASS ACTION UPDATE for UXIN, AMRN, UMC and BA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,, 4/08/2019 SRPT-US  GNW  Sarepta Therapeuticsâ€™ Gene Therapy Limb-Girdle Muscular Dystrophy Type 2E Clinical Data has been Accepted for a Late-breaking Oral Presentation at the 2019 MDA Clinical and Scientific Conference," 1/07/2019 G0176710 GNW  Alkermes plc, Inc. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Alkermes plc, Inc.",,12/03/2018 AMAG-US  GNW  Study of Feraheme demonstrates Improvements in  Fatigue and Quality Of Life in Iron Deficiency Anemia Patients,,,,, 6/09/2019 SAN-FR   GNW  SoliquaÂ® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments,,, 5/16/2018 ASND-US  GNW  Ascendis Pharma A/S Announces First Quarter 2018 Financial Results and Business Update Conference Call on May 30,," 3/16/2015 00422510 GNW  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. -- ACAD", 5/08/2018 AFMD-US  GNW  Affimed Announces First Quarter 2018 Financial Results and Corporate Update Conference Call,, 8/15/2018 PRQR-US  GNW  ProQR to Present Interim Phase 1/2 Results for QR-110 in Leberâ€™s Congenital Amaurosis 10 at the Symposium for Retinal Degeneration on Sept. 5th,," 5/02/2019 98978L20 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zogenix, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ZGNX",,, 6/16/2014 76133010 GNW  Revance Therapeutics Announces Proposed Public Offering of Common Stock,,,11/13/2018 ADVM-US  GNW  Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference,12/06/2018 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvitaâ„¢ (burosumab injection) for the Treatment of Xâ€“linked Hypophosphatemia (XLH) in Adults and Children,11/29/2017 AGLE-US  GNW  Aeglea BioTherapeutics Doses First Pediatric Patient with Arginase 1 Deficiency in its Phase 1/2 Trial with Pegzilarginase (AEB1102)," 7/17/2018 NSTG-US  GNW  NanoString Technologies Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock",,, 5/10/2018 RDUS-US  GNW  Radius Health Reports First Quarter 2018 Financial and Operating Results and Provides Business Update, 3/05/2018 ASMB-US  GNW  Assembly Biosciences to Present at Cowenâ€™s 38th Annual Healthcare Conference,,," 6/27/2018 02043Q10 GNW  Report: Developing Opportunities within Valvoline, Parker Drilling, Dean Foods, BioPharmX, Hasbro, and Alnylam Pharmaceuticals â€” Future Expectations, Projections Moving into 2018",,10/08/2018 00972L10 GNW  Akcea Announces Changes to Board of Directors,, 7/10/2018 PCRX-US  GNW  Pacira Reports Preliminary Net EXPARELÂ® Sales of $80.4 Million for Second Quarter of 2018, 6/04/2018 RTRX-US  GNW  Retrophin Announces Pivotal Phase 3 FORT Study of Fosmetpantotenate in PKAN Opens Enrollment to Pediatric Patients,"10/20/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Third Quarter 2017 Financial Results Call", 5/03/2018 EDIT-US  GNW  Editas Medicine Announces First Quarter 2018 Results and Update," 6/19/2017 CHMA-US  GNW  Chiasma Appoints Roni Mamluk, Ph.D. to Board of Directors"," 9/17/2019 55609910 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In MacroGenics, Inc. To Contact The Firm",,,, 3/05/2018 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 5/08/2018 PRTA-US  GNW  Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update, 9/12/2018 ZLAB-US  GNW  Zai Lab to Host Conference Call to Discuss its License and Collaboration Agreement with Novocure for Tumor Treating Fields in Greater China, 9/25/2014 78667J10 GNW  SAGE Therapeutics to Participate in the 2014 Leerink Partners Rare Disease Roundtable, 8/07/2018 CTMX-US  GNW  CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference,10/29/2018 GMAB-DK  GNW  Genmab Announces Positive Topline Results in Phase III MAIA Study of Daratumumab in Front Line Multiple Myeloma," 8/21/2013 92165910 GNW  UPCOMING DEADLINE: Levi & Korsinsky Reminds Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and of August 26, 2013 Deadline to Seek a Lead Plaintiff Position -- VNDA",, 4/11/2018 CBAY-US  GNW  CymaBay Announces Positive New 12-Week and 26-Week Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis at The International Liver Congressâ„¢ 2018,12/08/2010 45781M10 GNW  Inova Launches iPhone App for Trade Show Lead Capture,11/07/2017 CCXI-US  GNW  ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights,,, 8/29/2018 MNKD-US   GNW  MannKind Corporation to Present at Upcoming Conferences,, 3/07/2019 CYTK-US  GNW  Cytokinetics Announces Presentation of Results From FORTITUDE-ALS at the American Academy of Neurology 71st Annual Meeting,10/28/2018 ESPR-US     GNW  Esperion Announces Completion of Phase 3 LDL-C Lowering Development Program of Bempedoic Acid and Positive Cumulative Results," 4/11/2019 03236M20  GNW  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Amyris, Inc.",,11/15/2017 ACHN-US  GNW  Achillion Announces Pricing of Secondary Offering Of Common Stock," 3/27/2019 87166B10 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc.",10/02/2018 FOLD-US  GNW  Amicus Therapeutics Announces Presentation and Poster at the 23rd International Congress of the World Muscle Society,,, 6/07/2018 ADMA-US  GNW  ADMA Biologics Announces Proposed Public Offering of Common Stock, 6/25/2018 0JBRH7-E GNW  GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEXÂ® (cannabidiol) oral solution â€“ the First Plant-derived Cannabinoid Prescription Medicine, 9/21/2016 EPZM-US  GNW  Epizyme Establishes Collaboration with Foundation Medicine to Support Tazemetostat Phase 2 Clinical Trial,, 8/29/2018 MYOK-US  GNW  MyoKardia to Present at Two Upcoming Investor Conferences in September,, 1/08/2019 GLPG-NL  GNW  Sands Capital reports 5.7% holding in Galapagos,12/03/2018 PTLA-US  GNW  Updated Interim Results from Ongoing Phase 2a Study of Portola Pharmaceuticalsâ€™  Oral Syk/JAK Inhibitor Cerdulatinib Continues to Demonstrate Clinical Responses  in Heavily Pre-Treated T-Cell Malignancies,,,, 5/23/2018 CARA-US  GNW  Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensing Agreement to Commercialize KORSUVAâ„¢ Injection in Dialysis Patients with Pruritus, 2/21/2019 FLXN-US  GNW  Flexion Therapeutics Announces New In Vitro Data Showing Protective Effects of Triamcinolone Acetonide on Cartilage,10/16/2018 QURE-US  GNW  uniQure Announces Presentations at the Upcoming Annual Meeting of  The European Society of Gene and Cell Therapy (ESGCT),11/01/2018 AGIO-US   GNW  Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting, 8/16/2018 IOVA-US  GNW  Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center," 8/24/2017 ANAB-US  GNW  AnaptysBio Announces Appointment of J. Anthony Ware, M.D. to Board of Directors",, 8/29/2018 FATE-US  GNW  Fate Therapeutics to Present at Upcoming Investor Conferences, 7/14/2017 HZNP-US  GNW  Horizon Pharma plc Announces Four Poster Presentations on PROCYSBIÂ®Â (Cysteamine Bitartrate)  Delayed-Release Capsules at Cystinosis Research Network 2017 Family Conference,, 3/23/2018 ICPT-US  GNW  Intercept Announces Multiple New OcalivaÂ® (obeticholic acid) Data Presentations at the International Liver Congressâ„¢ 2018," 9/04/2019 48576U10   GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INS, OMCL, KPTI and CAH",,," 8/20/2018 ITCI-US  GNW  Intra-Cellular Therapies Appoints Dr. Suresh Durgam as Senior Vice President, Late Stage Clinical Development and Medical Affairs",,,, 8/30/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference, 7/31/2018 ATRA-US    GNW  Atara Biotherapeutics to Participate in the Canaccord Genuity 38th Annual Growth Conference,, 2/09/2018 DERM-US  GNW  Dermira to Present at Leerink Partners 7th Annual Global Healthcare Conference, 9/18/2018 FOMX-US  GNW  Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters," 8/08/2017 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Secondary Offering of 10,000,000 Shares of Common Stock", 9/18/2017 SUPN-US  GNW  Supernus Provides Update on SPN-810 Phase III Clinical Trials, 6/07/2018 FGEN-US  GNW  FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease,," 1/02/2019 CHRS-US  GNW  Coherus BioSciences Appoints Darlene Horton, M.D., Chief Medical and Regulatory Affairs Officer"," 3/21/2019 21833P10 GNW  CORBUS PHARMACEUTICALS HOLDINGS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action  lawsuit  has  been  filed  in  the  United States  District Court  for  the District of Massachusetts against Corbus Pharmaceuticals Holdings, Inc.",,11/08/2017 COLL-US  GNW  Collegium Reports Third Quarter Financial Results and Provides Corporate Update,11/14/2017 XBIT-US  GNW  XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific Sessions,,,12/07/2018 GBT-US   GNW  Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering, 9/13/2016 RGNX-US  GNW  REGENXBIO Publishes Data from Ongoing Preclinical Studies of NAVÂ® Gene Therapy  in Neurodegenerative Diseases, 8/30/2018 KURA-US  GNW  Kura Oncology to Present at H.C. Wainwright Global Investment Conference,12/20/2018 APLS-US  GNW  Apellis Pharmaceuticalsâ€™ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of C3 Glomerulopathy,11/19/2018 AXSM-US  GNW  Axsome Therapeutics to Participate in 2018 Global Mizuho Investor Conference, 3/14/2018 VYGR-US  GNW  Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results, 6/12/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on Zanubrutinib to Be Presented at the 15th International Conference on Malignant Lymphoma (ICML),," 3/02/2018 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2017 Financial and Operating Results", 3/17/2016 44842L10 GNW  Nasdaq Welcomes Hutchison China MediTech Limited to The Nasdaq Stock Market,10/30/2017 NTLA-US  GNW  Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2017 Earnings, 5/02/2018 ACIU-US  GNW  AC Immune Reports First Quarter 2018 Financial Results and Corporate Update,12/21/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board, 9/17/2018 GTHX-US  GNW  G1 Therapeutics to Report Myelopreservation Data from Randomized Phase 2 Trial of Trilaciclib/Chemotherapy/TecentriqÂ® in Small Cell Lung Cancer in Fourth Quarter 2018,,,12/11/2018 ATNX-US  GNW  CORRECTION: Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,"10/19/2017 PETQ-US  GNW  PetIQ, Inc. to Report Third Quarter 2017 Results on Monday, November 6th", 5/09/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Nature Medicine Publication of Longer-Term Data from Phase 2 Study of Setmelanotide for Treatment of LEPR Deficiency Obesity,11/27/2017 OPTN-US  GNW  Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights, 1/30/2018 TORC-US  GNW  resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,," 4/03/2018 SLDB-US  GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Solid Biosciences Inc. (SLDB)Â and Lead Plaintiff Deadline: May 28, 2018"," 7/26/2018 EOLS-US  GNW  Evolus to Release Second Quarter 2018 Financial Results on Thursday, August 2, 2018",,10/18/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Data Highlighting YUTIQâ„¢ to be Presented at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,12/07/2018 ORTX-US  GNW  Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors,,,,,,,,,,,,
, 4/03/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the 2019 American Urological Association (AUA) Annual Meeting,,,,," 4/30/2018 BDSI-US  GNW  BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2018 Financial Results on Thursday, May 10",,," 3/01/2013 82691710     GNW  SIGA to Host Fourth Quarter and Year End Business Update Call on March 6, 2013",10/31/2018 68375N10 GNW  SHAREHOLDER ALERT: OPK PVG USAT ABBV CHGG ACHC JT ADNT GOOG CWH OZK DY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 5/10/2018 46222210 GNW  FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome,11/16/2015 BMRN-US     GNW  Ernst & Young Names BioMarin CEO Jean-Jacques Bienaime EY Entrepreneur Of The YearÂ® 2015 National Award Winner in Life Sciences,,,," 2/14/2019 45290710 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ IMMU","10/29/2018 09062X10  GNW  New Research Coverage Highlights Rite Aid, The Boeing, Cabot, Biogen, McDonald's, and Pegasystems â€” Consolidated Revenues, Company Growth, and Expectations for 2018",, 4/01/2019 BCRX-US  GNW  BioCryst to Present at Upcoming Investor Conferences,,,,,12/20/2018 AKRX-US  GNW  Akorn Names Douglas S. Boothe as President and CEO,"11/03/2011 IMGN-US  GNW  ImmunoGen, Inc. Earns Milestone From Amgen With IND Achievement",10/28/2019 MYGN-US  GNW  Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting,12/20/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes,, 2/28/2017 INSM-US  GNW  Insmed to Present at the Cowen and Company 37th Annual Health Care Conference,, 5/09/2018 INO-US    GNW  Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results,"11/30/2018 64026810 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Nektar Therapeutics To Contact The Firm",, 3/07/2019 GERN-US  GNW  Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events,, 4/10/2019 02311120 GNW  Zhang Investor Law Reminds Investors of April 23 Deadline in Securities Class Action Lawsuit Against Amarin Corporation plc â€“ AMRN,,, 3/29/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/17/2018 BIIB-US  GNW  Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis,,11/29/2018 AMAG-US  GNW  AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia,,,,, 6/07/2019 SAN-FR   GNW  Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer,,, 5/08/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Dosing of First Subjects in Phase 1 Trial of TransCon CNP,, 5/13/2013 CLVS-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index, 5/03/2018 AFMD-US  GNW  Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference,, 8/08/2018 PRQR-US  GNW  ProQR Announces Financial Results for the Second Quarter of 2018,," 5/01/2019 98978L20 GNW  ZGNX CLASS ACTION REMINDER: Hagens Berman Reminds Zogenix (ZGNX) Investors of Securities Class Action, Encourages Investors Who Suffered Losses of $50,000+ to Contact the Firm",,," 5/21/2014 76133010 GNW  Revance Therapeutics Clinical Data to be Presented in ""Emerging Technologies"" Panel at the International Symposium of Facial Plastic Surgery in New York City",,,11/08/2018 ADVM-US  GNW  Adverum Biotechnologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update,11/14/2018 RARE-US   GNW  Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019,11/07/2017 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results, 7/16/2018 NSTG-US  GNW  NanoString Technologies Announces Commencement of Public Offering of Common Stock,,," 4/24/2018 RDUS-US  GNW  Radius Health to Announce First Quarter 2018 Financial Results, Host Conference Call and Live Webcast on May 10, 2018", 2/05/2018 ASMB-US  GNW  Assembly Biosciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference,,,12/15/2017 SAN-FR   GNW  Sanofi: FDA lifts clinical hold on fitusiran,,10/05/2018 00972L10 GNW  Akcea Announces Its Access and Distribution Strategy for TEGSEDIâ„¢ (inotersen),, 6/19/2018 0GXD90-E GNW  Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPARELÂ® in China, 5/24/2018 RTRX-US  GNW  Retrophin to Present at Upcoming Investor Conferences,10/16/2017 PACB-US  GNW  Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes, 4/30/2018 EDIT-US  GNW  Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the American Society of Gene & Cell Therapy Annual Meeting, 5/05/2017 CHMA-US  GNW  Chiasma Reports First Quarter 2017 Results," 9/04/2019 55609910 GNW  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",,,, 2/21/2018 MNTA-US  GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update, 5/01/2018 PRTA-US  GNW  Prothena to Report First Quarter 2018 Financial Results on May 8, 9/05/2018 ZLAB-US  GNW  Zai Lab Announces Pricing of Public Offering of American Depositary Shares, 9/16/2014 78667J10 GNW  SAGE Therapeutics Appoints Michael F. Cola to the Company's Board of Directors," 8/03/2018 23284F10 GNW  Report: Developing Opportunities within OMNOVA Solutions, Natural Health Trends, Vocera Communications, Oppenheimer, CytomX Therapeutics, and The Ultimate Software Group â€” Future Expectations, Projections Moving into 2018",10/21/2018 GMAB-DK  GNW  Genmab Announces Positive Topline Results in Phase III CASSIOPEIA Study of Daratumumab in Front Line Multiple Myeloma," 8/16/2013 92165910 GNW  Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA",, 3/15/2018 CBAY-US  GNW  CymaBay Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Corporate Update,12/02/2010 45781M10 GNW  Inova Resumes Trading on OTCBB,11/03/2017 CCXI-US  GNW  Presentations at ASN Kidney Week 2017 Highlight ChemoCentryx Platform in Treatment of Kidney Diseases ANCA-Associated Vasculitis and Focal Segmental Glomerulosclerosis (FSGS),,," 8/28/2018 56400P70  GNW  Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results",, 2/28/2019 CYTK-US  GNW  Cytokinetics Joins Global Initiative  To Recognize International Rare Disease Day,10/28/2018 ESPR-US     GNW  Esperion Announces Positive Top-Line Results from Final Pivotal Phase 3 Study of Bempedoic Acid," 4/11/2019 03236M20  GNW  AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action  lawsuit  has  been  filed  in  the  United States  District Court  for Northern District of California against Amyris, Inc.",,11/14/2017 ACHN-US  GNW  Achillion Announces Proposed Secondary Offering of Common Stock," 3/26/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP Reminds Syneos Health, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit", 9/26/2018 FOLD-US  GNW  Amicus Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology,,, 5/16/2018 ADMA-US  GNW  ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections, 6/06/2018 GWPH-US  GNW  GW Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference, 9/15/2016 EPZM-US  GNW  Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor,, 8/23/2018 MYOK-US  GNW  New Insights on Disease Burden for Hypertrophic Cardiomyopathy Patients Published in Circulation,," 1/07/2019 GLPG-NL  GNW  Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos",11/07/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update,,,, 5/14/2018 CARA-US  GNW  Cara Therapeutics to Present at the International Investigative Dermatology 2018 MeetingÂ ," 2/20/2019 FLXN-US  GNW  Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2018 Financial Results on February 28, 2019", 9/28/2018 QURE-US  GNW  uniQure to Participate in Multiple Upcoming Industry Conferences,11/01/2018 AGIO-US   GNW  Agios Reports Third Quarter 2018 Financial Results, 8/06/2018 IOVA-US  GNW  Iovance Biotherapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update, 8/10/2017 ANAB-US  GNW  AnaptysBio Announces Second Quarter 2017 Financial Results and Provides Pipeline Updates,, 8/07/2018 FATE-US  GNW  Fate Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference," 7/10/2017 HZNP-US  GNW  Horizon Pharma plc to Host Second-Quarter 2017 Conference Call and Webcast on Aug. 7, 2017",, 3/13/2018 ICPT-US  GNW  CORRECTING and REPLACING -- Intercept to Present at Upcoming Conference," 9/03/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ideanomics, Eagle Bancorp, Karyopharm Therapeutics, and National General Holdings and Encourages Investors to Contact the Firm",,," 8/15/2018 46116X10 GNW  Detailed Research: Economic Perspectives on Neos Therapeutics, Federated National Holding, FutureFuel, Golden Entertainment, Intra-Cellular Therapies, and HTG Molecular Diagnostics â€” What Drives Growth in Today's Competitive Landscape",,,," 8/09/2017 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017", 6/25/2018 ATRA-US    GNW  Atara Biotherapeutics Opens State-of-the-Art Operations and Manufacturing Facility to Support Robust Off-the-Shelf T-Cell Immunotherapy Pipeline,, 2/08/2018 DERM-US  GNW  Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 9/13/2018 FOMX-US  GNW  Foamix Announces Pricing of its Follow-on Offering of Ordinary Shares," 8/07/2017 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Second Quarter 2017 Results and Updates Full Year 2017 Guidance", 8/15/2017 SUPN-US  GNW  Supernus Defeats Second Generic Challenger to Oxtellar XRÂ®, 6/04/2018 FGEN-US  GNW  FibroGen to Present at Two Upcoming Investor Conferences,,12/19/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 3/19/2019 21833P10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASTE, CAG, INGN and CRBP",,11/07/2017 COLL-US  GNW  Collegium Receives FDA Approval for sNDA for XtampzaÂ® ER,11/03/2017 XBIT-US  GNW  XBiotechâ€™s MABp1 to be Featured in Oral Presentation at the American Heart Association Scientific Sessions,,,12/06/2018 GBT-US   GNW  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock, 9/07/2016 RGNX-US  GNW  REGENXBIO to Participate in Global Healthcare Conferences, 8/07/2018 KURA-US  GNW  Kura Oncology to Present at 2018 Wedbush PacGrow Healthcare Conference,12/20/2018 APLS-US  GNW  Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy,11/14/2018 AXSM-US  GNW  Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder, 3/09/2018 VYGR-US  GNW  Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinsonâ€™s Disease, 6/05/2019 BGNE-US  GNW  BeiGene to Present at the Goldman Sachs 40th Annual Global Healthcare Conference,, 3/01/2018 RETA-US  GNW  Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients With Mitochondrial Myopathies, 3/17/2016 44842L10 GNW  Hutchison China MediTech Limited (Nasdaq: HCM) to Ring The Nasdaq Stock Market Closing Bell in Celebration of IPO,10/03/2017 NTLA-US  GNW  Intellia Therapeutics to Present at October Healthcare Investor Conferences, 4/27/2018 ACIU-US  GNW  AC Immune Announces Results of Extraordinary Shareholders Meeting,"12/10/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for Î²-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting", 9/13/2018 GTHX-US  GNW  G1 Therapeutics Announces Appointment of Garry Nicholson to Board of Directors,,,12/11/2018 ATNX-US  GNW  Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer," 8/14/2017 PETQ-US  GNW  PetIQ, Inc. Reports Second Quarter Fiscal 2017 Financial Results", 4/02/2018 4502-JP  GNW  Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda for the Development and Commercialization of Preclinical Treatment for Prader-Willi Syndrome,"11/20/2017 OPTN-US  GNW  Optinose to Report Third Quarter 2017 Financial Results and Operational Highlights on November 27, 2017",,,, 3/29/2018 SLDB-US  GNW  Solid Biosciences Reports Full Year 2017 Financial Results and Provides Corporate Update," 7/18/2018 EOLS-US  GNW  Evolus, Inc. Announces Pricing of Public Offering of Common Stock",,10/15/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Receives FDA Approval of YUTIQâ„¢ (fluocinolone acetonide intravitreal implant) 0.18 mg,,,,,,,,,,,,,,,,,,,,,,"12/05/2018 ORTX-US  GNW  Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting",,,,,,,,,,,,
, 3/14/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update,,,,, 3/15/2018 BDSI-US  GNW  CORRECTING and REPLACING -- BioDelivery Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update,,,11/29/2012 82691710     GNW  ST-246(R) to be Branded Arestvyr(TM),"10/30/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK, PVG and USAT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/26/2018 46222210 GNW  Akcea Therapeutics Announces Presentations on Volanesorsen and FCS at the National Lipid Association Scientific Sessions,10/29/2015 BMRN-US     GNW  BioMarin Announces Third Quarter 2015 Financial Results and Company Update,,,," 2/13/2019 45290710 GNW  CLASS ACTION UPDATE for ARLO, IMMU, DBVT and YRIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",10/26/2018 4523-JP   GNW  Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimerâ€™s Disease (CTAD),," 3/06/2019 09058V10 GNW  Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics â€” Future Expectations, Projections Moving into 2019",,,,,"12/07/2018 AKRX-US  GNW  Supreme Court of the State of Delaware Rules Against Akorn, New CEO Search Underway","10/20/2011 IMGN-US  GNW  ImmunoGen, Inc. Earns Milestone With Start of SAR3419 Phase II Testing","10/24/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tencent Music, Myriad Genetics, Overstock.com, and Waitr Holdings and Encourages Investors to Contact the Firm",12/18/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211,, 2/23/2017 INSM-US  GNW  Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update,," 4/30/2018 INO-US    GNW  Inovio Pharmaceuticals to ReportÂ First Quarter 2018 Financial Results on May 9, 2018","11/30/2018 64026810 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOOG, OZK, NKTR, FIT and TSRO",," 2/28/2019 GERN-US  GNW  Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019",," 4/08/2019 02311120 GNW  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In AMRN, KHC, DPLO or VNDAÂ To Contact The Firm",,, 3/28/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Positive Expression Results from the Casimersen (SRP-4045) Arm of the ESSENCE Study,"11/19/2018 G0176710 GNW  INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alkermes plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",,"11/08/2018 00163U10 GNW  Detailed Research: Economic Perspectives on KB Home, Lennox International, CorVel, Acorda Therapeutics, PROS, and AMAG Pharmaceuticals â€” What Drives Growth in Today's Competitive Landscape",,,,, 6/02/2019 SAN-FR   GNW  Phase 3 trial of isatuximab combination therapy showed 40% reduction in the risk of disease progression or death for patients with relapsed/refractory multiple myeloma,,, 5/07/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Poster Presentation on TransCon PTH Phase 1 Trial at the European Congress of Endocrinology,,, 5/03/2018 AFMD-US  GNW  Affimed Introduces ROCK(TM) Platform for Tailored Immune Cell Engagers,, 8/01/2018 PRQR-US  GNW  ProQR Announces Publication on QR-110 for Leberâ€™s Congenital Amaurosis 10 in the Journal Molecular Therapy - Nucleic Acids,, 5/01/2019 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,," 5/21/2014 76133010 GNW  Revance Therapeutics, Inc. Announces Participation in Jefferies 2014 Global Healthcare Conference",,,"11/08/2018 00773U10 GNW  Investor Expectations to Drive Momentum within Consolidated Edison, MUELLER WATER PRODUCTS, Adverum Biotechnologies, Buckeye Partners, inTest, and Live Nation Entertainment â€” Discovering Underlying Factors of Influence",11/09/2018 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences,11/02/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present Preclinical Data at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting, 7/16/2018 NSTG-US  GNW  NanoString Technologies Provides Preliminary Revenue Results for Second Quarter 2018,,, 3/30/2018 RDUS-US  GNW  Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis, 2/02/2018 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),,,"12/05/2017 SRPT-US  GNW  Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors",,10/05/2018 00972L10 GNW  Akcea and Ionis Receive FDA Approval of TEGSEDIâ„¢ (inotersen) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults,," 6/18/2018 69512710 GNW  Consolidated Research: 2018 Summary Expectations for Microchip Technology, New Jersey Resources, Brown-Forman, Pacira Pharmaceuticals, Team, and Solaris Oilfield Infrastructure â€” Fundamental Analysis, Key Performance Indications", 5/23/2018 RTRX-US  GNW  Retrophin Receives Workplace Excellence Award,10/03/2017 PACB-US  GNW  Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting, 4/26/2018 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing First Quarter 2018 Corporate Update and Results, 3/30/2017 CHMA-US  GNW  Chiasma Announces Poster Presentation at ENDO 2017 on Evaluation of Acromegaly Symptoms from the Newly Developed Acromegaly Treatment Satisfaction Questionnaire, 8/29/2019 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences,,,, 2/13/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces FDA Approval and Launch of GlatopaÂ® (glatiramer acetate injection) 40 mg/mL, 4/23/2018 PRTA-US  GNW  Prothena Discontinues Development of NEOD001 for AL Amyloidosis, 9/02/2018 ZLAB-US  GNW  Zai Lab Announces Proposed Public Offering of American Depositary Shares,, 7/30/2018 CTMX-US  GNW  CytomX Therapeutics to Announce Second Quarter 2018 Financial Results,10/16/2018 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for Third Quarter of 2018," 8/14/2013 92165910 GNW  VANDA PHARMACEUTICALS DEADLINE ALERT: Levi & Korsinsky Notifies Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position -- VNDA",," 3/06/2018 CBAY-US  GNW  CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15","11/23/2010 45781M10 GNW  Inova Commences Work On $365,000 Network Solutions Project","11/01/2017 CCXI-US  GNW  ChemoCentryx to Hold Third Quarter 2017 Financial Results Conference Call on Tuesday, November 7, 2017",,, 8/02/2018 MNKD-US   GNW  MannKind Corporation Reports 2018 Second Quarter Financial ResultsÂ Conference Call to Begin Today at 5:00 PM ET,, 2/21/2019 CYTK-US  GNW  Cytokinetics Reports Fourth Quarter 2018 Financial Results,10/18/2018 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 4/11/2019 03236M20  GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Amyris, Inc. (AMRS)",,11/14/2017 ACHN-US  GNW  Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G," 3/26/2019 87166B10 GNW  CLASS ACTION UPDATE for SPB, STMP, VNDA and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 9/25/2018 03152W10 GNW  Report: Exploring Fundamental Drivers Behind Ocean Power Technologies, Amicus Therapeutics, Interpace Diagnostics Group, The Progressive, Fanhua, and Parsley Energy â€” New Horizons, Emerging Trends, and Upcoming Developments",,, 5/14/2018 ADMA-US  GNW  ADMA Biologics Reports First Quarter 2018 Financial Results, 5/16/2018 GWPH-US  GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of EpidiolexÂ® (cannabidiol oral solution) in Lennox-Gastaut Syndrome, 9/01/2016 C-US     GNW  Epizyme to Present at Upcoming Investor Conferences,," 8/21/2018 62857M10 GNW  Analysis: Positioning to Benefit within Alamos Gold, Nomad Foods, MyoKardia, Mesoblast, Core-Mark Holding, and Jounce Therapeutics â€” Research Highlights Growth, Revenue, and Consolidated Results",, 1/07/2019 GLPG-NL  GNW  Galapagos starts first Phase 1 trial with Toledo compound,11/06/2018 PTLA-US  GNW  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences,,,, 5/09/2018 CARA-US  GNW  Cara Therapeutics Reports First Quarter 2018 Financial Results, 2/11/2019 FLXN-US  GNW  Flexion Therapeutics Announces Publication of Data from Repeat Administration Trial of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in Rheumatology and Therapy, 9/24/2018 QURE-US  GNW  uniQure Provides Update on Dose-Confirmation Study  of AMT-061 in Patients with Hemophilia B,"10/18/2018 AGIO-US   GNW  Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018"," 7/30/2018 IOVA-US  GNW  Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018", 8/08/2017 ANAB-US  GNW  AnaptysBio to Present at Wedbush PacGrow Healthcare Conference,, 8/06/2018 FATE-US  GNW  Fate Therapeutics Reports Second Quarter 2018 Financial Results and Highlights Operational Progress, 6/27/2017 HZNP-US  GNW  Horizon Pharma plc Announces District Court Decision to Uphold VIMOVOÂ® (naproxen/esomeprazole magnesium) Patents,, 3/13/2018 ICPT-US  GNW  Intercept to Present at Upcoming Conference, 9/03/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 8/02/2018 ITCI-US  GNW  Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2018 Financial Results,,,," 8/02/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017", 6/15/2018 ATRA-US    GNW  Atara Biotherapeuticsâ€™ Tab-celâ„¢ Achieves Positive Long-Term Outcomes in Phase 2 Studies of Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas,, 1/31/2018 DERM-US  GNW  Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis, 9/12/2018 FOMX-US  GNW  Foamix Announces Proposed Follow-on Offering of Ordinary Shares," 8/07/2017 PRAH-US  GNW  PRA Health Sciences to acquire Symphony Health Solutions, a leading provider of integrated health data and analytics delivered as cloud-based solutions", 8/02/2017 SUPN-US  GNW  Supernus Announces Record Second Quarter 2017 Financial Results, 6/03/2018 FGEN-US  GNW  FibroGen Presents Clinical Results of Pamrevlumab Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer at ASCO 2018 Annual Meeting,,"11/30/2018 CHRS-US  GNW  Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS"," 3/17/2019 21833P10 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DBVT, AMRN, WTW and CRBP",,11/06/2017 COLL-US  GNW  Collegium Notified that the FDA Will Not Meet PDUFA Goal Date for sNDA for XtampzaÂ® ER,"11/02/2017 98400H10 GNW  IMPORTANT   XBIOTECH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas on behalf of investors who purchased and suffered losses in XBiotech, Inc.",,,12/04/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 8/16/2016 RGNX-US  GNW  Daniel TassÃ© Appointed to REGENXBIO Board of Directors, 8/06/2018 KURA-US  GNW  Kura Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update,12/03/2018 APLS-US  GNW  Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at ASH,11/09/2018 AXSM-US  GNW  Axsome Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update, 2/27/2018 VYGR-US  GNW  Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call, 6/04/2019 BGNE-US  GNW  BeiGene Chief Executive Officer John V. Oyler Elected to BIO Board of Directors,, 2/27/2018 RETA-US  GNW  Reata Provides Program Update on Phase 2 Rare Renal Clinical Trials,, 9/26/2017 NTLA-US  GNW  Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal Study, 4/05/2018 ACIU-US  GNW  AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer's disease,"12/07/2017 CRSP-US  GNW  CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in Î²-thalassemia"," 8/28/2018 GTHX-US  GNW  G1 Therapeutics to Present at H.C. Wainwright Investment Conference on September 5, 2018",,,12/06/2018 ATNX-US  GNW  Athenex to Host an R&D Day on December 17 in New York," 8/07/2017 PETQ-US  GNW  PetIQ, Inc. to Report Second Quarter 2017 Results on Monday, August 14th"," 3/19/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018",11/17/2017 OPTN-US  GNW  Optinose to Present at Piper Jaffray Healthcare Conference,,,," 3/28/2018 83422E10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Solid Biosciences, Inc. (SLDB)"," 7/16/2018 EOLS-US  GNW  Evolus, Inc. Announces Proposed Public Offering of Common Stock",,10/01/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Proceeds of $28.9 Million from Exercised Warrants,,,,,,,,,,,,,,,,,,,,,,11/08/2018 ORTX-US  GNW  Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations,,,,,,,,,,,,
," 3/14/2019 NOVN-CH  GNW  Progenics Asserts Ownership of PSMA-617 Intellectual Property, Including Composition of Matter Patent",,,,, 3/15/2018 BDSI-US  GNW  BioDelivery Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update,,,11/05/2012 82691710     GNW  SIGA Technologies Reports Financial Results for the Third Quarter of 2012,"10/29/2018 68375N10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SKX, OPK, PVG, ALNY and CPB", 4/26/2018 46222210 GNW  Akcea Therapeutics to Hold First Quarter 2018 Financial Results Webcast,10/27/2015 BMRN-US     GNW  BioMarin to Attend Upcoming Investor Conference in November,,,," 2/12/2019 45290710 GNW  CLASS ACTION UPDATE for ARLO, SOGO, IMMU and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",10/25/2018 09062X10  GNW  Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimerâ€™s Disease at the 2018 Clinical Trials on Alzheimerâ€™s Disease (CTAD) Conference,, 3/04/2019 BCRX-US  GNW  BioCryst Reports Fourth Quarter and Full Year 2018 Financial Results,,,,,11/26/2018 AKRX-US  GNW  Akorn Receives Product Approval, 5/06/2011 TURN-US  GNW  Harris & Harris Group Announces the Promotion of Misti Ushio to Managing Director and Executive Vice President,"10/23/2019 62855J10 GNW  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMINDS MYGN INVESTORS OF CLASS ACTION: Myriad Genetics (MYGN) Investors Who Suffered Significant Losses are Encouraged to Contact the Firm",11/29/2018 LXRX-US  GNW  FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes,," 2/16/2017 INSM-US  GNW  Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017",, 4/11/2018 INO-US    GNW  Inovio Awarded up to $56 Million from CEPIÂ to Advance DNA Vaccines Against Lassa Fever and MERS,"11/28/2018 64026810 GNW  CLASS ACTION UPDATE for NKTR, GSKY and RBBN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 1/31/2019 GERN-US  GNW  Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer,, 4/07/2019 02311120 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation plc of Class Action Lawsuit and Upcoming Deadline â€“ AMRNÂ Â ,,, 3/25/2019 SRPT-US  GNW  Sarepta Therapeutics to Provide Update on Duchenne Muscular Dystrophy Gene Therapy Program,11/15/2018 G0176710 GNW  Alkermes Losses Alert: Bernstein Liebhard LLP Announces First Investigation of Alkermes plc - ALKS,,11/06/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 5/07/2019 SAN-FR   GNW  Sanofi : DupixentÂ® (dupilumab) Approved for Severe Asthma by European Commission,,, 4/25/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentations,,, 4/16/2018 AFMD-US  GNW  Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy,, 7/12/2018 PRQR-US  GNW  ProQR Announces Presentations on Programs in Ophthalmology at Conferences in July,," 5/01/2019 98978L20 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm",,, 5/13/2014 76133010 GNW  Revance Therapeutics Releases First Quarter 2014 Financial Results,,,11/01/2018 ADVM-US  GNW  Adverum Biotechnologies Provides Program Updates,"11/09/2018 90400D10  GNW  Report: Exploring Fundamental Drivers Behind AcelRx Pharmaceuticals, Fossil Group, FMC, Ultragenyx Pharmaceutical, Shenandoah Telecommunications, and Marcus & Millichap â€” New Horizons, Emerging Trends, and Upcoming Developments",10/16/2017 AGLE-US  GNW  Aeglea BioTherapeutics Announces Clinical Collaboration with Merck to Evaluate the Combination of Aegleaâ€™s AEB1102 (pegzilarginase) with Merckâ€™s KEYTRUDAÂ® (pembrolizumab) for the Treatment of Small Cell Lung Cancer," 7/09/2018 NSTG-US  GNW  NanoString to Release Second Quarter 2018 Financial Results and Host Conference Call on Tuesday, August 7, 2018",,, 3/22/2018 RDUS-US  GNW  Radius Health Provides Update on CHMP Opinion for  Abaloparatide-SC, 1/04/2018 ASMB-US  GNW  Assembly Biosciences to Present at the J.P. Morgan Healthcare Conference,,,11/16/2017 02043Q10 GNW  Arbutusâ€™ LNP Licensee Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisiran,,10/04/2018 AKCA-US  GNW  Akcea and Ionis Announce Approval of TEGSEDIâ„¢ (inotersen injection) in Canada,," 6/15/2018 AET-US   GNW  Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPARELÂ®", 5/01/2018 RTRX-US  GNW  Retrophin Reports First Quarter 2018 Financial Results," 8/02/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2017 Financial Results", 3/28/2018 EDIT-US  GNW  Editas Medicine Names James C. Mullen as Chairman of the Board of Directors, 3/16/2017 CHMA-US  GNW  Chiasma Reports Fourth Quarter and Year End 2016 Results, 8/08/2019 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences,,,, 2/08/2018 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the LEERINK Partners 7th Annual Global Healthcare Conference, 3/20/2018 G7280010 GNW  Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases," 8/30/2018 ZLAB-US  GNW  Zai Lab Announces Financial Results and Corporate Progress for the Six Months ended June 30, 2018",, 7/17/2018 CTMX-US  GNW  CytomX Therapeutics Announces Closing of Public Offering of Common Stock, 9/18/2018 GMAB-DK  GNW  Capital Increase in Genmab as a Result of Employee Warrant Exercise," 8/09/2013 92165910 GNW  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Vanda Pharmaceuticals, Inc. to Contact the Firm -- VNDA",, 3/05/2018 CBAY-US  GNW  CymaBay Therapeutics to Participate in Upcoming Investor Conferences in March,"11/18/2010 45781M10 GNW  Inova Commences Work on $350,000 Network Solutions Projects", 9/05/2017 CCXI-US  GNW  ChemoCentryx to Present at Three Upcoming Investor Conferences,,, 7/27/2018 0FKLNL-E  GNW  MannKind and Tanner Pharma Group Enter into an ex-U.S. Distribution Agreement for AfrezzaÂ®,," 2/21/2019 CYTK-US  GNW  Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure","10/17/2018 29664W10    GNW  New Research Coverage Highlights Esperion Therapeutics, Summit Therapeutics, Ocwen Financial, Keane Group, Cellectis S.A, and Rapid7 â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 4/11/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Maiden Holdings, Uxin, Molson Coors, and Amyris and Encourages Investors to Contact the Firm",,11/06/2017 ACHN-US  GNW  Achillion Announces ACH-4471 Granted Orphan Drug Designation by the FDA and Positive Opinion for Orphan Drug Designation in the European Union for the Treatment of Paroxysmal Nocturnal Hemoglobinuria," 3/25/2019 87166B10 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: TAP, AKRX, SYNH, CTL", 9/20/2018 FOLD-US  GNW  Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders,,, 5/14/2018 BIO3-DE  GNW  ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest, 5/08/2018 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal Second Quarter 2018 Financial Results and Operational Progress, 8/11/2016 EPZM-US  GNW  Epizyme Doses First Patient in Global Phase 2 Study Evaluating Tazemetostat in Mesothelioma,, 8/08/2018 MYOK-US  GNW  MyoKardia Reports Second Quarter 2018 Financial Results,, 1/06/2019 GLPG-NL  GNW  Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis,11/01/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement Grants  Under NASDAQ Listing Rule 5635(c)(4),,,," 5/02/2018 CARA-US  GNW  Cara Therapeutics to Announce First Quarter 2018 Financial Results on May 9, 2018"," 2/08/2019 FLXN-US  GNW  Flexion Therapeutics to Ring Nasdaq Stock Market Opening Bell on Tuesday, February 12", 8/30/2018 QURE-US  GNW  uniQure to Participate at Multiple Upcoming Conferences,"10/04/2018 00847X10  GNW  New Research Coverage Highlights Camden Property Trust, Agios Pharmaceuticals, Crane, BorgWarner, Cognizant Technology Solutions, and Liberty Broadband â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 6/07/2018 IOVA-US  GNW  Iovance Biotherapeutics Announces First Patient Dosed in Europe for Ongoing C-144-01 Phase 2 Trials in Metastatic Melanoma, 6/01/2017 ANAB-US  GNW  AnaptysBio to Participate in Upcoming Investor Conferences,, 7/30/2018 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2018 Financial Results," 6/23/2017 HZNP-US  GNW  Horizon Pharma plc Completes Sale of European Marketing Rights for PROCYSBIÂ® (cysteamine bitartrate) delayed-release capsules and QUINSAIRâ„¢ (levofloxacin nebuliser solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farmaceutici S.p.A.",, 2/14/2018 ICPT-US  GNW  Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results and Provides Business Update," 9/02/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 7/26/2018 ITCI-US  GNW  Intra-Cellular Therapies to Host Second Quarter 2018 Financial Results Conference Call and Webcast,,,," 7/24/2017 AMPH-US  GNW  Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.", 6/13/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Publication of New Research Linking Epstein-Barr Virus (EBV) Infection and Multiple Sclerosis (MS),,11/09/2017 DERM-US  GNW  Dermira to Present at Upcoming Investor Conferences in November, 9/11/2018 FOMX-US  GNW  Foamix Announces Positive Topline Results from Third Phase 3 Trial (Study FX2017-22) Evaluating FMX101 Topical Minocycline Foam for Moderate-to-Severe Acne, 7/25/2017 PRAH-US  GNW  PRA Health Sciences to Report 2nd Quarter 2017 Earnings, 7/19/2017 SUPN-US  GNW  Supernus to Host Second Quarter 2017 Earnings Conference Call, 5/21/2018 FGEN-US  GNW  FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary FibrosisÂ at American Thoracic Society 2018,,11/27/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 3/15/2019 21833P10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc.  â€“ CRBP",,10/30/2017 COLL-US  GNW  Collegium to Host Conference Call to Discuss Third Quarter 2017 Financial Results and Provide Corporate Update,"10/26/2017 0BGL4K-E GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in XBiotech, Inc. and Set a Lead Plaintiff Deadline of December 26, 2017 -- XBIT",,,12/03/2018 GBT-US   GNW  GBT Announces Positive 24-week Results from Phase 3 HOPE Study Demonstrating Clinically and Statistically Significant Improvements inÂ Hemoglobin and Clinical Measures of Hemolysis and a Favorable Safety Profile, 8/09/2016 RGNX-US  GNW  REGENXBIO Reports Second Quarter 2016 Financial Results and Recent Operational Highlights," 7/31/2018 KURA-US  GNW  Kura Oncology Appoints Marc Grasso, M.D., as Chief Financial Officer and Chief Business Officer",12/02/2018 APLS-US  GNW  Apellis Pharmaceuticals Presents Updated Data from a Clinical Study of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria at ASH,"11/01/2018 AXSM-US  GNW  Axsome Therapeutics to Report Third Quarter 2018 Financial Results on November 9, 2018", 2/26/2018 VYGR-US  GNW  Voyager Therapeutics to Present at Cowen Health Care Conference, 6/01/2019 BGNE-US  GNW  BeiGene Announces Preliminary Phase 2 Results of Tislelizumab in Chinese Patients with Nasopharyngeal Cancer at the 2019 ASCO Annual Meeting,, 2/12/2018 RETA-US  GNW  Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial,, 9/07/2017 NTLA-US  GNW  Intellia Therapeutics to Present at Upcoming September Investor Healthcare Conferences, 3/20/2018 ACIU-US  GNW  AC Immune reports full-year 2017 financial results - successful first year as a public company,"12/05/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Medicine for Î²-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting", 8/08/2018 GTHX-US  GNW  G1 Therapeutics Provides Second Quarter 2018 Corporate and Financial Update,,,11/29/2018 04685N10 GNW  Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories," 7/21/2017 71639T10 GNW  Nasdaq Welcomes PetIQ, Inc. (Nasdaq: PETQ) to The Nasdaq Stock Market", 3/12/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results,11/08/2017 00CN92-E GNW  Optinose to Present at Jefferies 2017 London Healthcare Conference,,,," 3/28/2018 0FCNPT-E GNW  SOLID BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB", 6/22/2018 EOLS-US  GNW  Clinical Overview of PrabotulinumtoxinA for the Investigational Treatment  of Frown Lines to Be Featured During Summer Cosmetic Bootcamp 2018,, 9/12/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,"11/05/2018 ORTX-US  GNW  Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including theÂ Partial Exercise of Underwritersâ€™ Option",,,,,,,,,,,,
, 3/11/2019 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRAÂ® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting,,,,, 3/14/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference,,,"10/29/2012 82691710     GNW  SIGA to Host Third Quarter Business Update Call on November 5, 2012",10/28/2018 68375N10 GNW  SHAREHOLDER ALERT: SKX OPK PM PVG TGTX CPB SFIX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 4/21/2018 IONS-US  GNW  Akcea Therapeutics to Present Data on Inotersen for the Treatment of hATTR Amyloidosis at the 2018 American Academy of Neurology Annual Meeting,"10/15/2015 BMRN-US     GNW  BioMarin to Host Third Quarter 2015 Financial Results Conference Call and Webcast on Thursday, October 29 at 4:30pm ET",,,, 2/11/2019 IMMU-US  GNW  Immunomedics Announces Oral Presentation at the 2019 Genitourinary Cancers Symposium,10/23/2018 UCB-BE    GNW  UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus,," 3/04/2019 BCRX-US  GNW  BioCryst Advancing BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases, into Phase 1 Development",,,,,"11/07/2018 00972810 GNW  Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Akorn, Inc. (AKRX) and Encourages AKRX Investors to Contact the Firm", 3/15/2011 AMGN-US  GNW  Genmab A/S Summons Annual General Meeting,10/23/2019 MYGN-US  GNW  FDA Approves Myriadâ€™s myChoiceÂ® CDx Test to Help Identify Women Eligible for Treatment with ZejulaÂ® in Late-line Ovarian Cancer,"11/12/2018 52887230 GNW  Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus â€” Future Expectations, Projections Moving into 2018",, 2/14/2017 INSM-US  GNW  Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent,, 4/02/2018 INO-US    GNW  Inovio Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference,11/26/2018 64026810 GNW  SHAREHOLDER ALERT: HAS CPB ADNT SFIX GOOG CWH OZK NKTR AQUA RBBN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,," 1/17/2019 GERN-US  GNW  Geron Appoints Vice President, Pharmacovigilance and Drug Safety",," 4/02/2019 02311120 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm",,," 3/06/2019 80360710 GNW  Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics â€” Future Expectations, Projections Moving into 2019"," 9/27/2018 G0176710 GNW  Consolidated Research: 2018 Summary Expectations for Pan American Silver, Invesco, Diodes, INVESCO MORTGAGE CAPITAL INC, Alkermes plc, and Golar LNG Partners LP â€” Fundamental Analysis, Key Performance Indications",,11/01/2018 AMAG-US  GNW  AMAG Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update,,,,," 4/30/2019 SAN-FR   GNW  Sanofi: Annual General Meeting of April 30, 2019",,, 4/02/2018 ASND-US  GNW  Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer,,, 3/20/2018 AFMD-US  GNW  Affimed Reports Financial Results for Fourth Quarter  and Year End 2017,, 6/28/2018 PRQR-US  GNW  ProQR Initiates Phase 1/2 Clinical Trial of QR-313 for Dystrophic Epidermolysis Bullosa,, 5/01/2019 ZGNX-US  GNW  Zogenix to Release First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 8,,, 5/12/2014 008ZWN-E GNW  Revance Appoints Mark A. Prygocki to Its Board of Directors,,,10/17/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors,11/05/2018 RARE-US   GNW  Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update, 9/06/2017 AGLE-US  GNW  Aeglea BioTherapeutics Doses Two Patients in Repeat Dose Part of Phase 1/2 Clinical Trial for the Treatment of Arginase 1 Deficiency, 6/18/2018 NSTG-US  GNW  NanoString Establishes Netherlands Cancer Institute as aÂ Center of Excellence for Digital Spatial Profiling,,, 3/17/2018 RDUS-US  GNW  Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOSâ„¢ (abaloparatide) Injection at ENDO 2018 Annual Meeting,"12/18/2017 ASMB-US  GNW  Assembly Biosciences Appoints Sue Mahony, PhD to Board of Directors",,,11/13/2017 02043Q10 GNW  Arbutusâ€™ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA),,10/04/2018 AKCA-US  GNW  Akcea and Ionis Announce Approval of TEGSEDIâ„¢ (inotersen injection) in Canada,, 5/31/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference, 4/17/2018 RTRX-US  GNW  Retrophin to Report First Quarter 2018 Financial Results, 8/02/2017 PACB-US  GNW  PacBio Announces New Agreement with Novogene to Purchase Ten Sequel Systems, 3/06/2018 EDIT-US  GNW  Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update, 3/01/2017 CHMA-US  GNW  Chiasma to Present at the Cowen and Company 37th Annual Health Care Conference, 7/31/2019 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Second Quarter 2019 Financial Results,,,, 2/07/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast, 3/12/2018 PRTA-US  GNW  Prothena to Present a Broad Range of Scientific and Health Outcomes Data at the 16th International Symposium on Amyloidosis, 8/28/2018 ZLAB-US  GNW  Zai Lab Doses First Patient in Phase III Trial of ZL-2306 (niraparib) in Patients with Small-Cell Lung Cancer in China,, 7/12/2018 CTMX-US  GNW  CytomX Therapeutics Announces Pricing of Public Offering of Common Stock, 8/31/2018 GMAB-DK  GNW  Genmab Announces European Marketing Authorization for DARZALEXÂ® (daratumumab) for Front Line Multiple Myeloma," 8/02/2013 92165910 GNW  Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA",, 2/06/2018 CBAY-US  GNW  CymaBay Therapeutics to Participate in Investor Conferences in February,, 8/08/2017 CCXI-US  GNW  ChemoCentryx Reports Second Quarter 2017 Financial Results and Recent Highlights,,," 7/27/2018 MNKD-US   GNW  MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018",," 2/20/2019 CYTK-US  GNW  Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator", 8/27/2018 ESPR-US     GNW  Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Bempedoic Acid / Ezetimibe Combination Pill Study," 4/10/2019 03236M20  GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Amyris, Inc.",,11/01/2017 ACHN-US  GNW  Achillion Reports Third Quarter 2017 Financial Results and Provides Update on Clinical Programs," 3/25/2019 87166B10 GNW  Lawsuit for Investors in NASDAQ: SYNH shares against Syneos Health, Inc. announced by Shareholders Foundation", 9/11/2018 FOLD-US  GNW  Amicus Therapeutics Announces Board Appointments,,, 4/24/2018 ADMA-US  GNW  ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership, 5/08/2018 GWPH-US  GNW  GW Pharmaceuticals to Present at Bank of America Merrill Lynch 2018 Health Care Conference, 8/08/2016 EPZM-US  GNW  Epizyme Announces Second Quarter 2016 Financial Results and Progress Against Corporate Objectives,, 8/07/2018 MYOK-US  GNW  MyoKardia to Present at the 2018 Wedbush Pacgrow Healthcare Conference,, 1/04/2019 GLPG-NL  GNW  Fibrocor and Galapagos sign partnership in fibrosis,11/01/2018 PTLA-US  GNW  Portola Pharmaceuticals to Present New Interim Phase 2 Results for Cerdulatinib During an Oral Session at the 60th American Society of Hematology (ASH) Annual Meeting,,,, 4/10/2018 CARA-US  GNW  Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation, 2/01/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 8/23/2018 QURE-US  GNW  uniQure Announces First Patient Treated in Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B, 9/04/2018 AGIO-US   GNW  Agios Announces Chief Executive Officer Succession Plan, 5/31/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at Two Investor Conferences in June, 5/11/2017 ANAB-US  GNW  AnaptysBio Announces First Quarter 2017 Financial Results and Provides Pipeline Update,," 7/27/2018 31189P10 GNW  Recent Analysis Shows Synopsys, Rigel Pharmaceuticals, Fate Therapeutics, Philip Morris International, Sally Beauty, and Kimberly-Clark Market Influences â€” Renewed Outlook, Key Drivers of Growth", 6/20/2017 HZNP-US  GNW  Horizon Pharma plc Partners with Global GenesÂ® to Unite the Rare Disease Community at the Biotechnology Innovation Organization (BIO) International Convention,, 2/12/2018 ICPT-US  GNW  Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients with Compensated Cirrhosis," 8/30/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 7/23/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Publication Highlighting ITI-214 Mechanism of Action and Describing Positive Results in Preclinical Models of Heart Failure,,,, 6/01/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference, 6/07/2018 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,11/06/2017 DERM-US  GNW  Dermira Reports Third Quarter 2017 Financial Results and Announces that FDA Accepts New Drug Application for Glycopyrronium Tosylate for the Treatment of Patients with Primary Axillary Hyperhidrosis, 8/08/2018 FOMX-US  GNW  Foamix Reports Second Quarter 2018 Financial Results and Provides Corporate Update, 6/19/2017 PRAH-US  GNW  PRA Health Sciences and Jumo Announce Partnership, 6/21/2017 SUPN-US  GNW  Supernus Announces that its Partner Shire Receives FDA Approval for Mydayisâ„¢ for ADHD, 5/09/2018 FGEN-US  GNW  FibroGen Reports First Quarter 2018 Financial Results,,11/12/2018 CHRS-US  GNW  Coherus BioSciences Management to Present at the 27th Annual Credit Suisse Healthcare Conference, 3/15/2019 21833P10 GNW  SHAREHOLDER ALERT: DBVT VALE SVXY CRBP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 9/06/2017 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences,10/18/2017 XBIT-US  GNW  XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivydeâ“‡ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer,,,12/03/2018 GBT-US   GNW  GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA), 8/08/2016 RGNX-US  GNW  Daniel J. Abdun-Nabi Appointed to REGENXBIO Board of Directors, 7/30/2018 KURA-US  GNW  Kura Oncology to Report Second Quarter 2018Â Financial Results,"11/20/2018 APLS-US  GNW  Apellis Pharmaceuticals Expands Leadership Team, Appoints Adam Townsend as Chief Commercial Officer",10/18/2018 AXSM-US  GNW  Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Alzheimerâ€™s Disease Agitation, 2/20/2018 92915B10 GNW  Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimerâ€™s Disease and Other Tau-Related Neurodegenerative Diseases, 5/30/2019 BGNE-US  GNW  BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANEÂ® in Metastatic Pancreatic Cancer,, 1/18/2018 RETA-US  GNW  Reata Announces the Publication of Efficacy Data From the Beacon Study of Bardoxolone in Diabetic CKD in the American Journal of Nephrology,, 8/01/2017 NTLA-US  GNW  Â Intellia Therapeutics AnnouncesÂ Second Quarter 2017 Financial Results, 3/15/2018 ACIU-US  GNW  AC Immune prepares for a first in human study of a promising positron emission tomography (PET) tracer for Parkinson's disease,11/28/2017 CRSP-US  GNW  CRISPR Therapeutics to Participate in Upcoming Investor Conferences," 8/07/2018 GTHX-US  GNW  G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 14, 2018",,,11/26/2018 ATNX-US  GNW  Athenex Announces Initiation of a Phase I/II Clinical Study of Oraxol in Combination with Anti-PD1," 7/20/2017 PETQ-US  GNW  PetIQ, Inc. Announces Pricing of Initial Public Offering", 3/07/2018 RYTM-US  GNW  Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March,10/24/2017 00CN92-E GNW  Optinose (Nasdaq: OPTN) to Ring The Nasdaq Stock Market Opening Bell,,,, 3/14/2018 SLDB-US  GNW  Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy, 6/18/2018 EOLS-US  GNW  Evolus Expands Management Team with Appointment of Michael Mazen Jafar as Chief Marketing Officer,," 9/10/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Elects GÃ¶ran Ando, M.D. as Next Chairman of Board of Directors",,,,,,,,,,,,,,,,,,,,,,10/30/2018 68570P10 GNW  Orchard Therapeutics Announces Pricing of Initial Public Offering,,,,,,,,,,,,
, 3/07/2019 PGNX-US  GNW  Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2018 Financial Results and Business Update Call for March 14,,,,," 3/07/2018 BDSI-US  GNW  BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2017 Financial Results on Thursday, March 15",,, 8/06/2012 82691710     GNW  SIGA Technologies Reports Financial Results for the Second Quarter of 2012,"10/26/2018 68375N10 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â OPK", 4/17/2018 IONS-US  GNW  Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors,10/15/2015 BMRN-US     GNW  BioMarin Announces FDA Advisory Committee to Review Drisapersen for Treatment of Patients With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,," 2/11/2019 45290710 GNW  CLASS ACTION UPDATE for IMMU, MKL, GSM and VALE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",10/18/2018 BIIB-US   GNW  Biogen to Present Data from Alzheimerâ€™s Disease Portfolio at the 2018 Clinical Trials on Alzheimerâ€™s Disease (CTAD) Meeting,, 2/28/2019 BCRX-US  GNW  BioCryst to Present at Barclays Global Healthcare Conference,,,,,11/06/2018 AKRX-US  GNW  Akorn Provides Third Quarter 2018 Results, 3/04/2011 008D8Y-E GNW  Harris & Harris Group Notes Completion of Amgen Acquisition of BioVex,"10/23/2019 62855J10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ MYGN",11/08/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,, 1/04/2017 INSM-US  GNW  Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference,, 3/20/2018 INO-US    GNW  Inovio Closes License and Collaboration AgreementÂ with ApolloBio To Develop and CommercializeÂ VGX-3100 in Greater China,"11/23/2018 64026810 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â NKTR",,12/31/2018 GERN-US  GNW  Geron Announces New Board Leadership Structure,, 3/29/2019 02311120 GNW  VascepaÂ® Granted Priority Review Status from Health Canada,,, 3/05/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common Stock," 6/04/2018 G0176710 GNW  Detailed Research: Economic Perspectives on Bank of Nova Scotia, Eaton Corporation, Canadian National Railway, MakeMyTrip, Altisource Portfolio Solutions S.A., and Alkermes plc â€” What Drives Growth in Today's Competitive Landscape",,"10/25/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, November 1, 2018 at 8:00 a.m. ET",,,,," 4/26/2019 SAN-FR   GNW  Sanofi: FDA approves PraluentÂ® (alirocumab) to prevent heart attack, stroke and unstable angina requiring hospitalization",,, 3/28/2018 ASND-US  GNW  Ascendis Pharma A/S Reports Full Year 2017 Financial Results,,, 3/19/2018 AFMD-US  GNW  Affimed Appoints Dr. Leila Alland as Chief Medical Officer,, 6/14/2018 PRQR-US  GNW  ProQR to Present at the JMP Life Sciences Conference,," 4/29/2019 98978L20 GNW  ZGNX DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Zogenix, Inc. â€“ ZGNX",,, 5/06/2014 76133010 GNW  Horizon Technology Finance Announces First Quarter 2014 Financial Results,,,10/17/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Data Presented at the European Society of Gene and Cell Therapy (ESGCT),10/30/2018 RARE-US   GNW  Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results and Corporate Update, 8/31/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present at the 2017 Wells Fargo Healthcare Conference, 6/04/2018 NSTG-US  GNW  NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery,,, 3/12/2018 RDUS-US  GNW  Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOSâ„¢ (abaloparatide) Injection,12/08/2017 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),,, 9/20/2017 02043Q10 GNW  Arbutusâ€™ LNP Licensee Alnylam Announces Positive Phase 3 Results for LNP-Enabled Patisiran Program,," 9/25/2018 00972L10 GNW  New Research: Key Drivers of Growth for Akcea Therapeutics, Intel, Freeport-McMoRan, Sirius XM, Spark Energy, and General Motors â€” Factors of Influence, Major Initiatives and Sustained Production",," 5/03/2018 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results", 4/03/2018 RTRX-US  GNW  Retrophin Initiates Pivotal Phase 3 Clinical Trial of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis," 7/24/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Second Quarter 2017 Financial Results Call", 2/28/2018 EDIT-US  GNW  Editas Medicine Supports Rare Disease DayÂ® and Joins Global Movement to Raise Important Awareness for Rare Diseases, 1/09/2017 CHMA-US  GNW  Chiasma Provides Year-End Corporate Update and Preliminary Outlook for 2017, 7/24/2019 MGNX-US  GNW  MacroGenics Announces Date of Second Quarter 2019 Financial Results Conference Call,,,, 1/30/2018 MNTA-US  GNW  Momenta Pharmaceuticals Announces Positive Outcome for Contracted GlatopaÂ® (glatiramer acetate injection) Fill/Finish Manufacturer, 3/07/2018 PRTA-US  GNW  Prothena to Participate in the Barclays Global Healthcare Conference, 8/24/2018 ZLAB-US  GNW  Zai Lab Elects to Discontinue Development of ZL-3101 (Fugan) for Atopic Dermatitis,, 7/10/2018 CTMX-US  GNW  CytomX Therapeutics Announces Proposed Public Offering of Common Stock, 8/09/2018 GMAB-DK  GNW  Major Shareholder Announcement," 7/19/2013 92165910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA",," 2/01/2018 CBAY-US  GNW  CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",," 7/26/2017 CCXI-US  GNW  ChemoCentryx to Hold Second Quarter 2017 Financial Results Conference CallÂ on Tuesday, August 8, 2017",,," 6/29/2018 56400P70  GNW  Factors of Influence in 2018, Key Indicators and Opportunity within MannKind, Healthcare Services Group, Cadence, Superior Energy Services, National Presto Industries, and New Media Investment Group â€” New Research Emphasizes Economic Growth",," 2/07/2019 CYTK-US  GNW  Cytokinetics to Announce Fourth Quarter Results on February 21, 2019", 8/25/2018 ESPR-US     GNW  Esperion Announces Late-Breaking Oral Presentation of Final Results of Phase 3 Long-Term Safety Study of Bempedoic Acid at the European Society of Cardiology Congress, 4/09/2019 AMRS-US   GNW  Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-K,,"10/24/2017 ACHN-US  GNW  USPTO Grants Composition of Matter Patent to Achillion for ACH-4471, First-in-Class Small Molecule Complement Alternative Pathway Factor D Inhibitor"," 3/22/2019 87166B10 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KHC, AMRN, WTW and SYNH", 9/10/2018 FOLD-US  GNW  Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease,,, 3/05/2018 ADMA-US  GNW  ADMA Biologics Reports Full Year 2017 Financial Results," 5/03/2018 GWPH-US  GNW  GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018"," 8/01/2016 08149D-E GNW  Epizyme to Report Second Quarter 2016 Financial Results on August 8, 2016 and Participate in Upcoming Wedbush PacGrow Healthcare Conference",," 8/01/2018 MYOK-US  GNW  MyoKardia to Report Second Quarter 2018 Financial Results on  Wednesday, August 8, 2018",,12/21/2018 GLPG-NL  GNW  Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference,"10/25/2018 73701010 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Portola Pharmaceuticals, Cable One, Marriot Vacations Worldwide, United Technologies, Park-Ohio, and BioScrip â€” New Research Emphasizes Economic Growth",,,, 3/15/2018 CARA-US  GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results, 1/22/2019 FLXN-US  GNW  Flexion Therapeutics Names Christina Willwerth Chief Strategy Officer," 8/21/2018 N9006410 GNW  Report: Exploring Fundamental Drivers Behind Oaktree Specialty Lending, uniQure N.V, Mercury, Akebia Therapeutics, Mitel Networks, and Greenlight Capital Re â€” New Horizons, Emerging Trends, and Upcoming Developments"," 8/28/2018 AGIO-US   GNW  Agios to Present at the Citi 13th Annual Biotech Conference Wednesday, September 5, 2018"," 5/29/2018 46226010 GNW  Report: Exploring Fundamental Drivers Behind ServisFirst Bancshares, Iovance Biotherapeutics, Inc., MarineMax, TriNet Group, Dorian LPG, and AAON â€” New Horizons, Emerging Trends, and Upcoming Developments", 4/06/2017 ANAB-US  GNW  AnaptysBio Announces First-In-Human Dosing of ANB019,," 7/26/2018 31189P10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Fate Therapeutics, Inc. -- FATE", 6/19/2017 HZNP-US  GNW  Horizon Pharma plc Announces Health Canada Approval of PROCYSBIâ„¢Â (Cysteamine Delayed-Release Capsules)Â for the Treatment of Nephropathic Cystinosis,, 2/07/2018 ICPT-US  GNW  Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences," 8/28/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 6/06/2018 ITCI-US  GNW  Intra-Cellular Therapies Initiates Rolling Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia,,,, 5/10/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference, 6/07/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Appointment of Utpal Koppikar as Chief Financial Officer,,11/06/2017 24983L10 GNW  Dermira and UCB Agree to End Collaboration Agreement for CIMZIA, 8/01/2018 FOMX-US  GNW  Foamix Pharmaceuticals to Announce Second Quarter Financial Results on August 8, 5/22/2017 PRAH-US  GNW  PRA Health Sciences Named International Clinical Research Company of the Year, 6/01/2017 SUPN-US  GNW  Supernus to Present at Jefferies Healthcare Conference," 5/02/2018 FGEN-US  GNW  FibroGen to Report First Quarter 2018 Financial Results on Wednesday, May 9, 2018",,11/08/2018 CHRS-US  GNW  Coherus BioSciences Reports Corporate Highlights and Third Quarter 2018 Financial Results," 3/13/2019 21833P10 GNW  CLASS ACTION UPDATE for SPB, ARLO, AMRN and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 9/05/2017 COLL-US  GNW  Collegium Announces Scientific Presentations at PAINWeek 2017 Meeting,10/03/2017 XBIT-US  GNW  XBiotech Announces Addition of Renowned Dermatologist Dr. William Levis to its Scientific Advisory Board,,,12/02/2018 GBT-US   GNW  GBT to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Provide a Regulatory Update for Voxelotor, 8/02/2016 RGNX-US  GNW  FDA Grants Rare Pediatric Disease Designation to REGENXBIO's RGX-121 Gene Therapy for the Treatment of Mucopolysaccharidosis Type II (MPS II), 7/02/2018 KURA-US  GNW  Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,11/13/2018 APLS-US  GNW  Apellis Pharmaceuticals Reports Third Quarter 2018 Business Update and Financial Results,10/17/2018 AXSM-US  GNW  Axsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy, 2/07/2018 VYGR-US  GNW  Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference, 5/30/2019 BGNE-US  GNW  BeiGene Announces Acceptance of a Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma,,"12/11/2017 065BPX-E GNW  Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or Metastatic Melanoma",," 7/25/2017 45826J10 GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing", 2/06/2018 ACIU-US  GNW  AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference,11/13/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer," 8/01/2018 GTHX-US  GNW  G1 Therapeutics to Provide Second Quarter 2018 Corporate and Financial Update on August 8, 2018",,,"11/14/2018 ATNX-US  GNW  Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update",, 1/04/2018 RYTM-US  GNW  Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity,,,,, 1/30/2018 SLDB-US  GNW  Solid Biosciences Announces Closing of Initial Public Offering  and Full Exercise of Underwritersâ€™ Overallotment Option, 6/14/2018 EOLS-US  GNW  Evolus to Participate in Two Upcoming Investor Conferences,, 9/05/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Secures Pass-through Payment Status and Assignment of  C-Code for DEXYCUâ„¢,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/11/2019 PGNX-US  GNW  Progenics Acquires AZEDRAÂ® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility,,,,, 3/05/2018 BDSI-US  GNW  BioDelivery Sciences to Present at the 30th Annual ROTH Conference,,," 7/30/2012 82691710     GNW  SIGA to Host Second Quarter Business Update Call on August 6, 2012","10/25/2018 68375N10 GNW  CLASS ACTION UPDATE for SKX, OPK and PVG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 4/17/2018 46222210 GNW  Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR,10/12/2015 BMRN-US     GNW  BioMarinâ€™s Initial 6-Month Data From Phase 2 Study of Vosoritide (BMN 111) in Children With Achondroplasia Presented at the American Society for Bone and Mineral Research Annual 2015 Meeting,,,," 2/10/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NVIDIA, DXC Technology, Immunomedics, and Natural Health and Encourages Investors to Contact the Firm","10/17/2018 BIIB-US   GNW  IMRALDIâ„¢, Biogenâ€™s Adalimumab Biosimilar Referencing HumiraÂ®, Is Launched in the European Union",," 2/23/2019 BCRX-US  GNW  BioCryst Reports ZENITH-1 Results With Oral BCX7353 Which Confirm Rapid Onset of Action, Sustained Activity and Robust Dose Response for Treatment of Acute HAE Attacks",,,,,10/29/2018 AKRX-US  GNW  Akorn Receives Product Approval, 1/24/2011 TURN-US  GNW  Harris & Harris Group Notes Amgen to Acquire BioVex,"10/22/2019 62855J10 GNW  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Myriad Genetics, Inc.",11/06/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,,11/14/2016 SF-US    GNW  Insmed to Participate at November Investor Conferences,, 3/14/2018 INO-US    GNW  Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results,"11/20/2018 64026810 GNW  CLASS ACTION UPDATE for JT, NKTR and AQUA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,12/03/2018 GERN-US  GNW  Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy,," 3/29/2019 02311120 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LXRX, UXIN, AVEO and AMRN",,," 3/05/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Proposed $350,000,000 Public Offering of Common Stock"," 3/14/2018 G0176710 GNW  Research Report Identifies Barrick Gold, Atlassian, Marvell Technology Group, Orix Corp Ads, Alkermes plc, and Sierra Wireless with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",,"10/17/2018 00163U10 GNW  Report: Exploring Fundamental Drivers Behind CURO Group, BiondVax Pharmaceuticals, AMAG Pharmaceuticals, AcelRx Pharmaceuticals, Ballard Power, and Rhythm Pharmaceuticals â€” New Horizons, Emerging Trends, and Upcoming Developments",,,,, 4/26/2019 SAN-FR   GNW  ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes,,, 3/19/2018 ASND-US  GNW  Ascendis Pharma Announces Two Posters on Rare Disease Pipeline Programs at ENDO 2018,,, 3/15/2018 AFMD-US  GNW  Affimed to Present Data on AFM24 at AACR Annual Meeting 2018,, 6/12/2018 PRQR-US  GNW  ProQR Receives up to $5 Million in Partnership with EB Research Partnership and EB Medical Research Foundation to Develop QR-313 for the Treatment of Dystrophic Epidermolysis Bullosa,," 4/28/2019 98978L20 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines â€“ BA, SCOR, MWA and ZGNX",,," 4/29/2014 76133010 GNW  Revance Therapeutics to Release First Quarter 2014 Financial Results and Host Conference Call on Tuesday, May 13, 2014",,,"10/16/2018 00773U10 GNW  Consolidated Research: 2018 Summary Expectations for Mimecast, Shiloh Industries, Adverum Biotechnologies, AngioDynamics, Kimball Electronics, and Changyou â€” Fundamental Analysis, Key Performance Indications",10/26/2018 RARE-US   GNW  Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in Patients with Glut1 DS with Disabling Movement Disorders, 8/09/2017 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results, 5/31/2018 NSTG-US  GNW  NanoString Highlights Record Number of nCounter-Based Abstracts at the 2018 Annual Meeting of the American Society of Clinical Oncology,,, 3/06/2018 RDUS-US  GNW  Radius Health to Present at the Cowen 38th Annual Health Care Conference,11/08/2017 ASMB-US  GNW  Assembly Biosciences to Present at the Jefferies London Healthcare Conference,,, 9/20/2017 0GBP93-E GNW  Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy,, 9/24/2018 IONS-US  GNW  Akcea and Ionis Report Positive Data from  Phase 2 Study of AKCEA-APO(a)-LRx,, 5/01/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May, 3/05/2018 RTRX-US  GNW  Retrophin Announces Appointment of Casey Logan as Vice President of Corporate Development, 7/18/2017 PACB-US  GNW  Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform, 2/27/2018 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and Results,11/09/2016 CHMA-US  GNW  Chiasma Provides Corporate Update and Reports Third Quarter 2016 Results, 7/17/2019 MGNX-US  GNW  MacroGenics Provides Update on Flotetuzumab Program in Acute Myeloid Leukemia,,,," 1/05/2018 MNTA-US  GNW  Momenta Pharmaceuticals Reports Positive Top-Line Phase 1 Data Showing Proof of Mechanism for M281, an Anti-FcRn Monoclonal Antibody, in Healthy Volunteers"," 2/14/2018 PRTA-US  GNW  Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update", 8/22/2018 ZLAB-US  GNW  Zai Lab Announces Presentations at the 21st Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) and the IASLC 19th World Conference on Lung Cancer (WCLC),, 6/14/2018 CTMX-US  GNW  CytomX Announces Appointment of Lloyd A. Rowland Jr. as General Counsel, 8/08/2018 GMAB-DK  GNW  Genmab Announces Financial Results for the First Half of 2018," 7/07/2013 92165910 GNW  Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA",, 1/30/2018 CBAY-US  GNW  CymaBay Announces Pricing of Public Offering of Common Stock,, 6/06/2017 CCXI-US  GNW  Oral Presentations at ERA-EDTA Congress Highlight Fourth Potential Indication for Avacopan and Potential for CCR2 Inhibition in Focal Segmental Glomerulosclerosis (FSGS),,, 6/25/2018 0DK6LR-E  GNW  MannKind Set to Join Russell 3000Â® Index,, 1/22/2019 CYTK-US  GNW  Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA," 8/20/2018 29664W10    GNW  Market Trends Toward New Normal in Esperion Therapeutics, Oxford Immunotec Global, Limoneira, R1 RCM, Carbonite, and Shenandoah Telecommunications â€” Emerging Consolidated Expectations, Analyst Ratings"," 4/08/2019 03236M20  GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm",,"10/23/2017 ACHN-US  GNW  Achillion Announces Presentation of Data From OMEGA-1 Phase 2b Trial With Odalasvir, AL-335, and Simeprevir (JNJ-4178) at the 2017 Liver Meeting"," 3/21/2019 87166B10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH", 8/31/2018 FOLD-US  GNW  Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2018,,, 2/27/2018 ADMA-US  GNW  ADMA Biologics to Present at Raymond Jamesâ€™ 39th Annual Institutional Investors Conference," 4/19/2018 0JBRH7-E GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announces the Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epilepsy",,, 6/26/2018 MYOK-US  GNW  MyoKardia Doses First Patient in Pivotal Phase 3 EXPLORER-HCM Trial of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy,,12/17/2018 GLPG-NL  GNW  Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF),"10/23/2018 PTLA-US  GNW  Portola Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018",,,," 3/08/2018 CARA-US  GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results on March 15, 2018", 1/04/2019 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 8/08/2018 QURE-US  GNW  uniQure Announces Second Quarter 2018 Financial Results and Highlights Company Progress, 8/02/2018 AGIO-US   GNW  Agios Reports Second Quarter 2018 Financial Results, 5/10/2018 IOVA-US  GNW  Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update, 3/08/2017 ANAB-US  GNW  AnaptysBio Announces 2016 Operating Results and Pipeline Progress,, 6/01/2018 FATE-US  GNW  Fate Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference, 6/14/2017 HZNP-US  GNW  Horizon Pharma plc Presents New Data Analyses Further Demonstrating Clinical Benefit of KRYSTEXXAÂ® (pegloticase) in Patients with Uncontrolled Gout,, 2/01/2018 ICPT-US  GNW  Intercept Announces Updated U.S. Prescribing Information for OcalivaÂ® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis, 8/28/2019 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,," 5/31/2018 ITCI-US  GNW  Intra-Cellular Therapies Presents Data on Symptom Improvement by Lumateperone on Negative Symptoms, Depression, and Social Function in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting",,,," 5/08/2017 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017", 5/29/2018 ATRA-US    GNW  Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences,,10/13/2017 DERM-US  GNW  Dermira Highlights New Long-Term Safety Data for Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis at  Fall Clinical Dermatology Conference, 6/27/2018 FOMX-US  GNW  CORRECTING and REPLACING -- Foamix Announces Dosing of Last Patient in Phase 3 Rosacea Studies for Minocycline Foam FMX103, 5/04/2017 PRAH-US  GNW  PRA Health Sciences Announces The Center for Pediatric Clinical Development, 5/09/2017 SUPN-US  GNW  Supernus Announces First Quarter 2017 Financial Results," 4/27/2018 31572Q80 GNW  Consolidated Research: 2018 Summary Expectations for MGM Growth Properties, Reinsurance Group of America, Cincinnati Bell, GAIN Capital, FibroGen, and First Hawaiian â€” Fundamental Analysis, Key Performance Indications",,11/02/2018 CHRS-US  GNW  U.S. FDA Approves UDENYCAâ„¢ (pegfilgrastim-cbqv), 3/12/2019 CRBP-US  GNW  Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical Updates,, 8/09/2017 COLL-US  GNW  Collegium Reports Second Quarter Financial Results and Provides Corporate Update, 9/21/2017 XBIT-US  GNW  XBiotech to Present at Cantor Fitzgeraldâ€™s Global Healthcare Conference,,,"11/09/2018 37890U10 GNW  Report: Exploring Fundamental Drivers Behind California Water Service Group Holding, Canadian Solar, JELD-WEN Holding, CONSOL Coal Resources LP, Global Blood Therapeutics, and Pier 1 Imports â€” New Horizons, Emerging Trends, and Upcoming Developments", 8/01/2016 RGNX-US  GNW  REGENXBIO to Host Conference Call on August 9 to Discuss Second Quarter 2016 Financial Results and Recent Operational Highlights, 6/28/2018 KURA-US  GNW  Kura Oncology Announces Pricing of $67 Million Public Offering of Common Stock,11/07/2018 APLS-US  GNW  Apellis Pharmaceuticals to Present at Upcoming Investor Conferences,10/16/2018 AXSM-US  GNW  Axsome Therapeutics to Host Call Today with Key Opinion Leader Focusing on AXS-12 and Unmet Needs in Narcolepsy, 1/31/2018 VYGR-US  GNW  Voyager Therapeutics Announces CEO Succession Plan for 2018, 5/16/2019 BGNE-US  GNW  BeiGene Announces Clinical Data on Tislelizumab and Zanubrutinib to be Presented at the 24th Congress of the European Hematology Association,,"11/13/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial and Operating Results",," 7/24/2017 NTLA-US  GNW  Intellia Therapeutics Names Moncef Slaoui, Ph.D. and Frank Verwiel, M.D. to Its Board of Directors and Establishes a Science and Technology Committee",12/01/2017 ACIU-US  GNW  AC Immune Shares Insights from Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases,11/13/2017 CRSP-US  GNW  CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs, 7/09/2018 GTHX-US  GNW  G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel,,,"11/01/2018 ATNX-US  GNW  Athenex, Inc. to Report Third Quarter Earnings Results on November 14, 2018",,11/14/2017 RYTM-US  GNW  Rhythm Pharmaceuticals Reports Third Quarter 2017 Financial Results,,,,, 1/25/2018 SLDB-US  GNW  Solid Biosciences Announces Pricing of Initial Public Offering, 6/04/2018 EOLS-US  GNW  Evolus to Present at the Jefferies 2018 Global Healthcare Conference,, 9/05/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Fiscal 2018 Fourth Quarter & Full Year Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/03/2019 0JCPDC-E GNW  Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyLâ„¢,,,,, 2/06/2018 0657G1-E GNW  BioDelivery Sciences Announces BELBUCAÂ® Patent Litigation Settlement Agreement with Teva,,, 6/04/2012 82691710     GNW  SIGA Appoints William J. Haynes as General Counsel,"10/25/2018 68375N10 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OPKO Health, Inc. (OPK)Â & Lead Plaintiff Deadline: November 13, 2018", 3/26/2018 IONS-US  GNW  Akcea Convenes First FCS Global Connection Summit,10/01/2015 BMRN-US     GNW  BioMarin to Acquire Rights to Phenylketonuria (PKU) Franchise From Merck Serono,,,," 2/08/2019 45290710 GNW  IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU",10/11/2018 SHL-DE    GNW  Biogen Advances Research to Improve Outcomes for Patients With Multiple Sclerosis,, 2/18/2019 BCRX-US  GNW  BioCryst to Report Fourth Quarter and Full Year 2018 Financial Results on March 4,,,,,10/18/2018 AKRX-US  GNW  Akorn Appeals Fresenius Kabi Ruling," 6/08/2010 WYE-US   GNW  StemCells, Inc. Appoints R. Scott Greer to Board of Directors","10/21/2019 62855J10 GNW  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important November 26th Deadline in Securities Class Action â€“ MYGN",11/01/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides a Business Update,,11/03/2016 INSM-US  GNW  Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update,, 3/14/2018 INO-US    GNW  Inovioâ€™s DNA Immunotherapy Demonstrates Immune Response Results Key in Treating Chronic Hepatitis B Infection,"11/19/2018 64026810 GNW  Kessler Topaz Meltzer & Check, LLP â€“ Important Deadline Reminder for Nektar Therapeutics Investors",,12/03/2018 GERN-US  GNW  Geron Reports Updated Results from Phase 2 Portion of IMerge  at the 60th American Society of Hematology Annual Meeting,, 3/28/2019 AMRN-US  GNW  Amarin Submits Supplemental New Drug Application (sNDA) to U.S. FDA Seeking New Indication forÂ VascepaÂ® (icosapent ethyl) to Reduce the Risk of Major Adverse Cardiovascular Events Based on Landmark REDUCE-ITâ„¢ Cardiovascular Outcomes Study,,, 2/28/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 1/17/2018 G0176710 GNW  FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc (Nasdaq: ALKS) To Contact The Firm",,"10/04/2018 AMAG-US  GNW  AMAGÂ Pharmaceuticals andÂ EndoceuticsÂ Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response toÂ IntravaginalÂ Prasterone",,,,, 4/26/2019 SAN-FR   GNW  CHMP issues positive opinion for LibtayoÂ® (cemiplimab) in advanced cutaneous squamous cell carcinoma,,, 3/16/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Year-End 2017 Financial Results and Business UpdateÂ Conference Call on March 28,,, 3/13/2018 AFMD-US  GNW  Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call,, 6/04/2018 PRQR-US  GNW  ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference,," 4/26/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orion, Zogenix, BrightView, and Eventbrite and Encourages Investors to Contact the Firm",,, 4/21/2014 76133010 GNW  Revance Therapeutics Announces Positive Results From the RT002 Phase 1/2 Study in Glabellar Frown Lines,,, 9/19/2018 ADVM-US  GNW  Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD,10/22/2018 RARE-US   GNW  Ultragenyx Announces Exclusive License to REGENXBIO AAV Vectors to Develop Gene Therapy for CDD (CDKL5 Deficiency Disorder), 7/20/2017 AGLE-US  GNW  Aeglea BioTherapeutics Announces Leadership Change, 5/15/2018 NSTG-US  GNW  NanoString to Present at the 2018 UBS Global Health Care Conference,,, 3/01/2018 RDUS-US  GNW  Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update,11/02/2017 ASMB-US  GNW  Assembly Biosciences Announces Pricing of $60 Million Offering of Common Stock,,, 9/07/2017 SAN-FR   GNW  Sanofi Alliance Partner Alnylam Gives Update on Fitusiran,, 8/29/2018 AKCA-US  GNW  Akcea Therapeutics to Present at the Wells Fargo Healthcare Conference,, 4/26/2018 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call, 2/28/2018 RTRX-US  GNW  Retrophin to Present at the Barclays Global Healthcare Conference," 6/22/2017 PACB-US  GNW  PacBio Technology Resolves Complex Maize Genome, Driving Demand for Other Large-Scale AgBio Sequencing Projects"," 2/16/2018 EDIT-US  GNW  Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors",11/01/2016 CHMA-US  GNW  Chiasma Recognizes Acromegaly Awareness Day with New Resources for Patients and Data Presentation for Physicians, 7/10/2019 MGNX-US  GNW  MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China,,,," 1/03/2018 60877T10 GNW  Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEAÂ® (aflibercept)", 2/07/2018 PRTA-US  GNW  Prothena to Participate in the Leerink Partners 7th Annual Global Healthcare Conference, 8/20/2018 ZLAB-US  GNW  Zai Labâ€™s ZL-2306 (niraparib) Completes Pharmacokinetics (PK) Study in Chinese Ovarian Cancer Patients Showing Comparable Profile to non-Chinese Patients,, 6/04/2018 CTMX-US  GNW  CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probodyâ„¢ Platform and CX-072 at 2018 ASCO Annual Meeting, 7/27/2018 GMAB-DK  GNW  CHMP Issues Positive Opinion Recommending DARZALEXÂ® (daratumumab) for Front Line Multiple Myeloma," 7/02/2013 92165910 GNW  UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of July 23, 2013 to Seek a Lead Plaintiff Position -- VNDA",, 1/29/2018 CBAY-US  GNW  CymaBay Announces Proposed Public Offering of Common Stock,, 5/24/2017 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 6/25/2018 MNKD-US   GNW  Additional Positive AfrezzaÂ® Clinical Data from STAT Study To Be Presented at ADA 78th Scientific Sessions,,12/10/2018 CYTK-US  GNW  Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND, 8/10/2018 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 4/05/2019 03236M20  GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of Amyris, Inc. Â â€“ AMRS",, 9/20/2017 ACHN-US  GNW  Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series," 3/21/2019 87166B10 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL", 8/10/2018 FOLD-US  GNW  FDA Approves Galafoldâ„¢ (migalastat) for the Treatment of Certain Adult Patients with Fabry Disease,,,12/11/2017 ADMA-US  GNW  ADMA Files Biologics License Application For Its Third Plasma Collection Center, 4/12/2018 0JBRH7-E GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EpidiolexÂ® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting,,, 5/22/2018 MYOK-US  GNW  MyoKardia Announces Pricing of Public Offering of Common Stock,,11/27/2018 GLPG-NL  GNW  Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis,10/09/2018 PTLA-US  GNW  Portola Pharmaceuticals Supports 2018 World Thrombosis Day Campaign to Raise Awareness of Blood Clots as an Urgent and Growing Health Crisis,,,, 2/28/2018 CARA-US  GNW  Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVAâ„¢ (CR845/difelikefalin) in Chronic Liver Disease (CLD) Patients," 1/03/2019 FLXN-US  GNW  Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2018 RevenueÂ and Initial Revenue Guidance for 2019", 6/28/2018 QURE-US  GNW  uniQure Enrolls First Patient in Phase III HOPE-B Pivotal Study of AMT-061 in Patients with Hemophilia B," 7/23/2018 AGIO-US   GNW  Agios to Webcast Conference Call of Second Quarter 2018 Financial Results on August 2, 2018"," 5/03/2018 IOVA-US  GNW  Iovance Biotherapeutics to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 10, 2018", 3/04/2017 ANAB-US  GNW  AnaptysBio Announces Data from Scientific Collaboration with the Benaroya Research Institute Presented at the AAAAI 2017 Annual Meeting,, 5/16/2018 FATE-US  GNW  Fate Therapeutics and Memorial Sloan Kettering Cancer Center Expand Scope of License Agreement to include Gene-edited T-cell Immunotherapies, 6/14/2017 HZNP-US  GNW  Epidemiologic Study Findings Show Over 400 Percent Increase in Gout Patient Hospitalizations Since 1993,,12/07/2017 ICPT-US  GNW  Intercept to Present at Upcoming Conference," 8/27/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Karyopharm, L Brands, National General, and Mallinckrodt and Encourages Investors to Contact the Firm",,, 5/30/2018 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Jefferies 2018 Global Healthcare Conference,,,," 5/04/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2017", 5/17/2018 063Y8S-E   GNW  Atara Biotherapeutics to Present Long-Term Tab-celâ„¢ Phase 2 Clinical Outcomes for Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas at 23rd Congress of European Hematology Association,,10/05/2017 DERM-US  GNW  Dermira Completes Patient Enrollment in Two Phase 3 Pivotal Trials of Olumacostat Glasaretil for the Treatment of Acne Vulgaris, 6/27/2018 FOMX-US  GNW  Foamix Announces Dosing of Last Patient in Phase 3 Rosacea Studies for Minocycline Foam FMX103, 5/02/2017 PRAH-US  GNW  PRA Health Sciences Named Clinical Research Company of the Year, 4/26/2017 SUPN-US  GNW  Supernus to Host First Quarter 2017 Earnings Conference Call, 3/01/2018 FGEN-US  GNW  UPDATE - FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer,,10/22/2018 CHRS-US  GNW  Coherus BioSciences to Report Third Quarter 2018 Financial Results on November 8th, 3/11/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference,, 7/18/2017 COLL-US  GNW  Collegium to Host Conference Call to Discuss Second Quarter 2017 Financial Results and Provide Corporate Update, 9/20/2017 XBIT-US  GNW  XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with Onivydeâ“‡ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer,,,11/06/2018 GBT-US   GNW  GBT Reports Recent Business Progress and Provides Third Quarter 2018 Financial Results, 7/05/2016 RGNX-US  GNW  REGENXBIO Provides Update on Lead Gene Therapy Development Programs, 6/27/2018 KURA-US  GNW  Kura Oncology Announces Commencement of Public Offering of Common Stock,11/01/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces Poster Presentations at the American Society of Hematology Annual Meeting,10/16/2018 AXSM-US  GNW  Axsome Therapeutics Announces AXS-12 for the Treatment of Narcolepsy, 1/23/2018 VYGR-US  GNW  Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinsonâ€™s Disease, 5/09/2019 BGNE-US  GNW  BeiGene Reports First Quarter 2019 Financial Results,,11/06/2017 RETA-US  GNW  Reata Provides Update on Bardoxolone Methyl from the American Society of Nephrology Kidney Week Meeting,, 6/19/2017 NTLA-US  GNW  Intellia Therapeutics Announces Patent  for CRISPR/Cas Genome Editing in China,11/21/2017 ACIU-US  GNW  AC Immune to Host Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer's and other Neurodegenerative Diseases,11/10/2017 CRSP-US  GNW  CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC Annual Meeting, 6/08/2018 GTHX-US  GNW  G1 Therapeutics Announces Appointment of New Members to the Board of Directors,,,10/29/2018 ATNX-US  GNW  Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials,,"11/13/2017 00FMDK-E GNW  Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) to Ring The Nasdaq Stock Market Closing Bell",,,,,," 5/29/2018 EOLS-US  GNW  Evolus Appoints Veteran Healthcare Executive Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development",, 8/28/2018 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/03/2019 PGNX-US  GNW  Progenics and Curium Announce European Collaboration for Prostate Cancer Imaging Agent PyLâ„¢,,,,, 1/30/2018 05MP83-E GNW  BioDelivery Sciences Announces Launch and Availability of BELBUCAÂ® in Canada,,, 6/01/2012 82691710     GNW  Chancery Court Issues Final Judgment in Litigation Brought by PharmAthene,"10/24/2018 68375N10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, QRTEA, PVG, MCHP and CPB", 3/12/2018 46222210 GNW  Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo, 9/30/2015 09061G10    GNW  BioMarin to Present Research Results on Duchenne Muscular Dystrophy and Pompe Disease Programs at the 20th International Congress of the World Muscle Society,,,," 2/08/2019 45290710 GNW  IMMU FEB. 25 DEADLINE ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Case Seeking to Recover Investor Losses â€“ IMMU",10/06/2018 BIIB-US   GNW  New SPINRAZAÂ® (nusinersen) Data Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy,, 2/06/2019 BCRX-US  GNW  BioCryst Strengthens Cash Position With Flexible $100 Million Debt Facility,,,,,10/10/2018 AKRX-US  GNW  Akorn Receives Product Approval, 5/12/2010 MTEM-US  GNW  Threshold Pharmaceuticals Appoints Dr. David R. Parkinson to Board of Directors,10/21/2019 MYGN-US  GNW  Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience,"10/25/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on November 1, 2018",,"10/27/2016 INSM-US  GNW  Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016",," 3/12/2018 INO-US    GNW  Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2017 Financial Results on March 14, 2018",11/18/2018 64026810 GNW  SHAREHOLDER ALERT: TGTX ABBV MGTI HAS CPB CHGG ADNT GOOG NKTR SYF RBBN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,"11/28/2018 GERN-US  GNW  Geron to Host Analyst and Investor Event on December 10, 2018",," 3/28/2019 02311120 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CAG, AMRN, SYNH and CRBP",,," 2/28/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Second Year of Route 79, The Duchenne Scholarship Program"," 1/11/2018 G0176710 GNW  The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018",, 9/26/2018 AMAG-US  GNW  AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia,,,,, 4/26/2019 SAN-FR   GNW  Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER,,, 2/21/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs,,, 3/08/2018 AFMD-US  GNW  Affimed to Present at the Cowen and Company 38th Annual Health Care Conference,," 5/23/2018 PRQR-US  GNW  ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board",," 4/25/2019 98978L20 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm",,, 3/31/2014 008ZWN-E GNW  Revance Therapeutics Added to Russell 2000(R) and 3000(R) Indexes,,, 9/18/2018 ADVM-US  GNW  Adverum to Present at Cantor Global Healthcare Conference,10/18/2018 RARE-US   GNW  Ultragenyx Announces Approval of Mepseviiâ„¢ (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII," 7/10/2017 LLY-US   GNW  Aeglea BioTherapeutics Appoints James Wooldridge, M.D. as Chief Medical Officer", 5/08/2018 NSTG-US  GNW  NanoString Technologies Releases Operating Results for First Quarter of 2018,,, 2/14/2018 RDUS-US  GNW  Radius Health to Present at 2018 RBC Capital Markets Global Healthcare Conference,11/01/2017 ASMB-US  GNW  Assembly Biosciences Announces Proposed Underwritten Offering of Common Stock,,, 7/10/2017 SAN-FR   GNW  Sanofi Genzyme and Alnylam Report Positive Results from Ongoing phase 2 Open-Label Extension Study with Investigational RNAi Therapeutic Fitusiran in Patients with Hemophilia A and B With or...,, 8/27/2018 00972L10 GNW  Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA,, 4/06/2018 PCRX-US  GNW  Pacira Announces FDA Approval of Supplemental New Drug Application for EXPARELÂ®  as a Nerve Block to Produce Regional Analgesia, 2/27/2018 RTRX-US  GNW  Retrophin Reports Fourth Quarter and Full Year 2017 Financial Results," 6/15/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock", 2/08/2018 EDIT-US  GNW  Editas Medicine to Participate in Upcoming Investor Conferences, 9/30/2016 CHMA-US  GNW  Chiasma Names Mark J. Fitzpatrick Chief Executive Officer, 5/30/2019 MGNX-US  GNW  MacroGenics to Participate in Jefferies Healthcare Conference,,,,12/28/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the 36th Annual J. P. Morgan Healthcare Conference, 2/02/2018 PRTA-US  GNW  Prothena Announces Departure of Chief Medical Officer," 8/14/2018 ZLAB-US  GNW  Zai Lab Appoints Professor Kai-Xian Chen, Ph.D., to its Board of Directors",, 6/01/2018 CTMX-US  GNW  CytomX Announces Conference Call and Webcast to Review PROCLAIM-072 Clinical Data Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, 7/17/2018 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for Second Quarter of 2018," 7/01/2013 92165910 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Vanda Pharmaceuticals, Inc. to Contact Brower Piven Before the August 26, 2013 Lead Plaintiff Deadline -- VNDA",, 1/08/2018 CBAY-US  GNW  Enrollment Begins in Long-Term Extension Study of Seladelpar in Patients with Primary Biliary Cholangitis,, 5/23/2017 CCXI-US  GNW  ChemoCentryx Granted EU Orphan Drug Designation for Avacopan in the Treatment of Debilitating Kidney Disease C3 Glomerulopathy (C3G),,, 6/23/2018 MNKD-US   GNW  MannKind Presents Positive AfrezzaÂ® Clinical Data from STAT and AFFINITY Studies at ADA 78th Scientific Sessions,,"12/05/2018 CYTK-US  GNW  Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274, a Cardiac Myosin Inhibitor", 8/02/2018 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2018 Financial Results," 4/04/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Amyris, Inc. (AMRS) and Encourages AMRS Investors to Contact the Firm",, 9/11/2017 ACHN-US  GNW  Achillion Announces Strengthening of Management Team," 3/20/2019 87166B10 GNW  Pawar Law Group Announces a Securities Class Action Lawsuit Against Syneos Health, Inc. â€“ SYNH", 8/07/2018 FOLD-US  GNW  Amicus Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Updates,,,11/15/2017 ADMA-US  GNW  ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions, 4/09/2018 GWPH-US  GNW  NuCana plc Announces Appointment of Adam George to its Board of Directors,,, 5/21/2018 MYOK-US  GNW  MyoKardia Announces Proposed Public Offering of Common Stock,,11/26/2018 GLPG-NL  GNW  Transparency notification," 9/25/2018 PTLA-US  GNW  Portola Pharmaceuticals Receives FDA Orphan Drug Designation for Cerdulatinib, an Oral Syk/JAK Inhibitor for the Treatment of Peripheral T-Cell Lymphoma",,,, 2/07/2018 CARA-US  GNW  Cara Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference, 1/02/2019 FLXN-US  GNW  Flexion Therapeutics Enrolls First Patient in Phase 3 Trial of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in OA of the Hip and Reports Results from SHIP Study, 6/13/2018 QURE-US  GNW  uniQure Announces New Appointments to its Board of Directors," 6/29/2018 00847X10  GNW  Analysis: Positioning to Benefit within Biglari, Trustmark, Allscripts Healthcare Solutions, Agios Pharmaceuticals, Roadrunner Transportation, and OSI â€” Research Highlights Growth, Revenue, and Consolidated Results", 5/02/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in May, 2/13/2017 ANAB-US  GNW  AnaptysBio to Present Data from ANB020 Program at Two Upcoming Medical Meetings,, 5/10/2018 FATE-US  GNW  Fate Therapeutics Reports First Quarter 2018 Financial Results and Highlights Operational Progress, 5/26/2017 HZNP-US  GNW  Horizon Pharma plc to Participate in Upcoming Conferences,,11/27/2017 ICPT-US  GNW  Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development," 8/26/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 5/29/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting,,,," 5/04/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on May 8, 2017", 5/08/2018 ATRA-US    GNW  Atara Biotherapeutics Announces First Quarter 2018 Financial Results and Recent Operational Progress,, 9/20/2017 DERM-US  GNW  Dermira to Present at Cantor Fitzgerald Global Healthcare Conference, 6/14/2018 FOMX-US  GNW  Foamix Pharmaceuticals to Participate in the Cantor Dermatology & Aesthetics Summit," 4/25/2017 PRAH-US  GNW  PRA Health Sciences, Inc. Reports First Quarter 2017 Results", 4/05/2017 SUPN-US  GNW  Supernus Receives Final FDA Approval for Trokendi XRÂ® for Migraine Prophylaxis in Adults and Adolescents, 3/01/2018 FGEN-US  GNW  Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer,,10/09/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 3/07/2019 CRBP-US  GNW  Corbus Pharmaceuticals to Announce Full-Year 2018 Operational and Financial Results on March 12, 2019",, 6/08/2017 COLL-US  GNW  Collegium Announces Scientific Presentations at the 2017 International Conference on Opioids, 9/07/2017 XBIT-US  GNW  XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa,,,11/06/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 5/16/2016 RGNX-US  GNW  REGENXBIO and Biogen Enter Exclusive License Agreement for the Development of Gene Therapy Treatments for Rare Genetic Vision Disorders," 6/20/2018 KURA-US  GNW  Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial", 9/28/2018 APLS-US  GNW  Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference,10/12/2018 AXSM-US  GNW  Axsome Therapeutics to Present at Upcoming Investor Conferences,"11/16/2017 VYGR-US  GNW  Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced Parkinsonâ€™s Disease, AAV Novel Capsid and Delivery Optimization Efforts, and Pipeline Programs at its R&D Day", 4/09/2019 BGNE-US  GNW  BioAtla and BeiGene Form Worldwide Collaboration to Develop and Commercialize Novel Conditionally Active Biologic CTLA-4 Therapy,,11/03/2017 RETA-US  GNW  Reata Announces Primary Results from the Phase 2 CARDINAL Study of Bardoxolone in Alport Syndrome at the American Society of Nephrology Kidney Week 2017 Annual Meeting,, 6/06/2017 NTLA-US  GNW  Intellia Therapeutics and San Raffaele University and Research Hospital to Combine CRISPR/Cas9 Genome Editing with Enhanced Cell Therapies to Fight Cancer,11/13/2017 ACIU-US  GNW  AC Immune SA Reports Third Quarter 2017 Financial Results and Corporate Update,11/08/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update, 6/02/2018 GTHX-US  GNW  G1 Therapeutics Presents Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,,,"10/26/2018 04685N10 GNW  Recent Analysis Shows Prologis, Delek Logistics Partners, Fabrinet, New York Mortgage Trust, Petroleo Brasileiro S.A.- Petrobras, and Athenex Market Influences â€” Renewed Outlook, Key Drivers of Growth",,10/31/2017 RYTM-US  GNW  Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome,,,,,, 5/16/2018 EOLS-US  GNW  Evolus Announces Progress with DWP-450 Regulatory Submissions,," 8/15/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints John Weet, Ph.D., as SVP, Regulatory Affairs & Quality",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 1/02/2019 PGNX-US  GNW  Progenics Pharmaceuticals Expands Leadership Team with Appointment of Asha Das, M.D. as Chief Medical OfficerÂ ",,,,,12/20/2017 BDSI-US  GNW  BioDelivery Sciences Appoints Scott Plesha to President,,, 5/07/2012 82691710     GNW  SIGA Technologies Reports Financial Results for the First Quarter 2012,"10/23/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK, QRTEA and PVG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 2/28/2018 46222210 GNW  Akcea Therapeutics Recognizes Rare Disease Day by Spotlighting Several Historic â€œFirstsâ€ for People Living with Familial Chylomicronemia Syndrome, 9/29/2015 09061G10    GNW  BioMarin Receives Favorable Ruling in the Use of Exon 51 Antisense Oligonucleotides Patent Interference,,,," 2/08/2019 45290710 GNW   Pomerantz Law Firm Announces the Filing of a Class Action against Immunomedics, Inc. and Certain Officers â€“ IMMU",10/03/2018 BIIB-US   GNW  Biogen to Present Data from its Neurology Pipeline at the 2018 International Congress of Parkinsonâ€™s Disease and Movement Disorders (MDS),," 2/05/2019 BCRX-US  GNW  BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting",,,,," 8/01/2018 00972810 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Five Prime Therapeutics, Akorn, The Blackstone Group, Avaya, Tractor Supply, and CymaBay Therapeutics â€” New Research Emphasizes Economic Growth",,"10/16/2019 62855J10 GNW  MYGN SHAREHOLDER REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm","10/18/2018 52887230 GNW  Investor Expectations to Drive Momentum within Amkor Technology, Lexicon Pharmaceuticals, Parker Drilling, HFF, The Chefs' Warehouse, and Payment Data â€” Discovering Underlying Factors of Influence",,10/18/2016 00BL26-E GNW  Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease,, 2/12/2018 0653Y6-E  GNW  Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria,"11/16/2018 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â NKTR",,11/07/2018 GERN-US  GNW  Geron to Present at Upcoming Investor Conferences in November,, 3/28/2019 AMRN-US  GNW  New Updates to the American Diabetes Associationâ€™sÂ® 2019 Standards of Medical Care in Diabetes Incorporate Findings from the REDUCE-ITâ„¢ Cardiovascular Outcomes Study,,, 2/27/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Fourth Quarter 2018 and Full-Year 2018 Financial Results and Recent Corporate Developments," 1/09/2018 G0176710 GNW  ALKS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018",," 9/20/2018 AMAG-US  GNW  AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause",,,,, 4/08/2019 SAN-FR   GNW  Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance,,, 2/20/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Proposed Public Offering of ADSs,,, 2/15/2018 AFMD-US  GNW  Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares,, 5/09/2018 PRQR-US  GNW  ProQR Announces Results for the First Quarter of 2018,," 4/18/2019 98978L20 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zogenix, Inc. (ZGNX)",,, 3/26/2014 76133010 GNW  Revance Therapeutics Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook,,," 8/29/2018 ADVM-US  GNW  Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration","10/03/2018 90400D10  GNW  Research Report Identifies Ultragenyx Pharmaceutical, Helmerich & Payne, Buckeye Partners, Covanta Holding, Summit Midstream Partners, LP, and Seattle Genetics with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 6/06/2017 AGLE-US  GNW  Aeglea BioTherapeutics Prices Public Offering of Common Stock, 5/02/2018 NSTG-US  GNW  NanoString to Present at the Bank of America Merrill Lynch 2018Â Health Care Conference,,," 2/14/2018 RDUS-US  GNW  Radius Health to Announce Fourth Quarter and Full Year 2017 Financial Results, Host Conference Call and Live Webcast on March 1, 2018",10/05/2017 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),,," 7/29/2016 ALNY-US  GNW  Editas Medicine Appoints Akshay Vaishnaw, M.D., Ph.D., to its Board of Directors",, 8/06/2018 00972L10 GNW  Akcea Reports Financial Results and Highlights for Second Quarter 2018,, 3/06/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2018 Barclays Global Healthcare Conference, 2/13/2018 RTRX-US  GNW  Retrophin to Report Fourth Quarter and Full Year 2017 Financial Results," 6/14/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock", 1/25/2018 28106W10 GNW  Adverum Biotechnologies and Editas Medicine Extend Research Collaboration, 8/16/2016 CHMA-US  GNW  Chiasma Announces Workforce Reduction, 5/28/2019 MGNX-US  GNW  MacroGenics to Host Conference Call and Webcast to Review Margetuximab Phase 3 SOPHIA Study Presentation at ASCO,,,,11/08/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Stifel 2017 Healthcare Conference, 2/01/2018 PRTA-US  GNW  Prothena to Report Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 14, 6/29/2018 ZLAB-US  GNW  Zai Lab Announces Dosing of First Patient in Phase 3 China Registration Trial of ZL-2306 (niraparib) for First-Line Maintenance Therapy in Platinum Responsive Ovarian Cancer,, 5/31/2018 CTMX-US  GNW  CytomX to Present at the Jefferies 2018 Healthcare Conference, 7/11/2018 GMAB-DK  GNW  Genmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer Immunotherapies," 6/25/2013 92165910 GNW  Pomerantz Law Firm Has Filed a Class Action Against Vanda Pharmaceuticals, Inc. and Certain Officers -- VNDA",, 1/08/2018 CBAY-US  GNW  CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals America,, 5/10/2017 CCXI-US  GNW  ChemoCentryx Reports First Quarter 2017 Financial Results,,, 6/20/2018 MNKD-US   GNW  MannKind to Host Institutional Investor and Analyst Meeting,,"11/27/2018 23282W60 GNW  Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results"," 7/05/2018 29664W10    GNW  CLASS ACTION UPDATE for ESPR, SYMC, and PPG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 3/29/2019 03236M20  GNW  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Amyris, Inc.Â Investors (AMRS)",, 9/11/2017 ACHN-US  GNW  Achillion Announces Termination of Worldwide Collaboration for Hepatitis C With Janssen," 3/20/2019 87166B10 GNW  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Syneos Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"," 7/31/2018 03152W10 GNW  Report: Developing Opportunities within Amicus Therapeutics, Interpace Diagnostics Group, The Progressive, State Street, Alphabet, and VBI Vaccines â€” Future Expectations, Projections Moving into 2018",,,11/13/2017 ADMA-US  GNW  ADMA Biologics Announces Closing of $42M Follow-On Offering, 3/13/2018 GWPH-US  GNW  GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New EpidiolexÂ® (cannabidiol) Patents,,," 5/21/2018 MYOK-US  GNW  MyoKardia Announces Design of Phase 3 EXPLORER-HCM Study Evaluating Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy",,11/23/2018 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises, 9/20/2018 PTLA-US  GNW  Portola Pharmaceuticals Names Scott Garland President and Chief Executive Officer,,,, 1/31/2018 CARA-US  GNW  Cara Therapeutics Initiates Pivotal Phase 3 Efficacy Trial of KORSUVAâ„¢ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus,"12/20/2018 FLXN-US  GNW  Flexion Therapeutics to Report Preliminary Unaudited 2018 Revenue and Provide 2019 Revenue Guidance on January 3, 2019", 5/29/2018 QURE-US  GNW  uniQure Announces the Issuance of New Patents Providing Broad Protection of the Padua Variant of Factor IX in Gene Therapy, 6/26/2018 AGIO-US   GNW  Agios and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Ivosidenib in Greater China, 3/12/2018 IOVA-US  GNW  Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results  and Provides Corporate Update, 1/31/2017 ANAB-US  GNW  AnaptysBio Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,, 5/03/2018 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2018 Financial Results, 5/25/2017 HZNP-US  GNW  Horizon Pharma plc Named One of the Best Workplaces in Chicago by Fortune,,"11/22/2017 45845P10 GNW  DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) To Contact The Firm", 8/26/2019 48576U10   GNW  Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc. â€“ KPTI,,, 5/09/2018 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2018 Health Care Conference,,,, 3/31/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference," 5/08/2018 ATRA-US    GNW  Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases",, 9/14/2017 DERM-US  GNW  Dermira Announces Early Termination of the Hart-Scott-Rodino Waiting Period for License to Lebrikizumab, 5/08/2018 FOMX-US  GNW  Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update, 4/17/2017 PRAH-US  GNW  PRA Health Sciences to Report First Quarter 2017 Earnings, 3/07/2017 SUPN-US  GNW  Supernus Announces Settlement with Actavis on Trokendi XRÂ® Patent Litigation, 2/27/2018 FGEN-US  GNW  FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results,, 9/25/2018 CHRS-US  GNW  Coherus BioSciences Receives European Commission Approval for UDENYCAâ„¢ (Pegfilgrastim Biosimilar)," 3/05/2019 21833P10 GNW  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 6/01/2017 COLL-US  GNW  Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients, 6/09/2017 XBIT-US  GNW  XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis,,,11/01/2018 GBT-US   GNW  GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition, 5/05/2016 RGNX-US  GNW  REGENXBIO Reports First Quarter 2016 Financial Results and Recent Operational Highlights, 6/14/2018 KURA-US  GNW  Kura Oncology to Present at JMP Securities Life Sciences Conference, 9/12/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophy,10/11/2018 AXSM-US  GNW  Axsome Therapeutics to Focus on Growing Core CNS Portfolio; Establishes Axsome Pain and Primary Care Business Unit to Enhance Value of Non-CNS Assets,11/13/2017 VYGR-US  GNW  Voyager Therapeutics to Present at Investor Conferences in November, 4/01/2019 BGNE-US  GNW  BeiGene Announces Phase 1 Long-Term Exposure Data and Results from Structural and Mechanistic Analyses on Tislelizumab at the AACR Annual Meeting,,10/23/2017 RETA-US  GNW  Reata Announces First Patient Enrolled in Part 2 of MOXIe Study of Omaveloxolone for the Treatment of Friedreichâ€™s Ataxia,, 5/13/2017 NTLA-US  GNW  Intellia Therapeutics Announces Progress with CRISPR/Cas9 at the American Society of Gene & Cell Therapy Annual Meeting,11/02/2017 ACIU-US  GNW  AC Immune SA to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 2 Trial for Alzheimer's Disease,11/07/2017 0F9CZK-E GNW  CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor Reception at the 32nd Annual Society for Immunotherapy of Cancer Meeting, 5/16/2018 GTHX-US  GNW  G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,,,10/22/2018 04685N10 GNW  ESMO 2018: Athenex Presented Encouraging Clinical Trial Efficacy and Safety Results of Oraxol in the Treatment of Metastatic Breast Cancer,,"10/10/2017 RYTM-US  GNW  Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",,,,,," 5/16/2018 EOLS-US  GNW  Evolus to Provide Regulatory Update on Wednesday, May 16, 2018",, 8/03/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,"12/03/2018 PGNX-US  GNW  Progenics Doses First Patient in Pivotal Phase 3 Study of PyL, PSMA PET Imaging Agent, for the Detection of Prostate Cancer",,,,,12/18/2017 BDSI-US  GNW  BioDelivery Sciences Announces Notice of Allowance of Patent Strengthening Patent Protection on BELBUCAÂ® to 2032,,," 4/30/2012 82691710     GNW  SIGA to Host First Quarter Business Update Call on May 7, 2012","10/22/2018 68375N10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMPE, OPK, QRTEA and HTHT", 2/26/2018 IONS-US  GNW  Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017Â , 9/28/2015 09061G10    GNW  BioMarin Enrolls First Patient in Phase 1/2 Trial of Gene Therapy Drug Candidate BMN 270 for the Treatment of Hemophilia A,,,," 2/08/2019 45290710 GNW  CLASS ACTION UPDATE for IMMU, AGN, MAXR and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",10/02/2018 BIIB-US   GNW  Biogen Highlights at ECTRIMS 2018 Data on Its Industry-Leading Multiple Sclerosis Portfolio and a Range of Initiatives Aimed at Transforming Patient Care,, 1/04/2019 BCRX-US  GNW  BioCryst Appoints Steve Aselage to Board of Directors,,,,," 6/04/2018 00972810 GNW  Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation",,"10/16/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sundial, electroCore, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm",10/16/2018 LXRX-US  GNW  Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of XERMELOÂ® (Telotristat Ethyl) for the Treatment of Refractory Carcinoid Syndrome Diarrhea in Combination With Somatostatin Analog Therapy,,10/05/2016 45766930 GNW  Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor,, 2/05/2018 INO-US    GNW  Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences,"11/12/2018 64026810 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bank OZK, Nektar, and Honeywell and Encourages Investors to Contact the Firm",,11/01/2018 GERN-US  GNW  Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events,," 3/26/2019 02311120 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: AMRN, ASTE, INGN, VNDA",,," 2/27/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Positive and Robust Expression and Biomarker Data from the First Three-Patient Cohort Dosed in the MYO-101 Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy"," 1/08/2018 G0176710 GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alkermes plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 â€“ ALKS",, 9/06/2018 AMAG-US  GNW  AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes,,,,, 3/22/2019 SAN-FR   GNW  Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin),,, 2/08/2018 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in Leerink Partners 7th Annual Global Healthcare Conference,,, 2/13/2018 AFMD-US  GNW  Affimed Announces Pricing of Public Offering of Common Stock,, 4/30/2018 PRQR-US  GNW  ProQR Announces Conference Presentations for AxiomerÂ® RNA Editing Technology and QR-313 for DEB,," 4/17/2019 98978L20 GNW  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Zogenix, Inc. Investors (ZGNX)",,," 3/12/2014 76133010 GNW  Revance Therapeutics to Release Fourth Quarter and Full Year 2013 Financial Results and Host Conference Call on Wednesday, March 26, 2014",,," 8/24/2018 ADVM-US  GNW  Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema", 9/27/2018 RARE-US   GNW  Ultragenyx Announces Positive Topline Cohort 2 Results from Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency and Progression to Higher Dose, 6/05/2017 AGLE-US  GNW  Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock, 4/30/2018 NSTG-US  GNW  NanoString Partners with Multiple Leading Contract Research Organizations to Market Digital Spatial Profiling Service,,, 2/08/2018 RDUS-US  GNW  Radius Health to Present at Leerink Partners 7th Annual Global Healthcare Conference,10/02/2017 ASMB-US  GNW  Assembly Biosciences Announces 2017 AASLD Presentations,,, 5/24/2016 ALNY-US  GNW  BioXcel Begins Strategic Collaboration with Alnylam to Discover Novel RNAi Therapeutic Products,, 7/31/2018 AKCA-US  GNW  Akcea Announces Publication of Study Results Showing Multiple Benefits of Patient-to-Patient Connectivity in FCS,, 2/28/2018 JNJ-US   GNW  Pacira Reports Fourth Quarter and Full Year 2017Â Financial Results and Provides Business Update, 2/01/2018 RTRX-US  GNW  Retrophin to Present at the Leerink Partners 7th Annual Global Healthcare Conference, 5/22/2017 PACB-US  GNW  Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant and Animal Transcriptome Analysis, 1/08/2018 EDIT-US  GNW  Editas Medicine Reports on Recent Progress and Announces â€œEM22â€ Five-year Goals at J.P. Morgan Healthcare Conference, 8/10/2016 CHMA-US  GNW  Chiasma Provides Corporate Update and Reports Second Quarter 2016 Results, 5/15/2019 MGNX-US  GNW  MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer,,,,11/01/2017 MNTA-US  GNW  Momenta Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Corporate Update, 1/03/2018 PRTA-US  GNW  Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference," 6/05/2018 ZLAB-US  GNW  Zai Lab Expands Commercial Leadership Team, Appoints William Liang as Chief Commercial Officer",," 5/22/2018 CTMX-US  GNW  CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-2029, a CD71-Directed Probody Therapeutic", 6/29/2018 GMAB-DK  GNW  HuMaxÂ®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics,,, 1/02/2018 CBAY-US  GNW  CymaBay Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference,," 4/27/2017 CCXI-US  GNW  ChemoCentryx to Hold First Quarter 2017 Financial Results Conference Call on Wednesday, May 10, 2017",,, 6/07/2018 MNKD-US   GNW  MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase,,"11/27/2018 CYTK-US  GNW  Cytokinetics Completes Enrollment in FORTITUDE-ALS,  Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS", 7/03/2018 ESPR-US     GNW  Esperion to Host Analyst and Investor Day Event on July 10, 3/29/2019 AMRS-US   GNW  Amyris Delivers on First CBD Milestone; Earns $10 Million,," 8/08/2017 ACHN-US  GNW  Achillion Reports Second Quarter 2017 Financial Results and Proof-of-Concept With a First-in-Class, Oral Factor D Inhibitor"," 3/19/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Syneos Health, Inc. Investors"," 7/31/2018 FOLD-US  GNW  Amicus Therapeutics to Announce Second Quarter 2018 Financial Results on August 7, 2018",,,11/09/2017 ADMA-US  GNW  ADMA Biologics Announces Pricing of Follow-On Offering, 3/05/2018 GWPH-US  GNW  GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March,,, 5/10/2018 MYOK-US  GNW  MyoKardia to Present at the Bank of America Merrill Lynch 2018 Health Care Conference,,10/31/2018 GLPG-NL  GNW  Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF), 9/11/2018 PTLA-US  GNW  U.S. FDA Assigns PDUFA Date to Portola Pharmaceuticalsâ€™ Prior Approval Supplement for the Large-Scale Generation 2 Andexxa Process,,,,11/08/2017 CARA-US  GNW  Cara Therapeutics to Present at November Investor Conferences,12/17/2018 FLXN-US  GNW  Flexion Therapeutics Submits Supplemental New Drug Application (sNDA) for ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension), 5/21/2018 QURE-US  GNW  uniQure Presents New Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-Existing Anti-AAV5 Neutralizing Antibodies, 6/18/2018 AGIO-US   GNW  Agios Announces Initiation of Global Phase 3 Trial (ACTIVATE) of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused," 3/08/2018 IOVA-US  GNW  Iovance Biotherapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results and Provide a Corporate Update on Monday, March 12, 2018", 1/25/2017 ANAB-US  GNW  AnaptysBio Announces Pricing of Initial Public Offering,, 5/02/2018 FATE-US  GNW  Fate Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference," 5/23/2017 HZNP-US  GNW  Horizon Pharma plc Announces Agreement to Sell European Marketing Rights to PROCYSBIÂ® (cysteamine bitartrate) delayed-release capsules and QUINSAIRâ„¢ (levofloxacin inhalation solution) in Europe, Middle East and Africa (EMEA) Regions to Chiesi Farmaceutici S.p.A.",,"11/20/2017 45845P10 GNW  The Klein Law Firm Reminds Shareholders of a Class Action Filed on Behalf of Intercept Pharmaceuticals, Inc. Shareholders and a Lead Plaintiff Deadline of November 27, 2017"," 8/23/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 5/04/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences,,,," 3/13/2017 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016", 5/07/2018 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),, 9/14/2017 24983L10 GNW  New CIMZIAÂ® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) Congress, 5/07/2018 FOMX-US  GNW  Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101, 3/27/2017 PRAI-US  GNW  PRA Health Sciences Named Top Workplace in Philadelphia, 3/06/2017 SUPN-US  GNW  Supernus Announces Settlement with Zydus on Trokendi XRÂ® Patent Litigation," 2/21/2018 FGEN-US  GNW  FibroGen to Report Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018",, 9/21/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 3/04/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Appointment of Craig Millian as Chief Commercial Officer,, 5/30/2017 COLL-US  GNW  Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer, 6/01/2017 XBIT-US  GNW  XBiotech Presents Phase III Findings for its Antibody Therapy for Colorectal Cancer at the 2017 ASCO Meeting,,,10/04/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 5/03/2016 RGNX-US  GNW  REGENXBIO to Participate in May Investor Conferences, 5/22/2018 KURA-US  GNW  OncoDNA announces screening collaboration with Kura Oncology, 9/04/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces that All Four Severely Anemic Solirisâ„¢-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria in Ongoing Phase 1b Trial Have Been Transitioned to APL-2 Monotherapy, 9/28/2018 AXSM-US  GNW  Axsome Therapeutics Announces $8.9 Million Registered Direct Offering,"11/12/2017 VYGR-US  GNW  Voyager Therapeutics to Host R&D Day on November 16, 2017", 3/06/2019 BGNE-US  GNW  Ambrx and BeiGene Announce Global Research and Development Collaboration to Develop Next-Generation Biologics,,10/20/2017 RETA-US  GNW  Reata Announces Late-Breaking Presentation of Primary Results From Phase 2 CARDINAL Study at the American Society of Nephrology Kidney Week 2017 Annual Meeting,, 5/02/2017 NTLA-US  GNW  Intellia Therapeutics Announces First Quarter 2017 Financial Results,10/24/2017 ACIU-US  GNW  AC Immune to Present at Two Investor Conferences and Provide Scientific Updates at CTAD Conference,10/13/2017 CRSP-US  GNW  CRISPR Therapeutics Awarded Grant from Friedreichâ€™s Ataxia Research Alliance to Collaborate with University of Alabama at Birmingham on Gene-edited Treatments for Friedrichâ€™s Ataxia, 5/03/2018 GTHX-US  GNW  G1 Therapeutics Provides First Quarter 2018 Corporate and Financial Update,,,10/16/2018 ATNX-US  GNW  Athenex to Present Positive Data of Oraxol Clinical Trial in Breast Cancer at the ESMO 2018 Congress,,"10/04/2017 00FMDK-E GNW  Rhythm Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering",,,,,, 5/10/2018 EOLS-US  GNW  Evolus Reports First Quarter 2018 Financial Results,, 8/02/2018 EYPT-US    GNW  EyePoint Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/19/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation of Updated Safety and Tolerability Data for AZEDRAÂ® (iobenguane I 131) at the Radiological Society of North America (RSNA) Annual Meeting,,,,,12/14/2017 BDSI-US  GNW  BioDelivery Sciences Reacquires ONSOLISÂ® from Collegium Pharmaceutical,,, 3/08/2012 DMND-US      GNW  Diamond Foods Announces the Appointments of Two New Members to its Board of Directors,"10/22/2018 68375N10 GNW  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 2/15/2018 46222210 GNW  Akcea Announces FDA Advisory Committee Meeting to Review Volanesorsen as a Treatment for Familial Chylomicronemia Syndrome, 9/18/2015 BMRN-US     GNW  BioMarin Announces Kuvan(R) (sapropterin dihydrochloride) Patent Challenge Settlement,,,," 2/07/2019 45290710 GNW  February 25th Immunomedics Shareholder Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Immunomedics, Inc. â€“ IMMU",10/01/2018 BIIB-US   GNW  Helsinn Group strengthens the Board with the appointment of Francesco Granata,, 1/02/2019 BCRX-US  GNW  BioCryst Initiates Phase 1 Clinical Trial of Galidesivir,,,,," 5/02/2018 00972810 GNW  FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact The Firm",,"10/15/2019 62855J10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ MYGN", 9/24/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 54th Annual Meeting,, 9/27/2016 INSM-US  GNW  Insmed Appoints Roger Adsett as Chief Commercial Officer,," 1/22/2018 INO-US    GNW  Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models",11/12/2018 64026810 GNW  SHAREHOLDER ALERT: APOG COCP ABBV COST HTHT SFIX CWH OZK NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,11/01/2018 GERN-US  GNW  Geron Announces Two Oral Presentations on Imetelstat at Upcoming American Society of Hematology Annual Meeting,," 3/22/2019 02311120 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KHC, AMRN, WTW and SYNH",,, 2/27/2019 SRPT-US  GNW  Sarepta Exercises Option to Acquire Myonexus Therapeutics,"12/18/2017 G0176710 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",, 8/23/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 3/15/2019 SAN-FR   GNW  PraluentÂ® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease,,, 1/08/2018 ASND-US  GNW  Ascendis Pharma Provides Update on Rare Disease Endocrinology Pipeline and Presents Initial Phase 1 Data for TransCon PTH,,, 2/12/2018 AFMD-US  GNW  Affimed Announces Proposed Public Offering of Common Stock,, 4/23/2018 PRQR-US  GNW  ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO,," 4/17/2019 98978L20 GNW  ZOGENIX, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit hasÂ beenÂ filedÂ inÂ theÂ United States District Court for the Northern District of California against Zogenix, Inc.",,, 3/05/2014 76133010 GNW  Revance to Add Angus C. Russell as Chairman to Its Board of Directors,,," 8/20/2018 00773U10 GNW  Investor Expectations to Drive Momentum within Mazor Robotics, Kinross Gold, Mimecast, DBV Technologies S.A., Adamas Pharmaceuticals, and Adverum Biotechnologies â€” Discovering Underlying Factors of Influence", 9/26/2018 RARE-US   GNW  Ultragenyx to Present at Jefferies Gene Therapy Summit, 5/23/2017 AGLE-US  GNW  Aeglea BioTherapeutics Provides AEB1102 Program and Corporate Update," 4/18/2018 63009R10 GNW  Investor Expectations to Drive Momentum within Casella Waste, Prologis, Flushing Financial, AMERISAFE, Aclaris Therapeutics, and NanoString Technologies â€” Discovering Underlying Factors of Influence",,, 1/05/2018 RDUS-US  GNW  Radius Health to Present at the 36th Annual J.P. Morgan Healthcare Conference, 9/25/2017 ASMB-US  GNW  Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development,,,12/15/2014 02043Q10 GNW  Quarterly Changes to the NXTQ Index,, 7/23/2018 00972L10 GNW  Akcea Therapeutics to Hold Second Quarter 2018 Financial Results Webcast,," 2/27/2018 089W1N-E GNW  University of Tennessee Medical Center at Knoxville, Pacira Pharmaceuticals, and CQ-Insights Announce Collaboration to Minimize Opioid Use After Hernia Surgery", 1/08/2018 RTRX-US  GNW  Retrophin Provides Corporate Update and 2018 Outlook," 4/26/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2017 Financial Results", 1/03/2018 EDIT-US  GNW  Editas Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference," 7/27/2016 CHMA-US  GNW  Chiasma to Report Second Quarter 2016 Financial Results  on August 10, 2016", 5/01/2019 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and First Quarter 2019 Financial Results,,,,"11/01/2017 60877T10 GNW  Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIAÂ® (abatacept)",11/22/2017 PRTA-US  GNW  Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference, 5/30/2018 ZLAB-US  GNW  Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications,, 5/16/2018 CTMX-US  GNW  CytomX Therapeutics Announces Presentations at 2018 ASCO Annual Meeting, 5/25/2018 GMAB-DK  GNW  Genmab Announces that Janssen Will Stop Studies of Daratumumab in Combination with Anti-PD-(L)1,,,12/04/2017 CBAY-US  GNW  CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel,, 3/22/2017 CCXI-US  GNW  ChemoCentryx Receives FDA Orphan Drug Designation for Avacopan in the Treatment of Debilitating Kidney Disease C3 Glomerulopathy (C3G),,, 6/05/2018 MNKD-US   GNW  MannKind Establishes Market Price Stock Purchase Plan,,11/26/2018 CYTK-US  GNW  Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND," 6/29/2018 29664W10    GNW  CLASS ACTION UPDATE for ESPR, PPG and PCG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/27/2019 AMRS-US   GNW  Amyris to Present April 15 at Paradigm Capital Biosynthesis Conference â€“ Exploring the Most Disruptive Technology in the Cannabis Industry,," 8/01/2017 ACHN-US  GNW  Achillion to Host Second Quarter 2017 Results Conference Call on August 8, 2017", 3/18/2019 SYNH-US  GNW  Syneos Health Reports Fourth Quarter and Full Year 2018 Results," 7/30/2018 03152W10 GNW  Research Report Identifies General Dynamics, General Motors, Amicus Therapeutics, Drive Shack, Zoe's Kitchen, and Vishay Intertechnology with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",,,11/03/2017 ADMA-US  GNW  ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results, 2/27/2018 GWPH-US  GNW  GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis,,," 5/10/2018 MYOK-US  GNW  MyoKardia Doses First Patient in PIONEER Open-Label Extension Study of Mavacamten for Symptomatic, Obstructive Hypertrophic Cardiomyopathy",,"10/29/2018 36315X10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within ICON, Robert Half International, CenterPoint Energy, Galapagos NV, Canadian Pacific Railway, and Mobile Mini â€” New Research Emphasizes Economic Growth", 9/07/2018 PTLA-US  GNW  Portola Pharmaceuticals Announces Executive Leadership Change,,,,11/02/2017 CARA-US  GNW  Cara Therapeutics Reports Third Quarter 2017 Financial Results,12/04/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/18/2018 QURE-US  GNW  uniQure Presents Preclinical Data Demonstrating Advances in the Distribution of Gene Therapy, 6/04/2018 AGIO-US   GNW  New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients, 3/07/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in March, 4/14/2015 TSRO-US  GNW  TESARO Announces Upcoming Immuno-Oncology Presentations,, 4/16/2018 FATE-US  GNW  Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual Meeting Press Program, 5/15/2017 HZNP-US  GNW  Horizon Pharma plc Announces District Court Decision to Uphold PENNSAIDÂ® (diclofenac sodium topical solution) 2% w/w Patent,,"11/15/2017 45845P10 GNW  ICPT EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intercept Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 27, 2017"," 8/23/2019 48576U10   GNW  Karyopharm Therapeutics Inc. (KPTI), Mallinckrodt plc (MNK) & National General Holdings Corp. (NGHC) â€“ Class Action Reminder â€“ Bronstein, Gewirtz & Grossman, LLC",,, 5/03/2018 ITCI-US  GNW  Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update,,,," 3/09/2017 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 13, 2017"," 5/07/2018 ATRA-US    GNW  Biotech Industry Veteran Dietmar Berger, M.D., Ph.D., Joins Atara Biotherapeutics as Global Head of Research and Development",, 9/13/2017 DERM-US  GNW  Dermira Presents New Data Showing Impact of Primary Axillary Hyperhidrosis on Patients, 4/24/2018 FOMX-US  GNW  Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for May 9," 2/22/2017 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 Guidance", 2/28/2017 SUPN-US  GNW  Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results,11/08/2017 FGEN-US  GNW  FibroGen Reports Third Quarter 2017 Financial Results,, 9/17/2018 CHRS-US  GNW  Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October, 1/30/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares,, 5/23/2017 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences, 5/30/2017 XBIT-US  GNW  Dr. Razelle Kurzrock to Present Novel Biomarker Findings from XBiotech Phase III Colorectal Cancer Study Data at the 19th European Society for Medical Oncology World Congress on Gastrointestinal Cancer,,,10/04/2018 GBT-US   GNW  GBT Announces Upcoming Presentations at National Sickle Cell Disease Association of America (SCDAA) Convention, 4/19/2016 RGNX-US  GNW  Preclinical Data from REGENXBIOâ€™s RGX-314 and RGX-121 Gene Therapy Programs to be Presented at the American Society of Gene & Cell Therapy 19th Annual Meeting, 5/08/2018 KURA-US  GNW  Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update, 7/31/2018 APLS-US  GNW  Apellis Pharmaceuticals Reports Second Quarter 2018 Business Update and Financial Results, 9/24/2018 AXSM-US  GNW  Axsome Therapeutics to Present at Upcoming Investor Conferences,11/10/2017 VYGR-US  GNW  Voyager Therapeutics Announces Closing of Public Offering of Common Stock," 3/05/2019 07725L10 GNW  Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson â€” Fundamental Analysis, Key Performance Indications",," 9/13/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma",, 4/26/2017 45826J10 GNW  Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein Complexes,10/03/2017 ACIU-US  GNW  AC Immune Awarded Continuation of 2015 Grant from The Michael J. Fox Foundation for Parkinson's Research,10/04/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at Investor Conferences in October, 5/01/2018 GTHX-US  GNW  G1 Therapeutics to Present at UBS Global Healthcare Conference in May 2018,,,10/15/2018 ATNX-US  GNW  Athenex and Xiangxue Life Sciences Announce Preliminary Results of Patients Receiving T-Cell Receptor Affinity Enhancing Specific T-Cell Therapy (TAEST) Showed Encouraging Positive Clinical Signals,,,,,,,, 5/07/2018 EOLS-US  GNW  Evolus Appoints Allergan Aesthetics Head as President and Chief Executive Officer,, 8/01/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Appoints David Price as Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/08/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update,,,,, 1/13/2017 09060J10 GNW  MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI),,, 3/07/2012 064R0R-E     GNW  Kettle Brand(R) Brings Flavor Favorites Out of Retirement for 30th Birthday Celebration,10/21/2018 68375N10 GNW  SHAREHOLDER ALERT: AMPE NVRO PZZA OPK QRTEA MCHP COCP TGTX CPB TRVN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 2/12/2018 IONS-US  GNW  Akcea Therapeutics to Hold Fourth Quarter 2017 Financial Results Webcast, 9/02/2015 BMRN-US     GNW  BioMarin to Attend Upcoming Investor Conferences in September,,,," 2/07/2019 45290710 GNW  CLASS ACTION UPDATE for WBT, SOGO, IMMU and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 9/04/2018 BIIB-US   GNW  Biogen Enrolls First Patient in Global Phase 3 Study of BIIB093 (IV Glibenclamide) for Large Hemispheric Infarction,, 1/02/2019 BCRX-US  GNW  BioCryst to Present at 37th Annual J.P. Morgan Healthcare Conference,,,,," 5/01/2018 008G5M-E GNW  Rosen Law Firm Reminds Akorn, Inc. Investors of Important May 7 Deadline in Class Action â€“ AKRX",,"10/14/2019 62855J10 GNW  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important November 26th Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm â€“ MYGN", 9/24/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,, 9/08/2016 MS-US    GNW  Insmed to Participate at September Investor Conferences,, 1/17/2018 INO-US    GNW  Inovioâ€™s Co-Founder along with its Lead Antigen Designer  Named Among Top 20 Researchers With Most Granted U.S Patents for 2016,"11/11/2018 64026810 GNW  CLASS ACTION UPDATE for APOG, NKTR and SYF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,"10/25/2018 GERN-US  GNW  Geron to Announce Third Quarter 2018 Financial Results on November 1, 2018",, 3/21/2019 02311120 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation plc of Class Action Lawsuit and Upcoming Deadline â€“ AMRN,,," 2/20/2019 SRPT-US  GNW  Sarepta Therapeutics to Announce Limb-Girdle Muscular Dystrophy Type 2E Data Results and Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Developments on February 27, 2019","12/14/2017 G0176710 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Alkermes plc Shareholders and a Lead Plaintiff Deadline of January 22, 2018",," 8/23/2018 00163U10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within AMAG Pharmaceuticals, Pier 1 Imports, Gogo, IDT, Axalta Coating, and Sprouts Farmers Market â€” New Research Emphasizes Economic Growth",,,,, 3/08/2019 SAN-FR   GNW  Sanofi: Filing of the 2018 U.S. Form 20-F and French Â« Document de RÃ©fÃ©rence Â» containing the Annual Financial Report,,, 1/03/2018 ASND-US  GNW  Ascendis Pharma Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone for Pediatric Growth Hormone Deficiency,,, 2/01/2018 AFMD-US  GNW  Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas,, 4/11/2018 PRQR-US  GNW  ProQR Announces Annual Meeting of Shareholders,, 4/17/2019 98978L20 GNW  SHAREHOLDER ALERT: DPLO BV ZGNX MWA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,," 2/19/2014 76133010 GNW  Revance Therapeutics, Inc. Announces Participation in Cowen 34th Annual Health Care Conference",,, 8/08/2018 ADVM-US  GNW  Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update, 9/17/2018 RARE-US   GNW  Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chief Operating Officer, 5/16/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present at the UBS 2017 Global Healthcare Conference, 4/12/2018 NSTG-US  GNW  NanoString Showcases Groundbreaking Body of Research at the 2018 Annual Meeting of the American Association for Cancer Research,,, 1/02/2018 RDUS-US  GNW  Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications, 8/31/2017 ASMB-US  GNW  Assembly Biosciences Announces September Conference Participation,,,10/14/2014 ALNY-US  GNW  Tekmira's Partner Reports Positive Clinical Data for LNP-Enabled Patisiran,, 7/11/2018 00972L10 GNW  Akcea and Ionis Announce Approval of TEGSEDIâ„¢ (inotersen) in the European Union,, 2/22/2018 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call, 1/05/2018 0G632X-E GNW  Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)," 4/18/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. First Quarter 2017 Financial Results Call",12/11/2017 EDIT-US  GNW  Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia," 7/24/2016 16706W10 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders withÂ Losses on their Investment in Chiasma, Inc. ofÂ Class Action Lawsuit and Upcoming Deadline â€“ CHMA", 4/24/2019 MGNX-US  GNW  MacroGenics Announces Date of First Quarter 2019 Financial Results Conference Call,,,,10/18/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast,11/16/2017 PRTA-US  GNW  Prothena Highlights Breadth of Novel Pipeline at R&D Day, 5/29/2018 ZLAB-US  GNW  Zai Lab Announces Presentations at June Investor Conferences,, 5/09/2018 CTMX-US  GNW  CytomX Therapeutics Announces First Quarter 2018 Financial Results, 5/24/2018 GMAB-DK  GNW  Genmab Announces Topline Results in Phase III study of ArzerraÂ® in Indolent Non-Hodgkinâ€™s Lymphoma,,,12/04/2017 CBAY-US  GNW  CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel,, 3/14/2017 CCXI-US  GNW  ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results,,, 5/09/2018 MNKD-US   GNW  MannKind Corporation Reports 2018 First Quarter Financial Results,,11/07/2018 CYTK-US  GNW  Cytokinetics to Participate in Upcoming Investor Conferences," 6/28/2018 29664W10    GNW  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LC, ESPR, and MFGP"," 3/25/2019 03236M20  GNW  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Amyris, Inc. Investors (AMRS)",, 7/10/2017 ACHN-US  GNW  Achillion Pharmaceutials Announces Key Promotion and Discovery Organization Change," 3/17/2019 87166B10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, SYNH, BPI and CNDT", 6/26/2018 FOLD-US  GNW  Amicus Therapeutics Announces European Regulatory and Clinical Updates for AT-GAA in Pompe Disease,,,10/11/2017 00441H-E GNW  Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing, 2/21/2018 GWPH-US  GNW  GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006,,, 5/08/2018 MYOK-US  GNW  MyoKardia Reports First Quarter 2018 Financial Results,,10/24/2018 GLPG-NL  GNW  Hallmark third quarter 2018 and Annual R&D Update at Galapagos, 9/05/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement GrantsÂ Under NASDAQ Listing Rule 5635(c)(4),,,,10/31/2017 CARA-US  GNW  Cara Therapeutics to Present Late-Breaking Data at the American College of Rheumatology ACR/ARHP Annual Meeting,11/16/2018 FLXN-US  GNW  Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston GlobeÂ , 5/07/2018 QURE-US  GNW  uniQure Announces Closing Of Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares, 6/02/2018 AGIO-US   GNW  Updated Data from Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1m Relapsed or Refractory AML Continue to Show Durable Responses as a Single Agent," 3/01/2018 IOVA-US  GNW  Iovance Biotherapeutics Appoints Michael Weiser, M.D., Ph.D., to its Board of Directors",12/02/2014 TSRO-US  GNW  TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate,, 3/29/2018 FATE-US  GNW  Fate Therapeutics Announces Initial Clinical Data of FATE-NK100 for Recurrent Ovarian Cancer at the Innate Killer Summit 2018, 5/11/2017 HZNP-US  GNW  Horizon Pharma plc Announces Michelle Parsons as a 2017 Healthcare Businesswomen's Association Luminary,,"11/14/2017 45845P10 GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intercept Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 27, 2017 â€“ ICPT"," 8/21/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 4/26/2018 ITCI-US  GNW  Intra-Cellular Therapies Presents Data on ITI-214 at the 2018 American Academy of Neurology Annual Meeting,,,, 2/21/2017 06CR5C-E GNW  Amphastar Announces the Receipt of a CRL for Intranasal Naloxone for the Emergency Treatment of Opioid Overdose," 5/01/2018 ATRA-US    GNW  Atara Biotherapeutics Expands Commercial Leadership Team with the Appointment of Manuela Maronati as General Manager, Europe",, 9/07/2017 DERM-US  GNW  Dermira Presents New Data on Late-Stage Programs at Leading European Dermatology Congress, 4/16/2018 FOMX-US  GNW  Foamix Announces $16 Million Investment by OrbiMed, 2/02/2017 PRAH-US  GNW  PRA Health Sciences to Report Fourth Quarter 2016 Earnings and Issue 2017 Guidance, 2/27/2017 SUPN-US  GNW  Supernus to Present at Cowen Health Care Conference in March,"10/30/2017 FGEN-US  GNW  FibroGen to Report Third Quarter Financial Results on Wednesday, November 8, 2017",," 8/31/2018 19249H10 GNW  Research Report Identifies Holly Energy Partners, First Merchants, Enbridge Energy Management, Activision Blizzard, Coherus BioSciences, and Kala Pharmaceuticals with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement", 1/25/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock,, 5/10/2017 COLL-US  GNW  Collegium Reports First Quarter Financial Results and Provides Corporate Update, 4/28/2017 XBIT-US  GNW  XBiotech to Provide First Quarter 2017 Business Update,,," 9/27/2018 37890U10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Global Blood Therapeutics, Inc. (GBT)", 3/03/2016 RGNX-US  GNW  REGENXBIO Reports Fourth Quarter and Full-Year 2015 Financial Results and Recent Operational Progress, 5/03/2018 KURA-US  GNW  Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference, 7/24/2018 APLS-US  GNW  Apellis Pharmaceuticalsâ€™ APL-2 Receives Fast Track Designation from FDA for the Treatment of Patients with Geographic Atrophy, 9/19/2018 AXSM-US  GNW  Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Alzheimerâ€™s Disease Agitation,11/07/2017 VYGR-US  GNW  Voyager Therapeutics Announces Pricing of Public Offering of Common Stock, 3/04/2019 BGNE-US  GNW  BeiGene to Present at Upcoming Investor Conferences,," 8/14/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Second Quarter 2017 Financial and Operating Results",," 4/13/2017 45826J10 GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision", 9/12/2017 ACIU-US  GNW  AC IMMUNE COMPLETES RECRUITMENT FOR LOW-DOSE COHORT  IN WORLD'S FIRST CLINICAL TRIAL FOR ANTI-ABETA VACCINE TARGETING ALZHEIMER'S DISEASE-LIKE CHARACTERISTICS IN INDIVIDUALS WITH DOWN SYNDROME,"10/02/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer"," 4/26/2018 GTHX-US  GNW  G1 Therapeutics to Provide First Quarter 2018 Corporate and Financial Update on May 3, 2018",,," 9/25/2018 04685N10 GNW  Report: Developing Opportunities within RLJ Lodging Trust, Solar Capital, Athenex, Bonanza Creek Energy, Mueller Industries, and Corporate Office Properties Trust â€” Future Expectations, Projections Moving into 2018",,,,,,,, 5/03/2018 EOLS-US  GNW  Evolus to Present at the Bank of America Merrill Lynch 2018 Health Care Conference,, 7/25/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Presentation of Data Highlighting YUTIQâ„¢ for Posterior Segment Uveitis at the 36th Annual Scientific Meeting of the American Society of Retina Specialists,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/06/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 5/11/2016 09060J10 GNW  Collegium Licenses the U.S. rights to ONSOLISÂ® from BioDelivery Sciences,,, 3/01/2012 82691710     GNW  SIGA Technologies Reports Financial Results for the Fourth Quarter and Year Ended 2011,"10/19/2018 68375N10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â OPK", 2/07/2018 46222210 GNW  Akcea Completes Enrollment in Phase 2b Study of AKCEA-APO(a)-LRx," 9/01/2015 09061G10    GNW  BioMarin Launches kNOWyourDuchenne, Comprehensive Program for Patients With Duchenne Muscular Dystrophy to Understand Their Genetic Mutation",,,," 2/06/2019 45290710 GNW  CLASS ACTION UPDATE for IMMU, PRGO, DXC and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 8/28/2018 4523-JP   GNW  Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimerâ€™s Disease Treatment Aducanumab,,11/20/2018 BCRX-US  GNW  BioCryst Appoints Rare Disease Expert Theresa Heggie to Board of Directors,,,,," 4/30/2018 00972810 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action AgainstÂ Akorn, Inc. (AKRX) &Â Lead Plaintiff Deadline: May 7, 2018",,"10/09/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eldorado Resorts, Sundial, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm", 8/30/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,," 9/07/2016 45766930 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 â€“ INSM",, 1/09/2018 INO-US    GNW  Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Evaluate Novel Cancer Immunotherapy Combinations,"11/09/2018 64026810 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ NKTR",,"10/15/2018 37416310 GNW  Report: Developing Opportunities within CorEnergy Infrastructure Trust, Calumet Specialty Products Partners, Iron Mountain, Geron, Bruker, and Loews â€” Future Expectations, Projections Moving into 2018",, 3/20/2019 02311120 GNW  APRIL 23 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Amarin Corporation plc â€“ AMRN,,," 2/14/2019 80360710 GNW  Lysogene and Sarepta Therapeutics Announce Dosing of the First Patient in AAVance, a Phase 2/3 Clinical Trial Investigating LYS-SAF302, a Gene Therapy for the Treatment of MPS IIIA (Sanfilippo Syndrome Type A)","12/12/2017 G0176710 GNW  ALKS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018",, 8/06/2018 AMAG-US  GNW  AMAG Pharmaceuticals Completes Divestiture of Cord Blood RegistryÂ®,,,,, 3/08/2019 SAN-FR   GNW  Sanofi: FDA to undertake priority review of DupixentÂ® (dupilumab) for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps,,,12/21/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in 36th Annual J.P. Morgan Healthcare Conference,,,12/11/2017 AFMD-US  GNW  Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH,, 4/10/2018 PRQR-US  GNW  ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on AxiomerÂ® RNA A-to-I Editing Technology,," 4/16/2019 98978L20 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm",,," 2/11/2014 76133010 GNW  Revance Therapeutics, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Over-Allotment Option",,, 8/01/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline, 8/30/2018 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences, 5/09/2017 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2017 Financial Results," 4/10/2018 NSTG-US  GNW  NanoString Announces Launch of Breast Cancer 360 Research Panel, Expanding the 360 Series of Cancer Panels for Translational Research and Signature Development",,,"12/15/2017 RDUS-US  GNW  Radius Health Announces that the Committee for Medicinal Products for Human Use (CHMP) Will Issue a Third Day-180 List of Outstanding Issues in its Regulatory Review of Abaloparatide-SC, a Bone Building Agent for the Treatment of Osteoporosis in Postmenopausal Women at Increased Risk of Fracture", 7/28/2017 ASMB-US  GNW  Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),,, 4/28/2014 02043Q10 GNW  Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02),, 6/13/2018 00972L10 GNW  Akcea Announces Completion of Landmark Study to Assess Disease Burden in People Living with FCS,, 2/16/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference,12/28/2017 RTRX-US  GNW  Retrophin to Present at the 36th Annual J.P. Morgan Healthcare Conference, 2/13/2017 PACB-US  GNW  SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AGBT Conference,"12/06/2017 EDIT-US  GNW  Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock"," 7/08/2016 16706W10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Chiasma, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ CHMA", 4/03/2019 MGNX-US  GNW  MacroGenics Reports Presentation of Data at the AACR Annual Meeting 2019,,,,10/02/2017 MNTA-US  GNW  Momenta Pharmaceuticals Promotes Ganesh V. Kaundinya as Chief Operating Officer and Chief Scientific Officer,11/07/2017 PRTA-US  GNW  Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update, 5/21/2018 ZLAB-US  GNW  Zai Lab Announces Early Completion of Enrollment for ZL-2306 PK Study,, 5/07/2018 CTMX-US  GNW  CytomX to Present at the Bank of America Merrill Lynch 2018 Health Care Conference, 5/08/2018 GMAB-DK  GNW  Interim Report First Quarter 2018,,,11/13/2017 CBAY-US  GNW  CymaBay Therapeutics to Present at Three Investor Conferences,," 3/01/2017 CCXI-US  GNW  ChemoCentryx to Hold Fourth Quarter 2016 Financial Results Conference Call on Tuesday, March 14, 2017",,, 5/09/2018 500087-IN GNW  MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement for AfrezzaÂ® in India,,"11/01/2018 CYTK-US  GNW  Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results"," 6/26/2018 29664W10    GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 â€“ ESPR"," 3/25/2019 AMRS-US   GNW  Amyris to Present at H.C. Wainwright Global Life Sciences Conference on April 8, 2019",, 6/15/2017 ACHN-US  GNW  Achillion to Present at the 2017 JMP Securities Life Sciences Conference," 3/15/2019 87166B10 GNW  SYNEOS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Syneos Health, Inc.Â â€“ SYNH", 6/08/2018 FOLD-US  GNW  Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors,,, 8/23/2017 ADMA-US  GNW  ADMA Biologics to Present at Upcoming Investor Conferences, 2/06/2018 GWPH-US  GNW  GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February,,," 5/03/2018 MYOK-US  GNW  MyoKardia to Report First Quarter 2018 Financial Results on  Tuesday, May 8, 2018",,10/24/2018 ABBV-US  GNW  Galapagos and AbbVie restructure CF collaboration," 9/05/2018 73701010 GNW  Market Trends Toward New Normal in Shutterstock, CrossAmerica Partners LP, Allegiance Bancshares, Portola Pharmaceuticals, StoneMor Partners, and Catalyst Biosciences â€” Emerging Consolidated Expectations, Analyst Ratings",,,,"10/26/2017 CARA-US  GNW  Cara Therapeutics to Announce Third Quarter 2017 Financial Results on November 2, 2017",11/07/2018 FLXN-US  GNW  Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights, 5/02/2018 QURE-US  GNW  uniQure Announces Pricing of its Public Offering, 6/01/2018 AGIO-US   GNW  Agios Presents Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma and Other Solid Tumors, 2/14/2018 IOVA-US  GNW  Iovance Biotherapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference, 9/08/2014 MNTA-US  GNW  Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio,, 3/19/2018 FATE-US  GNW  Fate Therapeutics Announces Additional Clinical Data from Phase 1 Stage of PROTECT Clinical Trial of ProTmuneâ„¢, 5/08/2017 HZNP-US  GNW  Horizon Pharma plc Announces First-Quarter 2017 Results and Revises Full-Year 2017 Net Sales and Adjusted EBITDA Guidance,,"11/08/2017 45845P10 GNW  INTERCEPT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Intercept Pharmaceuticals, Inc. To Contact The Firm", 8/21/2019 KPTI-US    GNW  Karyopharm Announces Publication of XPOVIOâ„¢ (Selinexor) Phase 2b STORM Study Results in The New England Journal of Medicine,,, 3/13/2018 ITCI-US  GNW  Intra-Cellular Therapies Announces Positive Pre-NDA Meeting with FDA for Lumateperone for the Treatment of Schizophrenia,,,,12/27/2016 06CR5C-E GNW  Amphastar Pharmaceuticals Receives Complete Response Letter for PrimateneÂ® Mist, 4/09/2018 RUN-US     GNW  Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),," 8/08/2017 DERM-US  GNW  Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab", 3/08/2018 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018,"11/10/2016 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Secondary Offering of 7,500,000 Shares of Common Stock", 2/13/2017 SUPN-US  GNW  Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call,10/18/2017 AZN-GB   GNW  FibroGen Announces Acceptance by China FDA of Roxadustat New Drug Application (NDA) for Treatment of Anemia Associated With Dialysis and Non-Dialysis Chronic Kidney Disease (CKD),, 8/20/2018 CHRS-US  GNW  Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in SeptemberÂ , 1/24/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock,, 5/03/2017 COLL-US  GNW  Collegium to Host Conference Call to Discuss First Quarter 2017 Financial Results and Provide Corporate Update, 4/20/2017 XBIT-US  GNW  XBiotech Announces Outcome of EMAâ€™s Oral Explanation Meeting,,," 9/27/2018 37890U10 GNW  Analysis: Positioning to Benefit within CONSOL Coal Resources LP, QTS Realty Trust, MakeMyTrip, Momo, QIWI, and Global Blood Therapeutics â€” Research Highlights Growth, Revenue, and Consolidated Results", 3/01/2016 RGNX-US  GNW  REGENXBIO Announces Appointment of Faraz Ali as Chief Business Officer, 5/02/2018 KURA-US  GNW  Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies, 6/26/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces First Patient Enrolled in Phase 3 APL-2 Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Solirisâ„¢, 8/28/2018 AXSM-US  GNW  Axsome Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference,11/06/2017 VYGR-US  GNW  Voyager Therapeutics Announces Proposed Offering of Common Stock, 2/27/2019 BGNE-US  GNW  BeiGene Reports Fourth Quarter and Full Year 2018 Financial Results,, 8/14/2017 RETA-US  GNW  FDA Confirms That Use of mFARS as Primary Endpoint in Part 2 of the MOXIe Trial Can Support Approval of Omaveloxolone in Friedreichâ€™s Ataxia,, 4/11/2017 NTLA-US  GNW  Intellia Therapeutics Announces European Patent Officeâ€™s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent, 8/22/2017 ACIU-US  GNW  AC IMMUNE DISCOVERS NEXT-GENERATION ANTIBODIES FOCUSED ON NEURODEGENERATIVE DISEASES, 8/22/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies, 4/16/2018 AZN-GB   GNW  G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer,,, 9/17/2018 072PGF-E GNW  PSIâ€™s Acquisition of KINEX Strengthens Companyâ€™s Position as an IT Leader,,,,,,,, 4/23/2018 EOLS-US  GNW  Evolus to Present at the Inaugural Aesthetics Innovation Summit and ASAPSâ€™ The Aesthetic Meeting,, 7/11/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Data Highlighting YUTIQâ„¢ for Posterior Segment Uveitis to be Presented at the 36th Annual Scientific Meeting of the American Society of Retina Specialists,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/01/2018 PGNX-US  GNW  Progenics Pharmaceuticals Sets Third Quarter 2018 Financial Results and Business Update Call for November 8,,,,," 4/07/2016 00988N-E GNW  U.S. Patent and Trademark Office Upholds the Validity of MonoSol Rxâ€™s US Patent No. 8,765,167 in the Face of Multiple Inter Partes Review Challenges Brought by BioDelivery Sciences International, Inc. (BDSI)",,," 2/28/2012 82691710     GNW  SIGA to Host Fourth Quarter and Year End Business Update Call on March 1, 2012","10/19/2018 68375N10 GNW  CLASS ACTION UPDATE for LCI, OPK, MCHP and CPB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 1/05/2018 46222210 GNW  Akcea Initiates Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia and Established Cardiovascular Disease, 8/31/2015 09061G10    GNW  BioMarin Announces Two Oral and 19 Poster Presentations at the Society for the Study of Inborn Errors of Metabolism 2015 Annual Meeting,,,," 2/05/2019 45290710 GNW  CLASS ACTION UPDATE for TS, IMMU, GSM and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 7/30/2018 09062X10  GNW  New Research Coverage Highlights Texas Instruments, Biogen, Sanchez Energy, Amazon, Sirius XM, and JPMorgan Chase â€” Consolidated Revenues, Company Growth, and Expectations for 2018",,"11/16/2018 BCRX-US  GNW  BioCryst Presents Data Highlighting the Rapid and Sustained Plasma Concentrations of BCX7353 in HAE Patients at the Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology",,,,," 4/24/2018 07YYYW-E GNW  AKORN, INC. INVESTOR ALERT: Â Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of shareholders of Akorn, Inc.",,"10/08/2019 62855J10 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GNLN, VAL, MDP and MYGN"," 8/28/2018 52887230 GNW  Research Report Identifies Convergys, Amkor Technology, Discovery, Inc., ServiceMaster Global, Acadia Healthcare, and Lexicon Pharmaceuticals with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 8/31/2016 09TVZQ-E GNW  Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress,, 1/08/2018 INO-US    GNW  Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squamous Cell Cancer Advances to Phase 2,"11/08/2018 64026810 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, SFIX, CWH, HON, NKTR and SYF",," 9/27/2018 37416310 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Investigation of Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",," 3/20/2019 02311120 GNW  Class Action AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Update",,, 2/14/2019 SRPT-US  GNW  Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53,12/09/2017 G0176710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline â€“ ALKS,," 8/06/2018 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs",,,,, 3/01/2019 SAN-FR   GNW  Sanofi: CHMP recommends approval of DupixentÂ® (dupilumab) for asthma indication,,,11/21/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference,,,11/15/2017 AFMD-US  GNW  Affimed to Present at the Jefferies 2017 London Healthcare Conference,, 4/03/2018 PRQR-US  GNW  ProQR to Present at Two Upcoming Conferences,," 4/12/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Zogenix, Inc. (ZGNX) and Encourages ZGNX Investors to Contact the Firm",,, 2/05/2014 76133010 GNW  Revance Therapeutics Announces Pricing of Initial Public Offering,,," 7/24/2018 ADVM-US  GNW  Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications", 8/29/2018 RARE-US   GNW  Ultragenyx Announces FDA Accepts Proposal to Submit an NDA for UX007 for the Treatment of Long-Chain Fatty Acid Oxidation Disorders, 3/29/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present Preclinical Data for AEB1102 at 2017 AACR Annual Meeting," 4/09/2018 NSTG-US  GNW  NanoString to Release First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018",,,12/11/2017 RDUS-US  GNW  Fractured Truth Campaign Wins Bronze Pearl Award for Content Marketing Excellence in the Healthcare/Pharmaceutical Industry, 5/26/2017 ASMB-US  GNW  Assembly Biosciences Announces June Conference Presentations,,, 1/13/2014 02043Q10 GNW  Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases,," 6/12/2018 AKCA-US  GNW  Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis",, 2/15/2018 PCRX-US  GNW  Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPARELÂ® for Use as a Nerve Block to Produce Regional Analgesia,11/30/2017 RTRX-US  GNW  Retrophin to Present at the BMO 2017 Prescriptions for Success Healthcare Conference, 2/02/2017 PACB-US  GNW  Pacific Biosciences Announces Fourth Quarter 2016 Financial Results,"12/05/2017 EDIT-US  GNW  Editas Medicine, Inc., Announces Offering of Common Stock"," 7/05/2016 16706W10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Chiasma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 â€“ CHMA", 4/02/2019 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences,,,, 8/30/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the 2017 Wells Fargo Healthcare Conference,11/01/2017 PRTA-US  GNW  Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference, 5/02/2018 ZLAB-US  GNW  Zai Lab Reports Full Year 2017 Financial Results and Corporate Update,, 5/01/2018 CTMX-US  GNW  CytomX Therapeutics to Announce First Quarter 2018 Financial Results, 5/07/2018 GMAB-DK  GNW  Genmab Announces U.S. FDA Approval of DARZALEXÂ® (daratumumab) in Newly Diagnosed Multiple Myeloma,,,11/08/2017 CBAY-US  GNW  CymaBay Reports Third Quarter 2017 Financial Results and Corporate Updates,, 2/28/2017 CCXI-US  GNW  ChemoCentryx to Present at the Cowen and Company 37th Annual Health Care Conference,,," 5/02/2018 MNKD-US   GNW  MannKind Corporation to Hold 2018 First Quarter Financial Results Conference Call on May 9, 2018",,"10/18/2018 CYTK-US  GNW  Cytokinetics to Announce Third Quarter Results on November 1, 2018"," 6/23/2018 29664W10    GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ESPR"," 3/24/2019 03236M20  GNW  Bragar Eagel & Squire, P.C. is Investigating Amyris, Inc. (AMRS) on Behalf of Stockholders and Encourages AMRS Investors to Contact the Firm",, 6/05/2017 ACHN-US  GNW  Achillion to Present at the Jefferies 2017 Global Healthcare Conference," 3/15/2019 87166B10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Syneos Health, Inc.  To Contact The Firm", 6/01/2018 FOLD-US  GNW  Amicus Therapeutics to Present at Goldman Sachs 39th Annual Global Healthcare Conference,,, 8/11/2017 ADMA-US  GNW  ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results, 2/05/2018 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress,,, 4/04/2018 MYOK-US  GNW  MyoKardia Announces Appointment of Taylor C. Harris as Chief Financial Officer,,10/24/2018 GLPG-NL  GNW  Topline interim results of FALCON trial Part 1 in CF, 8/31/2018 PTLA-US  GNW  Portola Pharmaceuticals Submits Prior Approval Supplement to U.S. FDA for Large-Scale Generation 2 Andexxa Process,,,,10/25/2017 CARA-US  GNW  Cara Therapeutics Doses First Patient in Phase 1 Study of Oral CR845 in Non-Hemodialysis Chronic Kidney Disease Patients,"11/05/2018 FLXN-US  GNW  Flexion Therapeutics Announces Product-Specific J Code (J3304) for ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) Effective January 1, 2019", 5/01/2018 QURE-US  GNW  uniQure Announces Proposed Public Offering, 5/16/2018 AGIO-US   GNW  Agios to Present New Clinical Data from its IDH Programs at ASCO," 1/29/2018 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Closing of $172.5 Million Common Stock Public Offering", 3/13/2014 TSRO-US  GNW  TESARO and AnaptysBio Announce Collaboration and Exclusive Worldwide License Agreement for Multiple Immuno-Oncology Programs,, 3/05/2018 FATE-US  GNW  Fate Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Operational Progress," 5/08/2017 HZNP-US  GNW  Horizon Pharma plc Announces Agreement to Acquire River Vision Development Corp. and Teprotumumab (RV001), a Biologic in Late-Stage Development for Rare Eye Disease",,"11/07/2017 008G5M-E GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. â€“ ICPT"," 8/19/2019 48576U10   GNW  Shareholder Alert by Former Louisiana Attorney General: KSF Reminds EGBN, KPTI, LB, NGHC Investors of Lead Plaintiff Deadline in Class Action Lawsuits",,, 3/08/2018 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Cowen and Company 38th Annual Health Care Conference,,,,11/28/2016 PIPR-US  GNW  Amphastar Pharmaceuticals to Present at the 2016 Piper Jaffray Healthcare Conference, 3/16/2018 061X1L-E   GNW  Atara Biotherapeutics to Present at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT),, 8/07/2017 DERM-US  GNW  Dermira Reports Second Quarter 2017 Financial Results and Provides Corporate UpdateÂ , 3/06/2018 FOMX-US  GNW  Foamix Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference,"11/02/2016 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Third Quarter 2016 Results and Updates 2016 Guidance", 2/08/2017 SUPN-US  GNW  Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XRÂ®, 9/19/2017 FGEN-US  GNW  FibroGen Appoints Gerald Lema to Board of Directors,, 8/17/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 1/03/2019 CRBP-US  GNW  Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis",, 4/20/2017 COLL-US  GNW  Collegium to Present at the 42nd Annual Deutsche Bank Healthcare Conference, 4/10/2017 XBIT-US  GNW  XBiotech Announces Additions To Its Scientific Advisory Board,,, 9/26/2018 GBT-US   GNW  GBT Announces Participation at the 2018 Cantor Global Healthcare Conference, 1/07/2016 RGNX-US  GNW  REGENXBIO Provides Year-End 2015 Corporate Update, 5/01/2018 KURA-US  GNW  Kura Oncology to Report First Quarter 2018Â Financial Results, 6/26/2018 APLS-US  GNW  Apellis Pharmaceuticals Provides Update on Two Phase Ib Trials for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH), 8/08/2018 AXSM-US  GNW  Axsome Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update,11/02/2017 VYGR-US  GNW  Voyager Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Highlights, 2/22/2019 BGNE-US  GNW  BeiGene to Present at the 8th SVB Leerink Global Healthcare Conference,, 8/07/2017 RETA-US  GNW  Reata Announces First Patient Enrolled in Phase 3 CARDINAL Trial of Bardoxolone Methyl in the Treatment of Chronic Kidney Disease Due to Alport Syndrome,, 3/14/2017 NTLA-US  GNW  Intellia Therapeutics Announces Fourth Quarter and Full-Year 2016 Financial Results, 8/09/2017 ACIU-US  GNW  AC IMMUNE REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS, 8/10/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Second Quarter 2017 Financial Results  and Provides Business Update, 4/09/2018 GTHX-US  GNW  G1 Therapeutics to Present Preclinical Data on CDK4/6 Inhibitors Trilaciclib and G1T38 at the 2018 American Association for Cancer Research (AACR) Annual Meeting,,," 9/12/2018 ATNX-US  GNW  Athenex and its Collaborative Partner, Hanmi Pharmaceutical, Announce Strategic Realignment of their Joint Projects",,,,,,,, 4/05/2018 EOLS-US  GNW  Evolus Phase III European - Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to BotoxÂ® Meets Primary Endpoint,," 6/26/2018 30233G10   GNW  EyePoint Pharmaceuticals Appoints GÃ¶ran Ando, M.D., to Board of Directors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,"10/18/2018 74318710 GNW  Recent Analysis Shows Progenics Pharmaceuticals, Catabasis Pharmaceuticals, Warrior Met Coal, Preformed Line Products, Express, and Sanmina Market Influences â€” Renewed Outlook, Key Drivers of Growth",,,,,10/06/2014 09060J10 GNW  US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent,,,12/16/2011 82691710     GNW  Chancery Court Denies SIGA's Motion for Reconsideration in PharmAthene Litigation; Proceedings Continue,"10/18/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skechers, USA Technologies, OPKO Health and Encourages Investors to Contact the Firm","12/14/2017 46222210 GNW  Akcea Initiates Phase 2 Study of AKCEA-ANGPTL3-LRx in Patients with Hypertriglyceridemia, Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)"," 8/24/2015 09061G10    GNW  Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, From BioMarin",,,, 2/04/2019 45290710 GNW  SHAREHOLDER ALERT: GS IMMU DXC ALKS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 7/25/2018 4523-JP   GNW  Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimerâ€™s Disease at Alzheimerâ€™s Association International Conference (AAIC) 2018,,11/08/2018 BCRX-US  GNW  BioCryst to Present at Upcoming Investor Conferences,,,,," 4/23/2018 AKRX-US  GNW  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018 (AKRX)",,10/08/2019 MYGN-US  GNW  Myriad Genetics to Present Five Studies at the 2019 American Society of Human Genetics Annual Meeting, 8/22/2018 LXRX-US  GNW  UPDATE: Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,, 8/28/2016 45766930 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline â€“ INSM,, 1/02/2018 0H43Z0-E  GNW  Inovio Enters License and Collaboration AgreementÂ with ApolloBio To Develop and Commercialize VGX-3100 in Greater China,"11/06/2018 64026810 GNW  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Nektar Therapeutics",, 9/27/2018 GERN-US  GNW  Geron Announces Discontinuation of Imetelstat Collaboration by Janssen,," 3/19/2019 02311120 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VALE, SVXY, AMRN and NIO",,, 1/31/2019 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"12/07/2017 G0176710 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alkermes plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2018 â€“ ALKS",, 8/02/2018 AMAG-US  GNW  AMAG Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update,,,,, 3/01/2019 SAN-FR   GNW  Sanofi : CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes,,,11/16/2017 ASND-US  GNW  Ascendis Pharma A/S Reports Third Quarter 2017 Financial Results,,,11/07/2017 AFMD-US  GNW  Affimed Reports Financial Results for Third Quarter 2017,, 3/05/2018 PRQR-US  GNW  ProQR to Present at Upcoming Investor Conference,," 4/12/2019 98978L20 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against  Zogenix, Inc. and Certain Officers â€“Â ZGNX",,,,,, 6/04/2018 ADVM-US  GNW  Adverum Biotechnologies to Present at the 2018 Jefferies Global  Healthcare Conference, 8/27/2018 RARE-US   GNW  Ultragenyx Announces Approval of Mepseviiâ„¢ (vestronidase alfa) in Europe for the Treatment of Mucopolysaccharidosis VII, 3/28/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present at the 16th Annual Needham Healthcare Conference, 3/07/2018 NSTG-US  GNW  NanoString Technologies Releases Fourth Quarter and Full Year 2017 Operating Results and Provides 2018 Outlook,,,12/07/2017 RDUS-US  GNW  Radius Investigational Drug Elacestrant (RAD1901) Continues to Show Promise in Advanced ER+ / HER2- Breast Cancer at the 2017 San Antonio Breast Cancer Symposium, 2/21/2017 ASMB-US  GNW  Assembly Biosciences Announces the Closing and Early Termination of Hart-Scott-Rodino Waiting Period for License of Microbiome Gastrointestinal Development Programs to Allergan,,,12/16/2013 02043Q10 GNW  Tekmira Receives $5 Million Milestone Payment for Phase III Initiation of LNP-Enabled Patisiran (ALN-TTR02),, 6/05/2018 AKCA-US  GNW  Akcea Therapeutics Appoints Industry Leader Dr. Richard Moscicki to Board of Directors,, 2/14/2018 PCRX-US  GNW  Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPARELÂ® as a Nerve Block for Regional Analgesia,11/03/2017 RTRX-US  GNW  Retrophin Reports Additional Positive Data from Open-Label Extension of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)," 1/27/2017 PACB-US  GNW  Pacific Biosciences of California, Inc. Fourth Quarter 2016 Financial Results Call",11/07/2017 EDIT-US  GNW  Editas Medicine Announces Third Quarter 2017 Results and Update," 6/16/2016 16706W10 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Chiasma, Inc. -- CHMA", 3/08/2019 MGNX-US  GNW  MacroGenics to Participate in Upcoming Investor Conferences,,,, 8/02/2017 MNTA-US  GNW  Momenta Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update,10/31/2017 PRTA-US  GNW  Prothena to Report Third Quarter 2017 Financial Results on November 7, 4/24/2018 ZLAB-US  GNW  Zai Lab Limited Announces Presentations at May Investor Conferences,," 4/26/2018 23284F10 GNW  Report: Developing Opportunities within CytomX Therapeutics, Pegasystems, Greif, Belden, Payment Data, and KAR Auction Services â€” Future Expectations, Projections Moving into 2018", 4/17/2018 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for First Quarter of 2018,,,"11/01/2017 CBAY-US  GNW  CymaBay to Report Third Quarter 2017 Financial Results on Wednesday, November 8",, 2/14/2017 CCXI-US  GNW  Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases,,, 4/25/2018 MNKD-US   GNW  FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary,,10/16/2018 CYTK-US  GNW  Cytokinetics Unveils Expanded Development Pipeline  and Provides Key Updates on Late-Stage Clinical  Research Programs at R&D Day," 6/21/2018 29664W10    GNW  ESPR NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important Upcoming Deadline in Class Action â€“ ESPR"," 3/22/2019 03236M20  GNW  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Amyris, Inc. Investors (AMRS)",, 5/04/2017 ACHN-US  GNW  Achillion Reports First Quarter 2017 Financial Results and Provides Update on Clinical Programs," 3/14/2019 87166B10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Syneos Health, Inc. - SYNH", 5/30/2018 FOLD-US  GNW  Amicus Therapeutics Launches GalafoldÂ® (Migalastat) for Fabry Disease in Japan,,, 7/31/2017 ADMA-US  GNW  ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Methods, 2/05/2018 GWPH-US  GNW  GW Pharmaceuticals Announces the European Medicines Agency (EMA) Accepts EpidiolexÂ® (cannabidiol) Marketing Authorization Application (MAA) for Review,,, 4/02/2018 MYOK-US  GNW  MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients,,10/22/2018 GLPG-NL  GNW  POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET, 8/30/2018 PTLA-US  GNW  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences,,,,10/17/2017 CARA-US  GNW  Cara Therapeutics Announces Participation in ANESTHESIOLOGYÂ® 2017,"10/31/2018 FLXN-US  GNW  Flexion Therapeutics to Report Third-Quarter 2018 Financial Results on November 7, 2018", 4/30/2018 QURE-US  GNW  uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT)," 5/04/2018 AGIO-US   GNW  Agios Provides Business Update on Discovery Research Strategy and Pipeline, Progress on Clinical Programs, Commercial Launch Preparations and Reports First Quarter 2018 Financial Results at Investor Day"," 1/25/2018 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $150 Million of Common Stock",,, 2/27/2018 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2017 Financial Results, 5/01/2017 HZNP-US  GNW  Horizon Pharma plc Announces FDA Approval to Expand the Age Range for RAVICTIÂ® (glycerol phenylbutyrate) Oral Liquid to People with Urea Cycle Disorders Two Months of Age and Older,,11/01/2017 ICPT-US  GNW  Intercept Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update," 8/18/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Bancorp, Karyopharm, L Brands, and National General and Encourages Investors to Contact the Firm",,, 3/01/2018 ITCI-US  GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update,,,,"11/08/2016 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016", 3/06/2018 ATRA-US    GNW  Atara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference,, 7/25/2017 24983L10 GNW  UCB and Dermira Announce U.S. and EU Regulatory Submissions for CIMZIAÂ® (certolizumab pegol) for the treatment of Moderate-to-Severe Chronic Plaque Psoriasis, 2/28/2018 FOMX-US  GNW  Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update,10/10/2016 PRAH-US  GNW  PRA Health Sciences to Report Third Quarter 2016 Earnings, 1/30/2017 SUPN-US  GNW  Supernus Announces Issuance of Seventh U.S. Patent  Protecting Trokendi XRÂ®, 9/13/2017 FGEN-US  GNW  Fibrogen Presents Latest Data From Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at European Respiratory Society (ERS) International Congress 2017,, 8/08/2018 CHRS-US  GNW  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2018 Financial Results,12/18/2018 CRBP-US  GNW  Corbus Pharmaceuticals Announces Issuance of Composition of Matter Patent Related to Lenabasum,," 4/04/2017 COLL-US  GNW  Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy", 4/03/2017 XBIT-US  GNW  XBiotech Announces Top-Line Results for 514G3 Antibody Therapy in Serious Staphylococcus aureus Infections,,," 9/24/2018 37890U10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating Possible Securities Fraud Violations by Certain Officers and Directors of Alnylam, Global Blood, and NiSource on Behalf of Stockholders and Encourages Investors to Contact the Firm",12/30/2015 RGNX-US  GNW  FDA Grants Rare Pediatric Disease Designation to REGENXBIO's RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I (MPS I), 4/09/2018 KURA-US  GNW  Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018," 6/19/2018 APLS-US  GNW  Apellis Pharmaceuticals to Host R&D Day on June 26, 2018"," 8/01/2018 AXSM-US  GNW  Axsome Therapeutics to Report Second Quarter 2018 Financial Results on August 8, 2018",10/30/2017 VYGR-US  GNW  Voyager Therapeutics Announces Update to Parkinsonâ€™s Disease Program, 2/19/2019 BGNE-US  GNW  BeiGene Initiates Global Phase 2 Trial of Zanubrutinib in Patients with Relapsed or Refractory Marginal Zone Lymphoma,," 8/01/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",, 3/08/2017 NTLA-US  GNW  Intellia Therapeutics Demonstrates PioneeringÂ CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology, 7/10/2017 ACIU-US  GNW  AC IMMUNE PROVIDES SEVEN UPDATES ON ITS PIPELINE AND TECHNOLOGY AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE, 8/01/2017 CRSP-US  GNW  CRISPR Therapeutics Appoints Dr. Tony W. Ho to Head Research & Development, 3/12/2018 GTHX-US  GNW  G1 Therapeutics Announces Closing of Offering of Common Stock,,, 9/05/2018 ATNX-US  GNW  Athenex Announces Positive Recommendation by the Drug Safety Monitoring Board Upon the Second Interim Analysis and to Continue the Oraxol Phase III Program,,,,,,,, 3/29/2018 EOLS-US  GNW  Evolus Reports Fourth Quarter and Full Year 2017 Financial Results,, 6/25/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,"10/11/2018 PGNX-US  GNW  Progenics Advances 1095, PSMA-Targeted Therapeutic Candidate for the Treatment of Metastatic Prostate Cancer, into Phase 2 Clinical Development Following Discussions with the FDA",,,,,10/16/2012 09060J10 GNW  MonoSol Rx Defeats BioDelivery Sciences International's Reexamination Challenges to MonoSol Rx's PharmFilm(R) Patents,,,11/08/2011 82691710     GNW  SIGA Technologies Reports Financial Results for the Third Quarter of 2011,"10/17/2018 68375N10 GNW  CLASS ACTION UPDATE for SKX, OPK and USAT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",12/07/2017 IONS-US  GNW  Akcea to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference, 8/19/2015 09061G10    GNW  BioMarin Receives Rare Pediatric Disease Designation From FDA for Drisapersen for the Potential Treatment of Duchenne Muscular Dystrophy,,,," 2/04/2019 45290710 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Immunomedics, Inc. To Contact The Firm", 7/25/2018 4523-JP   GNW  Eisai and Biogen Present Detailed Results From Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimerâ€™s Disease at Alzheimerâ€™s Association International Conference (AAIC) 2018,,11/06/2018 BCRX-US  GNW  BioCryst Reports Third Quarter 2018 Financial Results,,,,," 4/19/2018 00972810 GNW  AKRX EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018",,"10/07/2019 62855J10 GNW  MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm", 8/22/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,," 8/05/2016 45766930 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Insmed Incorporated of Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 â€“ INSM",,"12/11/2017 INO-US    GNW  Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development","11/06/2018 64026810 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TRVN, HON, OZK and NKTR",," 9/26/2018 GERN-US  GNW  Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018",," 3/19/2019 02311120 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm",,, 1/02/2019 SRPT-US  GNW  Sarepta Therapeutics Enters into Long-term Strategic Relationship with Aldevron for GMP-grade Plasmid in Support of Gene Therapy Development and Commercial Manufacturing Strategy,"11/30/2017 G0176710 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alkermes plc (Nasdaq: ALKS) To Contact Brower Piven Before The Lead Plaintiff Deadline",," 7/26/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call  and Webcast on Thursday, August 2, 2018 at 8:00 a.m. ET",,,,, 3/01/2019 LXRX-US  GNW  CHMP Recommends Zynquistaâ„¢ (Sotagliflozin) for the Treatment of Adults With Type 1 Diabetes,,,11/02/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Third Quarter 2017 Financial Results Conference Call on November 16,,,11/02/2017 AFMD-US  GNW  Affimed to Present at the 26th Annual Credit Suisse Healthcare Conference,, 2/28/2018 PRQR-US  GNW  ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update,," 4/10/2019 98978L20 GNW  Bragar Eagel & Squire, P.C. is Investigating Zogenix, Inc. (ZGNX) on Behalf of Stockholders and Encourages ZGNX Investors to Contact the Firm",,,,,, 5/17/2018 ADVM-US  GNW  Adverum Biotechnologies Presents Additional Long-term Preclinical Data on ADVM-022 in Wet AMD at ASGCT 21st Annual Meeting, 8/02/2018 RARE-US   GNW  Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update, 3/23/2017 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results, 3/06/2018 NSTG-US  GNW  NanoString to Present at the 38th Annual Cowen Healthcare Conference,,,12/04/2017 RDUS-US  GNW  Radius Health Announces Five Presentations on elacestrant (RAD1901) at the San Antonio Breast Cancer Symposium (SABCS), 2/16/2017 ASMB-US  GNW  Assembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations,,,11/10/2013 02043Q10 GNW  Tekmira's Partner Initiates Phase III Trial With LNP-Enabled Patisiran (ALN-TTR02),, 6/01/2018 00972L10 GNW  Akcea and Ionis Receive Positive EU CHMP Opinion for TEGSEDI,, 2/12/2018 PCRX-US  GNW  FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPARELÂ® as a Nerve Block for Regional Analgesia,11/02/2017 RTRX-US  GNW  Retrophin to Present at the Jefferies 2017 London Healthcare Conference, 1/16/2017 PACB-US  GNW  Novogene Agrees to Buy Ten PacBio Sequel Systems for DNA Sequencing Services,11/03/2017 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and Results," 6/15/2016 16706W10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Chiasma, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 â€“ CHMA"," 3/01/2019 55609910 GNW  Investor Expectations to Drive Momentum within LPL Financial, Comcast, MacroGenics, Wayfair, Masimo, and Big Lots â€” Discovering Underlying Factors of Influence",,,," 7/24/2017 AMPH-US  GNW  Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.", 9/28/2017 PRTA-US  GNW  Prothena Reports Results from Phase 1b Multiple Ascending Dose Study of PRX003 in Patients with Psoriasis, 4/24/2018 ZLAB-US  GNW  Zai Lab Limited to Announce Full Year 2017 Financial Results,, 3/07/2018 CTMX-US  GNW  CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update, 4/10/2018 GMAB-DK  GNW  Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab,,,10/31/2017 CBAY-US  GNW  CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer,, 1/20/2017 CCXI-US  GNW  ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor CCX872 in Patients with Advanced Non-Resectable Pancreatic Cancer,,, 4/09/2018 MNKD-US   GNW  MannKind Announces Completion of Previously Announced $28.0 Million Registered Direct Offering,,"10/09/2018 23282W60 GNW  Report: Developing Opportunities within Denny's, Cytokinetics, Beazer Homes, Heidrick & Struggles International, Equity Commonwealth, and Spok â€” Future Expectations, Projections Moving into 2018"," 6/18/2018 29664W10    GNW  The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Molina Healthcare, Inc., Esperion Therapeutics, Inc., Kulicke and Soffa Industries, Inc., and PPG Industries, Inc.", 3/18/2019 AMRS-US   GNW  Amyris Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Announces Signing of $300 Million DefinitiveÂ Cannabinoid Agreement,, 5/02/2017 ACHN-US  GNW  Achillion to Present at the Deutsche Bank 42nd Annual Health Care Conference," 3/14/2019 SYNH-US  GNW  Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Monday, March 18, 2019", 5/09/2018 FOLD-US  GNW  Amicus Therapeutics to Present at Bank of America Merrill Lynch 2018 Health Care Conference,,, 6/27/2017 ADMA-US  GNW  ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders," 1/29/2018 GWPH-US  GNW  GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018",,, 3/08/2018 MYOK-US  GNW  MyoKardia Reports Fourth Quarter and Full Year 2017 Financial Results,,10/20/2018 GLPG-NL  GNW  PHASE  3  DATA  ON  FILGOTINIB  IN  BIOLOGIC-EXPERIENCED  RHEUMATOID  ARTHRITIS  TO  BE  PRESENTED  AT  2018  ACR/ARHP  ANNUAL  MEETING," 8/16/2018 73701010 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within BioScrip, Powell Industries, Portola Pharmaceuticals, Daktronics, Cable One, and Park-Ohio â€” New Research Emphasizes Economic Growth",,,,10/16/2017 CARA-US  GNW  Cara Therapeutics to Present Data at Kidney Week 2017,10/22/2018 FLXN-US  GNW  Flexion Therapeutics to Present Results from Phase 2 Trial Evaluating ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in Bilateral Knee OA at 2018 ACR Annual Meeting, 4/30/2018 QURE-US  GNW  uniQure Announces First Quarter 2018 Financial Results and Highlights Company Progress," 4/27/2018 AGIO-US   GNW  Agios Announces Revised Starting Time of 8:00am ET for Investor Day and First Quarter 2018 Financial Results Webcast on Friday, May 4, 2018"," 1/24/2018 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Public Offering of Common Stock",,, 2/23/2018 FATE-US  GNW  Fate Therapeutics Announces Receipt of CIRM Grant for Clinical Translation of FT516 Off-the-Shelf Engineered NK Cell Cancer Immunotherapy," 4/13/2017 HZNP-US  GNW  Horizon Pharma plc to Host First-Quarter 2017 Conference Call and Webcast on May 8, 2017",,"10/27/2017 45845P10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Intercept Pharmaceuticals, Inc. Shareholders and a Lead Plaintiff Deadline of November 27, 2017"," 8/16/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 2/22/2018 ITCI-US  GNW  Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast,,,,"10/28/2016 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2016", 2/28/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock,, 6/26/2017 DERM-US  GNW  Newly Published Nonclinical Data Highlight the Role of Olumacostat Glasaretil in Sebum Inhibition, 2/13/2018 FOMX-US  GNW  Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28," 7/28/2016 PRAH-US  GNW  PRA Health Sciences,Â Inc. Reports Second Quarter 2016 Results", 1/23/2017 SUPN-US  GNW  Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings, 9/05/2017 FGEN-US  GNW  FibroGen Announces Pamrevlumab Oral and Poster Presentations at European Respiratory Society International Congress 2017,, 7/27/2018 CHRS-US  GNW  Coherus BioSciences Receives Positive CHMP Opinion for UDENYCAâ„¢ (Pegfilgrastim Biosimilar Candidate),12/17/2018 CRBP-US  GNW  Corbus Pharmaceuticals Initiates â€œDETERMINEâ€ Phase 3 Study in Dermatomyositis,, 4/03/2017 COLL-US  GNW  Collegium Announces Expanded Managed Care Coverage for Xtampza ER for Medicare Part D Patients, 3/27/2017 XBIT-US  GNW  XBiotech Announces On-Time Submission to the EMA,,," 9/13/2018 37890U10 GNW  Bragar Eagel & Squire, P.C. is Investigating Global Blood Therapeutics, Inc. (GBT) on Behalf of Stockholders and Encourages Investors to Contact the Firm",12/18/2015 RGNX-US  GNW  REGENXBIO Added to Russell 2000(R) Index, 3/16/2018 KURA-US  GNW  Kura Oncology to Present at Oppenheimer 28th Annual Healthcare Conference, 5/31/2018 APLS-US  GNW  Apellis Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference, 7/17/2018 AXSM-US  GNW  Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimerâ€™s Association International Conference,10/30/2017 VYGR-US  GNW  Voyager Therapeutics to Host Third Quarter 2017 Financial Results and Corporate Highlights Conference Call," 2/13/2019 BGNE-US  GNW  BeiGene to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019 and Host Investor Event in Hong Kong",," 7/26/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Public Offering",, 3/01/2017 NTLA-US  GNW  Intellia Therapeutics to Present at March Investor Healthcare Conferences, 6/28/2017 ACIU-US  GNW  AC IMMUNE ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING," 7/25/2017 H1718210 GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing", 3/07/2018 GTHX-US  GNW  G1 Therapeutics Announces Pricing of Offering of Common Stock,,, 8/20/2018 ATNX-US  GNW  Athenex Appoints Randoll Sze as Chief Financial Officer,,,,,,,," 2/22/2018 EOLS-US  GNW  Evolus, Inc. (Nasdaq: EOLS) to Ring The Nasdaq Stock Market Closing Bell",," 5/16/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/09/2018 PGNX-US  GNW  Progenics Announces Publication of Pivotal Trial of AZEDRAÂ® (iobenguane I 131)Â in The Journal of Nuclear Medicine,,,,, 3/12/2012 089Q9Z-E GNW  MonoSol Rx Remains Confident in Patent Portfolio as Litigation Continues Against BioDelivery Sciences International,,,"11/03/2011 82691710     GNW  SIGA to Host Quarterly Business Update Call on November 17, 2011","10/17/2018 68375N10 GNW  Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis â€” Discovering Underlying Factors of Influence","11/15/2017 46222210 GNW  Akcea and Ionis Announce Acceptance of Marketing Applications in U.S., EU and Canada for Volanesorsen for the Treatment of FCS", 8/19/2015 09061G10    GNW  Forbes Ranks BioMarin 10th Most Innovative Company in the World,,,," 2/01/2019 45290710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XRAY, IMMU, AGN and DXC", 7/23/2018 09062X10  GNW  AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone,,"11/05/2018 BCRX-US  GNW  BioCryst to Present Abstracts at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology",,,,," 4/18/2018 00972810 GNW  Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Akorn, Inc. â€“ AKRX",,"10/04/2019 62855J10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ MYGN", 7/31/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,, 8/04/2016 INSM-US  GNW  Insmed Reports Second Quarter 2016 Financial Results,,12/06/2017 INO-US    GNW  Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors,11/06/2018 64026810 GNW  NKTR LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nektar Therapeutics; Important Deadline â€“ NKTR,," 8/14/2018 37416310 GNW  Recent Analysis Shows Automatic Data Processing, Denbury Resources, ITT, Cardinal Health, Geron, and The Hackett Group Market Influences â€” Renewed Outlook, Key Drivers of Growth",, 3/19/2019 AMRN-US  GNW  Cardiovascular Risk at Multiple Triglyceride Thresholds Highlighted in Presentation atÂ American College of Cardiologyâ€™s 68th Annual Scientific Session,,, 1/02/2019 SRPT-US  GNW  Sarepta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,"11/22/2017 0CJTL1-E GNW  ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm",," 6/18/2018 00163U10 GNW  Analysis: Positioning to Benefit within The Stars Group, AMAG Pharmaceuticals, ResMed, WestRock, Briggs & Stratton, and II-VI â€” Research Highlights Growth, Revenue, and Consolidated Results",,,,, 2/25/2019 SAN-FR   GNW  Sanofi: Positive results presented from two Phase 3 trials of DupixentÂ® (dupilumab) in severe chronic rhinosinusitis with nasal polyps,,,10/31/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Participation in Two Upcoming Investor Conferences,,,11/01/2017 AFMD-US  GNW  Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH,, 2/27/2018 PRQR-US  GNW  ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer,, 4/10/2019 98978L20 GNW  Zogenix Investigated by Block & Leviton LLP For Violations of Federal Securities Laws,,,,,, 5/09/2018 ADVM-US  GNW  Adverum Biotechnologies Reports First Quarter 2018 Financial Results and Provides Corporate Update, 7/27/2018 RARE-US   GNW  Ultragenyx to Host Conference Call for Second Quarter 2018 Financial Results and Corporate Update, 3/23/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present Topline Data fromÂ Phase 1 Trial of AEB1102 for Treatment of Arginase I Deficiency at 2017 ACMG Annual Clinical Genetics Meeting," 2/21/2018 NSTG-US  GNW  NanoString Technologies to Release Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call on Wednesday, March 7, 2018",,,11/27/2017 RDUS-US  GNW  Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), 1/09/2017 04539610 GNW  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs,,, 8/30/2013 02043Q10 GNW  Tekmira's Lipid Nanoparticle (LNP) Technology Highlighted in Two Peer-Reviewed Scientific Publications,," 5/29/2018 00972L10 GNW  New Research Coverage Highlights Cision Ltd., FCB Financial, Akcea Therapeutics, RE/MAX, Pain Therapeutics, and Regal Beloit â€” Consolidated Revenues, Company Growth, and Expectations for 2018",, 1/08/2018 06456T-E GNW  WellStar Health System and Pacira Pharmaceuticals Announce Partnership to Minimize Opioid Use and Standardize Outcomes Across Surgical Procedures,10/24/2017 RTRX-US  GNW  Retrophin to Report Third Quarter 2017 Financial Results, 1/12/2017 PACB-US  GNW  More Than 115 Presentations and Posters Feature PacBio SMRT Sequencing to Decipher Complex Plant and Animal Genomes at Annual PAG Conference,"10/19/2017 EDIT-US  GNW  Editas Medicine Demonstrates Dose-Dependent, In Vivo Editing with EDIT-101 in CEP290 Transgenic Mice", 6/14/2016 CHMA-US  GNW  Chiasma Announces Corporate Restructuring Plan and  Provides Regulatory Update Regarding Mycapssaâ„¢, 2/26/2019 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 2018 Financial Results,,,, 7/21/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces Jury Verdict in Enoxaparin Sodium Injection Patent Litigation Against Amphastar, 9/18/2017 PRTA-US  GNW  Prothena Presents New Research Supporting Clinical Relevance ofÂ Cardiac Biomarker NT-proBNP in AL Amyloidosis, 3/05/2018 ZLAB-US  GNW  Zai Lab Limited Appoints Billy Cho as Chief Financial Officer,, 3/01/2018 CTMX-US  GNW  CytomX to Present at Upcoming Investor Conferences, 2/21/2018 GMAB-DK  GNW  Genmab 2017 Annual Report,,,10/23/2017 CBAY-US  GNW  CymaBay to Host Post-AASLD Key Opinion Leader Meeting on Novel Treatments for Primary Biliary Cholangitis,," 1/20/2017 CCXI-US  GNW  ChemoCentryx, Inc. (Nasdaq: CCXI) to Ring The Nasdaq Stock Market Closing Bell Remotely from the Nasdaq Entrepreneurial Center in San Francisco",,, 4/06/2018 MNKD-US   GNW  MannKind Announces $28.0 Million Registered Direct Offering,,10/05/2018 23282W60 GNW  Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program," 6/14/2018 29664W10    GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 â€“ ESPR"," 3/18/2019 AMRS-US   GNW  Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream",, 4/22/2017 ACHN-US  GNW  Achillion Announces Additional Phase 2 Results Including 100% SVR24 for Genotype 1 HCV After 6-Weeks of Once Daily JNJ-4178," 3/13/2019 87166B10 GNW  SYNH APRIL 30th DEADLINE REMINDER: Rosen Law Firm Reminds Syneos Health, Inc. Investors of Important Deadline in Securities Class Action Lawsuit; Encourages Investors With Losses in Excess of $100K to Contact the Firm â€“ SYNH", 5/08/2018 FOLD-US  GNW  Amicus Therapeutics Announces First Quarter 2018 Financial Results and Corporate Updates,,, 6/06/2017 ADMA-US  GNW  ADMA Biologics Completes Acquisition of Biotestâ€™s Therapy Business Unit Assets, 1/24/2018 GWPH-US  GNW  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark EpidiolexÂ® (cannabidiol) Study in The Lancet,,," 3/08/2018 MYOK-US  GNW  MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients",,10/03/2018 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises, 8/09/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update,,,,10/16/2017 CARA-US  GNW  Cara Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA for I.V. CR845 in Chronic Kidney Disease-Associated Pruritus,"10/16/2018 33938J10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Iamgold, Mazor Robotics, Flexion Therapeutics, Hemisphere Media Group, Criteo S.A, and EP Energy â€” New Research Emphasizes Economic Growth", 4/27/2018 QURE-US  GNW  uniQure Announces to Present at Multiple Conferences in May," 4/11/2018 AGIO-US   GNW  Agios to Webcast Investor Day and First Quarter 2018 Financial Results on Friday, May 4, 2018", 1/24/2018 IOVA-US  GNW  Iovance Biotherapeutics Announces Preliminary Phase 2 Data for TIL Treatment in Head and Neck and Cervical Cancers,,, 2/20/2018 FATE-US  GNW  Fate Therapeutics Announces First Subject Treated with FATE-NK100 in DIMENSION Study for Advanced Solid Tumors, 4/12/2017 HZNP-US  GNW  Horizon Pharma plc Named One of the Best Workplaces in Health Care by Great Place to WorkÂ® and Fortune Magazine,,10/25/2017 ICPT-US  GNW  Intercept to Report Third Quarter 2017 Financial Results on November 1 and Present at Upcoming Conference, 8/15/2019 48576U10   GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI,,, 2/15/2018 ITCI-US  GNW  UPDATE - Intra-Cellular Therapies to Present at RBC Capital Markets 2018 Global Healthcare Conference,,,, 9/01/2016 AMPH-US  GNW  Amphastar Pharmaceuticals to Present at the 2016 Wells Fargo Healthcare Conference, 2/27/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Proposed Offering of Common Stock,," 6/06/2017 DERM-US  GNW  Dermira Announces Appointment of Ian Clements as Vice President, Investor Relations", 1/04/2018 FOMX-US  GNW  Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year, 7/18/2016 PRAH-US  GNW  PRA Health Sciences to Report Second Quarter 2016 Earnings, 1/03/2017 SUPN-US  GNW  Supernus to Present at the 2017 J.P. Morgan Healthcare Conference," 8/15/2017 FGEN-US  GNW  FibroGen, Inc. Announces Pricing of Follow-On Offering of Common Stock",," 7/27/2018 19249H10 GNW  Market Trends Toward New Normal in United Technologies, Paychex, Coherus BioSciences, InfraREIT, Cousins Properties, and Engility â€” Emerging Consolidated Expectations, Analyst Ratings",11/08/2018 CRBP-US  GNW  Corbus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update,, 3/28/2017 COLL-US  GNW  Collegium to Present at the 16th Annual Needham Healthcare Conference, 3/23/2017 XBIT-US  GNW  XBiotech Announces Addition of Dr. Dirk Arnold to its Scientific Advisory Board,,, 9/07/2018 GBT-US   GNW  GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference,12/01/2015 75901B10 GNW  REGENXBIO to Participate in Upcoming Investor and Scientific Conferences, 3/12/2018 KURA-US  GNW  Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results, 4/30/2018 APLS-US  GNW  Apellis Pharmaceuticals Reports First Quarter 2018 Business Update and Financial Results, 6/05/2018 AXSM-US  GNW  Axsome Therapeutics Initiates Phase 2 Trial of AXS-05 in Major Depressive Disorder,10/17/2017 VYGR-US  GNW  Voyager Therapeutics Announces New Data Presentations at the Congress of the European Society of Gene and Cell Therapy, 2/07/2019 BGNE-US  GNW  BeiGene to Present at the Guggenheim Healthcare Talks Idea Forum â€“ Oncology Day,," 7/25/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock",, 2/15/2017 NTLA-US  GNW  Intellia Therapeutics to Hold Conference Call to Address Patent Interference Proceedings, 5/22/2017 ACIU-US  GNW  AC IMMUNE AND ESSEX BIO-TECHNOLOGY ANNOUNCE RESEARCH COLLABORATION FOR NEURODEGENERATIVE DISEASES AND NEUROINFLAMMATION, 7/10/2017 CRSP-US  GNW  CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration, 3/05/2018 GTHX-US  GNW  G1 Therapeutics Announces Proposed Offering of Common Stock,,," 8/14/2018 ATNX-US  GNW  Athenex, Inc. Announces Second Quarter 2018 Results and Provides Corporate Update",,,,,,,,,, 5/08/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/05/2018 PGNX-US  GNW  Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer,,,,," 2/23/2012 008SRQ-E GNW  MonoSol Rx, LLC Remains Confident in Its Patent Portfolio",,, 9/22/2011 82691710     GNW  SIGA Comments on Court Ruling in PharmAthene Litigation,10/14/2018 68375N10 GNW  SHAREHOLDER ALERT: NVRO LCI CBS PZZA LOGM SKX OPK PM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,11/13/2017 46222210 GNW  Akcea Initiates AKCEA-ANGPTL3-LRx Phase 2 Program in Patients with Rare Hyperlipidemias, 8/03/2015 09061G10    GNW  BioMarin Announces Second Quarter 2015 Financial Results and Company Update,,,," 1/31/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NVIDIA, DXC Technology, Immunomedics, and Natural Health and Encourages Investors to Contact the Firm"," 7/20/2018 BIIB-US   GNW  Biogen to Host Investor Webcast to Discuss Alzheimerâ€™s Disease Portfolio on July 25, 2018",,10/23/2018 BCRX-US  GNW  BioCryst to Report Third Quarter 2018 Financial Results on November 6,,,,," 4/18/2018 0BGL4K-E GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018 â€“ AKRX",,"10/02/2019 62855J10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eldorado Resorts, Sundial, Tencent, and Myriad Genetics and Encourages Investors to Contact the Firm", 7/30/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update,, 7/29/2016 45766930 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline â€“ INSM,,11/29/2017 INO-US    GNW  Inovioâ€™s Further Analysis of VGX-3100 Phase 2b Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clinical Efficacy,"11/05/2018 64026810 GNW  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nektar Therapeutics and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",, 7/31/2018 GERN-US  GNW  Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events,, 3/18/2019 AMRN-US  GNW  Additional Real-World Data Show a Significant Risk Increase in Cardiovascular Events in People with Elevated Triglyceride Levels,,,12/31/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/22/2017 0F98BD-E GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Alkermes plc and Certain Officers â€“ ALKS,, 6/15/2018 0GQ93T-E GNW  AMAG Pharmaceuticals Announces Divestiture of Cord Blood RegistryÂ®,,,,, 2/12/2019 SAN-FR   GNW  Sanofi appoints Ameet Nathwani Chief Digital Officer,,, 9/27/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs,,,10/30/2017 AFMD-US  GNW  Affimed Announces Third Quarter 2017 Financial Results and Corporate Update Conference Call,, 2/12/2018 PRQR-US  GNW  Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQRâ€™s candidate QR-421a for Usher syndrome type 2A,, 4/08/2019 ZGNX-US  GNW  Zogenix Receives Refusal to File Letter from U.S. Food and Drug Administration for FINTEPLAÂ® New Drug Application,,,,,, 5/03/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Leadership Changes," 7/26/2018 RARE-US   GNW  Ultragenyx Announces First Patient Dosed in Phase 1/2 study of DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa); FDA Grants Fast Track Designation to Gene Therapy Program"," 3/17/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Announce Fourth Quarter and Full-Year 2016 Financial Results on Thursday, March 23", 2/12/2018 NSTG-US  GNW  NanoString Showcases Groundbreaking New Platforms at 2018 Advances in Genome Biology and Technology (AGBT) Conference,,,"11/27/2017 RDUS-US  GNW  Radius Health Announces Commercial Leadership Changes with Appointment of Joseph Kelly as Senior Vice President of Sales and Marketing, and Promotion of Amanda Mott to Senior Vice President of Market Access",11/11/2016 ASMB-US  GNW  Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting,,, 7/01/2013 02043Q10 GNW  Tekmira's LNP Technology Enables Alnylam's Positive Phase II ALN-TTR02 Data,, 5/29/2018 IONS-US  GNW  Akcea Therapeutics to Present at the Jefferies Global Healthcare Conference,, 1/04/2018 PCRX-US  GNW  Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million,10/13/2017 RTRX-US  GNW  Retrophin to Present New Data for Sparsentan at ASN Kidney Week 2017, 1/09/2017 PACB-US  GNW  UPDATE -- Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release,10/03/2017 EDIT-US  GNW  Editas Medicine to Participate in Investor Conferences in October, 5/31/2016 007MPF-E GNW  Chiasma to Present at Jefferies Global Healthcare Conference, 2/25/2019 MGNX-US  GNW  MacroGenics Announces Participation in SVB Leerink Global Healthcare Conference,,,, 7/19/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2017 Financial Results Conference Call and Webcast, 8/15/2017 PRTA-US  GNW  Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting, 2/07/2018 ZLAB-US  GNW  Zai Lab Limited to present at the Leerink Partners 7th Annual Global Healthcare Conference,, 2/22/2018 CTMX-US  GNW  CytomX Therapeutics to Announce Full-Year 2017 Financial Results and Host Operational Update Webcast Conference Call, 1/23/2018 GMAB-DK  GNW  Genmab Announces 2017 Net Sales Figures for DARZALEXÂ® (Daratumumab),,,10/09/2017 CBAY-US  GNW  CymaBay Announces Oral Late-Breaking Presentation of Interim Results from an Ongoing Phase 2 Study of Patients with Primary Biliary Cholangitis at the AASLD 2017 Liver Meeting,, 1/09/2017 CCXI-US  GNW  ChemoCentryx Provides Corporate Update Including Development Strategy for Lead Programs in Rare Renal Diseases,,, 3/19/2018 MNKD-US   GNW  MannKind Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference,,"10/02/2018 CYTK-US  GNW  Cytokinetics to Host R&D Day on October 16, 2018", 6/12/2018 ESPR-US     GNW  Esperion Announces Late-Breaking Oral Presentation of Full Study 4 Results (1002-048) at the International Symposium on Atherosclerosis," 3/12/2019 AMRS-US   GNW  Amyris to Present at 31st Annual Roth Conference on Tuesday, March 19, 2019",, 4/06/2017 ACHN-US  GNW  Achillion Announces Initiation of Patient Dosing in Phase 2 Study of ACH-4471 for Paroxysmal Nocturnal Hemoglobinuria, 3/13/2019 87166B10 GNW  SHAREHOLDER ALERT: AVP KHC SYNH CNDT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines," 4/26/2018 FOLD-US  GNW  Amicus Therapeutics to Announce First Quarter 2018 Financial Results on May 8, 2018",,, 5/30/2017 BIO3-DE  GNW  ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation,12/29/2017 GWPH-US  GNW  GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for EpidiolexÂ® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome,,, 3/06/2018 MYOK-US  GNW  MyoKardia to Present at the Cowen and Company 38th Annual Health Care Conference,, 9/24/2018 GLPG-NL  GNW  Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients, 8/09/2018 PTLA-US  GNW  Portola Pharmaceuticals Appoints Ernie Meyer as Executive Vice PresidentÂ and Chief Human Resources Officer,,,,10/04/2017 CARA-US  GNW  Cara Therapeutics to Present at the Janney Montgomery Scott Osteoarthritis Pain Conference,10/05/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 4/25/2018 QURE-US  GNW  uniQure Delivers Oral Presentation on Broad Set of Preclinical Data on AMT-130 in Huntingtonâ€™s Disease at the 2018 American Academy of Neurology Annual Meeting, 3/19/2018 AGIO-US   GNW  Agios Announces First Patient Dosed with MAT2A Inhibitor AG-270 in Phase 1 Study in Patients with Advanced Solid Tumors or Lymphoma with an MTAP Deletion,"12/13/2017 IOVA-US  GNW  Iovance Biotherapeutics Announces Manufacturing Decision, Provides Clinical Updates and Highlights Pipeline Expansion at Analyst Day 2017",,, 2/12/2018 FATE-US  GNW  Fate Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference, 4/07/2017 HZNP-US  GNW  Horizon Pharma plc Named to the Crainâ€™s Chicago Business 2017 â€œBest Places To Workâ€ List,,"10/25/2017 45845P10 GNW  ICPT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Intercept Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 27, 2017"," 8/15/2019 48576U10   GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KPTI, EGBN, CARB and CAH",,, 2/07/2018 ITCI-US  GNW  Intra-Cellular Therapies to Present at Upcoming Investor Conferences,,,," 8/08/2016 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016", 2/27/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress,, 5/30/2017 DERM-US  GNW  Dermira to Present at Jefferies 2017 Global Healthcare Conference, 1/03/2018 FOMX-US  GNW  Foamix Names Mr. David Domzalski as a Member of the Board of Foamix Pharmaceuticals, 5/17/2016 PRAH-US  GNW  PRA Health Sciences Named International Clinical Research Company of the Year,12/12/2016 SUPN-US  GNW  Supernus Wins Appeal Case on Oxtellar XRÂ®," 8/14/2017 FGEN-US  GNW  FibroGen, Inc. Announces Proposed Follow-On Offering of Common Stock",, 7/25/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,11/06/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in November,, 3/16/2017 COLL-US  GNW  Collegium Announces Scientific Presentation at American Academy of Pain Medicine 2017 Meeting, 3/09/2017 XBIT-US  GNW  XBiotech to Provide Fourth Quarter and Full Year 2016 Business Update,,, 9/06/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants,11/05/2015 75901B10 GNW  REGENXBIO Reports Third Quarter 2015 Results, 3/06/2018 KURA-US  GNW  Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference, 4/23/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces Closing of Offering of Common Stock, 5/29/2018 AXSM-US  GNW  Axsome Therapeutics to Present Data on AXS-05 at the 2018 American Society of Clinical Psychopharmacology Annual Meeting,10/06/2017 VYGR-US  GNW  Voyager Therapeutics Announces Multiple Data Presentations at the Congress of the European Society of Gene and Cell Therapy, 1/14/2019 BGNE-US  GNW  BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma,, 7/24/2017 RETA-US  GNW  Reataâ€™s Bardoxolone Methyl Demonstrated Improved Kidney Function in Patients With Alport Syndrome in Ongoing Phase 2 Portion of Phase 2/3 Cardinal Study,," 2/15/2017 45826J10 GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K.", 5/11/2017 ACIU-US  GNW  AC IMMUNE SA  REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS, 7/05/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at the Piper Jaffray GenomeRx Symposium, 3/05/2018 GTHX-US  GNW  G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data Showing Robust Myelopreservation Benefits in Patients with Small Cell Lung Cancer,,," 8/13/2018 0JS6XC-E GNW  Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Compounded Vasopressin Injection in Ready-to-Use Premix IV Bags",,,,,,,,,, 4/19/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/25/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference,,,,,"11/29/2011 008SRQ-E GNW  MonoSol Rx, LLC Remains Confident in Its Patent Portfolio",,, 8/24/2011 82691710     GNW  SIGA Awarded a $7.7 Million Grant for the Development of Antiviral Drugs for Arenaviruses,"10/13/2018 68375N10 GNW  OPK NOTICE ALERT: Rosen Law Firm Reminds OPKO Health, Inc. Investors of Important Deadline in First Filed Case by Firm â€“ OPK",10/23/2017 IONS-US  GNW  Akcea Therapeutics to Hold Third Quarter 2017 Financial Results Webcast, 7/27/2015 09061G10    GNW  BioMarin Joins the NASDAQ-100 Index,,,, 1/31/2019 45290710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. â€“ IMMU, 7/18/2018 BIIB-US   GNW  Data to be Presented From Biogenâ€™s Alzheimerâ€™s Disease Clinical Development Portfolio at the 2018 Alzheimerâ€™s Association International Conference (AAIC),,"10/16/2018 09058V10 GNW  Analysis: Positioning to Benefit within Ardelyx, AXT, TG Therapeutics, MarineMax, Oclaro, and BioCryst Pharmaceuticals â€” Research Highlights Growth, Revenue, and Consolidated Results",,,,," 4/03/2018 07YM31-E GNW  Hagens Berman Alerts Investors in Akorn, Inc. to the May 7, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action",,"10/02/2019 62855J10 GNW  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in VAL, NTAP, and MYGN of Filing Deadlines"," 7/23/2018 LXRX-US  GNW  UPDATE - Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018",," 7/29/2016 45766930 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insmed Incorporated",,11/27/2017 INO-US    GNW  Inovio Pharmaceuticals SynConÂ® TERT Cancer ImmunotherapyÂ Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor and Improves Survival in Preclinical Tumor Model,11/05/2018 64026810 GNW  SHAREHOLDER ALERT: PVG USAT COCP JT GOOG OZK NKTR FIT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,," 7/24/2018 GERN-US  GNW  Geron to Announce Second Quarter 2018 Financial Results on July 31, 2018",," 3/17/2019 02311120 GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DBVT, AMRN, WTW and CRBP",,,12/20/2018 SRPT-US  GNW  Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53,11/20/2017 REPH-US  GNW  Recro Pharma Secures $100 Million Credit Facility,," 6/11/2018 AMAG-US  GNW  AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies",,,,, 2/07/2019 SAN-FR   GNW  Sanofi delivers 2018 business EPS growth of 5.1% at CER,,, 9/26/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Proposed Public Offering of ADSs,,,10/25/2017 AFMD-US  GNW  AbCheck and Molecular Templates Announce Collaboration to Discover Therapeutic Oncology Leads,, 2/06/2018 PRQR-US  GNW  ProQR to Present at Upcoming Scientific Meeting and Investor Conference,, 4/01/2019 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,, 5/01/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Long-term Preclinical Efficacy Data on ADVM-022 Gene Therapy in Wet AMD, 6/29/2018 RARE-US   GNW  Ultragenyx Announces Positive CHMP Opinion for Mepseviiâ„¢ (vestronidase alfa)Â For the Treatment of Mucopolysaccharidosis VII, 2/28/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present Preclinical Data for AEB1102 at Keystone Symposia Conference on Tumor Metabolism, 2/05/2018 NSTG-US  GNW  NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology,,,11/02/2017 RDUS-US  GNW  Radius Health Reports Third Quarter 2017 Financial and Operating Results and Provides Business Update,11/09/2016 ASMB-US  GNW  Assembly Biosciences Initiates Phase 1 Clinical Program of ABI-H0731 for Treatment of Chronic Hepatitis B Virus Infection,,, 2/05/2013 0844XQ-E GNW  Karyopharm Therapeutics Announces Ken Weg & Barry Greene Join Board of Directors; Dr. Sharon Shacham Named President of Research & Development,, 5/10/2018 00972L10 GNW  FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome,, 1/03/2018 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference,10/05/2017 RTRX-US  GNW  Retrophin Announces Presentation of New Data from Physician-Initiated Treatment with Fosmetpantotenate at the Child Neurology Societyâ€™s 26th Annual Meeting, 1/09/2017 PACB-US  GNW  Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release, 9/26/2017 EDIT-US  GNW  Editas Medicine Receives EMAâ€™s Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10, 5/23/2016 CHMA-US  GNW  Chiasma to Participate in AACE and ECE 2016 Conferences, 2/19/2019 MGNX-US  GNW  MacroGenics Announces Date of Fourth Quarter and Full Year 2018 Financial Results Conference Call,,,, 6/07/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 38th Annual Global Healthcare Conference, 8/08/2017 PRTA-US  GNW  Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update, 1/03/2018 ZLAB-US  GNW  Zai Lab Limited to present at the 36th Annual J.P. Morgan Healthcare Conference,,12/18/2017 23284F10 GNW  CytomX Therapeutics Added to NASDAQ Biotechnology Index, 1/22/2018 NOVN-CH  GNW  Genmab Announces Novartisâ€™ Intention to Transition ArzerraÂ® (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets,,, 9/18/2017 CBAY-US  GNW  CymaBay Therapeutics to Present at Two Investor Conferences,, 1/04/2017 CCXI-US  GNW  ChemoCentryx to Present at the 35th Annual J.P. Morgan Healthcare Conference,,, 3/14/2018 MNKD-US   GNW  MannKind Corporation to Present at OppenheimerÂ 28th Annual Healthcare Conference,, 9/25/2018 CYTK-US  GNW  Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference," 6/06/2018 29664W10    GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 â€“ ESPR"," 3/05/2019 AMRS-US   GNW  Amyris to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, March 18, 2019",, 3/21/2017 ACHN-US  GNW  USPTO Grants Composition of Matter Patent to Achillion for Small Molecule Complement Alternative Pathway Factor D Inhibitors," 3/12/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Against SYNEOS HEALTH, INC. â€“ SYNH", 4/17/2018 FOLD-US  GNW  Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day,,, 5/25/2017 ADMA-US  GNW  ADMA Biologics to Present at Jefferies 2017 Healthcare Conference,12/28/2017 GWPH-US  GNW  GW Pharmaceuticals Announces Acceptance of NDA Filing for EpidiolexÂ® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome,,," 3/01/2018 MYOK-US  GNW  MyoKardia to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 8, 2018",, 9/17/2018 GLPG-NL  GNW  Galapagos issues new shares as result of public offering, 8/03/2018 PTLA-US  GNW  U.S. Centers for Medicare and Medicaid Services (CMS) Grants New Technology  Add-On Payment for Portola Pharmaceuticalsâ€™ Andexxa,,,, 8/31/2017 CARA-US  GNW  Cara Therapeutics to Participate in September Medical Meetings, 9/10/2018 FLXN-US  GNW  Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology, 3/14/2018 QURE-US  GNW  uniQure Announces 2017 Financial Results and Recent Company Progress," 3/05/2018 AGIO-US   GNW  Agios to Present at the Cowen 38th Annual Healthcare Conference Monday, March 12, 2018",12/13/2017 IOVA-US  GNW  Iovance Biotherapeutics Expands Pipeline of TIL Therapies into Lung Cancer,,,12/15/2017 FATE-US  GNW  Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 3/30/2017 HZNP-US  GNW  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVOÂ® (naproxen/esomeprazole) Delayed Release Tablets,,10/23/2017 ICPT-US  GNW  Intercept Announces Positive Results from Phase 2 AESOP Trial Evaluating OCA for the Treatment of Patients with Primary Sclerosing Cholangitis at The Liver MeetingÂ® 2017," 8/14/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 1/02/2018 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,," 8/04/2016 AMPH-US  GNW  Amphastar Pharmaceuticals, Inc. Purchases International Medication Systems (UK) Limited from UCB PHARMA GmbH", 2/21/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Chief Financial Officer Intention to Retire in April 2018,, 5/16/2017 DERM-US  GNW  Dermira Announces Closing of 3.00% Convertible Senior Notes Offering,11/15/2017 FOMX-US  GNW  Foamix Reports Third Quarter 2017 Financial Results and Provides Business Update," 5/02/2016 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Secondary Offering of 5,000,000 Shares of Common Stock",11/17/2016 SUPN-US  GNW  Supernus Receives Nasdaq Non-Compliance Notice, 8/07/2017 FGEN-US  GNW  FibroGen Announces Positive Topline Results from Phase 2 Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis,, 7/24/2018 CHRS-US  GNW  Coherus BioSciences to Report Second Quarter 2018 Financial Results on August 8th,"11/05/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Announce Third Quarter 2018 Operational and Financial Results on November 8, 2018",, 3/09/2017 COLL-US  GNW  Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update, 3/03/2017 XBIT-US  GNW  XBiotech Announces Registered Direct Offering of Common Shares,,, 9/06/2018 GBT-US   GNW  GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference,10/15/2015 75901B10 GNW  Dr. David C. Stump Appointed to REGENXBIO Board of Directors, 3/05/2018 KURA-US  GNW  Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results, 4/16/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces Proposed Offering of Common Stock, 5/22/2018 AXSM-US  GNW  Axsome Therapeutics to Present at the 2018 BIO International Convention,10/03/2017 VYGR-US  GNW  Voyager Therapeutics to Present at Investor Conferences in October, 1/03/2019 BGNE-US  GNW  BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 7/10/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Bardoxolone Methyl for the Treatment of Alport Syndrome",, 2/01/2017 NTLA-US  GNW  Intellia Therapeutics to Present at Leerink Partners 6th Annual Global Healthcare Conference, 4/03/2017 ACIU-US  GNW  Piramal Imaging and AC Immune present first clinical data for tau PET-imaging tracer at International Alzheimer's Conference, 6/19/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China, 3/01/2018 GTHX-US  GNW  G1 Therapeutics to Present at Investor Conferences in March 2018,,, 8/09/2018 ATNX-US  GNW  Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage,,,,,,,,,, 4/18/2018 EYPT-US    GNW  EyePoint Pharmaceuticalsâ€™ YUTIQâ„¢ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/17/2018 PGNX-US  GNW  Progenics Announces Addition of AZEDRAÂ® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma,,,,,"10/26/2011 089Q9Z-E GNW  MonoSol Rx, LLC Asserts Additional Patents to Infringement Lawsuit Against BioDelivery Sciences International, Inc.",,, 8/01/2011 82691710     GNW  SIGA Technologies Reports Financial Results for the Second Quarter and First Half of 2011,"10/12/2018 68375N10 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ OPK",10/16/2017 IONS-US  GNW  Akcea Presents Data Demonstrating Significant Burden of Illness in Familial Chylomicronemia Syndrome," 7/22/2015 NDAQ-US     GNW  BioMarin Pharmaceutical Inc. to Join the NASDAQ-100 Index Beginning July 27, 2015",,,," 1/31/2019 45290710 GNW  IMMU CLASS ACTION ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Securities Case Seeking to Recover Investor Losses â€“ IMMU", 7/05/2018 BIIB-US   GNW  Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months,, 9/25/2018 BCRX-US  GNW  BioCryst Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference,,,,," 4/03/2018 00972810 GNW  The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Akorn, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018 (AKRX)",,10/01/2019 62855J10 GNW  MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit," 7/23/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018",," 7/19/2016 45766930 GNW  IMPORTANT NOTICE TO SHAREHOLDERS:  Brower Piven Notifies Shareholders of Securities Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Insmed Incorporated To Contact Brower Piven Before The Lead Plaintiff Deadline â€“ INSM",,11/10/2017 INO-US    GNW  Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference,"11/04/2018 64026810 GNW  CLASS ACTION UPDATE for HON, DY, NKTR and FIT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 6/18/2018 GERN-US  GNW  Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress,, 3/16/2019 AMRN-US  GNW  High Risk of Atherosclerotic Cardiovascular Events Projected in People with Elevated Triglycerides Without Established Atherosclerotic Cardiovascular Disease,,,"12/11/2018 SRPT-US  GNW  Sarepta Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors", 9/14/2016 009T7W-E GNW  Flexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors,, 6/04/2018 AMAG-US  GNW  AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide,,,,, 2/06/2019 SAN-FR   GNW  Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director,,, 9/26/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH,,, 9/22/2017 AFMD-US  GNW  Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology,, 1/08/2018 PRQR-US  GNW  ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQRâ€™s AxiomerÂ® technology,, 3/25/2019 ZGNX-US  GNW  Zogenix to Present at Two Investor Conferences in April,,,,,, 3/06/2018 ADVM-US  GNW  Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update," 6/19/2018 90400D10  GNW  Report: Developing Opportunities within Spartan Motors, Ultragenyx Pharmaceutical, Advanced Energy Industries, Verisk Analytics, Cogent Communications, and ADTRAN â€” Future Expectations, Projections Moving into 2018", 2/16/2017 AGLE-US  GNW  Aeglea BioTherapeutics Appoints Dr. Suzanne Bruhn to Board of Directors," 1/26/2018 63009R10 GNW  New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Petroleum, GlycoMimetics, State Street, and Retail Properties of America â€” Factors of Influence, Major Initiatives and Sustained Production",,,10/18/2017 RDUS-US  GNW  Radius Health Receives FDA Fast Track Designation for Elacestrant (RAD1901), 9/28/2016 ASMB-US  GNW  Assembly Biosciences Announces Key Additions to Microbiome Team,,," 1/31/2013 02043Q10 GNW  Tekmira's LNP Technology Highlighted in Peer-Reviewed Publication, Cancer Discovery",, 5/03/2018 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for First Quarter 2018,,"12/14/2017 PCRX-US  GNW  Illinois Surgical Quality Improvement Collaborative and Pacira Pharmaceuticals, Inc. Announce Collaboration to Minimize Opioid Exposure for Postsurgical Patients", 9/11/2017 RTRX-US  GNW  Retrophin to Present at September Investor Conferences, 1/04/2017 PACB-US  GNW  GrandOmics Biosciences Expands Investment in PacBioâ€™s Sequel Systems for Precision Medicine Initiative, 9/12/2017 EDIT-US  GNW  Editas Medicine Initiates Clinical Natural History Study to Evaluate Patients with Leber Congenital Amaurosis Type 10 (LCA10), 5/11/2016 06CR5C-E GNW  Chiasma Reports First Quarter 2016 Results, 2/13/2019 MGNX-US  GNW  MacroGenics to Participate in Guggenheim Healthcare Talks Idea Forum,,,," 6/01/2017 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Santiago Arroyo, M.D., Ph.D. as Chief Medical Officer", 8/01/2017 PRTA-US  GNW  Prothena to Report Second Quarter 2017 Financial Results on August 8,12/19/2017 98887Q10 GNW  Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration,,11/28/2017 CTMX-US  GNW  CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic, 1/19/2018 GMAB-DK  GNW  U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma,,, 9/11/2017 CBAY-US  GNW  CymaBay Therapeutics Granted EMA Orphan Drug Designation for Seladelpar for the Treatment of Primary Biliary Cholangitis,,12/22/2016 CCXI-US  GNW  Vifor Pharma and ChemoCentryx Announce Expansion of Kidney Health Alliance to Include CCX140 to Treat Renal Diseases,,, 3/13/2018 MNKD-US   GNW  MannKind Announces STAT Study Results Accepted for Presentation at American Diabetes Associationâ€™s 78th Scientific Sessions,, 9/05/2018 CYTK-US  GNW  Cytokinetics to Present at the Morgan Stanley Global Healthcare Conference," 5/31/2018 008G5M-E    GNW  ESPR NEWS ALERT: Rosen Law Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. â€“ ESPR"," 2/12/2019 07V7ZP-E  GNW  Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications",," 2/28/2017 ACHN-US  GNW  Achillion Pharmaceuticals to Support a Natural History Study of C3 Glomerulopathy, a Rare Renal Disorder, Conducted by Experts at Imperial College London"," 3/12/2019 87166B10 GNW  CLASS ACTION UPDATE for ARLO, TYME, KHC and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 3/22/2018 FOLD-US  GNW  Amicus Therapeutics Announces Approval of GalafoldÂ® (Migalastat) for Fabry Disease in Japan,,, 5/12/2017 ADMA-US  GNW  ADMA Biologics Provides Corporate Update and Reports First Quarter 2017 Financial Results,12/22/2017 GWPH-US  GNW  Future Farm Strengthens Its Foothold in the Hemp-based CBD Market -- CFN Media,,, 2/14/2018 MYOK-US  GNW  MyoKardia to Present at the RBC Capital Marketsâ€™ 2018 Healthcare Conference,, 9/17/2018 GLPG-NL  GNW  Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of â‚¬296.2 million," 8/02/2018 PTLA-US  GNW  Portola Pharmaceuticals to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018",,,, 8/03/2017 CARA-US  GNW  Cara Therapeutics Reports Second Quarter 2017 Financial Results, 9/07/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/27/2018 QURE-US  GNW  uniQure to Participate in Multiple Conferences in March, 2/15/2018 AGIO-US   GNW  FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation,"12/07/2017 IOVA-US  GNW  Iovance Biotherapeutics to Webcast Analyst Day on Wednesday, December 13, 2017",,,12/13/2017 FATE-US  GNW  Fate Therapeutics Announces Pricing of Public Offering of Common Stock, 3/22/2017 HZNP-US  GNW  Horizon Pharma plc to Present Data on RAVICTIÂ® (glycerol phenylbutyrate) Oral Liquid for Urea Cycle Disorder Patients Aged Two Months to Two Years,,"10/23/2017 0BGL4K-E GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Intercept Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 27, 2017 â€“ ICPT"," 8/13/2019 48576U10   GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NFLX, KPTI, NGHC and TWOU",,,"12/07/2017 ITCI-US  GNW  Intra-Cellular Therapies Presents Data on Lumateperone, ITI-214 and ITI-333 at the 56th Annual Meeting of the American College of Neuropsychopharmacology",,,," 8/01/2016 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2016", 1/10/2018 ATRA-US    GNW  Atara Biotherapeutics Announces FDA Clearance to Proceed with Enrollment at U.S. Sites for Ongoing Global Phase 1 Clinical Study to Evaluate ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis,, 5/10/2017 DERM-US  GNW  Dermira Prices Offering of $250 Million of 3.00% Convertible Senior Notes,"11/01/2017 FOMX-US  GNW  Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 15, 2017"," 4/27/2016 PRAH-US  GNW  PRA Health Sciences, Inc. Reports First Quarter 2016 Results and Updates 2016 Guidance",11/14/2016 SUPN-US  GNW  Supernus Provides Business Update, 8/07/2017 FGEN-US  GNW  FibroGen Reports Second Quarter 2017 Financial Results,, 6/22/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,10/22/2018 CRBP-US  GNW  Corbus Pharmaceuticals Presents Lenabasum Long-Term Open-Label Clinical Data Showing Maintenance of Favorable Safety Profile and Further Improvement in Multiple Efficacy Endpoints in Systemic Sclerosis and Dermatomyositis Phase 2 Studies,, 2/28/2017 COLL-US  GNW  Collegium to Host Conference Call to Discuss 2016 Financial Results and Provide Corporate Update, 2/22/2017 XBIT-US  GNW  XBiotech Completes Dosing of Subjects in PK Study Being Conducted in Connection with European Marketing Application,,, 8/23/2018 GBT-US   GNW  GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis,10/01/2015 RGNX-US  GNW  FDA Grants Orphan Drug Designation to REGENXBIO's RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I (MPS I), 2/15/2018 KURA-US  GNW  Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer, 4/16/2018 APLS-US  GNW  Apellis Pharmaceuticals Provides Update on Phase 1b Open Label Study of APL-2 in PNH Patients Not Previously Treated with Eculizumab, 5/08/2018 AXSM-US  GNW  Axsome Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update, 9/18/2017 VYGR-US  GNW  Voyager Therapeutics Appoints Matthew P. Ottmer as Chief Operating Officer,"12/17/2018 BGNE-US  GNW  BeiGene Initiates Two Global Phase 3 Front-Line Clinical Trials of Tislelizumab, in Patients with Gastric Cancer and in Patients with Esophageal Cancer",," 6/22/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Friedreichâ€™s Ataxia",, 1/11/2017 NTLA-US  GNW  Intellia Therapeutics Joins Genomics Englandâ€™s Industry Consortium, 3/23/2017 ACIU-US  GNW  AC IMMUNE PROVIDES TWELVE UPDATES ON ITS PIPELINE  AT THE INTERNATIONAL CONFERENCE  ON ALZHEIMER'S AND PARKINSON'S DISEASES, 6/14/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at the JMP Securities Life Sciences Conference, 2/21/2018 GTHX-US  GNW  G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights,,," 8/03/2018 ATNX-US  GNW  Athenex, Inc. to Report Second Quarter Earnings Results on August 14, 2018",,,,,,,,,, 4/12/2018 EYPT-US    GNW  EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCUâ„¢,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/12/2018 PGNX-US  GNW  Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404,,,,,,,, 7/26/2011 82691710     GNW  SIGA to Participate in Goldman Sachs Small Cap Healthcare 1x1 Day,"10/10/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinduoduo, OPKO Health, and Cocrystal and Encourages Investors to Contact the Firm", 9/12/2017 46222210 GNW  Akcea and Ionis Announce Filing of New Drug Submission for Volanesorsen to Health Canada, 7/20/2015 09061G10    GNW  BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer,,,," 1/31/2019 45290710 GNW  Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of LOMA, IMMU, DBVT and AXGN", 6/28/2018 207940-KR GNW  Biogen Exercises Option to Increase Ownership in Samsung Bioepis,, 9/17/2018 BCRX-US  GNW  BioCryst Receives Additional $3.5 Million to Fund Clinical Trials of Galidesivir in Yellow Fever,,,,," 4/02/2018 00972810 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",," 9/30/2019 62855J10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (MYGN)"," 6/27/2018 52887230 GNW  Research Report Identifies Citizens Financial Group, Fifth Third, KKR & Co., Vista Outdoor, Devon Energy, and Lexicon Pharmaceuticals with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",," 7/19/2016 45766930 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 â€“ INSM",,11/09/2017 INO-US    GNW  Inovio Pharmaceuticals to ParticipateÂ In Upcoming Investment Conferences,"11/04/2018 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nektar Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ NKTR",, 5/17/2018 GERN-US  GNW  Geron Announces Oral Presentation at European Hematology Association Congress,," 3/13/2019 02311120 GNW  CLASS ACTION UPDATE for SPB, ARLO, AMRN and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,,"12/07/2018 80360710 GNW  New Research Coverage Highlights Callaway Golf, Synchrony Financial, Roper Technologies, Ringcentral, Sarepta Therapeutics, and Advanced Micro Devices â€” Consolidated Revenues, Company Growth, and Expectations for 2018", 4/13/2015 07BKS2-E GNW  Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alkermes,, 5/29/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conference,,,,," 2/06/2019 SAN-FR   GNW  Sanofi: FDA approves CabliviÂ® (caplacizumab-yhdp), the first NanobodyÂ®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)",,, 9/05/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Presentations on Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences,,, 9/13/2017 AFMD-US  GNW  Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer,,12/27/2017 PRQR-US  GNW  ProQR Announces Extraordinary General Meeting of Shareholders,, 3/19/2019 ZGNX-US  GNW  Zogenix Enters Exclusive Distribution Agreement with Nippon Shinyaku for FINTEPLAÂ®Â in Japan,,,,,, 2/26/2018 ADVM-US  GNW  Adverum Biotechnologies to Present at Upcoming Investor Conferences, 6/04/2018 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences, 1/17/2017 AGLE-US  GNW  Aeglea BioTherapeutics to Present New Data at 2017 ACMG Annual Clinical Genetics Meeting, 1/19/2018 NSTG-US  GNW  NanoString Reports Inducement Grant Under NASDAQ Listing Rules,,,10/13/2017 RDUS-US  GNW  Radius Health to Present First Health Economics Data on TYMLOSâ„¢ (abaloparatide) Injection at the Academy of Managed Care Pharmacy Nexus 2017, 9/21/2016 ASMB-US  GNW  Assembly Biosciences Announces Participation in HBV Scientific Meetings in China and South Korea,,,11/13/2012 TKM-CA   GNW  Tekmira Provides Corporate Update and Announces Third Quarter 2012 Results,, 5/02/2018 AKCA-US  GNW  Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS,,12/08/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2017 BMO Capital Markets Prescriptions for Success Healthcare Conference, 9/05/2017 RTRX-US  GNW  Retrophin Announces Cooperative Research and Development Agreement with NCATS and NGLY1.org to Identify Potential Small Molecule Therapeutics  for NGLY1 Deficiency,12/15/2016 PACB-US  GNW  PacBio Announces Termination of Agreement with Roche Diagnostics, 9/05/2017 EDIT-US  GNW  Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference," 5/03/2016 CHMA-US  GNW  Chiasma to Report First Quarter 2016 Financial Results on May 11, 2016", 2/12/2019 MGNX-US  GNW  MacroGenics Announces Pricing of Public Offering of Common Stock,,,, 5/10/2017 MNTA-US  GNW  UPDATE -- Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 7/05/2017 PRTA-US  GNW  Prothena Announces Initiation of Phase 2 PASADENA Study of PRX002/RG7935 in Patients with Early Parkinsonâ€™s Disease, 9/29/2017 ZLAB-US  GNW  Zai Lab Limited Announces Dosing of First Patient in Phase 3 Registration Trial of ZL-2306 (niraparib) for Treatment of Ovarian Cancer,,11/01/2017 CTMX-US  GNW  CytomX to Present at the Jefferies 2017 London Healthcare Conference, 1/09/2018 GMAB-DK  GNW  Major Shareholder Announcement,,, 8/15/2017 CBAY-US  GNW  CymaBay Therapeutics Announces the Publication of the Seladelpar Proof-of-Concept Study for Primary Biliary Cholangitis in Lancet Gastroenterology and Hepatology,,11/07/2016 CCXI-US  GNW  ChemoCentryx Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,, 3/12/2018 0D05N5-E  GNW  MannKind Restructures $79.7 Million Debt Obligation to the Mann Group and Reduces Principal Owed to Deerfield by $6.3 Million,, 8/28/2018 CYTK-US  GNW  Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter, 5/30/2018 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the Jefferies 2018 Global Healthcare Conference," 2/11/2019 AMRS-US   GNW  Amyris Appoints Industry Veteran as President, Sweeteners and Ingredients, to Deliver Accelerated Growth",, 2/23/2017 ACHN-US  GNW  Achillion Reports 2016 Fourth Quarter and Year-End Financial Results," 3/12/2019 87166B10 GNW  SYNH DEADLINE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Syneos Health, Inc. â€“ SYNH", 3/05/2018 FOLD-US  GNW  Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2018,,," 2/24/2017 ADMA-US  GNW  ADMA Biologics Reports Year End 2016 Financial Results,Â Accomplishments and Upcoming Milestones",12/21/2017 GWPH-US  GNW  GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors,,, 2/14/2018 MYOK-US  GNW  MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients,, 9/13/2018 GLPG-NL  GNW  Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106, 7/27/2018 PTLA-US  GNW  European CHMP Maintains Negative Opinion on Portola Pharmaceuticalsâ€™ Betrixaban Following Appeal,,,, 8/03/2017 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at the Canaccord Genuity 37th Annual Growth Conference, 8/28/2018 FLXN-US  GNW  Flexion Therapeutics to Present at the 2018 Wells Fargo Healthcare Conference, 2/01/2018 QURE-US  GNW  uniQure to Participate in Multiple Conferences in February, 2/14/2018 AGIO-US   GNW  Agios Reports Fourth Quarter and Full Year 2017 Financial Results,11/28/2017 IOVA-US  GNW  Iovance Biotherapeutics to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference,,,12/12/2017 FATE-US  GNW  Fate Therapeutics Announces Proposed Public Offering of Common Stock," 3/16/2017 HZNP-US  GNW  Horizon Pharma plc Announces ""UCD in Common"" for the Urea Cycle Disorder (UCD) Community",,"10/23/2017 45845P10 GNW  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit"," 8/12/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,11/27/2017 ITCI-US  GNW  Intra-Cellular Therapies to Participate at the 29th Annual Piper Jaffray Healthcare Conference,,,, 6/03/2016 05F9ZW-E GNW  Amphastar Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference, 1/04/2018 ATRA-US    GNW  Atara Biotherapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference,, 5/09/2017 DERM-US  GNW  Dermira Announces Proposed Offering of $250 Million of Convertible Senior Notes, 8/08/2017 FOMX-US  GNW  Foamix Reports Second Quarter 2017 Financial Results and Provides Business Update, 4/18/2016 PRAH-US  GNW  PRA Health Sciences Named Clinical Research Company of the Year,11/11/2016 SUPN-US  GNW  Supernus to Host a Business Update Call," 7/31/2017 FGEN-US  GNW  FibroGen to Report Second Quarter Financial Results on Monday, August 7, 2017",, 5/25/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,10/18/2018 CRBP-US  GNW  Corbus Pharmaceuticals Presents Data on Impact of Lenabasum on Inflammation of Airway Macrophages from Cystic Fibrosis Lungs at the 2018 North American Cystic Fibrosis Conference,, 2/01/2017 COLL-US  GNW  Collegium Announces Positive Topline Results of Human Abuse Potential Clinical Trial Evaluating the Oral Abuse of Xtampza ER, 2/21/2017 XBIT-US  GNW  XBiotech Reports Affirmative Interim Analysis of Global Phase 3 Colorectal Cancer Study,,," 8/21/2018 GBT-US   GNW  GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy", 9/22/2015 75901B10 GNW  REGENXBIO Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares, 2/08/2018 KURA-US  GNW  Kura Oncology to Present at the Leerink Partners 7th Annual Global Healthcare Conference, 3/19/2018 APLS-US  GNW  Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results, 5/03/2018 AXSM-US  GNW  Axsome Therapeutics Announces AXS-05 Poster Presentation at the 2018 Annual Meeting of the American Psychiatric Association, 9/06/2017 VYGR-US  GNW  Voyager Therapeutics Announces Positive Results from Ongoing Phase 1b Trial of VY-AADC01 for Advanced Parkinsonâ€™s Disease,12/15/2018 BGNE-US  GNW  BeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress,," 6/01/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Positive Data From Part One of Moxie Trial of Omaveloxolone for Friedreichâ€™s Ataxia",,"12/16/2016 00GBNS-E GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology", 3/17/2017 ACIU-US  GNW  AC IMMUNE REPORTS FULL YEAR 2016 FINANCIAL RESULTS  AND R&D UPDATE, 6/07/2017 CRSP-US  GNW  CRISPR Therapeutics Appoints James R. Kasinger as General Counsel," 2/14/2018 GTHX-US  GNW  G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018",,," 7/31/2018 04685N10 GNW  Report: Exploring Fundamental Drivers Behind Athenex, Crocs, Civeo, PLDT, Heartland Financial, and Prologis â€” New Horizons, Emerging Trends, and Upcoming Developments",,,,,,,,,," 3/28/2018 EYPT-US    GNW  pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners â€“ Company Will Rebrand as EyePoint Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 8/27/2018 74318710 GNW  Detailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health â€” What Drives Growth in Today's Competitive Landscape",,,,,,,, 7/13/2011 064R0R-E     GNW  Photo Release -- Kettle Brand(R) Launches All Natural Reduced Fat Potato Chip Line,"10/10/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK and USAT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 9/06/2017 IONS-US  GNW  Akcea Therapeutics Establishes Canadian Subsidiary," 7/15/2015 09061G10    GNW  BioMarin to Host Second Quarter 2015 Financial Results Conference Call and Webcast on Monday, August 3 at 4:30pm ET",,,," 1/30/2019 45290710 GNW  CLASS ACTION UPDATE for XPO, IMMU, MAXR and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 6/25/2018 BIIB-US   GNW  Biogen to Report Second Quarter 2018 Financial Results on July 24, 2018",, 9/06/2018 BCRX-US  GNW  CDC Awards BioCryst $35 Million RAPIVABÂ® Contract for Strategic National Stockpile,,,,," 3/31/2018 00972810 GNW  EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc. â€“ AKRX",," 9/27/2019 62855J10 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Myriad Genetics, Inc. and Certain Officers â€“ MYGN", 6/24/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care,, 6/08/2016 080RQG-E GNW  Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCEâ„¢ in Europe,,11/08/2017 INO-US    GNW  Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results,10/31/2018 64026810 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR),, 5/10/2018 GERN-US  GNW  Geron Corporation Reports First Quarter 2018 Financial Results,," 3/12/2019 02311120 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MAXR, AVEO, AMRN and CVS",,,11/30/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/25/2015 ALKS-US  GNW  Recro Pharma Reports Fourth Quarter and Full Year 2014 Financial Results,, 5/09/2018 AMAG-US  GNW  AMAG Pharmaceuticals Commends CMS for Clarifying Part D Coverage of Treatments for Moderate to Severe Dyspareunia Due to Menopause,,,,, 2/05/2019 SAN-FR   GNW  Sanofi  : Isatuximab Phase 3 trial meets primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma,,, 8/18/2017 ASND-US  GNW  Ascendis Pharma A/S Reports Second Quarter 2017 Financial Results,,, 9/04/2017 AFMD-US  GNW  Affimed to Present at the 2017 Wells Fargo Healthcare Conference - Boston,,11/29/2017 PRQR-US  GNW  ProQR Receives Orphan Drug Designation from EMA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa,, 3/01/2019 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,, 2/26/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Completion of Dosing of  First Cohort of Patients in the ADVANCE Phase 1/2 Clinical Trial of  ADVM-043 Gene Therapy for A1AT Deficiency, 5/23/2018 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that CrysvitaÂ® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine,12/07/2016 AGLE-US  GNW  Aeglea BioTherapeutics to Present at BMO Capital Markets Prescription for Success Healthcare Conference, 1/16/2018 NSTG-US  GNW  NanoString Appoints Thomas Bailey as Chief Financial Officer,,,"10/09/2017 RDUS-US  GNW  Radius Health to Announce Third Quarter 2017 Financial Results, Host Conference Call and Live Webcast on November 2, 2017", 6/01/2016 ASMB-US  GNW  Assembly Biosciences to Present at the Jefferies 2016 Global Healthcare Conference,,,11/12/2012 TKM-CA   GNW  Tekmira and Alnylam Restructure Relationship and Settle All Litigation,, 4/26/2018 00972L10 GNW  Akcea Therapeutics Announces Presentations on Volanesorsen and FCS at the National Lipid Association Scientific Sessions,,"12/07/2017 PCRX-US  GNW  Pacira Announces Promotions of Scott Braunstein, MD, to Chief Operating Officer and Richard Scranton, MD, to Chief Scientific Officer", 8/14/2017 RTRX-US  GNW  Retrophin Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),"11/02/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2016 Financial Results", 8/09/2017 EDIT-US  GNW  Editas Medicine Announces Second Quarter 2017 Results and Update, 4/29/2016 CHMA-US  GNW  Chiasma to Participate in Acromegaly Community Conference, 2/12/2019 MGNX-US  GNW  MacroGenics Announces Proposed Public Offering of Common Stock,,,, 5/10/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences," 6/12/2017 PRTA-US  GNW  Prothena Announces Appointment of Wagner Zago, PhD as Chief Scientific Officer", 9/22/2017 ZLAB-US  GNW  Zai Lab Limited Announces Closing of U.S. Initial Public Offering of ADSs,,10/26/2017 CTMX-US  GNW  CytomX Therapeutics to Announce Third Quarter 2017 Financial Results,11/29/2017 GMAB-DK  GNW  Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance,,, 8/10/2017 CBAY-US  GNW  CymaBay Reports Second Quarter 2017 Financial Results and Provides Corporate Update,,11/07/2016 06QBQ8-E GNW  ChemoCentryx Announces Presentations of Positive Results from Phase II ANCA-Associated Vasculitis Trials (â€˜CLEARâ€™ and â€˜CLASSICâ€™) of Orally Administered Complement 5a Receptor Inhibitor CCX168 (â€˜Avacopanâ€™),,, 3/01/2018 MNKD-US   GNW  MannKind Opens Enrollment of Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension,," 8/01/2018 23282W60 GNW  Market Trends Toward New Normal in US Foods Holding, Limelight Networks, Ladenburg Thalmann Financial Services, MPLX LP, Cytokinetics, and FuelCell Energy â€” Emerging Consolidated Expectations, Analyst Ratings", 5/29/2018 ESPR-US     GNW  Esperion Announces the Appointment of Jay P. Shepard to Board of Directors," 2/05/2019 AMRS-US   GNW  Amyris Announces $255 Million Cannabinoid Development, Licensing and Commercialization Agreement âˆ’ Represents Largest Collaboration Agreement to Date for Amyris",, 2/13/2017 05LK9B-E GNW  Achillion to Present at the Leerink Partners 6th Annual Global Healthcare Conference," 3/11/2019 87166B10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPB, MHLD, SYNH and CNDT", 2/28/2018 FOLD-US  GNW  Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates,,, 1/23/2017 ADMA-US  GNW  ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation and Become a Vertically Integrated Commercial Plasma Products Company,12/13/2017 GWPH-US  GNW  GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize SativexÂ® in U.S.,,, 1/19/2018 MYOK-US  GNW  MyoKardia Announces Appointment of Cynthia Ladd as General Counsel,, 9/12/2018 GLPG-NL  GNW  Galapagos raises $300 million gross proceeds in a U.S. public offering, 7/03/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 8/01/2017 14075510 GNW  Cara Therapeutics Appoints Mani Mohindru, Ph.D., Chief Financial Officer", 8/20/2018 FLXN-US  GNW  Flexion Therapeutics Announces Presentation of Phase 3 Data at Military Health System Research Symposium, 1/22/2018 QURE-US  GNW  uniQure Receives Orphan Medicinal Product Designation in Europe for AMT-130 in Huntingtonâ€™s disease," 1/31/2018 AGIO-US   GNW  Agios to Webcast Conference Call of Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018",11/13/2017 IOVA-US  GNW  Iovance Biotherapeutics to Present at the Jefferies 2017 London Healthcare Conference,,,12/11/2017 FATE-US  GNW  Fate Therapeutics Announces Day 100 Clinical Results from Phase 1 Stage of PROTECT Trial of ProTmuneâ„¢ and Initiation of Phase 2 Stage, 3/02/2017 HZNP-US  GNW  Horizon Pharma plc Announces Urea Cycle Disorders Medical Foods and Supplements Financial Assistance Program,,"10/20/2017 45845P10 GNW  IMPORTANT INTERCEPT PHARMACEUTICALS, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Intercept Pharmaceuticals, Inc."," 8/11/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Netflix, EQT, Eagle Bancorp, and Karyopharm and Encourages Investors to Contact the Firm",,,11/20/2017 ITCI-US  GNW  Intra-Cellular Therapies Receives FDA Fast Track Designation for Lumateperone for the Treatment of Schizophrenia,,,," 5/09/2016 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016", 1/03/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Pricing of Public Offering of Common Stock,, 5/08/2017 DERM-US  GNW  Dermira Reports First Quarter 2017 Financial Results and Provides Corporate UpdateÂ , 7/26/2017 FOMX-US  GNW  Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for August 9, 4/15/2016 PRAH-US  GNW  PRA Health Sciences to Report First Quarter 2016 Earnings,11/07/2016 SUPN-US  GNW  Supernus to Present at Three November Healthcare Conferences, 6/21/2017 FGEN-US  GNW  FibroGen Granted Orphan Drug Designation for Pamrevlumab in the Treatment of Pancreatic Cancer,, 5/22/2018 CHRS-US  GNW  Coherus Prices Public Offering of Common Stock,10/03/2018 CRBP-US  GNW  Corbus Pharmaceuticals Announces Patent Issuance Covering Use of Lenabasum for the Treatment of Fibrotic Diseases Providing Exclusivity to 2034,,12/15/2016 ESRX-US  GNW  Collegium Announces the Addition of Xtampza ER to Express Scriptsâ€™ Formulary, 2/16/2017 XBIT-US  GNW  XBiotech Meets Primary Endpoint in Phase 2 Study of MABp1 for Treatment of Hidradenitis Suppurativa (HS),,, 8/07/2018 GBT-US   GNW  GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference, 9/17/2015 RGNX-US  GNW  UPDATE: Photo Release -- Nasdaq Welcomes REGENXBIO Inc. to The Nasdaq Stock Market,12/18/2017 50127T10 GNW  Kura Oncology Added to Nasdaq Biotechnology Index, 2/23/2018 APLS-US  GNW  Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences," 5/01/2018 AXSM-US  GNW  Axsome Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018", 8/30/2017 VYGR-US  GNW  Voyager Therapeutics to Participate in September Investor Conferences,12/10/2018 BGNE-US  GNW  BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress,," 5/11/2017 RETA-US  GNW  Reata pharmaceuticals, inc. announces first quarter 2017 financial and operating results",,12/13/2016 NTLA-US  GNW  Intellia Therapeutics Names Graeme Bell Chief Financial Officer, 2/28/2017 ACIU-US  GNW  AC IMMUNE PARTNER GENENTECH TO START SECOND PHASE 3 CLINICAL TRIAL FOR ALZHEIMER'S THERAPY CRENEZUMAB, 6/06/2017 H1718210 GNW  CRISPR Therapeutics and MaSTherCell SA sign service agreement for the development and manufacturing of allogeneic cell therapies, 1/02/2018 GTHX-US  GNW  G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference,,, 7/26/2018 ATNX-US  GNW  Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints,,,,,,,,,, 3/19/2018 EYPT-US    GNW  pSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasertâ„¢ Three-Year Treatment for Posterior Segment Uveitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/07/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,,," 7/12/2011 82691710     GNW  SIGA to Discuss Second Quarter 2011 Results of Operations on August 1, 2011","10/10/2018 68375N10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In OPKO Health, Inc. (Nasdaq: OPK) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit", 9/05/2017 IONS-US  GNW  Akcea Expands Leadership Team in Preparation for First Commercial Launch, 6/29/2015 BMRN-US     GNW  BioMarin Announces FDA Accepts Drisapersen NDA for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,, 1/29/2019 45290710 GNW  SHAREHOLDER ALERT: IMMU PRGO AXGN W: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines," 6/19/2018 BIIB-US   GNW  Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018",, 9/04/2018 BCRX-US  GNW  CORRECTION -- BioCryst Reports Positive Results Across Multiple Endpoints in ZENITH-1 Trial of Oral BCX7353 as Acute Therapy for Hereditary Angioedema (HAE) Attacks,,,,," 3/28/2018 00972810 GNW  AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc.To Contact The Firm",, 9/25/2019 MYGN-US  GNW  Myriad Genetics Expands Board of Directors with Two Additional Members, 6/23/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care,, 5/09/2016 BAC-US   GNW  Insmed to Present at the Bank of America Global Healthcare Conference,,11/01/2017 45773H20  GNW  Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical StudyÂ for Glioblastoma in Combination with Regeneronâ€™s PD-1 Inhibitor,"10/31/2018 64026810 GNW  CLASS ACTION UPDATE for TGTX, HAS and NKTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 4/17/2018 GERN-US  GNW  Geron 2018 Annual Meeting of Stockholders to be Held on May 15,, 3/08/2019 02311120 GNW  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Amarin Corporation plc (AMRN),,,"11/08/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Pricing of $500,000,000 Public Offering of Common Stock"," 4/23/2010 G0176710 GNW  Alkermes, Inc. (ALKS) Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell",, 5/03/2018 AMAG-US  GNW  AMAG Pharmaceuticals Announces First Quarter 2018 Financial ResultsÂ and Raises Full Year Financial Guidance,,,,, 2/04/2019 SAN-FR   GNW  Sanofi: CHMP recommends approval of PraluentÂ® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease,,, 8/08/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Upcoming Investor Presentations,,, 8/01/2017 AFMD-US  GNW  Affimed Reports Financial Results for Second Quarter 2017,,11/21/2017 PRQR-US  GNW  ProQR to Present at the Annual Piper Jaffray Healthcare Conference,, 2/28/2019 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results,,,,,, 2/12/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Closing of $69 Million Public Offering, 5/17/2018 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of CrysvitaÂ® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH),11/21/2016 AGLE-US  GNW  Aeglea BioTherapeutics Announces Publication in Nature Medicine Demonstrating that Targeting Tumor Oxidative Stress with AEB3103 Suppresses Cancer Growth in Preclinical Models, 1/08/2018 NSTG-US  GNW  NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017,,, 9/29/2017 RDUS-US  GNW  Radius Health Initiates Phase 1 Clinical Trial of RAD140 for the Treatment of Hormone Receptor Positive Breast Cancer, 4/13/2016 ASMB-US  GNW  Assembly Biosciences to Present Data at The International Liver Congress(TM) 2016 that Supports Advancing Its CpAM Candidates into HBV Clinical Trials,,, 9/26/2012 TKM-CA   GNW  Tekmira Provides Periodic Update to Shareholders Regarding Litigation,, 4/26/2018 00972L10 GNW  Akcea Therapeutics to Hold First Quarter 2018 Financial Results Webcast,,11/14/2017 PCRX-US  GNW  Pacira Announces FDA Advisory Committee Meeting to Review sNDA for EXPARELÂ® as a Nerve Block for Regional Analgesia, 8/09/2017 RTRX-US  GNW  Retrophin Reports Second Quarter 2017 Financial Results,11/02/2016 076F95-E GNW  PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore, 8/09/2017 28106W10 GNW  Editas Medicine Achieves Milestone Under Juno Therapeutics Collaboration for Technical Progress Towards Overcoming the Tumor Microenvironment, 4/18/2016 06CR5C-E GNW  Chiasma Provides Update Regarding FDAâ€™s Complete Response Letter for Mycapssaâ„¢ New Drug Application, 2/06/2019 MGNX-US  GNW  MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab,,,, 5/02/2017 MNTA-US  GNW  Momenta Pharmaceuticals Reports First Quarter 2017 Financial Results," 5/16/2017 PRTA-US  GNW  Prothena Announces Appointment of Sarah Noonberg, MD, PhD as Chief Medical Officer", 9/21/2017 ZLAB-US  GNW  Nasdaq Welcomes Zai Lab Ltd. (Nasdaq: ZLAB) to The Nasdaq Stock Market,,"10/24/2017 CTMX-US  GNW  CytomX Therapeutics Appoints Charles S. Fuchs, M.D., MPH to Board of Directors",11/21/2017 GMAB-DK  GNW  Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma,,," 8/07/2017 CBAY-US  GNW  CymaBay to Report Second Quarter 2017 Financial Results on Thursday, August 10",,"10/28/2016 CCXI-US  GNW  ChemoCentryx to Hold Third Quarter 2016 Financial Results Conference Call on Monday, November 7, 2016",,, 2/27/2018 MNKD-US   GNW  MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results,," 7/26/2018 CYTK-US  GNW  Cytokinetics, Inc. Reports Second Quarter 2018 Financial Results", 5/25/2018 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),12/31/2018 AMRS-US   GNW  Amyris Announces Signing of Nutritional Product Royalty Agreement,,12/28/2016 0CN75T-E GNW  Achillion Announces Clinical Milestone for the Advancement of JNJ-4178 in Phase 2B Development  for Chronic HCV," 3/10/2019 87166B10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stamps.com, Syneos, and Weight Watchers and Encourages Investors to Contact the Firm", 2/27/2018 FOLD-US  GNW  Amicus Therapeutics Launches Healing Beyond Diseaseâ„¢ Initiatives to Change Peopleâ€™s Lives Living with Rare Diseases,,,11/10/2016 ADMA-US  GNW  ADMA Biologics Reports Third Quarter 2016 Results,12/11/2017 GWPH-US  GNW  GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriterâ€™s Option to Purchase Additional ADSs,,, 1/03/2018 MYOK-US  GNW  MyoKardia to Present at 36th Annual J.P. Morgan Healthcare Conference,, 9/12/2018 GLPG-NL  GNW  Galapagos announces launch of proposed public offering, 6/25/2018 PTLA-US  GNW  Portola Pharmaceuticals Appoints 30-Year Industry Veteran Glenn Brame as Senior Vice President of Technical Operations,,,," 7/27/2017 CARA-US  GNW  Cara Therapeutics to Announce Second Quarter 2017 Financial Results on August 3, 2017"," 8/17/2018 33938J10 GNW  Report: Developing Opportunities within Adesto Technologies, BLACKLINE INC, Altice, Flexion Therapeutics, EZCORP, and CorVel â€” Future Expectations, Projections Moving into 2018", 1/08/2018 QURE-US  GNW  uniQure Provides Year-End 2017 Corporate Update and Outlines Near-Term Objectives to Further Drive Shareholder Value, 1/23/2018 AGIO-US   GNW  Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,11/09/2017 IOVA-US  GNW  Iovance Biotherapeutics Announces New LN-144 Phase 2 Clinical Data from Metastatic Melanoma Trial to be Presented at SITC Meeting,,,12/11/2017 FATE-US  GNW  Fate Therapeutics Announces Successful Completion of Technology Transfer and Initiation of IND-Enabling Manufacture of FT500, 2/28/2017 HZNP-US  GNW  Horizon Pharma plc Launches RAREisâ„¢ Campaign Elevating Faces of the Rare Disease Community,,"10/19/2017 45845P10 GNW  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm"," 8/09/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,11/14/2017 ITCI-US  GNW  Intra-Cellular Therapies Presents Data on Mechanism of Action of Lumateperone and ITI-214 at the 2017 Society for Neuroscience (SfN) Annual Meeting,,,, 5/06/2016 07MDY1-E GNW  Amphastar Pharmaceuticals to Present at the 2016 Bank of America Merrill Lynch 19th Annual Health Care Conference, 1/02/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Proposed Offering of Common Stock,, 3/28/2017 DERM-US  GNW  Dermira to Present at Needham 16th Annual Healthcare Conference, 9/06/2016 RRSHQ-US GNW  Foamix to Present Corporate Overview at the Rodman & Renshaw 18th Annual Global Investment Conference, 3/31/2016 PRAH-US  GNW  PRA Health Sciences Receives Recognition from Vaccine Industry Excellence (ViE),10/11/2016 SUPN-US  GNW  Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD," 6/13/2017 FGEN-US  GNW  About FibroGen, Inc.FibroGen to Present at the Goldman Sachs 38th Annual Global Healthcare Conference",, 5/21/2018 CHRS-US  GNW  Coherus Announces Proposed Public Offering of Common Stock, 9/26/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in October,,11/29/2016 COLL-US  GNW  Collegium Announces Underwritersâ€™ Exercise of Option to Purchase Additional Shares, 1/17/2017 XBIT-US  GNW  XBiotech Phase 3 Data for Colorectal Cancer Therapy is Published in The Lancet Oncology,,, 8/03/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 9/17/2015 RGNX-US  GNW  Photo Release -- Nasdaq Welcomes REGENXBIO Inc. to The Nasdaq Stock Market,12/11/2017 KURA-US  GNW  Kura Oncology Identifies Potential Biomarkers of Activity for Lead Candidate Tipifarnib in Bone Marrow Cancers, 2/22/2018 APLS-US  GNW  Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy, 4/26/2018 AXSM-US  GNW  Axsome Therapeutics Announces Positive Outcome of Interim Analysis of STRIDE-1 Phase 3 Trial of AXS-05 in Treatment Resistant Depression, 8/08/2017 VYGR-US  GNW  Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights,12/05/2018 BGNE-US  GNW  BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 4/03/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Secures $35 Million Term Loan Facility",,12/01/2016 NTLA-US  GNW  Intellia Therapeutics Opens New Headquarters as Company Continues to Advance CRISPR/Cas9 Platform and Pipeline,12/09/2016 ACIU-US  GNW  AC IMMUNE PARTNER GENENTECH PRESENTS IMPORTANT DATA ON ALZHEIMER'S THERAPY CRENEZUMAB, 5/18/2017 CRSP-US  GNW  CRISPR Therapeutics Announces the Presentation of Data on its Lead Program at the Upcoming 22nd European Hematology Association Annual Congress,12/18/2017 06F69H-E GNW  G1 Therapeutics Added to Nasdaq Biotechnology Index,,, 7/18/2018 ATNX-US  GNW  Athenex Announces Axis Therapeutics Has Entered into a MOU with the Hong Kong Polytechnic University to Set Up a Joint Research Center on Cancer Immunotherapy,,,,,,,,,, 3/05/2018 EYPT-US    GNW  pSivida To Present at the 30th Annual ROTH Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/07/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,,, 6/27/2011 82691710     GNW  SIGA to Sell 1.7 Million Courses of ST-246(R) to National Stockpile Under Modified BARDA Contract,"10/08/2018 68375N10 GNW  Kaskela Law LLC Announces Investor Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm â€“ OPK", 8/31/2017 46222210 GNW  Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA, 6/25/2015 BMRN-US     GNW  BioMarin Announces EMA Validates MAA for Drisapersen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,," 1/28/2019 45290710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NSANY, APHA, CURO and IMMU", 6/18/2018 0H8HLM-E  GNW  Biogen Foundation Selects Grantees to Receive $10 Million Investment for STEM Education,, 9/04/2018 BCRX-US  GNW  BioCryst Reports Positive Results Across Multiple Endpoints in ZENITH-1 Trial of Oral BCX7353 as Acute Therapy for Hereditary Angioedema (HAE) Attacks,,,,," 3/27/2018 00972810 GNW  AKRX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 7, 2018",, 9/23/2019 62855J10 GNW  MYGN INVESTIGATION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of the Firmâ€™s Ongoing Investigation of Possible Disclosure Violations, 6/18/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions,, 5/05/2016 INSM-US  GNW  Insmed Reports First Quarter 2016 Financial Results,,"10/26/2017 INO-US    GNW  Inovio Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 8, 2017","10/30/2018 64026810 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Nektar Therapeutics, Inc. and Certain Officers â€“ NKTR",, 3/21/2018 GERN-US  GNW  Geron to Present at the Needham Healthcare Conference,," 3/08/2019 02311120 GNW  Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against Amarin Corporation (AMRN) and Lead Plaintiff Deadline: April 23, 2019",,,"11/07/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock",,, 5/02/2018 AMAG-US  GNW  AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer,,,,, 1/17/2019 SAN-FR   GNW  Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes,,, 8/03/2017 ASND-US  GNW  Ascendis Pharma A/S Announces Second Quarter 2017 Financial Results  Conference Call on August 18,,, 7/25/2017 AFMD-US  GNW  Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call,,11/20/2017 PRQR-US  GNW  ProQR Announces Results for the Third Quarter of 2017,, 2/21/2019 ZGNX-US  GNW  Zogenix to Release Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on February 28,,,,,, 2/08/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Pricing of  $60 Million Public Offering of Common Stock, 5/07/2018 RARE-US   GNW  Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update,11/09/2016 AGLE-US  GNW  Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2016 Financial Results, 1/04/2018 0DFXJ9-E GNW  NanoString and RikenGenesis Announce Partnership to Commercialize nCounter-Based Diagnostic Assays in Japan,,, 9/22/2017 RDUS-US  GNW  Radius Health to Present at Cantor Annual Global Healthcare Conference, 3/30/2016 ASMB-US  GNW  Assembly Biosciences to Present Data on New Series of HBV Core Protein Allosteric Modifiers at The International Liver Congressâ„¢ 2016,,, 9/19/2012 TKM-CA   GNW  Tekmira Provides Periodic Update to Shareholders Regarding Litigation,, 4/17/2018 IONS-US  GNW  Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors,,11/09/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at Two November Healthcare Conferences, 7/26/2017 RTRX-US  GNW  Retrophin to Report Second Quarter 2017 Financial Results,10/17/2016 PACB-US  GNW  Novel Human Genetics Discoveries Using PacBio Long-Read Sequencing to be Presented at ASHG Annual Meeting, 8/07/2017 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Second Quarter 2017 Corporate Update and Results, 4/15/2016 06CR5C-E GNW  FDA Issues Complete Response Letter for Mycapssaâ„¢ New Drug Application, 1/25/2019 MGNX-US  GNW  MacroGenics Announces Removal of Partial Clinical Hold on MGD009 Program by FDA,,,, 4/26/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 42nd Annual Health Care Conference, 5/09/2017 PRTA-US  GNW  Prothena Reports First Quarter 2017 Financial Results and Provides R&D Update, 9/20/2017 ZLAB-US  GNW  Zai Lab Ltd. (Nasdaq: ZLAB) to Ring The Nasdaq Stock Market Opening Bell in Celebration of their IPO,,10/16/2017 CTMX-US  GNW  CytomX Announces Upcoming Poster Presentations at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference,11/21/2017 GMAB-DK  GNW  Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma,,," 7/24/2017 CBAY-US  GNW  CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",,10/27/2016 CCXI-US  GNW  ChemoCentryx Reports Improvement in Renal Physiology and Stabilization of Kidney Function Following Treatment with Orally Administered Complement Inhibitor CCX168 (Avacopan) in Patient with Refractory C3 Glomerulopathy,,," 2/23/2018 MNKD-US   GNW  MannKind Corporation to Hold 2017 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2018",," 7/12/2018 CYTK-US  GNW  Cytokinetics to Announce Second Quarter Results on July 26, 2018"," 5/24/2018 0DBJVZ-E    GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder For Esperion Therapeutics, Inc. Investors","12/12/2018 AMRS-US   GNW  Amyris Receives GRAS Notification from FDA forÂ its New, Sugarcane-Derived, Zero Calorie Sweetener",,12/05/2016 ACHN-US  GNW  Data Presented at American Society of Hematology Meeting Demonstrate Potential Advantages of Factor D Inhibition for the Treatment of Complement Alternative Pathway-Mediated Diseases," 3/09/2019 87166B10 GNW  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Syneos Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 2/21/2018 FOLD-US  GNW  Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock,,, 9/01/2016 ADMA-US  GNW  ADMA Biologics to Present at Upcoming Investor Conferences,12/06/2017 GWPH-US  GNW  GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $276 Million,,,11/15/2017 MYOK-US  GNW  Preclinical Studies with MyoKardiaâ€™s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance,, 9/12/2018 GLPG-NL  GNW  MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner, 6/05/2018 PTLA-US  GNW  Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences,,,, 7/12/2017 CARA-US  GNW  Cara Therapeutics Announces Summary Data From Phase 1 Trial of Oral CR845 in Hemodialysis Patients with Chronic Kidney Disease, 8/07/2018 FLXN-US  GNW  Flexion Therapeutics Reports Second-Quarter 2018 Financial Results and Recent Business Highlights,12/18/2017 QURE-US  GNW  uniQure Announces Publication in the Journal Blood of Clinical Data  from Phase I/II Trial of AMT-060 In Patients with Severe Hemophilia B, 1/18/2018 AGIO-US   GNW  Agios Announces Pricing of $475 Million Public Offering of Common Stock,10/31/2017 IOVA-US  GNW  Iovance Biotherapeutics Reports Third Quarter 2017 Financial Results,,,"12/09/2017 FATE-US  GNW  Fate Therapeutics Announces Generation of CAR-targeted, TCR-nullÂ CD8Î±Î²+ T Cells from Clonal Engineered Master Pluripotent Cell LineÂ for Off-the-Shelf T-cell Immunotherapy", 2/27/2017 HZNP-US  GNW  Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Full-Year 2017 Net Sales and Adjusted EBITDA Guidance,,"10/18/2017 45845P10 GNW  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm", 8/09/2019 48576U10   GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI,,,11/13/2017 ITCI-US  GNW  Intra-Cellular Therapies Expands Its Executive Team with the Appointment of Dr. Andrew Satlin as Executive Vice President and Chief Medical Officer,,,," 5/04/2016 AMPH-US  GNW  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2016", 1/02/2018 ATRA-US    GNW  Atara Biotherapeutics Announces Initiation of Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD),, 3/21/2017 DERM-US  GNW  Dermira Presents New Data Highlighting Patient Outcomes in Axillary Hyperhidrosis at Maui Derm Meeting, 8/10/2016 FOMX-US  GNW  Foamix Reports Second Quarter 2016 Financial Results and Provides Business Update, 3/21/2016 077JW3-E GNW  PRA Health Sciences Named Top Workplace in Philadelphia,10/10/2016 SUPN-US  GNW  Supernus Schedules Conference Call to Present Results of  Phase IIb Clinical Trial of SPN-812 in Children with ADHD, 6/05/2017 FGEN-US  GNW  European Patent Office Maintains FibroGen Patent Relating to Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase Inhibitor Technology,, 5/14/2018 CHRS-US  GNW  U.S. Food and Drug Administration Accepts and Acknowledges Coherus BioSciences Biologics License Application of CHS-1701 (Pegfilgrastim Biosimilar Candidate) for Review, 9/20/2018 CRBP-US  GNW  Corbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery; Includes CRB-4001 with Planned NIH-Supported Phase 2 Study,,11/21/2016 COLL-US  GNW  Independent Review of XtampzaÂ® ER Published in Peer-Reviewed Medical Journal,12/07/2016 XBIT-US  GNW  XBiotech Completes Enrollment in Global Phase III Study using Xilonix Monotherapy to Treat Advanced Colorectal Cancer,,, 8/02/2018 GBT-US   GNW  GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results, 9/17/2015 RGNX-US  GNW  REGENXBIO Inc. (Nasdaq: RGNX) to Ring The Nasdaq Stock Market Opening Bell,12/10/2017 KURA-US  GNW  Kura Oncology Reports Positive Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia, 1/02/2018 APLS-US  GNW  Apellis Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference," 4/24/2018 AXSM-US  GNW  Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Depression, Alzheimerâ€™s Disease Agitation, and Nicotine Dependence", 8/02/2017 VYGR-US  GNW  Voyager Therapeutics to Host Second Quarter 2017 Financial Results and Corporate Highlights Conference Call,12/03/2018 BGNE-US  GNW  BeiGene Presents Clinical Results of Tislelizumab in Relapsed/Refractory Classical Hodgkinâ€™s Lymphoma at the 60th American Society of Hematology Annual Meeting,," 3/24/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing",,11/01/2016 NTLA-US  GNW  Intellia Therapeutics Reports Financial Results for Third Quarter 2016,11/23/2016 ACIU-US  GNW  AC IMMUNE APPOINTS EXPERIENCED LIFE SCIENCE PROFESSIONAL AS NEW CHIEF FINANCIAL OFFICER, 5/16/2017 CRSP-US  GNW  CRISPR Therapeutics and collaborators at the University of Florida awarded Target ALS Grant to develop CRISPR/Cas9-based approaches for ALS,12/06/2017 GTHX-US  GNW  G1 Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),,, 7/09/2018 ATNX-US  GNW  Athenex Names Timothy Cook as Senior Vice President of Global Commercial Oncology,,,,,,,,,, 2/09/2018 EYPT-US    GNW  pSivida to Present at the 2018 BIO CEO & Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 7/31/2018 PGNX-US  GNW  Following Azedraâ€™s Approval, Progenics Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update",,,,,,,, 6/22/2011 SIGA-US      GNW  Biotech Stock Review; PharmAthene Tops MicroStockProfit.com Watch List,"10/07/2018 68375N10 GNW  CLASS ACTION UPDATE for USAT, PVG, SKX OPK and MCHP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 8/29/2017 IONS-US  GNW  Akcea to Present at Wells Fargo Healthcare Conference, 6/17/2015 09061G10    GNW  BMN 111 (vosoritide) Improves Growth Velocity in Children With Achondroplasia in Phase 2 Study,,,, 1/25/2019 45290710 GNW  SHAREHOLDER ALERT: XRAY IMMU DBVT MAXR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 6/13/2018 BIIB-US   GNW  Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference,, 8/29/2018 BCRX-US  GNW  BioCryst Pharmaceuticals to Present at the Baird Global Healthcare Conference,,,,," 3/26/2018 0F98BD-E GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ AKRX",," 9/18/2019 62855J10 GNW  ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 5/24/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,, 5/03/2016 INSM-US  GNW  Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting,,10/24/2017 INO-US    GNW  Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection  in Pre-Clinical Study,10/12/2018 64026810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR,, 3/16/2018 GERN-US  GNW  Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events,, 3/07/2019 02311120 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Amarin Corporation plc - AMRN,,,11/06/2018 SRPT-US  GNW  SciCann Therapeutics Announces Positive ISA Report for â€œSteady Stomachâ€ CBD Combination Therapy Patent,,, 4/27/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 1/07/2019 SAN-FR   GNW  Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs,,,,,, 6/27/2017 AFMD-US  GNW  Affimed Presents Preclinical Data on AFM24 and AFM26 at EACR-AACR-SIC 2017,,11/14/2017 PRQR-US  GNW  ProQR Prices Approximately $20 Million Underwritten Public Offering and Concurrent Registered Direct Offering of Ordinary Shares,, 2/20/2019 ZGNX-US  GNW  Zogenix to Present at the 8th Annual SVB Leerink Global Healthcare Conference,,,,,, 2/07/2018 ADVM-US  GNW  Adverum Biotechnologies Announces Proposed Public Offering of Common Stock, 5/01/2018 RARE-US   GNW  Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results and Corporate Update,11/08/2016 AGLE-US  GNW  Aeglea BioTherapeutics to Present a Poster at the Society for Immunotherapy of Cancer 2016 Annual Meeting Suggesting Potential for AEB1102 Combination Therapy with Immuno-Oncology Checkpoint Inhibitors,12/07/2017 NSTG-US  GNW  NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology,,, 9/10/2017 RDUS-US  GNW  Radius Health Presents Positive Data for TYMLOSâ„¢ (abaloparatide) Injection from the ACTIVExtend Trial at ASBMR 2017 Annual Meeting, 2/19/2016 ASMB-US  GNW  Assembly Biosciences to Webcast Upcoming Investor Conferences,,, 7/17/2012 TKM-CA   GNW  Tekmira Provides Periodic Update to Shareholders Regarding Litigation,, 4/17/2018 00972L10 GNW  Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR,,10/31/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for Third Quarter 2017 Financial Results Webcast and Conference Call," 7/25/2017 RTRX-US  GNW  Retrophin Commences Patient Dosing in International, Registrational Phase 3 Trial of RE-024 in PKAN","10/13/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. Third Quarter 2016 Financial Results Call", 6/13/2017 28106W10 GNW  Editas Medicine to Participate in Investor Conferences in June, 3/31/2016 CHMA-US  GNW  Chiasma Announces Upcoming Events at ENDO 2016, 1/17/2019 MGNX-US  GNW  Updated Clinical Data from Combination of Margetuximab and Pembrolizumab in Gastric Cancer Presented at 2019 ASCO Gastrointestinal Cancers Symposium,,,, 4/18/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2017 Financial Results Conference Call and Webcast, 5/02/2017 PRTA-US  GNW  Prothena to Report First Quarter 2017 Financial Results on May 9, 9/20/2017 ZLAB-US  GNW  Zai Lab Limited Announces Pricing of U.S. Initial Public Offering of ADSs,, 9/13/2017 CTMX-US  GNW  CytomX to Present at the Cantor Fitzgerald Healthcare Conference,11/16/2017 GMAB-DK  GNW  Genmab Achieves USD 50 Million Sales Milestone in DARZALEXÂ® (daratumumab) Collaboration with Janssen,,, 7/19/2017 CBAY-US  GNW  CymaBay Announces Pricing of Public Offering of Common Stock,,"10/20/2016 CCXI-US  GNW  ChemoCentryx Appoints Henry A. McKinnell, Jr. to Board of Directors",,, 2/06/2018 MNKD-US   GNW  David Kendall Joins MannKind as Chief Medical Officer,, 6/16/2018 CYTK-US  GNW  Cytokinetics Announces Data  From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy Presented at the 2018 Annual Cure SMA Conference," 5/23/2018 29664W10    GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)",12/11/2018 AMRS-US   GNW  Amyris Closes on Debt Solution,,"11/30/2016 0CN75T-E GNW  Achillion Announces Initiation of Patient Dosing by Janssen in a Global, Short Treatment-Duration Phase 2b Study of JNJ-4178 in Chronic HCV"," 3/07/2019 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Syneos Health, Inc."," 2/21/2018 FOLD-US  GNW  Amicus Therapeutics to Announce Full-Year 2017 Financial Results on February 28, 2018",,, 8/12/2016 ADMA-US  GNW  ADMA Biologics Reports Second Quarter 2016 Results,12/05/2017 GWPH-US  GNW  GW Pharmaceuticals Announces Proposed Public Offering of ADSs,,,11/13/2017 MYOK-US  GNW  MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor,, 9/11/2018 GLPG-NL  GNW  GILEAD AND GALAPAGOS ANNOUNCE   FILGOTINIB MEETS PRIMARY AND  ALL KEY  SECONDARY ENDPOINTS IN FIRST PHASE 3  STUDY  IN  RHEUMATOID  ARTHRITIS, 6/04/2018 PTLA-US  GNW  Portola Pharmaceuticals Announces Retirement of CEO Bill Lis in 2018,,,, 6/29/2017 CARA-US  GNW  Cara Therapeutics Announces Top-line Results From Phase 2b Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis of the Hip or Knee, 8/03/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/11/2017 QURE-US  GNW  uniQure Added to NASDAQ Biotechnology Index, 1/17/2018 AGIO-US   GNW  Agios Announces Proposed Offering of Common Stock,"10/25/2017 IOVA-US  GNW  Iovance Biotherapeutics to Host Conference Call to Discuss Third Quarter 2017 Financial Results and Provide a Corporate Update on Tuesday, October 31, 2017",,,12/08/2017 FATE-US  GNW  Fate Therapeutics Announces First Subject Treated with FATE-NK100 in APOLLO Study for Recurrent Ovarian Cancer, 2/14/2017 HZNP-US  GNW  Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care Conference,,"10/14/2017 45845P10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ICPT"," 8/07/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,11/08/2017 ITCI-US  GNW  Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update,,,, 4/11/2016 05KDBG-E GNW  Amphastar Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference,12/29/2017 ATRA-US    GNW  Atara Biotherapeutics Announces FDA Clearance to Initiate Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD),, 3/17/2017 DERM-US  GNW  Dermira to Highlight Data for Three Clinical Programs atÂ Annual Maui Derm Meeting," 7/25/2016 FOMX-US  GNW  Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for Wednesday, August 10"," 3/17/2016 PRAH-US  GNW  PRA Holdings, Inc. Announces Completion of Cash Tender Offer for its 9.500% Senior Notes Due 2023", 8/19/2016 06CR5C-E GNW  Supernus Receives FDA Tentative Approval for Expanded Label of Trokendi XRÂ® to Include Migraine Prophylaxis in Adults, 5/09/2017 FGEN-US  GNW  FibroGen Reports First Quarter 2017 Financial Results,, 5/10/2018 CHRS-US  GNW  Coherus BioSciences Reports Corporate Highlights and First Quarter 2018 Financial Results, 9/18/2018 CRBP-US  GNW  Corbus Pharmaceuticals Receives Orphan Designation for Lenabasum for the Treatment of Dermatomyositis in the European Union,,11/11/2016 COLL-US  GNW  Collegium to Present at Upcoming Investor Conferences,12/06/2016 XBIT-US  GNW  XBiotech Completes Enrollment in Global Phase I/II Study for its True Humanâ„¢ Antibody Treatment for Serious Staphylococcus aureus Infections,,, 7/03/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 9/16/2015 75901B10 GNW  REGENXBIO Announces Pricing of Initial Public Offering,"11/09/2017 KURA-US  GNW  Kura Oncology to Host Investor Day on November 16, 2017",12/20/2017 APLS-US  GNW  Apellis Finalizes Phase 3 Clinical Trial Plans for Geographic Atrophy Treatment with APL-2," 4/19/2018 AXSM-US  GNW  Axsome Therapeutics Appoints Nick Pizzie, CPA, MBA, as Chief Financial Officer", 7/17/2017 VYGR-US  GNW  Voyager Therapeutics Announces Publication from the California Institute of Technology of a Second-Generation Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer to the Brain,12/01/2018 BGNE-US  GNW  BeiGene Announces Clinical Results of Zanubrutinib in Mantle Cell Lymphoma From Two Presentations at the 60th American Society of HematologyÂ Annual Meeting,," 3/03/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2016 Financial and Operating Results",,10/31/2016 NTLA-US  GNW  Intellia Therapeutics to Present at November Investor Healthcare Conferences,11/15/2016 ACIU-US  GNW  AC Immune SA announces results of annual general meeting, 5/12/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at Investor Conferences in May,11/28/2017 GTHX-US  GNW  G1 Therapeutics and AstraZeneca Enter Clinical Trial Collaboration in Non-Small Cell Lung Cancer,,, 7/02/2018 04685N10 GNW  Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors,,,,,,,,,, 2/07/2018 EYPT-US    GNW  pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 7/30/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces FDA Approval for AZEDRAÂ® (iobenguane I 131) to Treat Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma",,,,,,,, 5/15/2011 82691710     GNW  Protest Filed Against BARDA Over Smallpox Antiviral Biodefense Contract,"10/05/2018 68375N10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline â€“Â OPK", 4/30/2013 00CJVL-E GNW  Smart Card Alliance Concludes Successful Mobile and NFC Webinar Series with Examination of NFC Use Cases and Security, 6/08/2015 09061G10    GNW  BioMarin Submits Drisapersen MAA to EMA for the Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,," 1/25/2019 45290710 GNW  Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of YOGA, IMMU, AXGN and YRIV", 6/07/2018 0DR48Y-E  GNW  Biogen Enters Exclusive Option Agreement to Acquire TMSâ€™ Phase 2 Asset for Acute Stroke,," 8/15/2018 09058V10 GNW  New Research Coverage Highlights Cincinnati Bell, BioCryst Pharmaceuticals, Shutterstock, Kopin, Lands' End, and Pieris Pharmaceuticals â€” Consolidated Revenues, Company Growth, and Expectations for 2018",,,,," 3/23/2018 00972810 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Akorn, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018 â€“ AKRX",, 9/17/2019 62855J10 GNW  MYGN Loss Alert: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Ongoing Investigation for Possible Disclosure Violations, 5/22/2018 52887230 GNW  FDA to review Zynquistaâ„¢ (sotagliflozin) as potential treatment for type 1 diabetes,, 3/02/2016 INSM-US  GNW  Insmed to Present at the 36th Annual Cowen & Company Healthcare Conference,,10/16/2017 INO-US    GNW  Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in Advanced Bladder Cancer, 9/24/2018 64026810 GNW  BioXcel Therapeutics Expands Immuno-Oncology Partnership with Nektar into Clinical Development in Pancreatic Cancer,, 2/22/2018 GERN-US  GNW  Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results,, 3/07/2019 02311120 GNW  AMARIN CORPORATION PLC INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Amarin Corporation plc,,,11/02/2018 SRPT-US  GNW  Sarepta Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference,,," 4/26/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3, 2018 at 8:00 a.m. ET",,,,, 1/02/2019 ACER-US  GNW  Acer Therapeutics Announces In-license of Osanetant from Sanofi,,,,,, 6/06/2017 AFMD-US  GNW  Affimed Presents Data on First-in-Class BCMA-Targeting Immune Cell Engager AFM26 at ASCO Annual Meeting 2017,,11/13/2017 PRQR-US  GNW  ProQR Announces Proposed Public Offering of Ordinary Shares,, 2/06/2019 ZGNX-US  GNW  Zogenix Submits New Drug Application to U.S. Food & Drug Administration  and Marketing Authorization Application to European Medicines Agency  for FINTEPLAÂ® for the Treatment of Dravet Syndrome,,,,,, 1/25/2018 00773U10 GNW  Adverum Biotechnologies and Editas Medicine Extend Research Collaboration, 4/30/2018 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce CrysvitaÂ® (burosumab-twza) Now Launched in the U.S. for the Treatment of Xâ€“linked Hypophosphatemia (XLH) in Children and Adults,11/03/2016 06QBQ2-E GNW  Aeglea BioTherapeutics to Present New Data on AEB3103 at American Society of Hematology (ASH) 58th Annual Meeting,11/09/2017 NSTG-US  GNW  NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC),,, 9/07/2017 RDUS-US  GNW  Radius Health to Present at Morgan Stanley 15th Annual Global Healthcare Conference, 1/27/2016 ASMB-US  GNW  Assembly Biosciences Presents Clinical Data at Drug Formulation & Bioavailability Summit Showing Its Oral Gemicel(TM) Technology Achieves Targeted Delivery to the Lower GI Tract,,, 7/16/2012 TKM-CA   GNW  Tekmira's LNP Technology Enables Alnylam's Positive ALN-TTR02 Clinical Data,, 3/26/2018 IONS-US  GNW  Akcea Convenes First FCS Global Connection Summit,,10/25/2017 PCRX-US  GNW  Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement, 6/01/2017 RTRX-US  GNW  Retrophin Announces Expansion of Intellectual Property Estate for Sparsentan with Newly Issued Patents in the United States and Europe,10/13/2016 PACB-US  GNW  G10K and B10K Initiatives Select PacBio SMRT Sequencing for Next Phase of Genome Projects, 5/31/2017 EDIT-US  GNW  Editas Medicine Names Andrew Hirsch to Board of Directors, 3/14/2016 CHMA-US  GNW  Chiasma Reports Fourth Quarter and Year End 2015 Results, 1/07/2019 MGNX-US  GNW  MacroGenics to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,, 2/28/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference, 4/26/2017 PRTA-US  GNW  Prothena to Participate in the Deutsche Bank 42nd Annual Health Care Conference, 9/19/2017 0DW6T1-E GNW  Zai Lab Limited Announces Upsizing of U.S. Initial Public Offering of ADSs,, 9/08/2017 CTMX-US  GNW  CytomX Announces Upcoming Trials in Progress Poster Presentations at European Society for Medical Oncology Annual Meeting,11/14/2017 GMAB-DK  GNW  Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEXÂ® (daratumumab) in Japan and Updates Financial Guidance,,, 7/17/2017 CBAY-US  GNW  CymaBay Announces Proposed Public Offering of Common Stock,,10/18/2016 CCXI-US  GNW  ChemoCentryxâ€™s CCR2 Inhibitor CCX872 Shown to Reduce Liver Fibrosis in NASH Models,,, 1/16/2018 MNKD-US   GNW  MannKind Corporation to Present at NobleCon14 - Noble Capital Marketsâ€™ Fourteenth Annual Investor Conference,, 6/13/2018 CYTK-US  GNW  Cytokinetics to Present at the JMP Securities Life Sciences Conference," 5/23/2018 29664W10    GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ESPR",12/10/2018 03236M20  GNW  Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand,,"11/14/2016 ACHN-US  GNW  Achillion Pharmaceuticals, Inc.Â (Nasdaq: ACHN) to Ring The Nasdaq Stock Market Closing Bell"," 3/07/2019 87166B10 GNW  Block & Leviton LLP Reminds Shareholders of Important Deadlines: MAXR, MU, SYNH, CTL", 2/15/2018 FOLD-US  GNW  Amicus Therapeutics Prices Underwritten Offering of Common Stock,,, 7/29/2016 ADMA-US  GNW  ADMA Biologics Receives Complete Response Letter from FDA for Pending Biologics License Application,12/04/2017 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress,,,11/02/2017 MYOK-US  GNW  MyoKardia Reports Third Quarter 2017 Financial Results and Operational Progress,, 9/06/2018 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  ANNOUNCE  TORTUGA  PHASE  2  STUDY  OF FILGOTINIB  IN  ANKYLOSING  SPONDYLITIS  ACHIEVES  PRIMARY  ENDPOINT, 6/04/2018 PTLA-US  GNW  New Interim Phase 2a Study Results Demonstrate Broad Clinical Activity of Portola Pharmaceuticalsâ€™ Oral SYK/JAK Inhibitor Cerdulatinib,,,, 6/23/2017 CARA-US  GNW  Cara Receives Breakthrough Therapy Designation from FDA for I.V. CR845 for the Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients," 7/30/2018 FLXN-US  GNW  Flexion Therapeutics to Report Second-Quarter 2018 Financial Results on August 7, 2018","12/11/2017 QURE-US  GNW  uniQure Announces Updated, Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 In Patients with Severe Hemophilia B", 1/08/2018 AGIO-US   GNW  Agios Outlines Key 2018 Priorities Expanding Clinical and Research Programs to Drive Long Term Value,10/11/2017 IOVA-US  GNW  Iovance Biotherapeutics Announces Six Abstracts to be Presented at the Upcoming 2017 SITC Annual Meeting,,,12/06/2017 FATE-US  GNW  Fate Therapeutics and University of California San Diego Launch Research Collaboration to Develop iPSC-Derived CAR NK Cell Cancer Immunotherapies," 1/27/2017 HZNP-US  GNW  Horizon Pharma plc to Host Fourth-Quarter 2016 Conference Call and Webcast on February 27, 2017",,10/11/2017 ICPT-US  GNW  Intercept Announces Data to be Presented at The Liver MeetingÂ® 2017, 8/06/2019 KPTI-US    GNW  Karyopharm Reports Second Quarter 2019 Financial Results and  Highlights Recent Company Progress,,,11/03/2017 ITCI-US  GNW  Intra-Cellular Therapies to Host Third Quarter 2017 Financial Results Conference Call and Webcast,,,," 3/14/2016 AMPH-US  GNW  Amphastar Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2015","12/28/2017 ATRA-US    GNW  Atara Biotherapeutics to Host Corporate Update Conference Call on Friday, December 29, 2017, at 8:00 a.m. EST",, 3/07/2017 DERM-US  GNW  Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 6/01/2016 FOMX-US  GNW  Foamix to Present at the BIO International Convention," 3/03/2016 PRAH-US  GNW  PRA Holdings, Inc. Announces Preliminary Results of Cash Tender Offer and Increase in Maximum Tender Amount of Its 9.500% Senior Notes Due 2023"," 8/12/2016 SUPN-US  GNW  Supernus Announces Resignation of Dr. James Barrett from Board of Directors; Charles W. Newhall, III Elected Chairman"," 5/03/2017 FGEN-US  GNW  FibroGen to Report First Quarter Financial Results on May 9, 2017",," 5/10/2018 CHRS-US  GNW  Coherus BioSciences Appoints Samuel Nussbaum, M.D. to Board of Directors", 9/14/2018 CRBP-US  GNW  Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting,,11/10/2016 COLL-US  GNW  Collegium Reports Third Quarter Financial Results and Provides Corporate Update,11/17/2016 XBIT-US  GNW  XBiotech Announces Research Collaboration with Renowned Gastroenterologist,,, 6/27/2018 GBT-US   GNW  GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease, 6/11/2015 00BXRX-E GNW  REGENXBIO Enters Into Strategic Manufacturing Collaboration With Wuxi Apptec,11/07/2017 KURA-US  GNW  Kura Oncology Reports Third Quarter 2017 Financial Results and Provides Corporate Update,"12/19/2017 06J3QL-E GNW  Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer", 4/11/2018 AXSM-US  GNW  Axsome Therapeutics to Participate in the Leerink Partnersâ€™ 2018 CNS Day, 6/26/2017 VYGR-US  GNW  Voyager Therapeutics Announces Clinical Trial Update with VY-AADC01 for Advanced Parkinsonâ€™s Disease,11/20/2018 BGNE-US  GNW  BeiGene to Present at the 30th Annual Piper Jaffray Healthcare Conference,," 3/02/2017 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces the Retirement of Board Member Dennis Stone, M.D., and the Addition of New Board Member William D. McClellan, Jr.",,10/14/2016 NTLA-US  GNW  Intellia Therapeutics to Present Data at the  European Society of Gene & Cell Therapy Congress,11/11/2016 ACIU-US  GNW  AC Immune Reports Third Quarter 2016 Results," 5/11/2017 CRSP-US  GNW  CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business Update",11/08/2017 GTHX-US  GNW  G1 Therapeutics Reports Third Quarter 2017 Financial Results  and Recent Operational Highlights,,, 6/15/2018 ATNX-US  GNW  Athenex Announces Appointment to Board of Directors,,,,,,,,,, 2/07/2018 EYPT-US    GNW  pSivida's Second Phase 3 Study for Durasertâ„¢ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/26/2018 PGNX-US  GNW  Progenics Pharmaceuticals Completes Enrollment of Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyLâ„¢ in Prostate Cancer,,,,,,,, 5/13/2011 82691710     GNW  SIGA Technologies Awarded U.S. Government Contract Valued at Up to $2.8 Billion,"10/04/2018 68375N10 GNW  OPKO HEALTH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against OPKO Health, Inc.", 1/25/2013 46222210 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of ISIS Pharmaceuticals of Upcoming Deadline - ISIS," 6/04/2015 BMRN-US     GNW  Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs 36th Annual Global Healthcare Conference",,,," 1/24/2019 45290710 GNW  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Immunomedics, Inc.Â (IMMU)"," 5/31/2018 BIIB-US   GNW  Biogen Appoints Daniel Karp as EVP, Corporate Development",, 8/07/2018 BCRX-US  GNW  BioCryst Reports Second Quarter 2018 Financial Results,,,,," 3/13/2018 00972810 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akorn, Inc. (Nasdaq: AKRX) To Contact Brower Piven Before The Lead Plaintiff Deadline",, 9/16/2019 MYGN-US  GNW  Myriad Announces Research Collaboration with University of Leeds, 5/04/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Publication of New XERMELOÂ® (Telotristat Ethyl) Data in Clinical Therapeutics,, 2/25/2016 INSM-US  GNW  Insmed Reports Fourth Quarter 2015 Financial Results,,10/05/2017 45773H20  GNW  Inovioâ€™s Positive Zika Vaccine Clinical Study Data  Published in New England Journal of Medicine," 8/31/2018 64026810 GNW  Market Trends Toward New Normal in Caesars Entertainment, Nektar Therapeutics, Boston Scientific, Apollo Commercial Real Estate Finance, Kellogg, and Foot Locker â€” Emerging Consolidated Expectations, Analyst Ratings",,12/12/2017 GERN-US  GNW  Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting,," 3/06/2019 02311120 GNW  Investor Expectations to Drive Momentum within Amarin, PulteGroup, LivaNova, Teva Pharmaceutical Industries, Viad, and Activision Blizzard â€” Discovering Underlying Factors of Influence",,,10/31/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,," 4/24/2018 00163U10 GNW  Investor Expectations to Drive Momentum within AMN Healthcare Services, Cass Information, William Lyon Homes, AMAG Pharmaceuticals, Intersect ENT, and First Financial â€” Discovering Underlying Factors of Influence",,,,, 1/02/2019 SAN-FR   GNW  MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi,,,,,, 5/30/2017 AFMD-US  GNW  Affimed to Present at the Jefferies 2017 Global Healthcare Conference - New York,,"11/13/2017 PRQR-US  GNW  ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQRâ€™s Lead Program for Genetic Blindness",, 2/01/2019 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,, 1/04/2018 ADVM-US  GNW  Adverum Biotechnologies Provides 2018 Outlook," 4/23/2018 RARE-US   GNW  Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia", 9/15/2016 AGLE-US  GNW  Aeglea BioTherapeutics Doses First Patients in Phase 1 Trial of AEB1102 for the Treatment of Arginase I Deficiency,11/02/2017 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Third Quarter of 2017,,, 9/01/2017 RDUS-US  GNW  Radius Health to Present Eight Abstracts at the American Society of Bone and Mineral Research (ASBMR) 2017 Annual Meeting Including Results of the ACTIVE and ACTIVExtend Trials for TYMLOSâ„¢ (abaloparatide) Injection, 1/11/2016 ASMB-US  GNW  Assembly Biosciences Expands Senior Leadership Team,,, 6/04/2012 ALNY-US  GNW  Tekmira's LNP Technology Enables ALN-VSP Clinical Data,, 3/12/2018 00972L10 GNW  Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo,,10/18/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces FDA Acceptance of sNDA for EXPAREL as a Nerve Block to Produce Regional Analgesia, 5/25/2017 RTRX-US  GNW  Retrophin Announces Presentations for Late-Stage Clinical Development Programs at Upcoming Medical Congresses, 8/04/2016 PACB-US  GNW  Pacific Biosciences Releases New Software and Chemistry for Sequel System, 5/15/2017 EDIT-US  GNW  Editas Medicine Announces First Quarter 2017 Results and Update, 3/14/2016 CHMA-US  GNW  Chiasma Initiates Phase 3 Trial to Support European Registration of Octreotide Capsules for Patients with Acromegaly,12/07/2018 MGNX-US  GNW  MacroGenics Announces Partial Clinical Hold on MGD009 Phase 1 Studies,,,, 2/21/2017 MNTA-US  GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results, 4/02/2017 PRTA-US  GNW  Clinical Results Presented from Prothenaâ€™s Phase 1b Study of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinsonâ€™s Disease," 9/29/2016 TSRO-US  GNW  TESARO and Zai Lab Announce Collaboration, Development and License Agreement",, 8/10/2017 CTMX-US  GNW  CytomX to Present at the 2017 Wedbush PacGrow Healthcare Conference,11/09/2017 GMAB-DK  GNW  Major Shareholder Announcement,,, 7/17/2017 CBAY-US  GNW  CymaBay Announces Positive Interim Results from Its Ongoing Low-Dose Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis,,10/17/2016 CCXI-US  GNW  ChemoCentryx Announces Presentation of Positive Data from Ongoing Pilot Phase II Trial of CCX168 (Avacopan) in Atypical Hemolytic Uremic Syndrome (aHUS) at ASN Kidney Week 2016,,,11/07/2017 MNKD-US   GNW  MannKind Corporation Reports 2017 Third Quarter Financial Results,," 6/08/2018 CYTK-US  GNW  Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy to be Presented at the 2018 Annual Cure SMA Conference on June 16, 2018", 5/23/2018 ESPR-US     GNW  Esperion Announces Third Pivotal Phase 3 Study of Bempedoic Acid Meets Primary Endpoint,12/07/2018 AMRS-US   GNW  Amyris Takes Major Step Forward in Addressing its Convertible Debt,,11/03/2016 06QBQ2-E GNW  Achillion Announces Upcoming Presentations of Novel Research Into Complement Biology at the 58th Annual Meeting of the American Society of Hematology," 3/06/2019 87166B10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Syneos Health, Inc. to Contact the Firm", 2/14/2018 FOLD-US  GNW  Amicus Therapeutics Announces Public Offering of Common Stock,,, 6/16/2016 002N2S-E GNW  ADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference,"11/27/2017 GWPH-US  GNW  GW Pharmaceuticals to Report Q4 and Year-End Financial ResultsÂ and Host Conference Call on 4 December, 2017",,,11/01/2017 MYOK-US  GNW  MyoKardia Announces Presentations at  2017 American Heart Association Scientific Sessions,, 8/02/2018 GLPG-NL  GNW  Productive first half-year at Galapagos, 5/24/2018 0HH2Z7-E GNW  Portola Pharmaceuticals Receives $100 Million Milestone Payment from HealthCare Royalty Partners for FDA Approval of AndexxaÂ®,,,, 6/21/2017 CARA-US  GNW  Cara Therapeutics Reports Continuation of Phase 3 Trial of I.V. CR845 in Postoperative Pain Following Interim Assessment, 7/03/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/09/2017 QURE-US  GNW  uniQure Announces Presentation of Non-Clinical Data of AMT-061 at the 59th American Society of Hematology (ASH) Annual Meeting," 1/02/2018 AGIO-US   GNW  Agios to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018"," 9/25/2017 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Closing of $57.5 Million Common Stock Public Offering",,,11/21/2017 FATE-US  GNW  Fate Therapeutics to Present at the 2017 Piper Jaffray Healthcare Conference,12/22/2016 HZNP-IE  GNW  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTIÂ® (glycerol phenylbutyrate) Oral Liquid,,"10/05/2017 45845P10 GNW  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses Exceeding $100,000 to Contact the Firm"," 8/05/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,,10/05/2017 ITCI-US  GNW  Intra-Cellular Therapies Announces Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares of Common Stock,,,," 3/11/2016 AMPH-US  GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 14, 2016",12/11/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Updated Positive Interim Results from Multicenter Expanded Access Study of tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disorder (PTLD),, 3/04/2017 24983L10 GNW  New CIMZIAÂ® (certolizumab pegol) data in moderate-to-severe plaque psoriasis and psoriatic arthritis presented at American Academy of Dermatology 2017 Annual Meeting, 5/31/2016 FOMX-IL  GNW  Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Treatment of EGFRI Induced Rash for the 2016 ASCO Meeting," 3/02/2016 PRAH-US  GNW  PRA Health Sciences, Inc. Announces Secondary Offering of Five Million Shares of Common Stock", 8/02/2016 SUPN-US  GNW  Supernus Announces Second Quarter 2016 Financial Results," 4/06/2017 FGEN-US  GNW  FibroGen, Inc. Announces Pricing of Follow-On Offering of Common Stock",, 5/03/2018 CHRS-US  GNW  Coherus BioSciences Re-Submits Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate)," 8/29/2018 21833P10 GNW  Detailed Research: Economic Perspectives on Castlight Health, Inc, Noodles, Citi Trends, Corbus Pharmaceuticals, CEVA, and Acxiom â€” What Drives Growth in Today's Competitive Landscape",,11/02/2016 COLL-US  GNW  Collegium to Host Conference Call to Discuss Third Quarter 2016 Financial Results and Provide Corporate Update,11/10/2016 XBIT-US  GNW  XBiotech to Provide Third Quarter 2016 Business Update on November 15,,, 6/15/2018 GBT-US   GNW  GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress, 5/27/2015 00BXRX-E GNW  Dr. Jerry Karabelas Appointed to REGENXBIO Board of Directors,11/01/2017 KURA-US  GNW  Kura Oncology Announces Upcoming Presentations at American Society of Hematology Annual Meeting,"12/13/2017 APLS-US  GNW  Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) to Ring The Nasdaq Stock Market Closing Bell"," 3/27/2018 AXSM-US  GNW  Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Depression, Alzheimerâ€™s Disease Agitation, and Nicotine Dependence", 6/02/2017 VYGR-US  GNW  Voyager Therapeutics to Attend Upcoming Investor Conferences,11/16/2018 BGNE-US  GNW  BeiGene Announces Preliminary Clinical Data on PARP Inhibitor Pamiparib Presented at Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology,, 2/23/2017 RETA-US  GNW  Reata Announces Initiation of Phase 2/3 Study of Bardoxolone Methyl in the Treatment of Chronic Kidney Disease Due to Alport Syndrome,,10/05/2016 NTLA-US  GNW  Intellia Therapeutics to Present at Jefferies Gene Editing/Therapy Summit, 9/23/2016 ACIU-US  GNW  Switzerland's AC Immune Opens For Trading On NASDAQ, 5/08/2017 CRSP-US  GNW  CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT,11/08/2017 GTHX-US  GNW  G1 Therapeutics Makes Key Executive Appointments,,," 6/04/2018 ATNX-US  GNW  Athenex Names Christina Wang as Vice President of Clinical Operations and Corporate Development, Asia Pacific",,,,,,,,,, 1/24/2018 EYPT-US    GNW  pSivida Corp. Announces Second Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/25/2018 PGNX-US  GNW  Progenics Pharmaceuticals Presents Data Validating its Artificial Intelligence Imaging Analysis Technology for Use with PSMA-Targeted SPECT/CT,,,,,,,, 5/05/2011 82691710     GNW  SIGA Technologies Reports Financial Results for the First Quarter 2011,"10/03/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tribune Media, USA Technologies, and OPKO Health and Encourages Investors to Contact the Firm", 1/11/2013 46222210 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of ISIS Pharmaceuticals of Upcoming Deadline -- ISIS," 5/01/2015 BMRN-US     GNW  BioMarin Management to Present at the Deutsche Bank 40th Annual Health Care Conference on May 6th; Bank of America Merrill Lynch 2015 Health Care Conference on May 13th; and, the UBS Global Healthcare Conference on May 19th",,,," 1/24/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NVIDIA, DXC Technology, Immunomedics, and Natural Health and Encourages Investors to Contact the Firm"," 5/08/2018 AGTC-US   GNW  AGTC Announces Financial Results and Business Update for the Quarter EndedÂ March 31, 2018",, 8/06/2018 BCRX-US  GNW  BioCryst Pharmaceuticals Announces Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock,,,,," 3/09/2018 00972810 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Akorn, Inc. (AKRX)",," 9/12/2019 62855J10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ on Behalf of Investors of Myriad Genetics, Inc. - MYGN", 5/03/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update,, 1/05/2016 INSM-US  GNW  Insmed to Present at the 34th Annual J.P. Morgan Healthcare Conference,, 9/21/2017 INO-US    GNW  Inovio dMAbâ„¢ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial InfectionÂ In Preclinical Studies," 7/26/2018 64026810 GNW  Investor Expectations to Drive Momentum within Fidelity Southern, Nektar Therapeutics, CSG Systems International, Ellington Financial, NBT, and Paylocity Holding â€” Discovering Underlying Factors of Influence",,"12/06/2017 GERN-US  GNW  Geron to Host Analyst and Investor Meeting and Webcast on December 19, 2017",, 3/05/2019 AMRN-US  GNW  Amarin to Present at Cowenâ€™s 39th Annual Health Care Conference,,,"10/30/2018 80360710 GNW  Report: Exploring Fundamental Drivers Behind Sarepta Therapeutics, Reinsurance Group of America, Illinois Tool Works, ATN International, Morningstar, and Hubbell â€” New Horizons, Emerging Trends, and Upcoming Developments",,, 3/26/2018 AMAG-US  GNW  AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women,,,,,12/26/2018 OPNT-US  GNW  Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi,,,,,, 5/22/2017 AFMD-US  GNW  Affimed Announces Annual General Meeting of Shareholders,,"11/09/2017 PRQR-US  GNW  ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board Â ",, 1/02/2019 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,,12/28/2017 ADVM-US  GNW  Adverum Biotechnologies Doses First Patient in the  ADVANCE Phase 1/2 Clinical Trial of ADVM-043 for A1AT Deficiency, 4/17/2018 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce FDA Approval of CrysvitaÂ® (burosumab-twza) for the Treatment of Children and Adults with Xâ€“Linked Hypophosphatemia (XLH), 9/07/2016 AGLE-US  GNW  Aeglea BioTherapeutics Appoints Leading Experts to Inaugural Scientific Advisory Board,10/26/2017 NSTG-US  GNW  NanoString and the NSABP Foundation Enter into Agreement to Study Immunophenotypes in Colorectal Cancer,,, 8/10/2017 RDUS-US  GNW  New National Survey Reveals 82 Percent of Postmenopausal Women Miss Critical Connection Between Osteoporosis and Bone Fractures,12/21/2015 ASMB-US  GNW  Assembly Biosciences Appoints Biotech Veteran Alan J. Lewis to Board of Directors,,, 5/24/2012 TKM-CA   GNW  Tekmira Provides Periodic Update to Shareholders Regarding Litigation,, 3/06/2018 AKCA-US  GNW  Akcea Therapeutics to Present at Upcoming Investor Conferences,, 9/27/2017 PCRX-US  GNW  Pacira Pharmaceuticals CEO to Testify at White House Opioid Crisis Commission Meeting, 5/23/2017 RTRX-US  GNW  Retrophin to Present at the Jefferies 2017 Global Healthcare Conference," 8/04/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2016 Financial Results", 5/13/2017 EDIT-US  GNW  Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas, 2/29/2016 CHMA-US  GNW  Chiasma Joins Patient Organizations Worldwide in Support of Rare Disease Day,"12/03/2018 MGNX-US  GNW  Phase 1 Expansion Cohort Oral Presentations for Flotetuzumab, MacroGenicsâ€™ CD123 x CD3 DARTÂ® Molecule, in Relapsed/Refractory Acute Myeloid Leukemia Presented at 60th ASH Annual Meeting",,,, 2/17/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces Time Change for Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast, 3/09/2017 PRTA-US  GNW  Results for Prothenaâ€™s Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinsonâ€™s Disease to be Presented at the 13thâ€‹ International Conference on Alzheimer's and Parkinson's Diseases,,, 8/07/2017 CTMX-US  GNW  CytomX Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference Call,11/08/2017 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2017,,," 6/26/2017 CBAY-US  GNW  CymaBay Announces the Appointment of Klara Dickinson as Senior Vice President, Regulatory Affairs and Quality Assurance and the Promotion of Daniel Menold to Vice President, Finance",, 9/01/2016 CCXI-US  GNW  ChemoCentryx Reports Initial Results from Ongoing Phase Ib Clinical Trial of CCX872 in Patients with Advanced Pancreatic Cancer,,,"10/27/2017 MNKD-US   GNW  MannKind Corporation to Hold 2017 Third Quarter Financial Results Conference Call on November 7, 2017",, 5/17/2018 CYTK-US  GNW  Cytokinetics and Cure SMA Renew and Expand Partnership to Advance Education and Awareness of SMA, 5/22/2018 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference,"12/04/2018 AMRS-US   GNW  Amyris Celebrates Launch of New Zero Calorie, Naturally-Derived Sweetener",,11/03/2016 ACHN-US  GNW  Achillion Reports Third Quarter 2016 Financial Results And Provides Update On Clinical Programs," 3/05/2019 87166B10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SOGO, STMP, DPLO and SYNH", 2/13/2018 FOLD-US  GNW  Amicus Therapeutics to Present at LEERINK Partners 7th Annual Global Healthcare Conference,,, 5/13/2016 ADMA-US  GNW  ADMA Biologics Reports First Quarter 2016 Results,11/22/2017 GWPH-US  GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences,,,10/31/2017 MYOK-US  GNW  MyoKardia to Present at Two Upcoming Investor Conferences in November,, 7/19/2018 GLPG-NL  GNW  MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner, 5/09/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update,,,, 5/17/2017 CARA-US  GNW  Cara Therapeutics to Present at the 17th Annual Conference on Pain Therapeutics, 6/24/2018 BOLD-US  GNW  NodThera secures Â£28 million ($40 million) Series A Financing,11/01/2017 QURE-US  GNW  uniQure Announces Presentations at the 59th American Society of Hematology (ASH) Annual Meeting,12/26/2017 AGIO-US   GNW  Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation," 9/20/2017 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $50 Million of Common Stock",,,11/10/2017 FATE-US  GNW  Fate Therapeutics Announces Initial Clinical Data from Ongoing First-in-Human VOYAGE Study of FATE-NK100 for Relapsed / Refractory Acute Myelogenous Leukemia at SITC 2017 Annual Meeting,12/22/2016 HZNP-IE  GNW  Horizon Pharma plc to Present at the 35th Annual J.P. Morgan Healthcare Conference,,"10/05/2017 45845P10 GNW  IMPORTANT INTERCEPT PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Intercept Pharmaceuticals, Inc."," 8/05/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against EQT Corporation, Eagle Bancorp, Karyopharm, and L Brands, Encourages Investors to Contact the Firm",,,10/03/2017 ITCI-US  GNW  Intra-Cellular Therapies Announces Commencement of Enrollment of a Clinical Trial Evaluating ITI-214 in Patients with Parkinsonâ€™s Disease,,,,11/24/2015 AMPR-US  GNW  Amphastar Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthcare Conference,11/09/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Third Quarter 2017 Financial Results and Recent Highlights,, 3/03/2017 DERM-US  GNW  Dermira Presents New Data in Primary Axillary Hyperhidrosis and Acne at American Academy of Dermatology 2017 Annual Meeting, 5/26/2016 FOMX-IL  GNW  Foamix to Present Corporate Overview at the Jefferies 2016 Healthcare Conference," 2/24/2016 PRAH-US  GNW  PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance", 7/20/2016 SUPN-US  GNW  Supernus to Host Second Quarter 2016 Earnings Conference Call, 3/31/2017 31572Q80 GNW  FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase 2/3 Clinical Trial of Roxadustat in Anemia Associated With Lower Risk MDS,," 5/01/2018 CHRS-US  GNW  Coherus BioSciences Management to Present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada", 8/23/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Present at the Annual B. Riley FBR Healthcare Conference,,10/26/2016 COLL-US  GNW  Collegium Prices Public Offering of $80 million of Common Stock,10/12/2016 080RQG-E GNW  XBiotech Announces Successful Completion of EMA GMP Inspection,,, 6/08/2018 GBT-US   GNW  GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Researchâ€™s 12th Annual Symposium, 5/20/2015 00BXRX-E GNW  REGENXBIO Secures $70.5 Million in a Mezzanine Financing,10/31/2017 KURA-US  GNW  Kura Oncology to Report Third Quarter 2017 Financial Results,12/08/2017 APLS-US  GNW  Apellis Pharmaceuticals Presents Update on Phase 1b PHAROAH Trial of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) at Annual Scientific Assembly of the International PNH Interest Group (IPIG), 3/26/2018 AXSM-US  GNW  Axsome Therapeutics to Present at H.C. Wainwright Annual Global Life Sciences Conference, 6/01/2017 VYGR-US  GNW  Voyager Therapeutics Selects Lead Clinical Candidate for Huntingtonâ€™s Disease,11/15/2018 BGNE-US  GNW  Priority Review Granted to BeiGeneâ€™s New Drug Applications for Zanubrutinib and Tislelizumab in China,, 2/06/2017 RETA-US  GNW  Reata Scheduled to Attend Upcoming Investor Conferences,, 9/01/2016 MS-US    GNW  Intellia Therapeutics to Present at September Investor Healthcare Conferences, 9/22/2016 ACIU-US  GNW  AC Immune SA Announces Pricing of Upsized Initial Public Offering," 5/04/2017 CRSP-US  GNW  CRISPR Therapeutics Appoints Samarth Kulkarni, Ph.D. as President, Expanding Role Beyond Chief Business Officer To Oversee U.S. Operations",11/07/2017 GTHX-US  GNW  G1 Therapeutics to Present at Stifel 2017 Healthcare Conference,,, 6/04/2018 ATNX-US  GNW  Athenex Announces Poster Presentations at ASCO Annual Meeting,,,,,,,,,, 1/08/2018 EYPT-US    GNW  pSivida Submits New Drug Application (NDA) for Durasertâ„¢ Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 6/21/2018 74318710 GNW  New Research: Key Drivers of Growth for Five Below, Progenics Pharmaceuticals, Advanced Micro Devices, Agilysys, Altair Engineering, and Semtech â€” Factors of Influence, Major Initiatives and Sustained Production",,,,,,,," 4/29/2011 82691710     GNW  SIGA to Discuss First Quarter 2011 Results of Operations on May 5, 2011","10/01/2018 68375N10 GNW  November 13th OPKO Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against OPKO Health, Inc. - OPK"," 1/10/2013 46222210 GNW  Levi & Korsinsky Notifies Investors With Losses on Their Investment in Isis Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of February 26, 2013 to Seek a Lead Plaintiff Position -- ISIS", 4/30/2015 09061G10    GNW  BioMarin Announces First Quarter 2015 Financial Results and Company Update,,,," 1/24/2019 45290710 GNW  CLASS ACTION UPDATE for CURO, XPO and IMMU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 4/16/2018 09062X10  GNW  Factors of Influence in 2018, Key Indicators and Opportunity within McDonald's, Biogen, Freeport-McMoRan, Community Health, Enphase Energy, and Exxon Mobil â€” New Research Emphasizes Economic Growth",, 8/06/2018 BCRX-US  GNW  U.S. FDA Grants Fast Track Designation for BioCrystâ€™s BCX7353,,,,," 3/09/2018 07YYYW-E GNW  AKORN, INC. INVESTOR ALERT: Â Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of shareholders of Akorn, Inc. Â Â ",, 9/05/2019 MYGN-US  GNW  ProlarisÂ® Test Identifies Men with Prostate Cancer Who Can Safely Defer Treatment, 5/01/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,,11/24/2015 INSM-US  GNW  Insmed to Present at the Piper Jaffray 27th Annual Healthcare Conference,, 9/18/2017 45773H20  GNW  Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection," 6/04/2018 NKTR-US  GNW  BioXcel Therapeutics and Nektar Therapeutics Present Preclinical Pancreatic Cancer Data for BXCL701, NKTR-214 and Anti-PD1 Combination Therapy at ASCO 2018 Annual Meeting",,"11/28/2017 37416310 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Visa, The Kraft Heinz, AbbVie, Fossil Group, Geron, and Universal Insurance Holdings â€” New Research Emphasizes Economic Growth",, 3/04/2019 AMRN-US  GNW  Important New Data on VascepaÂ® (Icosapent Ethyl) from the REDUCE-ITâ„¢ Trial to Be Presented Regarding Reduction in Total Ischemic Events,,,10/24/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Third Quarter 2018 Financial Results and Recent Corporate Developments,,, 3/05/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,12/19/2018 SAN-FR   GNW  DengvaxiaÂ® vaccine approved for prevention of dengue in Europe,,,,,, 5/17/2017 AFMD-US  GNW  Affimed to Present Immune Cell Engager Data at ASCO Annual Meeting and EACR-AACR-SIC Special Conference,,10/31/2017 PRQR-US  GNW  ProQR to Present at EuroTIDES Conference,,12/03/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,,12/05/2017 ADVM-US  GNW  Adverum Biotechnologies Begins Patient Enrollment in theÂ ADVANCE Phase 1/2 Clinical Trial for A1AT Deficiency, 3/08/2018 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences, 9/01/2016 AGLE-US  GNW  Aeglea BioTherapeutics to Present at the 2016 Wells Fargo Healthcare Conference,10/11/2017 NSTG-US  GNW  NanoString Announces Preliminary Revenue for Third Quarter ofÂ Fiscal Year 2017,,, 8/08/2017 RDUS-US  GNW  Radius Health Announces Pricing of $300 Million of 3.00% Convertible Senior Notes due 2024,12/16/2015 ASMB-US  GNW  Assembly Biosciences to Present at Jefferies Microbiome Summit,,, 5/10/2012 TKM-CA   GNW  Tekmira's LNP Technology Enables Alnylam's ALN-TTR01 Clinical Data,, 2/28/2018 00972L10 GNW  Akcea Therapeutics Recognizes Rare Disease Day by Spotlighting Several Historic â€œFirstsâ€ for People Living with Familial Chylomicronemia Syndrome,, 9/26/2017 PCRX-US  GNW  New Research: Overprescribing of Postsurgical Opioids Poses a Serious Threat to Patients and their Communities; Women Undergoing Surgery are at Greatest Risk, 5/04/2017 RTRX-US  GNW  Retrophin Reports First Quarter 2017 Financial Results, 8/01/2016 PACB-US  GNW  HistoGenetics Wins Multi-Year Contract for HLA Typing Using PacBio Sequencing, 5/11/2017 EDIT-US  GNW  Editas Medicine Announces Pre-Clinical Data for Program to Treat Sickle Cell Disease and Beta-Thalassemia, 2/26/2016 CHMA-US  GNW  Chiasma to Report Fourth Quarter and Year End 2015 Financial Results on March 14,"11/29/2018 ZLAB-US  GNW  MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENTâ„¢ Molecule in Greater China",,,, 2/17/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted GlatopaÂ® (glatiramer acetate injection) Fill/Finish Manufacturer," 3/03/2017 PRTA-US  GNW  Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares",,, 7/27/2017 CTMX-US  GNW  CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and Provide Mid-Year Update,10/24/2017 GMAB-DK  GNW  Genmab Announces Additional Information Concerning Net Sales of DARZALEXÂ® (daratumumab) for Third Quarter of 2017,,, 5/11/2017 CBAY-US  GNW  CymaBay Reports First Quarter 2017 Financial Results and Provides Corporate Update,, 8/25/2016 CCXI-US  GNW  ChemoCentryx to Present at the Baird 2016 Global Healthcare Conference,,,10/23/2017 MNKD-US   GNW  MannKind Restructures Near-Term Debt Obligations,, 5/10/2018 CYTK-US  GNW  Cytokinetics to Hold Annual Meeting of Stockholders," 5/18/2018 29664W10    GNW  ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018",12/03/2018 AMRS-US   GNW  Amyris Partners with Camil Alimentos to Deliver Zero Calorie Sweetener Made from Sugarcane to Brazilian Consumers,,11/02/2016 CS-CH    GNW  Achillion to Present at the Credit Suisse 25th Annual Healthcare Conference," 3/01/2019 87166B10 GNW  SYNEOS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Syneos Health, Inc. - SYNH", 2/12/2018 FOLD-US  GNW  U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease,,, 5/13/2016 ADMA-US  GNW  ADMA Biologics Further Enhances Cash Position by Securing $4.0 Million in Additional Capital Through Amended Loan and Security Agreement with Oxford Finance,11/21/2017 GWPH-US  GNW  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present EpidiolexÂ® (cannabidiol) Data and Educational Programs at the American Epilepsy Society Annual Meeting,,,"10/26/2017 MYOK-US  GNW  MyoKardia to Announce Third Quarter 2017 Financial Results on Thursday, November 2, 2017",, 7/09/2018 GLPG-NL  GNW  Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF," 5/03/2018 PTLA-US  GNW  U.S. FDA Approves Portola Pharmaceuticalsâ€™ AndexxaÂ®, First and Only Antidote for the Reversal of Factor Xa Inhibitors",,,," 5/12/2017 CARA-US  GNW  Cara Therapeutics to Host KOL Meeting on Chronic Kidney Disease-Associated Pruritus on May 16, 2017", 6/21/2018 0FN118-E GNW  Flexion Therapeutics Named one of Boston Business Journalâ€™s Best Places to Work for the Second Year in a Row,11/01/2017 QURE-US  GNW  uniQure Announces Third Quarter 2017 Financial Results and Recent Company Progress,12/11/2017 AGIO-US   GNW  Data from Phase 1 Studies of Ivosidenib or Enasidenib in Combination with Full Doses of Standard of Care Chemotherapy Demonstrate Tolerability and Preliminary Clinical Activity in Newly Diagnosed AML Patients With an IDH Mutation," 9/19/2017 IOVA-US  GNW  Iovance Biotherapeutics, Inc. Announces Public Offering of Common Stock",,,11/01/2017 FATE-US  GNW  Fate Therapeutics Reports Third Quarter 2017 Financial Results,12/22/2016 HZNP-US  GNW  Horizon Pharma plc Announces Availability of QUINSAIRâ„¢ (levofloxacin inhalation solution) in Canada for the Treatment of Specific Lung Infections in Adults with Cystic Fibrosis,,"10/04/2017 45845P10 GNW  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm", 8/05/2019 48576U10   GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI,,,10/02/2017 ITCI-US  GNW  Intra-Cellular Therapies Announces Closing of $150 Million Public Offering of Common Stock,,,,"11/12/2015 03209R10 GNW  Amphastar Pharmaceuticals Reports Net Revenues of $63.9 Million for the Third Quarter Ended September 30, 2015",11/07/2017 ATRA-US    GNW  Atara Biotherapeutics to Participate in Four Upcoming Investor Conferences,, 3/02/2017 DERM-US  GNW  Dermira to Present at Cowen and Company 37th Annual  Health Care Conference," 5/16/2016 FOMX-US  GNW  Foamix Names Dr. Stanley Hirsch as Chairman, and Dr. Dalia Megiddo as a Member of the Board of Foamix Pharmaceuticals"," 2/18/2016 PRAH-US  GNW  PRA Holdings, Inc. Announces Cash Tender Offer for up to $75 Million Aggregate Principal Amount of its 9.500% Senior Notes due 2023", 6/22/2016 SUPN-US  GNW  Supernus Announces Issuance of Seventh U.S. Patent Protecting Oxtellar XRÂ®, 3/30/2017 FGEN-US  GNW  Positive Results Published in Nephrology Dialysis Transplantation From Two China Phase 2 Trials of Roxadustat for Treatment of Anemia in Chronic Kidney Disease,, 4/24/2018 CHRS-US  GNW  Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10th Â ," 8/21/2018 21833P10 GNW  Investor Expectations to Drive Momentum within Materialise NV, Southern First Bancshares, Ensco plc, Corbus Pharmaceuticals, TCP Capital, and Horizon Pharma Public â€” Discovering Underlying Factors of Influence",,10/25/2016 COLL-US  GNW  Collegium Announces Proposed Public Offering of Common Stock,10/11/2016 XBIT-US  GNW  XBiotech Announces Dismissal of Class Action Lawsuit in Texas,,, 6/05/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 4/28/2015 00BXRX-E GNW  Luke M. Beshar Appointed to REGENXBIO Board of Directors,10/28/2017 KURA-US  GNW  Kura Oncology Development Candidate KO-539 Shows Robust Preclinical Anti-Tumor Activity in NPM1- and DNMT3A-Mutant AML,12/02/2016 00CLR1-E GNW  Apellis Reports Positive Interim Results from Phase 1b Clinical Trials of APL-2 in PNH, 3/19/2018 AXSM-US  GNW  Axsome Therapeutics to Present at 17th Annual Needham Healthcare Conference, 5/09/2017 VYGR-US  GNW  Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights,11/13/2018 BGNE-US  GNW  BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,"12/12/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Requested Withdrawal of Registration Statement Due to Adverse Market Conditions",, 8/18/2016 NTLA-US  GNW  Intellia Therapeuticsâ€™ Preclinical Data Show Continued Progress in In Vivo Gene Editing With Systemic Lipid Nanoparticle Delivery of CRISPR/Cas9 components, 9/13/2016 ACIU-CH  GNW  AC Immune SA Commences Proposed Initial Public Offering of Common Shares, 4/27/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at the 42nd Annual Deutsche Bank Health Care Conference,11/06/2017 GTHX-US  GNW  G1 Therapeutics Announces Publication in Cancer Discovery Demonstrating That CDK4/6 Inhibition Enhances the Anti-Tumor T Cell Response,,, 5/21/2018 ATNX-US  GNW  Athenex to Present at UBS Global Healthcare Conference,,,,,,,,,, 1/04/2018 EYPT-US    GNW  pSivida Granted Waiver by the FDA for New Drug Application Filing Fee,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/04/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation of Updated Data from the Pivotal Trial of AZEDRAÂ® (iobenguane I 131) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,,,,,,,, 3/14/2011 82691710     GNW  SIGA Appoints William C. Bevins and Frances Fragos Townsend to Board of Directors," 9/30/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK and TRCO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders"," 1/04/2013 46222210 GNW  Gainey & McKenna Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against ISIS Pharmaceuticals, Inc. -- ISIS", 4/27/2015 BMRN-US     GNW  BioMarin Completes Rolling NDA Submission to FDA for Drisapersen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,,," 1/23/2019 45290710 GNW  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Immunomedics, Inc.Â ", 4/10/2018 AGTC-US   GNW  AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients with X-linked Retinoschisis (XLRS),, 8/01/2018 BCRX-US  GNW  BioCryst Pharmaceuticals Prices Public Offering of Common Stock,,,,," 3/09/2018 0F98BD-E GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers â€“ AKRX",, 9/03/2019 62855J10 GNW  MYGN INVESTIGATION REMINDER: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations," 4/26/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 3, 2018",,11/11/2015 INSM-US  GNW  Insmed to Present at the Stifel 2015 Healthcare Conference,, 9/11/2017 INO-US    GNW  Inovioâ€™s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times  In Patients with Recurrent Prostate Cancer, 5/17/2018 NKTR-US  GNW  BioXcel Therapeutics Announces Data Presentation at ASCO 2018 Annual Meeting,,11/20/2017 GERN-US  GNW  Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes,, 3/01/2019 02311120 GNW  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Amarin Corporation plc â€“ AMRN,,,"10/18/2018 SRPT-US  GNW  Sarepta Therapeutics to Announce Third Quarter 2018 Financial Results and Recent Corporate Developments on October 24, 2018",,, 2/27/2018 AMAG-US  GNW  AMAG Reports 2017 Financial Results and Company Update,,,,,12/18/2018 SAN-FR   GNW  Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq,,,,,, 5/17/2017 AFMD-US  GNW  Affimed Reports Financial Results for First Quarter 2017,,10/26/2017 PRQR-US  GNW  ProQR Announces Management Change and Key Promotions,,12/03/2018 ZGNX-US  GNW  Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLAÂ® (ZX008) in Dravet Syndrome,,,,,,11/15/2017 ADVM-US  GNW  Adverum Biotechnologies to Present at Upcoming Conferences," 3/07/2018 RARE-US   GNW  Ultragenyx Announces Positive Topline Results and DMC Review from First Cohort of Phase 1/2 Clinical Study of DTX301, an Investigational Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency", 8/29/2016 AGLE-US  GNW  Aeglea BioTherapeutics Doses First Patient in Phase 1 Trial of AEB1102 for  the Treatment of Hematological Malignancies, 9/18/2017 NSTG-US  GNW  NanoStringâ€™s Hyb & Seqâ„¢ Enables Liquid Biopsy by the Direct Capture and Sequencing of Cell-Free DNA,,, 8/07/2017 RDUS-US  GNW  Radius Health Announces Proposed Public Offering of $300 Million of Convertible Senior Notes due 2024,12/09/2015 ASMB-US  GNW  Clinical Study Shows Assembly Biosciences' Oral Gemicelâ„¢ Technology Can Achieve Targeted Delivery to the Lower GI Tract for Microbiome and Other Applications,,, 4/20/2012 TKM-CA   GNW  Tekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data,, 2/26/2018 IONS-US  GNW  Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017Â ,, 9/20/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference, 4/20/2017 RTRX-US  GNW  Retrophin to Report First Quarter 2017 Financial Results," 7/12/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. Second Quarter 2016 Financial Results Call", 5/08/2017 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing First Quarter 2017 Corporate Update and Results, 2/25/2016 CHMA-US  GNW  Chiasma to Present at Upcoming Investor Conferences,11/27/2018 MGNX-US  GNW  MacroGenics Announces Participation in Three Investor Conferences,,,, 2/17/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces HSR Clearance for Collaboration and License Agreement with CSL, 3/02/2017 PRTA-US  GNW  Prothena Announces Public Offering of Ordinary Shares,,, 6/29/2017 CTMX-US  GNW  CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate Â ,10/10/2017 GMAB-DK  GNW  Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer,,," 5/04/2017 CBAY-US  GNW  CymaBay to Report First Quarter 2017 Financial Results on Thursday, May 11",, 8/08/2016 CCXI-US  GNW  ChemoCentryx Reports Second Quarter 2016 Financial Results andÂ Provides Corporate Update,,,10/23/2017 56400P70  GNW  MannKind and BIOMM Submit Registration Dossier to Brazilian Health Regulatory Agency (ANVISA),, 5/01/2018 CYTK-US  GNW  Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS," 5/16/2018 29664W10    GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 â€“ ESPR","11/30/2018 AMRS-US   GNW  Amyris Partners with Givaudan to Introduce a Tabletop Application for its Zero Calorie, Naturally Sourced Sweetener",," 9/23/2016 ACHN-US  GNW  Achillion Announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssenâ€™s Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-NaÃ¯ve HCV"," 3/01/2019 87166B10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Syneos Health, Inc. (SYNH)", 2/07/2018 FOLD-US  GNW  Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at 14th Annual WORLDSymposiumâ„¢,,, 5/03/2016 ADMA-US  GNW  ADMA Biologics Announces Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,10/30/2017 GWPH-US  GNW  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug Application Submission to U.S. Food and Drug Administration for EpidiolexÂ® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome and Dravet Syndrome,,, 9/27/2017 MYOK-US  GNW  MyoKardia Provides Update on MYK-491 Clinical Progress,, 6/26/2018 GLPG-NL  GNW  Servier and Galapagos announce start of global ROCCELLA  Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients," 4/30/2018 PTLA-US  GNW  Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018",,,, 5/04/2017 CARA-US  GNW  Cara Therapeutics Reports First Quarter 2017 Financial Results, 6/01/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/31/2017 QURE-US  GNW  uniQure Announces Multiple Company Presentations at Upcoming November Conferences,12/11/2017 AGIO-US   GNW  New Data from Ivosidenib Phase 1 Dose-Escalation and Expansion Trial Demonstrate Durable Responses in Patients with IDH1m Relapsed or Refractory AML, 9/13/2017 IOVA-US  GNW  Iovance Biotherapeutics Announces Approval of First Clinical Trial Application by Competent Authority in Netherlands for a Phase 2 Trial of LN-145 for the Treatment of Patients with Cervical Cancer,,,11/01/2017 FATE-US  GNW  Fate Therapeutics Announces Six Presentations at the 2017 ASH Annual Meeting,12/08/2016 HZNP-US  GNW  Horizon Pharma plc to Participate in Investor Conference in December,," 9/28/2017 45845P10 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) To Contact Brower Piven Before The Lead Plaintiff Deadline"," 8/05/2019 48576U10   GNW  CLASS ACTION UPDATE for RMED, OMCL, KPTI and CURLF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,, 9/27/2017 ITCI-US  GNW  Intra-Cellular Therapies Prices $150 Million Public Offering of Common Stock,,,,"11/05/2015 03209R10 GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 12, 2015","11/01/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Two Presentations at 59th American Society of Hematology Annual Meeting, Including Positive Interim Results from a Multicenter Expanded Access Study of ATA129 for Patients with Epstein-Barr Virus (EBV)-Associated Cancers",, 3/01/2017 DERM-US  GNW  Dermira Prices $168.5 Million Public Offering of Common Stock, 5/10/2016 FOMX-US  GNW  Foamix Reports First Quarter 2016 Financial Results and Provides Business Update, 2/04/2016 PRAH-US  GNW  PRA Health Sciences to Report Fourth Quarter 2015 Earnings, 6/16/2016 SUPN-US  GNW  Supernus Provides Update on Trokendi XRÂ® Migraine sNDA and Reiterates Guidance, 3/01/2017 FGEN-US  GNW  FibroGen Reports Fiscal 2016 Financial Results,, 4/19/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants, 8/08/2018 CRBP-US  GNW  Corbus Pharmaceuticals Reports 2018 Second Quarter Financial Results and Provides Business Update,,10/05/2016 06CR5C-E GNW  Collegium Submits Supplemental New Drug Submission to FDA for XtampzaÂ® ER, 8/22/2016 XBIT-US  GNW  XBiotech Announces Grand Opening Date for New Commercial Manufacturing Facility,,, 5/17/2018 GBT-US   GNW  GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress, 4/23/2015 00BXRX-E GNW  REGENXBIO and Dimension Therapeutics Add Development of Treatments for Two Metabolic Diseases to Exclusive License Agreement,10/27/2017 KURA-US  GNW  Kura Oncology Lead Candidate Tipifarnib Shows Durable Anti-Tumor Activity in HRAS Mutant Head and Neck Cancer in AACR-NCI-EORTC Update,11/21/2016 00CLR1-E GNW  Apellis to Present Safety and Efficacy Data from Clinical Trials of APL-2 in PNH at December Scientific Meetings, 3/12/2018 AXSM-US  GNW  Axsome Therapeutics Presents Scientific Rationale for the Development of AXS-05 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics, 5/04/2017 VYGR-US  GNW  Voyager Therapeutics to Host First Quarter 2017 Financial Results and Corporate Highlights Conference Call,11/07/2018 BGNE-US  GNW  BeiGene Initiates Global Head-to-Head Phase 3 Clinical Trial of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,,"12/06/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Filing of Registration Statement for Proposed Public Offering",, 8/10/2016 002DGD-E GNW  Intellia Therapeutics to Present at 2016 Wedbush PacGrow Healthcare Conference,, 4/26/2017 H1718210 GNW  Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein Complexes," 9/18/2017 GTHX-US  GNW  G1 Therapeutics Added to Russell 2000Â®, 3000Â® and MicrocapÂ® Indexes",,," 5/14/2018 ATNX-US  GNW  Athenex, Inc. Announces First Quarter 2018 Results",,,,,,,,,, 1/02/2018 EYPT-US    GNW  pSivida to Present at the Annual Biotech Showcase Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/31/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference,,,,,,,, 3/09/2011 82691710     GNW  SIGA Technologies Reports Financial Results for the Fourth Quarter and Year Ended 2010," 9/27/2018 68375N10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, USAT and MCHP"," 1/04/2013 46222210 GNW  Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in ISIS Pharmaceuticals, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the February 26, 2013 Lead Plaintiff Deadline -- ISIS", 4/23/2015 09061G10    GNW  BioMarin Presents Data on Duchenne Muscular Dystrophy at the 67th American Academy of Neurology Annual Meeting,,,," 1/23/2019 45290710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XPO, IMMU, AXGN and AGN", 1/04/2018 CBST-US   GNW  Spark Therapeutics Announces Addition of Robert J. Perez to Board of Directors,, 8/01/2018 BCRX-US  GNW  BioCryst Pharmaceuticals Commences Public Offering of Common Stock,,,,, 2/26/2018 AKRX-US  GNW  Akorn Issues Statement on Investigation,, 8/30/2019 MYGN-US  GNW  Myriad Genetics to Present at the 2019 Morgan Stanley Global Healthcare Conference," 4/03/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Highlight Pipeline Progress at R&d Day on April 10, 2018",,11/06/2015 INSM-US  GNW  Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update,, 8/23/2017 INO-US    GNW  Inovio Pharmaceuticals to Participate inÂ Upcoming Investment Conferences,,,11/07/2017 GERN-US  GNW  Geron Announces November Investor Conference Presentation Webcasts,, 2/27/2019 AMRN-US  GNW  Amarin Reports Record Fourth Quarter and Full Year 2018 Financial Results  and Provides Update on Operations,,,"10/15/2018 SRPT-US  GNW  Sarepta and Lysogene Announce Exclusive License Agreement for LYS-SAF302, a Late-stage Gene Therapy for the Treatment of MPS IIIA, and Grant of Option Rights to an Additional CNS Gene Therapy Candidate",,," 2/20/2018 AMAG-US  GNW  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Tuesday, February 27, 2018 at 8:00 a.m. ET",,,,,11/29/2018 LXRX-US  GNW  FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes,,,,,, 5/10/2017 AFMD-US  GNW  Affimed Announces First Quarter 2017 Financial Results  and Corporate Update Conference Call,,10/24/2017 PRQR-US  GNW  ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference,,12/02/2018 ZGNX-US  GNW  Zogenix Presents Positive Findings on the Impact of Treatment with FINTEPLAÂ® (ZX008) on Everyday Executive Function in Patients with Dravet Syndrome,,,,,,11/08/2017 ADVM-US  GNW  Adverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update, 2/23/2018 RARE-US   GNW  Kyowa Kirin and Ultragenyx Announce CrysvitaÂ® (burosumab) Receives Conditional Marketing Authorization in Europe for the Treatment of Xâ€“Linked Hypophosphatemia in Children, 8/09/2016 AGLE-US  GNW  Aeglea BioTherapeutics Announces Second Quarter 2016 Financial Results, 9/07/2017 NSTG-US  GNW  NanoString to Webcast Presentation at the 2017 Morgan Stanley Global Healthcare Conference,,, 8/03/2017 RDUS-US  GNW  Radius Health Reports Second Quarter 2017 Financial and Operating Results and Provides Business Update,10/06/2015 ASMB-US  GNW  Assembly Biosciences to Describe Improved Methods for HBV Drug Development at Major International Meeting,,, 3/26/2012 TKM-CA   GNW  Tekmira Provides Periodic Update to Shareholders Regarding Litigation,, 2/15/2018 00972L10 GNW  Akcea Announces FDA Advisory Committee Meeting to Review Volanesorsen as a Treatment for Familial Chylomicronemia Syndrome,," 9/13/2017 AET-US   GNW  Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons Join Together in a Program to Reduce Opioid Exposure for  Patients Undergoing Wisdom Tooth Extraction", 4/12/2017 ARRY-US  GNW  Retrophin Appoints Ron Squarer to Board of Directors, 6/24/2016 PACB-US  GNW  Cold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome with PacBio SMRT Sequencing, 5/08/2017 EDIT-US  GNW  Editas Medicine to Present at Investor Conferences in May, 1/08/2016 CHMA-US  GNW  Chiasma Reviews 2015 Accomplishments and Outlines Core Objectives for 2016,11/14/2018 MGNX-US  GNW  MacroGenics Announces Poster Presentation on Preclinical PD-L1 x CD137 DARTÂ® Program at the EORTC-NCI-AACR Symposium in Dublin,,,, 2/07/2017 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2016 Financial Results Conference Call and Webcast," 2/14/2017 PRTA-US  GNW  Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update",,, 6/28/2017 CTMX-US  GNW  CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 Trial, 9/27/2017 GMAB-DK  GNW  Genmab Announces Approval of DARZALEXÂ® (daratumumab) for Relapsed or Refractory Multiple Myeloma in Japan,,, 4/13/2017 CBAY-US  GNW  CymaBay to Present Data from its Phase 2 Proof-of-Concept Study of Seladelpar in Patients With Primary Biliary Cholangitis at the EASL Liver Meeting 2017,," 8/01/2016 CCXI-US  GNW  ChemoCentryx to Hold Second Quarter 2016 Financial Results Conference Call on Monday, August 8, 2016",,,10/12/2017 MNKD-US   GNW  MannKind Donates AfrezzaÂ® to Support People with Diabetes Impacted by Hurricane Maria in Puerto Rico,," 4/26/2018 CYTK-US  GNW  Cytokinetics, Inc. Reports First Quarter 2018 Financial Results"," 5/14/2018 29664W10    GNW  DEADLINE ALERT: Shareholder Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. â€“ ESPR",11/13/2018 AMRS-US   GNW  Amyris Reports Third Quarter 2018 Financial Results,," 9/09/2016 00870Z-E GNW  Achillion Announces 100% SVR Reported in Janssenâ€™s Phase 2a Trial Evaluating Triple Combination of Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naive HCV"," 3/01/2019 87166B10 GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Syneos Health, Inc. (SYNH) and Encourages SYNH Investors to Contact the Firm", 1/29/2018 FOLD-US  GNW  Canadian Drug Expert Committee Grants Positive Recommendation for Reimbursement of Galafoldâ„¢ (migalastat) for Fabry Disease in Canada,,, 4/28/2016 ADMA-US  GNW  ADMA Biologics Announces Pricing of Public Offering of Common Stock, 9/05/2017 GWPH-US  GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences,,, 9/18/2017 MYOK-US  GNW  MyoKardia Presents Additional Positive Data from Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) at the Heart Failure Society of Americaâ€™s 21st Annual Scientific Meeting,, 6/20/2018 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises, 4/25/2018 PTLA-US  GNW  Portola Pharmaceuticals to Present New Interim Phase 2 Data for Cerdulatinib at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,,,," 4/27/2017 CARA-US  GNW  Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017", 5/08/2018 FLXN-US  GNW  Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights,10/27/2017 QURE-US  GNW  uniQure Announces Closing of its Public Offering,"12/10/2017 AGIO-US   GNW  Agios Presents Updated Data from DRIVE PK Study Demonstrating AG-348 is Well-Tolerated and Results in Clinically Relevant, Rapid and Sustained Hemoglobin Increases in Patients with Pyruvate Kinase Deficiency", 9/11/2017 IOVA-US  GNW  Iovance Biotherapeutics Partners with TrakCel for Personalized Patient Product Management,,,10/25/2017 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2017 Financial Results,12/08/2016 HZNP-US  GNW  Horizon Pharma plc Announces Topline Results from Phase 3 Study of Â ACTIMMUNEÂ® (interferon gamma-1b) in Friedreich's Ataxia,," 9/28/2017 45845P10 GNW  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc."," 8/02/2019 48576U10   GNW  SHAREHOLDER ALERT: CLAIMSFILER REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 9/26/2017 ITCI-US  GNW  Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock,,,,10/20/2015 03209R10 GNW  Amphastar Pharmaceuticals Launches Amphadase(R),10/26/2017 ATRA-US    GNW  Atara Biotherapeutics Receives Rare Pediatric Disease Designation from FDA for ATA230 for Treatment of Congenital Cytomegalovirus (CMV) Infection,, 2/28/2017 DERM-US  GNW  Dermira Announces Proposed Public Offering of Common Stock, 5/09/2016 FOMX-US  GNW  Foamix Announces Dosing of First Patient in Phase 3 Acne Studies for Minocycline Foam FMX101,12/07/2015 69354M10 GNW  WuXi PharmaTech and PRA Health Sciences Restructure Relationship in China, 6/02/2016 SUPN-US  GNW  Supernus Announces Issuance of Sixth U.S. Patent Protecting Oxtellar XRÂ®," 2/22/2017 FGEN-US  GNW  FibroGen to Report Fiscal 2016 Financial ResultsÂ on March 1, 2017",," 4/02/2018 CHRS-US  GNW  Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco", 7/25/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis,,"10/03/2016 COLL-US  GNW  Collegium Submits New Drug Submission to Health Canada for XtampzaÂ® ER, an Analgesic with Abuse-Deterrent Properties for the Treatment of Chronic Pain", 8/10/2016 XBIT-US  GNW  XBiotech to Provide Second Quarter 2016 Business Update on August 16,,, 5/07/2018 GBT-US   GNW  GBT Reports Recent Business Progress and First Quarter 2018 Financial Results, 4/08/2015 00BXRX-E GNW  REGENXBIO Licenses Key Technologies From University of Pennsylvania and University of Minnesota for the Development of Treatments for MPS I and MPS II,10/16/2017 KURA-US  GNW  Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer and for KO-539 in AML at Upcoming AACR-NCI-EORTC International Conference,, 3/07/2018 AXSM-US  GNW  Axsome Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update, 4/25/2017 VYGR-US  GNW  Voyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinsonâ€™s Disease,11/07/2018 BGNE-US  GNW  BeiGene Reports Third Quarter 2018 Financial Results,,11/14/2016 06CR5C-E GNW  Reata Announces Plan for Global Phase 2/3 Trial in Chronic Kidney Disease Caused by Alport Syndrome,, 8/04/2016 NTLA-US  GNW  Intellia Therapeutics Reports Financial Results for Second Quarter 2016,, 4/17/2017 BAYN-DE  GNW  CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio, 8/09/2017 GTHX-US  GNW  G1 Therapeutics Reports Second Quarter 2017 Financial Results and Recent Operational Highlights,,, 5/08/2018 ATNX-US  GNW  Athenex to Present at Deutsche Bankâ€™s 43rd Annual Health Care Conference,,,,,,,,,,12/14/2017 EYPT-US    GNW  HSS and pSivida Report Positive Phase 1 Knee Osteoarthritis Pain Study Data,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/31/2018 PGNX-US  GNW  Progenicsâ€™ Artificial Intelligence Technology for Automated Analysis of PSMA Targeted Prostate Cancer Images to be Featured at the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting,,,,,,,," 3/02/2011 82691710     GNW  SIGA to Discuss Fourth Quarter and Year-End 2010 Results of Operations on March 9, 2011"," 9/26/2018 68375N10 GNW  OPKO HEALTH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against OPKO Health, Inc.","12/28/2012 46222210 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against ISIS Pharmaceuticals, Inc., and Certain Officers -- ISIS", 4/21/2015 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,, 1/22/2019 45290710 GNW  SHAREHOLDER ALERT: YOGA YRCW IMMU YRIV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,"10/23/2017 09062X10  GNW  Research Report Identifies Sherwin-Williams, Charter Communications, Biogen, C. R. Bard, Mohawk Industries, and Humana Inc. with Renewed Outlook â€“ Fundamental Analysis, Calculating Forward Movement",, 7/27/2018 BCRX-US  GNW  BioCryst to Announce Second Quarter 2018 Financial Results on August 7,,,,," 1/11/2018 0F98BD-E GNW  Pomerantz LLP and Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX",, 8/22/2019 MYGN-US  GNW  Myriad Applauds the U.S. Preventive Services Task ForceÂ Recommendation on BRCA-Related Cancer Prevention, 3/29/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes,,"10/29/2015 INSM-US  GNW  Insmed to Host Third Quarter 2015 Financial Results Conference Call on Friday, November 6, 2015",, 8/08/2017 INO-US    GNW  Inovio Pharmaceuticals Reports 2017 Second Quarter Financial Results,,,11/01/2017 GERN-US  GNW  Geron Corporation Reports Third Quarter 2017 Financial Results,," 2/26/2019 02311120 GNW  CLASS ACTION UPDATE for PRGO, W, AMRN and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,,"10/08/2018 SRPT-US  GNW  Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with ParagonÂ Bioservices, Greatly Enhancing its Commercial Capacity for Future Gene Therapies Â ",,, 2/15/2018 ATRS-US  GNW  Antares Pharma Announces FDA Approval of Partnerâ€™s Product Utilizing Our QuickShot Auto Injector,,,,,"11/16/2018 SAN-FR   GNW  Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness",,,,,, 4/05/2017 AFMD-US  GNW  Affimed Presents Data on Immune Cell Engager Pipeline at the AACR Annual Meeting 2017,,10/06/2017 PRQR-US  GNW  ProQR to Present at the Chardan Inaugural Gene Therapy Conference,,11/29/2018 ZGNX-US  GNW  Zogenix to Host Investor Update Lunch on FINTEPLAÂ® at the American Epilepsy Society 2018 Annual Meeting,,,,,,"10/02/2017 ADVM-US  GNW  Adverum Biotechnologies Appoints Linda Neuman, M.D. as Vice President, Clinical Development", 2/20/2018 RARE-US   GNW  Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update," 7/18/2016 AGLE-US  GNW  Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE) to Ring The Nasdaq Stock Market Opening Bell", 9/05/2017 NSTG-US  GNW  Anthem Issues Positive Coverage Decision for NanoStringâ€™s ProsignaÂ® Breast Cancer Assay,,," 7/21/2017 RDUS-US  GNW  Radius Health Announces that the Committee for Medicinal Products for Human Use (CHMP) Has Issued a Second Day-180 List of Outstanding Issues in its Regulatory Review of Eladynosâ„¢ (Abaloparatide-SC), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture", 5/19/2015 04539610 GNW  Assembly Biosciences Discusses Mechanism of Action of Its HBV Antiviral Program at 2nd ANRS HBV Cure Workshop,,, 3/15/2012 063G1M-E GNW  Tekmira Provides Update on Progress in USPTO Patent Interference Proceedings,, 2/12/2018 IONS-US  GNW  Akcea Therapeutics to Hold Fourth Quarter 2017 Financial Results Webcast,, 9/06/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Multiple EXPAREL Data Presentations at the Upcoming New York School of Regional Anesthesia Annual Fall Symposium, 3/23/2017 RTRX-US  GNW  John A. Orwin Joins Retrophin Board of Directors, 4/26/2016 PACB-US  GNW  Pacific Biosciences and Advanced Analytical Technologies Announce Co-Marketing Agreement, 4/24/2017 EDIT-US  GNW  Editas Medicine to Present New Data Demonstrating Advancements for Translating CRISPR Technologies into Medicines at the American Society of Gene & Cell Therapy Annual Meeting, 1/04/2016 16706W10 GNW  Chiasma Expands Senior Management Team With Key Strategic Hires,11/09/2018 MGNX-US  GNW  MacroGenics Reports Presentation of Clinical Data at 33rd Annual SITC Meeting,,,, 2/01/2017 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Leerink Partners 6th Annual Global Healthcare Conference, 2/08/2017 PRTA-US  GNW  Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference,,, 5/25/2017 CTMX-US  GNW  CytomX to Present at the Jefferies 2017 Global Healthcare Conference, 8/29/2017 GMAB-DK  GNW  Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors,,, 3/30/2017 CBAY-US  GNW  CymaBay Therapeutics to Present at Two Investor Conferences in April,, 6/29/2016 06P5F0-E GNW  ChemoCentryx to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference,,,10/11/2017 MNKD-US   GNW  MannKind Announces $61 Million Registered Direct Offering of Common Stock,," 4/20/2018 23282W60 GNW  New Research Coverage Highlights MPLX LP, TESARO, LKQ, Cytokinetics, Keysight Technologies, and Charles River Laboratories International â€” Consolidated Revenues, Company Growth, and Expectations for 2018"," 5/10/2018 29664W10    GNW  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc.","11/08/2018 AMRS-US   GNW  Amyris Further Expands Relationship with Yifan Pharmaceutical Co., Ltd.",, 9/06/2016 ACHN-US  GNW  Achillion Presents Novel Research on Factor D Inhibition at the XXVIth International Complement Workshop," 3/01/2019 87166B10 GNW  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Syneos Health, Inc. â€“ SYNH", 1/22/2018 FOLD-US  GNW  Amicus Therapeutics Announces Presentations and Posters at 14th Annual WORLDSymposiumâ„¢ 2018,,, 4/27/2016 ADMA-US  GNW  ADMA Biologics Announces Proposed Public Offering of Common Stock, 8/07/2017 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal Third Quarter 2017 Financial Results and Operational Progress,,, 8/30/2017 MYOK-US  GNW  MyoKardia to Present at Two Upcoming Investor Conferences in September,, 6/14/2018 GLPG-NL  GNW  Transparency notification, 4/04/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,, 4/24/2017 CARA-US  GNW  Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety of I.V. CR845, 5/07/2018 FLXN-US  GNW  Flexion Therapeutics Names David Arkowitz as Chief Financial Officer,10/24/2017 QURE-US  GNW  uniQure Announces Pricing of its Public Offering,"12/05/2017 AGIO-US   GNW  Agios Appoints Jacqualyn Fouse, Ph.D., to the Board of Directors", 9/07/2017 IOVA-US  GNW  Iovance Biotherapeutics Enters into a Research Collaboration Focused on Hematologic Malignancies with The Ohio State University Comprehensive Cancer Center,,, 9/18/2017 FATE-US  GNW  Fate Therapeutics Initiates Phase 2 PROTECT Study of ProTmuneâ„¢ for Prevention of Acute Graft-versus-Host Disease,11/14/2016 HZNP-US  GNW  Horizon Pharma plc Presents Data on KRYSTEXXAÂ® (pegloticase) for the Management of  Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting,," 9/27/2017 0F98BD-E GNW  Pomerantz Law Firm Announces the Filing of a Class Action against  Intercept Pharmaceuticals, Inc. and Certain Officers â€“ ICPT"," 8/02/2019 48576U10   GNW  CLASS ACTION UPDATE for VNTR, MMM and KPTI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,, 9/18/2017 ITCI-US  GNW  Intra-Cellular Therapies to Participate at Upcoming Investor Conferences,,,," 8/12/2015 03209R10 GNW  Amphastar Pharmaceuticals Reports Net Revenues of $53.9 Million for the Second Quarter Ended June 30, 2015",10/25/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Six of Ten Progressive Multiple Sclerosis (MS) Patients Experienced Clinical Improvements in an Ongoing Phase 1 Study of Autologous ATA190,, 2/28/2017 DERM-US  GNW  Dermira Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update, 5/03/2016 FOMX-US  GNW  Foamix Announces Completion of Enrollment in Phase 2 Clinical Trial of Minocycline Foam (FMX103) for Treatment of Papulopustular Rosacea,"11/02/2015 PRAH-US  GNW  PRA Health Sciences,Â Inc. Reports Third Quarter 2015 Results and Provides Updated 2015 Guidance", 5/24/2016 SUPN-US  GNW  Supernus to Present at June Jefferies Healthcare Conference, 2/03/2017 FGEN-US  GNW  FibroGen Announces Publication of Pamrevlumab (FG-3019) Clinical Data in Pancreatic Cancer Showing Safety and Improved Survival Outcomes in Combination with Chemotherapy,, 3/13/2018 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants," 7/25/2018 21833P10 GNW  Consolidated Research: 2018 Summary Expectations for CACI International, SELECT EGY SVCS, Internap, Sotheby's, Verint, and Corbus Pharmaceuticals â€” Fundamental Analysis, Key Performance Indications",, 9/29/2016 COLL-US  GNW  Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER, 7/22/2016 XBIT-US  GNW  XBiotech Provides Update on Xilonixâ„¢ Phase III Programs in US and EU,,, 5/04/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants,11/18/2014 00BXRX-E GNW  Dr. James M. Wilson Joins REGENXBIO as Chief Scientific Advisor, 9/26/2017 BPMC-US  GNW  AUTOLUS LIMITED: Autolus Secures US$80 million Series C Funding,," 2/28/2018 AXSM-US  GNW  Axsome Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018", 3/15/2017 VYGR-US  GNW  Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights,11/05/2018 BGNE-US  GNW  BeiGene to Present Clinical Data on PARP Inhibitor Pamiparib at Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology,,"11/14/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Third Quarter 2016 Financial and Operating Results",, 6/03/2016 NTLA-US  GNW  Intellia Therapeutics to Present at the Jefferies 2016 Healthcare Conference and the International BIO Convention,," 4/13/2017 H1718210 GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision", 8/08/2017 GTHX-US  GNW  G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference,,," 5/03/2018 ATNX-US  GNW  Athenex, Inc. to Report First Quarter Earnings Results on May 14, 2018",,,,,,,,,,11/07/2017 EYPT-US    GNW  pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/22/2018 PGNX-US  GNW  Progenics Announces JAMA Oncology Publication Highlighting Companyâ€™s Imaging Analysis Platform,,,,,,,, 2/21/2011 82691710     GNW  New Smallpox Antiviral Procurement Commenced, 9/26/2018 68375N10 GNW  SHAREHOLDER ALERT: NVRO PZZA NLSN ZN HMNY GDS PVG OPK USAT MCHP COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines, 9/26/2012 TKM-CA   GNW  Tekmira Provides Periodic Update to Shareholders Regarding Litigation," 4/14/2015 09061G10    GNW  BioMarin to Host First Quarter 2015 Financial Results Conference Call and Webcast on Thursday, April 30 at 4:30pm ET",,,," 1/22/2019 45290710 GNW  Kessler Topaz Meltzer & Check, LLP Reminds Immunomedics, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit", 8/03/2017 09062X10  GNW  AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa,, 7/25/2018 BCRX-US  GNW  BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in  The New England Journal of Medicine,,,,," 9/07/2017 00972810 GNW  Akorn, Inc. (Nasdaq: AKRX) to Ring The Nasdaq Stock Market Opening Bell",, 8/21/2019 62855J10 GNW  MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations, 3/26/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes,,10/26/2015 INSM-US  GNW  Insmed Announces Upcoming Data Presentation at AMCP Nexus 2015,," 7/26/2017 INO-US    GNW  Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017",,,11/01/2017 GERN-US  GNW  Geron Announces Presentations at American Society of Hematology Annual Meeting,, 2/26/2019 02311120 GNW  A Securities Class Action Has Been Filed Against Amarin Corporation; Block & Leviton LLP Encourages Shareholders to Contact the Firm,,,"10/05/2018 SRPT-US  GNW  Sarepta Announces Agreement with Nationwide Childrenâ€™s Hospital for Rights to its Gene Therapy Program to Treat Charcot-Marie-Tooth (CMT) Neuropathy, Globally the Most Common Inherited Neuromuscular Disorder",,, 2/14/2018 00163U10 GNW  Antares Pharma Announces FDA Approval of Partnerâ€™s Product Utilizing Our QuickShot Auto Injector,,,,,11/11/2018 SAN-FR   GNW  Sanofi: ODYSSEY OUTCOMES investigators highlight at AHA that PraluentÂ® (alirocumab) was associated with fewer deaths from any cause,,,,,, 3/30/2017 AFMD-US  GNW  Affimed Reports Financial Results for Fourth Quarter and Year End 2016,, 9/25/2017 PRQR-US  GNW  ProQR Announces Positive Top-Line Results from a Phase 1b Study of QR-010 in Subjects with Cystic Fibrosis,,11/27/2018 ZGNX-US  GNW  Zogenix to Participate in the Global Mizuho Investor Conference 2018,,,,,, 9/28/2017 ADVM-US  GNW  Adverum Biotechnologies to Present at Upcoming Conferences, 2/14/2018 RARE-US   GNW  Ultragenyx to Host Conference Call for Fourth Quarter and Full Year 2017  Financial Results and Corporate Update, 7/18/2016 AGLE-US  GNW  Aeglea BioTherapeutics Provides Update on AEB1102 Clinical Program in Rare Diseases and Cancer, 8/31/2017 NSTG-US  GNW  NanoString to Webcast Presentation at the 2017 Baird Global Healthcare Conference,,, 7/18/2017 RDUS-US  GNW  Radius Health Announces New Employment Inducement Grant, 3/19/2015 04539610 GNW  Assembly Biosciences Announces Pricing of $75 Million Public Offering of Its Common Stock,,, 3/06/2012 ALNY-US  GNW  Tekmira Files Motion to Dismiss in Patent Infringement Suit,, 2/07/2018 00972L10 GNW  Akcea Completes Enrollment in Phase 2b Study of AKCEA-APO(a)-LRx,, 9/05/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2017 H.C. Wainwright 19th Annual Global Investment Conference, 3/07/2017 RTRX-US  GNW  Retrophin to Present at the Barclays Global Healthcare Conference," 4/21/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2016 Financial Results"," 4/24/2017 EDIT-US  GNW  Editas Medicine, Inc. (Nasdaq: EDIT) to Ring The Nasdaq Stock Market Opening Bell",11/30/2015 007MPF-E GNW  Chiasma Announces Addition of James R. Tobin and John F. Thero to Board of Directors,11/07/2018 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 3rd Quarter 2018 Financial Results,,,, 1/31/2017 TEVVF-IL GNW  Momenta Pharmaceuticals Announces District Court Decision to Invalidate Teva Pharmaceuticals Patents in COPAXONEÂ® (glatiramer acetate injection) 40 mg/mL Litigation, 2/01/2017 PRTA-US  GNW  Prothena to Report Fourth Quarter and Full Year 2016 Financial Results and Host Webcast Conference Call on February 14,,, 5/17/2017 CTMX-US  GNW  CytomX Announces Upcoming Poster Presentation at American Society for Clinical Oncology Annual Meeting, 8/24/2017 GMAB-DK  GNW  Genmab Announces Positive Topline Results in Phase III ALCYONE Study of Daratumumab in Front Line Multiple Myeloma,,," 3/29/2017 CBAY-US  GNW  CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D.",, 6/16/2016 CCXI-US  GNW  ChemoCentryx Announces Positive Top-Line Results for CCX168 from the Phase II ANCA-Associated Vasculitis CLASSIC Study and Advances Plans to Initiate Phase III Development,,,10/02/2017 MNKD-US   GNW  FDA Updates AfrezzaÂ® Prescribing Information,," 4/12/2018 CYTK-US  GNW  Cytokinetics to Announce First Quarter Results onÂ April 26, 2018", 5/10/2018 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the Bank of America Merrill Lynch 2018 Healthcare Conference,"10/30/2018 AMRS-US   GNW  Amyris to Announce Third Quarter 2018 Financial Results on Tuesday, November 13, 2018",, 9/01/2016 ACHN-US  GNW  Achillion to Present at Two Upcoming Investor Conferences," 2/27/2019 87166B10 GNW  Syneos (SYNH) Losses Alert: Bernstein Liebhard LLP Announces First Investigation of Syneos Health, Inc. - SYNH", 1/17/2018 FOLD-US  GNW  Amicus Therapeutics Launches Galafoldâ„¢ (Migalastat) for Treatment of Fabry Disease in Spain,,, 4/12/2016 ADMA-US  GNW  ADMA Biologics Announces Data on RI-002 to be Presented at the Clinical Immunology Society 2016 Annual Meeting," 7/24/2017 GWPH-US  GNW  GW Pharmaceuticals to Report Q3 Financial Results  and Host Conference Call on 7 August, 2017",,, 8/14/2017 MYOK-US  GNW  MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares,, 5/30/2018 GLPG-NL  GNW  GILEAD  AND  GALAPAGOS  ANNOUNCE  RESULTS  WITH FILGOTINIB IN THE  PHASE 2  EQUATOR  STUDY IN  PSORIATIC  ARTHRITIS  AND  PROGRESSION  INTO  PHASE  3 FOR THE SELECTION STUDY IN  ULCERATIVE  COLITIS, 3/23/2018 PTLA-US  GNW  Portola Pharmaceuticals Receives and Plans to Appeal Negative CHMP Opinion Regarding Marketing Authorization for Betrixaban in the European Union,,,, 4/05/2017 CARA-US  GNW  Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 5/04/2018 FLXN-US  GNW  Flexion Therapeutics Announces ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) Recommended for Unique J Code by CMS,10/23/2017 QURE-US  GNW  uniQure Announces Proposed Public Offering,11/17/2017 AGIO-US   GNW  Agios Presents Updated Phase 1 Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients with IDH1 Mutant Positive Glioma, 9/05/2017 IOVA-US  GNW  Iovance Biotherapeutics to Present at Two Upcoming September Conferences,,," 9/14/2017 FATE-US  GNW  Fate Therapeutics Appoints Jim Beitel as Senior Vice President, Corporate Development",11/11/2016 HZNP-US  GNW  Horizon Pharma plc Selected as One of Chicago Tribune's 2016 Top Workplaces,, 9/25/2017 ICPT-US  GNW  Intercept Statement Regarding OcalivaÂ® (obeticholic acid) Safety and Dosing in Primary Biliary Cholangitis (PBC) Patients, 8/01/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 9/07/2017 ITCI-US  GNW  Intra-Cellular Therapies Announces Positive Topline Data From 6-Week Open-label Safety Switching Study with Lumateperone in Patients with Schizophrenia,,,," 8/04/2015 03209R10 GNW  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 12, 2015","10/19/2017 ATRA-US    GNW  Atara Biotherapeutics Initiates 60 Patient, Global Phase 1 Clinical Study to Evaluate Allogeneic ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis (MS)",, 2/27/2017 DERM-US  GNW  Dermira Data from DRM04 and Olumacostat Glasaretil Clinical Programs to Be Presented at American Academy of Dermatology Annual Meeting," 4/28/2016 FOMX-US  GNW  Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for Tuesday, May 10",10/26/2015 PRAH-US  GNW  PRA Health Sciences Opens New Bioanalytical Laboratory in the Netherlands, 5/10/2016 SUPN-US  GNW  Supernus Enters Into Partial Settlement Agreement with Actavis on Oxtellar XRÂ®, 1/30/2017 FGEN-US  GNW  FibroGenâ€™s Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in China,, 3/08/2018 CHRS-US  GNW  Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results, 7/20/2018 CRBP-US  GNW  Corbus Pharmaceuticals Receives FDA Orphan Drug Designation for Lenabasum for the Treatment of Dermatomyositis,, 9/09/2016 0B17F0-E GNW  Review of XtampzaÂ® ER Published in The Journal of the American Medical Association, 7/02/2016 XBIT-US  GNW  XBiotech Presents Pivotal Phase III Data Showing Xilonixâ„¢ Demonstrated Significant Clinical Response in Advanced Colorectal Cancer Patients  Refractory to Further Treatment,,, 4/03/2018 GBT-US   GNW  GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference,10/28/2014 00BXRX-E GNW  REGENXBIO Appoints Dr. Stephen Yoo as Chief Medical Officer, 9/07/2017 KURA-US  GNW  Kura Oncology Announces Positive Phase 2 Study for Tipifarnib in HRAS Mutant Head and Neck Cancer,, 2/26/2018 AXSM-US  GNW  Axsome Therapeutics Announces Primary Endpoint Met in Phase 1 Trial of Next Generation Product Candidate AXS-09 Containing Chirally Pure Esbupropion and Dextromethorphan, 3/08/2017 VYGR-US  GNW  Voyager Therapeutics to Host Fourth Quarter and Full Year 2016 Financial Results Conference call,11/01/2018 BGNE-US  GNW  BeiGene to Present Clinical Data on Tislelizumab and Zanubrutinib at the 60th American Society of Hematology Annual Meeting,,"10/11/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Appoints Dawn Carter Bir as Vice President and Chief Commercial Officer",, 5/11/2016 05G643-E GNW  Intellia Therapeutics Announces Closing ofÂ Initial Public Offering,, 3/30/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference, 8/03/2017 GTHX-US  GNW  G1 Therapeutics Makes Key Appointments to Management Team,,," 4/30/2018 ATNX-US  GNW  Athenex, Inc. Announces Transition of James Zukin from Board of Directors to Advisory Role",,,,,,,,,,10/18/2017 EYPT-US    GNW  pSivida Corp. Announces First Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/09/2018 PGNX-US  GNW  Progenics Pharmaceuticals AnnouncesÂ First Quarter 2018 Financial Results and Business Update,,,,,,,, 2/16/2011 82691710     GNW  Small Business Administration Affirms Ruling After Appeal," 9/26/2018 68375N10 GNW  INVESTOR ALERT: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm â€“ OPK", 3/06/2012 ALNY-US  GNW  Tekmira Files Motion to Dismiss in Patent Infringement Suit, 3/30/2015 09061G10    GNW  BioMarin Announces One Oral and 7 Poster Presentations at the 2015 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting,,,, 1/18/2019 45290710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. â€“ IMMU, 1/17/2017 BIIBV-US  GNW  Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen,, 7/16/2018 BCRX-US  GNW  Idera Pharmaceuticals Provides Update on Corporate Strategy and Outlook,,,,, 7/19/2017 00972810 GNW  Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi,," 8/20/2019 62855J10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Myriad Genetics, Inc. - MYGN", 2/28/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference,,10/19/2015 INSM-US  GNW  The Balancing Act(R) on Lifetime to Feature NTM Lung Disease,, 7/19/2017 INO-US    GNW  Inovio Announces Pricing of Public Offering of Common Stock,,,10/31/2017 GERN-US  GNW  Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes,," 2/26/2019 02311120 GNW  CLASS ACTION UPDATE for SOGO, W, ASTE and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,,"10/03/2018 SRPT-US  GNW  Sarepta Therapeutics Announces that at the 23rd International Congress of the World Muscle Society, Jerry Mendell, M.D., Presented Positive Updated Results from the Four Children Dosed in the Gene Therapy Micro-dystrophin Trial to Treat Patients with Duchenne Muscular Dystrophy",,, 2/14/2018 00163U10 GNW  AMAG Pharmaceuticals Announces FDA Approval of MakenaÂ® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-Risk Women,,,,,11/07/2018 SAN-FR   GNW  New England Journal of Medicine publishes positive detailed results from PraluentÂ® (alirocumab) cardiovascular outcomes trial,,,,,, 3/23/2017 AFMD-US  GNW  Affimed Announces Fourth Quarter and Year End 2016 Financial Results and Corporate Update Conference Call,, 9/21/2017 PRQR-US  GNW  ProQR Presents in vivo Proof of Concept Data for the AxiomerÂ® RNA Editing Platform Technology,,11/26/2018 ZGNX-US  GNW  Zogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting,,,,,, 9/27/2017 ADVM-US  GNW  Adverum Biotechnologies Presents Updated Preclinical Data on ADVM-022 in Wet AMD at the 2017 Targeting Ocular Disorders Conference, 2/08/2018 RARE-US   GNW  Ultragenyx to Present at Leerink Partners Global Healthcare Conference, 5/23/2016 06CR5C-E GNW  Aeglea BioTherapeutics Receives FDA Fast Track Designation for AEB1102 for the Treatment of Patients with Hyperargininemia Secondary to Arginase I Deficiency, 8/08/2017 63009R10 GNW  NanoString and Lam Research Announce Strategic Development Collaboration to Advance Hyb & Seq Next Generation Sequencing Platform,,, 7/17/2017 RDUS-US  GNW  Radius Health Appoints Jesper HÃ¸iland as President and Chief Executive Officer To Lead The Next Stage Of Growth and Value Creation As A Fully Integrated Commercial Biotech Company, 3/18/2015 04539610 GNW  Assembly Biosciences Announces Proposed Public Offering of Common Stock,,, 2/29/2012 TKM-CA   GNW  Tekmira Updates Financial Guidance: Cash Runway Further Extended Into Second Half of 2013,, 1/05/2018 00972L10 GNW  Akcea Initiates Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia and Established Cardiovascular Disease,, 8/31/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference, 3/01/2017 RTRX-US  GNW  Retrophin Provides Sparsentan Regulatory Update; Reports Fourth Quarter and Full Year 2016 Financial Results," 4/05/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. First Quarter 2016 Financial Results Call"," 3/16/2017 EDIT-US  GNW  Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock",11/12/2015 16706W10 GNW  Chiasma Reports Third Quarter 2015 Financial Results and Recent Business Highlights,10/31/2018 MGNX-US  GNW  MacroGenics Announces Date of Third Quarter 2018 Financial Results Conference Call,,,, 1/06/2017 MNTA-US  GNW  Momenta Provides Year-End 2016 Corporate Update, 1/04/2017 PRTA-US  GNW  Prothena to Participate in the J.P. Morgan Healthcare Conference,,, 5/15/2017 CTMX-US  GNW  CytomX Announces Management Team Changes, 8/09/2017 GMAB-DK  GNW  Genmab Announces Financial Results for the First Half of 2017,,, 3/23/2017 CBAY-US  GNW  CymaBay Reports Fourth Quarter and Year End 2016 Financial Results,, 6/01/2016 CCXI-US  GNW  ChemoCentryx Receives European Medicines Agency PRIority MEdicines (PRIME) Designation for Accelerated Assessment of Complement 5a Receptor Inhibitor CCX168 for Treatment of Patients with ANCA-Associated Vasculitis,,,10/01/2017 MNKD-US   GNW  MannKind Corporation to Hold Investor Conference Call,, 3/05/2018 CYTK-US  GNW  Cytokinetics to Present at March Investor Conferences," 5/08/2018 29664W10    GNW  ESPERION INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Esperion Therapeutics, Inc. To Contact The Firm",10/23/2018 524494-IN GNW  Amyris Partners with IPCA Labs to Earn the 2018 CPhI Award for Excellence in Pharma: API Development,," 8/11/2016 06VHPT-E GNW  Achillion Announces Upcoming Presentation of Interim Phase 2a Results From the Janssen Sponsored Trial of Odalasvir, AL-335 and Simeprevir at the European Association for the Study of the Liver (EASL) Special Conference", 2/27/2019 SYNH-US  GNW  Syneos Health Delays Fourth Quarter and Year End 2018  Earnings Release Date and Conference Call, 1/08/2018 FOLD-US  GNW  Amicus Therapeutics Provides Full-Year 2018 Strategic Outlook and Financial Guidance,,," 3/23/2016 ADMA-US  GNW  ADMA Biologics Reports Year End 2015 Financial Results, Accomplishments and Upcoming Milestones", 6/07/2017 GWPH-US  GNW  GW Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference on 14 June,,, 8/10/2017 MYOK-US  GNW  MyoKardia to Present at 2017 Wedbush PacGrow Healthcare Conference,, 5/20/2018 GLPG-NL  GNW  GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS, 3/12/2018 PTLA-US  GNW  Portola Pharmaceuticals Announces New Interim Results from Ongoing ANNEXA-4 Study of Factor Xa Inhibitor Reversal Agent AndexXaÂ®  (Andexanet Alfa) in Patients with Life-Threatening Bleeding,,,, 3/30/2017 CARA-US  GNW  Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock, 5/03/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),10/19/2017 QURE-US  GNW  uniQure Strengthens Intellectual Property Portfolio with Acquisition of Patent Family Providing Broad Protection of the Hyperactive Padua Variant of Factor IX (FIX-Padua),11/01/2017 AGIO-US   GNW  Agios to Present New Data from PKR and IDH Programs at the 2017 ASH Annual Meeting, 8/31/2017 IOVA-US  GNW  Iovance Biotherapeutics Announces FDA Fast Track Designation for LN-144 for Treatment of Advanced Melanoma,,, 9/01/2017 FATE-US  GNW  Fate Therapeutics to Present at Upcoming Investor Conferences,11/07/2016 HZNP-US  GNW  Horizon Pharma plc Announces Third-Quarter 2016 Financial Results,, 9/01/2017 ICPT-US  GNW  Intercept to Present at Upcoming Conferences," 7/31/2019 48576U10   GNW  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS EGBN, KPTI, LB, NGHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits",,, 8/23/2017 ITCI-US  GNW  Intra-Cellular Therapies Announces Positive Regulatory Update On Schizophrenia Program,,,," 6/22/2015 03209R10 GNW  Amphastar Pharmaceuticals Receives Approval for AMPHADASE(R) Supplement, Marking the First Product From Its China Facility","10/16/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Abstract Publication for Two MSParis2017 Congress Presentations, Including Updated Interim Results from a Phase 1 Study of Autologous ATA190 in Patients with Progressive Multiple Sclerosis (MS)",, 2/22/2017 DERM-US  GNW  Dermira to Report Fourth Quarter and Full Year 2016 Financial Results, 3/09/2016 BCS-GB   GNW  Foamix to Present Corporate Overview at the Barclays Global Healthcare Conference,10/16/2015 PRAH-US  GNW  PRA Health Sciences to Report Third Quarter 2015 Results, 5/03/2016 SUPN-US  GNW  Supernus Announces First Quarter 2016 Financial Results, 1/20/2017 FGEN-US  GNW  Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers Symposium,, 3/01/2018 CHRS-US  GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March," 6/21/2018 CRBP-US  GNW  Corbus Pharmaceuticals Announces Resolution of Inflammation, Infection and Tissue Regeneration Conference",, 9/07/2016 0C5BX7-E GNW  Collegium to Present at the BioCentury NewsMakers Conference, 6/28/2016 XBIT-US  GNW  XBiotech Signs Agreement With Megapharm To Market Xilonixâ„¢ In Israel,,, 4/03/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 9/29/2014 00BXRX-E GNW  REGENXBIO's NAV(R) Technology Demonstrates Correction of Cardiovascular Symptoms of MPS I in Animal Model, 8/29/2017 KURA-US  GNW  Kura Oncology to Participate in Citiâ€™s 12th Annual Biotech Conference,, 2/05/2018 AXSM-US  GNW  Axsome Therapeutics to Present at 2018 BIO CEO & Investor Conference, 2/28/2017 VYGR-US  GNW  Voyager Therapeutics Supports Rare Disease DayÂ® and Global Movement to Raise Awareness for Rare Diseases,10/24/2018 BGNE-US  GNW  BeiGene Announces Acceptance of its New Drug Application in China and Top-Line Pivotal Data for Zanubrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,,10/06/2016 RETA-US  GNW  Reata Enrolls First Patient in Phase 3 CATALYST Trial of Bardoxolone Methyl in CTD-PAH Patients and Reports Positive Interim Data From CTD-PAH Patients in Phase 2 LARIAT Trial,," 5/11/2016 NTLA-US  GNW  Intellia Therapeutics, Inc. (Nasdaq: NTLA) to Ring The Nasdaq Stock Market Opening Bell",, 3/28/2017 CRSP-US  GNW  CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing," 8/01/2017 3621LQ10 GNW  G1 Therapeutics, Inc. (Nasdaq: GTHX) to Ring The Nasdaq Stock Market Closing Bell",,," 4/18/2018 04685N10 GNW  Report: Exploring Fundamental Drivers Behind Exponent, Monotype Imaging, Athenex, State Street, Heartland Financial, and IRSA Inversiones Y Representaciones S.A â€” New Horizons, Emerging Trends, and Upcoming Developments",,,,,,,,,,10/10/2017 COX-FR     GNW  pSivida and Nicox Enter Strategic Collaboration Agreement to Develop Sustained Release Drug to Lower Intraocular Pressure in Patients with Glaucoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/02/2018 PGNX-US  GNW  Summary Judgment Granted Upholding the Validity of Formulation Patent Protecting RELISTORÂ® Injection,,,,,,,, 2/11/2011 82691710     GNW  SIGA Appoints Daniel Luckshire as Chief Financial Officer," 9/25/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, Microchip Technology, and Cocrystal and Encourages Investors to Contact the Firm", 1/17/2012 ALNY-US  GNW  Tekmira Provides Periodic Update to Litigation, 3/18/2015 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 1/17/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NVIDIA, DXC Technology, Immunomedics, and Natural Health and Encourages Investors to Contact the Firm"," 1/05/2017 NAVB-US   GNW  BioXcel Appoints Eric K. Rowinsky, M.D. to its Board of Directors",, 7/10/2018 BCRX-US  GNW  Idera Pharmaceuticals Announces Termination of Merger Agreement with BioCryst Pharmaceuticals,,,,," 6/22/2017 00972810 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Akorn, Inc.",," 8/14/2019 62855J10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Myriad Genetics, Inc. - MYGN", 2/27/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conferences,,10/14/2015 INSM-US  GNW  INSMED Launches Comprehensive Educational Campaign to Raise Awareness of NTM Lung Disease,, 7/18/2017 INO-US    GNW  Inovio Announces Proposed Public Offering of Common Stock,,,10/25/2017 GERN-US  GNW  Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results,," 2/25/2019 02311120 GNW  CLASS ACTION UPDATE for YRIV, W, TAP and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",,, 9/28/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 2/05/2018 AMAG-US  GNW  AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for FerahemeÂ® (ferumoxytol injection),,,,,11/06/2018 SAN-FR   GNW  FDA grants priority review for DupixentÂ® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis,,,,,, 3/15/2017 AFMD-US  GNW  Affimed to Present at the Oppenheimer 27th Annual Healthcare Conference - New York,, 9/21/2017 PRQR-US  GNW  ProQR to Present at Two Investor Conferences in September,,11/08/2018 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Third Quarter Financial Results,,,,,," 9/07/2017 ADVM-US  GNW  Adverum Biotechnologies Appoints Eric G. Carter, M.D., Ph.D. toÂ Board of Directors"," 1/29/2018 RARE-US   GNW  Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and Executive Vice President", 5/20/2016 AGLE-US  GNW  Aeglea BioTherapeutics To Present at the UBS 2016 Global Healthcare Conference, 8/08/2017 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Second Quarter of 2017,,, 7/13/2017 RDUS-US  GNW  Radius Health Announces License and Development Agreement for Abaloparatide-SC with Teijin Limited in Japan, 2/20/2015 04539610 GNW  Assembly Biosciences to Present at 2015 RBC Capital Markets Healthcare Conference,,, 1/17/2012 ALNY-US  GNW  Tekmira Provides Periodic Update to Litigation,,"12/14/2017 00972L10 GNW  Akcea Initiates Phase 2 Study of AKCEA-ANGPTL3-LRx in Patients with Hypertriglyceridemia, Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)",, 8/09/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the 2017 Wedbush Pacgrow Healthcare Conference, 2/15/2017 RTRX-US  GNW  Retrophin to Report Fourth Quarter and Full Year 2016 Financial Results, 3/31/2016 PACB-US  GNW  PacBioâ€™s SMRT Sequencing Provides Scientists with a Superior Gorilla Genome Reference," 3/15/2017 EDIT-US  GNW  Editas Medicine, Inc., Announces Proposed Offering of Common Stock",11/11/2015 16706W10 GNW  Chiasma to Present at Upcoming Investor Conferences,10/29/2018 55609910 GNW  MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology,,,," 1/05/2017 60877T10 GNW  Momenta and CSL Announce Collaboration and License Agreement to Develop Fc Multimer Programs, Including M230, a Selective Immunomodulator of Fc Receptors",12/15/2016 PRTA-US  GNW  Prothena Announces Appointment of Chief Regulatory Officer,,, 5/05/2017 CTMX-US  GNW  CytomX Announces First Quarter 2017 Financial Results, 7/18/2017 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for Second Quarter of 2017,,," 3/16/2017 CBAY-US  GNW  CymaBay to Report Fourth Quarter And Year End 2016 Financial Results on Thursday, March 23",, 5/25/2016 CCXI-US  GNW  ChemoCentryx to Present at the Jefferies 2016 Healthcare Conference,,, 9/07/2017 MNKD-US   GNW  MannKind Responds to Hurricane Harvey Devastation with AfrezzaÂ® Donation,, 2/28/2018 CYTK-US  GNW  Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day," 5/07/2018 29664W10    GNW  Kaskela Law LLC: Shareholder Class Action Filed Against Esperion Therapeutics, Inc. - ESPR",10/19/2018 AMRS-US   GNW  Amyris Successfully Producing its New Zero Calorie Natural Sweetener at Industrial Scale,, 8/09/2016 ACHN-US  GNW  Achillion to Present at the 2016 Wedbush PacGrow Healthcare Conference," 1/25/2019 SYNH-US  GNW  Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Thursday, February 28, 2019",12/21/2017 FOLD-US  GNW  Amicus Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,, 3/07/2016 071V0F-E GNW  ADMA Biologics Announces Data Presented at 2016 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI), 5/24/2017 GWPH-US  GNW  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Groundbreaking Study of EpidiolexÂ® (cannabidiol) in The New England Journal of Medicine,,, 8/08/2017 MYOK-US  GNW  MyoKardia Announces Pricing of Public Offering of Common Stock,, 5/01/2018 GLPG-NL  GNW  Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients, 3/12/2018 PTLA-US  GNW  Portola Pharmaceuticals Appoints Biotech Legal Veteran John Moriarty as Executive Vice President and General Counsel,,,, 3/29/2017 CARA-US  GNW  Cara Therapeutics Announces Proposed Offering of Common Stock," 4/30/2018 FLXN-US  GNW  Flexion Therapeutics to Report First-Quarter 2018Â Financial Results on May 8, 2018",10/19/2017 QURE-US  GNW  uniQure Announces Hemophilia B Gene Therapy Program To Enter Pivotal Study With FIX-Padua Variant in 2018,11/01/2017 AGIO-US   GNW  Agios Reports Third Quarter 2017 Financial Results, 8/31/2017 IOVA-US  GNW  Iovance Biotherapeutics to Present Data at Upcoming ESMO 2017 Congress on Tumor-Infiltrating Lymphocyte Treatment for Lymphoma Indications,,, 8/16/2017 FATE-US  GNW  Fate Therapeutics Announces Issuance of U.S. Patent Covering Use of Viral Transduction Enhancers in Gene Therapy,11/04/2016 HZNP-US  GNW  Horizon Pharma plc to Participate in Investor Conferences in November,, 8/10/2017 ICPT-US  GNW  Intercept to Present at Upcoming Conference," 7/31/2019 48576U10   GNW  Rosen, a Leading Law Firm, Announces Filing of Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm â€“ KPTI",,, 8/09/2017 ITCI-US  GNW  Intra-Cellular Therapies Reports Second Quarter 2017 Financial Results and Provides Corporate Update,,,, 5/29/2015 AMPR-US  GNW  Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2015, 9/11/2017 ATRA-US    GNW  Atara Biotherapeutics Receives Positive Health Canada Regulatory Feedback for ATA129,, 2/08/2017 DERM-US  GNW  Dermira to Present at Leerink Partners 6th Annual Global Healthcare Conference, 3/07/2016 05GSQ9-E GNW  Foamix to Present Corporate Overview at the 28th Annual ROTH Conference,10/13/2015 PRAH-US  GNW  PRA Health Sciences Announces Appointment of New Director, 4/19/2016 SUPN-US  GNW  Supernus to Host First Quarter 2016 Earnings Conference Call,11/08/2016 FGEN-US  GNW  FibroGen Reports Financial Results for the Third Quarter of 2016 and Provides Corporate Update,, 2/27/2018 CHRS-US  GNW  Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th, 6/14/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Present at the JMP Securities Life Science Conference,, 9/06/2016 COLL-US  GNW  Collegium Announces the Launch of OpioidIQ, 6/08/2016 XBIT-US  GNW  XBiotech Appoints Trey Benson as New Commercial Head to Lead Strategic Commercial Development for the Companyâ€™s Extensive Product Portfolio,,, 3/15/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants, 8/27/2014 00BXRX-E GNW  Study Using REGENX Biosciences' NAV(R) Vector Highlights Potential for AAV-Mediated Gene Therapy to Treat Lysosomal Storage Diseases That Affect the CNS, 8/10/2017 KURA-US  GNW  Kura Oncology Announces Pricing of Public Offering of Common Stock,, 1/09/2018 AXSM-US  GNW  Axsome Therapeutics Announces AXS-02 Independent Data Monitoring Committee Recommends Continuation of COAST-1 Trial and Discontinuation of CREATE-1 Trial, 2/13/2017 VYGR-US  GNW  Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS),10/22/2018 BGNE-US  GNW  BeiGene Presents Preliminary Clinical Data on PARP Inhibitor Pamiparib in Combination with Low-Dose Temozolomide in Patients with Solid Tumors at European Society for Medical Oncology (ESMO) 2018 Congress,," 8/11/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Second Quarter 2016 Financial and Operating Results",, 5/05/2016 NTLA-US  GNW  Intellia Therapeutics Announces Pricing of Initial Public Offering,, 3/14/2017 MXCT-GB  GNW  CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte," 7/27/2017 3621LQ10 GNW  G1 Therapeutics to Ring Nasdaq Stock Market Closing Bell on Wednesday, August 2, 2017",,, 3/27/2018 ATNX-US  GNW  Athenex to Present at the 17th Annual Needham Healthcare Conference,,,,,,,,,, 9/26/2017 EYPT-US    GNW  pSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma Drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/26/2018 PGNX-US  GNW  Progenics Pharmaceuticals Sets First Quarter 2018 Financial Results Call for May 9,,,,,,,,11/18/2010 82691710     GNW  SIGA Comments on U.S. Government Survey on Smallpox Antiviral Acquisition," 9/24/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, Microchip Technology, and Cocrystal and Encourages Investors to Contact the Firm"," 2/15/2011 MRK-US   GNW  Aegerion Pharmaceuticals Appoints Diane L. Tribble, Ph.D., M.M.Sc., as Chief Scientific Officer", 3/17/2015 BMRN-US     GNW  Myriad and BioMarin Expand Collaboration to Evaluate myChoice HRD(TM) as a Companion Diagnostic for Talazoparib,,,, 1/17/2019 IMMU-US  GNW  Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application,"12/16/2016 09062X10  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2016 â€“ BIIB",, 6/25/2018 BCRX-US  GNW  BioCryst Reports Agreement with PMDA on Phase 3 Clinical Trial and Regulatory Requirements for Marketing Authorization of BCX7353 in Japan,,,,," 6/02/2017 00972810 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Akorn, Inc. (AKRX)",, 8/13/2019 MYGN-US  GNW  Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results, 2/22/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update,,10/06/2015 INSM-US  GNW  Insmed Announces Upcoming Data Presentations at Infectious Disease Week 2015,, 7/06/2017 INO-US    GNW  Inovioâ€™s DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation,,, 9/19/2017 GERN-US  GNW  Geron to Present at the Cantor Fitzgerald Healthcare Conference,," 2/19/2019 AMRN-US  GNW  Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019",,," 9/26/2018 SRPT-US  GNW  Sarepta Therapeutics and Jerry R. Mendell, M.D. from Nationwide Childrenâ€™s Hospital to Provide Update on Duchenne Muscular Dystrophy Gene Therapy Program from the 23rd International Annual Congress of the World Muscle Society",,, 1/08/2018 AMAG-US  GNW  AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results  and Provides 2018 Guidance,,,,,11/01/2018 SAN-FR   GNW  Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases,,,,,, 3/14/2017 AFMD-US  GNW  Affimed to Present at the Oppenheimer 27th Annual Healthcare Conference - New York,, 9/19/2017 PRQR-US  GNW  ProQR Receives Orphan Drug Designation from FDA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa and will Present Data at two Scientific Conferences,,11/07/2018 ZGNX-US  GNW  Zogenix to Present at Stifel 2018 Healthcare Conference,,,,,, 9/07/2017 ADVM-US  GNW  Adverum Biotechnologies to Present at BioCenturyâ€™s 24th Annual NewsMakers in the Biotech Industry Conference, 1/23/2018 RARE-US   GNW  Ultragenyx Announces Pricing of Public Offering of Common Stock, 5/19/2016 AGLE-US  GNW  Aeglea BioTherapeutics Announces First Quarter 2016 Financial Results, 8/08/2017 63009R10 GNW  NanoString and Lam Research Announce Strategic Development Collaboration to Advance Hyb & Seq Next Generation Sequencing Platform,,," 7/07/2017 RDUS-US  GNW  Radius Health to Announce Second Quarter 2017 Financial Results, Host Conference Call and Live Webcast on August 3, 2017", 2/17/2015 04539610 GNW  Assembly Biosciences Announces Senior Management Changes,,, 1/10/2012 TKM-CA   GNW  Tekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia,,12/07/2017 IONS-US  GNW  Akcea to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference,," 8/02/2017 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results"," 2/13/2017 RTRX-US  GNW  Retrophin Appoints William Rote Senior Vice President, Research and Development", 2/08/2016 PACB-US  GNW  Biomedical Research Advances Using PacBioâ€™s SMRT Sequencing Technology to be Featured at This Yearâ€™s AGBT Conference, 3/14/2017 28106W10 GNW  Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases,10/29/2015 16706W10 GNW  Chiasma to Report Third Quarter 2015 Financial Results on November 12,10/22/2018 MGNX-US  GNW  MacroGenics Announces Participation in Three Investor Conferences,,,, 1/03/2017 JPM-US   GNW  Momenta Pharmaceuticals to Webcast Presentation at the 35th Annual J. P. Morgan Healthcare Conference,"12/13/2016 PRTA-US  GNW  First-In-Human Assessment of PRX002, Prothenaâ€™s Anti-Alpha Synuclein Antibody for Parkinsonâ€™s Disease, Published in Movement Disorders Journal",,, 4/27/2017 CTMX-US  GNW  CytomX Therapeutics to Announce First Quarter 2017 Financial Results, 6/16/2017 GMAB-DK  GNW  Genmab Announces U.S. FDA Approval of DARZALEXÂ® (daratumumab) in Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma,,, 3/09/2017 CBAY-US  GNW  CymaBay Therapeutics to Present at Two Investor Conferences in March,, 5/23/2016 CCXI-US  GNW  ChemoCentryx Announces Presentation of Positive Results from Phase II ANCA-Associated Vasculitis CLEAR Trial of Orally Administered Complement 5a Receptor Inhibitor CCX168 at the 53rd ERA-EDTA Congress,,, 9/05/2017 MNKD-US   GNW  MannKind Corporation Relocates Headquarters to Westlake Village,," 2/15/2018 CYTK-US  GNW  Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results"," 5/07/2018 29664W10    GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Esperion Therapeutics, Inc. and Certain Officers â€“ ESPR","10/03/2018 AMRS-US   GNW  Amyris Signs First Major Supply and Distribution Agreement for its New, Zero Calorie Sweetener with ASR Group, the Worldâ€™s Largest Cane Sugar Refiner",, 8/04/2016 ACHN-US  GNW  Achillion Reports Second Quarter 2016 Financial Results," 1/07/2019 SYNH-US  GNW  Syneos Health Names Paul Colvin, President, Clinical Solutions",12/14/2017 FOLD-US  GNW  Amicus Therapeutics Submits New Drug Application to U.S. FDA for Migalastat for Treatment of Fabry Disease,,, 3/01/2016 0024VM-E GNW  ADMA Biologics to Present at Cowen and Company 36th Annual Health Care Conference, 5/15/2017 GWPH-US  GNW  GW Pharmaceuticals Announces Research & Development Management Appointments,,, 8/07/2017 MYOK-US  GNW  MyoKardia Announces Proposed Public Offering of Common Stock,, 4/27/2018 GLPG-NL  GNW  Galapagos presents strong disease-modifying effects in  preclinical model of osteoarthritis with GLPG1972 at OARSI 2018, 3/06/2018 PTLA-US  GNW  Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences,,,, 3/28/2017 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at the 16th Annual Needham Healthcare Conference, 4/29/2018 FLXN-US  GNW  Flexion Therapeutics Announces Presentation of Positive FX201 Data at the Osteoarthritis Research Society International World Congress,10/18/2017 QURE-US  GNW  uniQure Presents New Preclinical Data on AMT-130 in Huntingtonâ€™s Disease at the ESGCT 25th Anniversary Congress in Berlin,"10/31/2017 AGIO-US   GNW  Agios to Present at the 26th Annual Credit Suisse Healthcare Conference Tuesday, November 7, 2017", 8/16/2017 IOVA-US  GNW  Iovance Biotherapeutics Announces First Patient Dosed in C-145-04 Phase 2 Trial in Cervical Cancer,,, 8/14/2017 FATE-US  GNW  Fate Therapeutics Reports Second Quarter 2017 Financial Results,11/03/2016 HZNP-US  GNW  Horizon Pharma plc Announces Availability of RAVICTIÂ® (glycerol phenylbutyrate) Oral Liquid in Canada,, 7/31/2017 ICPT-US  GNW  Intercept Announces Positive Results from the Phase 2 AESOP Trial Evaluating OCA for the Treatment of Patients with Primary Sclerosing Cholangitis," 7/31/2019 48576U10   GNW  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of RMED, CTST, OMCL and KPTI",,, 7/20/2017 ITCI-US  GNW  Intra-Cellular Therapies Presents at the 2017 International College of Neuro-Psychopharmacology (CINP) Thematic Meeting on Treatment-Resistant Depression,,,," 5/13/2015 03209R10 GNW  Amphastar Pharmaceuticals Reports Net Revenues of $56.9 Million for the First Quarter Ended March 31, 2015", 9/05/2017 ATRA-US    GNW  Atara Biotherapeutics Receives FDA Orphan Drug Designation for ATA230,, 1/19/2017 24983L10 GNW  Final CIMZIAÂ® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic Plaque Psoriasis, 3/03/2016 FOMX-US  GNW  Foamix Reports Fiscal Year 2015 Financial Results and Provides Business Update, 9/29/2015 69354M10 GNW  PRA Health Sciences Collaborates With AMR to Accelerate Vaccine Development, 3/02/2016 SUPN-US  GNW  Supernus Announces Record Fourth Quarter and Full Year 2015 Financial Results,"11/01/2016 FGEN-US  GNW  FibroGen to Report Third Quarter 2016 Financial Results on November 8, 2016",, 1/02/2018 CHRS-US  GNW  Coherus BioSciences Management to Present at The 36th Annual J.P. Morgan Healthcare Conference, 6/13/2018 CRBP-US  GNW  Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018,, 9/01/2016 COLL-US  GNW  Collegium Announces Scientific Presentations at PAINWeek 2016 Meeting, 5/24/2016 XBIT-US  GNW  XBiotech to Present Positive Preliminary Survival Data on Xilonixâ„¢ at the 18th European Society of Medical Oncologyâ€™s World Congress on Gastrointestinal Cancer,,," 3/08/2018 GBT-US   GNW  Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock", 6/02/2014 00BXRX-E GNW  REGENX Biosciences and Voyager Therapeutics Announce License Agreement, 8/09/2017 KURA-US  GNW  Kura Oncology Announces Commencement of Public Offering of Common Stock,,12/19/2017 AXSM-US  GNW  Axsome Therapeutics to Present at Biotech Showcase 2018, 2/02/2017 VYGR-US  GNW  Voyager Therapeutics to Attend Upcoming Investor Conferences,"10/19/2018 07725L10 GNW  Detailed Research: Economic Perspectives on BeiGene, Costco Wholesale, Rogers, Advance Auto Parts, Celcuity, and Harris â€” What Drives Growth in Today's Competitive Landscape",," 6/23/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Interim Data From Extension Phase 2 LARIAT Study in Pulmonary Arterial Hypertension",,,, 3/10/2017 CRSP-US  GNW  CRISPR Therapeutics Reports Fourth Quarter and  Full Year 2016 Financial Results and Provides Business Update, 7/13/2017 GTHX-US  GNW  G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors,,," 3/26/2018 ATNX-US  GNW  Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results",,,,,,,,,, 9/22/2017 EYPT-US    GNW  pSivida to Present at the Ladenburg Thalmann 2017 Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/25/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,,,,,,,,11/07/2010 82691710     GNW  SIGA to Appeal Adverse Small Business Size Determination," 9/23/2018 68375N10 GNW  CLASS ACTION UPDATE for USAT and OPK: Levi & Korsinsky, LLP Notifies Investors of Class Actions on Behalf of Shareholders",, 2/25/2015 09061G10    GNW  BioMarin Announces Fourth Quarter and Full Year 2014 Financial Results,,,," 1/16/2019 45290710 GNW  IMMU $250K LOSS NOTICE: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc.; Reminds Investors with Losses Over $250K of Important Deadline â€“ IMMU","11/11/2016 09062X10  GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2016 â€“ BIIB",, 6/13/2018 09058V10 GNW  BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference,,,,, 4/07/2017 FRE-DE   GNW  Akorn Confirms Discussions with Fresenius Kabi,, 8/07/2019 62855J10 GNW  Myriad Will Seek FDA Approval of BRACAnalysis CDxÂ® As a Companion Diagnostic for LynparzaÂ® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer," 2/16/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call and Webcast on February 22, 2018",, 9/23/2015 INSM-US  GNW  Insmed to Present at the Leerink Partners Rare Disease Roundtable,, 6/28/2017 INO-US    GNW  Inovio Announces Leadership Appointments,,, 8/09/2017 GERN-US  GNW  Geron Corporation Reports Second Quarter 2017 Financial Results,, 2/14/2019 AMRN-US  GNW  Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference,,, 9/24/2018 SRPT-US  GNW  Sarepta Announces Clinical Hold Lifted for its Duchenne Muscular Dystrophy Micro-dystrophin Gene Therapy Program,,,"12/21/2017 AMAG-US  GNW  AMAG Pharmaceuticals Awards $300,000 in Grants to Further Research in Preterm Birth and  Neonatal Health",,,,,10/31/2018 SAN-FR   GNW  Sanofi Q3 2018 Performance Confirms Return to Growth,,,,,, 3/01/2017 AFMD-US  GNW  Affimed to Present Data on Immune Cell Engagers at the AACR Annual Meeting 2017,, 9/05/2017 PRQR-US  GNW  ProQRâ€™s Drug Candidate QRX-421 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA,,11/01/2018 ZGNX-US  GNW  Zogenix to Release Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 8,,,,,, 8/08/2017 ADVM-US  GNW  Adverum Biotechnologies Reports  Second Quarter 2017 Financial Results and Provides Update, 1/22/2018 RARE-US   GNW  Ultragenyx Announces Proposed Public Offering of Common Stock, 5/16/2016 AGLE-US  GNW  Aeglea BioTherapeutics Names Dr. Sandra Rojas-Caro as Chief Medical Officer," 7/10/2017 NSTG-US  GNW  NanoString to Release Second Quarter 2017 Financial Results and Host Conference Call on Tuesday, August 8, 2017",,, 6/04/2017 RDUS-US  GNW  Radius Presents Positive Data From A Fully Enrolled Ongoing Phase I Study for Investigational Drug Elacestrant (RAD1901) at the 2017 American Society of Clinical Oncology Annual Meeting (ASCO),12/03/2014 04539610 GNW  Assembly Biosciences to Present at Investor Conferences,,, 1/04/2012 TKM-CA   GNW  Tekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data,,"11/15/2017 00972L10 GNW  Akcea and Ionis Announce Acceptance of Marketing Applications in U.S., EU and Canada for Volanesorsen for the Treatment of FCS",, 7/26/2017 PCRX-US  GNW  Pacira Announces Publication of Phase 4 Study of EXPAREL in Patients Undergoing Total Knee Replacement in The Journal of Arthroplasty, 1/09/2017 06CR5C-E GNW  Retrophin Provides Corporate Update and 2017 Preview, 2/03/2016 PACB-US  GNW  Pacific Biosciences Announces Fourth Quarter 2015 Financial Results, 3/07/2017 EDIT-US  GNW  Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update,, 9/26/2018 MGNX-US  GNW  MacroGenics Announces Participation in Two Upcoming Investor Conferences,,,,"11/29/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Positive Top-Line Phase 3 Results for M923, a Proposed HUMIRAÂ® (adalimumab) Biosimilar",11/09/2016 PRTA-US  GNW  Prothena Reports Results from Phase 1b Study of PRX002 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinsonâ€™s Disease,,, 3/30/2017 CTMX-US  GNW  CytomX Therapeutics Appoints Marion McCourt to Board of Directors, 6/16/2017 GMAB-DK  GNW  Genmab Announces Preliminary Cervical Cancer Data from Tisotumab Vedotin Phase I/II Study,,, 2/07/2017 CBAY-US  GNW  CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference,, 5/12/2016 CCXI-US  GNW  ChemoCentryx Announces Data Presentation of Novel CCR6 Inhibitors at the 2016 Society for Investigative Dermatology (SID) Annual Meeting,,, 9/01/2017 MNKD-US   GNW  MannKind Corporation to Present at Upcoming Conferences,, 2/14/2018 CYTK-US  GNW  Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference, 5/04/2018 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the Deutsche Bank 43rd Annual Health Care Conference," 9/27/2018 002019-CN GNW  Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.",," 6/10/2016 07G766-E GNW  Achillion Presents Interim Phase 1 Results for ACH-4471, a Novel Orally-Administered Factor D Inhibitor, at the 21st Congress of the European Hematology Association", 1/04/2019 SYNH-US  GNW  Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events,11/08/2017 FOLD-US  GNW  Amicus Therapeutics Announces Third Quarter 2017  Financial Results and Corporate Updates,,, 2/24/2016 ADMA-US  GNW  ADMA Biologics Recognized as One of New Jerseyâ€™s â€œBest Places to Work 2016â€, 5/09/2017 GWPH-US  GNW  GW Pharmaceuticals plc Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress,,, 8/07/2017 MYOK-US  GNW  MyoKardia Reports Second Quarter 2017 Financial Results and Operational Progress,, 4/25/2018 GLPG-NL  GNW  Galapagos reports first quarter 2018 results, 3/05/2018 PTLA-US  GNW  Portola Pharmaceuticals to Host Webcast Event and Conference Call at ACC.18 to Discuss Late-Breaking Oral Presentation Highlighting New Interim Data for Andexanet Alfa,,,, 3/28/2017 CARA-US  GNW  Cara Therapeutics Announces Positive Top-Line Data From Part A of Phase 2/3 Trial of I.V. CR845 in Chronic Kidney Disease-Associated Pruritus, 4/26/2018 FLXN-US  GNW  Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTAÂ®Â (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress,10/06/2017 QURE-US  GNW  uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntingtonâ€™s disease,"10/25/2017 AGIO-US   GNW  Agios to Webcast Conference Call of Third Quarter 2017 Financial Results on November 1, 2017", 8/08/2017 IOVA-US  GNW  Iovance Biotherapeutics Appoints Timothy Morris as Chief Financial Officer,,, 8/09/2017 FATE-US  GNW  Fate Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference,10/25/2016 G4618810 GNW  Horizon Pharma plc Completes Acquisition of Raptor Pharmaceutical Corp.,, 7/31/2017 ICPT-US  GNW  CONTROL Trial Shows Statin Therapy Reversed LDL Increases to Below Baseline Levels in NASH Patients Treated with OCA," 7/30/2019 KPTI-US    GNW  Karyopharm to Report Second Quarter 2019 Financial Results on August 6, 2019",,," 7/11/2017 46116X10 GNW  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI) and Lead Plaintiff Deadline - July 11, 2017",,,, 5/11/2015 03209R10 GNW  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference, 8/31/2017 ATRA-US    GNW  Atara Biotherapeutics to Participate in Three Upcoming Investor Conferences,, 1/06/2017 DERM-US  GNW  Dermira Provides Corporate Update, 2/29/2016 0024VM-E GNW  Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare Conference, 9/10/2015 69354M10 GNW  PRA Health Sciences Looks to Expand Workforce in Pennsylvania, 2/25/2016 SUPN-US  GNW  Supernus to Present at March Cowen Health Care Conference,10/31/2016 FGEN-US  GNW  FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China,,12/01/2017 CHRS-US  GNW  Coherus BioSciences Management to Present at BMOâ€™s Prescriptions for Success Healthcare Conference," 6/06/2018 21833P10 GNW  Research Report Identifies Corbus Pharmaceuticals, Retrophin, Charter Financial, HighPoint Resources, Southern First Bancshares, and Oaktree Specialty Lending with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",, 8/16/2016 COLL-US  GNW  Collegium Announces Publication of Data on Alternative Modes of Administration of Xtampza ER, 5/18/2016 XBIT-US  GNW  XBiotech Provides First Quarter 2016 Corporate and Clinical Update,,, 3/08/2018 GBT-US   GNW  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock,, 8/07/2017 KURA-US  GNW  Kura Oncology Reports Second Quarter 2017  Financial Results and Provides Update on Tipifarnib Phase 2 Study,,12/14/2017 AXSM-US  GNW  Axsome Therapeutics Collaborates with World-Leading Nicotine Addiction Research Center for Phase 2 Trial of AXS-05 in Smoking Cessation, 1/25/2017 07MYH3-E GNW  Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Journal of Neuroscience,10/12/2018 BGNE-US  GNW  BeiGene Announces Updated Results from Phase 1 Clinical Trial of Zanubrutinib in Patients with WaldenstrÃ¶mâ€™s Macroglobulinemia,," 6/01/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares of Class A Common Stock",,,, 3/02/2017 CRSP-US  GNW  CRISPR Therapeutics to Present at the Annual Barclays Global Healthcare Conference, 5/30/2017 GTHX-US  GNW  G1 Therapeutics to Present Clinical Data on CDK4/6 Inhibitor Trilaciclib at the 2017 American Society of Clinical Oncology Annual Meeting,,," 2/26/2018 ATNX-US  GNW  Athenex, Inc. to Report Fourth Quarter and Full Year 2017 Earnings Results on March 26, 2018",,,,,,,,,, 9/11/2017 EYPT-US    GNW  pSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/02/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference,,,,,,,,11/02/2010 82691710     GNW  SIGA Technologies Reports Financial Results for the Third Quarter of 2010," 9/22/2018 68375N10 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers â€“Â OPK",, 2/20/2015 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 1/15/2019 45290710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, YRCW, IMMU and YRIV",10/24/2016 09062X10  GNW  Labaton Sucharow LLP Files Class Action Lawsuit on Behalf of Biogen Inc. Investors,, 5/29/2018 BCRX-US  GNW  BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress,,,,," 3/02/2017 AKRX-US  GNW  Akorn Receives FDA Approval for Ephedrine Sulfate Injection, USP",," 8/06/2019 MYGN-US  GNW  Myriad to Announce Fiscal Fourth-Quarter 2019 Financial Results on August 13, 2019", 1/02/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Poster Presentation at ASCO GI,, 9/22/2015 INSM-US  GNW  Insmed Announces Upcoming Data Presentations at ERS 2015,, 6/19/2017 INO-US    GNW  Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention,,, 7/31/2017 GERN-US  GNW  Geron Announces Updates to Imetelstat Clinical Development,, 1/23/2019 AMRN-US  GNW  New REDUCE-ITâ„¢ Trial Data Showing the Total Reduction in Ischemic EventsÂ Accepted for Presentation at theÂ American College of Cardiologyâ€™s 68th Annual Scientific Session,,, 9/21/2018 SRPT-US  GNW  Sarepta Receives Negative CHMP Re-examination Opinion for Eteplirsen,,,12/20/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,,,10/19/2018 SAN-FR   GNW  Sanofi: FDA approves asthma indication for DupixentÂ® (dupilumab),,,,,, 2/28/2017 AFMD-US  GNW  Affimed to Present at the Cowen and Company 37th Annual Health Care Conference,, 8/29/2017 PRQR-US  GNW  ProQR Completes Dosing of Cystic Fibrosis Patients in QR-010 Phase 1b Trial,,10/01/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,," 6/20/2017 ADVM-US  GNW  Adverum Biotechnologies, Inc. Announces Appointment ofÂ Athena Countouriotis, M.D. as SVP and Chief Medical Officer", 1/07/2018 RARE-US   GNW  Ultragenyx Announces Positive Interim Topline Results From First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) DeficiencyÂ , 4/19/2016 06P9WL-E GNW  Aeglea BioTherapeutics to Present New Data at American Association for Cancer Research (AACR) Annual Meeting, 7/05/2017 NSTG-US  GNW  NanoString Appoints J. Chad Brown as Senior Vice President of Sales and Marketing,,, 5/24/2017 RDUS-US  GNW  Radius Announces Positive Top-Line Results from Completed ACTIVExtend Study for TYMLOSâ„¢ in Postmenopausal Women with Osteoporosis,10/01/2014 04539610 GNW  Assembly Biosciences Announces $15.75 Million Registered Direct Offering,,,12/21/2011 TKM-CA   GNW  Tekmira Provides Periodic Update to Litigation,,11/13/2017 00972L10 GNW  Akcea Initiates AKCEA-ANGPTL3-LRx Phase 2 Program in Patients with Rare Hyperlipidemias,, 7/25/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for Second Quarter 2017 Financial Results Webcast and Conference Call, 1/04/2017 RTRX-US  GNW  Retrophin Appoints Elizabeth Reed General Counsel," 1/22/2016 PACB-US  GNW  UPDATE: Pacific Biosciences of California, Inc. Announces Date Change for 4th Quarter and Fiscal Year 2015 Financial Results;  Call Now Scheduled for February 3, 2016 at 4:30pm ET", 3/03/2017 EDIT-US  GNW  Editas Medicine Announces Departure of Chief Operating Officer,, 8/30/2018 MGNX-US  GNW  MacroGenics Announces Participation in Three Upcoming Investor Conferences,,,,"11/17/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Publication on the Design of M230, a Novel Autoimmune Disease Drug Candidate, in Science Translational Medicine",11/03/2016 06QBQ2-E GNW  Data for Prothenaâ€™s NEOD001 to be Presented at the 58th Annual American Society of Hematology Meeting,,, 3/19/2017 CTMX-US  GNW  CytomX Therapeutics Announces Teleconference and Webcast to Provide Corporate Update, 5/17/2017 GMAB-DK  GNW  Genmab Announces Plans for New Studies of Daratumumab,,, 2/02/2017 CBAY-US  GNW  CymaBay Announces Pricing of Public Offering of Common Stock,," 5/11/2016 CCXI-US  GNW  ChemoCentryx to Host R&D Day on May 18, 2016",,, 8/07/2017 MNKD-US   GNW  MannKind Corporation Reports 2017 Second Quarter Financial Results,," 2/12/2018 CYTK-US  GNW  Cytokinetics Names Robert Califf, M.D., to Board of Directors", 5/02/2018 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports First Quarter 2018 Financial Results," 9/25/2018 AMRS-US   GNW  Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 4, 2018",, 6/01/2016 ACHN-US  GNW  Achillion to Present at Three Upcoming Investor Conferences,12/18/2018 SYNH-US  GNW  Syneos Health to Present at the 37th Annual J.P. Morgan Healthcare Conference,"10/25/2017 FOLD-US  GNW  Amicus Therapeutics to Announce Third Quarter 2017  Financial Results on November 8, 2017",,,12/09/2015 ADMA-US  GNW  ADMA Biologics Expands Commercial Operations Team in Preparation for Commercial Launch of RI-002 in Second Half of 2016, 5/05/2017 GWPH-US  GNW  GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Health Care Conference on 17 May,,," 8/07/2017 MYOK-US  GNW  MyoKardia Reports Positive Topline Results in Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) in Symptomatic, Obstructive Hypertrophic Cardiomyopathy",, 4/24/2018 GLPG-NL  GNW  Galapagos reports initiation of FALCON clinical trial in cystic fibrosis, 2/28/2018 PTLA-US  GNW  Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update,,,, 3/13/2017 CARA-US  GNW  Cara Therapeutics to Present at March Medical Meetings, 4/24/2018 FLXN-US  GNW  Flexion Therapeutics to Present Data on ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) at the Academy of Managed Care Pharmacy Annual Meeting 2018,10/02/2017 QURE-US  GNW  uniQure Announces Company Presentations at Upcoming October Conferences," 9/05/2017 AGIO-US   GNW  Agios to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Monday, September 11, 2017", 8/01/2017 IOVA-US  GNW  Iovance Biotherapeutics Reports Second Quarter 2017 Financial Results,,, 8/08/2017 FATE-US  GNW  Fate Therapeutics Announces Publication of Preclinical Data in Cancer Research and FDA Clearance of Third IND for FATE-NK100,10/20/2016 HZNP-IE  GNW  Horizon Pharma plc Announces Pricing of Private Offering of Senior Notes,, 7/31/2017 ICPT-US  GNW  Intercept Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update," 7/29/2019 48576U10   GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Karyopharm Therapeutics Inc. To Contact The Firm",,," 7/10/2017 46116X10 GNW  DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Reminds Investors with Losses to Contact the Firm",,,," 5/07/2015 03209R10 GNW  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 13, 2015", 8/22/2017 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),, 1/05/2017 065JRH-E GNW  Lori Lyons-Williams Joins Dermira as Chief Commercial Officer," 2/18/2016 FOMX-US  GNW  Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2015 Financial Results Conference Call & Webcast Scheduled for Thursday, March 3"," 7/27/2015 69354M10 GNW  PRA Health Sciences, Inc. Reports Second Quarter 2015 Results and Provides Updated Guidance for 2015", 2/18/2016 SUPN-US  GNW  Supernus to Host Fourth Quarter and Full Year 2015 Earnings Conference Call, 8/08/2016 FGEN-US  GNW  FibroGen Reports Financial Results for the Second Quarter of 2016,,11/06/2017 CHRS-US  GNW  Coherus BioSciences Reports Third Quarter 2017 Operating and Financial Results," 6/06/2018 CRBP-US  GNW  Corbus Pharmaceuticals Appoints Former Director of FDA Office of New Drugs John K. Jenkins, MD to Board of Directors",, 8/10/2016 06CR5C-E GNW  Collegium Reports Second Quarter Financial Results and Provides Corporate Update, 5/16/2016 XBIT-US  GNW  XBiotech Names Industry Veteran Dawn McCollough to Head Clinical Operations,,, 3/06/2018 GBT-US   GNW  GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer,, 7/31/2017 KURA-US  GNW  Kura Oncology to Report Second Quarter 2017 Financial Results,,12/06/2017 AXSM-US  GNW  Axsome Therapeutics Announces Closing of $9.5 Million Registered Direct Offering, 1/20/2017 VYGR-US  GNW  Voyager Therapeutics Announces Updates from Phase 1b Trial of VY-AADC01 for Advanced Parkinsonâ€™s Disease,10/10/2018 BGNE-US  GNW  BeiGene Announces National Reimbursement Inclusion of VIDAZAÂ® (Azacitidine for Injection) by the State Medical Insurance Administration in China,," 5/26/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. (Nasdaq: RETA) to Ring The Nasdaq Stock Market Closing Bell",,,," 2/28/2017 CRSP-US  GNW  CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation", 5/23/2017 GTHX-US  GNW  G1 Therapeutics Announces Closing of Initial Public Offering,,, 2/20/2018 ATNX-US  GNW  Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the Treatment of Actinic Keratosis in the American Academy of Dermatology Meeting,,,,,,,,,, 9/11/2017 EYPT-US    GNW  pSivida to Present at Rodman & Renshaw Annual Global Investment Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/22/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRAÂ® (iobenguane I 131),,,,,,,,"10/29/2010 82691710     GNW  SIGA to Discuss Third Quarter Results of Operations on November 2, 2010", 9/21/2018 68375N10 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PVG OPK and USAT,, 2/10/2015 09061G10    GNW  Prosensa Announces Voluntary Delisting and Advance Liquidation Distribution,,,," 1/15/2019 45290710 GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Immunomedics, Inc. Investors","10/21/2016 09062X10  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit â€“ BIIB",, 5/24/2018 BCRX-US  GNW  BioCryst's BCX7353 Receives European Regulatory Designations for the Treatment of Hereditary Angioedema,,,,, 3/01/2017 AKRX-US  GNW  Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance,, 6/27/2019 MYGN-US  GNW  ProlarisÂ® Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer, 1/02/2018 LXRX-US  GNW  Lexicon Pharmaceuticals to Present at Upcoming Investor Conference,, 9/14/2015 INSM-US  GNW  Insmed Announces Upcoming Data Presentations at ICAAC/ICC 2015,, 6/15/2017 45773H20  GNW  Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues Leadership to Advance an Effective Preventive Solution,,, 5/09/2017 GERN-US  GNW  Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events,, 1/04/2019 AMRN-US  GNW  Amarin Provides Preliminary 2018 Results and 2019 Outlook,,, 9/07/2018 SRPT-US  GNW  Sarepta Therapeutics to Recognize World Duchenne Awareness Day at NASDAQ Opening Bell Ceremony,,,"12/20/2017 AMAG-US  GNW  New Patent Issued to AMAG Pharmaceuticals Entitled ""Methods of Reducing Risk of Preterm Birth""",,,,,10/19/2018 SAN-FR   GNW  Sanofi receives positive CHMP opinion for dengue vaccine,,,,,, 2/08/2017 AFMD-US  GNW  Affimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference,," 8/28/2017 PRQR-US  GNW  ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott Armstrong",, 9/25/2018 ZGNX-US  GNW  Zogenix to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology,,,,,, 5/22/2017 ADVM-US  GNW  Adverum Biotechnologies to Present at the Jefferies Global Healthcare Conference, 1/04/2018 RARE-US   GNW  Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients, 4/18/2016 06P9WL-E GNW  Aeglea BioTherapeutics to Present New Data at American Association for Cancer Research (AACR) Annual Meeting," 6/06/2017 NSTG-US  GNW  NanoString Technologies Announces Closing of Public Offering of 3,450,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares",,, 5/15/2017 RDUS-US  GNW  Radius Health Announces New Employment Inducement Grant, 7/25/2014 04539610 GNW  Assembly Biosciences Provides Update on Status of VEN 307,,,11/21/2011 ALNY-US  GNW  Tekmira's LNP Technology Enables Alnylam's ALN-TTR01 Clinical Data,,11/07/2017 AKCA-US  GNW  Akcea to Present at Stifel 2017 Healthcare Conference,, 7/25/2017 PCRX-US  GNW  Pacira Announces Topline Phase 3 Results for EXPARELÂ® as a Single-dose Nerve Block,12/29/2016 JPM-US   GNW  Retrophin to Present at the 35th Annual J.P. Morgan Healthcare Conference," 1/19/2016 PACB-US  GNW  Pacific Biosciences of California, Inc. Fourth Quarter and Year End 2015 Financial Results Call", 2/28/2017 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2016 Corporate Update and Results,," 8/21/2018 55609910 GNW  Recent Analysis Shows DURECT, Corporacion America Airports S.A., Golden Star Resources, MacroGenics, Merus N.V., and Superior Uniform Group Market Influences â€” Renewed Outlook, Key Drivers of Growth",,,,11/02/2016 MNTA-US  GNW  Momenta Pharmaceuticals Reports Third Quarter 2016 Financial Results,11/01/2016 PRTA-US  GNW  Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update,,, 3/02/2017 CTMX-US  GNW  CytomX Announces Full-Year 2016 Financial Results, 5/10/2017 GMAB-DK  GNW  Genmab Announces Financial Results for the First Quarter of 2017,,, 2/01/2017 CBAY-US  GNW  CymaBay Announces Proposed Public Offering of Common Stock,, 5/10/2016 CCXI-US  GNW  ChemoCentryx Reports First Quarter 2016 Financial Results and Provides Corporate Update,,, 8/07/2017 0FL5G3-E  GNW  MannKind and One Drop Partner to Launch the A-ONE Clinical Trial,," 2/02/2018 CYTK-US  GNW  Cytokinetics to Announce Fourth Quarter Results on February 15, 2018", 5/02/2018 ESPR-US     GNW  Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Long-Term Safety Study of Bempedoic Acid," 9/17/2018 AMRS-US   GNW  Amyris Provides Update on Leland, NC Production Facility",, 5/19/2016 ACHN-US  GNW  Achillion Announces Acceptance of Late Breaking Abstract for ACH-4471 at the 21st Congress of the European Hematology Association,"12/10/2018 87166B10 GNW  John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman","10/06/2017 FOLD-US  GNW  Amicus Therapeutics Appoints Michael C. Diem, MD as Senior Vice President of Business and Corporate Development",,,12/03/2015 ADMA-US  GNW  ADMA Biologics to Present at the Oppenheimer 26th Annual Healthcare Conference," 5/02/2017 GWPH-US  GNW  GW Pharmaceuticals to Report Q2 Financial Results  and Host Conference Call on 9 May, 2017",,," 7/31/2017 MYOK-US  GNW  MyoKardia to Announce Second Quarter 2017 Financial Results and Host Conference Call on Monday, August 7, 2017",, 4/19/2018 GLPG-NL  GNW  Galapagos creates new warrant plan, 2/20/2018 PTLA-US  GNW  Portola Pharmaceuticals Announces Results of CHMP Oral Explanations for Andexanet Alfa and Betrixaban,,,, 3/09/2017 CARA-US  GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results, 4/18/2018 FLXN-US  GNW  Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTAÂ® (triamcinolone acetonide extended-release injectable suspension) in theÂ Journal of Bone and Joint Surgery, 8/24/2017 QURE-US  GNW  uniQure Announces Company Participation at Citi Healthcare Conference, 8/08/2017 AGIO-US   GNW  Agios Reports Second Quarter 2017 Financial Results," 7/25/2017 IOVA-US  GNW  Iovance Biotherapeutics to Host Conference Call to Discuss Second Quarter 2017 Financial and Operating Results on Tuesday, August 1, 2017",,, 8/07/2017 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2017 Financial Results,10/13/2016 09YVY3-E GNW  Horizon Pharma plc Announces Proposed Private Offering of Senior Notes and Intention to Borrow Incremental Term Loans under its Existing Senior Secured Credit Facility,, 7/26/2017 ICPT-US  GNW  Intercept to Report Second Quarter 2017 Financial Results on July 31, 7/29/2019 48576U10   GNW  SHAREHOLDER ALERT: MBNKF RLGY FRED KPTI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,,," 7/07/2017 46116X10 GNW  ITCI Â NOTICE: Rosen Law Firm Reminds Intra-Cellular Therapies, Inc. Investors of Important July 11 Deadline in First Filed Class Action â€“ ITCI",,,, 4/14/2015 03209R10 GNW  Amphastar Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference, 8/22/2017 ATRA-US    GNW  Atara Biotherapeutics Expands Leadership Team with the Appointment of Dr. Kanya Rajangam as Senior Vice President and Chief Medical Officer,, 1/04/2017 DERM-US  GNW  Dermira Elects Emmanuel Caeymaex to Board of Directors, 1/07/2016 FOMX-US  GNW  Foamix Announces Positive Results From Phase 1 Study to Characterize Minocycline Bioavailability of FMX-101 Compared to SolodynÂ® (Minocycline HCl) Extended-Release Tablets, 7/20/2015 69354M10 GNW  PRA Health Sciences Launches New Initiative to Bolster Workforce, 2/08/2016 SUPN-US  GNW  Supernus Prevails in Oxtellar XRÂ® ANDA Litigation," 8/02/2016 FGEN-US  GNW  FibroGen to Report Second Quarter 2016 Financial Results on August 8, 2016",,11/01/2017 CHRS-US  GNW  Coherus BioSciences Management to Present at  Credit Suisse Scottsdale Healthcare Conference, 5/24/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference,, 8/04/2016 COLL-US  GNW  Collegium to Host Conference Call to Discuss Second Quarter 2016 Financial Results and Provide Corporate Update, 5/11/2016 XBIT-US  GNW  XBiotech to Provide First Quarter 2016 Business Update on May 18,,, 3/05/2018 GBT-US   GNW  GBT Announces New Employment Inducement Grants,, 7/18/2017 KURA-US  GNW  Kura Oncology Announces Issuance of U.S. Patent for Lead Product Candidate Tipifarnib in Head and Neck Cancer,,12/01/2017 AXSM-US  GNW  Axsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-Market," 1/05/2017 VYGR-US  GNW  Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors",10/08/2018 BGNE-US  GNW  BeiGene to Present Clinical Data on Zanubrutinib and Pamiparib at Upcoming Medical Meetings,," 5/25/2016 RETA-US  GNW  Reata Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering",,,, 2/15/2017 CRSP-US  GNW  CRISPR Therapeutics to Host Conference Call and Webcast to Provide an Update on the CRISPR/Cas9 U.S. Patent Interference Proceedings and Corresponding U.K. Patents, 5/16/2017 GTHX-US  GNW  G1 Therapeutics Announces Pricing of Initial Public Offering,,, 2/16/2018 ATNX-US  GNW  Athenex to Present at 2018 RBC Capital Markets Healthcare Conference,,,,,,,,,," 9/05/2017 EYPT-US    GNW  pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/20/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference,,,,,,,,10/13/2010 82691710     GNW  SIGA Selected for the Procurement of Smallpox Antiviral Drug for the Strategic National Stockpile and Responds to Small Business Size Protest, 9/20/2018 68375N10 GNW  SHAREHOLDER ALERT: ZN RMTI TTPH ABBV HMNY GDS PVG OPK USAT TRCO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,, 2/09/2015 09061G10    GNW  BioMarin Announces 2 Oral and 8 Poster Presentations at Lysosomal Disease Network's 11th Annual WORLD Symposium(TM),,,," 1/14/2019 45290710 GNW  CLASS ACTION UPDATE for YOGA and IMMU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders", 9/28/2016 09062X10  GNW  Anavex Compound to be Tested in Biogen Neurological Protection Model,, 5/24/2018 09058V10 GNW  BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference,,,,," 2/28/2017 AKRX-US  GNW  Akorn Receives Approval for Mycophenolate Mofetil for Injection, USP",, 6/25/2019 MYGN-US  GNW  Myriad Announces Publication of First Comprehensive Economic Study Demonstrating Cost Effectiveness of EndoPredictÂ®Â for Breast Cancer,12/05/2017 LXRX-US  GNW  Lexicon Pharmaceuticals Secures Up To $200 Million Non-Dilutive Term Loan Financing,, 8/06/2015 INSM-US  GNW  Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update,, 6/08/2017 INO-US    GNW  Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-CancerÂ ,,, 4/25/2017 GERN-US  GNW  Geron 2017 Annual Meeting of Stockholders to be Held on May 9,," 1/02/2019 AMRN-US  GNW  Amarin to Present at 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019",,, 9/04/2018 SRPT-US  GNW  Sarepta Therapeutics to Present at Two Upcoming Investor Conferences,,,11/08/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conference,,,,,"10/17/2018 SAN-FR   GNW  Cloverpop Launches First System of Record for Business Decisions, Driving Digital Transformation and Preparing Companies for The Human + AI Future",,,,,, 1/31/2017 AFMD-US  GNW  First Clinical Milestone Achieved in Collaboration between AbCheck and Lilly,, 8/16/2017 PRQR-US  GNW  ProQR Announces Results for the Second Quarter of 2017,, 9/04/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,," 5/10/2017 ADVM-US  GNW  Adverum Biotechnologies, Inc. Announces Data Presentations at the ARVO and ASGCT 2017 Annual Meetings", 1/04/2018 RARE-US   GNW  Ultragenyx to Present at J.P. Morgan Healthcare Conference, 4/12/2016 AGLE-US  GNW  Aeglea BioTherapeutics Announces Closing of Initial Public Offering and Partial Exercise of the Underwritersâ€™ Option," 6/01/2017 NSTG-US  GNW  NanoString Technologies Announces Pricing of Offering of 3,000,000 Shares of Common Stock",,, 5/15/2017 RDUS-US  GNW  Radius Health Appoints Pharmaceutical Executive Jose Carmona as Chief Financial Officer," 7/14/2014 04539610 GNW  Ventrus Biosciences Becomes Assembly Biosciences as Stockholders Approve Merger With Assembly Pharmaceuticals, Inc.",,,11/16/2011 TKM-CA   GNW  Tekmira Files for an Injunction in the Supreme Court of British Columbia Seeking Return of Confidential Documents,,11/06/2017 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for Third Quarter 2017,," 6/15/2017 PCRX-US  GNW  Pacira Pharmaceuticals Appoints Mark I. Froimson, M.D., to Board of Directors",11/30/2016 RTRX-US  GNW  Retrophin to Present at the BMO Capital Markets Healthcare Conference, 1/11/2016 PACB-US  GNW  Pacific Biosciences Provides Update on Launch of New Sequel System, 2/28/2017 EDIT-US  GNW  Editas Medicine Joins Global Movement to Raise Awareness on Rare Disease Day 2017,, 8/09/2018 MGNX-US  GNW  MacroGenics to Present at Wedbush PacGrow Healthcare Conference,,,,"11/02/2016 60877T10 GNW  Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIAÂ® (abatacept)",10/25/2016 PRTA-US  GNW  Prothena to Report Third Quarter 2016 Financial Results on November 1,,, 3/01/2017 CTMX-US  GNW  CytomX Therapeutics to Announce Full-Year 2016 Financial Results, 4/28/2017 GMAB-DK  GNW  Genmab Announces New Phase III Combination Study of Daratumumab in Multiple Myeloma,,, 1/05/2017 080RQG-E GNW  CymaBay Therapeutics Announces Successful Completion of Scientific Advice Discussions with the European Medicines Agency for Arhalofenate,, 5/10/2016 VIFN-CH  GNW  Vifor Pharma Licenses Rights to Commercialize ChemoCentryxâ€™s Orally-Administered Complement 5aR Inhibitor CCX168 for Orphan and Rare Renal Diseases in Europe and Certain Other Major Markets,,," 7/25/2017 MNKD-US   GNW  MannKind Corporation to Hold 2017 Second Quarter Financial Results Conference Call on August 7, 2017",, 1/03/2018 CYTK-US  GNW  Cytokinetics Announces Progress Against Vision 2020, 4/13/2018 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 9/12/2018 AMRS-US   GNW  Amyris to Host Launch of its New Zero Calorie Natural Sweetener in New York on December 3, 2018",, 5/03/2016 ACHN-US  GNW  Achillion Reports First Quarter 2016 Financial Results and Provides Update on Clinical Programs,"11/27/2018 SYNH-US  GNW  Syneos Health Releases the 2019 Health Trend Ten, Outlining Critical Shifts Impacting Drug Development and Commercialization",10/04/2017 FOLD-US  GNW  Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at World Muscle Society,,,11/10/2015 ADMA-US  GNW  ADMA Biologics Reports Third Quarter 2015 Results, 4/18/2017 GWPH-US  GNW  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Highlight New EpidiolexÂ® (cannabidiol) Data Released by the American Academy of Neurology,,, 5/09/2017 MYOK-US  GNW  MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress,, 4/12/2018 GLPG-NL  GNW  Galapagos announces ISABELA Phase 3 program in IPF," 2/15/2018 PTLA-US  GNW  Portola Pharmaceuticals to Announce Fourth Quarter and Full YearÂ 2017 Financial Results and Host Conference Call on Wednesday, February 28, 2018",,,," 3/02/2017 CARA-US  GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2016 Financial Results on March 9, 2017", 4/06/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 8/08/2017 QURE-US  GNW  uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress," 8/03/2017 AGIO-US   GNW  Agios to Present at the Canaccord Genuity 37th Annual Growth Conference Thursday, August 10, 2017"," 6/27/2017 46226010 GNW  Lion Biotechnologies, Inc. Changes Name to Iovance Biotherapeutics, Inc.",,, 5/15/2017 FATE-US  GNW  Fate Therapeutics Reports First Quarter 2017 Financial Results,10/13/2016 HZNP-US  GNW  Horizon Pharma plc Named One of the Country's Best Medium Workplaces by Fortune Magazine,, 6/22/2017 ICPT-US  GNW  Interceptâ€™s OcalivaÂ® (obeticholic acid) Receives 2017 Galien Chemical Synthesis Drug Award in Italy," 7/24/2019 48576U10   GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm",,," 6/26/2017 ITCI-US  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intra-Cellular Therapies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2017 â€“ ITCI",,,," 3/24/2015 03209R10 GNW  Amphastar Pharmaceuticals Reports Revenues of $55.9 Million for the Fourth Quarter Ended December 31, 2014", 8/07/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Second Quarter 2017 Financial Results and Recent Highlights,, 1/03/2017 DERM-US  GNW  Dermira Initiates Phase 3 Clinical Program in Acne, 1/04/2016 FOMX-US  GNW  Foamix to Present Corporate Overview at the 3rd Annual Dermatology Summit Meeting, 7/16/2015 69354M10 GNW  PRA Health Sciences Announces Time Change for Second Quarter 2015 Financial Results Conference Call,12/04/2015 SUPN-US  GNW  Supernus Announces Distribution of Common Stock by NEA, 7/25/2016 31572Q80 GNW  Astellas and FibroGen Announce First Patient Treated in Phase 3 Studies and Positive Phase 2 Results of Roxadustat in Patients with Chronic Kidney Disease in Japan,,10/23/2017 CHRS-US  GNW  Coherus BioSciences to Report Third Quarter 2017 Financial Results on November 6th, 5/22/2018 CRBP-US  GNW  Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations,, 8/01/2016 COLL-US  GNW  Collegium Receives European Patent Allowance Covering XtampzaÂ® ER, 5/03/2016 XBIT-US  GNW  XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer,,, 3/05/2018 GBT-US   GNW  GBT Announces Participation at Upcoming Investor Conferences in March,, 7/13/2017 50127T10 GNW  Kura Oncology Establishes Collaboration with Foundation Medicine to Support Tipifarnib Development in HRAS Mutant Head and Neck Cancer,,11/28/2017 AXSM-US  GNW  Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine, 1/03/2017 VYGR-US  GNW  Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer,10/01/2018 BGNE-US  GNW  BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,," 2/15/2017 H1718210 GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K.", 5/08/2017 0CRRZ8-E GNW  G1 Therapeutics Announces Launch of Initial Public Offering,,, 2/15/2018 ATNX-US  GNW  Athenex Meets Enrollment Target for Oraxol Phase III Clinical Trial in Metastatic Breast Cancer,,,,,,,,,," 8/01/2017 EYPT-US    GNW  pSivida to Present at Canaccord Genuity Growth Conference onÂ August 10, 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/19/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation of AZEDRAÂ® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting,,,,,,,, 8/05/2010 82691710     GNW  SIGA Technologies Reports Financial Results for the Second Quarter and First Half of 2010," 9/20/2018 68375N10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In OPKO Health, Inc. To Contact The Firm",, 2/04/2015 09061G10    GNW  BioMarin to Attend Upcoming Investor Conferences,,,," 1/14/2019 45290710 GNW  February 25th Immunomedics Shareholder Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Immunomedics, Inc. â€“ IMMU", 8/03/2016 09062X10  GNW  Amyris Enters Partnership with Biogen to Develop Alternative Cell Lines Supporting Production of Therapeutics,, 5/08/2018 BCRX-US  GNW  BioCryst Reports First Quarter 2018 Financial Results,,,,, 2/06/2017 AKRX-US  GNW  Akorn to Report Fourth Quarter and Full Year 2016 Results,, 6/19/2019 AZN-GB   GNW  Myriad Genetics Receives Second Insurance Reimbursement DecisionÂ for its BRACAnalysisÂ® Diagnostic System in Japan, 6/22/2016 07KYPZ-E GNW  Frank Palantoni joins Laboratoire M2 as CEO,," 7/28/2015 INSM-US  GNW  Insmed to Host Second Quarter 2015 Financial Results Conference Call on Thursday, August 6, 2015",, 6/07/2017 INO-US    GNW  Inovio Zika Vaccine Prevents Persistence of Virus and Damage in Male Reproductive Tract in Pre-Clinical Study,,, 4/10/2017 GERN-US  GNW  Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen,,11/28/2018 AMRN-US  GNW  Amarin to Participate in a Fireside Chat at Citiâ€™s 2018 Global Healthcare Conference,,, 8/31/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,11/08/2017 AMAG-US  GNW  AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children with Cerebral Palsy,,,,,10/16/2018 SAN-FR   GNW  Sanofi: DupixentÂ® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps,,,,,, 1/25/2017 AFMD-US  GNW  Affimed Announces Closing of Public Offering of Common Stock,, 7/05/2017 PRQR-US  GNW  ProQRâ€™s Drug Candidate QRX-411 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA,, 9/04/2018 ZGNX-US  GNW  Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome,,,,,, 5/09/2017 ADVM-US  GNW  Adverum Biotechnologies Reports First Quarter 2017 Financial Results and Provides Update,12/18/2017 RARE-US   GNW  Ultragenyx Sells Priority Review Voucher for $130 million,, 5/31/2017 NSTG-US  GNW  NanoString Technologies Announces Offering of Common Stock,,," 5/04/2017 RDUS-US  GNW  Radius Health, Inc. (Nasdaq: RDUS) to Ring The Nasdaq Stock Market Opening Bell", 6/09/2014 04539610 GNW  Ventrus Biosciences Files and Commences Mailing of Definitive Proxy Materials for July 10th Annual Meeting,,,10/20/2011 ALNY-US  GNW  Tekmira Provides Periodic Update to Litigation,,10/31/2017 AKCA-US  GNW  Akcea and Ionis Report Positive Phase 1/2a Data with AKCEA-APOCIII-LRx,, 6/14/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the JMP Securities Life Sciences Conference,11/19/2016 06QBQ8-E GNW  Retrophin Reports Additional Positive Data from Phase 2 DUET Study of Sparsentan in Focal Segmental Glomerulosclerosis at ASN Kidney Week 2016, 1/07/2016 PACB-US  GNW  BGI Expands Investment in SMRT Sequencing Technology for Its Global Service Business, 2/27/2017 EDIT-US  GNW  Editas Medicine to Present at Investor Conferences in March,, 8/07/2018 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results,,,,11/02/2016 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Scott M. Storer as Senior Vice President and Chief Financial Officer,"10/03/2016 PRTA-US  GNW  Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director",,, 2/21/2017 CTMX-US  GNW  CytomX Therapeutics to Present at Upcoming Investor Conferences, 4/28/2017 GMAB-DK  GNW  Genmab Announces European Marketing Authorization for DARZALEXÂ® (daratumumab) for Relapsed or Refractory Multiple Myeloma,,," 1/03/2017 06CR5C-E GNW  CymaBay Announces Exclusive Licensing Agreement with Kowa Pharmaceuticals America, Inc. for the Development and Commercialization of Arhalofenate in the United States",," 5/05/2016 CCXI-US  GNW  ChemoCentryx to Hold First Quarter 2016 Financial Results Conference Call on Tuesday, May 10, 2016",,, 7/17/2017 MNKD-US   GNW  Steven Binder Joins MannKind as Chief Financial Officer,,12/08/2017 CYTK-US  GNW  Cytokinetics Announces Presentation of Results From VITALITY-ALS at 28th International Symposium on ALS/MND, 3/27/2018 ESPR-US     GNW  Esperion Announces Positive Top-Line Results from Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor in Patients with Hypercholesterolemia," 8/30/2018 AMRS-US   GNW  Amyris to Present at Rodman & Renshaw 20th Annual Global Investment Conference on September 5, 2018",, 4/28/2016 ACHN-US  GNW  Achillion to Present at the Deutsche Bank 41st Annual Health Care Conference,11/14/2018 SYNH-US  GNW  Syneos Health Announces Corporate Leadership Positions, 9/21/2017 FOLD-US  GNW  U.S. FDA Grants Orphan Drug Designation for ATB200/AT2221 for Pompe Disease,,,11/03/2015 ADMA-US  GNW  ADMA Biologics Announces Data to be Presented at the International Primary Immunodeficiencies Congress in Budapest Hungary, 4/13/2017 GWPH-US  GNW  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences to Present Data on EpidiolexÂ® (cannabidiol) at the 2017 American Academy of Neurology Annual Meeting,,," 5/02/2017 MYOK-US  GNW  MyoKardia to Announce First Quarter 2017 Financial Results and Host Conference Call on Tuesday, May 9, 2017",, 3/23/2018 GLPG-NL  GNW  Publication of the annual report and invitation to the  annual shareholders' meeting, 1/22/2018 PTLA-US  GNW  Portola Pharmaceuticals Announces Acceptance of Late-Breaker Abstract Highlighting New Data for Andexanet Alfa at ACC.18,,,,11/29/2016 CARA-US  GNW  Cara Therapeutics Completes Planned Enrollment of Eight-Week Multi-Dose Phase of Adaptive Trial of I.V. CR845 in Chronic Kidney Disease-Associated Pruritus, 3/19/2018 FLXN-US  GNW  Flexion Therapeutics to Present at Needham & Company's 17th Annual Healthcare Conference, 8/07/2017 QURE-US  GNW  uniQure Announces Leadership Team Appointments and Nominations to its Board of Directors," 7/28/2017 AGIO-US   GNW  Agios to Webcast Conference Call of Second Quarter 2017 Financial Results on August 8, 2017"," 6/12/2017 46226010 GNW  JUNE 13 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm",,, 5/10/2017 FATE-US  GNW  Fate Therapeutics Announces FDA Clearance of Investigational New Drug Application for FATE-NK100 in Advanced Solid Tumors,"10/11/2016 HZNP-US  GNW  Horizon Pharma plc to Host Third-Quarter 2016 Conference Call and Webcast on November 7, 2016",, 6/12/2017 ICPT-US  GNW  Intercept Announces New Data Analysis From FLINT Trial of OCA in NASH Patients with Type 2 Diabetes, 7/24/2019 48576U10   GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics Inc. (KPTI),,," 6/19/2017 46116X10 GNW  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Intra-Cellular Therapies, Inc. Shareholders and a Lead Plaintiff Deadline of July 11, 2017",,,," 3/17/2015 03209R10 GNW  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 24, 2015", 8/02/2017 ATRA-US    GNW  Atara Biotherapeutics to Present at the Canaccord Genuity 37th Annual Growth Conference,,12/08/2016 24983L10 GNW  Second CIMZIAÂ® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis,12/03/2015 M4613510 GNW  Foamix Announces Positive Top-Line Results From Phase II Study for FDX104 (Doxycycline Foam) in the Prevention of Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers, 7/15/2015 69354M10 GNW  PRA Health Sciences to Report Second Quarter 2015 Results,12/02/2015 SUPN-US  GNW  Supernus to Attend Guggenheim Securities Boston Healthcare Conference, 7/08/2016 AZN-GB   GNW  FibroGen Announces Receipt of $62 Million License Payment  from AstraZeneca,, 9/07/2017 CHRS-US  GNW  Coherus BioSciences Provides Update on â€˜619 IPR Institution Decision, 5/15/2018 CRBP-US  GNW  Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting,, 7/06/2016 06P5F0-E GNW  Collegium to Present at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference, 4/19/2016 XBIT-US  GNW  XBiotech to Present Pivotal Phase 3 Data on Xilonixâ„¢Â at European Society of Medical Oncologyâ€™s World Congress on Gastrointestinal Cancer,,, 2/27/2018 GBT-US   GNW  GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results,, 6/26/2017 KURA-US  GNW  Kura Oncology Added to Russell 3000Â® Index,,11/08/2017 AXSM-US  GNW  Axsome Therapeutics Reports Third Quarter 2017 Financial Results,12/09/2016 VYGR-US  GNW  Voyager Therapeutics to Attend Upcoming Investor Conference, 9/25/2018 BGNE-US  GNW  BeiGene to Present at Upcoming Investor Conferences,,,,,,12/19/2016 CRSP-CH  GNW  Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies, 3/29/2017 0CRRZ8-E GNW  G1 Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting,,, 2/14/2018 ATNX-US  GNW  Athenex Announces Early Completion of Patients Enrollment for Two Phase III Clinical Studies of KX2-391 Ointment for Actinic Keratosis,,,,,,,,,, 7/18/2017 EYPT-US    GNW  Leading Retinal Specialists to Highlight pSividaâ€™s Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/08/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update,,,,,,,," 8/02/2010 82691710     GNW  SIGA to Discuss Second Quarter Results of Operations on August 5, 2010"," 9/18/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fanhua, Pretium Resources, and OPKO Health and Encourages Investors to Contact the Firm",," 2/03/2015 09061G10    GNW  BioMarin to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Wednesday, February 25 at 4:30pm ET",,,," 1/14/2019 45290710 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019", 5/16/2016 RGNX-US   GNW  REGENXBIO and Biogen Enter Exclusive License Agreement for the Development of Gene Therapy Treatments for Rare Genetic Vision Disorders,, 5/01/2018 BCRX-US  GNW  BioCryst Receives European Medicines Agency Approval for ALPIVABâ„¢ for the Treatment of Influenza,,,,,12/21/2016 AKRX-US  GNW  Akorn to Present at 35th Annual J.P Morgan Healthcare Conference,, 6/05/2019 MYGN-US  GNW  Myriad Genetics to Present at the 2019 Goldman Sachs Global Healthcare Conference," 4/07/2015 52887230 GNW  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) to Ring The Nasdaq Stock Market Closing Bell",, 1/06/2012 INSM-US  GNW  Amarantus Biosciences Releases New Video Interview With President and CEO Gerald Commissiong,, 6/01/2017 INO-US    GNW  Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combination with a PD-L1 Checkpoint Inhibitor,,, 4/09/2017 GERN-US  GNW  Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time,,11/26/2018 AMRN-US  GNW  Amarin Prices Public Offering of American Depositary Shares,,," 8/20/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program",,,11/06/2017 AMAG-US  GNW  Hypophosphatemia Data From AMAG Phase 3 Trial Presented at the American Society of Nephrology,,,,,10/01/2018 SAN-FR   GNW  Sanofi completes divestiture of Zentiva to Advent,,,,,, 1/20/2017 AFMD-US  GNW  Affimed Announces Pricing of Public Offering of Common Stock,," 6/15/2017 PRQR-US  GNW  ProQR R&D day Highlights Progress on Pipeline and Introduces AxiomerÂ®, a novel proprietary RNA Technology",, 8/30/2018 ZGNX-US  GNW  Zogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on Epileptology,,,,,," 4/20/2017 ADVM-US  GNW  Adverum Biotechnologies, Inc. Appoints Richard N. Spivey, Pharm.D., Ph.D. to Board of Directors",12/15/2017 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children,, 5/30/2017 NSTG-US  GNW  NanoString to Webcast Presentation at the 2017 Jefferies Healthcare Conference,,, 5/01/2017 RDUS-US  GNW  Radius Health Reports First Quarter 2017 Financial and Operating Results, 4/04/2014 04539610 GNW  Ventrus Biosciences Receives Date for Type B Pre-NDA Meeting With FDA for DOLIZEM (Diltiazem Hydrochloride Cream) in Anal Fissures,,, 6/29/2011 ALNY-US  GNW  Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam,,10/27/2017 AKCA-US  GNW  Akcea Therapeutics Named Among Top 100 Women-Led Businesses in Massachusetts for Second Consecutive Year,, 6/01/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference,11/10/2016 RTRX-US  GNW  Retrophin Reaches Agreement with FDA under Special Protocol Assessment for Pivotal Trial Evaluating RE-024 in PKAN, 1/05/2016 PACB-US  GNW  More Than 80 Presentations and Posters Feature PacBio SMRT Sequencing to Decipher Complex Plant and Animal Genomes at PAG Conference, 2/15/2017 061ZW0-E GNW  Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference,, 7/30/2018 MGNX-US  GNW  MacroGenics Announces Date of Second Quarter 2018 Financial Results Conference Call,,,,10/31/2016 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast at Two Upcoming Investor Conferences," 9/30/2016 PRTA-US  GNW  In Memoriam â€“  Friend, Scientific Innovator and Leader Dr. Dale B. Schenk has Passed Away",,, 2/02/2017 CTMX-US  GNW  CytomX to Present at Upcoming Investor Conferences, 4/18/2017 GMAB-DK  GNW  Genmab Announces Net Sales of DARZALEXÂ® (daratumumab) for First Quarter of 2017,,,"12/08/2016 CBAY-US  GNW  CymaBay Announces the Appointments of Robert Booth, Ph.D. and Caroline Loewy to Its Board of Directors",, 4/28/2016 CCXI-US  GNW  ChemoCentryx Receives FDA Orphan Products Development Grant for Orally Administered Complement 5a Receptor Inhibitor CCX168 for Treatment of ANCA-Associated Vasculitis,,, 7/12/2017 MNKD-US   GNW  Patrick McCauley Joins MannKind as Chief Commercial Officer,,12/01/2017 CYTK-US  GNW  Cytokinetics Announces Results of VITALITY-ALS to be Presented at the International Symposium on ALS/MND, 3/07/2018 ESPR-US     GNW  Esperion to Participate in Fireside Chat at March 2018 Investor Conferences," 8/30/2018 AMRS-US   GNW  Amyris Gets Green Light for Commercial Sales of its New, Natural, Zero-Calorie Sweetener",, 3/03/2016 BCS-GB   GNW  Achillion to Present at Two Upcoming Investor Conferences,11/06/2018 SYNH-US  GNW  Syneos Health Reports Third Quarter 2018 Results, 9/20/2017 FOLD-US  GNW  Amicus Therapeutics to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology,,, 9/30/2015 00089910 GNW  ADMA Biologics Receives Milestone Payment From Biotest AG for RI-002 BLA Submission to FDA, 3/29/2017 GWPH-US  GNW  GW Pharmaceuticals Announces EpidiolexÂ® Receives Orphan Drug Designation from the European Medicines Agency for the Treatment of Lennox-Gastaut Syndrome,,," 4/18/2017 MYOK-US  GNW  MyoKardia Appoints David Meeker, M.D., to Board of Directors",, 3/20/2018 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises,12/22/2017 PTLA-US  GNW  Portola Pharmaceuticals Provides Update on Biologics License Application (BLA) for AndexXaÂ® (andexanet alfa),,,,11/22/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at the 28th Annual Piper Jaffray Healthcare Conference, 3/08/2018 FLXN-US  GNW  Flexion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results, 7/31/2017 QURE-US  GNW  uniQure Reacquires Development and Commercialization Rights for its Gene Therapy Candidate in Hemophilia B, 6/24/2017 AGIO-US   GNW  New Data from Phase 1/2 Trial of Oral IDHIFAÂ® (enasidenib) Demonstrate Durable Complete Responses in Patients with IDH2 Mutant Relapsed or Refractory AML," 6/12/2017 46226010 GNW  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action AgainstÂ Lion Biotechnologies, Inc. (LBIO) & Lead Plaintiff Deadline: June 13, 2017",,, 5/08/2017 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2017 Financial Results, 9/29/2016 HZNP-US  GNW  Horizon Pharma plc Provides Update on PBM Formulary Status for Primary Care Medicines,, 5/25/2017 ICPT-US  GNW  Health Canada Grants Approval for Ocalivaâ„¢ (obeticholic acid) for the Treatment of Patients with Primary Biliary Cholangitis (PBC), 7/03/2019 KPTI-US    GNW  Karyopharm Announces FDA Approval of XPOVIOâ„¢ (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma,,," 6/09/2017 46116X10 GNW  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Reminds Investors with Losses to Contact the Firm",,,,"11/12/2014 03209R10 GNW  Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014"," 7/31/2017 ATRA-US    GNW  Atara Biotherapeutics Announces Two Presentations at  MSParis2017, Including Updated, Interim Results from a Phase 1 Study of Autologous ATA188 in Patients with Progressive Multiple Sclerosis (MS)",,11/09/2016 DERM-US  GNW  Dermira to Present at Stifel 2016 Healthcare Conference,12/02/2015 M4613510 GNW  Foamix to Host Conference Call & Webcast to Discuss Topline Results From Phase 2 Study of FDX-104 in Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers, 6/15/2015 69354M10 GNW  PRA Continues the Transformation of Clinical Trials With Predictivv(TM),11/12/2015 86845910 GNW  Supernus Announces Distribution of Common Stock by NEA, 6/09/2016 FGEN-US  GNW  FibroGen Announces Initiation by Astellas of Phase 3 Clinical Study in Japan of Roxadustat/ASP1517 for the Treatment of Anemia of Chronic Kidney Disease Triggering $10.0 Million Milestone Payment,, 9/01/2017 CHRS-US  GNW  Coherus BioSciences Management to Present at Three Investor Healthcare Conferences in September, 5/10/2018 CRBP-US  GNW  Corbus Pharmaceuticals Reports 2018 First Quarter Financial Results and Provides Business Update,, 6/27/2016 COLL-US  GNW  Collegium CEO Michael Heffernan Named EY Entrepreneur of the Year," 4/04/2016 080RQG-E GNW  European Medicines Agency Grants Accelerated Assessment of Marketing Authorization Application for Xilonixâ„¢, XBiotechâ€™s True Humanâ„¢ Therapeutic Antibody Treatment for Advanced Colorectal Cancer",,, 2/07/2018 GBT-US   GNW  GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference,, 6/14/2017 KURA-US  GNW  Kura Oncology Presents Preliminary Clinical and Preclinical Data for Tipifarnib in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma,, 9/18/2017 AXSM-US  GNW  Axsome Therapeutics to Present at Upcoming Investor Conferences,12/08/2016 VYGR-US  GNW  MRI Interventionsâ€™ ClearPointÂ® Neuro Navigation System Utilized in Voyager Therapeuticsâ€™ VY-AADC01 Phase 1b Trial; Positive Interim Results Reported, 9/21/2018 BGNE-US  GNW  BeiGene Announces Preliminary Results from the Phase 1 Clinical Trial of Zanubrutinib in Chinese Patients with B-Cell Lymphoma at Annual Meeting of the Chinese Society of Clinical Oncology,,,,,,"12/16/2016 00GBNS-E GNW  CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology", 1/10/2017 0CRRZ8-E GNW  G1 Therapeutics Initiates Three Drug Development Programs in Breast Cancer,,, 2/13/2018 ATNX-US  GNW  Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units,,,,,,,,,, 7/10/2017 30233G10   GNW  Alimera Sciences To Expand ILUVIENÂ® Indication in Europe for Posterior Uveitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/01/2018 PGNX-US  GNW  Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2017 Financial Results Call for March 8,,,,,,,, 6/23/2010 82691710     GNW  SIGA Completes Fourth Successful Human Safety Clinical Trial," 9/18/2018 68375N10 GNW  CLASS ACTION UPDATE for CBS PVG OPK USAT and TRCO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 1/30/2015 09061G10    GNW  BioMarin Announces Final Results of Tender Offer for Prosensa's Shares and Completion of Subsequent Offering Period,,,," 1/13/2019 45290710 GNW  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, IMMU and DXC"," 2/08/2016 AGTC-US   GNW  AGTC Announces Financial Results for the Quarter Ended December 31, 2015",, 4/26/2018 BCRX-US  GNW  BioCryst to Announce First Quarter 2018 Financial Results on May 8,,,,,12/12/2016 06CR5C-E GNW  Akorn Announces Completion of FDA Re-inspection of Decatur Facility,, 6/03/2019 MYGN-US  GNW  Myriad Genetics Announces New Results from Two Large Studies of Its myRiskÂ® Hereditary Cancer Test at American Society of Clinical Oncology, 1/07/2011 52887230 GNW  Lexicon Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com,, 6/14/2011 45766930 GNW  Insmed Inc. is Today's Focus Stock on MicroStockProfit.com,, 5/24/2017 INO-US    GNW  Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study,,, 4/05/2017 GERN-US  GNW  Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting,,11/26/2018 AMRN-US  GNW  Amarin Announces Proposed Public Offering of American Depositary Shares,,, 8/08/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Second Quarter 2018 Financial Results and Recent Corporate Developments,,,11/02/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights,,,,, 9/28/2018 SAN-FR   GNW  Sanofi  : FDA approves LibtayoÂ® (cemiplimab) as first and only treatment for advanced cutaneous squamous cell carcinoma,,,,,, 1/19/2017 AFMD-US  GNW  Affimed Announces Proposed Public Offering of Common Stock,, 6/13/2017 PRQR-US  GNW  ProQR to Participate in a Cystic Fibrosis Panel Discussion during the JMP Securities Life Science Conference,, 8/07/2018 ZGNX-US  GNW  Zogenix Prices Public Offering of Common Stock,,,,,, 4/17/2017 ADVM-US  GNW  Adverum Biotechnologies Announces Updated Presentation Time for ARM 5th Annual Cell & Gene Therapy Investor Day,12/04/2017 RARE-US   GNW  Ultragenyx and Kyowa Kirin Announce Positive 48-Week Data from Adult Phase 3 Study of Burosumab (KRN23) in X-Linked Hypophosphatemia,, 5/25/2017 NSTG-US  GNW  NanoString Highlights Record Number of nCounter-Related Research Abstracts Showcasing Advances in Precision Oncology at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO),,," 4/28/2017 RDUS-US  GNW  FDA Approves Radius Healthâ€™s TYMLOSâ„¢ (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture", 2/12/2014 04539610 GNW  Ventrus Biosciences Announces Results From Second Pivotal Phase 3 Trial of Diltiazem Cream (VEN 307) in Patients With Anal Fissure,,, 6/06/2011 ALNY-US  GNW  Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man and Clinical Activity,,10/23/2017 IONS-US  GNW  Akcea Therapeutics to Hold Third Quarter 2017 Financial Results Webcast,, 5/23/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Resignation of James Scibetta,11/03/2016 RTRX-US  GNW  Retrophin Reports Third Quarter 2016 Financial Results,12/15/2015 PACB-US  GNW  Pacific Biosciences Receives ISO 13485 and ISO 9001 Certification, 2/10/2017 EDIT-US  GNW  Editas Medicine to Present at Upcoming February Investor Conferences,," 6/06/2018 55609910 GNW  New Research Coverage Highlights Materialise NV, MacroGenics, GasLog Partners LP, TCP Capital, NantHealth, and Net 1 UEPS Technologies â€” Consolidated Revenues, Company Growth, and Expectations for 2018",,,,10/20/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date for Third Quarter 2016 Financial Results Conference Call and Webcast, 9/29/2016 PRTA-US  GNW  Prothena Outlines Phase 2 Development Strategy for PRX003,,, 2/02/2017 CTMX-US  GNW  CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial, 3/30/2017 GMAB-DK  GNW  Phase II Study of Daratumumab in Non-Hodgkinâ€™s Lymphoma Will Not Proceed to Stage 2 of Trial,,,12/07/2016 06CR5C-E GNW  CymaBay Therapeutics Announces the Initiation of its Next Phase 2 Study of Seladelpar (MBX-8025) in Patients with Primary Biliary Cholangitis,, 4/18/2016 06P9WL-E GNW  ChemoCentryx Announces Immuno-Oncology Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting,,, 6/29/2017 MNKD-US   GNW  MannKind Renegotiates Near-Term Maturities with Deerfield,,11/30/2017 CYTK-US  GNW  New Publication Summarizes Phase 1 Studies of CK-2127107  Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve Activation, 3/07/2018 ESPR-US     GNW  Esperion Announces Positive Top-Line Results from First Pivotal Phase 3 Study of Bempedoic Acid, 8/21/2018 AMRS-US   GNW  Amyris Announces Successful Closing of Secondary Offering,, 2/25/2016 ACHN-US  GNW  Achillion Reports 2015 Fourth Quarter and Year-End Financial Results,11/05/2018 SYNH-US  GNW  Syneos Health to Present at the Jefferies 2018 London Healthcare Conference, 9/19/2017 FOLD-US  GNW  U.S. FDA Grants Fast Track Designation for Amicus Therapeuticsâ€™ Migalastat for Treatment of Fabry Disease,,, 9/28/2015 00089910 GNW  ADMA Biologics Recognized as One of the 50 Fastest Growing Companies in New Jersey, 3/07/2017 GWPH-US  GNW  GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director - UK,,, 3/17/2017 MYOK-US  GNW  MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors,, 2/22/2018 GLPG-NL  GNW  Galapagos delivered in 2017,"12/22/2017 PTLA-US  GNW  Portola Pharmaceuticals to Webcast Corporate Update on January 9, 2018",,,,11/08/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at the Stifel 2016 Healthcare Conference, 3/07/2018 FLXN-US  GNW  Flexion Therapeutics to Present at the Cowen 38th Annual Health Care Conference, 7/21/2017 QURE-US  GNW  uniQure Announces the Successful Development and Scale-up of Manufacturing Processes for Its Hemophilia B Gene Therapy Program, 6/24/2017 AGIO-US   GNW  Agios Announces Updated Data from Fully Enrolled DRIVE PK Study Demonstrating AG-348â€™s Potential as the First Disease-modifying Treatment for Patients with Pyruvate Kinase Deficiency," 6/10/2017 46226010 GNW  DEADLINE TUESDAY: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm",,, 4/27/2017 FATE-US  GNW  Fate Therapeutics to Kick-Off 2017 Annual Meeting of International Society for Stem Cell Research with Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Focus Session, 9/12/2016 G4618810 GNW  Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business,, 5/19/2017 ICPT-US  GNW  Intercept Receives Innovation Award from the National Organization for Rare Disorders for the Development of OcalivaÂ® (obeticholic acid), 6/28/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 6/09/2017 46116X10 GNW  ITCI ALERT: Rosen Law Firm Reminds Intra-Cellular Therapies, Inc. Investors of Important Deadline in First Filed Class Action â€“ ITCI",,,,"11/04/2014 03209R10 GNW  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 12, 2014", 5/24/2017 ATRA-US    GNW  Atara Biotherapeutics to Present at Three Upcoming Investor Conferences,,11/07/2016 DERM-US  GNW  Dermira Reports Third Quarter 2016 Financial Results and Provides Corporate Update,12/01/2015 M4613510 GNW  Foamix to Present Corporate Overview at the Oppenheimer 26th Annual Healthcare Conference, 6/08/2015 69354M10 GNW  PRA Named Clinical Company of the Year,11/09/2015 86845910 GNW  Supernus to Present at Two Investor Conferences, 6/06/2016 GS-US    GNW  FibroGen to Present at the Goldman Sachs 37th Annual Global Healthcare Conference,, 8/28/2017 CHRS-US  GNW  Coherus BioSciences Announces Positive Topline Results for Clinical Pharmacokinetic Bioequivalence Study for CHS-1420 (HumiraÂ® Biosimilar Candidate) versus European Marketed Humira in Healthy Subjects, 4/26/2018 CRBP-US  GNW  Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference,, 6/22/2016 COLL-US  GNW  Collegium Announces Positive Topline Results for Hydrocodone DETERxÂ® Clinical Study, 3/28/2016 XBIT-US  GNW  XBiotech Advances to Phase II Portion of Clinical Study of Novel True Humanâ„¢ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus,,, 1/09/2018 GBT-US   GNW  GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD),, 6/07/2017 KURA-US  GNW  Kura Oncology Announces Data Presentations for Tipifarnib at the International Conference on Malignant Lymphoma and the European Hematology Association Annual Meeting,, 9/07/2017 AXSM-US  GNW  Axsome Announces CREATE-1 Interim Analysis Expected Year-End 2017,12/07/2016 VYGR-US  GNW  Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinsonâ€™s Disease, 9/20/2018 BGNE-US  GNW  BeiGene Presents Results on Anti-PD-1 Antibody Tislelizumab in Chinese Patients with Lung Cancers at the Annual Meeting of the Chinese Society of Clinical Oncology,,,,,,11/22/2016 CRSP-CH  GNW  CRISPR Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference, 1/03/2017 0CRRZ8-E GNW  G1 Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference,,," 1/25/2018 ATNX-US  GNW  Athenex, Inc. Announces Pricing of Offering of Common Stock",,,,,,,,,, 7/10/2017 30233G10   GNW  pSivida Out-licenses EMEA Rights for Durasertâ„¢ Three-year Treatment for Posterior Segment Uveitis While Retaining U.S. Commercial Rights; Amended Global Collaboration Agreement with Alimera for ILUVIENÂ® Improves pSividaâ€™s Revenue Generation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/15/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the 2018 RBC Capital Markets Global Healthcare Conference,,,,,,,, 6/21/2010 82691710     GNW  Andy Stern Joins SIGA's Board of Directors," 9/14/2018 68375N10 GNW  OPKO HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against OPKO Health, Inc. - OPK",, 1/23/2015 BMRN-US     GNW  BioMarin Announces Underwriters' Full Exercise of Option to Purchase Additional Shares,,,," 1/11/2019 45290710 GNW  IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU",11/30/2015 007MPF-E  GNW  Chiasma Announces Addition of James R. Tobin and John F. Thero to Board of Directors,, 4/02/2018 BCRX-US  GNW  Idera Pharmaceuticals Files Definitive Proxy Statement in Connection with Pending Merger with BioCryst Pharmaceuticals,,,,,11/29/2016 AKRX-US  GNW  Akorn Launches Ibuprofen Oral Suspension,, 6/02/2019 MYGN-US  GNW  BRACAnalysis CDxÂ® Companion Diagnostic Test Identifies Patients with Metastatic Pancreatic Cancer Who Benefited from Treatment with LynparzaÂ® (olaparib)," 5/11/2010 52887230 GNW  Liberty Analytics Co. Initiates Independent Research Coverage on Lexicon Pharmaceuticals, Inc.",," 6/30/2010 45766930 GNW  Emerging Stock Report Initiates Independent Research Coverage on Insmed, Inc.",, 5/10/2017 INO-US    GNW  Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results,,, 3/02/2017 GERN-US  GNW  Geron Announces Presentation at American Association for Cancer Research Annual Meeting,,11/20/2018 AMRN-US  GNW  Amarin to Present at the Evercore ISI HealthCONx Conference,,," 8/08/2018 SRPT-US  GNW  Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple CNS-targeted Gene Therapy programs and Access to Important Gene Therapy Talent and Tools",,,"10/19/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Host Third Quarter 2017 Financial Results Conference Call and Webcast on Thursday, November 2, 2017 at 8:00 a.m. ET",,,,," 9/26/2018 80105N10 GNW  New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera S.A, and ARMOUR Residential REIT â€” Consolidated Revenues, Company Growth, and Expectations for 2018",,,,,, 1/19/2017 AFMD-US  GNW  Affimed Announces Proposed Public Offering of Common Stock,, 6/08/2017 PRQR-US  GNW  ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial,," 8/06/2018 ZGNX-US  GNW  Zogenix Announces Proposed Public Offering of 6,000,000 Shares of Common Stock",,,,,, 4/06/2017 ADVM-US  GNW  Adverum Biotechnologies to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day,11/30/2017 RARE-US   GNW  Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4,, 5/10/2017 NSTG-US  GNW  NanoString Appoints Elisha W. Finney to Board of Directors,,," 4/05/2017 RDUS-US  GNW  Radius Health Announces Presentations at Upcoming Conferences and Its Plans to Announce First Quarter Financial Results on May 3, 2017",11/25/2013 04539610 GNW  Ventrus Biosciences Completes Enrollment of Second Pivotal Phase 3 Trial of Diltiazem Cream (VEN 307) in Patients With Anal Fissure,,, 6/03/2011 ALNY-US  GNW  Tekmira Files Amended Complaint in Alnylam Litigation,,10/16/2017 IONS-US  GNW  Akcea Presents Data Demonstrating Significant Burden of Illness in Familial Chylomicronemia Syndrome,, 5/10/2017 PCRX-US  GNW  Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference,10/21/2016 06QBQ8-E GNW  Retrophin to Present Additional Data from Phase 2 DUET Study of Sparsentan in Late-Breaking Oral Session at ASN Kidney Week 2016,"11/11/2015 PACB-US  GNW  Scientists Publish Unique Discoveries in Plant and Animal Genomic Investigations With Single Molecule, Real-Time Sequencing From PacBio", 1/09/2017 JPM-US   GNW  Editas Medicine Reports on Recent Progress and 2017 Goals at J.P. Morgan Healthcare Conference,, 6/05/2018 MGNX-US  GNW  MacroGenics to Present at Jefferies Global Healthcare Conference,,,," 9/27/2016 SHPG-IE  GNW  Momenta Pharmaceuticals to Regain Global Development and Commercialization Rights to M923, a Proposed Biosimilar of HUMIRAÂ® (adalimumab), Through Termination of Collaboration Agreement with Baxalta, Now Part of Shire", 9/26/2016 PRTA-US  GNW  Prothena Announces President and CEO Dr. Dale B. Schenk to Take Medical Leave,,, 1/09/2017 CTMX-US  GNW  UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference, 3/29/2017 GMAB-DK  GNW  Grant of Restricted Stock Units to two new Board Members and Grant of Restricted Stock Units and Warrants to the new Member of Management in Genmab,,,12/06/2016 CBAY-US  GNW  CymaBay Therapeutics Announces that the Recommended International  Nonproprietary Name for MBX-8025 is Seladelpar,, 3/14/2016 CCXI-US  GNW  ChemoCentryx Reports Fourth Quarter 2015 Financial Results and ProvidesÂ Corporate Update,,, 6/29/2017 MNKD-US   GNW  MannKind Draws Remaining Funds under Mann Group Loan Arrangement,,11/30/2017 CYTK-US  GNW  New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS, 2/23/2018 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 8/17/2018 AMRS-US   GNW  Amyris Announces Pricing of Secondary Offering,," 2/11/2016 ACHN-US  GNW  Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor","10/25/2018 SYNH-US  GNW  GSW, a Syneos Health Advertising Company,  Named Agency of the Year by Modern Healthcare & Ad Age", 9/14/2017 FOLD-US  GNW  Amicus Therapeutics Announces Approval for Galafoldâ„¢ (Migalastat) for Treatment of Fabry Disease in Canada,,, 9/22/2015 008FZT-E GNW  ADMA Biologics to Present at the Ladenburg Thalmann 2015 Healthcare Conference," 3/02/2017 GWPH-US  GNW  GW Pharmaceuticals to Present at the Cowen and Company 37th Annual Healthcare Conference on Wednesday, 8 March, 2017",,, 3/13/2017 MYOK-US  GNW  MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress,, 2/17/2018 GLPG-NL  GNW  Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego,12/19/2017 PTLA-US  GNW  U.S. Food and Drug Administration Approves Prior Approval Supplement for Commercial Launch of Portola Pharmaceuticalsâ€™ Novel Oral Anticoagulant BevyxxaÂ® (betrixaban),,,,11/03/2016 CARA-US  GNW  Cara Therapeutics Reports Third Quarter 2016 Financial Results, 3/06/2018 FLXN-US  GNW  Flexion Therapeutics Presents Clinical Data at AAOS 2018 Annual Meeting and the American Pain Society Annual Scientific Meeting, 7/18/2017 QURE-US  GNW  uniQure Expands Intellectual Property Portfolio with Newly Issued Patent Providing Broad Protection of Insect Cell-Based AAV Manufacturing, 6/03/2017 AGIO-US   GNW  Agios Presents Phase 1 Data from Dose-Escalation and Expansion Cohorts of AG-120 (Ivosidenib) in Patients with Previously Treated IDH1 Mutant Positive Cholangiocarcinoma," 6/05/2017 46226010 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Reminds Shareholders withÂ Losses on their Investment in Lion Biotechnologies, Inc. ofÂ Class Action Lawsuit and Upcoming Deadline â€“ LBIO",,, 4/20/2017 FATE-US  GNW  Fate Therapeutics to Present at the 5th Annual Cell & Gene Therapy Investor Day, 9/06/2016 MS-US    GNW  Horizon Pharma plc to Participate in Morgan Stanley Global Healthcare Conference,, 5/17/2017 ICPT-US  GNW  Intercept to Present at Upcoming Conferences, 6/19/2019 KPTI-US    GNW  Karyopharm Reports Updated Data from the Phase 2b SADAL Study at the  2019 International Conference on Malignant Lymphoma,,," 6/09/2017 46116X10 GNW  SHAREHOLDER ALERT:Â Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intra-Cellular Therapies, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ITCI",,,," 8/12/2014 03209R10 GNW  Amphastar Pharmaceuticals Reports Revenues of $49.0 Million for the Second Quarter Ended June 30, 2014", 5/10/2017 ATRA-US    GNW  Atara Biotherapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),,10/21/2016 DERM-US  GNW  Dermira Presents Data from DRM01 Phase 2b Clinical Program at Annual Meeting for Dermatologists,11/11/2015 FOMX-IL  GNW  Foamix to Present Corporate Overview at Jefferies Autumn 2015 Global Healthcare Conference in London, 5/12/2015 001THX-E GNW  PRA Sponsors Russian Regional Quality Assurance Forum,11/03/2015 86845910 GNW  Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance, 5/09/2016 FGEN-US  GNW  FibroGen Reports Financial Results for the First Quarter of 2016,, 8/21/2017 07JRW6-E GNW  Coherus Secures Private Placement from Temasek,"12/05/2016 CRBP-US  GNW  Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing Bell",, 6/20/2016 COLL-US  GNW  Collegium Announces Commercial Launch of XtampzaÂ® ER, 3/23/2016 080RQG-E GNW  XBiotech Announces European Medicines Agency (EMA) Validates Marketing Authorization Application (MAA) for Xilonixâ„¢ in the Treatment of Advanced Colorectal Cancer,,, 1/03/2018 GBT-US   GNW  GBT to Present at the 36th Annual J.P. Morgan Healthcare Conference,, 5/30/2017 KURA-US  GNW  Kura Oncology to Participate in Two Upcoming Investor Conferences,, 8/09/2017 AXSM-US  GNW  Axsome Therapeutics Reports Second Quarter 2017 Financial Results,11/29/2016 92915B10 GNW  REGENXBIO and Voyager Therapeutics Announce Exercise of Options for Rights to NAV Vectors, 9/20/2018 BGNE-US  GNW  BeiGene Presents Preliminary Results on Anti-PD-1 Antibody Tislelizumab in Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors at Annual Meeting of the Chinese Society of Clinical Oncology,,,,,,11/21/2016 06QBQ2-E GNW  CRISPR Therapeutics Announces Two Presentations Demonstrating the Potential for CRISPR Gene Editing To Treat Sickle Cell Disease and Î²-Thalassemia,12/05/2016 0CRRZ8-E GNW  G1 Therapeutics to Evaluate Trilaciclib (G1T28) in Combination with Immune Checkpoint Inhibitor in Small-Cell Lung Cancer,,," 1/22/2018 ATNX-US  GNW  Athenex, Inc. Announces Proposed Offering of Common Stock",,,,,,,,,, 6/28/2017 JNJ-US     GNW  pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/05/2018 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference,,,,,,,, 5/12/2010 82691710     GNW  SIGA CEO Dr. Eric Rose Addresses Congressional Appropriations Subcommittee on Behalf of the Alliance for Biosecurity," 9/14/2018 68375N10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. (OPK)",, 1/22/2015 BMRN-US     GNW  BioMarin Announces Pricing of Public Offering of Common Stock,,,, 1/11/2019 45290710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. â€“ IMMU,"10/02/2015 09062X10  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Biogen Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of October 19, 2015 -- BIIB",, 3/26/2018 09058V10 GNW  Eyenovia Appoints Three Industry Veterans to Board of Directors,,,,,11/28/2016 AKRX-US  GNW  Akorn Invalidates DurezolÂ® Patent Via Inter Partes Review Proceeding,, 5/14/2019 MYGN-US  GNW   Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting,,, 6/30/2010 45766930 GNW  Insmed Inc. is Today's Focus Stock on MicroStockProfit.com,, 5/10/2017 AZN-GB    GNW  Inovio Provides Update on MedImmune Launch of Combination Trial for HPV-associated Head & Neck Cancer,,, 3/01/2017 GERN-US  GNW  Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results,,"11/10/2018 AMRN-US  GNW  VascepaÂ® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-ITâ„¢  Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event  Primary Composite Endpoint",,, 7/31/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 9/29/2017 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Tracy Palmer Berns as Chief Compliance Officer,,,,, 9/15/2018 SAN-FR   GNW  Sanofi: Positive Phase 3 results presented for DupixentÂ® (dupilumab),,,,,, 1/11/2017 AFMD-US  GNW  Affimed Provides Update on NK-Cell Immuno-Oncology Platform,, 5/31/2017 PRQR-US  GNW  ProQR Receives Fast Track Designation from the FDA for QR-110 for Leberâ€™s Congenital Amaurosis Type 10,, 8/06/2018 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Second Quarter Financial Results,,,,,," 3/14/2017 ADVM-US  GNW  Adverum Biotechnologies, Inc. Appoints Patrick Machado, J.D. to Board of Directors",11/16/2017 RARE-US   GNW  Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency,, 5/04/2017 NSTG-US  GNW  NanoString Technologies Releases Operating Results for First Quarter of 2017,,, 4/03/2017 RDUS-US  GNW  New Analysis from ACTIVE Showed Consistent Fracture Reductions for Abaloparatide-SC Across Geographies, 9/11/2013 04539610 GNW  Ventrus Biosciences Announces Positive Results From Clinical Dermal Safety and Pharmacokinetic Studies of Diltiazem (VEN 307),,, 6/02/2011 ALNY-US  GNW  Tekmira Expands Oncology Pipeline With RNAi Therapeutic Targeting Novel Cancer Genes WEE1 and CSN5,,"10/04/2017 AKCA-US  GNW  Akcea Therapeutics Canada Appoints Nelly Komari, B. Pharm., MSc. as Medical Director",," 5/04/2017 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results",10/20/2016 RTRX-US  GNW  Retrophin to Report Third Quarter 2016 Financial Results,"10/22/2015 PACB-US  GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2015 Financial Results", 1/04/2017 JPM-US   GNW  Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference,, 5/07/2018 MGNX-US  GNW  MacroGenics to Present at Deutsche Bank Health Care Conference,,,, 9/23/2016 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors, 9/22/2016 PRTA-US  GNW  Prothena to Host Update on PRX003 Phase 2 Development Strategy,,, 1/09/2017 CTMX-US  GNW  CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference, 3/28/2017 GMAB-DK  GNW  Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab,,,11/28/2016 PIPR-US  GNW  CymaBay Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference,," 2/29/2016 CCXI-US  GNW  ChemoCentryx to Hold Fourth Quarter 2015 Financial Results Conference Call on Monday, March 14, 2016",,, 6/28/2017 MNKD-US   GNW  MannKind Draws Remaining Funds under Mann Group Loan Arrangement,,11/21/2017 CYTK-US  GNW  Cytokinetics Announces Negative Results From VITALITY-ALS, 2/20/2018 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Fourth Quarter and Full Year 2017 Financial Results, 8/16/2018 03236M20  GNW  Amyris Announces Launch of Secondary Offering by Certain Selling Stockholders,, 2/08/2016 ACHN-US  GNW  Achillion to Present at the  Leerink Partners 5th Annual Global Healthcare Conference,10/22/2018 SYNH-US  GNW  LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialisation Solutions Provider, 9/13/2017 FOLD-US  GNW  Amicus Therapeutics Announces Top-Line Phase 3 Results for SD-101 in Epidermolysis Bullosa,,, 9/21/2015 00089910 GNW  FDA Accepts ADMA Biologics License Application for RI-002, 2/08/2017 GWPRF-GB GNW  GW Pharmaceuticals to Present at the Leerink Partners 6th Annual Global Healthcare Conference on 15 February,,, 2/28/2017 MYOK-US  GNW  MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference,, 1/07/2018 GLPG-NL  GNW  Positive topline results with GLPG1972 in osteoarthritis patients,12/12/2017 PTLA-US  GNW  Portola Pharmaceuticals Provides Update on European  Marketing Authorization Application for Betrixaban,,,,10/31/2016 CARA-US  GNW  Cara Therapeutics to Present Data at Kidney Week 2016, 3/02/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 7/11/2017 QURE-US  GNW  uniQure Presents New Clinical Data in Hemophilia B Patients Demonstrating Therapeutic Efficacy of AAV5 Gene Therapy in the Presence of Pre-Existing Neutralizing Antibodies," 5/31/2017 AGIO-US   GNW  Agios Appoints David Scadden, M.D., to the Board of Directors"," 5/16/2017 46226010 GNW  LBIO ALERT: Rosen Law Firm Reminds Lion Biotechnologies, Inc. Investors of Important First Filed Class Action â€“ LBIO",,, 3/16/2017 FATE-US  GNW  Fate Therapeutics Reports Fourth Quarter 2016 Financial Results, 8/18/2016 00G0R2-E GNW  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOSÂ® (prednisone) Delayed-Release Tablets,, 5/04/2017 ICPT-US  GNW  Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update, 6/14/2019 KPTI-US    GNW  Â Karyopharm Reports New and Updated Selinexor Combination Data from the Phase 1b/2 STOMP Study at the European Hematology Association 2019 Annual Meeting,,," 6/09/2017 46116X10 GNW  ITCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intra-Cellular Therapies, Inc. and a Lead Plaintiff Deadline of July 11, 2017",,,," 8/05/2014 03209R10 GNW  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 12, 2014", 5/10/2017 ATRA-US    GNW  Atara Biotherapeutics Enhances Commercial Expertise with the Appointment of Dr. Derrell Porter to the Executive Leadership Team,,10/13/2016 DERM-US  GNW  Dermira to Present Data from DRM01 and DRM04 Clinical Programs at Fall Clinical Dermatology Conference,11/11/2015 M4613510 GNW  Foamix Reports Third Quarter 2015 Financial Results and Provides Business Update," 5/06/2015 69354M10 GNW  PRA Health Sciences, Inc. Reports First Quarter 2015 Results and Provides Updated Guidance for 2015",10/22/2015 SUPN-US  GNW  Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR(R) Label," 5/02/2016 FGEN-US  GNW  FibroGen to Report First Quarter 2016 Financial Results on May 9, 2016",, 8/07/2017 CHRS-US  GNW  Coherus BioSciences Reports Second Quarter 2017 Corporate Highlights and Financial Results," 4/16/2015 21833P10 GNW  Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing Bell",," 6/13/2016 COLL-US  GNW  Collegium Announces Election of John A. Fallon, M.D. to Board of Directors", 3/22/2016 XBIT-US  GNW  XBiotech to Provide Fourth Quarter and Full Year 2015 Business update,,,12/22/2017 MRK-US   GNW  GBT Appoints Wendy L. Yarno to Board of Directors,, 5/15/2017 KURA-US  GNW  Kura Oncology Reports First Quarter 2017 Operational and Financial Results,, 7/25/2017 AXSM-US  GNW  Axsome Therapeutics Announces AXS-06 (MoSEICâ„¢ Meloxicam and Esomeprazole) Meets Primary Endpoint in Phase 1 Clinical Trial,11/29/2016 92915B10 GNW  Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors, 9/16/2018 BGNE-US  GNW  BeiGene Announces Oral Data Presentations at Annual Meeting of the Chinese Society of Clinical Oncology,,,,,,11/08/2016 CRSP-CH  GNW  CRISPR Therapeutics to Present at the Stifel 2016 Healthcare Conference,11/21/2016 0CRRZ8-E GNW  G1 Therapeutics to Present Positive Clinical and Preclinical Data on CDK4/6 Inhibitor G1T28 at December Scientific Conferences,,, 1/22/2018 ATNX-US  GNW  Athenex Announces Encouraging Early Clinical Efficacy and Safety Data of Oraxol in Clinical Trial for the Treatment of Breast Cancer,,,,,,,,,, 6/22/2017 EYPT-US    GNW  pSivida Submits Marketing Authorization Application (MAA) for Approval of Durasertâ„¢ Three-year Treatment for Posterior Segment Uveitis in the European Union,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/01/2018 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentation of AZEDRAÂ® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting,,,,,,,," 5/10/2010 82691710     GNW  Emerging Stock Report Initiates Independent Research Coverage on SIGA Technologies, Inc."," 9/14/2018 68375N10 GNW  OPKO HEALTH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against OPKO Health, Inc.",, 1/21/2015 BMRN-US     GNW  BioMarin Announces Public Offering of Common Stock,,,," 1/10/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aphria, NVIDIA, DXC Technology, and Immunomedics and Encourages Investors to Contact the Firm"," 9/01/2015 09062X10  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Biogen Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of October 19, 2015 -- BIIB",," 3/23/2018 09058V10 GNW  Gainey McKenna & Egleston Announces They Have Filed A Class Action Lawsuit Against BioCryst Pharmaceuticals, Inc. (BCRX)",,,,,11/16/2016 AKRX-US  GNW  Akorn to Present at Piper Jaffray 28th Annual Healthcare Conference,, 5/09/2019 MYGN-US  GNW  New Publication Shows the EndoPredictÂ® Test Identifies Women with Early-Stage Breast Cancer Who Can Forgo Extended Endocrine Therapy,,,,, 5/08/2017 45773H20  GNW  Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy,,, 2/22/2017 GERN-US  GNW  Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results,,11/08/2018 AMRN-US  GNW  Amarin to Present at the Jefferies 2018 London Healthcare Conference,,, 7/25/2018 SRPT-US  GNW  Sarepta Therapeutics Announces that Phase 1/2a Duchenne Muscular Dystrophy (DMD) Micro-Dystrophin Gene Therapy Trial Placed on Clinical Hold Due to an Out-of-Specification Production Lot; No Observed Safety Events,,," 9/07/2017 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Laura Williams, M.D. as Senior Vice President of Clinical Development",,,,, 9/13/2018 SAN-FR   GNW  Sanofi to refocus two global business units,,,,,, 1/04/2017 AFMD-DE  GNW  Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration,, 5/17/2017 PRQR-US  GNW  ProQR Announces Results for the First Quarter of 2017,, 8/01/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,, 3/06/2017 ADVM-US  GNW  Adverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update,"11/15/2017 RARE-US   GNW  Ultragenyx Announces FDA Approval of MEPSEVIIâ„¢ (vestronidase alfa), the First Therapy for Progressive and Debilitating Rare Genetic Disease Mucopolysaccharidosis VII",," 4/05/2017 NSTG-US  GNW  NanoString Technologies to Release First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017",,, 3/31/2017 RDUS-US  GNW  Radius Health Announces Three Presentations on Elacestrant (RAD1901) and RAD140 at the 2017 American Association for Cancer Research Annual Meeting (AACR)," 7/07/2013 04539610 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS",,, 4/07/2011 ALNY-US  GNW  Tekmira Comments on Answer and Counterclaim Filed by Alnylam Pharmaceuticals,, 9/12/2017 AKCA-US  GNW  Akcea Announces Filing of New Drug Submission for Volanesorsen to Health Canada,, 4/27/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and Conference Call,10/06/2016 RTRX-US  GNW  Dr. Alvin Shih Departing Retrophin to Lead Biotechnology Start-Up,"10/12/2015 PACB-US  GNW  Pacific Biosciences of California, Inc. Third Quarter 2015 Financial Results Call",12/19/2016 CRSP-CH  GNW  Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies,, 5/07/2018 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results,,,, 8/31/2016 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the 2016 Wells Fargo Healthcare Conference, 9/06/2016 PRTA-US  GNW  Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer,,,"12/14/2016 06CR5C-E GNW  CytomX Announces U.S. FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Study of Anti-PD-L1 Probody Therapeutic, CX-072", 2/24/2017 GMAB-DK  GNW  CHMP Issues Positive Opinion Recommending DARZALEXÂ® (daratumumab) for Relapsed or Refractory Multiple Myeloma,,,11/10/2016 CBAY-US  GNW  CymaBay to Host Key Opinion Leader Meeting on Primary Biliary Cholangitis in New York City,, 2/25/2016 0024VM-E GNW  ChemoCentryx to Present at the Cowen and Company 36th Annual Healthcare Conference,,, 6/05/2017 MNKD-US   GNW  MannKind Engages Locust Walk to Explore Strategic Options for MannKindâ€™s Non-insulin Technosphere-based Pipeline Candidates,,11/13/2017 CYTK-US  GNW  Cytokinetics Announces Additional Results From COSMIC-HF at the American Heart Association Scientific Sessions 2017, 1/03/2018 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference, 8/06/2018 AMRS-US   GNW  Amyris Delivers Another Quarter of Profitable Growth while Executing well on Strategic Agenda,, 2/03/2016 ACHN-US  GNW  Achillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of Regulatory Affairs,"10/19/2018 SYNH-US  GNW  Syneos Health Schedules Third Quarter 2018 Earnings Call for Tuesday, November 6, 2018", 8/25/2017 FOLD-US  GNW  Amicus Therapeutics to Highlight Fabry Disease Program at the 13th International Congress of Inborn Errors of Metabolism (ICIEM),,, 9/17/2015 008FZT-E GNW  ADMA Biologics Receives FDA Approval for Second Plasma Collection Center, 2/07/2017 06CR5C-E GNW  GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma,,, 2/02/2017 MYOK-US  GNW  First Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491,, 1/02/2018 GLPG-NL  GNW  Update on progress in cystic fibrosis programs,12/05/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement GrantsÂ Under NASDAQ Listing Rule 5635(c)(4),,,,"10/27/2016 CARA-US  GNW  Cara Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016", 2/28/2018 FLXN-US  GNW  Flexion Therapeutics to Present at the 39th Annual Raymond James Institutional Investors Conference," 7/10/2017 QURE-US  GNW  uniQure Announces Updated, Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 In Patients with Severe Hemophilia B", 5/18/2017 AGIO-US   GNW  Agios to Present Updated Clinical Data from PKR Activator AG-348 at EHA," 5/16/2017 46226010 GNW  The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Lion Biotechnologies, Inc. Shareholders and a Lead Plaintiff Deadline of June 13, 2017",,, 3/13/2017 FATE-US  GNW  Fate Therapeutics Announces FDA Clearance of Investigational New Drug Application for FATE-NK100 Natural Killer Cell Cancer Immunotherapy, 8/08/2016 HZNP-US  GNW  Horizon Pharma plc Announces Second-Quarter 2016 Financial Results,, 4/27/2017 ICPT-US  GNW  Intercept to Report First Quarter 2017 Financial Results on May 4 and Present at Upcoming Conference, 6/03/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 6/08/2017 46116X10 GNW  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Reminds Investors with Losses to Contact the Firm",,,, 6/30/2014 AMPR-US  GNW  Amphastar Pharmaceuticals Announces Exercise of Over-Allotment Option, 5/04/2017 ATRA-US    GNW  Atara Biotherapeutics Announces First Quarter 2017 Financial Results and Recent Highlights,,10/03/2016 DERM-US  GNW  CIMZIAÂ® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis,"10/27/2015 M4613510 GNW  Foamix Pharmaceuticals Third Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, November 11", 4/27/2015 69354M10 GNW  PRA is Named International Clinical Company of the Year,10/20/2015 86845910 GNW  Supernus to Host Third Quarter 2015 Earnings Conference Call, 4/20/2016 FGEN-US  GNW  Promising Phase 2 Data Show Roxadustat Corrected Anemia in Chronic Kidney Disease Patients Before Intervention with Dialysis,," 8/07/2017 CHRS-US  GNW  Coherus BioSciences Files Petition for Inter Partes Review  of ENBRELÂ® Patent 8,163,522",,, 6/02/2016 COLL-US  GNW  Collegium Announces Poster Presentations for Xtampzaâ„¢ ER at the International Conference on Opioids, 3/09/2016 XBIT-US  GNW  XBiotech Enrolls Final Patient in Phase I Portion of Clinical Study of Novel True Humanâ„¢ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus,,,12/15/2017 GBT-US   GNW  Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering,, 5/08/2017 KURA-US  GNW  Kura Oncology to Report First Quarter 2017 Financial Results,, 7/17/2017 AXSM-US  GNW  Axsome Therapeutics Initiates Phase 2/3 Trial of AXS-05 for Alzheimerâ€™s Disease Agitation,11/10/2016 VYGR-US  GNW  Voyager Therapeutics Provides Third Quarter 2016 Investor Update, 9/05/2018 BGNE-US  GNW  BeiGene to Present Data on Anti-PD-1 Antibody Tislelizumab at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto,,,,,,10/18/2016 CRSP-US  GNW  CRISPR Therapeutics Announces Pricing of Initial Public Offering, 8/10/2016 0CRRZ8-E GNW  G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference,,, 1/22/2018 ATNX-US  GNW  Athenex Announces Encouraging Results of the First Cohort of Phase I Clinical Trial of Oraxol and CYRAMZAÂ® (Ramucirumab) Combination Treatment in Gastric Cancer,,,,,,,,,, 6/13/2017 EYPT-US    GNW  pSividaâ€™s Durasertâ„¢ Three-year Treatment for Posterior Segment Uveitis Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/02/2018 PGNX-US  GNW  Progenics Pharmaceuticals Completes Enrollment in Phase 3 Study of PSMA-Targeted Imaging Agent 1404,,,,,,,, 5/04/2010 82691710     GNW  Press Release Correction: SIGA Technologies Reports Operating Results for the First Quarter of 2010," 9/14/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Announces That Class Action Lawsuits Have Been Filed Against OPKO Health, Inc. (OPK) and Encourages Investors to Contact the Firm",, 1/15/2015 BMRN-US     GNW  BioMarin Announces Completion of Tender Offer for Prosensa's Shares and Commences Subsequent Offering Period,,,," 1/10/2019 45290710 GNW  KESSLER TOPAZ MELTZER & CHECK, LLP â€“ Reminds Investors of Securities Fraud Class Action Lawsuit Against IMMUNOMEDICS, INC. â€“ IMMU"," 8/28/2015 09062X10  GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Biogen Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit â€“ BIIB",, 3/22/2018 09058V10 GNW  BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference,,,,,11/03/2016 AKRX-US  GNW  Akorn Provides Third Quarter 2016 Results,, 5/07/2019 MYGN-US  GNW  Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial Results,,,,, 5/02/2017 INO-US    GNW  Inovio Pharmaceuticals to Participate inÂ Bank of America Merrill Lynch 2017 Healthcare Conference,,,12/06/2016 06QBQ2-E GNW  Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting,,11/01/2018 AMRN-US  GNW  Amarin Reports Third Quarter 2018 Financial Results and Provides Update on Operations,,," 7/20/2018 SRPT-US  GNW  Sarepta Therapeutics to Announce Second Quarter 2018 Financial Results and Recent Corporate Developments on August 8, 2018",,, 9/05/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 9/12/2018 SAN-FR   GNW  FDA to review supplemental Biologics License Application for PraluentÂ® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events,,,,,,12/06/2016 06QBQ2-E GNW  Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH,, 5/15/2017 PRQR-US  GNW  ProQR remembers co-founder Henri Termeer after his unexpected passing,, 8/01/2018 ZGNX-US  GNW  Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6,,,,,, 2/21/2017 ADVM-US  GNW  Adverum Biotechnologies to Present at Upcoming Investor Conferences,11/07/2017 90400D10  GNW  Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics,, 4/03/2017 NSTG-US  GNW  Digital Spatial Profiling Technology Enables Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Immune Response to Tumors,,, 3/10/2017 RDUS-US  GNW  Radius Health Receives Notification of PDUFA Extension for Abaloparatide-SC," 7/03/2013 04539610 GNW  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Ventrus Biosciences, Inc. to Contact the Firm",,, 3/16/2011 ALNY-US  GNW  Tekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information,, 9/12/2017 00972L10 GNW  Akcea and Ionis Announce Filing of New Drug Submission for Volanesorsen to Health Canada,, 4/11/2017 69512710 GNW  MonoSol Rx Appoints James S. Scibetta to Board of Directors, 9/30/2016 RTRX-US  GNW  Retrophin Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4),10/01/2015 PACB-US  GNW  PacBio Sequencing for Human Biomedical Research to be Featured at ASHG Annual Meeting,11/09/2016 SF-US    GNW  Editas Medicine to Present at the Stifel Healthcare Conference 2016,, 4/30/2018 MGNX-US  GNW  MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call,,,, 8/04/2016 MNTA-US  GNW  Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results, 8/30/2016 CS-CH    GNW  Prothena to Participate in Upcoming September Investor Conferences,,,12/13/2016 BMY-US   GNW  CytomX Announces Selection by Bristol-Myers Squibb of First Clinical Candidate Probody From Collaboration, 2/22/2017 GMAB-DK  GNW  Genmab 2016 Annual Report,,,11/10/2016 06CR5C-E GNW  CymaBay Therapeutics Announces U.S. Orphan Drug Designation for MBX-8025 for the Treatment of Primary Biliary Cholangitis,, 1/07/2016 CCXI-US  GNW  ChemoCentryx to Present at the 34th Annual J.P. Morgan Healthcare Conference,,, 5/31/2017 56400P70  GNW  MannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil,,11/06/2017 CYTK-US  GNW  Cytokinetics Announces Additional Results From COSMIC-HF to Be Presented at the American Heart Association Scientific Sessions 2017,12/14/2017 ESPR-US     GNW  Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors, 8/02/2018 AMRS-US   GNW  Amyris to Participate in Jefferies 2018 Global Industrials Conference,, 1/04/2016 ACHN-US  GNW  Achillion Appoints Dr. Joel Barrish as Chief Scientific Officer,10/17/2018 SYNH-US  GNW  Study Reveals Traditional Digital Advertising Rules Donâ€™t Apply in Clinical Trial Recruitment, 8/15/2017 FOLD-US  GNW  Amicus Therapeutics Announces Approval for Galafoldâ„¢ (Migalastat) for Treatment of Fabry Disease in Australia,,, 9/02/2015 00089910 GNW  ADMA Biologics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference, 2/07/2017 GWPH-US  GNW  GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress,,," 2/01/2017 MYOK-US  GNW  MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs",,12/18/2017 GLPG-NL  GNW  Transparency notification,"11/30/2017 PTLA-US  GNW  Portola Pharmaceuticals to Present New Data on Betrixaban, Andexanet Alfa and Cerdulatinib at the 59th American Society of Hematology (ASH) Annual Meeting",,,,10/12/2016 CARA-US  GNW  Cara Therapeutics to Participate in October Medical Meetings," 2/26/2018 FLXN-US  GNW  Flexion Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 8, 2018", 6/23/2017 QURE-US  GNW  uniQure Announces Clinical Data Presentations at the Upcoming International Society on Thrombosis and Hemostasis (ISTH) Congress, 5/17/2017 AGIO-US   GNW  Agios to Present New Clinical Data from its IDH Programs at ASCO," 5/15/2017 46226010 GNW  LBIO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Lion Biotechnologies, Inc. and a Lead Plaintiff Deadline of June 13, 2017",,, 3/09/2017 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2016 Financial Results," 7/07/2016 HZNP-US  GNW  Horizon Pharma plc to Host Second-Quarter 2016 Conference Call and Webcast on August 8, 2016",, 4/19/2017 ICPT-US  GNW  Intercept Announces New OcalivaÂ® (obeticholic acid) and INT-767 Data to be Presented at EASL 2017, 5/28/2019 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,," 6/08/2017 ITCI-US  GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intra-Cellular Therapies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2017 â€“ ITCI",,,, 6/25/2014 AMPR-US  GNW  Amphastar Pharmaceuticals Announces Pricing of Initial Public Offering, 4/21/2017 MRK-DE     GNW  Atara Bio Announces Collaboration with Merck to Evaluate KEYTRUDAÂ® (pembrolizumab) in Combination with ATA129 in Nasopharyngeal Carcinoma (NPC),,10/01/2016 DERM-US  GNW  Dermira Presents Data from DRM04 Phase 3 Clinical Program in Late-Breaking News Session at European Academy of Dermatology and Venereology Congress,10/20/2015 M4613510 GNW  Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea, 4/17/2015 69354M10 GNW  PRA Health Sciences to Report First Quarter 2015 Results,10/15/2015 SUPN-US  GNW  Supernus Announces Settlement With Par on Trokendi XR(R) Patent Litigation, 3/11/2016 FGEN-US  GNW  FibroGen Announces Publication of Phase 2 Study Results Supporting the Potential of FG-3019 to Treat Patients With Idiopathic Pulmonary Fibrosis,, 7/24/2017 CHRS-US  GNW  Coherus BioSciences to Report Second Quarter 2017  Financial Results on August 7th,,, 6/02/2016 COLL-US  GNW  Collegium to Present at Jefferies and William Blair Conferences, 3/08/2016 XBIT-US  GNW  XBiotech Announces Submission of Marketing Authorization Application (MAA) for Candidate Colorectal Cancer Therapy to European Medicines Agency (EMA),,,12/14/2017 GBT-US   GNW  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock,," 4/19/2017 KURA-US  GNW  Kura Oncology Granted U.S. Patent for Clinical-Stage ERK Inhibitor, KO-947",, 7/06/2017 AXSM-US  GNW  Axsome Therapeutics Appoints John Golubieski as Chief Financial Officer,11/01/2016 VYGR-US  GNW  Voyager Therapeutics to Host Third Quarter 2016 Investor Update Call, 9/04/2018 BGNE-US  GNW  BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,, 5/11/2016 0CRRZ8-E GNW  G1 Therapeutics Secures $47 Million Series C Financing,,, 1/16/2018 ATNX-US  GNW  Athenex Receives Positive Feedback from FDA on the Design of Phase III Clinical Trial for Oraxol,,,,,,,,,, 5/08/2017 EYPT-US    GNW  Durasertâ„¢ Three-year Treatment for Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/29/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRAÂ® (iobenguane I 131) in Pheochromocytoma and Paraganglioma,,,,,,,, 5/04/2010 82691710     GNW  SIGA Technologies Reports Operating Results for the First Quarter of 2010, 9/14/2018 68375N10 GNW  SHAREHOLDER ALERT: AMPE NVRO LCI CBS PZZA FIZZ CRON PM QRTEA OPK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines,," 1/12/2015 09061G10    GNW  BioMarin Provides Preliminary Data From Ongoing Phase 1/2 Pivotal Study of BMN 190 for Treatment of CLN2 Disorder, a Form of Batten Disease",,,, 1/05/2019 45290710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. â€“ IMMU, 8/19/2015 AGTC-US   GNW  AGTC Announces Strategic Collaboration With Biogen Effective and Biogen Equity Investment Closed,, 3/15/2018 BCRX-US  GNW  BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema,,,,,10/13/2016 AKRX-US  GNW  Akorn Announces Third Quarter 2016 Earnings Release and Conference Call Information,, 5/01/2019 MYGN-US  GNW  Myriad Announces Coverage Decision by KrogerÂ® Prescription Plans for GeneSightÂ®,,,,," 4/26/2017 INO-US    GNW  Inovio Pharmaceuticals to Report First Quarter 2017 Financial Results May 10, 2017",,,11/07/2016 GERN-US  GNW  Geron Announces November Investor Conference Presentation Webcasts,,10/26/2018 AMRN-US  GNW  Amarin Schedules Webcast Discussion of Primary REDUCE-ITâ„¢ Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association,,, 6/29/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 8/31/2017 AMAG-US  GNW  AMAG Announces U.S. FDA Filing Acceptance and Six-Month Review of FerahemeÂ® (ferumoxytol) for the Treatment of All Adult Patients With Iron Deficiency Anemia,,,,, 9/04/2018 SAN-FR   GNW  Sanofi reaches civil settlement with US SEC,,,,,,11/09/2016 AFMD-US  GNW  Affimed to Present at the Jefferies 2016 London Healthcare Conference,, 5/09/2017 PRQR-US  GNW  ProQR Announces R&D Day in New York on June 15,, 7/12/2018 ZGNX-US  GNW  Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome,,,,,, 1/18/2017 ADVM-US  GNW  Adverum Biotechnologies to Present AtÂ Phacilitate Cell & Gene Therapy World 2017,11/06/2017 RARE-US   GNW  Ultragenyx to Present at the Credit Suisse Healthcare Conference,, 3/29/2017 NSTG-US  GNW  NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research,,, 2/28/2017 RDUS-US  GNW  Radius Health to Present at Cowen and Company 37th Annual Health Care Conference," 6/28/2013 04539610 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS",,, 1/10/2011 TKM-CA   GNW  Proof of RNAi in Man Strengthens Leadership Position of Tekmira's LNP Delivery Technology,," 9/07/2017 00972L10 GNW  Akcea Therapeutics, Inc. (Nasdaq: AKCA) to Ring The Nasdaq Stock Market Closing Bell",," 4/03/2017 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference", 9/14/2016 RTRX-US  GNW  Retrophin to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series, 9/30/2015 69404D10 GNW  Pacific Biosciences Launches New Sequencing Platform Based on Its SMRT Technology,11/07/2016 EDIT-US  GNW  Editas Medicine Announces Third Quarter 2016 Results and Update,, 4/02/2018 MGNX-US  GNW  MacroGenics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares,,,, 8/04/2016 MNTA-US  GNW  Momenta Discontinues Further Accrual of its Phase 2 Trial of Necuparanib in Patients with Pancreatic Cancer Following Planned Interim Futility Analysis, 8/02/2016 PRTA-US  GNW  Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update,,,12/05/2016 BMY-US   GNW  CytomX Announces Fourth Target Selection by Bristol-Myers Squibb  Under Strategic Oncology Collaboration," 2/08/2017 GMAB-DK  GNW  Genmab Appoints Judith Klimovsky, MD, as Chief Development Officer",,,11/09/2016 CBAY-US  GNW  CymaBay Reports Third Quarter 2016 Financial Results,, 1/06/2016 CCXI-US  GNW  ChemoCentryx Announces Positive Results in Phase II ANCA-Associated Vasculitis CLEAR Trial of Orally Administered Complement 5a Receptor Inhibitor CCX168,,, 5/30/2017 MNKD-US   GNW  MannKind Provides Update on Senior Management,,"10/26/2017 CYTK-US  GNW  Cytokinetics, Inc. Reports Third Quarter 2017 Financial Results",12/01/2017 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 7/30/2018 AMRS-US   GNW  Amyris BIOSSANCE Brand Executes Significant Expansion with Agreement to Launch Across all 668 Sephora Inside JCPenney Stores,,12/16/2015 ACHN-US  GNW  Achillion Appoints Dr. Frank Verwiel to Board of Directors,10/15/2018 SYNH-US  GNW  Syneos Health Wins Society for Clinical Research Sites Eagle Award for Second Consecutive Year, 8/07/2017 FOLD-US  GNW  Amicus Therapeutics Announces Second Quarter 2017 Financial Results and Corporate Updates,,, 8/31/2015 ADMA-US  GNW  ADMA Biologics Receives Patent Issuance Pertaining to the Treatment of Immunodeficiency," 1/30/2017 GWPH-US  GNW  GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017",,, 1/03/2017 MYOK-US  GNW  MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi,,12/14/2017 GLPG-NL  GNW  Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries,11/21/2017 PTLA-US  GNW  Portola Pharmaceuticals Provides Update on BevyxxaÂ® (betrixaban) Commercial Launch,,,,10/03/2016 CARA-US  GNW  Cara Therapeutics to Participate in Webcast on Pain Targeting Mechanisms, 2/14/2018 FLXN-US  GNW  Flexion Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference, 6/15/2017 QURE-US  GNW  uniQure Publishes Data Further Demonstrating Favorable Immunogenicity Profile and Broad Utilization of AAV5-Based Gene Therapies, 5/04/2017 AGIO-US   GNW  Agios Reports First Quarter 2017 Financial Results," 5/11/2017 46226010 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Lion Biotechnologies, Inc. (NASDAQ:LBIO) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",,, 3/02/2017 FATE-US  GNW  Fate Therapeutics to Highlight Natural Killer Cell Programs and Engineered Pluripotent Cell Platform for Off-the-Shelf Cancer Immunotherapy at the 2017 AACR Annual Meeting, 4/29/2016 G4618810 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Horizon Pharma plc of Class Action Lawsuit and Upcoming Deadline â€“ HZNP,, 3/30/2017 ICPT-US  GNW  Intercept to Present at Upcoming Conference, 5/16/2019 KPTI-US    GNW  Karyopharm Announces Results of Clinical Studies Investigating Selinexor to be Presented at the European Hematology Association 2019 Annual Meeting,,," 6/08/2017 46116X10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI)Â and Lead Plaintiff Deadline: July 11, 2017",,,,"11/20/2012 MNTA-US  GNW  U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in ""Safe-Harbor"" Case", 4/20/2017 ATRA-US    GNW  Atara Bio Announces Positive Interim Results from Ongoing Phase 1 Trial of the Autologous Version of ATA188 in Patients with Primary and Secondary Progressive Multiple Sclerosis (MS) at the American Academy of Neurology (AAN) Annual Meeting 2017,, 9/28/2016 DERM-US  GNW  Dermira to Present Data from DRM04 Phase 3 Clinical Trials at Late-Breaking News Session at European Academy of Dermatology and Venereology Congress, 8/19/2015 M4613510 GNW  Foamix Reports Second Quarter 2015 Financial Results and Provides Business Update, 3/30/2015 69354M10 GNW  PRA Health Sciences Expands Global Phase I Patient Strategy, 9/02/2015 SUPN-US  GNW  Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR(R), 2/29/2016 FGEN-US  GNW  FibroGen Announces Fiscal 2015 Financial Results,, 6/12/2017 CHRS-US  GNW  Coherus BioSciences Receives Complete Response Letter from FDA for its Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate),,," 5/23/2016 COLL-US  GNW  Collegium Hosting Investor Day Event on May 25, 2016", 3/04/2016 080RQG-E GNW  European Medicines Agency Grants Eligibility for Submission of XBiotechâ€™s Marketing Authorization Application (MAA),,,12/11/2017 GBT-US   GNW  GBT Announces Presentation of Six Studies at ASH Supporting Voxelotor Sickle Cell Disease (SCD) Program,, 4/07/2017 50127T10 GNW  Kura Oncology Doses First Patient in Phase 1 Trial of ERK Inhibitor KO-947,, 6/19/2017 BMY-US   GNW  Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors,10/18/2016 VYGR-US  GNW  Voyager Therapeutics Announces Planned Transition Process for Chief Financial Officer, 9/04/2018 BGNE-US  GNW  BeiGene to Present at the Morgan Stanley 16th Annual Global Healthcare Conference,,,,,,, 4/15/2016 0CRRZ8-E GNW  G1 Therapeutics to Present Clinical and Preclinical Data on CDK4/6 Inhibitors G1T28 and G1T38 at the 2016 American Association for Cancer Research Annual Meeting,,, 1/08/2018 ATNX-US  GNW  Athenex Announces Chinese FDA Allowance of Investigational New Drug Application of Oraxol to Begin Clinical Trials,,,,,,,,,, 5/04/2017 EYPT-US    GNW  pSivida Corp. Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/02/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update,,,,,,,," 4/27/2010 82691710     GNW  SIGA to Discuss First Quarter Results of Operations on May 4, 2010"," 9/14/2018 OPK-US   GNW  Nasdaq Scheduled Resumption in OPKO Health, Inc.",, 1/07/2015 09061G10    GNW  BioMarin Announces Planned Changes to Board of Directors Leadership Structure,,,," 1/04/2019 45290710 GNW  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc. - IMMU"," 8/18/2015 09062X10  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of October 19, 2015 -- BIIB",, 2/28/2018 BCRX-US  GNW  BioCryst Announces Initiation of the APeX-S Long-Term Safety Trial of BCX7353 in Patients with Hereditary Angioedema,,,,, 8/25/2016 AKRX-US  GNW  Akorn Relaunches Ofloxacin Otic Solution,, 5/01/2019 MYGN-US  GNW  Myriad Genetics to Present at Two Upcoming Healthcare Conferences,,,,, 4/24/2017 INO-US    GNW  Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancers,,,11/03/2016 GERN-US  GNW  Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Events,,"10/25/2018 AMRN-US  GNW  Amarin To Report Third Quarter 2018 Results and Host Conference Call On November 1, 2018",,," 6/20/2018 80360710 GNW  Recent Analysis Shows First Interstate BancSystem, Spectrum Brands, Sarepta Therapeutics, Capstone Turbine, Main Street Capital, and Insteel Industries Market Influences â€” Renewed Outlook, Key Drivers of Growth",,, 8/08/2017 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Oscar Sanchez as Vice President of Quality,,,,, 7/31/2018 SAN-FR   GNW  Sanofi: Q2 2018 Performance Positions Sanofi for New Growth Phase,,,,,,11/08/2016 AFMD-US  GNW  Affimed to Present Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH,," 5/01/2017 PRQR-US  GNW  ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leberâ€™s Congenital Amaurosis Type 10 (LCA 10) and Usher Syndrome",, 7/02/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,,11/09/2016 PIPR-US  GNW  Adverum Biotechnologies to Present at Upcoming Investor Conferences,11/02/2017 RARE-US   GNW  Ultragenyx Reports Third Quarter 2017 Financial Results and Corporate Update,, 3/27/2017 NSTG-US  GNW  NanoString Highlights a Record Number of nCounter-Based Research Abstracts in Precision Oncology and Predictive Biomarkers at the 2017 American Association of Cancer Research (AACR) Annual Meeting,,, 2/23/2017 RDUS-US  GNW  Radius Health Reports Fourth Quarter and Full Year 2016 Financial and Operating Results," 6/17/2013 04539610 GNW  Ventrus Biosciences, Inc. Investor Alert: Scott+Scott, Attorneys at Law, LLP Notifies Investors of Upcoming Deadline in Ventrus Class Action Lawsuit -- VTUS",,,11/22/2010 TKM-CA   GNW  Tekmira Intellectual Property Portfolio Expands With Granting of Key Patents Covering LNP Manufacturing and Mitigation of siRNA Immune Stimulation,, 9/06/2017 IONS-US  GNW  Akcea Therapeutics Establishes Canadian Subsidiary,, 3/16/2017 PCRX-US  GNW  Trinity Health and Pacira Pharmaceuticals Announce Collaboration to Decrease Opioid Use Nationwide, 9/07/2016 RTRX-US  GNW  Retrophin Announces Positive Top-Line Results from Phase 2 DUET Study of Sparsentan in Patients with Focal Segmental Glomerulosclerosis," 8/05/2015 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2015 Financial Results",10/31/2016 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Third Quarter 2016 Corporate Update and Results,, 3/28/2018 MGNX-US  GNW  MacroGenics Announces Pricing of Public Offering of Common Stock,,,, 7/21/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date for Second Quarter 2016 Financial Results Conference Call and Webcast, 7/06/2016 0032QC-E GNW  Prothena to Participate in Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference,,,11/09/2016 CTMX-US  GNW  CytomX to Present at the Jefferies 2016 London  Healthcare Conference, 2/06/2017 GMAB-DK  GNW  Genmab Announces Updated 2016 Financial Guidance,,,11/09/2016 007HPS-E GNW  CymaBay Therapeutics Announces a Newly Issued U.S. Patent for the Use of MBX-8025 as a Treatment for Primary Biliary Cholangitis (PBC),,11/12/2015 CCXI-US  GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 5/10/2017 MNKD-US   GNW  MannKind Corporation Reports 2017 First Quarter Financial Results,,"10/12/2017 CYTK-US  GNW  Cytokinetics to Announce Third Quarter Results on October 26, 2017",11/13/2017 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the Jefferies 2017 London Healthcare Conference," 7/20/2018 AMRS-US   GNW  Amyris to Announce Second Quarter 2018 Financial Results on Monday, August 6, 2018",,"12/05/2015 ACHN-US  GNW  Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of Hematology and Nomination of ACH-4471, a Novel Small Molecule Factor D Inhibitor, for Clinical Development", 8/20/2018 SYNH-US  GNW  Syneos Healthâ„¢ Acquires Kinapse to Further Enhance End-to-End Capabilities," 7/25/2017 FOLD-US  GNW  Amicus Therapeutics to Announce Second Quarter 2017Â Financial Results on August 7, 2017",,, 8/11/2015 00089910 GNW  ADMA Biologics Reports Second Quarter 2015 Results,12/05/2016 06VZCN-E GNW  GW Announces New EpidiolexÂ® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome,,,12/08/2016 BMO-CA   GNW  MyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference,,12/11/2017 GLPG-NL  GNW  Transparency notification,11/07/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data on Betrixaban to be Presented at the America Heart Association (AHA) Scientific Sessions 2017,,,, 9/29/2016 CARA-US  GNW  Cara Therapeutics to Host Industry Symposium at the Orthopaedic Trauma Association 2016 Annual Meeting, 2/02/2018 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 6/06/2017 QURE-US  GNW  uniQure Announces Appointment ofÂ Steven L. Zelenkofske as Chief Medical Officer, 4/28/2017 AGIO-US   GNW  Agios Announces Closing of Over-Allotment Option in Public Offering," 5/11/2017 46226010 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action AgainstÂ Lion Biotechnologies, Inc. (LBIO) & Lead Plaintiff Deadline â€“ June 13, 2017",,, 3/01/2017 FATE-US  GNW  Fate Therapeutics to Present at Two Upcoming Conferences in March," 4/28/2016 G4618810 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Horizon Pharma plc of Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2016 - HZNP",, 3/16/2017 ICPT-US  GNW  Intercept to Present at Upcoming Conference," 5/15/2019 KPTI-US    GNW  Karyopharmâ€™s Founder Sharon Shacham, PhD, Receives NYIPLA Inventor of the Year Award",,," 6/07/2017 46116X10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",,,,11/07/2011 AGN-US   GNW  Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011," 4/03/2017 ATRA-US    GNW  Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer",, 9/20/2016 06X833-E GNW  Dermira Licenses DRM04 to Maruho for Hyperhidrosis in Japan," 8/13/2015 M4613510 GNW  Foamix Pharmaceuticals Second Quarter 2015 Conference Call & Webcast Scheduled for Thursday, August 20"," 2/18/2015 001THX-E GNW  PRA Health Sciences, Inc. Reports 4th Quarter and Full Year 2014 Results and 2015 Guidance", 8/27/2015 SUPN-US  GNW  Supernus to Attend FBR Healthcare Conference on September 9th," 2/19/2016 FGEN-US  GNW  FibroGen to Report Fourth Quarter and Full Year 2015 Financial Results  on February 29, 2016",, 6/01/2017 CHRS-US  GNW  Coherus BioSciences Management to Present at 36th NASDAQ OMX Investor ProgramÂ ,,, 5/11/2016 19459J10 GNW  Collegium Licenses the U.S. rights to ONSOLISÂ® from BioDelivery Sciences, 3/02/2016 XBIT-US  GNW  XBiotech to Deliver Presentation on Novel Study Design and Phase III Results From European Study on Xilonixâ„¢ During Meeting at the European Parliament,,,12/09/2017 GBT-US   GNW  GBT Announces New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease (SCD),, 4/05/2017 KURA-US  GNW  Kura Oncology Presents Preclinical Data Demonstrating Significant Anti-Tumor Activity of KO-947 and KO-539,, 5/09/2017 AXSM-US  GNW  Axsome Therapeutics Reports First Quarter 2017 Financial Results, 9/15/2016 VYGR-US  GNW  Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology, 8/31/2018 BGNE-US  GNW  BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkinâ€™s Lymphoma in China,,,,,,, 2/02/2016 0CRRZ8-E GNW  G1 Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference,,,"12/27/2017 ATNX-US  GNW  Athenex Receives Promising Innovative Medicine Designation from the United Kingdom MHRA for Oraxol, An Innovative Oral Form of Paclitaxel",,,,,,,,,," 4/19/2017 EYPT-US    GNW  pSivida Corp. to Report Third Quarter Fiscal Year 2017 Financial Results on Thursday, May 4th",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/02/2017 PGNX-US  GNW  Progenics Pharmaceuticals Completes Submission of NDA for AZEDRAÂ® (iobenguane I 131) in Pheochromocytoma and Paraganglioma,,,,,,,,," 9/14/2018 68375N10 GNW  CLASS ACTION UPDATE for OPK and FIZZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",, 1/06/2015 09061G10    GNW  BioMarin to Present at the J.P. Morgan Healthcare Conference,,,," 1/03/2019 45290710 GNW  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aphria, NVIDIA, DXC Technology, and Immunomedics and Encourages Investors to Contact the Firm", 7/02/2015 AGTC-US   GNW  AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration,, 2/27/2018 BCRX-US  GNW  BioCryst Reports Fourth Quarter and Full Year 2017 Financial Results,,,,, 8/24/2016 AKRX-US  GNW  Akorn to Present at Morgan Stanley Global Healthcare Conference,," 4/30/2019 MYGN-US  GNW  EndoPredictÂ® Predicts the Chemotherapy Benefit in Women  with Early ER-positive, HER2-negative Breast Cancer",,,,, 4/11/2017 INO-US    GNW  Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial,,,11/03/2016 06QBQ2-E GNW  Geron Announces Presentations at American Society of Hematology Annual Meeting,,10/19/2018 AMRN-US  GNW  Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in January 2017,,," 6/19/2018 SRPT-US  GNW  Sarepta Therapeutics Announces that at its First R&D Day, Jerry Mendell, M.D. Presented Positive Preliminary Results from the First Three Children Dosed in the Phase 1/2a Gene Therapy Micro-dystrophin Trial to Treat Patients with Duchenne Muscular Dystrophy",,, 8/03/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update,,,,, 7/26/2018 SAN-FR   GNW  Sanofi Head of Human Resources Roberto Pucci to retire;  Company names Caroline Luscombe to take over October 1st,,,,,,11/02/2016 AFMD-US  GNW  Affimed Reports Financial Results for Third Quarter 2016,, 4/27/2017 PRQR-US  GNW  ProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leberâ€™s Congenital Amaurosis Type 10 Patients,, 7/02/2018 ZGNX-US  GNW  Zogenix Welcomes New Global Chief Commercial Officer,,,,,,"11/08/2016 ADVM-US  GNW  Adverum Biotechnologies, Inc. Reports Third Quarter 2016 Financial Results",11/01/2017 RARE-US   GNW  Ultragenyx and Kyowa Hakko Kirin Announce FDA Not Currently Planning to Hold Advisory Committee Meeting for Burosumab Biologics License Application,, 3/23/2017 NSTG-US  GNW  NanoString Launches New PlexSet Technology as an Alternative to qPCR for Multiplexed High-Throughput Gene Expression Studies,,, 2/01/2017 RDUS-US  GNW  Mayo Clinic Proceedings Publishes Positive Results from the ACTIVExtend Clinical Trial of Abaloparatide-SC in Postmenopausal Women With Osteoporosis," 6/14/2013 04539610 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS",,,,, 9/05/2017 IONS-US  GNW  Akcea Expands Leadership Team in Preparation for First Commercial Launch,, 3/14/2017 PCRX-US  GNW  Phase 4 Study Shows EXPARELÂ® Versus an Active Comparator Significantly Reduces Opioid Consumption and Postsurgical Pain in Patients Undergoing Total Knee Arthroplasty, 8/15/2016 RTRX-US  GNW  Retrophin Appoints Neil McFarlane Chief Operating Officer," 7/13/2015 69404D10 GNW  Pacific Biosciences of California, Inc. Second Quarter 2015 Financial Results Call",10/17/2016 08FFFQ-E GNW  Editas Medicine to Present Data on CRISPR/Cas9-mediated Gene Editing in Hematopoietic Stem/Progenitor Cells at ESGCT-ISSCR 2016,, 3/09/2018 MGNX-US  GNW  MacroGenics to Present at Cowen Health Care Conference,,,," 6/23/2016 05T779-E GNW  Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors", 7/05/2016 PRTA-US  GNW  Prothena Presents New Data from Phase 1/2 Study of NEOD001 Demonstrating Improvements in Three Organ Systems in Previously-Treated Patients with AL Amyloidosis,,,11/03/2016 078V1F-E GNW  CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update, 1/24/2017 GMAB-DK  GNW  Genmab Announces 2016 Net Sales Figures for DARZALEXÂ® (Daratumumab),,,"11/02/2016 CBAY-US  GNW  CymaBay to Announce Third Quarter 2016 Financial Results on Wednesday, November 9",,11/09/2015 16383L10 GNW  ChemoCentryx Reports Third Quarter 2015 Financial Results and Provides Corporate Update,,, 5/04/2017 MNKD-US   GNW  MannKind and One Drop to collaborate on delivering better health outcomes for people with diabetes,," 9/19/2017 CYTK-US  GNW  Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure",11/09/2017 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference, 7/16/2018 AMRS-US   GNW  Amyrisâ€™s Biossance Brand leads in Clean Beauty with another record quarter; Expands capability and expertise to accelerate growth,,11/05/2015 ACHN-US  GNW  Achillion Reports Third Quarter And  Nine Month 2015 Financial Results, 8/17/2018 SYNH-US  GNW  Syneos Health to Present at the 2018 Baird Global Healthcare Conference, 7/18/2017 FOLD-US  GNW  Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares,,, 7/31/2015 ADMA-US  GNW  ADMA Biologics Announces Submission of RI-002 Biologics License Application (BLA) to FDA,12/05/2016 GWP-GB   GNW  GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress,,,12/02/2016 06CR5C-E GNW  MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491,,12/11/2017 GLPG-NL  GNW  Galapagos to enter NASDAQ Biotech Index,11/06/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports Third Quarter 2017 Financial Results  and Provides Corporate Update,,,," 9/15/2016 CARA-US  GNW  Cara Therapeutics Initiates Enrollment in Phase 2b Trial of Peripherally Acting Kappa Opioid Agonist, Oral CR845, in Chronic Pain Patients", 1/08/2018 FLXN-US  GNW  Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ZILRETTAâ„¢ (triamcinolone acetonide extended-release injectable suspension), 6/01/2017 QURE-US  GNW  uniQure Announces Company Presentation at Jefferies Healthcare Conference, 4/27/2017 AGIO-US   GNW  Agios and Aurigene Enter into Exclusive License Agreement for Novel Small Molecules for Cancer Metabolism Target," 5/11/2017 46226010 GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 â€“ LBIO",,, 2/27/2017 FATE-US  GNW  Fate Therapeutics and Regents of the University of Minnesota Expand Research Collaboration for Clinical Translation of Engineered iPSC-Derived Natural Killer Cell Cancer Immunotherapy," 3/24/2016 G4618810 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Horizon Pharma plc of Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2016 - HZNP",," 3/02/2017 ICPT-US  GNW  NICE Recommends OcalivaÂ® (obeticholic acid) for the Treatment of Patients with Primary Biliary Cholangitis in England, Wales and Northern Ireland", 5/09/2019 KPTI-US    GNW  Karyopharm Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress,,," 5/26/2017 46116X10 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of  Securities Class Action Lawsuit Against Intra-Cellular Therapies, Inc. â€“ ITCI",,,,"10/28/2011 AGN-US   GNW  Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.", 3/17/2017 ATRA-US    GNW  Atara Bio's Collaborating Investigators to Present Interim Results from Phase 1 Trial of the Autologous Version of ATA188 in Patients with Progressive Multiple Sclerosis (MS),, 9/12/2016 24983L10 GNW  Dermira Acquires Option to License Exclusive Rights for up to Three Early-Stage Programs from Takeda," 7/31/2015 BAYN-DE  GNW  Finacea(R) (azelaic acid) Foam 15%, Approved by U.S. FDA for Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea", 2/09/2015 69354M10 GNW  PRA Health Sciences Announces Appointment of New Director, 8/04/2015 86845910 GNW  Supernus Announces Second Quarter 2015 Financial Results, 2/16/2016 FGEN-US  GNW  FibroGen Publishes Encouraging Phase 2 Anemia Data  Demonstrating Roxadustatâ€™s Ability to Maintain Hemoglobin Levels in Patients With Chronic Kidney Disease,, 5/16/2017 CHRS-US  GNW  Coherus BioSciences Prevails in â€˜135 IPR Decision,,, 5/11/2016 COLL-US  GNW  Collegium Announces Poster Presentations for Xtampzaâ„¢ ER at American Pain Society Meeting, 2/18/2016 XBIT-US  GNW  XBiotech to Present at 4th Annual Sachs Cancer BioPartnering & Investment Forum,,,11/30/2017 GBT-US   GNW  Global Blood Therapeutics Announces New Employment Inducement Grants,, 3/29/2017 KURA-US  GNW  Preclinical Data for Kura Oncology Development Compounds to be Presented at AACR Annual Meeting 2017,, 5/08/2017 AXSM-US  GNW  Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimerâ€™s Disease Agitation, 9/12/2016 VYGR-US  GNW  Voyager Therapeutics and CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntingtonâ€™s Disease, 8/26/2018 BGNE-US  GNW  BeiGene Announces Acceptance of its First New Drug Application for Zanubrutinib in Relapsed/Refractory Mantle Cell Lymphoma by China Drug Administration,,,,,,,11/10/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at the Stifel 2015 Healthcare Conference,,,"12/18/2017 ATNX-US  GNW  Athenex, Inc. Added to Nasdaq Biotechnology Index",,,,,,,,,, 3/15/2017 EYPT-US    GNW  Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/31/2017 PGNX-US  GNW  Progenics Pharmaceuticals to Participate in November Investor Conferences,,,,,,,,," 9/13/2018 68375N10 GNW  OPKO Class Action: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. - OPK",,12/29/2014 09061G10    GNW  BioMarin Announces Approval of VIMIZIM(R) (elosulfase alfa) in Japan for Treatment of Morquio A Syndrome,,,,12/26/2018 45290710 GNW  Immunomedics and Johnson Matthey Announce Strategic Manufacturing Partnership, 5/07/2015 09062X10  GNW  Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell,, 2/27/2018 09058V10 GNW  BioCryst Pharmaceuticals and Idera Pharmaceuticals File Preliminary Proxy Statement and Investor Presentation in Connection with Pending Merger,,,,, 8/18/2016 0DVRCL-E GNW  Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development,," 4/23/2019 MYGN-US  GNW  Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019",,,,, 3/30/2017 INO-US    GNW  Inovio and Collaborators Receive NIH GrantÂ to Evaluate HIV Immunotherapy PENNVAXÂ®-GPâ€™s AbilityÂ to Induce Remission of HIV Infection and End Lifetime of Drug Therapy,,,10/26/2016 GERN-US  GNW  Geron Announces Conference Call to Discuss Third Quarter 2016 Financial Results,, 9/27/2018 AMRN-US  GNW  Amarin to Present at the Cantor Global Healthcare Conference,,, 6/13/2018 SRPT-US  GNW  Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Brammer Bio to Support Gene Therapy Development and Commercial Supply,,, 8/03/2017 AMAG-US  GNW  AMAG Completes FerahemeÂ® (ferumoxytol) FDA Submission for the Treatment of All Adult Patients With Iron Deficiency Anemia,,,,, 7/09/2018 0072XH-E GNW  Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases,,,,,,11/02/2016 AFMD-US  GNW  Affimed Reports Financial Results for Third Quarter 2016,, 4/20/2017 PRQR-US  GNW  ProQR to Present at the Deutsche Bank Health Care Conference,, 6/01/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,,10/20/2016 08FFFQ-E GNW  Adverum Biotechnologies Announces Data Presentations at the European Society of Gene and Cell Therapy (ESGCT) Meeting,10/30/2017 RARE-US   GNW  Ultragenyx to Host Conference Call for Third Quarter 2017 Financial Results and Corporate Update,, 3/01/2017 NSTG-US  GNW  NanoString Technologies Releases Fourth Quarter and Full Year 2016 Operating Results and Provides 2017 Outlook,,," 1/31/2017 RDUS-US  GNW  Radius Health to Announce Fourth Quarter and Full Year 2016 Financial Results, Host Conference Call and Live Webcast on February 23, 2017"," 5/31/2013 04539610 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- VTUS",,,,, 8/31/2017 00972L10 GNW  Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA,," 3/13/2017 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference", 8/04/2016 RTRX-US  GNW  Retrophin Reports Second Quarter 2016 Financial Results," 7/13/2015 69404D10 GNW  New Publications Highlight Utility of Single Molecule, Real-Time Sequencing for Structural Variation Detection, Haplotype Reconstruction and De Novo Human Genome Assembly",10/06/2016 EDIT-US  GNW  Editas Medicine Reports Inducement Grant to New Chief Medical Officer,, 2/27/2018 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 2017 Financial Results,,,," 6/09/2016 MNTA-US  GNW  Momenta Pharmaceuticals Initiates Phase 1 Trial of M281, an Anti-FcRn Monoclonal Antibody", 6/21/2016 PRTA-US  GNW  Prothena to Present at 15th International Symposium on Amyloidosis Showcasing Broad Commitment to Advancing New Therapies for Systemic Amyloidoses,,,10/27/2016 CTMX-US  GNW  CytomX Therapeutics to Announce Third Quarter 2016 Financial Results, 1/06/2017 GMAB-DK  GNW  Genmab Achieves USD 25 Million Sales Milestone in DARZALEXÂ® (daratumumab) Collaboration with Janssen,,,10/20/2016 06VHPT-E GNW  CymaBay Therapeutics Announces an Oral Late-Breaking Presentation of a Phase 2 Proof-of-Concept Study of MBX-8025 in Patients With Primary Biliary Cholangitis at the AASLD 2016 Liver Meeting,,11/05/2015 16383L10 GNW  ChemoCentryx Highlights Results in Diabetic Nephropathy and Atypical Hemolytic Uremic Syndrome at the American Society of Nephrology Annual Meeting,,," 4/28/2017 MNKD-US   GNW  MannKind Corporation to Hold 2017 First Quarter Financial Results Conference Call on May 10, 2017",, 9/18/2017 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at the HFSA 21st Annual Scientific Meeting,11/07/2017 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results," 7/12/2018 RILY-US   GNW  B. Riley Financial Subsidiaries Assist Amyris, Inc. with $36 Million Term Loan",,11/05/2015 ACHN-US  GNW  Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of Hematology Detailing Novel Results With Factor D Inhibitors, 8/06/2018 SYNH-US  GNW  Syneos Health Announces Pricing of Secondary Offering of Common Stock, 7/12/2017 FOLD-US  GNW  Amicus Therapeutics Prices UnderwrittenÂ Offering of Common Stock,,, 7/06/2015 ADMA-US  GNW  ADMA Biologics Announces Recent Commercialization Focused Appointments,12/01/2016 GWP-GB   GNW  GW Pharmaceuticals plc Announces EpidiolexÂ® (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting,,,"12/01/2016 MYOK-US  GNW  MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer",,11/23/2017 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises,"11/06/2017 PTLA-US  GNW  Portola Pharmaceuticals Appoints Industry Veteran John H. Lawrence, M.D., as Senior Vice President of Product Development and Chief Medical Officer",,,, 9/02/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at 23rd Annual NewsMakers in the Biotech Industry Conference,12/18/2017 FLXN-US  GNW  Flexion Therapeutics Enrolls First Patient in Study Evaluating the Pharmacokinetics and Safety of ZILRETTAâ„¢ (triamcinolone acetonide extended-release injectable suspension) in Osteoarthritis of the Shoulder and Hip, 5/11/2017 QURE-US  GNW  uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates," 4/27/2017 AGIO-US   GNW  Agios to Webcast Conference Call of First Quarter 2017 Financial Results on May 4, 2017"," 5/08/2017 46226010 GNW  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm",,, 2/08/2017 FATE-US  GNW  Fate Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare Conference," 3/09/2016 G4618810 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Horizon Pharma plc of Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2016 â€“ HZNP",, 2/23/2017 ICPT-US  GNW  Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Business Update, 5/08/2019 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,," 5/26/2017 46116X10 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Announces the Filing of a Class Action against Intra-Cellular Therapies, Inc. and Certain Officers â€“ ITCI",,,,"10/21/2011 AGN-US   GNW  Momenta Pharmaceuticals Announces Extension of Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.", 3/09/2017 ATRA-US    GNW  Atara Bio Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Highlights,, 8/08/2016 DERM-US  GNW  Dermira Reports Second Quarter 2016 Financial Results and Provides Corporate Update, 6/16/2015 M4613510 GNW  Foamix Receives Milestone Payment From Merz North America, 2/04/2015 69354M10 GNW  PRA Health Sciences to Report Fourth Quarter 2014 Earnings, 7/20/2015 86845910 GNW  Supernus to Host Second Quarter 2015 Earnings Conference Call," 1/27/2016 FGEN-US  GNW  FibroGen Announces Early Phase 2 Data From a Clinical Study of FG-3019 in Combination With Chemotherapy as Neoadjuvant in Locally Advanced, Unresectable Pancreatic Cancer",, 5/08/2017 CHRS-US  GNW  Coherus BioSciences Reports First Quarter 2017 Corporate Highlights and Financial Results,,, 5/10/2016 COLL-US  GNW  Collegium Reports First Quarter Financial Results and Provides Corporate Update, 2/11/2016 XBIT-US  GNW  XBiotech Engages in Research for Heart Attack Antibody Therapy,,,11/13/2017 GBT-US   GNW  Global Blood Therapeutics Announces Completion of Safety Review by Independent Data and Safety Monitoring Board (DSMB) for Phase 3 HOPE Study in Sickle Cell Disease,, 3/14/2017 KURA-US  GNW  Kura Oncology Reports Fourth Quarter and Full Year 2016 Operational and Financial Results,, 3/29/2017 AXSM-US  GNW  Axsome Therapeutics Announces Full Exercise of Underwriterâ€™s Option to Purchase Additional Shares, 8/12/2016 VYGR-US  GNW  Voyager Therapeutics to Attend Upcoming Investor Conferences, 8/09/2018 BGNE-US  GNW  BeiGene Reports Second Quarter 2018 Financial Results,,,,,,,10/21/2015 0CRRZ8-E GNW  Glenn P. Muir Appointed to G1 Therapeutics Board of Directors,,,12/15/2017 ATNX-US  GNW  Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications,,,,,,,,,, 2/10/2017 EYPT-US    GNW  pSivida to Present at the 2017 BIO CEO & Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/23/2017 PGNX-US  GNW  Progenics Pharmaceuticals Sets Third Quarter  2017 Financial Results Call for November 2,,,,,,,,," 9/12/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. (OPK) and Encourages Investors to Contact the Firm",,12/24/2014 06TW4J-E    GNW  BioMarin and Prosensa Announce Expiration of the Hart-Scott-Rodino Waiting Period for BioMarin's Proposed Acquisition of Prosensa,,,,"12/21/2018 45290710 GNW  Bragar Eagel & Squire, P.C. is Investigating Immunomedics, Inc. (IMMU) on Behalf of Stockholders and Encourages IMMU Investors to Contact the Firm"," 1/09/2015 09062X10  GNW  Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations",, 2/20/2018 BCRX-US  GNW  BioCryst to Announce Fourth Quarter and Full Year 2017 Financial Results on February 27,,,,, 8/04/2016 AKRX-US  GNW  Akorn Provides Second Quarter 2016 Results,, 4/23/2019 MYGN-US  GNW  Myriad to Present Multiple Womenâ€™s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting,,,,, 3/21/2017 INO-US    GNW  George Bickerstaff Elected to Inovioâ€™s Board of Directors,,, 9/12/2016 GERN-US  GNW  Geron Provides Update on Imetelstat Trials Being Conducted by Janssen,, 9/24/2018 AMRN-US  GNW  REDUCE-ITâ„¢ Cardiovascular Outcomes Study of VascepaÂ® (icosapent ethyl) CapsulesÂ Met Primary Endpoint,,, 6/11/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 7/24/2017 AMAG-US  GNW  AMAG Pharmaceuticals Launches Intrarosaâ„¢ (prasterone) in the U.S. â€“ a Novel Product to Treat Moderate to Severe Dyspareunia Due to Menopause,,,,, 6/29/2018 SAN-FR   GNW  Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab),,,,,,10/31/2016 AFMD-US  GNW  Affimed to Present at the Credit Suisse 25th Annual Healthcare Conference,, 4/10/2017 PRQR-US  GNW  ProQR Announces Annual Meeting of Shareholders,, 5/14/2018 ZGNX-US  GNW  Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference,,,,,,10/14/2016 ADVM-US  GNW  Adverum Biotechnologies Provides Update on Alpha-1 Antitrypsin Deficiency Program,10/26/2017 90400D10  GNW  Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyxâ€™s Acquisition of Dimension,," 2/27/2017 NSTG-US  GNW  The Novartis Institutes for BioMedical Research and NanoString Technologies Demonstrate a Novel Approach for High-Plex, Spatial Profiling of Proteins Using nCounter-Based Digital Quantification at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium",,, 1/06/2017 RDUS-US  GNW  Radius Health to Present at the 35th Annual J.P. Morgan Healthcare Conference," 5/29/2013 04539610 GNW  Shareholder Alert: Scott+Scott, Attorneys at Law, LLP Reminds Ventrus Biosciences, Inc. Investors of Upcoming Lead Plaintiff Deadline in Ventrus Class Action -- VTUS",,,,, 8/29/2017 IONS-US  GNW  Akcea to Present at Wells Fargo Healthcare Conference,, 3/07/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Pricing of $300 Million Aggregate Principal Amount of 2.375% Convertible Senior Notes due 2022, 7/21/2016 RTRX-US  GNW  Retrophin to Report Second Quarter 2016 Financial Results," 5/05/2015 69404D10 GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2015 Financial Results",10/03/2016 05F9ZW-E GNW  Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit,, 2/14/2018 MGNX-US  GNW  MacroGenics Announces Date of Fourth Quarter and Full Year 2017 Financial Results Conference Call,,,," 6/08/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Data Presentation on M923, a Proposed HUMIRAÂ® (adalimumab) Biosimilar, at EULAR 2016"," 6/09/2016 PRTA-US  GNW  Prothena Reports Results of Phase 1 Single Ascending Dose Study of PRX003, Demonstrating Target Engagement of the Novel Anti-MCAM Antibody for Inflammatory Diseases",,, 8/03/2016 CTMX-US  GNW  CytomX Announces Second Quarter 2016 Financial Results,12/19/2016 05TF66-E GNW  Genmab Announces Submission of Regulatory Application for Daratumumab in Relapsed/Refractory Multiple Myeloma in Japan and Updates Financial Guidance,,,10/20/2016 080RQG-E GNW  CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis,,11/04/2015 16383L10 GNW  ChemoCentryx Announces Immuno-Oncology Data Presentations at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting,,, 3/16/2017 MNKD-US   GNW  MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results,, 9/11/2017 CYTK-US  GNW  Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the HFSA 21st  Annual Scientific Meeting,11/06/2017 ESPR-US     GNW  Esperion Announces Initiation of Pivotal Phase 3 Study for the Bempedoic Acid / Ezetimibe Combination Pill, 7/02/2018 AMRS-US   GNW  Amyris Announces Non-Dilutive $36 Million Term Loan to Pay Off Stegodon and Other Short-Term Debt Maturities,,11/02/2015 ACHN-US  GNW  Achillion to Present at the Credit Suisse 24th Annual Healthcare Conference, 8/06/2018 SYNH-US  GNW  Syneos Health Announces Secondary Offering of Common Stock, 7/12/2017 FOLD-US  GNW  Amicus Therapeutics Announces PublicÂ Offering of Common Stock,,, 6/30/2015 008FZT-E GNW  ADMA Biologics Receives Notice of Allowance for U.S. Patent Pertaining to Its Lead Product Candidate RI-002,"11/30/2016 GWP-GB   GNW  GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016",,,"11/11/2016 MYOK-US  GNW  MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients",,11/21/2017 GLPG-NL  GNW  Galapagos initiates Phase 1 study with novel CF corrector GLPG3221,11/03/2017 PTLA-US  GNW  Portola Pharmaceuticals to Present at the Credit Suisse 26th Annual Healthcare Conference,,,, 9/01/2016 CARA-US  GNW  Cara Therapeutics to Sponsor Symposium and Present Posters at PAINWeek,"12/13/2017 FLXN-US  GNW  Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee", 5/10/2017 QURE-US  GNW  uniQure Presents New Data Demonstrating Successful and Effective Transduction of AAV5 Vector in the Presence of Pre-Existing Neutralizing Antibodies in Non-Human Primates, 4/26/2017 AGIO-US   GNW  Agios Announces Exercise of Over-Allotment Option in Public Offering," 5/06/2017 46226010 GNW  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm",,, 1/05/2017 FATE-US  GNW  Fate Therapeutics Announces First Patient Treated in ProTmuneâ„¢ PROTECT Clinical Trial for the Prevention of Graft-Versus-Host Disease,10/13/2015 SCMP-US  GNW  Timothy P. Walbert Joins Sucampo's Board of Directors,, 2/17/2017 ICPT-US  GNW  Intercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences," 5/02/2019 KPTI-US    GNW  Karyopharm to Report First Quarter 2019 Financial Results on May 9, 2019",,," 5/25/2017 46116X10 GNW  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Encourages Investors with Losses to Contact the Firm",,,,"10/07/2011 AGN-US   GNW  Momenta Pharmaceuticals Obtains Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.", 1/04/2017 JPM-US     GNW  Atara Bio to Present at the 35th Annual J.P. Morgan Healthcare Conference,, 6/13/2016 DERM-US  GNW  Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares, 6/01/2015 M4613510 GNW  Foamix to Present Corporate Overview at the Jefferies 2015 Global Healthcare Conference,, 6/17/2015 86845910 GNW  Supernus Corrects Earlier Statement Regarding Distribution of Common Stock by NEA, 1/06/2016 FGEN-US  GNW  FibroGen Enrolls First Patients in Phase 2 Clinical Study of Anti-Fibrotic Drug Candidate FG-3019 for the Treatment of Duchenne Muscular Dystrophy,, 5/01/2017 CHRS-US  GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in May,,, 5/04/2016 COLL-US  GNW  Collegium Announces Positive Topline Results of Comparative Clinical Trial Evaluating the Effect of Crushing Xtampzaâ„¢ ER Compared with OxyContinÂ®," 1/27/2016 98400H10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of XBiotech Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 â€“ XBIT",,,11/07/2017 GBT-US   GNW  Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference,, 3/07/2017 KURA-US  GNW  Kura Oncology to Report Fourth Quarter and Full Year 2016 Financial Results,, 3/23/2017 AXSM-US  GNW  Axsome Therapeutics to Present at the 16th Annual Needham Healthcare Conference, 8/11/2016 VYGR-US  GNW  Voyager Therapeutics Provides Second Quarter 2016 Investor Update, 8/08/2018 07725L10 GNW  BeiGene Announces Closing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering,,,,,,, 9/03/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at September Biotech Conferences,,,12/11/2017 04685N10 GNW  Almirall and Athenex announce strategic partnership for the treatment of actinic keratosis,,,,,,,,,, 2/07/2017 EYPT-US    GNW  pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/16/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations on AZEDRAÂ® (iobenguane I 131) and its Prostate Cancer Programs at the 30th Annual Congress of the European Association of Nuclear Medicine,,,,,,,,," 9/12/2018 68375N10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of OPKO Health, Inc.",,12/10/2014 09061G10    GNW  BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Brazil for Treatment of Morquio A Syndrome,,,,12/19/2018 IMMU-US  GNW  Immunomedics To Present at the 37th Annual J.P. Morgan Healthcare Conference, 5/19/2014 09062X10  GNW  Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index,, 2/19/2018 09058V10 GNW  BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at Two Upcoming Healthcare Investor Conferences,,,,, 7/21/2016 AKRX-US  GNW  Akorn Announces Second Quarter 2016 Earnings Release and Conference Call Information,, 4/17/2019 MYGN-US  GNW  Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Councilâ€™s 2019 Shatter List,,,,, 3/15/2017 INO-US    GNW  Inovio Pharmaceuticals Reports 2016 Fourth Quarter  and Year End Financial Results,,, 9/11/2016 GERN-US  GNW  Geron Announces Conference Call on September 12 at 8:00 A.M. Eastern Time,, 9/12/2018 AMRN-US  GNW  REDUCE-ITâ„¢ Trial Primary Results Accepted for Presentation at 2018 Scientific Sessions of American Heart Association,,," 6/08/2018 SRPT-US  GNW  Sarepta Therapeutics to Host R&D Day on Tuesday, June 19, 2018",,," 7/20/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Host Second Quarter 2017 Financial Results Conference Call and Webcast on Thursday, August 3, 2017 at 8:00 a.m. ET",,,,, 6/28/2018 SAN-FR   GNW  Sanofi  : Sanofi and Advent finalize negotiations for the acquisition of Zentiva,,,,,,10/26/2016 AFMD-US  GNW  Affimed Announces Third Quarter 2016 Financial Results and Corporate Update Conference Call,," 4/03/2017 PRQR-US  GNW  ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU",, 5/09/2018 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports First Quarter Financial Results,,,,,,"10/14/2016 ADVM-US  GNW  Adverum Biotechnologies, Inc. Announces New Executive Chair and CEO",10/10/2017 RARE-US   GNW  Ultragenyx and Kyowa Hakko Kirin Announce FDA Acceptance and Priority Review Designation of Burosumabâ€™s Biologics License Application,," 2/24/2017 NSTG-US  GNW  NanoString Technologies to Release Fourth Quarter and Fiscal Year 2016 Financial Results and Host Conference Call on Wednesday, March 1, 2017",,,12/08/2016 RDUS-US  GNW  Radius Presents Positive Phase I Data for Investigational Drug RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) 2016," 5/24/2013 04539610 GNW  Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Lead Plaintiff Deadline in Securities Class Action Against Ventrus Biosciences, Inc. -- VTUS",,,,, 8/08/2017 AKCA-US  GNW  Akcea Reports Financial Results and Highlights for Second Quarter 2017Â ,, 3/06/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Proposed Offering of $300 Million Aggregate Principal Amount of Convertible Senior Notes," 7/19/2016 RTRX-US  GNW  Retrophin Appoints Roy D. Baynes, M.D., Ph.D., to Board of Directors", 5/05/2015 PACB-US  GNW  Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche,10/03/2016 EDIT-US  GNW  Editas Medicine Expands Senior Management Team,, 2/06/2018 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 6/04/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Presentation of Final Data from Phase 1 Trial of Necuparanib in Patients with Pancreatic Cancer at ASCO," 5/23/2016 PRTA-US  GNW  Prothena to Present Wide Range of Studies on Amyloidosis, Including New Clinical Data on NEOD001, at International Symposium on Amyloidosis",,, 7/27/2016 CTMX-US  GNW  CytomX Therapeutics to Announce Second Quarter 2016 Financial Results and Provide Mid-Year Update,11/21/2016 06CR5C-E GNW  Genmab Announces U.S. FDA Approval of DARZALEXÂ® (daratumumab) for Relapsed Multiple Myeloma and Updates Financial Guidance,,,10/11/2016 CBAY-US  GNW  CymaBay Therapeutics Announces a Newly Issued U.S. Patent for MBX-8025 for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH),,"10/29/2015 16383L10 GNW  ChemoCentryx to Hold Third Quarter 2015 Financial Results Conference Call on Monday, November 9, 2015",,, 3/08/2017 MNKD-US   GNW  MannKind Corporation and Charles Mattocks Announce â€œREVERSEDâ€-Americaâ€™s First Docu-Series Tackling Diabetes,, 9/05/2017 CYTK-US  GNW  Cytokinetics to Present at September Investor Conferences,10/10/2017 ESPR-US     GNW  Esperion to Host Analyst and Investor Day Event on October 17, 6/27/2018 AMRS-US   GNW  Amyris Expands Production Contract with ADL BioPharmaÂ Due to Demand Growth,,"10/16/2015 ACHN-US  GNW  Achillion Announces That Janssen Has Initiated a Phase 2a Study to Evaluate the Combination of AL-335, Odalasvir (ACH-3102), and Simeprevir for the Treatment of Genotype 1 Chronic HCV", 8/02/2018 SYNH-US  GNW  Syneos Health Reports Second Quarter 2018 Results, 7/11/2017 FOLD-US  GNW  U.S. FDA Confirms Amicus Therapeutics May Submit New Drug Application for Migalastat for Fabry Disease,,, 6/29/2015 00089910 GNW  ADMA Biologics Joins Russell Microcap(R) Index,11/22/2016 06Y82H-E GNW  GW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November,,,11/07/2016 MYOK-US  GNW  MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results,,11/19/2017 GLPG-NL  GNW  ALBATROSS with GLPG2222 shows positive clinical results in CF patients,"10/30/2017 PTLA-US  GNW  Portola Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 6",,,, 8/05/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at Canaccord Genuity 36th Annual Growth Conference,"12/11/2017 FLXN-US  GNW  Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as Chief Medical Officer", 5/09/2017 QURE-US  GNW  uniQure Announces First Quarter 2017 Financial Results and Highlights Recent Company Progress, 4/24/2017 AGIO-US   GNW  Agios Announces Closing of Public Offering," 5/05/2017 46226010 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lion Biotechnologies, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ LBIO",,,11/22/2016 0D2L9X-E GNW  Fate Therapeutics Announces Private Financing, 1/23/2015 G4618810 GNW  Horizon Pharma plc (Nasdaq: HZNP) to Ring The Nasdaq Stock Market Opening Bell,, 2/10/2017 ICPT-US  GNW  Intercept to Provide Update on Phase 3 REGENERATE Trial of Obeticholic Acid for the Treatment of NASH Patients with Liver Fibrosis, 5/01/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/25/2017 ITCI-US  GNW  Intra-Cellular Therapies to Present at the American Society of Clinical Psychopharmacology 2017 Annual Meeting,,,," 9/30/2011 AMPR-US  GNW  Momenta Pharmaceuticals Files for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd."," 1/03/2017 080RQG-E   GNW  Atara Bio Concludes EMA Scientific Advice and Plans to Submit Conditional Marketing Authorization Application (MAA) in Europe for Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes (CTL), or ATA 129, for the Treatment of EBV-Associated Post Transplant Lymphoproliferative Disorder (EBV-PTLD)",, 6/08/2016 DERM-US  GNW  Dermira Prices $126 Million Public Offering of Common Stock, 5/12/2015 M4613510 GNW  Foamix Reports First Quarter Financial Results,, 6/17/2015 86845910 GNW  Supernus Announces Distribution of Common Stock by NEA,11/12/2015 FGEN-US  GNW  FibroGen Announces Third Quarter 2015 Financial Results,, 4/25/2017 CHRS-US  GNW  Coherus BioSciences Completes Patent Dance Exchange with Amgen for Neulasta Biosimilar,,, 4/27/2016 COLL-US  GNW  Collegium to Host Conference Call to Discuss First Quarter 2016 Financial Results and Provide Corporate Update," 1/22/2016 98400H10 GNW  INVESTOR NOTICE: Rosen Law Firm Reminds XBiotech Inc. Investors of Important February 1, 2016 Deadline in Class Action Filed by Firm â€“ XBIT",,,11/02/2017 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business ProgressÂ and Provides Third Quarter 2017 Financial Results,, 3/06/2017 KURA-US  GNW  Kura Oncology Reports Updated Clinical Activity Data in Ongoing Phase 2 Trial for Tipifarnib,, 3/21/2017 AXSM-US  GNW  Axsome Therapeutics Announces Pricing of Its Public Offering of Common Stock, 8/09/2016 VYGR-US  GNW  Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinsonâ€™s Disease, 8/02/2018 BGNE-US  GNW  BeiGene Announces Pricing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering,,,,,,, 8/11/2015 0CRRZ8-E GNW  G1 Therapeutics Announces Initiation of Two Phase 1b/2a Trials of CDK4/6 Inhibitor G1T28 in Small-Cell Lung Cancer,,,12/01/2017 ATNX-US  GNW  Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle,,,,,,,,,, 1/25/2017 EYPT-US    GNW  pSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/04/2017 PGNX-US  GNW  Data from Pivotal Phase 2b Study of Progenicsâ€™ AZEDRAÂ® (iobenguane I 131) to be Presented at the North American Neuroendocrine Tumor Society 2017 Annual Symposium,,,,,,,,," 9/10/2018 68375N10 GNW  Bragar Eagel & Squire, P.C. is Investigating OPKO Health, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm",,"12/10/2014 09061G10    GNW  FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of MPS IIIB (Sanfilippo Syndrome Type B)",,,,12/06/2018 IMMU-US  GNW  Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan, 3/21/2014 SOBI-SE   GNW  Health Canada approves Alprolix(TM),, 1/22/2018 09058V10 GNW  BioCryst Pharmaceuticals and Idera Pharmaceuticals Announce Merger to Combine Capabilities to Serve More Patients with Rare Diseases,,,,," 6/02/2016 AKRX-US  GNW  Akorn Updates Form S-8 Status by Filing Form 10-Qâ€™s for First, Second and Third Quarters of 2015",, 4/09/2019 MYGN-US  GNW  Myriad Genetics Submits First Module of the Premarket Approval Application to FDA for the myChoiceÂ® HRD CDx Test,,,,," 3/09/2017 INO-US    GNW  Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2016 Financial Results on March 15, 2017",,, 8/03/2016 GERN-US  GNW  Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Events,, 8/26/2018 AMRN-US  GNW  Amarinâ€™s REDUCE-ITâ„¢ Clinical Study Now Positioned to be Next Large  Cardiovascular Outcomes Study to Report Results,,," 6/07/2018 SRPT-US  GNW  Sarepta Therapeutics Appoints Gilmore Oâ€™Neill, M.B., M.M.Sc. as Chief Medical Officer",,, 6/26/2017 00163U10 GNW  AMAG Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for MakenaÂ® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector,,,,," 6/19/2018 SAN-FR   GNW  Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer",,,,,,10/04/2016 AFMD-US  GNW  Affimed Presents Preclinical Data on Lead Candidate AFM13 at the Annual Meeting of the Society for Natural Immunity,," 3/27/2017 PRQR-US  GNW  ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer",, 5/04/2018 ZGNX-US  GNW  Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9,,,,,,10/13/2016 06VHSY-E GNW  Adverum Biotechnologies to Present at the 2016 Ophthalmology Innovation Summit at the American Academy of Ophthalmology Annual Meeting,10/03/2017 DMTX-US   GNW  Ultragenyx to Acquire Dimension Therapeutics,, 2/22/2017 NSTG-US  GNW  NanoString Technologies to Present at the Cowen and Company 37th Annual Health Care Conference,,,11/03/2016 RDUS-US  GNW  Radius Health Reports Third Quarter 2016 Financial and Operating Results," 5/22/2013 04539610 GNW  Scott+Scott, Attorneys at Law, LLP Reminds Ventrus Biosciences, Inc. Investors of Upcoming Deadline in Securities Class Action Lawsuit -- VTUS",,,,,,, 3/01/2017 PCRX-US  GNW  Pacira Pharmaceuticals Reports 2016 Financial Results and Provides Business Update, 6/23/2016 RTRX-US  GNW  Retrophin Announces New Data from Physician-Initiated Treatment with RE-024 at the 20th International Congress of Parkinsonâ€™s Disease and Movement Disorders, 5/05/2015 PACB-US  GNW  Pacific Biosciences and RainDance Technologies Partner to Co-Develop and Commercialize Novel Solution For de novo Whole Genome Assembly, 9/06/2016 MS-US    GNW  Editas Medicine to Present at the Morgan Stanley Global Healthcare Conference,, 1/23/2018 MGNX-US  GNW  MacroGenics Announces Continuation of SOPHIA Study of Margetuximab Based on Completion of Interim Futility Analysis,,,, 5/25/2016 GS-US    GNW  Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 37th Annual Global Healthcare Conference, 5/19/2016 07G766-E GNW  Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress,,," 6/13/2016 CTMX-US  GNW  CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of Directors",11/10/2016 GMAB-DK  GNW  Genmab Announces Phase III Study of Daratumumab in Combination with Carfilzomib in Multiple Myeloma,,,10/06/2016 06VHPT-E GNW  CymaBay Therapeutics Announces an Oral Presentation Describing the Efficacy of MBX-8025 in a Preclincal Model of NASH at the AASLD 2016 Liver Meeting,, 9/02/2015 CCXI-US  GNW  ChemoCentryx to Present at the Rodman & Renshaw 17th Annual Global Investment Conference,,, 3/07/2017 MNKD-US   GNW  MannKind Corporation Announces Upcoming Events,," 8/02/2017 CYTK-US  GNW  Cytokinetics, Inc. Reports Second Quarter 2017 Financial Results",10/02/2017 ESPR-US     GNW  Esperion Completes Patient Enrollment in Global Pivotal Phase 3 Program for Bempedoic Acid, 6/26/2018 0FM8B8-E  GNW  Amyris and BGI Agree to Joint Venture to Develop Products to Improve Human Health in Greater China,, 9/17/2015 ACHN-US  GNW  Achillion Reports 100% SVR12 From Second Cohort of Patients in the Previously-Completed Six Week Phase 2 Trial Evaluating Odalasvir (ACH-3102) and Sofosbuvir for Genotype 1 HCV (â€œProxy Studyâ€)," 7/12/2018 SYNH-US  GNW  Syneos Health Schedules Second Quarter 2018 Earnings Call for Thursday, August 2, 2018", 6/28/2017 FOLD-US  GNW  Amicus Therapeutics Submits Japanese New Drug Application for Migalastat for Fabry Disease,,, 6/22/2015 008FZT-E GNW  ADMA Biologics Secures Up to $21 Million Loan Commitment From Oxford Finance, 9/26/2016 GWP-GB   GNW  GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EpidiolexÂ® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome,,,11/04/2016 06418D-E GNW  MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2016,,11/05/2017 GLPG-NL  GNW  Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study,10/11/2017 PTLA-US  GNW  Portola Pharmaceuticals Supports 2017 World Thrombosis Day Campaign to Raise Awareness about the Persistent Risk of Blood Clots,,,, 8/04/2016 CARA-US  GNW  Cara Therapeutics Reports Second Quarter 2016 Financial Results,12/07/2017 FLXN-US  GNW  Flexion Therapeutics Enrolls First Patient in Phase 2 Pharmacokinetics and Safety Study of ZILRETTAâ„¢ (triamcinolone acetonide extended-release injectable suspension) in  Bilateral Osteoarthritis of the Knee, 5/01/2017 QURE-US  GNW  uniQure Announces Company Presentations at Upcoming May Conferences, 4/18/2017 AGIO-US   GNW  Agios Announces Pricing of $250 Million Public Offering of Common Stock," 5/01/2017 46226010 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lion Biotechnologies, Inc. â€“ LBIO",,,11/07/2016 FATE-US  GNW  Fate Therapeutics Reports Third Quarter 2016 Financial Results,"10/21/2011 G4618810 GNW  Horizon Pharma, Inc [HZNP] to Ring The NASDAQ Stock Market Closing Bell in Celebration of July 2011 IPO",, 1/04/2017 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conference, 4/01/2019 48576U10   GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 5/23/2017 46116X10 GNW  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Encourages Investors with Losses to Contact the Firm",,,, 9/21/2011 AGN-US   GNW  Momenta Pharmaceuticals Sues Amphastar for Patent Infringement,"12/12/2016 06CR5C-E   GNW  Atara Bio Reaches Agreement with FDA on Design of Phase 3 Trials for its Lead Anti-Cancer Immunotherapy Program, Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes (CTL), or ATA 129, to Support Potential Approval in Two Separate Indications",, 6/07/2016 DERM-US  GNW  Dermira Announces Proposed Public Offering of Common Stock, 5/07/2015 008XK0-E GNW  Foamix Announces Appointment of Dr. Aaron Schwartz to Board of Directors,," 6/08/2015 86845910 GNW  Supernus Announces Webcast of Investor Day on June 17, 2015","11/05/2015 FGEN-US  GNW  FibroGen to Report Third Quarter 2015 Financial Results on November 12, 2015",, 4/24/2017 CHRS-US  GNW  Coherus BioSciences to Report First Quarter 2017  Financial Results on May 8th,,," 4/26/2016 06CR5C-E GNW  Collegium Receives FDA Approval for Xtampzaâ„¢ ER, an Analgesic with Abuse-Deterrent Properties for the Treatment of Chronic Pain", 1/21/2016 XBIT-US  GNW  XBiotech to Attend and Present at the ASCO 2016 Gastrointestinal Cancers Symposium,,,11/01/2017 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Data Presentations Supporting Sickle Cell Disease Program at 59th American Society of Hematology (ASH) Annual Meeting,, 2/27/2017 KURA-US  GNW  Kura Oncology Announces Presentation of Preliminary Clinical Data for Tipifarnib in HRAS Mutant Squamous Cell Carcinomas of the Head and Neck at TAT 2017,, 3/20/2017 AXSM-US  GNW  Axsome Therapeutics Announces Proposed Public Offering of Common Stock, 8/04/2016 VYGR-US  GNW  Voyager Therapeutics to Host Second Quarter 2016 Investor Update Call, 7/27/2018 BGNE-US  GNW  BeiGene Announces Proposed Hong Kong Initial Public Offering and Global Offering,,,,,,, 8/05/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at August Investor Conferences,,,"11/28/2017 ATNX-US  GNW  Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting on February 17, 2018",,,,,,,,,,11/07/2016 EYPT-US    GNW  Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/20/2017 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference,,,,,,,,," 9/07/2018 68375N10 GNW  Nasdaq Halts OPKO Health, Inc.",,12/09/2014 09061G10    GNW  BioMarin to Highlight Breadth of Innovative Development Pipeline at Analyst and Investor Day on December 10th in New York,,,,11/08/2018 IMMU-US  GNW  Immunomedics Announces Presentation at Upcoming Healthcare Conferences, 1/09/2014 SNSS-US   GNW  Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs,, 1/05/2018 BCRX-US  GNW  BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossificans Progressiva,,,,, 5/31/2016 AKRX-US  GNW  Akorn to Present at Two Upcoming Investor Conferences,," 4/04/2019 AZN-GB   GNW  Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership",,,,," 2/27/2017 INO-US    GNW  Inovioâ€™s SynConÂ® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy",,, 7/27/2016 GERN-US  GNW  Geron Announces Conference Call to Discuss Second Quarter 2016 Financial Results,, 8/25/2018 AMRN-US  GNW  Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Peripheral Arterial Revascularization in High Risk Statin-Treated Patients,,, 6/05/2018 SRPT-US  GNW  Sarepta Therapeutics to Present at Two Upcoming Investor Conferences,,, 6/01/2017 AMAG-US  GNW  AMAG Announces First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study Conducted by Velo Bio,,,,, 6/19/2018 SAN-FR   GNW  Sanofi  : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure,,,,,, 9/22/2016 AFMD-US  GNW  Affimed to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology,, 3/01/2017 PRQR-US  GNW  ProQR to Present at Two Upcoming Investor Conferences in March,, 5/01/2018 ZGNX-US  GNW  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4),,,,,, 9/16/2016 ADVM-US  GNW  Adverum Biotechnologies Presents Preclinical Data on Novel Gene Therapy Candidates for the Treatment of Wet AMD at The Retina Society 2016 Annual Meeting,10/02/2017 90400D10  GNW  Ultragenyx Comments on Dimension Therapeuticsâ€™ Announcement  that Ultragenyxâ€™s Offer is a â€œSuperior Proposalâ€Â ,, 2/16/2017 NSTG-US  GNW  NanoString Highlights Progress on Product Roadmap Featuring Multiple Innovative Technologies at 2017 Advances in Genome Biology and Technology (AGBT) Conference,,,11/01/2016 CS-CH    GNW  Radius Health to Present at the Credit Suisse 25th Annual Healthcare Conference," 5/21/2013 04539610 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Ventrus Biosciences, Inc. and Certain Officers -- VTUS",,,,,,, 2/16/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for 2016 Financial Results Webcast and Conference Call, 6/20/2016 RTRX-US  GNW  Retrophin Acquires Liquid Formulation of Ursodeoxycholic Acid," 5/04/2015 69404D10 GNW  BGI Adopts Single Molecule, Real-Time Sequencing from Pacific Biosciences", 8/09/2016 EDIT-US  GNW  Editas Medicine Announces Second Quarter 2016 Results and Update,, 1/18/2018 MGNX-US  GNW  Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium,,,, 5/19/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Data Presentation on Necuparanib at the 2016 ASCO Annual Meeting," 5/09/2016 007BX2-E GNW  Prothena to Present Clinical Results From its Phase 1 Single Ascending Dose Study of PRX003, an Anti-MCAM Antibody Being Investigated for Inflammatory Diseases, at EULAR 2016",,, 5/24/2016 CTMX-US  GNW  CytomX to Present at the Jefferies 2016 Healthcare Conference,11/02/2016 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial Guidance,,,10/05/2016 CBAY-US  GNW  CymaBay Therapeutics Announces Plans to Initiate Its Next Phase 2 Study of  MBX-8025 in Primary Biliary Cholangitis,, 8/06/2015 16383L10 GNW  ChemoCentryx Reports Second Quarter 2015 Financial Results and Provides Corporate Update,,, 2/21/2017 MNKD-US   GNW  MannKind Receives $16.7 Million From Sale of Valencia PropertyÂ ,, 8/02/2017 CYTK-US  GNW  Cytokinetics Announces Positive Results From Phase 2 Clinical Trial of Omecamtiv Mecarbil in Japanese Patients With Heart Failure, 8/11/2017 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 6/12/2018 0CNV7P-E  GNW  Amyris Announces Signing of Major UCP in Porto/AICEP Consortium Project Agreement Valued at $50 Million,, 9/01/2015 ACHN-US  GNW  Achillion to Present at Two Upcoming Investor Conferences," 7/02/2018 87166B10 GNW  Recent Analysis Shows WideOpenWest, Syneos Health, Aspen Insurance, Despegar, Frank's International N.V., and Transportadora de Gas del Sur S.A. Market Influences â€” Renewed Outlook, Key Drivers of Growth", 6/07/2017 FOLD-US  GNW  Amicus Therapeutics to Present at Goldman Sachs 38th Annual Global Healthcare Conference,,, 6/16/2015 008FZT-E GNW  ADMA Biologics to Present at the 2015 JMP Securities Life Sciences Conference, 9/07/2016 MS-US    GNW  GW Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference,,,"11/02/2016 MYOK-US  GNW  MyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy",,11/02/2017 GLPG-NL  GNW  Galapagos moving forward in CF programs at NACFC 2017,10/03/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 7/28/2016 CARA-US  GNW  Cara Therapeutics to Announce Second Quarter 2016 Financial Results on August 4, 2016",12/06/2017 FLXN-US  GNW  Flexion Therapeutics to Present at the BMO Capital Markets Prescriptions for Success  Healthcare Conference, 4/26/2017 QURE-US  GNW  uniQure Presents New Preclinical Data on AMT-130 in Huntingtonâ€™s Disease at CHDIâ€™s 12th Annual Huntingtonâ€™s Disease Therapeutics Conference, 4/17/2017 AGIO-US   GNW  Agios Announces Proposed Offering of Common Stock," 4/26/2017 46226010 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Lion Biotechnologies, Inc. (LBIO) & Lead Plaintiff Deadline â€“ June 13, 2017",,,11/03/2016 06QBQ2-E GNW  Fate Therapeutics Announces Oral Presentation on Natural Killer Cell Product Candidate FATE-NK100 at the 2016 ASH Annual Meeting,,,12/14/2016 071VWR-E GNW  European Commission Grants Interceptâ€™s OcalivaÂ® (obeticholic acid) Marketing Authorization for the Treatment of Primary Biliary Cholangitis, 2/28/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,," 5/18/2017 46116X10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI) and Lead Plaintiff Deadline: July 11, 2017",,,,,12/03/2016 ATRA-US    GNW  Atara Bio Announces Results from Ongoing Phase 2 Trial of Allogeneic Cytomegalovirus (CMV)-specific Cytotoxic T Lymphocytes (CTL) at the American Society of Hematology (ASH) Annual Meeting 2016,, 6/01/2016 DERM-US  GNW  Dermira Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Trials for DRM04 in Patients with Primary Axillary Hyperhidrosis," 4/29/2015 M4613510 GNW  Foamix Pharmaceuticals First Quarter 2015 Conference Call & Webcast Scheduled for Wednesday, May 13",, 5/19/2015 86845910 GNW  Supernus to Present at June Jefferies Healthcare Conference,11/03/2015 FGEN-US  GNW  FibroGen to Present Roxadustat Clinical Data in Four Presentations at American Society of Nephrology - Kidney Week 2015,, 3/27/2017 CHRS-US  GNW  Coherus BioSciences Appoints Erik Wiberg as  Executive Vice President of Corporate Development,,, 4/08/2016 05KDBG-E GNW  Collegium to Present at the 15th Annual Needham Healthcare Conference, 1/08/2016 XBIT-US  GNW  XBiotech Reports Additional Positive Data From Phase III European Trial of Xilonixâ„¢ in Advanced Colorectal Cancer,,,10/28/2017 GBT-US   GNW  Global Blood Therapeutics Announces Presentation of Case Study Demonstrating Positive Effect of Voxelotor (GBT440) in a Sickle Cell Disease Patient with Severe and Symptomatic Anemia,, 2/09/2017 KURA-US  GNW  Kura Oncology to Participate in Three Upcoming Investor Conferences,, 3/07/2017 AXSM-US  GNW  Axsome Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update, 6/22/2016 VYGR-US  GNW  Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinsonâ€™s Disease, 7/24/2018 BGNE-US  GNW  BeiGene Initiates Phase 3 Pivotal Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in China,,,,,,, 6/10/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at the BIO International Convention,,,11/22/2017 ATNX-US  GNW  Athenex to Present at 29th Annual Piper Jaffray Healthcare Conference,,,,,,,,,,11/07/2016 EYPT-US    GNW  pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/31/2017 PGNX-US  GNW  Progenics Pharmaceuticals Presents Data from AZEDRAÂ® Pivotal Phase 2b Study at the 5th International Symposium on Pheochromocytoma and Paraganglioma,,,,,,,,, 9/04/2018 OPK-US   GNW  OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients,,12/07/2014 09061G10    GNW  BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Australia for Treatment of Morquio A Syndrome,,,,11/07/2018 IMMU-US  GNW  Immunomedics Announces First Quarter Fiscal 2019 Results and Provides Corporate Update,12/02/2013 SOBI-SE   GNW  Sobi's partner Biogen Idec receives notification from FDA of PDUFA date extension for ALPROLIX(TM),, 1/03/2018 BCRX-US  GNW  BioCryst to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,,, 5/16/2016 AKRX-US  GNW  Akorn Provides First Quarter 2016 Results,, 4/02/2019 MYGN-US  GNW  Myriad Womenâ€™s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the ForesightÂ® and Prequelâ„¢ Prenatal Tests,,,,, 2/23/2017 INO-US    GNW  Inovio Reports New Positive Clinical Data on Vaccine Advances  in the Fight Against Emerging Infectious Diseases,,, 7/13/2016 GERN-US  GNW  Geron Announces Issuance of U.S. Patents Related to Imetelstat,," 8/21/2018 02311120 GNW  New Research Coverage Highlights pdvWireless, Fortuna Silver Mines, Nordic American Tankers, Amarin, Himax Technologies, and Retrophin â€” Consolidated Revenues, Company Growth, and Expectations for 2018",,," 6/04/2018 SRPT-US  GNW  Sarepta Therapeutics Appoints Louise Rodino-Klapac, Ph.D. to Lead Newly Created Gene TherapyÂ Business Unit",,, 5/31/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 6/13/2018 SAN-FR   GNW  Sanofi : Sanofi successfully prices USD 2 billion bond issue,,,,,, 9/01/2016 AFMD-US  GNW  Affimed to Present at Upcoming Investor Conferences,, 2/28/2017 PRQR-US  GNW  ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update,, 4/27/2018 ZGNX-US  GNW  Zogenix Announces Initial Quality of Life and Cognitive Function Data From Phase 3 Trial of ZX008 in Dravet Syndrome,,,,,," 8/09/2016 ADVM-US  GNW  Adverum Biotechnologies, Inc. Reports Second Quarter 2016 Financial Results",10/02/2017 90400D10  GNW  REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension Therapeutics,, 1/31/2017 NSTG-US  GNW  Humana Issues Positive Coverage Decision for NanoStringâ€™s ProsignaÂ® Breast Cancer Assay,,,"10/12/2016 RDUS-US  GNW  Radius Health to Announce Third Quarter 2016 Financial Results, Host Conference Call and Live Webcast on November 3, 2016"," 5/13/2013 04539610 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in Ventrus Biosciences, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff Deadline -- VTUS",,,,,,," 2/15/2017 061XBV-E GNW  Pacira Pharmaceuticals, Inc. to Present at the  2017 RBC Capital Marketsâ€™ Healthcare Conference", 5/26/2016 RTRX-US  GNW  Retrophin to Present at Upcoming Investor Conferences, 4/27/2015 69404D10 GNW  Pacific Biosciences Introduces New Solutions for Comprehensive and Efficient Targeted Sequencing and Multiplexing of Samples, 8/09/2016 28106W10 GNW  Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye,, 1/04/2018 MGNX-US  GNW  MacroGenics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,, 5/03/2016 MNTA-US  GNW  Momenta Pharmaceuticals Reports First Quarter 2016 Financial Results, 5/03/2016 PRTA-US  GNW  Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update,,, 5/06/2016 CTMX-US  GNW  CytomX Announces First Quarter 2016 Financial Results,10/07/2016 37230320 GNW  U.S. FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma,,, 9/08/2016 RRSHQ-US GNW  CymaBay Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference,, 7/30/2015 16383L10 GNW  ChemoCentryx Announces Changes to its Board of Directors,,, 2/01/2017 MNKD-US   GNW  MannKind Announces Launch of New Titration Pack and Field Force Expansion to Accelerate AfrezzaÂ® Growth,," 7/27/2017 CYTK-US  GNW  Cytokinetics Announces Start of FORTITUDE-ALS,  a Phase 2 Clinical Trial of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis", 8/09/2017 ESPR-US     GNW  Esperion Prices Public Offering of Common Stock, 6/11/2018 AMRS-US   GNW  Amyris Set to Join Russell MicrocapÂ® Index,, 8/10/2015 ACHN-US  GNW  Achillion Reports Second Quarter and Six Month 2015 Financial Results," 6/22/2018 SYNH-US  GNW  Syneos Health to Share Strategies Designed to Meet the Needs of Patients, Payers and Regulators at DIA Global Annual Meeting", 5/31/2017 FOLD-US  GNW  Amicus Therapeutics Receives Rare Pediatric Disease Designation for SD-101 for Patients with Epidermolysis Bullosa,,, 6/11/2015 008FZT-E GNW  ADMA Biologics & Jeffrey Modell Foundation Initiate Strategic Patient Advocacy Alliance, 8/09/2016 GWP-GB   GNW  GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress,,,10/31/2016 MYOK-US  GNW  MyoKardia to Present at Two Upcoming Investor Conferences in NovemberÂ ,,10/26/2017 GLPG-NL  GNW  Galapagos Q3: clinical success with GLPG1690 and MOR106 highlights strength of deep pipeline, 9/12/2017 PTLA-US  GNW  Portola Announces Pricing of Public Offering of Common Stock,,,, 7/13/2016 CARA-US  GNW  Cara Therapeuticsâ€™ Data to be Presented at the British Association for Psychopharmacology 2016 Summer Meeting,12/04/2017 FLXN-US  GNW  Flexion Therapeutics Reports Inducement Grants Under  NASDAQ Listing Rule 5635(c)(4), 4/25/2017 QURE-US  GNW  uniQure Receives European Medicines Agency Priority Medicines (PRIME) Designation for AMT-060 in Hemophilia B," 3/30/2017 AGIO-US   GNW  Agios to Present at the 16th Annual Needham Healthcare Conference on Tuesday April 4, 2017"," 4/24/2017 46226010 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Lion Biotechnologies, Inc. Shareholders and a Lead Plaintiff Deadline of June 13, 2017",,,"10/31/2016 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2016 Financial Results on November 7, 2016",,,12/09/2016 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conference, 2/28/2019 KPTI-US    GNW  Karyopharm Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,,," 5/18/2017 46116X10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Intra-Cellular Therapies, Inc. Shareholders and a Lead Plaintiff Deadline of July 11, 2017",,,,,11/04/2016 ATRA-US    GNW  Atara Bio Announces Third Quarter 2016 Financial Results and Recent Highlights,, 5/11/2016 0C84H2-E GNW  Dermira to Present Preclinical Data from DRM01 Acne Program at the Society for Investigative Dermatology 75th Annual Meeting, 4/20/2015 008XK0-E GNW  Foamix Pharmaceuticals Ltd. Announces Closing of Its $69 Million Public Offering of Ordinary Shares,, 5/05/2015 86845910 GNW  Supernus Announces First Quarter 2015 Financial Results,10/29/2015 FGEN-US  GNW  FibroGen Appoints Jeffrey Edwards to Board of Directors,, 3/13/2017 CHRS-US  GNW  Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial Results,,, 4/07/2016 COLL-US  GNW  Collegium Announces Publication of Data on the Durability of Pain Relief with Xtampza ER, 1/07/2016 XBIT-US  GNW  XBiotech to Host Overview of Strategy and Findings for Its European Phase III Trial for Treatment of Colorectal Cancer With Xilonixâ„¢,,,10/24/2017 GBT-US   GNW  Global Blood Therapeutics Announces Approval of First-in-Class â€œVoxelotorâ€ as Nonproprietary Name for GBT440,, 1/17/2017 KURA-US  GNW  Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia,, 2/27/2017 AXSM-US  GNW  Axsome Therapeutics to Present at the 29th Annual ROTH Conference, 5/12/2016 VYGR-US  GNW  Voyager Therapeutics Provides First Quarter 2016 Investor Update, 7/24/2018 BGNE-US  GNW  BeiGene Initiates Global Phase 3 Trial of PARP Inhibitor Pamiparib in Patients with Advanced Gastric Cancer,,,,,,, 5/27/2015 0CRRZ8-E GNW  G1 Therapeutics Announces Positive Phase 1a Data for CDK4/6 Inhibitor G1T28,,,"11/20/2017 CLRB-US  GNW  Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder",,,,,,,,,,10/31/2016 EYPT-US    GNW  pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/31/2017 PGNX-US  GNW  Progenics Pharmaceuticals Provides Update on Timing of NDA Submission for AZEDRAÂ®,,,,,,,,, 8/28/2018 OPK-US   GNW  OPKO Healthâ€™s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial,,12/03/2014 09061G10    GNW  BioMarin to Host Analyst and Investor Day on December 10th in New York,,,,11/07/2018 45290710 GNW  Immunomedics Expands Clinical Collaboration With Astrazeneca to Include Metastatic Non-Small Cell Lung Cancer,11/12/2013 BIIB-US   GNW  Sobi's partner Biogen Idec expects mid-2014 US launch of ELOCTATE(r),,11/16/2017 BCRX-US  GNW  BioCryst to Present at 29th Annual Piper Jaffray Healthcare Conference,,,,, 5/10/2016 AKRX-US  GNW  Akorn Completes 2014 Financial Statement Restatement and Reports Audited 2015 and Restated 2014 Results,, 3/21/2019 MYGN-US  GNW  Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting,,,,, 2/13/2017 GCHC-US   GNW  Inovio and ApolloBio to Collaborate on Development and Commercialization of HPV Pre-cancer Immunotherapy VGX-3100 in Greater China,,, 5/05/2016 GERN-US  GNW  Geron Corporation Reports First Quarter 2016 Financial Results and Recent Events,, 8/01/2018 AMRN-US  GNW  Amarin Reports Second Quarter 2018 Financial Results and Provides Update on Operations,,," 6/01/2018 SRPT-US  GNW  As Anticipated, Sarepta Receives Negative CHMP Opinion for EXONDYSÂ® (eteplirsen) to Treat Patients with Duchenne Muscular Dystrophy in Europe",,," 5/16/2017 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs",,,,," 6/11/2018 SAN-FR   GNW  Sanofi Launches ""Action 2018"", a Worldwide Employee Stock Purchase Plan",,,,,, 8/10/2016 AFMD-US  GNW  Affimed Reports Financial Results for Second Quarter 2016 and Provides Corporate Update,," 2/27/2017 PRQR-US  GNW  On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day",, 4/25/2018 ZGNX-US  GNW  Zogenix Announces Presentation of New Efficacy and Safety Data from its FirstÂ Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome,,,,,, 8/09/2016 00773U10 GNW  Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye,10/02/2017 90400D10  GNW  Dimension Board Determines that Ultragenyxâ€™s Unsolicited ProposalÂ to Acquire Dimension for $6.00 Per Share Constitutes a â€œSuperior Proposalâ€,, 1/10/2017 063Z5S-E GNW  Blue Cross Blue Shield Association Evidence Street Issues Positive Assessment for NanoStringâ€™s ProsignaÂ® Breast Cancer Assay,,, 9/19/2016 RDUS-US  GNW  Radius Presents Abaloparatide Transdermal Patch Development Program at American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting," 5/09/2013 04539610 GNW  Scott+Scott, Attorneys at Law, LLP Files Securities Class Action Lawsuit Against Ventrus Biosciences, Inc. -- VTUS",,,,,,," 1/25/2017 PCRX-US  GNW  Pacira Pharmaceuticals Announces Collaboration with DePuy Synthes to Support Promotion, Education and Training of EXPARELÂ® in Orthopedics", 5/03/2016 RTRX-US  GNW  Retrophin Reports First Quarter 2016 Financial Results," 4/15/2015 69404D10 GNW  Pacific Biosciences of California, Inc. First Quarter 2015 Financial Results Call", 8/09/2016 28106W10 GNW  Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye,, 1/04/2018 MGNX-US  GNW  MacroGenics Enters Research Collaboration with Roche to Develop a Novel Bispecific Molecule,,,, 4/26/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Time Change for First Quarter 2016 Financial Results Conference Call and Webcast, 3/16/2016 PRTA-US  GNW  Data from Prothenaâ€™s Preclinical Program on Conformation-Specific Antibodies Against Misfolded Transthyretin Published in Amyloid,,, 4/26/2016 BCXQL-US GNW  CytomX to Present at the 2016 Bank of America Merrill Lynch Healthcare Conference, 9/28/2016 002K8G-E GNW  Major Shareholder Announcement,,, 8/09/2016 CBAY-US  GNW  CymaBay Reports Second Quarter 2016 Financial Results,," 7/29/2015 16383L10 GNW  ChemoCentryx to Hold Second Quarter 2015 Financial Results Conference Call on Thursday, August 6, 2015",,," 1/27/2017 MNKD-US   GNW  MannKind Corporation to Hold Investor Conference Call on February 1, 2017",," 7/26/2017 CYTK-US  GNW  Cytokinetics to Announce Second Quarter Results on August 2, 2017", 8/08/2017 ESPR-US     GNW  Esperion Announces Proposed Public Offering of Common Stock," 5/21/2018 AMRS-US   GNW  BioDisrupt, Amyris Annual Investor Conference Provides Close-up of Technology & Strategy",, 8/03/2015 ACHN-US  GNW  Achillion Announces That Janssen Has Initiated a Phase I Study to Evaluate the Effect of Simeprevir and Odalasvir (ACH-3102) on AL-335 Pharmacokinetics, 6/21/2018 SYNH-US  GNW  Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients, 5/19/2017 FOLD-US  GNW  Amicus Therapeutics Announces Planned Analysis of Primary Endpoints in Phase 3 Epidermolysis Bullosa Study,,, 5/22/2015 00089910 GNW  ADMA Biologics to Present at the 2015 Marcum MicroCap Conference," 8/02/2016 GWP-GB   GNW  GW Pharmaceuticals to Report Q3 Financial Results  and Host Conference Call on 9 August, 2016",,,10/03/2016 MYOK-US  GNW  MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares,, 9/27/2017 GLPG-NL  GNW  Galapagos and MorphoSys report first promising signs of clinical activity in a Phase 1 study with IL-17C antibody MOR106 in atopic dermatitis patients, 9/11/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Proposed Offering of Common Stock,,,, 7/05/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference,11/28/2017 FLXN-US  GNW  Flexion Therapeutics to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference, 4/24/2017 QURE-US  GNW  uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT), 3/13/2017 CELG-US   GNW  Agios Announces MTAP Pathway Research Program as Development Program and Development Candidate Under Master Research and Collaboration Agreement with Celgene," 4/20/2017 46226010 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Lion Biotechnologies, Inc. (NASDAQ: LBIO) To Contact Brower Piven Before The Lead Plaintiff Deadline",,,10/05/2016 070JFC-E GNW  Fate Therapeutics Announces Issuance of U.S. Patent Protecting Enhanced Hematopoietic Stem Cell Compositions,,,11/11/2016 ICPT-US  GNW  Intercept Presents New Data at AASLD Examining the Effects of OcalivaÂ® (Obeticholic Acid) on Non-Invasive Assessments of Liver Fibrosis in Patients with PBC, 2/26/2019 KPTI-US    GNW  Karyopharm Announces Outcome of FDA Advisory Committee Meeting Reviewing Selinexor for the Treatment of Patients with Triple Class Refractory Multiple Myeloma,,, 5/18/2017 ITCI-US  GNW  Intra-Cellular Therapies to Present Data on its Novel Compound ITI-333 at the Society of Biological Psychiatry 72nd Annual Meeting,,,,,11/03/2016 063Y8S-E   GNW  Atara Bio's Collaborating Investigators to Present Results from Phase 2 Trial of Allogeneic Cytomegalovirus (CMV)-specific Cytotoxic T Lymphocytes (CTL) at the American Society of Hematology (ASH) Annual Meeting 2016,, 5/10/2016 DERM-US  GNW  Dermira Reports First Quarter 2016 Financial Results and Provides Corporate Update, 4/15/2015 008XK0-E GNW  Foamix Pharmaceuticals Ltd. Announces Upsizing and Pricing of Its $60 Million Public Offering of Ordinary Shares,, 4/21/2015 86845910 GNW  Supernus to Host First Quarter 2015 Earnings Conference Call,"10/22/2015 FGEN-US  GNW  Phase 2 Data for Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Show Anemia Correction in Incident Dialysis Chronic Kidney Disease Patients Regardless of Iron Repletion Status, Iron Supplementation Regimen, or Dialysis Modality",, 3/06/2017 CHRS-US  GNW  Coherus Addresses Trade Secret Action Filed by Amgen,,, 3/15/2016 06CR5C-E GNW  Collegium Reports 2015 Financial Results and Provides Corporate Update, 1/07/2016 XBIT-US  GNW  XBiotech Advances to Final Dosing Cohort in Phase 1/2 Clinical Study of Novel True Humanâ„¢ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus,,,10/23/2017 GBT-US   GNW  Global Blood Therapeutics Announces Discontinuation of Idiopathic Pulmonary Fibrosis (IPF) Program,, 1/04/2017 06CR5C-E GNW  Kura Oncology Receives FDA Clearance to Proceed with Clinical Trial for ERK Inhibitor KO-947 and Nominates KO-539 as Development Candidate for Menin-MLL Inhibitor Program,, 2/14/2017 AXSM-US  GNW  Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Treatment Resistant Depression, 5/11/2016 VYGR-US  GNW  Voyager Therapeutics to Present at Upcoming Investor Conferences, 7/22/2018 BGNE-US  GNW  BeiGene Announces Preliminary Topline Results of Pivotal Trial in China for Anti-PD-1 Antibody Tislelizumab in Hodgkinâ€™s Lymphoma,,,,,,, 5/13/2015 0CRRZ8-E GNW  G1 Therapeutics to Present New Data on CDK4/6 Inhibitor G1T28 at the 2015 American Society of Clinical Oncology Annual Meeting,,,"11/20/2017 ATNX-US  GNW  ESMO Asia 2017: Oraxol (oral paclitaxel, Athenex) Can Achieve Similar Exposure to IV Paclitaxel in Cancer Patients",,,,,,,,,,10/04/2016 EYPT-US    GNW  Phase 3 trial of Medidurâ„¢ in Posterior Segment Uveitis Meets Enrollment Target,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/09/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces Second Quarter 2017 Financial Results and Business Update,,,,,,,,," 8/14/2018 68375N10 GNW  Recent Analysis Shows Williams Partners, GameStop, Opko Health, Athersys, CSX, and Kratos Defense & Security Solutions Market Influences â€” Renewed Outlook, Key Drivers of Growth",,11/24/2014 09061G10    GNW  BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock; Will Add Duchenne Muscular Dystrophy Products to Rare-Disease Portfolio,,,,"10/31/2018 IMMU-US  GNW  Immunomedics to Report First Quarter Fiscal 2019 Results and Host Conference Call and Webcast on November 7, 2018",10/25/2013 REGN-US   GNW  Protein Engineering Market - Global Forecast to 2017,,11/07/2017 BCRX-US  GNW  BioCryst Reports Third Quarter 2017 Financial Results,,,,," 5/06/2016 AKRX-US  GNW  Akorn Outlines Timeline for 2015 Form 10-K Filing, First Quarter 2016 Form 10-Q Filing and Investor Conference Calls",, 3/14/2019 MYGN-US  GNW  Myriadâ€™s myPathÂ® Melanoma Test Receives Medicare Coverage,,,,, 1/30/2017 INO-US    GNW  Inovio Pharmaceuticals to Participate inÂ Upcoming Investment Conferences,,, 4/27/2016 GERN-US  GNW  Geron Announces Conference Call to Discuss First Quarter 2016 Financial Results,, 7/26/2018 AMRN-US  GNW  Amarin Announces Approval for VascepaÂ® in United Arab Emirates,,, 5/31/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 5/15/2017 AMAG-US  GNW  AMAG Pharmaceuticals Completes Financing Transactions in Support of Future Growth Strategy,,,,," 6/08/2018 80105N10 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within CNH Industrial N.V, Sanofi, New York, Nabors Industries, Aptiv, and PagSeguro Digital â€” New Research Emphasizes Economic Growth",,,,,, 8/03/2016 AFMD-US  GNW  Affimed Announces Second Quarter 2016 Financial Results and Corporate Update Conference Call,, 2/07/2017 PRQR-US  GNW  ProQR to Present at the LEERINK Partners Global Healthcare Conference,, 4/11/2018 ZGNX-US  GNW  Zogenix to Participate in LEERINK Partners CNS Day,,,,,, 8/09/2016 00773U10 GNW  Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye, 9/19/2017 90400D10  GNW  Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to a â€œSuperior Proposalâ€,, 1/10/2017 NSTG-US  GNW  NanoString Technologies Provides Preliminary Operational and Financial Results for 2016,,, 9/18/2016 RDUS-US  GNW  Radius Announces Publication of Additional Positive Results from the Phase 3 ACTIVE Trial of Abaloparatide-SC in JBMR, 3/01/2013 04539610 GNW  Ventrus Biosciences Announces Poster Presentation on the Quality of Compounded Topical Diltiazem Hydrochloride Formulations for Anal Fissure at the American Pharmacists Association Meeting,,,,,,, 1/06/2017 PCRX-US  GNW  Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million, 4/21/2016 DB-DE    GNW  Retrophin to Present at the Deutsche Bank 41st Annual Health Care Conference," 3/23/2015 69404D10 GNW  Pacific Biosciences Announces Launch of Certified Service Provider Program for Single Molecule, Real-Time Sequencing; Adds New Informatics Partners", 8/03/2016 EDIT-US  GNW  Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital,,"12/11/2017 MGNX-US  GNW  Phase 1 Data for Flotetuzumab, MacroGenicsâ€™ CD123 x CD3 DARTÂ® Molecule, Presented at 59th Annual ASH Meeting",,,, 4/25/2016 DB-DE    GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 2/29/2016 PRTA-IE  GNW  Prothena to Present Preclinical Data for PRX003 at 2016 AAAAI Annual Meeting,,, 4/21/2016 23284F10 GNW  CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates, 9/22/2016 37230320 GNW  Major Shareholder Announcement,,," 8/02/2016 CBAY-US  GNW  CymaBay to Announce Second Quarter 2016 Financial Results on Tuesday, August 9",, 5/29/2015 16383L10 GNW  Positive Results From ChemoCentryx Phase II Diabetic Nephropathy Trial With Chemokine Receptor CCR2 Inhibitor CCX140 Highlighted at the 52nd ERA-EDTA Congress,,, 1/09/2017 SNY-FR    GNW  MannKind Receives $30.6 Million From Sanofi,, 7/05/2017 CYTK-US  GNW  Cytokinetics Announces Baseline Data From First Cohort of Phase 2 Clinical Trial of CK-2127107 in Patients With SMA, 8/08/2017 ESPR-US     GNW  Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2017 Financial Results," 5/18/2018 06ZGX0-E  GNW  Amyris Sustainable Lubricants Joint Venture Company, Novvi, and Chevron Enter Agreement To Develop and Bring To Market New Renewable Base Oil Technologies",, 6/18/2015 ACHN-US  GNW  Achillion to Present at the JMP Securities Life Sciences Conference 2015," 6/05/2018 SYNH-US  GNW  Syneos Health Consulting Releases 10th Annual Biopharmaceutical Dealmakers Survey â€“ Predicts M&A Landscape to Continue Bull Run, While Buyers Begin to Become More Risk Averse", 5/15/2017 FOLD-US  GNW  Amicus Therapeutics Announces Positive Functional Data from Initial Patients in Pompe Phase 1/2 Study,,, 5/12/2015 00089910 GNW  ADMA Biologics Reports First Quarter 2015 Results, 7/18/2016 GWP-GB   GNW  GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising $289.8 Million on the NASDAQ Global Market and Full Exercise of Underwriterâ€™s Option to Purchase Additional ADSs,,, 9/27/2016 MYOK-US  GNW  MyoKardia Announces Pricing of Proposed Public Offering of Common Stock,, 9/21/2017 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises, 9/06/2017 PTLA-US  GNW  Portola Pharmaceuticals to Present at the 2017 Morgan Stanley Global Healthcare Conference,,,, 6/29/2016 CARA-US  GNW  Cara Therapeutics Initiates Adaptive Phase 2/3 Trial of I.V. CR845 for Treatment of Chronic Kidney Disease-Associated Pruritus,11/20/2017 FLXN-US  GNW  Flexion Therapeutics Announces Full Commercial Launch and Nationwide Availability of ZILRETTAâ„¢ (triamcinolone acetonide extended-release injectable suspension), 4/20/2017 QURE-US  GNW  uniQure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in Europe," 2/28/2017 AGIO-US   GNW  Agios to Present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017"," 4/20/2017 46226010 GNW  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm",,, 9/26/2016 FATE-US  GNW  Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmuneâ„¢ in Allogeneic Hematopoietic Cell Transplantation,,,11/03/2016 ICPT-US  GNW  Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update, 2/26/2019 KPTI-US    GNW  Karyopharm Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss Selinexor for the Treatment of Patients with Triple Class Refractory Multiple Myeloma Who Have Received At Least Three Prior Therapies,,," 5/16/2017 46116X10 GNW  ITCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Intra-Cellular Therapies, Inc. and a Lead Plaintiff Deadline of July 11, 2017",,,,,10/18/2016 080RQG-E   GNW  Atara Bio Granted Access to Priority Medicines (PRIME) Regulatory Support for Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes (CTL) for Treatment of EBV-Associated Post Transplant Lymphoproliferative Disorder (EBV-PTLD),, 5/10/2016 DERM-US  GNW  Dermira Announces Positive Topline Phase 2b Clinical Trial Results for DRM01 in Patients with Facial Acne Vulgaris, 4/01/2015 008XK0-E GNW  Foamix Pharmaceuticals Ltd. Files Registration Statement for Proposed Follow-On Offering,, 4/02/2015 86845910 GNW  Supernus Announces Issuance of Sixth U.S. Patent Protecting Trokendi XR(R), 8/13/2015 31572Q80 GNW  FibroGen Announces Second Quarter 2015 Financial Results,, 3/02/2017 CHRS-US  GNW  Statement by Coherus CEO Regarding Biosimilars User Fees,,, 3/10/2016 COLL-US  GNW  Collegium to Host Conference Call to Discuss 2015 Financial Results and Provide Corporate Update, 1/06/2016 98400H10 GNW  XBiotech Added to NASDAQ Biotechnology Index,,,10/11/2017 GBT-US   GNW  Global Blood Therapeutics Announces Presentation of New Data Showing Positive Effect of GBT440 on Sickle Cell Disease Patient with Variant Genotype,," 1/03/2017 KURA-US  GNW  Kura Oncology Appoints Steven Stein, M.D. to Board of Directors",, 2/13/2017 AXSM-US  GNW  Axsome Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference, 5/05/2016 VYGR-US  GNW  Voyager Therapeutics to Host First Quarter 2016 Investor Update Call, 7/22/2018 BGNE-US  GNW  BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in WaldenstrÃ¶m Macroglobulinemia (WM),,,,,,, 4/15/2015 0CRRZ8-E GNW  G1 Therapeutics to Present New Data on CDK4/6 Inhibitor G1T28 at the American Association for Cancer Research Annual Meeting,,,"11/09/2017 ATNX-US  GNW  Athenex, Inc. Announces Third Quarter 2017 Results",,,,,,,,,, 9/27/2016 06RDL7-E   GNW  pSivida Corp. Strengthens Board of Directors With Leading Ophthalmologist,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/26/2017 PGNX-US  GNW  Progenics Pharmaceuticals Sets Second Quarter 2017 Financial Results Call for August 9,,,,,,,,, 8/07/2018 OPK-US   GNW  OPKO Health Reports Second Quarter 2018 Financial Results,,11/19/2014 09061G10    GNW  BioMarin to Attend Upcoming Investor Conferences,,,, 9/12/2018 IMMU-US  GNW  Immunomedics and Samsung BioLogics Announce Strategic Manufacturing Partnership,10/16/2013 HBIO-US   GNW  Harvard Bioscience Names Robert E. Gagnon as Chief Financial Officer,,11/01/2017 BCRX-US  GNW  BioCryst to Present at the Jefferies 2017 London Healthcare Conference,,,,, 3/22/2016 06CR5C-E GNW  Akorn Provides Preliminary Unaudited Full Year 2015 Financial Results and Issues 2016 Financial Guidance,," 3/07/2019 62855J10 GNW  Report: Exploring Fundamental Drivers Behind ArcelorMittal, Cohen & Steers, Myriad Genetics, Lexington Realty Trust, NorthWestern, and Chesapeake Utilities â€” New Horizons, Emerging Trends, and Upcoming Developments",,,,,12/21/2016 45773H20  GNW  Inovioâ€™s Zika VaccineÂ Generates Robust Immune Responses in First Human Study,,, 4/20/2016 06P9WL-E GNW  Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual Meeting,," 7/24/2018 AMRN-US  GNW  Amarin to Report Second Quarter 2018 Results and Host Conference Call on August 1, 2018",,, 5/03/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies,,, 5/10/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Host Analyst Day on May 24th in New York,,,,, 6/04/2018 SAN-FR   GNW  Sanofi: New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma,,,,,, 5/31/2016 AFMD-DE  GNW  Affimed to Present at the Jefferies 2016 Healthcare Conference,,11/14/2016 PRQR-US  GNW  ProQR Announces Results for the Third Quarter of 2016,, 3/06/2018 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results,,,,,, 7/07/2016 ADVM-US  GNW  Adverum Biotechnologies Provides wet AMD Program Update, 9/18/2017 DMTX-US   GNW  Dimension Confirms Receipt of Unsolicited Proposal from Ultragenyx,,12/22/2016 NSTG-US  GNW  NanoString Technologies to Present at J.P. Morgan 35th Annual Healthcare Conference,,," 8/30/2016 RDUS-US  GNW  Radius Health Announces Three Presentations on RAD1901 at the San Antonio Breast Cancer Symposium (SABCS) December 6-10, 2016", 2/11/2013 04539610 GNW  Ventrus Biosciences to Present at the Leerink Swann Global Healthcare Conference,,,,,,," 1/03/2017 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at theÂ 35th Annual J.P. Morgan Healthcare Conference", 4/19/2016 RTRX-US  GNW  Retrophin to Report First Quarter 2016 Financial Results, 3/02/2015 69404D10 GNW  Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies, 8/02/2016 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing Second Quarter 2016 Corporate Update and Results,,12/05/2017 MGNX-US  GNW  MacroGenics Announces Closing of MGA012 Global Collaboration and License Agreement with Incyte,,,, 4/19/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2016 Financial Results Conference Call and Webcast, 2/24/2016 PRTA-US  GNW  Prothena Announces Appointment of Chief Commercial Officer,,, 3/16/2016 CTMX-US  GNW  CytomX Announces Data to be Presented at the American Association for Cancer Research Annual Meeting 2016, 9/12/2016 GMAB-DK  GNW  Major Shareholder Announcement,,, 7/07/2016 CBAY-US  GNW  CymaBay Announces Participation at Cantor Fitzgerald Healthcare Conference on July 12th in New York,, 5/26/2015 16383L10 GNW  Positive Clinical Data From ChemoCentryx Phase II Trial in Diabetic Nephropathy to be Presented at the 52nd Annual ERA-EDTA Congress,,, 1/05/2017 JPM-US    GNW  CORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference,, 6/29/2017 CYTK-US  GNW  Cytokinetics Announces Start of Phase 1b Clinical Trial of  CK-2127107 in Elderly Subjects With Limited Mobility, 8/08/2017 ESPR-US     GNW  Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin, 5/14/2018 AMRS-US   GNW  Amyris Continues Strong Momentum and Execution with 77% Revenue Growth and Exceeds Gross Margin Target,, 5/19/2015 ACHN-US  GNW  Achillion Enters Into Worldwide Collaboration for Hepatitis C With Janssen, 6/05/2018 SYNH-US  GNW  Syneos Health to Present Actionable Commercial Insights Designed for Biopharmaceutical Companies atÂ BIO International Convention, 5/10/2017 FOLD-US  GNW  Amicus Therapeutics to Present at Two Upcoming Investor Conferences,,, 4/07/2015 00089910 GNW  ADMA Biologics Announces Data to be Presented at the Clinical Immunology Society 2015 Annual Meeting, 7/12/2016 GWP-GB   GNW  GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Raising $252.0 Million on NASDAQ Global Market,,, 9/26/2016 MYOK-US  GNW  MyoKardia Announces Proposed Public Offering of Common Stock,, 8/09/2017 GLPG-NL  GNW  GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial," 9/05/2017 PTLA-US  GNW  Reminder: Portola Pharmaceuticals to Host Webcast and Conference Call Today, Tuesday, Sept. 5 to Provide Further Details on BevyxxaÂ® (betrixaban) Launch",,,, 6/09/2016 CARA-US  GNW  Cara Therapeutics to Present Preclinical Data at June Medical Meetings,11/17/2017 FLXN-US  GNW  Flexion Therapeutics Named Top Place to Work for 2017 by Theâ€‹ â€‹Bostonâ€‹ â€‹Globeâ€‹, 4/04/2017 QURE-US  GNW  uniQure Publishes Data Demonstrating Wide Distribution of AAV5 in the Central Nervous System, 2/16/2017 AGIO-US   GNW  Agios Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key 2017 Milestones," 4/20/2017 46226010 GNW  IMPORTANT LION  BIOTECHNOLOGIES, INC.  INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Lion Biotechnologies, Inc.",,, 9/07/2016 FATE-US  GNW  Fate Therapeutics and Memorial Sloan Kettering Cancer Center Launch Partnership for Development of Off-the-Shelf T-Cell Immunotherapies,,,11/01/2016 ICPT-US  GNW  Intercept Announces OcalivaÂ® (Obeticholic Acid) Data in PBC to be Presented at the 2016 AASLD Annual Meeting, 2/25/2019 KPTI-US    GNW  Karyopharm Strengthens Management Team with Appointment of Michael P. Mason as Chief Financial Officer,,," 5/15/2017 46116X10 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Intra-Cellular Therapies, Inc. (ITCI)",,,,,10/11/2016 ATRA-US    GNW  Atara Bio Receives Positive Opinion from EMA on Orphan Drug Designation for Allogeneic Cytomegalovirus (CMV)-specific Cytotoxic T Lymphocytes (CTL) for Treatment of CMV Infection in Patients with Impaired Immune Systems,, 4/05/2016 05KDBG-E GNW  Dermira to Present at 15th Annual Needham Healthcare Conference," 3/18/2015 M4613510 GNW  Foamix Reports Financial Results for the Year Ended December 31, 2014",," 3/23/2015 86845910 GNW  Georges Gemayel, Ph.D., Joins Supernus Board of Directors", 8/12/2015 31572Q80 GNW  Nephrology Dialysis Transplantation Reports Phase 2 Data of Investigational Orally Active HIF-PHI Roxadustat (FG-4592) Shows Improved Hemoglobin Levels in Non-Dialysis CKD Subjects With Anemia,, 3/02/2017 CHRS-US  GNW  Coherus Announces CHS-1420 Pharmacokinetic Clinical Bioequivalence Study Meets Primary Endpoint,,, 3/03/2016 COLL-US  GNW  Collegium Announces Publication of Data on the In Vitro Assessment of IV Abuse of Xtampza ER in Journal of Opioid Management,12/21/2015 98400H10 GNW  Deadline in Lawsuit for Investors in XBiotech Inc (NASDAQ:XBIT) Shares Announced by Shareholders Foundation,,,10/03/2017 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Presentations of GBT440 Data at Two Sickle Cell Disease Meetings in October,,12/01/2016 KURA-US  GNW  Kura Oncology Presents Preclinical Data on KO-947 and Menin-MLL Inhibitor Program at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics,, 2/07/2017 AXSM-US  GNW  Axsome Therapeutics to Present at the 2017 BIO CEO & Investor Conference, 4/29/2016 VYGR-US  GNW  Voyager Therapeutics Highlights Programs in Parkinsonâ€™s Disease and ALS; Announces Expansion of CNS Pipeline at R&D Day, 7/20/2018 BGNE-US  GNW  BeiGene Attends Hearing Before the Listing Committee of the Stock Exchange of Hong Kong Limited,,,,,,, 4/08/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at the 14th Annual Needham Healthcare Conference,,,"10/30/2017 ATNX-US  GNW  Athenex, Inc. to Report Third Quarter 2017 Earnings Results on November 9, 2017",,,,,,,,,, 9/22/2016 LTS.PRA-US GNW  pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/02/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces the Presentation of Data From Two Automated Bone Scan Index Studies at the 2017 ASCO Annual Meeting,,,,,,,,, 8/03/2018 OPK-US   GNW  OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children,,"11/04/2014 09061G10    GNW  Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Credit Suisse 2014 Healthcare Conference",,,, 8/28/2018 IMMU-US  GNW  Immunomedics Announces Participation in Upcoming Healthcare Conferences,10/03/2013 TTPH-US   GNW  Karyopharm Therapeutics Announces Appointment of Garen Bohlin to Board of Directors,,10/27/2017 BCRX-US  GNW  BioCryst Announces Late Breaker Presentation of BCX7353 Phase 2 APeX-1 Trial Results at the ACAAIâ€™s 2017 Annual Scientific Meeting,,,,, 3/07/2016 AKRX-US  GNW  Akorn Receives Expected Additional Delinquency Notice From Nasdaq,, 3/06/2019 MYGN-US  GNW  Myriad Announces Publication of Expanded Carrier Screen Study in Genetics in Medicine Â ,,,,,12/06/2016 INO-US    GNW  Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine Institute,,, 4/05/2016 GERN-US  GNW  Geron to Present at the Needham Healthcare Conference,," 6/28/2018 AMRN-US  GNW  Amarin Reports Last Patient Study Visit Has Occurred, an Important Step Towards Completion of REDUCE-ITâ„¢ Cardiovascular Outcomes Study",,, 5/03/2018 SRPT-US  GNW  Sarepta Therapeutics Announces First Quarter 2018 Financial Results and Recent Corporate Developments,,, 5/05/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Pricing of $300 Million of 3.25% Convertible Senior Notes Due 2022,,,,," 5/29/2018 BIVV-US  GNW  Amunix announces report by Bioverativ on unprecedented half-life obtained in patients treated with a novel, long-acting FVIII utilizing Amunixâ€™s XTENÂ® technology",,,,,, 5/23/2016 N0104510 GNW  Affimed Announces Annual General Meeting of Shareholders,,10/27/2016 PRQR-US  GNW  ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients,, 2/27/2018 ZGNX-US  GNW  Zogenix to Release Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call and Webcast on March 6,,,,,, 5/12/2016 00773U10 GNW  Avalanche Biotechnologies Closes Transaction With Annapurna Therapeutics and Changes Name to Adverum Biotechnologies, 9/18/2017 90400D10  GNW  Ultragenyx Proposes to Acquire Dimension Therapeutics for $5.50 Per Share in Cash,,12/12/2016 NSTG-US  GNW  Prosigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested in Updated Analysis of TransATAC Study Presented at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium,,, 8/16/2016 RDUS-US  GNW  JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women  With Osteoporosis,11/13/2012 04539610 GNW  Ventrus Biosciences Reports Third Quarter 2012 Financial Results,,,,,,,11/29/2016 PCRX-US  GNW  Pacira Pharmaceuticals and GeneAlign Announce Partnership to Develop Low-Opioid Pain Management Protocols for Postsurgical Patients at High Risk of Addiction, 4/04/2016 RTRX-US  GNW  Retrophin Names Gary A. Lyons Chairman of the Board of Directors, 2/03/2015 PACB-US  GNW  Pacific Biosciences Reports Fourth Quarter 2014 Financial Results," 7/29/2016 ALNY-US  GNW  Editas Medicine Appoints Akshay Vaishnaw, M.D., Ph.D., to its Board of Directors",,11/15/2017 MGNX-US  GNW  MacroGenics Names Dr. Jay Siegel to its Board of Directors,,,," 3/09/2016 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Jose-Carlos Gutierrez-Ramos, Ph.D. to Board of Directors", 2/18/2016 PRTA-US  GNW  Prothena Reports Fourth Quarter and Full Year 2015 Financial Results; Provides Financial Guidance and R&D Update,,, 3/07/2016 CTMX-US  GNW  CytomX Announces Year-End 2015 Financial Results, 8/31/2016 37230320 GNW  Genmab's Total Number of Voting Rights and Total Share Capital,,, 5/31/2016 CBAY-US  GNW  CymaBay Therapeutics Announces Top Line Efficacy and Safety Data From Its Phase 2 Study of Mbx-8025 in Patients With Primary Biliary Cholangitis (PBC),, 5/12/2015 16383L10 GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 1/05/2017 JPM-US    GNW  MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference,, 6/23/2017 CYTK-US  GNW  Cytokinetics Announces Presentations at the Cure SMA 2017 Annual SMA Conference, 8/02/2017 ESPR-US     GNW  Esperion to Provide Bempedoic Acid Franchise Development Program Updates and Second Quarter Financial Results, 5/10/2018 AMRS-US   GNW  Amyris to Participate in Upcoming Investor Conferences,, 5/07/2015 00448Q20 GNW  Achillion Reports First Quarter 2015 Financial Results, 5/21/2018 SYNH-US  GNW  Syneos Health to Present at Upcoming Investors Conferences, 5/09/2017 FOLD-US  GNW  Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates,,, 3/18/2015 00089910 GNW  ADMA Biologics Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full, 7/12/2016 GWP-GB   GNW  GW Pharmaceuticals Announces Proposed Public Offering of ADSs,,," 9/21/2016 MYOK-US  GNW  MyoKardia Outlines Path to Registration for MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients and Provides Pipeline and Research Updates at Inaugural R&D Day",, 7/27/2017 GLPG-NL  GNW  Solid financials support R&D progress," 9/01/2017 PTLA-US  GNW  Portola Pharmaceuticals to Host Webcast and Conference Call Tuesday, Sept. 5 to Provide Further Details on BevyxxaÂ® (betrixaban) Launch",,,, 6/06/2016 CARA-US  GNW  Cara Therapeutics Resumes Patient Recruitment for Adaptive Phase 3 Trial of I.V. CR845 in Postoperative Pain,11/06/2017 FLXN-US  GNW  Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights, 4/03/2017 QURE-US  GNW  uniQure Announces Presentations at Upcoming  April Conferences," 2/09/2017 AGIO-US   GNW  Agios to Webcast Conference Call of Fourth Quarter and Full Year 2016 Financial Results on February 16, 2017"," 4/20/2017 46226010 GNW  LBIO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Lion Biotechnologies, Inc. and a Lead Plaintiff Deadline of June 13, 2017",,, 8/31/2016 070JFC-E GNW  Fate Therapeutics to Present at Upcoming Investor Conferences,,,10/28/2016 ICPT-US  GNW  Intercept to Report Third Quarter 2016 Financial Results on November 3," 2/21/2019 48576U10   GNW  Research Report Identifies Johnson & Johnson, Schlumberger, Karyopharm Therapeutics, WYNDHAM DESTINATIONS, INC, ASGN, and Suburban Propane Partners with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",,," 5/15/2017 46116X10 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) To Contact Brower Piven Before The Lead Plaintiff Deadline",,,,, 9/08/2016 MS-US      GNW  Atara Bio to Participate in the Morgan Stanley Global Healthcare Conference,," 3/14/2016 06PNP8-E GNW  Dermiraâ€™s Co-founder and Chief Medical Officer, Eugene A. Bauer, M.D., Receives Presidential Citation from the American Academy of Dermatology"," 3/10/2015 M4613510 GNW  Foamix Pharmaceuticals Fourth Quarter 2014 Conference Call & Webcast Scheduled for Wednesday, March 18",, 3/10/2015 SUPN-US  GNW  Supernus Announces Fourth Quarter and Full Year 2014 Results," 8/10/2015 31572Q80 GNW  FibroGen to Report Second Quarter 2015 Financial Results on August 13, 2015",, 3/01/2017 CHRS-US  GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March,,, 2/11/2016 COLL-US  GNW  Collegium Announces Favorable Judgment by the District Court of Massachusetts,"12/18/2015 98400H10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of XBiotech Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 â€“ XBIT",,, 9/26/2017 GBT-US   GNW  Global Blood Therapeutics Announces New Employment Inducement Grants,,11/15/2016 KURA-US  GNW  Kura Oncology to Present Preclinical Data on Pipeline Programs at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics,, 1/04/2017 AXSM-US  GNW  Axsome Therapeutics to Present at Biotech Showcase 2017, 4/25/2016 VYGR-US  GNW  Voyager Therapeutics (Nasdaq: VYGR) to Ring The Nasdaq Stock Market Opening Bell, 7/03/2018 BGNE-US  GNW  BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,, 3/16/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at 22nd Annual Future Leaders in the Biotech Industry Conference,,,10/05/2017 ATNX-US  GNW  Athenex Announces Positive Recommendations from the Drug Safety Monitoring Board to Continue the Oraxol Phase III Program,,,,,,,,,, 9/20/2016 EYPT-US    GNW  pSivida Reports Inducement Awards to New President and Chief Executive Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/01/2017 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference,,,,,,,,," 8/02/2018 OPK-US   GNW  OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018",,10/23/2014 09061G10    GNW  BioMarin Announces Third Quarter 2014 Financial Results,,,, 8/23/2018 IMMU-US  GNW  Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update, 9/10/2013 09062X10  GNW  Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease,,10/24/2017 BCRX-US  GNW  BioCryst to Announce Third Quarter 2017 Financial Results on November 7,,,,, 2/25/2016 AKRX-US  GNW  Akorn Announces Conference Call to Provide Business Updates; Partial Prepayment of Term Loan Facility,, 2/26/2019 MYGN-US  GNW  Myriadâ€™s BRACAnalysis CDxÂ® Test Successfully Identified Patients with Metastatic Pancreatic Cancer Who Benefitted from Treatment with Olaparib,,,,,12/01/2016 0653Y6-E  GNW  Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based Monoclonal Antibodies Against Zika Virus,,, 3/17/2016 06P9WL-E GNW  Geron Announces Presentations at American Association of Cancer Research Annual Meeting,, 6/25/2018 AMRN-US  GNW  Real-World Data Supports Association Between High Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs in People with Diabetes Mellitus,,, 4/30/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 5/03/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Proposed Offering of $250 Million of Convertible Senior Notes due 2022,,,,, 5/23/2018 0GX6NZ-E GNW  UPDATE -- Biome Grow Announces Appointment of Mark Lievonen to Board of Directors,,,,,, 5/18/2016 N0104510 GNW  Affimed Reports Financial Results for First Quarter 2016,, 9/27/2016 PRQR-US  GNW  ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC,, 2/08/2018 ZGNX-US  GNW  Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference,,,,,, 5/10/2016 0D13XX-E GNW  Avalanche Biotechnologiesâ€™ Stockholders Vote in Favor of Annapurna Transaction, 9/11/2017 RARE-US   GNW  Ultragenyx and Kyowa Hakko Kirin Announce Additional Burosumab Data in X-Linked Hypophosphatemia (XLH) and Tumor-Induced Osteomalacia (TIO) at ASBMR,,12/05/2016 NSTG-US  GNW  NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 and Immuno-Oncology Studies at the 39th Annual CTRC-AACR San Antonio Breast Cancer Symposium,,, 8/04/2016 RDUS-US  GNW  Radius Health Reports Second Quarter 2016 Financial and Operating Results,11/08/2012 04539610 GNW  Ventrus Biosciences to Present at the Lazard Capital Markets 9th Annual Healthcare Conference,,,,,,,"11/22/2016 PCRX-US  GNW  American College of Surgeons Launches Education Program on Opioids and Surgery: Use, Abuse, and Alternatives", 3/30/2016 06CR5C-E GNW  Retrophin Completes Enrollment of Phase 2 DUET Study of Sparsentan in Focal Segmental Glomerulosclerosis," 1/09/2015 69404D10 GNW  Pacific Biosciences of California, Inc. Fourth Quarter and Year End 2014 Financial Results Call", 7/28/2016 EDIT-US  GNW  Editas Medicine Announces Scientific Multi-Year Collaboration with Fondazione Telethon and Ospedale San Raffaele Â ,,11/13/2017 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 2/24/2016 BCS-GB   GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 2/09/2016 PRTA-US  GNW  Data From Prothenaâ€™s Ongoing Phase 1/2 Clinical Trial of NEOD001 in AL Amyloidosis Published in the Journal of Clinical Oncology,,, 3/03/2016 0024VM-E GNW  CytomX to Present at Cowen and Companyâ€™s 36th Annual Health Care Conference, 8/31/2016 37230320 GNW  Genmab Announces U.S. FDA Approval of Arzerra(r) (ofatumumab) in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL,,, 5/19/2016 CBAY-US  GNW  CymaBay Therapeutics to Present at UBS Global Healthcare Conference,, 5/06/2015 16383L10 GNW  ChemoCentryx Reports First Quarter 2015 Financial Results and Provides Corporate Update,,, 1/04/2017 MNKD-US   GNW  MannKind Announces Key Addition to Its Executive Management Ranks,, 6/13/2017 CYTK-US  GNW  Cytokinetics to Participate in Panel on Neuromuscular Disorders at the JMP Securities Life Sciences Conference, 7/26/2017 ESPR-US     GNW  Esperion Announces Initiation of Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor, 5/09/2018 AMRS-US   GNW  Amyris Presents Its No Compromiseâ„¢ Product Portfolio at Techonomy New York,, 4/30/2015 ACHN-US  GNW  Achillion to Present at Two Upcoming Investor Conferences, 5/09/2018 SYNH-US  GNW  Syneos Health Reports First Quarter 2018 Results," 5/02/2017 FOLD-US  GNW  Amicus Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017",,, 3/13/2015 00089910 GNW  ADMA Biologics Announces Pricing of Public Offering of Common Stock, 6/27/2016 06CR5C-E GNW  GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for EpidiolexÂ® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome,,, 9/14/2016 MYOK-US  GNW  MyoKardia to Host R&D Day on September 21,, 7/27/2017 GLPG-NL  GNW  Servier licenses GLPG1972 in osteoarthritis from Galapagos, 8/21/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and Andexanet Alfa at the European Society of Cardiology (ESC) Congress 2017,,,, 5/31/2016 CARA-US  GNW  Cara Therapeutics Selected to Present at the 2016 International Conference on Opioids,11/02/2017 FLXN-US  GNW  Flexion Therapeutics Highlights Two Clinical Data Presentations at the 2017 American College of Rheumatology Annual Meeting, 3/15/2017 QURE-US  GNW  uniQure Announces 2016 Financial Results and Provides Update on Company Progress, 1/09/2017 AGIO-US   GNW  Agios Announces Key Upcoming Milestones to Support Evolution to a Commercial Stage Biopharmaceutical Company in 2017," 4/19/2017 46226010 GNW  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm",,, 8/10/2016 002DGD-E GNW  Fate Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference,,,10/14/2016 ICPT-US  GNW  Intercept Pharmaceuticals Receives Positive CHMP Opinion for OcalivaÂ® (Obeticholic Acid) for the Treatment of Primary Biliary Cholangitis in the European Union," 2/21/2019 KPTI-US    GNW  Karyopharm to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019",,," 5/15/2017 ITCI-US  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Intra-Cellular Therapies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2017 â€“ ITCI",,,,, 8/08/2016 ATRA-US    GNW  Atara Bio Announces Second Quarter 2016 Financial Results and Recent Highlights,, 3/03/2016 DERM-US  GNW  Dermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update, 3/04/2015 M4613510 GNW  Foamix to Present Corporate Overview at the 27th Annual ROTH Conference,, 2/18/2015 86845910 GNW  Supernus to Present at March Cowen Conference, 8/06/2015 31572Q80 GNW  FibroGen Appoints Jeffrey W. Henderson to Board of Directors,, 2/21/2017 CHRS-US  GNW  Coherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13th,,," 2/04/2016 COLL-US  GNW  Collegium Announces Issuance of U.S. Patent Covering DETERxÂ®, an Abuse-Deterrent, Extended-Release Technology Platform","12/11/2015 98400H10 GNW  SECURITIES FRAUD ALERT: The Law Firm of Andrews & Springer LLC Announces That a Securities Fraud Class Action Has Been Filed Against XBiotech, Inc. - XBIT",,, 9/06/2017 GBT-US   GNW  Global Blood Therapeutics To Convene Sickle Cell Disease Influencers atÂ Annual Sickle Cell Disease (SCD) Therapeutics Conference,,11/07/2016 KURA-US  GNW  Kura Oncology Reports Third Quarter 2016 Financial Results,, 1/03/2017 06CR5C-E GNW  Axsome Therapeutics Receives FDA Clearance of IND for Phase 2/3 Trial of AXS-05 in Alzheimerâ€™s Disease Agitation," 4/14/2016 VYGR-US  GNW  Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016", 6/15/2018 BGNE-US  GNW  BeiGene Provides Development Update and Presents Clinical Data on Zanubrutinib at the 23rd Congress of the European Hematology Association,,,,,,, 2/05/2015 0CRRZ8-E GNW  G1 Therapeutics Raises $33 Million in Series B Financing,,," 9/25/2017 ATNX-US  GNW  Athenex, Inc. Announces First Patient Recruitment in Phase III Clinical Trials for KX-01 Ointment for Actinic Keratosis",,,,,,,,,, 9/15/2016 EYPT-US    GNW  pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/04/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces First Quarter 2017 Financial Results and Business Update,,,,,,,,, 7/16/2018 OPK-US   GNW  OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada,,"10/08/2014 09061G10    GNW  BioMarin to Host Third Quarter 2014 Financial Results Conference Call and Webcast on Thursday, October 23 at 4:30pm ET",,,," 8/16/2018 IMMU-US  GNW  Immunomedics to Report Fourth Quarter and Fiscal Year 2018 Results and Host Conference Call and WebcastÂ on August 23, 2018", 9/05/2013 PTLA-US   GNW  Portola Pharmaceuticals Announces Participation at Upcoming Investor Conferences,,10/04/2017 BCRX-US  GNW  BioCryst Announces RAPIVABÂ® (peramivir injection) and Galidesivir Presentations at IDWeek 2017â„¢,,,,, 1/27/2016 AKRX-US  GNW  Akorn Announces Conclusion of Audit Committee Independent Investigation,, 2/22/2019 MYGN-US  GNW  VectraÂ® Study Published in the Journal Current Medical Research & Opinion,,,,,11/25/2016 INO-US    GNW  Inovio Applies to Cease Reporting to Canadian Securities Regulatory Authorities; NASDAQ ListingÂ and US Reporting Unaffected,,, 2/25/2016 GERN-US  GNW  Geron Corporation Reports Fourth Quarter and Annual 2015 Financial Results,, 6/12/2018 AMRN-US  GNW  Amarin and Mochida Announce Collaboration on Future Development of  EPA-based Drug Products and Indications,,," 4/27/2018 80360710 GNW  Investor Expectations to Drive Momentum within Blackbaud, Pieris Pharmaceuticals, Sarepta Therapeutics, Cambrex, Stoneridge, and First Interstate BancSystem â€” Discovering Underlying Factors of Influence",,, 5/02/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update,,,,, 5/22/2018 80105N10 GNW  FDA to review Zynquistaâ„¢ (sotagliflozin) as potential treatment for type 1 diabetes,,,,,, 5/17/2016 AFMD-DE  GNW  Affimed to Present at the UBS Global Healthcare Conference -- New York,, 9/06/2016 PRQR-US  GNW  ProQR to Present at Scientific and Investor Conferences in September,, 2/06/2018 ZGNX-US  GNW  Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome,,,,,," 5/06/2016 0G1HZT-E GNW  Avalanche Biotechnologies, Inc. Reports First Quarter 2016 Financial Results", 9/06/2017 RARE-US   GNW  Ultragenyx to Present at the Morgan Stanley Global Healthcare Conference,,12/01/2016 NSTG-US  GNW  The Scientist Magazine Names NanoString Technologies nCounter Vantage 3D Panels a Top 10 Innovation of 2016,,, 8/02/2016 RDUS-US  GNW  Radius Health to Present at the 36th Annual Canaccord Genuity Growth Conference,"11/05/2012 04539610 GNW  Ventrus Biosciences Receives FDA Written Feedback, Targets NDA Filing for Diltiazem (VEN 307) in Anal Fissures Following Second Phase 3 Study",,,,,,,11/11/2016 PCRX-US  GNW  Pacira Pharmaceuticals Unveils Virtual Reality Training Simulation to Enhance Administration Technique Education for EXPARELÂ® in Total Knee Replacement Surgery, 3/24/2016 RTRX-US  GNW  Retrophin Announces Acceptance of Four RE-024 Abstracts for Presentation at the 20th International Congress of Parkinsonâ€™s Disease and Movement Disorders, 1/05/2015 69404D10 GNW  Pacific Biosciences Customers Present Work on Complex De Novo Genomes and Genome Annotation at the International Plant & Animal Genome XXIII Conference, 5/24/2016 EDIT-US  GNW  Editas Medicine to Present at Upcoming June Investor Conferences,,11/10/2017 MGNX-US  GNW  MacroGenics Announces Poster Presentations at 32nd Annual SITC Meeting 2017,,,, 2/18/2016 MNTA-US  GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results, 2/04/2016 PRTA-US  GNW  Prothena to Report Fourth Quarter and Full Year 2015 Financial Results and Host Webcast Conference Call on February 18,,," 2/23/2016 CTMX-US  GNW  CytomX Therapeutics, Inc. (Nasdaq:CTMX) to Ring The Nasdaq Stock Market Closing Bell", 8/23/2016 37230320 GNW  Genmab Announces European Regulatory Submission for Daratumumab in Relapsed Multiple Myeloma,,, 5/11/2016 CBAY-US  GNW  CymaBay Reports First Quarter 2016 Financial Results,," 4/22/2015 16383L10 GNW  ChemoCentryx to Hold First Quarter 2015 Financial Results Conference Call on Wednesday, May 6, 2015",,, 1/03/2017 LFSCQ-US  GNW  MannKind Receives $1 Million Milestone From RLS,, 5/15/2017 CYTK-US  GNW  Cytokinetics Announces Orphan Drug Designation for CK-2127107 for the Treatment of Spinal Muscular Atrophy, 6/26/2017 ESPR-US     GNW  Esperion Announces FDA Confirmation of Regulatory Pathway to Approval for the Combination of Bempedoic Acid and Ezetimibe," 5/08/2018 AMRS-US   GNW  Amyris to Announce First Quarter 2018 Financial Results on Monday, May 14, 2018",, 4/25/2015 00448Q20 GNW  Achillion Presents Detailed Clinical Results on ACH-3102 and ACH-3422 at the International Liver Congress, 5/09/2018 SYNH-US  GNW  Syneos Health Promotes Jason Meggs to Chief Financial Officer, 5/02/2017 FOLD-US  GNW  Amicus Therapeutics Launches Galafoldâ„¢ (Migalastat) for Treatment of Fabry Disease in France,,, 3/12/2015 00089910 GNW  ADMA Biologics Announces Proposed Public Offering of Common Stock, 6/21/2016 06CR5C-E GNW  GW Pharmaceuticals Announces New Planned Epidiolex (Cannabidiol or CBD) Development Program in Infantile Spasms (IS),,, 9/01/2016 MYOK-US  GNW  MyoKardia to Present at 2016 Wells Fargo Healthcare Conference,, 7/05/2017 GLPG-NL  GNW  New Phase 2 study with filgotinib in non-infectious uveitis, 8/15/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces AndexXaÂ® (Andexanet Alfa) Biologics License Application Resubmission Accepted for Review by U.S. FDA,,,, 5/05/2016 CARA-US  GNW  Cara Therapeutics Reports First Quarter 2016 Financial Results,"10/30/2017 FLXN-US  GNW  Flexion Therapeutics to Report Third-Quarter 2017 Financial Results on November 6, 2017", 3/03/2017 QURE-US  GNW  uniQure Receives 2017 Frost & Sullivan Manufacturing Leadership Award, 1/03/2017 AGIO-US   GNW  Agios Appoints Ian Clark to Board of Directors," 4/19/2017 46226010 GNW  SHAREHOLDER ALERT:Â  Pomerantz Law Firm Announces the Filing of a  Class Action against Lion Biotechnologies, Inc. and Certain Officers â€“ LBIO",,, 8/08/2016 061VB7-E GNW  Fate Therapeutics Reports Second Quarter 2016 Financial Results,,, 9/19/2016 ICPT-US  GNW  Intercept Pharmaceuticals Files New Drug Submission to Health Canada for Marketing Approval of Obeticholic Acid for the Treatment of Patients with Primary Biliary Cholangitis, 2/07/2019 KPTI-US    GNW  Karyopharm Announces FDA Advisory Committee Meeting to Review Selinexor for the Treatment of Patients with Triple Class Refractory Multiple Myeloma Who Have Received At Least Three Prior Therapies,,," 5/15/2017 46116X10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Intra-Cellular Therapies, Inc. To Contact The Firm",,,,, 8/04/2016 ATRA-US    GNW  Atara Bio to Present at the Canaccord Genuity 36th Annual Growth Conference,, 3/01/2016 DERM-US  GNW  Dermira to Report Fourth Quarter and Full Year 2015 Financial Results, 3/03/2015 M4613510 GNW  Foamix to Present Corporate Overview at the Barclays Global Healthcare Conference,, 2/17/2015 86845910 GNW  Supernus to Host Fourth Quarter and Full Year 2014 Earnings Conference Call, 7/27/2015 31572Q80 GNW  FibroGen Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in Duchenne Muscular Dystrophy,, 2/17/2017 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,,, 2/02/2016 COLL-US  GNW  Collegium Provides Litigation Update,12/11/2015 XBIT-US  GNW  XBiotech Announces Agreement With the NCIC Clinical Trials Group to Collaborate on Phase II Study in Non-Small Cell Lung Cancer (NSCLC),,, 9/05/2017 GBT-US   GNW  Global Blood Therapeutics Receives Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of Sickle Cell Disease (SCD),,11/04/2016 KURA-US  GNW  Kura Oncology Presents Update on Pipeline Programs Targeting RAS-ERK Pathway at European Scientific Oncology Conference,,11/14/2016 AXSM-US  GNW  Axsome Therapeutics Reports Third Quarter 2016 Financial Results, 3/17/2016 VYGR-US  GNW  Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update, 6/06/2018 BGNE-US  GNW  BeiGene to Present at the Goldman Sachs 39th Annual Global Healthcare Conference,,,,,,, 2/02/2015 0CRRZ8-E GNW  G1 Therapeutics to Present at 17th Annual BIO CEO & Investor Conference,,," 9/18/2017 ATNX-US  GNW  Athenex, Inc. Added to Russell 2000Â® and Russell 3000Â® Indexes",,,,,,,,,, 9/12/2016 EYPT-US    GNW  pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/27/2017 PGNX-US  GNW  Progenics Pharmaceuticals Sets First Quarter 2017 Financial Results Call for May 4,,,,,,,,," 6/12/2018 OPK-US   GNW  GeneDx Announces Completion of 100,000 Exome Sequences",, 9/24/2014 09061G10    GNW  FDA Receives Paragraph IV Notice Letter for KUVAN(R) (sapropterin dihydrochloride) Tablets,,,," 8/10/2018 45290710 GNW  Factors of Influence in 2018, Key Indicators and Opportunity within Immunomedics, Vertex Pharmaceuticals, Ralph Lauren, Alliant Energy, TreeHouse Foods, and Lincoln National â€” New Research Emphasizes Economic Growth"," 8/06/2013 HPTX-US   GNW  Hyperion Therapeutics Announces Larry J. Singer as Vice President, Manufacturing",, 9/21/2017 BCRX-US  GNW  BioCrystâ€™s RAPIVABÂ® (peramivir injection) Receives FDA Approval for a Pediatric Indication,,,,, 1/21/2016 AKRX-US  GNW  Akorn Appoints Greg Lawless as Chief Human Resources Officer,, 2/15/2019 MYGN-US  GNW  Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer,,,,,11/21/2016 INO-US    GNW  Inovioâ€™s Co-Founder and Chair of its Scientific Advisory Board Selected as a Top 20 Translational Researcher,,, 2/17/2016 GERN-US  GNW  Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2015 Financial Results,, 6/07/2018 AMRN-US  GNW  Amarin Sponsors Three Scientific Presentations Scheduled for American Diabetes Association Scientific Sessions,,," 4/23/2018 SRPT-US  GNW  Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Devel-opments on May 3, 2018",,, 5/02/2017 AMAG-US  GNW  AMAG Announces Positive Topline Data From Phase 3 FerahemeÂ® (ferumoxytol) Label Expansion Study,,,,, 5/21/2018 SAN-FR   GNW  Sanofi: New England Journal of Medicine publishes two positive Phase 3 trials showing DupixentÂ® (dupilumab) improved moderate-to-severe asthma,,,,,, 5/11/2016 N0104510 GNW  Affimed Announces First Quarter 2016 Financial Results and Corporate Update Conference Call,, 8/17/2016 PRQR-US  GNW  ProQR Announces Results for the Second Quarter of 2016,, 1/31/2018 ZGNX-US  GNW  Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome,,,,,, 4/27/2016 0F9D18-E GNW  Avalanche Biotechnologies to Present at Upcoming Scientific Meetings, 8/31/2017 RARE-US   GNW  Ultragenyx to Present at the Baird 2017 Global Healthcare Conference,,11/30/2016 NSTG-US  GNW  NanoString Technologies Highlights Advances in Precision Oncology at the 58th Annual Meeting of the American Society of Hematology,,," 7/20/2016 RDUS-US  GNW  Radius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2016 Annual Meeting September 16-19, 2016"," 9/24/2012 04539610 GNW  Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development",,,,,,,"11/10/2016 PCRX-US  GNW  Correction: Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November", 3/09/2016 RTRX-US  GNW  Retrophin Announces New Data Supporting Further Clinical Development of RE-024 for PKAN at the 2016 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting,12/18/2014 69404D10 GNW  Pacific Biosciences Appoints Kathy Ordonez to Board of Directors, 5/16/2016 EDIT-US  GNW  Editas Medicine Announces First Quarter 2016 Results and Update,,11/08/2017 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Third Quarter 2017 Financial Results,,,, 2/10/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Early HSR Clearance for Biosimilars Collaboration With Mylan, 2/01/2016 PRTA-IE  GNW  Prothena to Participate in BIO CEO & Investor and Leerink Partners Healthcare Conferences,,,12/18/2015 CTMX-US  GNW  CytomX Added to Russell 2000Â® Index, 8/17/2016 06CR5C-E GNW  Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Relapsed Multiple Myeloma,,," 5/02/2016 CBAY-US  GNW  CymaBay to Announce First Quarter 2016 Financial Results on Wednesday, May 11",," 4/20/2015 16383L10 GNW  ChemoCentryx Initiates Clinical Trial of CCX872, Its Next-Generation, Orally Administered CCR2 Inhibitor, in Pancreatic Cancer",,,11/09/2016 SNY-FR    GNW  MannKind and Sanofi Reach Agreement on AFREZZAÂ®,, 5/11/2017 CYTK-US  GNW  Cytokinetics to Hold Annual Meeting of Stockholders, 6/14/2017 ESPR-US     GNW  Esperion to Present at the JMP Securities 2017 Life Sciences Conference, 5/03/2018 AMRS-US   GNW  Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient,, 4/08/2015 00448Q20 GNW  Achillion Announces Upcoming Presentations at the International Liver Congress 2015 (EASL), 5/03/2018 SYNH-US  GNW  Syneos Health Leaders Honored by the Healthcare Businesswomenâ€™s Association, 4/06/2017 FOLD-US  GNW  Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day,,, 3/09/2015 00089910 GNW  ADMA Biologics Reports Year End 2014 Results and Upcoming Milestones, 5/31/2016 GS-US    GNW  GW Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare Conference and the Jefferies 2016 Healthcare Conference,,, 8/10/2016 08149D-E GNW  MyoKardia to Present at the 2016 Wedbush PacGrow Healthcare Conference,, 6/20/2017 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises, 8/09/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update,,,, 5/04/2016 CARA-US  GNW  Cara Therapeutics to Sponsor Symposium at American Pain Society 35th Annual Scientific Meeting,10/11/2017 FLXN-US  GNW  Flexion Therapeutics Announces Pricing of Public Offering of Common Stock, 3/01/2017 QURE-US  GNW  uniQure Announces Presentations at Upcoming March Conferences," 1/03/2017 AGIO-US   GNW  Agios to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017"," 4/19/2017 IOVA-US  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 â€“ LBIO",,, 8/08/2016 FATE-US  GNW  Fate Therapeutics Announces $10.3 Million Common Stock Private Placement,,, 9/02/2016 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences, 2/04/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/10/2017 ITCI-US  GNW  Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update,,,,, 7/18/2016 04651310   GNW  AMAG Pharmaceuticals CEO William Heiden Elected to PhRMA Board of Directors,, 3/01/2016 0024VM-E GNW  Dermira to Present at Cowen and Company 36th Annual Health Care Conference, 2/26/2015 M4613510 GNW  Foamix to Present Corporate Overview at the Cowen & Company 35th Annual Health Care Conference,, 1/21/2015 86845910 GNW  Supernus Sues TWi for Infringement of Oxtellar XR(R) Patents, 6/29/2015 31572Q80 GNW  FibroGen Announces Receipt of $120 Million License Payment from AstraZeneca,, 2/08/2017 CHRS-US  GNW  Coherus Prices Public Offering of Common Stock,,, 1/25/2016 COLL-US  GNW  Collegium Appoints Ted Schroeder to Board of Directors,12/07/2015 98400H10 GNW  XBiotech Announces Positive Results in European Phase III Study for Its Breakthrough Therapy for Colorectal Cancer,,, 8/30/2017 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Participation in Multiple Investor Conferences in September,,11/01/2016 CS-CH    GNW  Kura Oncology to Participate in Two Upcoming Investor Conferences,,11/10/2016 AXSM-US  GNW  Axsome Therapeutics Enters into $20 Million Term Loan Agreement with Silicon Valley Bank, 3/14/2016 VYGR-US  GNW  Voyager Therapeutics to Present at Alliance for Regenerative Medicineâ€™s 4th Annual Cell & Gene Therapy Investor Day, 6/05/2018 BGNE-US  GNW  BeiGene to Present at the William Blair 2018 Growth Stock Conference,,,,,,, 9/10/2014 0CRRZ8-E GNW  G1 Therapeutics Initiates Phase 1 Clinical Trial of G1T28-1,,," 9/11/2017 ATNX-US  GNW  CORRECTING and REPLACING: Athenex, Inc.",,,,,,,,,, 9/01/2016 EYPT-US    GNW  pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/20/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces Presentations at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting,,,,,,,,, 6/11/2018 OPK-US   GNW  OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity,, 9/23/2014 09061G10    GNW  BioMarin to Attend Upcoming Investor Conferences,,,, 7/30/2018 IMMU-US  GNW  Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions, 7/15/2013 GMAB-DK   GNW  Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case,, 9/15/2017 BCRX-US  GNW  BioCryst Pharmaceuticals Announces Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock,,,,, 1/19/2016 AKRX-US  GNW  Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection,, 2/13/2019 MYGN-US  GNW  Myriad Genetics to Present at Multiple Upcoming Healthcare Conferences,,,,,11/16/2016 05MFY1-E  GNW  Inovio Wins Deloitteâ€™s â€œFast 500â€ Growth Award,,, 2/10/2016 GERN-US  GNW  Geron to Present at the RBC Capital Markets Healthcare Conference,, 5/24/2018 0657G1-E GNW  Amarin Announces Patent Litigation Settlement Agreement with Teva,,, 3/30/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 4/26/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the Deutsche Bank Health Care Conference,,,,, 5/16/2018 SAN-FR   GNW  Sanofi: DupixentÂ® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis,,,,,, 4/21/2016 06P9WL-E GNW  Affimed Presents Data on EGFRwt and EGFRvIII-targeting NK- and T-Cell TandAbs at the AACR Annual Meeting 2016,, 7/19/2016 06CR5C-E GNW  ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis,,12/04/2017 ZGNX-US  GNW  Zogenix Announces New Positive Efficacy and Safety Data from  Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome,,,,,, 3/03/2016 ADVM-US  GNW  Avalanche Biotechnologies Reports Fourth Quarter and Fiscal 2015 Financial Results, 8/24/2017 RARE-US   GNW  Ultragenyx Announces Burosumab Data Presentations at ASBMR 2017 Annual Meeting,,11/11/2016 NSTG-US  GNW  UPDATE â€“ NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance  Immuno-Oncology Research,,," 7/15/2016 RDUS-US  GNW  Radius Health to Announce Second Quarter 2016 Financial Results, Host Conference Call and Live Webcast on August 4, 2016", 8/29/2012 04539610 GNW  Ventrus Biosciences to Present at Upcoming Investor Conferences in September,,,,,,,"11/10/2016 PIPR-US  GNW  Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November", 3/03/2016 RTRX-US  GNW  Retrophin to Present at the Barclays Global Healthcare Conference,11/10/2014 69404D10 GNW  Researchers Use PacBio Sequencing to Create More Complete Human Genome Reference and Discover New Forms of Structural Variation; Paper Published in Nature, 5/16/2016 064Q9G-E GNW  Editas Medicine Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Advance New CRISPR/Cas9 Medicines,,11/01/2017 MGNX-US  GNW  MacroGenics Announces Date of Third Quarter 2017 Financial Results Conference Call,,,, 2/05/2016 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2015 Financial Results Conference Call and Webcast," 1/07/2016 PRTA-US  GNW  Prothena Announces Pricing of Public Offering of 2,250,000 Ordinary Shares",,,"12/11/2015 23284F10 GNW  CytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166", 8/10/2016 GMAB-DK  GNW  Genmab Enters Commercial License Agreement with Gilead for DuoBody(R) Technology,,, 3/29/2016 CBAY-US  GNW  CymaBay Reports Fourth Quarter and Full Year 2015 Financial Results,, 3/12/2015 16383L10 GNW  ChemoCentryx Reports Fourth Quarter 2014 Financial Results and Provides Corporate Update,,,11/09/2016 MNKD-US   GNW  MannKind Corporation Reports 2016 Third Quarter Financial Results,, 5/08/2017 CYTK-US  GNW  Cytokinetics Announces Pricing of Public Offering of Common Stock, 5/31/2017 ESPR-US     GNW  Esperion to Present at the Jefferies 2017 Global Healthcare Conference," 4/03/2018 AMRS-US   GNW  Amyris to Present at H.C. Wainwright Global Life Sciences Investment Conference on April 9, 2018",, 3/05/2015 00448Q20 GNW  Achillion Reports 2014 Fourth Quarter and Year-End Financial Results, 4/30/2018 SYNH-US  GNW  Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery, 4/03/2017 FOLD-US  GNW  Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study,,, 2/23/2015 00089910 GNW  ADMA Biologics Announces Positive Data on Primary and Secondary Endpoints from its Pivotal Phase III Clinical Trial for RI-002 at the AAAAI Medical Conference, 5/16/2016 UBS-CH   GNW  GW Pharmaceuticals to Present at the 2016 UBS Global Healthcare Conference on 24 May,,, 8/09/2016 MYOK-US  GNW  MyoKardia Reports Second Quarter 2016 Financial Results and Continued Progress on Clinical Programs,, 6/20/2017 GLPG-NL  GNW  Galapagos' R&D Update 2017: rapidly advancing our product candidates, 8/03/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Resubmission of Biologics License Application for AndexXaÂ® (Andexanet Alfa),,,," 4/28/2016 CARA-US  GNW  Cara Therapeutics to Announce First Quarter 2016 Financial Results on May 5, 2016",10/10/2017 FLXN-US  GNW  Flexion Therapeutics Announces Proposed Public Offering of Common Stock, 2/06/2017 QURE-NL  GNW  uniQure Announces Presentations at Upcoming February Conferences,12/15/2016 AGIO-US   GNW  Agios Provides Update on PKR Program," 4/18/2017 46226010 GNW  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lion Biotechnologies, Inc. (LBIO)",,," 8/02/2016 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2016 Financial Results on August 8, 2016",,, 8/17/2016 0B6G4F-E GNW  New England Journal of Medicine Publishes Results of Phase 3 POISE Trial of OcalivaÂ® (Obeticholic Acid) for the Treatment of PBC, 1/08/2019 KPTI-US    GNW  Karyopharm Announces Submission of Marketing Authorization Application to the  European Medicines Agency for Selinexor for the Treatment of Patients with  Penta-Refractory Multiple Myeloma,,, 5/08/2017 ITCI-US  GNW  Intra-Cellular Therapies Presents Data Supporting the Potential for Potent and Rapid Antidepressant Activity with Lumateperone,,,,, 7/12/2016 ATRA-US    GNW  Atara Bio Doses First Patient in Multi-Center Expanded Access Protocol for Study of Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes (EBV-CTLs) in EBV-Associated Lymphomas and Lymphoproliferative Disorders,, 2/29/2016 DERM-US  GNW  Dermira Completes Patient Enrollment for DRM04 Phase 3 Pivotal Trials in Primary Axillary Hyperhidrosis,12/16/2014 M4613510 GNW  Foamix Earns US$ 2.5 Million Milestone Payment From Bayer HealthCare,, 1/16/2015 SUPN-US  GNW  Supernus Sues Par for Infringement of Trokendi XR(R) Patents, 6/01/2015 31572Q80 GNW  FibroGen to Webcast Presentation at the Goldman Sachs Global Healthcare Conference,, 2/07/2017 CHRS-US  GNW  Coherus Announces Proposed Public Offering of Common Stock,,," 1/21/2016 COLL-US  GNW  Collegium Announces FDA Acceptance of IND Application for Abuse-Deterrent, Hydrocodone DETERxÂ®","12/03/2015 98400H10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of XBiotech Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 â€“ XBIT",,, 8/09/2017 GBT-US   GNW  Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare Conference,,10/31/2016 KURA-US  GNW  Kura Oncology to Report Third Quarter 2016 Financial Results,,10/04/2016 AXSM-US  GNW  Axsome Therapeutics Announces Publication of Research Showing AXS-02 Inhibits Pain in Animal Model of Complex Regional Pain Syndrome, 3/10/2016 VYGR-US  GNW  Voyager Therapeutics to Host Fourth Quarter and Full Year 2015 Investor Update Call, 6/01/2018 BGNE-US  GNW  BeiGene to Present Data on Zanubrutinib and Host an Investor Call from the 23rd Congress of the European Hematology Association,,,,,,," 6/17/2014 0CRRZ8-E GNW  G1 Therapeutics Completes Leadership Team With Appointment of Raj Malik, MD, Chief Medical Officer and Greg Mossinghoff, Chief Business Officer",,, 9/11/2017 ATNX-US  GNW  ContraVir Pharmaceuticals Receives HBV IND Approval for Tenofovir Exalidex (TXLâ„¢) in the United States,,,,,,,,,, 8/29/2016 EYPT-US    GNW  pSivida Announces 13 New Patents Issued or Allowed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/30/2017 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference,,,,,,,,, 5/18/2018 OPK-US   GNW  OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test,," 9/16/2014 BMRN-US     GNW  Nora Therapeutics Names Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning",,,, 7/23/2018 45290710 GNW  Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers, 6/03/2013 TSRX-US   GNW  Trius Appoints Matthew Onaitis as General Counsel,, 9/12/2017 BCRX-US  GNW  BioCryst Pharmaceuticals Prices Public Offering of Common Stock,,,,, 1/14/2016 AKRX-US  GNW  Akorn Provides Material Updates,, 2/11/2019 MYGN-US  GNW  Myriad Announces Prequelâ„¢ Prenatal Screen with  Expanded Aneuploidy Analysis for all 23 Chromosome Pairs,,,,,11/14/2016 INO-US    GNW  Inovioâ€™s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer,,, 1/14/2016 GERN-US  GNW  Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes,, 5/23/2018 AMRN-US  GNW  Amarin to Present at the Jefferies Global Healthcare Conference,,," 3/20/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Launch of Route 79, The Duchenne Scholarship Program",,," 4/25/2017 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Arpad Simon, M.D. as Vice President of Pharmacovigilance",,,,, 5/14/2018 SAN-FR   GNW  Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period,,,,,, 4/21/2016 N0104510 GNW  Affimed Presents Data on AFM13-mediated Innate/Adaptive Immune Crosstalk at the AACR Annual Meeting 2016,, 6/21/2016 PRQR-US  GNW  ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC,,11/29/2017 ZGNX-US  GNW  Zogenix Announces Initiation of Phase 3 Trial for  ZX008 in Lennox-Gastaut Syndrome,,,,,, 3/02/2016 0024VM-E GNW  Avalanche Biotechnologies to Present at Upcoming Investor Conferences, 8/24/2017 RARE-US   GNW  Ultragenyx and Kyowa Hakko Kirin Announce Submission of Burosumabâ€™s Biologics License Application in the US,,11/10/2016 NSTG-US  GNW  NanoString Technologies Teams with the OHSU Knight Cancer Institute to Develop Myeloid Gene Expression Panels to Advance  Immuno-Oncology Research,,, 7/05/2016 RDUS-US  GNW  Radius Health to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference, 8/09/2012 04539610 GNW  Ventrus Biosciences Reports Second Quarter 2012 Financial Results,,,,,,,"11/02/2016 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results", 2/25/2016 RTRX-US  GNW  Retrophin Reports Fourth Quarter and Full Year 2015 Financial Results,10/27/2014 69404D10 GNW  New DNA Sequencing Facility Established in China Based on PacBio's SMRT Sequencing Platform, 5/09/2016 EDIT-US  GNW  Editas Medicine to Host Conference Call Discussing First Quarter 2016 Corporate Update and Results,,"11/01/2017 MGNX-US  GNW  MacroGenics to Present Phase 1 Data on Flotetuzumab, a CD123 x CD3 DARTÂ® Molecule, at 59th Annual ASH Meeting",,,, 2/01/2016 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 1/05/2016 PRTA-US  GNW  Prothena Announces Proposed Offering of Ordinary Shares,,,12/01/2015 0DZ2BK-E GNW  CytomX to Present at Oppenheimer's 26th Annual Healthcare Conference, 8/09/2016 37230320 GNW  Genmab Announces Financial Results for the First Half of 2016 and Improves 2016 Financial Guidance,,, 3/28/2016 CBAY-US  GNW  CymaBay Announces the Appointment of Paul F. Truex and Robert J. Weiland to its Board of Directors,," 2/26/2015 16383L10 GNW  ChemoCentryx to Hold Fourth Quarter 2014 Financial Results Conference Call on Thursday, March 12, 2015",,,"11/01/2016 MNKD-US   GNW  MannKind Corporation to Hold 2016 Third Quarter Financial Results Conference Call on November 9, 2016",, 5/08/2017 CYTK-US  GNW  Cytokinetics Announces Proposed Public Offering of Common Stock, 5/22/2017 ESPR-US     GNW  Esperion Provides Update on Common Stock Trading Activity," 2/26/2018 AMRS-US   GNW  Amyris to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15, 2018",, 2/18/2015 ACHN-US  GNW  Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock," 4/17/2018 SYNH-US  GNW  Syneos Health Schedules First Quarter 2018 Earnings Call for Wednesday, May 9, 2018", 3/08/2017 FOLD-US  GNW  Amicus Therapeutics Launches Galafoldâ„¢ (Migalastat) for Treatment of Fabry Disease in Italy,,, 2/20/2015 00089910 GNW  ADMA Biologics to Present at Cowen and Company 35th Annual Health Care Conference, 5/05/2016 GWP-GB   GNW  GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress,,," 7/14/2016 MYOK-US  GNW  SHaRe Registry Data Published in PNAS Demonstrate the Power of Combining Clinical, Genetic and Structural Data to Gain Insight into Hypertrophic Cardiomyopathy",, 5/17/2017 GLPG-NL  GNW  Galapagos creates new warrant plan," 8/02/2017 PTLA-US  GNW  Portola Pharmaceuticals to Announce Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 9",,,, 4/20/2016 CARA-US  GNW  Cara Therapeutics Announces Removal of FDA Clinical Hold on CLIN3001 Postoperative Pain Trial for I.V. CR845,10/06/2017 FLXN-US  GNW  Flexion Therapeutics Announces FDA Approval of Zilrettaâ„¢ (triamcinolone acetonide extended-release injectable suspension)  for Osteoarthritis (OA) Knee Pain, 1/30/2017 QURE-NL  GNW  uniQure Announces FDA Breakthrough Therapy Designation for  AMT-060 in Hemophilia B,12/05/2016 AGIO-US   GNW  Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies," 4/18/2017 46226010 GNW  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Lion Biotechnologies, Inc.",,, 7/26/2016 070JFC-E GNW  Fate Therapeutics Announces Issuance of U.S. Patent on Compositions of Human Induced Pluripotent Cells,,, 8/04/2016 ICPT-US  GNW  Intercept Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update, 1/02/2019 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/04/2017 ITCI-US  GNW  Intra-Cellular Therapies To Present at the 19th Annual Conference of the International Society for Bipolar Disorders,,,,, 6/23/2016 ATRA-US    GNW  Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes (EBV-CTLs) from European Medicines Agency (EMA),, 2/04/2016 DERM-US  GNW  Dermira to Present at the Leerink Partners 5th Annual Global Healthcare Conference,12/05/2014 M4613510 GNW  Foamix to Present Corporate Overview at the Oppenheimer & Co. 25th Annual Healthcare Conference,,12/10/2014 86845910 GNW  Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR(R),,," 1/31/2017 CHRS-US  GNW  Coherus BioSciences Files Four Petitions for Inter Partes Review Against AbbVieâ€™s HUMIRAÂ® Formulation Patent 9,085,619",,," 1/08/2016 COLL-US  GNW  Collegium Pharmaceutical, Inc. Prices Public Offering of $55.0 Million of Common Stock",11/23/2015 98400H10 GNW  XBiotech Provides Update on Phase III Oncology Study in Europe,,, 8/07/2017 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results,,10/31/2016 KURA-US  GNW  Kura Oncology to Participate in the 9th European Scientific Oncology Conference,, 9/19/2016 AXSM-US  GNW  Axsome Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference, 2/29/2016 VYGR-US  GNW  Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference, 5/17/2018 BGNE-US  GNW  BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Chinese Patients with Ovarian Cancer,,,,,,, 5/20/2014 0CRRZ8-E GNW  Photo Release -- G1 Therapeutics Appoints Dr. Mark Velleca as Chief Executive Officer,,, 8/31/2017 ATNX-US  GNW  Athenex Pharmaceutical Division and SunGen Pharma Announce Terbutaline Sulfate Injection Product Launch,,,,,,,,,, 8/15/2016 EYPT-US    GNW  Topline Results from First Phase 3 Trial of pSividaâ€™s Medidurâ„¢ Presented at ASRS Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/30/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces Positive Topline Results from Registrational Phase 2b Trial of AZEDRAÂ®,,,,,,,,, 5/08/2018 OPK-US   GNW  OPKO Health Reports First Quarter 2018 Financial Results,, 9/15/2014 09061G10    GNW  BioMarin Named by CenterWatch as One of the Fastest Developers of Medicines,,,, 7/18/2018 IMMU-US  GNW  FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer, 5/17/2013 GSK-GB    GNW  Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case,, 9/11/2017 BCRX-US  GNW  BioCryst Pharmaceuticals Commences Public Offering of Common Stock,,,,,11/13/2015 00972810 GNW  Akorn Receives Additional Delinquency Notice from Nasdaq,, 2/08/2019 MYGN-US  GNW  Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting,,,,,"11/10/2016 INO-US    GNW  Inovio Pharmaceuticals Zika Vaccine Protects AnimalsÂ from Infection, Brain Damage and Death",,,11/30/2015 GERN-US  GNW  Geron Announces December Conference Presentation Webcasts,, 5/02/2018 AMRN-US  GNW  Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations,,, 3/12/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Plan to Submit a New Drug Application (NDA) for Accelerated Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53,,," 4/19/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Host First Quarter 2017 Financial Results Conference Call and Webcast on Tuesday, May 2, 2017 at 8:00 a.m. ET",,,,, 5/14/2018 SAN-FR   GNW  Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period,,,,,, 3/30/2016 N0104510 GNW  Affimed Reports Financial Results for Fourth Quarter and Year End 2015,, 6/01/2016 06CR5C-E GNW  ProQRâ€™s Drug Candidate QR-110 for Leberâ€™s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation,,11/29/2017 ZGNX-US  GNW  Zogenix to Participate in the Global Mizuho Investor Conference 2017,,,,,, 2/01/2016 ADVM-US  GNW  Avalanche Biotechnologies and Annapurna Therapeutics Announce Proposed Merger, 8/22/2017 RARE-US   GNW  Ultragenyx Announces Top-Line Results from Phase 3 Study of Ace-ER in GNE Myopathy,,11/07/2016 NSTG-US  GNW  NanoString Launches Technology Access Program (TAP) for Transformative Platform for High-Plex Digital Spatial Profiling,,, 6/01/2016 RDUS-US  GNW  Radius Health to Present at the Goldman Sachs Thirty-Seventh Annual 2016 Healthcare Conference, 6/25/2012 04539610 GNW  Ventrus Biosciences Announces Results From Pivotal Phase 3 Trial of Iferanserin (VEN 309) in Patients With Hemorrhoidal Disease,,,,,,,10/20/2016 PCRX-US  GNW  Pacira Pharmaceuticals Continues to Build Out Robust Commercial Leadership Team, 2/24/2016 05MYKN-E GNW  Retrophin Receives European Orphan Drug Designation for RE-024 for the Treatment of Pantothenate Kinase-Associated Neurodegeneration,10/23/2014 69404D10 GNW  Pacific Biosciences Reports Third Quarter 2014 Financial Results, 5/04/2016 28106W10 GNW  Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics,," 9/10/2017 MGNX-US  GNW  Phase 1 Data for Flotetuzumab, MacroGenicsâ€™ CD123 x CD3 DARTÂ® Molecule, Presented at ESMO Congress 2017",,,, 1/08/2016 60877T10 GNW  Momenta Pharmaceuticals Announces Worldwide Collaboration With Mylan to Jointly Develop and Commercialize Six Biosimilar Products,12/01/2015 PRTA-US  GNW  Prothena to Participate in Oppenheimer and RBC Capital Markets Healthcare Investor Conferences,,,11/23/2015 23284F10 GNW  CytomX Reports Third Quarter 2015 Financial Results, 7/25/2016 37230320 GNW  Daratumumab Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration in Combination with Standard of Care Regimens for Previously Treated Multiple Myeloma,,, 3/28/2016 0793RM-E GNW  CymaBay Therapeutics Announces Acceptance of Arhalofenate Phase 2b Gout Study Manuscript in Arthritis and Rheumatology,, 2/17/2015 16383L10 GNW  ChemoCentryx to Present at the Cowen and Company 35th Annual Health Care Conference,,, 9/02/2016 MNKD-US   GNW  MannKind Corporation to Present at the Rodman & Renshaw 18th Annual Global Investment Conference,, 5/03/2017 CYTK-US  GNW  Cytokinetics and the ALS AssociationÂ Renew Partnership to Advance the Fight Against ALS, 5/19/2017 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference, 2/08/2018 AMRS-US   GNW  Amyris Aprinnova Joint Venture Launches Pharmaceutical Grade Neossance Squalane USP â€“ Opens New Market Among FDA Regulated Products,, 2/11/2015 00448Q20 GNW  Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 3/27/2018 SYNH-US  GNW  Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution, 3/02/2017 FOLD-US  GNW  Amicus Therapeutics to Present at Upcoming Investor Conferences,,, 2/17/2015 00089910 GNW  ADMA Biologics Announces Data to be Presented at 2015 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI), 5/04/2016 07MDY1-E GNW  GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference on 10 May,,," 7/11/2016 MYOK-US  GNW  MyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 PIONEER-HCM Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients",, 5/15/2017 GLPG-NL  GNW  Seven abstracts on filgotinib accepted by EULAR 2017, 7/27/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,, 4/05/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at the 15th Annual Needham Healthcare Conference, 9/07/2017 FLXN-US  GNW  Flexion Therapeutics to Present Data on Zilrettaâ„¢Â (FX006) at PAINWeek 2017, 1/25/2017 QURE-NL  GNW  uniQure Appoints Alexander Kuta as Senior Vice President of Regulatory Affairs,12/04/2016 AGIO-US   GNW  Agios Announces New Data from AG-348 and AG-519 Demonstrating Potential for First Disease-modifying Treatment for Patients with PK Deficiency," 4/14/2017 46226010 GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Lion Biotechnologies, Inc. To Contact The Firm",,, 6/20/2016 06CR5C-E GNW  Fate Therapeutics Announces FDA Fast Track Designation for ProTmuneâ„¢,,, 7/28/2016 ICPT-US  GNW  Intercept to Report Second Quarter 2016 Financial Results on August 4 and Present at Upcoming Conference, 1/02/2019 KPTI-US    GNW  Karyopharm to Present at the 37th Annual J.P. Morgan Healthcare Conference,,, 5/01/2017 ITCI-US  GNW  Intra-Cellular Therapies Provides Corporate Update On Schizophrenia Program,,,,, 6/15/2016 002N2S-E   GNW  Atara Bio to Present at the JMP Securities Life Sciences Conference,, 1/08/2016 DERM-US  GNW  Dermira Completes Patient Enrollment for Third CIMZIAÂ® (certolizumab pegol) Phase 3 Clinical Trial in Psoriasis Program and Updates Guidance for Release of Topline Data,"11/14/2014 M4613510 GNW  Foamix Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014",,12/09/2014 86845910 GNW  Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R),,, 1/10/2017 CHRS-US  GNW  Coherus BioSciences Announces Positive Topline 24-Week Treatment  Phase Three Results for CHS-1420 (HUMIRAÂ® Biosimilar Candidate)  in Patients with Psoriasis,,,12/16/2015 COLL-US  GNW  Collegium Announces Publication of Nasal Human Abuse Potential Study in American Academy of Pain Medicine,11/20/2015 98400H10 GNW  XBiotech Added to the MSCI US Small Cap 1750 and the MSCI Investable Market 2500 Indexes,,, 7/26/2017 GBT-US   GNW  Global Blood Therapeutics Announces New Employment Inducement Grants,, 9/14/2016 06TZSP-E GNW  Kura Oncology to Participate in the 2016 Aegis Growth Conference,, 9/06/2016 AXSM-US  GNW  Axsome Therapeutics to Present at Upcoming Investor Conferences, 2/02/2016 VYGR-US  GNW  Voyager Therapeutics Promotes Jeff Goater to Chief Financial Officer, 5/15/2018 BGNE-US  GNW  BeiGene to Present at the 2018 UBS Global Healthcare Conference,,,,,,,,,," 8/14/2017 ATNX-US  GNW  Athenex, Inc. Announces Second Quarter 2017 Results",,,,,,,,,, 8/09/2016 EYPT-US    GNW  Primary Endpoint Met in pSividaâ€™s Utilization Study of New Medidurâ„¢ Inserter with Smaller Diameter Needle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/24/2017 PGNX-US  GNW  Data from Phase 2 Study of Progenicsâ€™ PSMA-Targeted Imaging Agent 1404 Published in Journal of Nuclear Medicine,,,,,,,,," 5/02/2018 OPK-US   GNW  OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018",, 9/10/2014 09061G10    GNW  BioMarin to Attend Upcoming Investor Conferences in London,,,, 6/15/2018 IMMU-US  GNW  Immunomedics Announces Closing of Public Offering of Common Stock, 5/01/2013 GWP-GB    GNW  NASDAQ Welcomes GW Pharmaceuticals to The NASDAQ Stock Market,, 9/05/2017 BCRX-US  GNW  BioCryst Announces Positive Results from its APeX-1 Phase 2 Trial in HAE,,,,,11/04/2015 00972810 GNW  Akorn Provides Business and Financial Guidance Update,, 2/05/2019 MYGN-US  GNW  Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results,,,,,11/09/2016 INO-US    GNW  Inovio Pharmaceuticals Reports 2016 Third Quarter Financial Results,,,11/10/2015 GERN-US  GNW  Geron to Present At the Stifel Healthcare Conference,," 4/26/2018 AMRN-US  GNW  Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018",,, 3/01/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results and Recent Corporate Developments,,, 4/17/2017 AMAG-US  GNW  AMAG Submits Supplemental New Drug Application to FDA for MakenaÂ® (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use,,,,," 5/02/2018 SAN-FR   GNW  Sanofi: Annual General Shareholders' Meeting of May 2, 2018",,,,,, 3/23/2016 N0104510 GNW  Affimed Announces Fourth Quarter and Year End 2015 Financial Results and Corporate Update Conference Call,, 6/01/2016 002N2S-E GNW  ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference,,"11/28/2017 ZGNX-US  GNW  Zogenix To Host Call with Pediatric Epilepsy Expert Joseph Sullivan, M.D., on Dravet Syndrome and ZX008 on Monday, December 4",,,,,,"11/20/2015 00773U10 GNW  Avalanche Biotechnologies, Inc. Names Paul B. Cleveland as CEO", 7/27/2017 RARE-US   GNW  Ultragenyx Reports Second Quarter 2017 Financial Results and Corporate Update,,11/02/2016 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Third Quarter of 2016,,, 5/31/2016 06CR5C-E GNW  Radius Announces FDA Acceptance for Filing of New Drug Application for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis, 5/30/2012 04539610 GNW  Ventrus to Present at the Jefferies 2012 Global Healthcare Conference,,,,,,,10/17/2016 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for Third Quarter 2016 Financial Results Webcast and Conference Call, 2/23/2016 RTRX-US  GNW  Retrophin to Present at the Cowen and Company 36th Annual Health Care Conference,10/20/2014 69404D10 GNW  PacBio Sequencing for Allele-Specific HLA Typing to be Showcased at American Society for Histocompatibility and Immunogenetics (ASHI) Annual Meeting, 4/27/2016 0F9D18-E GNW  Editas Medicine Announces Presentations at Upcoming Scientific Conferences,, 9/05/2017 MGNX-US  GNW  MacroGenics Advances Two First-in-Class Clinical DARTÂ® Molecules,,,, 1/05/2016 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the 34th Annual J. P. Morgan Healthcare Conference,11/05/2015 PRTA-US  GNW  Prothena to Present New Preclinical Data for NEOD001 at 57th Annual American Society of Hematology Meeting,,,, 6/23/2016 080RQG-E GNW  Genmab Provides Update on Marketing Authorization Application for Arzerra(r) (ofatumumab) as Maintenance Therapy for Patients with Relapsed CLL,,," 3/22/2016 CBAY-US  GNW  CymaBay Announces the Appointment of Dr. Evan Stein, M.D., Ph.D., to its Board of Directors",, 1/06/2015 16383L10 GNW  ChemoCentryx to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,, 8/25/2016 MNKD-US   GNW  Securities Class Action Against MannKind Dismissed,, 5/01/2017 CYTK-US  GNW  Cytokinetics Announces Results from Dose Escalation Phase of COSMIC-HF Presented at Heart Failure 2017, 5/18/2017 ESPR-US     GNW  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 2/01/2018 AMRS-US   GNW  Amyris Biossance Starts 2018 with Over 300% Retail Sales Growth â€“ Now Available Across SEPHORA Canada Stores,, 2/10/2015 ACHN-US  GNW  Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock, 3/06/2018 SYNH-US  GNW  Syneos Health to Present at Upcoming Barclays Global Healthcare Conference, 3/01/2017 FOLD-US  GNW  Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates,,,12/15/2014 00089910 GNW  ADMA Biologics Receives $5M Tranche From Hercules Technology Growth Capital," 4/28/2016 GWP-GB   GNW  GW Pharmaceuticals to Report Q2, Half-Year Financial Results  and Host Conference Call on 5 May, 2016",,, 5/16/2016 UBS-CH   GNW  MyoKardia to Present at 2016 UBS Global Healthcare Conference,, 5/07/2017 GLPG-NL  GNW  Galapagos presents three posters on filgotinib in Crohn's disease at DDWÂ® 2017, 7/06/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and Andexanet Alfa at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Scientific and Standardization Committee Meeting,,,, 3/10/2016 CARA-US  GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results, 8/30/2017 FLXN-US  GNW  Flexion Therapeutics to Present at the 2017 Wells Fargo Healthcare Conference, 1/09/2017 QURE-US  GNW  uniQure Outlines Key Initiatives for 2017 and Vision for 2018,11/18/2016 AGIO-US   GNW  Agios Announces Phase 1 Data from Dose Expansion Cohorts of AG-120 in Patients with IDH1 Mutant Positive Glioma and Chondrosarcoma," 1/04/2016 IOVA-US  GNW  Lion Biotechnologies Submits Investigational New Drug Application to Conduct Studies in Cervical, Head and Neck Cancer",,, 6/16/2016 070JFC-E GNW  Fate Therapeutics to Host Off-the-Shelf Cancer Immunotherapy Focus Session at 2016 Annual Meeting of International Society for Stem Cell Research,,, 7/06/2016 ICPT-US  GNW  Intercept Pharmaceuticals Announces Closing of Public Offering of Convertible Senior Notes and Exercise in Full of Option to Purchase Additional Notes,12/04/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 3/01/2017 ITCI-US  GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Corporate Update,,,,, 6/06/2016 ATRA-US    GNW  Atara Bio Announces Clinical Trial Results for the Treatment of EBV+ Nasopharyngeal Carcinoma using Allogeneic Epstein-Barr Virus Cytotoxic T-Lymphocyte Product Candidate,, 1/07/2016 DERM-US  GNW  Dermira Provides DRM01 and DRM04 Development Program Updates,11/13/2014 M4613510 GNW  Foamix Announces Two New U.S. Patents Relating to Topical Tetracycline Compositions,,11/24/2014 86845910 GNW  Supernus Announces Issuance of Fifth U.S. Patent Protecting Trokendi XR(R),,, 1/04/2017 0CT6N9-E GNW  Coherus BioSciences Management to Present at The 35th Annual J.P. Morgan Healthcare Conference,,,12/14/2015 19459J10 GNW  Collegium Added to the NASDAQ Biotechnology Index,11/12/2015 98400H10 GNW  XBiotech Provides Third Quarter 2015 Corporate and Clinical Update,,, 7/10/2017 GBT-US   GNW  Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric Population,, 9/02/2016 000KWW-E GNW  Kura Oncology to Participate in the 5th Annual Gateway Conference,, 9/02/2016 AXSM-US  GNW  Axsome Therapeutics Announces Transition of Chief Medical Officer,"12/18/2015 VYGR-US  GNW  Voyager Therapeutics Added to Russell 2000Â®, 3000Â® and Global Indexes", 5/09/2018 BGNE-US  GNW  BeiGene Reports First Quarter 2018 Financial Results,,,,,,,,,," 8/10/2017 ATNX-US  GNW  Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Three New Sterile Injectable Products from its 503(B) Facility",,,,,,,,,," 8/03/2016 EYPT-US    GNW  pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/09/2017 PGNX-US  GNW  Progenics Pharmaceuticals AnnouncesÂ Fourth Quarter and Full-Year 2016 Financial Results and Business Update,,,,,,,,, 5/01/2018 OPK-US   GNW  OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories,, 8/19/2014 09061G10    GNW  BioMarin to Present at Upcoming Investor Conferences,,,, 6/13/2018 IMMU-US  GNW  Immunomedics Announces Pricing of Public Offering of Common Stock, 4/16/2013 GMAB-DK   GNW  Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit,, 9/04/2017 BCRX-US  GNW  BioCryst Announces Corporate Update Conference Call and Webcast,,,,,10/21/2015 00972810 GNW  Akorn Provides Update on Alternative Fulfillment Systems,," 1/28/2019 MYGN-US  GNW  Myriad to Announce Fiscal Second-Quarter 2019 Financial Results on February 5, 2019",,,,,11/04/2016 INO-US    GNW  Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences,,,11/05/2015 GERN-US  GNW  Geron Corporation Reports Third Quarter 2015 Financial Results,, 4/23/2018 AMRN-US  GNW  Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer,,, 2/28/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 4/04/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement With Endoceutics for U.S. Rights to Intrarosaâ„¢ (Prasterone),,,,, 4/30/2018 SAN-FR   GNW  Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma,,,,,, 3/17/2016 06P9WL-E GNW  Affimed to Present Data on NK- and T-Cell Engagers at the AACR Annual Meeting 2016,, 5/18/2016 PRQR-US  GNW  ProQR Announces Results for the First Quarter of 2016,,11/21/2017 ZGNX-US  GNW  New Data from Zogenixâ€™s Phase 3 Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting,,,,,,"11/09/2015 00773U10 GNW  Avalanche Biotechnologies, Inc. Reports Third Quarter 2015 Financial Results", 7/21/2017 RARE-US   GNW  Ultragenyx to Host Conference Call for Second Quarter 2017 Financial Results and Corporate Update,,10/19/2016 NSTG-US  GNW  NanoString Technologies Presents Update on Hyb & Seqâ„¢ Next-Generation Sequencing Chemistry at ASHG Annual Meeting,,, 5/13/2016 RDUS-US  GNW  Radius Health Announces New Employment Inducement Grants, 5/15/2012 04539610 GNW  Ventrus to Present at the Bank of America Merrill Lynch 2012 Health Care Conference,,,,,,, 9/21/2016 PCRX-US  GNW  Pacira Pharmaceuticals Announces Official Launch of EXPAREL to the Oral Surgeon Community to Treat Pain Following Oral and Maxillofacial Procedures, 2/11/2016 RTRX-US  GNW  Retrophin to Report Fourth Quarter and Full Year 2015 Financial Results,10/15/2014 69404D10 GNW  Pacific Biosciences Releases New DNA Sequencing Chemistry to Enhance Read Length and Accuracy for the Study of Human and Other Complex Genomes, 4/27/2016 EDIT-US  GNW  Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference,, 8/31/2017 MGNX-US  GNW  MacroGenics Announces Termination of Duvortuxizumab Collaboration and License Agreement with Janssen,,,,12/21/2015 MNTA-US  GNW  Momenta Resumes Patient Enrollment in the Necuparanib (MOM-M402-103) Phase 2 Study,11/04/2015 PRTA-IE  GNW  Prothena to Present at the 2015 Credit Suisse Healthcare Conference on November 10,,,, 6/02/2016 37230320 GNW  Genmab Announces Phase III Studies of Ofatumumab in Relapsing Multiple Sclerosis,,," 3/21/2016 CBAY-US  GNW  CymaBay to Announce Fourth Quarter and Year-End 2015 Financial Results on Tuesday, March 29",,12/12/2014 16383L10 GNW  ChemoCentryx Announces Positive Results in Phase II Diabetic Nephropathy Trial With CCR2 Inhibitor CCX140,,, 8/08/2016 MNKD-US   GNW  MannKind Corporation Reports 2016 Second Quarter Financial Results,," 4/27/2017 CYTK-US  GNW  Cytokinetics, Inc. Reports First Quarter 2017 Financial Results", 5/12/2017 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the Bank of America Merrill Lynch 2017 Healthcare Conference, 1/17/2018 AMRS-US   GNW  Amyris Announces Over $25 Million in Grants,, 2/09/2015 00448Q20 GNW  Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102, 2/28/2018 SYNH-US  GNW  Syneos Health Reports Fourth Quarter and Full Year 2017 Results, 2/27/2017 FOLD-US  GNW  Amicus Therapeutics Launches Galafoldâ„¢ (Migalastat) for Treatment of Fabry Disease in the United Kingdom,,,12/03/2014 00089910 GNW  ADMA Biologics Announces Positive Top-Line Phase III Data for Primary Immune Deficiency Disease (PIDD) Patients, 4/21/2016 06CR5C-E GNW  GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex,,, 5/12/2016 MYOK-US  GNW  MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress,, 4/29/2017 GLPG-NL  GNW  Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI, 6/23/2017 PTLA-US  GNW  U.S. FDA Approves BevyxxaÂ® (betrixaban)Â First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients,,,, 3/03/2016 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at 23rd Annual Future Leaders in the Biotech Industry Conference, 8/08/2017 FLXN-US  GNW  Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights,12/19/2016 QURE-US  GNW  uniQure Appoints Matthew Kapusta as  Chief Executive Officer,11/03/2016 06QBQ2-E  GNW  Agios to Present New Data from PKR and IDH Programs at the 2016 ASH Annual Meeting,12/21/2015 IOVA-US  GNW  Lion Biotechnologies Enters Clinical and Preclinical Research Collaboration With MedImmune,,, 6/11/2016 FATE-US  GNW  Fate Therapeutics Announces Preclinical Data from Immuno-Regulatory CD34+ Cell Therapy for Autoimmune Diseases,,, 6/30/2016 ICPT-US  GNW  Intercept Pharmaceuticals Announces Pricing of Public Offering of Convertible Senior Notes,12/03/2018 KPTI-US    GNW  Karyopharm Reports Updated Selinexor Data from the Phase 2b STORM and Phase 1b/2 STOMP Studies in Relapsed/Refractory Multiple Myeloma at the American Society of Hematology 2018 Annual Meeting,,, 2/28/2017 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Cowen and Company 37th Annual Health Care Conference,,,,, 5/31/2016 ATRA-US    GNW  Atara Bio to Present at Three Upcoming Investor Conferences,,12/15/2015 DERM-US  GNW  Dermira Added to NASDAQ Biotechnology Index,"11/10/2014 M4613510 GNW  Foamix Pharmaceuticals Third Quarter 2014 Conference Call & Webcast Scheduled for Monday, November 17, 2014",,11/21/2014 86845910 GNW  Supernus Sues Zydus for Infringement of Trokendi XR(R) Patents,,,12/07/2016 BMO-CA   GNW  Coherus BioSciences to Present at BMO â€“ Prescriptions for Success Healthcare Conference on December 14th,,,11/30/2015 COLL-US  GNW  Collegium to Present at the 27th Annual Piper Jaffray Healthcare Conference,11/11/2015 98400H10 GNW  XBiotech Identifies Positive Donors for Anti-Clostridium difficile Therapeutic Antibody Only Two Weeks After Initial Screening,,, 6/28/2017 GBT-US   GNW  Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD),, 8/10/2016 KURA-US  GNW  Kura Oncology Reports Second Quarter 2016 Financial Results,, 8/09/2016 AXSM-US  GNW  Axsome Therapeutics Reports Second Quarter 2016 Financial Results,12/17/2015 VYGR-US  GNW  Voyager Therapeutics Reports Third Quarter 2015 Financial Results, 5/04/2018 BGNE-US  GNW  BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference,,,,,,,,,, 8/01/2017 ATNX-US  GNW  Athenex Announces Recent Product Launches in Commercial Business,,,,,,,,,, 8/01/2016 EYPT-US    GNW  pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/23/2017 PGNX-US  GNW  Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2016 Financial Results Call for March 9,,,,,,,,, 4/27/2018 OPK-US   GNW  OPKO Health to Remain on the Tel Aviv Stock Exchange,, 7/30/2014 09061G10    GNW  BioMarin Sells Priority Review Voucher for $67.5 Million,,,, 6/11/2018 IMMU-US  GNW  Immunomedics Announces Proposed Public Offering of Common Stock, 3/13/2013 SNSS-US   GNW  Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights,, 8/23/2017 BCRX-US  GNW  BioCryst to Present at Three Upcoming Investor Conferences,,,,,10/13/2015 00972810 GNW  Akorn Appoints Duane A. Portwood as Chief Financial Officer,, 1/04/2019 MYGN-US  GNW  GeneSightÂ® GUIDED Study Published in the Journal of Psychiatric Research,,,,,"10/26/2016 INO-US    GNW  Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016",,,11/05/2015 GERN-US  GNW  Geron Announces Presentations at American Society of Hematology Annual Meeting,, 4/12/2018 AMRN-US  GNW  Amarin Sponsors Three Scientific Presentations Scheduled for National Lipid Association Scientific Sessions,,, 2/27/2018 SRPT-US  GNW  Sarepta Therapeutics to Present at Two Upcoming Investor Conferences,,, 3/28/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the Needham Healthcare Conference,,,,, 4/27/2018 SAN-FR   GNW  Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER,,,,,, 2/29/2016 AFMD-DE  GNW  Affimed to Present at the Cowen and Company 36th Annual Health Care Conference,, 4/25/2016 PRQR-US  GNW  ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting,,11/14/2017 ZGNX-US  GNW  Zogenix to Present at Stifel 2017 Healthcare Conference,,,,,," 8/26/2015 00773U10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL", 6/23/2017 RARE-US   GNW  Ultragenyx Provides Regulatory Update on Burosumab (KRN23),,"10/18/2016 NSTG-US  GNW  NanoString Enhances Solid Tumor Profiling with 3D Biology Capabilities for Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples",,, 5/05/2016 RDUS-US  GNW  Radius Health Reports First Quarter 2016 Financial and Operating Results, 5/14/2012 04539610 GNW  Ventrus Biosciences Announces Positive Results From Pivotal Phase 3 Trial of Diltiazem (VEN 307) in Patients With Anal Fissures,,,,,,," 9/01/2016 MS-US    GNW  Pacira Pharmaceuticals, Inc. to Present at the  Morgan Stanley Global Healthcare Conference", 2/10/2016 RTRX-US  GNW  Statement on Imprimis Pharmaceuticalsâ€™ Announcement Regarding ThiolaÂ®,10/14/2014 69404D10 GNW  PacBio Sequencing for Human Applications to be Featured at ASHG Annual Meeting, 4/06/2016 05KDBG-E GNW  Editas Medicine to Present at 15th Annual Needham Healthcare Conference,, 8/30/2017 MGNX-US  GNW  MacroGenics to Participate in Three Investor Conferences in September,,,,"12/21/2015 60877T10 GNW  Baxalta and Momenta Announce M923, a Proposed HUMIRA (adalimumab) Biosimilar, Met Primary Endpoint in Pharmacokinetic Study",11/02/2015 PRTA-US  GNW  Prothena Reports Third Quarter 2015 Financial Results and Provides R&D Update,,,, 5/30/2016 GMAB-DK  GNW  Genmab Achieves USD 30 Million Milestone in DARZALEX(r) (daratumumab) Collaboration with Janssen,,, 3/17/2016 CBAY-US  GNW  CymaBay Therapeutics Announces Positive Results from its Pilot Phase 2 Clinical Study of MBX-8025 in Patients with Homozygous Familial Hypercholesterolemia,,"12/11/2014 16383L10 GNW  ChemoCentryx to Host Conference Call on Friday, December 12, 2014 to Discuss Top-Line Phase II Results in Patients With Diabetic Nephropathy With CCX140, an Orally Administered CCR2 Inhibitor",,," 8/01/2016 MNKD-US   GNW  MannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 2016",, 4/21/2017 CYTK-US  GNW  Cytokinetics Added to S&P SmallCap 600, 5/04/2017 ESPR-US     GNW  Esperion Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2017 Financial Results,12/29/2017 AMRS-US   GNW  DSM and Amyris Close Transactions for Brazilian Production Facility,, 2/06/2015 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences, 2/08/2018 SYNH-US  GNW  Syneos Health Names Lisa van Capelle  Chief Human Resources Officer," 2/22/2017 FOLD-US  GNW  Amicus Therapeutics to Announce Full-Year 2016 Financial Results and Corporate Updates on March 1, 2017",,,12/02/2014 00089910 GNW  ADMA Biologics to Present at the Oppenheimer 25th Annual Healthcare Conference, 4/11/2016 GWP-GB   GNW  GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex,,, 5/02/2016 06CR5C-E GNW  MyoKardia Receives Orphan Drug Designation for MYK-461 for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM),, 4/27/2017 GLPG-NL  GNW  Galapagos reports first quarter 2017 results, 6/15/2017 PTLA-US  GNW  Portola Pharmaceuticals Presents Interim Phase 2a Safety and Efficacy Data for Cerdulatinib at the International Congress of Malignant Lymphoma,,,," 3/03/2016 CARA-US  GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2015 Financial Results on March 10, 2016"," 8/01/2017 FLXN-US  GNW  Flexion Therapeutics to Report Second-Quarter 2017 Financial Results on August 8, 2017",12/03/2016 QURE-US  GNW  uniQure Announces First Clinical Data From Second Dose Cohort of AMT-060 in Ongoing Phase I/II trial in Patients with Severe Hemophilia B,11/03/2016 AGIO-US   GNW  Agios Reports Third Quarter 2016 Financial Results and Reviews Recent Progress in IDH and PKR Development Programs,12/15/2015 IOVA-US  GNW  Lion Biotechnologies Announces Selection for Addition to NASDAQ Biotechnology Index,,," 5/17/2016 FATE-US  GNW  Fate Therapeutics Appoints Chris M. Storgard, M.D. as Chief Medical Officer",,, 6/29/2016 C-US     GNW  Intercept Pharmaceuticals Announces Public Offering of Convertible Senior Notes,12/01/2018 KPTI-US    GNW  Karyopharm Reports Positive Top-Line Phase 2b SADAL Data for Selinexor in Patients with Diffuse Large B-Cell Lymphoma at the American Society of Hematology 2018 Annual Meeting,,, 2/22/2017 ITCI-US  GNW  Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast,,,,, 5/18/2016 ATRA-US    GNW  UPDATE: New Abstract Links -- Atara Bio Announces Presentations of Clinical Data from EBV-CTL and STM 434 Product Candidates at the Upcoming 2016 American Society of Clinical Oncology (ASCO) Annual Meeting,,11/19/2015 24983L10 GNW  Dermira Completes Patient Enrollment for Second CIMZIA(R) (certolizumab pegol) Phase 3 Clinical Trial in Psoriasis Program,10/29/2014 M4613510 GNW  Foamix Pharmaceuticals to Host Key Opinion Leader Meeting and Webcast on November 4th in New York City,,11/11/2014 86845910 GNW  Supernus Announces Third Quarter 2014 Results,,,11/29/2016 080RQG-E GNW  Coherusâ€™ Marketing Authorization Application to European Medicines Agency for CHS-1701 (Pegfilgrastim Biosimilar Candidate) Accepted,,,11/12/2015 19459J10 GNW  Collegium Reports Third Quarter Financial Results and Provides Corporate Update,11/09/2015 98400H10 GNW  XBiotech Announces Positive Results for Its Anti-Ebola Therapeutic Candidates Following Evaluation by USAMRIID,,, 6/23/2017 GBT-US   GNW  Global Blood Therapeutics Announces New Data Supporting  Ongoing Clinical Development of GBT440 in Adolescents with Sickle Cell Disease,, 8/03/2016 KURA-US  GNW  Kura Oncology to Report Second Quarter 2016 Financial Results,, 7/05/2016 AXSM-US  GNW  Axsome Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference,"11/16/2015 92915B10 GNW  Voyager Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares"," 5/01/2018 BGNE-US  GNW  BeiGene Appoints Senior Pharmaceutical ExecutiveÂ Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.",,,,,,,,,," 7/31/2017 ATNX-US  GNW  Athenex, Inc. to Report Second Quarter 2017 Earnings Results on August 14, 2017",,,,,,,,,, 7/27/2016 EYPT-US    GNW  pSivida's Medidurâ„¢ Maintains Same High Statistical Significance in Primary Endpoint through 12 Months in First Phase 3 Trial (p Less Than 0.00000001),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/14/2017 PGNX-US  GNW  Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer,,,,,,,,, 3/23/2018 OPK-US   GNW  OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes,, 7/30/2014 09061G10    GNW  BioMarin Announces Second Quarter 2014 Financial Results,,,, 6/04/2018 IMMU-US  GNW  Immunomedics Provides Business Update at the ASCO 2018 Investor Event, 2/11/2013 BNO-AU    GNW  Bionomics Provides BNC101 Update at US Cancer Stem Cell Conference,, 8/07/2017 BCRX-US  GNW  BioCryst Reports Second Quarter 2017 Financial Results,,,,, 9/28/2015 00972810 GNW  Akorn Launches Myorisan(TM) 30 mg Capsules,,12/31/2018 MYGN-US  GNW  Peter D. Meldrum (1947-2018),,,,,10/24/2016 INO-US    GNW  Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed,,,10/29/2015 GERN-US  GNW  Geron Announces Conference Call to Discuss Third Quarter 2015 Financial Results,, 4/12/2018 AMRN-US  GNW  VascepaÂ® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin-Treated Patients with Reduced Kidney Function and Persistent High Triglycerides,,," 2/08/2018 SRPT-US  GNW  Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Developments on March 1, 2018",,, 3/06/2017 AMAG-US  GNW  AMAG Announces Management Changes and New Commercial Appointments,,,,, 4/24/2018 SAN-FR   GNW  Sanofi Head of Global R&D Elias Zerhouni to retire;  Company names John Reed to take over on July 1,,,,,, 2/29/2016 AFMD-DE  GNW  Affimed to Present at the Cowen and Company 36th Annual Health Care Conference,, 4/07/2016 PRQR-US  GNW  ProQR Announces Annual Meeting of Shareholders,,11/07/2017 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Third Quarter 2017 Financial Results,,,,,," 8/13/2015 00773U10 GNW  Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program", 6/07/2017 RARE-US   GNW  Ultragenyx to Present at Goldman Sachs 38th Annual Global Healthcare Conference,,"10/05/2016 NSTG-US  GNW  NanoString Technologies to Release Third Quarter 2016 Financial Results and Host Conference Call on Wednesday, November 2, 2016",,, 5/02/2016 RDUS-US  GNW  Radius Health to Present at the Bank of America Merrill Lynch 2016 Health Care Conference, 5/09/2012 04539610 GNW  Ventrus Biosciences Reports First Quarter 2012 Financial Results,,,,,,," 8/09/2016 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at the  2016 Wedbush PacGrow Healthcare Conference", 1/27/2016 RTRX-US  GNW  Retrophin to Present at the Leerink Partners 5th Annual Global Healthcare Conference,10/06/2014 69404D10 GNW  Human Longevity Inc. Adds PacBio(R) Sequencing to Enable Additional Insight Into Human Genetic Variation, 3/30/2016 EDIT-US  GNW  Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results,, 8/09/2017 MGNX-US  GNW  MacroGenics to Present at the Wedbush PacGrow Healthcare Conference,,,,12/07/2015 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Matthew P. Ottmer as Chief Operating Officer,"10/15/2015 PRTA-US  GNW  Prothena to Initiate PRONTO, a Global Trial of NEOD001 in Patients With  AL Amyloidosis With Primary Endpoint of Cardiac Response",,,, 5/23/2016 071VWR-E GNW  Genmab Announces European Conditional Marketing Authorization for DARZALEX(r) (daratumumab) for Multiple Myeloma,,, 3/03/2016 CBAY-US  GNW  CymaBay Therapeutics to Present at Two Upcoming Investor Conferences in March,,"12/04/2014 16383L10 GNW  ChemoCentryx Granted EU Orphan Drug Designation for CCX168, an Orally Administered Complement C5a Receptor Inhibitor, for the Treatment of Microscopic Polyangiitis and Granulomatosis With Polyangiitis, Two Forms of ANCA-Associated Vasculitis",,, 8/01/2016 MNKD-US   GNW  Mannkind Assumes Responsibility for Distribution of AfrezzaÂ® and Launches Patient Reimbursement and Adherence Support Programs,," 4/13/2017 CYTK-US  GNW  Cytokinetics to Announce First Quarter Results on April 27, 2017", 3/28/2017 ESPR-US     GNW  Esperion to Participate in Fireside Chat at the 16th Annual Needham Healthcare Conference,"11/21/2017 03236M20  GNW  Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017",,"12/22/2014 00448Q20 GNW  Achillion Shows Potential for ""Best-in-Disease"" HCV Regimen - 100% SVR4 Following a Dual 6-Week ACH-3102-Based Regimen and Separately a 4.8 Log10 Reduction With ACH-3422"," 2/06/2018 SYNH-US  GNW  When It Comes to Artificial Intelligence in Healthcare, Patients Fear the Replacement of Doctors, Yet Are Open to AI Nurse Support", 2/15/2017 FOLD-US  GNW  Amicus Therapeutics Presents Additional Positive Preliminary Phase 1/2 Data at WORLDSymposiumâ„¢ 2017,,,"11/25/2014 00089910 GNW  ADMA Biologics, Inc. (Nasdaq:ADMA) to Ring The Nasdaq Stock Market Opening Bell"," 3/18/2016 36197T10 GNW  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of GW Pharmaceuticals plc of Class Action and a Lead Plaintiff Deadline of March 21, 2016 â€“ GWPH",,, 4/13/2016 061RN4-E GNW  MyoKardia Names Mary Cranston to Board of Directors,, 4/25/2017 GLPG-NL  GNW  Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus, 5/18/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Phase 2a Safety and Efficacy Cerdulatinib Data to be Presented at the European Hematology Association (EHA),,,, 2/25/2016 CARA-US  GNW  Cara Therapeutics Provides Update on CLIN3001 Postoperative Pain Trial for I.V. CR845, 7/10/2017 FLXN-US  GNW  Flexion Therapeutics to Hold Investor & Analyst Day Today,12/02/2016 QURE-US  GNW  uniQure to Present at the Genetic Rx Boston Biotech Conference at Harvard Medical School,"11/01/2016 AGIO-US   GNW  Agios to Present at the 25th Annual Credit Suisse Healthcare Conference Tuesday, November 8, 2016",11/16/2015 IOVA-US  GNW  Lion Biotechnologies to Participate in Upcoming Investor Conferences,,, 5/16/2016 FATE-US  GNW  Fate Therapeutics Announces Preclinical Data Highlighting Persistent Effector Function of Allogeneic Natural Killer Cell Cancer Immunotherapy,,, 6/09/2016 ICPT-US  GNW  Intercept Pharmaceuticals Appoints Sandip Kapadia as Chief Financial Officer,"11/13/2018 48576U10   GNW  Report: Developing Opportunities within Evelo Biosciences, ADMA Biologics, Karyopharm Therapeutics, Pingtan Marine Enterprise, Rosetta Stone, and Williams Companies â€” Future Expectations, Projections Moving into 2018",,, 1/04/2017 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,,, 5/18/2016 ATRA-US    GNW  Atara Bio Announces Presentations of Clinical Data from EBV-CTL and STM 434 Product Candidates at the Upcoming 2016 American Society of Clinical Oncology (ASCO) Annual Meeting,,11/10/2015 24983L10 GNW  Dermira Reports Third Quarter 2015 Financial Results and Provides Corporate Update,10/06/2014 M4613510 GNW  Foamix Pharmaceuticals Ltd. Announces Initiation of Phase II Trial With FDX104 in Chemotherapy Induced Rash,,11/07/2014 86845910 GNW  Supernus Announces Issuance of Fourth U.S. Patent Protecting Trokendi XR(R),,,11/17/2016 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,,,11/09/2015 COLL-US  GNW  Collegium to Host Conference Call to Discuss Q3 Financial Results and Provide Corporate Update,11/05/2015 98400H10 GNW  XBiotech to Provide Third Quarter Business Update,,, 6/06/2017 GBT-US   GNW  Global Blood Therapeutics Announces Participation at the Goldman Sachs 38th Annual Global Healthcare Conference,, 6/16/2016 KURA-US  GNW  Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Lower Risk Myelodysplastic Syndromes,, 6/27/2016 AXSM-US  GNW  Axsome Therapeutics Added to Russell 3000Â® and Russell 2000Â® Indexes,11/10/2015 92915B10 GNW  Voyager Therapeutics Announces Pricing of Initial Public Offering, 4/16/2018 BGNE-US  GNW  BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer at the American Association for Cancer Research Annual Meeting,,,,,,,,,," 7/27/2017 ATNX-US  GNW  Athenex, Inc. Announces Approval of Tax Incentives from State of New York for the Dunkirk Facility",,,,,,,,,," 7/20/2016 06TB7P-E   GNW  Data Shows pSividaâ€™s Tethadurâ„¢ Provides Prolonged, Sustained Release of AvastinÂ® With High Drug Efficacy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 2/08/2017 008SHY-E GNW  Progenics Pharmaceuticals, Inc. to Participate in  February Investor Conferences",,,,,,,,, 3/16/2018 OPK-US   GNW  OPKO Health Announces Landmark Study Showing 4KscoreÂ® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology,, 7/23/2014 BMRN-US     GNW  Sarah Cannon Research UK and BioMarin Collaborate on EMBRACA Clinical Study in Hereditary Breast Cancer With BRCA Mutation,,,, 6/03/2018 45290710 GNW  Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers, 9/17/2012 LONN-CH   GNW  Bionomics Acquires US-Based Cancer Stem Cell Company Eclipse Therapeutics,," 8/02/2017 BCRX-US  GNW  BioCryst Announces Initiation of ZENITH-1, a Clinical Trial to Evaluate BCX7353 as an Acute Treatment of Hereditary Angioedema Attacks",,,,, 9/21/2015 00972810 GNW  Akorn Launches Doxercalciferol Injection,,12/27/2018 MYGN-US  GNW  Myriad Genetics to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,,,10/21/2016 INO-US    GNW  Inovio CEO Selected As 2016 Healthcare Innovator,,,10/13/2015 GERN-US  GNW  Geron to Present at the BIO Investor Forum,," 4/04/2018 AMRN-US  GNW  Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and VascepaÂ® Promotion Initiatives",,, 2/05/2018 SRPT-US  GNW  Sarepta Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference,,, 3/01/2017 BARC-GB  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,," 4/17/2018 SAN-FR   GNW  Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi's European generics business",,,,,, 2/22/2016 N0104510 GNW  Affimed to Speak at Symposium on Emerging Approaches in Cancer Immunotherapy,, 3/01/2016 BCS-GB   GNW  ProQR to Highlight a Growing Pipeline During a Research & Development Day and Present at the Barclays Global Healthcare Conference,,10/31/2017 ZGNX-US  GNW  Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7,,,,,," 8/12/2015 00773U10 GNW  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Avalanche Biotechnologies, Inc. and a Lead Plaintiff Deadline of September 8, 2015 - AAVL", 6/01/2017 RARE-US   GNW  Ultragenyx to Present at Jefferies Global Healthcare Conference,," 9/13/2016 63009R10 GNW  NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors",,, 4/21/2016 DB-DE    GNW  Radius Health to Present at the Deutsche Bank 41st Annual Health Care Conference, 5/01/2012 04539610 GNW  Ventrus to Present at the 37th Annual Deutsche Bank Health Care Conference,,,,,,," 8/04/2016 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results", 1/11/2016 RTRX-US  GNW  Retrophin Announces Preliminary Full-Year 2015 Revenue of Approximately $99.9 Million," 9/30/2014 69404D10 GNW  Pacific Biosciences of California, Inc. Third Quarter 2014 Financial Results Call", 3/01/2016 0CD35M-E GNW  Editas Medicine to Present at Cowen and Company 36th Annual Health Care Conference,, 8/02/2017 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Second Quarter 2017 Financial Results,,,,11/13/2015 MNTA-US  GNW  Momenta Announces Temporary Pause of Patient Enrollment in the Necuparanib (MOM-M402-103) Phase 2 Study, 9/22/2015 PRTA-IE  GNW  Prothena to Present at Ladenburg Thalmann 2015 Healthcare Conference on September 29,,,, 5/18/2016 37230320 GNW  Genmab Announces Positive Topline Result in Phase III POLLUX Study of Daratumumab in Relapsed or Refractory Multiple Myeloma,,, 2/02/2016 CBAY-US  GNW  CymaBay Therapeutics to Present at the BIO CEO & Investor Conference,,"11/20/2014 16383L10 GNW  ChemoCentryx's CCX168, an Orally Administered Complement C5a Receptor Inhibitor, Granted Orphan-Drug Designation in Atypical Hemolytic Uremic Syndrome Treatment by the FDA",,, 7/08/2016 MNKD-US   GNW  MannKind Corporation to Present at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference,, 3/29/2017 CYTK-US  GNW  Cytokinetics to Present at the 16th Annual Needham Healthcare Conference, 3/20/2017 ESPR-US     GNW  Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval for an LDL-C Lowering Indication for Bempedoic Acid,11/17/2017 0FYVPM-E  GNW  DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris,,11/25/2014 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences," 2/01/2018 SYNH-US  GNW  Syneos Health Schedules Fourth Quarter and Year End 2017 Earnings Call for Wednesday, February 28, 2018", 2/15/2017 FOLD-US  GNW  Amicus Therapeutics Presents Important New Scientific Findings and Preclinical Data for Pompe Program at WORLDSymposiumâ„¢ 2017,,,"11/18/2014 008FZT-E GNW  ADMA Biologics Opens Plasma Collection Center in Marietta, Georgia", 3/14/2016 06CR5C-E GNW  GW Pharmaceuticals Announces Positive Phase 3 Pivotal Study Results for EpidiolexÂ® (cannabidiol),,, 3/18/2016 MYOK-US  GNW  MyoKardia Reports Fourth Quarter and 2015 Financial Results and Key Milestones,, 4/21/2017 GLPG-NL  GNW  Galapagos announces capital increase, 5/09/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Cerdulatinib Data to be Presented at the International Conference on Malignant Lymphoma (ICML),,,, 2/18/2016 CARA-US  GNW  Cara Therapeutics to Sponsor Symposium and Present Poster at the American Academy of Pain Medicineâ€™s 32nd Annual Meeting," 7/03/2017 FLXN-US  GNW  Flexion Therapeutics to Hold Investor and Analyst Day on July 10, 2017",11/22/2016 QURE-US  GNW  uniQure Announces Financial Results For  Third Quarter 2016 and Provides Update on Company Progress,"10/27/2016 AGIO-US   GNW  Agios to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016",11/09/2015 IOVA-US  GNW  Lion Biotechnologies Announces Agreement With WuXi AppTec to Increase TIL Manufacturing Capacity,,, 5/09/2016 FATE-US  GNW  Fate Therapeutics Reports First Quarter 2016 Financial Results,,, 6/01/2016 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences,11/08/2018 KPTI-US    GNW  Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress,,,12/01/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 55th Annual Meeting of the American College of Neuropsychopharmacology,,,,, 5/09/2016 ATRA-US    GNW  Atara Bioâ€™s Collaborating Investigators to Present Clinical Data on EBV-CTL at 2016 American Transplant Congress,,10/12/2015 DERM-US  GNW  Dermira Completes Patient Enrollment for First CIMZIA(R) (Certolizumab Pegol) Phase 3 Clinical Trial in Psoriasis Program, 9/23/2014 008XK0-E GNW  Foamix Pharmaceuticals Ltd. Announces Closing of Initial Public Offering,,11/04/2014 86845910 GNW  Supernus to Present at Two Investor Conferences,,,11/09/2016 CHRS-US  GNW  Coherus BioSciences Reports Third Quarter 2016 Operating and Financial Results,,,"11/09/2015 COLL-US  GNW  Collegium Announces FDA Tentative Approval for Xtampza(TM) ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain",10/26/2015 98400H10 GNW  XBiotech Initiates Program to Develop Antibody Against Clostridium Difficile,,, 5/18/2017 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Presentation of GBT440 Data in Adolescents with Sickle Cell Disease at European Hematology Associationâ€™s 22nd Congress,, 6/14/2016 KURA-US  GNW  Kura Oncology to Participate in the 2016 JMP Life Sciences Conference,, 6/13/2016 002N2S-E GNW  Axsome Therapeutics to Present at the 2016 JMP Securities Life Sciences Conference, 6/02/2014 00BXRX-E GNW  REGENX Biosciences and Voyager Therapeutics Announce License Agreement, 4/16/2018 BGNE-US  GNW  BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab  in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas,,,,,,,,,," 7/19/2017 ATNX-US  GNW  Athenex, Inc. Announces Commencement of Patient Enrollment for Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer",,,,,,,,,, 7/15/2016 EYPT-US    GNW  pSivida Corp. Announces Plan to Consolidate all Research and Development in Current U.S. Facility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/22/2016 PGNX-US  GNW  Progenics Pharmaceuticals Announces Independent Committeeâ€™s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404,,,,,,,,, 3/01/2018 OPK-US   GNW  OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results,," 7/09/2014 09061G10    GNW  BioMarin to Host Second Quarter 2014 Financial Results Conference Call and Webcast on Wednesday, July 30 at 4:30pm ET",,,, 6/03/2018 IMMU-US  GNW  Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer, 6/27/2012 09062X10  GNW  Sunesis Pharmaceuticals Receives $1.5 Million Milestone Payment From Biogen Idec Related to Kinase Inhibitor Program,, 7/24/2017 BCRX-US  GNW  BioCryst to Announce Second Quarter 2017 Financial Results on August 7,,,,, 9/17/2015 AKRX-US  GNW  Akorn Launches Two Additional Promethazine Syrup Formulations,,12/26/2018 MYGN-US  GNW  Myriad Announces Publication of VectraÂ® Study in Journal Rheumatology,,,,,10/12/2016 INO-US    GNW  Inovio Expands Executive Team  to Advance its DNA Immunotherapy Product Portfolio,,, 9/16/2015 GERN-US  GNW  Geron Announces Initiation of Janssen Phase 2 Clinical Trial of Imetelstat in Myelofibrosis,, 4/04/2018 AMRN-US  GNW  Amarinâ€™s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events,,, 1/31/2018 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 2/27/2017 00163U10 GNW  AMAG and Palatin Announce Rekyndaâ„¢ Data Presentations at the International Society for the Study of Womenâ€™s Sexual Health Annual Meeting,,,,, 4/12/2018 SAN-FR   GNW  Sanofi to invest â‚¬350 million in Canadian vaccine facility,,,,,, 2/04/2016 AFMD-DE  GNW  Affimed to Present at the Leerink Partners 5th Annual Global Healthcare Conference,, 2/17/2016 PRQR-US  GNW  ProQR Announces Results for the Fourth Quarter and Full Year 2015,,10/16/2017 ZGNX-US  GNW  Interim Survey Results Demonstrate Impact on Siblings of Children Suffering from Severe Epilepsy,,,,,, 8/05/2015 00773U10 GNW  Avalanche Biotechnologies Awarded as Technology Pioneer by World Economic Forum, 5/23/2017 RARE-US   GNW  Ultragenyx Announces Recombinant Human Beta-Glucuronidase Biologics License Application and Marketing Authorization Application Filed and Accepted for Review; FDA Grants Priority Review Status,, 8/25/2016 NSTG-US  GNW  NanoString Technologies to Present at Two Upcoming Healthcare Conferences,,," 4/15/2016 RDUS-US  GNW  Radius Announces Three Oral Presentations for Abaloparatide-SC at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Disease", 4/30/2012 04539610 GNW  Ventrus Biosciences Completes Enrollment of Pivotal Phase 3 Trial of Iferanserin (VEN 309) in Patients With Hemorrhoidal Disease,,,,,,, 8/01/2016 PCRX-US  GNW  New Research: Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known,12/17/2015 RTRX-US  GNW  Retrophin Statement on Indictment of Martin Shkreli," 9/23/2014 PACB-US  GNW  Macrogen Selects Single Molecule, Real-Time Sequencing for High-Quality de Novo Asian Human Reference Genomes", 2/08/2016 EDIT-US  GNW  Editas Medicine Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares,, 7/26/2017 MGNX-US  GNW  MacroGenics Announces Date of Second Quarter 2017 Financial Results Conference Call,,,,11/10/2015 MNTA-US  GNW  Momenta Pharmaceuticals Announces U.S. Court of Appeals Decision to Remand Enoxaparin Case Back to District Court," 8/05/2015 LGNZZ-US GNW  Poseida Therapeutics, Inc., Expands Board of Directors",,,, 5/17/2016 37230320 GNW  Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL accepted for priority review by FDA,,, 1/20/2016 CBAY-US  GNW  CymaBay Therapeutics Announces Successful Completion of End-of-Phase 2 Discussions With FDA for Arhalofenate,,"11/17/2014 16383L10 GNW  ChemoCentryx's Orally Administered C5aR Inhibitor CCX168 Shows Benefit in Non-Renal ANCA Vasculitis Disease Activity, in Addition to Previously Shown Kidney Disease Improvements",,, 6/12/2016 064095-E  GNW  MannKind Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins,, 3/29/2017 23282W60 GNW  Cytokinetics Announces Start of Second Cohort in Phase 2  Clinical Trial of CK-2127107 in Patients With  Spinal Muscular Atrophy, 3/07/2017 ESPR-US     GNW  Esperion Announces Initiation of Phase 2 Triplet Oral Therapy Study of Bempedoic Acid/Ezetimibe/Atorvastatin,11/14/2017 AMRS-US   GNW  Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017,,11/08/2014 00448Q20 GNW  Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD), 1/22/2018 SYNH-US  GNW  PALIO and GSW to Operate as Singular Advertising Powerhouse Under GSW Brand, 2/14/2017 FOLD-US  GNW  Amicus Therapeutics Highlights New Fabry Program Data at WORLDSymposiumâ„¢ 2017,,,11/10/2014 00089910 GNW  ADMA Biologics to Present at the 9th International Respiratory Syncytial Virus (RSV) Symposium," 2/12/2016 36197T10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of GW Pharmaceuticals plc of Class Action Lawsuit and a Lead Plaintiff Deadline of March 21, 2016 â€“ GWPH",,," 3/07/2016 MYOK-US  GNW  MyoKardia Names Sunil Agarwal, M.D., to Board of Directors, New VPs Strengthen Research and Development",, 4/21/2017 GLPG-NL  GNW  Galapagos announces closing of public offering of  American Depositary Shares for gross proceeds of â‚¬363.9 million, 5/08/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports First QuarterÂ 2017 Financial Results and Provides Corporate Update,,,,12/09/2015 14075510 GNW  Cara Therapeutics Announces Positive Top-Line Results From Phase 2a Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis of the Knee or Hip, 6/28/2017 FLXN-US  GNW  Flexion Therapeutics Announces Appointment of Mark Levine as General Counsel,11/22/2016 QURE-US  GNW  uniQure Announces Financial Results ForÂ Third Quarter 2016 and Provides Update on Company Progress, 9/20/2016 AGIO-US   GNW  Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,11/05/2015 46226010 GNW  Lion Biotechnologies Announces Third Quarter 2015 Financial Results,,," 5/02/2016 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2016 Financial Results on May 9, 2016",,, 5/27/2016 ICPT-US  GNW  FDA Grants Accelerated Approval to Ocalivaâ„¢ (Obeticholic Acid) for the Treatment of Patients with PBC,11/07/2018 KPTI-US    GNW  Karyopharmâ€™s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma,,,11/23/2016 ITCI-US  GNW  Intra-Cellular Therapies to Participate at Upcoming Investor Conferences,,,,, 5/05/2016 ATRA-US    GNW  Atara Bio Announces First Quarter 2016 Financial Results and Recent Highlights,,10/07/2015 24983L10 GNW  Dermira Presents Data From DRM01 Phase 2a Trial at European Academy of Dermatology and Venereology, 9/18/2014 008XK0-E GNW  Foamix Pharmaceuticals Ltd. Prices Initial Public Offering,,10/29/2014 86845910 GNW  Supernus to Host Third Quarter 2014 Earnings Conference Call,,,11/07/2016 CHRS-US  GNW  Coherus BioSciences Receives Decision Denying Institution of the â€˜166 IPR Related to AbbVieâ€™s HUMIRAÂ® Formulation,,,"10/12/2015 COLL-US  GNW  Collegium Provides Update on FDA Review of Xtampza(TM) ER, an Abuse-Deterrent Analgesic for the Treatment of Chronic Pain",10/21/2015 98400H10 GNW  XBiotech Presents Findings at Investigator Conference for Staphylococcus Aureus Program,,, 5/01/2017 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2017 Financial Results,, 6/03/2016 KURA-US  GNW  Kura Oncology to Participate in the Jefferies 2016 Healthcare Conference,, 5/11/2016 AXSM-US  GNW  Axsome Therapeutics Reports First Quarter 2016 Financial Results,, 4/10/2018 BGNE-US  GNW  BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Previously Treated Hepatocellular Carcinoma,,,,,,,,,, 7/12/2017 ATNX-US  GNW  Athenex Pharmaceutical Division Receives FDA Clearance to Import Sodium Bicarbonate 8.4% Injection to Address U.S. Drug Shortage,,,,,,,,,, 7/14/2016 EYPT-US    GNW  Investigator-Sponsored Phase 2 Study Results Show pSividaâ€™s MedidurÂ® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/07/2016 0DFZ3G-E GNW  Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyLâ„¢,,,,,,,,," 2/26/2018 OPK-US   GNW  OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018",, 6/10/2014 09061G10    GNW  BioMarin to Present at the Wells Fargo Healthcare Conference on June 17th,,,, 6/01/2018 IMMU-US  GNW  Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer," 2/09/2012 CMCSA-US  GNW  Cisco Systems, Comcast, FedEx Added to Dow Jones U.S. Contrarian Opportunities Index",, 6/13/2017 BCRX-US  GNW  BioCryst to Present at the JMP Securities 2017 Life Sciences Conference,,,,, 8/14/2015 00972810 GNW  Akorn Receives NASDAQ Delinquency Notice,,"12/19/2018 AZN-GB   GNW  BRACAnalysis CDxÂ® Approved by U.S. Food and Drug Administration as Companion Diagnostic for AstraZenecaâ€™s LynparzaÂ® (olaparib) in Patients with Advanced-Stage, BRCA-Mutated Ovarian Cancer",,,,, 9/12/2016 INO-US    GNW  Inovioâ€™s Zika Vaccine Selected As 2016 Technology Breakthrough,,, 9/02/2015 GERN-US  GNW  Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies,, 3/29/2018 AMRN-US  GNW  Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings,,," 1/08/2018 SRPT-US  GNW  Sarepta Therapeutics Pre-Announces Fourth Quarter 2017 Revenue and Provides Full-Year 2018 Revenue Guidance for EXONDYS 51Â® (eteplirsen), Representing Approximately 100 Percent Year-over-Year Growth",,, 2/14/2017 AMAG-US  GNW  AMAG Reports Fourth Quarter and Full Year 2016 Financial Results,,,,, 3/29/2018 SAN-FR   GNW  Sanofi: EMA to review sotagliflozin as potential  treatment for type 1 diabetes,,,,,, 1/25/2016 AFMD-DE  GNW  Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA(R) (pembrolizumab) for Patients with Hodgkin Lymphoma,, 2/03/2016 PRQR-NL  GNW  ProQR to Present at the Leerink Partners Global Healthcare Conference,,"10/05/2017 ZGNX-US  GNW  Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwritersâ€™ Option to Purchase Additional Shares",,,,,, 7/23/2015 00773U10 GNW  Avalanche Biotechnologies Announces Leadership Transition, 5/10/2017 RARE-US   GNW  Ultragenyx to Present at Bank of America Merrill Lynch Healthcare Conference,, 8/03/2016 NSTG-US  GNW  NanoString Technologies Releases Operating Results for Second Quarter of 2016,,," 4/12/2016 RDUS-US  GNW  Radius Health to Announce First Quarter 2016 Financial Results, Host Conference Call and Live Webcast on May 5, 2016", 3/08/2012 04539610 GNW  Ventrus Announces Two Studies Addressing Hemorrhoid Disease to be Presented at Digestive Disease Week Conference,,,,,,, 7/15/2016 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for Second Quarter 2016 Financial Results  Webcast and Conference Call,11/16/2015 RTRX-US  GNW  Retrophin Receives European Orphan Drug Designation for Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis," 9/17/2014 69404D10 GNW  Single Molecule, Real-Time (SMRT) DNA Sequencing Tracks Infectious Disease Pathogens More Effectively Than Short-Read Technologies", 2/02/2016 EDIT-US  GNW  Editas Medicine Announces Pricing of Initial Public Offering,," 7/17/2017 MGNX-US  GNW  Phase 1 Data for Flotetuzumab, MacroGenicsâ€™ CD123 x CD3 DARTÂ® Molecule, Accepted for Oral Presentation at ESMO Congress 2017",,,,11/06/2015 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 8/04/2015 G7280010 GNW  Prothena Reports Second Quarter 2015 Financial Results and Provides R&D Update,,,, 5/10/2016 37230320 GNW  Genmab Announces Financial Results for the First Quarter of 2016,,, 1/06/2016 CBAY-US  GNW  CymaBay Therapeutics to Present at the Biotech Showcase 2016,,11/06/2014 16383L10 GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 6/10/2016 MNKD-US   GNW  MannKind Announces Collaboration with JDRF,, 3/23/2017 CYTK-US  GNW  Origent Data Sciences and Cytokinetics Advance Collaboration Intended to Validate Predictive Analytics Model in ALS, 3/06/2017 ESPR-US     GNW  Esperion Announces Oral Presentation on Genetic Validation of ATP Citrate Lyase Inhibition at the American College of Cardiology 66th Annual Scientific Session,"11/07/2017 AMRS-US   GNW  Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017",,11/06/2014 00448Q20 GNW  Achillion Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform at the 56th Annual Meeting of the American Society of Hematology," 1/15/2018 SYNH-US  GNW  The Klein Law Firm Notifies Shareholders of a Class Action Filed on Behalf of Syneos Health, Inc. (formerly INC Research Holdings, Inc.) Shareholders and a Lead Plaintiff Deadline of January 30, 2018 (INCR, SYNH)", 2/06/2017 FOLD-US  GNW  Amicus Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare Conference,,,11/10/2014 00089910 GNW  ADMA Biologics Reports Third Quarter 2014 Financial and Operational Results, 2/10/2016 GWP-GB   GNW  GW Pharmaceuticals plc Reports First Quarter 2016 Financial Results and Operational Progress,,, 3/01/2016 MYOK-US  GNW  MyoKardia to Present at Cowen and Company 36th Annual Health Care Conference,, 4/17/2017 GLPG-NL  GNW  Galapagos raises $338 million gross proceeds in a U.S. public offering," 5/01/2017 PTLA-US  GNW  Portola Pharmaceuticals to Announce First Quarter 2017 Financial Results and Host Conference Call on Monday, May 8",,,,12/01/2015 CARA-US  GNW  Cara Therapeutics to Present Poster at the ASHP 2015 Midyear Clinical Meeting, 6/23/2017 FLXN-US  GNW  Flexion Therapeutics Named One of Boston Business Journalâ€™s Best Places to Work,"11/15/2016 QURE-NL  GNW  uniQure Completes Strategic Review to Refocus its Pipeline, Reduce Operating Costs and Deliver Long-Term Shareholder Value", 9/14/2016 AGIO-US   GNW  Agios Announces Pricing of $150 Million Public Offering of Common Stock,11/02/2015 46226010 GNW  Lion Biotechnologies Announces the Departure of Dr. Laszlo Radvanyi,,, 4/05/2016 05KDBG-E GNW  Fate Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference,,, 5/18/2016 ICPT-US  GNW  Intercept Announces Ocalivaâ„¢ (Obeticholic Acid) Data in PBC to be Presented at DDW 2016,11/07/2018 KPTI-US    GNW  Karyopharm to Present at the Jefferies 2018 London Healthcare Conference,,,11/09/2016 ITCI-US  GNW  Intra-Cellular Therapies Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,,,," 4/19/2016 07CBJY-E   GNW  Atara Bioâ€™s Collaborator QIMR Berghofer Medical Research Institute Reports Positive Clinical Data for T Cell Immunotherapy in Nasopharyngeal Cancer (NPC), a Solid Tumor",, 9/30/2015 24983L10 GNW  Dermira Elects Kathleen Sebelius to Board of Directors, 6/18/2014 008XK0-E GNW  Foamix Pharmaceuticals to Present at the 2014 BIO International Convention on June 26th in San Diego,,10/14/2014 86845910 GNW  Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R),,,11/04/2016 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,,," 9/11/2015 COLL-US  GNW  Collegium Announces FDA Advisory Committees Unanimously Recommend Approval of Xtampza ER(TM), an Abuse-Deterrent Analgesic for Chronic Pain",10/19/2015 98400H10 GNW  XBiotech Strengthens Intellectual Property Portfolio for Its True Human(TM) Antibody Technology,,, 3/29/2017 GBT-US   GNW  Global Blood Therapeutics to Present at the 16th Annual Needham Healthcare Conference,, 5/11/2016 KURA-US  GNW  Kura Oncology Reports First Quarter 2016 Financial Results,, 5/03/2016 06CR5C-E GNW  Axsome Therapeutics Receives FDA Fast Track Designation for AXS-02 for the Treatment of the Pain of Knee Osteoarthritis Associated with Bone Marrow Lesions,, 4/03/2018 BGNE-US  GNW  BeiGene Appoints J. Samuel Su to its Board of Directors,,,,,,,,,," 7/05/2017 ATNX-US  GNW  Athenex, Inc. Announces Submission of Investigational New Drug Application of Oraxol to Chinese FDA",,,,,,,,,, 7/08/2016 06TB7P-E   GNW  pSivida Announces Poster and Oral Presentation on Controlled Release of AvastinÂ® from Tethadurâ„¢ Biodegradable Matrix at the 2016 Controlled Release Society Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/08/2016 PGNX-US  GNW  Progenics Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,,,,, 1/26/2018 OPK-US   GNW  OPKO Health Announces Leadership Changes at BioReference Laboratories,, 5/27/2014 09061G10    GNW  BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease,,,, 5/30/2018 IMMU-US  GNW  Immunomedics to Present at Jefferies 2018 Global Healthcare Conference,"12/06/2011 CELG-US   GNW  Aegerion Pharmaceuticals Adds to Management Team Anne Marie Cook as SVP, General Counsel, and Mary Weger as SVP, Human Resources",, 6/05/2017 BCRX-US  GNW  BioCryst Announces RAPIVABÂ® Pediatric sNDA Acceptance,,,,, 8/04/2015 00972810 GNW  Akorn Appoints Randy Pollard as Interim Chief Financial Officer,,12/19/2018 MYGN-US  GNW  EndoPredictÂ® Test Receives Positive NICE Recommendation for Patients with Early Breast Cancer,,,,, 9/01/2016 C-US      GNW  Inovio Pharmaceuticals to Present at Upcoming Investment Conferences,,, 8/05/2015 GERN-US  GNW  Geron Corporation Reports Second Quarter 2015 Financial Results,, 3/28/2018 AMRN-US  GNW  Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference,,, 1/02/2018 SRPT-US  GNW  Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,, 2/14/2017 06CR5C-E GNW  AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosaâ„¢ (Prasterone),,,,," 3/29/2018 SAN-FR   GNW  Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018",,,,,, 1/21/2016 N0104510 GNW  Affimed Appoints Dr. Joerg Windisch as Chief Operating Officer and Adds Dr. Bernhard Ehmer to Supervisory Board,,11/30/2015 PRQR-US  GNW  ProQR Announces R&D Day and Provides Update on Innovation Portfolio,,10/02/2017 ZGNX-US  GNW  Zogenix Prices Public Offering of Common Stock,,,,,," 7/22/2015 00773U10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015-- AAVL", 5/04/2017 RARE-US   GNW  Ultragenyx Reports First Quarter 2017 Financial Results and Corporate Update,," 7/07/2016 NSTG-US  GNW  NanoString Technologies to Release Second Quarter 2016 Financial Results and Host Conference Call on Wednesday, August 3, 2016",,, 4/01/2016 RDUS-US  GNW  Radius Health Announces New Employment Inducement Grants, 3/05/2012 04539610 GNW  Ventrus to Present at the 24th Annual ROTH OC Growth Stock Conference,,,,,,," 5/31/2016 05F9ZW-E GNW  Pacira Pharmaceuticals, Inc. to Present at the Jefferies 2016 Healthcare Conference",11/05/2015 RTRX-US  GNW  Retrophin Announces Research Collaboration With the Grace Wilsey Foundation and the Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame, 7/24/2014 69404D10 GNW  Pacific Biosciences Reports Second Quarter 2014 Financial Results,,, 6/17/2017 MGNX-US  GNW  MacroGenics Presents Updated Data from Phase 1 Study of MGD010 at Annual European Congress of Rheumatology (EULAR 2017),,,,11/04/2015 MNTA-US  GNW  Momenta Pharmaceuticals Reports Third Quarter 2015 Financial Results, 6/29/2015 G7280010 GNW  Prothena Announces Addition of Seasoned Executive to Board of Directors,,,, 4/20/2016 37230320 GNW  Genmab Announces Daratumumab Data to be Presented at 2016 ASCO Annual Meeting,,,11/13/2015 23257D10 GNW  CymaBay Announces Participation at Three Upcoming Investor Conferences,,11/05/2014 16383L10 GNW  ChemoCentryx Reports Third Quarter 2014 Financial Results and Provides Corporate Update,,, 5/09/2016 MNKD-US   GNW  MannKind Announces Pricing of Registered Direct Public Offering of Common Stock and Warrants,, 3/22/2017 23282W60 GNW  Cytokinetics Announces Preclinical Data for CK-2127107 Presented at MDA Scientific Conference, 2/22/2017 ESPR-US     GNW  Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial Results,"10/25/2017 AMRS-US   GNW  Amyris to Announce Third Quarter 2017 Financial ResultsÂ on Wednesday, November 8, 2017",,11/04/2014 00448Q20 GNW  Achillion Reports Third Quarter and Nine Month 2014 Financial Results," 1/11/2018 87166B10 GNW  Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for INC Research Holdings, Inc. Shareholders â€“ INCR", 1/24/2017 FOLD-US  GNW  Amicus Therapeutics Announces Presentations and Posters at 13th Annual WORLDSymposiumâ„¢ 2017,,,11/05/2014 00089910 GNW  ADMA Biologics Approved for Trading on NASDAQ, 2/04/2016 GWP-GB   GNW  GW Pharmaceuticals to Present at the Leerink Partners 5th Annual Global Healthcare Conference,,, 2/23/2016 MYOK-US  GNW  MyoKardia Announces Transition of Chief Medical Officer,, 4/17/2017 GLPG-NL  GNW  Galapagos announces launch of proposed public offering, 3/07/2017 PTLA-US  GNW  Portola Pharmaceuticals Announces Betrixaban and AndexXaâ„¢ (andexanet alfa)  Presentations at ACC.17,,,,11/25/2015 CARA-US  GNW  Cara Therapeutics to Webcast Presentation at the Piper Jaffray 27th Annual Healthcare Conference, 6/10/2017 FLXN-US  GNW  Flexion Therapeutics to Present Data on Zilrettaâ„¢ (FX006) at the American Diabetes Associationâ€™s 77th Scientific Sessions,11/03/2016 N9006410 GNW  uniQure Announces Upcoming Presentation of Data at Annual American Society of Hematology Meeting, 9/13/2016 AGIO-US   GNW  Agios Announces Proposed Offering of Common Stock,"10/07/2015 IOVA-US  GNW  Lion Biotechnologies Obtains Exclusive License From NIH to Develop and Commercialize TIL in Bladder, Lung, Breast and HPV-Associated Cancers",,, 3/03/2016 FATE-US  GNW  Fate Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results,,, 5/05/2016 ICPT-US  GNW  Intercept Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update,11/05/2018 KPTI-US    GNW  Karyopharm Therapeutics to Ring Nasdaq Closing Bell on November 6th,,,11/02/2016 ITCI-US  GNW  Intra-Cellular Therapies to Host Third Quarter 2016 Financial Results Conference Call and Webcast,,,,, 4/06/2016 05KDBG-E   GNW  Atara Bio to Present at the 15th Annual Needham Healthcare Conference,, 9/29/2015 DERM-US  GNW  Dermira to Present Data for DRM01 Acne Program at EADV Congress 2015, 6/11/2014 008XK0-E GNW  Foamix Establishes U.S. Subsidiary and Strengthens Executive Management With Appointment of Senior U.S. Leadership Team,,10/02/2014 SUPN-US  GNW  Supernus Sues Actavis for Infringement of Trokendi XR(R) Patents,,,11/01/2016 CHRS-US  GNW  Coherus BioSciences to Report Third Quarter 2016  Financial Results on November 9th,,, 9/04/2015 19459J10 GNW  Collegium to Present Highlights From Xtampza(TM) ER (Oxycodone Extended-Release Capsules) Clinical Development Program at PAINWeek,10/02/2015 98400H10 GNW  XBiotech Announces Publication of Clinical Results Supporting the Potential of Its True Human(TM) Antibody as a Cardiovascular Therapy,,, 3/13/2017 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results,, 3/17/2016 KURA-US  GNW  Kura Oncology Reports Fourth Quarter and Full Year 2015 Operational and Financial Results,, 4/20/2016 06CR5C-E GNW  Axsome Therapeutics Receives Pre-IND Guidance from FDA for AXS-05 for Agitation in Patients with Alzheimerâ€™s Disease,, 3/05/2018 BGNE-US  GNW  BeiGene to Present at Upcoming Investor Conferences,,,,,,,,,," 6/19/2017 ATNX-US  GNW  Athenex, Inc. Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment Option",,,,,,,,,, 7/05/2016 EYPT-US    GNW  pSivida Announces Successful Completion of Two Preclinical Studies of Durasertâ„¢ Sustained-Release Insert Delivering Repurposed Cancer Drug to Treat Wet AMD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/07/2016 PGNX-US  GNW  Progenics Pharmaceuticals AnnouncesÂ Third Quarter 2016 Financial Results and Business Update,,,,,,,,, 1/23/2018 OPK-US   GNW  Cocrystal Pharma Provides Update on Reverse Stock Split,, 5/06/2014 09061G10    GNW  BioMarin to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference on May 14th and the UBS Global Healthcare Conference on May 20th,,,, 5/21/2018 IMMU-US  GNW  Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration,12/06/2011 GMAB-DK   GNW  Genmab Announces Appeal of US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit,, 5/31/2017 BCRX-US  GNW  BioCryst to Present at the Jefferies 2017 Global Healthcare Conference,,,,, 7/15/2015 00972810 GNW  Akorn Announces Nasdaq's Acceptance of Its Plan to Regain Compliance,,12/07/2018 MYGN-US  GNW  Prospective Study Demonstrates EndoPredictÂ® Can Guide Chemotherapy DecisionÂ For Women with Early-Stage Breast Cancer,,,,, 8/29/2016 INO-US    GNW  Inovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy,,, 4/30/2015 37416310 GNW  Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events,, 3/27/2018 AMRN-US  GNW  Amarin Commemorates National Triglycerides Day on March 28,,,12/29/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 2/09/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conference,,,,, 3/28/2018 SAN-FR   GNW  Sanofi: Availability of the Pre-quarterly Results Communication,,,,,, 1/20/2016 N0104510 GNW  Affimed to Host Hodgkin's Lymphoma Day with Key Opinion Leaders on January 26th in New York City,,11/23/2015 PRQR-US  GNW  ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials,,"10/02/2017 ZGNX-US  GNW  Zogenix Announces Proposed Public Offering of 4,300,000 Shares of Common Stock",,,,,," 7/13/2015 0F98BD-E GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Avalanche Biotechnologies, Inc. and Certain Officers â€“ AAVL", 4/28/2017 RARE-US   GNW  Ultragenyx to Host Conference Call for First Quarter 2017  Financial Results and Corporate Update,, 6/02/2016 NSTG-US  GNW  NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO),,, 4/01/2016 RDUS-US  GNW  Radius Presents Analysis Results on Fracture Risk Reduction in Phase 3 ACTIVE Trial for Investigational Drug Abaloparatide-SC at the ENDO 2016 Annual Meeting, 2/28/2012 04539610 GNW  Ventrus to Present at Cowen and Company 32nd Annual Health Care Conference,,,,,,," 5/03/2016 BCXQL-US GNW  Pacira Pharmaceuticals, Inc. to Present at the  Bank of America Merrill Lynch 2016 Health Care Conference",11/03/2015 RTRX-US  GNW  Retrophin Reports Third Quarter 2015 Financial Results," 7/02/2014 69404D10 GNW  Pacific Biosciences of California, Inc. Second Quarter 2014 Financial Results Call",,, 5/03/2017 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results,,,,10/28/2015 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Credit Suisse 24th Annual Healthcare Conference," 6/17/2015 G7280010 GNW  Prothena Presents Clinical Results Demonstrating Robust, Rapid Reduction in Levels of Free Serum Alpha-Synuclein of Up to 96% After Single Dose of PRX002, Novel Protein Immunotherapy for Parkinson's Disease",,,, 4/20/2016 37230320 GNW  Genmab Updates Financial Guidance for 2016,,,11/12/2015 23257D10 GNW  CymaBay Announces Third Quarter Financial Results,,"10/22/2014 16383L10 GNW  ChemoCentryx to Hold Third Quarter 2014 Financial Results Conference Call on Wednesday, November 5, 2014",,, 5/09/2016 MNKD-US   GNW  MannKind Corporation Reports 2016 First QuarterÂ Financial Results,, 3/20/2017 CYTK-US  GNW  Cytokinetics Announces Additional Results From COSMIC-HF Presented at ACC.17, 2/15/2017 ESPR-US     GNW  Esperion to Participate in Fireside Chat at RBC Capital Markets Global Healthcare Conference,10/09/2017 AMRS-US   GNW  Amyris Appoints Chief Operating Officer to Support Continued Strong Growth,,10/08/2014 00448Q20 GNW  Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting, 1/10/2018 87166B10 GNW  Syneos Health Releases 2018 Commercial Trends Forecast, 1/09/2017 FOLD-US  GNW  Amicus Therapeutics Provides Full-Year 2017 Strategic Outlook and Financial Guidance,,,," 2/02/2016 GWP-GB   GNW  GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 10 February, 2016",,, 2/04/2016 MYOK-US  GNW  MyoKardia Publishes Article in Science Demonstrating That MYK-461 Prevents and Reverses Disease in Genetic Mouse Models of Hypertrophic Cardiomyopathy,, 4/06/2017 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises, 3/01/2017 PTLA-US  GNW  Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences,,,,11/11/2015 14075510 GNW  Cara Therapeutics to Webcast Presentation at the Stifel 2015 Healthcare Conference, 5/22/2017 FLXN-US  GNW  Flexion to Present New Cost-Effectiveness Data on Zilrettaâ„¢ (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting, 9/26/2016 N9006410 GNW  uniQure to Present at the Jefferies Gene Editing and Gene Therapy Summit in New York City," 9/06/2016 MS-US     GNW  Agios to Present at Morgan Stanley Global Healthcare Conference Tuesday, September 13, 2016", 9/16/2015 IOVA-US  GNW  Lion Biotechnologies Announces Positive Updated Data From NCI's Phase 2 Study of TIL Therapy in the Treatment of Metastatic Melanoma,,," 2/25/2016 FATE-US  GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2015 Financial Results on March 3, 2016",,, 4/28/2016 ICPT-US  GNW  Intercept to Report First Quarter 2016 Financial Results on May 5,11/02/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,10/31/2016 ITCI-US  GNW  Intra-Cellular Therapies PresentsÂ the ITI-007 Clinical Development Program in Schizophrenia at the CNS Summit 2016 Annual Conference,,,,, 3/28/2016 JEF.XX2-US GNW  Atara Bio Announces Participation in Two Upcoming Immuno-Oncology Conferences,, 9/10/2015 24983L10 GNW  Skin Disposition Study Results for Dermira's DRM01 Program in Acne Presented at International Dermatology Meeting, 6/03/2014 008XK0-E GNW  Foamix Announces Collaboration With National Institutes of Health,, 9/22/2014 86845910 GNW  Supernus Provides Business Update,,,11/01/2016 CS-CH    GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in NovemberÂ ,,, 8/24/2015 19459J10 GNW  Collegium Publishes Data From Xtampza(TM) ER Phase 3 Clinical Trial in the Journal PAIN,10/01/2015 XBIT-US  GNW  XBiotech Receives FDA Fast Track Designation for Its Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus Aureus,,, 3/01/2017 GBT-US   GNW  Global Blood Therapeutics Announces Participation at Two Upcoming  Investor Conferences in March,, 3/11/2016 KURA-US  GNW  Kura Oncology to Report Fourth Quarter and Full Year 2015 Financial Results,, 4/04/2016 0CQL0Q-E GNW  Axsome Therapeutics to Present at the 15th Annual Needham Healthcare Conference,, 2/28/2018 BGNE-US  GNW  BeiGene Reports Fourth Quarter and Full Year 2017 Financial Results,,,,,,,,,," 6/14/2017 04685N10 GNW  Nasdaq Welcomes Athenex, Inc. (Nasdaq: ATNX) to The Nasdaq Stock Market",,,,,,,,,, 5/05/2016 EYPT-US    GNW  pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/07/2016 PGNX-US  GNW  Progenics Announces $50 Million RELISTORÂ® Royalty-Backed Financing,,,,,,,,, 1/12/2018 OPK-US   GNW  OPKOâ€™S GeneDx Announces Research Collaboration with Radboud University Medical Center,, 5/01/2014 BMRN-US     GNW  BioMarin Announces First Quarter 2014 Financial Results and VIMIZIM(TM) Launch Progress,,,, 5/16/2018 IMMU-US  GNW  Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer,11/17/2011 GMAB-DK   GNW  Genmab Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit,," 5/30/2017 BCRX-US  GNW  Robert A. Ingram Named Chairman of BioCryst Pharmaceuticals, Inc.",,,,, 7/08/2015 AKRX-US  GNW  Akorn Launches Acetylcysteine Injection,,12/07/2018 MYGN-US  GNW  Myriad Announces Important New Data for Its EndoPredictÂ® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium,,,,, 8/16/2016 INO-US    GNW  Inovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences,,, 4/27/2015 GERN-US  GNW  Geron to Present at the Bank of America Merrill Lynch Healthcare Conference,, 3/21/2018 AMRN-US  GNW  Amarin Announces First Middle East Approval for VascepaÂ®,,,12/27/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Publication of Long-Term Pulmonary Function of Eteplirsen-Treated Patients Compared to Natural History of Duchenne Muscular Dystrophy in The Journal of Neuromuscular Diseases,,," 2/07/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on Tuesday, February 14, 2017 at 8:00 a.m. ET",,,,," 3/27/2018 80105N10 GNW  Consolidated Research: 2018 Summary Expectations for Anheuser-Busch InBev SA/NV, Sanofi, Sogou Inc. Sponsored ADR, Unilever, Janus Capital Group, and Kosmos Energy â€” Fundamental Analysis, Key Performance Indications",,,,,, 1/14/2016 N0104510 GNW  Affimed Announces Addition of Dr. Andrew Evens to Scientific Advisory Board,,10/01/2015 N7154210 GNW  ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences,, 9/29/2017 ZGNX-US  GNW  Zogenix Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome,,,,,," 7/10/2015 00773U10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL", 4/27/2017 RARE-US   GNW  Ultragenyx Initiates Global Phase 3 Study of UX007 in Glut1 DS Patients with Disabling Movement Disorders,, 5/26/2016 NSTG-US  GNW  Cigna Issues Positive Coverage Decision for NanoStringâ€™s ProsignaÂ® Breast Cancer Assay,,, 3/30/2016 06CR5C-E GNW  Radius Health Submits New Drug Application to the U.S. Food and Drug Administration for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis, 1/13/2012 04539610 GNW  Ventrus Announces Publication of Prior Phase 2b Study on the Safety and Efficacy of Iferanserin in the Treatment of Hemorrhoid Disease,,,,,,," 5/02/2016 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports First Quarter 2016 Financial Results",10/20/2015 RTRX-US  GNW  Retrophin to Report Third Quarter 2015 Financial Results, 6/19/2014 07C8K6-E GNW  Pacific Biosciences and GenDx Initiate Co-Marketing Activities for Full-Length HLA Gene Sequencing Products,,, 4/27/2017 MGNX-US  GNW  MacroGenics Announces Registered Direct Offering of Common Stock,,,,10/26/2015 MNTA-US  GNW  Momenta Pharmaceuticals Announces Publication of Two Glatopa (glatiramer acetate injection) Manuscripts, 6/16/2015 0CXBJZ-E GNW  Prothena to Present at JMP Securities Life Science Conference 2015 on June 23,,,, 4/04/2016 GMAB-DK  GNW  Patent Infringement Lawsuit Filed Against Genmab and Janssen in the United States Regarding DARZALEX(r),,,11/10/2015 23257D10 GNW  CymaBay Therapeutics Announces the Initiation of a Phase 2 Study of MBX-8025 in Patients With Primary Biliary Cholangitis/Cirrhosis,,"10/21/2014 16383L10 GNW  ChemoCentryx's Orally Administered CCR9 Inhibitor, CCX507, Shown to be Well Tolerated and Effective in CCR9 Blockade in Phase I Study",,, 5/05/2016 MNKD-US   GNW  MannKind Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,, 3/06/2017 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Results from COSMIC-HF at ACC.17, 1/25/2017 ESPR-US     GNW  Esperion Completes Enrollment of Pivotal Phase 3 Long-Term Safety and Tolerability Study of Bempedoic Acid in Patients with Hypercholesterolemia,10/05/2017 03236M20  GNW  Amyris Enters into Product Development and Production Agreement with Royal DSM for Human Nutrition Ingredient,, 8/19/2014 00448Q20 GNW  Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors," 1/08/2018 87166B10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Syneos Health, Inc. (formerly INC Research Holdings, Inc.) of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 30, 2018 â€“ INCR", 1/04/2017 0B8Z3S-E GNW  National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafoldâ„¢ (migalastat) for Fabry Disease in England,,,, 1/29/2016 36197T10 GNW  IMPORTANT GW PHARMACEUTICALS SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Commenced Against GW Pharmaceuticals plc in the Southern District of New York -- GWPH,,,11/04/2015 62857M10 GNW  MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2015,, 4/05/2017 GLPG-NL  GNW  Galapagos doses first psoriatic arthritis patient with filgotinib, 2/28/2017 PTLA-US  GNW  Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update,,,,11/09/2015 14075510 GNW  Cara Therapeutics Reports Third Quarter 2015 Financial Results, 5/18/2017 FLXN-US  GNW  Flexion Therapeutics Announces Upcoming Data Presentation at the American Diabetes Association's 77th Scientific Sessions, 9/22/2016 N9006410 GNW  uniQure Announces Management and Board Changes, 8/16/2016 AGIO-US   GNW  Agios Appoints Andrew Hirsch as Chief Financial Officer, 9/14/2015 46226010 GNW  Lion Biotechnologies Opens Enrollment in Phase 2 Study of LN-144 for the Treatment of Refractory Metastatic Melanoma,,, 2/21/2016 06CR5C-E GNW  Fate Therapeutics to Present Preclinical Data for ProTmuneâ„¢ at 2016 BMT Tandem Meetings,,, 4/16/2016 ICPT-US  GNW  Intercept Announces Winners of Practice to Policy Health Awards Program to Encourage New Research and Improve Care for People Living with PBC,11/01/2018 KPTI-US    GNW  Karyopharm Announces Results of Clinical Studies Investigating Selinexor in Multiple Myeloma and Diffuse Large B-Cell Lymphoma to be Presented at the American Society of Hematology 2018 Annual Meeting,,, 9/28/2016 ITCI-US  GNW  Intra-Cellular Therapies Announces Top-Line Results from the Second Phase 3 Trial of ITI-007 in Patients with Schizophrenia (Study â€˜302),,,,, 3/23/2016 080RQG-E   GNW  Atara Bio Receives EMA Orphan Drug Designation for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes to Treat Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder,, 9/03/2015 DERM-US  GNW  Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR Meeting, 4/21/2014 008XK0-E GNW  Foamix Announces the Issuance of Five Additional US Patents,, 9/04/2014 86845910 GNW  Supernus Announces Issuance of Fourth US Patent Protecting Oxtellar XR(R),,,10/21/2016 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,,, 8/12/2015 19459J10 GNW  Collegium Reports Second Quarter Financial Results and Provides Corporate Update, 9/01/2015 98400H10 GNW  XBiotech Advances Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus Aureus,,, 2/27/2017 GBT-US   GNW  Global Blood Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares,, 2/04/2016 KURO-US  GNW  Kura Oncology to Participate in the Leerink Global Healthcare Conference,, 3/28/2016 AXSM-US  GNW  Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions,, 2/27/2018 BGNE-US  GNW  BeiGene Announces Approval of REVLIMIDÂ® for Newly Diagnosed Multiple Myeloma in China,,,,,,,,,," 6/14/2017 ATNX-US  GNW  Athenex, Inc. Announces Pricing of Initial Public Offering",,,,,,,,,, 5/04/2016 EYPT-US    GNW  pSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/24/2016 PGNX-US  GNW  Progenics Pharmaceuticals Sets Third Quarter 2016 Financial Results Call for November 7,,,,,,,,,11/27/2017 OPK-US   GNW  OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy,, 4/28/2014 09061G10    GNW  BioMarin Announces European Commission Approval for VIMIZIM(R) (elosulfase alfa) for the Treatment of Morquio A Syndrome in Patients of All Ages,,,, 5/09/2018 IMMU-US  GNW  Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update, 9/16/2011 09062X10  GNW  Biogen Idec Inc (BIIB) - N 100 - to Ring The NASDAQ Stock Market Opening Bell,, 5/25/2017 BCRX-US  GNW  BioCryst Reports Additional Positive Results From the Second Interim Analysis of Its APeX-1 Trial,,,,, 5/18/2015 00972810 GNW  Akorn Receives NASDAQ Delinquency Notice,,12/06/2018 MYGN-US  GNW  Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations,,,,, 8/11/2016 INO-US    GNW  Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen,,, 4/07/2015 GERN-US  GNW  Geron to Present at the 14th Annual Needham Healthcare Conference,, 3/12/2018 AMRN-US  GNW  VascepaÂ® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipids and Inflammatory Markers in Patients With Persistent High Triglycerides and Elevated High-Sensitivity C-Reactive Protein (hsCRP),,,"12/05/2017 SRPT-US  GNW  Sarepta Therapeutics Elects Biopharmaceutical Veteran, Michael W. Bonney, to its Board of Directors",,, 2/03/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekyndaâ„¢ (bremelanotide),,,,, 3/26/2018 LXRX-US  GNW  Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes,,,,,, 1/12/2016 AFMD-DE  GNW  Affimed to Present at Noble Financial Capital Markets' 12th Annual Investor Conference,, 9/23/2015 PRQR-NL  GNW  ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable,, 8/08/2017 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Second Quarter 2017 Financial Results,,,,,, 5/14/2015 00773U10 GNW  Avalanche Biotechnologies Presents Three Posters at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting," 4/18/2017 RARE-US   GNW  Ultragenyx, Kyowa Hakko Kirin and Kyowa Kirin International Announce Positive 24-Week Data from Adult Phase 3 Study of Burosumab (KRN23) in X-Linked Hypophosphatemia",, 5/24/2016 NSTG-US  GNW  NanoString Technologies to Present at the Jefferies 2016 Healthcare Conference,,, 3/11/2016 RDUS-US  GNW  Radius Health Announces New Employment Inducement Grants,12/21/2011 04539610 GNW  Ventrus BioSciences Completes Enrollment of Pivotal Phase 3 Trial of Diltiazem (VEN 307) in Patients With Anal Fissures,,,,,,," 4/19/2016 PCRX-US  GNW  Pacira Pharmaceuticals Appoints Charles A. Reinhart, III, as Chief Financial Officer", 9/16/2015 RTRX-US  GNW  Retrophin to Present at the Leerink Partners 4th Annual Rare Disease Roundtable," 5/14/2014 69404D10 GNW  Single Molecule, Real-Time (SMRT) DNA Sequencing Technology From Pacific Biosciences to be Featured in 20 Presentations at the American Society for Microbiology 2014 Annual Meeting",,, 4/26/2017 MGNX-US  GNW  MacroGenics to Present at Two Upcoming Investor Conferences in May,,,,10/21/2015 MNTA-US  GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2015 Financial Results Conference Call and Webcast, 6/12/2015 0CXBJZ-E GNW  Prothena's NEOD001 Protein Immunotherapy Clinical Data Highlighted in Oral Presentation at the 20th Congress of the European Hematology Association,,,, 4/01/2016 080RQG-E GNW  CHMP Issues Positive Opinion Recommending DARZALEX(r) (daratumumab) for Relapsed and Refractory Multiple Myeloma,,,"11/05/2015 23257D10 GNW  CymaBay Therapeutics to Present Results From Two Arhalofenate Phase 2 Studies at the American College of Rheumatology (ACR) Annual Meeting, November 6 - 11",,10/20/2014 16383L10 GNW  ChemoCentryx Releases Phase III SHIELD 4 Clinical Results in Patients With Crohn's Disease,,," 5/02/2016 MNKD-US   GNW  MannKind Corporation to Hold 2016 First Quarter Financial Results Conference Call on May 9, 2016",, 2/28/2017 CYTK-US  GNW  Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day, 1/09/2017 ESPR-US     GNW  Esperion Announces Initiation of Global Cardiovascular Outcomes Trial for Bempedoic Acid, 9/26/2017 03236M20  GNW  Amyris Enters into Second Major Product Development and Production Agreement with Royal DSM,," 8/15/2014 00448Q20 GNW  Achillion Achieves 100 Percent Sustained Virologic Response Rate (SVR4) From an Eight Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV (""Proxy Study"")"," 1/04/2018 87166B10 GNW  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INC Research Holdings, Inc. (INCR)Â & Lead Plaintiff Deadline - February 2, 2018",12/23/2016 FOLD-US  GNW  Amicus Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,," 1/25/2016 36197T10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of GW Pharmaceuticals plc of Class Action Lawsuit and a Lead Plaintiff Deadline of March 21, 2016 â€“ GWPH",,,11/03/2015 62857M10 GNW  MyoKardia Announces Closing of Initial Public Offering,, 4/04/2017 GLPG-NL  GNW  Galapagos announces three new Phase 2 Proof-of-Concept studies with filgotinib," 2/21/2017 PTLA-US  GNW  Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial Results and Host Conference Call on Tuesday, February 28",,,,"11/02/2015 14075510 GNW  Cara Therapeutics to Announce Third Quarter 2015 Financial Results on November 9, 2015", 5/04/2017 FLXN-US  GNW  Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights, 9/16/2016 N9006410 GNW  uniQure Receives NASDAQ Deficiency Letter Related to Board Composition," 8/05/2016 CF.PRA-CA GNW  Agios to Present at Canaccord Genuity 36th Annual Growth Conference Wednesday, August 10, 2016", 9/03/2015 46226010 GNW  Lion Biotechnologies to Participate in Upcoming Investor and Scientific Conferences,,, 2/03/2016 070JFC-E GNW  Fate Therapeutics to Present at Leerink Partners  5th Annual Global Healthcare Conference,,, 4/14/2016 ICPT-US  GNW  New Analyses of the Phase 3 POISE Trial of Ocalivaâ„¢ (Obeticholic Acid) for the Treatment of PBC Presented at EASL,"11/01/2018 KPTI-US    GNW  Karyopharm to Report Third Quarter 2018 Financial Results on November 8, 2018",,, 8/04/2016 ITCI-US  GNW  Intra-Cellular Therapies Reports Second Quarter 2016 Financial Results and Provides Corporate Update,,,,, 3/16/2016 06P9WL-E   GNW  Atara Bio Announces Collaborating Investigators to Present Data from a Late Breaking Abstract at the American Association for Cancer Research (AACR) Annual Meeting,, 8/13/2015 24983L10 GNW  Dermira Reports Second Quarter 2015 Financial Results and Provides Corporate Update," 2/27/2014 008XK0-E GNW  Foamix, Ltd., to Present at the 34th Annual Cowen & Company Health Care Conference -- Successful Phase 2 for First Ever Topical Minocycline for Acne and Impetigo",, 8/21/2014 86845910 GNW  Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R),,,10/06/2016 CHRS-US  GNW  Coherus BioSciences Announces FDA Acceptance of 351(k) Biologics License Application to U.S. Food and Drug Administration for  CHS-1701 (Pegfilgrastim Biosimilar Candidate),,, 8/07/2015 00772J-E GNW  Collegium to Host Conference Call to Discuss Financial Results and Provide Corporate Update, 8/17/2015 98400H10 GNW  XBiotech Completes Enrollment for Xilonix(TM) Phase III Registration Study in Europe,,, 2/22/2017 GBT-US   GNW  Global Blood Therapeutics Prices a $125.0 Million Upsized Common Stock Public Offering,,12/03/2015 50127T10 GNW  Kura Oncology Announces Data Presentation on Lead Product Candidate Tipifarnib at the Upcoming ASH Meeting,, 3/24/2016 AXSM-US  GNW  Axsome Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results,, 2/09/2018 BGNE-US  GNW  BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma at 2018 Genitourinary Cancers Symposium,,,,,,,,,," 6/14/2017 04685N10 GNW  Athenex, Inc. (Nasdaq: ATNX) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO",,,,,,,,,, 5/02/2016 EYPT-US    GNW  pSividaâ€™s Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/21/2016 06R5X7-E GNW  Progenics Pharmaceuticals to Present at the 23rd Annual Prostate Cancer Foundation Scientific Retreat,,,,,,,,,"11/27/2017 68375N10 GNW  Report: Developing Opportunities within PayPal, Exelixis, International Business Machines, Opko Health, Envision Healthcare, and Zynga â€” Future Expectations, Projections Moving into 2018",," 4/16/2014 09061G10    GNW  BioMarin to Host First Quarter 2014 Financial Results Conference Call and Webcast on Thursday, May 1 at 5:00 p.m. ET",,,," 5/02/2018 IMMU-US  GNW  Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018", 4/05/2011 SNSS-US   GNW  Millennium Pharmaceuticals and Sunesis Pharmaceuticals Announce Collaboration for Kinase Inhibitors in Oncology,, 5/09/2017 BCRX-US  GNW  BioCryst to Present at the Bank of America Merrill Lynch 2017 Health Care Conference,,,,, 4/27/2015 00972810 GNW  Akorn Announces Recent Executive Appointments,,11/19/2018 MYGN-US  GNW  Myriad Announces $50 Million Accelerated Share Repurchase Program,,,,, 8/08/2016 45773H20  GNW  GeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine,,, 4/03/2014 37416310 GNW  ALERT: Rosen Law Firm Reminds Geron Corporation Investors of Important Class Action Deadline -- GERN,, 3/12/2018 AMRN-US  GNW  Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs,,,11/30/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 2/02/2017 AMAG-US  GNW  AMAG Pharmaceuticals Announces Positive Topline Results from Definitive Pharmacokinetic Study for Makena Subcutaneous Administration,,,,, 3/15/2018 SAN-FR   GNW  Sanofi successfully prices EUR 8 billion of bond issues,,,,,,12/14/2015 AFMD-US  GNW  Affimed Added to NASDAQ Biotech IndexÂ®,, 9/14/2015 N7154210 GNW  ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment,, 8/01/2017 ZGNX-US  GNW  Zogenix to Release Second Quarter 2017 Financial Results and Host Conference Call and Webcast on August 8,,,,,," 5/13/2015 00773U10 GNW  Avalanche Biotechnologies, Inc. Reports First Quarter 2015 Financial Results"," 4/10/2017 RARE-US   GNW  Ultragenyx Appoints Deborah Dunsire, M.D., to Board of Directors",, 5/09/2016 NSTG-US  GNW  Aetna Issues Positive Coverage Decision for NanoStringâ€™s ProsignaÂ®Â Breast Cancer Assay,,, 2/29/2016 RDUS-US  GNW  Radius Health to Present at the Cowen and Company 36th Annual Health Care Conference,11/18/2011 04539610 GNW  Ventrus Announces Acquisition of Title to Hemorrhoids Product,,,,,,, 4/14/2016 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for First Quarter 2016 Financial Results  Webcast and Conference Call,"12/22/2014 76129910 GNW  Attention Retrophin, Inc. (RTRX) Shareholders: Retrophin Mislead Investors According to a Newly Filed Class Action"," 4/30/2014 69404D10 GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2014 Financial Results",,, 4/25/2017 MGNX-US  GNW  MacroGenics Announces Date of First Quarter 2017 Financial Results Conference Call,,,,"10/05/2015 60877T10 GNW  Baxalta and Momenta Announce Initiation of Pivotal Clinical Trial for M923, a Biosimilar Version of HUMIRA (adalimumab)", 6/12/2015 G7280010 GNW  Opportunity to Improve Diagnosis and Treatment of Systemic Amyloidosis Highlighted in Patient Experience Survey Presented at the 20th Congress of the European Hematology Association,,,, 3/30/2016 37230320 GNW  Genmab Announces Positive Interim Result in Phase III Castor Study of Daratumumab in Relapsed or Refractory Multiple Myeloma,,,"11/04/2015 23257D10 GNW  CymaBay to Announce Third Quarter 2015 Financial Results on Thursday, November 12",," 9/22/2014 16383L10 GNW  ChemoCentryx Appoints Israel F. Charo, M.D., Ph.D., Senior Vice President of Research",,," 4/19/2016 MNKD-US   GNW  Analyst Call Rescheduled to April 26, 2016",, 2/27/2017 CYTK-US  GNW  Cytokinetics to Present at March Investor Conferences, 1/08/2017 ESPR-US     GNW  Esperion Announces Initiation of Three Pivotal Phase 3 Studies for Bempedoic Acid," 9/06/2017 AMRS-US   GNW  Amyris to Present at Rodman & Renshaw 19th Annual Global Investment Conference on September 11, 2017",, 8/07/2014 00448Q20 GNW  Achillion Reports Second Quarter and Six Month 2014 Financial Results," 1/03/2018 87166B10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In INC Research Holdings, Inc. (Nasdaq: INCR) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",12/21/2016 FOLD-US  GNW  Amicus Therapeutics Announces Closing of Offering of Senior Convertible Notes and Exercise in Full of Option to Purchase Additional Notes,,,,12/24/2015 GWP-GB   GNW  The Lancet Neurology Publishes Data From the EpidiolexÂ® Expanded Access Program in Children and Young Adults With Treatment-Resistant Epilepsy,,,"10/29/2015 MYOK-US  GNW  Nasdaq Welcomes MyoKardia, Inc. to The Nasdaq Stock Market",, 3/23/2017 GLPG-NL  GNW  Publication of the annual report and invitation to the  annual and extraordinary shareholders' meetings, 2/08/2017 PTLA-US  GNW  FDA Informs Portola Pharmaceuticals at Mid-Cycle Review for Betrixaban That It Has Not Identified Issues that Require an Advisory Committee Meeting,,,,10/29/2015 14075510 GNW  Cara Therapeutics to Present Late-Breaking Poster at Kidney Week 2015, 5/01/2017 FLXN-US  GNW  Flexion Therapeutics to Present at the Deutsche Bank 42nd Annual Health Care Conference, 8/25/2016 N9006410 GNW  uniQure Announces Financial Results For Second Quarter 2016 and Update on Company Progress, 8/04/2016 AGIO-US   GNW  Agios Reports Second Quarter 2016 Financial Results, 8/31/2015 46226010 GNW  Lion Biotechnologies Announces Strategic Hires,,, 1/26/2016 FATE-US  GNW  Fate Therapeutics Announces FDA Clearance of Investigational New Drug Application for ProTmune for Prevention of Acute GvHD and CMV Infection,,, 4/07/2016 06CR5C-E GNW  FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocalivaâ„¢ (obeticholic acid) for the Treatment of PBC,10/29/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Closing of Additional $22.5 Million of 3.00% Convertible Senior Notes Due 2025 Pursuant to Exercise in Full of Initial Purchasersâ€™ Option,,, 7/25/2016 ITCI-US  GNW  Intra-Cellular Therapies to Host Second Quarter 2016 Financial Results Conference Call and Webcast,,,,, 3/03/2016 ATRA-US    GNW  Atara Bio Announces Fourth Quarter and Full Year 2015 Financial Results and Recent Highlights,, 8/11/2015 24983L10 GNW  Dermira Announces Closing of Follow-on Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,,, 8/19/2014 86845910 GNW  Supernus to Attend FBR HealthCare Conference in September,,,10/06/2016 CHRS-US  GNW  Coherus BioSciences Completes two Pharmacokinetic Bioequivalence Studies of CHS-0214,,," 8/07/2015 00772J-E GNW  Collegium Announces FDA Advisory Committee Meeting for Xtampza(TM) ER, an Abuse-Deterrent Analgesic for Chronic Pain", 8/07/2015 XBIT-US  GNW  XBiotech Announces Expansion of Global Phase 3 Registration Study in Europe using Xilonix(TM) for Treatment of Metastatic Colorectal Cancer,,, 2/21/2017 GBT-US   GNW  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock,,12/01/2015 KURO-US  GNW  Kura Oncology to Present at the Oppenheimer 2015 Healthcare Conference,, 3/17/2016 AXSM-US  GNW  Axsome Therapeutics Initiates Phase 3 Study of AXS-05 for Treatment Resistant Depression,, 2/07/2018 BGNE-US  GNW  BeiGene to Present at the LEERINK Partners 7th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,, 4/27/2016 EYPT-US    GNW  pSivida Corp. Announces Third Quarter Fiscal Year 2016 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/07/2016 PGNX-US  GNW  Progenics Pharmaceuticals Announces Appointment of Bryce V. Tenbarge as Vice President of Commercial,,,,,,,,,11/08/2017 OPK-US   GNW  OPKO Health Reports 2017 Third Quarter Highlights and Financial Results,, 4/14/2014 09061G10    GNW  FDA Extends Market Exclusivity Six Months for BioMarin's Rare Disease Therapy KUVAN(R) (sapropterin dihydrochloride) Powder for Oral Solution and Tablets,,,, 4/25/2018 IMMU-US  GNW  Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, 3/03/2011 GENTY-US  GNW  Gentium Appoints Adrian Haigh as Senior Vice President of Commercial Operations,, 5/04/2017 BCRX-US  GNW  BioCryst Reports First Quarter 2017 Financial Results,,,,, 4/24/2015 00972810 GNW  Akorn Appoints Terry Rappuhn to Board of Directors,,11/12/2018 MYGN-US  GNW  Myriad to Present New Data from Its Industry-Leading Portfolio of Genetic Tests for Breast Cancer at the 2018 San Antonio Breast Cancer Symposium,,,,, 8/08/2016 INO-US    GNW  Inovio Pharmaceuticals Reports 2016 Second Quarter Financial Results,,, 9/03/2013 XNPT-US  GNW  Jeryl L. Hilleman Joins Ocera Therapeutics as Chief Financial Officer,, 3/05/2018 AMRN-US  GNW  Amarin Announces Closing of Underwriterâ€™s Purchase of Additional Shares,,,"11/30/2017 80360710 GNW  Report: Exploring Fundamental Drivers Behind Morgan Stanley, TripAdvisor, Xerox, Sarepta Therapeutics, Semgroup, and Toll Brothers â€” New Horizons, Emerging Trends, and Upcoming Developments",,, 1/25/2017 QURE-NL  GNW  uniQure Appoints Alexander Kuta as Senior Vice President of Regulatory Affairs,,,,, 3/10/2018 SAN-FR   GNW  Sanofi and Regeneron announce plans to make PraluentÂ® more accessible and affordable for patients with the greatest health risk and unmet need,,,,,,12/06/2015 AFMD-DE  GNW  Affimed Presents Additional Data on Combination of AFM13 with Checkpoint Inhibitors at ASH,, 8/19/2015 N7154210 GNW  ProQR Announces Results for the Second Quarter of 2015,, 6/22/2017 ZGNX-US  GNW  Zogenix Receives Orphan Drug Designation from FDA for ZX008 in Treatment of Lennox Gastaut Syndrome,,,,,, 4/28/2015 0D98KG-E GNW  Avalanche Biotechnologies to Present at Upcoming Scientific Meetings, 4/06/2017 RARE-US   GNW  Ultragenyx and Kyowa Kirin International Announce Positive Data from Pediatric Phase 2 Studies of Burosumab (KRN23) in X-Linked Hypophosphatemia,, 5/05/2016 NSTG-US  GNW  NanoString Technologies Releases Operating Results for First Quarter of 2016,,, 2/25/2016 RDUS-US  GNW  Radius Health Reports Fourth Quarter and Full Year 2015 Financial and Operating Results,11/14/2011 04539610 GNW  Ventrus Reports Third Quarter 2011 Financial Results,,,,,,, 4/05/2016 PCRX-US  GNW  Pacira Pharmaceuticals Appoints Robert Weiland as Chief Commercial Officer,"12/16/2014 76129910 GNW  UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Retrophin, Inc. and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX", 4/29/2014 69404D10 GNW  HistoGenetics Selects PacBio(R) DNA Sequencing Platform to Enhance Human Leukocyte Antigen (HLA) Typing,,, 3/31/2017 MGNX-US  GNW  Eight Posters Based on MacroGenics-developed Molecules Featured at AACR Annual Meeting 2017,,,,10/01/2015 MNTA-US  GNW  Momenta Presents Three Glatopa (glatiramer acetate injection) Posters at ECTRIMS 2015 Meeting, 6/09/2015 G7280010 GNW  Prothena Announces First Human Dosed in Phase 1 Study of PRX003 for the Treatment of Psoriasis and Other Inflammatory Diseases,,,, 3/21/2016 37230320 GNW  Genmab Announces Studies of Daratumumab in Combination with Atezolizumab in a Solid Tumor and Multiple Myeloma,,,"10/08/2015 23257D10 GNW  CymaBay Announces the Appointment of Robert J. Wills, Ph.D., as Chairman of the Board of Directors",," 8/05/2014 16383L10 GNW  ChemoCentryx Announces Financial Results for the Second Quarter Ended June 30, 2014",,, 4/19/2016 MNKD-US   GNW  MannKind Expands Commercial Capabilities With Two New Hires,," 2/16/2017 CYTK-US  GNW  Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial Results", 1/04/2017 ESPR-US     GNW  Esperion to Present at the 35th Annual J.P. Morgan Healthcare Conference, 8/10/2017 AMRS-US   GNW  Amyris Delivers Another Strong Quarter with Revenue of $25.7 Million and Product Sales Increase of 159% over 2nd Quarter of 2016,, 7/01/2014 00448Q20 GNW  Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes,"12/22/2017 87166B10 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against INC Research Holdings, Inc. â€“ INCR",12/15/2016 FOLD-US  GNW  Amicus Therapeutics Announces Pricing of Offering of Convertible Senior Notes,,,,12/07/2015 36197T10 GNW  GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2015 Financial Results and Operational Progress,,,"10/29/2015 MYOK-US  GNW  MyoKardia, Inc. (Nasdaq: MYOK) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO",, 3/22/2017 GLPG-NL  GNW  Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067, 2/03/2017 PTLA-US  GNW  Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa,,,,10/26/2015 14075510 GNW  Cara Therapeutics to Present at 2nd Human Abuse Liability & Abuse-Deterrent Formulations Conference, 4/28/2017 FLXN-US  GNW  Flexion Therapeutics Highlights Two Clinical Data Presentations at the Osteoarthritis Research Society International 2017 World Congress, 8/25/2016 QURE-US  GNW  uniQure Announces Financial Results For Second Quarter 2016 and Update on Company Progress," 7/28/2016 AGIO-US   GNW  Agios to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016", 8/10/2015 46226010 GNW  Lion Biotechnologies Announces Second Quarter 2015 Financial Results,,, 1/06/2016 070JFC-E GNW  Fate Therapeutics to Present at Biotech Showcase 2016,,, 3/30/2016 ICPT-US  GNW  Intercept Announces New OCA Data in PBC and NASH to be Presented at EASL 2016,10/26/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Management Change,,, 7/06/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference,,,,, 2/29/2016 0024VM-E   GNW  Atara Bio to Present at the Cowen and Company 36th Annual Health Care Conference,, 8/05/2015 24983L10 GNW  Dermira Prices Follow-On Public Offering of Common Stock,,, 8/14/2014 86845910 GNW  Supernus Receives FDA Fast Track Designation for SPN-810,,, 9/27/2016 CHRS-US  GNW  Coherus BioSciences Regains Development and Commercial Rights to CHS-0214 From Shire,,," 7/06/2015 19459J10 GNW  Collegium Added to Russell 2000(R), 3000(R) and Global Indexes", 7/28/2015 98400H10 GNW  XBiotech Provides Second Quarter 2015 Corporate and Clinical Update,,, 2/16/2017 GBT-US   GNW  Global Blood Therapeutics Announces Initiation of Phase 1 Trial  to Evaluate the Physiologic Effects of GBT440 in Healthy Volunteers Under Hypoxemic Conditions,,11/30/2015 50127T10 GNW  Kura Oncology to Present at Upcoming Investor Conference,, 3/15/2016 AXSM-US  GNW  Axsome Therapeutics Receives New U.S. Patent Covering AXS-02 for the Treatment of Complex Regional Pain Syndrome,, 2/05/2018 BGNE-US  GNW  BeiGene Announces Commercial Availability of VIDAZAÂ®  (Azacitidine for Injection) in China,,,,,,,,,,,,,,,,,,,, 3/24/2016 05ND6J-E   GNW  pSivida to Present at the Sidoti Spring 2016 Emerging Growth Convention,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/02/2016 075BYT-E GNW  Progenics Pharmaceuticals to Present at the 23rd Annual NewsMakers in the Biotech Industry Conference,,,,,,,,,11/07/2017 OPK-US   GNW  OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the ClarosÂ® 1 Platform,," 3/21/2014 BMRN-US     GNW  BioMarin Appoints Pioneer in Personalized Medicine, Dennis J. Slamon, M.D., Ph.D., to Board of Directors",,,, 4/09/2018 IMMU-US  GNW  Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer, 6/10/2010 SNSS-US   GNW  Stock Alert for Sunesis Pharmaceuticals Inc. Issued by MicroStockProfit,, 4/24/2017 BCRX-US  GNW  BioCryst to Announce First Quarter 2017 Financial Results May 4,,,,, 4/24/2015 00972810 GNW  Akorn to Make Additional Financial Restatements,,11/06/2018 MYGN-US  GNW  Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results,,,,, 8/04/2016 INO-US    GNW  Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs,,," 1/03/2011 37416310 GNW  Statman, Harris & Eyrich, LLC Announces Lawsuit Filed Against Geron Corporation",, 3/01/2018 AMRN-US  GNW  Amarin Announces Start of Final Clinical Site Visits in the REDUCE-IT Cardiovascular Outcomes Study,,,11/09/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Exercise of Initial Purchasersâ€™ Option to Purchase Additional Convertible Senior Notes Due 2024,,, 1/09/2017 AMAG-US  GNW  AMAG Pharmaceuticals Provides Financial and Business Update,,,,," 3/10/2018 SAN-FR   GNW  Sanofi: PraluentÂ® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate",,,,,,12/06/2015 AFMD-DE  GNW  Affimed Presents Data Comparing T-cell- and NK-cell-engaging TandAbs AFM11 and AFM12 at ASH,, 6/26/2015 N7154210 GNW  ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients,," 6/14/2017 98978L20 GNW  Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and Co-Founder of Clovis Oncology, to Board of Directors",,,,,," 4/13/2015 00773U10 GNW  Avalanche Biotechnologies, Inc. (Nasdaq: AAVL) to Ring The Nasdaq Stock Market Closing Bell", 3/22/2017 RARE-US   GNW  Ultragenyx Announces Topline Data from Phase 2 UX007 Glucose Transporter Type-1 Deficiency Syndrome Seizure Study,, 4/27/2016 NSTG-US  GNW  NanoString Technologies to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,,," 2/02/2016 RDUS-US  GNW  Radius Health to Announce Fourth Quarter and Full Year 2015 Financial Results, Host Conference Call and Live Webcast on February 25, 2016","11/14/2011 04539610 GNW  Ventrus Validates Large Patient Potential for VEN 309 With Survey Data From 10,000 Consumers",,,,,,," 3/08/2016 BCS-GB   GNW  Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference","12/12/2014 76129910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX"," 4/02/2014 69404D10 GNW  Pacific Biosciences of California, Inc. First Quarter 2014 Financial Results Call",,, 3/29/2017 MGNX-US  GNW  MacroGenics to Present at the Needham Healthcare Conference,,,," 9/18/2015 MNTA-US  GNW  Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors", 6/08/2015 G7280010 GNW  Prothena to Present Clinical Results From Its Phase 1 Single Ascending Dose Study of PRX002 at 19th International Congress of Parkinson's Disease and Movement Disorders,,,, 3/17/2016 37230320 GNW  Constitution of the Board of Directors in Genmab A/S and Grant of Warrants to Employees in Genmab,,, 9/03/2015 CBAY-US  GNW  CymaBay Therapeutics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference,," 7/23/2014 16383L10 GNW  ChemoCentryx to Hold Second Quarter 2014 Financial Results Conference Call on Tuesday, August 5, 2014",,, 4/11/2016 MNKD-US   GNW  MannKind to Discuss U.S. Commercialization Update for AfrezzaÂ®,," 2/03/2017 CYTK-US  GNW  Cytokinetics to Announce Fourth Quarter Results on February 16, 2017",11/28/2016 ESPR-US     GNW  Esperion Therapeutics Announces Publication of Definitive Paper on Bempedoic Acid Mechanism of Action in Nature Communications, 8/09/2017 03236M20  GNW  Amyris Announces Closing of $50 Million in Second Tranche Equity Financing â€“ Fully Capitalized with Very Strong Business Momentum,, 6/11/2014 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,"12/18/2017 87166B10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of INC Research Holdings, Inc. Shareholders and a Lead Plaintiff Deadline of January 30, 2018",12/14/2016 FOLD-US  GNW  Amicus Therapeutics Announces Proposed Offering of Convertible Senior Notes,,,,12/07/2015 GWP-GB   GNW  GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy,,,,, 3/10/2017 GLPG-NL  GNW  New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease," 1/03/2017 PTLA-US  GNW  Portola Pharmaceuticals to Webcast Corporate Update on January 10, 2017",,,,10/19/2015 CARA-US  GNW  Cara Therapeutics to Sponsor Symposium and Present Poster at ANESTHESIOLOGY 2015, 4/26/2017 FLXN-US  GNW  Flexion Therapeutics Announces Pricing of $175 Million 3.375% Convertible Senior Notes due 2024, 8/17/2016 N9006410 GNW  uniQure to Present at Upcoming Investor Conferences in September, 6/11/2016 07G766-E  GNW  AG-348 Achieves Proof-of-Concept in Ongoing Phase 2 DRIVE-PK Study and Demonstrates Rapid and Sustained Hemoglobin Increases in Adults with Pyruvate Kinase Deficiency, 6/24/2015 46226010 GNW  Lion Biotechnologies to Join Russell Global Index,,,12/07/2015 31189P10 GNW  Fate Therapeutics Provides Update on Adoptive Immunotherapy Programs for Hematopoietic Cell Transplantation,,, 3/16/2016 ICPT-US  GNW  Intercept Pharmaceuticals to Study the Role of Gut Microbiota in the Treatment of Non-Viral Liver Diseases by Obeticholic Acid,10/11/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Pricing of $150 Million of Convertible Senior Notes,,, 6/30/2016 ITCI-US  GNW  Intra-Cellular Therapies Reports Completion of Enrollment of ITI-007-302 Phase 3 Clinical Trial for the Treatment of Schizophrenia,,,,, 2/08/2016 ATRA-US    GNW  Atara Bio Receives FDA Orphan Drug Designation for EBV-CTL to Treat Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder (EBV-PTLD),, 8/04/2015 24983L10 GNW  Dermira Commences Follow-on Public Offering of Common Stock,,, 8/11/2014 86845910 GNW  Supernus Announces Second Quarter 2014 Results,,, 9/16/2016 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,,, 7/01/2015 19459J10 GNW  Collegium Expands Leadership Team With Vice President of Regulatory Affairs and Quality Assurance, 7/15/2015 98400H10 GNW  XBiotech to Provide Second Quarter Business Update,,, 2/14/2017 GBT-US   GNW  Global Blood Therapeutics Announces Publication of Paper Describing Discovery of GBT440 in ACS Medicinal Chemistry Letters,,11/30/2015 KURO-US  GNW  Kura Oncology Announces First Patient Dosed in an Investigator-Sponsored Phase 2 Trial of Tipifarnib in Patients With HRAS Mutant Urothelial Cancer,," 2/22/2016 AXSM-US  GNW  Axsome Therapeutics, Inc. (Nasdaq: AXSM) to Ring The Nasdaq Stock Market Opening Bell",, 2/05/2018 BGNE-US  GNW  BeiGene to Present Tislelizumab Data in Urothelial CarcinomaÂ at the 2018 Genitourinary Cancers Symposium,,,,,,,,,,,,,,,,,,,, 3/15/2016 EYPT-US    GNW  Additional Favorable Six-Month Safety Results for pSivida's Medidurâ„¢ for Posterior Uveitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/04/2016 PGNX-US  GNW  Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results,,,,,,,,,"11/03/2017 OPK-US   GNW  OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017",, 3/05/2014 09061G10    GNW  BioMarin Announces Pricing of Public Offering of Common Stock,,,, 3/05/2018 IMMU-US  GNW  Immunomedics to Present at Cowen and Company 38th Annual Health Care Conference, 5/18/2010 MLNM-US   GNW  Infinity Announces Senior Management Promotion,, 4/12/2017 BCRX-US  GNW  BioCryst Expands Development of BCX7353 to Explore Treatment of Acute HAE Attacks,,,,," 4/20/2015 00972810 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 4, 2015 -- AKRX",,11/05/2018 MYGN-US  GNW  Myriad Receives the Prestigious 2018 Utah Top Workplaces Award,,,,, 8/03/2016 INO-US    GNW  Inovio will Independently Develop Hepatitis B Immunotherapy,,,"12/13/2010 GERN-US  GNW  Statman, Harris & Eyrich, LLC Announces Investigation of Geron Corporation",, 2/28/2018 AMRN-US  GNW  Amarin Sponsors Multiple Scientific Presentations Scheduled for 2018 American College of Cardiology Annual Scientific Session & Expo,,,11/08/2017 SRPT-US  GNW  Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024,,," 1/09/2017 AMAG-US  GNW  AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekyndatm (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder",,,,, 3/08/2018 SAN-FR   GNW  Sanofi Completes Acquisition of Bioverativ Inc.,,,,,,"12/02/2015 AFMD-DE  GNW  Affimed Announces Appointment of Andrew Curtis to Lead Corporate Strategy and Business Development, Expansion of US Presence",, 6/16/2015 N7154210 GNW  ProQR to Present at the JMP Securities Life Science Conference,, 5/31/2017 ZGNX-US  GNW  Zogenix to Present at the Jefferies 2017 Global Healthcare Conference,,,,,, 3/25/2015 00773U10 GNW  Avalanche Biotechnologies and the University of Washington Enter Into Exclusive License Agreement to Develop Gene Therapy Medicines to Treat Color Blindness, 3/02/2017 BARC-GB   GNW  Ultragenyx to Present at Upcoming Investor Conferences,, 4/18/2016 NSTG-US  GNW  NanoString Technologies Presents Proof-of-Concept Data for Multiplexed Digital IHC in Tumor Tissues at AACR Meeting,,," 1/28/2016 RDUS-US  GNW  Radius Health Announces Conference Call and Webcast to Provide An Update on Its Progress on Corporate Milestones, Including Its Clinical Collaboration for Investigational Drug RAD1901","11/09/2011 04539610 GNW  Ventrus BioSciences to Announce 3Q 2011 Financial Results, Clinical Update and Omnibus Market Research Results: Conference Call and Webcast",,,,,,, 3/01/2016 07D0VD-E GNW  New Analysis Shows Use of EXPAREL Reduces Length of Hospital Stay and Improves Discharge Status Compared to Standard Analgesic Modality in Total Knee Arthroplasty,"12/08/2014 76129910 GNW  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX", 3/31/2014 69404D10 GNW  Pacific Biosciences Releases Software Upgrade to Support Full-Length Transcript Sequencing and HLA Haplotype Phasing,,, 2/28/2017 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 2016 Financial Results,,,, 9/03/2015 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Morgan Stanley Global Healthcare Conference, 6/02/2015 G7280010 GNW  Prothena Presents Compelling New Data From Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis at 2015 ASCO Annual Meeting,,,, 3/10/2016 37230320 GNW  Genmab Announces Submission of Supplemental Biologics License Application to FDA for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL,,, 5/15/2015 003MH3-E GNW  CymaBay Therapeutics Inc. (Nasdaq: CBAY) to Ring The Nasdaq Stock Market Closing Bell,," 6/03/2014 16383L10 GNW  ChemoCentryx's CCX168, an Orally Administered Complement C5a Receptor Inhibitor, Granted Orphan-Drug Designation in ANCA-Associated Diseases by the FDA",,, 4/05/2016 SNY-FR    GNW  MannKind Regains AfrezzaÂ® Marketing Rights,, 2/02/2017 CYTK-US  GNW  Cytokinetics and Royalty Pharma Announce $100 Million Transaction for Omecamtiv Mecarbil,11/09/2016 ESPR-US     GNW  Esperion Therapeutics to Present at the Stifel 2016 Healthcare Conference," 8/03/2017 03236M20  GNW  Amyris Announces Agreements For $50 Million in Second Tranche of Equity Financing, Exceeding Previous Target of $95 Million",, 6/10/2014 00448Q20 GNW  Achillion Announces Initiation of ACH-3422 Dosing in HCV-Infected Patients and Ability to Resume Sovaprevir Clinical Program for the Treatment of Chronic HCV,"12/18/2017 87166B10 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In INC Research Holdings, Inc. (Nasdaq: INCR) To Contact Brower Piven Before The Lead Plaintiff Deadline",12/08/2016 FOLD-US  GNW  Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease,,,,11/30/2015 36197T10 GNW  GW Pharmaceuticals Announces Date and Time Change for Q4 and Year-End 2015 Financial Results and Conference Call,,,,, 2/23/2017 GLPG-NL  GNW  Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451,"12/23/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces FDA Accepts New Drug Application for Priority Review and EMA Validates Marketing Authorization Application  for Oral, Factor Xa Inhibitor Anticoagulant Betrixaban",,,,10/13/2015 CARA-US  GNW  Cara Therapeutics Achieves Milestone Payments From Japan and South Korea Partners for Development of CR845 in Uremic Pruritus, 4/25/2017 FLXN-US  GNW  Flexion Therapeutics Announces Proposed Convertible Senior Notes Offering, 7/27/2016 QURE-NL  GNW  uniQure Presents Updated Clinical Data in Patients with Severe Hemophilia B Demonstrating up to 9 Months of Sustained Levels of Factor IX Activity and Therapeutic Effect, 6/09/2016 07G766-E  GNW  Agios Reports Initial Data from Phase 1 Study of AG-519 in Healthy Volunteers, 6/10/2015 46226010 GNW  Lion Biotechnologies Receives Orphan Drug Designation for LN-144 for the Treatment of Malignant Melanoma,,,12/03/2015 070JFC-E GNW  Fate Therapeutics to Present at Oppenheimer & Co. 26th Annual Healthcare Conference,,, 2/23/2016 ICPT-US  GNW  Intercept Pharmaceuticals Reports 2015 Financial Results and Provides Business Update,10/09/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Proposed Private Offering of $150 Million of Convertible Senior Notes,,," 6/28/2016 06CR5C-E GNW  Intra-Cellular Therapies Announces Initiation of ITI-007-201 Phase 3 Clinical Trial for the Treatment of Agitation in Patients with Dementia, Including Alzheimerâ€™s Disease",,,,, 1/27/2016 ATRA-US    GNW  Atara Bio Announces Participation in Two Upcoming Investor Conferences,, 8/03/2015 24983L10 GNW  Dermira Doses First Patients in DRM04 Phase 3 Program in Axillary Hyperhidrosis,,, 7/29/2014 86845910 GNW  Supernus to Host Second Quarter 2014 Earnings Conference Call,,, 9/01/2016 MS-US    GNW  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in SeptemberÂ ,,," 6/25/2015 19459J10 GNW  Collegium Announces Publication of ""Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations With Abuse-Deterrent Properties,"" in Pain Medicine", 7/07/2015 98400H10 GNW  XBiotech Announces Publication of Clinical Results Supporting Its True Human(TM) Antibody Therapy for Type 2 Diabetes Mellitus,,, 1/18/2017 GBT-US   GNW  Global Blood Therapeutics Announces Enrollment of First Patient  in Phase 3 HOPE Study in Sickle Cell Disease,,11/11/2015 KURO-US  GNW  Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference,, 2/01/2016 00FKGV-E GNW  Axsome Therapeutics to Present at the 2016 BIO CEO & Investor Conference,, 1/31/2018 BGNE-US  GNW  BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma,,,,,,,,,,,,,,,,,,,, 2/08/2016 EYPT-US    GNW  pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/26/2016 06CR5C-E GNW  Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTORÂ® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain,,,,,,,,,10/26/2017 68375N10 GNW  OPKO Health Licensee TESARO Announces FDA Approval of VARUBIÂ® IV for Delayed Nausea and Vomiting Associated with Chemotherapy,, 3/04/2014 09061G10    GNW  BioMarin Announces Public Offering of Common Stock,,,, 2/15/2018 IMMU-US  GNW  Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference, 5/12/2010 MTEM-US   GNW  Threshold Pharmaceuticals Appoints Dr. David R. Parkinson to Board of Directors,, 4/03/2017 BCRX-US  GNW  BioCryst Announces Mundipharma Receives Approval for MundesineÂ® in Japan,,,,, 3/20/2015 00972810 GNW  Akorn Launches Phenylephrine HCl Ophthalmic Solution,,11/02/2018 MYGN-US  GNW  Myriad Presents Two New Studies at the Western Section of the American Urological Association,,,,, 7/26/2016 06X1SR-E  GNW  Inovio Pharmaceuticals Doses First Subject in Zika Vaccine Clinical Trial,,,,, 2/27/2018 AMRN-US  GNW  Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations,,,"11/07/2017 SRPT-US  GNW  Sarepta Therapeutics Announces FDA Clearance of IND for the Companyâ€™s PPMO Exon 51 Candidate, SRP-5051",,, 1/03/2017 AMAG-US  GNW  AMAG Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,,, 3/08/2018 SAN-FR   GNW  Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform,,,,,,12/01/2015 N0104510 GNW  Affimed to Present at the Oppenheimer 26th Annual Healthcare Conference -- New York,, 5/21/2015 N7154210 GNW  ProQR Therapeutics Announces Results for the First Quarter of 2015,, 5/22/2017 ZGNX-US  GNW  Zogenix Announces Presentation of ZX008 Mechanism of Action Data at Annual Meeting of Society of Biological Psychiatry,,,,,," 3/18/2015 00773U10 GNW  Avalanche Biotechnologies to Host Analyst and Investor Day on March 25, 2015", 2/16/2017 RARE-US   GNW  Ultragenyx Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Update,, 4/14/2016 NSTG-US  GNW  NanoString Technologies Unveils New nCounter Vantageâ„¢ Assays to Power Cancer Research With 3D Biologyâ„¢,,, 1/27/2016 RDUS-US  GNW  Radius Health Announces Clinical Collaboration With a Leading Pharmaceutical Company to Evaluate RAD1901 Combination Regimens in Advanced Breast Cancer, 8/16/2011 04539610 GNW  Ventrus Announces the Launch of the First Pivotal Trial of VEN 309 for the Treatment of Hemorrhoids,,,,,,," 2/25/2016 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports 2015 Financial Results","11/21/2014 76129910 GNW  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Retrophin, Inc. (RTRX) to Contact the Firm", 2/10/2014 69404D10 GNW  Pacific Biosciences Highlights Increased Focus on Human Genome Research at AGBT 2014; Releasing 54x Coverage Human Genome Data for de novo Assembly,,, 2/27/2017 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 8/04/2015 MNTA-US  GNW  Momenta Pharmaceuticals Reports Second Quarter 2015 Financial Results, 5/21/2015 G7280010 GNW  Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results at 20th Congress of the European Hematology Association,,,, 3/09/2016 GMAB-DK  GNW  Genmab Achieves Second Milestone in Daratumumab NHL Study Under Collaboration with Janssen,,,,," 6/02/2014 16383L10 GNW  ChemoCentryx's Orally-Administered Complement 5a Receptor Inhibitor, CCX168, Shows Benefit in ANCA-Associated Vasculitis Based on Birmingham Vasculitis Activity Score and Renal Disease Measurements",,, 3/14/2016 MNKD-US   GNW  MannKind Corporation Reports 2015 Fourth Quarter and Full Year  Financial Results,,12/16/2016 23282W60 GNW  Cytokinetics Added to Nasdaq Biotechnology Index,11/03/2016 ESPR-US     GNW  Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results," 8/01/2017 AMRS-US   GNW  Amyris to Announce Second Quarter 2017 Financial Results on Thursday, August 10, 2017",, 5/07/2014 00448Q20 GNW  Achillion Reports First Quarter 2014 Financial Results,"12/14/2017 87166B10 GNW  INCR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving INC Research Holdings, Inc. and a Lead Plaintiff Deadline of January 30, 2018",11/28/2016 FOLD-US  GNW  Amicus Therapeutics Announces U.S. Regulatory Pathway for Migalastat for Fabry Disease,,,,11/25/2015 GWP-GB   GNW  New Epidiolex(R) (CBD) Data Accepted for Presentation at the 69th Annual Meeting of the American Epilepsy Society,,,,, 2/23/2017 GLPG-NL  GNW  Galapagos reports strong financial results and newsflow-rich pipeline,12/19/2016 73701010 GNW  Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXaâ„¢ (andexanet alfa),,,, 9/28/2015 CARA-US  GNW  Cara Therapeutics to Present at the American Academy of Physical Medicine and Rehabilitation Annual Assembly," 4/25/2017 FLXN-US  GNW  Flexion Therapeutics to Report First-Quarter 2017 Financial Results on May 4, 2017", 7/11/2016 N9006410 GNW  uniQure Announces Oral Presentation of Updated Results for AMT-060 at the World Federation of Hemophilia (WFH) 2016 World Congress, 6/01/2016 07G766-E  GNW  Agios to Host Conference Call from the 21st Congress of the European Hematology Association, 6/08/2015 46226010 GNW  Lion Biotechnologies Names Molly Henderson Chief Financial Officer,,,11/05/2015 31189P10 GNW  Fate Therapeutics to Present Strategy for the Development of Off-the-Shelf Cancer Immunotherapies at ASH 2015,,, 2/17/2016 ICPT-US  GNW  Intercept to Report 2015 Full Year Financial Results on February 23 and Present at Upcoming Conference,10/05/2018 KPTI-US    GNW  U.S. Food and Drug Administration Accepts Karyopharmâ€™s New Drug Application for Selinexor and Grants Priority Review,,, 6/15/2016 002N2S-E GNW  Intra-Cellular Therapies to Present at the JMP Securities Life Sciences Conference,,,,, 1/04/2016 ATRA-US    GNW  Atara Bio to Present at the 34th Annual J.P. Morgan Healthcare Conference,, 6/09/2015 24983L10 GNW  Dermira's Phase 2a DRM01 Acne Trial Data Presented at the World Congress of Dermatology Meeting,,, 7/08/2014 86845910 GNW  Supernus to Receive $30 Million in Non-Dilutive Royalty Deal,,, 8/31/2016 CHRS-US  GNW  Coherus BioSciences Announces New Employment Inducement Grants,,, 6/15/2015 19459J10 GNW  Collegium to Present Xtampza ER(TM) Oral Human Abuse Potential Data at the College on Problems of Drug Dependence 77th Annual Meeting, 7/06/2015 98400H10 GNW  XBiotech Treats First Patient in Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus,,, 1/03/2017 GBT-US   GNW  Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference,,11/04/2015 50127T10 GNW  Kura Oncology Announces Pricing of Public Offering of Common Stock,, 1/27/2016 AXSM-US  GNW  Axsome Therapeutics Announces Issuance of U.S. Patent Covering AXS-02 for the Treatment of Bone Marrow Lesions of the Knee,, 1/22/2018 BGNE-US  GNW  BeiGene Announces Closing of $800 Million Public Offering,,,,,,,,,,,,,,,,,,,, 2/01/2016 EYPT-US    GNW  pSivida Corp Announces Second Quarter Fiscal Year 2016 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/22/2016 PGNX-US  GNW  Progenics Pharmaceuticals Sets Second Quarter  2016 Financial Results Call for August 4,,,,,,,,,10/12/2017 OPK-US   GNW  OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEEÂ® in Japan,, 3/04/2014 09061G10    GNW  BioMarin to Present at the Barclays Global Healthcare Conference in Miami,,,, 2/08/2018 IMMU-US  GNW  Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update,,, 3/29/2017 BCRX-US  GNW  BioCryst to Present at the 16th Annual Needham Healthcare Conference,,,,," 3/17/2015 00972810 GNW  Akorn Files Annual Report on Form 10-K for Year Ended December 31, 2014; Restates Second and Third Quarter 2014 Financial Statements",,10/30/2018 MYGN-US  GNW  Myriad Genetics to Present at the Stephens New York Investment Conference,,,,," 7/26/2016 INO-US    GNW  Inovio Pharmaceuticals to Report Second Quarter 2016 Financial Results August 8, 2016",,,,," 2/20/2018 AMRN-US  GNW  Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference CallÂ on February 27th, 2018",,,11/06/2017 SRPT-US  GNW  Sarepta Therapeutics and Nationwide Childrenâ€™s Hospital Announce FDA Clearance of IND for Micro-Dystrophin Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy,,,12/21/2016 GMCR-US  GNW  AMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors,,,,, 3/07/2018 SAN-FR   GNW  Sanofi: Filing of the 2017 U.S. Form 20-F and French Â« Document de RÃ©fÃ©rence Â» containing the Annual Financial Report,,,,,,11/11/2015 N0104510 GNW  Affimed CEO to Present at the Jefferies 2015 Global Healthcare Conference -- London,, 4/29/2015 N7154210 GNW  ProQR to Present at Two Upcoming Investor Conferences in May,, 5/04/2017 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports First Quarter 2017 Financial Results,,,,,," 3/05/2015 00773U10 GNW  Avalanche Biotechnologies, Inc. Reports Fourth Quarter and Fiscal 2014 Financial Results", 2/10/2017 05LK9B-E  GNW  Ultragenyx to Present at Leerink Partners Global Healthcare Conference,," 4/13/2016 NSTG-US  GNW  NanoString Technologies to Release First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5, 2016",,,12/22/2015 RDUS-US  GNW  Radius Health to Present at the 34th Annual J.P. Morgan Healthcare Conference, 7/19/2011 04539610 GNW  Ventrus Biosciences Announces Exercise of Underwriters' Over-Allotment Option and Closing of $51.75 Million Underwritten Registered Offering,,,,,,, 2/11/2016 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for 2015 Financial Results Webcast and Conference Call,"11/19/2014 76129910 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Retrophin, Inc. to Contact Brower Piven Before the December 19, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RTRX"," 2/04/2014 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Fourth Quarter 2013 Financial Results",,, 2/16/2017 MGNX-US  GNW  MacroGenics Announces Date of Fourth Quarter and Full Year 2016 Financial Results Conference Call,,,, 7/21/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2015 Financial Results Conference Call and Webcast, 5/13/2015 G7280010 GNW  Prothena to Present Updated Clinical Data From Ongoing Phase 1/2 Study of NEOD001 at 2015 ASCO Annual Meeting,,,, 3/09/2016 37230320 GNW  Genmab Announces European Regulatory Submission for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL,,,,," 5/08/2014 16383L10 GNW  ChemoCentryx Announces Financial Results for the First Quarter Ended March 31, 2014",,, 3/14/2016 MNKD-US   GNW  MannKind Announces Appointment of Michael Castagna as Chief Commercial Officer,,12/09/2016 CYTK-US  GNW  Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND,11/01/2016 CS-CH       GNW  Esperion Therapeutics to Present at the Credit Suisse 25th Annual Healthcare Conference, 7/26/2017 AMRS-US   GNW  Amyris Biossance Launches in SEPHORA Canada Stores,, 5/01/2014 00448Q20 GNW  Achillion to Present at Three Upcoming Investor Conferences,"12/12/2017 87166B10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of INC Research Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 30, 2018 â€“ INCR",11/11/2016 FOLD-US  GNW  Journal of Medical Genetics Publishes Pivotal Phase 3 ATTRACT Study of Migalastat for Patients with Fabry Disease,,,,11/24/2015 GWP-GB   GNW  GW Pharmaceuticals to Present at the Piper Jaffray 27th Annual Healthcare Conference,,,,, 2/01/2017 GLPG-NL  GNW  Galapagos doses first patient with novel CF corrector GLPG2222,"11/28/2016 06QBQ2-E GNW  Portola Pharmaceuticals Announces AndexXaâ„¢ (andexanet alfa), Betrixaban and Cerdulatinib Data to be Presented at 2016 American Society of Hematology Annual Meeting and Exposition",,,, 9/22/2015 14075510 GNW  Cara Therapeutics to Present Data at the 8th World Congress on Itch," 4/07/2017 FLXN-US  GNW  Flexion Therapeutics Announces Appointment of  Yamo Deniz, MD, as Chief Medical Officer", 7/07/2016 QURE-NL  GNW  uniQure Appoints Jonathan Garen as Chief Business Officer, 5/19/2016 07G766-E  GNW  Agios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association, 5/19/2015 46226010 GNW  Lion Biotechnologies to Participate in Upcoming Investor Conferences,,,11/05/2015 31189P10 GNW  Fate Therapeutics to Present Preclinical Data for ProTmune(TM) at ASH 2015 Annual Meeting,,, 2/04/2016 ICPT-US  GNW  Intercept to Present at Upcoming Investor Conferences,10/01/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/31/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Jefferies 2016 Healthcare Conference,,,,,12/18/2015 04651310   GNW  Atara Bio Added to the NASDAQ Biotechnology Index,, 6/02/2015 24983L10 GNW  Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology,,, 5/21/2014 86845910 GNW  Supernus to Present at Jefferies Healthcare Conference in June,,, 8/09/2016 CHRS-US  GNW  Coherus BioSciences Reports Second Quarter 2016 Financial and Operating Results,,," 6/08/2015 19459J10 GNW  Collegium Announces Issuance of U.S. Patent Covering DETERx(R) - an Abuse-Deterrent, Extended-Release Technology Platform", 7/01/2015 98400H10 GNW  XBiotech Conducts Investigators Meeting to Update the Status of Its Phase III Registration Study Underway in Europe,,,12/16/2016 37890U10 GNW  Global Blood Therapeutics Added to NASDAQ Biotechnology Index,,10/28/2015 50127T10 GNW  Kura Oncology Announces Launch of Public Offering of Common Stock,, 1/04/2016 00FKGV-E GNW  Axsome Therapeutics to Present at Biotech Showcase 2016,, 1/17/2018 BGNE-US  GNW  BeiGene Announces Pricing of $750 Million Public Offering,,,,,,,,,,,,,,,,,,,, 1/28/2016 EYPT-US    GNW  pSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/08/2016 0032QC-E GNW  Progenics Pharmaceuticals to Present at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference,,,,,,,,, 9/19/2017 OPK-US   GNW  OPKOâ€™s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care,, 2/26/2014 BMRN-US     GNW  BioMarin Announces Fourth Quarter and Full Year 2013 Financial Results,,,," 2/06/2018 IMMU-US  GNW  Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018",,, 3/09/2017 BCRX-US  GNW  BioCryst Pharmaceuticals Prices Public Offering of Common Stock,,,,, 3/11/2015 00972810 GNW  Akorn Provides Update on Recent Product Launches,,"10/24/2018 MYGN-US  GNW  Myriad to Announce Fiscal First-Quarter 2019 Financial Results on November 6, 2018",,,,, 7/14/2016 INO-US    GNW  Inovio Deploys DNA-based Monoclonal Antibody Technology in Quest to Cure HIV,,,,, 1/30/2018 AMRN-US  GNW  Amarin Prices Public Offering of American Depositary Shares,,,11/03/2017 SRPT-US  GNW  Sarepta Therapeutics and Nationwide Childrenâ€™s Hospital Announce U.S. Food and Drug Administration (FDA) Clearance of the IND Application for the GALGT2 Gene Therapy Program,,,12/15/2016 AMAG-US  GNW  AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research,,,,, 3/06/2018 SAN-FR   GNW  Sanofi's Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director,,,,,,11/10/2015 N0104510 GNW  Affimed Reports Financial Results for Third Quarter 2015,, 4/29/2015 N7154210 GNW  ProQR Therapeutics Announces Annual Shareholder Meeting,, 4/27/2017 ZGNX-US  GNW  Zogenix Completes Enrollment in First ZX008 Phase 3 Clinical Trial in Dravet Syndrome,,,,,, 2/25/2015 00773U10 GNW  Avalanche Biotechnologies to Present at Upcoming Investor Conferences, 2/09/2017 RARE-US   GNW  Ultragenyx to Host Conference Call for Fourth Quarter and Full Year 2016  Financial Results and Corporate Update,, 4/11/2016 0FF62M-E GNW  HalioDx and NanoString Technologies Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology,,,12/07/2015 RDUS-US  GNW  Radius Health Appoints Former GlaxoSmithKline CEO Jean-Pierre Garnier to Board of Directors, 6/22/2011 04539610 GNW  Ventrus Receives SPA Response From FDA and Will Update and File the First Pivotal Trial Protocol to its IND,,,,,,," 2/02/2016 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) to Ring The Nasdaq Stock Market Opening Bell","11/13/2014 76129910 GNW  Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Retrophin, Inc. -- RTRX"," 1/10/2014 69404D10 GNW  Pacific Biosciences of California, Inc. Fourth Quarter and Year End 2013 Financial Results Call",,, 2/09/2017 MGNX-US  GNW  MacroGenics to Present at the Leerink Partners 6th Annual Global Healthcare Conference,,,, 6/25/2015 60877T10 GNW  Momenta Pharmaceuticals Announces CFO Retirement and Succession Plan, 5/05/2015 G7280010 GNW  Prothena Reports First Quarter 2015 Financial Results and Provides R&D Update,,,, 3/08/2016 37230320 GNW  Genmab Provides Update on Ofatumumab Development in Autoimmune Indications,,,,," 4/29/2014 16383L10 GNW  ChemoCentryx to Hold First Quarter 2014 Financial Results Conference Call on Thursday, May 8, 2014",,," 3/11/2016 56400P70  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016 â€“ MNKD",,12/07/2016 CYTK-US  GNW  Origent Data Sciences and Cytokinetics Present Analyses Demonstrating Baseline Data Predict Measures of Vital Capacity in Patients With ALS,10/13/2016 ESPR-US     GNW  Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any Dose, 7/17/2017 AMRS-US   GNW  Amyris Enters Into First Product Development and Production Agreement With Royal DSM For Food and Nutrition Molecule,," 4/30/2014 00448Q20 GNW  Achillion Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, for HCV","12/04/2017 87166B10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In INC Research Holdings, Inc. To Contact The Firm",11/07/2016 FOLD-US  GNW  Amicus Therapeutics Announces Third Quarter 2016 Financial Results and Corporate Updates,,,,"11/24/2015 36197T10 GNW  GW Pharmaceuticals to Report Q4 and Year-End 2015 Financial Results and Host Conference Call on 3 December, 2015",,,,, 1/20/2017 GLPG-NL  GNW  Galapagos creates new warrant plan,11/14/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Ill Patients with Extended-Duration Betrixaban,,,, 9/09/2015 14075510 GNW  Cara Therapeutics Initiates Phase 3 Program for I.V. CR845 in Acute Postoperative Pain, 4/04/2017 FLXN-US  GNW  Flexion Therapeutics Announces Issuance of Two New Patents Further Strengthening Intellectual Property Protection (IP) for Zilrettaâ„¢ (FX006)," 6/27/2016 QURE-NL  GNW  uniQure Appoints Maria E. Cantor as Senior Vice President, Investor Relations & Communications", 5/17/2016 AGIO-US   GNW  AgiosÂ Updates 2016 Financial Guidance, 5/01/2015 GNBP-US  GNW  Lion Biotechnologies Announces Pricing of Secondary Offering of Shares by Selling Stockholders,,,11/03/2015 31189P10 GNW  Fate Therapeutics Reports Third Quarter 2015 Financial Results,,,12/17/2015 ICPT-US  GNW  FDA Extends PDUFA Date for Obeticholic Acid for the Treatment of PBC, 9/25/2018 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,, 5/26/2016 07L8WW-E GNW  Intra-Cellular Therapies to Present at the American Society of Clinical Psychopharmacology 2016 Annual Meeting,,,,,12/14/2015 ATRA-US    GNW  Atara Bio Announces Results From the Phase 2 Proof-of-Concept PINTA 745 Clinical Trial for Protein Energy Wasting in Patients With End Stage Renal Disease,, 5/28/2015 24983L10 GNW  Dermira to Present at Jefferies 2015 Global Healthcare Conference,,, 5/20/2014 86845910 GNW  Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM),,, 8/09/2016 06CR5C-E GNW  Coherus BioSciences Submits 351(k) Biologics License Application to U.S. Food and Drug Administration for CHS-1701 (Pegfilgrastim Biosimilar Candidate),,, 6/01/2015 19459J10 GNW  Collegium Expands Commercial Organization With Key Appointments, 6/24/2015 00GL6Z-E GNW  XBiotech Added to Russell 2000 Index,,,12/05/2016 GBT-US   GNW  Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study,,10/14/2015 50127T10 GNW  Kura Oncology Appoints Thomas Malley to Board of Directors,,11/24/2015 AXSM-US  GNW  Axsome Therapeutics Announces Closing of Initial Public Offering,, 1/16/2018 BGNE-US  GNW  BeiGene Announces Proposed Public Offering,,,,,,,,,,,,,,,,,,,, 1/13/2016 30233G10   GNW  pSivida Closes $17.8 Million Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/13/2016 0FFL92-E GNW  Progenics Pharmaceuticals Announces Presentations on its Prostate Cancer Imaging Programs at SNMMI 2016,,,,,,,,, 9/12/2017 OPK-US   GNW  OPKOâ€™s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings,, 2/25/2014 09061G10    GNW  BioMarin to Present at the Cowen Healthcare Conference in Boston,,,, 1/11/2018 IMMU-US  GNW  Immunomedics Announces Agreement with University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) into Prostate Cancer,,, 3/08/2017 BCRX-US  GNW  BioCryst Pharmaceuticals Commences Public Offering of Common Stock,,,,, 3/10/2015 00972810 GNW  Akorn Reaffirms 2015 Revenue and EPS Guidance,,10/23/2018 MYGN-US  GNW  Myriad Announces Publication of Foresightâ„¢ Carrier Screen Clinical Utility Study in Genetics in Medicine,,,,, 6/20/2016 INO-US    GNW  Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial,,,,, 1/29/2018 AMRN-US  GNW  Amarin Announces Proposed Public Offering of American Depositary Shares,,,11/01/2017 SRPT-US  GNW  Sarepta Therapeutics to Present at the 26th Annual Credit Suisse Healthcare Conference,,,11/03/2016 AMAG-US  GNW  AMAG Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,,,, 3/02/2018 SAN-FR   GNW  Sanofi : FDA to review DupixentÂ® (dupilumab) as potential treatment for moderate-to-severe asthma,,,,,,11/06/2015 N0104510 GNW  Affimed Presents Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC,, 2/26/2015 N7154210 GNW  ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014,, 4/27/2017 ZGNX-US  GNW  Zogenix to Release First Quarter 2017 Financial Results and Host Conference Call and Webcast on May 4,,,,,, 1/08/2015 00773U10 GNW  Avalanche Biotechnologies Prices Public Offering of $141.6 Million of Common Stock, 1/05/2017 RARE-US   GNW  Ultragenyx and Kyowa Kirin International Announce Marketing Authorization Application for KRN23 Filed and Accepted for Review by European Medicines Agency,, 4/11/2016 NSTG-US  GNW  NanoString Technologies and HalioDx Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology,,,12/07/2015 RDUS-US  GNW  Radius Health Announces Conference Call and Webcast on New Data for Investigational Drug RAD1901 to be Presented at San Antonio Breast Cancer Symposium 2015, 5/31/2011 04539610 GNW  Ventrus Receives Notice of Allowance for U.S. Patent for VEN 307,,,,,,, 1/07/2016 PCRX-US  GNW  Pacira Pharmaceuticals Reports Estimated Full-Year 2015 Total Revenue of $249.0 Million,"11/10/2014 07YM31-E GNW  Hagens Berman Reminds Investors of the December 19, 2014 Lead Plaintiff Deadline in the Class Action Against Retrophin, Inc. (NASDAQ: RTRX)","12/03/2013 69404D10 GNW  Pacific Biosciences, the Wellcome Trust Sanger Institute and Public Health England Collaborate to Finish Genomes of 3,000 Bacterial Strains",,, 1/25/2017 MGNX-US  GNW  MacroGenics Announces Appointments to Board of Directors,,,," 6/18/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg", 4/28/2015 G7280010 GNW  Prothena to Present at Upcoming Investor Healthcare Conferences,,,, 2/17/2016 37230320 GNW  Genmab 2015 Annual Report,,,,," 3/27/2014 16383L10 GNW  ChemoCentryx Appoints Anne-Marie S. Duliege, M.D., M.S. to Chief Strategic Development Role and Head of Immuno-Oncology",,," 3/07/2016 MNKD-US   GNW  MannKind Corporation to Hold 2015 Fourth Quarter and Full Year Financial Results Conference Call on March 14, 2016",,12/02/2016 CYTK-US  GNW  Cytokinetics Announces Presentations at the International Symposium on ALS/MND, 8/04/2016 ESPR-US     GNW  Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Second Quarter 2016 Financial Results, 6/20/2017 AMRS-US   GNW  Amyris Partners with Queensland on Biofutures  Acceleration Program in Next Step Toward Planned  Development of Biorefinery,," 3/14/2014 00448Q20 GNW  Achillion Announces Oral Presentations Given at APASL 2014 Detailing Clinical Activity of ACH-3102, Second-Generation NS5A Inhibitor, Against Genotype 1b HCV"," 7/13/2017 87166B10 GNW  Stull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR)","11/01/2016 FOLD-US  GNW  Amicus Therapeutics to Announce Third Quarter 2016 Financial Results on November 7, 2016",,,,10/27/2015 36197T10 GNW  GW Pharmaceuticals and the Government of New South Wales Announce a Strategic Agreement to Study Epidiolex(R) and CBDV in a Clinical Trial and Research Program for Children With Epilepsy,,,,, 1/17/2017 GLPG-NL  GNW  Dr. Walid Abi-Saab joins Galapagos as Chief Medical Officer,11/07/2016 PTLA-US  GNW  Portola Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,,, 9/03/2015 14075510 GNW  Cara Therapeutics to Webcast Presentation at 22nd Annual NewsMakers in the Biotech Industry Conference, 3/28/2017 FLXN-US  GNW  Flexion Therapeutics to Present at Needham & Companyâ€™s 16th Annual Healthcare Conference, 6/11/2016 QURE-NL  GNW  uniQure Presents Clinical Data from Ongoing Phase I/II Study in Hemophilia B Demonstrating 6 Months of Sustained Increases in Factor IX Activity, 5/17/2016 00847X10  GNW  AgiosÂ and Celgene Establish New Collaboration in MetabolicÂ Immuno-Oncology and Amend Certain Rights from 2010 Agreement, 4/08/2015 GNBP-US  GNW  Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated With HPV-TIL,,,"10/29/2015 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2015 Financial Results on November 3, 2015",,,12/11/2015 ICPT-US  GNW  Gino Santini and Daniel Welch Elected to Board of Directors of Intercept Pharmaceuticals, 9/20/2018 KPTI-US    GNW  Selinexor Clinical Data to be Presented at the 21st Annual Meeting of the Chinese Society of Clinical Oncology,,, 5/18/2016 05V7PQ-E GNW  Intra-Cellular Therapies presents at the Annual Meetings of the Society of Biological Psychiatry and the American Psychiatric Association,,,,,"12/06/2015 ATRA-US    GNW  Atara Bio Announces Positive Results From a Phase 2 Clinical Trial of Cytomegalovirus Targeted Cytotoxic T Lymphocytes (CMV-CTL), a Novel Approach to Adoptive Immunotherapy, to Treat Patients With Refractory CMV Disease in the Central Nervous System (CNS)",, 5/12/2015 24983L10 GNW  Dermira Reports First Quarter 2015 Financial Results and Provides Corporate Update,,, 5/12/2014 86845910 GNW  Supernus Announces First Quarter 2014 Results,,, 8/08/2016 CHRS-US  GNW  Coherus BioSciences Announces Positive Topline Phase Three Results forÂ CHS-1420 (HumiraÂ® Biosimilar Candidate) in Patients with Psoriasis,,, 5/27/2015 00772J-E GNW  Collegium to Present at the Jefferies 2015 Global Healthcare Conference, 6/15/2015 98400H10 GNW  CORRECTING and REPLACING -- XBiotech Announces Publication of Phase 2 Clinical Results for Its True Human(TM) Antibody MABp1 for Treating Acne Vulgaris,,,12/04/2016 GBT-US   GNW  Global Blood Therapeutics Announces New Long-Term Clinical Data from Ongoing Phase 1/2 Trial of GBT440 in Sickle Cell Disease at ASH,, 9/30/2015 50127T10 GNW  Kura Oncology Initiates Phase 2 Study of Tipifarnib in Peripheral T-cell Lymphoma,,11/19/2015 05464T10 GNW  Axsome Therapeutics Announces Pricing of Initial Public Offering,, 1/09/2018 BGNE-US  GNW  BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement  for Anti-PD-1 Antibody Tislelizumab,,,,,,,,,,,,,,,,,,,, 1/07/2016 30233G10   GNW  pSivida Announces Pricing of $16 MillionÂ Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 6/09/2016 PGNX-US  GNW  Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors",,,,,,,,, 8/31/2017 OPK-US   GNW  OPKO Health to Present at Upcoming September Conferences,, 2/20/2014 09061G10    GNW  BioMarin Receives Positive Opinion From the CHMP in the European Union for VIMIZIM(TM) (elosulfase alfa) for Morquio A Syndrome,,,, 1/08/2018 072LZ4-E GNW  Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million,,, 2/27/2017 BCRX-US  GNW  BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results,,,,, 3/04/2015 00972810 GNW  Akorn Adopts Comprehensive Policy to Support the Use of Its Products to Promote Human Health,,10/22/2018 MYGN-US  GNW  Myriadâ€™s BRACAnalysis CDxÂ® Test Identifies Patients with Newly Diagnosed Advanced Ovarian Cancer Who May Benefit from Maintenance Treatment with LynparzaÂ®,,,,, 5/16/2016 INO-US    GNW  Inovio Pharmaceuticals Zika VaccineÂ Produces Robust Immune Responses in Non-Human Primates,,,,, 1/23/2018 AMRN-US  GNW  Amarinâ€™s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events,,,10/31/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,10/27/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 3/01/2018 SAN-FR   GNW  Sanofi Announces Receipt of Antitrust Clearances in Connection with the Acquisition of Ablynx,,,,,,11/05/2015 AFMD-DE  GNW  Affimed to Present Data on NK- and T-Cell Engagers at ASH,, 2/04/2015 N7154210 GNW  ProQR to Present at the 2015 Leerink Global Healthcare Conference,, 3/15/2017 ZGNX-US  GNW  Zogenix to Participate in the Oppenheimer 27th Annual Healthcare Conference,,,,,, 1/05/2015 00773U10 GNW  Avalanche Biotechnologies Announces Proposed Public Offering of Common Stock and Partial Release of Lock-Up Agreements in Connection Therewith, 1/04/2017 RARE-US   GNW  Ultragenyx to Present at J.P. Morgan Healthcare Conference,, 3/21/2016 NSTG-US  GNW  NanoString Technologies Receives Favorable Final Local Coverage Determination by Noridian Healthcare Solutions for Its Prosigna Breast Cancer Assay,,,12/04/2015 RDUS-US  GNW  Radius Announces European Medicines Agency Validates Marketing Authorization Application for Abaloparatide-SC for the Treatment of Osteoporosis in Postmenopausal Women," 5/18/2011 04539610 GNW  Ventrus Biosciences (VTUS) President, Chairman & CEO to Ring the NASDAQ Stock Market Closing Bell",,,,,,,"12/28/2015 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference","11/06/2014 76129910 GNW  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX","10/22/2013 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2013 Financial Results",,, 1/05/2017 MGNX-US  GNW  MacroGenicsâ€™ MGD006 Granted Orphan Drug Status for AML by FDA,,,, 6/18/2015 MNTA-US  GNW  Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit, 4/23/2015 0CXBJZ-E GNW  Dr. Dale Schenk to Participate on Expert Panel at World Medical Innovation Forum: Neurosciences,,,, 2/04/2016 37230320 GNW  Major Shareholder Announcement,,,,," 3/13/2014 16383L10 GNW  ChemoCentryx Announces Financial Results for the Quarter and Year Ended December 31, 2013",,," 3/03/2016 56400P70  GNW  EQUITY NOTICE: Rosen Law Firm Reminds MannKind Corp. Investors of Important March 15, 2016 Deadline in Class Action Filed by Firm â€“ MNKD",,"12/01/2016 CYTK-US  GNW  Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil", 6/28/2016 ESPR-US     GNW  Esperion Therapeutics Provides Clinical Development and Regulatory Update for Bempedoic Acid," 6/19/2017 AMRS-US   GNW  DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Amyris, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2017 â€“ AMRS",, 3/07/2014 00448Q20 GNW  Achillion Reports 2013 Fourth Quarter and Year-End Financial Results," 3/30/2017 87166B10 GNW  Catalyst Biosciences Announces Emergence from Key Patent Opposition Period Supporting Marzeptacog Alfa (activated), Catalystâ€™s Lead Clinical Program", 9/22/2016 FOLD-US  GNW  Amicus Therapeutics to Present at LEERINK Roundtable Series: Rare Disease & Immuno-Oncology,,,,10/27/2015 36197T10 GNW  GW Pharmaceuticals and Otsuka Announce Results From Two Remaining Sativex(R) Phase 3 Cancer Pain Trials,,,,,12/20/2016 GLPG-NL  GNW  SAPHIRA 1 topline shows competitive clinical results in G551D patients,11/07/2016 06418D-E GNW  Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data to be Presented at American Heart Association Scientific Sessions 2016,,,, 9/01/2015 14075510 GNW  Cara Therapeutics to Sponsor Symposium and Present Posters at PAINWeek, 3/09/2017 FLXN-US  GNW  Flexion Reports Year-End 2016 Financial Results, 5/31/2016 N9006410 GNW  uniQure Announces Results for First Quarter 2016, 5/05/2016 AGIO-US   GNW  Agios Reports First Quarter 2016 Financial Results, 3/30/2015 46226010 GNW  Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma,,,10/28/2015 31189P10 GNW  Fate Therapeutics Strengthens Intellectual Property Position With New U.S. Patent Covering Induced Pluripotent Cell Compositions,,,12/07/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Initiation of Prospective Trial to Explore Effect of Combined OCA and Statin Therapy on Lipid Metabolism in NASH Patients, 9/13/2018 KPTI-US    GNW  Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma Presented at the Society of Hematologic Oncology 2018 Annual Meeting,,, 5/10/2016 05V7PQ-E GNW  Intra-Cellular Therapies to Present at the American Psychiatric Association 169th Annual Meeting and the Society of Biological Psychiatry 71st Annual Meeting,,,,,12/05/2015 ATRA-US    GNW  Atara Bio Announces Positive Results From Phase 1 Clinical Trial of Wilmsâ€™ Tumor 1 Targeted Cytotoxic T Lymphocytes (WT1-CTL) Product Candidate in Hematologic Malignancies,, 4/09/2015 24983L10 GNW  Dermira Doses First Patient in DRM01 Phase 2b Acne Trial,,, 4/29/2014 86845910 GNW  Supernus to Host First Quarter 2014 Earnings Conference Call,,, 7/25/2016 CHRS-US  GNW  Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th,,, 5/12/2015 00772J-E GNW  Collegium Pharmaceutical Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares, 6/15/2015 98400H10 GNW  XBiotech Announces Publication of Phase 2 Clinical Results for Its True Human(TM) Antibody MABp1 for Treating Acne Vulgaris,,,11/30/2016 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Investor Webcast to Review GBT440 Data Being Presented at ASH that Support Sickle Cell Disease Program,, 9/16/2015 50127T10 GNW  Kura Oncology Cleared for Quotation on the OTCQB,, 8/10/2015 00FKGV-E GNW  Axsome Therapeutics Announces Enrollment of the First Patient in a Phase 3 Trial of AXS-02 for Complex Regional Pain Syndrome (CRPS),, 1/08/2018 07725L10 GNW  BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region,,,,,,,,,,,,,,,,,,,, 1/06/2016 EYPT-US    GNW  pSivida Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/02/2016 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference,,,,,,,,, 8/08/2017 OPK-US   GNW  OPKO Health Reports Second Quarter 2017 Business and Financial Results,, 2/19/2014 09061G10    GNW  BioMarin to Present at Two Upcoming Investor Conferences in New York,,,, 1/04/2018 IMMU-US  GNW  Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,, 2/27/2017 BCRX-US  GNW  BioCryst Reports Positive Interim Results from its APeX-1 Trial,,,,, 3/02/2015 00972810 GNW  Akorn Announces Filing Extension for Form 10-K,,10/19/2018 MYGN-US  GNW  New Studies Highlight Performance of VectraÂ® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab,,,,, 5/11/2016 UBS-CH    GNW  Inovio Pharmaceuticals to Present at UBS Global Healthcare Conference,,,,, 1/17/2018 AMRN-US  GNW  Amarin Announces Commencement of VASCEPAÂ® Clinical Development in Mainland China,,,10/31/2017 SRPT-US  GNW  Sarepta Therapeutics Signs Exclusive Global Collaboration with Duke University for Gene Editing CRISPR/Cas9 Technology to Develop New Treatments for Duchenne Muscular Dystrophy (DMD),,,"10/19/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Host Third Quarter 2016 Financial Results Conference Call and Webcast on Thursday, November 3, 2016 at 8:00 a.m. ET",,,,, 2/23/2018 SAN-FR   GNW  Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ,,,,,,11/05/2015 AFMD-DE  GNW  Affimed to Present Data on NK- and T-Cell Engagers at ASH,,11/24/2014 N7154210 GNW  ProQR Therapeutics Announces Results for the Third Quarter of 2014,, 3/09/2017 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results,,,,,,12/15/2014 00773U10 GNW  Annual Changes to the NASDAQ Biotechnology Index,11/30/2016 RARE-US   GNW  Ultragenyx Announces Positive Data from Phase 2 Study of UX007 in Long-Chain Fatty Acid Oxidation Disorder Patients,, 3/10/2016 NSTG-US  GNW  NanoString Technologies and Cell Signaling Technology Announce Agreement to Expand Suite of 3D Biology Assays,,,11/17/2015 RDUS-US  GNW  Radius Health Has Submitted a Marketing Authorization Application for the Investigational Drug Abaloparatide-SC for the Treatment of Postmenopausal Osteoporosis in Europe, 5/02/2011 04539610 GNW  Ventrus Adds Third Treatment Arm of Shorter Treatment Duration to Its Phase III Study of Iferanserin in Hemorrhoids,,,,,,,"12/15/2015 PCRX-US  GNW  Pacira Pharmaceuticals Announces Favorable Resolution With U.S. Food and Drug Administration, Which Reaffirms the Broad Indication for EXPARELÂ®","11/04/2014 76129910 GNW  EQUITY ALERT: Rosen Law Firm Reminds Retrophin, Inc. Investors of Important Class Action Deadline -- RTRX","10/03/2013 69404D10 GNW  Pacific Biosciences of California, Inc. Third Quarter 2013 Financial Results Call",,, 1/05/2017 MGNX-US  GNW  MacroGenics to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,, 6/04/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Oral and Poster Presentations Relating to Novel Autoimmune Programs at EULAR 2015," 4/08/2015 G7280010 GNW  Prothena Announces Pricing of Public Offering of 3,300,000 Ordinary Shares",,,, 1/19/2016 GMAB-DK  GNW  Genmab Announces U.S. FDA Approval of Arzerra(r) (ofatumumab) as Extended Treatment for Recurrent or Progressive CLL,,,,," 3/03/2014 16383L10 GNW  ChemoCentryx to Hold Fourth Quarter and Year-End 2013 Financial Results Conference Call on Thursday, March 13, 2014",,, 2/26/2016 MNKD-US   GNW  MannKind to Potentially File 2015 10-K Filing Extension,,11/30/2016 23282W60 GNW  The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patients With Chronic Heart Failure, 5/04/2016 ESPR-US     GNW  Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2016 Financial Results," 6/17/2017 03236M20  GNW  JUNE 19 DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm",, 2/10/2014 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,"11/15/2016 87166B10 GNW  Cellectar Biosciences Announces INC Research as the CRO for the Phase II Trial of CLR 131 in Hematologic Malignancies; $2M NCI Grant Covers Half of Study Cost, with Potential Option to Pursue Additional $3M for Pivotal Trial", 9/13/2016 FOLD-US  GNW  UPDATE -- Amicus Therapeutics to Present at Bank of America Merrill Lynch Global Healthcare Conference 2016,,,, 9/15/2015 36197T10 GNW  GW Pharmaceuticals Announces Positive Proof of Concept Data in Schizophrenia,,,,,12/15/2016 GLPG-NL  GNW  The Lancet publishes FITZROY study results with filgotinib in Crohn's disease,11/02/2016 CS-CH    GNW  Portola Pharmaceuticals to Present at the Credit Suisse  25th Annual Healthcare Conference,,,, 8/17/2015 14075510 GNW  Cara Therapeutics Initiates Phase 2 Trial of Oral CR845 in Osteoarthritis, 3/03/2017 FLXN-US  GNW  Flexion Therapeutics to Present at Upcoming Investor Conferences, 5/19/2016 N9006410 GNW  uniQure Announces Oral Presentation of Clinical Data from Ongoing Phase I/II Study of AMT-060 in Hemophilia B at the 21st Congress of the European Hematology Association," 5/02/2016 AGIO-US   GNW  Agios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016", 3/03/2015 GNBP-US  GNW  Lion Biotechnologies Announces Closing of Underwritten Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares,,,10/12/2015 31189P10 GNW  Fate Therapeutics Announces Leadership Transition,,,12/02/2015 ICPT-US  GNW  Intercept to Present at the Oppenheimer Healthcare Conference, 9/04/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/04/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,,,,,11/05/2015 ATRA-US    GNW  Atara Biotherapeutics Announces Third Quarter 2015  Financial Results,, 4/08/2015 24983L10 GNW  Dermira to Present at the 14th Annual Needham Healthcare Conference,,, 3/12/2014 86845910 GNW  Supernus Announces Fourth Quarter and Full Year 2013 Results,,, 7/11/2016 CHRS-US  GNW  Coherus Announces Positive Topline Results for CHS-1701 (Pegfilgrastim Biosimilar Candidate) Pharmacokinetic and Pharmacodynamic Biosimilarity Study,,, 5/07/2015 00772J-E GNW  Collegium Pharmaceutical Announces Pricing of Its Initial Public Offering, 6/08/2015 98400H10 GNW  XBiotech Appoints Kelly R. Thornburg as Senior Vice President of Operations,,,11/30/2016 071VWR-E GNW  Global Blood Therapeutics Announces GBT440 Granted Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease,, 8/05/2015 00GKS0-E GNW  Kura Oncology to Present at the 2015 Wedbush PacGrow Healthcare Conference,," 4/09/2015 00FKGV-E GNW  Axsome Therapeutics Announces Appointment of Randall Kaye, M.D. as Chief Medical Officer",, 1/02/2018 BGNE-US  GNW  BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab  in Patients with Hepatocellular Carcinoma,,,,,,,,,,,,,,,,,,,,12/28/2015 EYPT-US    GNW  pSivida Plans Medidurâ„¢ EU Marketing Approval Application Based on Single Phase 3 Clinical Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/05/2016 PGNX-US  GNW  Progenics Pharmaceuticals Announces First Quarter 2016 Financial and Business Results,,,,,,,,," 8/03/2017 OPK-US   GNW  OPKO Health to Announce 2017 Second Quarter Financial Results on August 8, 2017",, 2/17/2014 09061G10    GNW  BioMarin to Discuss FDA Approval of VIMIZIM(TM) and Provide Preliminary 2013 Results,,,,12/06/2017 IMMU-US  GNW  Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) In Patients With Relapsed Or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC),,, 2/15/2017 BCRX-US  GNW  BioCryst to Announce Fourth Quarter and Year End 2016 Financial Results February 27,,,,, 2/27/2015 00972810 GNW  Akorn to Present at the Barclays Global Healthcare Conference,,10/18/2018 MYGN-US  GNW  Bendcare Endorses VectraÂ® Testing for Patients with Rheumatoid Arthritis,,,,, 5/09/2016 INO-US    GNW  Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results,,,,, 1/04/2018 AMRN-US  GNW  Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook,,,10/25/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Third Quarter 2017 Financial Results and Recent Corporate Developments,,,10/12/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for MakenaÂ® and FerahemeÂ®,,,,, 2/08/2018 BIVV-US  GNW  Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.,,,,,,11/03/2015 N0104510 GNW  Affimed Announces Third Quarter 2015 Financial Results and Corporate Update Conference Call,, 9/23/2014 N7154210 GNW  ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares,, 3/02/2017 ZGNX-US  GNW  Zogenix to Release Fourth Quarter and Full-Year 2016 Financial Results and Host Conference Call and Webcast on March 9,,,,,,11/26/2014 00773U10 GNW  Avalanche Biotechnologies to Present at the 26th Annual Piper Jaffray Healthcare Conference,11/11/2016 080RQG-E  GNW  Ultragenyx Announces Withdrawal of Marketing Authorization Application for Aceneuramic Acid Prolonged Release (Ace-ER) in the European Union,, 2/29/2016 NSTG-US  GNW  NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial ResultsÂ and Provides 2016 Outlook,,,11/12/2015 RDUS-US  GNW  Radius Health to Host 2015 Investor Day on November 17th in New York City," 3/18/2011 04539610 GNW  Ventrus Announces Improved, FDA-Recommended Endpoints Proposed for Phase III Hemorrhoid Study",,,,,,,"11/24/2015 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at the  27th Annual Piper Jaffray Healthcare Conference","11/04/2014 76129910 GNW  Stull, Stull & Brody Announces the Investigation of Possible Breaches of Fiduciary Duties of Officers and Directors of Retrophin, Inc. (NASDAQ: RTRX)",10/03/2013 69404D10 GNW  Pacific Biosciences Introduces New Chemistry With Longer Read Lengths to Detect Novel Features in DNA Sequence and Advance Genome Studies of Large Organisms,,,12/13/2016 MGNX-US  GNW  MacroGenics Highlights Progress at 2016 R&D Day,,,, 6/01/2015 60877T10 GNW  Momenta Pharmaceuticals to Present New Data From Phase 1 Trial of Necuparanib in Patients With Pancreatic Cancer, 4/06/2015 G7280010 GNW  Prothena Announces Proposed Offering of Ordinary Shares,,,,12/21/2015 GMAB-DK  GNW  Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen,,,,, 2/25/2014 16383L10 GNW  ChemoCentryx to Present at the Cowen and Company 34th Annual Health Care Conference,,, 2/26/2016 MNKD-US   GNW  MannKind Mourns the Passing of Chairman Emeritus Alfred E. Mann,,11/22/2016 CYTK-US  GNW  Cytokinetics to Participate in Upcoming Investor Conferences, 3/08/2016 BCS-GB      GNW  Esperion Therapeutics to Present at the Barclays Global Healthcare Conference," 6/15/2017 03236M20  GNW  MONDAY DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm",, 1/13/2014 00448Q20 GNW  Achillion Reports HCV Pipeline Progress and Outlines 2014 HCV Milestones,10/01/2015 87166B10 GNW  INC Research Enhances Clinical Trial Efficiency Through iCardiac Site Certification, 9/12/2016 FOLD-US  GNW  Amicus Therapeutics to Present at Bank of America Merrill Lynch Global Healthcare Conference 2016,,,, 9/10/2015 GWP-GB   GNW  GW Pharmaceuticals to Present at Two Upcoming Investor Conferences,,,,,12/08/2016 GLPG-NL  GNW  Start Phase 2b/3 study with filgotinib in ulcerative colitis,11/01/2016 PTLA-US  GNW  Portola Pharmaceuticals Expands Clinical Collaboration Agreement with Daiichi Sankyo Worth Up to $25 Million to Develop AndexXaâ„¢ (andexanet alfa) in Germany,,,, 8/10/2015 14075510 GNW  Cara Therapeutics Reports Second Quarter 2015 Financial Results," 3/02/2017 FLXN-US  GNW  Flexion Therapeutics to Report Year-End 2016 Financial Results on March 9, 2017", 5/12/2016 N9006410 GNW  uniQure to Present at Upcoming Investor Conferences in New York City, 3/30/2016 AGIO-US   GNW  Agios Announces Initiation of Phase 1/2 Frontline Combination Study of AG-221 or AG-120 with VIDAZAÂ® (azacitidine for injection) in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Not Eligible for Intensive Chemotherapy, 3/02/2015 46226010 GNW  Lion Biotechnologies to Present at Cowen and Company's 35th Annual Healthcare Conference,,, 9/02/2015 31189P10 GNW  Fate Therapeutics to Present at September Investor Conferences,,,"11/30/2015 45845P10 GNW  Intercept Pharmaceuticals Initiates Phase 1 Study of INT-767, a Dual FXR and TGR5 Agonist"," 9/04/2018 ABEO-US    GNW  Karyopharm Appoints Carsten Thiel, Ph.D., to its Board of Directors",,, 4/28/2016 ITCI-US  GNW  Intra-Cellular Therapies Reports First Quarter 2016 Financial Results and Provides Corporate Update,,,,,11/05/2015 ATRA-US    GNW  Atara Bioâ€™s Collaborating Investigators to Present Data From Two Cellular Therapy Product Candidates at the American Society of Hematology (ASH) Annual Meeting 2015,, 3/25/2015 24983L10 GNW  Dermira Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update,,, 1/27/2014 86845910 GNW  Supernus Announces Issuance of First Use Patents Protecting SPN-812 as a Novel Non-Stimulant ADHD Product,,, 6/28/2016 CHRS-US  GNW  Coherus Announces Positive Phase 2b Efficacy Data on Novel Oral Therapy in Relapsing Remitting Multiple Sclerosis,,, 3/17/2015 00772J-E GNW  Collegium Pharmaceutical to Present Xtampza ER(TM) Pivotal Phase III Data at the 2015 American Academy of Pain Medicine Annual Meeting, 5/28/2015 98400H10 GNW  XBiotech Launching Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus Aureus,,,11/28/2016 GBT-US   GNW  Global Blood Therapeutics Announces Initiation of Phase 2a Trial of GBT440 in Idiopathic Pulmonary Fibrosis (IPF),, 5/27/2015 50127T10 GNW  Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference,, 3/19/2015 00FKGV-E GNW  Axsome Therapeutics Appoints World Leading Experts to Depression Scientific Advisory Board,,12/18/2017 BGNE-US  GNW  BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients with Ovarian Cancer,,,,,,,,,,,,,,,,,,,,12/22/2015 EYPT-US    GNW  pSivida's Medidurâ„¢ Meets Primary Efficacy Endpoint in Phase 3 Trial: High Statistical Significance in Prevention of Recurrence of Posterior Uveitis (p Less Than 0.00000001),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/02/2016 BAYN-DE  GNW  Progenics Licenses PSMA Antibody Technology to Bayer for Development of Alpha-Radiolabeled Therapeutic Antibodies,,,,,,,,, 6/22/2017 OPK-US   GNW  OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD,, 2/14/2014 09061G10    GNW  BioMarin Announces FDA Approval for VIMIZIM(TM) (elosulfase alfa) for the Treatment of Patients With Morquio A Syndrome,,,,"11/27/2017 45290710 GNW  Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics â€” Research Highlights Growth, Revenue, and Consolidated Results",,, 1/30/2017 BCRX-US  GNW  BioCryst Announces the Acceptance of Peramivir MAA Filing by the European Medicines Agency,,,,, 2/26/2015 00972810 GNW  CORRECTING and REPLACING -- Akorn Reports Preliminary Fourth Quarter and Full Year 2014 Results,,10/16/2018 MYGN-US  GNW  Myriad Receives FDA Approval of BRACAnalysis CDxÂ® as Companion Diagnostic for Pfizerâ€™s TALZENNAÂ® (talazoparib),,,,," 5/04/2016 INO-US    GNW  Inovio Pharmaceuticals Showcases its Broad PipelineÂ of DNA-based Immunotherapies, Vaccines and dMAbsÂ at the American Society of Gene & Cell Therapy",,,,,12/19/2017 AMRN-US  GNW  Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018,,,"10/16/2017 SRPT-US  GNW  Sarepta Therapeutics to Announce Third Quarter 2017 Financial Results and Recent Corporate Developments on October 25, 2017",,, 9/07/2016 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing,,,,, 2/07/2018 SAN-FR   GNW  Sanofi Delivers 2017 Business EPS(1) in line with Guidance,,,,,,10/14/2015 N0104510 GNW  Affimed Announces Significant Investment by an Existing Shareholder,, 9/18/2014 N7154210 GNW  ProQR Announces Pricing of Initial Public Offering,, 3/01/2017 ZGNX-US  GNW  Zogenix Receives Orphan Drug Designation in the European Union for ZX008 in Lennox Gastaut Syndrome,,,,,,11/13/2014 00773U10 GNW  Avalanche Biotechnologies to Present at the Jefferies Global Healthcare Conference,11/08/2016 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences,, 2/29/2016 NSTG-US  GNW  NanoString Technologies and Merck Expand Collaboration to Develop and Commercialize Novel Diagnostic Test to Predict Response to KEYTRUDAÂ® (pembrolizumab),,,11/11/2015 RDUS-US  GNW  Radius Health to Present at the Goldman Sachs U.S. Emerging/SMID Cap Growth Conference, 3/03/2011 04539610 GNW  Ventrus Hires inVentiv Clinical Solutions and Almac Group for Its Phase III Pivotal Trial in the Treatment of Hemorrhoids With Iferanserin Ointment,,,,,,,11/17/2015 PCRX-US  GNW  New Survey Sheds Light on Prescription Drug Use Among Women After Surgery in the United States,"11/04/2014 76129910 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX", 9/25/2013 69404D10 GNW  Pacific Biosciences Announces Agreement With Roche Diagnostics to Develop and Supply DNA Sequencing-Based Products for Clinical Diagnostics,,,12/12/2016 MGNX-US  GNW  MacroGenics Licenses Synthonâ€™s Technology to Develop an Anti-B7-H3 ADC,,,, 5/26/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock," 3/19/2015 G7280010 GNW  Prothena Reports Robust Reduction of Free Serum Alpha-Synuclein of up to 96% After Single Dose of PRX002, a Novel Protein Immunotherapy for Parkinson's Disease",,,,12/18/2015 GMAB-DK  GNW  Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen,,,,, 1/08/2014 16383L10 GNW  ChemoCentryx to Present at the 32nd Annual J.P. Morgan Healthcare Conference,,, 2/19/2016 MNKD-US   GNW  Alfred Mann Steps Down as Executive Chairman of Mannkind,,11/14/2016 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at the AHA Annual Scientific Meeting," 3/02/2016 29664W10    GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 14, 2016 â€“ ESPR"," 6/14/2017 03236M20  GNW  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline - June 19, 2017",,11/26/2013 00448Q20 GNW  Achillion to Present at the Three Upcoming Healthcare Conferences, 8/25/2015 87166B10 GNW  INC Research Enhances Therapeutic Expertise With Key Promotions in General Medicine and CNS, 9/01/2016 FOLD-US  GNW  Amicus Therapeutics to Present at Robert W. Baird & Co. 2016 Healthcare Conference,,,, 8/06/2015 36197T10 GNW  GW Pharmaceuticals plc Reports Third Quarter 2015 Financial Results and Operational Progress,,,,,11/29/2016 GLPG-NL  GNW  Galapagos increases share capital through warrant exercises,"10/31/2016 PTLA-US  GNW  Portola Pharmaceuticals to Announce Third Quarter 2016 Financial Results  and Host Conference Call on Monday, November 7",,,, 8/04/2015 14075510 GNW  Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares, 2/23/2017 FLXN-US  GNW  Flexion Therapeutics Initiates Clinical Trial to Evaluate the Safety of Repeat Administration of Zilrettaâ„¢ (FX006) in Patients with Osteoarthritis of the Knee, 5/09/2016 N9006410 GNW  uniQure Announces the Nomination of Jack Kaye to its Board of Directors and Proposed Corporate Governance Changes," 3/01/2016 AGIO-US   GNW  Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8", 2/26/2015 GNBP-US  GNW  Lion Biotechnologies Prices Public Offering of Common Stock,,, 8/06/2015 31189P10 GNW  Fate Therapeutics to Present at Upcoming Investor Conferences,,,11/14/2015 45845P10 GNW  Intercept Presents New PBC Data at AASLD 2015, 8/29/2018 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,, 4/21/2016 ITCI-US  GNW  Intra-Cellular Therapies to Host First Quarter 2016 Financial Results Conference Call and Webcast,,,,,10/29/2015 ATRA-US    GNW  Atara Biotherapeutics Announces Participation in Three Investor Conferences,, 3/23/2015 24983L10 GNW  Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting,,, 1/07/2014 86845910 GNW  Supernus Announces Issuance of Third US Patent Protecting Oxtellar XR(R),,, 6/13/2016 CHRS-US  GNW  Coherus BioSciences Provides Update on IPRs,,, 3/10/2015 00772J-E GNW  Collegium Pharmaceutical Raises $50 Million Financing to Support Commercial Development of Its Lead Abuse-Deterrent Product Candidate, 5/26/2015 98400H10 GNW  XBiotech Successfully Clones First Anti-Ebola Therapeutic Antibody Product Candidate,,,11/09/2016 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2016 Financial Results,, 5/18/2015 00GKS0-E GNW  First Patient Dosed in Phase 2 Study of Tipifarnib in Advanced Cancers With HRAS Mutations,, 3/05/2015 00FKGV-E GNW  Axsome Therapeutics Announces FDA Fast Track Designation for AXS-02 for the Treatment of Pain Associated With Complex Regional Pain Syndrome,,12/11/2017 BGNE-US  GNW  BeiGene Presents Initial Phase 1b Data for BTK Inhibitor Zanubrutinib (BGB-3111) Combined with PD-1 Antibody Tislelizumab (BGB-A317) at the 59th American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,11/05/2015 EYPT-US    GNW  pSivida Corp. Provides Company Update and Reports First Quarter FY 2016 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/21/2016 PGNX-US  GNW  Progenics Pharmaceuticals Sets First Quarter  2016 Financial Results Call for May 5,,,,,,,,, 6/15/2017 OPK-US   GNW  OPKO Provides Update to Topline Data of Phase 3 Clinical Study of hGH-CTP in Growth Hormone Deficient Adults,, 2/13/2014 09061G10    GNW  BioMarin Presents 15 Abstracts From Basic Research to Clinical Trials at Lysosomal Disease Network's 10th Annual WORLDSymposium(TM),,,,11/13/2017 IMMU-US  GNW  Immunomedics Announces Presentations and Investor Event at the 2017 San Antonio Breast Cancer Symposium,,, 1/08/2017 BCRX-US  GNW  BioCryst Receives Health Canada Approval for RAPIVABÂ® for the Treatment of Influenza,,,,, 2/26/2015 00972810 GNW  Akorn Reports Preliminary Fourth Quarter and Full Year 2014 Results,,10/10/2018 MYGN-US  GNW  Myriad Announces New Laboratory Agreement with PfizerÂ®,,,,, 5/02/2016 INO-US    GNW  Inovio Pharmaceuticals CompletesÂ Acquisition of Needle-Free Injection Technology,,,,,12/18/2017 AMRN-US  GNW  Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco,,, 9/29/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 9/01/2016 MS-US    GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conference,,,,, 2/07/2018 SAN-FR   GNW  Zealand reports royalty revenue for the fourth quarter of 2017,,,,,,10/14/2015 N0104510 GNW  Affimed Announces Significant Investment by an Existing Shareholder,,,, 2/15/2017 ZGNX-US  GNW  Zogenix to Participate in the 2017 RBC Capital Markets Healthcare Conference,,,,,,"11/12/2014 00773U10 GNW  Avalanche Biotechnologies, Inc. Reports Third Quarter 2014 Financial Results",11/07/2016 RARE-US   GNW  Ultragenyx Reports Third Quarter 2016 Financial Results and Corporate Update,, 2/22/2016 NSTG-US  GNW  NanoString Technologies to Present at the Cowen and Company 36th Annual Health Care Conference,,,11/05/2015 RDUS-US  GNW  Radius Health Reports Third Quarter 2015 Financial and Operating Results, 2/07/2011 04539610 GNW  Ventrus to Present at 2011 BIO CEO & Investor Conference,,,,,,,"11/11/2015 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. to Present at the Jefferies Autumn 2015 Global Healthcare Conference","10/24/2014 76129910 GNW  Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Retrophin, Inc. - RTRX"," 8/01/2013 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2013 Financial Results",,,12/08/2016 MGNX-US  GNW  MacroGenics to Host 2016 R&D Day,,,, 5/19/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 3/05/2015 G7280010 GNW  Prothena Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Financial Guidance and R&D Update,,,,12/09/2015 GMAB-DK  GNW  Genmab Achieves USD 5 Million Milestone in Daratumumab Collaboration with Janssen,,,,,12/03/2013 16383L10 GNW  ChemoCentryx Announces Positive Top-Line CCX168 Phase II Data in ANCA-Associated Renal Vasculitis,,, 2/16/2016 MNKD-US   GNW  MannKind Corporation to Present at the RBC Capital Markets 2016 Healthcare Conference,,11/07/2016 CYTK-US  GNW  Cytokinetics Announces New Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2016, 2/25/2016 ESPR-US     GNW  Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial Results," 6/06/2017 03236M20  GNW  The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Amyris, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017",,11/12/2013 00448Q20 GNW  Achillion Reiterates HCV Pipeline Priorities and Reports Third Quarter and Nine Month 2013 Financial Results, 8/17/2015 87166B10 GNW  INC Research Announces Closing of Secondary Offering, 8/31/2016 FOLD-US  GNW  Amicus Therapeutics to Highlight Fabry Disease Program at Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium,,,, 8/06/2015 36197T10 GNW  GW Pharmaceuticals Receives FDA Fast Track and EMA Orphan Designations for Intravenous Cannabidiol in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE),,,,,11/28/2016 GLPG-NL  GNW  Galapagos initiates Phase 1 study with cystic fibrosis drug GLPG2737,10/25/2016 PTLA-US  GNW  Portola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism in Acute Medically Ill Patients,,,," 8/03/2015 14075510 GNW  Cara Therapeutics to Announce Second Quarter 2015 Financial Results on August 10, 2015", 2/15/2017 FLXN-US  GNW  Flexion Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference, 5/09/2016 N9006410 GNW  uniQure Announces the Nomination of Jack Kaye to its Board of Directors and Proposed Corporate Governance Changes, 2/18/2016 AGIO-US   GNW  Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones, 2/25/2015 GNBP-US  GNW  Lion Biotechnologies Announces Public Offering of Common Stock,,, 8/05/2015 31189P10 GNW  Fate Therapeutics Reports Second Quarter 2015 Financial Results,,,11/14/2015 45845P10 GNW  Intercept Presents New Data Analyses on Non-Invasive Liver Testing From FLINT Trial of Obeticholic Acid in Nonalcoholic Steatohepatitis at AASLD 2015, 8/28/2018 KPTI-US    GNW  Karyopharm to Present Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma at the Society of Hematologic Oncology 2018 Annual Meeting,,, 4/06/2016 ITCI-US  GNW  Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference,,,,,10/21/2015 ATRA-US    GNW  Atara Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Exclusive License and Research Agreements,, 3/18/2015 24983L10 GNW  Dermira to Report Fourth Quarter and Full Year 2014 Financial Results,,,12/24/2013 86845910 GNW  Supernus Announces Resignation of Board Member,,, 6/10/2016 CHRS-US  GNW  Coherus Presents Study Results Demonstrating Equivalence of its CHS-0214 Biosimilar to Etanercept,,," 2/26/2015 00772J-E GNW  Collegium Pharmaceutical Announces Notice of Allowance for U.S. Patent Covering DETERx(R), an Abuse-Deterrent, Extended-Release, Technology Platform", 5/18/2015 98400H10 GNW  XBiotech Secures Approval From Data Safety Monitoring Board to Continue Phase 3 Registration Study in Europe for Its Novel Cancer Immunotherapy,,,11/03/2016 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Presentation of Data Supporting Sickle Cell Disease Program at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition Conference,, 4/27/2015 00GKS0-E GNW  Faheem Hasnain Joins Kura Oncology Board of Directors,, 9/17/2014 UTHR-US  GNW  Axsome Therapeutics Announces Appointments to Its Board of Directors,,12/09/2017 BGNE-US  GNW  BeiGene Presents Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) in Non-Hodgkinâ€™s Lymphoma at the 59th American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,10/30/2015 EYPT-US    GNW  pSivida Corp Announces First Quarter FY 2016 Financial Results Release Date and Conference Call Information,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/06/2016 05KDBG-E GNW  Progenics Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference,,,,,,,,, 6/07/2017 OPK-US   GNW  OPKOâ€™S GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing,, 2/11/2014 09061G10    GNW  BioMarin Announces Selection of NAGLU Fusion Protein Drug Development Candidate BMN 250 for the Treatment of Sanfilippo B (MPS IIIB),,,,11/09/2017 IMMU-US  GNW  Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update,,, 1/04/2017 BCRX-US  GNW  BioCryst to Present at the J.P. Morgan Healthcare Conference,,,,, 1/29/2015 00972810 GNW  Akorn Announces Fourth Quarter 2014 Earnings Release and Conference Call Information,,10/09/2018 MYGN-US  GNW  Myriad and Pfizer Build Upon a Previously Announced Companion Diagnostic Agreement,,,,, 4/27/2016 INO-US    GNW  Inovio Partners with National Cancer Institute and Mayo Clinic to Initiate Hepatitis C Immunotherapy Clinical Trial,,,,,11/14/2017 AMRN-US  GNW  Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk,,, 9/28/2017 SRPT-US  GNW  Sarepta Therapeutics to Present at the 22nd International Annual Congress of the World Muscle Society,,, 8/09/2016 AMAG-US  GNW  AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update,,,,," 1/31/2018 SAN-FR   GNW  Sanofi: Sanofi, DNDi seek European Medicines Agency  review for sleeping sickness treatment",,,,,,10/06/2015 N0104510 GNW  Affimed to Present Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC,,,, 2/13/2017 ZGNX-US  GNW  Zogenix Announces Initiation of Clinical Efficacy Portion of Study 1504 for ZX008 in Dravet Syndrome,,,,,,10/30/2014 00773U10 GNW  Avalanche Biotechnologies to Participate in Nomura's Biotechnology Conference,10/31/2016 RARE-US   GNW  Ultragenyx to Host Conference Call for Third Quarter 2016  Financial Results and Corporate Update,," 2/12/2016 NSTG-US  GNW  NanoString Technologies to Release Fourth Quarter 2015 Financial Results and  Host Conference Call on Monday, February 29, 2016",,,11/02/2015 RDUS-US  GNW  Radius Health to Present Promising Single-Agent Data for Investigational Oral Drug RAD1901 at 2015 American Association for Cancer Research â€“ National Cancer Institute â€“ European Organisation for Research and Treatment of Cancer (AACR-NCI-EORTC) International Conference, 2/01/2011 04539610 GNW  Ventrus Completes Clinical Development Staffing,,,,,,,"11/06/2015 PCRX-US  GNW  New Study Finds Decreased Opioid Use, Hospital Stay and Readmission Rates With EXPAREL Following Knee Replacement Surgery","10/23/2014 76129910 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Retrophin, Inc. to Contact Brower Piven Before the December 19, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RTRX", 7/18/2013 PACB-US  GNW  Pacific Biosciences Appoints John F. Milligan to Board of Directors,,,11/02/2016 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Third Quarter 2016 Financial Results,,,, 5/18/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock, 2/19/2015 G7280010 GNW  Prothena to Report Fourth Quarter and Full Year 2014 Financial Results and Host Webcast and Conference Call on March 5,,,,11/23/2015 37230320 GNW  Genmab Announces Ofatumumab Phase III Study in Follicular Lymphoma to be Stopped Following Planned Interim Analysis,,,,,"11/07/2013 16383L10 GNW  ChemoCentryx Announces Financial Results for the Quarter Ended September 30, 2013",,," 2/10/2016 56400P70  GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016 â€“ MNKD",,11/07/2016 CYTK-US  GNW  Cytokinetics Announces Publication  Relating to Novel Smooth Muscle Myosin Inhibitor, 2/16/2016 ESPR-US     GNW  Esperion Therapeutics to Present at the 2016 RBC Capital Markets Global Healthcare Conference, 6/06/2017 AMRS-US   GNW  Amyris Announces Reverse Stock Split - Delivering on Strong Product Revenue Growth and Execution,,11/11/2013 00448Q20 GNW  Achillion to Present at the Credit Suisse Healthcare Conference, 8/03/2015 87166B10 GNW  INC Research's Michael Gibertini and Alan Ong Named to Annual PharmaVOICE 100, 8/10/2016 FOLD-US  GNW  UPDATE -- New England Journal of Medicine Publishes Pivotal Phase 3 FACETS Study of Migalastat for Patients with Fabry Disease,,,," 7/23/2015 36197T10 GNW  GW Pharmaceuticals to Report Q3 2015 Financial Results and Host Conference Call on 6 August, 2015",,,,,11/24/2016 GLPG-NL  GNW  Galapagos selected for Stoxx Europe 600 Index,10/13/2016 PTLA-US  GNW  Portola Pharmaceuticals Supports â€œWorld Thrombosis Dayâ€ Campaign to Increase Awareness of Risks of Blood Clots,,,, 7/29/2015 14075510 GNW  Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock, 2/07/2017 009T7W-E GNW  Flexion Therapeutics Announces New Drug Application for Zilrettaâ„¢ (FX006) Accepted by U.S. Food and Drug Administration," 5/09/2016 N9006410 GNW  uniQure Presents Preclinical Data on AAV Re-Administration, Regulated Gene Expression and Total Brain Transduction at ASGCT"," 2/11/2016 AGIO-US   GNW  Agios to Webcast Conference Call of Fourth Quarter and Full Year 2015 Financial Results on February 18, 2016", 2/24/2015 GNBP-US  GNW  Lion Biotechnologies Announces Its Listing on the Nasdaq Global Market,,," 7/29/2015 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2015 Financial Results on August 5, 2015",,,11/09/2015 45845P10 GNW  Intercept Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Business Update," 8/17/2018 48576U10   GNW  Report: Developing Opportunities within FORTERRA INC, Baytex Energy, MAG Silver, Bojangles', Ciner Resources LP, and Karyopharm Therapeutics â€” Future Expectations, Projections Moving into 2018",,, 4/04/2016 05KDBG-E GNW  Intra-Cellular Therapies to Present at the 15th Annual Needham Healthcare Conference,,,,,"10/20/2015 ATRA-US    GNW  Atara Bio Receives FDA Orphan Drug Designation for STM 434, Atara Bio's Activin Inhibitor for Ovarian Cancer",, 3/12/2015 24983L10 GNW  Dermira Announces Late-Breaking Oral Presentation on DRM01 in Acne at 2015 AAD Annual Meeting,,,"12/23/2013 86845910 GNW  Supernus Announces FDA Approval of Its Partner's Product, Orenitram(TM)",,, 6/03/2016 0CT6N9-E GNW  Coherus BioSciences to Present at Jefferies 2016 Healthcare Conference on June 8,,," 2/17/2015 00772J-E GNW  Collegium Pharmaceutical Secures FDA Acceptance for Filing of NDA for XTAMPZA ER(TM) (Oxycodone Extended-Release Capsules), an Abuse-Deterrent Analgesic for Chronic Pain", 4/29/2015 98400H10 GNW  XBiotech Enrolls First Patient Under Revised Protocol for U.S. Phase 3 Registration Study Using Xilonix(TM) for Treatment of Metastatic Colorectal Cancer,,,10/24/2016 GBT-US   GNW  Global Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin Endpoint,, 3/30/2015 00GKS0-E GNW  Kura Oncology's Menin-MLL Inhibitor Program Shows Promise in Study Published in Cancer Cell; Program Targeting Acute Leukemias Licensed From University of Michigan,,,,12/09/2017 BGNE-US  GNW  BeiGene Presents Updated Preliminary Phase 1b Data on BTK Inhibitor Zanubrutinib (BGB-3111) Combined with GAZYVAÂ® (Obinutuzumab) at the 59th American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/11/2016 PGNX-US  GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2015 Financial and Business Results,,,,,,,,, 6/05/2017 OPK-US   GNW  OPKO Health Provides Commercial Update for RAYALDEE,," 2/05/2014 09061G10    GNW  BioMarin to Host Fourth Quarter and Full Year 2013 Financial Results Conference Call and Webcast on Monday, March 3 at 8:00 a.m. ET",,,,11/09/2017 IMMU-US  GNW  Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth,,,11/17/2016 BCRX-US  GNW  BioCryst to Present at the Piper Jaffray Healthcare Conference November 30,,,,, 1/20/2015 00972810 GNW  Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution,,10/03/2018 MYGN-US  GNW  Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting,,,,," 4/26/2016 INO-US    GNW  Inovio Pharmaceuticals to Report First Quarter 2016 Financial Results May 9, 2016",,,,,11/13/2017 AMRN-US  GNW  VascepaÂ® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease,,," 9/25/2017 SRPT-US  GNW  Sarepta Therapeutics Appoints Guriqbal S. Basi, Ph.D. as Chief Scientific Officer",,," 7/21/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Host Conference Call on August 9, 2016 at 8:00 a.m. ET to Discuss Financial Results for the Second Quarter Ended June 30, 2016",,,,, 1/29/2018 SAN-FR   GNW  Sanofi to acquire Ablynx for â‚¬3.9 Billion,,,,,, 9/23/2015 AFMD-DE  GNW  Affimed to Present at the Leerink Partners Inaugural Immuno-Oncology Roundtable Conference,,,, 2/08/2017 ZGNX-US  GNW  Zogenix to Participate in the Leerink Partners 6th Annual Global Healthcare Conference,,,,,,10/09/2014 00773U10 GNW  Avalanche Biotechnologies to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2014 Annual Meeting,10/26/2016 RARE-US   GNW  Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of KRN23 in Pediatric Patients with X-Linked Hypophosphatemia (XLH),, 2/11/2016 NSTG-US  GNW  NanoString Technologies Presents Proof-of-Concept Data for Novel Massively Parallel Single Molecule Sequencing Chemistry at AGBT Meeting,,,"10/28/2015 RDUS-US  GNW  Radius Health to Announce Third Quarter 2015 Financial Results, Host Conference Call and Live Webcast on November 5, 2015",12/23/2010 04539610 GNW  Ventrus Biosciences Announces Closing of Initial Public Offering of Common Stock,,,,,,,"10/27/2015 PCRX-US  GNW  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2015 Financial Results","10/22/2014 76129910 GNW  Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Has Been Filed in the Southern District of New York Against Retrophin, Inc. -- RTRX"," 7/17/2013 69404D10 GNW  Pacific Biosciences of California, Inc. Second Quarter 2013 Financial Results Call",,,11/01/2016 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 5/18/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Data Presentation on Necuparanib (M402) at the 2015 ASCO Annual Meeting, 2/18/2015 G7280010 GNW  Prothena to Present at the 2015 RBC Capital Markets' Healthcare Conference in New York on February 25,,,,11/19/2015 37230320 GNW  Genmab Achieves USD 45 Million Milestone in DARZALEX(TM) (daratumumab) Collaboration With Janssen,,,,,11/06/2013 16383L10 GNW  ChemoCentryx to Present at the 2013 Credit Suisse Annual Health Care Conference,,," 2/08/2016 56400P70  GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in MannKind Corp. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit â€“ MNKD",,"10/27/2016 CYTK-US  GNW  Cytokinetics, Inc. Reports Third Quarter 2016 Financial Results"," 2/01/2016 29664W10    GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 14, 2016 â€“ ESPR"," 5/23/2017 03236M20  GNW  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Amyris, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017",,"11/02/2013 00448Q20 GNW  Achillion's Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile", 7/30/2015 87166B10 GNW  INC Research Reports Second Quarter 2015 Results, 8/10/2016 FOLD-US  GNW  New England Journal of Medicine Publishes Pivotal Phase 3 FACETS Study of Migalastat for Patients with Fabry Disease,,,, 7/21/2015 36197T10 GNW  GW Pharmaceuticals Announces Appointment of Julian Gangolli to Board of Directors,,,,,11/22/2016 GLPG-NL  GNW  Phase 3 study with filgotinib initiated in Crohn's disease, 9/13/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces Upcoming Data Presentations on  AndexXaâ„¢ (andexanet alfa) at Neurocritical Care Society 2016 Annual Meeting,,,, 7/27/2015 14075510 GNW  Cara Therapeutics Announces Proposed Offering of Common Stock,12/12/2016 009T7W-E GNW  Flexion Therapeutics Submits New Drug Application for Zilrettaâ„¢ to Treat Knee Osteoarthritis Pain, 5/03/2016 N9006410 GNW  uniQure Appoints Paul Firuta as Chief Commercial Officer, 2/08/2016 AGIO-US   GNW  Agios Appoints Steve Hoerter as Chief Commercial Officer, 2/17/2015 46226010 GNW  Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee,,," 7/15/2015 31189P10 GNW  Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research",,,11/03/2015 45845P10 GNW  Intercept Announces Data to be Presented at the 2015 AASLD Annual Meeting, 8/07/2018 KPTI-US    GNW  Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress,,, 3/30/2016 ITCI-US  GNW  Intra-Cellular Therapies Announces Upcoming Presentations at the 5th Biennial Schizophrenia International Research Society Conference,,,,,"10/14/2015 ATRA-US    GNW  Atara Bio to Host Investor Day on October 21, 2015",, 2/05/2015 24983L10 GNW  Dermira Announces Positive Phase 2b Results for DRM04 in Patients With Hyperhidrosis,,,12/12/2013 86845910 GNW  Supernus Posts Exciting Clinical Data Regarding Trokendi XR(TM) and Oxtellar XR(TM) on the Company Website,,, 5/26/2016 0CT6N9-E GNW  Coherus BioSciences Advances Differentiated IP Strategy for  Humira Market Access,,,, 4/17/2015 98400H10 GNW  XBiotech Closes Initial Public Offering,,,10/24/2016 37890U10 GNW  GUERBET : 3rd quarter 2016 revenue,, 3/12/2015 00GKS0-E GNW  Kura Oncology Announces License Agreement With Janssen Pharmaceutica for Development and Commercialization of Tipifarnib; Closes $60 Million Private Placement and Completes Reverse Merger,,,,12/04/2017 BGNE-US  GNW  BeiGene to Webcast an Analyst and Investor Event from the American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/09/2016 05GSQ9-E GNW  Progenics Pharmaceuticals to Present at 28th Annual ROTH Conference,,,,,,,,, 5/18/2017 OPK-US   GNW  OPKO Healthâ€™s 4KscoreÂ® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting,, 1/21/2014 BMRN-US     GNW  BioMarin Announces Agreement With Repligen for Pre-clinical Compounds,,,,"11/02/2017 IMMU-US  GNW  Immunomedics to Report First Quarter Fiscal 2018 Results and Host Conference Call and Webcast on November 9, 2017",,,11/07/2016 BCRX-US  GNW  BioCryst Reports Third Quarter 2016 Financial Results,,,,, 1/15/2015 00972810 GNW  Akorn Confirms Generic Durezol(R) Patent Challenge,, 9/26/2018 MYGN-US  GNW  Myriad Announces New GeneSightÂ® Study Published in Personalized Medicine,,,,, 3/30/2016 INO-US    GNW  Inovio Ebola Vaccine Generates Robust Immune Responses in Humans,,,,,11/13/2017 AMRN-US  GNW  Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical Costs,,, 9/06/2017 SRPT-US  GNW  Sarepta Therapeutics to Ring Nasdaq Stock Market Closing Bell in Recognition of World Duchenne Awareness Day,,, 7/18/2016 00163U10 GNW  AMAG Pharmaceuticals CEO William Heiden Elected to PhRMA Board of Directors,,,,, 1/23/2018 SAN-FR   GNW  Sanofi: Availability of the Pre-quarterly Results Communication,,,,,, 8/04/2015 N0104510 GNW  Affimed Reports Financial Results for Second Quarter 2015,,,, 1/30/2017 ZGNX-US  GNW  Zogenix Announces Issuance of U.S. Patent for ZX008 in Dravet Syndrome,,,,,,10/01/2014 00773U10 GNW  Avalanche Biotechnologies to Participate in Gene Therapy Panel at the BIO Investor Forum, 9/27/2016 05LK9B-E  GNW  Ultragenyx to Present at Leerink Partners Roundtable Series,, 2/09/2016 NSTG-US  GNW  American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients,,,10/12/2015 RDUS-US  GNW  Investigational Drug Abaloparatide Reduces the Incidence of Fractures in Postmenopausal Women With Osteoporosis,,,,,,,,10/20/2015 PCRX-US  GNW  Pacira Pharmaceuticals Announces the Promotion of James S. Scibetta to President,"10/22/2014 76129910 GNW  Robbins Arroyo LLP: Retrophin, Inc. (RTRX) Misled Shareholders According to a Recently Filed Class Action", 5/16/2013 69404D10 GNW  Pacific Biosciences and Sage Science Announce Co-Marketing Partnership,,,10/26/2016 MGNX-US  GNW  MacroGenics Announces Date of Third Quarter 2016 Financial Results Conference Call,,,, 5/12/2015 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at the UBS 2015 Global Healthcare Conference,"12/15/2014 0CXBJZ-E GNW  Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients With AL Amyloidosis",,,,11/17/2015 GMAB-DK  GNW  Major Shareholder Announcement,,,,,"10/31/2013 16383L10 GNW  ChemoCentryx, Inc. to Hold Third Quarter 2013 Financial Results Conference Call on Thursday, November 7, 2013",,," 1/27/2016 MNKD-US   GNW  MannKind Corporation to Hold Investor Conference Call on February 3, 2016",,"10/18/2016 CYTK-US  GNW  Cytokinetics Announces First Patient Enrolled in VIGOR-ALS, an Open-Label Extension Clinical Trial of Tirasemtiv"," 1/29/2016 29664W10    GNW  The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR"," 5/22/2017 03236M20  GNW  AMRS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Amyris, Inc. and a Lead Plaintiff Deadline of June 19, 2017",,"10/25/2013 00448Q20 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Achillion Pharmaceutical, Inc. of Class Action Lawsuit and Upcoming Deadline -- ACLN", 7/29/2015 87166B10 GNW  INC Research Further Reinforces Focus on Asia/Pacific Region Through Participation in Key Activities Supporting Clinical Research Sites, 8/09/2016 FOLD-US  GNW  Amicus Therapeutics Announces Second Quarter 2016 Financial Results and Corporate Updates,,,, 6/11/2015 36197T10 GNW  GW Pharmaceuticals Initiates Second Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome,,,,,10/27/2016 36315X10 GNW  Robust progress in Q3 2016, 8/30/2016 07CQ0K-E GNW  Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4â„¢ Study of Factor Xa Inhibitor Antidote AndexXaâ„¢ (andexanet alfa) in Patients with Acute Major Bleeding,,,, 7/23/2015 14075510 GNW  Cara Therapeutics Announces Positive Results From Phase 2 Trial in Uremic Pruritus,12/09/2016 009T7W-E GNW  Flexion Therapeutics to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference, 4/19/2016 QURE-NL  GNW  uniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy," 2/03/2016 AGIO-US   GNW  Agios to Present at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10", 2/11/2015 GNBP-US  GNW  Lion Biotechnologies Obtains Exclusive License From NIH for Next-Generation TIL Technology,,, 7/14/2015 31189P10 GNW  Fate Therapeutics and Regents of the University of Minnesota Enter Into Research Collaboration for Translation of Natural Killer Cell Cancer Immunotherapies,,,11/02/2015 45845P10 GNW  Intercept to Report Third Quarter 2015 Financial Results on November 9th, 8/06/2018 KPTI-US    GNW  Karyopharm Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Selinexor as a Treatment for Patients with Penta-Refractory Multiple Myeloma,,, 2/29/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Cowen and CompanyÂ 36th Annual Health Care Conference,,,,,10/05/2015 ATRA-US    GNW  Atara Bioâ€™s PINTA 745 Improves Insulin Sensitivity and Alters Fat Metabolism in Mice Fed With a High Fat Diet,, 1/29/2015 24983L10 GNW  Dermira to Present at the 2015 Leerink Global Healthcare Conference,,,11/21/2013 86845910 GNW  Supernus to Present at Piper Jaffray Healthcare Conference in December,,, 5/23/2016 CHRS-US  GNW  Coherus Prices Public Offering of Common Stock,,,, 4/14/2015 98400H10 GNW  XBiotech Announces Pricing of Initial Public Offering,,,10/12/2016 GBT-US   GNW  Global Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal Officer,,,,,,11/13/2017 BGNE-US  GNW  BeiGene Expands Global Pivotal Program for BTK Inhibitor BGB-3111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/01/2016 PGNX-US  GNW  Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2015 Financial Results Call for March 11,,,,,,,,, 5/15/2017 OPK-US   GNW  OPKO Announces Multiple Presentations at the 112th American Urological Association Annual MeetingÂ ,, 1/21/2014 BMRN-US     GNW  Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio,,,, 9/15/2017 IMMU-US  GNW  Immunomedics Announces Agreements to Exchange Approximately $80.0 Million of Its 4.75% Convertible Senior Notes Due 2020 for Common Stock,,,10/26/2016 BCRX-US  GNW  BioCryst Announces Late Breaker Presentation of Galidesivir (BCX4430) Nonclinical Results in Zika Virus Infection at IDWeek 2016,,,,,12/19/2014 00972810 GNW  Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference,, 9/25/2018 MYGN-US  GNW  Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association,,,,, 3/30/2016 INO-US    GNW  Inovio Pharmaceuticals HPV Immunotherapy Selected as â€œBest Therapeutic Vaccineâ€ by World Vaccine Congress,,,,,11/07/2017 AMRN-US  GNW  Amarin to Present at the Jefferies London Healthcare Conference,,," 9/06/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Positive Results in Its Study Evaluating Gene Expression, Dystrophin Production, and Dystrophin Localization in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53 Treated with Golodirsen (SRP-4053)",,," 7/12/2016 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts",,,,, 1/22/2018 SAN-FR   GNW  Sanofi to Acquire Bioverativ for $11.6 Billion,,,,,, 7/28/2015 N0104510 GNW  Affimed Announces Second Quarter 2015 Financial Results and Corporate Update Conference Call,,,, 1/05/2017 ZGNX-US  GNW  Zogenix Announces CFO Transition,,,,,," 9/23/2014 00773U10 GNW  Avalanche Biotechnologies, Inc., Appoints Industry Leader Roman G. Rubio, M.D., as Senior Vice President and Head of Translational Medicine", 9/19/2016 RARE-US   GNW  Ultragenyx Reports Positive Interim Data from Pediatric and Adult Phase 2 Studies of KRN23 in X-Linked Hypophosphatemia,, 1/27/2016 NSTG-US  GNW  NanoString Technologies to Present at the Leerink Partners 5th Annual Global Healthcare Conference,,,10/10/2015 RDUS-US  GNW  Radius Health Presents Positive Phase 3 Top-Line Data for Investigational Osteoporosis Therapy Abaloparatide at the American Society for Bone and Mineral Research 2015 Annual Meeting,,,,,,,,10/13/2015 PCRX-US  GNW  Pacira Pharmaceuticals Announces Timing for Third Quarter 2015 Financial Results Webcast and Conference Call,"10/22/2014 76129910 GNW  Hagens Berman Announces the Filing of a Class Action Against Retrophin, Inc. (RTRX)"," 5/06/2013 69404D10 GNW  New Assembly Method Published for Rapid and Automated Genome Sequencing Using Long-Read, Single Molecule, Real-Time (SMRT(R)) Sequencing",,, 9/23/2016 MGNX-US  GNW  MacroGenics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable,,,, 5/06/2015 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch 2015 Health Care Conference,12/08/2014 G7280010 GNW  Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York,,,,11/16/2015 GMAB-DK  GNW  Genmab Announces U.S. FDA Approval of DARZALEX(TM) (daratumumab) for Multiple Myeloma and Updates Financial Guidance,,,,, 9/23/2013 16383L10 GNW  ChemoCentryx to Present at BioCentury's NewsMakers in the Biotech Industry Conference,,, 1/22/2016 56400P70  GNW  IMPORTANT MANNKIND SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Commenced in the United States District Court for the Central District of California Against MannKind Corporation -- MNKD,,"10/13/2016 CYTK-US  GNW  Cytokinetics to Announce Third Quarter Results on October 27, 2016"," 1/22/2016 29664W10    GNW  IMPORTANT ESPERION SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Commenced in the United States District Court for the Eastern District of Michigan Against Esperion Therapeutics, Inc. -- ESPR", 5/22/2017 AMRS-US   GNW  Amyris Exceeds Previous Debt Reduction Goal of $75 Million â€“ $86 Million In Debt Retired,,"10/25/2013 00448Q20 GNW  ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN"," 7/13/2015 87166B10 GNW  INC Research Schedules Second Quarter 2015 Earnings Call for Thursday, July 30th", 8/03/2016 FOLD-US  GNW  Amicus Therapeutics to Submit Japanese New Drug Application for Migalastat for Fabry Disease in 1H17,,,," 5/19/2015 36197T10 GNW  GW Appoints Senior Industry Executive to President, North America and Relocates CEO to the U.S.",,,,,10/27/2016 36315X10 GNW  Galapagos to present progress in CF programs at NACFC 2016, 8/26/2016 07CQ0K-E GNW  Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXAâ„¢-4 Study of AndexXaâ„¢ (andexanet alfa)  at European Society of Cardiology 2016 Congress,,,, 6/23/2015 14075510 GNW  Cara Therapeutics Completes Enrollment of Phase 2 Trial of I.V. CR845 in Uremic Pruritus,11/16/2016 FLXN-US  GNW  Flexion Therapeutics Announces Pricing of Public Offering of Common Stock, 4/19/2016 N9006410 GNW  uniQure To Present Data On Gene Therapy Technology Advances At Annual Meeting Of The American Society Of Gene And Cell Therapy, 1/11/2016 AGIO-US   GNW  Agios Outlines Key 2016 Goals and Priorities, 2/10/2015 GNBP-US  GNW  Lion Biotechnologies Obtains Exclusive License From NIH to Develop and Commercialize TIL Therapy in Metastatic Melanoma,,, 6/05/2015 31189P10 GNW  Fate Therapeutics Enters Into Sponsored Research Agreement With Boston Children's Hospital to Develop Immunoregulatory Cell Therapy for Treatment of Autoimmune Diseases,,,10/28/2015 ICPT-US  GNW  Intercept Pharmaceuticals Announces Results of Phase 2 Trial of OCA in NASH Patients in Japan, 8/03/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 2/25/2016 ITCI-US  GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2015 Financial Results and Provides Corporate Update,,,,,10/05/2015 ATRA-US    GNW  Atara Bioâ€™s Collaborating Investigators to Present Data at the American Society of Nephrology Kidney Week 2015,, 1/08/2015 24983L10 GNW  Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis,,,11/12/2013 86845910 GNW  Supernus Pharmaceuticals Reports Third Quarter 2013 Financial Results,,, 5/23/2016 CHRS-US  GNW  Coherus Announces Proposed Public Offering of Common Stock,,,,,,,"10/07/2016 GBT-US   GNW  Global Blood Therapeutics Presents GBT440 Data that Continue to Support Durability, Safety and Mechanism of Action in Sickle Cell Disease",,,,,,11/13/2017 BGNE-US  GNW  BeiGene Reports Third Quarter 2017 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/01/2016 PGNX-US  GNW  Progenics Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,,,,, 5/09/2017 OPK-US   GNW  CORRECTION -- OPKO Health Inc.,, 1/14/2014 09061G10    GNW  BioMarin Doses First Patient in Phase 2 Trial With BMN 111 for the Treatment of Children With Achondroplasia,,,, 9/11/2017 IMMU-US  GNW  Immunomedics Presents Interim Phase 2 Results With Sacituzumab Govitecan (IMMU-132) in Patients With Pretreated Metastatic Urothelial Cancer,,,10/24/2016 BCRX-US  GNW  BioCryst to Announce Third Quarter 2016 Financial Results November 7,,,,,11/06/2014 00972810 GNW  Akorn Reports Preliminary 2014 Third Quarter Results,, 8/31/2018 MYGN-US  GNW  Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference,,,,, 3/29/2016 INO-US    GNW  Inovio Updates INO-3112 HPV Immunotherapy Development Plan,,,,,11/01/2017 AMRN-US  GNW  Amarin Reports Third Quarter 2017 Financial Results  and Provides Update on Operations,,," 9/05/2017 80360710 GNW  Sarepta Therapeutics, Inc. (Nasdaq: SRPT) to Ring The Nasdaq Stock Market Closing Bell",,, 5/25/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 1/22/2018 SAN-FR   GNW  Sanofi to Acquire Bioverativ for $11.6 Billion,,,,,, 6/30/2015 00G64K-E GNW  Affimed Added to Russell 2000(R) Index,,,,12/05/2016 ZGNX-US  GNW  Zogenix Announces New Efficacy and Safety Data for ZX008 in Treatment of Seizures in Lennox Gastaut Syndrome & Dravet Syndrome,,,,,, 9/19/2014 00773U10 GNW  Avalanche Biotechnologies to Present at the NewsMakers in the Biotech Industry Conference, 9/18/2016 RARE-US   GNW  Ultragenyx Reports Positive Interim Data from Phase 2 Study of KRN23 for the Treatment of Tumor-Induced Osteomalacia,, 1/10/2016 NSTG-US  GNW  NanoString Technologies Provides Preliminary Operational and Financial Results for 2015,,," 9/22/2015 75046920 GNW  Radius Health, Inc. Announces Webcast on Investigational Drug RAD1901, Upcoming Presentations and Investor Day in New York City on November 17th, 2015",,,,,,,,"11/24/2014 69512710 GNW  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 -- PCRX","10/21/2014 76129910 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against Retrophin, Inc. and Certain of Its Officers - RTRX"," 4/23/2013 69404D10 GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2013 Financial Results",,, 9/20/2016 MGNX-US  GNW  MacroGenics Announces the Promotion of Three Executives,,,, 5/01/2015 MNTA-US  GNW  Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 40th Annual Health Care Conference,12/02/2014 G7280010 GNW  Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis,,,,11/03/2015 37230320 GNW  Genmab Announces Financial Results for the First Nine Months of 2015 and Improves 2015 Financial Guidance,,,,, 9/18/2013 16383L10 GNW  ChemoCentryx to Regain Global Rights for Vercirnon From GlaxoSmithKline,,, 1/21/2016 MNKD-US   GNW  MannKind Enters Into Collaboration and License Agreement,, 9/29/2016 CYTK-US  GNW  Cytokinetics Announces Early Termination of Hart-Scott-Rodino Waiting Period for Expanded Collaboration With Astellas," 1/13/2016 29664W10    GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 14, 2016 â€“ ESPR"," 5/19/2017 AMRS-US   GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amyris, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2017 â€“ AMRS",,"10/10/2013 00448Q20 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $250,000 in Losses From Investment in Achillion Pharmaceuticals, Inc. to Contact Brower Piven Before the December 9, 2013 Lead Plaintiff Deadline -- ACHN"," 6/10/2015 87166B10 GNW  INC Research Advocates Disruptive Innovation in Clinical Development, Reinforces Commitment to Site Relationships at DIA 2015 Annual Meeting"," 8/01/2016 FOLD-US  GNW  Amicus Therapeutics to Announce Second Quarter 2016  Financial Results on August 9, 2016",,,, 5/15/2015 36197T10 GNW  GW Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares,,,,,10/12/2016 36315X10 GNW  Transparency notification - FMR LLC reaches 10% threshold," 8/19/2016 080RQG-E GNW  Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA)  for IndexXaâ„¢ (andexanet alfa), a Factor Xa Inhibitor Antidote",,,, 6/10/2015 14075510 GNW  Cara Therapeutics to Sponsor Symposium and Present Poster at the College on Problems of Drug Dependence 77th Annual Meeting,11/15/2016 FLXN-US  GNW  Flexion Therapeutics Announces Proposed Public Offering of Common Stock, 4/04/2016 N9006410 GNW  CORRECTING and REPLACING -- uniQure Announces Results for Fourth Quarter and Financial Year 2015," 1/04/2016 AGIO-US   GNW  Agios to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11", 2/02/2015 46226010 GNW  Lion Biotechnologies Announces Allowance of IND Application to Begin New Phase 2 Study in Metastatic Melanoma,,, 5/27/2015 31189P10 GNW  Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,,, 9/28/2015 ICPT-US  GNW  Intercept Pharmaceuticals Announces Initiation of REGENERATE Trial for Obeticholic Acid in NASH Patients With Advanced Liver Fibrosis, 8/02/2018 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,, 2/18/2016 ITCI-US  GNW  Intra-Cellular Therapies to Host Fourth Quarter and Full-Year 2015 Financial Results Conference Call and Webcast,,,,, 9/24/2015 ATRA-US    GNW  Atara Bio's T-Cell Product Candidate Activated Against Wilms' Tumor 1 Protein Demonstrates Encouraging Results in Patients With Plasma Cell Leukemia,,12/22/2014 24983L10 GNW  Dermira Added to Russell 2000(R) Index,,,11/06/2013 86845910 GNW  Supernus Announces Third Quarter 2013 Earnings Conference Call and Webcast,,, 5/17/2016 CHRS-US  GNW  Coherus BioSciences Provides Update on â€˜135 IPR,,,,,,, 9/28/2016 37890U10 GNW  GUERBET : 2016 half-year results,,,,,,11/01/2017 BGNE-US  GNW  BeiGene Announces Oral Presentation and Posters at the 59th American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/07/2016 PGNX-US  GNW  Progenics Pharmaceuticals Commences Pivotal Phase 3 Study of PSMA Targeted Imaging Agent 1404 for Prostate Cancer,,,,,,,,, 5/09/2017 OPK-US   GNW  OPKO Health Reports 2016 Financial and Operating Results,, 1/13/2014 09061G10    GNW  American College of Medical Genetics and Genomics Practice Guidelines Support Lifelong Therapy to Manage Phenylketonuria (PKU),,,, 8/30/2017 IMMU-US  GNW  Immunomedics to Participate in Upcoming Investor Conferences,,, 9/26/2016 BCRX-US  GNW  BioCryst Closes $23 Million Senior Credit FacilityÂ ,,,,,"10/21/2014 00972810 GNW  Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information",, 8/21/2018 MYGN-US  GNW  Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results,,,,, 3/22/2016 INO-US    GNW  Inovioâ€™s DNA-based Monoclonal Antibody and DNA Vaccine Provide 100% Protection Against Lethal Chikungunya Virus Challenge in Preclinical StudyÂ ,,,,,"10/25/2017 AMRN-US  GNW  Amarin to Report Third Quarter 2017 Results and Host Conference Call on November 1, 2017",,, 8/31/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 5/19/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces 2016 Analyst Day,,,,, 1/19/2018 SAN-FR   GNW  Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee,,,,,, 6/23/2015 N0104510 GNW  Affimed Announces Opening of US Operations and Key US-based Hires,,,,11/22/2016 ZGNX-US  GNW  New Data on Zogenixâ€™s ZX008 for Lennox Gastaut Syndrome & Dravet Syndrome to be Presented at 70th Annual American Epilepsy Society Meeting,,,,,," 9/11/2014 00773U10 GNW  Avalanche Biotechnologies, Inc. Reports Second Quarter 2014 Financial Results", 9/16/2016 RARE-US   GNW  Ultragenyx to Host Conference Call to Discuss KRN23 Data Presented at ASBMR 2016 Annual Meeting,,12/23/2015 NSTG-US  GNW  NanoString Technologies to Present at J.P. Morgan 34th Annual Healthcare Conference,,, 9/09/2015 RDUS-US  GNW  Radius Health Appoints Global Pharmaceutical Leader David P. Snow as Chief Commercial Officer,,,,,,,,"11/21/2014 69512710 GNW  EQUITY ALERT: Rosen Law Firm Reminds Pacira Pharmaceuticals, Inc. Investors of Important December 2, 2014 Deadline in Class Action -- PCRX","10/21/2014 76129910 GNW  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX"," 4/16/2013 69404D10 GNW  Pacific Biosciences of California, Inc. First Quarter 2013 Financial Results Call",,, 9/12/2016 MGNX-US  GNW  Takeda and MacroGenics Announce the Conclusion of their MGD010 License and Option Agreement,,,, 5/01/2015 60877T10 GNW  Momenta Pharmaceuticals Reports First Quarter 2015 Financial Results,11/03/2014 G7280010 GNW  Prothena Reports Third Quarter 2014 Financial Results and R&D Progress,,,,10/25/2015 GMAB-DK  GNW  Genmab Achieves $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen,,,,," 9/10/2013 16383L10 GNW  ChemoCentryx Announces Top-Line Interim Results for CCX140, an Orally Administered CCR2 Inhibitor, in an Ongoing 52 Week Phase II Trial in Patients With Diabetic Nephropathy",,," 1/20/2016 56400P70  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016 â€“ MNKD",, 9/19/2016 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at the HFSA Annual Scientific Meeting, 1/13/2016 ESPR-US     GNW  Esperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability Study," 5/18/2017 03236M20  GNW  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm",,"10/08/2013 00448Q20 GNW  Pomerantz Law Firm Has Filed a Class Action Against Achillion Pharmaceuticals, Inc. and Certain Officers - ACHN", 6/09/2015 87166B10 GNW  INC Research First CRO to Launch Site Advocacy Group to Enhance the Clinical Research Process," 7/12/2016 06CR5C-E GNW  Amicus Therapeutics Appoints Former FDA Division Deputy Director Andrew Mulberg as Vice President, Regulatory Strategy",,,, 5/11/2015 36197T10 GNW  GW Pharmaceuticals to Present at Bank of America Merrill Lynch 2015 Healthcare Conference,,,,, 9/29/2016 36315X10 GNW  MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis, 8/17/2016 PTLA-US  GNW  Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXaâ„¢ (andexanet alfa),,,, 6/05/2015 14075510 GNW  Cara Therapeutics to Present at the 2015 International Conference on Opioids,"11/11/2016 FLXN-US  GNW  Flexion Therapeutics Announces Presentation of Phase 3 Data Demonstrating that Extended-Release Zilrettaâ„¢ Achieves Clinically Significant Improvement of Pain, Stiffness and Function in Patients with Osteoarthritis of the Knee", 4/04/2016 N9006410 GNW  uniQure Announces Results for Fourth Quarter and Financial Year 2015,12/18/2015 AGIO-US   GNW  Agios Announces Initiation of Phase 1b Frontline Trial of AG-221 or AG-120 in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients, 1/26/2015 46226010 GNW  Lion Biotechnologies Amends CRADA With National Cancer Institute to Develop TIL Therapy for Additional Cancer Indications,,, 5/20/2015 31189P10 GNW  Fate Therapeutics Announces Pricing of Public Offering of Common Stock,,, 9/08/2015 45845P10 GNW  Intercept to Present at the Baird Healthcare Conference," 7/31/2018 KPTI-US    GNW  Karyopharm to Report Second Quarter 2018 Financial Results on August 7, 2018",,, 2/16/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 2016 RBC Capital Marketsâ€™ Healthcare Conference,,,,," 9/02/2015 04651310   GNW  Atara Biotherapeutics, Inc. to Present at Upcoming Investor Conferences in September 2015",,11/12/2014 24983L10 GNW  Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update,,,11/06/2013 86845910 GNW  Supernus Announces Release of Exciting New Clinical Data on Trokendi XR(TM),,," 5/16/2016 CHRS-US  GNW  Coherus BioSciences Appoints Patrick Oâ€™Brien as Senior Vice President, Investor Relations",,,,,,, 9/14/2016 GBT-US   GNW  Global Blood Therapeutics Announces Publication of Preclinical Results Supporting GBT440 Program for Hypoxemic Pulmonary Disorders,,,,,, 9/28/2017 BGNE-US  GNW  BeiGene Presents Preliminary Phase 1 Data for BGB-A317 in Chinese Patients with Advanced Tumors at the 20th Annual Meeting of CSCO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/03/2015 PGNX-US  GNW  Progenics Pharmaceuticals Achieves Target Enrollment in its Phase 2b Pivotal Trial of Azedraâ„¢,,,,,,,,," 5/08/2017 OPK-US   GNW  OPKO Health to Announce 2017 First Quarter Financial Results on May 9, 2017",, 1/13/2014 09061G10    GNW  BioMarin Announces Selection of Factor VIII Gene Therapy Drug Development Candidate BMN 270 for the Treatment of Hemophilia A,,,, 8/21/2017 IMMU-US  GNW  Immunomedics Announces Publication of Phase 2 Results With Labetuzumab Govitecan (IMMU-130) That Demonstrate Promising Efficacy as a Single Agent in Patients With Metastatic Colorectal Cancer,,, 9/07/2016 BCRX-US  GNW  BioCryst Announces Positive Study Results for BCX4430 Delayed Treatment of Ebola Virus Infection in a Non-Human Primate Model,,,,, 9/30/2014 00972810 GNW  Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion,, 8/13/2018 MYGN-US  GNW  Myriad Reschedules Release of Fiscal Fourth-Quarter 2018 Financial Results,,,,, 3/16/2016 INO-US    GNW  Inovio Signs Collaborative Research Agreements  With Wistar Institute for DNA-based Immunotherapies and Vaccines,,,,, 9/25/2017 AMRN-US  GNW  Amarin and HLS Therapeutics Announce Agreement to Commercialize VascepaÂ® in Canada,,, 8/24/2017 SRPT-US  GNW  Sarepta Therapeutics to Present at Three Upcoming Investor Conferences,,, 5/03/2016 AMAG-US  GNW  AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results,,,,, 1/08/2018 SAN-FR   GNW  Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs,,,,,, 6/17/2015 00G64K-E GNW  AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership,,,,11/22/2016 ZGNX-US  GNW  Zogenix to Participate in Oppenheimer Life Sciences Summit 2016,,,,,, 8/05/2014 00773U10 GNW  Avalanche Biotechnologies Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares, 9/01/2016 RARE-US   GNW  Ultragenyx to Present at Baird 2016 Global Healthcare Conference,,12/07/2015 63009R10 GNW  NanoString Technologies Announces Eleven Prosigna/PAM50 Presentations at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium,,, 8/18/2015 75046920 GNW  Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors,,,,,,,,"11/17/2014 69512710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Pacira Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PCRX","10/20/2014 76129910 GNW  Pomerantz Law Firm Announces the Filing of a Class Action Against Retrophin, Inc. and Certain Officers -- RTRX", 4/11/2013 69404D10 GNW  Photo Release -- Pacific Biosciences Launches the PacBio(R) RS II Sequencing System,,, 8/31/2016 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 4/20/2015 MNTA-US  GNW  Momenta Presents Key Glatopa(TM) (glatiramer acetate injection) Data at American Academy of Neurology Annual Meeting, 8/26/2014 G7280010 GNW  Prothena Announces Presentation at Federation of European Physiological Societies 2014 Congress,,,,10/23/2015 37230320 GNW  Major shareholder announcement for Genmab A/S,,,,, 9/04/2013 16383L10 GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,, 1/11/2016 MNKD-US   GNW  MannKind Provides Update on Senior Management,, 9/09/2016 CYTK-US  GNW  Cytokinetics Announces Additional Results From COSMIC-HF to Be Presented at the HFSA Annual Scientific Meeting," 1/12/2016 29664W10    GNW  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR)"," 5/18/2017 03236M20  GNW  AMRS ALERT: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important Deadline in First Filed Class Action â€“ AMRS",, 9/27/2013 00448Q20 GNW  Achillion Provides Pipeline Update, 5/21/2015 87166B10 GNW  INC Research to Present at Upcoming Investor Conferences, 7/06/2016 FOLD-US  GNW  Amicus Therapeutics Expands Biologics Pipeline with New Preclinical Program for Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency,,,, 5/11/2015 36197T10 GNW  GW Pharmaceuticals plc Reports Second Quarter 2015 Financial Results and Operational Progress,,,,, 9/27/2016 36315X10 GNW  Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel disease, 8/09/2016 PTLA-US  GNW  Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update,,,, 5/12/2015 14075510 GNW  Cara Therapeutics Reports First Quarter 2015 Financial Results,11/07/2016 FLXN-US  GNW  Flexion Therapeutics Reports Third Quarter 2016 Financial Results, 3/22/2016 N9006410 GNW  uniQure Announces Preclinical Proof of Concept for Gene Therapy Approach in Huntington's Disease,12/06/2015 AGIO-US   GNW  Agios Announces Data from Ongoing Phase 1/2 Trial of AG-221 Showing Durable Responses in Patients with Advanced Hematologic Malignancies, 1/12/2015 46226010 GNW  Lion Biotechnologies CSO Laszlo Radvanyi Co-authors Study in Clinical Cancer Research,,, 5/18/2015 31189P10 GNW  Fate Therapeutics Announces Proposed Public Offering of Common Stock,,, 8/31/2015 45845P10 GNW  FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis," 7/25/2018 KPTI-US    GNW  Karyopharm Appoints Ian Karp as Vice President, Investor and Public Relations",,, 2/01/2016 ITCI-US  GNW  Intra-Cellular Therapies to Present at the Leerink Partnersâ€™ 5th Annual Global Healthcare Conference,,,,, 8/31/2015 04651310   GNW  Atara Biotherapeutics Announces Completion of Enrollment in PINTA 745 Phase 2 Clinical Trial in End-Stage Renal Disease Patients With Protein Energy Wasting,,10/02/2014 24983L10 GNW  Dermira Prices Initial Public Offering,,, 9/05/2013 86845910 GNW  Supernus Launches Trokendi XR(TM) in the United States,,, 5/09/2016 CHRS-US  GNW  Coherus BioSciences Reports First Quarter 2016 Financial and Operating Results,,,,,,, 9/06/2016 GBT-US   GNW  Global Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and Care,,,,,, 9/21/2017 BGNE-US  GNW  BeiGene Announces Presentation at the 20th Annual Meeting of the Chinese Society of Clinical Oncology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/16/2015 PGNX-US  GNW  Progenics Pharmaceuticals Announces  the Appointment of Patrick Fabbio as Chief Financial Officer,,,,,,,,," 3/28/2017 68375N10 GNW  ChromaDex Appoints Steven D. Rubin, J.D., to its Board of Directors",," 1/08/2014 09061G10    GNW  Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets",,,, 8/16/2017 IMMU-US  GNW  Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline,,, 8/31/2016 BCRX-US  GNW  BioCryst to Present at the Baird 2016 Global Healthcare Conference September 8,,,,, 8/12/2014 009WCF-E GNW  Akorn Completes Acquisition of VersaPharm,," 8/01/2018 62855J10 GNW  Research Report Identifies Myriad Genetics, Celldex Therapeutics, Charles River Laboratories International, Louisiana-Pacific, Integrated Device Technology, and Beazer Homes with Renewed Outlook â€” Fundamental Analysis, Calculating Forward Movement",,,,, 3/14/2016 INO-US    GNW  Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy for Next-Generation Vaccines,,,,, 9/20/2017 AMRN-US  GNW  Amarin to Present at Cantor Global Healthcare Conference,,, 7/31/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 4/27/2016 DB-DE    GNW  AMAG Pharmaceuticals to Participate in the Deutsche Bank 41st Annual Healthcare Conference,,,,, 1/07/2018 SAN-FR   GNW  Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance,,,,,, 6/17/2015 N0104510 GNW  AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership,,,,11/08/2016 ZGNX-US  GNW  Zogenix to Participate in Stifel 2016 Healthcare Conference,,,,,, 7/31/2014 00773U10 GNW  Avalanche Biotechnologies Prices Initial Public Offering of $102.0 Million of Common Stock, 8/23/2016 RARE-US   GNW  Ultragenyx Announces KRN23 Data Presentations at ASBMR 2016 Annual Meeting,,11/05/2015 NSTG-US  GNW  NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum,,, 8/06/2015 75046920 GNW  Radius Health Reports Second Quarter 2015 Financial and Operating Results,,,,,,,,"10/29/2014 69512710 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Pacira Pharmaceuticals, Inc. to Contact Brower Piven Before the December 2, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- PCRX", 3/27/2014 76129910 GNW  The NASDAQ Stock Market Leads U.S. Exchanges for IPOs in Q1 2014, 2/05/2013 69404D10 GNW  Pacific Biosciences Completes $20.5 Million Debt Financing,,, 8/04/2016 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 4/17/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Data Presentations on Glatopa(TM) (glatiramer acetate injection) at the American Academy of Neurology's (AAN) 2015 Annual Meeting, 8/18/2014 G7280010 GNW  Dr. Dale Schenk to Discuss Parkinson's Disease at 2014 Rejuvenation Biotechnology Conference,,,,10/16/2015 GMAB-DK  GNW  Major Shareholder Announcement,,,,, 8/23/2013 16383L10 GNW  ChemoCentryx Announces GlaxoSmithKline's Release of Top-Line Results From the SHIELD-1 Phase III Study of Vercirnon,,, 1/05/2016 MNKD-US   GNW  MannKind Corporation Announces Termination of License and Collaboration Agreement With Sanofi,, 9/08/2016 CYTK-US  GNW  Cytokinetics Announces Next-Generation Fast Skeletal Muscle Activator Entering IND-Enabling Studies, 1/12/2016 ESPR-US     GNW  Esperion Therapeutics Announces Initiation of Phase 2 Clinical Study of Bempedoic Acid in Patients Treated With High-Dose Statin Therapy," 5/16/2017 03236M20  GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Amyris, Inc. (Nasdaq: AMRS) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",, 9/06/2013 00448Q20 GNW  Achillion to Present at the Two Upcoming Healthcare Conferences," 5/14/2015 87166B10 GNW  CORRECTING and REPLACING -- INC Research Completes Secondary Offering, Stock Repurchase and Debt Refinancing; Updates 2015 Business Outlook", 6/10/2016 FOLD-US  GNW  Amicus Therapeutics Appoints Craig A. Wheeler to Board of Directors,,,, 5/11/2015 36197T10 GNW  GW Pharmaceuticals Initiates Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome,,,,, 9/25/2016 36315X10 GNW  Endoscopic improvements with filgotinib are consistent with clinical remission rates in patients with Crohn's disease," 8/02/2016 PTLA-US  GNW  Portola Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 9",,,, 5/06/2015 14075510 GNW  Cara Therapeutics to Present at American Pain Society 34th Annual Scientific Meeting,11/03/2016 009T7W-E GNW  Flexion Therapeutics Announces that Analysis from Phase 3 Clinical Trial of Zilrettaâ„¢ for Osteoarthritis of the Knee to be presented at AAHKS, 3/14/2016 N9006410 GNW  uniQure Announces Dosing of First Patient in High-Dose Cohort in Phase I/II Hemophilia B Clinical Trial,12/05/2015 AGIO-US   GNW  Agios Announces Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Responses in Patients with Advanced Hematologic Malignancies, 1/06/2015 46226010 GNW  Lion Biotechnologies to Present at Biotech Showcase,,, 5/07/2015 31189P10 GNW  Fate Therapeutics Reports First Quarter 2015 Financial Results,,, 8/05/2015 45845P10 GNW  Intercept Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update, 7/18/2018 KPTI-US    GNW  Karyopharm Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Selinexor as a Treatment for Patients with Penta-Refractory Multiple Myeloma,,,12/23/2015 ITCI-US  GNW  Intra-Cellular Therapies Reports Initiation of Patient Enrollment for ITI-007 Phase 3 Clinical Trials in Bipolar Depression,,,,, 8/06/2015 04651310   GNW  Atara Biotherapeutics Announces Second Quarter 2015 Results,,,,, 8/29/2013 86845910 GNW  Supernus to Present at Two Investor Conferences in September,,, 5/04/2016 BAC-US   GNW  Coherus BioSciences to Present at Bank of America Merrill Lynch Health Care Conference on May 11,,,,,,, 8/31/2016 GBT-US   GNW  Global Blood Therapeutics Announces Participation at Two  Upcoming Investor Conferences in September,,,,,, 9/11/2017 BGNE-US  GNW  BeiGene Presents Preliminary Phase 1 Data for BGB-A317 in Multiple Solid Tumors at the ESMO 2017 Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/10/2015 PGNX-US  GNW  Progenics Pharmaceuticals to Present at the Stifel Healthcare Conference,,,,,,,,, 3/22/2017 OPK-US   GNW  OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder,," 1/07/2014 09061G10    GNW  Jean-Jacques Bienaime, CEO of BioMarin, to Present at the 32nd Annual J.P. Morgan Healthcare Conference",,,, 8/07/2017 IMMU-US  GNW  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2017 Results,,, 8/11/2016 BCRX-US  GNW  BioCryst Announces Initiation of the APeX-1 Clinical Trial of BCX7353 for Hereditary Angioedema,,,,, 8/05/2014 00972810 GNW  Akorn Reports Preliminary 2014 Second Quarter Results,," 8/01/2018 MYGN-US  GNW  Myriad to Announce Fiscal Fourth-Quarter 2018 Financial Results on August 14, 2018",,,,, 3/14/2016 INO-US    GNW  Inovio Pharmaceuticals Reports 2015 Fourth Quarter and Year End Financial Results,,,,, 9/13/2017 AMRN-US  GNW  Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer,,," 7/27/2017 SRPT-US  GNW  Sarepta Therapeutics Announces its Partner, Genethon, Published New Micro-Dystrophin Gene Therapy Data in Nature Communications",,," 4/21/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Host Conference Call on May 3, 2016 at 8:00 a.m. ET to Discuss Financial Results for the First Quarter Ended March 31, 2016",,,,,12/18/2017 SAN-FR   GNW  Sanofi and Alnylam submit Marketing Authorization Application  to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis,,,,,, 6/03/2015 N0104510 GNW  Affimed Announces Newly Formed Scientific Advisory Board,,,,11/07/2016 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results,,,,,,, 8/09/2016 CF.PRA-CA GNW  Ultragenyx to Present at Upcoming Investor Conferences,,11/05/2015 63009R10 GNW  NanoString Technologies Expands 3D Biology Portfolio With the Commercial Launch of Seven New nCounter PanCancer Profiles to Deeply Probe Cancer Biology,,, 8/05/2015 75046920 GNW  Radius Health to Present at the 35th Annual Canaccord Genuity Growth Conference,,,,,,,,"10/22/2014 69512710 GNW  EQUITY ALERT: Rosen Law Firm Reminds Pacira Pharmaceuticals, Inc. Investors of Important Class Action Deadline -- PCRX",," 2/05/2013 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Fourth Quarter 2012 Financial Results",,, 8/03/2016 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Second Quarter 2016 Financial Results,,,, 4/16/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Conference Call Details Regarding FDA Approval for Glatopa(TM) (glatiramer acetate injection), 8/04/2014 G7280010 GNW  Prothena Reports Second Quarter 2014 Financial Results and R&D Progress,,,,10/08/2015 GMAB-DK  GNW  Major Shareholder Announcement,,,,," 8/12/2013 16383L10 GNW  ChemoCentryx Announces Financial Results for the Quarter Ended June 30, 2013",,,12/29/2015 MNKD-US   GNW  MannKind Corporation to Present at the J.P. Morgan 2016 Healthcare Conference,, 9/01/2016 CYTK-US  GNW  Cytokinetics and Amgen to Advance Omecamtiv Mecarbil to Phase 3 Clinical Development, 1/06/2016 ESPR-US     GNW  Esperion Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference, 5/15/2017 AMRS-US   GNW  Amyris Reports 164% Product Revenue Growth over Prior Year & Continued Strong Outlook,, 8/07/2013 00448Q20 GNW  Achillion Reports Second Quarter and Six Month 2013 Financial Results," 5/14/2015 87166B10 GNW  INC Research Completes Secondary Offering, Stock Repurchase and Debt Refinancing; Updates 2015 Business Outlook", 6/01/2016 FOLD-US  GNW  Amicus Therapeutics to Present at the Goldman Sachs 37th Annual Global Healthcare Conference,,,," 5/06/2015 36197T10 GNW  GW Pharmaceuticals to Report Q2 2015 Financial Results and Host Conference Call on 11 May, 2015",,,,, 9/19/2016 36315X10 GNW  Galapagos increases share capital through warrant exercises, 6/01/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces Dosing of First Patient in Phase 2a Study of Cerdulatinib for Treatment of Hematologic Cancer and Upcoming Presentations of New Phase 1 Clinical Data at ASCO and EHA Annual Meetings,,,," 5/05/2015 14075510 GNW  Cara Therapeutics to Announce First Quarter 2015 Financial Results on May 12, 2015",11/01/2016 FLXN-US  GNW  Flexion Therapeutics Reports Primary Endpoint Met in Clinical Trial Evaluating Investigational Drug Candidate Zilrettaâ„¢ in Type 2 Diabetes Patients with Knee Osteoarthritis, 3/02/2016 QURE-NL  GNW  uniQure to Present at the 36th Cowen & Company Health Care Conference,11/08/2015 00847X10  GNW  Agios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors, 1/05/2015 46226010 GNW  Lion Biotechnologies Submits Investigational New Drug Application to Conduct Phase 2 Study in Metastatic Melanoma,,, 5/06/2015 31189P10 GNW  Juno Therapeutics and Fate Therapeutics Announce Strategic Research Collaboration to Improve the Therapeutic Profile of Engineered T Cell Immunotherapies,,, 7/29/2015 45845P10 GNW  Intercept to Report Second Quarter 2015 Financial Results on August 5 and Present at Upcoming Conferences, 7/02/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,12/21/2015 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 34th Annual J.P. Morgan Healthcare Conference,,,,, 7/15/2015 04651310   GNW  Atara Bio Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,, 8/19/2013 86845910 GNW  Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR(TM),,, 5/02/2016 CHRS-US  GNW  Coherus BioSciences to Report First Quarter 2016 Financial Results on May 9,,,,,,, 8/10/2016 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2016 Financial Results,,,,,, 9/08/2017 BGNE-US  GNW  BeiGene Presents Preliminary Phase 1/2 Clinical Data on PARP Inhibitor BGB-290 in Patients with Advanced Solid Tumors at the European Society for Medical Oncology 2017 Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/09/2015 PGNX-US  GNW  Progenics Pharmaceuticals Announces Third Quarter 2015 Financial Results,,,,,,,,, 3/14/2017 OPK-US   GNW  OPKO Health's GeneDx to have Significant Presence at ACMG 2017,, 1/06/2014 09061G10    GNW  Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program,,,, 7/10/2017 IMMU-US  GNW  Published Results from Clinical Trials Demonstrate Therapeutic Potential for Immunomedicsâ€™ Sacituzumab Govitecan (IMMU-132) in the Treatment of Metastatic Solid Cancers,,, 8/04/2016 BCRX-US  GNW  BioCryst Reports Second Quarter 2016 Financial Results,,,,," 7/15/2014 00972810 GNW  Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information",, 7/31/2018 00BZNS-E GNW  Myriad Announces Closing of Counsyl Acquisition,,,,," 3/11/2016 INO-US    GNW  Inovio Pharmaceuticals Appoints DNA Immunotherapy Pioneer David B. Weiner, Ph.D., to its Board of Directors",,,,, 9/06/2017 AMRN-US  GNW  Amarin to Present at Rodman & Renshawâ€™s Global Investment Conference,,, 7/24/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Pricing of $325 Million Public Offering of Common Stock,,, 4/11/2016 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Edward Myles as Chief Financial Officer,,,,,12/15/2017 SAN-FR   GNW  Sanofi: FDA lifts clinical hold on fitusiran,,,,,, 5/29/2015 N0104510 GNW  Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 Binding Affinities Correlate with Potent T-cell Activation and Cytotoxicity,,,,10/31/2016 ZGNX-US  GNW  Zogenix to Release Third Quarter 2016 Financial Results and Host Conference Call and Webcast on November 7,,,,,,, 8/08/2016 RARE-US   GNW  Ultragenyx Reports Second Quarter 2016 Financial Results and Corporate Update,,11/02/2015 63009R10 GNW  NanoString Technologies Releases Financial Results for Third Quarter of 2015,,," 7/30/2015 75046920 GNW  Radius Health to Announce Second Quarter 2015 Financial Results, Host Conference Call and Live Webcast on August 6, 2015",,,,,,,,"10/21/2014 69512710 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 -- PCRX",," 1/29/2013 69404D10 GNW  Pacific Biosciences' Software Upgrade Enhances De Novo Genome Assembly, Variant Calling and cDNA Transcript Analysis",,, 7/27/2016 MGNX-US  GNW  MacroGenics Announces Date of Second Quarter 2016 Financial Results Conference Call,,,," 4/16/2015 MNTA-US  GNW  Momenta Pharmaceuticals Announces FDA Approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg", 7/31/2014 G7280010 GNW  Initiation of Multiple Ascending Dose Phase 1 Study of PRX002 in Patients With Parkinson's Disease,,,,10/05/2015 37230320 GNW  Genmab Reaches $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen,,,,," 8/01/2013 16383L10 GNW  ChemoCentryx, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 12, 2013",,,12/23/2015 MNKD-US   GNW  MannKind Announces Appointment of Duane DeSisto as Chief Executive Officer,," 8/17/2016 CYTK-US  GNW  Cytokinetics Completes Enrollment in VITALITY-ALS, Phase 3 Clinical Trial of Tirasemtiv in Patients With ALS",10/25/2010 ESPR.XX1-US GNW  Former Chief Scientific Officer of Warner-Lambert and President of Parke-Davis Pharmaceutical Research Joins Aastrom Board of Directors," 5/15/2017 03236M20  GNW  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm",, 7/01/2013 00448Q20 GNW  Achillion Provides Update on Sovaprevir Development Program, 4/27/2015 87166B10 GNW  INC Research Reports First Quarter 2015 Results, 5/31/2016 071VWR-E GNW  Amicus Therapeutics Announces European Commission Approval for Galafoldâ„¢ (Migalastat) in Patients with Fabry Disease in European Union,,,, 5/06/2015 36197T10 GNW  GW Pharmaceuticals Initiates Phase 2 Clinical Study of Cannabidivarin (CBDV) in Epilepsy,,,,, 8/22/2016 36315X10 GNW  FINCH filgotinib Phase 3 program initiated in rheumatoid arthritis, 5/31/2016 GS-US    GNW  Portola Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference,,,, 4/15/2015 007V62-E GNW  Cara Therapeutics to Present at 3rd Conference on the Therapeutic Potential of Kappa Opioids,"10/28/2016 FLXN-US  GNW  Flexion Therapeutics to Report Third-Quarter 2016 Financial Results on November 7, 2016", 2/15/2016 QURE-NL  GNW  uniQure to Present at the RBC Capital Markets 2016 Global Healthcare Conference,11/05/2015 00847X10  GNW  Agios to Present New Data From Lead Programs at the 2015 ASH Annual Meeting,12/22/2014 GNBP-US  GNW  Lion Biotechnologies Announces Closing of Underwritten Common Stock Offering,,," 5/04/2015 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2015 Financial Results on May 7, 2015",,," 7/21/2015 45845P10 GNW  Intercept Pharmaceuticals Appoints Richard Kim as Senior Vice President, Commercial Head of U.S.", 6/25/2018 KPTI-US    GNW  Karyopharm Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),,,12/09/2015 ITCI-US  GNW  Intra-Cellular Therapies Presents Additional Efficacy and Safety Data From the Positive Phase 3 Clinical Trial of ITI-007 for the Treatment of Schizophrenia and From the Positron Emission Tomography Study,,,,, 7/09/2015 04651310   GNW  Atara Bio Announces Pricing of Its $180.0 Million Offering of Common Stock,,,,, 8/13/2013 86845910 GNW  Supernus Pharmaceuticals Reports Second Quarter 2013 Financial Results,,, 3/29/2016 BCS-GB   GNW  Coherus BioSciences to Present at Barclays Generic Pharmaceuticals Symposium on April 6,,,,,,, 8/09/2016 GBT-US   GNW  Global Blood Therapeutics to Present at the Wedbush PacGrow Healthcare Conference,,,,,, 8/31/2017 CELG-US  GNW  BeiGene Announces Closing of Global Strategic Oncology Collaboration with Celgene Corporation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/02/2015 PGNX-US  GNW  Progenics Pharmaceuticals Sets Third Quarter Financial Results Call for November 9,,,,,,,,, 3/14/2017 OPK-US   GNW  OPKO Health to Participate in the Barclays Global Healthcare Conference,,"11/26/2013 09061G10    GNW  Dan Spiegelman, CFO of BioMarin, to Present at the Deutsche Bank 2013 BioFest Conference in Boston",,,, 6/29/2017 IMMU-US  GNW  Immunomedics Announces Results of Special Stockholder Meeting,,, 7/21/2016 BCRX-US  GNW  BioCryst to Announce Second Quarter 2016 Financial Results August 4,,,,," 9/12/2013 00972810 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company to Akorn, Inc. -- HITK",, 7/25/2018 MYGN-US  GNW  Myriad Announces Publication of IMPACT Study in Journal of Psychiatric Research,,,,," 3/03/2016 INO-US    GNW  Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2015 Financial Results on March 14, 2016",,,,, 8/14/2017 AMRN-US  GNW  Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee,,, 7/24/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Proposed $250 Million Public Offering of Common Stock,,, 4/06/2016 05KDBG-E GNW  AMAG Pharmaceuticals to Participate in 15th Annual Needham Healthcare Conference,,,,,12/13/2017 SAN-FR   GNW  Sanofi  : Sanofi presents R&D strategy and innovative pipeline,,,,,, 5/29/2015 N0104510 GNW  Affimed ASCO Data Demonstrate Consistent Potency of NK-Cell-Engaging Combination Therapy with Checkpoint Modulators,,,, 9/20/2016 ZGNX-US  GNW  Zogenix to Participate in Two Upcoming Investor Conferences,,,,,,, 8/01/2016 RARE-US   GNW  Ultragenyx to Host Conference Call for Second Quarter 2016 Financial Results and Corporate Update,,"10/12/2015 63009R10 GNW  NanoString Technologies to Release Third Quarter 2015 Financial Results and Host Conference Call on Monday, November 2, 2015",,," 7/28/2015 75046920 GNW  Radius Health, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares",,,,,,,,"10/17/2014 69512710 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Pacira Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- PCRX",, 1/29/2013 69404D10 GNW  Pacific Biosciences Names TSMC Supplier of the Year,,, 6/28/2016 MGNX-US  GNW  MacroGenics Announces Closing of Collaboration and License Agreement with Janssen to Develop MGD015,,,, 4/15/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2015 Financial Results Conference Call and Webcast," 6/25/2014 G7280010 GNW  Prothena Announces Pricing of Public Offering of 4,750,000 Ordinary Shares",,,, 9/29/2015 GMAB-DK  GNW  Major Shareholder Announcement,,,,, 6/19/2013 16383L10 GNW  ChemoCentryx Announces Completion of Target Enrollment of CCX140 Phase II Clinical Trial in Diabetic Nephropathy,,,11/20/2015 56400P70  GNW  MannKind Announces Senior Management Changes,," 7/28/2016 CYTK-US  GNW  Cytokinetics, Inc. Reports Second Quarter 2016 Financial Results",, 5/11/2017 03236M20  GNW  Amyris Announces Closing Of First Tranche Of Up To $95 Million In Equity Financing And Conversion Of Over $55 Million Of Debt To Equity,, 6/12/2013 00448Q20 GNW  Achillion to Present at the Wells Fargo 2013 Healthcare Conference," 4/17/2015 87166B10 GNW  INC Research Schedules First Quarter 2015 Earnings Call for Monday, April 27th", 5/05/2016 FOLD-US  GNW  Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,,,, 4/27/2015 36197T10 GNW  GW Pharmaceuticals Announces Proposed Public Offering of ADSs,,,,, 7/29/2016 36315X10 GNW  Galapagos receives transparency notification from Federated, 5/27/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting,,,, 4/07/2015 14075510 GNW  Cara Therapeutics to Webcast Presentation at 14th Annual Needham Healthcare Conference, 9/29/2016 009T7W-E GNW  Flexion Therapeutics Announces Appointment of John MageeÂ as Vice President of Sales, 1/07/2016 N9006410 GNW  uniQure Announces Preliminary Topline Results from Low-Dose Cohort in Hemophilia B Phase I/II Gene Therapy Clinical Trial,11/05/2015 00847X10  GNW  Agios Reports Third Quarter 2015 Financial Results,12/17/2014 GNBP-US  GNW  Lion Biotechnologies Announces Pricing of Underwritten Common Stock Offering,,, 4/29/2015 31189P10 GNW  Fate Therapeutics to Present at Deutsche Bank 40th Annual Health Care Conference,,, 6/29/2015 45845P10 GNW  Intercept Pharmaceuticals Submits Applications in the U.S. and Europe for Marketing Approval of Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis, 6/15/2018 KPTI-US    GNW  Karyopharm Presents Updated Selinexor Phase 1b/2 STOMP Myeloma Data from Multiple Combinations at the European Hematology Association 2018 Annual Meeting,,,12/07/2015 ITCI-US  GNW  Intra-Cellular Therapies to Present at the 54th Annual Meeting of the American College of Neuropsychopharmacology,,,,, 7/07/2015 04651310   GNW  Atara Bio Announces Proposed Offering of Common Stock,,,,, 8/07/2013 SUPN-US  GNW  Supernus Sues Watson for Infringement of Oxtellar XR(TM) Patents,,, 3/07/2016 CHRS-US  GNW  Coherus BioSciences to Present at Barclays Global Healthcare Conference on March 16,,,,,,," 7/28/2016 37890U10 GNW  GUERBET : Revenue at June 30, 2016: EU376.7 million, up 65.7%",,,,,, 8/30/2017 BGNE-US  GNW  BeiGene Announces Presentations at the European Society for Medical Oncology 2017 Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/13/2015 PGNX-US  GNW  Progenics Announces Offer to Acquire EXINI,,,,,,,,, 3/08/2017 OPK-US   GNW  OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological DisorderÂ ,,11/19/2013 09061G10    GNW  FDA Advisory Committee Recommends Approval for BioMarin's Vimizim(TM) for the Treatment of Patients With Morquio A Syndrome,,,, 6/01/2017 IMMU-US  GNW  Immunomedics to Present at Jefferies 2017 Global Healthcare Conference,,, 7/05/2016 BCRX-US  GNW  BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases,,,,," 9/04/2013 00972810 GNW  HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company -- HITK",, 7/18/2018 MYGN-US  GNW  Myriad Announces Coverage Decision by KrogerÂ® Prescription Plans for Vectra DAÂ®,,,,, 2/17/2016 45773H20  GNW  Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses in Preclinical Study,,,,, 8/02/2017 AMRN-US  GNW  Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations,,, 7/19/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Second Quarter 2017 Financial Results and Recent Corporate Developments,,," 4/04/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces the U.S. Commercial Launch of New Single-Dose, Preservative-Free MakenaÂ® (hydroxyprogesterone caproate injection)",,,,,12/13/2017 SAN-FR   GNW  Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma,,,,,, 5/27/2015 00G64K-E GNW  Affimed to Present at the Jefferies 2015 Healthcare Conference -- New York,,,, 9/08/2016 ZGNX-US  GNW  Zogenix to have Significant Presence at 12th European Congress on Epileptology,,,,,,, 7/28/2016 RARE-US   GNW  Ultragenyx Announces Completion of Enrollment in Phase 3 Study of KRN23 in Adults with X-Linked Hypophosphatemia (XLH),, 9/11/2015 63009R10 GNW  NanoString Technologies to Unveil Strategic Roadmap for Growth and Market Expansion,,," 7/27/2015 75046920 GNW  Radius Health Announces That it Has Hired Dr. Lorraine Fitzpatrick, Former GlaxoSmithKline Development Leader for Denosumab, as Chief Medical Officer",,,,,,,,"10/07/2014 69512710 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Pacira Pharmaceuticals, Inc. to Contact Brower Piven Before the December 2, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- PCRX",," 1/15/2013 69404D10 GNW  Pacific Biosciences of California, Inc. 4th Quarter 2012 Financial Results Call",,, 6/10/2016 MGNX-US  GNW  MacroGenics Presents Data from Phase 1 Study of MGD010 at Annual European Congress of Rheumatology (EULAR 2016),,,, 3/02/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Publication Revealing Development of a Novel Process to Generate High-Quality Hyper-sialylated IVIg Drug Candidate in PNAS, 6/23/2014 G7280010 GNW  Prothena Announces Proposed Offering of Ordinary Shares,,,, 9/25/2015 37230320 GNW  CHMP Grants Accelerated Assessment for Daratumumab for Double Refractory Multiple Myeloma,,,,, 6/05/2013 16383L10 GNW  ChemoCentryx to Present at Two Upcoming Healthcare Conferences and Ring Opening Bell at the NASDAQ Stock Market,,,11/12/2015 56400P70  GNW  MannKind Announces Pricing of Registered Direct Offering,, 7/27/2016 CYTK-US  GNW  Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS,," 5/10/2017 03236M20  GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline: June 19, 2017",, 5/30/2013 00448Q20 GNW  Achillion Nominates ACH-3422 as Nucleotide for the Treatment of Chronic HCV, 4/16/2015 87166B10 GNW  INC Research Establishes Site Advocacy Group Focused on Improving Key Aspect of Clinical Trial Management, 5/03/2016 FOLD-US  GNW  Amicus Therapeutics Announces First Quarter 2016 Financial Results and Corporate Updates,,,, 4/27/2015 36197T10 GNW  GW Pharmaceuticals plc Announces US Patent Allowance for Use of Cannabidivarin (CBDV) in Treating Epilepsy,,,,, 7/28/2016 36315X10 GNW  Focus on filgotinib and cystic fibrosis, 5/23/2016 074WZL-E GNW  Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and AndexXaâ„¢ (andexanet alfa) at International Society on Thrombosis and Haemostasis (ISTH) 2016 Scientific and Standardization Committee Meeting,,,, 3/26/2015 14075510 GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results, 9/14/2016 009T7W-E GNW  Flexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors, 1/06/2016 N9006410 GNW  uniQure Announces Conference Call and Webcast to Discuss Topline Results From Low-Dose Cohort in Hemophilia B Phase I/II Gene Therapy Clinical Trial,"11/03/2015 AGIO-US   GNW  Agios to Present at Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10","12/15/2014 46226010 GNW  Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director",,, 4/08/2015 31189P10 GNW  Fate Therapeutics to Present at 14th Annual Needham Healthcare Conference,,," 6/22/2015 45845P10 GNW  Intercept Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, M.D., Ph.D. as Senior Vice President of Medical Affairs", 6/01/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,11/23/2015 46116X10 GNW  Intra-Cellular Therapies to Participate at Upcoming Investor Conferences,,,,, 6/15/2015 04651310   GNW  Atara Biotherapeutics Exercises Exclusive License to T-Cell Technology From Memorial Sloan Kettering Cancer Center,,,,, 8/06/2013 86845910 GNW  Supernus Announces Second Quarter 2013 Earnings Conference Call and Webcast,,, 2/29/2016 CHRS-US  GNW  Coherus BioSciences Reports Fourth Quarter and Year End 2015 Financial and Operating Results,,,,,,, 4/27/2016 37890U10 GNW  GUERBET : 1st quarter 2016 revenue,,,,,, 8/30/2017 BGNE-US  GNW  BeiGene to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/12/2015 PGNX-US  GNW  Data From Phase 2 Study of Progenicsâ€™ 1404 Imaging Agent Presented at EANM Congress 2015,,,,,,,,, 3/07/2017 68375N10 GNW  OPKO Subsidiary GenPath Womenâ€™s Health Announces the Availability of ClariTestâ„¢,,11/19/2013 09061G10    GNW  BioMarin Stock Trading Halted Today,,,, 5/10/2017 IMMU-US  GNW  Immunomedics Announces Third Quarter Fiscal 2017 Results and Clinical Program Developments,,, 5/26/2016 BCRX-US  GNW  BioCryst to Present at Two Upcoming Investor Conferences,,,,," 9/12/2012 00972810 GNW  Napoli Bern Ripka Shkolnik, LLP Files Civil Complaint Against Akorn, Inc. -- AKRX",, 6/28/2018 AZN-GB   GNW  BRACAnalysisÂ® CDx Identifies Patients Who Respond to LynparzaÂ® in SOLO-1 Study,,,,, 2/02/2016 INO-US    GNW  Inovio Pharmaceuticals to Participate in Upcoming Investor Conferences,,,,," 7/26/2017 AMRN-US  GNW  Amarin to Report Second Quarter 2017 Results  and Host Conference Call on August 2, 2017",,, 7/19/2017 80360710 GNW  Sarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping,,, 3/16/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces First Patient Enrolled in Head-to-Head Phase 3 Clinical Trial Evaluating FerahemeÂ® in Adults With Iron Deficiency Anemia,,,,,12/11/2017 SAN-FR   GNW  FDA Approves Sanofi's AdmelogÂ® (insulin lispro injection),,,,,, 5/21/2015 N0104510 GNW  Affimed Reports Financial Results for First Quarter 2015,,,, 8/09/2016 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results,,,,,,, 7/27/2016 RARE-US   GNW  Ultragenyx Announces Completion of Enrollment in Phase 3 Study of Aceneuramic Acid Extended Release (Ace-ER) in GNE Myopathy,, 9/10/2015 63009R10 GNW  NanoString Technologies Expands Immuno-Oncology Portfolio With Commercial Launch of Innovative nCounter RNA:Protein PanCancer Immune Profiling Panel,,," 7/22/2015 75046920 GNW  Radius Health, Inc. Announces Pricing of Public Offering",,,,,,,,"10/07/2014 69512710 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 -- PCRX",," 1/08/2013 69404D10 GNW  100K Pathogen Genome Project Selects PacBio SMRT(R) DNA Sequencing to Generate High-Quality, Finished Genomes",,, 5/18/2016 MGNX-US  GNW  MacroGenics Enters Collaboration and License Agreement with Janssen to Develop New DART Molecule for Treatment of Cancer,,,, 2/18/2015 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at Cowen and Company's 35th Annual Health Care Conference, 5/27/2014 G7280010 GNW  Prothena to Present at the Jefferies 2014 Global Healthcare Conference in New York,,,, 9/19/2015 37230320 GNW  U.S. FDA Grants Priority Review for Ofatumumab as Maintenance Therapy for Relapsed CLL,,,,," 5/28/2013 16383L10 GNW  ChemoCentryx Announces Appointment of Health Care Insurance Executive Ira Klein, MD, to Company's Board of Directors",,,11/11/2015 56400P70  GNW  MannKind Confirms Planned Stock Sale,, 7/27/2016 23282W60 GNW  Cytokinetics and Astellas Announce Option Right for Tirasemtiv and Expansion of Global Collaboration for CK-2127107 in ALS,, 5/10/2017 03236M20  GNW  Amyris On-Track To Double Revenue For Vitamin E Partnership  With Nenter & Announces Exclusive Vitamin A License With Royal DSM,," 5/28/2013 00448Q20 GNW  Achillion Names Milind Deshpande, Ph.D., as President, Chief Executive Officer, Following Announced Retirement of Michael Kishbauch"," 4/01/2015 87166B10 GNW  INC Research Ranked ""Top CRO to Work With"" Among Large Global CROs for a Second Straight Time in Biannual CenterWatch Survey"," 4/26/2016 FOLD-US  GNW  Amicus Therapeutics to Announce First Quarter 2016 Financial Results on May 3, 2016",,,, 4/24/2015 36197T10 GNW  GW Pharmaceuticals Receives Orphan Drug Designation From FDA for Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy,,,,, 6/23/2016 36315X10 GNW  Invitation to the Special and Extraordinary Shareholders' Meetings of 26 July 2016 - Nomination of Mary Kerr for Galapagos' Board of Directors, 5/05/2016 PTLA-US  GNW  Portola Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update,,,, 3/19/2015 14075510 GNW  Cara Therapeutics to Sponsor Symposium and Present Poster at the American Academy of Pain Medicine's 31st Annual Meeting, 9/12/2016 FLXN-US  GNW  Flexion Therapeutics Announces Two Key Corporate Appointments,12/18/2015 N9006410 GNW  uniQure Appoints Dan Soland as Chief Executive Officer,"10/29/2015 00847X10  GNW  Agios to Webcast Conference Call of Third Quarter 2015 Financial Results on November 5, 2015",12/08/2014 46226010 GNW  Lion Biotechnologies Announces Positive New Data From Lead TIL Melanoma Program at ASH,,, 3/18/2015 31189P10 GNW  Fate Therapeutics to Present at the Regen Med Investor Day,,, 5/19/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Pivotal Phase 3 Clinical Trial of Obeticholic Acid in NASH, 6/01/2018 KPTI-US    GNW  Karyopharm to Present Selinexor Phase 2/3 SEAL Data at the American Society of Clinical Oncology 2018 Annual Meeting,,,11/11/2015 ITCI-US  GNW  Intra-Cellular Therapies to Present at Jefferies Autumn 2015 Global Healthcare Conference in London,,,,," 5/27/2015 04651310   GNW  Atara Biotherapeutics, Inc. to Present at Upcoming Investor Conferences in June 2015",,,,, 6/27/2013 86845910 GNW  Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR(TM),,, 2/29/2016 0DXJT0-E GNW  Coherus BioSciences Announces Private Placement of $100 Million Senior Convertible Notes,,,,,,, 4/14/2016 37890U10 GNW  Guerbet: Record earnings in 2015,,,,,, 8/10/2017 BGNE-US  GNW  BeiGene Announces Pricing of $175 Million Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/12/2015 PGNX-US  GNW  Phase 2 Dosimetry Data for Progenicsâ€™ AZEDRA Presented at EANM Congress 2015,,,,,,,,," 3/03/2017 OPK-US   GNW  OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development",,11/15/2013 09061G10    GNW  FDA Posts Briefing Documents for Advisory Committee Meeting Reviewing Vimizim(TM) for the Treatment of Morquio A Syndrome,,,, 5/10/2017 IMMU-US  GNW  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2017 Results,,, 5/05/2016 BCRX-US  GNW  BioCryst Reports First Quarter 2016 Financial Results,,,,,,, 6/21/2018 MYGN-US  GNW  Top-Five National Payer Issues Positive Coverage DecisionÂ for Myriadâ€™s ProlarisÂ® Test for Prostate Cancer,,,,, 1/28/2016 INO-US    GNW  Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial,,,,, 6/12/2017 AMRN-US  GNW  Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell,,, 7/18/2017 SRPT-US  GNW  Sarepta Therapeutics Secures $100 Million in Debt Financing,,, 2/26/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,12/04/2017 SAN-FR   GNW  Sanofi's ToujeoÂ® met main objective in head-to-head study versus insulin degludec,,,,,, 5/13/2015 N0104510 GNW  Affimed to Present Data at ASCO to Highlight Potency of NK-Cell-Engaging Combination Therapy with Checkpoint Modulators,,,, 8/02/2016 ZGNX-US  GNW  Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9,,,,,,, 7/14/2016 RARE-US   GNW  Ultragenyx Announces Positive Topline Data from Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7,, 9/09/2015 63009R10 GNW  ESMO Clinical Practice Guidelines for Breast Cancer Recommend the Use of Prosigna/PAM50 Assay for Determining Potential Benefit From Chemotherapy,,," 7/21/2015 75046920 GNW  Radius Health, Inc. Announces Proposed Public Offering",,,,,,,,"10/06/2014 69512710 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against Pacira Pharmaceuticals, Inc. -- PCRX",,11/06/2012 69404D10 GNW  Pacific Biosciences Delivers Enhanced DNA Sequencing Chemistry and Software to Help Solve Complex Genetic Problems,,, 5/11/2016 MGNX-US  GNW  MacroGenics to Present MGD010 Clinical Data at EULAR 2016,,,, 2/17/2015 60877T10 GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results, 5/05/2014 0CXBJZ-E GNW  Prothena Reports First Quarter 2014 Financial Results and Provides R&D Updates,,,, 9/09/2015 GMAB-DK  GNW  Genmab Announces European Regulatory Submission for Daratumumab in Double Refractory Multiple Myeloma,,,,," 5/21/2013 16383L10 GNW  ChemoCentryx Announces Phase I Data With CCX507, Company's New Generation Orally Administered CCR9 Inhibitor",,,11/09/2015 56400P70  GNW  MannKind Corporation Reports 2015 Third Quarter Financial Results,," 7/14/2016 CYTK-US  GNW  Cytokinetics to Announce Second Quarter Results on July 28, 2016",," 5/09/2017 AMRS-US   GNW  Amyris to Host & Videocast 1st Annual Biotech Summit and Investor Day on Tuesday, May 16, 2017",, 5/15/2013 00448Q20 GNW  Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team, 2/24/2015 87166B10 GNW  INC Research Reports Fourth Quarter and Full-Year 2014 Results, 4/01/2016 FOLD-US  GNW  Amicus Therapeutics Receives Positive CHMP Opinion for Approval of Migalastat in Patients with Fabry Disease in European Union,,,, 4/22/2015 36197T10 GNW  GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy,,,,, 6/15/2016 36315X10 GNW  Galapagos' R&D Update 2016," 4/28/2016 PTLA-US  GNW  Portola Pharmaceuticals to Announce First Quarter 2016 Financial Results  and Host Conference Call on Thursday, May 5",,,," 3/19/2015 14075510 GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2014 Financial Results on March 26, 2015", 8/31/2016 009T7W-E GNW  Flexion Therapeutics to Present at 2016 Wells Fargo Healthcare Conference,12/14/2015 N9006410 GNW  uniQure Added to NASDAQ Biotechnology Index,10/26/2015 00847X10  GNW  Agios to Present Clinical Data from Ongoing AG-120 Phase 1 Trial in Advanced Solid Tumors at AACR-NCI-EORTC,12/01/2014 46226010 GNW  Lion Biotechnologies to Present at the Piper Jaffray 26th Annual Healthcare Conference,,, 3/12/2015 31189P10 GNW  Fate Therapeutics Reports Year-End 2014 Financial Results,,, 5/11/2015 45845P10 GNW  Intercept Pharmaceuticals Announces First Quarter 2015 Financial Results, 5/31/2018 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,,11/06/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the CTAD 2015 Conference,,,,, 5/20/2015 04651310   GNW  Update: Atara Biotherapeutics' Collaborating Investigators to Present Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting,,,,, 6/10/2013 86845910 GNW  Supernus Receives Tentative Approval for Trokendi XR(TM),,, 2/26/2016 CHRS-US  GNW  Coherus BioSciences to Present at Cowen and Company Healthcare Conference on March 8,,,,,,, 2/29/2016 GBT-US   GNW  Global Blood Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference,,,,,, 8/09/2017 BGNE-US  GNW  BeiGene Announces Proposed Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 9/24/2015 74318710 GNW  Progenics Pharmaceuticals to Host Research and Development Day on October 1, 2015",,,,,,,,, 3/01/2017 OPK-US   GNW  OPKO Health Reports 2016 Financial and Operating Results,,11/15/2013 09061G10    GNW  BioMarin Announces French ATU Granted for Vimizim(TM) for the Treatment of Morquio A Syndrome,,,, 4/05/2017 IMMU-US  GNW  Immunomedics Reports Sacituzumab Govitecan (IMMU-132) is Active in Patients With Metastatic Small-Cell Lung Cancer Who Are Sensitive or Resistant to First-Line Chemotherapy,,, 4/21/2016 BCRX-US  GNW  BioCryst to Announce First Quarter 2016 Financial Results May 5,,,,,,," 6/18/2018 62855J10 GNW  DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 â€“ MYGN",,,,, 1/22/2016 INO-US    GNW  GeneOne Life Science and Inovio Pharmaceuticals to CollaborateÂ on Zika Virus Vaccine Development,,,,, 6/12/2017 AMRN-US  GNW  VascepaÂ® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides,,, 7/18/2017 80360710 GNW  Sarepta Therapeutics and BioMarin Pharmaceutical Inc. Announce Execution of a Global Settlement and a License Agreement Resolving Exon Skipping Patent Litigation,,," 2/23/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces FDA Approval of New Single-Dose, Preservative-Free MakenaÂ® (hydroxyprogesterone caproate injection)",,,,,12/01/2017 SAN-FR   GNW  Sanofi ends development of Clostridium difficile vaccine,,,,,, 5/13/2015 N0104510 GNW  Affimed Announces First Quarter 2015 Financial Results Conference Call,,,," 6/21/2016 ZGNX-US  GNW  Zogenix Announces Agreement to Refinance Debt, Further Increasing Companyâ€™s Expected 2017 Cash Balance",,,,,,, 7/13/2016 RARE-US   GNW  Ultragenyx to Present Phase 3 Data for Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7 (MPS 7) at 14th International Symposium on MPS and Related Diseases,," 8/27/2015 63009R10 GNW  NanoString Technologies to Host Investor Day on September 11, 2015",,," 7/20/2015 75046920 GNW  Radius Health Announced That it Has Appointed Debasish Roychowdhury, MD, to Its Board of Directors and the Formation of the Radius Oncology Clinical Advisory Board (OCAB)",,,,,,,,"10/03/2014 69512710 GNW  Pomerantz Law Firm Announces the Filing of a Class Action Against Pacira Pharmaceuticals, Inc. and Certain Officers -- PCRX",,"10/25/2012 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Third Quarter 2012 Financial Results",,, 5/10/2016 MGNX-US  GNW  First Dosing of Pfizer DART Candidate in Phase 1 Study Triggers Milestone Payment to MacroGenics,,,, 2/03/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast, 5/01/2014 G7280010 GNW  Prothena to Host Webcast and Conference Call to Discuss Interim Phase 1 Data of Ongoing NEOD001 Study in Patients With AL Amyloidosis on May 2,,,, 9/04/2015 GMAB-DK  GNW  U.S. FDA Grants Priority Review for Daratumumab for Double Refractory Multiple Myeloma,,,,, 5/15/2013 16383L10 GNW  ChemoCentryx to Host Analyst Day,,,"11/02/2015 56400P70  GNW  MannKind Corporation to Hold 2015 Third Quarter Financial Results Conference Call on November 9, 2015",, 7/05/2016 CYTK-US  GNW  Cytokinetics to Present at Cantor Fitzgeraldâ€™s  2nd Annual Healthcare Conference,," 5/09/2017 AMRS-US   GNW  Amyris to Announce First Quarter 2017 Financial Results on Monday, May 15, 2017",, 5/09/2013 00448Q20 GNW  Achillion to Present at Three Upcoming Investor Conferences, 2/04/2015 87166B10 GNW  INC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive David Norton, 3/22/2016 FOLD-US  GNW  Amicus Therapeutics Announces Expanded Access Program for Migalastat,,,, 4/21/2015 36197T10 GNW  GW Pharmaceuticals Initiates Second Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome,,,,, 6/09/2016 GLPG-BE  GNW  Galapagos selected for AEX Index, 4/14/2016 06P9WL-E GNW  Portola Pharmaceuticals Announces Upcoming Cerdulatinib Data Presentation at American Association for Cancer Research (AACR) Annual Meeting 2016,,,, 3/13/2015 14075510 GNW  Cara Therapeutics to Webcast Presentation at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference, 8/03/2016 FLXN-US  GNW  Flexion Therapeutics Reports Second-Quarter 2016 Financial Results,11/30/2015 N9006410 GNW  uniQure Announces Financial Results for Third Quarter 2015 and Provides Update on Product Pipeline and Company Developments,10/16/2015 00847X10  GNW  Agios Outlines Key Clinical Development & Research Strategies,11/21/2014 GNBP-US  GNW  Lion Biotechnologies Announces Clinical Data Update at American Society of Hematology Annual Meeting,,," 3/05/2015 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2014 Financial Results on March 12, 2015",,, 5/04/2015 45845P10 GNW  Intercept to Report First Quarter 2015 Financial Results on May 11 and Present at Upcoming Conferences," 5/24/2018 KPTI-US    GNW  Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-9274 in China and Other Regions in Asia",,,11/05/2015 46116X10 GNW  Intra-Cellular Therapies Reports Third Quarter 2015 Financial Results and Provides Corporate Update,,,,, 5/14/2015 04651310   GNW  Atara Biotherapeutics' Collaborating Investigators to Present Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting,,,,, 5/20/2013 86845910 GNW  Supernus to Present at Two Investor Conferences,,, 2/15/2016 CHRS-US  GNW  Coherus BioSciences to Report Fourth Quarter and Year End 2015 Financial Results on February 29,,,,,,, 2/10/2016 37890U10 GNW  Guerbet: 2015 annual revenue,,,,,, 8/09/2017 BGNE-US  GNW  BeiGene Reports Second Quarter 2017 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/06/2015 PGNX-US  GNW  Progenics Pharmaceuticals Announces Second Quarter 2015 Financial Results,,,,,,,,," 2/27/2017 OPK-US   GNW  OPKO Health to Announce 2016 Fourth Quarter Financial Results on March 1, 2017",,"11/05/2013 09061G10    GNW  Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Credit Suisse 2013 Healthcare Conference",,,, 4/04/2017 IMMU-US  GNW  Immunomedics Presents Preclinical Study That Demonstrates Increased SN-38 Delivery With Labetuzumab Govitecan (IMMU-130) Compared With Irinotecan,,, 4/07/2016 BCRX-US  GNW  BioCryst to Present at Two Upcoming Investor Conferences,,,,,,, 6/18/2018 MYGN-US  GNW  Myriadâ€™s BRACAnalysis CDxÂ® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer,,,,, 1/19/2016 INO-US    GNW  Inovio Pharmaceuticals Awarded Grant to Advance Needle-Free Vaccine Delivery Device,,,,, 6/01/2017 AMRN-US  GNW  Amarin to Present at the Jefferies 2017 Global Healthcare Conference,,, 6/30/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 2/17/2016 AMAG-US  GNW  AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results,,,,,11/29/2017 SAN-FR   GNW  Sanofi updates information on dengue vaccine,,,,,, 5/13/2015 N0104510 GNW  Affimed Announces First Quarter 2015 Financial Results Conference Call,,,, 6/07/2016 ZGNX-US  GNW  Zogenix Announces Initiation of Multi-National Phase 3 Clinical Trial for ZX008 in Dravet Syndrome,,,,,,, 6/28/2016 06CR5C-E  GNW  Ultragenyx Receives Breakthrough Therapy Designation for KRN23 in Pediatric Patients with X-Linked Hypophosphatemia,, 8/26/2015 63009R10 GNW  NanoString Technologies to Present at Upcoming Investor Conferences,,, 7/15/2015 75046920 GNW  Radius Health Today Announced Preclinical Data for Its Investigational Drug RAD1901 in Combination With CDK and mTOR Inhibitors,,,,,,,," 2/25/2014 69512710 GNW  Pacira Pharmaceuticals, Inc. Webcast Replay of 2013 Financial Results Conference Call",,10/22/2012 69404D10 GNW  Pacific Biosciences Releases Software Upgrade to Advance Bacterial DNA Methylation Analysis and De Novo Genome Assembly Projects,,, 5/04/2016 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and First Quarter 2016 Financial Results,,,, 1/29/2015 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences, 4/30/2014 G7280010 GNW  Prothena Announces Appointment of Chief Legal Officer,,,, 9/02/2015 37230320 GNW  Major Shareholder Announcement,,,,," 5/13/2013 16383L10 GNW  ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013",,,10/26/2015 MNKD-US   GNW  MannKind Announces Termination of Stock Lending Agreement,, 6/30/2016 CYTK-US  GNW  Cytokinetics Announces Start of Phase 2 Clinical Trial  of CK-2127107 in Patients With Chronic Obstructive Pulmonary Disease,, 5/08/2017 03236M20  GNW  Royal DSM To Make Equity Investment In Amyris With the Purpose of Establishing a Long-Term Relationship,, 5/07/2013 00448Q20 GNW  Achillion Reports First Quarter 2013 Financial Results," 1/27/2015 87166B10 GNW  INC Research Schedules Fourth Quarter and Full-Year 2014 Earnings Call for Tuesday, February 24th", 3/02/2016 FOLD-US  GNW  Amicus Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference,,,, 4/13/2015 36197T10 GNW  GW Pharmaceuticals Notes New Epidiolex(R) Data Released by the American Academy of Neurology,,,,, 6/01/2016 36315X10 GNW  Galapagos creates new warrant plan," 4/06/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces Presentation of Phase 3 APEX Study Results at International Society on Thrombosis and Haemostasis (ISTH)  SSC Meeting 2016 on May 27, 2016",,,, 2/10/2015 14075510 GNW  Cara Therapeutics Issued Additional U.S. Patent Covering the Expanded Use of Kappa Opioid Receptor Agonist CR845 and Analogs for the Treatment and Prevention of Pain-Related Conditions," 7/25/2016 FLXN-US  GNW  Flexion Therapeutics to Report Second-Quarter 2016 Financial Results on August 3, 2016",11/23/2015 N9006410 GNW  uniQure Announces Conference Call and Webcast to Discuss Third Quarter Financial Results and Corporate Update,"10/08/2015 00847X10  GNW  Agios to Webcast R&D Day on October 16, 2015",11/12/2014 46226010 GNW  Lion Biotechnologies Announces Management Change,,, 3/03/2015 31189P10 GNW  Fate Therapeutics Expands and Strengthens Leadership Team,,, 4/23/2015 45845P10 GNW  Intercept Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution and Cirrhosis Prevention in High-Risk NASH Patients, 5/17/2018 KPTI-US    GNW  Karyopharm to Present Selinexor Phase 1b/2 STOMP Data at the European Hematology Association 2018 Annual Meeting,,,10/29/2015 46116X10 GNW  Intra-Cellular Therapies to Host Third Quarter 2015 Financial Results Conference Call and Webcast,,,,," 5/12/2015 04651310   GNW  Atara Biotherapeutics, Inc. to Present at the UBS Global Healthcare Conference",,,,, 5/13/2013 86845910 GNW  Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results,,, 2/05/2016 CHRS-US  GNW  Coherus BioSciences to Present at Bloomberg Intelligence Healthcare Event on February 12th,,,,,,, 2/08/2016 GBT-US   GNW  Global Blood Therapeutics Announces Changes to Board of Directors,,,,,, 7/05/2017 BGNE-US  GNW  BeiGene to Host Investor Conference Call on Global Strategic Collaboration with Celgene,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/04/2015 PGNX-US  GNW  Progenics Pharmaceuticals Announces Exclusive Worldwide Licensing Agreement With Johns Hopkins University for Agent to Image Prostate Cancer Using PET Scan,,,,,,,,, 2/21/2017 OPK-US   GNW  OPKO Health to Participate at Upcoming Healthcare Investment Conferences,,10/31/2013 09061G10    GNW  BioMarin Initiates Phase 3 Trial for BMN 673 for the Treatment of Metastatic gBRCA Breast Cancer,,,, 4/04/2017 IMMU-US  GNW  Immunomedics Reports Sacituzumab Govitecan (Immu-132) Delivers High Levels of sn-38 That Overcome Chemoresistant Tumors With Moderate to Strong Trop-2 Expression,,, 3/09/2016 BCRX-US  GNW  BioCryst to Present at Barclays Healthcare Conference,,,,,,," 6/17/2018 62855J10 GNW  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Myriad Genetics, Inc., Allegiant Travel Company, Aceto Corporation, and Gridsum Holding Inc.",,,,, 1/05/2016 INO-US    GNW  Inovio Pharmaceuticals to Present at  Biotech Showcase,,,,, 5/18/2017 AMRN-US  GNW  Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care,,, 6/28/2017 SRPT-US  GNW  Sarepta Therapeutics Appoints Douglas S. Ingram as President and Chief Executive Officer,,," 2/04/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Host Conference Call on February 17, 2016 at 8:00 a.m. ETÂ to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2015",,,,,"11/09/2017 SAN-FR   GNW  Sanofi, Principia agree to develop multiple sclerosis drug candidate",,,,,, 5/12/2015 00G64K-E GNW  Affimed N.V. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares,,,, 5/31/2016 ZGNX-US  GNW  Zogenix to Participate in Jefferies 2016 Healthcare Conference,,,,,,," 6/20/2016 RARE-US   GNW  Ultragenyx Appoints Karah Parschauer as Executive Vice President, General Counsel",, 8/13/2015 63009R10 GNW  NanoString Technologies Receives Favorable Final Local Coverage Determination by Palmetto GBA for Its Prosigna Breast Cancer Assay,,, 7/14/2015 RDUS-US  GNW  Radius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2015 Annual Meeting,,,,,,,, 5/14/2012 TSRX-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,"10/10/2012 69404D10 GNW  Pacific Biosciences of California, Inc. 3rd Quarter 2012 Financial Results Call",,, 5/04/2016 MGNX-US  GNW  MacroGenics to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,,,, 1/21/2015 60877T10 GNW  Momenta Pharmaceuticals Announces Supreme Court Decision to Remand Generic Copaxone(R) Case Back to CAFC, 4/23/2014 G7280010 GNW  Prothena's NEOD001 Demonstrates Encouraging Cardiac Biomarker Responses in Ongoing Phase 1 Study in Patients With Immunoglobulin Light Chain (AL) Amyloidosis,,,, 8/27/2015 37230320 GNW  Data Published in The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses in Heavily Pre-treated Relapsed or Refractory Multiple Myeloma Patients,,,,," 5/02/2013 16383L10 GNW  ChemoCentryx, Inc. to Hold First Quarter 2013 Financial Results Conference Call on Monday, May 13, 2013",,,10/23/2015 56400P70  GNW  MannKind Announces Dual Listing on the Tel Aviv Stock Exchange,, 6/14/2016 CYTK-US  GNW  Cytokinetics to Participate in Upcoming Investor Conferences,, 5/08/2017 03236M20  GNW  Amyris Announces Agreements For Up to $95 Million In Equity Financing And In-Process Initiative To Significantly Reduce Debt,, 4/23/2013 00448Q20 GNW  Achillion Presents New Data on ACH-3102 to Treat Hepatitis C at the International Liver Congress, 1/19/2015 87166B10 GNW  INC Enhances Clinical Delivery Focus With Executive Leadership Promotions, 3/01/2016 FOLD-US  GNW  Amicus Therapeutics Highlights New Phase 3 Fabry Data and Preclinical Pompe Data at WORLDSymposiumâ„¢ 2016,,,, 3/31/2015 36197T10 GNW  GW Pharmaceuticals Initiates First Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome,,,,, 5/25/2016 36315X10 GNW  FITZROY Phase 2 study with filgotinib in Crohn's Disease presented as late breaker at DDW 2016, 4/04/2016 06CR5C-E GNW  Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiichi Sankyo to Develop Andexanet Alfa with Edoxaban in Japan,,,, 2/02/2015 14075510 GNW  Cara Therapeutics to Webcast Presentation at 17th Annual BIO CEO & Investor Conference, 7/06/2016 FLXN-US  GNW  Flexion Therapeutics Adds Three New Executives in Key Roles to Support the Planned Commercial Launch of Zilrettaâ„¢,11/12/2015 QURE-NL  GNW  uniQure to Present at the Jefferies 2015 Global Healthcare Conference - London, 9/23/2015 AGIO-US   GNW  Agios to Present at Leerink Partners Rare Disease Roundtable,10/20/2014 46226010 GNW  Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy,,, 2/25/2015 31189P10 GNW  Fate Therapeutics to Present at Cowen & Company 35th Annual Health Care Conference,,, 4/13/2015 008BK4-E GNW  Intercept Announces New Data in PBC and NASH to be Presented at EASL 2015, 5/16/2018 KPTI-US    GNW  Karyopharm to Present Selinexor Phase 2 SEAL Data at the American Society of Clinical Oncology 2018 Annual Meeting,,,10/09/2015 ITCI-US  GNW  Intra-Cellular Therapies to Present at the CNS Summit 2015 Conference,,,,, 5/07/2015 0DHGMT-E   GNW  Atara Biotherapeutics Announces First Quarter 2015 Results,,,,, 5/06/2013 86845910 GNW  Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast,,," 2/01/2016 CHRS-US  GNW  Coherus Announces the Appointment of Jim Daly,  Executive Chairman, Commercial Advisory Committee",,,,,,, 1/06/2016 GBT-US   GNW  Global Blood Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference,,,,,, 7/05/2017 BGNE-US  GNW  BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in China in Patients with Urothelial Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/28/2015 PGNX-US  GNW  Progenics Announces Breakthrough Therapy Designation for Azedra in Pheochromocytoma and Paraganglioma,,,,,,,,, 2/08/2017 OPK-US   GNW  OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis,,10/24/2013 09061G10    GNW  BioMarin Announces Third Quarter 2013 Financial Results,,,, 2/28/2017 IMMU-US  GNW  Immunomedics to Present at Cowen and Company 37th Annual Health Care Conference,,, 3/07/2016 BCRX-US  GNW  Study Results From Zika Virus Infected Mice Treated With BCX4430 to be Presented at WHO Conference,,,,,,," 6/16/2018 62855J10 GNW  NOTICE MYGN: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action â€“ MYGN",,,,, 1/04/2016 INO-US    GNW  Inovio Pharmaceuticals Adds Dr. Prakash Bhuyan to VGX-3100 Leadership Team for HPV-Related Dysplasia,,,,, 5/03/2017 AMRN-US  GNW  Amarin Reports First Quarter 2017 Financial ResultsÂ and Provides Update on Operations,,," 6/28/2017 SRPT-US  GNW  Sarepta Therapeutics to Announce Second Quarter 2017 Financial Results and Recent Corporate Developments on July 19, 2017",,, 2/02/2016 AMAG-US  GNW  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,11/02/2017 SAN-FR   GNW  Sanofi and Alnylam present positive complete results       from APOLLO Phase 3 study of investigational patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy,,,,,, 5/12/2015 N0104510 GNW  Affimed N.V. Announces Shareholder Meeting,,,, 5/10/2016 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports First Quarter 2016 Financial Results,,,,,,, 6/07/2016 RARE-US   GNW  Ultragenyx and Takeda enter into a Collaboration to Develop and Commercialize Therapies for Rare Genetic Diseases,, 8/04/2015 63009R10 GNW  NanoString Technologies Releases Financial Results for Second Quarter of 2015,,, 6/17/2015 75046920 GNW  Radius Announces Positive Top-Line Data From ACTIVExtend Trial Including Combined 25 Month Results,,,,,,,,,, 9/19/2012 69404D10 GNW  Pacific Biosciences Increases Sequencing Performance of the PacBio RS With Introduction of the Automated MagBead Station,,, 4/27/2016 MGNX-US  GNW  MacroGenics Announces Date of First Quarter 2016 Financial Results Conference Call,,,,12/01/2014 60877T10 GNW  Momenta Pharmaceuticals' Necuparanib Receives Fast Track Designation From the FDA for the Treatment of Patients With Metastatic Pancreatic Cancer, 4/08/2014 0CXBJZ-E GNW  First Human Dosed in Phase 1 Study of PRX002 for Treatment of Parkinson's Disease,,,, 8/14/2015 37230320 GNW  Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology,,,,, 5/02/2013 16383L10 GNW  ChemoCentryx to Present at Bank of America Merrill Lynch Healthcare Conference,,,10/05/2015 MNKD-US   GNW  MannKind to Present at Aegis Capital Corp. 2015 Growth Conference,, 5/23/2016 CYTK-US  GNW  Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at Heart Failure 2016 Congress,," 5/05/2017 03236M20  GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. â€“ AMRS",, 4/23/2013 00448Q20 GNW  Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients,"12/06/2014 87166B10 GNW  Video Interview: Jamie Macdonald, Chief Executive Officer, INC Research, Inc. [INCR]", 2/26/2016 FOLD-US  GNW  Amicus Therapeutics Announces Full-Year 2015 Financial Results and Corporate Updates,,,, 2/25/2015 36197T10 GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 5/24/2016 36315X10 GNW  Successful completion of End-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis (RA), 3/24/2016 07Z992-E GNW  Portola Pharmaceuticals Announces Topline Results from Phase 3 APEX Trial of Betrixaban for Prevention of Blood Clots in Acute Medically Ill Patients,,,,12/18/2014 14075510 GNW  Cara Therapeutics Announces Addition to the NASDAQ Biotechnology Index, 6/08/2016 FLXN-US  GNW  Flexion Therapeutics Announces Pricing of Public Offering of Common Stock,"10/07/2015 N9006410 GNW  uniQure to Host Investor Day in New York City on October 15, 2015", 8/06/2015 00847X10  GNW  Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress, 9/05/2014 46226010 GNW  Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference,,, 2/05/2015 31189P10 GNW  Fate Therapeutics to Present at the 2015 Leerink Global Healthcare Conference,,, 4/06/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Completion of Public Offering, 5/10/2018 KPTI-US    GNW  Karyopharm Reports First Quarter 2018 Financial Results and Highlights Recent Progress,,, 9/28/2015 46116X10 GNW  Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares,,,,, 4/20/2015 04651310   GNW  EBV-CTL Clinical Trial Data Presented by Atara Biotherapeutics' Collaborating Investigators at a Plenary Session at the American Association for Cancer Research Annual Meeting 2015,,,,, 5/06/2013 86845910 GNW  Supernus Announces Closing of $90 Million of 7.50% Convertible Senior Secured Notes Due 2019,,, 2/01/2016 CHRS-US  GNW  Coherus Announces CHS-1701 (NeulastaÂ® Biosimilar) Met Both Primary Endpoints in Registration-Enabling Immunogenicity Study,,,,,,, 1/04/2016 GBT-US   GNW  Global Blood Therapeutics Appoints Scott Morrison to Board of Directors,,,,,, 6/29/2017 BGNE-US  GNW  BeiGene Presents Preliminary Phase 1 Data on BGB-A317 in Patients with Hepatocellular Carcinoma at the ESMO 19th World Congress on Gastrointestinal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/21/2015 74318710 GNW  Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 6,,,,,,,,, 2/07/2017 OPK-US   GNW  OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer,,10/20/2013 09061G10    GNW  Five Data Presentations on BioMarin's BMN 673 PARP Inhibitor at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,,,, 2/27/2017 45290710 GNW  Immunomedics Issues Open Letter Highlighting the Clear Decision to Vote for Immunomedics to Ensure Continued Value Creation,,, 2/23/2016 BCRX-US  GNW  BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results,,,,,,," 6/15/2018 62855J10 GNW  UPDATE -- The Klein Law Firm Reminds Investors of Class Actions Commenced on Behalf of Shareholders of Fluor Corporation, Aceto Corporation, Prothena Corporation, Allegiant Travel Company, and Myriad Genetics, Inc.",,,,,11/23/2015 INO-US    GNW  Inovio Pharmaceuticals to Present at  Piper Jaffray Healthcare Conference,,,,," 4/25/2017 AMRN-US  GNW  Amarin to Report First Quarter 2017 Results  and Host Conference Call on May 3, 2017",,, 6/27/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Grand Opening of its Research and Manufacturing Center at Andover,,, 1/11/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces Preliminary 2015 Financial Results and  Provides 2016 Financial Guidance,,,,,11/02/2017 SAN-FR   GNW  Sanofi : Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed,,,,,, 5/12/2015 00G64K-E GNW  Affimed to Present at the UBS Global Healthcare Conference - New York,,,, 5/05/2016 ZGNX-US  GNW  Zogenix Announces New Efficacy and Safety Data on ZX008 for Treatment of Seizures in Dravet Syndrome,,,,,,, 6/01/2016 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences,, 7/30/2015 63009R10 GNW  NanoString Technologies to Present at the Canaccord Genuity Growth Conference,,, 6/03/2015 RDUS-US  GNW  Radius Health to Present at the Goldman Sachs Thirty-Sixth Annual 2015 Healthcare Conference,,,,,,,,,," 9/12/2012 PACB-US  GNW  Pacific Biosciences Appoints Lucy Shapiro, Ph.D. to Board of Directors",,, 4/19/2016 MGNX-US  GNW  MacroGenics Presents Data from Five Preclinical Programs at AACR Annual Meeting 2016,,,,"12/01/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R)", 3/18/2014 G7280010 GNW  Prothena Announces Clinical Data to be Presented at the International Symposium on Amyloidosis,,,, 8/12/2015 37230320 GNW  Genmab Announces Financial Results for the First Half of 2015,,,,, 4/22/2013 16383L10 GNW  ChemoCentryx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Over-Allotment Option,,, 9/04/2015 MNKDW-US  GNW  MannKind Announces Renewal of Shelf Registration and ATM Agreements,," 5/20/2016 CYTK-US  GNW  Cytokinetics Appoints Edward M. Kaye, M.D., to Board of Directors",, 5/05/2017 AMRS-US   GNW  Amyris Announces Much Better Than Expected Sales Of Farnesene To Meet Accelerated Demand For Liquid Farnesene Rubber By Global Tire Brands,, 4/16/2013 00448Q20 GNW  Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV,12/04/2014 87166B10 GNW  INC Research Expands Relationship With Society for Clinical Research Sites as First Circle of Sustainability Sponsor," 2/18/2016 FOLD-US  GNW  Amicus Therapeutics to Announce Full-Year 2015 Financial Results and Corporate Updates on February 26, 2016",,,, 2/05/2015 36197T10 GNW  GW Pharmaceuticals to Present at the Leerink 2015 Global Healthcare Conference,,,,, 5/19/2016 36315X10 GNW  Galapagos increases share capital through warrant exercises," 3/24/2016 PTLA-US  GNW  Portola Pharmaceuticals to Hold Conference Call on Thursday, March 24, at 8:30 am ET",,,,12/17/2014 14075510 GNW  Cara Therapeutics Reports Positive Top-Line Data From Phase 1b Trial of I.V. CR845 in Dialysis Patients, 6/07/2016 FLXN-US  GNW  Flexion Therapeutics Announces Proposed Public Offering of Common Stock, 9/19/2015 QURE-NL  GNW  Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy," 8/05/2015 AGIO-US   GNW  Agios to Present at Canaccord Genuity 35th Annual Growth Conference Wednesday, August 12, 2015", 8/20/2014 46226010 GNW  Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer,,, 1/12/2015 31189P10 GNW  Fate Therapeutics Announces Key 2015 Objectives for the Advancement of Programmed Cellular Therapeutics Pipeline,,, 3/31/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 5/07/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwritersâ€™ Option to Purchase Additional Shares,,, 9/24/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the Ladenburg Thalmann 2015 Healthcare Conference,,,,, 4/19/2015 0DHGMT-E   GNW  Atara Biotherapeutics' Collaborating Investigators' Abstract on T-Cell Therapy for EBV Lymphoma to be Presented at a Clinical Trials Plenary Session at the American Association for Cancer Research Annual Meeting 2015 is Now Available,,,,, 4/26/2013 86845910 GNW  Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019,,, 1/11/2016 19249H10 GNW  Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoint in Phase 3 Rheumatoid Arthritis Clinical Study (RaPsODY),,,,,,,12/31/2015 GBT-US   GNW  Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease,,,,,, 6/16/2017 BGNE-US  GNW  BeiGene Presents Initial Phase 1 Data on BTK Inhibitor BGB-3111 Combined with Obinutuzumab at the 14th International Conference on Malignant Lymphoma and Announces Additional Planned Global Registrational Trials for BGB-3111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/07/2015 74318710 GNW  Progenics Pharmaceuticals Announces Plans to Move Forward With 1404 Phase 3 Trial,,,,,,,,, 2/01/2017 OPK-US   GNW  OPKOâ€™S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute,,10/10/2013 09061G10    GNW  BioMarin Announces Exercise by Underwriters of Full Over-Allotment Option,,,, 2/23/2017 IMMU-US  GNW  Immunomedics Announces Companyâ€™s Immune Checkpoint Inhibitor Enhances Anti-Tumor Potency of T-Cell-Redirecting Bispecific Antibodies,,, 2/16/2016 BCRX-US  GNW  BioCryst to Announce Fourth Quarter & 2015 Financial Results February 23,,,,,,," 6/14/2018 62855J10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 â€“ MYGN",,,,,11/19/2015 011000-KR GNW  GeneOne Life Science and Inovio Pharmaceuticalsâ€™ MERS Vaccine  Approved for First-in-Human Study,,,,," 3/21/2017 AMRN-US  GNW  Amarin Corporation CEO, John Thero, to Chair the American Heart Associationâ€™s Heart & Stroke Ball in New York City",,, 6/21/2017 SRPT-US  GNW  Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of Duchenne Muscular Dystrophy,,, 1/06/2016 AMAG-US  GNW  AMAG Pharmaceuticals Announces $60 Million Share Repurchase Program,,,,,"10/31/2017 SAN-FR   GNW  Sanofi : Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma",,,,,, 5/06/2015 00G64K-E GNW  Affimed N.V. Announces Pricing of Public Offering of Common Stock,,,, 5/03/2016 ZGNX-US  GNW  Zogenix to Release First Quarter 2016 Financial Results and Host Conference Call and Webcast on May 10,,,,,,, 5/09/2016 RARE-US   GNW  Ultragenyx Reports First Quarter 2016 Financial Results and Corporate Update,," 7/21/2015 63009R10 GNW  NanoString Technologies to Release Second Quarter 2015 Financial Results and Host Conference Call on Tuesday, August 4, 2015",,, 6/01/2015 RDUS-US  GNW  Radius Health Announces Engagement With Myrtle Potter & Company for Development of Abaloparatide Commercialization Strategy,,,,,,,,,," 7/26/2012 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Second Quarter 2012 Financial Results",,, 4/06/2016 05KDBG-E GNW  MacroGenics to Present at the 15th Annual Needham Healthcare Conference,,,,11/24/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at 2014 Deutsche Bank BioFEST, 3/06/2014 0CXBJZ-E GNW  Prothena Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Research and Development Update,,,, 7/22/2015 37230320 GNW  Genmab Announces Submission of Supplemental Biologics License Application to FDA for Ofatumumab as Maintenance Therapy for Relapsed CLL,,,,, 4/16/2013 16383L10 GNW  ChemoCentryx Announces Pricing of Follow-On Offering,,, 8/10/2015 56400P70  GNW  Mannkind Announces Addition of Chief Medical Officer,, 5/13/2016 CYTK-US  GNW  Cytokinetics Announces Additional COSMIC-HF Results to Be Presented at Heart Failure 2016,," 5/04/2017 03236M20  GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Amyris, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017",, 3/01/2013 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,11/13/2014 87166B10 GNW  INC Research Announces Closing of Initial Public Offering, 2/10/2016 FOLD-US  GNW  Amicus Therapeutics Announces Presentations and Posters at 12th Annual WORLDSymposiumâ„¢ 2016 Â ,,,, 2/04/2015 36197T10 GNW  GW Pharmaceuticals plc Reports First Quarter 2015 Financial Results and Operational Progress,,,,, 5/17/2016 0C7ZX1-E GNW  Listing of existing shares on Euronext Brussels & Amsterdam, 3/01/2016 0024VM-E GNW  Portola Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference,,,,"12/02/2014 14075510 GNW  Cara Therapeutics Announces Appointment of Joseph Stauffer, D.O., as Chief Medical Officer", 5/26/2016 009T7W-E GNW  Flexion Therapeutics Receives Positive Guidance from FDA on New Drug Application (NDA) Submission for Zilrettaâ„¢ for Osteoarthritis of the Knee, 9/01/2015 QURE-NL  GNW  uniQure to Present at NewsMakers in the Biotech Industry Conference - NYC," 7/30/2015 00847X10  GNW  Agios to Webcast Conference Call of Second Quarter 2015 Financial Results on August 6, 2015", 8/11/2014 46226010 GNW  Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit,,, 1/06/2015 31189P10 GNW  Fate Therapeutics to Present at Biotech Showcase 2015,,, 3/31/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Proposed Offering of Common Stock, 5/04/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 9/22/2015 46116X10 GNW  Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock,,,,," 4/13/2015 04651310   GNW  Atara Biotherapeutics, Inc. to Present at the 2015 Jefferies Immuno-Oncology Summit",,,,, 4/24/2013 86845910 GNW  Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes,,, 1/04/2016 CHRS-US  GNW  Coherus BioSciences to Present at J.P. Morgan Healthcare Conference on January 11,,,,,,,12/06/2015 GBT-US   GNW  Global Blood Therapeutics Announces Positive Phase 1/2 Data Supporting Development of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease,,,,,, 6/15/2017 BGNE-US  GNW  BeiGene Presents Updated Phase 1 Data on BTK Inhibitor BGB-3111 in Patients with WaldenstrÃ¶mâ€™s Macroglobulinemia at the 14th International Conference on Malignant Lymphoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/24/2015 74318710 GNW  Progenics Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference,,,,,,,,, 1/10/2017 OPK-US   GNW  OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics,,"10/10/2013 09061G10    GNW  BioMarin to Host Third Quarter 2013 Financial Results Conference Call and Webcast on Thursday, October 24 at 5:00 p.m. ET",,,, 2/21/2017 IMMU-US  GNW  Immunomedics Files Federal Lawsuit Against venBio for Continuing Material Violations of the Federal Securities Laws,,, 2/08/2016 BCRX-US  GNW  BioCryst Announces Results From OPuS-2,,,,,,," 6/12/2018 62855J10 GNW  FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact The Firm",,,,,11/10/2015 011000-KR GNW  GeneOne Life Science and the Walter Reed Army Institute of Research Partner to Develop MERS Vaccine,,,,, 3/16/2017 02311120 GNW  Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events Within the REDUCE-IT Study,,, 5/31/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,," 1/05/2016 AMAG-US  GNW  AMAG Pharmaceuticals, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference",,,,,10/24/2017 SAN-FR   GNW  Sanofi Files Suit in the U.S. to Defend Its Patent Rights on LantusÂ® and LantusÂ® SoloStarÂ®,,,,,, 5/04/2015 00G64K-E GNW  Affimed N.V. Announces Proposed Public Offering of Common Stock,,,, 4/21/2016 ZGNX-US  GNW  New Data on Zogenix's ZX008 for Dravet Syndrome to be Presented at 14thÂ International Child Neurology Congress,,,,,,, 5/06/2016 RARE-US   GNW  Ultragenyx to Present at Bank of America Merrill Lynch Healthcare Conference,, 7/16/2015 065C1X-E GNW  NCCN Clinical Practice Guidelines for Breast Cancer Acknowledge Prosigna/PAM50 as Clinically Validated for Prediction of Prognosis,,, 5/27/2015 75046920 GNW  Radius Health to Present at the Jefferies 2015 Health Care Conference,,,,,,,,,," 7/23/2012 69404D10 GNW  Pacific Biosciences Names David Botstein, Ph.D. to Its Board of Directors",,, 3/16/2016 MGNX-US  GNW  MacroGenics Announces Five Posters at AACR Annual Meeting 2016,,,,11/06/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences, 3/03/2014 0CXBJZ-E GNW  Prothena Announces Appointment of Chief Business Officer,,,, 7/10/2015 37230320 GNW  Major Shareholder Announcement for Genmab A/S,,,,, 4/15/2013 16383L10 GNW  ChemoCentryx Announces Proposed Public Offering of Common Stock,,, 8/10/2015 MNKD-US   GNW  MannKind Corporation Reports 2015 Second Quarter Financial Results,, 5/11/2016 CYTK-US  GNW  Cytokinetics to Hold Annual Meeting of Stockholders,," 5/03/2017 03236M20  GNW  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm",, 2/27/2013 00448Q20 GNW  Achillion Pharmaceuticals Announces Closing of Public Offering,, 2/09/2016 FOLD-US  GNW  Amicus Therapeutics Strengthens Executive Leadership Team,,,," 1/27/2015 36197T10 GNW  GW Pharmaceuticals to Report Q1, 2015 Financial Results and Host Conference Call on 4 February, 2015",,,,, 5/09/2016 36315X10 GNW  Galapagos starts Phase 1 study with potentiator GLPG2451 for CF, 2/26/2016 PTLA-US  GNW  Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Corporate Update,,,,12/02/2014 14075510 GNW  Cara Therapeutics Announces Positive Top-Line Results From Phase 1a / 1b Trial of Tablet Formulation of Oral CR845 for the Treatment of Acute and Chronic Pain, 5/12/2016 FLXN-US  GNW  Flexion Therapeutics Reports First-Quarter 2016 Financial Results, 8/27/2015 N9006410 GNW  uniQure Announces Financial Results for Second Quarter 2015, 6/24/2015 00847X10  GNW  Agios Announces First Patient Dosed with AG-881 in Phase 1 Study in Patients with Advanced Solid Tumors with an IDH Mutation, 7/30/2014 46226010 GNW  Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center,,,12/18/2014 31189P10 GNW  Fate Therapeutics Announces Interim Data From Ongoing Phase 2 PUMA Study,,, 3/20/2015 008BK4-E GNW  Intercept Announces New Data Analyses From FLINT Trial of Obeticholic Acid in NASH," 5/03/2018 KPTI-US    GNW  Karyopharm to Report First Quarter 2018 Financial Results on May 10, 2018",,," 9/21/2015 46116X10 GNW  Intra-Cellular Therapies Announces Completion of Phase 1 Studies for ITI-214, a Phosphodiesterase Type 1 Inhibitor, and Assumes IND Sponsorship for ITI-214",,,,," 4/09/2015 04651310   GNW  Atara Biotherapeutics, Inc. to Present at the Needham Healthcare Conference",,,,, 3/14/2013 86845910 GNW  Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results,,,12/21/2015 CHRS-US  GNW  Coherus BioSciences Signs Strategic Manufacturing Agreement With KBI Biopharma for Commercial Supply of CHS-1701,,,,,,,11/30/2015 GBT-US   GNW  Global Blood Therapeutics Announces Upcoming Investor Webcasts Including Event to Highlight GBT440 Data in Sickle Cell Disease at ASH,,,,,, 6/14/2017 BGNE-US  GNW  BeiGene Presents Updated Phase 1 Data on BTK Inhibitor BGB-3111 in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at the 14th International Conference on Malignant Lymphoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/03/2015 74318710 GNW  RELISTOR(R) Receives European Approval for Expanded Indication to Treat All Opioid-Induced Constipation,,,,,,,,, 1/09/2017 OPK-US   GNW  OPKO Announces Initiation of ClarosÂ® 1 Clinical Trial for Total PSA,,10/09/2013 09061G10    GNW  BioMarin Announces Pricing of $340 Million of Senior Subordinated Convertible Notes Due 2018 and $340 Million of Senior Subordinated Convertible Notes Due 2020,,,, 2/17/2017 IMMU-US  GNW  Immunomedics Presents Updated Results With Sacituzumab Govitecan (IMMU-132) in Heavily-Pretreated Patients With Metastatic Urothelial Cancer,,, 1/04/2016 BCRX-US  GNW  BioCryst to Present at the J.P. Morgan Healthcare Conference,,,,,,," 6/08/2018 62855J10 GNW  MYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN",,,,,11/09/2015 INO-US    GNW  Inovio Pharmaceuticals Reports 2015 Third Quarter Results,,,,, 3/15/2017 AMRN-US  GNW  Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology,,, 5/30/2017 SRPT-US  GNW  Sarepta Therapeutics to Present Company Overview at the Goldman Sachs 38th Annual Global Healthcare Conference,,, 1/04/2016 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Nicholas Grund as Chief Commercial Officer,,,,,10/16/2017 SAN-FR   GNW  Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis,,,,,, 5/04/2015 00G64K-E GNW  Affimed N.V. Announces Proposed Public Offering of Common Stock,,,, 3/10/2016 ZGNX-US  GNW  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results,,,,,,, 4/29/2016 RARE-US   GNW  Ultragenyx to Host Conference Call for First Quarter 2016 Financial Results and Corporate Update,, 7/15/2015 63009R10 GNW  NanoString Technologies Launches New nCounter SPRINT(TM) Profiler Designed to Meet Needs of the Individual Researcher,,, 5/08/2015 RDUS-US  GNW  Radius Health to Present at the Bank of America Merrill Lynch 2015 Health Care Conference,,,,,,,,,, 7/23/2012 69404D10 GNW  Pacific Biosciences and Imec Announce Collaboration to Develop Advanced Microchips for Single Molecule Sequencing Applications,,, 3/07/2016 MGNX-US  GNW  Data from MacroGenicsâ€™ Preclinical Studies of MGD009 Presented at Keystone Symposiaâ€™s Antibodies as Drugs (X2) Conference,,,,11/05/2014 60877T10 GNW  Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results, 2/18/2014 G7280010 GNW  Prothena to Report Fourth Quarter and Full Year 2013 Financial Results and Host Webcast and Conference Call on March 6,,,, 7/09/2015 GMAB-DK  GNW  Genmab Announces Completion of Rolling Submission of Biologics License Application for Daratumumab in Multiple Myeloma and Achievement of a USD 15 Million Milestone,,,,, 3/13/2013 16383L10 GNW  ChemoCentryx Announces 2012 Fourth Quarter and Year-End Financial Results,,," 8/04/2015 56400P70  GNW  MannKind Corporation to Hold 2015 Second Quarter Financial Results Conference Call on August 10, 2015",, 5/02/2016 CYTK-US  GNW  Cytokinetics to Ring Nasdaq Closing Bell to Launch ALS Awareness Month,," 5/02/2017 03236M20  GNW  AMRS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Amyris, Inc. and a Lead Plaintiff Deadline of June 19, 2017",, 2/21/2013 ACHN-US  GNW  Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock,, 2/03/2016 FOLD-US  GNW  Amicus Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference,,,, 1/08/2015 36197T10 GNW  GW Pharmaceuticals and Otsuka Announce Results in First of Three Sativex(R) Phase 3 Cancer Pain Trials,,,,, 4/29/2016 36315X10 GNW  Galapagos and AbbVie expand their cystic fibrosis collaboration," 2/19/2016 PTLA-US  GNW  Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2015 Financial Results and Host Conference Call on Friday, February 26",,,,11/25/2014 14075510 GNW  Cara Therapeutics to Webcast Presentation at 26th Annual Piper Jaffray Healthcare Conference," 5/05/2016 FLXN-US  GNW  Flexion Therapeutics to Report First-Quarter 2016 Financial Results on May 12, 2016", 8/10/2015 QURE-NL  GNW  uniQure Announces Receipt of $53 Million From Bristol-Myers Squibb for Target Selection Payment and Additional Equity Investment," 6/23/2015 00BBFF-E  GNW  Agios Appoints Maykin Ho, Ph.D., to its Board of Directors", 7/25/2014 46226010 GNW  Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center,,,12/08/2014 31189P10 GNW  Fate Therapeutics Highlights Effects of Nutrient-Rich Media on Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood,,, 3/02/2015 45845P10 GNW  Intercept Pharmaceuticals Announces 2014 Financial Results, 5/02/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock,,, 9/21/2015 46116X10 GNW  Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock,,,,," 3/27/2015 04651310   GNW  Atara Biotherapeutics, Inc. Appoints Eric Dobmeier, Chief Operating Officer of Seattle Genetics, Inc., to Its Board of Directors",,,,, 3/07/2013 86845910 GNW  Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast,,,12/08/2015 CHRS-US  GNW  Coherus BioSciences Reports Update to CHS-1701 Program,,,,,,,11/12/2015 GBT-US   GNW  Global Blood Therapeutics Reports Recent Business Progress and Third Quarter 2015 Financial Results,,,,,, 6/07/2017 BGNE-US  GNW  BeiGene to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/27/2015 PGNX-US  GNW  Progenics Pharmaceuticals to Present at Jefferies 2015 Healthcare Conference,,,,,,,,, 1/04/2017 OPK-US   GNW  OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference,,10/07/2013 09061G10    GNW  BioMarin Announces Proposed Offering of $300 Million of Senior Subordinated Convertible Notes Due 2018 and $300 Million Senior Subordinated Convertible Notes Due 2020,,,," 2/15/2017 IMMU-US  GNW  Immunomedics Sends Letter to Stockholders Highlighting Value Creating Global Licensing Agreement, Underscoring Fulfillment of Promise to Stockholders",,,11/24/2015 BCRX-US  GNW  BioCryst To Present At Two Upcoming Investor Conferences,,,,,,, 6/06/2018 007B2M-E GNW  Crescendo Bioscience Announces Four Studies with VectraÂ® DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting,,,,,11/05/2015 INO-US    GNW  Inovioâ€™s INO-3112 Shows Robust Immune Responses  in Patients With Head & Neck Cancer,,,,, 2/28/2017 AMRN-US  GNW  Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations,,, 5/01/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,12/22/2015 AMAG-US  GNW  AMAG Pharmaceuticals Awards Grants to Fund Prematurity Prevention Research,,,,,10/12/2017 SAN-FR   GNW  Sanofi invests â‚¬170 million in new vaccine production facility in France,,,,,, 3/25/2015 N0104510 GNW  Affimed Announces Financial Results for Fourth Quarter and Year End 2014,,,, 3/04/2016 ZGNX-US  GNW  Zogenix to Release Fourth Quarter and Full-Year 2015 Financial Results and Host Conference Call and Webcast on March 10,,,,,,, 4/21/2016 RARE-US   GNW  Ultragenyx Reports Positive Interim Data from Phase 2 Study of KRN23 for the Treatment of Tumor-Induced Osteomalacia,," 7/08/2015 63009R10 GNW  NanoString Technologies Names Alessandra Cesano, M.D., Ph.D. as Chief Medical Officer",,, 5/06/2015 75046920 GNW  Radius Health Reports First Quarter 2015 Financial and Operating Results,,,,,,,,,," 7/18/2012 69404D10 GNW  Pacific Biosciences of California, Inc. 2nd Quarter 2012 Financial Results Call",,, 2/29/2016 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and 2015 Financial Results,,,,10/22/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast, 2/03/2014 G7280010 GNW  Prothena Announces Closing of Underwritten Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Ordinary Shares From Perrigo,,,, 7/07/2015 GMAB-DK  GNW  Genmab Announces European Regulatory Submission for Ofatumumab as Maintenance Therapy for Relapsed CLL,,,,," 2/28/2013 16383L10 GNW  ChemoCentryx, Inc. to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Wednesday, March 13, 2013",,, 7/31/2015 56400P70  GNW  MannKind Triples Production Capacity for Afrezza,," 4/29/2016 CYTK-US  GNW  Cytokinetics, Inc. (Nasdaq: CYTK) to Ring The Nasdaq Stock Market Closing Bell",, 5/02/2017 AMRS-US   GNW  Amyris Announces Key Advancements Under DARPA Multi-Year Technology Investment Agreement â€“ Enables Development of Industrial-Scale Fermentation Process For Virtually Any Biological Molecule,, 2/20/2013 00448Q20 GNW  Achillion Reports 2012 Fourth Quarter and Year-End Financial Results,, 1/11/2016 FOLD-US  GNW  Amicus Therapeutics Provides Full-Year 2016 Strategic Outlook and Financial Guidance,,,, 1/08/2015 36197T10 GNW  GW Pharmaceuticals Provides Update on Epidiolex(R) Program in Treatment Resistant Childhood Epilepsies,,,,, 4/28/2016 36315X10 GNW  Galapagos kick-starts 2016 with Q1 cash position of EU988 M, 2/17/2016 PTLA-US  GNW  Portola Pharmaceuticals Announces Biologics License Application for Andexanet Alfa Accepted for Review by FDA,,,,11/11/2014 14075510 GNW  Cara Therapeutics to Webcast Presentation at 2014 Stifel Healthcare Conference, 4/28/2016 FLXN-US  GNW  Flexion Therapeutics Enrolls First Patient in Phase 2 Trial of Zilrettaâ„¢ Among Type 2 Diabetes Patients With Knee Osteoarthritis, 7/16/2015 N9006410 GNW  Dr. Charles W. Richard Joins uniQure as Senior Vice President to Lead Development of CNS-focused Gene Therapy Pipeline, 5/18/2015 00847X10  GNW  Agios Announces FDA Fast Track Designation Granted to AG-120 for Treatment of Patients with Acute Myelogenous Leukemia with an IDH1 Mutation, 7/23/2014 46226010 GNW  Lion Biotechnologies Leases New Research Laboratory,,,12/06/2014 31189P10 GNW  Fate Therapeutics Unveils Preclinical Findings of Newly-Identified Small Molecule Modulator Combination for Ex Vivo Programming of Mobilized Peripheral Blood,,, 2/23/2015 45845P10 GNW  Intercept to Report Full Year 2014 Financial Results on March 2 and Present at Upcoming Conferences, 5/01/2018 KPTI-US    GNW  Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock,,, 9/16/2015 46116X10 GNW  Intra-Cellular Therapies Announces Positive Top-Line Results From the First Phase 3 Trial of ITI-007 in Patients With Schizophrenia and Confirms the Unique Pharmacology of ITI-007 in a Separate Positron Emission Tomography Study,,,,, 3/19/2015 04651310   GNW  Atara Biotherapeutics' Collaborating Investigators to Present Clinical Data on T-Cell Therapy for EBV Lymphoma at a Clinical Trials Plenary Session at the American Association for Cancer Research Annual Meeting 2015,,,,, 2/01/2013 86845910 GNW  Supernus Launches Oxtellar XR(TM) in the United States,,,11/10/2015 CHRS-US  GNW  Coherus BioSciences to Present at Jefferies Autumn 2015 Global Healthcare Conference on November 18,,,,,,,"11/10/2015 GBT-US   GNW  Global Blood Therapeutics Announces Multiple Data Presentations Supporting GBT440 Program for Hypoxemic Pulmonary Disorders, Including Idiopathic Pulmonary Fibrosis",,,,,, 6/07/2017 BGNE-US  GNW  BeiGene to Present Data on BGB-3111 at the 14th International Conference on Malignant Lymphoma and to Host Conference Call,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/06/2015 PGNX-US  GNW  Progenics Pharmaceuticals Announces First Quarter 2015 Financial Results,,,,,,,,,12/30/2016 OPK-US   GNW  OPKO Health Provides Update on hGH-CTP Clinical Programs,,10/01/2013 MYGN-US     GNW  Myriad Genetics and BioMarin Advance PARP Collaboration Into Phase 3,,,, 2/14/2017 IMMU-US  GNW  Immunomedics Comments on Baseless venBio Lawsuit,,,11/05/2015 09058V10 GNW  BioCryst Reports Third Quarter 2015 Financial Results,,,,,,," 6/04/2018 62855J10 GNW  Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc.",,,,,"10/26/2015 INO-US    GNW  Inovio Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call November 9, 2015",,,,," 2/22/2017 AMRN-US  GNW  Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017",,, 4/27/2017 SRPT-US  GNW  Sarepta Therapeutics Announces First Quarter 2017 Financial Results and Recent Corporate Developments,,,"11/23/2015 AMAG-US  GNW  AMAG Pharmaceuticals Responds to Recent Complete Response Letter From the FDA for the Single-Dose, Preservative-Free Vial of Makena(R)",,,,,10/11/2017 SAN-FR   GNW  Sanofi: Availability of the Pre-quarterly Results Communication,,,,,, 3/24/2015 N0104510 GNW  Affimed Completes TandAb Development Candidate Activities Meeting Amphivena's and Janssen's Criteria and Achieves Milestone Ahead of Schedule,,,, 2/03/2016 ZGNX-US  GNW  Zogenix to Participate in LEERINK Partners 5th Annual Global Healthcare Conference,,,,,,, 3/23/2016 RARE-US   GNW  Ultragenyx and Saint Louis Universityâ€™s Center for World Health and Medicine Announce Research Collaboration to Advance Muscular Dystrophy Treatment,, 7/07/2015 63009R10 GNW  NanoString Technologies Announces Publication of Clinical Study Demonstrating the Ability of Its Prosigna Breast Cancer Assay to Predict Response to Chemotherapy,,, 4/30/2015 75046920 GNW  Radius Health to Present at the Deutsche Bank 40th Annual Health Care Conference,,,,,,,,,," 7/16/2012 PACB-US  GNW  Pacific Biosciences Appoints Jonas Korlach, Ph.D. Chief Scientific Officer",,, 2/16/2016 MGNX-US  GNW  MacroGenics Announces Date of Fourth Quarter and Full Year 2015 Financial Results Conference Call,,,,10/09/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer, 1/29/2014 G7280010 GNW  Prothena Announces Pricing of Secondary Offering of Ordinary Shares by Perrigo,,,, 6/05/2015 GMAB-DK  GNW  Genmab Announces Start of Rolling Submission of Biologics License Application for Daratumumab for Double Refractory Multiple Myeloma to the FDA,,,,, 2/20/2013 16383L10 GNW  ChemoCentryx to Present at Upcoming Investor Conferences,,, 7/29/2015 56400P70  GNW  MannKind Announces Stock and Note Exchange Agreements With Holders of Outstanding 5.75% Senior Convertible Notes,," 4/28/2016 CYTK-US  GNW  Cytokinetics, Inc. Reports First Quarter 2016 Financial Results",," 5/01/2017 AMRS-US   GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amyris, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2017 â€“ AMRS",, 2/20/2013 00448Q20 GNW  Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock,, 1/04/2016 FOLD-US  GNW  Amicus Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference and 3rd Annual Dermatology Summit,,,,12/22/2014 36197T10 GNW  GW Pharmaceuticals Added to NASDAQ Biotechnology Index,,,,, 4/21/2016 36315X10 GNW  Galapagos reports additional data with filgotinib from the Phase 2 FITZROY study, 2/01/2016 PTLA-US  GNW  Portola Pharmaceuticals Enters Into Licensing Agreements for Investigational Agent Andexanet Alfa in Japan Worth Up to $120 Million,,,,11/10/2014 14075510 GNW  Cara Therapeutics Reports Third Quarter 2014 Financial Results, 4/07/2016 009T7W-E GNW  Flexion Therapeutics to Present at 15th Annual Needham Healthcare Conference, 6/11/2015 N9006410 GNW  uniQure Announces Financial Results for First Quarter 2015, 5/07/2015 00847X10  GNW  Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120, 6/23/2014 46226010 GNW  Lion Biotechnologies Appoints Dr. Laszlo Radvanyi as Chief Scientific Officer,,,11/25/2014 31189P10 GNW  Fate Therapeutics to Present at Piper Jaffray 26th Annual Healthcare Conference,,, 2/19/2015 008BK4-E GNW  Intercept Announces Promotion of Lisa Bright to Chief Commercial & Corporate Affairs Officer, 4/30/2018 KPTI-US    GNW  Karyopharm Announces Positive Top-Line Data from Phase 2b STORM Study Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma,,, 9/01/2015 46116X10 GNW  Intra-Cellular Therapies Announces Publication of Positive Phase 2 Schizophrenia Study in the Journal Biological Psychiatry,,,,, 3/03/2015 04651310   GNW  Atara Biotherapeutics Names David A. Carmel as Head of Immunotherapy,,,,, 1/14/2013 86845910 GNW  Supernus Appoints Victor Vaughn as Senior Vice President of Sales,,,11/09/2015 CHRS-US  GNW  Coherus BioSciences Reports Third Quarter 2015 Financial and Operating Results and Corporate Events,,,,,,,11/05/2015 GBT-US   GNW  Global Blood Therapeutics Announces New GBT440 Data in Sickle Cell Disease to be Presented at the American Society of Hematology (ASH) Annual Meeting,,,,,, 6/05/2017 BGNE-US  GNW  BeiGene Presents Initial Phase 1 Data on Anti-PD-1 Antibody BGB-A317 Combined with PARP Inhibitor BGB-290 at the 2017 American Society for Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/29/2015 74318710 GNW  Progenics Pharmaceuticals Sets First Quarter 2015 Financial Results Call for May 6,,,,,,,,,12/19/2016 68375N10 GNW  OPKO Health to be Added to the NASDAQ Biotechnology Index,, 9/29/2013 09061G10    GNW  BioMarin Provides Updated Phase 1/2 Data on BMN 673 in Breast Cancer at the European Cancer Congress 2013,,,, 2/09/2017 IMMU-US  GNW  Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments,,,11/04/2015 09058V10 GNW  Biocryst to Present at the Jefferies Autumn 2015 Global Healthcare Conference,,,,,,," 6/04/2018 0DBJVZ-E GNW  Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for Myriad Genetics, Inc. Investors â€“ MYGN",,,,,10/19/2015 INO-US    GNW  Inovio and Partner Advance MERS Vaccine,,,,, 2/09/2017 05LK9B-E GNW  Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference,,," 4/17/2017 SRPT-US  GNW  Sarepta Therapeutics to Announce First Quarter 2017 Financial Results and Recent Corporate Developments on April 27, 2017",,,"11/18/2015 00163U10 GNW  AMAG Pharmaceuticals Receives Complete Response Letter From FDA for Single-Dose, Preservative-Free Vial of Makena(R) (hydroxyprogesterone caproate injection)",,,,,10/06/2017 EBS-US   GNW  Emergent BioSolutions Completes Acquisition of ACAM2000Â® Business From Sanofi,,,,,, 3/18/2015 00G64K-E GNW  Affimed Announces Fourth Quarter and Year End 2014 Financial Results Conference Call,,,, 1/19/2016 ZGNX-US  GNW  Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome,,,,,,," 3/21/2016 RARE-US   GNW  Ultragenyx Appoints Lars Ekman, M.D., Ph.D., to Board of Directors",, 6/01/2015 065C1X-E GNW  NanoString Technologies Highlights Results from Three Significant New Prosigna Studies Presented at the 51st Annual Meeting of the American Society of Clinical Oncology,,," 4/28/2015 75046920 GNW  Radius Health to Announce First Quarter 2015 Financial Results, Host Conference Call and Live Webcast on May 6, 2015",,,,,,,,,," 5/01/2012 69404D10 GNW  Pacific Biosciences of California, Inc. Announces First Quarter 2012 Financial Results",,, 2/04/2016 MGNX-US  GNW  MacroGenics to Present at the LEERINK Partners 5th Annual Global Healthcare Conference,,,,10/02/2014 60877T10 GNW  Momenta Pharmaceuticals to Host 2014 R&D Day, 1/27/2014 G7280010 GNW  Prothena Announces Proposed Secondary Offering of Ordinary Shares by Perrigo,,,, 6/02/2015 37230320 GNW  Genmab Gains License to Antibody Panel Targeting CD19,,,,, 2/06/2013 16383L10 GNW  ChemoCentryx to Present at 15th Annual BIO CEO & Investor Conference,,, 6/09/2015 56400P70  GNW  Career of Diabetes and Medical Pioneer Al Mann Honored at Boston Gala,," 4/14/2016 CYTK-US  GNW  Cytokinetics to Announce First Quarter Results  on April 28, 2016",, 5/01/2017 AMRS-US   GNW  Amyris Announces Industrial Production Of Leading Healthy Sweetener Product in 2018,," 2/19/2013 00448Q20 GNW  Achillion to Report Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on February 20, 2013",,12/22/2015 FOLD-US  GNW  Amicus Therapeutics Commences Phase 1/2 Study of Novel ERT for Treatment of Pompe Disease,,,,12/02/2014 36197T10 GNW  GW Pharmaceuticals plc Reports 2014 Q4 and Full Year Financial Results,,,,, 4/07/2016 MPSYY-DE GNW  Galapagos and MorphoSys initiate Phase 1 study in joint antibody program MOR106," 1/08/2016 PTLA-US  GNW  Portola Pharmaceuticals to Webcast Corporate Update on January 12, 2016",,,,"11/03/2014 14075510 GNW  Cara Therapeutics to Announce Third Quarter 2014 Financial Results on November 10, 2014", 4/04/2016 FLXN-US  GNW  Flexion Therapeutics Announces Presentation of Results  From Pivotal Phase 2b and Phase 3 Clinical Trials for Zilrettaâ„¢  at Osteoarthritis Research Society  International (OARSI) 2016 World Congress, 5/27/2015 0CDXXJ-E GNW  uniQure to Present at the Jefferies 2015 Healthcare Conference," 4/29/2015 00BBFF-E  GNW  Agios Pharmaceuticals Selects Third Novel IDH Mutant Inhibitor, AG-881, for Clinical Development", 5/27/2014 46226010 GNW  Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference,,,11/11/2014 31189P10 GNW  Fate Therapeutics Reports Third Quarter 2014 Financial Results,,, 2/10/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares, 4/10/2018 KPTI-US    GNW  Karyopharmâ€™s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Penta-Refractory Multiple Myeloma,,, 8/05/2015 46116X10 GNW  Intra-Cellular Therapies Reports Second Quarter 2015 Financial Results and Provides Corporate Update,,,,, 3/02/2015 04651310   GNW  FDA Grants Breakthrough Therapy Designation to Epstein-Barr Virus (EBV) Targeted T-Cells for Treatment of EBV-Associated Lymphoproliferative Disease,,,,,11/29/2012 SUPN-US  GNW  Supernus Announces Pricing of Public Offering,,,11/09/2015 19249H10 GNW  Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoints in Phase 3 Psoriasis Clinical Study (RaPsODY),,,,,,,10/22/2015 37890U10 GNW  Guerbet - Revenue at 30 September 2015: EU343.6 million; +10.2% at constant exchange rates,,,,,, 5/17/2017 BGNE-US  GNW  BeiGene to Present at the 2017 UBS Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/08/2015 74318710 GNW  Progenics Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference,,,,,,,,,11/30/2016 OPK-US   GNW  OPKO Health to Participate at Three Investment Conferences in December,," 9/23/2013 09061G10    GNW  BioMarin Doses First Patient in Phase 1/2 Trial With BMN 190 for the Treatment of Neuronal Ceroid Lipofuscinosis Type 2, a Form of Batten Disease",,,, 2/09/2017 IMMU-US  GNW  Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2017 Results,,,10/27/2015 09058V10 GNW  BioCryst to Announce Third Quarter 2015 Financial Results November 5,,,,,,," 6/01/2018 62855J10 GNW  MYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN",,,,, 9/30/2015 45773H20  GNW  Inovio to Participate in Upcoming Investor Conferences,,,,, 1/20/2017 AMRN-US  GNW  Amarin Announces Debt Restructuring and Related Private Placement of Exchangeable Senior Notes,,, 4/05/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),,,11/11/2015 00163U10 GNW  AMAG Pharmaceuticals to Participate in the Jefferies Autumn 2015 Global Healthcare Conference in London,,,,,10/05/2017 SAN-FR   GNW  Sanofi  : Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding PraluentÂ® (alirocumab),,,,,, 3/03/2015 N0104510 GNW  Affimed to Present at the 27th Annual ROTH Conference,,,, 1/11/2016 ZGNX-US  GNW  Zogenix Announces Initiation of Phase 3 Program for ZX008 in Dravet Syndrome,,,,,,, 3/02/2016 RARE-US   GNW  Ultragenyx to Present at the Cowen and Company 36th Annual Health Care Conference,, 5/14/2015 63009R10 GNW  NanoString Technologies Announces Favorable Draft Local Coverage Determination by Palmetto GBA for Its Prosigna Breast Cancer Assay,,, 4/10/2015 75046920 GNW  Radius Health Today Announced That it Has Appointed Brent Hatzis-Schoch as Senior Vice President and General Counsel,,,,,,,,,," 4/18/2012 69404D10 GNW  Pacific Biosciences of California, Inc. 1st Quarter 2012 Financial Results Call",,,12/02/2015 MGNX-US  GNW  MacroGenics to Present at the Oppenheimer 26th Annual Healthcare Conference,,,, 9/17/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference, 1/23/2014 G7280010 GNW  Prothena to Receive $30 Million Upfront Payment from Roche Triggered by the Expiration of Hart-Scott-Rodino Waiting Period,,,, 5/21/2015 37230320 GNW  Ofatumumab and Daratumumab Data to Be Presented at 20th Congress of EHA,,,,," 1/07/2013 16383L10 GNW  ChemoCentryx Advances a New Generation CCR9 Inhibitor, CCX507, Into Clinical Development",,, 5/27/2015 MNKD-US   GNW  MannKind to Present at Upcoming Conferences,, 4/05/2016 CYTK-US  GNW  Cytokinetics to Present at the 15th Annual  Needham Healthcare Conference,," 4/27/2017 AMRS-US   GNW  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm",, 2/08/2013 00448Q20 GNW  Achillion to Present at the 2013 Leerink Swann Global Healthcare Conference,,"11/23/2015 03152W10 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amicus Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 â€“ FOLD",,,,11/26/2014 36197T10 GNW  GW Pharmaceuticals to Present at the 26th Annual Piper Jaffray Healthcare Conference,,,,, 4/07/2016 MPSYY-DE GNW  MorphoSys and Galapagos Initiate Phase 1 Study in Joint Antibody Program MOR106,12/18/2015 PTLA-US  GNW  Portola Pharmaceuticals Completes BLA Submission to U.S. Food and Drug Administration for Andexanet Alfa,,,,"10/29/2014 14075510 GNW  Cara Therapeutics Announces Positive Results From Human Abuse Liability Trial of Peripheral Opioid for Acute Pain, I.V. CR845", 4/01/2016 009T7W-E GNW  Flexion to Present Pivotal Phase 2b and Phase 3 Results for Zilrettaâ„¢ at Osteoarthritis Research Society International (OARSI) 2016 World Congress, 5/26/2015 N9006410 GNW  uniQure Announces Closing of Strategic Collaboration with Bristol-Myers Squibb to Develop Gene Therapies for Cardiovascular Disease," 4/28/2015 00847X10  GNW  Agios Pharmaceuticals to Webcast Conference Call of First Quarter 2015 Financial Results on May 7, 2015", 4/07/2014 46226010 GNW  Lion Biotechnologies' Lead Program With National Cancer Institute Demonstrates Positive Results in Patients With Stage 4 Metastatic Melanoma,,,"11/04/2014 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2014 Financial Results on November 11, 2014",,, 2/04/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Pricing of Public Offering, 4/02/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 8/03/2015 46116X10 GNW  Intra-Cellular Therapies Expands Leadership Team,,,,, 2/26/2015 04651310   GNW  Atara Biotherapeutics Announces Fourth Quarter and Full Year 2014 Operating Results,,,,,11/20/2012 86845910 GNW  Supernus Announces Positive Phase IIb Results on SPN-810 and Decision to Advance to Late Stage Development,,,10/28/2015 CHRS-US  GNW  Coherus BioSciences to Present at Credit Suisse Healthcare Conference on November 10,,,,,,,10/14/2015 GBT-US   GNW  Global Blood Therapeutics to Present at BIO Investor Forum,,,,,, 5/10/2017 BGNE-US  GNW  BeiGene Reports First Quarter 2017 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/07/2015 74318710 GNW  Progenics Announces the Initiation of Fuji's Phase 2 Trial for 1404 in Japan,,,,,,,,,11/23/2016 OPK-US   GNW  OPKO Announces U.S. Launch of RAYALDEEâ„¢,, 9/23/2013 09061G10    GNW  BioMarin to Attend NewsMakers in the Biotech Industry Conference,,,," 2/07/2017 0CS5PZ-E GNW  Immunomedics Strongly Encourages Stockholders to Reject the venBio Nominees â€” With Four New Independent Directors and a Robust Value-Maximization Process, Stockholders Should Not Risk Giving venBio Directors Control of the Immunomedics Board of Directors",,,10/08/2015 09058V10 GNW  BioCryst Announces Completion of Patient Enrollment in OPuS-2: a Clinical Trial of Avoralstat in Patients With HAE,,,,,,, 6/01/2018 MYGN-US  GNW  Myriad Genetics Presents Second Pivotal Validation Study for riskScoreâ„¢ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting,,,,, 9/21/2015 INO-US    GNW  Inovio Receives $24 Million Option Grant From DARPA to Advance Ebola Program Development,,,,, 1/05/2017 AMRN-US  GNW  Amarin Provides Preliminary 2016 Results and 2017 Outlook,,," 4/03/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Appointment of Catherine Stehman-Breen, M.D., M.S. as Chief Medical Officer",,,11/03/2015 00163U10 GNW  AMAG Pharmaceuticals Reports Third Quarter 2015 Financial Results,,,,, 9/28/2017 09MM7T-E GNW  Thermalin Announces: Collaboration with Sanofi to Develop Next Generation Insulin Therapies,,,,,, 2/03/2015 N0104510 GNW  Affimed to Present at the BIO CEO & Investor Conference and at the Leerink Partners Global Healthcare Conference,,,,12/14/2015 ZGNX-US  GNW  Zogenix Announces FDA Acceptance of Investigational New Drug Application for ZX008 Phase 3 Clinical Trial in Dravet Syndrome,,,,,,, 3/01/2016 RARE-US   GNW  Ultragenyx Announces Data Presentations of rhGUS and rhPPCA at 12th Annual WORLD Symposiumâ„¢,, 5/12/2015 63009R10 GNW  St. Gallen International Breast Cancer Guidelines Recognize Power of Prosigna/PAM50 to Inform Treatment Decisions and Spare Low Risk Breast Cancer Patients Unnecessary Chemotherapy,,," 4/09/2015 75046920 GNW  Radius Health Announces Upcoming Oral Presentation ""Treatment With Abaloparatide Significantly Reduces Wrist Fractures Compared to Teriparatide"" in the HOT TOPICS Session at the ECTS-IBMS 2015 Congress on April 28, 2015",,,,,,,,,," 2/07/2012 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2011",,,11/07/2015 MGNX-US  GNW  Data from MacroGenicsâ€™ Ongoing Phase 1 Study of Enoblituzumab (MGA271) Presented at 30th Annual SITC Meeting 2015,,,, 9/08/2014 MNTA-US  GNW  Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio,12/30/2013 G7280010 GNW  Prothena to be Added to NASDAQ Biotechnology Index and NASDAQ Global Select Market,,,, 5/19/2015 37230320 GNW  Genmab Enters Commercial DuoBody(r) Technology Agreement With BioNTech in Field of Immuno-oncology,,,,, 1/03/2013 CCXI-US  GNW  ChemoCentryx to Present at the 31st Annual J.P. Morgan Healthcare Conference,,, 5/21/2015 56400P70  GNW  James S. Shannon Rejoins MannKind's Board of Directors,, 4/04/2016 CYTK-US  GNW  Cytokinetics Announces Start of Phase 2 Clinical Trial of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure,," 4/26/2017 03236M20  GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Amyris, Inc. (Nasdaq: AMRS) To Contact Brower Piven Before The Lead Plaintiff Deadline",, 1/17/2013 00448Q20 GNW  Achillion to Present at the Noble Financial Capital Markets' Ninth Annual Equity Conference,,11/12/2015 FOLD-US  GNW  Amicus Therapeutics to Present at Goldman Sachs US Emerging / SMID Cap Growth Conference,,,,"11/24/2014 36197T10 GNW  GW Pharmaceuticals to Report Q4, Year-End 2014 Financial Results and Host Conference Call on 2 December, 2014",,,,, 4/06/2016 36315X10 GNW  Galapagos initiates a Phase 2a study with GLPG1690 in idiopathic pulmonary fibrosis patients,12/05/2015 PTLA-US  GNW  Portola Pharmaceuticals Announces Andexanet Alfa and Cerdulatinib Data Presentations at the 2015 American Society of Hematology Annual Meeting and Exposition,,,,10/27/2014 14075510 GNW  Cara Therapeutics Announces the Unexpected Death of Chief Medical Officer Dr. Robert Medve, 3/10/2016 FLXN-US  GNW  Flexion Reports Year-End 2015 Financial Results, 4/15/2015 0CDXXJ-E GNW  uniQure Announces Closing of Follow-on Public Offering, 3/24/2015 00BBFF-E  GNW  Agios Pharmaceuticals Announces Orphan Drug Designation of AG-348 for Treatment of Pyruvate Kinase Deficiency, 3/24/2014 46226010 GNW  Lion Biotechnologies to Present at the 4th Annual Cancer Immunotherapy Conference,,,10/30/2014 31189P10 GNW  Fate Therapeutics to Present at Nomura Biotechnology Conference,,, 2/03/2015 45845P10 GNW  Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock, 3/19/2018 KPTI-US    GNW  Karyopharm to Present Preclinical Data at the American Association for Cancer Research 2018 Annual Meeting,,, 7/30/2015 46116X10 GNW  Intra-Cellular Therapies to Host Second Quarter 2015 Financial Results Conference Call and Webcast,,,,, 2/18/2015 04651310   GNW  Atara Biotherapeutics Announces Closing of Underwritten Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares,,,,,11/19/2012 86845910 GNW  Supernus Receives Three Years of Market Exclusivity for Oxtellar XR(TM),,,10/27/2015 CHRS-US  GNW  Coherus BioSciences to Present at Bloomberg Biosimilars Conference on November 2,,,,,,,10/12/2015 GBT-US   GNW  Global Blood Therapeutics Announces GBT440 Receives FDA Fast Track Designation for Sickle Cell Disease,,,,,, 4/21/2017 BGNE-US  GNW  BeiGene Announces Presentation on a Phase I Study of PD-1 Antibody BGB-A317 in Combination with PARP Inhibitor BGB-290 at the 2017 American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/16/2015 74318710 GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial Results,,,,,,,,,11/17/2016 OPK-US   GNW  OPKO Presents Data on RAYALDEEÂ® at ASN Kidney Week 2016,, 9/17/2013 09061G10    GNW  BioMarin Provides Highlights Ahead of Research and Development Day,,,," 2/02/2017 IMMU-US  GNW  Immunomedics Mails Letter to Stockholders Highlighting Strength of New Board and Deep Engagement in Robust, Value-Creating Strategic and CMC Processes",,,10/08/2015 09058V10 GNW  BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353,,,,,,, 5/31/2018 MYGN-US  GNW  Myriad Genetics to Present at Two Upcoming Investor Conferences,,,,, 9/17/2015 45773H20  GNW  Inovio Pharmaceuticals Publishes Successful Phase 2b Trial Results of Its HPV Immunotherapy in The Lancet,,,,,12/16/2016 AMRN-US  GNW  Amarin Announces Contractual Reminder of Optional Put to Holders of $15.1 million Principal Amount of Outstanding 3.50% Exchangeable Senior Notes Due 2032,,, 3/31/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,10/28/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Head-to-Head Phase 3 Clinical Trial Evaluating Feraheme(R) in Adults With Iron Deficiency Anemia,,,,, 9/28/2017 SAN-FR   GNW  Sanofi and Regeneron Announce Approval of DupixentÂ® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union,,,,,, 1/29/2015 N0104510 GNW  Affimed N.V. (Nasdaq: AFMD) to Ring The Nasdaq Stock Market Opening Bell,,,,12/07/2015 98978L20 GNW  Zogenix Announces New Efficacy and Safety Data on ZX008 for Treatment of Seizures in Dravet Syndrome,,,,,,, 2/25/2016 RARE-US   GNW  Ultragenyx Reports Fourth Quarter 2015 and Full-Year 2015 Financial Results and Corporate Update,, 5/07/2015 63009R10 GNW  NanoString Technologies to Present at the UBS Global Healthcare Conference,,, 3/13/2015 75046920 GNW  Radius Health to Present at the Bank of America Merrill Lynch Smid Cap Conference,,,,,,,,,," 1/31/2012 69404D10 GNW  UPDATE: Pacific Biosciences of California, Inc. Announces Time Change for 4th Quarter and Fiscal Year 2011 Financial Results",,,11/05/2015 MGNX-US  GNW  Publication in PLOS Pathogens Shows the Potential of DARTÂ® Molecules for HIV Reservoir Elimination Strategy,,,, 8/28/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA,12/11/2013 0CXBJZ-E GNW  Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co-Promote Antibodies for Treatment of Parkinson's Disease,,,, 5/13/2015 GMAB-DK  GNW  HuMax-TF-ADC and Daratumumab Data to Be Presented at 2015 ASCO Annual Meeting,,,,,11/27/2012 16383L10 GNW  ChemoCentryx Expands CCR2 Inhibitor Franchise with CCX872,,, 5/07/2015 56400P70  GNW  MannKind Corporation Reports 2015 First Quarter Financial Results,, 3/31/2016 CYTK-US  GNW  Origent Data Sciences and Cytokinetics Announce  Research Collaboration on Predictive Analytics Model in ALS,," 4/26/2017 03236M20  GNW  IMPORTANT AMYRIS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Amyris, Inc.",, 1/07/2013 00448Q20 GNW  Achillion Reports Interim Results on ACH-3102,,11/03/2015 03152W10 GNW  Amicus Therapeutics Announces Third Quarter 2015 Financial Results and Corporate Updates,,,,11/17/2014 36197T10 GNW  GW Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference,,,,, 4/03/2016 36315X10 GNW  Galapagos increases share capital through warrant exercises,12/04/2015 PTLA-US  GNW  Portola Announces Pricing of Public Offering of Common Stock,,,, 9/17/2014 14075510 GNW  Cara Therapeutics to Sponsor Symposium at American Academy of Pain Management 2014 Annual Clinical Meeting, 3/07/2016 009T7W-E GNW  Flexion Therapeutics to Present at Cowen and Companyâ€™s  36th Annual Health Care Conference, 4/09/2015 0CDXXJ-E GNW  uniQure Announces Pricing of Follow-on Public Offering," 2/20/2015 00847X10  GNW  Agios Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference on Monday, March 2", 3/21/2014 46226010 GNW  Lion Biotechnologies to Present at the BioCentury Future Leaders Conference,,, 9/03/2014 31189P10 GNW  Fate Therapeutics to Present at Rodman & Renshaw 16th Annual Global Investment Conference,,, 1/29/2015 008BK4-E GNW  Intercept Receives Breakthrough Therapy Designation From FDA for Obeticholic Acid for Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis, 3/15/2018 KPTI-US    GNW  Karyopharm Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Progress,,, 7/22/2015 46116X10 GNW  Intra-Cellular Therapies Announces Phase 3 Clinical Development Program for the Treatment of Depressive Episodes Associated With Bipolar Disorder (Bipolar Depression),,,,, 2/12/2015 0DHGMT-E   GNW  Atara Bio Announces Pricing of Its $65.5 Million Offering of Common Stock,,,,,11/12/2012 NDAQ-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,10/26/2015 CHRS-US  GNW  Coherus BioSciences to Report Third Quarter 2015 Financial Results on November 9,,,,,,, 9/29/2015 37890U10 GNW  Guerbet: 2015 half-year results,,,,,, 4/21/2017 BGNE-US  GNW  BeiGene Announces Initiation of First Pivotal Study in China of PD-1 Antibody BGB-A317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/09/2015 74318710 GNW  Progenics Pharmaceuticals Sets Fourth Quarter and Year End 2014 Financial Results Call for March 16,,,,,,,,,11/07/2016 OPK-US   GNW  OPKO Health Reports Third Quarter Financial and Operating Results,, 9/05/2013 09061G10    GNW  BioMarin to Host a Research and Development Day on September 17th,,,, 1/30/2017 IMMU-US  GNW  Immunomedics Sets the Record Straight in New Presentation,,, 9/29/2015 09058V10 GNW  Sanj K. Patel Appointed to BioCryst's Board of Directors,,,,,,, 5/31/2018 074FLV-E GNW  GeneSightÂ® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting,,,,, 9/15/2015 45773H20  GNW  Inovio's Chief Operating Officer Selected by PharmaVoice as One of the Most Inspirational Leaders in the Global Industry,,,,,11/14/2016 AMRN-US  GNW  Pure EPA VascepaÂ® (icosapent ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Parameters in Statin-Treated Women with Persistent High Triglycerides,,," 3/30/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Addition of Kenneth Fischbeck, M.D. and Matthew Wood M.D., Ph.D. to the Companyâ€™s Strategic and Scientific Advisory Board",,,"10/20/2015 00163U10 GNW  AMAG Pharmaceuticals to Host Conference Call on November 3, 2015 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Nine Months Ended September 30, 2015",,,,, 9/20/2017 0GBP93-E GNW  Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy,,,,,, 1/20/2015 N0104510 GNW  Affimed Appoints Dr. Martin Treder as Chief Scientific Officer,,,,11/25/2015 ZGNX-US  GNW  New Data on Zogenix's ZX008 for Dravet Syndrome to be Presented at 69th Annual American Epilepsy Society Meeting,,,,,,, 2/18/2016 RARE-US   GNW  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2015  Financial Results and Corporate Update,, 5/06/2015 63009R10 GNW  NanoString Technologies Releases Financial Results for First Quarter of 2015,,, 3/10/2015 75046920 GNW  Radius Health Reports Fourth Quarter and Full Year 2014 Financial and Operating Results,,,,,,,,,," 1/27/2012 69404D10 GNW  Pacific Biosciences of California, Inc. 4th Quarter and Fiscal Year 2011 Financial Results Call",,,11/04/2015 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Third Quarter 2015 Financial Results,,,, 7/31/2014 60877T10 GNW  Momenta Pharmaceuticals Reports Second Quarter 2014 Financial Results,11/12/2013 G7280010 GNW  Prothena Reports Third Quarter 2013 Financial Results,,,, 5/12/2015 GMAB-DK  GNW  Genmab Announces Financial Results for the First Quarter of 2015,,,,,"11/13/2012 16383L10 GNW  ChemoCentryx Announces Financial Results for the Quarter Ended September 30, 2012",,, 5/06/2015 56400P70  GNW  MannKind to Present at Bank of America Merrill Lynch 2015 Healthcare Conference,, 3/01/2016 CYTK-US  GNW  Cytokinetics to Present at March Investor Conferences,," 4/20/2017 03236M20  GNW  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm",,11/30/2012 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,,"10/27/2015 03152W10 GNW  Amicus Therapeutics to Announce Third Quarter 2015 Financial Results on November 3, 2015",,,,10/30/2014 36197T10 GNW  GW Pharmaceuticals Commences Phase 2/3 Clinical Trial of Epidiolex(R) as a Potential Treatment for Epilepsy in Dravet Syndrome,,,,, 3/25/2016 36315X10 GNW  Publication of the annual report and invitation to the Annual and Extraordinary Shareholders' Meetings,12/03/2015 PTLA-US  GNW  Portola Pharmaceuticals Announces Proposed Offering of Common Stock,,,, 8/07/2014 14075510 GNW  Cara Therapeutics Reports Second Quarter 2014 Financial Results," 3/03/2016 FLXN-US  GNW  Flexion Therapeutics to Report Year-End 2015 Earnings Results on March 10, 2016", 4/07/2015 0CDXXJ-E GNW  uniQure Announces Launch of Follow-on Public Offering, 2/17/2015 00847X10  GNW  Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results, 3/04/2014 46226010 GNW  Lion Biotechnologies to Present at the 26th Annual ROTH Conference,,, 8/12/2014 31189P10 GNW  Fate Therapeutics Reports Second Quarter 2014 Financial Results,,, 1/12/2015 45845P10 GNW  Intercept Provides 2014 Year-End Update and Planned 2015 Milestones," 3/08/2018 KPTI-US    GNW  Karyopharm to Report Fourth Quarter and Year End 2017 Financial Results on March 15, 2018",,, 6/23/2015 46116X10 GNW  Intra-Cellular Therapies Reports Initiation of Randomization for ITI-007-302 Phase 3 Trial in Schizophrenia,,,,, 2/09/2015 04651310   GNW  Atara Bio Announces Proposed Offering of Common Stock,,,,,11/07/2012 86845910 GNW  Supernus Pharmaceuticals Reports Third Quarter 2012 Financial Results,,,10/01/2015 19249H10 GNW  Coherus Announces Topline Results of CHS-1701 Pharmacokinetic and Pharmacodynamic Biosimilarity Study,,,,,,," 9/24/2015 37890U10 GNW  Global Blood Therapeutics Appoints Philip A. Pizzo, M.D. to Board of Directors",,,,,," 4/06/2017 BGNE-US  GNW  Myriad Genetics and BeiGene Sign Agreement to Develop Companion Diagnostics for Use with BeiGeneâ€™s Novel PARP Inhibitor, BGB-290",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/02/2015 74318710 GNW  Progenics Pharmaceuticals Announces Presentation at ENDO 2015,,,,,,,,,"11/03/2016 OPK-US   GNW  OPKO to Announce Third Quarter Operating and Financial Results on November 7, 2016",," 9/03/2013 09061G10    GNW  BioMarin to Attend Upcoming Conferences: Citi Biotech Day, Morgan Stanley Global Healthcare Conference and Baird Healthcare Conference",,,, 1/27/2017 IMMU-US  GNW  Immunomedics Issues Statement to Stockholders and Files Investor Presentation,,, 8/07/2015 09058V10 GNW  BioCryst Reports Second Quarter 2015 Financial Results,,,,,,," 5/28/2018 MYGN-US  GNW  Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.",,,,, 9/08/2015 45773H20  GNW  Inovio Pharmaceuticals Announces First Patient Dosed With Universal HIV Vaccine,,,,,11/11/2016 05F9ZW-E GNW  Amarin to Present at the Jefferies 2016 London Healthcare Conference,,," 3/28/2017 SRPT-US  GNW  Scott+Scott, Attorneys at Law, LLP Announces Investigation of Sarepta Therapeutics, Inc.",,, 8/24/2015 00163U10 GNW  AMAG Pharmaceuticals Appoints Joseph Vittiglio as General Counsel and Secretary,,,,, 9/16/2017 SAN-FR   GNW  Sanofi and Regeneron Announce Positive Study Results for DupixentÂ® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis,,,,,, 1/07/2015 N0104510 GNW  Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs,,,,11/11/2015 ZGNX-US  GNW  Zogenix to Participate in Stifel 2015 Healthcare Conference,,,,,,, 2/09/2016 RARE-US   GNW  Ultragenyx to Present at the Leerink Partners Annual Healthcare Conference,, 5/05/2015 63009R10 GNW  NanoString Technologies and Cancer Immunotherapy Trials Network (CITN) Enter Into a Collaboration to Identify Biomarker Assays for Novel Cancer Immunotherapies,,," 3/09/2015 75046920 GNW  Radius Health Announced Today That it Has Acquired the License to Develop and Market RAD1901 in Japan, and Has Hired Dinesh Purandare, Former Sanofi Oncology Executive to the Position of Senior Vice President (SVP) and Head of Global Oncology at Radius",,,,,,,,,,"10/27/2011 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Third Quarter Financial Results",,,11/04/2015 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 7/30/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference,10/28/2013 0CXBJZ-E GNW  Prothena Announces Research and Development Day and Webcast,,,, 5/06/2015 GMAB-DK  GNW  First Quarter 2015 Net Sales Figures for Arzerra(r) (Ofatumumab),,,,,11/05/2012 16383L10 GNW  ChemoCentryx to Present at Two Upcoming Investor Conferences,,," 4/30/2015 56400P70  GNW  MannKind Corporation to Hold 2015 First Quarter Financial Results Conference Call on May 8, 2015",, 2/29/2016 CYTK-US  GNW  Cytokinetics Joins Global Movement to Recognize International Rare Disease Day,, 4/18/2017 AMRS-US   GNW  Amyris Agrees to Exclusive China Manufacturing with Blue California Enabling Continued Record Product Revenue Growth into Asian Markets,,11/13/2012 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,,"10/22/2015 03152W10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 â€“ FOLD",,,,10/22/2014 36197T10 GNW  GW Pharmaceuticals Announces Epidiolex(R) Receives Orphan Designation From European Medicines Agency for the Treatment of Dravet Syndrome,,,,, 3/18/2016 36315X10 GNW  Results from 10-week analysis of Phase 2 study with filgotinib in Crohn's Disease presented at ECCO,11/12/2015 PTLA-US  GNW  Portola Pharmaceuticals to Host Analyst and Investor Day on November 19,,,, 8/06/2014 14075510 GNW  Cara Therapeutics Initiates Proof-of-Concept Phase II Trial of I.V. CR845 in Uremic Pruritus, 2/18/2016 009T7W-E GNW  Flexion Therapeutics to Present at RBC Capital Markets 2016 Global Healthcare Conference, 4/06/2015 0CDXXJ-E GNW  uniQure Announces Webcast to Discuss Bristol-Myers Squibb Collaboration," 2/10/2015 00847X10  GNW  Agios Pharmaceuticals to Webcast Conference Call of Fourth Quarter and Full Year 2014 Financial Results on February 17, 2015", 2/03/2014 46226010 GNW  Lion Biotechnologies Issues Letter to Shareholders,,," 8/05/2014 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2014 Financial Results on August 12, 2014",,, 1/07/2015 45845P10 GNW  Intercept to Present at the J.P. Morgan 33rd Annual Healthcare Conference, 3/01/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 6/17/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the JMP Securities Life Sciences Conference 2015,,,,, 1/09/2015 04651310   GNW  Atara to Present at the J.P. Morgan Healthcare Conference,,,,,11/05/2012 86845910 GNW  Supernus Announces Issuance of Two Patents Covering Trokendi XR(TM),,," 9/09/2015 19249H10 GNW  Coherus Appoints Juliana M. Reed, Vice President, Government Affairs",,,,,,, 9/03/2015 37890U10 GNW  Global Blood Therapeutics Announces Participation at Three September Conferences,,,,,, 4/02/2017 BGNE-US  GNW  BeiGene Presents Phase IB Data on RAF Dimer Inhibitor BGB-283 at the 2017 American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/26/2015 74318710 GNW  Progenics Pharmaceuticals Presents Positive Phase 2 Data for PSMA ADC in Metastatic Castration-Resistant Prostate Cancer,,,,,,,,,10/27/2016 OPK-US   GNW  OPKO Health Enters Companion Animal Health Market,," 9/03/2013 09061G10    GNW  BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs",,,, 1/24/2017 IMMU-US  GNW  Immunomedics Mails Letter to Stockholders,,, 8/06/2015 09058V10 GNW  Robert Ingram Appointed to BioCryst's Board of Directors,,,,,,," 5/26/2018 62855J10 GNW  DEADLINE ALERT: Shareholder Class Action Against Myriad Genetics, Inc. â€“ MYGN",,,,, 8/26/2015 INO-US    GNW  Inovio Pharmaceuticals to Participate in Citi and Rodman & Renshaw Investor Conferences,,,,,11/03/2016 AMRN-US  GNW  Amarin Reports Third Quarter 2016 Financial Results and Provides Update on Operations,,, 3/17/2017 SRPT-US  GNW  Sarepta Therapeutics Announces Presentations at the 2017 MDA Scientific Conference,,, 8/17/2015 00163U10 GNW  AMAG Pharmaceuticals Completes Acquisition of Cord Blood Registry,,,,, 9/16/2017 SAN-FR   GNW  Sanofi and Regeneron Announce Positive Study Results for DupixentÂ® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis,,,,,,12/08/2014 N0104510 GNW  Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH,,,,11/09/2015 98978L20 GNW  Zogenix Provides Corporate Update and Reports Third Quarter 2015 Financial Results,,,,,,, 1/05/2016 RARE-US   GNW  Ultragenyx to Present at the J.P. Morgan Healthcare Conference,," 4/22/2015 63009R10 GNW  NanoString Technologies to Release First Quarter 2015 Financial Results and Host Conference Call on Wednesday, May 6, 2015",,, 3/02/2015 75046920 GNW  Radius Health Appoints Former Novartis Executive Tony Rosenberg to Board of Directors,,,,,,,,,,"10/19/2011 69404D10 GNW  Pacific Biosciences of California, Inc. Third Quarter 2011 Earnings Conference Call",,,10/28/2015 MGNX-US  GNW  MacroGenics Announces Date of Third Quarter 2015 Financial Results Conference Call,,,, 7/15/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast,"10/03/2013 G7280010 GNW  Prothena Announces Pricing of Public Offering of 5,910,000 Ordinary Shares",,,, 4/27/2015 GMAB-DK  GNW  Genmab Announces Phase III Study of Arzerra(r) Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL,,,,,"10/24/2012 16383L10 GNW  ChemoCentryx to Report Data for CCX140, an Orally Administered CCR2 Inhibitor, at The American Society of Nephrology's Kidney Week 2012",,, 4/27/2015 56400P70  GNW  MannKind to Manufacture 12 Unit Cartridge Strength of AFREZZA(R) Following FDA Approval,," 2/16/2016 CYTK-US  GNW  Cytokinetics, Inc. Reports Fourth Quarter 2015 Financial Results",, 4/13/2017 AMRS-US   GNW  Amyrisâ€™s Biossance Delivers Record First-Quarter Sales â€“ #1 Eye Product at Sephora and On Track for Much Better than Expected 2017,,11/12/2012 00448Q20 GNW  Achillion Provides Update on Clinical HCV Development Programs,,"10/08/2015 03152W10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 â€“ FOLD",,,,10/14/2014 36197T10 GNW  GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy,,,,, 3/16/2016 36315X10 GNW  Galapagos doses first CF patient with G551D mutation in SAPHIRA 1 study,11/11/2015 PTLA-US  GNW  The New England Journal of Medicine Publishes Results of Portola Pharmaceuticalsâ€™ Phase 3 ANNEXA Studies of Andexanet Alfa,,,," 7/31/2014 14075510 GNW  Cara Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014", 2/16/2016 FLXN-US  GNW  Flexion Therapeutics Reports Primary Endpoint Met in Pivotal Phase 3 Trial of Zilrettaâ„¢ in Knee Osteoarthritis, 4/06/2015 N9006410 GNW  uniQure Announces Results for Fourth Quarter and Financial Year 2014," 2/03/2015 00847X10  GNW  Agios Pharmaceuticals to Present at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11",,,, 7/31/2014 070JFC-E GNW  Fate Therapeutics Secures Up to $20 Million in Debt Financing,,,12/05/2014 45845P10 GNW  Intercept Announces Publication of Meta-Analysis From the Global PBC Study Group in Gastroenterology, 2/07/2018 KPTI-US    GNW  Karyopharm to Participate in Upcoming Investor Conferences,,, 6/15/2015 46116X10 GNW  Intra-Cellular Therapies Reports Completion of Enrollment With 450 Patients Randomized in the ITI-007-301 Phase 3 Clinical Trial for the Treatment of Schizophrenia,,,,,11/12/2014 04651310   GNW  Atara Biotherapeutics Announces Third Quarter 2014 Operating Results,,,,,10/31/2012 86845910 GNW  Supernus Announces Resignation of Board Member,,, 9/04/2015 CHRS-US  GNW  Coherus BioSciences to Present at Morgan Stanley Global Healthcare Conference on September 17,,,,,,," 8/13/2015 GBT-US   GNW  Global Blood Therapeutics, Inc. (Nasdaq: GBT) to Ring The Nasdaq Stock Market Opening Bell",,,,,, 3/22/2017 BGNE-US  GNW  BeiGene Reports Fourth Quarter and Full Year 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/23/2015 74318710 GNW  Progenics Pharmaceuticals to Present Full Phase 2 Data for PSMA ADC at the 2015 ASCO GU Symposium,,,,,,,,, 5/09/2016 OPK-US   GNW  SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction,, 8/16/2013 09061G10    GNW  BioMarin Announces Oral Presentation of BMN 673 Most Recent Data on Breast and Ovarian Cancers at the European Cancer Congress 2013,,,, 1/18/2017 IMMU-US  GNW  Immunomedics Highlights Expanded Pipeline Positioning Company for Sustained Value Creation,,, 7/23/2015 09058V10 GNW  BioCryst to Announce Second Quarter 2015 Financial Results August 7,,,,,,," 5/24/2018 0B1C3M-E GNW  The Klein Law Firm Reminds Investors of a Class Action on Behalf of Myriad Genetics, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2018 (MYGN)",,,,, 8/19/2015 45773H20  GNW  Inovio Pharmaceuticals DNA Vaccine Protects 100% Against Deadly MERS Virus in Non-Human Primates,,,,,"10/27/2016 AMRN-US  GNW  Amarin to Report Third Quarter 2016 Results and Host Conference Call on November 3, 2016",,, 3/02/2017 SRPT-US  GNW  Sarepta Therapeutics to Present Company Overview at the Cowen and Company 37th Annual Health Care Conference,,, 8/12/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Pricing of Private Offering of $500 Million of Senior Notes Due 2023,,,,," 9/11/2017 SAN-FR   GNW  Sanofi, Regeneron: Dupilumab Hits Main Objectives in Late-Stage Asthma Trial",,,,,,11/18/2014 N0104510 GNW  Affimed Reports Financial Results for Third Quarter 2014,,,,11/02/2015 98978L20 GNW  Zogenix to Release Third Quarter 2015 Financial Results and Host Conference Call & Webcast on November 9,,,,,,,12/03/2015 RARE-US   GNW  Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of KRN23 in Adults With X-Linked Hypophosphatemia (XLH),, 4/16/2015 63009R10 GNW  NanoString Technologies Empowers Cancer Researchers With Three Innovative New Products for the nCounter Analysis System,,," 2/24/2015 75046920 GNW  Radius Health to Present at the BIO-Europe Spring 2015 Paris Expo March 9-11, 2015",,,,,,,,,," 8/04/2011 69404D10 GNW  Pacific Biosciences of California, Inc. Announces Second Quarter Financial Results",,,10/28/2015 MGNX-US  GNW  MacroGenics Regains European and Other Regional Rights to Enoblituzumab,,,, 6/09/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at the Wells Fargo Healthcare Conference, 8/12/2013 G7280010 GNW  Prothena Reports Second Quarter 2013 Financial Results,,,, 4/16/2015 GMAB-DK  GNW  Genmab Achieves USD 10 Million Milestone in Daratumumab Collaboration with Janssen,,,,,"10/02/2012 16383L10 GNW  ChemoCentryx Reports Data for CCX872, the Company's Orally Bioavailable, Next-Generation CCR2 Inhibitor, in a Preclinical Model of Diabetic Nephropathy",,, 2/24/2015 56400P70  GNW  MannKind Corporation Reports 2014 Fourth Quarter and Full Year Financial Results,, 2/03/2016 CYTK-US  GNW  Cytokinetics to Participate in Upcoming Investor Conferences,, 4/03/2017 AMRS-US   GNW  Amyris Enables Launch of New High-Performance Tackifier from Cray Valley Featuring Sustainably-Sourced Resin Technology,,11/08/2012 00448Q20 GNW  Achillion Reports Third Quarter and Nine Month 2012 Financial Results,,10/02/2015 FOLD-US  GNW  Amicus Therapeutics to Host FDA Update Conference Call Today,,,,10/14/2014 36197T10 GNW  GW Pharmaceuticals Announces Preliminary Topline Results of Phase 2a Ulcerative Colitis Trial,,,,, 3/07/2016 36315X10 GNW  Galapagos selected for BEL 20 Index,11/09/2015 PTLA-US  GNW  Portola Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update,,,, 7/31/2014 14075510 GNW  Cara Therapeutics Initiates Human Abuse Liability Trial of CR845,12/04/2015 009T7W-E GNW  Flexion Therapeutics to Present at Oppenheimer 26th Annual Healthcare Conference, 3/12/2015 N9006410 GNW  Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate Update, 1/12/2015 00847X10  GNW  Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration,,,, 7/29/2014 31189P10 GNW  Fate Therapeutics Announces FDA Clearance of IND for Clinical Development of PROHEMA in Inherited Metabolic Disorders,,,11/25/2014 008BK4-E GNW  Intercept to Present at Upcoming Investor Conferences, 2/01/2018 KPTI-US    GNW  Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,, 5/26/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the Jefferies 2015 Global Healthcare Conference,,,,,11/06/2014 04651310   GNW  Atara Biotherapeutics' Collaborating Investigators to Present Data at the American Society of Hematology Annual Meeting 2014,,,,,10/22/2012 86845910 GNW  Supernus Receives FDA Approval for Oxtellar XR(TM) in Epilepsy,,, 9/03/2015 19249H10 GNW  Coherus Provides Updates on Clinical Studies,,,,,,," 8/12/2015 GBT-US   GNW  Nasdaq Welcomes Global Blood Therapeutics, Inc. to The Nasdaq Stock Market",,,,,, 3/09/2017 BGNE-US  GNW  BeiGene Announces Initiation of Pivotal Study in China with BTK Inhibitor BGB-3111 in Patients with Relapsed or Refractory CLL/SLL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/17/2015 74318710 GNW  Progenics Pharmaceuticals to Present at the 2015 RBC Capital Markets' Healthcare Conference,,,,,,,,, 1/13/2016 ARNI-US  GNW  Arno Therapeutics Completes $7.4 Million Common Stock Financing,, 7/25/2013 09061G10    GNW  BioMarin Provides BMN 673 Program Update,,,, 1/18/2017 IMMU-US  GNW  Immunomedics Announces New Data for IMMU-132 at Investor R&D Day,,, 6/18/2015 BCRX-US  GNW  BioCryst to Present at the JMP Securities Life Sciences Conference,,,,,,," 5/24/2018 62855J10 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline: June 19, 2018",,,,, 8/10/2015 45773H20  GNW  Inovio Pharmaceuticals Reports 2015 Second Quarter Results; Conference Call Will Discuss New Cancer Partnership,,,,,"10/25/2016 AMRN-US  GNW  Pure EPA VascepaÂ® Now Available in New, Smaller Half-Gram Capsule Size",,,10/04/2016 80360710 GNW  Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summitâ€™s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy,,, 8/05/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Closing of $231 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,," 9/08/2017 SAN-FR   GNW  Sanofi, Regeneron: Cemiplimab Receives FDA Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma",,,,,,11/12/2014 065NB4-E GNW  Affimed to Present at the Jefferies Global Healthcare Conference - London,,,,10/19/2015 ZGNX-US  GNW  Zogenix Provides Regulatory Update for ZX008,,,,,,,12/02/2015 RARE-US   GNW  Ultragenyx to Present at the Oppenheimer Annual Healthcare Conference,, 4/01/2015 63009R10 GNW  NanoString Technologies and MD Anderson to Collaborate on Development of Multi-Omic Assays Simultaneously Profiling Gene and Protein Expression,,, 2/24/2015 75046920 GNW  Radius Health to Present at the Cowen and Company 35th Annual Health Care Conference,,,,,,,,,," 7/22/2011 69404D10 GNW  Pacific Biosciences of California, Inc. Second Quarter 2011 Earnings Conference Call",,,10/22/2015 MGNX-US  GNW  MacroGenics and Merck to Collaborate on Immuno-Oncology Study Evaluating Margetuximab in Combination with KEYTRUDA(R) (pembrolizumab) for Advanced Gastric Cancer,,,, 6/05/2014 60877T10 GNW  Momenta Pharmaceuticals Receives Orphan Drug Designation for Necuparanib (Formerly M402) in Pancreatic Cancer, 8/07/2013 G7280010 GNW  Prothena to Present at the Wedbush Securities Life Sciences Management Access Conference in New York,,,," 3/26/2015 37230320 GNW  Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to two Board Members and Grant of Warrants to Employees in Genmab",,,,, 8/30/2012 16383L10 GNW  ChemoCentryx to Present at the BioCentury NewsMakers in the Biotech Industry Conference,,, 2/18/2015 56400P70  GNW  MannKind Corporation to Present at the RBC Capital Markets Global Healthcare Conference,," 2/02/2016 CYTK-US  GNW  Cytokinetics to Announce Fourth Quarter Results on  February 16, 2016",, 3/06/2017 AMRS-US   GNW  Amyris & Kuraray Deliver Superior Performance in Sumitomoâ€™s Dunlop Winter Maxx 02 Car Tires Driving Accelerated Growth for Amyris,, 9/27/2012 00448Q20 GNW  Achillion Announces Positive Proof-of-Concept Data With ACH-3102,,10/02/2015 FOLD-US  GNW  Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy,,,, 9/29/2014 36197T10 GNW  GW Pharmaceuticals Research and Development Day Details,,,,, 3/03/2016 36315X10 GNW  Galapagos reports largest cash balance ever,11/06/2015 PTLA-US  GNW  Portola Pharmaceuticals Announces Phase 3 ANNEXAâ„¢-R Part 2 Study Results to be Presented at American Heart Association Scientific Sessions 2015,,,, 7/16/2014 07G79K-E GNW  Cara Therapeutics Earns Milestone Payment From Maruishi Pharmaceutical for Completion of Phase 1 Clinical Trial of I.V. CR845 in Japan,12/01/2015 FLXN-US  GNW  Flexion Therapeutics Enrolls First Patient in Pharmacokinetic Study of Zilrettaâ„¢ for Osteoarthritis of the Knee, 2/23/2015 N9006410 GNW  uniQure to Present at the at the Cowen and Company 35th Annual Health Care Conference," 1/05/2015 00847X10  GNW  Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12",,,, 6/30/2014 31189P10 GNW  Fate Therapeutics Submits IND Application for the Clinical Development of PROHEMA(R) in Inherited Metabolic Disorders,,,11/17/2014 45845P10 GNW  Intercept Pharmaceuticals Appoints Lisa Bright as Head of Europe," 1/31/2018 06S9LL-E   GNW  Multiple Myeloma Research Foundation (MMRF) and Karyopharm Collaboration Drives the Advancement of Selinexor, a First-In-Class, Next-Generation Myeloma Therapy",,, 5/18/2015 46116X10 GNW  Intra-Cellular Therapies Announces Further Analyses of the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 168th Annual Meeting of the American Psychiatric Association,,,,,"10/22/2014 04651310   GNW  Atara Biotherapeutics Doses First Patient in Phase 1 Clinical Study of STM 434, an Activin Inhibitor",,,,, 8/29/2012 86845910 GNW  Supernus to Present at Two Investor Conferences in September 2012,,, 8/10/2015 19249H10 GNW  Coherus BioSciences Reports Second Quarter 2015 Financial and Operating Results,,,,,,, 4/23/2015 37890U10 GNW  Guerbet: 1st quarter 2015 revenue,,,,,, 3/07/2017 BGNE-US  GNW  BeiGene and Guangzhou Development District Establish Joint Venture to Build Biologics Manufacturing Facility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/03/2015 74318710 GNW  Progenics Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference,,,,,,,,, 1/17/2014 OPK-US   GNW  OPKO CEO Phil Frost Featured in Exclusive Interview at RedChip Emerging Growth Showcase on Jan. 22-23,, 7/25/2013 09061G10    GNW  BioMarin Announces Second Quarter 2013 Financial Results,,,, 1/12/2017 IMMU-US  GNW  Immunomedics to Mail Letter to Stockholders Highlighting Unprecedented ProgressÂ Toward Enhanced Value Creation,,, 6/17/2015 09058V10 GNW  BioCryst Licenses Worldwide Rights to Commercialize RAPIVAB(R) Influenza Treatment to CSL Limited,,,,,,, 5/23/2018 074K1Y-E GNW  Myriad Announces Seven New Payer Coverage Decisions for ProlarisÂ®,,,,, 8/10/2015 45773H20  GNW  Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune,,,,, 9/12/2016 AMRN-US  GNW  Amarinâ€™s REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee,,," 1/29/2015 80360710 GNW  UPDATE - SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Sarepta Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 6, 2015 -- SRPT",,, 8/05/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Proposed Private Offering of $450 Million of Senior Notes Due 2023,,,,, 9/07/2017 SAN-FR   GNW  Sanofi Alliance Partner Alnylam Gives Update on Fitusiran,,,,,,11/11/2014 065NB4-E GNW  Affimed Announces Third Quarter 2014 Financial Results Conference Call,,,, 9/30/2015 98978L20 GNW  Zogenix Reports Positive Top-Line Results From Relday(TM) Phase 1b Multi-Dose Clinical Trial,,,,,,,12/02/2015 RARE-US   GNW  Ultragenyx Reports Positive Interim 40-Week Data From Pediatric Phase 2 Study of KRN23 in X-Linked Hypophosphatemia,, 3/18/2015 63009R10 GNW  NanoString Technologies' Prosigna Breast Cancer Assay Included in German Breast Cancer Treatment Guidelines,,," 2/19/2015 75046920 GNW  Radius Health to Announce Fourth Quarter and Full Year 2014 Financial Results, Host Conference Call and Live Webcast on March 10, 2015",,,,,,,,,, 5/16/2011 NDAQ-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,10/13/2015 MGNX-US  GNW  MacroGenics Highlights Progress at 2015 R&D Day,,,, 5/06/2014 60877T10 GNW  Momenta Pharmaceuticals Reports First Quarter 2014 Financial Results, 7/22/2013 0CXBJZ-E GNW  Prothena Welcomes New Director to Its Board,,,, 3/18/2015 37230320 GNW  Genmab Acquires Antibody Assets from iDD Biotech,,,,," 8/10/2012 16383L10 GNW  ChemoCentryx Announces Financial Results for the Quarter Ended June 30, 2012",,," 2/17/2015 56400P70  GNW  MannKind Corporation to Hold 2014 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2015",, 1/11/2016 CYTK-US  GNW  Cytokinetics Outlines Vision 2020 Strategic Initiative to Advance Portfolio of Muscle Biology Drug Candidates,, 3/02/2017 AMRS-US   GNW  Amyris More Than Doubles Revenues Over 2015 And Provides Strong Growth Outlook,, 9/21/2012 00448Q20 GNW  Achillion to Webcast September 27th Analyst Day,," 9/30/2015 FOLD-US  GNW  Amicus Therapeutics Completes Acquisition of Scioderm, Inc.",,,, 9/24/2014 36197T10 GNW  GW Pharmaceuticals to Present at the Leerink Rare Disease Roundtable 2014,,,,, 3/01/2016 09BBH3-E GNW  Galapagos receives transparency notification from Johnson & Johnson,11/04/2015 PTLA-US  GNW  Portola Pharmaceuticals to Present at Credit SuisseÂ 24th Annual Healthcare Conference,,,," 6/24/2014 14075510 GNW  Cara Therapeutics Announces Appointment of Robert Medve, M.D., as Chief Medical Officer",11/16/2015 FLXN-US  GNW  Flexion Therapeutics to Present at Stifel 2015 Healthcare Conference, 2/06/2015 N9006410 GNW  uniQure to Present at the at the Leerink Partners Global Healthcare Conference,12/16/2014 00847X10  GNW  Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option,,,, 6/05/2014 31189P10 GNW  Fate Therapeutics to Highlight Potential Clinical Applications of Ex Vivo Hematopoietic Cell Modulation at 12th International Cord Blood Symposium,,,11/08/2014 45845P10 GNW  Intercept Announces Additional Data for OCA in Primary Biliary Cirrhosis, 1/25/2018 KPTI-US    GNW  Karyopharm Announces Agreement for Biogen to Acquire KPT-350 for the Treatment of Neurological and Neurodegenerative Conditions,,, 5/11/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the 2015 UBS Global Healthcare Conference,,,,,"10/16/2014 04651310   GNW  Photo Release -- Nasdaq Welcomes Atara Biotherapeutics, Inc. (Nasdaq: ATRA) to The Nasdaq Stock Market",,,,, 8/10/2012 86845910 GNW  Supernus Pharmaceuticals Reports Second Quarter 2012 Financial Results,,, 7/28/2015 19249H10 GNW  Coherus BioSciences to Report Second Quarter 2015 Financial Results on August 10,,,,,,, 3/12/2015 37890U10 GNW  Guerbet: 2014 annual results,,,,,, 3/02/2017 BGNE-US  GNW  BeiGene Announces Initiation of First Pivotal Study in ChinaÂ with BTK Inhibitor BGB-3111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/23/2015 74318710 GNW  Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma,,,,,,,,, 1/17/2014 OPK-US   GNW  RedChip Emerging Growth Showcase on Jan. 22-23 Featuring Exclusive Interview With Dr. Phil Frost,," 7/03/2013 09061G10    GNW  BioMarin to Host Second Quarter 2013 Financial Results Conference Call and Webcast on Thursday, July 25 at 5:00 p.m. ET",,,, 1/09/2017 06P9WL-E GNW  Immunomedics Announces Antitumor Effect of Sacituzumab Govitecan (IMMU-132) in Triple-Negative Breast Cancer Can be Enhanced With DNA-Repair Inhibitors,,, 5/26/2015 09058V10 GNW  BioCryst to Present at the Jefferies 2015 Healthcare Conference,,,,,,," 5/22/2018 62855J10 GNW  MYGN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018",,,,," 7/30/2015 45773H20  GNW  Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call August 10, 2015",,,,, 9/07/2016 RRSHQ-US GNW  Amarin to Present at the Rodman & Renshaw 18th Annual Global Investment Conference,,,"12/31/2014 80360710 GNW  Stull, Stull & Brody Announces the Investigation of Possible Breaches of Fiduciary Duties of Officers and Directors of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)",,, 7/30/2015 00163U10 GNW  AMAG Pharmaceuticals Prices Public Offering of $201 Million of Common Stock,,,,, 9/07/2017 SAN-FR   GNW  Sanofi rated AA by Scope Ratings,,,,,, 9/17/2014 00G64K-E GNW  Affimed Announces Closing of Initial Public Offering,,,, 9/23/2015 ZGNX-US  GNW  Zogenix to Participate in the Leerink Partners 4th Annual Rare Disease Roundtable,,,,,,,11/11/2015 RARE-US   GNW  Ultragenyx to Present at Upcoming Investor Conferences,," 3/03/2015 63009R10 GNW  NanoString Technologies Appoints Robert Hershberg, M.D., Ph.D. to Its Board of Directors",,, 2/16/2015 75046920 GNW  Radius Health to Present at the 2015 RBC Capital Markets Global Healthcare Conference,,,,,,,,,," 4/27/2011 69404D10 GNW  Pacific Biosciences of California, Inc. Announces First Quarter Financial Results",,,10/06/2015 MGNX-US  GNW  MacroGenics to Host 2015 R&D Day,,,, 5/02/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Presentation of Data Supporting Sialylation Platform, 7/01/2013 G7280010 GNW  Prothena to Present at the Eighth Annual JMP Securities Healthcare Conference in New York,,,, 3/16/2015 GMAB-DK  GNW  Genmab Retains Partial Rights for HuMax-TAC-ADC - Will Not Exercise Co-development Right,,,,," 6/08/2012 16383L10 GNW  ChemoCentryx Announces Peer-Reviewed Publication of Positive Phase 2 Clinical Data with CCX354, a Novel Inhibitor of Chemokine Receptor CCR1 in Patients with Rheumatoid Arthritis",,, 1/12/2015 56400P70  GNW  MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO,, 1/10/2016 CYTK-US  GNW  Cytokinetics Presents Analyses Demonstrating Predictive Value of Slow Vital Capacity for Clinical Outcomes in ALS,, 2/03/2017 AMRS-US   GNW  Amyris Provides Business Update,, 8/31/2012 00448Q20 GNW  Achillion to Present at Four Upcoming Investor Conferences,, 9/22/2015 03152W10 GNW  Amicus Therapeutics to Present at LEERINK Partners Rare Disease Roundtable,,,, 8/28/2014 36197T10 GNW  GW Pharmaceuticals to Present at Upcoming Investor Conferences,,,,, 2/16/2016 36315X10 GNW  Galapagos starts SAPHIRA Phase 2 study with GLPG1837 in cystic fibrosis patients,"11/02/2015 PTLA-US  GNW  Portola Pharmaceuticals to Announce Third Quarter 2015 Financial Results and Host Conference Call on Monday, November 9",,,, 6/18/2014 14075510 GNW  Cara Therapeutics Initiates Phase Ia/Ib Trial of Tablet Formulation of Oral CR845 for the Treatment of Acute and Chronic Pain,11/09/2015 FLXN-US  GNW  Flexion Therapeutics Reports Third-Quarter 2015 Financial Results, 1/09/2015 N9006410 GNW  uniQure Appoints Matthew Kapusta as Chief Financial Officer,12/10/2014 00847X10  GNW  Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock,,,, 5/28/2014 31189P10 GNW  Fate Therapeutics to Present at Jefferies 2014 Global Healthcare Conference,,,11/06/2014 45845P10 GNW  FLINT Trial in NASH Published in The Lancet, 1/03/2018 KPTI-US    GNW  Karyopharm Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,, 5/07/2015 0DCCGR-E GNW  Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2015 Health Care Conference,,,,,10/16/2014 04651310   GNW  Atara Biotherapeutics (Nasdaq: ATRA) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO,,,,," 7/20/2012 86845910 GNW  Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer",,, 5/27/2015 19249H10 GNW  Coherus BioSciences to Present at Jefferies Healthcare Conference on June 3,,,,,,,10/23/2014 37890U10 GNW  Guerbet Revenue at 30 September 2014 : EU302.5 million +6.1% at constant exchange rates,,,,,, 3/02/2017 BGNE-US  GNW  BeiGene Announces Presentation of Phase IB Data on BGB-283 at the 2017 American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/02/2014 74318710 GNW  Progenics Pharmaceuticals Announces Presentation at RSNA Annual Meeting,,,,,,,,, 1/10/2014 68375N10 GNW  OPKO Chairman Phil Frost in Exclusive RedChip TV Interview Airing on Bloomberg,, 7/01/2013 09061G10    GNW  Vimizim Marketing Application Submitted to ANVISA in Brazil,,,, 1/09/2017 IMMU-US  GNW  Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan,,, 5/13/2015 09058V10 GNW  BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema,,,,,,," 5/18/2018 62855J10 GNW  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Myriad Genetics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 â€“ MYGN",,,,, 7/29/2015 45773H20  GNW  Inovio Pharmaceuticals' DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge,,,,, 8/31/2016 AMRN-US  GNW  Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa,,,"12/29/2014 06ZQG4-E GNW  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Sarepta Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 6, 2015 -- SRPT",,, 7/29/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Proposed Public Offering of $200 Million of Common Stock,,,,, 8/28/2017 SAN-FR   GNW  Sanofi completes the acquisition of Protein Sciences,,,,,, 9/12/2014 00G64K-E GNW  Affimed Announces Pricing of Initial Public Offering,,,, 9/03/2015 ZGNX-US  GNW  Zogenix to Participate in the Wells Fargo 2015 Healthcare Conference,,,,,,,11/09/2015 RARE-US   GNW  Ultragenyx Reports Third Quarter 2015 Financial Results and Corporate Update,, 2/24/2015 63009R10 GNW  NanoString Technologies Releases Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Outlook,,, 2/03/2015 75046920 GNW  Radius Health to Present at 2015 BIO CEO Investor Conference to be Held February 9th & 10th in New York City,,,,,,,,,," 4/25/2011 69404D10 GNW  Pacific Biosciences of California, Inc. First Quarter 2011 Earnings Conference Call",,,10/01/2015 MGNX-US  GNW  MacroGenics Announces Presentation at 30th Annual SITC Meeting 2015,,,, 4/30/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences, 6/17/2013 G7280010 GNW  Prothena Shares to Be Added to Russell Global Index,,,, 3/11/2015 37230320 GNW  Capital Increase in Genmab as a Result of Employee Warrant Exercise and Projection of Improved Cash Position at the End of 2015,,,,, 6/07/2012 16383L10 GNW  ChemoCentryx Announces Appointment of James L. Tyree to the Company's Board of Directors,,, 1/08/2015 56400P70  GNW  MannKind Earns $50 Million in Milestone Payments From Sanofi,, 1/04/2016 CYTK-US  GNW  Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-2127107 in Patients With Spinal Muscular Atrophy,," 1/31/2017 AMRS-US   GNW  Amyris to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Thursday, March 2, 2017",, 8/30/2012 00448Q20 GNW  Achillion to Raise $41.8 Million Through Registered Direct Offering,, 9/15/2015 FOLD-US  GNW  Amicus Therapeutics Plans to Submit New Drug Application (NDA) for Migalastat for Fabry Disease Following Positive Pre-NDA Meeting With FDA,,,, 8/06/2014 36197T10 GNW  GW Pharmaceuticals plc Reports 2014 Third Quarter Financial Results,,,,, 2/01/2016 GLPG-BE  GNW  Galapagos receives transparency notification from Wellington Management Group LLP,10/30/2015 PTLA-US  GNW  Portola Pharmaceuticals Completes Enrollment in Pivotal Phase 3 APEX Study  of Betrixaban for Prevention of Blood Clots in Acute Medically Ill Patients,,,," 6/02/2014 14075510 GNW  Cara Therapeutics Names Eric J. Vandal Vice President, Commercial Operations","11/02/2015 FLXN-US  GNW  Flexion Therapeutics to Report Third-Quarter 2015 Financial Results on November 9, 2015", 1/08/2015 N9006410 GNW  Xenon Pharmaceuticals Outlines Key Anticipated Milestones for 2015,12/09/2014 00847X10  GNW  Agios Pharmaceuticals Announces Proposed Offering of Common Stock,,,, 5/13/2014 31189P10 GNW  Fate Therapeutics Reports First Quarter 2014 Financial Results,,,11/06/2014 45845P10 GNW  Intercept Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Business Updates,12/10/2017 KPTI-US    GNW  Karyopharm Presents Positive Phase 1/2 Eltanexor Data at the American Society of Hematology 2017 Annual Meeting,,, 4/30/2015 46116X10 GNW  Intra-Cellular Therapies Reports First Quarter 2015 Financial Results and Provides Corporate Update,,,,,10/15/2014 04651310   GNW  Atara Biotherapeutics Announces Pricing of Its Initial Public Offering,,,,, 7/13/2012 86845910 GNW  Supernus Provides Update on the Launch of Its Two Epilepsy Products Trokendi XR(TM) and SPN-804,,, 5/11/2015 19249H10 GNW  Coherus BioSciences Reports First Quarter 2015 Financial and Operating Results,,,,,,, 3/24/2014 37890U10 GNW  Guerbet and Sirtex to Collaborate on Clinical Studies in Primary and Secondary Liver Cancer,,,,,, 2/27/2017 BGNE-US  GNW  BeiGene to Present at the Cowen and Company 37th Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/11/2014 74318710 GNW  Progenics Pharmaceuticals to Participate in Upcoming Conferences,,,,,,,,,"10/30/2013 68375N10 GNW  Arno Therapeutics Completes $30.7 Million Financing, Recapitalization and 1-for-8 Reverse Stock Split",," 6/06/2013 09061G10    GNW  UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs Global Healthcare Conference",,,," 1/05/2017 IMMU-US  GNW  Immunomedics Announces Investor R&D Day on January 18, 2017",,, 5/08/2015 09058V10 GNW  BioCryst Reports First Quarter 2015 Financial Results,,,,,,, 5/15/2018 MYGN-US  GNW  Myriad Genetics to Present Eight Studies at the 2018 American SocietyÂ ofÂ ClinicalÂ Oncology Annual Meeting,,,,, 7/27/2015 45773H20  GNW  Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer,,,,, 8/26/2016 AMRN-US  GNW  Amarin Announces Mandatory Exchange of Exchangeable Senior NotesÂ Issued in May 2014 and November 2015,,,"12/24/2014 AVII-US  GNW  SECURITIES ALERT: Rosen Law Firm Reminds Sarepta Therapeutics, Inc. Investors of Important Deadline in Class Action Seeking to Recover Investor Losses - SRPT",,, 7/23/2015 00163U10 GNW  AMAG Pharmaceuticals Reports Record Second Quarter 2015 Financial Results,,,,, 8/08/2017 SAN-FR   GNW  Sanofi Files Suit in the U.S. to Defend its Patent Rights on LantusÂ®,,,,,,,,,, 8/10/2015 98978L20 GNW  Zogenix Provides Corporate Update and Reports Second Quarter 2015 Financial Results,,,,,,,11/06/2015 RARE-US   GNW  Ultragenyx Announces Update to UX007 Development Program in Glucose Transporter Type-1 Deficiency Syndrome,, 2/18/2015 63009R10 GNW  NanoString Technologies to Present at the Cowen 35th Annual Health Care Conference,,, 1/29/2015 75046920 GNW  Radius Health Announces Oral Presentation of the ACTIVE Phase 3 Clinical Trial of Abaloparatide-SC for Postmenopausal Women With Osteoporosis at the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2015),,,,,,,,,, 2/15/2011 69404D10 GNW  Pacific Biosciences of California Announces Fourth Quarter and Fiscal Year 2010 Operating Results,,, 9/22/2015 MGNX-US  GNW  MacroGenics to Participate in Two Upcoming Investor Conferences,,,, 4/15/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2014 Financial Results Conference Call and Webcast, 5/29/2013 G7280010 GNW  Prothena to Present at the Jefferies 2013 Global Healthcare Conference in New York,,,, 3/02/2015 37230320 GNW  Genmab 2014 Annual Report,,,,, 6/06/2012 16383L10 GNW  ChemoCentryx to Present at the 2012 Wells Fargo Securities Healthcare Conference,,, 1/07/2015 56400P70  GNW  MannKind Corporation to Present at the J.P. Morgan 2015 Healthcare Conference,,12/08/2015 CYTK-US  GNW  Cure SMA and Cytokinetics Announce Partnership to Advance Education and Awareness of Spinal Muscular Atrophy,, 1/05/2017 AMRS-US   GNW  Amyris Appoints Kathleen Valiasek as Chief Financial Officer,, 8/10/2012 00448Q20 GNW  Achillion to Present at the 2012 Wedbush Pacgrow Lifesciences Management Access Conference,," 8/31/2015 FOLD-US  GNW  Amicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc.",,,," 7/30/2014 36197T10 GNW  GW Pharmaceuticals to Report Q3 2014 Financial Results and Host Conference Call on 6 August, 2014",,,,, 1/26/2016 36315X10 GNW  Galapagos reports results with GLPG1205 in ulcerative colitis,10/13/2015 PTLA-US  GNW  Portola Pharmaceuticals Announces FDA Grants Fast Track Designation to Betrixaban for Prevention of Blood Clots in Acute Medically Ill Patients,,,, 5/12/2014 14075510 GNW  Cara Therapeutics Reports First Quarter 2014 Financial Results, 9/08/2015 33938J10 GNW  Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial for FX006,12/05/2014 N9006410 GNW  uniQure to Present at the Oppenheimer 25th Healthcare Conference - NYC,12/09/2014 00847X10  GNW  Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors,,,," 5/06/2014 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2014 Financial Results on May 13, 2014",,,10/31/2014 45845P10 GNW  Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences,12/10/2017 KPTI-US    GNW  Karyopharm Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at the American Society of Hematology 2017 Annual Meeting,,, 4/24/2015 46116X10 GNW  Intra-Cellular Therapies to Host First Quarter 2015 Financial Results Conference Call and Webcast,,,,, 9/23/2014 0DHGMT-E   GNW  Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan Kettering Cancer Center,,,,, 6/26/2012 86845910 GNW  Supernus Receives Tentative Approval of Trokendi XR(TM) From FDA,,, 5/04/2015 19249H10 GNW  Coherus BioSciences to Report First Quarter 2015 Financial Results on May 11,,,,,,,,,,,,, 2/08/2017 BGNE-US  GNW  BeiGene to Participate in the LEERINK Partners 6th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/07/2014 74318710 GNW  Progenics Pharmaceuticals Announces Third Quarter 2014 Financial Results,,,,,,,,," 5/02/2013 0BGL4K-E GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection With the Sale of the Company to OPKO Health, Inc.",, 6/06/2013 09061G10    GNW  BioMarin to Present at the Goldman Sachs Global Healthcare Conference,,,,12/27/2016 IMMU-US  GNW  Immunomedics Announces Achievement of Patient Enrollment Into Single-Arm Phase 2 Study With Sacituzumab Govitecan (IMMU-132) in Triple-Negative Breast Cancer,,, 5/05/2015 09058V10 GNW  BioCryst to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference,,,,,,," 5/13/2018 62855J10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",,,,, 7/23/2015 INO-US    GNW  Inovio Pharmaceuticals and European Organization for Research and Treatment of Cancer to Collaborate on Large Phase II Cervical Cancer Trial,,,,, 8/15/2016 AMRN-US  GNW  Amarin Announces Underwritersâ€™ Exercise of Option to Purchase Additional American Depositary Shares,,,"12/09/2014 80360710 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against Sarepta Therapeutics, Inc. to Recover Investor Losses -- SRPT",,, 7/22/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Further Expansion of Maternal Health Portfolio,,,,, 7/31/2017 SAN-FR   GNW  Sanofi: Online Availability of Sanofi Group's Half-Year Financial Report for 2017,,,,,,,,,," 8/05/2015 98978L20 GNW  Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares",,,,,,,11/03/2015 RARE-US   GNW  Ultragenyx to Present at the Credit Suisse Annual Healthcare Conference,," 2/10/2015 63009R10 GNW  NanoString Technologies to Release Fourth Quarter 2014 Financial Results and Host Conference Call on Tuesday, February 24, 2015",,," 1/28/2015 75046920 GNW  Radius Health, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares",,,,,,,,,," 2/08/2011 69404D10 GNW  Pacific Biosciences of California, Inc. Fourth Quarter 2010 Earnings Conference Call",,, 8/05/2015 MGNX-US  GNW  MacroGenics Provides Update on Corporate Progress and Second Quarter 2015 Financial Results,,,, 2/24/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 34th Annual Health Care Conference, 5/14/2013 G7280010 GNW  Prothena Reports First Quarter Financial Results,,,, 3/02/2015 GMAB-DK  GNW  Genmab Announces That Agreement to Transfer Ofatumumab Collaboration to Novartis is Now Effective,,,,," 5/26/2012 CCXI-US  GNW  ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule Inhibitor of C5aR, at the 49th European Renal Association - European Dialysis and Transplant Association Congress",,,11/25/2014 56400P70  GNW  MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference,,11/24/2015 CYTK-US  GNW  Cytokinetics to Present at 27th Annual Piper Jaffray Healthcare Conference,,12/29/2016 000KLZ-E  GNW  Amyris Agrees Debt Exchange to Extend Maturities to 2019,, 8/08/2012 00448Q20 GNW  Achillion Reports Second Quarter and Six Month 2012 Financial Results,, 8/05/2015 03152W10 GNW  Amicus Therapeutics Announces Second Quarter 2015 Financial Results and Corporate Updates,,,, 6/25/2014 GWP-GB   GNW  GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Totaling Approximately $169.8 Million on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Additional ADSs,,,,," 1/25/2016 GLPG-BE  GNW  Transparency notification - Gilead Sciences, Inc. holds 14.75% of Galapagos shares", 9/24/2015 73701010 GNW  Portola Pharmaceuticals Appoints Dr. David C. Stump to Board of Directors,,,," 5/05/2014 14075510 GNW  Cara Therapeutics to Announce First Quarter 2014 Financial Results on May 12, 2014", 9/01/2015 FLXN-US  GNW  Flexion Therapeutics Granted Fast Track Status by the FDA for FX006 for Treatment of Osteoarthritis of the Knee,12/01/2014 N9006410 GNW  uniQure Announces Results for the Third Quarter of 2014,"12/08/2014 00847X10  GNW  Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency",,,, 4/30/2014 31189P10 GNW  Fate Therapeutics to Present at Deutsche Bank 39th Annual Health Care Conference,,,10/08/2014 45845P10 GNW  Intercept Announces Data to be Presented at the 2014 AASLD Annual Meeting,11/13/2017 KPTI-US    GNW  Karyopharm Therapeutics to Present at the Jefferies 2017 London Healthcare Conference,,, 3/31/2015 0DCCGR-E GNW  Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program at the 15th International Congress on Schizophrenia Research,,,,,,,,,, 6/07/2012 86845910 GNW  Supernus Pharmaceuticals Reports First Quarter 2012 Financial Results,,, 4/30/2015 19249H10 GNW  Coherus BioSciences to Present at Deutsche Bank Health Care Conference on May 7,,,,,,,,,,,,, 1/25/2017 BGNE-US  GNW  BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in WaldenstrÃ¶mâ€™s Macroglobulinemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/27/2014 74318710 GNW  Progenics Pharmaceuticals Sets Third Quarter Financial Results Call for November 7,,,,,,,,," 4/02/2012 ADYX-US  GNW  Frost Gamma Investments Trust Increases Stake in Alliqua, Inc.",, 6/05/2013 09061G10    GNW  BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU,,,,"12/22/2016 06CR5C-E GNW  Immunomedics Awarded Additional Intellectual Property Protection for IMMU-140, an Antibody-Drug Conjugate With Dual-Therapeutic Potential",,, 4/23/2015 09058V10 GNW  BioCryst to Announce First Quarter 2015 Financial Results May 8,,,,,,," 5/12/2018 62855J10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline â€“ MYGN",,,,, 7/13/2015 45773H20  GNW  Inovio's CEO Appointed to Aspen Institute's Health Innovators Fellowship,,,,, 8/11/2016 AMRN-US  GNW  Amarin Prices Public Offering of American Depositary Shares,,,"12/09/2014 06ZQG4-E GNW  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sarepta Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 6, 2015 -- SRPT",,," 7/17/2015 AMAG-US  GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on July 23, 2015 at 8:00 a.m. ET to Discuss Financial Results for the Three and Six Months Ended June 30, 2015",,,,, 7/21/2017 SAN-FR   GNW  Sanofi and Regeneron Receive Positive CHMP Opinion for DupixentÂ® (dupilumab) to Treat Adult Patients with  Moderate-to-Severe Atopic Dermatitis,,,,,,,,,, 8/03/2015 98978L20 GNW  Zogenix to Release Second Quarter 2015 Financial Results and Host Conference Call & Webcast on August 10,,,,,,,11/03/2015 RARE-US   GNW  Ultragenyx to Host Conference Call for Third Quarter 2015  Financial Results and Corporate Update,, 1/28/2015 63009R10 GNW  NanoString Technologies to Present at 2015 Leerink Global Healthcare Conference,,," 1/22/2015 75046920 GNW  Radius Health, Inc. Announces Pricing of Public Offering",,,,,,,,,, 1/06/2011 69404D10 GNW  Pacific Biosciences to Present at Annual J.P. Morgan Healthcare Conference,,, 7/28/2015 05LJZC-E GNW  MGD011 Advances Into Clinical Development,,,, 2/10/2014 60877T10 GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results, 4/23/2013 G7280010 GNW  First Patient Dosed in Phase I Study of Prothena's Therapeutic Antibody for Treatment of AL Amyloidosis,,,, 2/19/2015 37230320 GNW  Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology,,,,, 5/25/2012 16383L10 GNW  ChemoCentryx Announces Transfer of Existing Shares Between Current Stockholders,,,11/03/2014 56400P70  GNW  MannKind Corporation Reports 2014 Third Quarter Financial Results,,11/08/2015 AMGN-US  GNW  Amgen and Cytokinetics Announce Late-Breaking Presentation of COSMIC-HF Trial at AHA Scientific Sessions 2015,,12/14/2016 07P25S-E  GNW  Chevron Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil Technology,, 8/07/2012 00448Q20 GNW  Achillion Announces Positive SVR4 Results From Phase 2 Study of Sovaprevir (Formerly ACH-1625) and Advancement of ACH-3102,," 7/29/2015 03152W10 GNW  Amicus Therapeutics to Announce Second Quarter 2015 Financial Results on August 5, 2015",,,, 6/18/2014 GWP-GB   GNW  GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Totalling Approximately $148 Million on NASDAQ Global Market,,,,, 1/19/2016 GLPG-BE  GNW  Galapagos and Gilead complete closing of their global collaboration for filgotinib, 9/15/2015 PTLA-US  GNW  Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints,,,, 4/02/2014 14075510 GNW  Cara Therapeutics to Webcast Presentation at 13th Annual Needham Healthcare Conference, 8/06/2015 33938J10 GNW  Flexion Therapeutics Reports Second-Quarter 2015 Financial Results,11/21/2014 N9006410 GNW  uniQure to Host Investor Day in New York City,12/08/2014 00BBFF-E  GNW  Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016,,,, 4/23/2014 31189P10 GNW  Fate Therapeutics Announces FDA Clearance of IND Amendment for Clinical Development of PROHEMA(R) in Pediatric Patients,,, 9/12/2014 45845P10 GNW  Intercept Pharmaceuticals Recognizes International PBC Day,11/03/2017 KPTI-US    GNW  Karyopharm Therapeutics to Participate in the Credit Suisse 26th Annual Healthcare Conference,,, 3/25/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the 15th International Congress on Schizophrenia Research,,,,,,,,,," 5/04/2012 86845910 GNW  Supernus Pharmaceuticals, Inc. Announces Closing of Initial Public Offering",,, 4/15/2015 19249H10 GNW  Coherus BioSciences and Baxter Announce Amendment to Etanercept Biosimilar Collaboration Agreement,,,,,,,,,,,,,12/30/2016 BGNE-US  GNW  BeiGene Announces First Patient Dosing in China Phase I Trial with Investigational Anti-PD-1 Monoclonal Antibody BGB-A317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/20/2014 74318710 GNW  Phase 2 Data for Progenics' 1404 Imaging Agent Presented at EANM Congress,,,,,,,,, 1/23/2012 68375N10 GNW  ChromaDex Corp. Names Consumer Products Veteran Jeffrey Himmel CEO,, 6/03/2013 09061G10    GNW  BioMarin Provides Preliminary Data on Ongoing Phase 1/2 Trial for BMN 673 for the Treatment of Solid Tumors at 2013 American Society of Clinical Oncology Annual Meeting,,,,12/12/2016 IMMU-US  GNW  Immunomedics Announces Novel Immuno-Oncology Program Targeting Trop-2-Expressing Cancers,,, 4/07/2015 BCRX-US  GNW  BioCryst to Present at the Needham Healthcare Conference,,,,,,," 5/11/2018 62855J10 GNW  EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc. â€“ MYGN",,,,, 5/27/2015 45773H20  GNW  Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical Development,,,,, 8/10/2016 AMRN-US  GNW  Amarin Announces Proposed Public Offering of American Depositary Shares,,," 3/22/2014 80360710 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Sarepta Therapeutics, Inc. to Contact Brower Piven Before the March 28, 2014 Lead Plaintiff Deadline (SRPT)",,, 6/29/2015 AMAG-US  GNW  AMAG Pharmaceuticals to Acquire Cord Blood Registry,,,,, 7/14/2017 EBS-US   GNW  Emergent BioSolutions to Acquire ACAM2000Â® Business From Sanofi,,,,,,,,,, 7/30/2015 98978L20 GNW  Zogenix Prices Public Offering of Common Stock,,,,,,,10/29/2015 RARE-US   GNW  Ultragenyx Pharmaceutical and Arcturus Therapeutics Announce a Research Collaboration and License Agreement to Develop RNA Therapeutics for Rare Diseases,, 1/08/2015 63009R10 GNW  NanoString Technologies Provides Update on 2014 Operational and Preliminary Financial Results,,," 1/20/2015 75046920 GNW  Radius Health, Inc. Announces Proposed Public Offering",,,,,,,,,,11/30/2010 69404D10 GNW  Pacific Biosciences Announces Third Quarter of 2010 Operating Results,,, 7/14/2015 55609910 GNW  MacroGenics Announces Pricing of Public Offering of Common Stock,,,, 2/05/2014 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at the 2014 Leerink Global Healthcare Conference, 3/28/2013 G7280010 GNW  Prothena Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Research and Development Update,,,, 2/04/2015 GMAB-DK  GNW  Major Shareholder Announcement,,,,, 5/10/2012 16383L10 GNW  ChemoCentryx Announces First Quarter 2012 Financial Results,,,"10/27/2014 56400P70  GNW  MannKind Corporation to Hold 2014 Third Quarter Financial Results Conference Call on November 3, 2014",,11/06/2015 CYTK-US  GNW  Cytokinetics Announces Results From COSMIC-HF to be Presented in Late Breaking Clinical Trial Session at American Heart Association Scientific Sessions,,12/13/2016 AMRS-US   GNW  Amyris & NIKKOL GROUP Create Leading Cosmetics Ingredient Joint Venture,," 7/31/2012 00448Q20 GNW  Achillion to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012",, 6/29/2015 03152W10 GNW  Amicus Therapeutics Joins Russell 3000(R) and Russell 2000(R) Indexes,,,, 6/17/2014 GWP-GB   GNW  GW Pharmaceuticals Announces Proposed Public Offering of ADSs,,,,, 1/19/2016 GLPG-BE  GNW  Galapagos advances CF clinical development, 9/10/2015 PTLA-US  GNW  Portola Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference,,,, 3/27/2014 14075510 GNW  Cara Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results, 8/04/2015 FLXN-US  GNW  Flexion Therapeutics Secures $30 Million in Debt Financing,11/10/2014 N9006410 GNW  uniQure to Present at Jefferies Global Healthcare Conference - London,12/07/2014 00847X10  GNW  Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies,,,, 4/10/2014 070JFC-E GNW  Fate Therapeutics Secures U.S. Patent for Class of Small Molecule Modulators Key to the Development of iPSC-Based Therapeutics,,, 8/26/2014 45845P10 GNW  Intercept to Present at Upcoming Investor Conferences,11/02/2017 KPTI-US    GNW  Karyopharm Reports Third Quarter 2017 Financial Results and Highlights Recent Progress,,, 3/12/2015 46116X10 GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2014 Financial Results and Provides Corporate Update,,,,,,,,,," 4/30/2012 86845910 GNW  Supernus Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering",,, 3/31/2015 19249H10 GNW  Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock,,,,,,,,,,,,,12/21/2016 BGNE-US  GNW  BeiGene Announces First Patient Dosing in China with Investigational PARP Inhibitor BGB-290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/06/2014 PGNX-US  GNW  Progenics Receives $40 Million Milestone Following FDA Approval of RELISTOR for OIC Patients With Chronic Non-Cancer Pain,,,,,,,,,10/13/2011 68375N10 GNW  Sagebrush Gold Provides Shareholder Update,, 5/30/2013 09061G10    GNW  BioMarin to Present at the Jefferies Global Healthcare Conference,,,,12/06/2016 IMMU-US  GNW  Immunomedics Introduces New Antibody-Drug Conjugate at Annual Meeting of American Society of Hematology,,, 3/31/2015 09058V10 GNW  BioCryst Awarded BCX4430 Advanced Development Contract,,,,,,," 5/10/2018 62855J10 GNW  MYRIAD GENETICS, INC. INVESTOR UPDATE:  Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Utah on behalf of shareholders of Myriad Genetics, Inc.",,,,, 5/26/2015 INO-US    GNW  Inovio to Present at Jefferies Healthcare Conference,,,,,11/30/2015 007MPF-E GNW  Chiasma Announces Addition of James R. Tobin and John F. Thero to Board of Directors,,," 3/07/2014 80360710 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Sarepta Therapeutics, Inc. to Contact Brower Piven Before the March 28, 2014 Lead Plaintiff Deadline -- SRPT",,, 6/09/2015 00163U10 GNW  AMAG Pharmaceuticals Appoints Aaron Pelta as Vice President of Business Development,,,,, 7/12/2017 SAN-FR   GNW  Sanofi: Availability of the Pre-quarterly Results Communication,,,,,,,,,," 7/28/2015 98978L20 GNW  Zogenix Announces Proposed Public Offering of 3,800,000 Shares of Common Stock",,,,,,,10/13/2015 RARE-US   GNW  Ultragenyx Announces Positive Interim Data From Phase 2 Study of UX007 in Long-Chain Fatty Acid Oxidation Disorder Patients,,12/22/2014 63009R10 GNW  NanoString Technologies to Present at J.P. Morgan 33rd Annual Healthcare Conference,,, 1/12/2015 75046920 GNW  Radius Announces Follow-Up on the Positive Phase 3 Top-Line Results for Its Investigational Drug Abaloparatide-SC in Postmenopausal Women With Severe Osteoporosis,,,,,,,,,,"11/16/2010 69404D10 GNW  Pacific Biosciences of California, Inc. Third Quarter 2010 Earnings Conference Call",,, 7/13/2015 55609910 GNW  MacroGenics Announces Proposed Public Offering of Common Stock,,,, 1/21/2014 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2013 Financial Results Conference Call and Webcast, 3/25/2013 G7280010 GNW  Prothena Announces Appointments of Chief Medical Officer and Chief Financial Officer,,,, 2/04/2015 GMAB-DK  GNW  Fourth Quarter and Full Year 2014 Net Sales Figures for Arzerra (ofatumumab),,,,," 4/30/2012 16383L10 GNW  ChemoCentryx Appoints Joseph M. Feczko, M.D. to Company's Board of Directors",,, 9/29/2014 56400P70  GNW  MannKind Announces Receipt of $150 Million Licensing Upfront Payment,,"10/29/2015 CYTK-US  GNW  Cytokinetics, Inc. Reports Third Quarter 2015 Financial Results",,12/06/2016 AMRS-US   GNW  Amyris Partners with Queensland to Create the leading Industrial Biotechnology Hub in Southeast Asia,, 7/10/2012 00448Q20 GNW  Achillion to Present at the 2012 JMP Securities Healthcare Conference,, 6/25/2015 03152W10 GNW  Amicus Therapeutics Announces Galafold(TM) Marketing Authorization Application (MAA) Validated by European Medicines Agency (EMA),,,, 6/17/2014 36197T10 GNW  GW Pharmaceuticals Announces Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy From Physician-Led Expanded Access Treatment Program,,,,, 1/13/2016 36315X10 GNW  Galapagos and Gilead cleared by US FTC to close their global partnership on filgotinib, 8/27/2015 73701010 GNW  Portola Pharmaceuticals to Present Preclinical Data with Andexanet Alfa and Factor Xa Inhibitor Edoxaban at European Society of Cardiology Congress 2015,,,," 3/20/2014 14075510 GNW  Cara Therapeutics to Announce Fourth Quarter and Full Year 2013 Financial Results on March 27, 2014", 8/04/2015 33938J10 GNW  Flexion Therapeutics Expands Supply Capacity for FX006 by Entering Into Agreement With Patheon,10/27/2014 N9006410 GNW  AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data from Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate,11/18/2014 00847X10  GNW  Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML),,,, 3/17/2014 31189P10 GNW  Fate Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results,,, 8/11/2014 45845P10 GNW  Intercept Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business Update,11/01/2017 KPTI-US    GNW  Karyopharm to Present Phase 1b/2 STOMP Clinical Data at the American Society of Hematology 2017 Annual Meeting,,, 3/11/2015 46116X10 GNW  Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,,, 3/30/2015 19249H10 GNW  Coherus Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,"12/07/2016 07725L10 GNW  Cancer Genetics, Inc. Is Selected by BeiGene, Ltd. to Collaborate on Clinical Trial Services & Advance Portfolio of Novel Oncology Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/22/2014 74318710 GNW  Progenics Pharmaceuticals Presents Long Term Follow-Up of Pivotal Phase 2 Trial of Azedra in Malignant Pheochromocytoma,,,,,,,,," 5/19/2011 COCP-US  GNW  BioZone Pharmaceuticals, Inc. Acquires Baker-Cummins Dermatological Products From Aero Pharmaceuticals, Inc.",, 5/30/2013 09061G10    GNW  FDA Accepts Vimizim BLA and Grants Priority Review Designation,,,,11/28/2016 0BWYJ5-E GNW  Immunomedics Postpones 2016 Annual Meeting of Stockholders,,, 2/26/2015 09058V10 GNW  BioCryst to Present at Two Upcoming Investor Conferences,,,,,,," 5/08/2018 62855J10 GNW  The Klein Law Firm Announces a Class Action Filed on Behalf of Myriad Genetics, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2018",,,,, 5/12/2015 45773H20  GNW  Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola,,,,," 8/05/2015 LGNZZ-US GNW  Poseida Therapeutics, Inc., Expands Board of Directors",,," 8/07/2012 80360710 GNW  Sarepta Therapeutics, Inc. [SRPT] to Ring The NASDAQ Stock Market Closing Bell",,, 6/09/2015 00163U10 GNW  AMAG Pharmaceuticals Launches Initiative to Raise Awareness of Preterm Birth and the Importance of a Full-Term Pregnancy,,,,, 7/11/2017 SAN-FR   GNW  Sanofi to acquire Protein Sciences,,,,,,,,,," 7/07/2015 98978L20 GNW  Zogenix to Host Key Opinion Leader Meeting Tuesday, July 14, in New York City",,,,,,,10/02/2015 RARE-US   GNW  Ultragenyx Announces Aceneuramic Acid Prolonged Release Marketing Authorization Application Filed and Accepted for Review by European Medicines Agency,,11/07/2014 63009R10 GNW  NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum,,,12/21/2014 75046920 GNW  Radius Announces Positive Phase 3 Top-Line Results for Its Investigational Drug Abaloparatide-SC in Postmenopausal Women With Severe Osteoporosis,,,,,,,,,,,,, 5/30/2015 55609910 GNW  MacroGenics Presents Updated Data from Phase 1 Study of Margetuximab at ASCO Annual Meeting 2015,,,,"12/12/2013 60877T10 GNW  Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business"," 3/21/2013 G7280010 GNW  Prothena to Report Fourth Quarter and Full Year 2012 Financial Results and Host Webcast and Conference Call on March 28, 2013",,,, 2/03/2015 GMAB-DK  GNW  Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple Myeloma,,,,,,,, 9/24/2014 56400P70  GNW  MannKind Announces Closing of Global Licensing Agreement With Sanofi,,"10/27/2015 23282W60 GNW  Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, aÂ Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure",,12/01/2016 3405-JP   GNW  Amyris Signs Multi-Year Collaboration Extension with Kuraray,, 6/14/2012 00448Q20 GNW  Achillion to Present at 2012 Wells Fargo Securities Healthcare Conference,, 6/17/2015 03152W10 GNW  Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option,,,, 6/06/2014 36197T10 GNW  GW Pharmaceuticals Announces Epidiolex(R) Receives Fast Track Designation From FDA for the Treatment of Dravet Syndrome,,,,,12/22/2015 GLPG-BE  GNW  Galapagos receives transparency notification from Wellington Management Group LLP, 8/04/2015 73701010 GNW  Portola Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update,,,, 2/05/2014 14075510 GNW  Cara Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Over-Allotment Option," 7/30/2015 33938J10 GNW  Flexion Therapeutics to Report Second-Quarter 2015 Financial Results on August 6, 2015", 9/25/2014 N9006410 GNW  uniQure to Present at the Leerink Partners Rare Disease Roundtable Conference,11/07/2014 00847X10  GNW  Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results,,,, 3/17/2014 31189P10 GNW  Fate Therapeutics Appoints Dr. Robert S. Epstein to Its Board of Directors,,, 8/04/2014 45845P10 GNW  Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference,"10/26/2017 KPTI-US    GNW  Karyopharm to Report Third Quarter 2017 Financial Results on November 2, 2017",,, 3/05/2015 0DCCGR-E GNW  Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock,,,,,,,,,,,,, 3/23/2015 19249H10 GNW  Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating Results,,,,,,,,,,,,,12/05/2016 BGNE-US  GNW  BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with WaldenstrÃ¶mâ€™s Macroglobulinemia at the 2016 American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/08/2014 74318710 GNW  Progenics Pharmaceuticals Announces Second Quarter 2014 Financial Results,,,,,,,,," 3/02/2011 ADYX-US  GNW  Frost Gamma Investments Trust Makes Strategic Investment in Alliqua, Inc.",, 5/30/2013 BMRN-US     GNW  Vimizim MAA Validated by the EMA,,,,11/18/2016 0BWYJ5-E GNW  Immunomedics Comments on Receipt of Director Nominations,,, 2/18/2015 09058V10 GNW  BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results,,,,,,, 5/08/2018 MYGN-US  GNW  Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results,,,,, 5/11/2015 45773H20  GNW  Inovio Pharmaceuticals Reports 2015 First Quarter Financial Results,,,,, 5/15/2014 02311120 GNW  Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes,,,11/12/2010 80360710 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,," 6/05/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the Barclays High Yield Bond and Syndicated Loan Conference",,,,, 7/10/2017 SAN-FR   GNW  Sanofi Genzyme and Alnylam Report Positive Results from Ongoing phase 2 Open-Label Extension Study with Investigational RNAi Therapeutic Fitusiran in Patients with Hemophilia A and B With or...,,,,,,,,,, 7/06/2015 98978L20 GNW  Zogenix Expands Senior Leadership Team to Further Drive Strategic Focus on CNS Disorders and Orphan Drug Development,,,,,,, 9/02/2015 RARE-US   GNW  Ultragenyx to Present at the Baird Health Care Conference,,11/04/2014 63009R10 GNW  NanoString Technologies Releases Financial Results for Third Quarter of 2014,,,12/19/2014 75046920 GNW  FDA Accepts IND Application for Radius Health's Investigational Drug RAD1901 Being Developed for Potential Use in Metastatic Breast Cancer,,,,,,,,,,,,, 5/27/2015 55609910 GNW  MacroGenics Preclinical Research on MGD006 DART(R) Molecule Published in Science Translational Medicine,,,,11/25/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentation at the 2013 Deutsche Bank BioFEST Conference, 3/19/2013 G7280010 GNW  Prothena Announces Appointment of Biotech Pioneer to Board of Directors,,,,12/12/2014 GMAB-DK  GNW  Genmab to Receive $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen,,,,,,,, 9/02/2014 56400P70  GNW  MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference,,"10/15/2015 CYTK-US  GNW  Cytokinetics to Announce Third Quarter Results on October 29, 2015",,11/22/2016 05GSQ9-E  GNW  Amyris to Present at Four Upcoming Investor Conferences in December,, 6/11/2012 06M48D-E GNW  Achillion Appoints Kurt Graves to Its Board of Directors,, 6/11/2015 03152W10 GNW  Amicus Therapeutics Prices Underwritten Offering of Common Stock,,,, 5/08/2014 36197T10 GNW  GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2014 Health Care Conference,,,,,12/22/2015 36315X10 GNW  Galapagos creates new warrant plans," 7/28/2015 73701010 GNW  Portola Pharmaceuticals to Announce Second Quarter 2015 Financial Results and Host Conference Call on Tuesday, August 4",,,, 1/31/2014 14075510 GNW  Cara Therapeutics Announces Pricing of Initial Public Offering, 7/29/2015 33938J10 GNW  Flexion Therapeutics Completes Enrollment in Phase 3 Clinical Trial With Lead Compound FX006 in Patients With Osteoarthritis of the Knee, 9/02/2014 N9006410 GNW  uniQure Announces Results for the Second Quarter and First Half of 2014 and Provides Update on Gene Therapy Programs,11/06/2014 00847X10  GNW  Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting,,,, 3/12/2014 31189P10 GNW  Fate Therapeutics Commences Phase 2 Clinical Trial of PROHEMA(R) for the Treatment of Hematologic Malignancies,,, 6/06/2014 45845P10 GNW  Intercept to Present at Upcoming Investor Conferences,10/12/2017 KPTI-US    GNW  Karyopharm and Ono Pharmaceutical Co. Ltd. Sign Exclusive License Agreement to Develop and Commercialize Selinexor and KPT-8602 in Japan and Other Countries in Asia,,, 3/04/2015 0DCCGR-E GNW  Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,, 3/17/2015 19249H10 GNW  Coherus Finalizes CHS-1701 BLA Enabling Clinical Program and Initiates Pivotal Pharmacokinetic and Pharmacodynamic Study,,,,,,,,,,,,,12/05/2016 06QBQ2-E GNW  BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia at the 2016 American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/31/2014 74318710 GNW  Progenics Pharmaceuticals Sets Second Quarter Financial Results Call for August 8,,,,,,,,,,, 5/20/2013 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,11/15/2016 IMMU-US  GNW  Immunomedics Expands Antibody-Drug Conjugate Program to Potentially Address Most of Human Cancers,,, 2/05/2015 09058V10 GNW  BioCryst to Announce 2014 Financial Results February 18 & Present at the 2015 Leerink Global Healthcare Conference,,,,,,," 5/07/2018 0DBJVZ-E GNW  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Myriad Genetics, Inc. Investors",,,,, 5/05/2015 45773H20  GNW  Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing,,,,, 5/09/2014 02311120 GNW  Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations,,, 8/24/2010 80360710 GNW  AVI BioPharma Inc. is Today's Focus Stock on MicroStockProfit.com,,, 6/02/2015 00163U10 GNW  AMAG Pharmaceuticals Announces New Senior Management Appointments,,,,," 6/15/2017 SAN-FR   GNW  Sanofi Launches ""Action 2017"", a Worldwide Employee Stock Purchase Plan",,,,,,,,,, 7/06/2015 98978L20 GNW  Zogenix to Participate in Cantor Fitzgerald Healthcare Conference,,,,,,, 9/01/2015 90400D10  GNW  Ultragenyx Announces Presentation of Data From Long-Chain Fatty Acid Oxidation Disorder Patients With Cardiomyopathy Treated With Triheptanoin,,"10/09/2014 63009R10 GNW  NanoString Technologies to Release Third Quarter 2014 Financial Results and Host Conference Call on Tuesday, November 4, 2014",,,"12/15/2014 75046920 GNW  The NASDAQ OMX Group, Inc. Today Announced That Radius Health Will be Added to Its Biotechnology Index Effective Before Market Open on Monday, December 22, 2014",,,,,,,,,,,,, 5/06/2015 55609910 GNW  MacroGenics Provides Update on Corporate Progress and First Quarter 2015 Financial Results,,,,11/06/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences, 2/27/2013 G7280010 GNW  Prothena Achieves Orphan Drug Status in EU for Lead Program NEOD001,,,,12/04/2014 GMAB-DK  GNW  Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin's Lymphomas,,,,,,,, 8/11/2014 56400P70  GNW  MannKind Corporation Reports 2014 Second Quarter Financial Results,," 7/29/2015 CYTK-US  GNW  Cytokinetics, Inc. Reports Second Quarter 2015 Financial Results",,11/16/2016 AMRS-US   GNW  Amyris Achieves Key Milestone in Major Drug Discovery Collaboration,, 6/06/2012 00448Q20 GNW  Achillion Announces Resignation of Chief Medical Officer,, 6/10/2015 03152W10 GNW  Amicus Therapeutics Announces Public Offering of Common Stock,,,, 5/07/2014 36197T10 GNW  GW Pharmaceuticals plc Reports Second Quarter 2014 Financial Results and Operational Progress,,,,,12/17/2015 GLPG-BE  GNW  GALAPAGOS AND GILEAD ANNOUNCE GLOBAL PARTNERSHIP TO DEVELOP FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY DISEASES, 6/24/2015 73701010 GNW  Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin Complex Concentrate Did Not,,,,, 6/03/2015 33938J10 GNW  Flexion Therapeutics' Final FX006 Data From Completed Phase 2b Dose-Ranging Trial Published in Journal of Bone and Joint Surgery, 8/11/2014 N9006410 GNW  uniQure Acquires Cardiology Gene Therapy Company InoCard,"10/27/2014 00847X10  GNW  Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014",,,," 3/11/2014 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2013 Financial Results on March 17, 2014",,, 5/28/2014 008BK4-E GNW  Intercept Announces that FDA Grants Fast Track Designation to Obeticholic Acid for the Treatment of Patients with Primary Biliary Cirrhosis, 9/20/2017 KPTI-US    GNW  Karyopharm Announces Successful Outcome from Phase 2 Portion of Phase 2/3 SEAL Study Evaluating Selinexor in Patients with Previously Treated Advanced Dedifferentiated Liposarcoma,,, 2/23/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the Cowen and Company 35th Annual Healthcare Conference,,,,,,,,,,,,, 3/16/2015 19249H10 GNW  Coherus BioSciences to Report Fourth Quarter and Year End 2014 Financial Results on March 23,,,,,,,,,,,,,11/23/2016 BGNE-US  GNW  BeiGene Announces Closing of $200 Million Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/14/2014 74318710 GNW  Progenics Holds Conference Call This Morning on FDA Appeal Response Regarding Relistor(R) sNDA for Patients With Chronic Non-Cancer Pain,,,,,,,,,,, 5/16/2013 09061G10    GNW  BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO,,,,11/14/2016 IMMU-US  GNW  Immunomedics to Provide Clinical Update on Sacituzumab Govitecan (IMMU-132) in Triple-Negative Breast Cancer at San Antonio Breast Cancer Symposium,,, 1/26/2015 09058V10 GNW  FDA Grants Fast Track Designation for BCX4161 for the Treatment of Hereditary Angioedema,,,,,,, 5/07/2018 074FLV-E GNW  Landmark Study Shows GeneSightÂ® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder,,,,," 5/01/2015 45773H20  GNW  Inovio Pharmaceuticals to Report First Quarter 2015 Financial Results May 11, 2015",,,,," 5/05/2014 02311120 GNW  Amarin to Report First Quarter 2014 Results and Host Conference Call on May 9, 2014",,, 7/19/2010 80360710 GNW  AVI BioPharma Inc. is Today's Focus Stock on MicroStockProfit.com,,," 5/28/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the Jefferies 2015 Healthcare Conference",,,,, 6/11/2017 SAN-FR   GNW  Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating PraluentÂ® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia,,,,,,,,,, 6/18/2015 98978L20 GNW  Zogenix Announces Shareholders and Board of Directors Approve Reverse Stock Split,,,,,,, 8/13/2015 90400D10  GNW  Ultragenyx Reports Second Quarter 2015 Financial Results and Corporate Update,," 8/27/2014 63009R10 GNW  NanoString Announces Unexpected Death of Chief Medical Officer, J. Wayne Cowens, MD",,,12/11/2014 75046920 GNW  Radius Health Presents RAD1901 Data at 2014 San Antonio Breast Cancer Symposium,,,,,,,,,,,,, 4/16/2015 05LJZC-E GNW  MacroGenics Announces Presentations at AACR Annual Meeting 2015,,,,11/05/2013 60877T10 GNW  Momenta Pharmaceuticals Reports Third Quarter 2013 Financial Results," 2/19/2013 G7280010 GNW  Video Interview: Dr. Dale Schenk, Chief Executive Officer, Prothena Corporation plc [PRTA]",,,,11/24/2014 GMAB-DK  GNW  Genmab Announces Phase II Study of Daratumumab in Smoldering Multiple Myeloma,,,,,,,, 8/11/2014 56400P70  GNW  Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin,," 7/15/2015 CYTK-US  GNW  Cytokinetics to Announce Second Quarter Results on July 29, 2015",,11/02/2016 AMRS-US   GNW  Amyris Reports Third Quarter 2016 Results,, 5/21/2012 00448Q20 GNW  Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C,, 6/08/2015 03152W10 GNW  Amicus Therapeutics Strengthens Executive Leadership Team,,,, 5/07/2014 36197T10 GNW  GW Pharmaceuticals Receives Investigational New Drug (IND) From FDA for Phase 2/3 Clinical Trial of Epidiolex(R) in the Treatment of Dravet Syndrome,,,,,12/07/2015 36315X10 GNW  Filgotinib meets primary endpoint in phase 2 study in patients with moderate to severe Crohn's disease," 6/22/2015 73701010 GNW  Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect of Factor Xa Inhibitor Eliquis (apixaban)",,,,, 5/07/2015 009T7W-E GNW  Flexion Therapeutics Reports First-Quarter 2015 Financial Results, 8/04/2014 0CDXXJ-E GNW  Chiesi and uniQure Provide Update on Glybera(r) Launch,10/21/2014 00847X10  GNW  Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation,,,, 3/06/2014 31189P10 GNW  Fate Therapeutics Announces Publication of Its Proprietary Stem Cell Modulation Platform for Developing iPSC-Based Regenerative Therapeutics,,, 5/07/2014 45845P10 GNW  Intercept Pharmaceuticals Reports First Quarter 2014 Financial Results," 9/12/2017 KPTI-US    GNW  Karyopharm Appoints Michael Falvey as Chief Financial Officer, Adds New Clinical Strategy and Human Resources Executives and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)",,, 2/17/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the 2015 RBC Capital Markets' Healthcare Conference,,,,,,,,,,,,, 2/23/2015 19249H10 GNW  Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2,,,,,,,,,,,,,11/17/2016 BGNE-US  GNW  BeiGene Announces Pricing of $200 Million Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/12/2014 74318710 GNW  Progenics Schedules Investor Conference Call Following FDA Advisory Committee,,,,,,,,,,, 5/14/2013 09061G10    GNW  BioMarin to Present at the UBS Global Healthcare Conference,,,,11/04/2016 IMMU-US  GNW  Immunomedics Receives Edison Patent Award From Research & Development Council of New Jersey for the Fourth Time,,, 1/14/2015 09058V10 GNW  BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema,,,,,,," 5/06/2018 62855J10 GNW  Kaskela Law LLC: Shareholder Class Action Filed Against Myriad Genetics, Inc. - MYGN",,,,, 4/30/2015 45773H20  GNW  Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,, 5/02/2014 02311120 GNW  Amarin Announces Presentation of New MARINE and ANCHOR Post-Hoc Analyses at National Lipid Association Annual Scientific Sessions Showing Vascepa(R) Significantly Reduced Apolipoprotein C-III Levels,,,,,, 5/28/2015 00163U10 GNW  AMAG Pharmaceuticals Receives Complete Response Letter From FDA for the Single-Dose Vial of Makena(R) (Hydroxyprogesterone Caproate Injection),,,,, 5/22/2017 SAN-FR   GNW  Sanofi and Regeneron Announce FDA Approval of KevzaraÂ® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients,,,,,,,,,, 5/27/2015 98978L20 GNW  Zogenix Announces New Efficacy Data From a Long-Term Study of Low-Dose Fenfluramine for Treatment of Dravet Syndrome,,,,,,, 8/06/2015 90400D10  GNW  Ultragenyx to Host Conference Call for Second Quarter 2015 Financial Results and Corporate Update,, 8/21/2014 63009R10 GNW  NanoString Technologies to Present at Upcoming Investor Conferences,,,11/24/2014 75046920 GNW  The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study of the Investigational Drug Abaloparatide in Postmenopausal Women With Osteoporosis,,,,,,,,,,,,, 3/16/2015 05LJZC-E GNW  MacroGenics Initiates Phase 1 Study of MGD010 for the Treatment of Autoimmune Disorders,,,,10/15/2013 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2013 Financial Results Conference Call and Webcast, 2/13/2013 G7280010 GNW  Prothena to Ring NASDAQ Stock Market Opening Bell,,,,11/10/2014 37230320 GNW  Genmab Announces New Phase III Combination Study of Daratumumab in Frontline Multiple Myeloma,,,,,,,," 8/05/2014 56400P70  GNW  MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014",, 7/14/2015 CYTK-US  GNW  Cytokinetics Announces Start of Phase 3 Clinical Trial of Tirasemtiv in Patients With ALS,,"10/31/2016 AMRS-US   GNW  Amyris to Present at Benchmark Micro Cap Discovery One-on-One Conference December 1, 2016",, 5/18/2012 00448Q20 GNW  Achillion Announces Executive Promotion,, 6/03/2015 03152W10 GNW  Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union,,,," 5/06/2014 36197T10 GNW  GW Pharmaceuticals Appoints Dr. Kenneth Sommerville as VP, Clinical Science",,,,,12/04/2015 36315X10 GNW  Galapagos increases share capital through warrant exercises," 6/15/2015 006RGD-E GNW  Portola Pharmaceuticals Appoints Industry Leader Tao Fu as Executive Vice President, Chief Commercial and Business Officer",,,,," 4/30/2015 33938J10 GNW  Flexion Therapeutics to Report First-Quarter 2015 Financial Results on May 7, 2015", 7/01/2014 0CDXXJ-E GNW  uniQure Secures Additional $10M Venture Loan from Hercules Capital,10/15/2014 00847X10  GNW  Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221,,,, 2/28/2014 31189P10 GNW  Fate Therapeutics Observes Rare Disease Day 2014,,, 5/06/2014 008BK4-E GNW  Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week, 9/08/2017 KPTI-US    GNW  Karyopharm Announces Presentation of Selinexor and KPT-9274 Clinical Data at the European Society of Medical Oncology 2017 Annual Meeting,,, 2/02/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the Leerink Global Healthcare Conference,,,,,,,,,,,,, 2/04/2015 19249H10 GNW  Coherus BioSciences to Present at Leerink Healthcare Conference on February 11,,,,,,,,,,,,,11/16/2016 BGNE-US  GNW  BeiGene Announces Proposed Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/11/2014 74318710 GNW  Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Consider and Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists,,,,,,,,,,, 5/02/2013 09061G10    GNW  BioMarin to Present at the Baird Growth Stock Conference,,,,11/02/2016 IMMU-US  GNW  Immunomedics Announces First Quarter Fiscal 2017 Results and Clinical Program Developments,,, 1/06/2015 09058V10 GNW  BioCryst to Present at J.P. Morgan Healthcare Conference,,,,,,," 5/04/2018 62855J10 GNW  MYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN",,,,, 4/29/2015 INO-US    GNW  Inovio Pharmaceuticals Announces Public Offering of Common Stock,,,,," 3/31/2014 02311120 GNW  Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules",,,,,, 5/20/2015 00163U10 GNW  AMAG Pharmaceuticals Expands Resources Dedicated to Reducing the Risk of Preterm Birth,,,,, 5/19/2017 SAN-FR   GNW  Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar,,,,,,,,,, 5/11/2015 98978L20 GNW  Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results,,,,,,, 8/05/2015 90400D10  GNW  Ultragenyx Announces Initiation of Phase 2 Study of Recombinant Human Beta-Glucuronidase in Patients Under Five Years Old With Mucopolysaccharidosis 7,, 8/05/2014 63009R10 GNW  NanoString Technologies Releases Financial Results for Second Quarter of 2014,,,11/17/2014 09BV2S-E GNW  Radius Health's Investigational Drug RAD1901 Selected as One of Informa and Kantar Health's 2014 Top 10 Most Interesting Oncology Projects to Watch,,,,,,,,,,,,, 3/03/2015 55609910 GNW  MacroGenics Provides Update on Corporate Progress and 2014 Financial Results,,,, 9/04/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Three Upcoming Investor Conferences, 1/07/2013 G7280010 GNW  Prothena Announces Addition of Industry Veterans to Board of Directors,,,,11/06/2014 GMAB-DK  GNW  Genmab Announces Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology Annual Meeting (ASH),,,,,,,," 6/27/2014 56400P70  GNW  MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes",, 7/14/2015 CYTK-US  GNW  Cytokinetics and the ALS Association Announce Awarding of Grant for Phase 3 Clinical Trial and Biomarker Research Collaboration,,10/31/2016 AMRS-US   GNW  BIOSSANCEâ„¢ to Launch in Sephora Stores,, 5/15/2012 00448Q20 GNW  ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C,, 5/26/2015 03152W10 GNW  Amicus Therapeutics' Fabry Monotherapy Granted Accelerated Assessment by European Regulators,,,," 4/29/2014 36197T10 GNW  GW Pharmaceuticals to Report Q2 2014 and Half Year Financial Results and Host Conference Call on 7 May, 2014",,,,,11/21/2015 36315X10 GNW  Invitation to the Special Shareholders' Meeting of Galapagos on 22 December 2015, 6/09/2015 73701010 GNW  Portola Pharmaceuticals Announces Upcoming Data Presentations on Andexanet Alfa at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress,,,,, 4/29/2015 009T7W-E GNW  Flexion Therapeutics Awarded Approximately $2 Million From U.S. Department of Defense to Conduct Clinical Trial of FX006 in Military Personnel With Osteoarthritis of the Knee, 6/12/2014 N9006410 GNW  uniQure Announces Will Lewis as New Board Member,"10/06/2014 00847X10  GNW  Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014",,,, 2/27/2014 31189P10 GNW  Fate Therapeutics to Present at Upcoming March Conferences,,, 5/01/2014 45845P10 GNW  Intercept to Host First Quarter 2014 Update on May 7 and Present at Upcoming Investor Conferences, 8/30/2017 KPTI-US    GNW  Karyopharm Announces the Presentation of Selinexor and KPT-9274 Clinical Data at the European Society of Medical Oncology 2017 Annual Meeting,,, 1/12/2015 46116X10 GNW  Intra-Cellular Therapies to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,12/15/2014 19249H10 GNW  Coherus BioSciences Reports Third Quarter 2014 Financial and Operating Results,,,,,,,,,,,,,11/11/2016 BGNE-US  GNW  BeiGene Presents Updated Clinical Data on PD-1 Antibody BGB-A317 in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 31st Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/02/2014 74318710 GNW  Progenics Pharmaceuticals CEO Mark Baker to Present at Jefferies Global Healthcare Conference,,,,,,,,,,, 4/25/2013 BMRN-US     GNW  BioMarin Announces First Quarter 2013 Financial Results,,,,10/27/2016 IMMU-US  GNW  Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2017 Results,,, 1/05/2015 09058V10 GNW  BioCryst Pharmaceuticals Announces the Appointment of Lynne Powell as Chief Commercial Officer,,,,,,," 5/04/2018 62855J10 GNW  MYGN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Myriad Genetics, Inc. and a Lead Plaintiff Deadline of June 19, 2018",,,,, 4/21/2015 45773H20  GNW  Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy to Treat Chronic Hepatitis B Infection,,,,, 2/27/2014 02311120 GNW  Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations,,,,,," 5/13/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the UBS Global Healthcare Conference",,,,," 5/10/2017 SAN-FR   GNW  Sanofi: Annual General Shareholders' Meeting of May 10, 2017",,,,,,,,,, 5/04/2015 98978L20 GNW  Zogenix to Release First Quarter 2015 Financial Results and Host Conference Call & Webcast on May 11,,,,,,, 8/04/2015 90400D10  GNW  Ultragenyx to Present at Upcoming Investor Conferences,," 7/21/2014 63009R10 GNW  NanoString Technologies to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 5, 2014",,,11/17/2014 75046920 GNW  Radius Health to Present at the Jefferies 2014 Global London Healthcare Conference,,,,,,,,,,,,,11/11/2014 55609910 GNW  MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results,,,, 8/06/2013 60877T10 GNW  Momenta Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference,"12/21/2012 0CXBJZ-E GNW  Prothena Begins Trading on NASDAQ Global Market Under Symbol ""PRTA""",,,,11/06/2014 GMAB-DK  GNW  Genmab Announces Additional Data from Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL,,,,,,,, 5/27/2014 56400P70  GNW  MannKind to Present at Upcoming Conferences,, 6/19/2015 CYTK-US  GNW  Cytokinetics Presents Results From Phase I Studies of CK-2127107,,10/28/2016 AMRS-US   GNW  Amyris Enters Collaboration with Top 10 Pharmaceutical Company for Biosynthetic Drug Discovery,, 5/09/2012 00448Q20 GNW  Achillion Reports First Quarter 2012 Financial Results,, 5/05/2015 03152W10 GNW  Amicus Therapeutics Announces First Quarter 2015 Financial Results and Corporate Updates,,,, 4/28/2014 36197T10 GNW  GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain,,,,,"11/20/2015 36315X10 GNW  Galapagos initiates Phase 1 First-in-Human study with GLPG1972, receives EU3.5 million milestone from Servier", 6/03/2015 006RGD-E GNW  Portola Pharmaceuticals to Present at Goldman Sachs 36th Annual Global Healthcare Conference,,,,, 4/08/2015 33938J10 GNW  Flexion Therapeutics to Present at 14th Annual Needham Healthcare Conference, 6/06/2014 N9006410 GNW  uniQure Announces Results for the First Quarter 2014, 9/23/2014 00847X10  GNW  Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable,,,, 2/26/2014 31189P10 GNW  Fate Therapeutics Announces Observed Effects of Pharmacologic Modulation on T Cell Compartment From Its Phase 1b Study of PROHEMA(R),,," 4/30/2014 45845P10 GNW  Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer", 8/30/2017 KPTI-US    GNW  Karyopharm Therapeutics to Participate in Upcoming Investor Conferences,,,11/25/2014 46116X10 GNW  Intra-Cellular Therapies Announces Enrollment of First Patient in Phase 3 Trial of ITI-007 for the Treatment of Schizophrenia,,,,,,,,,,,,,12/08/2014 19249H10 GNW  Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12,,,,,,,,,,,,,11/10/2016 BGNE-US  GNW  BeiGene Reports Third Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/30/2014 74318710 GNW  Progenics Pharmaceuticals' PSMA ADC Data Selected for Poster Highlight Presentation at ASCO 2014,,,,,,,,,,, 4/24/2013 09061G10    GNW  BioMarin Submits Vimizim MAA to EMA for the Treatment of MPS IVA,,,,10/24/2016 45290710 GNW  Immunomedics Engages Greenhill & Co. as Strategic Advisor,,,12/23/2014 09058V10 GNW  BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema,,,,,,," 5/04/2018 62855J10 GNW  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline â€“ June 19, 2018",,,,, 4/09/2015 45773H20  GNW  Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients,,,,," 2/24/2014 02311120 GNW  Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014",,,,,, 5/05/2015 00163U10 GNW  AMAG Pharmaceuticals Reports Record First Quarter 2015 Financial Results and Increases Financial Guidance,,,,, 4/28/2017 SAN-FR   GNW  Zealand reports Q1 2017 royalty revenue,,,,,,,,,, 4/27/2015 98978L20 GNW  Dr. Stephen Farr Appointed as CEO of Zogenix to Lead New Strategic Focus and Advance Late-Stage CNS Product Pipeline,,,,,,, 7/21/2015 90400D10  GNW  Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares,, 6/11/2014 63009R10 GNW  NanoString Technologies to Participate in the JMP Securities Healthcare Conference 2014,,,11/10/2014 75046920 GNW  Radius Health Reports Third Quarter 2014 Financial and Operating Results,,,,,,,,,,,,, 8/06/2014 55609910 GNW  MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference,,,, 8/01/2013 60877T10 GNW  Momenta Pharmaceuticals Reports Second Quarter 2013 Financial Results,,,,,11/05/2014 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2014,,,,,,,, 5/12/2014 56400P70  GNW  MannKind Corporation Reports 2014 First Quarter Financial Results,, 6/16/2015 CYTK-US  GNW  Cytokinetics to Present at the 9th Annual JMP Securities Life Sciences Conference 2015,,10/26/2016 AMRS-US   GNW  Amyris Executes Definitive Collaboration Agreements with Leading Global Nutraceuticals Partner,," 5/09/2012 00448Q20 GNW  Achillion Advances Second Generation Pan-Genotypic NS5A Inhibitor, ACH-3102, Into Clinical Development",," 5/01/2015 03152W10 GNW  Amicus Therapeutics to Announce First Quarter 2015 Financial Results on May 5, 2015",,,, 3/17/2014 36197T10 GNW  GW Pharmaceuticals Provides Update on Cannabinoid Pipeline,,,,,11/12/2015 36315X10 GNW  Galapagos reports third quarter 2015 cash position of EU374 M, 5/29/2015 73701010 GNW  Portola Pharmaceuticals Presents Updated Data From Ongoing Phase 1/2a Study of Dual Kinase Inhibitor Cerdulatinib,,,,, 3/23/2015 33938J10 GNW  Flexion Reports Year-End 2014 Financial Results, 6/03/2014 N9006410 GNW  uniQure Announces Analysis of Six-Year Follow-up Data for Glybera(R), 8/13/2014 00BBFF-E  GNW  Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation,,,,11/13/2013 31189P10 GNW  Fate Therapeutics Reports Third Quarter 2013 Financial Results,,, 4/12/2014 008BK4-E GNW  Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session, 8/08/2017 KPTI-US    GNW  Karyopharm Reports Second Quarter 2017 Financial Results and Highlights Recent Progress,,,11/21/2014 46116X10 GNW  Intra-Cellular Therapies Announces Additional Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia,,,,,,,,,,,,,12/04/2014 19249H10 GNW  Coherus BioSciences to Host Earnings Conference Call on December 15,,,,,,,,,,,,,11/03/2016 BGNE-US  GNW  BeiGene Announces Oral Presentations on BTK Inhibitor BGB-3111 at the 2016 American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/09/2014 74318710 GNW  Progenics Pharmaceuticals Announces First Quarter 2014 Financial Results,,,,,,,,,,, 4/18/2013 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,10/19/2016 IMMU-US  GNW  Immunomedics Announces New Patents for Antibody-Drug Conjugates and Vaccines for Cancer Therapy,,,12/23/2014 09058V10 GNW  BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection,,,,,,, 5/04/2018 MYGN-US  GNW  Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer,,,,, 4/08/2015 INO-US    GNW  Inovio Pharmaceuticals Selected by DARPA to Lead a $45 Million Program to Expedite Development of Novel Products to Prevent and Treat Disease Caused by Ebola,,,,, 2/06/2014 02311120 GNW  Amarin to Present at the 2014 Leerink Global Healthcare Conference,,,,,," 4/29/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences",,,,, 4/28/2017 SAN-FR   GNW  Sanofi Delivers Robust Q1 2017 Financial Results,,,,,,,,,, 4/24/2015 98978L20 GNW  Zogenix Closes Sale of Zohydro(R) ER Business to Pernix,,,,,,," 7/20/2015 90400D10  GNW  Ultragenyx Appoints John Pinion as Chief Quality Operations Officer and Senior Vice President, Analytical Sciences and Research",, 5/19/2014 63009R10 GNW  NanoString Technologies to Participate in the Jefferies 2014 Global Healthcare Conference,,,11/03/2014 75046920 GNW  Radius Health Appoints Industry Veteran Dr. Willard Dere to Board of Directors,,,,,,,,,,,,, 8/05/2014 55609910 GNW  MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results,,,, 7/26/2013 MNTA-US  GNW  Momenta Pharmaceuticals Announces Potential for 2014 Market Entry of Generic Copaxone(R),,,,,11/03/2014 37230320 GNW  Genmab Announces Conditional Transfer of Ofatumumab Agreement,,,,,,,, 5/07/2014 56400P70  GNW  MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference,, 6/11/2015 CYTK-US  GNW  Cytokinetics Announces Poster Presentation on CK-2127107 at the 19th International SMA Researcher Meeting,,"10/25/2016 AMRS-US   GNW  Amyris to Announce Third Quarter Financial Results on Wednesday, November 2, 2016",, 4/23/2012 00448Q20 GNW  Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C,," 4/27/2015 FOLD-US  GNW  Amicus Therapeutics Appoints David Allsop as Senior Vice President, International",,,, 2/28/2014 36197T10 GNW  GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome,,,,,11/08/2015 GLPG-BE  GNW  Galapagos builds on strong profile of filgotinib in 7 presentations at ACR 2015, 5/18/2015 006RGD-E GNW  Portola Pharmaceuticals Announces Upcoming Data Presentation on Dual Kinase Inhibitor Cerdulatinib at American Society of Clinical Oncology (ASCO) Annual Meeting,,,,," 3/16/2015 33938J10 GNW  Flexion Therapeutics to Report Year-End 2014 Earnings Results on March 23, 2015", 5/29/2014 N9006410 GNW  uniQure and Medison Sign Glybera(R) Distribution Agreement for Israel, 8/07/2014 00847X10  GNW  Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results,,,,"11/06/2013 31189P10 GNW  Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2013 Financial Results on November 13, 2013",,, 4/11/2014 45845P10 GNW  Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis," 8/01/2017 KPTI-US    GNW  Karyopharm to Report Second Quarter 2017 Financial Results on August 8, 2017",,,11/03/2014 46116X10 GNW  Intra-Cellular Therapies Reports Third Quarter 2014 Financial Results and Provides Corporate Update,,,,,,,,,,,,,11/12/2014 19249H10 GNW  Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,,,11/01/2016 CS-CH    GNW  BeiGene to Participate in 25th Annual Credit Suisse Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/01/2014 74318710 GNW  Progenics Pharmaceuticals Sets First Quarter 2014 Financial Results Call for May 9,,,,,,,,,,," 4/04/2013 09061G10    GNW  BioMarin to Host First Quarter 2013 Financial Results Conference Call and Webcast on Thursday, April 25 at 5:00 p.m. ET",,,,10/12/2016 IMMU-US  GNW  Immunomedics Announces Closing of $30 Million Financing,,,12/22/2014 09058V10 GNW  BioCryst's RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza,,,,,,," 5/03/2018 62855J10 GNW  Myriad Lawsuit: Bernstein Liebhard LLP Reminds Investors of Important Deadline in Class Action Against Myriad Genetics, Inc. - MYGN",,,,, 3/19/2015 45773H20  GNW  Inovio Pharmaceuticals to Present at Alliance Regenerative Medicine's 2015 Regen Med Investor Day,,,,," 2/04/2014 AMRN-IE  GNW  Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales",,,,,," 4/22/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on May 5, 2015 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2015",,,,, 4/28/2017 SAN-FR   GNW  Sanofi and Regeneron Announce KevzaraÂ® (sarilumab) Biologics License Application Resubmission  Accepted for Review by US FDA,,,,,,,,,, 3/26/2015 98978L20 GNW  Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study,,,,,,, 7/15/2015 90400D10  GNW  Ultragenyx Announces Pricing of Public Offering of Common Stock,, 5/07/2014 63009R10 GNW  NanoString Technologies Releases First Quarter 2014 Financial Results,,,10/28/2014 75046920 GNW  Radius Health to Present at the 2014 BIO-Europe International Partnering Conference,,,,,,,,,,,,, 7/29/2014 55609910 GNW  MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call,,,, 7/16/2013 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2013 Financial Results Conference Call and Webcast,,,,,10/23/2014 37230320 GNW  Genmab Reaches USD 10 Million Milestone in Daratumumab Collaboration with Janssen,,,,,,,," 5/05/2014 56400P70  GNW  MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014",, 6/04/2015 CYTK-US  GNW  Cytokinetics and The ALS Association Announce Partnership to Advance the Fight Against ALS,,10/13/2016 AMRS-US   GNW  Amyris Agrees to CollaborationÂ TermsÂ with Leading Global Food Ingredients and Nutraceuticals Partner,, 4/21/2012 00448Q20 GNW  Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C,, 3/19/2015 03152W10 GNW  Amicus Therapeutics Provides Positive Global Regulatory Updates From EMA and FDA Meetings for Fabry Monotherapy,,,, 2/26/2014 36197T10 GNW  GW Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference,,,,,11/04/2015 36315X10 GNW  Dr. Christine Mummery appointed to Galapagos' Board of Directors, 5/06/2015 73701010 GNW  Portola Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update,,,,, 3/06/2015 009T7W-E GNW  Flexion Therapeutics Announces Changes to Board of Directors, 5/27/2014 0CDXXJ-E GNW  uniQure Announces Successful Transfection of Liver Cells with AAV5 and Strong Safety Data from Acute Intermittent Porphyria Clinical Trial," 7/28/2014 00847X10  GNW  Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014",,,,10/04/2013 070JFC-E GNW  Fate Therapeutics Announces Closing of Initial Public Offering and Exercise of Option to Purchase Additional Shares,,, 4/04/2014 45845P10 GNW  Data From Intercept's Pivotal Phase 3 POISE Trial of Its FXR Agonist Obeticholic Acid to Treat Primary Biliary Cirrhosis and Other Key Obeticholic Acid Data to be Presented at EASL 2014, 6/23/2017 KPTI-US    GNW  Karyopharm Reports Updated Phase 2b SADAL Data for Selinexor in Diffuse Large B-Cell Lymphoma at the 2017 European Hematology Association Annual Meeting,,,11/03/2014 0DCCGR-E GNW  Intra-Cellular Therapies and Takeda Announce Mutual Termination of Collaboration to Develop Phosphodiesterase (PDE1) Inhibitors for CNS Disorders,,,,,,,,,,,,,11/06/2014 19249H10 GNW  Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock,,,,,,,,,,,,,10/07/2016 BGNE-US  GNW  BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenstromâ€™s Macroglobulinemia at 9th International Workshop on Waldenstromâ€™s Macroglobulinemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/24/2014 PGNX-US  GNW  Progenics Pharmaceuticals Announces the Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC,,,,,,,,,,, 4/02/2013 CPRX-US     GNW  Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2012 Financial Results,,,,10/05/2016 IMMU-US  GNW  Immunomedics Announces $30 Million Financing,,,12/18/2014 09058V10 GNW  BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema,,,,,,, 5/02/2018 MYGN-US  GNW  Myriad Genetics Named to Forbes 2018 List of Americaâ€™s Best Midsize Employers,,,,," 3/18/2015 45773H20  GNW  Inovio Pharmaceuticals Appoints Scott M. White, M.D. Vice President, Clinical Development -- Infectious Diseases",,,,, 1/21/2014 02311120 GNW  Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request,,,,,," 4/08/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the 14th Annual Needham Healthcare Conference",,,,, 4/24/2017 SAN-FR   GNW  Sanofi and Regeneron Receive CHMP Positive Opinion for KevzaraÂ® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis,,,,,,,,,, 3/10/2015 98978L20 GNW  Zogenix Reports Fourth Quarter and Full Year 2014 Financial Results,,,,,,, 7/14/2015 90400D10  GNW  Ultragenyx Announces Proposed Public Offering of Common Stock,, 5/01/2014 63009R10 GNW  NanoString Technologies to Participate in the 2014 Bank of America Merrill Lynch Health Care Conference,,,"10/23/2014 75046920 GNW  Radius Health Sponsors The Cancer Support Community ""Elevating the Patient Voice"" Symposium in Recognition of National Breast Cancer Awareness Month",,,,,,,,,,,,," 7/24/2014 55609910 GNW  MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients",,,, 6/25/2013 60877T10 GNW  Momenta Pharmaceuticals Announces Issuance of U.S. Patent for Sialylation Technology,,,,,10/22/2014 37230320 GNW  Third Quarter 2014 Net Sales Figures for Arzerra(r),,,,,,,, 4/07/2014 56400P70  GNW  MannKind Updates Status of New Drug Application for AFREZZA(R),, 5/13/2015 23282W60 GNW  Cytokinetics to Hold Annual Meeting of Stockholders,,10/04/2016 AMRS-US   GNW  Amyris and Autodesk Offer Powerful Open Source Tools for Genetic Design to Enable Rapid DNA Engineering,, 3/08/2012 00448Q20 GNW  Achillion Reports 2011 Fourth Quarter and Year-End Financial Results,, 3/03/2015 03152W10 GNW  Amicus Therapeutics Announces Full-Year 2014 Financial Results and Corporate Updates,,,, 2/10/2014 36197T10 GNW  GW Pharmaceuticals to Present at the Leerink Global Healthcare Conference,,,,,10/15/2015 36315X10 GNW  Galapagos advances triple combination therapy in cystic fibrosis," 5/05/2015 73701010 GNW  Portola Pharmaceuticals Announces Collaboration With Ora, Inc. for Syk-selective Inhibitor (PRT2761) in Ophthalmic Diseases",,,,, 2/24/2015 33938J10 GNW  Flexion Therapeutics Completes Enrollment in Pivotal Phase 2b Confirmatory Clinical Trial With Lead Compound FX006, 5/15/2014 N9006410 GNW  uniQure to Present at the BioEquity Europe and Jefferies Global Healthcare Conferences," 7/24/2013 00BBFF-E  GNW  NASDAQ Welcomes Agios Pharmaceuticals, Inc. to The NASDAQ Stock Market",,,,10/02/2013 31189P10 GNW  Fate Therapeutics to Present at World Muscle Society Congress,,, 4/03/2014 45845P10 GNW  Intercept Pharmaceuticals Announces Pricing of Public Offering, 6/07/2017 KPTI-US    GNW  Karyopharm Doses First Patient in Pivotal Phase 3 BOSTON Study Evaluating Selinexor in Patients with Relapsed/Refractory Multiple Myeloma,,,"10/27/2014 46116X10 GNW  Intra-Cellular Therapies to Host Conference Call on Monday, November 3, at 8:30 am Eastern Time, on Third Quarter 2014 Financial Results",,,,,,,,,,,,, 2/07/2011 19249H10 GNW  The NASDAQ Stock Market to Celebrate 40th Anniversary and Ring Opening Bell With Category-Defining NASDAQ Listed Companies,,,,,,,,,,,,,10/04/2016 BGNE-US  GNW  BeiGene to Host Conference Call on BGB-3111 Data Presentation at IWWM-9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 4/07/2014 74318710 GNW  Progenics Pharmaceuticals CEO, Mark R. Baker, to Present at 13th Annual Needham Healthcare Conference",,,,,,,,,,, 4/01/2013 09061G10    GNW  BioMarin Submits CTA for BMN-190 for Batten Disease,,,, 8/31/2016 CS-CH    GNW  Immunomedics to Present at Upcoming Investor Conferences,,,12/15/2014 09058V10 GNW  BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses,,,,,,," 4/30/2018 62855J10 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Myriad Genetics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2018 â€“ MYGN",,,,, 3/16/2015 45773H20  GNW  Inovio Pharmaceuticals and Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy and Infectious Diseases,,,,, 1/15/2014 02311120 GNW  Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed,,,,,, 4/01/2015 00163U10 GNW  AMAG Pharmaceuticals Announces New Management Appointments,,,,," 3/03/2017 SAN-FR   GNW  Sanofi: Filing of the 2016 U.S. Form 20-F and French ""Document de RÃ©fÃ©rence"" containing the Annual Financial Report",,,,,,,,,, 3/10/2015 98978L20 GNW  Zogenix Announces Agreement of Sale of Zohydro(R) ER Business to Pernix for $100 Million at Closing Plus Potential Milestones of $283.5 Million,,,,,,, 7/09/2015 90400D10  GNW  Ultragenyx Releases Positive Interim 40-Week Bone Treatment Data From Ongoing Pediatric Phase 2 Study of KRN23 in X-Linked Hypophosphatemia,," 4/30/2014 63009R10 GNW  NanoString Technologies Appoints Veteran Diagnostics Executive Tina S. Nova, Ph.D. to Its Board of Directors",,,"10/21/2014 75046920 GNW  Radius Health to Announce Third Quarter 2014 Financial Results, Host Conference Call and Live Webcast on Nov 11, 2014",,,,,,,,,,,,, 6/19/2014 55609910 GNW  MacroGenics Initiates Phase 1 Study of MGD006 for the Treatment of Acute Myeloid Leukemia,,,, 5/23/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,,,,, 9/10/2014 37230320 GNW  Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration,,,,,,,," 4/01/2014 56400P70  GNW  FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes",," 4/30/2015 23282W60 GNW  Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results",, 9/30/2016 AMRS-US   GNW  Amyris Expands in Global Nutraceuticals Market with  New Collaboration and Partner Funding of $30 Million,, 3/02/2012 00448Q20 GNW  Achillion Fourth Quarter and Full Year 2011 Financial Release and Conference Call Alert,, 2/26/2015 03152W10 GNW  Amicus Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference,,,, 2/05/2014 36197T10 GNW  GW Pharmaceuticals plc Reports First Quarter 2014 Financial Results and Operational Progress,,,,,10/09/2015 36315X10 GNW  Positive safety and tolerability for novel potentiator GLPG1837, 5/05/2015 006RGD-E GNW  Portola Pharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference,,,,, 2/17/2015 33938J10 GNW  Flexion Therapeutics to Present at RBC Capital Markets Healthcare Conference, 4/09/2014 N9006410 GNW  uniQure Announces Changes in Management Team,,,,,"10/01/2013 070JFC-E GNW  Fate Therapeutics, Inc. Announces Pricing of Initial Public Offering",,, 4/01/2014 45845P10 GNW  Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock, 5/31/2017 KPTI-US    GNW  Karyopharm Therapeutics to Participate in Upcoming Investor Conferences,,,10/13/2014 46116X10 GNW  Intra-Cellular Therapies Announces Topline Safety Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia,,,,,,,,,,,,,,,,,,,,,,,,,,"10/03/2016 BGNE-US  GNW  BeiGene Appoints Ross Pettit as Senior Vice President, Global Development Operations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/01/2014 PGNX-US  GNW  Progenics Pharmaceuticals and Centre for Probe Development and Commercialization Announce Agreement to Manufacture Targeted Radiotherapeutic Candidate for Ultra-Orphan Indications,,,,,,,,,,, 4/01/2013 09061G10    GNW  BioMarin Submits Vimizim BLA to the U.S. FDA for the Treatment of MPS IVA,,,, 8/18/2016 IMMU-US  GNW  Preclinical Study on Enhancing Sacituzumab Govitecan (IMMU-132) Activity in SN-38-Resistant Cancer Cells Published,,,11/20/2014 09058V10 GNW  BioCryst to Present at Two Upcoming Investor Conferences,,,,,,, 4/27/2018 MYGN-US  GNW  Myriad Genetics to Present at Two Upcoming Healthcare Conferences,,,,, 3/16/2015 45773H20  GNW  Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial Results,,,,,12/20/2013 02311120 GNW  Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed,,,,,, 3/03/2015 AMAG-US  GNW  AMAG Pharmaceuticals Announces Closing of $201 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option,,,,, 3/03/2017 SAN-FR   GNW  Sanofi Pasteur and MedImmune Collaborate on Monoclonal Antibody to Prevent Illnesses Associated with RSV,,,,,,,,,, 3/02/2015 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2014 Financial Results,,,,,,, 6/25/2015 90400D10  GNW  Ultragenyx Names Daniel G. Welch as Chairman of the Board,," 4/16/2014 63009R10 GNW  NanoString Technologies to Release First Quarter 2014 Financial Results and Host Conference Call on Wednesday, May 7, 2014",,,"10/07/2014 75046920 GNW  Radius Health, Inc. Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Shares",,,,,,,,,,,,, 5/27/2014 55609910 GNW  MacroGenics and Takeda Enter Strategic Alliance to Develop DART for Treatment of Autoimmune Disorders,,,, 5/09/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,,,,, 8/25/2014 37230320 GNW  Major Shareholder Announcement,,,,,,,, 2/19/2014 56400P70  GNW  MannKind Corporation to Present at Upcoming Conferences,,11/14/2011 EPRSQ-US GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,," 9/16/2016 074KMF-E  GNW  Amyris to Present at Singular Research 11th Annual ""Best of The Uncovereds"" Conference September 22, 2016",, 3/01/2012 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,," 2/25/2015 03152W10 GNW  Amicus Therapeutics to Announce Full-Year 2014 Financial Results on March 3, 2015",,,," 1/29/2014 36197T10 GNW  GW Pharmaceuticals to Report Q1 2014 Financial Results and Host Conference Call on 5 February, 2014",,,,,10/08/2015 36315X10 GNW  Galapagos to present promising findings in cystic fibrosis programs at NACFC 2015," 4/29/2015 73701010 GNW  Portola Pharmaceuticals to Announce First Quarter 2015 Financial Results and Host Conference Call on Wednesday, May 6",,,,, 2/02/2015 33938J10 GNW  Flexion Therapeutics Initiates Phase 3 Clinical Trial of FX006 in Patients With Osteoarthritis of the Knee, 3/26/2014 N9006410 GNW  uniQure Announces Results for Financial Year 2013,,,,, 8/14/2013 070JFC-E GNW  Fate Therapeutics Files Registration Statement for Proposed Initial Public Offering,,, 3/16/2014 45845P10 GNW  Intercept Announces Positive Pivotal Phase 3 POISE Trial Results, 5/18/2017 KPTI-US    GNW  Karyopharmâ€™s Phase 2b SADAL Data Evaluating Selinexor in Diffuse Large B-Cell Lymphoma Selected for Oral Presentation at the 2017 European Hematology Association Annual Meeting,,,10/06/2014 46116X10 GNW  Intra-Cellular Therapies to Present Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia at the American Neurological Association 139th Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,, 9/11/2016 BGNE-US  GNW  BeiGene Receives Approval to Initiate Clinical Trials in China with PD-1 Antibody BGB-A317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/13/2014 74318710 GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2013 Financial Results and Initiates Clinical Development of Small Molecule Targeted Therapeutic,,,,,,,,,,, 3/25/2013 09061G10    GNW  BioMarin Completes Additional Partial Exchange of Convertible Notes Due 2017 for Common Stock,,,, 8/17/2016 IMMU-US  GNW  Immunomedics Announces Fiscal 2016 Results and Clinical Program Developments,,,11/06/2014 09058V10 GNW  BioCryst Reports Third Quarter 2014 Financial Results,,,,,,, 4/27/2018 MYGN-US  GNW  New Study Finds that 24 Percent of Women Seen in the Obstetrics-Gynecology Setting Met NCCN Guidelines for Hereditary Cancer Genetic Testing,,,,," 3/06/2015 45773H20  GNW  Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2014 Financial Results on March 16, 2015",,,,,12/16/2013 02311120 GNW  Amarin Announces Leadership Changes,,,,,," 2/27/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 35th Annual Healthcare Conference",,,,," 3/02/2017 SAN-FR   GNW  Sanofi  : Sanofi's Board of Directors Proposes Appointment  of Melanie Lee, PhD and Bernard CharlÃ¨s  as New Independent Directors",,,,,,,,,, 2/10/2015 98978L20 GNW  Zogenix Appoints Industry Veteran Renee Tannenbaum to Its Board of Directors,,,,,,," 6/22/2015 90400D10  GNW  Ultragenyx Appoints Jayson Dallas, M.D., as Chief Commercial Officer and Senior Vice President",, 4/03/2014 065C1X-E GNW  NanoString Technologies Announces $45 Million Term Loan Agreement With Capital Royalty,,,"10/02/2014 RDUS-US  GNW  Radius Health, Inc. Announces Pricing of Public Offering",,,,,,,,,,,,, 5/07/2014 55609910 GNW  MacroGenics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference,,,, 4/30/2013 60877T10 GNW  Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results,,,,, 8/13/2014 GMAB-DK  GNW  Genmab Announces Financial Results for the First Half of 2014 and Improves 2014 Financial Guidance,,,,,,,, 2/18/2014 56400P70  GNW  MannKind Corporation Reports 2013 Fourth Quarter and Full Year Financial Results,," 5/12/2010 23282W60 GNW  Liberty Analytics Co. Initiates Independent Research Coverage on Cytokinetics, Inc.",, 9/15/2016 AMRS-US   GNW  Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products,, 2/16/2012 00448Q20 GNW  Virology Profile Following Treatment With ACH-1625 Discussed in Oral Presentation at 2012 Asian Pacific Liver Conference,, 2/10/2015 03152W10 GNW  Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015,,,, 1/14/2014 GWP-GB   GNW  GW Pharmaceuticals plc Announces the Closing of Its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Additional ADSs,,,,,10/02/2015 36315X10 GNW  Galapagos raises EU1.2 million through warrant exercises, 4/08/2015 73701010 GNW  Portola Pharmaceuticals Announces New Topline Data From Phase 3 ANNEXA-A(TM) Trial Part 2: Breakthrough Designated Andexanet Alfa Successfully Meets Primary Endpoint for Prolonged Reversal of Factor Xa Inhibitor Eliquis (apixaban),,,,,12/17/2014 33938J10 GNW  Flexion Therapeutics Announces Exercise of Underwriters' Over-Allotment Option and Closing of Public Offering of Common Stock, 3/21/2014 N9006410 GNW  uniQure to Present at Future Leaders in Biotech Conference,,,,, 4/22/2013 064BG1-E GNW  Fate Therapeutics Presents Preclinical Efficacy Data for WNT7A-Analog Program at Muscular Dystrophy Association 2013 Scientific Conference,,, 3/14/2014 45845P10 GNW  Intercept Pharmaceuticals Announces 2013 Financial Results, 5/04/2017 KPTI-US    GNW  Karyopharm Reports First Quarter 2017 Financial Results and Highlights Recent Progress,,," 8/12/2014 46116X10 GNW  Intra-Cellular Therapies Reports Financial Results for Second Quarter Ended June 30, 2014",,,,,,,,,,,,,,,,,,,,,,,,,," 9/06/2016 BGNE-US  GNW  BeiGene Appoints Jane Huang, M.D. as Chief Medical Officer, Hematology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/10/2014 74318710 GNW  Progenics Pharmaceuticals Sets 4Q and Year-End 2013 Financial Results Call for March 13,,,,,,,,,,, 3/19/2013 09061G10    GNW  BioMarin to Advance BMN-701 for Pompe Disease to Next Phase of Development,,,, 8/11/2016 IMMU-US  GNW  Immunomedics Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2016 Financial Results,,,10/30/2014 09058V10 GNW  BioCryst to Announce Third Quarter 2014 Financial Results November 6,,,,,,," 4/25/2018 62855J10 GNW  MYRIAD GENETICS, INC. INVESTOR ALERT:  Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Utah on behalf of shareholders of Myriad Genetics, Inc.",,,,, 3/05/2015 45773H20  GNW  Inovio Pharmaceuticals Welcomes Nancy Wysenski to Its Board of Directors,,,,,"12/02/2013 02311120 GNW  Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations",,,,,, 2/25/2015 00163U10 GNW  AMAG Pharmaceuticals Prices Public Offering of $175 Million of Common Stock,,,,, 2/08/2017 SAN-FR   GNW  Sanofi Delivers 2016 Sales and Business EPS(1) Growth at CER(2),,,,,,,,,, 2/05/2015 98978L20 GNW  Zogenix to Participate in Leerink Global Healthcare Conference,,,,,,, 6/17/2015 00D326-E  GNW  Ultragenyx to Present at the JMP Securities Healthcare Conference,, 2/26/2014 63009R10 GNW  NanoString Technologies Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook,,,"10/01/2014 RDUS-US  GNW  Radius Health, Inc. Announces Proposed Public Offering",,,,,,,,,,,,, 5/06/2014 55609910 GNW  MacroGenics Provides Update on Corporate Progress and First Quarter 2014 Financial Results,,,, 4/09/2013 60877T10 GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2013 Financial Results Conference Call and Webcast,,,,, 8/11/2014 37230320 GNW  Genmab Announces New Phase III Study of Daratumumab in Front Line Multiple Myeloma,,,,,,,," 2/04/2014 56400P70  GNW  MannKind Corporation to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on February 18, 2014",,,, 9/09/2016 AMRS-US   GNW  Amyris in Partnership with BoticÃ¡rio Group Named Gold Winner by Cosmetics Design for Breakthrough Ingredient â”€  NeossanceÂ® Hemisqualane,, 2/08/2012 00448Q20 GNW  Achillion to Present at Three Upcoming Investor Conferences,, 2/10/2015 03152W10 GNW  Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015,,,, 1/14/2014 36197T10 GNW  Ipsen and GW Pharmaceuticals plc Enter Into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America,,,,, 9/25/2015 36315X10 GNW  Galapagos to advance filgotinib to Phase 3 in rheumatoid arthritis, 3/10/2015 73701010 GNW  Portola Announces Pricing of Public Offering of Common Stock,,,,,12/12/2014 33938J10 GNW  Flexion Therapeutics Announces Pricing of Public Offering of Common Stock, 3/17/2014 0CDXXJ-E GNW  uniQure and Chiesi Announce Six Year Follow-up Data from Glybera(r) Treated Patients,,,,, 2/25/2013 0024VM-E GNW  Fate Therapeutics to Present at Cowen & Co. 33rd Annual Health Care Conference,,, 3/10/2014 45845P10 GNW  Intercept Pharmaceuticals to Host 2013 Full Year Financial Results and Business Update Conference Call on March 17, 5/03/2017 KPTI-US    GNW  Karyopharm and Anivive Lifesciences Sign Exclusive Global License Agreement for Verdinexor for Animal Health Applications,,," 8/05/2014 46116X10 GNW  Intra-Cellular Therapies to Host Conference Call on Tuesday, August 12, at 8:30 am Eastern Time, on Second Quarter 2014 Financial Results",,,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2016 BGNE-US  GNW  BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/04/2014 74318710 GNW  Progenics Pharmaceuticals Sets 1Q 2014 Financial Results Call for March 13,,,,,,,,,,, 3/19/2013 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 8/05/2016 45290710 GNW  IMMUNOMEDICS 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU",,,10/08/2014 09058V10 GNW  RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014,,,,,,," 4/24/2018 62855J10 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc.",,,,, 2/02/2015 45773H20  GNW  Inovio Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,11/07/2013 02311120 GNW  Amarin Reports Third Quarter 2013 Financial Results and Provides Update on Operations,,,,,, 2/24/2015 00163U10 GNW  AMAG Pharmaceuticals Announces Proposed Public Offering of $125 Million of Common Stock,,,,, 1/09/2017 SNY-FR   GNW  MannKind Receives $30.6 Million From Sanofi,,,,,,,,,, 1/30/2015 98978L20 GNW  Zogenix Receives FDA Approval of New Formulation of Zohydro(R) ER,,,,,,, 6/08/2015 90400D10  GNW  Ultragenyx Announces Completion of Enrollment in Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7,, 2/19/2014 63009R10 GNW  NanoString Technologies to Participate in the Cowen 34th Annual Health Care Conference,,, 9/25/2014 75046920 GNW  Radius Health to Present at BioCentury NewsMakers in the Biotech Industry Conference,,,,,,,,,,,,, 5/05/2014 55609910 GNW  MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014,,,, 2/25/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,,,,, 7/31/2014 GMAB-DK  GNW  GSK and Genmab Announce Positive Interim Result for Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL,,,,,,,, 1/10/2014 56400P70  GNW  MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA,,,," 9/07/2016 RRSHQ-US  GNW  Amyris to Present at Rodman & Renshaw 18th Annual Global Investment Conference on September 12, 2016",, 2/03/2012 00448Q20 GNW  Achillion Announces Executive Promotion,, 2/04/2015 03152W10 GNW  Amicus Therapeutics to Present at Leerink Global Healthcare Conference,,,," 5/03/2013 36197T10 GNW  Video Interview: Justin Gover, CEO, GW Pharmaceuticals [GWPH]",,,,, 9/22/2015 GLPG-BE  GNW  Galapagos presents promising pre-clinical and Phase 1 results with autotaxin inhibitor GLPG1690 at ERS, 3/09/2015 006RGD-E GNW  Portola Pharmaceuticals Announces Proposed Offering of Common Stock,,,,,12/08/2014 33938J10 GNW  Flexion Therapeutics Announces Public Offering of Common Stock, 2/10/2014 0CDXXJ-E GNW  uniQure Announces Closing of Initial Public Offering,,,,, 2/07/2013 070JFC-E GNW  Fate Therapeutics to Present at 15th Annual BIO CEO & Investor Conference,,, 2/18/2014 45845P10 GNW  Intercept to Present at Upcoming Healthcare Conferences," 4/27/2017 KPTI-US    GNW  Karyopharm to Report First Quarter 2017 Financial Results on May 4, 2017",,, 7/31/2014 46116X10 GNW  Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel,,,,,,,,,,,,,,,,,,,,,,,,,," 8/24/2016 BGNE-US  GNW  BeiGene Appoints Amy Peterson, M.D. as Chief Medical Officer, Immuno-oncology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/21/2014 PGNX-US  GNW  Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,,,,,, 3/18/2013 09061G10    GNW  BioMarin Completes Partial Exchange of Convertible Notes Due 2017 for Common Stock,,,," 8/03/2016 45290710 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 â€“ IMMU",,,10/07/2014 09058V10 GNW  BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress,,,,,,," 4/23/2018 62855J10 GNW  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Myriad Genetics, Inc. (NASDAQ: MYGN) To Contact Brower Piven Before The Lead Plaintiff Deadline",,,,,"11/24/2014 45773H20  GNW  Inovio Pharmaceuticals, Inc. (Nasdaq: INO) to Ring The Nasdaq Stock Market Opening Bell",,,,,"11/06/2013 02311120 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Amarin Corp. plc and Its Board of Directors and a Lead Plaintiff Deadline of January 3, 2014",,,,,," 2/19/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the 2015 RBC Capital Markets' Healthcare Conference",,,,,12/02/2016 06CR5C-E GNW  MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491,,,,,,,,,, 1/12/2015 98978L20 GNW  Zogenix Provides Business Update,,,,,,, 6/04/2015 90400D10  GNW  Ultragenyx Appoints Dennis Huang as Chief Technical Operations Officer and Senior Vice President,," 2/05/2014 63009R10 GNW  NanoString Technologies to Release Fourth Quarter 2013 Financial Results and Host Conference Call on Wednesday, February 26, 2014",,, 9/11/2014 75046920 GNW  Radius Health to Present at the BioCentury NewsMakers in the Biotech Industry Conference,,,,,,,,,,,,, 4/30/2014 05LJZC-E GNW  MacroGenics Appoints Atul Saran as Senior Vice President and General Counsel,,,, 2/15/2013 60877T10 GNW  Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial Results,,,,, 7/23/2014 37230320 GNW  Second Quarter 2014 Net Sales Figures for Arzerra(r),,,,,,,, 1/08/2014 56400P70  GNW  MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference,,,," 8/24/2016 AMRS-US   GNW  Biossanceâ„¢ Launches The Detoxifier â”€ A Breakthrough, Innovative Modeling Mask",, 1/13/2012 00448Q20 GNW  Achillion to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference,, 1/26/2015 03152W10 GNW  Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium,,,, 5/01/2013 GWP-GB   GNW  NASDAQ Welcomes GW Pharmaceuticals to The NASDAQ Stock Market,,,,, 8/10/2015 GLPG-BE  GNW  DARWIN 2 24-week monotherapy data in RA confirm previous results and support best-in-class potential for filgotinib, 3/02/2015 73701010 GNW  Portola Announces Full Results From Positive Phase 3 ANNEXA(TM)-R Study Demonstrating That Andexanet Alfa Rapidly and Significantly Reversed Anticoagulant Effect of Factor Xa Inhibitor XARELTO(R),,,,,12/01/2014 33938J10 GNW  Flexion Therapeutics Announces That FDA Has Removed Clinical Hold on FX006, 2/05/2014 0CDXXJ-E GNW  uniQure Announces Pricing of Initial Public Offering,,,,,,,, 2/18/2014 008BK4-E GNW  Intercept Expands Its Board of Directors With Appointments of Sanj K. Patel and Glenn Sblendorio, 4/25/2017 KPTI-US    GNW  Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock,,, 6/27/2014 46116X10 GNW  Intra-Cellular Therapies to be Added to the Russell 3000(R) and Russell 2000(R) Indexes,,,,,,,,,,,,,,,,,,,,,,,,,, 8/18/2016 BGNE-US  GNW  BeiGene Receives Approval to Initiate Clinical Trials in China with PARP Inhibitor BGB-290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/20/2014 PGNX-US  GNW  Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,,,,,," 2/28/2013 09061G10    GNW  BioMarin to Attend Upcoming Conferences: Cowen Healthcare Conference, Credit Suisse Global Healthcare Conference and Barclays Global Healthcare Conference",,,," 7/28/2016 45290710 GNW  Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU",,, 9/18/2014 BCRX-US  GNW  BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases,,,,,,," 4/23/2018 62855J10 GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (MYGN)",,,,, 4/23/2013 45773H20  GNW  RedChip Emerging Growth Showcase Takes Place May 1,,,,,11/05/2013 02311120 GNW  Gainey McKenna & Egleston Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Amarin Corp. plc -- AMRN,,,,,, 2/09/2015 AMAG-US  GNW  AMAG Announces Final Fourth Quarter and Year End 2014 Financial Results,,,,,11/10/2016 SELB-US  GNW  Selecta Biosciences Receives Exclusive Rights to Peanut Allergy and Celiac Disease Programs,,,,,,,,,,12/03/2014 98978L20 GNW  Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference,,,,,,, 6/02/2015 90400D10  GNW  Ultragenyx Releases Positive 16-Week Interim Data From Pediatric Phase 2 Study of KRN23 in X-Linked Hypophosphatemia,, 1/29/2014 63009R10 GNW  NanoString Technologies to Participate in the Leerink Swann Global Healthcare Conference 2014,,, 9/08/2014 75046920 GNW  Radius Health to Host Scientific Panel Discussion for Investors on Investigational Drug Abaloparatide at ASBMR 2014,,,,,,,,,,,,, 4/29/2014 55609910 GNW  MacroGenics Announces Date of First Quarter 2014 Financial Results Conference Call,,,, 2/07/2013 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,,,,, 7/18/2014 0CPNB1-E GNW  Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma,,,,,,,,11/28/2012 UNISQ-US  GNW  Divine Skin Appoints Two New Independent Directors,,,," 8/17/2016 AMRS-US   GNW  Biossanceâ„¢ Launches  The Illuminator â”€ A Clinically Proven, Weightless Eye Gel",, 1/09/2012 00448Q20 GNW  Achillion Reports Clinical Data on Portfolio of Protease Inhibitors,, 1/12/2015 03152W10 GNW  Amicus Therapeutics Provides Full-Year 2015 Strategic Outlook and Financial Guidance,,,, 8/30/2010 GWP-GB   GNW  Cannabis Science Raising Working Capital and Entering European Medical Cannabis Market With Expanded Opportunity Among Europe's 500 Million Citizens Following German Approval,,,,, 8/06/2015 36315X10 GNW  Patient recruitment completed in FITZROY Phase 2 Crohn's disease study with filgotinib, 3/02/2015 73701010 GNW  Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2014 Financial Results and Provides Corporate Update,,,,,11/17/2014 33938J10 GNW  Flexion Therapeutics to Present at Stifel Healthcare Conference 2014,11/11/2013 0CDXXJ-E GNW  uniQure Announces Confidential Submission of Draft Registration Statement for Initial Public Offering,,,,,,,, 2/05/2014 45845P10 GNW  Intercept to Present at Leerink Global Healthcare Conference, 4/24/2017 KPTI-US    GNW  Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock,,, 6/13/2014 46116X10 GNW  Intra-Cellular Therapies to Participate in a Fireside Chat at the 9th Annual JMP Securities Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,, 8/10/2016 BGNE-US  GNW  BeiGene Reports Second Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 2/06/2014 PGNX-US  GNW  Progenics Pharmaceuticals CEO, Mark R. Baker, to Present at 16th Annual BIO CEO & Investor Conference",,,,,,,,,,, 2/21/2013 09061G10    GNW  BioMarin Announces Fourth Quarter and Full Year 2012 Financial Results,,,," 7/24/2016 45290710 GNW  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of  Class Action Lawsuit and Upcoming Deadline â€“ IMMU",,, 9/06/2014 09058V10 GNW  BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting,,,,,,," 4/23/2018 62855J10 GNW  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Myriad Genetics, Inc. To Contact The Firm",,,,,12/13/2012 45773H20  GNW  RedChip Announces Availability of Presentation Archives From December Small-Cap Virtual Conference,,,,,"11/05/2013 02311120 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Amarin Corporation, plc and Certain Officers -- AMRN",,,,,," 2/05/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the Leerink Global Healthcare Conference",,,,,11/09/2016 SNY-FR   GNW  MannKind and Sanofi Reach Agreement on AFREZZAÂ®,,,,,,,,,,"12/01/2014 98978L20 GNW  Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the Safety, Tolerability and Effectiveness of Zohydro(R) ER",,,,,,, 5/28/2015 90400D10  GNW  Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of Aceneuramic Acid (Sialic Acid) Extended Release in GNE Myopathy,, 1/23/2014 63009R10 GNW  NanoString Technologies Prices Follow-On Offering,,, 8/28/2014 75046920 GNW  Radius Health Reports Proof of Mechanism for RAD1901 and Presentation at 4th Annual Brain Metastases Research and Emerging Therapy Conference in September,,,,,,,,,,,,, 4/28/2014 55609910 GNW  MacroGenics to Present Pre-Clinical Data on Novel DART Candidate MGD010 for Autoimmune Disorders at IMMUNOLOGY 2014,,,, 1/24/2013 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast,,,,, 7/14/2014 0CPNB1-E GNW  Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen,,,,,,,, 3/18/2011 56400P70  GNW  Pomerantz Law Firm Reminds Shareholders of MannKind Corp of Upcoming Deadline -- MNKD,,,," 8/08/2016 0653F3-E  GNW  Amyris Wins Three-Year, Multi-Million-Dollar Contract from U.S. Department of Energy to Further Manufacturing of  Cellulose-Derived Farnesene",, 1/04/2012 00448Q20 GNW  ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C,, 1/08/2015 03152W10 GNW  Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac Endpoints From Fabry Monotherapy Study 011 and Long Term Extension Study,,,, 7/06/2010 SCH-DE   GNW  Cannabis Science Hails Latest International Recognition of Medical Cannabis By Big Pharma,,,,, 8/05/2015 36315X10 GNW  Galapagos on track to deliver on pipeline in second half 2015," 2/26/2015 73701010 GNW  Portola Pharmaceuticals Receives FDA Orphan Drug Designation for Andexanet Alfa, Its Breakthrough-Designated Factor Xa Inhibitor Antidote",,,,,11/13/2014 33938J10 GNW  Flexion Therapeutics Reports Third-Quarter 2014 Financial Results,10/04/2013 CDI-FR   GNW  Christian Meyer Joins uniQure as Chief Medical Officer,,,,,,,, 1/12/2014 45845P10 GNW  Intercept Reports Additional Details About FLINT Trial Provided by NIDDK, 4/04/2017 KPTI-US    GNW  Karyopharm Reports Interim Phase 2b SADAL Data at the 2017 American Association for Cancer Research Annual Meeting,,, 6/12/2014 46116X10 GNW  Intra-Cellular Therapies to Present at Upcoming Scientific Conferences,,,,,,,,,,,,,,,,,,,,,,,,,, 7/05/2016 BGNE-US  GNW  BeiGene Announces First Patient Dosing forÂ Investigational BTK Inhibitor BGB-3111 in China,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/30/2014 74318710 GNW  Progenics 1404 Imaging Agent Shows High Accuracy in Detecting Cancer Within the Prostate Gland in Interim Analysis of Phase 2 Study,,,,,,,,,,, 2/21/2013 09061G10    GNW  BioMarin Licenses Factor VIII Gene Therapy Program for Hemophilia A From University College London and St. Jude Children's Research Hospital,,,," 7/18/2016 45290710 GNW  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU",,, 9/04/2014 09058V10 GNW  BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies,,,,,,," 4/23/2018 62855J10 GNW  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Â Myriad Genetics, Inc.",,,,,12/03/2012 45773H20  GNW  RedChip Small-Cap Virtual Conference to Include Presentations from Emerging Healthcare Companies,,,,,"11/05/2013 02311120 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $150,000 in Losses from Investment in Amarin Corporation plc to Contact Brower Piven Before the January 3, 2014 Lead Plaintiff Deadline -- AMRN",,,,,," 2/03/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on February 9, 2015 at 4:30 p.m. ET to Discuss Financial Results for the Quarter and Year Ended 2014",,,,,10/28/2016 SAN-FR   GNW  Sanofi Announces Strong Q3 2016 Results,,,,,,,,,,11/12/2014 98978L20 GNW  Zogenix to Participate in Stifel 2014 Healthcare Conference,,,,,,, 5/26/2015 90400D10  GNW  Ultragenyx to Present at the Jefferies 2015 Global Healthcare Conference,, 1/21/2014 63009R10 GNW  NanoString Technologies Launches Follow-On Offering,,, 8/19/2014 75046920 GNW  Radius Health Announces Presentations at the American Society for Bone and Mineral Research 2014 Annual Meeting,,,,,,,,,,,,, 4/06/2014 55609910 GNW  MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting,,,,11/27/2012 60877T10 GNW  Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST,,,,, 7/07/2014 0CPNB1-E GNW  Genmab Reaches USD 25 Million Milestone in Daratumumab Collaboration with Janssen,,,,,,,, 3/04/2011 56400P70  GNW  Pomerantz Law Firm Reminds Shareholders of MannKind Corp of Upcoming Deadline -- MNKD,,,, 8/04/2016 AMRS-US   GNW  Amyris Reports Second Quarter 2016 Results,,12/05/2011 00448Q20 GNW  Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C,,12/22/2014 03152W10 GNW  Amicus Therapeutics to Present Program Updates at 33rd Annual J.P. Morgan Healthcare Conference,,,," 6/28/2010 GWP-GB   GNW  Cannabis Science Reports Important Validation for Medical Cannabis as Bayer Pays '$15 Million Milestone Payment' for GW Pharmaceuticals' Sativex(R) for MS, as the UK Government Approves ""First Prescription Cannabis Medicine""",,,,," 7/29/2015 36315X10 GNW  Galapagos' selective JAK1 inhibitor filgotinib meets key efficacy endpoints, shows ACR70 responses up to 39%, and maintains safety profile after 24 weeks of treatment in DARWIN 1 Phase 2B study", 2/25/2015 73701010 GNW  Portola Pharmaceuticals to Present at the Cowen and Company 35th Annual Health Care Conference,,,,,11/06/2014 33938J10 GNW  Flexion Therapeutics to Report Third-Quarter 2014 Financial Results, 9/24/2013 06S6MV-E GNW  uniQure Selected as Fierce 15 Company by FierceBiotech,,,,,,,, 1/10/2014 45845P10 GNW  Intercept to Present at the J.P. Morgan Healthcare Conference, 4/03/2017 KPTI-US    GNW  Karyopharm Announces Management Change,,, 5/06/2014 46116X10 GNW  Intra-Cellular Therapies Presents New Data From the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 167th Annual Meeting of the American Psychiatric Association,,,,,,,,,,,,,,,,,,,,,,,,,, 6/29/2016 BGNE-US  GNW  BeiGene Announces Initiation of a Combination Trial of the BTK Inhibitor BGB-3111 with the PD-1 Antibody BGB-A317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/30/2014 74318710 GNW  Progenics Pharmaceuticals Presents Positive Data From a Phase 2 Trial of PSMA ADC in Patients With Chemotherapy Experienced Metastatic Castrate Resistant Prostate Cancer,,,,,,,,,,, 2/20/2013 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 7/05/2016 45290710 GNW  Hagens Berman Reminds Immunomedics, Inc. (NASDAQ: IMMU) Investors of August 8, 2016 Lead Plaintiff Deadline in Securities Class Action",,, 9/03/2014 09058V10 GNW  BioCryst to Present at Rodman & Renshaw Conference,,,,,,," 4/23/2018 0FCNPT-E GNW  MYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN",,,,,,,,,,"10/31/2013 02311120 GNW  Amarin to Report Third Quarter 2013 Results and Host Conference Call on November 7, 2013",,,,,, 1/11/2015 00163U10 GNW  AMAG Pharmaceuticals Provides Business Update and 2015 Financial Guidance,,,,, 5/31/2016 SNY-FR   GNW  Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial,,,,,,,,,,11/06/2014 ZGNX-US  GNW  Zogenix Reports Third Quarter 2014 Financial Results,,,,,,, 5/11/2015 90400D10  GNW  Ultragenyx Reports First Quarter 2015 Financial Results and Corporate Update,, 1/15/2014 63009R10 GNW  NanoString Technologies Secures Exclusive Option From Massachusetts General Hospital to License Intellectual Property for New Multiplexed Protein Analysis Method,,, 8/12/2014 75046920 GNW  Radius Health Reports Second Quarter 2014 Financial and Operating Results,,,,,,,,,,,,, 4/01/2014 55609910 GNW  MacroGenics to Present at the 13th Annual Needham Healthcare Conference,,,,"11/20/2012 60877T10 GNW  U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in ""Safe-Harbor"" Case",,,,, 7/03/2014 GMAB-DK  GNW  GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Ineligible for Fludarabine-based Therapy,,,,,,,, 2/18/2011 56400P70  GNW  Pomerantz Law Firm Reminds Shareholders of MannKind Corp of Upcoming Deadline -- MNKD,,,, 8/03/2016 03236M20  GNW  Amyris Enters Partnership with Biogen to Develop Alternative Cell Lines Supporting Production of Therapeutics,,11/21/2011 00448Q20 GNW  Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference,,12/22/2014 03152W10 GNW  Amicus Therapeutics Added to NASDAQ Biotechnology Index (NBI),,,,,,,,, 7/15/2015 36315X10 GNW  Galapagos licenses Organoid Technology from the HUB foundation for use in cystic fibrosis and IBD research," 2/24/2015 73701010 GNW  Portola Pharmaceuticals to Announce Fourth Quarter and Year End 2014 Financial Results and Host Conference Call on Monday, March 2",,,,,"10/22/2014 33938J10 GNW  Flexion Therapeutics, Inc. (Nasdaq: FLXN) to Ring The Nasdaq Stock Market Opening Bell",,,,,,,,, 1/09/2014 45845P10 GNW  Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones, 3/31/2017 KPTI-US    GNW  Karyopharm to Present Selinexor Phase 2b SADAL Data at the American Association for Cancer Research Annual Meeting 2017,,, 5/05/2014 46116X10 GNW  Intra-Cellular Therapies Reports First Quarter 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,, 6/06/2016 BGNE-US  GNW  BeiGene to Participate in Goldman Sachs 37th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 1/29/2014 74318710 GNW  Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors",,,,,,,,,,," 2/19/2013 09061G10    GNW  BioMarin to Attend Upcoming Conferences: Canaccord Genuity Orphan Drug Day, Citibank Global Healthcare Conference and RBC Capital Markets Healthcare Conference",,,," 7/01/2016 45290710 GNW  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 â€“ IMMU",,, 9/02/2014 09058V10 GNW  BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting,,,,,,," 4/20/2018 62855J10 GNW  Pomerantz Law Firm Announces the Filing of a Class Action against Myriad Genetics, Inc. and Certain Officers â€“ MYGN",,,,,,,,,,10/22/2013 02311120 GNW  Amarin Announces Plans to Reduce Expenses by Decreasing Staff Following Recent FDA Advisory Committee Vote,,,,,," 1/08/2015 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at the 33rd Annual J.P. Morgan Healthcare Conference",,,,, 5/23/2016 SAN-FR   GNW  Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020,,,,,,,,,,10/31/2014 98978L20 GNW  Zogenix and Purdue Pharma Exchange Waivers of Regulatory Exclusivity for Extended-Release Hydrocodone Products,,,,,,, 5/05/2015 90400D10  GNW  Ultragenyx to Host Conference Call for First Quarter 2015 Financial Results and Corporate Update,, 1/13/2014 63009R10 GNW  NanoString Technologies Files Registration Statement With SEC for a Follow-On Public Offering,,, 8/07/2014 75046920 GNW  Radius Health to Present at the Canaccord Genuity 34th Annual Growth Conference,,,,,,,,,,,,, 3/31/2014 55609910 GNW  MacroGenics to Present Pre-clinical Data on MGD007 at the AACR Annual Meeting,,,,11/08/2012 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,,,,, 6/27/2014 GMAB-DK  GNW  GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine-refractory CLL,,,,,,,," 2/17/2011 56400P70  GNW  Glancy Binkow & Goldberg LLP, Representing Shareholders of MannKind Corporation, Announces an April 1, 2011 Deadline to Move for Appointment as Lead Plaintiff in the Shareholder Lawsuit -- MNKD",,,, 7/19/2016 0CJPVM-E  GNW  American Refining Group Invests in Novvi to Accelerate Amyris Commercialization of Renewable Base Oil and Lubricant Platform,,11/08/2011 00448Q20 GNW  Achillion Reports Third Quarter and Nine Month 2011 Financial Results,,12/11/2014 03152W10 GNW  Amicus Therapeutics to Submit European Marketing Application for Migalastat Monotherapy for Fabry Disease,,,,,,,,, 6/19/2015 36315X10 GNW  Galapagos raises EU4.4 million through warrant exercises," 2/09/2015 73701010 GNW  Portola Pharmaceuticals Appoints Two Biotechnology Industry Veterans, Laura Brege and Dr. Dennis Fenton, to Board of Directors",,,,, 9/17/2014 33938J10 GNW  Flexion Therapeutics Announces Clinical Hold of FX006 Phase 2b Clinical Trial in Osteoarthritis of the Knee,,,,,,,,, 1/09/2014 008BK4-E GNW  Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology, 3/30/2017 KPTI-US    GNW  U.S. FDA Division of Hematology Products Lifts Partial Clinical Hold on Karyopharmâ€™s Selinexor Clinical Trials,,, 5/01/2014 46116X10 GNW  Intra-Cellular Therapies to Present at the Deutsche Bank 39th Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,, 6/05/2016 BGNE-US  GNW  BeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/28/2014 74318710 GNW  Senior Management of Progenics Pharmaceuticals to Webcast Discussion of Phase 2 Data From Two Trials in Prostate Cancer,,,,,,,,,,, 2/19/2013 09061G10    GNW  BioMarin Announces Kuvan Significantly Improves Inattentiveness in Kuvan Responding PKU Patients,,,, 6/28/2016 IMMU-US  GNW  Immunomedics Announces New U.S. Patent for Sacituzumab Govitecan (Immu-132) Antibody-Drug Conjugate (ADC),,, 8/29/2014 BCRX-US  GNW  BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease,,,,,,," 4/19/2018 MYGN-US  GNW  Myriad Announces Launch of ""Go Green"" Sustainability Initiative In Support of Earth Day",,,,,,,,,,10/16/2013 02311120 GNW  Amarin Announces FDA Advisory Committee Outcome for the Use of Vascepa in the Treatment of High Triglycerides With Mixed Dyslipidemia,,,,,,"12/29/2014 AMAG-US  GNW  AMAG Pharmaceuticals and Takeda Announce Mutual Termination of Agreement to License, Develop and Commercialize Ferumoxytol in Ex-U.S. Territories, Including Europe",,,,, 5/17/2016 SNY-FR   GNW  ALK appoints Carsten Hellmann as new President and CEO,,,,,,,,,,10/30/2014 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Third Quarter 2014 Financial Results,,,,,,, 4/23/2015 90400D10  GNW  Ultragenyx Granted Additional Orphan Drug Designations for Triheptanoin,, 1/13/2014 63009R10 GNW  NanoString Technologies Announces Preliminary Unaudited Fourth Quarter 2013 Revenue,,," 8/06/2014 75046920 GNW  Radius Health to Announce Second Quarter 2014 Financial Results, Host Conference Call and Live Webcast on Aug 12, 2014",,,,,,,,,,,,, 3/20/2014 55609910 GNW  MacroGenics Provides Update on Corporate Progress and 2013 Financial Results,,,,11/07/2012 60877T10 GNW  Momenta Pharmaceuticals Reports Third Quarter 2012 Financial Results,,,,, 6/04/2014 09D8G6-E GNW  Genmab Announces DuoBody and HexaBody Platform Collaboration With Undisclosed Biotechnology Company,,,,,,,, 2/07/2011 56400P70  GNW  Pomerantz Law Firm Has Filed a Class Action Against Mannkind Corporation -- MNKD,,,," 7/18/2016 AMRS-US   GNW  Amyris to Announce Second Quarter Financial Results on Thursday, August 4, 2016",,11/03/2011 00448Q20 GNW  Achillion to Present at the Credit Suisse 2011 Healthcare Conference,,12/04/2014 03152W10 GNW  Amicus Therapeutics to Present at Oppenheimer Healthcare Conference,,,,,,,,, 6/18/2015 36315X10 GNW  Galapagos completes recruitment for ORIGIN Phase 2 trial with GLPG1205 in ulcerative colitis patients, 2/05/2015 73701010 GNW  Portola's Factor Xa Inhibitor Betrixaban Successfully Passes Futility Analysis in Phase 3 APEX Study; Trial Continues as Planned and Remains on Track for Enrollment Completion by Year-End,,,,, 9/09/2014 33938J10 GNW  Flexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Candidate FX006,,,,,,,,, 1/02/2014 45845P10 GNW  Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9, 3/29/2017 KPTI-US    GNW  Karyopharm to Present at the 16th Annual Needham Healthcare Conference,,," 4/30/2014 46116X10 GNW  Intra-Cellular Therapies Announces Upcoming Presentations on ITI-007 at the American Psychiatric Association 167th Annual Meeting, the Society of Biological Psychiatry 69th Annual Meeting, and the International Review of Psychosis & Bipolarity Annual Meeting",,,,,,,,,,,,,,,,,,,,,,,,,, 5/19/2016 BGNE-CN  GNW  BeiGene Announces Presentation on BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/06/2013 74318710 GNW  Progenics Pharmaceuticals Announces That Data From a Phase I Study of Its 1404 Imaging Agent Has Been Presented at the Society for Urologic Oncology Meeting,,,,,,,,,,, 2/11/2013 09061G10    GNW  Presentations at WORLD Symposium: Vimizim Phase 3 Results and BMN-701 Phase 1/2 Patient Demographics,,,, 6/21/2016 IMMU-US  GNW  Immunomedics Appoints Michael R. Garone as New Chief Financial Officer,,, 8/13/2014 BCRX-US  GNW  BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases,,,,,,," 4/17/2018 MYGN-US  GNW  Myriad to Announce Fiscal Third-Quarter 2018 Financial Results on May 8, 2018",,,,,,,,,,10/16/2013 02311120 GNW  Amarin Corporation (NASDAQ: AMRN) Stock Trading Halted Today; FDA Advisory Committee to Review sNDA for Vascepa(R) ANCHOR Indication,,,,,,11/14/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Presentation at Jefferies 2014 Global Healthcare Conference in London,,,,, 4/05/2016 SNY-FR   GNW  MannKind Regains AfrezzaÂ® Marketing Rights,,,,,,,,,,10/27/2014 ZGNX-US  GNW  Zogenix Acquires U.K.-Based Brabant Pharma,,,,,,, 4/22/2015 90400D10  GNW  Ultragenyx Announces Positive Data From Investigator-Sponsored Trial of Triheptanoin in Glucose Transporter Type-1 Deficiency Syndrome,, 1/06/2014 63009R10 GNW  NanoString Technologies to Present at the JP Morgan 32nd Annual Healthcare Conference,,, 6/18/2014 75046920 GNW  Radius Health Announces Oral Presentations at the International Society of Endocrinology and the Endocrine Society (ICE/ENDO 2014),,,,,,,,,,,,, 3/13/2014 55609910 GNW  MacroGenics Announces Date of Year End 2013 Financial Results Conference Call,,,,10/18/2012 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Third Quarter 2012 Financial Results Conference Call,,,,, 5/30/2014 GMAB-DK  GNW  Genmab Announces Ofatumumab Development Plans in RRMS and NMO,,,,,,,," 1/28/2011 MNKD-US   GNW  Harwood Feffer LLP is Investigating Potential Violations of Federal Securities Laws by MannKind Corporation on Behalf of Investors Who Have Losses in Excess of $100,000",,,, 6/29/2016 0DMYDK-E  GNW  Ginkgo Bioworks and Amyris Partner to Accelerate Commercialization of Bio-Based Products,,"10/25/2011 00448Q20 GNW  Achillion Pharmaceuticals, Inc. (ACHN) President and CEO to Ring The NASDAQ Stock Market Opening Bell",,11/24/2014 03152W10 GNW  Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option,,,,,,,,, 6/15/2015 36315X10 GNW  AbbVie and Galapagos present cystic fibrosis corrector and potentiator screening approach at ECFS conference, 1/26/2015 73701010 GNW  Portola Pharmaceuticals Announces Dr. Robert Califf Retires From the Board of Directors to Accept Position as Deputy Commissioner for Medical Products and Tobacco at the Food and Drug Administration (FDA),,,,," 9/03/2014 33938J10 GNW  Flexion Therapeutics to Start FX006 Phase 3 Pivotal Trial in 2014; Following FDA Meeting, Development Plan Advanced by One Year",,,,,,,,,"10/04/2013 KERX-US  GNW  Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors", 3/16/2017 KPTI-US    GNW  Karyopharm Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Selinexor Clinical Update,,, 4/07/2014 46116X10 GNW  Intra-Cellular Therapies Announces Multiple Presentations on ITI-007 at the 4th Biennial Schizophrenia International Research Society (SIRS) Conference,,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2016 BGNE-US  GNW  BeiGene Reports First Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,12/06/2013 74318710 GNW  Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Experienced Cohort in Phase II PSMA ADC Clinical Trial in Prostate Cancer,,,,,,,,,,, 2/11/2013 CPRX-US     GNW  Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline,,,," 6/20/2016 45290710 GNW  Hagens Berman Alerts Immunomedics, Inc. (NASDAQ: IMMU) Investors of Securities Class Action and August 8, 2016 Lead Plaintiff Deadline",,, 8/05/2014 09058V10 GNW  BioCryst Reports Second Quarter 2014 Financial Results,,,,,,, 4/02/2018 AZN-GB   GNW  Myriad Receives Pre-Market Approval for its BRACAnalysisÂ® Diagnostic System in Japan,,,,,,,,,,"10/09/2013 02311120 GNW  Amarin to Host Conference Call on October 16, 2013 to Discuss Results of FDA Advisory Committee Meeting on ANCHOR Supplemental New Drug Application (sNDA) for Vascepa(R)",,,,,,11/12/2014 00163U10 GNW  AMAG Pharmaceuticals Completes Acquisition of Lumara Health's Maternal Health Business,,,,, 2/09/2016 SAN-FR   GNW  Sanofi delivered 2015 business EPS up 8.5% on a reported basis and stable at constant exchange rates consistent with guidance,,,,,,,,,,10/01/2014 98978L20 GNW  Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review,,,,,,, 4/13/2015 90400D10  GNW  Ultragenyx Appoints Daniel G. Welch to Board of Directors,,11/18/2013 63009R10 GNW  NanoString Technologies to Participate in the Piper Jaffray 25th Annual Healthcare Conference,,," 6/05/2014 RDUS-US  GNW  Radius Health, Inc. Announces Pricing of Initial Public Offering",,,,,,,,,,,,, 3/06/2014 05LJZC-E GNW  MacroGenics Appoints Matthew Fust to Its Board of Directors,,,, 8/30/2012 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences,,,,, 5/23/2014 GMAB-DK  GNW  GSK and Genmab Receive CHMP Positive Opinion for Arzerra(tm) in Combination with Chlorambucil or Bendamustine as a First-line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) Who Are Not Eligible for Fludarabine-based Therapy,,,,,,,,11/10/2010 MNKD-US   GNW  Emisphere Technologies Announces Financial and Operational Results for the Third Quarter and First Nine Months of 2010,,,," 6/28/2016 GIVN-CH   GNW  Amyris Announces Long term, Multi-Million-Dollar Collaboration in Cosmetic Active Ingredients with Givaudan",,10/13/2011 00448Q20 GNW  Achillion Announces Nomination of Second Generation NS5A Inhibitor for the Treatment of Hepatitis C,,11/18/2014 03152W10 GNW  Amicus Therapeutics Prices Underwritten Offering of Common Stock,,,,,,,,, 6/10/2015 36315X10 GNW  Galapagos DARWIN 1 and 2 studies have completed 24 weeks of treatment, 1/12/2015 73701010 GNW  Portola Pharmaceuticals Initiates Phase 4 Study to Support Accelerated Approval of Andexanet Alfa -- Its Breakthrough-Designated Factor Xa Inhibitor Antidote,,,,, 8/07/2014 33938J10 GNW  Flexion Therapeutics Reports Second-Quarter 2014 Financial Results,,,,,,,,, 4/30/2013 008BK4-E GNW  Intercept Pharmaceuticals Announces Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis Presented at EASL, 3/10/2017 KPTI-US    GNW  Karyopharm Announces Partial Clinical Hold to Pause Enrollment in Selinexor Trials,,, 4/02/2014 46116X10 GNW  Intra-Cellular Therapies Announces Upcoming Presentations at the 4th Biennial Schizophrenia International Research Society Conference,,,,,,,,,,,,,,,,,,,,,,,,,," 5/04/2016 BGNE-US  GNW  BeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/25/2013 74318710 GNW  Progenics Pharmaceuticals Relaunching Registrational Trial of Azedra to Treat Pheochromocytomas,,,,,,,,,,, 2/06/2013 09061G10    GNW  BioMarin to Present at the BIO CEO & Investor Conference,,,," 6/16/2016 45290710 GNW  IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a class action lawsuit has been commenced on behalf of shareholders of  Immunomedics, Inc. - IMMU",,, 7/22/2014 09058V10 GNW  BioCryst to Announce Second Quarter 2014 Financial Results August 5,,,,,,, 3/06/2018 MYGN-US  GNW  Myriad Applauds AACU Position Statement on Molecular Testing for Risk Stratification in Prostate Cancer,,,,,,,,,,10/03/2013 02311120 GNW  Amarin Informed by FDA That October 16th Advisory Committee Meeting Will Take Place as Scheduled,,,,,,"10/30/2014 00163U10 GNW  AMAG Pharmaceuticals Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014",,,,, 1/10/2016 IPH-FR   GNW  Sanofi and Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology,,,,,,,,,, 9/18/2014 98978L20 GNW  New Data Shows Zohydro(R) ER Reduced Pain and Improved Function in People With Chronic Pain,,,,,,, 3/25/2015 90400D10  GNW  Ultragenyx Reports Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update,,11/05/2013 63009R10 GNW  NanoString Technologies Releases Third Quarter 2013 Financial Results and Updates 2013 Outlook,,,,,,,,,,,,,,,, 3/03/2014 55609910 GNW  MacroGenics to Present at the 26th Annual ROTH Conference,,,, 8/08/2012 60877T10 GNW  Momenta to Present at the Canaccord Genuity 32nd Annual Growth Conference,,,,, 5/19/2014 GMAB-DK  GNW  GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma,,,,,,,,,,,, 6/14/2016 4914-JP   GNW  Takasago and Amyris Begin Commercialization of Novel Fragrance Product Being Introduced at the 2016 World Perfumery Congress,,10/03/2011 00448Q20 GNW  Achillion to Present Updated Clinical and Preclinical Data on Multiple Compounds at AASLD 2011,,11/17/2014 03152W10 GNW  Amicus Therapeutics Announces Public Offering of Common Stock,,,,,,,,, 5/26/2015 GLPG-BE  GNW  Galapagos receives transparency notifications, 1/09/2015 73701010 GNW  Portola Announces Phase 3 ANNEXA-R Study of Andexanet Alfa and Factor Xa Inhibitor XARELTO(R) (rivaroxaban) Met Primary Endpoint With High Statistical Significance,,,,," 7/31/2014 33938J10 GNW  Flexion Therapeutics to Report Second Quarter 2014 Financial Results on August 7, 2014",,,,,,,,, 4/25/2013 45845P10 GNW  Intercept Pharmaceuticals to Present at Upcoming Healthcare Conferences," 3/09/2017 KPTI-US    GNW  Karyopharm to Report Fourth Quarter and Year End 2016 Financial Results on March 16, 2017",,, 3/25/2014 46116X10 GNW  Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,, 4/20/2016 BGNE-CN  GNW  BeiGene (Nasdaq: BGNE) to Ring The Nasdaq Stock Market Opening Bell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/11/2013 74318710 GNW  Progenics Pharmaceuticals Announces Third Quarter Financial Results,,,,,,,,,,," 1/31/2013 09061G10    GNW  BioMarin to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call and Webcast on Thursday, February 21 at 5:00 p.m. ET",,,," 6/16/2016 45290710 GNW  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. -- IMMU",,, 6/03/2014 BCRX-US  GNW  BioCryst Announces Exercise of Over-Allotment Option and Completion of Public Offering,,,,,,, 3/01/2018 MYGN-US  GNW  Myriad Genetics Demonstrates Strong Commitment to Preventing Hereditary Colon Cancer as Part of National Colorectal Cancer Awareness Month,,,,,,,,,," 9/25/2013 02311120 GNW  Amarin Announces Enrollment of the REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients",,,,,,"10/27/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on October 30, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Nine Months Ended September 30, 2014",,,,, 1/05/2016 MNKD-US  GNW  MannKind Corporation Announces Termination of License and Collaboration Agreement With Sanofi,,,,,,,,,," 9/04/2014 98978L20 GNW  Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients",,,,,,, 3/20/2015 90400D10  GNW  Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update,,10/29/2013 63009R10 GNW  NanoString Technologies to Present at Credit Suisse 2013 Healthcare Conference,,,,,,,,,,,,,,,, 2/12/2014 55609910 GNW  MacroGenics Announces Pricing of Public Offering of Common Stock,,,," 8/03/2012 60877T10 GNW  Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals",,,,, 5/07/2014 37230320 GNW  Genmab Announces Financial Results for the First Quarter of 2014,,,,,,,,,,,, 6/13/2016 EAD-NL    GNW  Amyris Fuels First Delivery of New Airbus A350-900 Airplane for Cathay Pacific as Part of Two-Year Biojet Agreement,, 9/22/2011 00448Q20 GNW  Achillion to Present at the JMP Healthcare Conference,,11/15/2014 03152W10 GNW  Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology,,,,,,,,, 5/19/2015 36315X10 GNW  Galapagos announces capital increase," 1/06/2015 73701010 GNW  Portola Pharmaceuticals Announces Webcast of Corporate Presentation on January 12, 2015",,,,, 7/28/2014 33938J10 GNW  Flexion Therapeutics and Southwest Research Institute(R) (SwRI(R)) Sign Worldwide Exclusive License for Proprietary Microsphere Manufacturing Technologies,,,,,,,,, 4/08/2013 45845P10 GNW  Intercept Pharmaceuticals Announces Upcoming EASL Presentation, 3/02/2017 KPTI-US    GNW  Karyopharm Announces Results from Interim Analysis of Phase 2 SOPRA Study Evaluating Selinexor in Relapsed/Refractory Acute Myeloid Leukemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/17/2016 06P9WL-E GNW  BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/04/2013 74318710 GNW  Progenics Pharmaceuticals Sets Third Quarter Financial Results Conference Call for November 11,,,,,,,,,,, 1/18/2013 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 6/10/2016 45290710 GNW  Gainey McKenna & Egleston Announces A ClassÂ Action Lawsuit Has Been Filed Against Immunomedics, Inc. (IMMU)",,, 6/02/2014 09058V10 GNW  BioCryst to Present at Two Upcoming Investor Conferences,,,,,,, 2/27/2018 MYGN-US  GNW  Myriad Genetics to Present at Two Upcoming Healthcare Conferences,,,,,,,,,, 9/18/2013 02311120 GNW  Amarin to Present at the 2013 Aegis Capital Healthcare Conference,,,,,, 9/29/2014 00163U10 GNW  AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business,,,,,"12/23/2015 ZEAL-DK  GNW  Zealand announces that Sanofi has submitted LixiLan for regulatory review in the US, triggering a USD 20 million milestone payment",,,,,,,,,, 9/02/2014 98978L20 GNW  Zogenix to Participate in Morgan Stanley Global Healthcare Conference 2014,,,,,,, 3/09/2015 90400D10  GNW  Ultragenyx Announces Presentation of Disease Burden Data in Adult Patients With X-Linked Hypophosphatemia,,"10/16/2013 63009R10 GNW  NanoString Technologies to Release Third Quarter 2013 Financial Results and Host Conference Call on Tuesday, November 5, 2013",,,,,,,,,,,,,,,, 2/10/2014 55609910 GNW  MacroGenics Announces Proposed Public Offering of Common Stock,,,, 8/02/2012 60877T10 GNW  Momenta Pharmaceuticals Reports Second Quarter 2012 Financial Results,,,,, 5/01/2014 0CPNB1-E GNW  Genmab Announces New Phase III Study of Daratumumab in Multiple Myeloma & Improves 2014 Financial Guidance,,,,,,,,,,,, 6/06/2016 0DYWVW-E  GNW  Amyris Announces Collaboration with Johnson & Johnson Innovation for Biosynthetic Drug Discovery,, 8/31/2011 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,,11/06/2014 03152W10 GNW  Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates,,,,,,,,, 5/19/2015 36315X10 GNW  Galapagos announces closing of NASDAQ IPO,"11/17/2014 73701010 GNW  Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)",,,,, 7/24/2014 33938J10 GNW  Flexion Therapeutics Announces Board Changes,,,,,,,,, 3/18/2013 45845P10 GNW  Intercept Pharmaceuticals Announces 2012 Financial Results and Provides Business Update, 3/01/2017 KPTI-US    GNW  Karyopharm Announces the Presentation of New Data at the 2017 American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 4/11/2016 BGNE-US  GNW  BeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/11/2013 74318710 GNW  Progenics Pharmaceuticals Announces a Changing of the Guard on Its Board Of Directors,,,,,,,,,,, 1/07/2013 09061G10    GNW  BioMarin Acquires Zacharon Pharmaceuticals,,,," 6/10/2016 45290710 GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Immunomedics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 â€“ IMMU",,, 5/28/2014 09058V10 GNW  BioCryst Pharmaceuticals Prices Public Offering of Common Stock,,,,,,, 2/20/2018 MYGN-US  GNW  NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer,,,,,,,,,, 9/09/2013 02311120 GNW  Amarin Announces 30th Patent for Vascepa(R),,,,,," 9/16/2014 00163U10 GNW  AMAG Pharmaceuticals Appoints Judith Johnson, M.D. as Vice President of Pharmacovigilance and Pharmacoepidemiology",,,,,10/29/2015 SAN-FR   GNW  Sanofi grew sales and business EPS(1) in Q3 2015,,,,,,,,,, 9/02/2014 98978L20 GNW  Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief,,,,,,, 3/04/2015 90400D10  GNW  Ultragenyx to Present at the Barclays Global Healthcare Conference,,"10/01/2013 63009R10 GNW  NanoString Technologies, Inc. and Fluidigm Corporation Settle Lawsuits",,,,,,,,,,,,,,,," 2/05/2014 55609910 GNW  MacroGenics Achieves Milestone as Servier Exercises Option to Develop and Commercialize DART-Based Candidate, MGD006",,,, 7/16/2012 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Second Quarter 2012 Financial Results Conference Call,,,,, 4/30/2014 37230320 GNW  First Quarter 2014 Net Sales Figures for Arzerra,,,,,,,,,,,, 5/27/2016 0024VM-E  GNW  Amyris to Participate in June 2016 Investor Conferences,, 8/08/2011 00448Q20 GNW  Achillion Reports Second Quarter and Six Month 2011 Financial Results,,"11/03/2014 03152W10 GNW  Amicus Therapeutics Announces Timing of Third Quarter 2014 Financial Results, Upcoming Scientific Conference and Other Corporate Updates",,,,,,,,, 5/18/2015 36315X10 GNW  Galapagos announces full exercise of underwriters' option to purchase additional shares,11/10/2014 73701010 GNW  Portola Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update,,,,, 6/17/2014 33938J10 GNW  Flexion Therapeutics Announces Positive Topline Results From Phase 2a Pharmacokinetic Trial With Lead Compound FX006,,,,,,,,, 3/12/2013 45845P10 GNW  Intercept Pharmaceuticals to Host 2012 Fourth Quarter and Full Year Financial Results Conference Call on March 18, 1/31/2017 05LK9B-E   GNW  Karyopharm to Participate in Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/30/2016 BGNE-US  GNW  BeiGene Reports Fourth Quarter and Full Year 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/05/2013 74318710 GNW  Progenics Pharmaceuticals to Present at Stifel Healthcare Conference,,,,,,,,,,, 1/03/2013 BMRN-US     GNW  BioMarin to Present at the J.P. Morgan Healthcare Conference,,,, 6/07/2016 IMMU-US  GNW  Immunomedics to Present at Jefferies 2016 Global Healthcare Conference,,, 5/27/2014 09058V10 GNW  BioCryst Commences Public Offering of Common Stock,,,,,,, 2/15/2018 MYGN-US  GNW  JAMA Oncology Publication Demonstrates EndoPredictÂ® (EPClin) Significantly Outperforms Oncotype DXÂ® Recurrence Score in Early-Stage Breast Cancer,,,,,,,,,, 8/26/2013 0BQ1HD-E GNW  Amarin Announces Submission of Supplemental New Drug Application for Novasep as Fourth Vascepa(R) Active Pharmaceutical Ingredient Supplier,,,,,," 9/08/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors",,,,," 9/14/2015 ZEAL-DK  GNW  Sanofi has announced the successful completion of LixiLan-L, the second pivotal Phase III trial with LixiLan to demonstrate positive results",,,,,,,,,, 8/05/2014 ZGNX-US  GNW  Zogenix Reports Second Quarter 2014 Financial Results,,,,,,, 2/25/2015 90400D10  GNW  Ultragenyx to Present at the Cowen and Company 35th Annual Health Care Conference in Boston,, 8/26/2013 63009R10 GNW  NanoString Technologies to Participate in Upcoming Investor Conferences,,,,,,,,,,,,,,,,12/11/2013 55609910 GNW  MacroGenics Announces Publication of Cancer Stem Cell Research in Lung Cancer,,,, 7/02/2012 60877T10 GNW  First Patient Dosed With M402 in Phase 1/2 Clinical Trial in Metastatic Pancreatic Cancer,,,,, 4/17/2014 GMAB-DK  GNW  GSK and Genmab Receive FDA Approval for Arzerra(r) (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based Therapy is Considered Inappropriate,,,,,,,,,,,, 5/20/2016 097955-KR GNW  Amyris & CJ CheilJedang Corporation Creating Manufacturing and Sales Partnership,, 8/02/2011 00448Q20 GNW  Achillion to Host Conference Call to Discuss Second Quarter Financial Results and Upcoming Milestones,,10/19/2014 03152W10 GNW  Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011,,,,,,,,, 5/14/2015 GLPG-BE  GNW  Galapagos (Nasdaq: GLPG) to Ring The Nasdaq Stock Market Opening Bell,11/06/2014 73701010 GNW  Portola Pharmaceuticals Announces Upcoming Presentations at the American Society of Hematology 2014 Annual Meeting,,,,, 6/12/2014 33938J10 GNW  Flexion Therapeutics Announces Changes to Board of Directors,,,,,,,,, 3/04/2013 008BK4-E GNW  Intercept Pharmaceuticals Appoints Daniel Regan as Chief Commercial Officer, 1/03/2017 JPM-US     GNW  Karyopharm to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/16/2016 BGNE-US  GNW  BeiGene Announces Presentations on BGB-283 and Other Pipeline Agents at the 2016 American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/09/2013 74318710 GNW  Progenics Pharmaceuticals Announces Second Quarter 2013 Financial Results,,,,,,,,,,,12/21/2012 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,," 6/06/2016 IMMU-US  GNW  Immunomedicsâ€™ Sacituzumab Govitecan (IMMU-132) Demonstrates Efficacy and Safety in Non-Small-Cell Lung Cancer Patients With Multiple Prior Treatments, Including Immuno-Oncology",,," 5/27/2014 09058V10 GNW  BioCryst Announces Positive Results From OPuS-1, a Phase 2 Trial of BCX4161 for the Prophylactic Treatment of Hereditary Angioedema",,,,,,, 2/07/2018 MYGN-US  GNW  Myriadâ€™s myRiskÂ® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation,,,,,,,,,, 8/13/2013 02311120 GNW  Amarin to Present at the Canaccord Genuity 33rd Annual Growth Conference,,,,,," 8/29/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences",,,,, 8/31/2015 SNY-FR   GNW  Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes,,,,,,,,,," 8/01/2014 98978L20 GNW  Zogenix Announces Departure of Chief Commercial Officer, Scott Shively",,,,,,, 2/24/2015 00D326-E  GNW  Ultragenyx Appoints Michael Narachi to Board of Directors,, 8/06/2013 63009R10 GNW  NanoString Technologies Releases Second Quarter 2013 Financial Results and Provides 2013 Outlook,,,,,,,,,,,,,,,,12/09/2013 55609910 GNW  MacroGenics Announces Presentation of Pre-Clinical Data on DART(R) Molecule Targeting CD123-Positive Leukemic Stem Cells at 55th Annual Meeting of the American Society of Hematology,,,, 6/22/2012 60877T10 GNW  Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation,,,,, 4/09/2014 GMAB-DK  GNW  Passing of Genmab A/S' Annual General Meeting,,,,,,,,,,,, 5/11/2016 002MSQ-E  GNW  Amyris to Participate in Upcoming Investor Conferences in May 2016,, 7/26/2011 00448Q20 GNW  Achillion Announces Executive Promotion,, 9/30/2014 03152W10 GNW  Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable,,,,,,,,, 5/13/2015 36315X10 GNW  Galapagos raises $275 million gross proceeds with NASDAQ IPO,11/06/2014 73701010 GNW  Portola Pharmaceuticals to Present at the Credit Suisse 2014 Healthcare Conference,,,,," 6/11/2014 33938J10 GNW  Flexion Therapeutics to Present at Wells Fargo Securities Research, Economics & Strategy 2014 Healthcare Conference",,,,,,,,, 2/25/2013 45845P10 GNW  Intercept Pharmaceuticals to Present at the Cowen and Company 33rd Annual Healthcare Conference,12/15/2016 0616DB-E   GNW  Karyopharm and Collaborators Awarded Grant for ALS Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/07/2016 BGNE-US  GNW  BeiGene Receives Approval to Initiate Clinical Trials in China With BGB-3111,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/02/2013 74318710 GNW  Progenics Pharmaceuticals Second Quarter Conference Call Set for August 9,,,,,,,,,,,12/11/2012 CPRX-US     GNW  Catalyst Pharmaceutical Partners Announces Automatic Conversion of $5 Million Promissory Note Into Shares of Common Stock,,,, 6/06/2016 IMMU-US  GNW  Immunomedics Announces Sacituzumab Govitecan (IMMU-132) is Active in Patients With Previously-Treated Metastatic Small-Cell Lung Cancer,,, 5/24/2014 09058V10 GNW  BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27,,,,,,, 2/06/2018 MYGN-US  GNW  Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results,,,,,,,,,, 8/08/2013 02311120 GNW  Amarin Reports Second Quarter 2013 Financial Results and Provides Update on Operations,,,,,, 8/12/2014 00163U10 GNW  AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer,,,,, 8/10/2015 SNY-FR   GNW  Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States,,,,,,,,,, 7/22/2014 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Second Quarter 2014 Financial Results,,,,,,, 2/17/2015 00D326-E  GNW  Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares,," 7/17/2013 63009R10 GNW  NanoString Technologies to Release Second Quarter 2013 Financial Results and Host Conference Call on Tuesday, August 6, 2013",,,,,,,,,,,,,,,,11/12/2013 55609910 GNW  MacroGenics Provides Corporate Progress Update and Third Quarter 2013 Financial Results,,,, 6/04/2012 60877T10 GNW  Momenta Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Oncology Drug Candidate M402,,,,, 3/26/2014 0CPNB1-E GNW  Genmab Reaches $22 Million Milestone in Daratumumab Collaboration with Janssen,,,,,,,,,,,, 5/10/2016 AMRS-US   GNW  Amyris First Quarter 2016 Results Deliver Strong Renewable Product Sales Growth and Continued Reduction in Operating Expenses,, 7/11/2011 00448Q20 GNW  Achillion Announces Initiation of Phase 1 Trial of ACH-2928 for the Treatment of Hepatitis C,, 8/20/2014 FOLD-US  GNW  Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012,,,,,,,,, 5/06/2015 36315X10 GNW  Galapagos listed 10 years on Euronext Amsterdam and Brussels,"11/03/2014 73701010 GNW  Portola Pharmaceuticals to Announce Third Quarter 2014 Financial Results and Host Conference Call on Monday, November 10, 2014",,,,, 5/27/2014 33938J10 GNW  Flexion Therapeutics to Present at the 2014 Jefferies Healthcare Conference,,,,,,,,, 2/07/2013 45845P10 GNW  Intercept Pharmaceuticals to Present at Leerink Swann 2013 Global Healthcare Conference,12/05/2016 KPTI-US    GNW  Karyopharm Presents Updated Phase 1b STOMP Data at the American Society of Hematology 2016 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2016 0024VM-E GNW  BeiGene to Present at Cowen and Company 36th Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 7/16/2013 74318710 GNW  Progenics Pharmaceuticals to Webcast Investor and Analyst Day July 18, 2013",,,,,,,,,,,11/27/2012 09061G10    GNW  BioMarin to Present at the Deutsche Bank BioFEST Conference,,,, 6/03/2016 IMMU-US  GNW  Immunomedics Provides Update on Triple-Negative Breast Cancer Presentation at ASCO,,, 5/09/2014 09058V10 GNW  BioCryst to Present at Bank of America Merrill Lynch 2014 Healthcare Conference,,,,,,," 1/25/2018 MYGN-US  GNW  Myriad to Announce Fiscal Second-Quarter 2018 Financial Results on February 6, 2018",,,,,,,,,," 8/02/2013 02311120 GNW  Amarin to Report Second Quarter 2013 Results and Host Conference Call on August 8, 2013",,,,,," 8/01/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in Jefferies Boston Healthcare Summit",,,,, 8/10/2015 MNKD-US  GNW  MannKind Corporation Reports 2015 Second Quarter Financial Results,,,,,,,,,," 7/17/2014 98978L20 GNW  Zogenix Announces Appointment of David Brushwood, J.D., R.Ph., to External Safe Use Board",,,,,,, 2/10/2015 90400D10  GNW  Ultragenyx Announces Positive 36-Week Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7,,,,,,,,,,,,,,,,,,11/11/2013 55609910 GNW  MacroGenics to Present Pre-Clinical Data on Targeting CD123-Positive Leukemic Stem Cells at the 55th ASH Annual Meeting,,,, 5/30/2012 60877T10 GNW  Momenta to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference,,,,, 3/05/2014 0CPNB1-E GNW  Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma,,,,,,,,,,,," 5/06/2016 AMRS-US   GNW  Biossanceâ„¢ Announces the Blacklist â”€ 2,000+ Potentially Harmful Cosmetic Ingredients it Refuses to Use while Delivering Products Consumers Love to Use",, 6/27/2011 00448Q20 GNW  Achillion Pharmaceuticals Announces Closing of Public Offering and Exercise of Overallotment Option,, 8/07/2014 03152W10 GNW  Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates,,,,,,,,, 5/06/2015 GLPG-BE  GNW  Galapagos announces launch of proposed global offering,10/16/2014 73701010 GNW  Portola Pharmaceuticals Announces Commercial Supply Agreement for Andexanet Alfa With Lonza,,,,, 5/08/2014 009T7W-E GNW  Flexion Therapeutics Reports First-Quarter 2014 Financial Results,,,,,,,,, 1/07/2013 45845P10 GNW  Intercept Pharmaceuticals Announces Initiation of Phase 2 NASH Trial of OCA in Japan,12/04/2016 KPTI-US    GNW  Karyopharm Presents Updated Phase 2b STORM Data at the American Society of Hematology 2016 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/07/2015 0FTRYX-E GNW  BeiGene Presents Clinical Data for BTK Inhibitor BGB-3111 at 57th ASH Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/02/2013 74318710 GNW  Progenics Pharmaceuticals to Present at JMP Securities Healthcare Conference,,,,,,,,,,,11/27/2012 09061G10    GNW  BioMarin to Host a Research and Development Day on December 6th,,,, 5/19/2016 IMMU-US  GNW  Immunomedics to Report Updated Results for Sacituzumab Govitecan (IMMU-132) in Breast and Lung Cancers at Clinical Science Symposia ofÂ 2016 ASCO Annual Meeting,,, 5/08/2014 09058V10 GNW  BioCryst Reports First Quarter 2014 Financial Results,,,,,,, 1/22/2018 MYGN-US  GNW  Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer,,,,,,,,,, 7/12/2013 AMRN-IE  GNW  Amarin Announces Completion of Offering of American Depositary Shares,,,,,, 7/29/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014,,,,," 8/10/2015 EVT-DE   GNW  Evotec, Apeiron Biologics and Sanofi Jointly Develop Novel Small Molecule-Based Cancer Immunotherapies",,,,,,,,,, 7/14/2014 98978L20 GNW  Zogenix Announces New Patent Valid Through 2032 For DosePro(R) Needle-Free Delivery System,,,,,,, 2/04/2015 00D326-E  GNW  Ultragenyx Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,11/11/2013 55609910 GNW  MacroGenics DART Therapeutic Selected by Boehringer Ingelheim as a Bi-Specific Pre-Clinical Development Candidate,,,, 5/11/2012 60877T10 GNW  Momenta to Present at the Bank of America Merrill Lynch 2012 Health Care Conference,,,,, 3/04/2014 GMAB-DK  GNW  Genmab 2013 Annual Report,,,,,,,,,,,," 4/29/2016 AMRS-US   GNW  Amyris to Announce First Quarter Financial Results on Tuesday, May 10, 2016",, 6/23/2011 00448Q20 GNW  Achillion Pharmaceuticals Leads MicroStockProfit.com Stock Watchlist,," 7/31/2014 03152W10 GNW  Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014",,,,,,,,, 5/01/2015 GLPG-BE  GNW  BNP Paribas notify of 4.8% shareholding in Galapagos,10/02/2014 73701010 GNW  Portola Announces Pricing of Public Offering of Common Stock,,,,," 5/01/2014 33938J10 GNW  Flexion Therapeutics to Report First Quarter 2014 Financial Results on May 8, 2014",,,,,,,,,12/19/2012 45845P10 GNW  Intercept Pharmaceuticals Announces Completion of Enrollment in Phase 3 Primary Biliary Cirrhosis POISE Trial,12/04/2016 06QBQ2-E   GNW  Karyopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data at the American Society of Hematology 2016 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/23/2015 BGNE-CN  GNW  BeiGene Announces Abstract on BGB-3111 to be Presented at the 2015 American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 7/01/2013 74318710 GNW  Progenics Pharmaceuticals Announces Key Strategic Hire,,,,,,,,,,,11/20/2012 09061G10    GNW  BioMarin to Present at the Piper Jaffray Healthcare Conference,,,, 5/04/2016 IMMU-US  GNW  Immunomedics Announces Third Quarter Fiscal 2016 Results and Clinical Program Developments,,, 4/28/2014 09058V10 GNW  BioCryst to Announce First Quarter 2014 Financial Results May 8,,,,,,, 1/12/2018 AZN-GB   GNW  Myriad Receives FDA Approval of BRACAnalysis CDxÂ® as Companion Diagnostic for Lynparzaâ„¢ (olaparib) In Patients with Metastatic Breast Cancer,,,,,,,,,, 7/08/2013 02311120 GNW  Amarin Announces Public Offering of American Depositary Shares,,,,,," 7/25/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on July 29, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Six Months Ended June 30, 2014",,,,, 8/07/2015 EVT-DE   GNW  Sanofi and Evotec Align Forces to Develop Next Generation Therapies in Diabetes,,,,,,,,,, 7/09/2014 98978L20 GNW  Zogenix Reports Positive Development on U.S. District Court Ruling,,,,,,, 2/03/2015 00D326-E  GNW  Ultragenyx Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,,,,,,11/05/2013 55609910 GNW  MacroGenics Announces Timing for Third Quarter 2013 Financial Results and Conference Call,,,, 5/03/2012 60877T10 GNW  Momenta Pharmaceuticals Reports First Quarter 2012 Financial Results,,,,, 2/05/2014 37230320 GNW  Arzerra(R) Fourth Quarter and Full Year 2013 Net Sales Figures,,,,,,,,,,,, 4/27/2016 AMRS-US   GNW  Amyris Signs Five Year BiofeneÂ® Supply Agreement with leading Global Nutraceuticals Company with Over $100 Million of Expected Value,, 6/22/2011 00448Q20 GNW  Achillion Initiates 12-Week Dosing in Phase 2 Trial of ACH-1625 for the Treatment of Chronic Hepatitis C,, 6/30/2014 03152W10 GNW  Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012,,,,,,,,, 5/01/2015 36315X10 GNW  Galapagos creates new warrant plan,10/01/2014 73701010 GNW  Portola Pharmaceuticals Announces Proposed Offering of Common Stock,,,,, 4/30/2014 33938J10 GNW  Flexion Therapeutics Initiates a Phase 2b Confirmatory Dose-Ranging Trial With Lead Compound FX006,,,,,,,,,11/12/2012 45845P10 GNW  Intercept Pharmaceuticals Announces Completion of Enrollment in FLINT,11/30/2016 06QBQ2-E   GNW  Karyopharm and the Multiple Myeloma Research Foundation Announce Panel Discussion Featuring Leading Multiple Myeloma Thought Leaders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"11/09/2015 BGNE-CN  GNW  BeiGene Appoints Dr. Zhengming Du as Senior Vice President, Head of Chemistry and Manufacturing Controls",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/20/2013 PGNX-US  GNW  Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,11/19/2012 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,, 5/02/2016 IMMU-US  GNW  Immunomedics Announces Abstract on Sacituzumab Govitecan (IMMU-132) in Patients With Triple-Negative Breast Cancer Selected for Best of ASCO Program,,, 3/03/2014 09058V10 GNW  BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection,,,,,,, 1/03/2018 AZN-GB   GNW  Myriad Genetics Announces Expanded Research Collaboration with AstraZeneca,,,,,,,,,, 6/21/2013 02311120 GNW  Amarin Announces Positive Results of Phase 1 Clinical Trial Measuring the Bioavailability of a Fixed-Dose Combination of Vascepa(R) and a Statin Compared to Concomitant Administration,,,,,, 6/11/2014 00163U10 GNW  AMAG Pharmaceuticals Appoints Melissa Bradford Klug as Senior Vice President of Business Development and Strategy,,,,, 7/30/2015 ZLDPY-DK GNW  Lixisenatide (Lyxumia(R)) royalty revenue increased in Q2 2015 as Sanofi confirms the submission of a NDA in the US,,,,,,,,,, 7/02/2014 98978L20 GNW  Zogenix Provides Update on Development of Abuse Deterrent Formulations of Zohydro(R) ER,,,,,,, 1/12/2015 90400D10  GNW  Ultragenyx Announces Intent to File for Conditional Approval in Europe for Sialic Acid Extended-Release Tablets in Hereditary Inclusion Body Myopathy,,,,,,,,,,,,,,,,,,10/16/2013 55609910 GNW  MacroGenics Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment Option,,,, 4/20/2012 60877T10 GNW  Momenta Pharmaceuticals Announces Date of First Quarter 2012 Financial Results Conference Call,,,,, 1/29/2014 37230320 GNW  Major Shareholder Announcement,,,,,,,,,,,, 4/25/2016 AMRS-US   GNW  Amyris Named Gold 2016 Edison Award Winner -- One of Highest Accolades for Innovation in Business,, 6/22/2011 00448Q20 GNW  Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock,, 5/14/2014 03152W10 GNW  Amicus Therapeutics to Present at UBS Global Healthcare Conference,,,,,,,,, 4/27/2015 GLPG-BE  GNW  Filgotinib as monotherapy also hits primary endpoint in DARWIN 2 trial,10/01/2014 73701010 GNW  Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis (Apixaban) Met Primary and Secondary Endpoints With High Statistical Significance,,,,, 4/02/2014 33938J10 GNW  Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference,,,,,,,,,11/08/2012 45845P10 GNW  Intercept Pharmaceuticals to Present Phase 2a Portal Hypertension Data at AASLD's Liver Meeting,11/10/2016 05F9ZW-E   GNW  Karyopharm to Present at the Jefferies 2016 London Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/02/2015 0FTRYX-E GNW  BeiGene Announces Appointment of Dr. RuiRong Yuan as Chief Medical Officer and President of Global Clinical Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/19/2013 74318710 GNW  Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,,,,,,11/09/2012 09061G10    GNW  BioMarin to Present at the Credit Suisse Healthcare Conference,,,, 4/29/2016 06CR5C-E GNW  Immunomedics Reports Responses With Sacituzumab Govitecan (IMMU-132) in Patients With Metastatic Solid Cancers Who Failed Prior Checkpoint-Inhibitor Therapy,,, 3/01/2014 09058V10 GNW  BioCryst Presents BCX4161 Phase 1 Trial and Kallikrein Inhibition Assay Results,,,,,,,12/19/2017 MYGN-US  GNW  Myriad Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,,,,,,,, 6/19/2013 02311120 GNW  Amarin Informed by FDA of October 16th Advisory Committee Date in Connection With Supplemental New Drug Application (sNDA) for Vascepa(R) in the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidemia,,,,,, 6/06/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Patent Term Extension for Ferumoxytol in the U.S.,,,,, 7/30/2015 SAN-FR   GNW  Sanofi delivers solid sales and business EPS(1) growth in Q2 2015,,,,,,,,,, 6/16/2014 98978L20 GNW  Zogenix to Present at Two Upcoming Conferences,,,,,,, 1/07/2015 00D326-E  GNW  Ultragenyx Announces License of Intellectual Property Related to the Treatment of Huntington's Disease With Triheptanoin,,,,,,,,,,,,,,,,,,"10/10/2013 05LJZC-E GNW  NASDAQ Welcomes MacroGenics, Inc. (NASDAQ: MGNX) to The NASDAQ Stock Market",,,, 3/12/2012 60877T10 GNW  Momenta to Present at the Barclays Capital Global Healthcare Conference,,,,, 1/14/2014 GMAB-DK  GNW  Genmab Announces DuoBody Platform Collaboration With Lilly,,,,,,,,,,,, 4/11/2016 AMRS-US   GNW  Amyris Creates Program to Reduce the Cost and Increase Access to Leading Malaria Treatment,, 6/20/2011 00448Q20 GNW  Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock,, 5/05/2014 03152W10 GNW  Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates,,,,,,,,, 4/15/2015 GLPG-BE  GNW  Galapagos files registration statement in the United States for a proposed global offering, 9/02/2014 73701010 GNW  Portola Pharmaceuticals to Present at the 2014 Morgan Stanley Global Healthcare Conference,,,,, 3/27/2014 33938J10 GNW  Flexion Reports Year-End 2013 Financial Results,,,,,,,,,10/15/2012 45845P10 GNW  Intercept Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares,11/07/2016 KPTI-US    GNW  Karyopharm Reports Third Quarter 2016 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/28/2015 0FTRYX-E GNW  BeiGene Announces Abstracts to be Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/10/2013 00768Q-E GNW  Progenics Pharmaceuticals Presents PSMA-Related Data at SNMMI 2013,,,,,,,,,,,11/06/2012 09061G10    GNW  BioMarin to Present at the Lazard Capital Markets Healthcare Conference,,,, 4/28/2016 IMMU-US  GNW  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2016 Financial Results,,, 2/26/2014 09058V10 GNW  BioCryst Reports Fourth Quarter and Full Year 2013 Financial Results,,,,,,,"12/12/2017 MYGN-US  GNW  Myriadâ€™s BRACAnalysis CDxÂ® Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, Talazoparib",,,,,,,,,, 5/30/2013 02311120 GNW  Amarin to Present at the Jefferies 2013 Global Healthcare Conference,,,,,," 5/13/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at the UBS Global Healthcare Conference",,,,," 7/29/2015 ZLDPY-DK GNW  Sanofi has announced that the first LixiLan Phase III trial, LixiLan-O, met primary study endpoint",,,,,,,,,, 6/02/2014 98978L20 GNW  Zogenix Officers to Report Withholding of Shares,,,,,,, 1/06/2015 90400D10  GNW  Ultragenyx Initiates New Development Program Studying KRN23 for the Treatment of Tumor-Induced Osteomalacia,,,,,,,,,,,,,,,,,,,,,, 3/02/2012 60877T10 GNW  Momenta to Present at the Cowen and Company 32nd Annual Health Care Conference,,,,,12/17/2013 GMAB-DK  GNW  GSK and Genmab Receive Priority Review from FDA for Arzerra(r) (ofatumumab) as 1st Line Treatment for Chronic Lymphocytic Leukemia (CLL),,,,,,,,,,,, 3/21/2016 AMRS-US   GNW  Amyris Brotas Plant Sold Out for 2017-2020 Farnesene Volume  â”€ Project for Dedicated Flavors & Fragrances Initiated,, 5/25/2011 00448Q20 GNW  Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C,, 5/01/2014 03152W10 GNW  Amicus Therapeutics to Announce First Quarter 2014,,,,,,,,, 4/14/2015 GLPG-BE  GNW  Galapagos' JAK1 inhibitor filgotinib (GLPG0634) meets primary and other key efficacy endpoints after 12 weeks of treatment in DARWIN 1 Phase 2B study, 8/06/2014 73701010 GNW  Portola Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update,,,,," 3/20/2014 33938J10 GNW  Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014",,,,,,,,,10/11/2012 45845P10 GNW  Intercept Pharmaceuticals Announces Pricing of Initial Public Offering,11/03/2016 KPTI-US    GNW  Karyopharm Therapeutics Inc. (Nasdaq: KPTI) to Ring The Nasdaq Stock Market Closing Bell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/01/2013 PGNX-US  GNW  Progenics Pharmaceuticals' Data From a Phase 1 Study of PSMA ADC Presented at ASCO 2013,,,,,,,,,,,11/05/2012 09061G10    GNW  BioMarin Phase 3 Study of GALNS for the Treatment of MPS IVA Meets Primary Endpoint,,,, 4/22/2016 CELG-US  GNW  Immunomedics Appoints Dr. Sol J. Barer Special Advisor to the Chairman,,, 2/25/2014 09058V10 GNW  BioCryst Announces Peramivir NDA Acceptance by the FDA,,,,,,,12/08/2017 MYGN-US  GNW  Myriad Genetics Presents Results From Two Important EndoPredictÂ® Studies at the 2017 San Antonio Breast Cancer Symposium,,,,,,,,,, 5/30/2013 02311120 GNW  Amarin Announces Additional Effects of Vascepa(R) on Lipoprotein Particle Concentration From the ANCHOR Study Presented at the National Lipid Association 2013 Annual Scientific Sessions,,,,,, 4/28/2014 00163U10 GNW  Study Showing Effectiveness of MuGard(R) for Management of Oral Mucositis Featured in the Journal Cancer,,,,, 6/09/2015 SAN-FR   GNW  FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent(r) (alirocumab) Injection for Patients with Hypercholesterolemia,,,,,,,,,, 5/30/2014 98978L20 GNW  Zogenix to Present at Jefferies 2014 Global Healthcare Conference,,,,,,, 1/05/2015 90400D10  GNW  Ultragenyx to Present at the J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 2/24/2012 60877T10 GNW  Momenta to Present at the 2012 Citi Global Health Care Conference,,,,,12/11/2013 GMAB-DK  GNW  Major Shareholder Announcement,,,,,,,,,,,," 3/17/2016 AMRS-US   GNW  Amyris Biossanceâ„¢ Brand Launches The Refresher â”€ Luxurious, Quick & Effective Biodegradable Makeup Removing Cloths",, 5/20/2011 00448Q20 GNW  Achillion to Present at Two Upcoming Investor Conferences,, 4/29/2014 03152W10 GNW  Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011,,,,,,,,, 3/27/2015 36315X10 GNW  Publication of Annual Report 2014 and invitation to the Annual Shareholders' Meeting to be held on 28 April 2015," 7/30/2014 73701010 GNW  Portola Pharmaceuticals to Announce Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 6, 2014",,,,, 2/26/2014 33938J10 GNW  Flexion Therapeutics to Present at the 34th Annual Cowen Health Care Conference,,,,,,,,,,11/03/2016 06QBQ2-E   GNW  Karyopharm to Present Updated Phase 2b STORM and Phase 1b STOMP Clinical Data at the American Society of Hematology 2016 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/31/2013 74318710 GNW  Progenics Pharmaceuticals to Present at Jefferies Global Healthcare Conference,,,,,,,,,,,10/31/2012 09061G10    GNW  Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into Strategic Collaboration for Firdapse(TM) in North America,,,, 4/20/2016 IMMU-US  GNW  Immunomedics Awarded U.S. Patent for Novel Immuno-Oncology Agents for Cancer Therapy,,, 2/20/2014 09058V10 GNW  BioCryst to Present at Three Upcoming Investor Conferences,,,,,,,12/06/2017 MYGN-US  GNW  Myriad Genetics Presents Pivotal Validation Study for New riskScoreâ„¢ Test at the 2017 San Antonio Breast Cancer Symposium,,,,,,,,,," 5/22/2013 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa(R) and Statin Therapy",,,,,, 4/24/2014 00163U10 GNW  AMAG Announces First Quarter 2014 Financial Results,,,,, 6/09/2015 ZEAL-DK  GNW  Zealand informs of updates given by Sanofi on Lyxumia(r) and LixiLan on an IR Thematic Conference Call on Diabetes,,,,,,,,,, 5/19/2014 00FV7G-E GNW  Zogenix Closes Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International,,,,,,,12/15/2014 90400D10  GNW  Ultragenyx Announces Initiation of Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7,,,,,,,,,,,,,,,,,,,,,, 2/13/2012 60877T10 GNW  Momenta to Present at the Leerink Swann 2012 Global Healthcare Conference,,,,,12/06/2013 0CPNB1-E GNW  Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen - Financial Guidance Improved,,,,,,,,,,,, 3/09/2016 AMRS-US   GNW  Amyris Reports Fourth Quarter and Fiscal Year 2015 Financial Results,, 5/18/2011 00448Q20 GNW  Achillion Added to the NASDAQ Biotechnology Index (NBI),, 3/27/2014 03152W10 GNW  Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference,,,,,,,,," 3/27/2015 36315X10 GNW  Galapagos raises EU5.8 million through warrant exercises, Board and Executive Committee members invest"," 7/07/2014 4568-JP  GNW  Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Daiichi Sankyo for Phase 3 Studies of Factor Xa Inhibitor Antidote, Andexanet Alfa, and Edoxaban",,,,, 2/18/2014 33938J10 GNW  Flexion Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,11/02/2016 KPTI-US    GNW  Karyopharm to Ring the Nasdaq Stock Market Closing Bell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/17/2013 74318710 GNW  Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index,,,,,,,,,,,10/25/2012 09061G10    GNW  BioMarin Announces Third Quarter 2012 Financial Results,,,, 4/19/2016 IMMU-US  GNW  Immunomedics Reports Sacituzumab Govitecan (IMMU-132) Shows Significant Clinical Activity in Metastatic Urothelial Cancer,,, 2/12/2014 09058V10 GNW  BioCryst to Announce Fourth Quarter and 2013 Financial Results February 26,,,,,,,11/10/2017 074FLV-E GNW  Myriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSightÂ® Test to Improve Mental Health Outcomes for Veterans,,,,,,,,,, 5/09/2013 02311120 GNW  Photo Release -- Amarin Reports First Quarter 2013 Financial Results and Provides Update on Operations,,,,,," 4/22/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on April 24, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2014",,,,, 3/19/2015 80105N10 GNW  Evotec and Sanofi Sign Definitive Agreement for Major Multi-Component Strategic Alliance,,,,,,,,,, 5/08/2014 98978L20 GNW  Zogenix Reports First Quarter 2014 Financial Results,,,,,,,12/03/2014 90400D10  GNW  Ultragenyx to Present at the Oppenheimer Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 2/09/2012 60877T10 GNW  Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011,,,,,12/06/2013 GMAB-DK  GNW  Genmab Reaches Fourth Milestone in Lundbeck Collaboration,,,,,,,,,,,, 3/01/2016 AMRS-US   GNW  Amyris Biossanceâ„¢ Brand Launches The Purifier â”€ a Unique Soothing Cleansing Oil,, 5/16/2011 NDAQ-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,, 3/03/2014 03152W10 GNW  Amicus Therapeutics Announces Full-Year 2013 Financial Results and Corporate Updates,,,,,,,,," 3/17/2015 36315X10 GNW  Galapagos regains rights to GLPG1690, announces end of alliance with Janssen", 6/12/2014 73701010 GNW  Portola Pharmaceuticals to Present at the 2014 Wells Fargo Securities Healthcare Conference,,,,, 2/11/2014 33938J10 GNW  Flexion Therapeutics Announces Pricing of Initial Public Offering,,,,,,,,,,"10/31/2016 KPTI-US    GNW  Karyopharm to Report Third Quarter 2016 Financial Results on November 7, 2016",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/13/2013 CLVS-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,,,,,,,,,"10/04/2012 09061G10    GNW  BioMarin to Host Third Quarter 2012 Financial Results Conference Call and Webcast on Thursday, October 25 at 5:00 p.m. ET",,,, 4/18/2016 IMMU-US  GNW  Immunomedics Presents Updated Phase 2 Results With Labetuzumab Govitecan (IMMU-130) in Patients With Metastatic Colorectal Cancer,,, 1/02/2014 09058V10 GNW  BioCryst to Present at J.P. Morgan Healthcare Conference,,,,,,,11/09/2017 MYGN-US  GNW  Myriad Genetics to Present at the 2017 Jefferies London Healthcare Conference,,,,,,,,,," 5/03/2013 02311120 GNW  Amarin to Report First Quarter 2013 Results and Host Conference Call on May 9, 2013",,,,,, 4/16/2014 AMAG-US  GNW  AMAG Pharmaceuticals Announces Appointment of Jim Sulat to Its Board of Directors and the Transition of Chairman Role to Gino Santini,,,,, 3/19/2015 ZEAL-DK  GNW  Zealand announces that Sanofi has published top-line results from the ELIXA cardiovascular safety outcomes study of Lyxumia(r) (lix-isenatide),,,,,,,,,, 4/30/2014 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present First Quarter 2014 Financial Results,,,,,,,11/10/2014 90400D10  GNW  Ultragenyx Reports Third Quarter 2014 Financial Results and Corporate Update,,,,,,,,,,,,,,,,,,,,,, 2/01/2012 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2011 Financial Results,,,,,"12/04/2013 0CPNB1-E GNW  Genmab Announces Expansion of DuoBody Platform Collaboration with Janssen Biotech, Inc.",,,,,,,,,,,, 2/29/2016 05Q1KD-E  GNW  Amyris Announces Collaboration Agreement With COFCO Nutrition and Health Research Institute of China,, 5/04/2011 00448Q20 GNW  Achillion Reports First Quarter 2011 Financial Results,," 3/03/2014 03152W10 GNW  Amicus Therapeutics Appoints Jay A. Barth, MD as Chief Medical Officer and Promotes Bradley L. Campbell to Chief Operating Officer",,,,,,,,, 3/06/2015 36315X10 GNW  Galapagos to be included in Amsterdam Midcap Index, 6/11/2014 73701010 GNW  Portola Pharmaceuticals Announces Positive Phase 2 Data With FDA-Designated Breakthrough Therapy Andexanet Alfa and Enoxaparin,,,,,,,,,,,,,,,10/11/2016 KPTI-US    GNW  Karyopharm to Present at the 15th Annual BIO Investor Forum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/10/2013 74318710 GNW  Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results,,,,,,,,,,, 9/26/2012 09061G10    GNW  BioMarin Announces Phase 1 Results for BMN-111 for Achondroplasia,,,, 4/18/2016 IMMU-US  GNW  Immunomedics Announces Potent Anti-Tumor Activities with IMMU-114 in Preclinical Study in Acute and Chronic Leukemia,,, 5/13/2013 CLVS-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,,,,,11/07/2017 MYGN-US  GNW  Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results,,,,,,,,,, 4/30/2013 02311120 GNW  Amarin Announces Approval of Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier,,,,,," 4/01/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference",,,,, 3/19/2015 80105N10 GNW  Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia(r) (lixisenatide),,,,,,,,,, 4/24/2014 98978L20 GNW  Zogenix Announces Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International,,,,,,,11/04/2014 90400D10  GNW  Ultragenyx to Present at the Credit Suisse Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 1/26/2012 60877T10 GNW  Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. Stayed",,,,,11/26/2013 0CPNB1-E GNW  Genmab Reaches First Milestone in Daratumumab Collaboration With Janssen & Improves 2013 Financial Guidance,,,,,,,,,,,," 2/23/2016 AMRS-US   GNW  Amyris to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on Wednesday, March 9, 2016",, 4/08/2011 00448Q20 GNW  Achillion to Present at Upcoming Investor Conferences,, 2/27/2014 03152W10 GNW  Amicus Therapeutics to Present at Cowen and Company 34th Annual Health Care Conference,,,,,,,,, 3/06/2015 GLPG-BE  GNW  Galapagos reports 2014 financial results," 5/14/2014 73701010 GNW  Portola Pharmaceuticals Announces Two Presentations of Data on Cerdulatinib, an Oral Dual Syk/JAK Inhibitor, at 2014 ASCO Annual Meeting",,,,,,,,,,,,,,,10/05/2016 078V1F-E   GNW  Karyopharm to Present Updated SIGN Phase 2 Clinical Data at European Society of Medical Oncology 2016 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/06/2013 74318710 GNW  Progenics Pharmaceuticals to Host Conference Call to Review First Quarter 2013 Financial Results on May 10,,,,,,,,,,, 9/26/2012 09061G10    GNW  BioMarin Announces Decision to Start Phase 3 Program for PEG-PAL in 2Q 2013,,,, 3/17/2016 IMMU-US  GNW  Immunomedics to Present Updated Clinical Trial Results for Antibody-Drug Conjugates at Cancer Conference,,," 9/15/2011 BCRX-US  GNW  Five Prime Therapeutics, Inc. Elects Peder Jensen, M.D. to Its Board of Directors",,,,,,,11/06/2017 001D3K-E GNW  Myriad Genetics Collaborates with CareFirst BlueCross BlueShield on  Coverage with Evidence Development (CED) Study for the VectraÂ® DA Test,,,,,,,,,, 4/23/2013 02311120 GNW  Amarin Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidemia,,,,,," 2/27/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 34th Annual Healthcare Conference",,,,," 3/15/2015 REGN-US  GNW  Sanofi, Regeneron: 18-Month Results of ODYSSEY LONG TERM Trial with Praluent(TM) (alirocumab) Published in The New England Journal of Medicine",,,,,,,,,, 4/02/2014 98978L20 GNW  Zogenix Reports Granting of Inducement Awards,,,,,,,10/30/2014 90400D10  GNW  Ultragenyx Granted EU Orphan Drug Designation for KRN23 for the Treatment of X-Linked Hypophosphatemia,,,,,,,,,,,,,,,,,,,,,,"12/22/2011 60877T10 GNW  Momenta to Host Investor Conference Call on December 23, 2011 to Discuss Follow-On Biologics Collaboration With Baxter",,,,,11/13/2013 GMAB-DK  GNW  Capital Increase in Genmab as a Result of Employee Warrant Exercise and Projection of Improved Cash Position at the End of 2013,,,,,,,,,,,, 2/19/2016 AMRS-US   GNW  Amyris Announces Closing of $20 Million Private Placement,, 3/30/2011 00448Q20 GNW  Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C,," 2/26/2014 03152W10 GNW  Amicus Therapeutics to Announce Full-Year 2013 Financial Results on March 3, 2014",,,,,,,,, 2/23/2015 36315X10 GNW  Galapagos reports that the last patient in DARWIN 1 has completed 12 weeks of treatment, 5/12/2014 73701010 GNW  Portola Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update,,,,,,,,,,,,,,, 9/29/2016 KPTI-US    GNW  Karyopharm Publishes Preclinical Data in Nature Demonstrating Selinexorâ€™s Potential in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 4/24/2013 74318710 GNW  Progenics Pharmaceuticals to Present at Needham Healthcare Conference,,,,,,,,,,," 9/05/2012 09061G10    GNW  BioMarin Names Jeff Ajer Senior Vice President, Chief Commercial Officer",,,, 3/14/2016 IMMU-US  GNW  Immunomedics Provides Update on Phase 3 PANCRIT-1 Trial of Clivatuzumab Tetraxetan in Patients With Advanced Pancreatic Cancer,,, 6/30/2010 09058V10 GNW  BioCryst Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com,,,,,,,11/02/2017 MYGN-US  GNW  Myriad Announces GeneSightÂ® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive Disorder,,,,,,,,,, 4/18/2013 02311120 GNW  Amarin Announces Approval of Supplemental New Drug Application for Chemport as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier,,,,,, 2/25/2014 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Edward Jordan as Senior Vice President of Sales and Marketing,,,,," 3/09/2015 RDUS-US  GNW  Radius Health Announced Today That it Has Acquired the License to Develop and Market RAD1901 in Japan, and Has Hired Dinesh Purandare, Former Sanofi Oncology Executive to the Position of Senior Vice President (SVP) and Head of Global Oncology at Radius",,,,,,,,,, 3/26/2014 98978L20 GNW  Zogenix Appoints James Breitmeyer to Its Board of Directors,,,,,,,10/27/2014 90400D10  GNW  Ultragenyx Granted Orphan Drug Designation for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome,,,,,,,,,,,,,,,,,,,,,,12/05/2011 60877T10 GNW  Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals,,,,,11/07/2013 37230320 GNW  Genmab to Present Product and Proprietary Technology data at American Society of Hematology Annual Meeting (ASH),,,,,,,,,,,, 2/08/2016 AMRS-US   GNW  Amyrisâ€™s Fast-Growing Skin Care Brand Biossanceâ„¢ Introduces The Nourisher Precious Rose Face Oil,, 3/16/2011 00448Q20 GNW  Achillion Granted U.S. Patent for ACH-1625 and Related Protease Inhibitors,, 2/12/2014 03152W10 GNW  Amicus Therapeutics Highlights Data Featured at Lysosomal Disease Network WORLD Symposium 2014,,,,,,,,, 2/16/2015 36315X10 GNW  Galapagos reports positive Phase 1 results for GLPG1690, 5/12/2014 006RGD-E GNW  Portola Pharmaceuticals Begins Enrollment in Phase 3 Study of FDA-Designated Breakthrough Therapy Andexanet Alfa and Factor Xa Inhibitor XARELTO(R),,,,,,,,,,,,,,, 9/28/2016 KPTI-US    GNW  Karyopharm Publishes Preclinical and Phase 1 Clinical Data for Selinexor in Ovarian Cancer in Clinical Cancer Research Publication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/15/2013 SLXP-US  GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2012 Financial Results,,,,,,,,,,, 8/23/2012 09061G10    GNW  BioMarin to Present at the NewsMakers Conference,,,, 3/08/2016 IMMU-US  GNW  Immunomedics Develops Novel Antibody-Based Products for Autoimmune Disease and Cancer Therapy,,," 5/11/2010 09058V10 GNW  Skymark Research Initiates Independent Research Coverage on BioCryst Pharmaceuticals, Inc.",,,,,,,10/30/2017 007B2M-E GNW  Crescendo Bioscience Announces Six Presentations at theÂ American College of Rheumatology 2017 Annual Meeting,,,,,,,,,, 4/08/2013 02311120 GNW  Amarin Announces New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in MARINE and ANCHOR Studies of Vascepa(R),,,,,, 2/18/2014 00163U10 GNW  Study Shows MuGard(R) is More Effective Than Sham-Control at Reducing Mouth and Throat Soreness Associated With Oral Mucositis in Head and Neck Cancer Patients,,,,," 1/22/2015 80105N10 GNW  UPCOMING DEADLINE: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Sanofi SA and a Lead Plaintiff Deadline of February 2, 2015",,,,,,,,,, 3/05/2014 ZGNX-US  GNW  Zogenix Reports Fourth Quarter and Full Year 2013 Financial Results,,,,,,,10/13/2014 90400D10  GNW  Ultragenyx Announces Interim Data From Phase 2 Extension Study of Sialic Acid Extended-Release at International Congress of the World Muscle Society,,,,,,,,,,,,,,,,,,,,,,12/01/2011 60877T10 GNW  TIME CHANGE: Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST,,,,,11/06/2013 37230320 GNW  Genmab Announces Financial Results for the First Nine Months of 2013,,,,,,,,,,,, 2/01/2016 03236M20  GNW  BIOSSANCEâ„¢ to Launch on HSN on February 18,, 3/02/2011 00448Q20 GNW  Achillion Reports 2010 Fourth Quarter and Year-End Financial Results,, 2/11/2014 03152W10 GNW  Amicus Therapeutics to Present at 2014 Leerink Global Healthcare Conference,,,,,,,,, 2/11/2015 36315X10 GNW  Galapagos receives EU1.6 million IWT grant for hepatitis B program, 5/12/2014 73701010 GNW  Portola Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Health Care Conference,,,,,,,,,,,,,,," 9/12/2016 KPTI-US    GNW  Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/08/2013 74318710 GNW  Progenics Pharmaceuticals to Host Conference Call to Review Fourth Quarter Financial Results on March 15,,,,,,,,,,, 8/09/2012 09061G10    GNW  BioMarin to Present at the Canaccord Genuity Growth Conference,,,, 3/02/2016 IMMU-US  GNW  Immunomedics to Present at Cowen and Company 36th Annual Health Care Conference,,,,,,,,,,10/26/2017 MYGN-US  GNW  EndoPredict (EPclin) Shown in Second Study to be More Effective than Oncotype DXÂ® (RS) in Women with Intermediate Risk of Breast Cancer Recurrence,,,,,,,,,," 3/07/2013 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,111 Related to Vascepa(R) and Planned ANCHOR Indication",,,,,, 2/12/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Pricing of $175 Million of 2.50% Convertible Senior Notes Due 2019,,,,," 1/20/2015 80105N10 GNW  ALERT: Rosen Law Firm Reminds Sanofi Investors of Important February 2, 2015 Class Action Deadline - SNY",,,,,,,,,, 3/05/2014 98978L20 GNW  Zogenix Reports Granting of Inducement Awards,,,,,,, 9/24/2014 90400D10  GNW  Ultragenyx to Present at the Leerink Partners Rare Disease Roundtable,,,,,,,,,,,,,,,,,,,,,,11/28/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST,,,,,10/23/2013 37230320 GNW  Arzerra(r) Third Quarter 2013 Net Sales Figures,,,,,,,,,,,, 1/25/2016 AMRS-US   GNW  Muck Daddyâ„¢ Named Official Hand Cleaner of Pirelli World Challenge,, 2/09/2011 00448Q20 GNW  Achillion to Present at Upcoming Investor Conferences,, 1/30/2014 FOLD-US  GNW  Amicus Therapeutics Announces Presentations and Posters at Lysosomal Disease Network WORLD Symposium,,,,,,,,, 2/09/2015 36315X10 GNW  BNP Paribas notify of 5.08% shareholding in Galapagos," 5/05/2014 73701010 GNW  Portola Pharmaceuticals to Announce First Quarter 2014 Financial Results and Host Conference Call on Monday, May 12, 2014",,,,,,,,,,,,,,, 9/06/2016 KPTI-US    GNW  Karyopharm Reports Positive Top-Line Phase 2b STORM Results and Reviews the Planned Development Path for Selinexor in Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/05/2013 74318710 GNW  Progenics Pharmaceuticals' Novel Small Molecule Drugs Targeting PSMA Successfully Visualize Prostate Cancer,,,,,,,,,,, 8/01/2012 09061G10    GNW  BioMarin Announces Second Quarter 2012 Financial Results,,,, 2/26/2016 IMMU-US  GNW  Immunomedics Announces Termination of Epratuzumab Licensing Agreement With UCB,,,,,,,,,,"10/24/2017 MYGN-US  GNW  Myriad to Announce Fiscal First-Quarter 2018 Financial Results on November 7, 2017",,,,,,,,,, 2/28/2013 02311120 GNW  Amarin Reports Fourth Quarter and Year-End 2012 Financial Results and Provides Update on Operations,,,,,, 2/10/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Proposed Offering of $150 Million of Convertible Senior Notes due 2019,,,,," 1/20/2015 80105N10 GNW  SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sanofi -- SNY",,,,,,,,,, 2/27/2014 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2013 Financial Results,,,,,,, 9/15/2014 90400D10  GNW  Ultragenyx Announces Positive Results From a Long-Term Phase 1/2 Study of KRN23 in Adult Patients With X-Linked Hypophosphatemia,,,,,,,,,,,,,,,,,,,,,,11/07/2011 60877T10 GNW  Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011,,,,,10/18/2013 GMAB-DK  GNW  GSK and Genmab Announce Submission to US Regulatory Authorities for Arzerra(r) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL),,,,,,,,,,,, 1/15/2016 AMRS-US   GNW  Amyris Launches Pathways Program,,12/06/2010 00448Q20 GNW  Achillion to Present Data From Studies of ACH-1625 in Hepatitis C at Asian Pacific Liver Conference,, 1/13/2014 03152W10 GNW  Amicus Therapeutics Provides Full-Year 2014 Strategic Outlook and Financial Guidance,,,,,,,,, 1/22/2015 36315X10 GNW  Galapagos receives EU2.5 million IWT grant for antibiotic research, 4/14/2014 73701010 GNW  Portola Pharmaceuticals Announces Publication of Phase 3 APEX Study Design and Rationale in American Heart Journal,,,,,,,,,,,,,,, 8/30/2016 KPTI-US    GNW  Karyopharm to Host Conference Call with Update on Multiple Myeloma Plans,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 2/14/2013 74318710 GNW  Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC,,,,,,,,,,, 7/25/2012 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,, 2/05/2016 IMMU-US  GNW  U.S. Food and Drug Administration (FDA) Grants Breakthrough Therapy Designation to Immunomedics for Sacituzumab Govitecan for the Treatment of Patients With Triple-Negative Breast Cancer,,,,,,,,,,10/24/2017 MYGN-US  GNW  Myriad Submits BRACAnalysisÂ® CDx Application for Regulatory Approval in Japan for HER2- Metastatic Breast Cancer,,,,,,,,,, 2/26/2013 02311120 GNW  Amarin Announces Submission of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides With Mixed Dyslipidemia,,,,,," 2/10/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Participate in the Leerink Global Healthcare Conference",,,,, 1/19/2015 80105N10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Sanofi of Class Action Lawsuit and Upcoming Deadline -- SNY,,,,,,,,,," 2/13/2014 98978L20 GNW  Data From Zohydro(TM) ER (hydrocodone bitartrate) Phase 3 Clinical Trial Published in Pain Medicine Demonstrates Its Benefit as a Therapeutic Option for the Management of Pain Severe Enough to Require Daily, Around-the-Clock, Long-Term Opioid Treatment and for Which Alternative Treatment Options Are Inadequate",,,,,,, 9/04/2014 90400D10  GNW  Ultragenyx to Present at the Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,"10/28/2011 60877T10 GNW  Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.",,,,,10/10/2013 GMAB-DK  GNW  Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis,,,,,,,,,,,," 1/14/2016 AMRS-US   GNW  Muck Daddyâ„¢ Named Official Hand Cleaner of SCORE InternationalÂ®  and SCORE World Desert Championship, Featuring the SCORE Baja 1000",,11/04/2010 00448Q20 GNW  Achillion Awarded $2.0 Million in Qualified Therapeutic Discovery Project Grants,, 1/10/2014 03152W10 GNW  Amicus Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference,,,,,,,,, 1/21/2015 36315X10 GNW  Delta Lloyd notify of 4.96% shareholding in Galapagos," 3/27/2014 006RGD-E GNW  Portola Pharmaceuticals Initiates Phase 2 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, and Factor Xa Inhibitor Edoxaban",,,,,,,,,,,,,,, 8/04/2016 KPTI-US    GNW  Karyopharm Reports Second Quarter 2016 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 1/22/2013 00768Q-E GNW  Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline,,,,,,,,,,," 7/11/2012 09061G10    GNW  BioMarin to Host Second Quarter 2012 Financial Results Conference Call and Webcast on Wednesday, August 1 at 5:00 p.m. ET",,,, 2/03/2016 IMMU-US  GNW  Immunomedics Announces Second Quarter Fiscal 2016 Results and Clinical Program Developments,,,,,,,,,,10/19/2017 MYGN-US  GNW  GeneSightÂ® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use,,,,,,,,,," 2/22/2013 02311120 GNW  Amarin to Report Fourth Quarter and Year-End 2012 Results and Host Conference Call on February 28, 2013",,,,,, 2/10/2014 00163U10 GNW  Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer,,,,, 1/19/2015 SAN-FR   GNW  VECT-HORUS announces the signing of a scientific collaboration agreement with SANOFI,,,,,,,,,, 2/12/2014 98978L20 GNW  Zogenix Establishes External Safe-Use Board,,,,,,, 9/03/2014 90400D10  GNW  Ultragenyx Announces Positive Interim Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7,,,,,,,,,,,,,,,,,,,,,,10/24/2011 60877T10 GNW  Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms,,,,,10/04/2013 37230320 GNW  GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL),,,,,,,,,,,, 1/04/2016 AMRS-US   GNW  Amyris Signs First Multi-Million-Dollar BiofeneÂ® Ingredient Supply Agreement  for Global Nutraceuticals and Vitamins Market,,10/27/2010 00448Q20 GNW  Achillion Reports Third Quarter and Nine Month Financial Results,,12/30/2013 03152W10 GNW  Amicus Therapeutics Completes Debt Financing of Up to $25 Million -- Follows $15 Million Equity Financing,,,,,,,,, 1/09/2015 36315X10 GNW  Vicki Sato resigns from Galapagos Board," 3/19/2014 006RGD-E GNW  Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway",,,,,,,,,,,,,,, 8/03/2016 KPTI-US    GNW  Karyopharm to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/29/2012 74318710 GNW  Progenics Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,,,,,, 6/19/2012 09061G10    GNW  BioMarin to Present at the NASDAQ OMX 28th Investor Program,,,, 1/28/2016 IMMU-US  GNW  Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2016 Financial Results,,,,,,,,,,10/18/2017 AZN-GB   GNW  Myriadâ€™s BRACAnalysis CDxÂ® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for LynparzaÂ® (olaparib) in Metastatic Breast Cancer,,,,,,,,,, 2/21/2013 02311120 GNW  Amarin to Present at the CITI 2013 Global Healthcare Conference,,,,,, 2/06/2014 00163U10 GNW  AMAG Provides Business Outlook for 2014 and Reports 2013 Financial Results,,,,,"12/29/2014 80105N10 GNW  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi SA and Its Board of Directors and a Lead Plaintiff Deadline of February 2, 2015 -- SNY",,,,,,,,,, 2/11/2014 98978L20 GNW  Zogenix Provides Update on Zohydro(TM) ER (hydrocodone bitartrate) Launch Readiness Plans,,,,,,, 8/27/2014 90400D10  GNW  Ultragenyx to Present at the Baird Health Care Conference,,,,,,,,,,,,,,,,,,,,,,10/24/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2011 Financial Results,,,,, 9/13/2013 37230320 GNW  FDA Grants GSK and Genmab's Arzerra(R) (Ofatumumab) Breakthrough Therapy Designation for Previously Untreated Chronic Lymphocytic Leukemia,,,,,,,,,,,,12/17/2015 AMRS-US   GNW  Amyris Appoints Margo Georgiadis to Board of Directors,,10/20/2010 00448Q20 GNW  Achillion Announces Executive Promotions,,11/20/2013 03152W10 GNW  Amicus Therapeutics Strengthens Biologics Business Strategy,,,,,,,,, 1/08/2015 36315X10 GNW  Galapagos starts Phase 2 trial with GLPG1205 in ulcerative colitis patients, 3/18/2014 73701010 GNW  Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors,,,,,,,,,,,,,,," 7/28/2016 KPTI-US    GNW  Karyopharm to Report Second Quarter 2016 Financial Results on August 4, 2016",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/28/2012 74318710 GNW  Progenics Pharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,,,,,, 6/07/2012 09061G10    GNW  BioMarin to Present at the William Blair Growth Stock Conference,,,, 1/05/2016 IMMU-US  GNW  Immunomedics Announces New Patent Covering the Use of Antibody-SN-38 Conjugates Combination,,,,,,,,,,10/02/2017 MYGN-US  GNW  Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month,,,,,,,,,," 2/12/2013 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,129 Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,," 2/04/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on February 6, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Year Ended 2013",,,,,12/21/2014 80105N10 GNW  EQUITY ALERT: Rosen Law Firm Reminds Sanofi Investors of Important Class Action Deadline - SNY,,,,,,,,,, 2/04/2014 98978L20 GNW  Zogenix to Present at Leerink Swann 2014 Global Healthcare Conference,,,,,,, 8/11/2014 90400D10  GNW  Ultragenyx Reports Second Quarter 2014 Financial Results and Corporate Update,,,,,,,,,,,,,,,,,,,,,,"10/21/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Extension of Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.",,,,, 9/10/2013 37230320 GNW  Genmab Announces New Study of Daratumumab in Double Refractory Multiple Myeloma,,,,,,,,,,,,11/05/2015 03236M20  GNW  Amyris Reports Third Quarter 2015 Financial Results,, 9/30/2010 00448Q20 GNW  Achillion Announces Dosing of First Patient in Phase II Trial of ACH-1625 for the Treatment of Hepatitis C,,11/20/2013 03152W10 GNW  Amicus Therapeutics and GSK Announce Revised Fabry Agreement,,,,,,,,,12/19/2014 36315X10 GNW  Galapagos initiates first Phase 1 study in cystic fibrosis and will receive milestone payment from AbbVie, 2/27/2014 73701010 GNW  Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,, 7/27/2016 KPTI-US    GNW  Karyopharm to Present Updated Phase 2 Clinical Data from SIGN Study at European Society of Medical Oncology 2016 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/12/2012 NDAQ-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,,,,,,,,, 5/31/2012 09061G10    GNW  BioMarin Announces Pricing of Public Offering of Common Stock,,,,12/10/2015 45290710 GNW  Immunomedics Reports Continuing Positive Results With Sacituzumab Govitecan in Heavily Pre-Treated Metastatic Triple-Negative Breast Cancer Patients,,,,,,,,,, 9/15/2017 MYGN-US  GNW  Myriad Genetics Announces Positive Data Supporting New riskScoreâ„¢ Test at the 36th Annual Conference of the National Society of Genetic Counselors,,,,,,,,,, 2/07/2013 02311120 GNW  Amarin to Present at the Leerink Swann Global Healthcare Conference 2013,,,,,, 1/31/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Issuance of New U.S. Patent for Ferumoxytol,,,,,"12/20/2014 80105N10 GNW  SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sanofi -- SNY",,,,,,,,,, 2/04/2014 98978L20 GNW  Zogenix Reports Granting of Inducement Awards,,,,,,, 8/06/2014 90400D10  GNW  Ultragenyx to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,10/17/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the BioCentury NewsMakers Conference,,,,, 8/26/2013 37230320 GNW  Genmab Reaches Milestone in DuoBody Platform Collaboration With Janssen,,,,,,,,,,,,10/30/2015 03236M20  GNW  Amyris Honored to Receive United Nations Association Global Citizen Award,, 9/15/2010 00448Q20 GNW  Achillion to Present Multiple Posters at AASLD's The Liver Meeting 2010,,11/12/2013 03152W10 GNW  Amicus Therapeutics Announces Third Quarter 2013 Financial Results,,,,,,,,,12/16/2014 36315X10 GNW  Galapagos regains full rights to GPR84 inhibitor GLPG1205, 2/24/2014 73701010 GNW  Portola Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference,,,,,,,,,,,,,,, 7/27/2016 KPTI-US    GNW  Karyopharm Announces Phase 1b Selinexor Sarcoma Data Published in Journal of Clinical Oncology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/08/2012 74318710 GNW  Progenics Pharmaceuticals Announces Third Quarter 2012 Financial Results,,,,,,,,,,, 5/30/2012 09061G10    GNW  BioMarin Announces Public Offering of Common Stock,,,,12/07/2015 45290710 GNW  Immunomedics Reports Initial Results of a Phase I First-In-Man Study With IMMU-114 in Hematologic Malignancies,,,,,,,,,, 9/12/2017 MYGN-US  GNW  Myriad Genetics to Present Three Studies at the 2017  National Society of Genetic Counselors Annual Conference,,,,,,,,,," 2/07/2013 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,146 Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,, 1/22/2014 00163U10 GNW  AMAG Pharmaceuticals Receives Complete Response Letter From U.S. Food and Drug Administration for the Supplemental New Drug Application for Feraheme(R) for the Broader IDA Indication,,,,,12/19/2014 80105N10 GNW  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Sanofi of Class Action Lawsuit and Upcoming Deadline -- SNY,,,,,,,,,, 1/13/2014 98978L20 GNW  Zogenix Announces Preliminary Fourth Quarter 2013 Gross Product Sales,,,,,,, 8/05/2014 90400D10  GNW  Ultragenyx Announces License of Intellectual Property for the Treatment of Epilepsy and Other Seizure-Related Disorders With Triheptanoin,,,,,,,,,,,,,,,,,,,,,,"10/07/2011 60877T10 GNW  Momenta Pharmaceuticals Obtains Temporary Restraining Order Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.",,,,, 8/14/2013 37230320 GNW  Genmab Announces Financial Results for the First Half of 2013 and Improves 2013 Financial Guidance,,,,,,,,,,,,"10/21/2015 03236M20  GNW  Amyris to Announce Third Quarter Financial Results on Thursday, November 5, 2015",, 8/18/2010 00448Q20 GNW  Achillion Announces Private Placement of $50 Million,, 9/26/2013 03152W10 GNW  Amicus Therapeutics to Present at Leerink Swann Rare Disease Roundtable,,,,,,,,,12/12/2014 36315X10 GNW  Galapagos selects second component of its investigational cystic fibrosis combination treatment," 2/20/2014 73701010 GNW  Portola Pharmaceuticals to Announce Fourth Quarter and Year End 2013 Financial Results and Host Conference Call on Thursday, February 27, 2014",,,,,,,,,,,,,,, 7/06/2016 05G2H2-E   GNW  Karyopharm to Present at Cantor Fitzgeraldâ€™s 2nd Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/06/2012 74318710 GNW  Progenics Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference,,,,,,,,,,, 5/30/2012 09061G10    GNW  BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,12/03/2015 IMMU-US  GNW  Immunomedics to Participate in the 26th Annual Oppenheimer Healthcare Conference,,,,,,,,,, 9/05/2017 MYGN-US  GNW  Myriad Launches riskScoreâ„¢ Beginning the Next Epoch in Hereditary Cancer Testing,,,,,,,,,," 2/01/2013 02311120 GNW  Amarin Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results",,,,,," 1/21/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on January 22, 2014 at 7:30 a.m. E.T. to Provide a Regulatory Update",,,,,"12/11/2014 80105N10 GNW  SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi SA and Its Board of Directors and a Lead Plaintiff Deadline of February 2, 2015 -- SNY",,,,,,,,,," 1/09/2014 00FBLN-E GNW  Zogenix and Mallinckrodt Agree to End Co-Promotion for SUMAVEL(R) DosePro(R) Effective January 31, 2014",,,,,,," 7/23/2014 00D326-E  GNW  Ultragenyx Appoints Sunil Agarwal, M.D. as Chief Medical Officer and Senior Vice President",,,,,,,,,,,,,,,,,,,,,," 9/30/2011 AMPR-US  GNW  Momenta Pharmaceuticals Files for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.",,,,, 7/24/2013 37230320 GNW  Arzerra(R) Second Quarter 2013 Net Sales Figures,,,,,,,,,,,,10/21/2015 03236M20  GNW  Amyris Expands Distribution of Muck Daddy(TM),, 8/13/2010 00448Q20 GNW  Achillion Reports Second Quarter and Six Month Financial Results,," 9/11/2013 03152W10 GNW  Amicus Therapeutics' CEO John F. Crowley to Advocate for Rare and Orphan Disease Community in Washington, D.C. This Week",,,,,,,,,12/09/2014 36315X10 GNW  Galapagos increases share capital through warrant exercises," 2/03/2014 006RGD-E GNW  Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Bayer and Janssen for Phase 3 Studies of Andexanet Alfa*, Investigational Factor Xa Inhibitor Reversal Agent, and XARELTO(R)",,,,,,,,,,,,,,, 6/22/2016 KPTI-US    GNW  Karyopharm Initiates Phase 1 Clinical Trial with KPT-9274,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/02/2012 74318710 GNW  Progenics Pharmaceuticals to Host Conference Call to Review Third Quarter Financial Results on November 8,,,,,,,,,,, 5/29/2012 09061G10    GNW  BioMarin to Present at the Goldman Sachs Global Healthcare Conference,,,,12/02/2015 45290710 GNW  Immunomedics Announces Voting Results From 2015 Annual Meeting of Stockholders,,,,,,,,,, 8/30/2017 MYGN-US  GNW  Myriad Genetics to Present at the 2017 Morgan Stanley Global Healthcare Conference,,,,,,,,,," 1/31/2013 02311120 GNW  Amarin Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,, 1/13/2014 00163U10 GNW  AMAG Pharmaceuticals Announces Preliminary Fourth Quarter and Annual 2013 Financial Results,,,,,12/10/2014 80105N10 GNW  Robbins Arroyo LLP: Sanofi (SNY) Misled Shareholders According to a Recently Filed Class Action,,,,,,,,,, 1/07/2014 98978L20 GNW  Zogenix Reports Granting of Inducement Awards,,,,,,, 7/14/2014 90400D10  GNW  Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,,,,,,,,,,,, 9/21/2011 60877T10 GNW  Momenta Pharmaceuticals Sues Amphastar for Patent Infringement,,,,, 7/18/2013 37230320 GNW  Genmab Files IND for HuMax-TF-ADC,,,,,,,,,,,,10/20/2015 03236M20  GNW  Amyris Wins a SEPAWA Innovation Award for Breakthrough Emollient - Neossance(R) Hemisqualane,, 7/22/2010 00448Q20 GNW  Achillion Pharmaceuticals Announces Nomination of NS5A Inhibitor as a Lead Clinical Candidate for Treatment ff HCV,, 9/10/2013 03152W10 GNW  Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease,,,,,,,,,11/24/2014 36315X10 GNW  Galapagos completes recruitment for Darwin 2 monotherapy study with GLPG0634 (filgotinib) in RA," 1/13/2014 006RGD-E GNW  Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis",,,,,,,,,,,,,,, 6/16/2016 KPTI-US    GNW  Karyopharm Outlines Key Selinexor Clinical Development Achievements,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/28/2012 74318710 GNW  Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients,,,,,,,,,,, 5/29/2012 09061G10    GNW  BioMarin to Present at the Jefferies Global Healthcare Conference,,,,12/01/2015 IMMU-US  GNW  Immunomedics to Present First Clinical Results With Anti-HLA-DR Antibody for Treatment of Hematologic Malignancies at the 2015 Annual Meeting of the American Society of Hematology,,,,,,,,,, 8/29/2017 MYGN-US  GNW  Myriad Genetics to Present at the 2017 Wells Fargo Healthcare Conference,,,,,,,,,, 1/24/2013 02311120 GNW  Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG),,,,,," 1/09/2014 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference",,,,,"12/09/2014 80105N10 GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Sanofi to Contact Brower Piven Before the February 2, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- SNY",,,,,,,,,,12/17/2013 98978L20 GNW  Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team,,,,,,, 7/09/2014 90400D10  GNW  Ultragenyx Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,, 9/19/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the UBS Global Life Sciences Conference and Pharmaceutical Strategic Alliances Conference,,,,, 7/15/2013 GMAB-DK  GNW  Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case,,,,,,,,,,,,10/15/2015 03236M20  GNW  Amyris Announces Pricing of Its $57.6 Million of Convertible Senior Notes Due 2019 With a Conversion Price of $2.25 Per Share,, 6/03/2010 00448Q20 GNW  Achillion to Present at Upcoming Conference,, 9/05/2013 03152W10 GNW  Amicus Therapeutics to Present at Stifel Nicolaus 2013 Healthcare Conference,,,,,,,,,11/17/2014 GLPG-BE  GNW  Galapagos presents clean drug-drug interaction profile with GLPG0634 (filgotinib) at ACR 2014," 1/06/2014 73701010 GNW  Portola Pharmaceuticals Announces Webcast of Corporate Presentation on January 13, 2014",,,,,,,,,,,,,,, 6/15/2016 002N2S-E   GNW  Karyopharm to Present at the 2016 JMP Securities Life Science Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/20/2012 74318710 GNW  Progenics Pharmaceuticals Provides Corporate Update,,,,,,,,,,, 5/08/2012 09061G10    GNW  BioMarin Appoints Dan Spiegelman as Executive Vice President and Chief Financial Officer,,,,11/09/2015 45290710 GNW  Immunomedics Reports Improved Progression-Free Survival Results With Sacituzumab Govitecan in Triple-Negative Breast Cancer,,,,,,,,,, 8/17/2017 MYGN-US  GNW  EndoPredictÂ® Receives Positive Coverage Decisions From Medicare and Anthem,,,,,,,,,, 1/23/2013 02311120 GNW  Amarin Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results,,,,,, 1/07/2014 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources,,,,,"12/05/2014 80105N10 GNW  SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sanofi - SNY",,,,,,,,,,12/11/2013 98978L20 GNW  Zogenix Reports Granting of Inducement Awards,,,,,,, 7/07/2014 90400D10  GNW  Ultragenyx Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,, 9/08/2011 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences,,,,, 7/04/2013 37230320 GNW  Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder,,,,,,,,,,,,10/14/2015 03236M20  GNW  Amyris Announces Offering of $50 Million of Convertible Senior Notes Due 2019,, 5/13/2010 00448Q20 GNW  Biopharma Stock Alert for Achillion Pharmaceuticals Inc. Issued by MicroStockProfit,, 8/08/2013 03152W10 GNW  Amicus Therapeutics to Present at Two August Investor Conferences,,,,,,,,,11/12/2014 GLPG-BE  GNW  Galapagos completes recruitment for Darwin 1 study with GLPG0634 (filgotinib) in RA,"12/09/2013 73701010 GNW  Portola Pharmaceuticals Announces New Phase 2 Results Confirming Immediate, Dose-Dependent and Well-Tolerated Reversal of Anticoagulation Activity of XARELTO(R) (rivaroxaban) With Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Reversal Agent",,,,,,,,,,,,,,, 6/10/2016 KPTI-US    GNW  Karyopharm Presents Preliminary STOMP Phase 1b Clinical Data at 2016 European Hematology Association Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/30/2012 74318710 GNW  Progenics Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference,,,,,,,,,,, 5/08/2012 09061G10    GNW  BioMarin to Present at the Deutsche Bank Healthcare Conference,,,,11/09/2015 45290710 GNW  Immunomedics Announces Sacituzumab Govitecan Is Synergistic With Chemotherapeutics That Target Cell Division in Triple-Negative Breast Cancer,,,,,,,,,, 8/08/2017 MYGN-US  GNW  Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and  Fiscal Full-Year 2017 Financial Results,,,,,,,,,, 1/22/2013 02311120 GNW  Amarin Announces Publication of Additional Inflammatory Marker Data From MARINE and ANCHOR Phase 3 Clinical Trials in the American Journal of Cardiovascular Drugs,,,,,,11/15/2013 00163U10 GNW  AMAG Pharmaceuticals Announces Presentation at Jefferies 2013 Global Healthcare Conference in London,,,,,12/05/2014 80105N10 GNW  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Sanofi -- SNY,,,,,,,,,,12/10/2013 98978L20 GNW  Zogenix Announces FDA Approval of 4 mg SUMAVEL(R) DosePro(R) (sumatriptan injection) Needle-Free Delivery System,,,,,,, 7/01/2014 90400D10  GNW  Ultragenyx Announces Initiation of a Phase 2 Study of KRN23 for Pediatric X-Linked Hypophosphatemia in the US and EU,,,,,,,,,,,,,,,,,,,,,, 8/16/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the 2011 Wedbush Life Sciences Management Access Conference,,,,, 6/17/2013 0CGRYV-E GNW  Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhead,,,,,,,,,,,,10/12/2015 03236M20  GNW  Amyris Achieves Record Low Cost Farnesene Production,, 5/11/2010 00448Q20 GNW  Achillion Announces Positive Once-Daily Dosing Results With ACH-1625 to Treat Hepatitis C,, 8/07/2013 03152W10 GNW  Amicus Therapeutics Announces Second Quarter 2013 Financial Results,,,,,,,,,11/06/2014 36315X10 GNW  GSK discloses good efficacy in psoriasis with GSK2856184,12/03/2013 73701010 GNW  Portola Pharmaceuticals Announces Upcoming Data Presentations on Andexanet Alfa (PRT4445*) and PRT2070 at 55th American Society of Hematology (ASH) Annual Meeting,,,,,,,,,,,,,,, 6/01/2016 KPTI-US    GNW  Karyopharm to Present at the Jefferies 2016 Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/09/2012 74318710 GNW  Progenics Pharmaceuticals Announces Second Quarter 2012 Financial Results,,,,,,,,,,, 5/08/2012 09061G10    GNW  BioMarin to Present at the Baird Growth Stock Conference,,,,11/04/2015 45290710 GNW  Immunomedics Announces First Quarter Fiscal 2016 Results and Clinical Program Developments,,,,,,,,,," 7/28/2017 MYGN-US  GNW  Myriad to Announce Fiscal Fourth-Quarter 2017 Financial Results on August 8, 2017",,,,,,,,,," 1/11/2013 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,,"10/29/2013 00163U10 GNW  AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs",,,,,12/05/2014 80105N10 GNW  EQUITY ALERT: Lawsuit Filed Against Sanofi to Recover Investor Losses - SNY,,,,,,,,,,12/04/2013 98978L20 GNW  Zogenix to Present at the Oppenheimer 24th Annual Healthcare Conference,,,,,,, 6/24/2014 90400D10  GNW  Ultragenyx Announces Results From Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults,,,,,,,,,,,,,,,,,,,,,, 8/08/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference,,,,, 6/11/2013 37230320 GNW  Teprotumumab Restarts Clinical Development in New Indication,,,,,,,,,,,,10/06/2015 03236M20  GNW  Third Unique Fermentation Product Successfully Produced at Amyris Industrial Plant in Brasil,, 5/10/2010 00448Q20 GNW  Achillion Reports First Quarter Financial Results,," 8/01/2013 03152W10 GNW  Amicus Therapeutics to Announce Second Quarter 2013 Financial Results on August 7, 2013",,,,,,,,,"10/27/2014 36315X10 GNW  Galapagos and Calchan collaborate on osteoarthritis research, PS2.4 million grant awarded by Innovate UK","11/25/2013 73701010 GNW  Portola Pharmaceuticals Receives Breakthrough Therapy Designation From FDA for Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Antidote",,,,,,,,,,,,,,, 5/19/2016 KPTI-US    GNW  Karyopharm to Present Preliminary STOMP Phase 1B Clinical Data at 2016 European Hematology Association Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/02/2012 74318710 GNW  Progenics Pharmaceuticals to Host Conference Call to Review Second Quarter Financial Results on August 9,,,,,,,,,,, 4/26/2012 BMRN-US     GNW  BioMarin Announces First Quarter 2012 Financial Results,,,,10/29/2015 45290710 GNW  Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2016 Financial Results,,,,,,,,,," 6/19/2017 MYGN-US  GNW  Virginia C. Drosos, President of Assurex Health, Receives theÂ EY Entrepreneur of the YearÂ 2017 Award in Ohio Valley Region",,,,,,,,,, 1/02/2013 AMRN-IE  GNW  Amarin to Present at the 31st Annual J.P. Morgan Healthcare Conference,,,,,,10/23/2013 00163U10 GNW  AMAG Reports Third Quarter and Nine Month 2013 Financial Results,,,,,12/04/2014 80105N10 GNW  Pomerantz Law Firm Announces the Filing of a Class Action Against Sanofi and Certain Officers -- SNY,,,,,,,,,,12/03/2013 06WHYZ-E GNW  Zogenix and Battelle Expand DosePro Technology Business Agreement,,,,,,, 6/18/2014 90400D10  GNW  Ultragenyx to Present at the JMP Securities Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 8/04/2011 60877T10 GNW  Momenta Pharmaceuticals Reports $1.26 Earnings Per Share for the Second Quarter of 2011,,,,, 5/31/2013 05PZGR-E GNW  Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program,,,,,,,,,,,, 9/23/2015 03236M20  GNW  Amyris Announces Multi-Year Technology Investment Agreement With DARPA Worth Up to $35 Million,,,, 6/25/2013 03152W10 GNW  Amicus Therapeutics Announces Chaperone-Advanced Replacement Therapy in Development for Mucopolysaccharidosis Type I (MPS I),,,,,,,,,10/20/2014 36315X10 GNW  Galapagos discloses novel target and presents favorable Phase 1 data for GLPG1205 at UEG Week,11/11/2013 73701010 GNW  Portola Pharmaceuticals Announces Additional Positive Phase 2 Proof-of-Concept Data for Andexanet Alfa (PRT4445*),,,,,,,,,,,,,,, 5/18/2016 06N2PB-E   GNW  Karyopharm to Present Selinexor Clinical Data at the American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/15/2012 74318710 GNW  Progenics Pharmaceuticals to Present at the BIO International Convention,,,,,,,,,,," 4/05/2012 09061G10    GNW  BioMarin to Host First Quarter 2012 Financial Results Conference Call and Webcast on Thursday, April 26 at 5:00 p.m. ET",,,,10/19/2015 45290710 GNW  Immunomedics Reports Durable Responses in Patients With Advanced Solid Cancers After Therapy With Sacituzumab Govitecan,,,,,,,,,, 6/15/2017 MYGN-US  GNW  Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with VectraÂ® DA at the 2017 Annual European Congress of Rheumatology,,,,,,,,,, 1/02/2013 02311120 GNW  Amarin Announces Submission of a Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier,,,,,,"10/17/2013 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on October 23, 2013 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended September 30, 2013",,,,,12/02/2014 80105N10 GNW  Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration,,,,,,,,,,"11/12/2013 98978L20 GNW  Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters",,,,,,, 5/19/2014 90400D10  GNW  Ultragenyx Announces KRN23 Phase 1/2 Study Data to be Presented at ICE/ENDO Meeting on June 23rd and June 24th,,,,,,,,,,,,,,,,,,,,,, 7/25/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2011,,,,, 5/29/2013 37230320 GNW  GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia,,,,,,,,,,,, 9/11/2015 03236M20  GNW  Amyris to Enter Into Exclusive Cosmetic Distribution Partnership With Leading Brazil Cosmetic Retailer,,,, 6/17/2013 03152W10 GNW  Amicus Therapeutics to Host Conference Call Today at 8:00 a.m. ET to Discuss Regulatory Strategy for Migalastat HCl Monotherapy for Fabry Disease,,,,,,,,,10/17/2014 36315X10 GNW  Galapagos creates new warrant plan,11/05/2013 73701010 GNW  Portola Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update,,,,,,,,,,,,,,, 5/09/2016 KPTI-US    GNW  Karyopharm Reports First Quarter 2016 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/08/2012 74318710 GNW  Progenics Pharmaceuticals Announces First Quarter 2012 Financial Results,,,,,,,,,,, 3/08/2012 09061G10    GNW  BioMarin Completes Enrollment for Phase 3 Trial for GALNS for the Treatment of MPS IVA,,,, 9/08/2015 45290710 GNW  Immunomedics Reports Interim Phase 2 Results With Sacituzumab Govitecan in Lung Cancers,,,,,,,,,, 6/08/2017 MYGN-US  GNW  Crescendo Bioscience Announces Six Studies with VectraÂ® DA Will Be Presented at the 2017 Annual European Congress of Rheumatology,,,,,,,,,,"12/19/2012 02311120 GNW  Amarin Announces Submission of Supplemental New Drug Application for Chemport, Inc. as an Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier",,,,,,10/16/2013 00163U10 GNW  AMAG Pharmaceuticals Receives Notice of 3-month Extension of the PDUFA Action Date for the Supplemental New Drug Application for Feraheme(R) for the Broader IDA Indication,,,,,11/21/2014 ZEAL-DK  GNW  Zealand informs that Sanofi has confirmed development plans for LixiLan at Investor Relations Thematic Seminar,,,,,,,,,,11/05/2013 98978L20 GNW  Zogenix Prices Public Offering of Common Stock,,,,,,, 5/12/2014 90400D10  GNW  Ultragenyx Reports First Quarter 2014 Financial Results and Corporate Update,,,,,,,,,,,,,,,,,,,,,, 6/21/2011 60877T10 GNW  Momenta Pharmaceuticals CEO Craig Wheeler Named Ernst & Young Entrepreneur Of The Year(R) 2011 New England Award Winner,,,,, 5/17/2013 37230320 GNW  Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case,,,,,,,,,,,, 9/09/2015 03236M20  GNW  Amyris and IDRI Announce Agreement to Explore Testing and Development of Amyris Materials for Use in Vaccine Adjuvant Formulations,,,, 5/30/2013 03152W10 GNW  Amicus Therapeutics to Present at Jefferies 2013 Global Healthcare Conference,,,,,,,,,10/15/2014 36315X10 GNW  Bart Filius joins Galapagos as CFO,"10/31/2013 73701010 GNW  Portola Pharmaceuticals to Announce Third Quarter 2013 Financial Results and Host Conference Call on Tuesday, November 5, 2013",,,,,,,,,,,,,,," 5/02/2016 KPTI-US    GNW  Karyopharm to Report First Quarter 2016 Financial Results on May 9, 2016",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/04/2012 74318710 GNW  Progenics Pharmaceuticals to Host Conference Call to Review First Quarter Financial Results on May 8,,,,,,,,,,, 3/06/2012 09061G10    GNW  BioMarin to Present at the Barclays Global Healthcare Conference,,,, 9/02/2015 IMMU-US  GNW  Immunomedics to Present at Upcoming Investor Conferences,,,,,,,,,, 6/04/2017 MYGN-US  GNW  Myriadâ€™s BRACAnalysis CDxÂ® Test Identified Patients with Metastatic Breast Cancer Who Benefited from Treatment with Olaparib in Phase 3 OlympiAD Study,,,,,,,,,,12/17/2012 02311120 GNW  Amarin Announces Completion of Dosing in a Fixed-Dose Combination Study With Vascepa(R) and a Leading Statin,,,,,,10/14/2013 00163U10 GNW  Ferumoxytol Abstract Recognized as a Presidential Poster Recipient at American College of Gastroenterology Annual Scientific Meeting,,,,,10/29/2014 SAN-FR   GNW  Statement from Sanofi Board of Directors,,,,,,,,,,11/04/2013 ZGNX-US  GNW  Altus Formulation Signs Agreement With Zogenix for Development of Abuse Deterrent Formulations of Zohydro(TM) ER,,,,,,, 4/30/2014 90400D10  GNW  Ultragenyx Announces Positive Data From Phase 2 Study of Sialic Acid Extended-Release at Emerging Sciences Session of American Academy of Neurology Annual Meeting,,,,,,,,,,,,,,,,,,,,,, 6/20/2011 60877T10 GNW  Momenta Pharmaceuticals Study Showing M402 Inhibits Tumor Metastasis in Multiple Murine Oncology Models Published in PLoS One,,,,, 5/07/2013 37230320 GNW  Genmab Announces Financial Results for the First Quarter of 2013,,,,,,,,,,,," 9/02/2015 AMRS-US   GNW  Amyris to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015",,,, 5/14/2013 03152W10 GNW  Amicus Therapeutics to Present at UBS Global Healthcare Conference,,,,,,,,,10/09/2014 36315X10 GNW  Galapagos presents novel cystic fibrosis combination therapy at NACFC,"10/24/2013 73701010 GNW  Portola Pharmaceuticals Announces Enrollment Has Begun in Phase 1/2 Study of PRT2070, an Oral Dual Syk/JAK Inhibitor for Genetically-Defined Hematologic Cancers",,,,,,,,,,,,,,, 4/20/2016 06W0Z6-E   GNW  Karyopharm Presents Data Demonstrating the Potential of Nuclear Export Protein Exportin 1 (XPO1) Inhibition in the Treatment of Traumatic Brain Injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/29/2012 74318710 GNW  Progenics Pharmaceuticals to Participate in Investor Conferences,,,,,,,,,,, 2/22/2012 09061G10    GNW  BioMarin to Present at the RBC Global Healthcare Conference,,,, 8/19/2015 45290710 GNW  Immunomedics Announces Fiscal 2015 Results and Clinical Program Developments,,,,,,,,,, 6/02/2017 MYGN-US  GNW  Myriad Announces 17 Additional Health Insurance Plans Covering EndoPredictâ„¢,,,,,,,,,,"12/13/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,, 9/09/2013 AMAG-US  GNW  AMAG Pharmaceuticals Announces Appointment of Barbara Deptula to Board of Directors,,,,,10/16/2014 80105N10 GNW  Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy,,,,,,,,,,11/04/2013 98978L20 GNW  Zogenix Announces Proposed Public Offering of Common Stock,,,,,,, 4/28/2014 90400D10  GNW  Sialic Acid Extended-Release Phase 2 Study Data to be Presented at American Academy of Neurology Annual Meeting,,,,,,,,,,,,,,,,,,,,,, 5/27/2011 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences,,,,, 5/01/2013 GMAB-DK  GNW  Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia,,,,,,,,,,,, 9/02/2015 AMRS-US   GNW  Amyris Set to Increase Global Growth of Its Cosmetic Emollients Through ISO 22716 Certification,,,, 5/09/2013 03152W10 GNW  Amicus Therapeutics Announces First Quarter 2013 Financial Results and Corporate Updates,,,,,,,,, 9/25/2014 36315X10 GNW  Galapagos increases share capital through warrant exercises,10/17/2013 73701010 GNW  Portola Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,, 4/06/2016 48576U10   GNW  Karyopharm Taps TransPerfect as eTMF and Functional TMF Provider,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/15/2012 74318710 GNW  Progenics Pharmaceuticals Announces Retirement of Founder Paul J. Maddon,,,,,,,,,,, 2/22/2012 09061G10    GNW  BioMarin to Present at the Citi Global Health Care Conference,,,, 8/19/2015 IMMU-US  GNW  Immunomedics Appoints Arthur S. Kirsch as Director,,,,,,,,,," 6/02/2017 MYGN-US  GNW  Myriad Genetics Announces Results from a Large 2,000 Patient Clinical Utility Study of Its myRiskÂ® Hereditary Cancer Test at the 53rd Annual Meeting of ASCO",,,,,,,,,,12/12/2012 02311120 GNW  David Stack Appointed to Amarin Board of Directors,,,,,," 9/03/2013 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences",,,,, 8/21/2014 SAN-FR   GNW  Zealand Pharma A/S - Interim report for H1 2014 (un-audited),,,,,,,,,,11/04/2013 98978L20 GNW  Zogenix Reports Third Quarter 2013 Financial Results,,,,,,, 3/27/2014 90400D10  GNW  Ultragenyx Announces Preliminary Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7,,,,,,,,,,,,,,,,,,,,,, 5/25/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Date for 2011 Annual Meeting of Stockholders,,,,, 5/01/2013 GMAB-DK  GNW  Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration,,,,,,,,,,,, 8/31/2015 03236M20  GNW  Amyris Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready for Industrial Scale Fermentation in Less Than 12 Months,,,," 5/02/2013 03152W10 GNW  Amicus Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013",,,,,,,,, 9/18/2014 36315X10 GNW  Galapagos reports high participation rate in long term extension study with GLPG0634 in RA patients,10/16/2013 006RGD-E GNW  Portola Pharmaceuticals Announces Proposed Offering of Common Stock,,,,,,,,,,,,,,, 4/05/2016 05KDBG-E   GNW  Karyopharm to Present at the 15th Annual Needham Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/15/2012 74318710 GNW  Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2011 Financial Results,,,,,,,,,,, 2/21/2012 09061G10    GNW  BioMarin Announces Chief Financial Officer Jeffrey Cooper to Leave the Company,,,, 8/18/2015 45290710 GNW  Immunomedics Extends U.S. Patent Protection for Antibody-Drug Conjugate Program to 2033,,,,,,,,,, 5/31/2017 MYGN-US  GNW  Myriad Genetics to Present at the 2017 William Blair Growth Stock Conference,,,,,,,,,,12/11/2012 02311120 GNW  Amarin Announces Additional Vascepa(R) (icosapent ethyl) Supplier,,,,,, 8/07/2013 00163U10 GNW  AMAG Pharmaceuticals Announces Issuance of New U.S. Patent for Ferumoxytol,,,,, 8/11/2014 80105N10 GNW  Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin,,,,,,,,,,11/01/2013 98978L20 GNW  Zogenix Pursues Development of Abuse Deterrent Formulations of Zohydro(TM) ER With Altus Formulation,,,,,,, 3/27/2014 90400D10  GNW  The NASDAQ Stock Market Leads U.S. Exchanges for IPOs in Q1 2014,,,,,,,,,,,,,,,,,,,,,," 5/12/2011 60877T10 GNW  Momenta Pharmaceuticals Appoints Nic G. Scalfarotto, D.V.M., Vice President of Regulatory Affairs",,,,, 4/24/2013 37230320 GNW  Arzerra First Quarter 2013 Net Sales Figures,,,,,,,,,,,, 8/10/2015 AMRS-US   GNW  Amyris & Genome Compiler Launch Testing Program for Pharma and Biotech Companies to Explore DNA Design and Construction Solutions,,,, 4/24/2013 03152W10 GNW  Amicus Therapeutics to Present at 12th Annual Needham Healthcare Conference,,,,,,,,, 8/08/2014 GLPG-BE  GNW  Galapagos cash position of EU232 M provides solid basis for R&D pipeline investment,10/15/2013 73701010 GNW  Portola Pharmaceuticals Announces Release of Lock-up Restriction for Common Stock Held by a Director of the Company,,,,,,,,,,,,,,, 3/31/2016 KPTI-US    GNW  Karyopharm Receives NIAID Grant to Advance Development of KPT-350 for the Treatment of Lupus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 3/13/2012 74318710 GNW  Progenics Pharmaceuticals to Host Conference Call to Review Fourth Quarter and Year-End 2011 Financial Results on March 15,,,,,,,,,,, 2/16/2012 09061G10    GNW  BioMarin Announces Fourth Quarter and Full Year 2011 Financial Results,,,, 8/13/2015 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2015 Financial Results,,,,,,,,,, 5/30/2017 MYGN-US  GNW  Myriad Genetics to Present at the 2017 Goldman Sachs Global Healthcare Conference,,,,,,,,,,12/06/2012 02311120 GNW  Amarin Announces $100 Million Non-Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives,,,,,, 8/01/2013 00163U10 GNW  AMAG Announces Second Quarter and Six Month 2013 Financial Results,,,,, 8/07/2014 80105N10 GNW  Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy,,,,,,,,,,10/25/2013 98978L20 GNW  Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules,,,,,,, 3/24/2014 90400D10  GNW  Ultragenyx Reports Fourth Quarter and Full Year 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,, 5/05/2011 60877T10 GNW  Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2011,,,,, 4/17/2013 GMAB-DK  GNW  Passing of Genmab A/S' Annual General Meeting,,,,,,,,,,,, 8/06/2015 03236M20  GNW  Amyris Reports Second Quarter 2015 Financial Results,,,, 3/12/2013 03152W10 GNW  Amicus Therapeutics Announces Full-Year 2012 Financial Results and Corporate Updates,,,,,,,,, 8/05/2014 GLPG-BE  GNW  Galapagos receives milestone in osteoarthritis alliance with Servier,10/14/2013 73701010 GNW  Portola Pharmaceuticals Announces First Phase 2 Results Demonstrating Extended Duration Infusion With Andexanet Alfa (PRT4445*) Provides Prolonged Reversal of Anticoagulation Activity of Factor Xa Inhibitor Eliquis(R),,,,,,,,,,,,,,, 3/16/2016 06P9WL-E   GNW  Karyopharm to Present Data on Oncology Pipeline at the 2016 American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/09/2011 74318710 GNW  Progenics Pharmaceuticals Announces Third Quarter 2011 Financial Results,,,,,,,,,,, 2/16/2012 09061G10    GNW  BioMarin Initiates Phase 1 Trial for BMN-111 for the Treatment of Achondroplasia,,,, 8/04/2015 IMMU-US  GNW  Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Immune Thrombocytopenia,,,,,,,,,, 5/25/2017 MYGN-US  GNW  Medicare Coverage of ProlarisÂ® Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer,,,,,,,,,,"12/04/2012 02311120 GNW  Amarin Announces U.S. Patent 8,324,195 Issuance for Vascepa(R)",,,,,," 7/30/2013 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Host Conference Call on August 1, 2013 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended June 30, 2013",,,,, 7/31/2014 SNY-FR   GNW  SANOFI: Solid sales and Business EPS(1) growth at CER in Q2 2014,,,,,,,,,,10/01/2013 98978L20 GNW  Zogenix Provides Update on Zohydro(TM) ER NDA,,,,,,, 3/21/2014 90400D10  GNW  Ultragenyx to Present at the BioCentury Future Leaders in the Biotech Industry Conference,,,,,,,,,,,,,,,,,,,,,, 4/28/2011 60877T10 GNW  Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences,,,,, 4/16/2013 GMAB-DK  GNW  Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit,,,,,,,,,,,," 8/03/2015 AMRS-US   GNW  Amyris to Present at Jefferies 11th Annual Industrials Conference on August 10, 2015",,,," 3/07/2013 03152W10 GNW  Amicus Therapeutics to Announce Full-Year 2012 Financial Results on March 12, 2013",,,,,,,,, 7/25/2014 36315X10 GNW  Galapagos creates new warrant plan,10/09/2013 73701010 GNW  Portola Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Study of PRT2070,,,,,,,,,,,,,,, 3/14/2016 KPTI-US    GNW  Karyopharm Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/08/2011 74318710 GNW  Progenics Pharmaceuticals to Participate in Investor Conferences,,,,,,,,,,, 2/07/2012 09061G10    GNW  BioMarin to Present at the BIO CEO & Investor Conference,,,, 6/02/2015 45290710 GNW  Immunomedics Reports Labetuzumab Govitecan is Active in Relapsed Metastatic Colorectal Cancer,,,,,,,,,, 5/18/2017 MYGN-US  GNW  Myriad Genetics to Present Seven Studies at the 2017 American SocietyÂ ofÂ ClinicalÂ Oncology Annual Meeting,,,,,,,,,,"11/27/2012 02311120 GNW  Amarin Announces U.S. Patent 8,318,715 Issuance for Vascepa(R)",,,,,," 7/23/2013 00163U10 GNW  AMAG Pharmaceuticals Appoints Carol Satler, M.D., Ph.D. as Senior Vice President of Medical and Scientific Affairs",,,,, 7/10/2014 0072XH-E GNW  First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia,,,,,,,,,, 8/08/2013 98978L20 GNW  Zogenix Reports Second Quarter 2013 Financial Results,,,,,,, 3/11/2014 90400D10  GNW  Ultragenyx Announces First Patient Enrolled in Phase 2 Study of Triheptanoin in Glucose Transporter Type-1 Deficiency Syndrome,,,,,,,,,,,,,,,,,,,,,, 4/25/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2011 Financial Results,,,,, 4/02/2013 37230320 GNW  Daratumumab Granted Fast Track Designation From U.S. Food and Drug Administration,,,,,,,,,,,, 7/30/2015 03236M20  GNW  Amyris Announces Closings of Conversion and Restructuring of Approximately $175 Million of Convertible Debt and $25 Million Private Placement,,,," 3/04/2013 03152W10 GNW  Amicus Therapeutics Introduces Proprietary ""CHART"" Platform Technology",,,,,,,,, 7/23/2014 36315X10 GNW  MorphoSys and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development, 9/05/2013 73701010 GNW  Portola Pharmaceuticals Announces Participation at Upcoming Investor Conferences,,,,,,,,,,,,,,," 3/07/2016 KPTI-US    GNW  Karyopharm to Report Fourth Quarter and Full Year 2015 Financial Results on March 14, 2016",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,11/03/2011 74318710 GNW  Progenics to Host Conference Call to Review Third Quarter 2011 Financial Results on November 9,,,,,,,,,,," 1/23/2012 09061G10    GNW  BioMarin to Host Fourth Quarter and Full Year 2011 Financial Results Conference Call and Webcast on Thursday, February 16 at 5:00 p.m. ET",,,, 6/02/2015 45290710 GNW  Immunomedics Announces Durable Responses in Metastatic Lung Cancer Patients Treated With Sacituzumab Govitecan,,,,,,,,,, 5/12/2017 MYGN-US  GNW  Myriad Geneticsâ€™ ProlarisÂ® Test Accurately Predicts the 10-Year Risk of Metastases in Men Treated for Prostate Cancer,,,,,,,,,,"11/26/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,247 Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,, 7/03/2013 00163U10 GNW  AMAG Pharmaceuticals Appoints Amit Verma as Vice President of Marketing,,,,, 7/09/2014 REGN-US  GNW  Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis,,,,,,,,,, 8/05/2013 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Second Quarter 2013 Financial Results,,,,,,, 2/26/2014 90400D10  GNW  Ultragenyx to Present at Cowen and Company 34th Annual Health Care Conference in Boston,,,,,,,,,,,,,,,,,,,,,, 3/01/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference,,,,, 3/25/2013 37230320 GNW  Arzerra Receives Approval in Japan,,,,,,,,,,,," 7/27/2015 03236M20  GNW  Amyris to Announce Second Quarter Financial Results on Thursday, August 6, 2015",,,, 2/27/2013 03152W10 GNW  Amicus Therapeutics to Present at Cowen and Company 33rd Annual Health Care Conference,,,,,,,,, 7/23/2014 GLPG-NL  GNW  MorphoSys and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development, 7/24/2013 00C9HF-E GNW  NASDAQ Welcomes Heat Biologics (NASDAQ:HTBX) to The NASDAQ Stock Market,,,,,,,,,,,,,,, 3/04/2016 KPTI-US    GNW  Karyopharmâ€™s Selinexor First-in-Human Phase 1 Clinical Trial Data Published in Journal of Clinical Oncology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,10/14/2011 74318710 GNW  Progenics Pharmaceuticals to Present at NewsMakers Conference,,,,,,,,,,,12/09/2011 VRUS.XX1-US GNW  Quarterly Changes to the NASDAQ Q-50 Index,,,, 6/01/2015 45290710 GNW  Immunomedics Reports Promising Results With Sacituzumab Govitecan in Patients With Metastatic Gastrointestinal Cancers,,,,,,,,,, 5/05/2017 MYGN-US  GNW  Myriad Genetics to Present Results from Four Studies at the  American Urological Association 2017 Annual Meeting,,,,,,,,,,"11/20/2012 02311120 GNW  Amarin Announces U.S. Patent 8,314,086 Issuance for Vascepa(R)",,,,,," 6/24/2013 00163U10 GNW  New Campaign Wants Patients to Know ""Iron Matters""",,,,, 6/19/2014 MACK-US  GNW  Merrimack Pharmaceuticals to Regain Worldwide Rights to Develop and Commercialize MM-121,,,,,,,,,, 8/01/2013 98978L20 GNW  Zogenix Begins Promotion of Migranal(R) Nasal Spray,,,,,,, 2/12/2014 90400D10  GNW  Ultragenyx Announces Presentation of Data From a Single Patient Treated With Recombinant Human Beta-Glucuronidase at 10th Annual World Lysosomal Disease Network Symposium,,,,,,,,,,,,,,,,,,,,,, 2/23/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Webcast of Presentations at Upcoming Investment Conferences,,,,, 3/07/2013 37230320 GNW  Genmab 2012 Annual Report,,,,,,,,,,,, 7/27/2015 03236M20  GNW  Amyris Announces Signing of Agreements for Conversion and Restructuring of Approximately $175 Million of Convertible Debt and $25 Million Private Placement,,,, 2/15/2013 03152W10 GNW  Amicus Therapeutics Presents Additional 6-Month Results from Phase 3 Fabry Monotherapy Study at LDN World Symposium,,,,,,,,, 7/04/2014 36315X10 GNW  Galapagos raises EU1.9 million through warrant exercises, 5/31/2013 KMDA-IL  GNW  NASDAQ Welcomes Kamada Ltd. [KMDA] to The NASDAQ Stock Market,,,,,,,,,,,,,,, 2/03/2016 KPTI-US    GNW  Karyopharm to Present at the Leerink Partners 5th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/16/2011 74318710 GNW  Progenics Pharmaceuticals to Present at UBS Global Life Sciences Conference,,,,,,,,,,, 4/06/2011 MYGN-US     GNW  Myriad Genetics and BioMarin Pharmaceutical Inc. Enter Into Agreement,,,, 6/01/2015 45290710 GNW  Immunomedics Reports Complete Responses in Patients With Metastatic Triple-Negative Breast Cancer After Sacituzumab Govitecan Treatment,,,,,,,,,, 5/02/2017 MYGN-US  GNW  Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results,,,,,,,,,,"11/19/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa(R) and FDA Approved MARINE Indication",,,,,," 6/24/2013 AMAG-US  GNW  AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer",,,,, 6/14/2014 80105N10 GNW  Sanofi Reports Positive Phase 3 Results for Toujeo(R),,,,,,,,,, 6/27/2013 98978L20 GNW  Zogenix and Valeant Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Migranal(R) Nasal Spray,,,,,,, 2/11/2014 90400D10  GNW  Ultragenyx Announces Initiation of Phase 2 Study for Patients with Long-Chain Fatty Acid Oxidation Disorders,,,,,,,,,,,,,,,,,,,,,, 2/10/2011 60877T10 GNW  Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2010,,,,, 2/28/2013 37230320 GNW  Genmab Announces Sale of Manufacturing Facility to Baxter,,,,,,,,,,,," 7/20/2015 03236M20  GNW  Amyris Announces Early Success of Muck Daddy(TM), High-Performance Hand Cleaner -- With Initial Pre-Launch Product Shipments Surpassing 3,000 Units",,,, 2/14/2013 03152W10 GNW  Amicus Therapeutics Advances Chaperone-Enzyme Replacement Therapy (ERT) Combination Platform in Pompe Disease,,,,,,,,," 7/01/2014 36315X10 GNW  Galapagos initiates Phase 1 study with GLPG1690, triggering EU6.6 M milestone in the alliance with Janssen Pharmaceutica NV",,,,,,,,,,,,,,,, 1/19/2016 KPTI-US    GNW  Karyopharm Initiates Second Generation SINEâ„¢ Compound Clinical Trial in Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 9/15/2011 74318710 GNW  Progenics Pharmaceuticals Announces Strategic Focus on Oncology,,,,,,,,,,, 2/25/2011 MRX-US      GNW  Medicis Reports Fourth Quarter and Year-End 2010 Results,,,, 5/26/2015 45290710 GNW  Immunomedics to Present at Jefferies 2015 Global Healthcare Conference,,,,,,,,,, 4/27/2017 62855J10 GNW  Myriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDxÂ® Test to Identify Patients with Germline BRCA Mutations for RubracaÂ® (rucaparib) Treatment,,,,,,,,,,11/08/2012 02311120 GNW  Amarin Reports Third Quarter 2012 Financial Results and Provides Update on Operations,,,,,, 6/10/2013 00163U10 GNW  AMAG Pharmaceuticals Obtains US Commercial Rights to MuGard(TM) A Prescription Oral Rinse to Manage Oral Mucositis,,,,, 6/14/2014 80105N10 GNW  Sanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient Experience and Outcomes,,,,,,,,,, 6/25/2013 98978L20 GNW  Zogenix Launches Improved Migraine Toolbox in Conjunction With National Migraine Awareness Month,,,,,,," 2/06/2014 90400D10  GNW  Ultragenyx Appoints Clay Siegall, Ph.D. and Matthew Fust to Board of Directors",,,,,,,,,,,,,,,,,,,,,, 2/09/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the Leerink Swann Hot Topics Roundtable Conference,,,,, 2/06/2013 061NC9-E GNW  Arzerra Fourth Quarter and Full Year 2012 Net Sales Figures,,,,,,,,,,,," 7/16/2015 03236M20  GNW  Amyris Announces Multi-Year, Multi-Million-Dollar Agreement With Global Food Ingredients Supplier",,,, 2/13/2013 03152W10 GNW  Amicus Therapeutics Presents Additional Results From Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study for Fabry Disease at LDN World Symposium,,,,,,,,, 6/17/2014 36315X10 GNW  Galapagos cystic fibrosis program progresses towards therapy for largest patient group,,,,,,,,,,,,,,,, 1/14/2016 KPTI-US    GNW  Karyopharm Initiates Clinical Trial of Oral Selinexor in Advanced Liposarcoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/09/2011 74318710 GNW  Progenics Pharmaceuticals Announces Second Quarter 2011 Financial Results,,,,,,,,,,,,,,, 5/15/2015 45290710 GNW  Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan for Non-Small Cell Lung Cancer Therapy,,,,,,,,,," 4/18/2017 MYGN-US  GNW  Myriad to Announce Fiscal Third-Quarter 2017 Financial Results on May 2, 2017",,,,,,,,,,"11/01/2012 02311120 GNW  Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012",,,,,, 6/07/2013 00163U10 GNW  AMAG Pharmaceuticals Announces Submission of a Type II Variation for Rienso Label Expansion in Europe to Include All Adult Iron Deficiency Anemia Patients Who Cannot Take Oral Iron,,,,, 5/28/2014 LLY-US   GNW  Sanofi and Lilly announce licensing agreement for Cialis(R) (tadalafil) OTC,,,,,,,,,, 6/05/2013 98978L20 GNW  Zogenix Announces Initiatives to Reach Key Business Milestones,,,,,,, 2/05/2014 90400D10  GNW  Ultragenyx Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,,,,,,,,,,,, 2/09/2011 60877T10 GNW  Momenta Pharmaceuticals to Present at the 13th Annual BIO CEO Investor Conference,,,,, 1/24/2013 37230320 GNW  Major Shareholder Announcement,,,,,,,,,,,, 7/01/2015 AMRS-US   GNW  Amyris Announces Update and Correction Regarding Its SMA Industria Quimica Joint Venture with Usina Sao Martinho,,,, 2/07/2013 03152W10 GNW  Amicus Therapeutics Announces Posters and Presentations at Lysosomal Disease Network WORLD Symposium,,,,,,,,, 5/12/2014 36315X10 GNW  Galapagos to hold Annual R&D Update on 17 June 2014 in New York,,,,,,,,,,,,,,,, 1/04/2016 KPTI-US    GNW  Karyopharm to Present at the 34th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 8/02/2011 74318710 GNW  Progenics to Host Conference Call to Review Second Quarter 2011 Financial Results on August 9,,,,,,,,,,,,,,, 5/14/2015 45290710 GNW  Immunomedics Announces Five Presentations at 2015 ASCO Focusing on Antibody-Drug Conjugate Programs,,,,,,,,,, 4/17/2017 MYGN-US  GNW  Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification Between Myriad Genetics and A Common Public Database,,,,,,,,,,"10/30/2012 02311120 GNW  Amarin Announces U.S. Patent 8,298,554 Issuance for Vascepa(TM)",,,,,," 6/03/2013 00163U10 GNW  AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences",,,,," 5/05/2014 SAN-FR   GNW  Sanofi: Annual General Shareholder Meeting of May 5, 2014",,,,,,,,,," 5/20/2013 98978L20 GNW  Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics",,,,,,, 1/30/2014 RARE-US   GNW  Ultragenyx Announces Pricing of Initial Public Offering,,,,,,,,,,,,,,,,,,,,,, 2/08/2011 60877T10 GNW  Momenta Pharmaceuticals Awarded U.S. Patent for Methods of Preparing Glatiramer Acetate,,,,,12/17/2012 37230320 GNW  Genmab Unveils a New Antibody Technology Platform: HexaBody,,,,,,,,,,,, 6/30/2015 AMRS-US   GNW  Amyris Announces Total's Decision to Proceed With Jet Fuel Joint Venture and Plans to Restructure and Convert $175 Million of Outstanding Convertible Debt for Common Stock,,,, 2/04/2013 03152W10 GNW  Amicus Therapeutics to Participate in BIO CEO & Investor Conference and Leerink Swann Global Healthcare Conference,,,,,,,,, 4/30/2014 36315X10 GNW  Invitation to the Extraordinary General Shareholders' Meeting to be held on 19 May 2014,,,,,,,,,,,,,,,,12/07/2015 KPTI-US    GNW  Karyopharm Therapeutics Presents Positive Clinical Data on the Activity of Selinexor in Combination with Other Anticancer Agents across Multiple Hematologic Malignancies at the 2015 American Society of Hematology (ASH) Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 6/28/2011 74318710 GNW  Progenics Submits RELISTOR(R) Supplemental NDA for the Treatment of Opioid-Induced Constipation in Patients With Chronic, Non-Cancer Pain",,,,,,,,,,,,,,, 5/12/2015 45290710 GNW  Immunomedics Extends U.S. Patent Protection for Sacituzumab Govitecan to 2033,,,,,,,,,," 4/06/2017 BGNE-US  GNW  Myriad Genetics and BeiGene Sign Agreement to Develop Companion Diagnostics for Use with BeiGeneâ€™s Novel PARP Inhibitor, BGB-290",,,,,,,,,,"10/23/2012 02311120 GNW  Amarin Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa(TM)",,,,,, 5/21/2013 00163U10 GNW  Ferumoxytol Treatment Produced Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease Who Had Failed or Could Not Tolerate Oral Iron Therapy,,,,, 5/05/2014 05LNMP-E GNW  Shantha's Pentavalent Pediatric Vaccine prequalified by World Health Organization,,,,,,,,,, 5/09/2013 98978L20 GNW  Zogenix Reports First Quarter 2013 Financial Results,,,,,,,12/20/2013 00D326-E  GNW  Ultragenyx Announces Results From Phase 2 Study of Sialic Acid Extended-Release Treatment in Hereditary Inclusion Body Myopathy,,,,,,,,,,,,,,,,,,,,,, 1/27/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2010 Financial Results,,,,,"12/13/2012 37230320 GNW  Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance",,,,,,,,,,,, 6/29/2015 AMRS-US   GNW  Amyris Announces Successful Completion of Volkswagen Renewable Diesel Evaluation Program,,,, 1/07/2013 03152W10 GNW  Amicus Therapeutics Provides Full-Year 2013 Financial Guidance and Strategic Outlook,,,,,,,,, 4/28/2014 36315X10 GNW  Galapagos announces management change,,,,,,,,,,,,,,,,11/30/2015 KPTI-US    GNW  Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) in Hematologic Malignancies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 6/02/2011 74318710 GNW  Progenics Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference,,,,,,,,,,,,,,, 5/06/2015 45290710 GNW  Immunomedics Announces Third Quarter Fiscal 2015 Results and Clinical Program Developments,,,,,,,,,, 4/05/2017 MYGN-US  GNW  Pivotal Study Results for Myriadâ€™s myPathÂ® Melanoma Test Highlighted  In Two Additional Scientific Publications,,,,,,,,,," 9/10/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/349,150 Related to Vascepa(TM) and FDA Approved MARINE Indication",,,,,, 5/06/2013 00163U10 GNW  Ferumoxytol Results in Significant Hemoglobin Increases in Adult Iron Deficiency Anemia Patients With Abnormal Uterine Bleeding Who Had Failed or Could Not Tolerate Oral Iron Therapy,,,,, 4/30/2014 SNY-FR   GNW  Sanofi: Slowing of Brain Atrophy and Reductions in New MS Lesions Sustained at Three Years in Patients Treated with Genzyme's Lemtrada,,,,,,,,,, 5/03/2013 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results,,,,,,,12/17/2013 00D326-E  GNW  Ultragenyx Investigational New Drug Application for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome is in Effect,,,,,,,,,,,,,,,,,,,,,, 1/19/2011 60877T10 GNW  Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors,,,,,12/13/2012 37230320 GNW  Genmab Reaches Third Milestone in Lundbeck Collaboration,,,,,,,,,,,, 6/25/2015 03236M20  GNW  Amyris & Dinaco Announce Exclusive Re-Seller Agreement for Neossance(R) Cosmetic Ingredients in Brazil,,,, 1/04/2013 03152W10 GNW  Amicus Therapeutics Announces Positive Results From All Four Cohorts in Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Co-Administration Study for Pompe Disease,,,,,,,,, 4/24/2014 07M9VQ-E GNW  Baker Brothers notify of 4.99% shareholding in Galapagos,,,,,,,,,,,,,,,,11/09/2015 48576U10   GNW  Karyopharm Reports Third Quarter 2015 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
," 5/20/2011 74318710 GNW  Progenics Announces Results of Methylnaltrexone Phase 3 Safety Study in Chronic, Non-Malignant Pain Patients",,,,,,,,,,,,,,, 4/30/2015 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2015 Financial Results,,,,,,,,,, 3/20/2017 MYGN-US  GNW  Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting,,,,,,,,,," 9/06/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/284,408 Related to Vascepa(TM) and FDA Approved MARINE Indication",,,,,,,,,,," 4/28/2014 SAN-FR   GNW  The World's First, Large-Scale Dengue Vaccine Efficacy Study Successfully Achieved Its Primary Clinical Endpoint",,,,,,,,,, 5/02/2013 98978L20 GNW  Zogenix Reports Positive Top-Line Results From Extended Relday(TM) Phase 1 Clinical Trial,,,,,,,12/04/2013 00D326-E  GNW  Ultragenyx Announces Initiation of Phase 1/2 Study of Recombinant Human Beta-Glucuronidase (rhGUS) in Mucopolysaccharidosis Type 7 (MPS 7),,,,,,,,,,,,,,,,,,,,,," 1/04/2011 60877T10 GNW  Momenta Pharmaceuticals Appoints Young T. Kwon as Vice President, Business Development",,,,,12/11/2012 37230320 GNW  Genmab Reaches Milestone in DuoBody Platform Collaboration With Janssen,,,,,,,,,,,, 6/09/2015 03236M20  GNW  Amyris & Ipca Laboratories Ltd. Sign Letter of Intent for Development and Supply of Active Pharmaceutical Ingredients,,,, 1/02/2013 FOLD-US  GNW  Amicus Therapeutics to Present at 31st Annual J.P. Morgan Healthcare Conference,,,,,,,,, 4/17/2014 36315X10 GNW  GSK2586184 met primary endpoint in Phase 2a psoriasis study,,,,,,,,,,,,,,,,11/05/2015 KPTI-US    GNW  Karyopharm to Present Data on Oncology Pipeline at American Society of Hematology 2015 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/10/2011 PGNX-US  GNW  Progenics Pharmaceuticals Announces First Quarter 2011 Financial Results,,,,,,,,,,,,,,," 4/20/2015 45290710 GNW  Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments",,,,,,,,,, 3/13/2017 MYGN-US  GNW  Myriad Genetics Launches the EndoPredictÂ® Test in the United States for Patients with Breast Cancer,,,,,,,,,," 9/05/2012 02311120 GNW  Amarin Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa(TM) and FDA Approved MARINE Indication",,,,,,,,,,, 4/25/2014 SAN-FR   GNW  SANOFI : Sanofi Reaches New Milestone in Fight Against Malaria: 300 million ASAQ Treatments Delivered in Africa,,,,,,,,,, 3/27/2013 98978L20 GNW  Zogenix and Battelle Extend DosePro Co-Marketing Partnership,,,,,,,"10/06/2013 00D326-E  GNW  Ultragenyx Announces the Presentation of Data From a Single Dose Phase 1 Study, Conducted by Kyowa Hakko Kirin Co. Ltd. (KHK), of KRN23 in X-linked Hypophosphatemia (XLH) in Adults",,,,,,,,,,,,,,,,,,,,,,12/22/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Exercise and Closing of Over-Allotment Option,,,,,12/09/2012 37230320 GNW  New Preliminary Efficacy Data for Daratumumab Presented at ASH,,,,,,,,,,,, 6/08/2015 03236M20  GNW  Amyris Announces Executive Appointments to Accelerate Growth,,,,12/19/2012 GSK-GB   GNW  Amicus Therapeutics and GlaxoSmithKline Announce Top Line 6-Month Primary Treatment Period Results From First Phase 3 Fabry Monotherapy Study,,,,,,,,, 4/10/2014 36315X10 GNW  Galapagos raises EU2.4 million through warrant exercises,,,,,,,,,,,,,,,,"11/02/2015 48576U10   GNW  Karyopharm to Report Third Quarter 2015 Financial Results on November 9, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
, 5/09/2011 74318710 GNW  Progenics to Host First Quarter 2011 Financial Results Conference Call and Webcast May 10,,,,,,,,,,,,,,, 4/06/2015 45290710 GNW  Immunomedics to Provide Update on Sacituzumab Govitecan for the Therapy of Solid Cancers,,,,,,,,,, 2/23/2017 MYGN-US  GNW  GeneSightÂ® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical Therapeutics,,,,,,,,,," 9/04/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for U.S. Application 13/282,145 Related to Vascepa(TM) and FDA Approved MARINE Indication",,,,,,,,,,, 4/21/2014 SNY-FR   GNW  Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business,,,,,,,,,, 3/15/2013 98978L20 GNW  Zogenix Reports Fourth Quarter and Full Year 2012 Financial Results,,,,,,, 9/26/2013 00D326-E  GNW  Ultragenyx Announces Three Abstracts Accepted for Poster Presentation at 18th Annual World Muscle Society Congress,,,,,,,,,,,,,,,,,,,,,,12/13/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Completion of Public Offering of Common Stock,,,,,12/05/2012 37230320 GNW  Genmab Announces DuoBody Platform Collaboration With Kyowa Hakko Kirin,,,,,,,,,,,," 6/02/2015 03236M20  GNW  Amyris Announces Designation of Bram Klaeijsen, Seasoned Global Business Leader From Cargill, to Board of Directors",,,,11/12/2012 03152W10 GNW  Amicus Therapeutics to Present at Lazard Capital Markets' Healthcare Conference,,,,,,,,, 4/01/2014 GLPG-BE  GNW  Charles River Laboratories and Galapagos complete transaction,,,,,,,,,,,,,,,,10/19/2015 48576U10   GNW  Karyopharm Initiates STOMP Clinical Trial of Oral Selinexor in Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/19/2015 IMMU-US  GNW  Immunomedics Presents Updated Results With Sacituzumab Govitecan in Lung Cancer,,,,,,,,,," 2/17/2017 AZN-GB   GNW  Myriadâ€™s BRACAnalysis CDxÂ® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, Olaparib",,,,,,,,,, 8/28/2012 02311120 GNW  Amarin Announces Additional Publication of MARINE Phase 3 Clinical Trial Results in the Journal of Clinical Lipidology,,,,,,,,,,, 4/07/2014 GENZ-US  GNW  Sanofi: Genzyme to Resubmit Lemtrada Application for FDA Review,,,,,,,,,, 3/07/2013 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2012 Financial Results,,,,,,, 9/16/2013 00D326-E  GNW  Ultragenyx Announces Positive Data From Retrospective Study of UX007 Triheptanoin in Patients With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD),,,,,,,,,,,,,,,,,,,,,,12/08/2010 60877T10 GNW  Momenta Pharmaceuticals Prices Underwritten Offering of Common Stock,,,,,11/07/2012 37230320 GNW  CORRECTION: Genmab Announces Financial Results for the First Nine Months of 2012 and Improves 2012 Financial Guidance,,,,,,,,,,,," 5/22/2015 03236M20  GNW  Amyris to Participate in Panel Discussion at Cowen and Company 43rd Annual Technology, Media & Telecom Conference on May 28, 2015",,,,11/08/2012 03152W10 GNW  Amicus Therapeutics Announces Additional Preliminary Results From Ongoing Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study for Fabry Disease,,,,,,,,, 3/28/2014 36315X10 GNW  Invitation to the Annual and Extraordinary General Shareholders' Meetings to be held on 29 April 2014,,,,,,,,,,,,,,,, 9/03/2015 48576U10   GNW  Karyopharm Advancing Neuroprotective SINE(TM) Compounds in Amyotrophic Lateral Sclerosis (ALS),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/12/2015 45290710 GNW  Immunomedics Announces Completion of Offering of $85 Million of 4.75% Convertible Senior Notes Due 2020,,,,,,,,,, 2/17/2017 MYGN-US  GNW  Myriadâ€™s ProlarisÂ® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate Cancer,,,,,,,,,, 8/08/2012 02311120 GNW  Amarin Reports Second Quarter 2012 Financial Results and Provides Update on Operations,,,,,,,,,,, 3/31/2014 SAN-FR   GNW  Sanofi Appoints Dr. Anne C. Beal to the Newly Created Position of Chief Patient Officer,,,,,,,,,, 2/26/2013 98978L20 GNW  Zogenix Provides Update on Zohydro(TM) ER Regulatory Review,,,,,,, 9/03/2013 00D326-E  GNW  Ultragenyx Announces Collaboration With Kyowa Hakko Kirin to Develop and Commercialize Phase 2-Stage KRN23 for X-Linked Hypophosphatemia,,,,,,,,,,,,,,,,,,,,,,12/07/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock,,,,,11/07/2012 37230320 GNW  Genmab Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance,,,,,,,,,,,, 5/05/2015 03236M20  GNW  Amyris Reports First Quarter 2015 Financial Results,,,,11/05/2012 03152W10 GNW  Amicus Therapeutics Announces Third Quarter 2012 Financial Results & Corporate Updates,,,,,,,,, 3/21/2014 GLPG-BE  GNW  Euronext Amsterdam to become Market of Reference for Galapagos,,,,,,,,,,,,,,,, 8/10/2015 48576U10   GNW  Karyopharm Reports Second Quarter 2015 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/05/2015 45290710 GNW  Immunomedics Announces Pricing of Offering of $85 Million of 4.75% Convertible Senior Notes Due 2020,,,,,,,,,, 2/07/2017 MYGN-US  GNW  Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results,,,,,,,,,," 7/31/2012 02311120 GNW  Amarin to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012",,,,,,,,,,, 1/30/2014 LLY-US   GNW  Sanofi Files Suit in The U.S. To Defend Its Patent Rights on Lantus(R) and Lantus(R) SoloStar(R),,,,,,,,,, 1/07/2013 98978L20 GNW  Zogenix Announces Preliminary Fourth Quarter 2012 Gross Product Sales,,,,,,, 8/28/2013 00D326-E  GNW  Ultragenyx Announces Presentation of Three Abstracts at the 12th International Congress of Inborn Errors of Metabolism (ICIEM 2013),,,,,,,,,,,,,,,,,,,,,,12/06/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the 2010 Deutsche Bank BioFEST,,,,,10/31/2012 37230320 GNW  Arzerra Third Quarter 2012 Net Sales Figures,,,,,,,,,,,, 5/01/2015 03236M20  GNW  Amyris Hosts Event to Preview Launch of Biossance(TM) Brand,,,,11/05/2012 03152W10 GNW  Amicus Therapeutics Announces Updated Results From Phase 2 Extension Study of Migalastat HCl for Fabry Disease,,,,,,,,," 3/18/2014 36315X10 GNW  Galapagos to present favorable pre-clinical data on GLPG1790, a selective ephrin receptor kinase inhibitor, at AACR in San Diego",,,,,,,,,,,,,,,," 8/03/2015 48576U10   GNW  Karyopharm to Report Second Quarter 2015 Financial Results on August 10, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/04/2015 45290710 GNW  Immunomedics Announces Proposed Offering of $85 Million of Convertible Senior Notes Due 2020,,,,,,,,,," 1/24/2017 MYGN-US  GNW  Myriad to Announce Fiscal Second-Quarter 2017 Financial Results on February 7, 2017",,,,,,,,,, 7/26/2012 02311120 GNW  Amarin Announces FDA Approval of Vascepa(TM) (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients With Severe Hypertriglyceridemia,,,,,,,,,,," 1/15/2014 ZEAL-DK  GNW  CORRECTION: Zealand announces advance by Sanofi of LixiLan, the single injection Lyxumia(r)/Lantus(r) combination product, towards Phase III development and a related milestone payment",,,,,,,,,, 1/03/2013 98978L20 GNW  Zogenix Reports Positive Results From Relday(TM) Phase 1 Clinical Trial,,,,,,, 8/26/2013 00D326-E  GNW  Ultragenyx Investigational New Drug Application for UX007 is Active,,,,,,,,,,,,,,,,,,,,,,12/02/2010 60877T10 GNW  Momenta Pharmaceuticals Sues Teva for Patent Infringement,,,,,10/16/2012 37230320 GNW  Major Shareholder Announcement,,,,,,,,,,,," 4/16/2015 03236M20  GNW  Amyris to Announce First Quarter Financial Results on Tuesday, May 5, 2015",,,,"11/01/2012 03152W10 GNW  Amicus Therapeutics to Announce Third Quarter 2012 Financial Results on November 5, 2012",,,,,,,,, 3/13/2014 07Q8KB-E GNW  Charles River Laboratories to acquire Galapagos' Argenta and BioFocus service operations for up to EU134 million,,,,,,,,,,,,,,,, 6/22/2015 48576U10   GNW  Karyopharm Presents Hematologic Cancer Data on Lead Drug Candidate Selinexor at International Conference on Malignant Lymphoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/04/2015 45290710 GNW  Immunomedics Announces Second Quarter Fiscal 2015 Results and Clinical Program Developments,,,,,,,,,, 1/06/2017 MYGN-US  GNW  The EndoPredictÂ® Test Receives Positive Coverage Decisions from Multiple Blue Cross Blue Shield Affiliate Plans,,,,,,,,,, 7/25/2012 02311120 GNW  Amarin Receives Notice of Intention to Grant on European Patent,,,,,,,,,,," 1/15/2014 SAN-FR   GNW  Zealand Announces Advance by Sanofi of LixiLan, the Single Injection Lyxumia(R)/Lantus(R) Combination Product, Towards Phase III Development and a Related Milestone Payment",,,,,,,,,,12/07/2012 98978L20 GNW  Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro(TM) ER for Management of Chronic Pain,,,,,,, 8/14/2013 00D326-E  GNW  Ultragenyx Receives Approval of Clinical Trial Application (CTA) for a Phase 1/2 Trial Testing UX003 in Mucopolysaccharidosis Type 7 (MPS 7),,,,,,,,,,,,,,,,,,,,,,"11/08/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Nature Biotechnology Publication Demonstrating CHO Cells Can Produce Galactose-Alpha-1,3-Galactose Antigens on Proteins",,,,,10/16/2012 GMAB-DK  GNW  Capital Increase in Genmab as a Result of Execution of a Private Placement to Johnson & Johnson Development Corporation,,,,,,,,,,,, 4/09/2015 03236M20  GNW  Amyris & Squalan Natural Health Partner to Accelerate Development and Sales of Neossance(R) Personal Care Products,,,,10/22/2012 03152W10 GNW  Amicus Therapeutics Achieves Target Enrollment in Second Phase 3 Fabry Monotherapy Study,,,,,,,,, 3/07/2014 GLPG-BE  GNW  Galapagos reports 2013 financial results,,,,,,,,,,,,,,,, 6/15/2015 0844XQ-E   GNW  Karyopharm Presents Hematologic Cancer Data on Lead Drug Candidate Selinexor at European Hematology Association Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/03/2015 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2015 Financial Results,,,,,,,,,, 1/05/2017 063Z5S-E GNW  EndoPredictÂ® Reviewed by Blue Cross Blue Shield Associationâ€™s Evidence Street,,,,,,,,,, 7/24/2012 02311120 GNW  Amarin Announces Publication of ANCHOR Phase 3 Clinical Trial Results in The American Journal of Cardiology,,,,,,,,,,, 1/13/2014 80105N10 GNW  Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases,,,,,,,,,,12/07/2012 98978L20 GNW  Trading of Zogenix Common Stock Halted,,,,,,, 8/07/2013 00D326-E  GNW  Ultragenyx to Present at Upcoming Healthcare Investor Conferences,,,,,,,,,,,,,,,,,,,,,,11/05/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the Credit Suisse 2010 Healthcare Conference,,,,, 9/21/2012 37230320 GNW  Agreement for Daratumumab Receives Antitrust Clearance,,,,,,,,,,,, 3/03/2015 03236M20  GNW  Amyris & Genome Compiler Partner to Commercialize DNA Construction Software Services for the Pharma and Biotech Industries,,,,10/16/2012 03152W10 GNW  Amicus Therapeutics Announces Data Presentations and Posters at Upcoming Scientific Meetings,,,,,,,,, 3/07/2014 36315X10 GNW  Galapagos receives EU2 million from osteoarthritis alliance with Servier,,,,,,,,,,,,,,,, 6/01/2015 48576U10   GNW  Karyopharm Presents Clinical Data for Selinexor (KPT-330) in Patients With Recurrent Glioblastoma and Advanced Sarcomas at 2015 ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/29/2015 45290710 GNW  Immunomedics Announces Dismissal of Putative Class Action Lawsuit,,,,,,,,,,12/28/2016 MYGN-US  GNW  Myriad Genetics to Present at the 2017 JP Morgan Healthcare Conference,,,,,,,,,, 7/02/2012 02311120 GNW  Amarin Announces Notice of Allowance for Additional U.S. Patent Covering AMR101,,,,,,,,,,,"12/19/2013 SNY-FR   GNW  Sanofi, Regeneron To Collaborate with American College of Cardiology for PCSK9 Inhibitor Clinical Program",,,,,,,,,,11/26/2012 98978L20 GNW  Zogenix Appoints New Chief Commercial Officer,,,,,,, 8/05/2013 00D326-E  GNW  Ultragenyx Initiates New Development Program Studying Triheptanoin (UX007) for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS),,,,,,,,,,,,,,,,,,,,,,11/02/2010 60877T10 GNW  Momenta Pharmaceuticals Receives Four Therapeutic Discovery Project Credits Totaling Nearly $1M,,,,, 8/30/2012 0CPNB1-E GNW  Additional Details Concerning Issue of Shares to Johnson & Johnson Development Corporation as Part of the Daratumumab Agreement,,,,,,,,,,,, 2/24/2015 AMRS-US   GNW  Amyris Secures Equity Financing Commitment,,,,10/11/2012 03152W10 GNW  Amicus Therapeutics Announces Positive Pompe Program Updates,,,,,,,,," 2/28/2014 GSK-GB   GNW  Galapagos provides status update for GSK2586184 in GSK's psoriasis, lupus, and ulcerative colitis clinical studies",,,,,,,,,,,,,,,, 5/30/2015 48576U10   GNW  Karyopharm Presents Clinical Data for Selinexor (KPT-330) in Patients With Heavily Pretreated Gynecological Cancers and Asian Patients With Advanced Malignancies at 2015 ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/20/2015 45290710 GNW  Immunomedics Reports Phase 1/2 Results With Sacituzumab Govitecan (IMMU-132) in Patients With Metastatic Gastrointestinal Cancers,,,,,,,,,,12/27/2016 007B2M-E GNW  Positive Clinical Utility Results of Crescendoâ€™s VectraÂ® DA Test for Rheumatoid Arthritis Published in the Journal Arthritis & Rheumatology,,,,,,,,,, 6/04/2012 02311120 GNW  AMR101 Phase 3 Study Data in Patients With Diabetes Mellitus (Type 2) to be Presented at the American Diabetes Association's 72nd Scientific Sessions,,,,,,,,,,,"12/12/2013 SNY-FR   GNW  VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia",,,,,,,,,,11/15/2012 98978L20 GNW  Zogenix to Present at the 24th Annual Piper Jaffray Healthcare Conference,,,,,,, 7/11/2013 00D326-E  GNW  Ultragenyx Gains Worldwide Rights for Triheptanoin (UX007),,,,,,,,,,,,,,,,,,,,,,11/01/2010 60877T10 GNW  Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2010,,,,, 8/30/2012 37230320 GNW  Genmab Enters Worldwide Agreement With Janssen for Daratumumab,,,,,,,,,,,, 2/24/2015 03236M20  GNW  Amyris Reports Fourth Quarter and Year-End 2014 Financial Results,,,, 9/13/2012 03152W10 GNW  Amicus Therapeutics to Present at UBS Annual Global Life Sciences Conference,,,,,,,,, 2/21/2014 36315X10 GNW  Galapagos to present GLPG0634 and GLPG0974 at International Conference on IBD,,,,,,,,,,,,,,,, 5/28/2015 48576U10   GNW  Karyopharm Initiates STORM Clinical Trial of Oral Selinexor (KPT-330) in Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/06/2015 45290710 GNW  Immunomedics Appoints Dr. Francois Wilhelm Chief Medical Officer,,,,,,,,,,12/22/2016 007B2M-E GNW  United Rheumatology Issues Clinical Practice Guidelines and Recommends the VectraÂ® DA Test for Adults with Rheumatoid Arthritis,,,,,,,,,, 5/29/2012 02311120 GNW  Amarin to Present at the Jefferies 2012 Global Healthcare Conference,,,,,,,,,,,"10/04/2013 KERX-US  GNW  Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors",,,,,,,,,,11/13/2012 98978L20 GNW  Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection,,,,,,, 7/03/2013 00D326-E  GNW  Ultragenyx Announces a Positive Signal in Interim Data from Phase 2 Study of UX001 in Hereditary Inclusion Body Myopathy,,,,,,,,,,,,,,,,,,,,,,10/26/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2010 Financial Results,,,,, 8/15/2012 37230320 GNW  Genmab Announces Financial Results for the First Half 2012 and Improves 2012 Financial Guidance,,,,,,,,,,,," 2/03/2015 03236M20  GNW  Amyris to Announce Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 24, 2015",,,, 9/06/2012 03152W10 GNW  Amicus Therapeutics Presents Updated Patient Screening Profiles From Phase 3 Fabry Study,,,,,,,,, 2/17/2014 36315X10 GNW  Galapagos completes patient recruitment in Proof of Concept study with GLPG0974 in ulcerative colitis,,,,,,,,,,,,,,,, 5/27/2015 0844XQ-E   GNW  Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) in Solid Tumors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/05/2015 45290710 GNW  Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan (IMMU-132) for Triple-Negative Breast Cancer Therapy,,,,,,,,,,12/09/2016 MYGN-US  GNW  The EndoPredictÂ® Test Significantly Outperforms the First-Generation Test in Predicting the Risk of Node-Negative and Node-Positive Breast Cancer Recurrence,,,,,,,,,, 5/29/2012 02311120 GNW  Amarin Announces U.S. Patent Issuance for AMR101,,,,,,,,,,,"10/02/2013 KERX-US  GNW  Keryx Biopharmaceuticals Announces Appointment of Douglass H. Laidlaw, Ph.D., as Director, Medical Affairs",,,,,,,,,,11/12/2012 NDAQ-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,,,,, 5/29/2013 00D326-E  GNW  Ultragenyx to Present at the Jefferies 2013 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,"10/26/2010 60877T10 GNW  Momenta Pharmaceuticals Announces M118 Selected as a ""Top 10 Cardiovascular/Metabolic Projects to Watch"" Windhover Expert Panel",,,,, 7/25/2012 37230320 GNW  Arzerra Second Quarter 2012 Net Sales Figures,,,,,,,,,,,, 2/02/2015 03236M20  GNW  Amyris to Launch Biopharma Platform,,,, 8/27/2012 03152W10 GNW  Amicus Therapeutics Announces Posters and Presentations at Society for the Study of Inborn Errors of Metabolism Symposium 2012,,,,,,,,, 2/03/2014 36315X10 GNW  Galapagos receives EU2.3 million IWT grant for fibrosis research,,,,,,,,,,,,,,,, 5/21/2015 0844XQ-E   GNW  Karyopharm to Present Hematologic Cancer Data on Lead Drug Candidate Selinexor at European Hematology Association Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/15/2014 45290710 GNW  Immunomedics Reports Preliminary Results From Pretargeted Imaging Study in Patients With Metastatic Breast Cancer,,,,,,,,,,11/28/2016 075MPM-E GNW  Myriad Genetics Will Present Results from Six Breast Cancer Studies at SABCS,,,,,,,,,, 5/24/2012 02311120 GNW  Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions,,,,,,,,,,, 9/25/2013 EPRSQ-US GNW  Ion Channel Modulators - Global Strategic Business Report - 2013-2018,,,,,,,,,,11/08/2012 98978L20 GNW  Zogenix Reports Third Quarter 2012 Financial Results,,,,,,, 5/15/2013 00D326-E  GNW  Ultragenyx Advances Clinical Development of UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7),,,,,,,,,,,,,,,,,,,,,,10/26/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the Oppenheimer 21st Annual Healthcare Conference,,,,, 6/04/2012 37230320 GNW  Genmab A/S to Ring The NASDAQ Stock Market Closing Bell,,,,,,,,,,,, 1/20/2015 03236M20  GNW  Amyris to Enter the Industrial Cleaning Products Market,,,, 8/09/2012 03152W10 GNW  Amicus Therapeutics to Present at Canaccord Genuity Growth Conference,,,,,,,,, 1/29/2014 36315X10 GNW  First clinical centers opened for Phase 2 Crohn's study with GLPG0634,,,,,,,,,,,,,,,, 5/13/2015 48576U10   GNW  Karyopharm to Present Solid Tumor Data on Lead Drug Candidate Selinexor at 2015 American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/12/2014 45290710 GNW  Immunomedics Reports Expanded Phase 1/2 Trials Confirm Activity and Good Safety Profile of Sacituzumab Govitecan (Immu-132) in Patients With Advanced Triple-Negative Breast Cancer,,,,,,,,,,11/12/2016 MYGN-US  GNW  Crescendo Bioscience Announces Four Studies with VectraÂ® DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting,,,,,,,,,, 5/08/2012 02311120 GNW  Amarin Reports First Quarter 2012 Financial Results and Provides Update on Operations,,,,,,,,,,, 8/01/2013 0975LF-E GNW  VIVUS Announces Commercial Supply Agreement With Sanofi to Produce Avanafil,,,,,,,,,,11/08/2012 98978L20 GNW  Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain,,,,,,," 5/01/2013 00D326-E  GNW  Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President",,,,,,,,,,,,,,,,,,,,,,10/25/2010 60877T10 GNW  Momenta Pharmaceuticals Awarded Second U.S. Patent for Evaluating Mixtures of Low Molecular Weight Heparins by Chain Profiles or Chain Mapping,,,,, 6/04/2012 37230320 GNW  Genmab Enters DuoBody Technology Collaboration,,,,,,,,,,,,12/16/2014 03236M20  GNW  Amyris Renewable Jet Fuel Receives Regulatory Approval in Brazil,,,, 8/07/2012 FOLD-US  GNW  Amicus Therapeutics Announces Second Quarter 2012 Financial Results & Corporate Updates,,,,,,,,, 1/13/2014 GLPG-BE  GNW  Galapagos receives EU2.9 million IWT grant for cystic fibrosis research,,,,,,,,,,,,,,,, 5/11/2015 48576U10   GNW  Karyopharm Reports First Quarter 2015 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/04/2014 45290710 GNW  Immunomedics to Present at 25th Annual Oppenheimer Healthcare Conference,,,,,,,,,,11/07/2016 MYGN-US  GNW  Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDxÂ®,,,,,,,,,," 5/01/2012 02311120 GNW  Amarin to Report First Quarter 2012 Financial Results and Host Conference Call on May 8, 2012",,,,,,,,,,, 7/03/2013 SAN-FR   GNW  AMAG Pharmaceuticals Appoints Amit Verma as Vice President of Marketing,,,,,,,,,,10/25/2012 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results,,,,,,, 4/08/2013 00D326-E  GNW  Ultragenyx Initiates Novel Disease Monitoring Program for Hereditary Inclusion Body Myopathy,,,,,,,,,,,,,,,,,,,,,,10/19/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the Newsmakers in the Biotech Industry Conference,,,,, 5/24/2012 37230320 GNW  Milestone Triggered in Connection With Filing of New Drug Application in Japan for Arzerra,,,,,,,,,,,,12/03/2014 03236M20  GNW  Amyris Appoints Raffi Asadorian as Chief Financial Officer,,,," 8/01/2012 03152W10 GNW  Amicus Therapeutics to Announce Second Quarter 2012 Financial Results on August 7, 2012",,,,,,,,, 1/06/2014 36315X10 GNW  Van Herk Investments notify of 5.3% shareholding in Galapagos,,,,,,,,,,,,,,,, 5/07/2015 0844XQ-E   GNW  Karyopharm to Present at Bank of America Merrill Lynch 2015 Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/03/2014 45290710 GNW  Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders,,,,,,,,,,11/04/2016 07CGH7-E GNW  The GeneSightÂ® Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder,,,,,,,,,, 3/20/2012 02311120 GNW  Amarin Announces Notification of Patent Allowance for AMR101,,,,,,,,,,, 4/11/2013 AMRS-US  GNW  Amyris Scientists Describe Breakthrough in Development of Anti-Malarial Drug Precursor,,,,,,,,,,10/23/2012 98978L20 GNW  Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology,,,,,,, 3/29/2013 00D326-E  GNW  Ultragenyx to Present at the 20th Annual Future Leaders in the Biotech Industry Conference,,,,,,,,,,,,,,,,,,,,,, 9/17/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the UBS Global Life Sciences Conference,,,,, 5/15/2012 GMAB-DK  GNW  Genmab Announces Financial Results for the First Quarter 2012,,,,,,,,,,,,11/10/2014 03236M20  GNW  Amyris Launches Second Innovative and Renewable Ingredient for Cosmetics Industry,,,, 7/17/2012 GSK-GB   GNW  Amicus Therapeutics and GlaxoSmithKline Expand Fabry Disease Collaboration,,,,,,,,,12/16/2013 00DYYX-E GNW  Galapagos selects pre-clinical candidate for cystic fibrosis,,,,,,,,,,,,,,,," 5/05/2015 48576U10   GNW  Karyopharm to Report First Quarter 2015 Financial Results on May 11, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/21/2014 45290710 GNW  Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Pemphigus,,,,,,,,,,11/01/2016 MYGN-US  GNW  Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results,,,,,,,,,, 3/06/2012 02311120 GNW  Amarin to Present at the 24th Annual ROTH OC Growth Stock Conference,,,,,,,,,,, 3/18/2013 SAN-FR   GNW  Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-121 in Combination With Paclitaxel in Patients With Platinum-Resistant or Refractory Advanced Ovarian Cancers,,,,,,,,,, 9/27/2012 ZGNX-US  GNW  Zogenix Announces Availability of New Resources for Migraine Sufferers at www.SUMAVELDosePro.com to Support National Pain Awareness Month,,,,,,, 3/06/2013 00D326-E  GNW  Ultragenyx to Present at the Barclays Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 9/13/2010 60877T10 GNW  Momenta Pharmaceuticals Awarded U.S. Patent for Evaluating Mixtures of Low Molecular Weight Heparins by Chain Profiles or Chain Mapping,,,,, 4/27/2012 37230320 GNW  New Drug Application for Arzerra Submitted in Japan,,,,,,,,,,,,11/04/2014 03236M20  GNW  Amyris Reports Third Quarter 2014 Financial Results,,,, 7/02/2012 03152W10 GNW  Amicus Therapeutics Announces Publication of BLISS Quantitative Histology Method in Archives of Pathology & Laboratory Medicine,,,,,,,,,12/06/2013 36315X10 GNW  Galapagos increases share capital through warrant exercises,,,,,,,,,,,,,,,, 4/17/2015 48576U10   GNW  Karyopharm to Present Late-Breaking Data at American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/20/2014 45290710 GNW  Immunomedics Presents Clinical Data on Novel Antibody-Drug Conjugates for Solid Cancer Therapy,,,,,,,,,,10/27/2016 07GG7T-E GNW  The Myriad myPathÂ® Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma Diagnostic,,,,,,,,,, 2/29/2012 02311120 GNW  Amarin Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Update on Operations,,,,,,,,,,, 2/04/2013 ZEAL-DK  GNW  Zealand Pharma Announces Once-Daily Lyxumia(R) (lixisenatide) Approved in Europe for the Treatment of Type 2 Diabetes,,,,,,,,,, 8/30/2012 98978L20 GNW  Zogenix to Present at Stifel Nicolaus 2012 Healthcare Conference,,,,,,, 3/04/2013 00D326-E  GNW  Ultragenyx to Present at the Cowen and Company 33rd Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,, 9/10/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Change to Board of Directors,,,,, 4/25/2012 GMAB-DK  GNW  Passing of Genmab A/S' Annual General Meeting,,,,,,,,,,,,10/16/2014 03236M20  GNW  Amyris Receives Green Chemistry Innovation Award From U.S. Environmental Protection Agency,,,, 6/26/2012 03152W10 GNW  Amicus Therapeutics Announces Positive Preliminary Results From Ongoing Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Co-Administration Study for Pompe Disease,,,,,,,,,12/04/2013 36315X10 GNW  Galapagos reports positive Phase 1 results for GLPG1205,,,,,,,,,,,,,,,, 4/13/2015 48576U10   GNW  Karyopharm Granted U.S. Composition-of-Matter Patent for Selinexor (KPT-330),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/14/2014 45290710 GNW  Immunomedics Announces Six Presentations on Epratuzumab in Lupus at Leading Rheumatology Meeting,,,,,,,,,,10/26/2016 62855J10 GNW  Myriadâ€™s BRACAnalysis CDxÂ® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib,,,,,,,,,," 2/22/2012 02311120 GNW  Amarin to Report Fourth Quarter and Year-End 2011 Results and Host Conference Call on February 29, 2012",,,,,,,,,,,12/10/2012 09WBJY-E GNW  Myriad Announces Diabetes Collaboration With Sanofi,,,,,,,,,, 8/08/2012 ZGNX-US  GNW  Zogenix Reports Second Quarter 2012 Financial Results,,,,,,, 1/10/2013 00D326-E  GNW  Ultragenyx Announces In-Licensing of Clinical-Stage Product Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders,,,,,,,,,,,,,,,,,,,,,, 9/08/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference,,,,, 4/25/2012 37230320 GNW  Arzerra First Quarter 2012 Net Sales Figures,,,,,,,,,,,,"10/13/2014 03236M20  GNW  Amyris to Announce Third Quarter Financial Results on Tuesday, November 4, 2014",,,, 6/20/2012 03152W10 GNW  Amicus Therapeutics Appoints Robert Essner to Board of Directors,,,,,,,,,11/27/2013 GLPG-BE  GNW  Galapagos announces GSK2586184 JAK1 molecule moves into Phase 2 for ulcerative colitis,,,,,,,,,,,,,,,," 4/01/2015 0844XQ-E   GNW  Karyopharm Appoints Mikael Dolsten, MD, PhD to Its Board of Directors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/07/2014 45290710 GNW  Immunomedics Receives Third Edison Patent Award From Research & Development Council of New Jersey,,,,,,,,,,10/25/2016 RULE-US  GNW  Myriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with Diabetes,,,,,,,,,, 2/22/2012 02311120 GNW  Amarin to Present at the CITI 2012 Global Healthcare Conference,,,,,,,,,,,11/27/2012 ZEAL-DK  GNW  Zealand Pharma to Host a Capital Markets Day in New York,,,,,,,,,, 8/01/2012 083NJ9-E GNW  Zogenix Repays Outstanding Loan With Oxford Finance LLC and Silicon Valley Bank,,,,,,, 1/02/2013 00D326-E  GNW  Ultragenyx to Present at the 2013 31st Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 8/26/2010 60877T10 GNW  Momenta Pharmaceuticals Provides Litigation Update,,,,, 4/18/2012 37230320 GNW  Genmab Revised Financial Calendar for 2012,,,,,,,,,,,, 9/09/2014 03236M20  GNW  Braskem Joins Amyris and Michelin to Accelerate the Industrialization and Commercialization of Renewable Isoprene,,,," 6/13/2012 03152W10 GNW  Amicus Therapeutics Appoints Ted W. Love, M.D. to Board of Directors",,,,,,,,,11/20/2013 07Q8KB-E GNW  Galapagos announces that BioFocus has signed an integrated drug discovery collaboration with Boehringer Ingelheim,,,,,,,,,,,,,,,, 3/18/2015 48576U10   GNW  Karyopharm to Present Data on Its Novel Oral PAK4 Allosteric Modulator (PAM) at the American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/05/2014 45290710 GNW  Immunomedics Announces First Quarter Fiscal 2015 Results and Clinical Program Developments,,,,,,,,,,10/21/2016 ABC-US   GNW  Myriad Genetics Inc. Forms Relationship with ION Solutions to Deliver Quality Hereditary Cancer Tests and Services to the Nationâ€™s Largest Network of Community Oncologists,,,,,,,,,, 2/16/2012 02311120 GNW  Amarin Corporation Appoints Dr. Steven Ketchum to Head Research and Development and Announces Inducement Grant Under NASDAQ Rule 5635(c)(4),,,,,,,,,,,11/16/2012 ZEAL-DK  GNW  Zealand Pharma Announces That Once-Daily Lyxumia(R)1 (Lixisenatide) Has Received CHMP Positive Opinion for the Treatment of Adults With Type 2 Diabetes in the EU,,,,,,,,,, 7/31/2012 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Second Quarter 2012 Financial Results,,,,,,,12/20/2012 BLK-US    GNW  Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing,,,,,,,,,,,,,,,,,,,,,, 8/09/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the Canaccord 30th Annual Global Growth Conference and the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference,,,,, 3/27/2012 37230320 GNW  Genmab A/S Summons Annual General Meeting,,,,,,,,,,,, 8/07/2014 03236M20  GNW  Amyris Reports Second Quarter 2014 Financial Results,,,, 6/04/2012 03152W10 GNW  Amicus Therapeutics to Participate in Three June Conferences,,,,,,,,,11/15/2013 36315X10 GNW  Galapagos business update,,,,,,,,,,,,,,,, 3/18/2015 48576U10   GNW  Karyopharm to Present Data on Oncology Pipeline at American Association for Cancer Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/29/2014 45290710 GNW  Immunomedics Provides Update on Phase 2 Study of Isactuzumab Govitecan in Patients With Diverse Metastatic Solid Cancers,,,,,,,,,,10/20/2016 MYGN-US  GNW  Myriad to Announce Fiscal First-Quarter 2017 Financial Results on November 1,,,,,,,,,, 2/13/2012 02311120 GNW  Amarin Announces FDA Advisory Committee Will Not Be Scheduled in Connection With New Drug Application for AMR101,,,,,,,,,,," 9/24/2012 ASMB-US  GNW  Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development",,,,,,,,,," 7/30/2012 98978L20 GNW  Zogenix and Battelle Launch ""Less is More"" DosePro(R) Marketing Campaign",,,,,,,10/30/2012 00D326-E  GNW  Ultragenyx Announces Completion of Phase 2 Study Enrollment for UX001 in Hereditary Inclusion Body Myopathy,,,,,,,,,,,,,,,,,,,,,, 8/02/2010 60877T10 GNW  Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2010,,,,, 3/26/2012 07B9NB-E GNW  Genmab Announces Patent Settlement Agreement for Ofatumumab,,,,,,,,,,,, 7/31/2014 03236M20  GNW  First International Commercial Flight Completed With Newly Approved Amyris-Total Aviation Biofuel,,,, 5/21/2012 FOLD-US  GNW  Amicus Therapeutics Added to NASDAQ Biotechnology Index,,,,,,,,,11/12/2013 36315X10 GNW  Galapagos subsidiary BioFocus signs agreement with Biogen Idec in scleroderma,,,,,,,,,,,,,,,, 3/16/2015 48576U10   GNW  Karyopharm Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/27/2014 45290710 GNW  Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2015 Financial Results,,,,,,,,,,10/18/2016 MYGN-US  GNW  Myriad Genetics Teams Up with Project BioEYES to Advance STEM Education in Utah,,,,,,,,,, 2/07/2012 02311120 GNW  Amarin to Present at the Leerink Swann 2012 Global Healthcare Conference,,,,,,,,,,, 9/04/2012 80105N10 GNW  Hagens Berman: German Drug Manufacturer's Apology for Thalidomide Tragedy Decried as Attempt to Deny Responsibility,,,,,,,,,, 7/24/2012 98978L20 GNW  Zogenix Prices Public Offering of Common Stock and Warrants to Purchase Common Stock,,,,,,,10/10/2012 00D326-E  GNW  Ultragenyx Announces Three Abstracts Accepted for Poster Presentation at 17th Annual World Muscle Society Congress,,,,,,,,,,,,,,,,,,,,,, 7/28/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2010 Financial Results,,,,, 3/19/2012 GMAB-DK  GNW  Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL,,,,,,,,,,,," 7/17/2014 03236M20  GNW  Amyris to Announce Second Quarter Financial Results on Thursday, August 7, 2014",,,, 5/14/2012 TSRX-US  GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,,,,,,,10/21/2013 36315X10 GNW  Galapagos increases share capital through warrant exercises,,,,,,,,,,,,,,,," 3/09/2015 48576U10   GNW  Karyopharm to Report Fourth Quarter and Full Year 2014 Financial Results on March 16, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/22/2014 45290710 GNW  Immunomedics to Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates at Upcoming Conferences,,,,,,,,,,10/17/2016 MYGN-US  GNW  Myriad Will Present New Data on Its Variant Classification Program at the ASHG Annual Meeting,,,,,,,,,, 1/04/2012 02311120 GNW  Amarin Corporation plc Announces Pricing of $150 Million of Exchangeable Senior Notes Due 2032,,,,,,,,,,, 8/24/2012 SAN-FR   GNW  Zealand Pharma A/S - Interim Report for H1 2012 (Unaudited),,,,,,,,,, 7/23/2012 98978L20 GNW  Zogenix Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock,,,,,,,10/03/2012 00D326-E  GNW  Ultragenyx to Present at the 11th Annual BIO Investor Forum in San Francisco,,,,,,,,,,,,,,,,,,,,,, 7/27/2010 60877T10 GNW  Momenta Pharmaceuticals Provides Update Regarding Generic Lovenox(R) Litigation,,,,, 3/07/2012 GMAB-DK  GNW  Genmab 2011 Annual Report,,,,,,,,,,,, 7/09/2014 03236M20  GNW  Brazilian Airline GOL to Make First International Commercial Flights With Newly Approved Amyris-Total Aviation Biofuel,,,, 5/10/2012 03152W10 GNW  Amicus Therapeutics Announces First Quarter 2012 Financial Results,,,,,,,,,10/17/2013 36315X10 GNW  Galapagos presents superior potentiator series for CF,,,,,,,,,,,,,,,, 2/23/2015 0844XQ-E   GNW  Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits of Karyopharm's SINE(TM) Compounds in the Treatment of Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/20/2014 45290710 GNW  Immunomedics Announces European Orphan Drug Designation for Isactuzumab Govitecan for Pancreatic Cancer Treatment,,,,,,,,,,10/08/2016 62855J10 GNW  Myriadâ€™s myChoiceÂ® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib,,,,,,,,,, 1/03/2012 02311120 GNW  Amarin Corporation plc Announces Offering of $150 Million of Exchangeable Senior Notes Due 2032,,,,,,,,,,," 7/23/2012 SAN-FR   GNW  Merrimack Pharmaceuticals, Inc. [MACK] to Ring The NASDAQ Stock Market Opening Bell on Tuesday, July 24, 2012",,,,,,,,,, 7/16/2012 98978L20 GNW  Zogenix Announces U.S. Food and Drug Administration (FDA) Acceptance for Review of Zohydro ER(TM) New Drug Application (NDA) for Treatment of Chronic Pain,,,,,,, 8/30/2012 00D326-E  GNW  Ultragenyx to Present at the Stifel Nicolaus Weisel Healthcare Conference 2012 in Boston,,,,,,,,,,,,,,,,,,,,,, 7/23/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Conference Call Details Regarding Approval for Generic Lovenox(R),,,,, 2/10/2012 37230320 GNW  Genmab Reaches Second Milestone in Lundbeck Collaboration,,,,,,,,,,,, 6/16/2014 AMRS-US   GNW  Total and Amyris Renewable Jet Fuel Ready for Use in Commercial Aviation,,,," 5/04/2012 03152W10 GNW  Amicus Therapeutics to Announce First Quarter 2012 Financial Results on May 10, 2012",,,,,,,,,10/16/2013 36315X10 GNW  Galapagos to present Phase 1 data on FFA2 antagonist GLPG0974 at UEG Week in Berlin,,,,,,,,,,,,,,,, 2/05/2015 48576U10   GNW  Karyopharm to Present at Leerink Partners Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/13/2014 45290710 GNW  Immunomedics Announces Presentations at the 2014 European Association of Nuclear Medicine Congress,,,,,,,,,,10/07/2016 MYGN-US  GNW  Myriad Announces Four Poster Presentations at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting,,,,,,,,,, 1/03/2012 02311120 GNW  Amarin Commences 2012 With Letter to Shareholders,,,,,,,,,,," 7/10/2012 0772LP-E GNW  Despite Benefit, Hospitals Not Always Alerted of Incoming Stroke Patients",,,,,,,,,, 7/12/2012 98978L20 GNW  Zogenix Begins Relday(TM) Clinical Trial for Schizophrenia,,,,,,," 8/09/2012 00D326-E  GNW  Ultragenyx to Present at the Canaccord Genuity 32nd Annual Growth Conference on August 16, 2012",,,,,,,,,,,,,,,,,,,,,, 7/23/2010 60877T10 GNW  Momenta Pharmaceuticals Announces FDA Approval for First Generic Lovenox(R),,,,, 2/07/2012 GMAB-DK  GNW  Arzerra Fourth Quarter and Full Year 2011 Net Sales Figures,,,,,,,,,,,, 6/09/2014 4914-JP   GNW  Takasago and Amyris to Begin Commercialization of Novel Fragrance Products,,,," 4/16/2012 03152W10 GNW  Amicus Therapeutics Names William D. Baird, III Chief Financial Officer",,,,,,,,,10/16/2013 36315X10 GNW  Galapagos to present GLPG0634 at ACR,,,,,,,,,,,,,,,, 1/08/2015 48576U10   GNW  Karyopharm Announces Orphan Designation Granted by FDA for Selinexor (KPT-330) in Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/26/2014 45290710 GNW  Immunomedics Publishes Results on Immunotherapy of Solid Cancers Mediated by a Novel Bispecific Antibody,,,,,,,,,,10/04/2016 075MPM-E GNW  The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing,,,,,,,,,,12/19/2011 02311120 GNW  Amarin Announces Appointment of Joseph T. Kennedy as General Counsel and Issuance of Inducement Grant Under NASDAQ Rule 5635(c)(4),,,,,,,,,,, 6/11/2012 ZEAL-DK  GNW  Zealand Pharma Announces That Its Partner Sanofi Has Applied for Regulatory Approval of Lixisenatide (Lyxumia(R))1 for the Treatment of Type 2 Diabetes in Japan,,,,,,,,,," 6/07/2012 98978L20 GNW  Zogenix and Mallinckrodt, a Covidien Company, Enter Exclusive Co-Promotion Agreement for SUMAVEL(R) DosePro(R)",,,,,,, 8/07/2012 00D326-E  GNW  Ultragenyx to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference on August 15,,,,,,,,,,,,,,,,,,,,,, 6/11/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at Goldman Sachs 31st Annual Global Healthcare Conference,,,,,12/20/2011 GMAB-DK  GNW  Genmab Announces Progress With DuoBody(TM) Platform,,,,,,,,,,,, 5/23/2014 03236M20  GNW  Amyris Prices $75 Million Convertible Senior Notes Due 2019,,,, 3/07/2012 03152W10 GNW  Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Exercise of Over-Allotment Option,,,,,,,,, 9/30/2013 36315X10 GNW  Delta Lloyd notify of 9.93% shareholding in Galapagos,,,,,,,,,,,,,,,, 1/07/2015 48576U10   GNW  Karyopharm to Present at J.P. Morgan 33rd Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/25/2014 45290710 GNW  Immunomedics Announces Fiscal 2014 Results and Clinical Program Developments,,,,,,,,,,10/03/2016 MYGN-US  GNW  CORRECTED: Crescendo Bioscience Announces Four Poster Presentations at the American College of Rheumatology 2016 Annual Meeting,,,,,,,,,,12/14/2011 02311120 GNW  Amarin Announces the Addition of Industry Veteran Patrick O'Sullivan to Board,,,,,,,,,,, 6/09/2012 ZEAL-DK  GNW  Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA,,,,,,,,,, 5/30/2012 98978L20 GNW  Zogenix Submits IND for Second DosePro(R) Candidate Relday(TM),,,,,,," 7/05/2012 00D326-E  GNW  Ultragenyx Initiates Phase 2 Study of UX001 in Hereditary Inclusion Body Myopathy, a Rare Neuromuscular Disease",,,,,,,,,,,,,,,,,,,,,, 6/02/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference,,,,,12/15/2011 GMAB-DK  GNW  Genmab Announces Progress With Lundbeck Collaboration,,,,,,,,,,,, 5/22/2014 03236M20  GNW  Amyris to Offer $75 Million Convertible Senior Notes Due 2019,,,, 3/01/2012 03152W10 GNW  Amicus Therapeutics Prices Underwritten Offering of Common Stock,,,,,,,,, 9/24/2013 36315X10 GNW  AbbVie and Galapagos to co-develop cystic fibrosis therapies,,,,,,,,,,,,,,,, 1/06/2015 48576U10   GNW  Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/11/2014 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2014 Financial Results,,,,,,,,,,10/03/2016 007B2M-E GNW  Crescendo Bioscience Announces Four Poster Presentations at the American College of Rheumatology 2016 Annual Meeting,,,,,,,,,,12/07/2011 02311120 GNW  Amarin Announces Dosing of First Patient in Cardiovascular Outcomes Study REDUCE-IT,,,,,,,,,,, 5/23/2012 06LNN2-E GNW  QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of Stockholders,,,,,,,,,, 5/14/2012 98978L20 GNW  Zogenix Reports First Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference,,,,,12/11/2011 GMAB-DK  GNW  Genmab Announces Preliminary Safety and Efficacy Data for Daratumumab,,,,,,,,,,,, 5/08/2014 03236M20  GNW  Amyris Reports First Quarter 2014 Financial Results,,,, 3/01/2012 03152W10 GNW  Amicus Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,, 9/18/2013 36315X10 GNW  Galapagos creates new warrant plan,,,,,,,,,,,,,,,, 1/05/2015 48576U10   GNW  Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/09/2014 45290710 GNW  Immunomedics Announces Orphan Drug Designation for IMMU-132 for Pancreatic Cancer Therapy,,,,,,,,,, 9/29/2016 MYGN-US  GNW  Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy,,,,,,,,,,11/25/2011 AMRN-IE  GNW  Amarin Announces FDA Acceptance for Filing of AMR101 NDA,,,,,,,,,,, 5/03/2012 06SH4T-E GNW  Zealand Pharma Signs Licensing Agreement With Abbott for the Further Clinical Development and Commercialization of AP214 (ZP1480) for Prevention of Acute Kidney Injury,,,,,,,,,, 5/03/2012 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Date for 2010 Annual Meeting of Stockholders,,,,,12/08/2011 37230320 GNW  Genmab's Financial Calendar for 2012,,,,,,,,,,,, 5/07/2014 03236M20  GNW  Amyris Receives Roundtable on Sustainable Biomaterials (RSB) Sustainability Certification,,,, 2/28/2012 03152W10 GNW  Amicus Therapeutics to Present at 2012 RBC Global Healthcare Conference,,,,,,,,, 6/01/2011 36315X10 GNW  Evotec Acquires Compound Management Business From Galapagos,,,,,,,,,,,,,,,,12/15/2014 48576U10   GNW  Karyopharm Announces Addition to the NASDAQ Biotechnology Index,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/09/2014 45290710 GNW  Scientific Data on Epratuzumab in Systemic Lupus Erythematosus to be Presented at EULAR 2014,,,,,,,,,, 9/26/2016 MYGN-US  GNW  Myriad to Present New myRisk Hereditary Cancer Data Further Demonstrating  the Benefits of Gene Panel Testing,,,,,,,,,,11/25/2011 02311120 GNW  Amarin Announces Resignation of David Feigal from Board of Directors,,,,,,,,,,, 3/15/2012 SAN-FR   GNW  Zealand Pharma A/S Announces Full Year Results and Annual Report for 2011,,,,,,,,,, 3/29/2012 98978L20 GNW  Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/06/2010 60877T10 GNW  Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2010,,,,,12/06/2011 GMAB-DK  GNW  Genmab Announces Appeal of US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit,,,,,,,,,,,, 4/30/2014 03236M20  GNW  Amyris Helps Launch Brazilian Industrial Biotech Association,,,, 2/13/2012 03152W10 GNW  Amicus Therapeutics Announces Fourth Quarter and Full-Year 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,12/11/2014 48576U10   GNW  Karyopharm Initiates Third Registration-Directed Clinical Trial of Oral Selinexor (KPT-330),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/02/2014 45290710 GNW  Immunomedics Announces Objective Responses in Five Types of Solid Cancer With IMMU-132,,,,,,,,,, 9/07/2016 RULE-US  GNW  Myriad RBMâ€™s TruCultureÂ® and Gene Expression Profiling Characterizes  Immune Responses in Landmark Study Led by Institut Pasteur,,,,,,,,,,11/21/2011 AMRN-IE  GNW  Amarin Added to NASDAQ Biotechnology Index,,,,,,,,,,,12/08/2011 ZEAL-DK  GNW  Zealand Pharma Announces Further Positive Results Presented by Sanofi From the GetGoal Phase III Program for Lixisenatide (Lyxumia(R)1)) in Type 2 Diabetes,,,,,,,,,, 3/08/2012 98978L20 GNW  Zogenix Reports Fourth Quarter and Full Year 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/28/2010 60877T10 GNW  Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2010 Financial Results,,,,,11/17/2011 GMAB-DK  GNW  Genmab Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit,,,,,,,,,,,," 4/23/2014 03236M20  GNW  Amyris to Announce First Quarter Financial Results on Thursday, May 8, 2014",,,, 2/13/2012 03152W10 GNW  Amicus Therapeutics Presents Patient Screening Profiles From Phase 3 Fabry Study,,,,,,,,,,,,,,,,,,,,,,,,,12/08/2014 48576U10   GNW  Karyopharm Presents Positive Clinical Data for Selinexor (KPT-330) in NHL Patients at ASH 2014 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/02/2014 45290710 GNW  Immunomedics Reports IMMU-130 is Active in Patients With Irinotecan-Refractory Colorectal Cancer,,,,,,,,,, 9/01/2016 074FLV-E GNW  Myriad Genetics Completes Acquisition of Assurex Health,,,,,,,,,,11/16/2011 02311120 GNW  Amarin's Phase 3 ANCHOR Study Results Presented at American Heart Association's Scientific Sessions 2011,,,,,,,,,,,12/06/2011 ZEAL-DK  GNW  Positive Results Reported by Sanofi for Once-Daily Lixisenatide (Lyxumia(R) 1) in Combination With Lantus(R) (insulin glargine) in Type 2 Diabetes,,,,,,,,,, 2/27/2012 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/28/2010 60877T10 GNW  Momenta Pharmaceuticals to Present at Deutsche Bank 35th Annual Healthcare Conference,,,,,11/02/2011 GMAB-DK  GNW  Genmab Announces Financial Results for the First Nine Months of 2011 and Updated 2011 Financial Guidance,,,,,,,,,,,, 4/16/2014 03236M20  GNW  Amyris Biorefinery Successfully Restarts Industrial Production in Brazil,,,, 2/10/2012 03152W10 GNW  Amicus Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,12/08/2014 48576U10   GNW  Karyopharm Presents Positive Combination Data for Selinexor (KPT-330) in Multiple Myeloma Patients at ASH 2014 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/01/2014 45290710 GNW  Immunomedics Reports Development of Improved Cancer Immunotherapy at the 2014 Annual Meeting of the American Society of Clinical Oncology,,,,,,,,,, 8/30/2016 MS-US    GNW  Myriad Genetics to Present at the 2016 Morgan Stanley Global Healthcare Conference,,,,,,,,,,11/15/2011 02311120 GNW  Amarin's Phase 3 MARINE Study Results Presented at American Heart Association's Scientific Sessions 2011,,,,,,,,,,,12/05/2011 ZEAL-DK  GNW  Zealand Pharma Announces New Results on Lixisenatide (Lyxumia(R)1) for Type 2 Diabetes Presented by Sanofi at the 21st World Diabetes Congress,,,,,,,,,, 2/10/2012 98978L20 GNW  Zogenix to Present at Leerink Swann 2012 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/26/2011 GMAB-DK  GNW  Arzerra Third Quarter 2011 Net Sales Figures,,,,,,,,,,,, 4/04/2014 03236M20  GNW  Amyris to Begin Selling Biofene Online at Farnesene.net,,,, 2/09/2012 03152W10 GNW  Amicus Therapeutics Presents Preclinical Studies of Chaperone AT3375 for Gaucher Disease,,,,,,,,,,,,,,,,,,,,,,,,,12/04/2014 48576U10   GNW  Karyopharm to Present at Oppenheimer 25th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/01/2014 45290710 GNW  Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer,,,,,,,,,, 8/09/2016 MYGN-US  GNW  Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results,,,,,,,,,,11/14/2011 02311120 GNW  Amarin's Phase 3 MARINE and ANCHOR Study Data to be Presented at American Heart Association's Scientific Sessions 2011,,,,,,,,,,,11/09/2011 0BGXN5-E GNW  LaVoie Group Named One of Fastest Growing Private Companies in the US by Inc. Magazine,,,,,,,,,, 1/25/2012 98978L20 GNW  Zogenix and Battelle to Collaborate on Advanced Drug Delivery Technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/05/2011 GMAB-DK  GNW  Genmab Announces Top-Line Phase II Results for Ofatumumab Combined with Chemotherapy in Second Line Aggressive Lymphoma,,,,,,,,,,,, 4/03/2014 03236M20  GNW  Amyris and BASF Reach Agreement for Strain Engineering Collaboration,,,," 2/08/2012 03152W10 GNW  Amicus Therapeutics to Announce Fourth Quarter and Full-Year 2011 Financial Results on February 13, 2012",,,,,,,,,,,,,,,,,,,,,,,,,12/01/2014 48576U10   GNW  Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) in Oncology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/29/2014 45290710 GNW  Immunomedics to Present at Upcoming Healthcare Conferences,,,,,,,,,, 8/03/2016 074FLV-E GNW  Myriad Genetics Signs Definitive Agreement to Acquire Assurex Health,,,,,,,,,,11/14/2011 02311120 GNW  Semi-Annual Changes to the NASDAQ Biotechnology Index,,,,,,,,,,,"10/27/2011 SAN-FR   GNW  ImmunoGen, Inc. Reports First Quarter Fiscal Year 2012 Financial Results and Provides Quarterly Update",,,,,,,,,,12/21/2011 98978L20 GNW  Zogenix Reviews Positive Sales Trends and 2012 Commercial Initiatives for SUMAVEL(R) DosePro(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/03/2011 37230320 GNW  Genmab Announces Financial Results for the First Half of 2011 and Improved Guidance,,,,,,,,,,,, 3/31/2014 03236M20  GNW  Amyris and Kuraray Expand Collaboration in Farnesene-Based Polymers,,,, 2/07/2012 03152W10 GNW  Amicus Therapeutics Awarded Grant From Muscular Dystrophy Association for Pompe Disease Program,,,,,,,,,,,,,,,,,,,,,,,,,12/01/2014 48576U10   GNW  Karyopharm Announces Additional Orphan Designations Granted for Selinexor (KPT-330) by European Commission,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/20/2014 45290710 GNW  Immunomedics Reports Results With IMMU-132 in Patients With Pancreatic Cancer,,,,,,,,,, 7/26/2016 MYGN-US  GNW  Myriad to Announce Fiscal Fourth-Quarter 2016 Financial Results on August 9,,,,,,,,,,11/10/2011 02311120 GNW  Amarin to Present at Two Upcoming Investor Conferences,,,,,,,,,,,"10/20/2011 IMGN-US  GNW  ImmunoGen, Inc. Earns Milestone With Start of SAR3419 Phase II Testing",,,,,,,,,,"12/21/2011 065R2Q-E GNW  Zogenix and Astellas Agree to End Co-Promotion for SUMAVEL(R) DosePro(R) Effective March 31, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/24/2011 37230320 GNW  Genmab Announces Zalutumumab Update,,,,,,,,,,,, 2/25/2014 03236M20  GNW  Amyris Reports Fourth Quarter and Year-End 2013 Financial Results,,,, 1/30/2012 03152W10 GNW  Amicus Therapeutics Announces Posters and Presentations at Lysosomal Disease Network WORLD Symposium,,,,,,,,,,,,,,,,,,,,,,,,,11/24/2014 48576U10   GNW  Karyopharm Presents Data on Oncology Pipeline at EORTC-NCI-AACR Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/19/2014 45290710 GNW  Immunomedics Reports Updated Results With 90Y-Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer,,,,,,,,,, 7/11/2016 00B83N-E GNW  Myriad Announces Positive Results for an EndoPredictÂ® Clinical Study Published in the Journal of the National Cancer Institute,,,,,,,,,,11/07/2011 02311120 GNW  Amarin Reports Third Quarter 2011 Results,,,,,,,,,,,10/19/2010 SAN-FR   GNW  Pomerantz Law Firm Files Class Action Suit Against Genzyme Corp. -- GENZ,,,,,,,,,,12/20/2011 98978L20 GNW  Zogenix Completes Zohydro(TM) Pre-NDA Meetings With FDA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2011 37230320 GNW  Genmab Announces Financial Results for the First Quarter 2011,,,,,,,,,,,, 2/25/2014 03236M20  GNW  IFF and Amyris Advance Innovative Collaboration to Develop Ingredients for the Flavors and Fragrances Market,,,, 1/23/2012 03152W10 GNW  Amicus Therapeutics Appoints Bradley L. Campbell as Chief Business Officer,,,,,,,,,,,,,,,,,,,,,,,,,11/10/2014 48576U10   GNW  Karyopharm Reports Third Quarter 2014 Financial Results and Highlights Recent Progress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/15/2014 45290710 GNW  Immunomedics to Present Updated Phase II Results From Antibody-Drug Conjugate Programs at 2014 ASCO,,,,,,,,,, 6/29/2016 62855J10 GNW  Myriadâ€™s myChoiceÂ® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESAROâ€™s Pivotal Phase 3 Ovarian Cancer Study with Niraparib,,,,,,,,,,"11/03/2011 02311120 GNW  Amarin Announces Q3, 2011 Results Conference Call",,,,,,,,,,,,,,,,,,,,,11/21/2011 98978L20 GNW  Zogenix to Present at Two Upcoming Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/27/2011 GMAB-DK  GNW  Arzerra First Quarter 2011 Net Sales Figures,,,,,,,,,,,, 2/06/2014 03236M20  GNW  Amyris Continues to Expand Sales of Squalane in Asia,,,, 1/09/2012 03152W10 GNW  Amicus Therapeutics Provides Full-Year 2012 Strategic Outlook and Financial Guidance,,,,,,,,,,,,,,,,,,,,,,,,,11/10/2014 48576U10   GNW  Karyopharm Initiates Registration-Directed Clinical Study of Selinexor (KPT-330) in Patients With Richter's Transformation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/13/2014 45290710 GNW  Immunomedics Announces U.S. Patent for IMMU-114,,,,,,,,,, 6/10/2016 007B2M-E GNW  Crescendo Bioscience Announces that New Data on VectraÂ® DA Will Be Presented at the European League Against Rheumatism 17th Annual Congress,,,,,,,,,,11/01/2011 02311120 GNW  Amarin Corporation PLC (AMRN) to Ring The NASDAQ Stock Market Closing Bell,,,,,,,,,,,,,,,,,,,,,11/10/2011 ZGNX-US  GNW  Zogenix Reports Third Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/06/2011 37230320 GNW  Passing of Genmab A/S' Annual General Meeting,,,,,,,,,,,," 1/30/2014 03236M20  GNW  Amyris to Announce Fourth Quarter and Full Year 2013 Financial Results on Tuesday, February 25, 2014",,,, 1/06/2012 03152W10 GNW  Amicus Therapeutics Announces Positive Preliminary Results From Ongoing Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study for Fabry Disease,,,,,,,,,,,,,,,,,,,,,,,,,11/06/2014 48576U10   GNW  Karyopharm Announces Data Presentations at American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/07/2014 45290710 GNW  Immunomedics Announces Third Quarter Fiscal 2014 Results and Clinical Program Developments,,,,,,,,,, 6/07/2016 MYGN-US  GNW  Myriad Board Approves $200 Million Increase in Share Repurchase Program,,,,,,,,,,10/31/2011 02311120 GNW  Amarin to Ring NASDAQ Closing Bell,,,,,,,,,,,,,,,,,,,,,11/04/2011 98978L20 GNW  Zogenix Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/15/2011 37230320 GNW  Genmab A/S Summons Annual General Meeting,,,,,,,,,,,,12/24/2013 03236M20  GNW  Amyris Meets Funding Milestones and Announces $28 Million Private Placement With Participation From New and Existing Investors,,,,12/22/2011 03152W10 GNW  Amicus Therapeutics to Present at 30th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2014 48576U10   GNW  Karyopharm to Present at Credit Suisse 2014 Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/07/2014 IMMU-US  GNW  Immunomedics Closes $30 Million Public Offering of Common Stock,,,,,,,,,," 6/06/2016 MYGN-US  GNW  Myriad myRiskÂ® Hereditary Cancer Test Demonstrates the Magnitude  of Breast and Ovarian Cancer Risk in Nearly 100,000 Patients",,,,,,,,,, 9/26/2011 02311120 GNW  Amarin Announces NDA Submission for AMR101 for the Treatment of Patients With Very High Triglycerides,,,,,,,,,,,,,,,,,,,,,"10/12/2011 98978L20 GNW  Zogenix to Host Investor Meeting on October 13, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/28/2011 37230320 GNW  Genmab Announces Year End 2010 Financial Results and 2011 Guidance,,,,,,,,,,,,12/17/2013 03236M20  GNW  Amyris Continues Successful Commercialization,,,,12/19/2011 03152W10 GNW  Amicus Therapeutics Completes Enrollment of 67 Patients in Phase 3 Study of Migalastat HCl for Fabry Disease,,,,,,,,,,,,,,,,,,,,,,,,,11/04/2014 48576U10   GNW  Karyopharm Appoints J. Scott Garland to Its Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/05/2014 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2014 Financial Results,,,,,,,,,, 6/06/2016 05KFM2-E GNW  Myriad Genetics to Present at the 2016 Goldman Sachs Healthcare Conference,,,,,,,,,, 9/19/2011 02311120 GNW  Amarin to Present at the UBS Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,, 9/30/2011 98978L20 GNW  Zogenix Achieves Zohydro(TM) Long-Term Safety Database for NDA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/03/2011 37230320 GNW  Arzerra Fourth Quarter and Full Year 2010 Net Sales Figures,,,,,,,,,,,,12/05/2013 03236M20  GNW  Amyris and TOTAL Form Fuels Joint Venture,,,,12/01/2011 03152W10 GNW  Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease,,,,,,,,,,,,,,,,,,,,,,,,,"10/30/2014 48576U10   GNW  Karyopharm to Report Third Quarter 2014 Financial Results on November 10, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/02/2014 IMMU-US  GNW  Immunomedics Prices $30 Million Public Offering of Common Stock,,,,,,,,,, 6/05/2016 MYGN-US  GNW  Myriad Will Present Three New Hereditary Cancer Studies at the ASCO Annual Meeting,,,,,,,,,, 9/01/2011 02311120 GNW  Amarin Announces Successful MARINE Phase 3 Clinical Trial Results Published in The American Journal of Cardiology,,,,,,,,,,,,,,,,,,,,, 9/19/2011 98978L20 GNW  Zogenix to Present at UBS 2011 Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/16/2010 GMAB-DK  GNW  Genmab's Financial Calendar for 2011,,,,,,,,,,,,11/15/2013 03236M20  GNW  Amyris Announces Transition of Chief Financial Officer,,,,"11/09/2011 03152W10 GNW  Amicus Therapeutics to Present at Lazard Capital Markets 8th Annual Healthcare Conference on Wednesday, November 16, 2011",,,,,,,,,,,,,,,,,,,,,,,,,10/27/2014 48576U10   GNW  Karyopharm Expands Global Presence With European Subsidiary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/01/2014 45290710 GNW  Immunomedics Announces Proposed Public Offering of Common Stock,,,,,,,,,, 5/31/2016 0C1XKN-E GNW  Myriad Acquires Sividon Diagnostics,,,,,,,,,, 8/25/2011 02311120 GNW  Data From Amarin's AMR101 Phase 3 MARINE Trial to be Presented at the European Society of Cardiology (ESC) Congress 2011,,,,,,,,,,,,,,,,,,,,, 9/16/2011 98978L20 GNW  Zogenix Prices Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/09/2010 37230320 GNW  Genmab Announces Results for the Nine Month Period of 2010 and Updated 2010 Financial Guidance,,,,,,,,,,,,10/31/2013 03236M20  GNW  Amyris Reports Third Quarter 2013 Financial Results,,,,11/01/2011 03152W10 GNW  Amicus Therapeutics Announces Third Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,, 9/29/2014 48576U10   GNW  Karyopharm Announces Clinical Data for Selinexor (KPT-330) in Advanced Solid Tumors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/23/2014 45290710 GNW  Immunomedics Highlights Clinical Pipeline for Solid Cancer and Lupus Therapy at R & D Day,,,,,,,,,, 5/19/2016 MYGN-US  GNW  Myriad Geneticsâ€™ Statement on HIPAA Complaint from Four Patients,,,,,,,,,, 8/12/2011 02311120 GNW  Amarin to Present at the Wedbush Securities Life Sciences Management Access Conference,,,,,,,,,,,,,,,,,,,,, 8/24/2011 98978L20 GNW  Zogenix Files Registration Statement for Proposed Follow-On Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/26/2010 37230320 GNW  Genmab Announces Start of Ofatumumab Phase III Head to Head Study in Follicular Lymphoma,,,,,,,,,,,,10/23/2013 03236M20  GNW  Amyris to Enter Partnership to Supply Renewable Jet Fuel to GOL Airlines,,,,"10/27/2011 03152W10 GNW  Amicus Therapeutics to Announce Third Quarter 2011 Financial Results on November 1, 2011",,,,,,,,,,,,,,,,,,,,,,,,, 9/25/2014 48576U10   GNW  Karyopharm to Host Conference Call to Discuss Selinexor (KPT-330) Data Presented at ESMO 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/10/2014 45290710 GNW  Immunomedics to Ring Opening Bell and Host R&D Day at the NASDAQ Stock Market,,,,,,,,,," 5/18/2016 075MPM-E GNW  Myriad Announces Plans to Launch a Web Portal for Patients that Will Provide Access to Test Results, Tools and Health Information",,,,,,,,,, 8/10/2011 02311120 GNW  Amarin Announces Agreement From FDA on Special Protocol Assessment for AMR101 Outcomes Study,,,,,,,,,,,,,,,,,,,,, 8/17/2011 98978L20 GNW  Zogenix Reports Positive Phase 3 Results for Zohydro -- Meets Primary Efficacy Endpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/25/2010 37230320 GNW  Genmab Announces Reorganization Plan,,,,,,,,,,,,"10/17/2013 03236M20  GNW  Amyris to Announce Third Quarter Financial Results on Thursday, October 31, 2013",,,,10/19/2011 03152W10 GNW  Amicus Therapeutics Announces Close of Patient Recruitment in First Phase 3 Study of Amigal(TM) for Fabry Disease,,,,,,,,,,,,,,,,,,,,,,,,, 9/09/2014 48576U10   GNW  Karyopharm Announces Three Clinical Data Presentations at ESMO 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/08/2014 45290710 GNW  Immunomedics Reports Preclinical Results on SN-38 Antibody-Drug Conjugates as a Potential Novel Platform for Treating Cancer,,,,,,,,,, 5/18/2016 MYGN-US  GNW  Myriad to Present New Research at the 2016 ASCO Annual Meeting,,,,,,,,,, 8/09/2011 02311120 GNW  Amarin Reports Second Quarter 2011 Results,,,,,,,,,,,,,,,,,,,,, 8/16/2011 98978L20 GNW  Zogenix to Hold Conference Call to Discuss Pivotal Phase 3 Results for Zohydro for Treatment of Chronic Pain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/21/2010 37230320 GNW  Arzerra Third Quarter 2010 Net Sales Figures,,,,,,,,,,,,10/11/2013 03236M20  GNW  Amyris Meets Major Milestone at Its Farnesene Production Facility,,,," 9/14/2011 03152W10 GNW  Amicus Therapeutics to Present at UBS Global Life Sciences Conference on Monday, September 19, 2011",,,,,,,,,,,,,,,,,,,,,,,,, 8/08/2014 0844XQ-E   GNW  Karyopharm Appoints Justin Renz Executive Vice President and Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/07/2014 45290710 GNW  Immunomedics Reports Results From Three Phase I Trials With IMMU-130 in Metastatic Colorectal Cancer,,,,,,,,,, 5/11/2016 007B2M-E GNW  Crescendo Bioscience Launches Web Portal for Patients with Rheumatoid Arthritis,,,,,,,,,, 8/08/2011 02311120 GNW  Amarin to Present at the 2011 Canaccord Genuity Growth Conference,,,,,,,,,,,,,,,,,,,,, 8/10/2011 98978L20 GNW  Zogenix Reports Second Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/18/2010 37230320 GNW  Genmab Announces Update on Zalutumumab,,,,,,,,,,,,10/07/2013 03236M20  GNW  Amyris to Present at the Advanced Biofuels Leadership Conference,,,, 9/12/2011 03152W10 GNW  Amicus Therapeutics and GlaxoSmithKline Commence Second Phase 3 Study of Amigal(TM) for Fabry Disease,,,,,,,,,,,,,,,,,,,,,,,,, 8/07/2014 48576U10   GNW  Karyopharm to Present at the Wedbush 2014 Life Sciences Management Access Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/07/2014 45290710 GNW  Immunomedics Announces Multiple Partial Responses With IMMU-132 in Solid Cancers,,,,,,,,,, 5/06/2016 06WP58-E GNW  Myriad to Present Three New Studies at the AUA Annual Meeting,,,,,,,,,," 8/08/2011 02311120 GNW  Amarin Announces Q2, 2011 Results Conference Call",,,,,,,,,,,,,,,,,,,,, 8/04/2011 98978L20 GNW  Zogenix Announces Publication of SUMAVEL(R) DosePro(R) Phase 4 Clinical Data,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/13/2010 37230320 GNW  Genmab Announces Antibody Development Collaboration With Lundbeck,,,,,,,,,,,, 9/13/2013 03236M20  GNW  Amyris to Present at the Credit Suisse Small & Mid Cap Conference,,,, 9/01/2011 03152W10 GNW  Amicus Therapeutics Announces Management Team Addition and Changes,,,,,,,,,,,,,,,,,,,,,,,,, 8/07/2014 48576U10   GNW  Karyopharm Therapeutics Reports Second Quarter Financial Results for 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 3/31/2014 45290710 GNW  Immunomedics to Provide Clinical Trial Updates on Solid-Tumor Antibody-Drug Conjugates at Cancer Conference,,,,,,,,,, 5/03/2016 MYGN-US  GNW  Myriad Genetics Reports Fiscal Third-Quarter 2016 Financial Results,,,,,,,,,, 8/04/2011 02311120 GNW  Phase 3 ANCHOR and MARINE Trial Data to be Presented in November at the American Heart Association's Scientific Sessions,,,,,,,,,,,,,,,,,,,,, 8/02/2011 98978L20 GNW  Zogenix Announces 2011 Second Quarter Conference Call and Webcast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/16/2010 37230320 GNW  GlaxoSmithKline and Genmab Refocus Development Program for Ofatumumab in Autoimmune Indications,,,,,,,,,,,, 8/08/2013 03236M20  GNW  Amyris Reports Second Quarter 2013 Financial Results,,,," 8/31/2011 03152W10 GNW  Amicus Therapeutics to Present at Stifel Nicolaus Annual Healthcare Conference on Wednesday, September 7, 2011",,,,,,,,,,,,,,,,,,,,,,,,," 8/01/2014 48576U10   GNW  Karyopharm to Host Second Quarter 2014 Earnings Call on August 7, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/26/2014 45290710 GNW  Immunomedics Extends Patent Life on Therapeutic Antibodies,,,,,,,,,, 5/02/2016 BAC-US   GNW  Myriad Genetics to Present at the Bank of America Health Care Conference,,,,,,,,,, 8/01/2011 02311120 GNW  Amarin Successfully Completes All Remaining Clinical Studies for AMR101 NDA,,,,,,,,,,,,,,,,,,,,, 7/18/2011 98978L20 GNW  Zogenix Closes $30 Million Royalty Financing With Cowen Healthcare Royalty Partners II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/14/2010 37230320 GNW  Genmab Updates Corporate Strategy,,,,,,,,,,,, 8/08/2013 03236M20  GNW  Amyris Signs Agreement for Up to $60 Million in Funding From Temasek,,,, 8/08/2011 03152W10 GNW  Amicus Therapeutics Announces Second Quarter 2011 Financial Results and Multiple Upcoming Milestones,,,,,,,,,,,,,,,,,,,,,,,,, 6/30/2014 48576U10   GNW  Karyopharm Announces Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/26/2014 45290710 GNW  Immunomedics to Present at Cowen and Company 34th Annual Health Care Conference,,,,,,,,,, 4/22/2016 MYGN-US  GNW  Myriad to Announce Fiscal Third-Quarter 2016 Financial Results on May 3,,,,,,,,,, 7/07/2011 02311120 GNW  Amarin Completes All Non-Clinical Work for AMR101 NDA Submission,,,,,,,,,,,,,,,,,,,,, 7/12/2011 98978L20 GNW  Zogenix and DURECT Announce Development and License Agreement for Antipsychotic Product Candidate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/14/2010 37230320 GNW  Genmab and Seattle Genetics Enter Into Antibody-Drug Conjugate Research Collaboration,,,,,,,,,,,," 7/23/2013 03236M20  GNW  Amyris to Announce Second Quarter Financial Results on Thursday, August 8, 2013",,,," 8/03/2011 03152W10 GNW  Amicus Therapeutics to Present at Canaccord Genuity Growth Conference on Wednesday, August 10, 2011",,,,,,,,,,,,,,,,,,,,,,,,, 6/26/2014 48576U10   GNW  Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/10/2014 45290710 GNW  Immunomedics Announces Second Quarter Fiscal 2014 Results and Clinical Program Developments,,,,,,,,,, 4/14/2016 06P9WL-E GNW  Myriad Genetics Announces Presentations at the 2016 American Association for Cancer Research Annual Meeting,,,,,,,,,, 6/01/2011 02311120 GNW  Amarin to Present at the Jefferies 2011 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,, 6/30/2011 98978L20 GNW  Zogenix Enters $30 Million Royalty Financing Agreement With Cowen Healthcare Royalty Partners II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/10/2010 37230320 GNW  Genmab Announces Results of Ofatumumab Phase II Study in Multiple Sclerosis,,,,,,,,,,,," 7/12/2013 03236M20  GNW  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Amyris, Inc. to Contact the Firm",,,," 8/02/2011 03152W10 GNW  Amicus Therapeutics to Announce Second Quarter 2011 Financial Results on August 8, 2011",,,,,,,,,,,,,,,,,,,,,,,,, 6/25/2014 48576U10   GNW  Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/06/2014 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2014 Financial Results,,,,,,,,,, 3/30/2016 MYGN-US  GNW  Myriad myRiskÂ® Hereditary Cancer Article in Journal of Clinical Oncology Highlights Importance of Expanding Genetic Testing for Breast Cancer Patients,,,,,,,,,, 5/31/2011 02311120 GNW  Amarin Announces Global Supply Network for AMR101,,,,,,,,,,,,,,,,,,,,, 6/13/2011 98978L20 GNW  Zogenix to Present at 2011 Wells Fargo Securities Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/08/2010 37230320 GNW  GSK and Genmab Announce Start of Ofatumumab Phase III Combination Study in Non-Hodgkin's Lymphoma,,,,,,,,,,,, 6/20/2013 03236M20  GNW  Amyris and Total Announce Successful Demonstration Flight With Renewable Jet Fuel During Paris Air Show,,,, 6/29/2011 03152W10 GNW  Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer,,,,,,,,,,,,,,,,,,,,,,,,," 6/24/2014 48576U10   GNW  Karyopharm Initiates Registration-Directed, Randomized Study of Selinexor (KPT-330) in Older Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/04/2014 45290710 GNW  Immunomedics Ranks 4th in the Patent Board Biotechnology Industry Scorecard,,,,,,,,,, 3/21/2016 00999W-E GNW  Myriad Genetics Teams Up with Access HealthÂ® to Educate the Public about Hereditary Cancer and Genetic Testing,,,,,,,,,, 5/19/2011 02311120 GNW  Additional Detail of Successful MARINE Phase III Trial to be Presented at the National Lipid Association 2011 Annual Scientific Sessions,,,,,,,,,,,,,,,,,,,,, 5/27/2011 98978L20 GNW  Zogenix to Present Additional SUMAVEL(R) DosePro(R) Phase 4 Results at Headache Meetings in June,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/17/2010 37230320 GNW  Genmab Announces 2010 First Half Year Results and Improved Guidance,,,,,,,,,,,," 5/22/2013 03236M20  GNW  Amyris to Participate at the Cowen Technology, Media & Telecommunications Conference",,,," 4/27/2011 03152W10 GNW  Amicus Therapeutics to Announce First Quarter 2011 Financial Results on May 4, 2011",,,,,,,,,,,,,,,,,,,,,,,,, 6/16/2014 48576U10   GNW  Karyopharm Announces: FDA Considers the Effectiveness and Safety Technical Sections Complete to Support Conditional Approval for the New Animal Drug Application for Verdinexor (KPT-335) to Treat Lymphoma in Client Owned Dogs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/09/2014 45290710 GNW  Immunomedics Announces Initiation of Phase III Clinical Trial of Clivatuzumab Tetraxetan in Patients With Pancreatic Cancer,,,,,,,,,, 3/18/2016 MYGN-US  GNW  The Myriad myRiskÂ® Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer,,,,,,,,,, 5/19/2011 02311120 GNW  Amarin-Sponsored Posters to be Presented Today at the National Lipid Association 2011 Annual Scientific Sessions,,,,,,,,,,,,,,,,,,,,, 5/25/2011 98978L20 GNW  Zogenix Stockholders Elect Mark Wiggins to Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/10/2010 37230320 GNW  Genmab Announces Top-Line Interim Results for Ofatumumab in Diffuse Large B-Cell Lymphoma,,,,,,,,,,,," 5/17/2013 03236M20  GNW  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Amyris, Inc. to Contact Brower Piven Before the July 15, 2013 Lead Plaintiff Deadline -- AMRS",,,," 4/06/2011 07JSST-E GNW  At National Tay-Sachs & Allied Diseases Science Symposium, Leading Neurodegenerative Disease Researchers Present Breakthroughs",,,,,,,,,,,,,,,,,,,,,,,,, 6/13/2014 48576U10   GNW  Karyopharm Announces First Combination Data of Selinexor With Low-Dose Dexamethasone in Heavily Pretreated Multiple Myeloma Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/31/2013 45290710 GNW  Immunomedics Announces U.S. Patent for Antibody-SN-38 Conjugates,,,,,,,,,, 3/15/2016 076LJN-E GNW  Myriad Presents Second Pivotal Validation Study for Its myPathÂ® Melanoma Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/18/2011 98978L20 GNW  Zogenix Highlights DosePro(R) Needle-Free Delivery System at 2011 AAPS National Biotechnology Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/21/2010 37230320 GNW  Arzerra Second Quarter 2010 Net Sales Figures,,,,,,,,,,,," 5/17/2013 03236M20  GNW  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors With Losses on Their Investment in Amyris, Inc. of Class Action Lawsuit and the Deadline of July 15, 2013 to Seek a Lead Plaintiff Position",,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/09/2014 48576U10   GNW  Karyopharm Announces Initiation of Phase 2 Study of Selinexor (KPT-330) in Patients with Hormone Refractory Prostate Cancer (SHIP Study),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/09/2013 45290710 GNW  Immunomedics Reports Promising Activity With Veltuzumab in Relapsed Immune Thrombocytopenia,,,,,,,,,, 3/08/2016 BCS-GB   GNW  Myriad Genetics to Present at the Barclays Capital 2016 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/16/2011 ZGNX-US  GNW  Zogenix Reports First Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/06/2010 37230320 GNW  Genmab Announces Interim Results of Ofatumumab Phase II Study in Multiple Sclerosis,,,,,,,,,,,, 5/13/2013 03236M20  GNW  R. Neil Williams Joins Amyris Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/02/2014 48576U10   GNW  Karyopharm Updates Data for Selinexor in Solid Tumors at 2014 ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/04/2013 45290710 GNW  Immunomedics Announces Outcome of 2013 Annual Meeting of Stockholders,,,,,,,,,, 3/08/2016 0729L6-E GNW  Myriad Advances Proprietary myVisionÂ® Variant Classification Tools  to a Broader Range of Cancer Risk Genes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2011 98978L20 GNW  Zogenix to Highlight DosePro(R) Needle-Free Delivery System at 2011 AAPS National Biotechnology Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/01/2010 37230320 GNW  GlaxoSmithKline and Genmab Announce Amendment to Ofatumumab Agreement,,,,,,,,,,,, 4/30/2013 03236M20  GNW  Amyris Reports First Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/31/2014 0844XQ-E   GNW  Karyopharm Provides Data Update for Selinexor in Non-Hodgkin's Lymphoma and Acute Myeloid Leukemia at 2014 ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/04/2013 45290710 GNW  Immunomedics Announces Orphan Drug Designation for IMMU-132 for Small Cell Lung Cancer Therapy,,,,,,,,,, 2/23/2016 00DYYX-E GNW  Myriad Genetics Expands Strategic Research Collaboration With AbbVie,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/04/2011 98978L20 GNW  Zogenix to Hold Conference Call to Discuss First Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/15/2010 37230320 GNW  Genmab Announces Change in Management,,,,,,,,,,,, 4/29/2013 AMRS-US   GNW  IFF and Amyris Announce a Multi-Year Collaboration to Develop and Commercialize Sustainable Ingredients for the Flavors and Fragrances Market,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 5/30/2014 48576U10   GNW  Karyopharm to Webcast Investor & Analyst Briefing on Monday, June 2, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/03/2013 45290710 GNW  Immunomedics to Present at Oppenheimer 24th Annual Healthcare Conference,,,,,,,,,, 2/22/2016 TSRO-US  GNW  Myriad Expands Diagnostic Research Collaboration With TESARO and Merck,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/13/2011 98978L20 GNW  Zogenix Demonstrates Increased Overall Patient Satisfaction With SUMAVEL(R) DosePro(R) Over Multiple Migraine Attacks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/07/2010 37230320 GNW  Genmab Presents Data From a Pivotal Trial of Zalutumumab Versus Best Supportive Care in Patients With Refractory Head and Neck Cancer,,,,,,,,,,,," 4/16/2013 03236M20  GNW  Amyris to Announce First Quarter Financial Results on Tuesday, April 30, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/22/2014 48576U10   GNW  Karyopharm Announces Six Data Presentations at the 19th Congress of the European Hematology Association,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/02/2013 45290710 GNW  Immunomedics Announces Presentations at the 2013 Annual Meeting of the American Society of Hematology,,,,,,,,,, 2/02/2016 MYGN-US  GNW  Myriad Genetics Reports Fiscal Second-Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/12/2011 98978L20 GNW  Zogenix Announces SUMAVEL(R) DosePro(R) Named Patient Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/02/2010 37230320 GNW  Change in Constitution of the Board of Directors,,,,,,,,,,,, 4/15/2013 03236M20  GNW  Amyris Selects Laserson as Squalane Distributor in Europe,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2014 48576U10   GNW  Karyopharm Announces Second Orphan Drug Designation for Selinexor in Diffuse Large B-Cell Lymphoma (DLBCL),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/08/2013 45290710 GNW  Immunomedics Announces IMMU-132 is Active in Patients Refractory to Irinotecan,,,,,,,,,, 1/21/2016 MYGN-US  GNW  Myriad to Announce Fiscal Second-Quarter 2016 Financial Results on February 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/16/2011 98978L20 GNW  Zogenix Announces Extension of SUMAVEL(R) DosePro(TM) U.S. Patent Protection by Eight Years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2010 37230320 GNW  Genmab Announces 2010 First Quarter Results,,,,,,,,,,,, 4/11/2013 AMRS-US   GNW  Amyris Scientists Describe Breakthrough in Development of Anti-Malarial Drug Precursor,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/19/2014 48576U10   GNW  Karyopharm Receives Orphan Drug Designation for Acute Myeloid Leukemia (AML),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/05/2013 45290710 GNW  Immunomedics Awarded Key Patent for TROP-2 Antibody,,,,,,,,,, 1/07/2016 MYGN-US  GNW  Myriad Advances Prostate and Renal Cancer Molecular Diagnostic Tests at the 2016 ASCO Genitourinary Cancers Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/03/2011 ZGNX-US  GNW  Zogenix Reports Fourth Quarter and Full Year 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/28/2010 37230320 GNW  Arzerra First Quarter 2010 Net Sales Figures,,,,,,,,,,,, 4/05/2013 03236M20  GNW  Amyris Names Karen Rohde as Chief Human Resources Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/07/2014 48576U10   GNW  Karyopharm Therapeutics Reports First Quarter Financial Results for 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/04/2013 45290710 GNW  Immunomedics Announces First Quarter Fiscal 2014 Results and Clinical Program Developments,,,,,,,,,, 1/04/2016 MYGN-US  GNW  Myriad Genetics to Present at the 34th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2011 98978L20 GNW  Zogenix to Present SUMAVEL(R) DosePro(TM) Phase 4 Results at American Academy of Neurology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/01/2013 03236M20  GNW  Amyris Highlights Progress in Total and Cosan Partnerships,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/05/2014 48576U10   GNW  Karyopharm to Present at Upcoming Healthcare Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/25/2013 45290710 GNW  Immunomedics Announces 4 Presentations on Epratuzumab at 2013 American College of Rheumatology Annual Meeting,,,,,,,,,,12/10/2015 62855J10 GNW  myChoice HRD(TM) Test Identifies Breast Cancer Patients Likely to Respond to Platinum-Containing Therapies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/16/2011 98978L20 GNW  Zogenix to Hold Conference Call to Discuss Fourth Quarter and Full Year 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/21/2013 0C8MLW-E  GNW  Amyris Welcomes Proposed Change of Control in Its Sugarcane Supplier in Brazil,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/29/2014 48576U10   GNW  Phase 2 Study of Selinexor (KPT-330) Initiated by Karyopharm in Patients With Recurrent Glioblastoma After Failure of Radiation and Temozolomide (KING Study),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,"10/25/2013 45290710 GNW  Epratuzumab's Mechanism of Action Featured in Blood, Official Journal of The American Society of Hematology",,,,,,,,,,12/09/2015 62855J10 GNW  Multiple Scientific Presentations at the San Antonio Breast Cancer Symposium Highlight the Clinical Utility of the Myriad myRisk(TM) Hereditary Cancer Gene Panel Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/10/2011 98978L20 GNW  Zogenix Announces Completion of Enrollment in ZX002 Phase 3 Efficacy Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/14/2013 05M7CK-E  GNW  Amyris and Firmenich Announce Expansion of Collaboration in Flavors & Fragrances,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/24/2014 48576U10   GNW  Phase 2 Study of Selinexor (KPT-330) Initiated by Karyopharm in Patients With Advanced Gynecologic Malignancies (SIGN Study),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/24/2013 45290710 GNW  Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2014 Financial Results,,,,,,,,,,12/01/2015 MYGN-US  GNW  United States Patent and Trademark Office Grants Patent for Vectra(R) DA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/09/2011 98978L20 GNW  Zogenix Receives 2011 Drug Delivery Partnerships Innovation Award for SUMAVEL(R) DosePro(TM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 3/11/2013 03236M20  GNW  Amyris Joins Bonsucro, the Leading Sustainability Standard for Sugarcane",,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/22/2014 48576U10   GNW  Karyopharm Announces Five Clinical Data Presentations at ASCO 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/23/2013 45290710 GNW  Immunomedics Announces 90 Y-Clivatuzumab Tetraxetan in Combination With Low-Dose Gemcitabine is Active in Patients With Late-Stage Pancreatic Cancer,,,,,,,,,,11/17/2015 62855J10 GNW  Myriad Will Present Eight Studies at the 2015 San Antonio Breast Cancer Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/08/2011 98978L20 GNW  Zogenix to Participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/19/2013 03236M20  GNW  Amyris Reports Fourth Quarter and 2012 Year-End Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/21/2014 48576U10   GNW  Karyopharm Announces a Phase 1 Trial of Selinexor (KPT-330) in Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/22/2013 45290710 GNW  Immunomedics Develops Dendritic-Cell Vaccine Technology for Lymphomas and Leukemias,,,,,,,,,,11/16/2015 MYGN-US  GNW  Myriad RBM DiscoveryMAP(R) Technology Identifies Novel Biomarkers That May Predict Increased Risk of Cardiovascular Events in Patients With Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/06/2011 065R2Q-E GNW  Zogenix and Desitin Announce Marketing Approval for SUMAVEL(R) DosePro(TM) in Germany and the United Kingdom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/19/2013 03236M20  GNW  Amyris Names Zanna McFerson as Chief Business Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/15/2014 48576U10   GNW  Karyopharm Announces Initiation of a Phase 1 Study of Decitabine (Dacogen(R)) and Selinexor (KPT-330) in Acute Myeloid Leukemia (AML),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/22/2013 45290710 GNW  Immunomedics Reports Multiple Objective Responses in Solid Cancers With IMMU-132,,,,,,,,,,11/07/2015 MYGN-US  GNW  Crescendo Bioscience Announces That New Studies With Vectra(R) DA Data Will be Presented at the American College of Rheumatology 2015 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/23/2010 98978L20 GNW  Zogenix Announces Partial Exercise of Over-Allotment Option for Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/01/2013 03236M20  GNW  Photo Release -- Amyris Ships First Truckload of Biofene From Its New Plant in Brazil,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/10/2014 48576U10   GNW  Karyopharm Appoints Chris Primiano as General Counsel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/10/2013 45290710 GNW  Immunomedics Announces Presentations at Upcoming Conferences,,,,,,,,,,11/03/2015 62855J10 GNW  Myriad Genetics Reports Fiscal First-Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2010 98978L20 GNW  Zogenix Receives 2010 Most Innovative Product Award for SUMAVEL(R) DosePro(TM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 1/15/2013 03236M20  GNW  Amyris to Announce 2012 Fourth Quarter Financial Results on Tuesday, February 19",,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/08/2014 48576U10   GNW  Karyopharm Therapeutics to Present at 13th Annual Needham Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/09/2013 45290710 GNW  Immunomedics Announces Termination of Agreement and Return of Worldwide Rights to Veltuzumab for All Non-Cancer Indications,,,,,,,,,,10/28/2015 62855J10 GNW  Myriad Genetics to Present at the 2015 Credit Suisse Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/02/2010 98978L20 GNW  Zogenix and Desitin Announce First European Marketing Approval for SUMAVEL(R) DosePro(TM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/27/2012 AMRS-US   GNW  Amyris Secures Additional Financing and Announces Start of Biofene(R) Production at Its Paraiso Facility in Brazil,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/05/2014 48576U10   GNW  Karyopharm Therapeutics Reports 2013 Year-End Financial Results and Provides Update on Clinical Development Plans,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/30/2013 45290710 GNW  Immunomedics Confirms Funding of Department of Defense Clinical Trial Grant for Milatuzumab in Lupus,,,,,,,,,,10/22/2015 MYGN-US  GNW  Crescendo Bioscience Highlights New Studies With Vectra(R) DA That Will Be Presented at the American College of Rheumatology 2015 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/30/2010 98978L20 GNW  Zogenix Announces Completion of Enrollment in ZX002 Phase 3 12-Month Safety Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/06/2012 03236M20  GNW  Amyris Reports Third Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/27/2014 48576U10   GNW  Karyopharm Therapeutics Announces Initiation of an Investigator Sponsored Phase 1 Dose Escalation Study of Its Lead Drug Candidate Selinexor (KPT-330) in Singapore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/30/2013 45290710 GNW  Immunomedics Reports Updated Results of Labetuzumab-SN-38 in Metastatic Colorectal Cancer,,,,,,,,,,10/21/2015 62855J10 GNW  Myriad Will Highlight New Data on Its myRisk(TM) Hereditary Cancer Test at the National Society of Genetic Counselors Annual Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/22/2010 98978L20 GNW  Zogenix Announces Pricing of Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"10/16/2012 03236M20  GNW  Amyris to Announce Third Quarter Financial Results on Tuesday, November 6, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/26/2014 48576U10   GNW  Karyopharm Therapeutics Announces Nine Presentations on its Selective Inhibitors of Nuclear Export (SINE) Compounds and PAK4 Inhibitors at the American Association of Cancer Research (AACR) Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/04/2013 45290710 GNW  Immunomedics to Present at Stifel Healthcare Conference 2013,,,,,,,,,,"10/20/2015 62855J10 GNW  Myriad to Announce Fiscal First Quarter 2016 Financial Results on November 3, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/09/2012 03236M20  GNW  Amyris Names Charles Kraft as Vice President of Global Manufacturing & Process Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/06/2014 48576U10   GNW  Karyopharm Therapeutics to Present at Upcoming Healthcare Conferences in February,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/03/2013 45290710 GNW  Immunomedics Appoints Peter P. Pfreundschuh as New Chief Financial Officer,,,,,,,,,,10/09/2015 62855J10 GNW  Myriad to Present New Data on Its myRisk(TM) Hereditary Cancer Test at the CGA-ICC Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/31/2012 03236M20  GNW  Amyris Reports Second Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/22/2014 48576U10   GNW  Karyopharm Therapeutics Presents Clinical Data on Selinexor (KPT-330) in Colorectal Cancer From Ongoing Phase 1 Study and Preclinical Data on Novel PAK4 Inhibitors at American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/22/2013 45290710 GNW  Immunomedics Announces Fiscal 2013 Results,,,,,,,,,,10/08/2015 62855J10 GNW  Myriad Genetics to Highlight New Clinical Outcomes Data on myPath(R) Melanoma at the American Society of Dermatopathology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/31/2012 03236M20  GNW  Amyris Enhances Strategic Partnership With Total for Renewable Diesel and Jet Fuels,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/14/2014 48576U10   GNW  Karyopharm Therapeutics Announces Data Presentations at American Society of Clinical Oncology Annual Gastrointestinal Cancers Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/20/2013 45290710 GNW  Immunomedics Appoints Richard L. Sherman to Board of Directors,,,,,,,,,,10/07/2015 MYGN-US  GNW  Myriad Genetics and Tufts Health Plan Sign Agreement to Cover Prolaris(R) for Members With Localized Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 7/11/2012 03236M20  GNW  Amyris to Announce 2012 Second Quarter Financial Results on Tuesday, July 31",,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/08/2014 48576U10   GNW  Karyopharm Therapeutics Announces Award of Grant From National Multiple Sclerosis Society to Further Develop Selective Inhibitors of Nuclear Export (SINE) Compounds,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/14/2013 45290710 GNW  Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free Survival in Previously Untreated Follicular Lymphoma,,,,,,,,,,10/05/2015 MYGN-US  GNW  Myriad to Present Seven Studies at the ASHG Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/19/2012 07LY1Q-E  GNW  Photo Release -- Azul Brazilian Airlines Makes Successful Demonstration Flight With Amyris Renewable Jet Fuel Produced From Sugarcane,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 1/07/2014 48576U10   GNW  Karyopharm Therapeutics Announces Submission of New Animal Drug Application Effectiveness and Safety Sections for Novel, Oral, Small-Molecule Selective Inhibitor of Nuclear Export (SINE) Verdinexor for Canine Lymphoma to FDA's Center for Veterinary Medicine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/12/2013 45290710 GNW  Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials,,,,,,,,,,10/01/2015 62855J10 GNW  Myriad Appoints Jan Schluchter as Chief Commercial Officer for Europe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/12/2012 AMRS-US   GNW  Amyris is Awarded $8 Million DARPA Contract Under 'Living Foundries' Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/20/2013 48576U10   GNW  Karyopharm Therapeutics Added to Russell 3000(R) and Russell 2000(R) Indexes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/09/2013 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2013 Financial Results,,,,,,,,,, 9/24/2015 MYGN-US  GNW  Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/04/2012 ERJ-BR    GNW  Renewable Jet Fuel Flight Scheduled During Rio+20 Environment Conference in Brazil,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/11/2013 48576U10   GNW  Karyopharm Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Its Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 7/16/2013 45290710 GNW  Immunomedics Constructs New Humanized Antibody for B-Cell Mediated Cancer and Autoimmune Diseases,,,,,,,,,, 9/14/2015 MYGN-US  GNW  Myriad Genetics to Present at the 2015 Morgan Stanley Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/08/2012 03236M20  GNW  Amyris Reports First Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"12/08/2013 48576U10   GNW  Karyopharm Therapeutics Presents Promising Data for Selinexor, an Oral, First-in-Class Selective Inhibitors of Nuclear Export (SINE) Compound, in Hematologic Malignancies at 2013 ASH Annual Meeting",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 7/03/2013 45290710 GNW  Immunomedics Reports First Results From Phase Ib Study of 90Y-Clivatuzumab in Patients With Metastatic Pancreatic Cancer After 2 or More Prior Therapies,,,,,,,,,," 9/11/2015 MYGN-US  GNW  Myriad Genetics, Inc. (Nasdaq: MYGN) to Ring The Nasdaq Stock Market Opening Bell",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/02/2012 03236M20  GNW  Amyris Realigns Senior Leadership to Support Growth Strategy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/07/2013 48576U10   GNW  Karyopharm Therapeutics Announces Highlights From Poster Presentations on Selective Inhibitors of Nuclear Export (SINE) Compounds in Hematologic Malignancies at 2013 ASH Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/14/2013 45290710 GNW  Immunomedics to Present at Wells Fargo Securities 2013 Healthcare Conference,,,,,,,,,, 9/09/2015 62855J10 GNW  Myriad Adds to Scientific Evidence for the myPlan(R) Lung Cancer Prognostic Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 4/30/2012 GENO-US   GNW  Genomatica Appoints Jeff Lievense as Executive Vice President, Process Technology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/05/2013 48576U10   GNW  Karyopharm Therapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/13/2013 45290710 GNW  Immunomedics Presents Epratuzumab's Mechanism of Action in Systemic Lupus Erythematosus,,,,,,,,,, 9/02/2015 62855J10 GNW  Myriad Genetics to Host 2015 Investor Day in New York City,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 4/19/2012 03236M20  GNW  Amyris to Announce 2012 First Quarter Financial Results on Tuesday, May 8",,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/02/2013 48576U10   GNW  Karyopharm Therapeutics to Host Investor Reception and Webcast at the 2013 American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/13/2013 45290710 GNW  Immunomedics Reports That UCB Announces New Results From Phase 2B Open-Label Extension Study Evaluating the Long-Term Effects of Epratuzumab in SLE,,,,,,,,,," 9/01/2015 MYGN-US  GNW  Crescendo Bioscience Names Elena Hitraya M.D., Ph.D., as Chief Medical Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/12/2011 0BTLR7-E  GNW  Semi-Annual Changes to the NASDAQ Clean Edge Green Energy Index,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/08/2013 48576U10   GNW  Karyopharm Therapeutics Announces Data Presentations at American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,," 6/12/2013 45290710 GNW  Immunomedics Reports Progress With Labeling Proteins, Including Antibodies, for Improved PET Imaging",,,,,,,,,, 8/13/2015 62855J10 GNW  Myriad Receives Favorable Medicare Final Coverage Decision for the Prolaris(R) Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"10/01/2010 03236M20  GNW  Video Interview: John Melo, CEO of Amyris, Inc. (AMRS)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2013 KPTI-US    GNW  Karyopharm Therapeutics Announces Pricing of Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/11/2013 45290710 GNW  Combination of 90Y-Epratuzumab and Veltuzumab is Active in Non-Hodgkin Lymphoma,,,,,,,,,, 8/11/2015 62855J10 GNW  Myriad Genetics Reports Fiscal Fourth-Quarter and Full Year 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 9/27/2010 03236M20  GNW  Amyris, Inc. Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell",,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/22/2013 HLT.XX1-US GNW  Karyopharm Therapeutics Announces Oral Presentations at the American College of Rheumatology (ACR) on the Use of Selective Inhibitors of Nuclear Export (SINE) XPO1 Antagonists in Preclinical Models of Autoimmune Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/10/2013 45290710 GNW  90Y-Epratuzumab Study Shows Improvement of Therapy Results Following R-CHOP,,,,,,,,,," 7/29/2015 62855J10 GNW  Myriad to Announce Fiscal Fourth Quarter 2015 Financial Results on August 11, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/07/2013 0844XQ-E   GNW  Karyopharm Therapeutics Files Registration Statement for Proposed Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/10/2013 45290710 GNW  Immunomedics Develops Novel Dual System for Tumor Detection and Imaging,,,,,,,,,, 5/29/2015 MYGN-US  GNW  Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/03/2013 TTPH-US    GNW  Karyopharm Therapeutics Announces Appointment of Garen Bohlin to Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/10/2013 45290710 GNW  New Data From Epratuzumab to be Presented at EULAR 2013,,,,,,,,,, 5/29/2015 62855J10 GNW  Myriad Significantly Advances the myChoice(R) HRD(TM) Companion Diagnostic Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/07/2013 0844XQ-E   GNW  Karyopharm Therapeutics Announces Preclinical Data for Selinexor (KPT-330) in Acute Myeloblastic Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) Models at FASEB Science Research Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/03/2013 45290710 GNW  Immunomedics Announces Six Presentations at the Society of Nuclear Medicine and Molecular Imaging 2013 Annual Meeting,,,,,,,,,, 5/28/2015 MYGN-US  GNW  Myriad Genetics to Present at the 2015 Goldman Sachs Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/31/2013 06GYTR-E   GNW  Karyopharm Therapeutics Secures $19 Million in Series B Financing Extension,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/30/2013 45290710 GNW  Immunomedics Presents Clinical Progress of Antibody-Drug Conjugate Programs at Conference of New York Biotechnology Association,,,,,,,,,, 5/15/2015 MYGN-US  GNW  Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 7/31/2013 0844XQ-E   GNW  Karyopharm Therapeutics Initiates a Phase 1b Food-Effect Clinical Trial With the Novel Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Advanced Sarcomas,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/29/2013 45290710 GNW  Immunomedics to Present at Jefferies 2013 Global Healthcare Conference,,,,,,,,,, 5/13/2015 62855J10 GNW  Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/13/2013 VSTM-US    GNW  Karyopharm Therapeutics Announces Appointment of Paul Brannelly as Senior Vice President of Finance and Administration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,," 5/28/2013 45290710 GNW  Immunomedics Invents Method to Label Peptides and Other Proteins, Including Antibodies, With PET and MRI Imaging Radionuclides",,,,,,,,,, 5/07/2015 62855J10 GNW  Myriad to Present New Clinical Data on Prolaris(R) at the AUA 2015 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 6/02/2013 0844XQ-E   GNW  Karyopharm Therapeutics Presents Clinical Data for Selinexor (KPT-330), a First-in-Class Selective Inhibitor of Nuclear Export (SINE), in Solid Tumors at the 2013 ASCO Annual Meeting",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/08/2013 45290710 GNW  Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program Developments,,,,,,,,,, 5/05/2015 62855J10 GNW  Myriad Genetics Reports Fiscal Third-Quarter 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 5/28/2013 0844XQ-E   GNW  Karyopharm Therapeutics to Present New Data on Selective Inhibitor of Nuclear Export (SINE), KPT-330, at 2013 EHA Congress",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/07/2013 45290710 GNW  Immunomedics Announces Three New Patent Awards,,,,,,,,,," 4/22/2015 62855J10 GNW  Myriad to Announce Fiscal Third Quarter 2015 Financial Results on May 5, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2013 0844XQ-E   GNW  Karyopharm Therapeutics Raises $48.2 Million in Series B Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/25/2013 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial Results,,,,,,,,,, 4/01/2015 MYGN-US  GNW  Myriad and AstraZeneca Expand Research Collaboration on Lynparza,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 5/15/2013 0844XQ-E   GNW  Karyopharm Therapeutics to Present Clinical Data on Selective Inhibitor of Nuclear Export (SINE), KPT-330, at 2013 ASCO Annual Meeting",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/10/2013 45290710 GNW  Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors,,,,,,,,,, 3/20/2015 62855J10 GNW  Myriad Announces Prolaris(R) Test Biopsy Results From EMPATHY-P Study at European Association of Urology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/09/2013 0844XQ-E   GNW  Karyopharm Therapeutics to Present Data on Selective Inhibitors of Nuclear Export (SINE) to Treat Influenza and HIV at International Congress on Antiviral Research (ICAR),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/09/2013 45290710 GNW  Immunomedics Reports First Results of Labetuzumab-SN-38 in Colorectal Cancer,,,,,,,,,, 3/17/2015 62855J10 GNW  Myriad and BioMarin Expand Collaboration to Evaluate myChoice HRD(TM) as a Companion Diagnostic for Talazoparib,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/26/2013 0844XQ-E   GNW  Karyopharm Therapeutics Announces 15 Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models at the American Association of Cancer Research (AACR) Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/08/2013 45290710 GNW  Immunomedics Creates Novel Antibody-Cytokine Conjugates for Cancer Therapy,,,,,,,,,, 3/04/2015 62855J10 GNW  Myriad Publishes myPath(TM) Melanoma Pivotal Validation Study in the Journal of Cutaneous Pathology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/05/2013 0844XQ-E   GNW  Karyopharm Therapeutics Announces Ken Weg & Barry Greene Join Board of Directors; Dr. Sharon Shacham Named President of Research & Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/08/2013 45290710 GNW  Immunomedics Announces Clivatuzumab-Based Blood Test Can Differentiate Between Pancreatic Cancer and Chronic Pancreatitis,,,,,,,,,, 3/02/2015 62855J10 GNW  Myriad Genetics to Present at the Barclays Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 1/17/2013 0844XQ-E   GNW  Karyopharm Therapeutics Initiates Treatment of Patients With Acute Myeloid Leukemia (AML) in Phase 1 Trial With Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/01/2013 45290710 GNW  Immunomedics Settles Finra Arbitration Proceedings Relating to Its Prior Investment in Certain Securities,,,,,,,,,, 2/24/2015 62855J10 GNW  Myriad Board Approves $200 Million Increase in Share Repurchase Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"12/04/2012 0844XQ-E   GNW  Karyopharm Therapeutics Initiates a Phase IIb Efficacy Study with its Novel, Oral Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Dogs with Non-Hodgkin Lymphomas (NHL)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/01/2013 45290710 GNW  Immunomedics Announces Presentations at the 2013 Annual Meeting of the American Association for Cancer Research,,,,,,,,,, 2/06/2015 62855J10 GNW  Myriad Genetics to Present at the 2015 Leerink Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/13/2012 0844XQ-E   GNW  Karyopharm Therapeutics Announces Eight Presentations on Selective Inhibitors of Nuclear Export (SINE) for Hematologic Malignancies at the American Society of Hematology (ASH) Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/27/2013 IMMU-US  GNW  Immunomedics Announces Closing of Public Offering and Full Exercise of Overallotment Option by Underwriters,,,,,,,,,," 2/03/2015 MYGN-US  GNW  Myriad Announces Retirement of Peter D. Meldrum, President and CEO",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/25/2013 45290710 GNW  Immunomedics to Present at Cowen and Company 33rd Annual Health Care Conference,,,,,,,,,, 2/03/2015 62855J10 GNW  Myriad Genetics Reports Fiscal Second-Quarter 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/22/2013 IMMU-US  GNW  Immunomedics Prices $14.0 Million Public Offering of Common Stock,,,,,,,,,, 1/22/2015 62855J10 GNW  Myriad Genetics Names Johnathan M. Lancaster as Vice President of Medical Affairs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/21/2013 IMMU-US  GNW  Immunomedics Announces Proposed Public Offering of Common Stock,,,,,,,,,," 1/21/2015 62855J10 GNW  Myriad Genetics to Announce 2Q15 Financial Results on February 3, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/07/2013 45290710 GNW  Immunomedics Announces Second Quarter Fiscal 2013 Results and Clinical Program Developments,,,,,,,,,, 1/20/2015 RULE-US  GNW  Myriad RBM Joins Institut Pasteur in the Global Fight Against Tuberculosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/28/2013 45290710 GNW  Immunomedics in Collaboration With Algeta to Evaluate Potential of Epratuzumab Conjugated to Alpha-Emitter Thorium-227,,,,,,,,,, 1/08/2015 62855J10 GNW  Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/25/2013 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Second Quarter Fiscal 2013 Financial Results,,,,,,,,,, 1/05/2015 62855J10 GNW  Myriad Genetics to Present at the 2015 J.P. Morgan Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/08/2013 45290710 GNW  Immunomedics Announces U.S. Patent for Hexavalent DOCK-AND-LOCK(TM) Complexes,,,,,,,,,,12/22/2014 MYGN-US  GNW  Myriad Genetics Names Bernard Tobin as President of Crescendo Bioscience,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/21/2012 45290710 GNW  Immunomedics Announces New Patent for Antibodies Targeting CD19,,,,,,,,,,12/19/2014 62855J10 GNW  Myriad Receives FDA Approval of BRACAnalysis CDx(TM) as Companion Diagnostic for Lynparza(TM) (olaparib) in Ovarian Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/12/2012 45290710 GNW  Immunomedics Develops New Bispecific Antibodies That Exhibit Potent Anti-Lymphoma Activity,,,,,,,,,,12/09/2014 62855J10 GNW  Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/12/2012 IMMU-US  GNW  David Stack Appointed to Amarin Board of Directors,,,,,,,,,,12/03/2014 62855J10 GNW  Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/11/2012 45290710 GNW  Immunomedics Provides Clinical Updates on Subcutaneous Injections of Veltuzumab in Autoimmune Disease and Cancer,,,,,,,,,,12/02/2014 62855J10 GNW  Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/11/2012 45290710 GNW  Immunomedics Reports Updated Clinical Results on Potential New Treatment Regimens for Non-Hodgkin Lymphoma,,,,,,,,,,11/20/2014 62855J10 GNW  TESARO and Myriad Announce Companion Diagnostics Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/10/2012 45290710 GNW  Addition of Epratuzumab to Combination Chemotherapy May be Beneficial in Acute Lymphocytic Leukemia,,,,,,,,,,11/19/2014 62855J10 GNW  Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/10/2012 45290710 GNW  Epratuzumab's B-Cell Modulation Effect Elucidated in Preclinical Study,,,,,,,,,,11/10/2014 62855J10 GNW  Crescendo Bioscience to Feature New Data on Vectra(R) DA at 2014 ACR Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/06/2012 45290710 GNW  Immunomedics to Present at Oppenheimer 23rd Annual Healthcare Conference,,,,,,,,,,11/07/2014 62855J10 GNW  Myriad myPath(TM) Melanoma Improves Diagnosis and Treatment Plans,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/05/2012 45290710 GNW  Immunomedics Announces Outcome of 2012 Annual Meeting of Stockholders,,,,,,,,,,11/04/2014 62855J10 GNW  Myriad Genetics Reports Fiscal First Quarter 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/05/2012 45290710 GNW  Immunomedics Develops Novel Bispecific Antibodies for Diverse Solid Cancers,,,,,,,,,,11/03/2014 62855J10 GNW  Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/13/2012 45290710 GNW  Lupus Patients Treated With Epratuzumab Report Improvements in Health-Related Quality of Life,,,,,,,,,,10/29/2014 62855J10 GNW  Myriad Genetics to Present at the 2014 Credit Suisse Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/12/2012 45290710 GNW  Long-Term Efficacy and Safety Results of Epratuzumab in Lupus Presented at Rheumatology Conference,,,,,,,,,,10/27/2014 62855J10 GNW  Myriad Announces Inclusion of Prolaris(R) Test in NCCN Guidelines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/09/2012 45290710 GNW  Immunomedics Named Edison Patent Award Winner in Biotechnology by Research & Development Council of New Jersey,,,,,,,,,,10/24/2014 62855J10 GNW  Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/08/2012 45290710 GNW  Immunomedics Announces First Quarter Fiscal 2013 Results and Clinical Program Developments,,,,,,,,,,"10/21/2014 62855J10 GNW  Myriad Genetics to Announce 1Q15 Financial Results on November 4, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/05/2012 45290710 GNW  Immunomedics Reports Potential Product Advances at the 2012 Annual Meeting of the American Society of Hematology,,,,,,,,,,10/17/2014 62855J10 GNW  Myriad Receives Draft Medicare Coverage for Prolaris(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/01/2012 45290710 GNW  Immunomedics to Participate in Brean Capital 2012 Life Sciences Summit,,,,,,,,,,10/08/2014 62855J10 GNW  Myriad Appoints R. Bryan Riggsbee as Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/26/2012 45290710 GNW  Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2013 Financial Results,,,,,,,,,," 9/30/2014 MYGN-US  GNW  CereSpir Incorporated Appoints Adrian N. Hobden, Ph.D., as Chairman of Its Board of Directors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/09/2012 45290710 GNW  Immunomedics Discovers Potential New Therapy for Graft-Versus-Host Disease,,,,,,,,,, 9/29/2014 62855J10 GNW  Myriad Presents Tumor BRACAnalysis CDx(TM) Study at ESMO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/13/2012 45290710 GNW  Immunomedics to Present at 2012 UBS Global Life Sciences Conference,,,,,,,,,, 9/09/2014 62855J10 GNW  Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in 35 Percent of Cases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/23/2012 45290710 GNW  Immunomedics Announces Fiscal 2012 Results,,,,,,,,,, 9/03/2014 62855J10 GNW  Myriad Publishes myRisk Hereditary Cancer Study in Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/10/2012 45290710 GNW  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2012 Financial Results,,,,,,,,,, 8/28/2014 62855J10 GNW  Myriad Genetics to Present at the Morgan Stanley Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/07/2012 45290710 GNW  Immunomedics to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference,,,,,,,,,, 8/12/2014 62855J10 GNW  Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 7/24/2012 45290710 GNW  Karolinska Institutet and Immunomedics Develop New Anti-HIV Drug,,,,,,,,,," 7/30/2014 62855J10 GNW  Myriad Genetics to Announce Financial Results for the Fiscal Fourth Quarter and Full Year 2014 on August 12, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/14/2012 45290710 GNW  Immunomedics to Present at 2012 Wells Fargo Securities Healthcare Conference,,,,,,,,,, 6/10/2014 007B2M-E GNW  Crescendo Bioscience to Present Multiple Studies at 2014 EULAR Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/13/2012 45290710 GNW  Immunomedics Reports Updated Results From Phase I Pretargeting Therapy Study in Colorectal Cancer,,,,,,,,,," 6/09/2014 62855J10 GNW  Myriad Announces Retirement of James Evans, Chief Financial Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/13/2012 45290710 GNW  Immunomedics Develops Potential New Treatment Regimen for Non-Hodgkin Lymphoma,,,,,,,,,, 6/03/2014 62855J10 GNW  Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,," 6/11/2012 45290710 GNW  Immunomedics Reports Development of a New Labeling Kit for Attaching Fluorine-18 to Peptides and Temperature-Sensitive Biomolecules, Including Antibodies",,,,,,,,,, 6/02/2014 62855J10 GNW  Myriad Genetics Announces Participation in Innovative Collaboration to Accelerate Hereditary Cancer Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/08/2012 45290710 GNW  Epratuzumab Results in Lupus Presented at 2012 Annual European Congress of Rheumatology,,,,,,,,,, 6/02/2014 62855J10 GNW  Myriad myPath(TM) Melanoma Test Improves the Reliability of Melanoma Diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/05/2012 45290710 GNW  Immunomedics Announces Results From 3 Clinical Trials Will be Presented at the 59th Annual Meeting of the Society of Nuclear Medicine,,,,,,,,,, 6/02/2014 62855J10 GNW  Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/04/2012 45290710 GNW  Immunomedics Reports Final Survival Data From Two-Part Pancreatic Cancer Study With Yttrium-90-Labeled Clivatuzumab Tetraxetan Combined With Gemcitabine,,,,,,,,,, 5/30/2014 62855J10 GNW  Myriad Presents Data on BRACAnalysis CDx(TM) and HRD(TM) at 2014 ASCO Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/29/2012 45290710 GNW  Immunomedics to Present at Jefferies 2012 Global Healthcare Conference,,,,,,,,,, 5/15/2014 62855J10 GNW  Myriad Strengthens Commitment to Cancer Research at the ASCO 50th Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/25/2012 45290710 GNW  Immunomedics to Present Final Results of Pancreatic Cancer Study With Clivatuzumab at 2012 Annual Meeting of the American Society of Clinical Oncology,,,,,,,,,, 5/14/2014 007B2M-E GNW  Crescendo Bioscience's Vectra(R) DA Predicts Radiographic Progression in Patients With Early Rheumatoid Arthritis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/10/2012 45290710 GNW  Immunomedics to Present at Bank of America Merrill Lynch 2012 Health Care Conference,,,,,,,,,, 5/09/2014 62855J10 GNW  Myriad Genetics to Present at the Bank of America 2014 Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/08/2012 45290710 GNW  Immunomedics Announces Third Quarter Fiscal 2012 Results and Clinical Program Developments,,,,,,,,,, 5/06/2014 62855J10 GNW  Myriad Genetics Reports Financial Results for Third Quarter of Fiscal Year 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/01/2012 45290710 GNW  Immunomedics Awarded New Patent for Pretargeted Imaging and Therapy of Cancer With Bispecific Antibody,,,,,,,,,, 5/06/2014 0B14LQ-E GNW  Myriad and UnitedHealthcare Sign Three-Year Agreement Making myRisk(TM) Hereditary Cancer Test Available to United Members,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/03/2012 45290710 GNW  Immunomedics Develops Novel Agents Targeting Renal Cell Carcinoma,,,,,,,,,, 5/01/2014 MYGN-US  GNW  Myriad to Launch EndoPredict(R) in Canada,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/02/2012 45290710 GNW  Immunomedics Develops Bispecific Hexavalent Antibodies for Diverse Epithelial Cancers,,,,,,,,,, 5/01/2014 62855J10 GNW  Myriad Genetics to Present Three Clinical Studies on Prolaris(R) at the 2014 American Urological Association Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/02/2012 45290710 GNW  Immunomedics Reports Clinical Results of Pretargeted Radioimmunotherapy of Colorectal Cancer,,,,,,,,,," 4/22/2014 62855J10 GNW  Myriad Genetics to Announce Financial Results for the Third Quarter of Fiscal Year 2014 on Tuesday, May 6, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 3/26/2012 45290710 GNW  Immunomedics to Report Progress With Novel DNL Agents Targeting Solid Tumors at Cancer Conference,,,,,,,,,, 4/07/2014 62855J10 GNW  Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 3/07/2012 45290710 GNW  Immunomedics Appoints Marcella LoCastro to Board of Directors,,,,,,,,,, 3/25/2014 62855J10 GNW  Myriad to Present Seven Clinical Studies at the Annual Clinical Genetics Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/22/2012 45290710 GNW  Immunomedics to Present at Upcoming Healthcare Conferences,,,,,,,,,, 3/24/2014 62855J10 GNW  Myriad Announces HRD Companion Diagnostic Collaboration With Tesaro,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/08/2012 45290710 GNW  Immunomedics Announces Second Quarter Fiscal 2012 Results and Clinical Program Developments,,,,,,,,,, 3/20/2014 RULE-US  GNW  Institut Pasteur and Myriad RBM Publish Initial Results From Landmark Study of Immune Response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/31/2012 45290710 GNW  Immunomedics Awarded Broad Patent for Anti-CD20 and Anti-CD22 Combination Therapy,,,,,,,,,, 3/20/2014 62855J10 GNW  SGO Updates Hereditary Cancer Recommendations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/20/2012 45290710 GNW  Immunomedics Reports Final Results From Phase Ib/II Study of Yttrium-90-Labeled Clivatuzumab Tetraxetan and Gemcitabine in Advanced Pancreatic Cancer,,,,,,,,,, 3/04/2014 62855J10 GNW  NCCN Updates Guidelines for Hereditary Colon Cancer Testing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/18/2012 45290710 GNW  Immunomedics Reports Clivatuzumab-Based Blood Test Highly Sensitive and Specific for Early-Stage Pancreatic Cancer Detection,,,,,,,,,, 3/03/2014 62855J10 GNW  Myriad Publishes Clinical Utility Study for Prolaris(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/12/2012 45290710 GNW  Immunomedics Announces Presentations at Gastrointestinal Cancers Symposium Showcasing Advances in Pancreatic Cancer Diagnosis and Therapy,,,,,,,,,, 2/18/2014 62855J10 GNW  Myriad Genetics Publishes Prolaris(R) Data in the Journal of Urology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/28/2011 45290710 GNW  Immunomedics and UCB Announce Restructuring of Epratuzumab License Agreement,,,,,,,,,," 2/07/2014 0D8SX2-E GNW  BRCA Patent Owners and Gene by Gene, Ltd. Resolve Patent Suit",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/14/2011 45290710 GNW  Immunomedics Awarded New Patent for Improved Cell Lines for Protein Therapeutic Manufacturing,,,,,,,,,, 2/04/2014 62855J10 GNW  Myriad Genetics Reports Financial Results for Second Quarter of Fiscal Year 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/13/2011 45290710 GNW  Immunomedics Announces Results From Two Clinical Trials at Hematology Conference,,,,,,,,,, 2/04/2014 62855J10 GNW  Myriad Genetics to Acquire Crescendo Bioscience(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/12/2011 45290710 GNW  Immunomedics Develops Novel Antibody-Based Therapeutics for Mantle Cell and Other Lymphomas,,,,,,,,,, 1/29/2014 62855J10 GNW  Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/12/2011 45290710 GNW  Immunomedics Reports Subcutaneous Injections of Low-Dose Veltuzumab Produced High Rates of Response in Relapsed Immune Thrombocytopenia,,,,,,,,,, 1/28/2014 62855J10 GNW  Myriad Publishes Data on Its Variant Classification Program in Clinical Genetics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/09/2011 45290710 GNW  Immunomedics Creates Targeted Therapeutics for Solid Cancers,,,,,,,,,," 1/23/2014 62855J10 GNW  Myriad Genetics to Announce Financial Results for the Second Quarter of Fiscal Year 2014 on Tuesday February 4, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/07/2011 45290710 GNW  Immunomedics Announces Outcome of 2011 Annual Meeting of Stockholders,,,,,,,,,, 1/23/2014 62855J10 GNW  Myriad Genetics to Present Five Clinical Studies at 2014 ASCO GU Cancer Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/06/2011 45290710 GNW  Immunomedics to Present at Oppenheimer 22nd Annual Healthcare Conference,,,,,,,,,, 1/07/2014 62855J10 GNW  Myriad Genetics to Present at the 32nd Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/16/2011 45290710 GNW  Immunomedics' Product Candidates to be Presented at the 2011 Annual Meeting of the American Society of Hematology,,,,,,,,,,12/14/2013 62855J10 GNW  Myriad's HRD(TM) Test Significantly Predicts Response to Cisplatin Treatment in Patients With Triple Negative Breast Cancer in Second Research Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/15/2011 45290710 GNW  Immunomedics Awarded Additional U.S. Patent for Anti-CD20 Treatment of Autoimmune Diseases,,,,,,,,,,12/12/2013 62855J10 GNW  Myriad myRisk Hereditary Cancer(TM) Test Significantly Improves Detection of Women at Risk for Hereditary Cancer by 51 Percent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/11/2011 45290710 GNW  Immunomedics Receives Thomas Alva Edison Patent Award From Research & Development Council of New Jersey,,,,,,,,,,12/09/2013 62855J10 GNW  Myriad Genetics Announces Cancer Research Collaboration With Janssen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,"11/08/2011 45290710 GNW  Epratuzumab Phase IIB Data Demonstrated Sensitivity of BICLA, a Novel BILAG-Based Composite Endpoint",,,,,,,,,,12/05/2013 62855J10 GNW  Myriad Genetics Announces Upcoming Investor Event,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/07/2011 45290710 GNW  Immunomedics to Participate in Upcoming Conferences,,,,,,,,,,12/04/2013 62855J10 GNW  Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/04/2011 45290710 GNW  Immunomedics Announces First Quarter Fiscal 2012 Results and Clinical Program Developments,,,,,,,,,,11/20/2013 MYGN-US  GNW  Myriad Genetics Announces Second HRD Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/02/2011 45290710 GNW  Immunomedics Announces FDA Allows Resumption of Clivatuzumab Tetraxetan Clinical Trial,,,,,,,,,,11/12/2013 62855J10 GNW  Myriad Genetics Launches myPath(TM) Melanoma Diagnostic Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/11/2011 45290710 GNW  Immunomedics Awarded U.S. Patent for Cytokine-Antibody Complexes,,,,,,,,,,11/08/2013 62855J10 GNW  Myriad Genetics to Present at the 2013 Credit Suisse Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/22/2011 45290710 GNW  Immunomedics Announces Partial Clinical Hold on Clivatuzumab Tetraxetan Clinical Trial,,,,,,,,,,11/05/2013 62855J10 GNW  Myriad Genetics Reports Financial Results for First Quarter of Fiscal Year 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/12/2011 45290710 GNW  Immunomedics to Present at 2011 UBS Global Life Sciences Conference,,,,,,,,,,10/29/2013 62855J10 GNW  Myriad myPlan(TM) Lung Cancer Test Launched to Leading Oncologists,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/02/2011 45290710 GNW  Immunomedics to Webcast Presentation at Stifel Nicolaus 2011 Healthcare Conference,,,,,,,,,,10/28/2013 62855J10 GNW  Myriad myPlan(TM) Lung Cancer Test Meets Primary Endpoint in Validation Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/24/2011 45290710 GNW  Immunomedics Announces Fiscal 2011 Results,,,,,,,,,,10/24/2013 62855J10 GNW  Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/09/2011 45290710 GNW  Immunomedics to Present at Wedbush Securities 2011 Life Sciences Management Access Conference,,,,,,,,,,"10/23/2013 62855J10 GNW  Myriad Genetics to Announce Fiscal First Quarter 2014 Financial Results on Tuesday November 5, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 7/19/2011 45290710 GNW  Immunomedics Awarded Additional Patent for PEGylation Method,,,,,,,,,,"10/22/2013 06JJ0P-E GNW  BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/27/2011 45290710 GNW  Immunomedics Receives Third Milestone Payment From Nycomed,,,,,,,,,,10/14/2013 62855J10 GNW  Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/16/2011 45290710 GNW  Immunomedics to Present at 2011 Wells Fargo Securities Healthcare Conference,,,,,,,,,,10/09/2013 62855J10 GNW  Myriad Genetics Study Highlights Importance of myRisk(TM) Hereditary Cancer Testing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/08/2011 45290710 GNW  Immunomedics Reports Advances With New Imaging Agent Developments for Positron Emission Tomography,,,,,,,,,,10/07/2013 62855J10 GNW  Myriad's myRisk Hereditary Cancer(TM) Test Improves Colon Cancer Testing by 60 Percent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/07/2011 45290710 GNW  Antibody-Directed Radiation Therapy Appears to Improve Response to Standard-of-Care for Aggressive Lymphoma,,,,,,,,,,10/01/2013 62855J10 GNW  Myriad Genetics and BioMarin Advance PARP Collaboration Into Phase 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/07/2011 45290710 GNW  Immunomedics Reports Final Survival Data With Yttrium-90-Labeled Clivatuzumab Tetraxetan and Low-Dose Gemcitabine in Advanced Pancreatic Cancer,,,,,,,,,, 9/25/2013 62855J10 GNW  Myriad Genetics' myPlan(TM) Lung Cancer Test Meets Primary Clinical Endpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/06/2011 45290710 GNW  Immunomedics Reports First Clinical Results of New Antibody-Directed Radiation Therapy for Colorectal Cancer,,,,,,,,,, 9/05/2013 62855J10 GNW  Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/03/2011 45290710 GNW  Immunomedics to Present at Jefferies 2011 Global Healthcare Conference,,,,,,,,,, 9/05/2013 62855J10 GNW  Myriad Genetics Launches myRisk(TM) Hereditary Cancer Panel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/02/2011 45290710 GNW  Immunomedics Announces Presentations at the 16th Congress of the European Hematology Association,,,,,,,,,, 9/04/2013 62855J10 GNW  Myriad Genetics Expands Collaboration with AstraZeneca on Olaparib Phase 3 Clinical Trials,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/31/2011 45290710 GNW  Immunomedics Announces Updates on 4 Clinical Trials Will be Provided at the Society of Nuclear Medicine's 58th Annual Meeting,,,,,,,,,, 8/13/2013 62855J10 GNW  Myriad Genetics Reports Full-Year and Fiscal Fourth-Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/10/2011 45290710 GNW  Immunomedics Announces Third Quarter Fiscal 2011 Results and Clinical Program Developments,,,,,,,,,, 7/30/2013 62855J10 GNW  Myriad Genetics Announces Date of Full-Year and Fourth-Quarter Fiscal 2013 Financial Results Conference Call,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/03/2011 45290710 GNW  Immunomedics to Present at Bank of America Merrill Lynch 2011 Health Care Conference,,,,,,,,,, 7/15/2013 62855J10 GNW  Myriad Expands Its Patient Financial Assistance Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/02/2011 45290710 GNW  Results From Single-Dose Escalation Study of Y-90-Clivatuzumab Tetraxetan in Advanced Pancreatic Cancer Published,,,,,,,,,, 6/24/2013 62855J10 GNW  Myriad and TESARO Enter Into Companion Diagnostic Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,," 4/06/2011 45290710 GNW  Immunomedics Awarded U.S. Patent for Veltuzumab, Company's Humanized Anti-CD20 Antibody in Advanced Clinical Testing",,,,,,,,,, 6/17/2013 62855J10 GNW  DaVita Labs and Myriad RBM Announce Biomarker Research Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/06/2011 45290710 GNW  Immunomedics Announces Preclinical Results of TF2 for Pretargeted Imaging of Colon Cancer,,,,,,,,,, 6/13/2013 62855J10 GNW  Supreme Court Upholds Myriad's cDNA Patent Claims,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/05/2011 45290710 GNW  Immunomedics Presents New DNL-Derived Antibodies for Mantle Cell Lymphoma at AACR Annual Meeting,,,,,,,,,, 6/03/2013 62855J10 GNW  Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/05/2011 45290710 GNW  Immunomedics Reports Progress on Development of Antibody-SN-38 Conjugates at Cancer Meeting,,,,,,,,,, 6/01/2013 62855J10 GNW  AstraZeneca Advances PARP Inhibitor Into Phase 3 Trial With BRACAnalysis(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 4/04/2011 45290710 GNW  Immunomedics Develops New DNL-Derived Antibody-Interferon Conjugate for Blood Cancer Treatment,,,,,,,,,," 5/30/2013 62855J10 GNW  Myriad Genetics to Present PROLARIS(R) Data at ASCO 2013, Continuing Its Commitment to Cancer Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 3/28/2011 45290710 GNW  Immunomedics to Report on New Antibody-SN-38 Conjugates and Diverse Novel DNL Agents at AACR 102nd Annual Meeting,,,,,,,,,, 5/14/2013 62855J10 GNW  Myriad Genetics to Present at the Bank of America Merrill Lynch Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 3/24/2011 45290710 GNW  Immunomedics Awarded Three US Patents Covering Its Cancer Therapeutic Product Candidates and Technologies,,,,,,,,,, 5/07/2013 62855J10 GNW  Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 3/09/2011 45290710 GNW  Immunomedics Awarded Two Additional U.S. Patents for Dock-and-Lock Technology,,,,,,,,,, 5/02/2013 62855J10 GNW  Myriad Genetics Announces 2013 Analyst and Investor Day,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/25/2011 45290710 GNW  Immunomedics Announces Presentations at Upcoming Healthcare Conferences,,,,,,,,,, 5/02/2013 62855J10 GNW  Myriad to Present New Molecular Data for Patients With Prostate Cancer at the American Urological Association 2013 Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 2/04/2011 45290710 GNW  Immunomedics Announces Second Quarter Fiscal 2011 Results and Clinical Program Developments,,,,,,,,,," 4/18/2013 62855J10 GNW  Myriad Genetics to Announce Third Fiscal Quarter 2013 Results on Tuesday, May 7, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/24/2011 45290710 GNW  Immunomedics Reports First Experimental Studies Combining Antibody-Drug Conjugate With Antibody-Directed Radiation Therapy for Pancreatic Cancer,,,,,,,,,, 4/17/2013 62855J10 GNW  Myriad Adopts RainDance's Thunderstorm Platform for Next-Generation Sequencing Based Hereditary Cancer Panel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 1/21/2011 45290710 GNW  Immunomedics Reports Targeted Therapy for Advanced Pancreatic Cancer Improves Survival,,,,,,,,,, 3/26/2013 62855J10 GNW  Myriad and PharmaMar Announce First Commercial Partnership With Myriad's New HRD Test,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/22/2010 45290710 GNW  New Candidate Antibody-Drug Conjugate Gains Broad Patent Coverage,,,,,,,,,, 3/06/2013 62855J10 GNW  BRCA Testing Granted Preventive Care Designation Under the Affordable Care Act,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/14/2010 45290710 GNW  UCB Announces Start of Phase III Program With Epratuzumab for Patients With Moderate to Severe Systemic Lupus Erythematosus,,,,,,,,,, 3/05/2013 62855J10 GNW  Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/07/2010 45290710 GNW  Immunomedics Develops New Antibody-Drug Conjugate for Hematologic Cancer Therapy,,,,,,,,,, 3/01/2013 62855J10 GNW  Noridian Prices Molecular Pathology Codes; Myriad Confirms Guidance for Fiscal 2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/06/2010 45290710 GNW  Results From Phase II Trial of Epratuzumab and Rituximab as Initial Treatment for Follicular Lymphoma Reported in an Oral Presentation at ASH,,,,,,,,,, 2/05/2013 62855J10 GNW  Myriad Genetics Reports Second Quarter Fiscal Year 2013 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/06/2010 45290710 GNW  First Results From Phase II Study of Fractionated Radioimmunotherapy With Y-90 Epratuzumab in Aggressive Lymphoma Presented at Hematology Conference,,,,,,,,,," 1/15/2013 62855J10 GNW  Myriad Genetics to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/05/2010 45290710 GNW  Immunomedics Reports Progress With Milatuzumab at 52nd ASH Annual Meeting,,,,,,,,,,12/17/2012 62855J10 GNW  Myriad Genetics to Present at the 2013 J.P. Morgan Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,12/01/2010 45290710 GNW  Immunomedics Announces Outcome of 2010 Annual Meeting of Stockholders,,,,,,,,,,12/10/2012 09WBJY-E GNW  Myriad Announces Diabetes Collaboration With Sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/11/2010 45290710 GNW  Immunomedics' Product Candidates to be Presented at the 52nd ASH Annual Meeting,,,,,,,,,,12/07/2012 62855J10 GNW  Myriad Genetics' HRD Test Predicts Response to Platinum Therapy in Triple-Negative Breast Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/09/2010 45290710 GNW  Epratuzumab Phase IIB Data Presented at ACR Show,,,,,,,,,,11/30/2012 62855J10 GNW  Supreme Court of the United States to Hear Isolated DNA Patent Case,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/04/2010 45290710 GNW  Immunomedics Announces First Quarter Fiscal 2011 Results and Clinical Program Developments,,,,,,,,,,11/28/2012 62855J10 GNW  Myriad Genetics' Prolaris Test Predicts Biochemical Recurrence in Prostate Cancer Patients Following Radiation Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,11/02/2010 45290710 GNW  Immunomedics Awarded 12 Qualifying Therapeutic Discovery Project Grants,,,,,,,,,,11/15/2012 62855J10 GNW  Myriad Genetics to Present at the Piper Jaffray Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/28/2010 45290710 GNW  Immunomedics to Present at Upcoming Healthcare Conferences,,,,,,,,,,11/05/2012 62855J10 GNW  Myriad Genetics Reports First Quarter Fiscal Year 2013 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/12/2010 45290710 GNW  Immunomedics Awarded Additional U.S. Patent for Antibody Therapy of Autoimmune Diseases,,,,,,,,,,11/01/2012 62855J10 GNW  Myriad Genetics to Present at the 2012 Credit Suisse Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,10/08/2010 45290710 GNW  Immunomedics to Webcast October 15th R&D Day,,,,,,,,,,"10/15/2012 62855J10 GNW  Myriad Genetics to Announce First Fiscal Quarter 2013 Results on Monday, November 5, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 9/15/2010 45290710 GNW  Immunomedics to Present at 2010 UBS Global Life Sciences Conference,,,,,,,,,,10/10/2012 62855J10 GNW  Myriad's HRD Score Detects Loss of DNA Repair Function in Ovarian Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/26/2010 45290710 GNW  Immunomedics Announces Fiscal 2010 Results,,,,,,,,,,10/03/2012 62855J10 GNW  Myriad Genetics Sponsors Cancer Awareness Initiatives in Support of National Hereditary Breast and Ovarian Cancer Week,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/18/2010 45290710 GNW  Immunomedics and GE Healthcare in Research Collaboration,,,,,,,,,, 9/24/2012 62855J10 GNW  Noridian Notifies Myriad of Initial Draft Decision to Classify Prolaris(R) as a Non-Covered Service,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 8/10/2010 45290710 GNW  Immunomedics Awarded Additional U.S. Patent for Internalizing anti-CD74 Antibodies and Methods of Use,,,,,,,,,, 8/30/2012 62855J10 GNW  Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/25/2010 45290710 GNW  Epratuzumab Data From Phase IIB EMBLEM(TM) Study Presented at 9th International Congress on Systemic Lupus Erythematosis,,,,,,,,,, 8/16/2012 62855J10 GNW  U.S Court of Appeals Upholds Myriad's Gene Patents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/21/2010 45290710 GNW  Results From Randomized Study of Epratuzumab in Patients With Systemic Lupus Erythematosus Presented at European Rheumatology Congress,,,,,,,,,, 8/14/2012 62855J10 GNW  Myriad Genetics Reports Fourth Quarter and Fiscal Year 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/16/2010 45290710 GNW  New Data From EMBLEM(TM) Study Show Pipeline Drug Epratuzumab Provided Significant Efficacy for Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus,,,,,,,,,, 7/26/2012 62855J10 GNW  Myriad Genetics and Pharma Mar Enter Into Companion Diagnostic Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/15/2010 45290710 GNW  Immunomedics Doses First Patient in Phase I/II Study of Milatuzumab-Doxorubicin Conjugate for Multiple Myeloma Therapy,,,,,,,,,," 7/24/2012 62855J10 GNW  Myriad Genetics to Announce Fiscal Fourth Quarter and Fiscal Year 2012 Results on Tuesday, August 14, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/09/2010 45290710 GNW  Immunomedics Announces Preclinical Results of Pretargeted Imaging and Therapy of Cancer,,,,,,,,,, 7/09/2012 MYGN-US  GNW  Peter Meldrum Joins the Endocyte Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/09/2010 45290710 GNW  Immunomedics Presents New Antibody for Pretargeting Epithelial Cancers at Medical Conference,,,,,,,,,, 6/06/2012 62855J10 GNW  Myriad Genetics Receives the Charles R. Smart Visionary Award From the American Cancer Society(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/08/2010 45290710 GNW  Immunomedics Reports First Clinical Experience With New Generation of Bispecific Antibody,,,,,,,,,, 6/04/2012 62855J10 GNW  Myriad's Lung Cancer Prognosis Test Shown to Significantly Predict Survival in Early Stage Lung Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/07/2010 45290710 GNW  Immunomedics Reports Updated Results of Targeted Therapy for Advanced Pancreatic Cancer,,,,,,,,,, 5/22/2012 62855J10 GNW  Myriad Genetics to Present at Upcoming Investor Conferences in June,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/04/2010 45290710 GNW  Immunomedics to Present at Upcoming Investor Conferences,,,,,,,,,, 5/16/2012 62855J10 GNW  Myriad Genetics Announces Presentation of Lung Cancer Study at American Society for Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 6/01/2010 45290710 GNW  Immunomedics to Report Progress on Cancer Imaging and Therapy in 9 Presentations at the Society of Nuclear Medicine's 57th Annual Meeting,,,,,,,,,, 5/02/2012 62855J10 GNW  Myriad Genetics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/25/2010 45290710 GNW  Immunomedics Receives Second Milestone Payment From Nycomed,,,,,,,,,, 5/01/2012 62855J10 GNW  Myriad Genetics Reports Record Third Fiscal Quarter 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/13/2010 45290710 GNW  Results From Randomized Study of Epratuzumab in Patients With Lupus to be Presented at European Rheumatology Congress,,,,,,,,,," 4/10/2012 62855J10 GNW  Myriad Genetics to Announce Fiscal 2012 Third Quarter Results on Tuesday, May 1, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/10/2010 45290710 GNW  Immunomedics Announces Third Quarter Fiscal 2010 Results and Clinical Program Developments,,,,,,,,,, 3/29/2012 62855J10 GNW  Myriad Study Finds High Prevalence of Mutations in the PMS2 Gene,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,, 5/10/2010 45290710 GNW  BioPharma Stock Alert for Immunomedics Inc. Issued by MicroStockProfit,,,,,,,,,, 3/28/2012 62855J10 GNW  Myriad and Cephalon Enter Into Companion Diagnostic Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 3/26/2012 62855J10 GNW  Supreme Court of the United States Remands Gene Patenting Case,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 2/27/2012 62855J10 GNW  Prolaris(R) Test Awarded Best Poster Honor at 27th Annual EAU Congress in Paris, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 2/24/2012 62855J10 GNW  Myriad's Prolaris(R) Test Shown to Significantly Predict Prostate Cancer Outcome in Needle Biopsy Tissue,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 2/22/2012 62855J10 GNW  Myriad Genetics to Present at the Cowen and Company 32nd Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 2/06/2012 62855J10 GNW  Myriad Genetics to Present at the Leerink Swann 2012 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 2/02/2012 62855J10 GNW  Myriad's Prolaris(R) Test Shown to Significantly Predict Biochemical Recurrence Risk After Prostatectomy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 1/31/2012 62855J10 GNW  Myriad Genetics Reports Second Quarter Fiscal Year 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 1/18/2012 62855J10 GNW  Myriad Genetics Acquires Exclusive Rights to RAD51C Gene,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 1/17/2012 62855J10 GNW  Myriad Genetics to Announce Fiscal 2012 Second Quarter Results on Tuesday, January 31, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 1/09/2012 MYRX-US  GNW  Sera Prognostics Appoints Jay Boniface, Ph.D., Vice President of Research & Development",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,12/28/2011 62855J10 GNW  Myriad Genetics to Present at the 30th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,12/09/2011 62855J10 GNW  Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,12/01/2011 62855J10 GNW  Myriad Genetics to Present at the 22nd Annual Oppenheimer Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,11/21/2011 62855J10 GNW  Myriad Genetics to Attend the 23rd Annual Piper Jaffray Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,11/01/2011 62855J10 GNW  Myriad Genetics Reports First Quarter Fiscal Year 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,"10/11/2011 62855J10 GNW  Myriad Genetics to Announce Fiscal 2012 First Quarter Results on Tuesday, November 1, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 9/08/2011 007B2M-E GNW  Myriad Genetics Makes Strategic Debt Investment With Exclusive Option to Acquire Crescendo Bioscience,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 9/08/2011 MYGN-US  GNW  Crescendo Bioscience(R) Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/30/2011 62855J10 GNW  Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/15/2011 62855J10 GNW  Myriad Announces New $200 Million Share Repurchase Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/09/2011 62855J10 GNW  Myriad Genetics Reports Fourth Quarter and Fiscal Year 2011 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 7/29/2011 62855J10 GNW  Myriad Applauds the Court of Appeals' Decision to Uphold Gene Patenting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 7/26/2011 06453N-E GNW  Advanced Clinical Concepts Reinforces Its Growth Trend: Selects R. Steven Lang as Senior Vice President, Client Services",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 7/19/2011 62855J10 GNW  Myriad Genetics to Announce Fiscal Fourth Quarter and Fiscal Year 2011 Results on Tuesday, August 9, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 6/09/2011 62855J10 GNW  OnDose(R) Study Demonstrates Need for Improved Dosing Approach for Colorectal Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 6/06/2011 62855J10 GNW  Myriad's PROLARIS(R) Test Shown to Significantly Predict Prostate Cancer Outcome From Needle Biopsy Tissue,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2011 62855J10 GNW  Myriad Genetics Completes Acquisition of Rules-Based Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 5/26/2011 MYGN-US  GNW  Topin & Associates Has Been Selected by Myriad Genetics, Inc., to Market OnDose(R) Dose Optimization Technology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/24/2011 62855J10 GNW  Myriad Genetics to Present at the Jefferies Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/18/2011 62855J10 GNW  Myriad Genetics Announces Presentation of Prostate Cancer Study at American Society for Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/10/2011 62855J10 GNW  Myriad Genetics Licenses Novel Technology From Chronix Biomedical,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/03/2011 62855J10 GNW  Myriad Genetics Reports Fiscal 2011 Third Quarter Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 4/27/2011 62855J10 GNW  Myriad Genetics Announces Agreement to Acquire Rules-Based Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 4/06/2011 62855J10 GNW  Myriad Genetics and BioMarin Pharmaceutical Inc. Enter Into Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 4/05/2011 62855J10 GNW  Myriad Genetics to Announce Fiscal Third Quarter Financial Results on Tuesday, May 3, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2011 62855J10 GNW  Myriad Announces New $100 Million Share Repurchase Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 2/16/2011 62855J10 GNW  Myriad Genetics to Present at the Citi Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 2/09/2011 62855J10 GNW  Myriad's PROLARIS(TM) Test Shown to Significantly Predict Prostate Cancer Outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 1/27/2011 62855J10 GNW  Myriad Genetics Reports Fiscal 2011 Second Quarter Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 1/10/2011 62855J10 GNW  Myriad Genetics to Report Fiscal 2011 Second Quarter Financial Results on January 27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,12/22/2010 62855J10 GNW  Myriad Genetics to Present at the 29th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,"12/20/2010 62855J10 GNW  Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,12/14/2010 62855J10 GNW  Newly Published Study Finds High Prevalence of BRCA Mutations in Breast Carcinoma in Situ (CIS),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,12/08/2010 62855J10 GNW  Myriad Acquires Novel Technology From Melanoma Diagnostics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,11/29/2010 62855J10 GNW  Myriad Genetics Applauds Major Health Economic Study That Supports Broad Application of Genetic Testing for Hereditary Colon Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,11/04/2010 62855J10 GNW  Myriad Genetics to Present at The Lazard Capital Markets 7th Annual Healthcare Conference and The Stephens Fall Investment Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,11/02/2010 62855J10 GNW  Myriad Genetics Reports Fiscal 2011 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,10/26/2010 62855J10 GNW  Myriad and Abbott Enter Into Cooperative Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,10/21/2010 62855J10 GNW  Myriad Genetics to Present at Morningstar's 5th Annual Stocks Forum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,10/14/2010 62855J10 GNW  Myriad Genetics to Present Prostate Cancer Data at the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,10/12/2010 62855J10 GNW  Myriad Genetics to Report Fiscal 2011 First Quarter Financial Results on November 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,10/11/2010 62855J10 GNW  Myriad Genetics' PROLARIS Test Accurately Predicts Survival With Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,10/04/2010 62855J10 GNW  Study Reveals High Prevalence of BRCA Mutations in Women With Triple Negative Breast Cancer (TNBC),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 9/09/2010 MYGN-US  GNW  Myrexis Reports Fiscal Year 2010 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2010 62855J10 GNW  Myriad Genetics to Present at the UBS Global Life Sciences Conference and the Fifth Annual JMP Securities Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2010 62855J10 GNW  Myriad Announces Additional Stock Repurchase Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/24/2010 62855J10 GNW  Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference and the Stifel Nicolaus Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/10/2010 62855J10 GNW  Myriad Genetics Reports Fiscal 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 8/03/2010 62855J10 GNW  Myriad Genetics Establishes Charitable Program to Give Back to Salt Lake Community,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 7/20/2010 62855J10 GNW  Myriad Genetics to Report Fiscal 2010 Fourth Quarter and Year-End Financial Results on August 10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 7/08/2010 62855J10 GNW  Myriad Genetics Announces New Executive Vice President of International Operations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 6/30/2010 MYRX-US  GNW  Myriad Pharmaceuticals Formally Adopts Its Name Change to Myrexis, Inc. Effective July 1, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 6/10/2010 62855J10 GNW  Myriad Genetics Elects Former Roche Molecular Systems CEO Heiner Dreismann to Its Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2010 62855J10 GNW  Myriad Genetics to Present at the Goldman Sachs 31st Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2010 62855J10 GNW  Myriad Genetics to Present at the William Blair & Company 30th Annual Growth Stock Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/26/2010 62855J10 GNW  Myriad Genetics to Present at the GARP Research and Securities Company Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/13/2010 62855J10 GNW  Myriad Genetics to Present at the Citi 2010 Global Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/04/2010 62855J10 GNW  Myriad Announces Stock Repurchase Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 5/04/2010 62855J10 GNW  Myriad Genetics Reports Financial Results for Fiscal 2010 Third Quarter,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,, 4/28/2010 62855J10 GNW  Myriad Genetics to Present at the Ninth Annual JMP Securities Research Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,," 4/27/2010 62855J10 GNW  Myriad Genetics Announces New, Convenient OnDose(TM) Sampling Kit",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
